Citrus Sinensis ID: 012684

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------46
Protein Sequence
METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSSPSSRSKSSCSTSSI
Secondary Structure (PSIPRED)
ccccccccEEEEEcccccccccHHHHHHcccccccccccHHHHHHHHHHcccHHHHHHHHHccccccccccccccHHHHHHHcccHHHHHHHHHcccccccccccccccHHHHHHcccHHHHHHHHHHccccccccccccccccccccEEccccccEEcEEEEEEEEEEEEEEccEEEEEEEEcccccccHHHHHHHHHHHHHHHHcccccEEEEEEEEEccccEEEEEEEcccccHHHHHHccccccHHHHHHHHHHHHHHHHHHHccccccEEEcccccccEEEcccccEEEEccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHcccccccccccHHHHHHHHcccccccccccccHHHHHHHHHHHccccccccccHHHHHHHHHHHHHHHcccccccHHcccccHHHHHHHHccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccEEEHHHHHHHccHHHHHHHHHccccccccccccccHHHHHHHcccHHHHHHHHHccccccccccccccHHHHHHHcccHHHHHHHHHccccccccccccccHHHHHHHcccHHHHHHHHHcccccccccccccccccccHHHHcHHHcccccccccccccccEEEcccEEEEEEEcccccccccccHHHHHHHHHHHHHHHcHcHHHEEEEEEcccccEEEEccccccEHHHHHcccccccHHHHHHHHHHHHHHHHHHHccccccEEcccccHHHEEEcccccEEEccccccEEccccccEccccEEcccccccHHHHHcccccccHHHHHHHHHHHHHHccccccccccHHHHHHHHHHcccccccccccccHHHHHHHHHHHHcccHHHcccHHHHHHHHHccccccccccccccEcccccccccccccccccccccccccEcccccc
Coil and Loop (DISEMBL)
metkvpvrttllkqsslapdreRKEAElngldddgeeikpEFRLMFLANERDVEGIKELLDSgidvnfrdidNRTALHVAACQGFTEVVSLLLErgadvdpkdrwgstplgdaiyYKNHEVIKLLEKhgakplmapmhvkharevpeyeidpheldftnsveiTKGTFILAFWRGIQVAVKKLgeevisdddRVRAFRDELALLQKIRHPNVVQFLGavtqsspmmivteylpkgDLRAFLKrkgalkpstAVRFALDIARgmnylhenkpvpiihrdlepsnilrddsgnlkvadfgvsklltvkedrpltcqdtscryvapevfkneeydtkvDVFSFALILQEMIegcppftmkhdnevpkayaarqrppfkapAKLYARGLKELIEECwnekpakrptFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMlkkdhsspssrsksscstssi
Flexible Loop (DISEMBL)
metkvpvrttllkqsslapdrerkeaelngldddgeeiKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLergadvdpkdrwgstplgdaiYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLgeevisdddrVRAFRDELAllqkirhpnvVQFLgavtqsspmMIVTEYLPKGDLRAFLKrkgalkpstAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSklltvkedrpltcqdtscryvapevfkneeydtkVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYaarqrppfkaPAKLYARGLKELIEecwnekpakrptfrQIITRlesinnsinhkrrwKIRTMKCFHNLEAmlkkdhsspssrsksscstssi
Low Complexity Region (SEG)
METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDHsspssrsksscstssI
Disordered region (IsUnstruct)
****************************************EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD******Y*******FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEA**********************
Disordered Region (DISOPRED)
******V********************************PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG*AIYYKNHEVIKLLE********************EYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV*****LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN*******************************************
Disordered Region (DISEMBL)
METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAML********************
Disordered Region (DISPRO)
*****PVRT***KQSSLAPDRERKEA****LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP*MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRT*******************************
Transmembrane Helix (TMHMM)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
oooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSSPSSRSKSSCSTSSI
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	458	2.2.26 [Sep-21-2011]
Q54H46	642	Probable serine/threonine	yes	no	0.548	0.390	0.367	2e-39
P18160	2410	Dual specificity protein	no	no	0.556	0.105	0.372	2e-38
Q2MHE4	390	Serine/threonine-protein	no	no	0.519	0.610	0.375	4e-38
Q54H45	690	Probable serine/threonine	no	no	0.543	0.360	0.369	4e-38
Q7T6Y2	1624	Putative serine/threonine	N/A	no	0.530	0.149	0.354	1e-37
Q7T6X2	1657	Putative serine/threonine	N/A	no	0.521	0.144	0.337	2e-37
Q54TA1	749	Probable serine/threonine	no	no	0.513	0.313	0.361	7e-37
Q54IP4	653	Dual specificity protein	no	no	0.554	0.388	0.338	9e-37
Q54TM7	1288	Probable serine/threonine	no	no	0.526	0.187	0.377	1e-36
Q5UQG7	1651	Putative serine/threonine	N/A	no	0.508	0.141	0.354	1e-36

>sp|Q54H46|DRKA_DICDI Probable serine/threonine-protein kinase drkA OS=Dictyostelium discoideum GN=drkA PE=3 SV=1

 Score =  163 bits (413), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 103/280 (36%), Positives = 157/280 (56%), Gaps = 29/280 (10%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           +ID H++     V I KG +    L  WRG QVAVKKL    I +++ ++ F  E+ L++
Sbjct: 368 DIDIHQIKI--GVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNI-NENILKEFHREINLMK 424

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMN 264
            +RHPNV+QFLG+      + I TEY+P+G L + L  +   L+ S  ++  +D A+G+ 
Sbjct: 425 NLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVI 484

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
           YLH + PV I+HRDL+  N+L D++  +KVADFG+S +   ++   +T   T C + +PE
Sbjct: 485 YLHNSTPV-ILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPC-WTSPE 540

Query: 325 VFKNEEYDTKVDVFSFALILQEMIE------GCPPFTMKHDNEVPKAYAARQRPPF--KA 376
           V +++ Y  K DV+SF +IL E         G PPF +     +        RPP     
Sbjct: 541 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQV-----IFAVGREGMRPPVPQNG 595

Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
           P K       +L+ +C NE P+ RPT  Q + RLESI++S
Sbjct: 596 PPKYI-----QLLIDCLNENPSHRPTMEQCLERLESIDSS 630

Dictyostelium discoideum (taxid: 44689)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1

>sp|P18160|SPLA_DICDI Dual specificity protein kinase splA OS=Dictyostelium discoideum GN=splA PE=1 SV=3

 Score =  160 bits (406), Expect = 2e-38,   Method: Composition-based stats.
 Identities = 111/298 (37%), Positives = 154/298 (51%), Gaps = 43/298 (14%)

Query: 147  EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
            EYEID +EL+F  +  I KG F      +WR   VA+K +  +       +  F++E+ +
Sbjct: 2107 EYEIDFNELEFGQT--IGKGFFGEVKRGYWRETDVAIKIIYRDQFKTKSSLVMFQNEVGI 2164

Query: 204  LQKIRHPNVVQFLGAVTQSSP--MMIVTEYLPKGDLRAFLKRKGAL---KPSTAVRFALD 258
            L K+RHPNVVQFLGA T        IVTE++  G LR FL     L    P   ++ ALD
Sbjct: 2165 LSKLRHPNVVQFLGACTAGGEDHHCIVTEWMGGGSLRQFLTDHFNLLEQNPHIRLKLALD 2224

Query: 259  IARGMNYLHENKPVPIIHRDLEPSNILRD---DSGN----------LKVADFGVSKLLTV 305
            IA+GMNYLH   P PI+HRDL   NIL D   D  N           K++DFG+S+L   
Sbjct: 2225 IAKGMNYLHGWTP-PILHRDLSSRNILLDHNIDPKNPVVSSRQDIKCKISDFGLSRLKM- 2282

Query: 306  KEDRPLTCQDTSC-RYVAPEVFKNEEYDTKVDVFSFALILQEMI------EGCPPFTMKH 358
             E      Q   C  Y+APEVFK +    K DV+S+ ++L E++      +   P  M H
Sbjct: 2283 -EQASQMTQSVGCIPYMAPEVFKGDSNSEKSDVYSYGMVLFELLTSDEPQQDMKPMKMAH 2341

Query: 359  DNEVPKAYAARQRP-PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
                  AY + + P P    +K      KE++ +CW+  P  RPTF+QII  L+ + +
Sbjct: 2342 ----LAAYESYRPPIPLTTSSK-----WKEILTQCWDSNPDSRPTFKQIIVHLKEMED 2390

Essential for spore differentiation.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 0

EC: .

EC: 2

>sp|Q2MHE4|HT1_ARATH Serine/threonine-protein kinase HT1 OS=Arabidopsis thaliana GN=HT1 PE=1 SV=1

 Score =  159 bits (402), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 96/256 (37%), Positives = 143/256 (55%), Gaps = 18/256 (7%)

Query: 172 FWRGI----QVAVKKLGEEVISDDDRVR---AFRDELALLQKIRHPNVVQFLGAVTQSSP 224
            +RGI     VAVK +      ++ R +    F+ E+ALL ++ HPN+VQF+ A  +   
Sbjct: 100 IYRGIYKQRAVAVKMVRIPTHKEETRAKLEQQFKSEVALLSRLFHPNIVQFIAACKKPPV 159

Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
             I+TEY+ +G+LR +L +K   +L   T +R ALDI+RGM YLH      +IHRDL+ +
Sbjct: 160 YCIITEYMSQGNLRMYLNKKEPYSLSIETVLRLALDISRGMEYLHSQG---VIHRDLKSN 216

Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
           N+L +D   +KVADFG S L T  + R       + R++APE+ K + Y  KVDV+SF +
Sbjct: 217 NLLLNDEMRVKVADFGTSCLET--QCREAKGNMGTYRWMAPEMIKEKPYTRKVDVYSFGI 274

Query: 343 ILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           +L E+     PF      +   A A + +RPP  A  +     L  LI+ CW+E P+KRP
Sbjct: 275 VLWELTTALLPFQGMTPVQAAFAVAEKNERPPLPASCQ---PALAHLIKRCWSENPSKRP 331

Query: 402 TFRQIITRLESINNSI 417
            F  I+  LE  +  +
Sbjct: 332 DFSNIVAVLEKYDECV 347

Serine/threonine kinase involved in the control of stomatal movement in response to CO(2). Shows a reduced response to ABA or light compared to CO(2).

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54H45|DRKB_DICDI Probable serine/threonine-protein kinase drkB OS=Dictyostelium discoideum GN=drkB PE=3 SV=1

 Score =  159 bits (402), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 102/276 (36%), Positives = 152/276 (55%), Gaps = 27/276 (9%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           +ID  ++     V I KG F    L  WRG QVAVKKL    I +++ ++ F  E+ L++
Sbjct: 385 DIDTQQIKI--GVRIGKGNFGEVYLGTWRGSQVAVKKLPAHNI-NENILKEFHREINLMK 441

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMN 264
            +RHPNV+QFLG+   S  + I TEY+P+G L + L   K  +  S   R  +D A+G+ 
Sbjct: 442 NLRHPNVIQFLGSCLISPDICICTEYMPRGSLYSILHNEKIKISWSLVKRMMIDAAKGII 501

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
           YLH + PV I+HRDL+  N+L D++  +KVADFG+S +   ++   +T   T C + +PE
Sbjct: 502 YLHGSTPV-ILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPC-WTSPE 557

Query: 325 VFKNEEYDTKVDVFSFALILQEMIE------GCPPFTMKHDNEVPKAYAARQRPPFKAPA 378
           V +++ Y  K DV+SF +IL E         G PPF         +   A  R   + P 
Sbjct: 558 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPF---------QVIFAVGREGMRPPT 608

Query: 379 KLYA-RGLKELIEECWNEKPAKRPTFRQIITRLESI 413
             Y      +L+++C NE P++RPT  Q +  LESI
Sbjct: 609 PKYGPPKYIQLLKDCLNENPSQRPTMEQCLEILESI 644

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6Y2|YR831_MIMIV Putative serine/threonine-protein kinase/receptor R831 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R831 PE=4 SV=2

 Score =  157 bits (397), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 96/271 (35%), Positives = 154/271 (56%), Gaps = 28/271 (10%)

Query: 162  EITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
            +I  G++ + F   W+G+ VAVKK  ++ +S+  ++  FR E+A L +++H N+V F+GA
Sbjct: 1369 QIGLGSYGIVFNGKWKGVDVAVKKFVKQKLSET-QLLEFRAEMAFLSELKHSNIVTFIGA 1427

Query: 219  VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA------LDIARGMNYLHENKPV 272
              +   + IVTEY+  G+LR  LK      P   + FA         A G++YLH + P+
Sbjct: 1428 CIKKPNICIVTEYMRMGNLRDVLKN-----PDIKITFANKLKLLYGAAMGIDYLHSSNPM 1482

Query: 273  PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEY 331
             I+HRD++P+NIL D+  N+K+ADFG ++   +KED   +T   T C + APEV + E+Y
Sbjct: 1483 -IVHRDIKPANILVDEHFNVKIADFGFAR---IKEDNTTMTRCGTPC-WTAPEVIRGEKY 1537

Query: 332  DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP--PFKAPAKLYARGLKELI 389
              K DVFSF +++ E++ G  PF   +  +V        RP  P   P +       +LI
Sbjct: 1538 CEKADVFSFGVVMWEVLTGKEPFAECNFMKVSLDILEGGRPIIPSDCPHE-----FAKLI 1592

Query: 390  EECWNEKPAKRPTFRQIITRLESINNSINHK 420
            ++CW+ K  KRPT  +++ +L  I    +HK
Sbjct: 1593 KKCWHAKAHKRPTMTEVVQQLMLITEQFDHK 1623

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q7T6X2|YR826_MIMIV Putative serine/threonine-protein kinase/receptor R826 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R826 PE=4 SV=2

 Score =  157 bits (396), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 86/255 (33%), Positives = 151/255 (59%), Gaps = 16/255 (6%)

Query: 162  EITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
            +I  G++ + +   W+ + VA+KK  ++ I D++ +   R+E+A L+K+ HPN++  +GA
Sbjct: 1404 QIGLGSYGVVYRGKWKNVDVAIKKFIKQKI-DENHLLGIREEIAFLKKLHHPNIITMVGA 1462

Query: 219  VTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
              +   + IVTEY+ KG+LR  ++     L+    ++  ++IA+G++YLH   P PIIHR
Sbjct: 1463 SLKKPNICIVTEYMAKGNLRDAMRTCTPKLEWHQKIKILVNIAKGISYLHSFDP-PIIHR 1521

Query: 278  DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 337
            D++PSNIL D++ N+K+ADFG ++   +KE+  +  +  +  + APE+ +N+ YD KVDV
Sbjct: 1522 DIKPSNILIDENWNVKIADFGFAR---IKEENAIMTRCGTPCWTAPEIIRNDIYDEKVDV 1578

Query: 338  FSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP--PFKAPAKLYARGLKELIEECWNE 395
            FSF +++ E++    PF   +  ++        RP  P   P +       +L+ +CW+ 
Sbjct: 1579 FSFGIVMWEVLTCKEPFIGANFMKITMDILEDVRPKIPQDCPEE-----FAKLMRKCWHA 1633

Query: 396  KPAKRPTFRQIITRL 410
            K  KRPT   +I  L
Sbjct: 1634 KSTKRPTMDDVIIVL 1648

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TA1|DRKC_DICDI Probable serine/threonine-protein kinase drkC OS=Dictyostelium discoideum GN=drkC PE=3 SV=1

 Score =  155 bits (392), Expect = 7e-37,   Method: Compositional matrix adjust.
 Identities = 95/263 (36%), Positives = 144/263 (54%), Gaps = 28/263 (10%)

Query: 162 EITKGTFILAFWRGIQVAVKK---LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
           E+  GT     WRGI VA+KK   L E+   D+D +     E  ++ ++RHPN+ QFLG 
Sbjct: 504 EVFTGT-----WRGIIVAIKKAKLLNED---DEDFLNELAQEATIMSQLRHPNICQFLGT 555

Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF------ALDIARGMNYLHENKPV 272
                 ++IV EY+P G L   L       PS ++ +      ALDIA+GMNYLH   P+
Sbjct: 556 CNNPPEILIVMEYMPLGSLYRILH-----DPSISLDWPRMKSMALDIAKGMNYLHCCDPI 610

Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEE 330
            +IHRDL+  N+L D+   +K++DFG+S       D+   +T   T C + APEV +N+ 
Sbjct: 611 -VIHRDLKSHNLLVDEHYRVKISDFGLSTRFKKHLDKKTAMTPVGTPC-WTAPEVLRNDP 668

Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
           Y  K DVFSFA++L E++    P+      ++  +    +  P   P    +     LI 
Sbjct: 669 YTEKADVFSFAIVLWEIVTREDPYQGMPTFQIVISVGQHKLRPIVPPQ--VSAPFTRLIT 726

Query: 391 ECWNEKPAKRPTFRQIITRLESI 413
           ECW+E P +RP+F++I+ RLE++
Sbjct: 727 ECWSEDPQQRPSFQEIVKRLEAM 749

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54IP4|SHKB_DICDI Dual specificity protein kinase shkB OS=Dictyostelium discoideum GN=shkB PE=3 SV=1

 Score =  155 bits (391), Expect = 9e-37,   Method: Compositional matrix adjust.
 Identities = 93/275 (33%), Positives = 155/275 (56%), Gaps = 21/275 (7%)

Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+  +EID +E+ +    ++  G F   +    RG +VA+KKL + V  +++ +  F+ E
Sbjct: 161 EIIRWEIDRNEISYNREAKLGSGAFGSVYKGIVRGKEVAIKKLTQTVF-EENTMNEFKKE 219

Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
           ++L+ K+R+P+++ F+GA T    + IVTE +PKG + + L+ K         + A+ IA
Sbjct: 220 VSLMAKLRNPHLLLFMGACTAPEDLSIVTELMPKGSVHSLLRAKEDTSDFITFKRAILIA 279

Query: 261 R----GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
           R    GM +LH +    I+H DL+P+N+L D +  +KVADFG+SK +       L  Q  
Sbjct: 280 RDTVLGMTWLHASN---ILHLDLKPANLLVDQNWVVKVADFGLSKYMKPDSKDKLLGQAG 336

Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---VPKAYAARQRP- 372
           S  Y+APE+  N+ YD KVDVFSF+++L E++    P+   + +    V      + RP 
Sbjct: 337 SPLYMAPEMLVNQPYDGKVDVFSFSILLWELLTKQEPYNKLYSSYPQLVEGVVNKKNRPI 396

Query: 373 -PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
            P   P +     LK+L+  CW+  P++RP+F +I
Sbjct: 397 IPDYFPTR-----LKDLLARCWDHYPSRRPSFAEI 426

Required for proper chemotaxis and phagocytosis; proper spatiotemporal control of F-actin levels in chemotaxing cells. Negative regulator of the PI3K (phosphatidylinositol 3 kinase) pathway. Predominantly phosphorylates serines and threonines and tyrosines at a lower level.

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q54TM7|DRKD_DICDI Probable serine/threonine-protein kinase drkD OS=Dictyostelium discoideum GN=drkD PE=2 SV=1

 Score =  154 bits (389), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 97/257 (37%), Positives = 137/257 (53%), Gaps = 16/257 (6%)

Query: 163  ITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
            I +G +   F   WRG +VAVK L  + + +   +   R E+ LL K+RHPN+V F+GA 
Sbjct: 857  IGRGGYGQVFRGSWRGTEVAVKMLFNDNV-NLKLISDLRKEVDLLCKLRHPNIVLFMGAC 915

Query: 220  TQSSPMMIVTEYLPKGDL-RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
            T+ S   IVTEYL +G L    L     +     ++   D ARGM YLH   P+ IIHRD
Sbjct: 916  TEPSSPCIVTEYLSRGSLANILLDESIEMDWGLRLQLGFDCARGMTYLHSRNPI-IIHRD 974

Query: 279  LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
            L+  N+L DDS  +KVADFG   L TVK          +  +VAPEV   E Y  K DV+
Sbjct: 975  LKTDNLLVDDSWQVKVADFG---LATVKSHTFAKTMCGTTGWVAPEVLAEEGYTEKADVY 1031

Query: 339  SFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA--PAKLYARGLKELIEECWNEK 396
            S+A++L E++    P+  K+  +V ++    +R P  A  P K  A     L+  CW   
Sbjct: 1032 SYAIVLWELLTRLIPYAGKNTMQVVRSIDRGERLPMPAWCPPKYAA-----LMNRCWETD 1086

Query: 397  PAKRPTFRQIITRLESI 413
            P  RP+F +I+  +E +
Sbjct: 1087 PTHRPSFPEILPIMEGM 1103

Dictyostelium discoideum (taxid: 44689)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q5UQG7|YR818_MIMIV Putative serine/threonine-protein kinase/receptor R818 OS=Acanthamoeba polyphaga mimivirus GN=MIMI_R818 PE=4 SV=1

 Score =  154 bits (389), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 90/254 (35%), Positives = 147/254 (57%), Gaps = 21/254 (8%)

Query: 164  TKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
            + G   +  W+ I VAVKK  ++ I D+ ++  FR E+A L ++RHP+++  +GA  +  
Sbjct: 1404 SYGIVNMGKWKNINVAVKKFVKQKI-DEKQMLEFRAEIAFLSQLRHPHIILMIGACLKRP 1462

Query: 224  PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL--DIARGMNYLHENKPVPIIHRDLEP 281
             + IVTE++  G LR  +K     KP   ++  +    A G+ YLH + P+ IIHRD++P
Sbjct: 1463 NICIVTEFMGNGSLRNVIKTT---KPEWKLKIKMLYQTALGIGYLHNSDPI-IIHRDIKP 1518

Query: 282  SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
            SNIL DDS N+K+ADFG +++   +E+  +T   T C + APE+ + E+Y  KVDVFSF 
Sbjct: 1519 SNILVDDSMNVKIADFGFARI--KEENSVMTRCGTPC-WTAPEIIRGEKYTEKVDVFSFG 1575

Query: 342  LILQEMIEGCPPFT----MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 397
            +++ E++    PF+    MK   ++ +   AR + P   P         +L+++CW+ KP
Sbjct: 1576 IVMWEVLTCKEPFSGCNFMKVSMDILE--GARPQIPSDCPID-----FTKLMKQCWHAKP 1628

Query: 398  AKRPTFRQIITRLE 411
             KRP+   +I  L 
Sbjct: 1629 DKRPSMEDVIMGLN 1642

Acanthamoeba polyphaga (taxid: 5757)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	458
356555470	456	PREDICTED: probable serine/threonine-pro	0.958	0.962	0.794	0.0
255562560	466	protein kinase, putative [Ricinus commun	0.960	0.944	0.796	0.0
356549162	455	PREDICTED: probable serine/threonine-pro	0.956	0.962	0.789	0.0
225443668	462	PREDICTED: dual specificity protein kina	0.965	0.956	0.775	0.0
224076914	423	predicted protein [Populus trichocarpa]	0.923	1.0	0.792	0.0
449459316	458	PREDICTED: serine/threonine-protein kina	0.945	0.945	0.782	0.0
356499380	454	PREDICTED: dual specificity protein kina	0.949	0.958	0.733	0.0
449433589	460	PREDICTED: probable serine/threonine-pro	0.951	0.947	0.753	0.0
356553484	453	PREDICTED: serine/threonine-protein kina	0.956	0.966	0.72	0.0
102139950	467	protein kinase, putative [Musa balbisian	0.949	0.931	0.706	0.0

>gi|356555470|ref|XP_003546054.1| PREDICTED: probable serine/threonine-protein kinase drkB-like [Glycine max]

 Score =  741 bits (1912), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 351/442 (79%), Positives = 395/442 (89%), Gaps = 3/442 (0%)

Query: 1   METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
           ME+K P R TL KQSSLAP+R  KEAEL     DGE +    RLM+ A E DV+GI+E L
Sbjct: 1   MESKNPARFTLGKQSSLAPERHNKEAELQ---KDGEAVDQGVRLMYSAFEGDVDGIREAL 57

Query: 61  DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
           +SG+ VN++DIDNRTALHVAAC+GFT+VV LLL++GA+VDPKDRWGSTPL DAI+YK ++
Sbjct: 58  ESGVSVNYKDIDNRTALHVAACEGFTDVVDLLLQKGAEVDPKDRWGSTPLADAIFYKKND 117

Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
           VIKLLEKHGAKPLMAPMHV HAREVPEYEI+P ELDFTNSVEITKGTF  A WRG +VAV
Sbjct: 118 VIKLLEKHGAKPLMAPMHVNHAREVPEYEINPKELDFTNSVEITKGTFCSALWRGTKVAV 177

Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
           KKLGE+VISD+++V+AFRDELAL QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR F
Sbjct: 178 KKLGEDVISDEEKVKAFRDELALFQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRDF 237

Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           +KRKGALKPSTAVRFALDIARG+ YLHENKP PIIHRDLEPSNILRDDSG+LKVADFGVS
Sbjct: 238 MKRKGALKPSTAVRFALDIARGVGYLHENKPSPIIHRDLEPSNILRDDSGHLKVADFGVS 297

Query: 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360
           KLL VKED+PLTCQDTSCRYVAPEVF+ EEYDTKVDVFSFALILQEMIEGCPPF+ K D+
Sbjct: 298 KLLAVKEDKPLTCQDTSCRYVAPEVFRQEEYDTKVDVFSFALILQEMIEGCPPFSAKQDD 357

Query: 361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420
           EVPK YAA++RPPF+APAK Y+ G++ELIEECWNE PAKRPTFRQIIT+LESI N+I HK
Sbjct: 358 EVPKVYAAKERPPFQAPAKRYSHGIRELIEECWNENPAKRPTFRQIITKLESIYNTIGHK 417

Query: 421 RRWKIRTMKCFHNLEAMLKKDH 442
           R WK+R +KCF NLEA+LK+DH
Sbjct: 418 RHWKVRPLKCFQNLEALLKRDH 439

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255562560|ref|XP_002522286.1| protein kinase, putative [Ricinus communis] gi|223538539|gb|EEF40144.1| protein kinase, putative [Ricinus communis]

 Score =  740 bits (1910), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 360/452 (79%), Positives = 396/452 (87%), Gaps = 12/452 (2%)

Query: 1   METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEE-----------IKPEFRLMFLAN 49
           ME K  VR TL KQSSLAP+R R+E   N  ++  E+           I P  RLM+  +
Sbjct: 1   MEGKSSVRFTLGKQSSLAPERSREEDVSNDQEEGSEDMSNDPEEELEDIHPGVRLMYSCH 60

Query: 50  ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
           E D++GI+ELLDSGIDVNFRDIDNRTALH+AACQG+T+VV+LLL  GA+ DPKDRWGSTP
Sbjct: 61  EGDLDGIRELLDSGIDVNFRDIDNRTALHLAACQGYTDVVALLLNNGAETDPKDRWGSTP 120

Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFI 169
           L DAIYYKNH+VIKLLEK GAKPLMAPMHV HAREVPEYEI+PHELDFTNSVEITKGTF 
Sbjct: 121 LADAIYYKNHDVIKLLEKRGAKPLMAPMHVNHAREVPEYEINPHELDFTNSVEITKGTFH 180

Query: 170 LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
           LA WRGIQVAVKKLGE+VISD+D+VRAF DELALLQKIRHPNVVQFLGAVTQSSPMMIVT
Sbjct: 181 LASWRGIQVAVKKLGEDVISDEDKVRAFSDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 240

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           EYL KGDLRAFLK+KGAL+P TAVRF LDIARG+NYLHENKP PIIHRDLEPSNILRDDS
Sbjct: 241 EYLHKGDLRAFLKKKGALRPGTAVRFGLDIARGLNYLHENKP-PIIHRDLEPSNILRDDS 299

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
           G+LKVADFGVSKLLTVKED+PLTCQDTSCRYVAPEVFK+EEYDTKVDVFSFALILQEMIE
Sbjct: 300 GHLKVADFGVSKLLTVKEDKPLTCQDTSCRYVAPEVFKHEEYDTKVDVFSFALILQEMIE 359

Query: 350 GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409
           GCPPF+ K D EVPK+YAA++RPPF+AP K Y  GLK+LI+ECWNE PAKRPTFRQIIT+
Sbjct: 360 GCPPFSAKQDLEVPKSYAAKERPPFRAPTKHYPHGLKDLIQECWNENPAKRPTFRQIITK 419

Query: 410 LESINNSINHKRRWKIRTMKCFHNLEAMLKKD 441
           LESI NSI HKRRWK+R +KCF N EAMLKKD
Sbjct: 420 LESIYNSIGHKRRWKVRPLKCFQNFEAMLKKD 451

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356549162|ref|XP_003542966.1| PREDICTED: probable serine/threonine-protein kinase drkA-like [Glycine max]

 Score =  729 bits (1881), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 349/442 (78%), Positives = 393/442 (88%), Gaps = 4/442 (0%)

Query: 1   METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
           ME+K P R TL KQSSLAP+R  KEAEL    +DGE +    RLM+ A E DV+GI E L
Sbjct: 1   MESKNPARFTLGKQSSLAPERHNKEAELQ---NDGEVVDQGVRLMYSAFEGDVDGICEAL 57

Query: 61  DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
           + G+ VN++DIDNRTALHVA C+GFT+VV LLL++GA+VDPKDRWGSTPL DAI+YK ++
Sbjct: 58  EFGVSVNYKDIDNRTALHVAVCEGFTDVVDLLLQKGAEVDPKDRWGSTPLADAIFYKKND 117

Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
           VIKLLEKHGAK LMAPMHV HAREVPEYEI+P ELDFTNSVEITKGTF +A WRG +VAV
Sbjct: 118 VIKLLEKHGAKLLMAPMHVNHAREVPEYEINPKELDFTNSVEITKGTFCIALWRGTEVAV 177

Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
           KKLGE+VISD+++V+AFRDELAL QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR F
Sbjct: 178 KKLGEDVISDEEKVKAFRDELALFQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRDF 237

Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           LKRKGALKPSTAVRFALDIARG+ YLHENKP PIIHRDLEPSNILRDDSG+LKVADFGVS
Sbjct: 238 LKRKGALKPSTAVRFALDIARGVGYLHENKPSPIIHRDLEPSNILRDDSGHLKVADFGVS 297

Query: 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360
           KLL VKED+PLTC DTSCRYVAPEVF+ +EYDTKVDVFSFALILQEMIEGCPPF+ K DN
Sbjct: 298 KLLAVKEDKPLTCHDTSCRYVAPEVFR-QEYDTKVDVFSFALILQEMIEGCPPFSAKQDN 356

Query: 361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420
           EVPK YAA++RPPF+APAK Y+ G++ELIEECWNE PAKRPTFRQIITRLESI N+I+HK
Sbjct: 357 EVPKVYAAKERPPFRAPAKHYSYGIRELIEECWNENPAKRPTFRQIITRLESIYNTISHK 416

Query: 421 RRWKIRTMKCFHNLEAMLKKDH 442
           R WK+R +KCF NLEA+LK+DH
Sbjct: 417 RHWKVRPLKCFQNLEALLKRDH 438

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|225443668|ref|XP_002263226.1| PREDICTED: dual specificity protein kinase shkB [Vitis vinifera] gi|297740576|emb|CBI30758.3| unnamed protein product [Vitis vinifera]

 Score =  719 bits (1856), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 346/446 (77%), Positives = 391/446 (87%), Gaps = 4/446 (0%)

Query: 1   METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELL 60
           +E+K  VR TL KQSSLAP+R R EA   G   D E I P  RLM+LANE D+EG++ELL
Sbjct: 3   VESKTAVRFTLGKQSSLAPERARDEALTEGEQGDVEGIDPRVRLMYLANEGDLEGLRELL 62

Query: 61  DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
           DSG+DVNFRDIDNRTALHVAACQGF++VV  LL+ GA++D +DRWGSTPL DAI+YKNH+
Sbjct: 63  DSGMDVNFRDIDNRTALHVAACQGFSDVVEFLLKNGAEIDLEDRWGSTPLADAIHYKNHD 122

Query: 121 VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAV 180
           VIKLLEKHGA+ LMAPMHV +AREVPEYEIDP ELDFTNSV+ITKGT+ +A WRGIQVAV
Sbjct: 123 VIKLLEKHGAQHLMAPMHVNNAREVPEYEIDPKELDFTNSVDITKGTYRIASWRGIQVAV 182

Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF 240
           K+LG+EVI D+D+V+AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL AF
Sbjct: 183 KRLGDEVIIDEDKVKAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLHAF 242

Query: 241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
           LKRKGALK +TAV+FALDIARGMNYLHE++P  IIHRDLEPSNILRDDSG+LKVADFGVS
Sbjct: 243 LKRKGALKTATAVKFALDIARGMNYLHEHRPEAIIHRDLEPSNILRDDSGHLKVADFGVS 302

Query: 301 KLL----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356
           KLL    TVKED PL CQ+TSCRY+APEVFKNE YDTKVDVFSFALILQEMIEGCPPF+ 
Sbjct: 303 KLLKVANTVKEDYPLICQETSCRYLAPEVFKNEAYDTKVDVFSFALILQEMIEGCPPFSA 362

Query: 357 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
           K +NEVPK YAA++RPPF+AP+KLY+ GLKELIEECWNE P KRPTF QI+TRL+ I N 
Sbjct: 363 KPENEVPKVYAAQERPPFRAPSKLYSHGLKELIEECWNENPTKRPTFGQILTRLDRIYNH 422

Query: 417 INHKRRWKIRTMKCFHNLEAMLKKDH 442
           +  KRRWK+R +KCF NLEAM KKDH
Sbjct: 423 LGQKRRWKVRPLKCFQNLEAMWKKDH 448

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|224076914|ref|XP_002305047.1| predicted protein [Populus trichocarpa] gi|222848011|gb|EEE85558.1| predicted protein [Populus trichocarpa]

 Score =  711 bits (1836), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/428 (79%), Positives = 385/428 (89%), Gaps = 5/428 (1%)

Query: 8   RTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVN 67
           R TL KQSSLAP+R+R+E+++   D DG  + P  RLM+LANE ++EGIKEL++S +DVN
Sbjct: 1   RFTLGKQSSLAPERDREESDV---DMDG--VDPGVRLMYLANEGNLEGIKELVNSDVDVN 55

Query: 68  FRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
           FRDID RTALH+A+CQG T+VV LLL+ GA++DPKDRWGSTPL DAI+YKNH+VIKLLEK
Sbjct: 56  FRDIDGRTALHIASCQGLTQVVDLLLDHGAEIDPKDRWGSTPLADAIFYKNHDVIKLLEK 115

Query: 128 HGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEV 187
            GAKPLMAPMHVKHAREVPEYEI+P ELDFTNSVE+TKGTF +A WRGIQVAVKKLGEEV
Sbjct: 116 RGAKPLMAPMHVKHAREVPEYEINPDELDFTNSVELTKGTFCVALWRGIQVAVKKLGEEV 175

Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
           +SD+D+VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE+LPKGD  AFLKRKGAL
Sbjct: 176 LSDEDKVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEFLPKGDFCAFLKRKGAL 235

Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           KP  AVR ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG+LKVADFG+SKLLTVKE
Sbjct: 236 KPIAAVRLALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGHLKVADFGISKLLTVKE 295

Query: 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367
           ++PL   D S RYVAPEVFKNEEYDTKVD+FSFALILQEMIEGCPPF+ K ++EVP AYA
Sbjct: 296 EKPLISLDNSWRYVAPEVFKNEEYDTKVDIFSFALILQEMIEGCPPFSAKQEHEVPSAYA 355

Query: 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRT 427
           A++RPPF+AP K YA GLKELI+ECW+E PAKRPTFRQI+TRL++I NSI HKRRWK+R 
Sbjct: 356 AKERPPFRAPTKSYAHGLKELIQECWHENPAKRPTFRQILTRLDAIQNSIGHKRRWKVRP 415

Query: 428 MKCFHNLE 435
           +KCF NLE
Sbjct: 416 LKCFQNLE 423

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449459316|ref|XP_004147392.1| PREDICTED: serine/threonine-protein kinase CTR1-like [Cucumis sativus]

 Score =  709 bits (1830), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 341/436 (78%), Positives = 384/436 (88%), Gaps = 3/436 (0%)

Query: 7   VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV 66
           VR  L KQSS+APDR+ +EAEL    +DGEEI P  RLM+LANE D+EGIKELLDSGIDV
Sbjct: 11  VRFLLGKQSSMAPDRQPEEAELA---EDGEEIDPGVRLMYLANEGDLEGIKELLDSGIDV 67

Query: 67  NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
           NF DIDNRTALH+AACQG  E+V LLL RGA++DPKDRWGSTPL DAI+YKNHEVIKLLE
Sbjct: 68  NFHDIDNRTALHIAACQGCNEIVDLLLRRGAEIDPKDRWGSTPLADAIFYKNHEVIKLLE 127

Query: 127 KHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEE 186
           K GAK LMAPMHVKHAREVPEYEIDP E DFTNSV +TKGTF LA WRGIQVAVK+L E+
Sbjct: 128 KRGAKHLMAPMHVKHAREVPEYEIDPKEFDFTNSVNLTKGTFHLASWRGIQVAVKELPED 187

Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA 246
           VIS++D+V AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL   L +KG 
Sbjct: 188 VISEEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLCQLLHKKGP 247

Query: 247 LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
           LKP  AV+FALDIARGMNYLHENKP PIIHRDLEPSNILRDD+GNLKVADFGVSKLLTVK
Sbjct: 248 LKPIVAVKFALDIARGMNYLHENKPAPIIHRDLEPSNILRDDTGNLKVADFGVSKLLTVK 307

Query: 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366
           ED+PLTCQDT+CRYVAPEVFKN  YDTKVDVFSFALILQEMIEG PPF+ K +N + K Y
Sbjct: 308 EDKPLTCQDTACRYVAPEVFKNNGYDTKVDVFSFALILQEMIEGQPPFSNKKENAICKGY 367

Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIR 426
           AA  RPPFKAPAK YA G+KELIE CW+E+P+KRPTFRQIITRLE+I++S++H+RRWK+ 
Sbjct: 368 AAGMRPPFKAPAKCYAHGIKELIEACWDERPSKRPTFRQIITRLETIHHSLSHRRRWKLP 427

Query: 427 TMKCFHNLEAMLKKDH 442
           T++CF + +A +++DH
Sbjct: 428 TLRCFQDPDAKIRRDH 443

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356499380|ref|XP_003518519.1| PREDICTED: dual specificity protein kinase pyk1-like [Glycine max]

 Score =  667 bits (1722), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 328/447 (73%), Positives = 372/447 (83%), Gaps = 12/447 (2%)

Query: 4   KVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEE-IKPEFRLMFLANERDVEGIKELLDS 62
           K+  R +L +QSSLAP+R        G   D  E + P  RLM+LANE D +GIKELLD+
Sbjct: 5   KLQPRFSLGRQSSLAPER-------GGCGGDASEALDPAVRLMYLANEGDSDGIKELLDA 57

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
           G DVNF DID RTALHVAACQG T+VV LLL RGADVDP+DRWGSTPL DA+YYKNH+V+
Sbjct: 58  GSDVNFTDIDGRTALHVAACQGRTDVVGLLLRRGADVDPQDRWGSTPLVDAMYYKNHDVV 117

Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
           KLLEKHGA+P MAPMHV++AREVPEYEIDP ELDFTNSV ITKGTF +A WRG QVAVK 
Sbjct: 118 KLLEKHGARPPMAPMHVQNAREVPEYEIDPSELDFTNSVCITKGTFRIALWRGTQVAVKT 177

Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
           LGEE+ +DDD+V+AF DEL LL+KIRHPNVVQFLGAVTQS+PMMIVTEYLP+GDLRA+LK
Sbjct: 178 LGEELFTDDDKVKAFHDELTLLEKIRHPNVVQFLGAVTQSTPMMIVTEYLPQGDLRAYLK 237

Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           RKGALKP TAV+FALDIARGMNYLHE+KP  IIHRDLEPSNILRDDSG+LKVADFGVSKL
Sbjct: 238 RKGALKPVTAVKFALDIARGMNYLHEHKPEAIIHRDLEPSNILRDDSGHLKVADFGVSKL 297

Query: 303 L----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358
           L    TVKED+P+T  DTS RYVAPEV+KNEEYDTKVDVFSFALILQEMIEGCPPF  K 
Sbjct: 298 LKVAKTVKEDKPVTSLDTSWRYVAPEVYKNEEYDTKVDVFSFALILQEMIEGCPPFYEKP 357

Query: 359 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418
           +NEVPKAY   +RPPF+A  KLYA GLK+LIEECW+EKP +RPTFRQII RLE I   + 
Sbjct: 358 ENEVPKAYVENERPPFRASPKLYAYGLKQLIEECWDEKPYRRPTFRQIIGRLEDIYYHLA 417

Query: 419 HKRRWKIRTMKCFHNLEAMLKKDHSSP 445
            KRRWK+R   CF NLE + + + ++P
Sbjct: 418 QKRRWKVRAPGCFQNLEVIFRGNRTNP 444

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449433589|ref|XP_004134580.1| PREDICTED: probable serine/threonine-protein kinase drkD-like [Cucumis sativus]

 Score =  665 bits (1715), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 331/439 (75%), Positives = 368/439 (83%), Gaps = 3/439 (0%)

Query: 6   PVRTTLLKQSSLAPDRERKEAELNGL---DDDGEEIKPEFRLMFLANERDVEGIKELLDS 62
           PV+  L KQSSLAPD +    +L  L       E I    RLM+LANE D+EGI E+LDS
Sbjct: 4   PVKFKLGKQSSLAPDGDVHLEDLEELVKQHQTEEGIDSRVRLMYLANEGDLEGINEVLDS 63

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
           G+DVNFRDIDNRTALH+AACQGF +VV+LLLERGA+VD KDRWGSTPL DAI+YKNH+VI
Sbjct: 64  GVDVNFRDIDNRTALHIAACQGFADVVALLLERGAEVDSKDRWGSTPLRDAIHYKNHDVI 123

Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
           KLLEKHGAKP +APM VK+AREVP+YEIDP ELDFTNSV ITKGTF  A WRG +VAVK+
Sbjct: 124 KLLEKHGAKPPVAPMLVKNAREVPDYEIDPKELDFTNSVNITKGTFRRASWRGTEVAVKE 183

Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
           LGE++ +D+++VRAFRDELALLQKIRHPNVVQFLGAVTQS PMMIVTEYLPKGDL A L 
Sbjct: 184 LGEDLFTDEEKVRAFRDELALLQKIRHPNVVQFLGAVTQSWPMMIVTEYLPKGDLGALLS 243

Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           RK  +K  + VR ALDIARGMNYLHENKP PIIHR+LEPSNILRDDSG+LKVADFGVSKL
Sbjct: 244 RKREIKTMSVVRLALDIARGMNYLHENKPAPIIHRNLEPSNILRDDSGHLKVADFGVSKL 303

Query: 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
           LTVKED+  TC +TS RY APEVFKNEEYDTKVDVFSFALILQEM+EGC PF  K D+EV
Sbjct: 304 LTVKEDKFSTCSETSRRYQAPEVFKNEEYDTKVDVFSFALILQEMLEGCSPFPDKADSEV 363

Query: 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 422
           PK YAA +RPPF A  K YA GLKELIEECWNEKP KRPTFRQIIT+LE I N   HKRR
Sbjct: 364 PKLYAAGERPPFGALIKRYANGLKELIEECWNEKPNKRPTFRQIITQLEFIYNRFCHKRR 423

Query: 423 WKIRTMKCFHNLEAMLKKD 441
           WK+R +KCF N+EAMLKKD
Sbjct: 424 WKVRPLKCFQNIEAMLKKD 442

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356553484|ref|XP_003545086.1| PREDICTED: serine/threonine-protein kinase HT1-like [Glycine max]

 Score =  657 bits (1696), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 324/450 (72%), Positives = 371/450 (82%), Gaps = 12/450 (2%)

Query: 1   METK-VPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKEL 59
           METK +  R +L +QSSLAP+R        G  D  E + P  RLM+LANE D +GIKEL
Sbjct: 1   METKKLHPRFSLGRQSSLAPERA-------GAGDSSEALDPAVRLMYLANEGDSDGIKEL 53

Query: 60  LDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
           LD+G +VNF DID RT+LHVAACQG T+VV LLL RGA VDP+DRWGSTPL DA+YYKNH
Sbjct: 54  LDAGSNVNFTDIDGRTSLHVAACQGRTDVVDLLLRRGAHVDPQDRWGSTPLVDAMYYKNH 113

Query: 120 EVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVA 179
           +V+KLLEKHGA+P MAPMHV++AREVPEYEIDP ELDFTNSV ITKGTF +A WRGIQVA
Sbjct: 114 QVVKLLEKHGARPPMAPMHVQNAREVPEYEIDPSELDFTNSVCITKGTFRIALWRGIQVA 173

Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
           VK LGEE+ +DDD+V+AF  EL LL+KIRHPNVVQFLGAVTQS+PMMIVTEYLP+GDL A
Sbjct: 174 VKTLGEELFTDDDKVKAFHYELTLLEKIRHPNVVQFLGAVTQSTPMMIVTEYLPQGDLGA 233

Query: 240 FLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299
           +LKRKGALKP TAV+FALDIARGMNYLHE+KP  IIHRDLEPSNILRDDSG+LKVADFGV
Sbjct: 234 YLKRKGALKPVTAVKFALDIARGMNYLHEHKPEAIIHRDLEPSNILRDDSGHLKVADFGV 293

Query: 300 SKLL----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
           SKLL     VKED+P+   DTS RYVAPEV++NEEYDT VDVFSFALILQEMIEGCPPF 
Sbjct: 294 SKLLKVAKMVKEDKPVASLDTSWRYVAPEVYRNEEYDTNVDVFSFALILQEMIEGCPPFF 353

Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
            K +NEVPKAY   +RPPF+A  KLYA GLK+LIEECW+EKP +RPTFRQII RLE I  
Sbjct: 354 AKPENEVPKAYVENERPPFRASPKLYAYGLKQLIEECWDEKPYRRPTFRQIIGRLEDIYY 413

Query: 416 SINHKRRWKIRTMKCFHNLEAMLKKDHSSP 445
            +  KR WK+RT  CF NLEA+ + + ++P
Sbjct: 414 HLAQKRGWKVRTPGCFQNLEAIFRGNRTNP 443

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|102139950|gb|ABF70090.1| protein kinase, putative [Musa balbisiana]

 Score =  647 bits (1669), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 327/463 (70%), Positives = 368/463 (79%), Gaps = 28/463 (6%)

Query: 1   METKVPVRTTLLKQSSLAPDRERKEAE-LNGLDDDG----EEIKPEFRLMFLANERDVEG 55
           ME K   R TL KQSSLAPDR+  E + L   D DG    EE+    RLM+LANE D+ G
Sbjct: 1   MEAKSTGRFTLGKQSSLAPDRDDGELQALRSGDLDGLQVPEEVDANIRLMYLANEGDLAG 60

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST------- 108
           I+E L SG+DVNFRDID+RTALHVAACQGF +VV LLL+RGA VDP+DRWGST       
Sbjct: 61  IEETLASGVDVNFRDIDDRTALHVAACQGFADVVQLLLDRGAQVDPEDRWGSTSNFITIA 120

Query: 109 ----PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEIT 164
               PL DA++YKNHEVIKL EKHGAK  + PM V++AREVPEYEIDP ELDFTNSV IT
Sbjct: 121 PAKQPLADAVHYKNHEVIKLFEKHGAKLRVTPMRVENAREVPEYEIDPSELDFTNSVNIT 180

Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRV--------RAFRDELALLQKIRHPNVVQFL 216
           KGTFI+A WRGIQVAVKK  ++V++D+D++        RAFRDELALLQ+IRHPNVVQFL
Sbjct: 181 KGTFIIAKWRGIQVAVKKFNDDVMADEDKLWDFFIFCRRAFRDELALLQQIRHPNVVQFL 240

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
           GAVTQSSPMMIVTEYL KGDLRA+L RK  L+PS+AV FALDIARGMNYLHE+KP  IIH
Sbjct: 241 GAVTQSSPMMIVTEYLRKGDLRAYLNRKRTLRPSSAVLFALDIARGMNYLHEHKPEAIIH 300

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLL----TVKEDRPLTCQDTSCRYVAPEVFKNEEYD 332
           RDLEPSNILRDDSG+LKVADFGVSKLL    TVKE+RPLTC DT+CRYVAPEVF NEEYD
Sbjct: 301 RDLEPSNILRDDSGHLKVADFGVSKLLKVAKTVKEERPLTCLDTACRYVAPEVFLNEEYD 360

Query: 333 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           TKVDVFSFALILQEMIEGCPPF+ K DNEVPKAY ++QRPPF+AP K YA GLKELIE C
Sbjct: 361 TKVDVFSFALILQEMIEGCPPFSYKQDNEVPKAYVSKQRPPFRAPPKQYAHGLKELIEHC 420

Query: 393 WNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLE 435
           W+E PA RPTFR+II RL  I N I  KRRWK+     +  L+
Sbjct: 421 WSENPADRPTFREIIDRLSKIQNHIAQKRRWKVSLFNFYLGLQ 463

Source: Musa balbisiana

Species: Musa balbisiana

Genus: Musa

Family: Musaceae

Order: Zingiberales

Class: Liliopsida

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	458
TAIR|locus:2117129	459	AT4G18950 [Arabidopsis thalian	0.945	0.943	0.716	2e-166
TAIR|locus:2098999	471	AT3G58760 [Arabidopsis thalian	0.965	0.938	0.656	4.5e-153
TAIR|locus:2044034	479	AT2G43850 [Arabidopsis thalian	0.908	0.868	0.483	1.5e-99
TAIR|locus:2045258	476	AT2G31800 [Arabidopsis thalian	0.910	0.876	0.474	4.1e-97
TAIR|locus:2080517	477	AT3G59830 [Arabidopsis thalian	0.912	0.876	0.474	3e-94
TAIR|locus:2014849	438	VIK "VH1-interacting kinase" [	0.825	0.863	0.461	5.8e-82
TAIR|locus:2827943	546	STY8 "serine/threonine/tyrosin	0.674	0.565	0.354	5e-44
TAIR|locus:2128043	570	STY17 "serine/threonine/tyrosi	0.620	0.498	0.359	1.7e-43
WB|WBGene00016030	850	C24A1.3 [Caenorhabditis elegan	0.558	0.301	0.360	1.4e-40
DICTYBASE|DDB_G0289791	642	drkA "DRK subfamily protein ki	0.558	0.398	0.374	1.1e-39

TAIR|locus:2117129 AT4G18950 [Arabidopsis thaliana (taxid:3702)]

 Score = 1619 (575.0 bits), Expect = 2.0e-166, P = 2.0e-166
 Identities = 313/437 (71%), Positives = 363/437 (83%)

Query:     8 RTTLLKQSSLAPDR--ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
             R T+ +QSS+AP++  E        + +DGEEI    RLM+LANE D+EGIKEL+DSGID
Sbjct:     9 RFTIGRQSSMAPEKIPEPSVHSEEEVFEDGEEIDGGVRLMYLANEGDIEGIKELIDSGID 68

Query:    66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
              N+RDID+RTALHVAACQG  +VV LLL+R A+VDPKDRWGSTP  DAI+YKN +VIK+L
Sbjct:    69 ANYRDIDDRTALHVAACQGLKDVVELLLDRKAEVDPKDRWGSTPFADAIFYKNIDVIKIL 128

Query:   126 EKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGE 185
             E HGAK  MAPMHVK AREVPEYEI+P ELDFT S EITKGT+ +A WRGIQVAVKKL +
Sbjct:   129 EIHGAKHPMAPMHVKTAREVPEYEINPSELDFTQSKEITKGTYCMAMWRGIQVAVKKLDD 188

Query:   186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG 245
             EV+SDDD+VR F DELALLQ++RHPN+VQFLGAVTQS+PMMIVTEYLP+GDLR  LKRKG
Sbjct:   189 EVLSDDDQVRKFHDELALLQRLRHPNIVQFLGAVTQSNPMMIVTEYLPRGDLRELLKRKG 248

Query:   246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
              LKP+TAVR+ALDIARGM+YLHE K  PIIHRDLEPSNILRDDSG+LKVADFGVSKL+TV
Sbjct:   249 QLKPATAVRYALDIARGMSYLHEIKGDPIIHRDLEPSNILRDDSGHLKVADFGVSKLVTV 308

Query:   306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365
             KED+P TCQD SCRY+APEVF +EEYDTK DVFSFALI+QEMIEG  PF  K D+E  +A
Sbjct:   309 KEDKPFTCQDISCRYIAPEVFTSEEYDTKADVFSFALIVQEMIEGRMPFAEKEDSEASEA 368

Query:   366 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKI 425
             YA + RP FKAP+K Y  GLK LIEECW+EKPAKRPTFR+II RLESI + + HKR+W++
Sbjct:   369 YAGKHRPLFKAPSKNYPHGLKTLIEECWHEKPAKRPTFREIIKRLESILHHMGHKRQWRM 428

Query:   426 RTMKCFHNLEAMLKKDH 442
             R + CF N E   KK H
Sbjct:   429 RPLTCFQNFEH--KKKH 443

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009695 "jasmonic acid biosynthetic process" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010200 "response to chitin" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

TAIR|locus:2098999 AT3G58760 [Arabidopsis thaliana (taxid:3702)]

 Score = 1493 (530.6 bits), Expect = 4.5e-153, P = 4.5e-153
 Identities = 298/454 (65%), Positives = 351/454 (77%)

Query:     1 METKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIK-------PEFRLMFLANERDV 53
             ++ K P R  L +QSSLAP+       L   +DD            P  RLM+LANE D+
Sbjct:     3 IKPKSPARFKLGRQSSLAPESRTPIDTLTEDEDDDLAAAATAGIGDPTIRLMYLANEGDI 62

Query:    54 EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
             +GI ++LDSG +V++RDID RTALHVAACQG T+VV LLL RGA VD KDRWGSTPL DA
Sbjct:    63 DGINKMLDSGTNVDYRDIDARTALHVAACQGRTDVVELLLSRGAKVDTKDRWGSTPLADA 122

Query:   114 IYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW 173
             +YYKNH+VIKLLEKHGAKP +APMHV   +EVPEYEI P ELDF+NSV+I+KGTF  A W
Sbjct:   123 VYYKNHDVIKLLEKHGAKPTIAPMHVLTDKEVPEYEIHPTELDFSNSVKISKGTFNKASW 182

Query:   174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
             RGI VAVK  GEE+ +D+D+V AFRDELALLQKIRHPNVVQFLGAVTQS+PMMIVTEYLP
Sbjct:   183 RGIDVAVKTFGEEMFTDEDKVNAFRDELALLQKIRHPNVVQFLGAVTQSTPMMIVTEYLP 242

Query:   234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
             KGDLR +L RKG L P+ AV+FAL+IARGMNYLHE+KP  IIH DLEP NILRDDSG+LK
Sbjct:   243 KGDLRQYLDRKGPLMPAHAVKFALEIARGMNYLHEHKPEAIIHCDLEPPNILRDDSGHLK 302

Query:   294 VADFGVSKLL----TVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
             VADFGVSKLL    TVK+DRP+ TC D+S RY+APEV++NEEYDTKVDVFSFALILQEMI
Sbjct:   303 VADFGVSKLLVVKKTVKKDRPVVTCLDSSWRYMAPEVYRNEEYDTKVDVFSFALILQEMI 362

Query:   349 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
             EGC PF    D EVPKAY   +RPPF AP K Y  GL+ELI++CW+++ +KRPTFR II+
Sbjct:   363 EGCEPFHEIEDREVPKAYIEDERPPFNAPTKSYPFGLQELIQDCWDKEASKRPTFRVIIS 422

Query:   409 RLESINNSINHKRRWKIRTMKCFHNLEAMLKKDH 442
              LE I++ I  KR WK+   +C        K+D+
Sbjct:   423 TLELISDRIARKRSWKVMLGRCLPRFRLFTKRDY 456

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

TAIR|locus:2044034 AT2G43850 [Arabidopsis thaliana (taxid:3702)]

 Score = 988 (352.9 bits), Expect = 1.5e-99, P = 1.5e-99
 Identities = 209/432 (48%), Positives = 281/432 (65%)

Query:     7 VRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPE-----FRLMFLANERDVEGIKELLD 61
             +R +  +QSSL P R   ++  +  DD+     PE      +L+F+A++ DV GI+ELLD
Sbjct:    42 MRFSFGRQSSLDPIRRSPDSSKS--DDEPHMSVPENLDSTMQLLFMASKGDVRGIEELLD 99

Query:    62 SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
              GIDVN  D+D RTALH+AAC+G   VV  LL R A++D +DRWGST   DA YY N +V
Sbjct:   100 EGIDVNSIDLDGRTALHIAACEGHLGVVKALLSRRANIDARDRWGSTAAADAKYYGNLDV 159

Query:   122 IKLLEKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQV 178
               LL+  GAK P     PM V + REVPEYE++P E+    S  I+KG + +A W G +V
Sbjct:   160 YNLLKARGAKVPKTRKTPMTVSNPREVPEYELNPLEVQVRKSDGISKGAYQVAKWNGTRV 219

Query:   179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
             +VK L ++  SD +R+ AFR EL LL+K+RHPNV+QF+GAVTQ+ PMMIV EY PKGDL 
Sbjct:   220 SVKILDKDSYSDPERINAFRHELTLLEKVRHPNVIQFVGAVTQNIPMMIVVEYNPKGDLS 279

Query:   239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
              +L++KG L PS A+RFALDIARGMNYLHE KP PIIH DL+P NIL D  G LK++ FG
Sbjct:   280 VYLQKKGRLSPSKALRFALDIARGMNYLHECKPDPIIHCDLKPKNILLDRGGQLKISGFG 339

Query:   299 VSKLLTVKEDRPLTCQ-----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
             + +L  + +D+          D S  Y+APEV+K+E +D +VD  SF +IL E+ EG P 
Sbjct:   340 MIRLSKISQDKAKVANHKAHIDLSNYYIAPEVYKDEIFDLRVDAHSFGVILYEITEGVPV 399

Query:   354 FTMKHDNEVPKAYAAR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
             F  +   EV +      +RP FK  ++ Y   +KELIE+CW+ +   RPTF +II RL+ 
Sbjct:   400 FHPRPPEEVARMMCLEGKRPVFKTKSRSYPPDIKELIEKCWHPEAGIRPTFSEIIIRLDK 459

Query:   413 INNSINHKRRWK 424
             I  + + +  WK
Sbjct:   460 IVANCSKQGWWK 471

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2045258 AT2G31800 [Arabidopsis thaliana (taxid:3702)]

 Score = 965 (344.8 bits), Expect = 4.1e-97, P = 4.1e-97
 Identities = 203/428 (47%), Positives = 275/428 (64%)

Query:     7 VRTTLLKQSSLAPDRERKEAELNGLD-DDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
             +R +  +QSSL P R   +   NG      + +    +L+F+A   DVEG+++LLD GID
Sbjct:    42 MRFSFGRQSSLDPIRRSPDGS-NGPQLAVPDNLDATMQLLFVACRGDVEGVQDLLDEGID 100

Query:    66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
             VN  D+D RTALH+AAC+G  +VV LLL R A++D +DRWGST   DA YY N +V  +L
Sbjct:   101 VNSIDLDGRTALHIAACEGHVDVVKLLLTRKANIDARDRWGSTAAADAKYYGNMDVFNIL 160

Query:   126 EKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
             +  GAK P     PM V + REVPEYE++P EL    +  I+KG + +A W G +V+VK 
Sbjct:   161 KARGAKVPKTKRTPMVVANPREVPEYELNPQELQVRKADGISKGIYQVAKWNGTKVSVKI 220

Query:   183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
             L +++  D D + AF+ EL L +K+RHPNVVQF+GAVTQ+ PMMIV+EY PKGDL ++L+
Sbjct:   221 LDKDLYKDSDTINAFKHELTLFEKVRHPNVVQFVGAVTQNVPMMIVSEYHPKGDLGSYLQ 280

Query:   243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
             +KG L P+  +RFALDIARGMNYLHE KP P+IH DL+P NI+ D  G+LKVA FG+   
Sbjct:   281 KKGRLSPAKVLRFALDIARGMNYLHECKPEPVIHCDLKPKNIMLDSGGHLKVAGFGLISF 340

Query:   303 LTVKEDRPLTCQ-----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
               +  D+          D S   +APEV+K+E +D  VD +SF ++L EMIEG  PF  K
Sbjct:   341 AKLSSDKSKILNHGAHIDPSNYCMAPEVYKDEIFDRSVDSYSFGVVLYEMIEGVQPFHPK 400

Query:   358 HDNEVPKAYAAR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
                E  K      +RP FKA +K   + ++ELIEECW+ +   RPTF +II RL+ I   
Sbjct:   401 PPEEAVKLMCLEGRRPSFKAKSKSCPQEMRELIEECWDTETFVRPTFSEIIVRLDKIFVH 460

Query:   417 INHKRRWK 424
              + +  WK
Sbjct:   461 CSKQGWWK 468

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2080517 AT3G59830 [Arabidopsis thaliana (taxid:3702)]

 Score = 938 (335.3 bits), Expect = 3.0e-94, P = 3.0e-94
 Identities = 203/428 (47%), Positives = 272/428 (63%)

Query:     7 VRTTLLKQSSLAPDRERKEA-ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
             +R +  +QSSL P R   E+          E +    +L+F+A++ DV G++ELL+ GID
Sbjct:    42 MRFSFGRQSSLDPIRRSPESLSCEPHMSVPENLDSTMQLLFMASKGDVNGVEELLNEGID 101

Query:    66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
             VN  D+D RTALH+A+C+G  +VV +LL R A++D +DRWGST   DA YY N EV  LL
Sbjct:   102 VNSIDLDGRTALHIASCEGHYDVVKVLLSRRANIDARDRWGSTAAVDAKYYGNVEVYNLL 161

Query:   126 EKHGAK-PLM--APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKK 182
             +  GAK P     PM V + +EVPEYE++P EL       I+KGT+ +A W G +V+VK 
Sbjct:   162 KARGAKAPKTRKTPMTVGNPKEVPEYELNPLELQVRKVDGISKGTYQVAKWNGTRVSVKI 221

Query:   183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
               ++  SD +RV AF +EL LL K RHPN+VQF+GAVTQ+ PMMIV E  PKGDL  +L+
Sbjct:   222 FDKDSYSDPERVNAFTNELTLLAKARHPNIVQFVGAVTQNLPMMIVVECNPKGDLSVYLQ 281

Query:   243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
             +KG L PS A+RFALDIARGMNYLHE KP PIIH +L P NIL D  G LK++ FG+ KL
Sbjct:   282 KKGRLSPSKALRFALDIARGMNYLHECKPDPIIHCELMPKNILLDRGGQLKISGFGLIKL 341

Query:   303 LTVKEDRPLTCQ-----DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
               + ED           D S  Y+APE++K+E +D + DV SF +IL E+ EG   F  K
Sbjct:   342 SKIGEDSAKVVNHEAQIDKSNYYIAPEIYKDEVFDKRADVHSFGVILYELTEGVSLFHPK 401

Query:   358 HDNEVPKAYAAR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
                EV ++     +RP  +  +K Y   LKELIEECW+ + + RP F +II RL+ I  +
Sbjct:   402 PPEEVAESICIEGKRPTIRTKSKSYPPELKELIEECWHPEISVRPIFSEIIIRLDKIVTN 461

Query:   417 INHKRRWK 424
              + +  WK
Sbjct:   462 CSKQGWWK 469

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

GO:0048610 "cellular process involved in reproduction" evidence=RCA

GO:0048868 "pollen tube development" evidence=RCA

TAIR|locus:2014849 VIK "VH1-interacting kinase" [Arabidopsis thaliana (taxid:3702)]

 Score = 822 (294.4 bits), Expect = 5.8e-82, P = 5.8e-82
 Identities = 186/403 (46%), Positives = 256/403 (63%)

Query:    44 LMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
             +++ A++ D   +++LL+     V+ RD D RT LHVA+  G+ +VV  LLE GADV+ +
Sbjct:    41 ILWHAHQNDAAAVRKLLEEDPTLVHARDYDKRTPLHVASLHGWIDVVKCLLEFGADVNAQ 100

Query:   103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH--AREVP-------EYEIDPH 153
             DRW +TPL DA   +  ++I+LL+ HG   L    +  H   + VP       ++EI+P 
Sbjct:   101 DRWKNTPLADAEGARKQKMIELLKSHGG--LSYGQNGSHFEPKPVPPPIPKKCDWEIEPA 158

Query:   154 ELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRV-RAFRDELALLQKIRH 209
             ELDF+N+  I KG+F   + A+WRG  VAVK++    +SDD  V + FR E+ LL K+RH
Sbjct:   159 ELDFSNAAMIGKGSFGEIVKAYWRGTPVAVKRILPS-LSDDRLVIQDFRHEVDLLVKLRH 217

Query:   210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
             PN+VQFLGAVT+  P+M++TEYL  GDL  +LK KG L P+TAV FALDIARGM YLH N
Sbjct:   218 PNIVQFLGAVTERKPLMLITEYLRGGDLHQYLKEKGGLTPTTAVNFALDIARGMTYLH-N 276

Query:   270 KPVPIIHRDLEPSNILRDDSG--NLKVADFGVSKLLTVKEDRP---LTCQDTSCRYVAPE 324
             +P  IIHRDL+P N+L  +S   +LKV DFG+SKL+ V+       +T +  S RY+APE
Sbjct:   277 EPNVIIHRDLKPRNVLLVNSSADHLKVGDFGLSKLIKVQNSHDVYKMTGETGSYRYMAPE 336

Query:   325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384
             VFK+  YD KVDVFSFA+IL EM+EG PPF      E  K  +   RP F++  K     
Sbjct:   337 VFKHRRYDKKVDVFSFAMILYEMLEGEPPFANHEPYEAAKHVSDGHRPTFRS--KGCTPD 394

Query:   385 LKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRT 427
             L+ELI +CW+    +RP+F  I+ RLE I  ++     W + T
Sbjct:   395 LRELIVKCWDADMNQRPSFLDILKRLEKIKETLPSDHHWGLFT 437

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA;ISS

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0009966 "regulation of signal transduction" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0009734 "auxin mediated signaling pathway" evidence=IMP

GO:0009742 "brassinosteroid mediated signaling pathway" evidence=IMP

GO:0010305 "leaf vascular tissue pattern formation" evidence=IMP

GO:0005829 "cytosol" evidence=RCA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009863 "salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2827943 STY8 "serine/threonine/tyrosine kinase 8" [Arabidopsis thaliana (taxid:3702)]

 Score = 464 (168.4 bits), Expect = 5.0e-44, P = 5.0e-44
 Identities = 121/341 (35%), Positives = 196/341 (57%)

Query:    98 DVDPKDRWGSTP---LGDAIYYKNHEVIKLLEKHGAKPLMAPM--HVKHARE-VPE-YEI 150
             DV   D W       L DA+   + E++KL ++ G+K        H K + E +P   EI
Sbjct:   215 DVFVVDGWSQEETDGLRDAL---SKEILKLKDQPGSKQKSISFFEHDKSSNELIPACIEI 271

Query:   151 -----DPHELDFTN-SVE--ITKGTFILAFWRGI----QVAVKKLGEEVISDDDRVRAFR 198
                  D  E+D T   +E  +  G++     RG     +VA+K L  + ++++  +R F 
Sbjct:   272 PTDGTDEWEIDVTQLKIEKKVASGSYG-DLHRGTYCSQEVAIKFLKPDRVNNE-MLREFS 329

Query:   199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
              E+ +++K+RH NVVQFLGA T+S  + IVTE++ +G +  FL K+K A K  T ++ AL
Sbjct:   330 QEVFIMRKVRHKNVVQFLGACTRSPTLCIVTEFMARGSIYDFLHKQKCAFKLQTLLKVAL 389

Query:   258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
             D+A+GM+YLH+N    IIHRDL+ +N+L D+ G +KVADFGV+++    E   +T +  +
Sbjct:   390 DVAKGMSYLHQNN---IIHRDLKTANLLMDEHGLVKVADFGVARVQI--ESGVMTAETGT 444

Query:   318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
              R++APEV +++ Y+ K DVFS+A++L E++ G  P+      +       +   P K P
Sbjct:   445 YRWMAPEVIEHKPYNHKADVFSYAIVLWELLTGDIPYAFLTPLQAAVGVVQKGLRP-KIP 503

Query:   378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418
              K + + +K L+E CW++ P +RP F +II  L+ I   +N
Sbjct:   504 KKTHPK-VKGLLERCWHQDPEQRPLFEEIIEMLQQIMKEVN 543

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

TAIR|locus:2128043 STY17 "serine/threonine/tyrosine kinase 17" [Arabidopsis thaliana (taxid:3702)]

 Score = 459 (166.6 bits), Expect = 1.7e-43, P = 1.7e-43
 Identities = 107/298 (35%), Positives = 172/298 (57%)

Query:   147 EYEIDPHELDFTNSVEI-TKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
             E+EID  +L     V   + G      +   +VA+K L  E ++ +  +R F  E+ +++
Sbjct:   284 EWEIDMKQLKIEKKVACGSYGELFRGTYCSQEVAIKILKPERVNAE-MLREFSQEVYIMR 342

Query:   206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMN 264
             K+RH NVVQF+GA T+S  + IVTE++ +G +  FL K KG  K  + ++ ALD+++GMN
Sbjct:   343 KVRHKNVVQFIGACTRSPNLCIVTEFMTRGSIYDFLHKHKGVFKIQSLLKVALDVSKGMN 402

Query:   265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
             YLH+N    IIHRDL+ +N+L D+   +KVADFGV+++ T  E   +T +  + R++APE
Sbjct:   403 YLHQNN---IIHRDLKTANLLMDEHEVVKVADFGVARVQT--ESGVMTAETGTYRWMAPE 457

Query:   325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384
             V +++ YD + DVFS+A++L E++ G  P++     +       +   P K P + + + 
Sbjct:   458 VIEHKPYDHRADVFSYAIVLWELLTGELPYSYLTPLQAAVGVVQKGLRP-KIPKETHPK- 515

Query:   385 LKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDH 442
             L EL+E+CW + PA RP F +II  L  +   +    R K +    F  L    KK H
Sbjct:   516 LTELLEKCWQQDPALRPNFAEIIEMLNQLIREVGDDERHKDKHGGYFSGL----KKGH 569

GO:0004672 "protein kinase activity" evidence=IEA;ISS

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0008152 "metabolic process" evidence=IEA

GO:0016597 "amino acid binding" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004712 "protein serine/threonine/tyrosine kinase activity" evidence=ISS

GO:0005829 "cytosol" evidence=IDA

GO:0009658 "chloroplast organization" evidence=IGI

GO:0007015 "actin filament organization" evidence=RCA

WB|WBGene00016030 C24A1.3 [Caenorhabditis elegans (taxid:6239)]

 Score = 376 (137.4 bits), Expect = 1.4e-40, Sum P(2) = 1.4e-40
 Identities = 97/269 (36%), Positives = 143/269 (53%)

Query:   154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
             E++F  S  I  G+F   +   +RG  VAVK+                 E+++L ++ HP
Sbjct:   515 EIEFQES--IGSGSFGKVYKGTYRGKLVAVKRYRAMAFGCKSETDMLCREVSILSRLAHP 572

Query:   211 NVVQFLG-AVTQSSPMMIVTEYLPKGDL--RAFLKRKG--ALKPSTAVRFALDIARGMNY 265
             NVV F+G ++   S   I+TE++  G L  R   +RK    + P+  +R +LD+ARGM Y
Sbjct:   573 NVVAFVGTSLDDPSQFAIITEFVENGSLFRRENGERKNYRVMDPAFRLRISLDVARGMRY 632

Query:   266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
             LHE+   P+IHRDL   NIL    G   VADFG S+ +  +ED  LT Q  + R++APEV
Sbjct:   633 LHESAAKPVIHRDLNSHNILIHADGRSVVADFGESRFVCQREDENLTKQPGNLRWMAPEV 692

Query:   326 FKNE-EYDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVPKAYAARQRPPF-KAPAKLYA 382
             F    +YD KVDVFSFAL++ E+     PF+ +K      +    R RP     P   + 
Sbjct:   693 FSQSGKYDRKVDVFSFALVIWEIHTAELPFSHLKPAAAAAEMTYKRGRPTLPNQPTAQFP 752

Query:   383 RGLKELIEECWNEKPAKRPTFRQIITRLE 411
               +  LI + W+ + + RP F +I+  LE
Sbjct:   753 AHILSLIPQAWHPESSSRPDFVEIVALLE 781

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0043652 "engulfment of apoptotic cell" evidence=IMP

DICTYBASE|DDB_G0289791 drkA "DRK subfamily protein kinase" [Dictyostelium discoideum (taxid:44689)]

 Score = 410 (149.4 bits), Expect = 1.1e-39, Sum P(2) = 1.1e-39
 Identities = 103/275 (37%), Positives = 157/275 (57%)

Query:   149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
             +ID H++     V I KG +    L  WRG QVAVKKL    I+++  ++ F  E+ L++
Sbjct:   368 DIDIHQIKI--GVRIGKGNYGEVYLGTWRGSQVAVKKLPAHNINENI-LKEFHREINLMK 424

Query:   206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMN 264
              +RHPNV+QFLG+      + I TEY+P+G L + L  +   L+ S  ++  +D A+G+ 
Sbjct:   425 NLRHPNVIQFLGSCLIPPDICICTEYMPRGSLYSILHDQALQLQWSLLIKMMIDAAKGVI 484

Query:   265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
             YLH + PV I+HRDL+  N+L D++  +KVADFG+S +   ++   +T   T C + +PE
Sbjct:   485 YLHNSTPV-ILHRDLKSHNLLVDENWKVKVADFGLSTI--EQQGATMTACGTPC-WTSPE 540

Query:   325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPPF--KAPAKLY 381
             V +++ Y  K DV+SF +IL E      P+      +V  A      RPP     P K Y
Sbjct:   541 VLRSQRYTEKADVYSFGIILWECATRQDPYFGIPPFQVIFAVGREGMRPPVPQNGPPK-Y 599

Query:   382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
                  +L+ +C NE P+ RPT  Q + RLESI++S
Sbjct:   600 I----QLLIDCLNENPSHRPTMEQCLERLESIDSS 630

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005575 "cellular_component" evidence=ND

GO:0016740 "transferase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016021 "integral to membrane" evidence=IEA

GO:0016020 "membrane" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

GO:0044351 "macropinocytosis" evidence=RCA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

No confident hit for EC number transfering in SWISSPROT detected by BLAST

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Fail to connect to STRING server

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	458
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	6e-67
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	2e-64
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	2e-63
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	9e-63
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-62
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	1e-59
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-53
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	7e-48
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	6e-45
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-44
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	6e-42
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	9e-42
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-40
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	3e-38
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	9e-38
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-37
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	5e-37
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	2e-36
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	5e-36
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	5e-36
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	7e-36
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	1e-35
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-35
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	9e-35
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	1e-34
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	1e-34
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	2e-34
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-34
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	4e-34
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	6e-34
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	7e-34
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	1e-33
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	2e-33
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-33
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	1e-32
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-32
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	5e-32
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-32
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	8e-32
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	1e-31
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-31
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	1e-31
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-31
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	9e-31
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	1e-30
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	2e-30
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	3e-30
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	4e-30
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	4e-30
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	8e-30
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	8e-30
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	1e-29
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	1e-29
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	1e-29
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	2e-29
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	3e-29
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-29
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	4e-29
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	5e-29
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	6e-29
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	7e-29
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	8e-29
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	9e-29
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-28
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	5e-28
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	6e-28
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	9e-28
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	1e-27
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-27
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	2e-27
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	2e-27
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	4e-27
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	4e-27
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	8e-27
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	8e-27
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	9e-27
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-26
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	1e-26
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-26
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	1e-26
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	2e-26
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-26
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	4e-26
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	4e-26
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	6e-26
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	6e-26
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	9e-26
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	1e-25
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-25
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-25
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	2e-25
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	3e-25
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	4e-25
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	4e-25
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	5e-25
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	6e-25
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	1e-24
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	1e-24
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	2e-24
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	3e-24
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	4e-24
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	4e-24
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	6e-24
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-24
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-23
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	2e-23
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	2e-23
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	2e-23
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-23
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	3e-23
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	4e-23
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	5e-23
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	7e-23
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	8e-23
pfam12796	91	pfam12796, Ank_2, Ankyrin repeats (3 copies)	1e-22
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	1e-22
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	1e-22
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-22
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	3e-22
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	3e-22
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-22
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	4e-22
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	5e-22
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	5e-22
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	6e-22
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	6e-22
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	6e-22
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-22
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	8e-22
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	9e-22
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	2e-21
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	2e-21
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-21
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	3e-21
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	3e-21
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	3e-21
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	4e-21
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-21
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	7e-21
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-21
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	9e-21
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	1e-20
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-20
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	2e-20
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	2e-20
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	3e-20
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	4e-20
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	4e-20
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	5e-20
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	6e-20
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-19
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-19
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-19
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	1e-19
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	2e-19
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-19
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	2e-19
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-19
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	2e-19
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	3e-19
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	4e-19
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	5e-19
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	6e-19
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	8e-19
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	8e-19
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	9e-19
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-18
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-18
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-18
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	1e-18
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	1e-18
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-18
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-18
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-18
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-18
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-18
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-18
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-18
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	3e-18
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	3e-18
cd05037	259	cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom	4e-18
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-18
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	5e-18
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	6e-18
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	7e-18
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	7e-18
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	8e-18
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	8e-18
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	8e-18
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	9e-18
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	1e-17
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-17
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	1e-17
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-17
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	2e-17
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-17
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	2e-17
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	2e-17
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-17
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-17
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	3e-17
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-17
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	5e-17
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	5e-17
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	5e-17
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	6e-17
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	6e-17
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-17
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	8e-17
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	9e-17
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	1e-16
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-16
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-16
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	3e-16
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	3e-16
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	3e-16
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	4e-16
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	5e-16
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	5e-16
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	5e-16
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	5e-16
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	6e-16
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	7e-16
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	7e-16
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	7e-16
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	9e-16
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-15
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	1e-15
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-15
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	1e-15
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-15
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-15
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	2e-15
pfam12796	91	pfam12796, Ank_2, Ankyrin repeats (3 copies)	3e-15
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	3e-15
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	3e-15
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	3e-15
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	5e-15
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	7e-15
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	8e-15
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	8e-15
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	1e-14
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	2e-14
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	2e-14
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	3e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-14
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	3e-14
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	4e-14
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-14
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	6e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	6e-14
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	7e-14
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	1e-13
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	1e-13
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	1e-13
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-13
PHA03095	471	PHA03095, PHA03095, ankyrin-like protein; Provisio	2e-13
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	3e-13
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	4e-13
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	6e-13
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	7e-13
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	8e-13
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	9e-13
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	1e-12
PHA02988	283	PHA02988, PHA02988, hypothetical protein; Provisio	1e-12
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	1e-12
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	1e-12
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	1e-12
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-12
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	2e-12
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	2e-12
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-12
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	3e-12
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	4e-12
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	6e-12
PTZ00322	664	PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fruct	6e-12
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	9e-12
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	1e-11
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	1e-11
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-11
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	2e-11
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	2e-11
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	2e-11
PHA02874	434	PHA02874, PHA02874, ankyrin repeat protein; Provis	2e-11
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	3e-11
PHA02874	434	PHA02874, PHA02874, ankyrin repeat protein; Provis	4e-11
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	4e-11
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	5e-11
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	1e-10
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-10
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-10
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	3e-10
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	7e-10
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	1e-09
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	1e-09
PHA03095	471	PHA03095, PHA03095, ankyrin-like protein; Provisio	3e-09
cd05076	274	cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do	4e-09
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	5e-09
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	5e-09
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	1e-08
COG0666	235	COG0666, Arp, FOG: Ankyrin repeat [General functio	1e-08
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	1e-08
PHA03100	422	PHA03100, PHA03100, ankyrin repeat protein; Provis	1e-08
PHA02878	477	PHA02878, PHA02878, ankyrin repeat protein; Provis	1e-08
PLN03192	823	PLN03192, PLN03192, Voltage-dependent potassium ch	2e-08
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	2e-08
cd00204	126	cd00204, ANK, ankyrin repeats; ankyrin repeats med	3e-08
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	3e-08
PHA03100	422	PHA03100, PHA03100, ankyrin repeat protein; Provis	3e-08
pfam00023	33	pfam00023, Ank, Ankyrin repeat	3e-08
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	3e-08
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	8e-08
PHA03100	422	PHA03100, PHA03100, ankyrin repeat protein; Provis	9e-08
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	1e-07
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	1e-07
cd05078	258	cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat	1e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	2e-07
pfam13637	54	pfam13637, Ank_4, Ankyrin repeats (many copies)	2e-07
pfam13637	54	pfam13637, Ank_4, Ankyrin repeats (many copies)	2e-07
cd05077	262	cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do	3e-07
pfam13857	56	pfam13857, Ank_5, Ankyrin repeats (many copies)	3e-07
PHA02876	682	PHA02876, PHA02876, ankyrin repeat protein; Provis	4e-07
COG0666	235	COG0666, Arp, FOG: Ankyrin repeat [General functio	5e-07
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	6e-07
PLN00113	968	PLN00113, PLN00113, leucine-rich repeat receptor-l	7e-07
PLN03192	823	PLN03192, PLN03192, Voltage-dependent potassium ch	1e-06
PHA02875	413	PHA02875, PHA02875, ankyrin repeat protein; Provis	2e-06
COG0666	235	COG0666, Arp, FOG: Ankyrin repeat [General functio	3e-06
PHA02878	477	PHA02878, PHA02878, ankyrin repeat protein; Provis	5e-06
PHA02876	682	PHA02876, PHA02876, ankyrin repeat protein; Provis	5e-06
PHA03095	471	PHA03095, PHA03095, ankyrin-like protein; Provisio	2e-05
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-05
pfam13606	30	pfam13606, Ank_3, Ankyrin repeat	3e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	5e-05
smart00248	30	smart00248, ANK, ankyrin repeats	5e-05
PHA03095	471	PHA03095, PHA03095, ankyrin-like protein; Provisio	7e-05
PHA03100	422	PHA03100, PHA03100, ankyrin repeat protein; Provis	7e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	1e-04
PHA02875	413	PHA02875, PHA02875, ankyrin repeat protein; Provis	1e-04
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-04
PHA02878	477	PHA02878, PHA02878, ankyrin repeat protein; Provis	2e-04
PHA02875	413	PHA02875, PHA02875, ankyrin repeat protein; Provis	2e-04
PHA02876	682	PHA02876, PHA02876, ankyrin repeat protein; Provis	3e-04
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	3e-04
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	4e-04
PHA02876	682	PHA02876, PHA02876, ankyrin repeat protein; Provis	8e-04
PHA02878	477	PHA02878, PHA02878, ankyrin repeat protein; Provis	0.002
PHA02876	682	PHA02876, PHA02876, ankyrin repeat protein; Provis	0.002
PHA02946	446	PHA02946, PHA02946, ankyin-like protein; Provision	0.002
TIGR00870	743	TIGR00870, trp, transient-receptor-potential calci	0.002
PHA02716	764	PHA02716, PHA02716, CPXV016; CPX019; EVM010; Provi	0.003
PHA02736	154	PHA02736, PHA02736, Viral ankyrin protein; Provisi	0.003
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.003
PHA02798	489	PHA02798, PHA02798, ankyrin-like protein; Provisio	0.003

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  214 bits (548), Expect = 6e-67
 Identities = 82/266 (30%), Positives = 136/266 (51%), Gaps = 30/266 (11%)

Query: 162 EITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212
           ++ +G F        +G       +VAVK L E   + ++    F +E ++++K+ HPN+
Sbjct: 6   KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEG--ASEEEREEFLEEASIMKKLSHPNI 63

Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKP 271
           V+ LG  TQ  P+ IVTEY+P GDL  FL++ G  L     ++ AL IA+GM YL     
Sbjct: 64  VRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLESKN- 122

Query: 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC----RYVAPEVFK 327
              +HRDL   N L  ++  +K++DFG+S+ +   +      +        +++APE  K
Sbjct: 123 --FVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDY---YRKRGGGKLPIKWMAPESLK 177

Query: 328 NEEYDTKVDVFSFALILQEMIEGC-PPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARG 384
           + ++ +K DV+SF ++L E+      P+    + EV +      R   P   P +LY   
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDELY--- 234

Query: 385 LKELIEECWNEKPAKRPTFRQIITRL 410
             EL+ +CW   P  RPTF +++  L
Sbjct: 235 --ELMLQCWAYDPEDRPTFSELVEDL 258

Length = 258

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  207 bits (530), Expect = 2e-64
 Identities = 82/253 (32%), Positives = 129/253 (50%), Gaps = 36/253 (14%)

Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
            + ++VAVK L E+  + + ++  F  E  +++K+ HPNVV+ LG  T+  P+ IV EY+
Sbjct: 26  KKKVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNVVKLLGVCTEEEPLYIVMEYM 83

Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
             GDL ++L K +  L  S  + FAL IARGM YL        IHRDL   N L  ++  
Sbjct: 84  EGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLESK---NFIHRDLAARNCLVGENLV 140

Query: 292 LKVADFGVSKLLTVKE-------DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           +K++DFG+S+ L   +         P+       R++APE  K  ++ +K DV+SF ++L
Sbjct: 141 VKISDFGLSRDLYDDDYYRKRGGKLPI-------RWMAPESLKEGKFTSKSDVWSFGVLL 193

Query: 345 QEMI-------EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 397
            E+         G     +     +   Y  R   P   P +LY     +L+ +CW E P
Sbjct: 194 WEIFTLGEQPYPGMSNEEVLEY--LKNGY--RLPQPPNCPPELY-----DLMLQCWAEDP 244

Query: 398 AKRPTFRQIITRL 410
             RPTF +++  L
Sbjct: 245 EDRPTFSELVEIL 257

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  205 bits (524), Expect = 2e-63
 Identities = 86/267 (32%), Positives = 133/267 (49%), Gaps = 43/267 (16%)

Query: 166 GTFILAFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           G       +G      ++VAVK L E+  + + ++  F  E  +++K+ HPN+V+ LG  
Sbjct: 13  GEVYKGTLKGKGDGKEVEVAVKTLKED--ASEQQIEEFLREARIMRKLDHPNIVKLLGVC 70

Query: 220 TQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
           T+  P+MIV EY+P GDL  +L+  R   L  S  + FAL IARGM YL        IHR
Sbjct: 71  TEEEPLMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHR 127

Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKE-------DRPLTCQDTSCRYVAPEVFKNEE 330
           DL   N L  ++  +K++DFG+S+ L   +         P+       R++APE  K  +
Sbjct: 128 DLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPI-------RWMAPESLKEGK 180

Query: 331 YDTKVDVFSFALILQEMI-------EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
           + +K DV+SF ++L E+         G     +     + K Y  R   P   P +LY  
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEY--LKKGY--RLPKPPNCPPELY-- 234

Query: 384 GLKELIEECWNEKPAKRPTFRQIITRL 410
              +L+ +CW E P  RPTF +++  L
Sbjct: 235 ---KLMLQCWAEDPEDRPTFSELVEIL 258

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  203 bits (520), Expect = 9e-63
 Identities = 84/266 (31%), Positives = 134/266 (50%), Gaps = 29/266 (10%)

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+ KG       +  +VAVK L E+  + ++  + F  E  +++K+ HPNVV+ LG  T+
Sbjct: 10  EVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLGHPNVVRLLGVCTE 67

Query: 222 SSPMMIVTEYLPKGDLRAFLKR---------KGALKPSTAVRFALDIARGMNYLHENKPV 272
             P+ +V EY+  GDL  +L++         K  L     + FA+ IA+GM YL   K  
Sbjct: 68  EEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK-- 125

Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC----RYVAPEVFKN 328
             +HRDL   N L  +   +K++DFG+S+ +   +      + T      R++APE  K+
Sbjct: 126 -FVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY---YRKKTGGKLPIRWMAPESLKD 181

Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGL 385
             + +K DV+SF ++L E+   G  P+    + EV +      R P     P +LY    
Sbjct: 182 GIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPEYCPDELY---- 237

Query: 386 KELIEECWNEKPAKRPTFRQIITRLE 411
            EL+  CW   P  RPTF +++ RLE
Sbjct: 238 -ELMLSCWQLDPEDRPTFSELVERLE 262

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  202 bits (517), Expect = 2e-62
 Identities = 92/259 (35%), Positives = 138/259 (53%), Gaps = 14/259 (5%)

Query: 157 FTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +    ++  G+F     A  +  G  VAVK L +          A R E+ +L+++ HPN
Sbjct: 1   YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRRLSHPN 59

Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKP 271
           +V+ + A      + +V EY   GDL  +L R G L    A + AL I RG+ YLH N  
Sbjct: 60  IVRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNG- 118

Query: 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEE 330
             IIHRDL+P NIL D++G +K+ADFG++K L  K    LT    +  Y+APEV      
Sbjct: 119 --IIHRDLKPENILLDENGVVKIADFGLAKKLL-KSSSSLTTFVGTPWYMAPEVLLGGNG 175

Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG---LKE 387
           Y  KVDV+S  +IL E++ G PPF+ ++  +  +       PP +     ++ G    K+
Sbjct: 176 YGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKD 235

Query: 388 LIEECWNEKPAKRPTFRQI 406
           LI++C N+ P+KRPT  +I
Sbjct: 236 LIKKCLNKDPSKRPTAEEI 254

Length = 260

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  195 bits (498), Expect = 1e-59
 Identities = 79/255 (30%), Positives = 129/255 (50%), Gaps = 22/255 (8%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           ++ +G+F    LA  +  G  VA+K + ++ I  D        E+ +L+K++HPN+V+  
Sbjct: 6   KLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKD--RERILREIKILKKLKHPNIVRLY 63

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
                   + +V EY   GDL   LK++G L    A  +   I   + YLH      I+H
Sbjct: 64  DVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKG---IVH 120

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDT 333
           RDL+P NIL D+ G++K+ADFG+++ L   E        T      Y+APEV   + Y  
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKL-----TTFVGTPEYMAPEVLLGKGYGK 175

Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEE 391
            VD++S  +IL E++ G PPF    D+++ + +    + +PPF  P    +   K+LI +
Sbjct: 176 AVDIWSLGVILYELLTGKPPF--PGDDQLLELFKKIGKPKPPFPPPEWDISPEAKDLIRK 233

Query: 392 CWNEKPAKRPTFRQI 406
              + P KR T  + 
Sbjct: 234 LLVKDPEKRLTAEEA 248

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  177 bits (452), Expect = 2e-53
 Identities = 79/256 (30%), Positives = 118/256 (46%), Gaps = 49/256 (19%)

Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
           + +G F    LA  +  G +VA+K +  +       +     E+ +L+K+ HPN+V+  G
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKII--KKEDSSSLLEELLREIEILKKLNHPNIVKLYG 58

Query: 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIH 276
                + + +V EY   G L+  LK     L     +R  L I  G+ YLH N    IIH
Sbjct: 59  VFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIH 115

Query: 277 RDLEPSNIL-RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTK 334
           RDL+P NIL   D+G +K+ADFG+SKLLT  +    T   T   Y+APEV   +  Y  K
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP-AYMAPEVLLGKGYYSEK 174

Query: 335 VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394
            D++S  +IL E+ E                                   LK+LI +   
Sbjct: 175 SDIWSLGVILYELPE-----------------------------------LKDLIRKMLQ 199

Query: 395 EKPAKRPTFRQIITRL 410
           + P KRP+ ++I+  L
Sbjct: 200 KDPEKRPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  165 bits (419), Expect = 7e-48
 Identities = 70/232 (30%), Positives = 113/232 (48%), Gaps = 16/232 (6%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM--IVTEYLPKG 235
           +AVK + E     ++ + A   E+ +L  ++HPN+V++ G+          I  EY+  G
Sbjct: 28  MAVKSV-ELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGG 86

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
            L + LK+ G L      ++   I  G+ YLH N    I+HRD++ +NIL D  G +K+A
Sbjct: 87  SLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLA 143

Query: 296 DFGVSKLL--TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
           DFG +K L      +   + + T   ++APEV + EEY    D++S    + EM  G PP
Sbjct: 144 DFGCAKRLGDIETGEGTGSVRGTP-YWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202

Query: 354 FTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402
           ++    N +   Y    + + P    P  L     K+ + +C    P KRPT
Sbjct: 203 WSE-LGNPMAALYKIGSSGEPPEI--PEHLSE-EAKDFLRKCLRRDPKKRPT 250

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score =  157 bits (398), Expect = 6e-45
 Identities = 94/279 (33%), Positives = 149/279 (53%), Gaps = 36/279 (12%)

Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
           + I+  EL    +  I KG F   +L  +RG +VAVK L ++  +     +AF  E +++
Sbjct: 1   WAINSKELKLGAT--IGKGEFGDVMLGDYRGQKVAVKCLKDDSTA----AQAFLAEASVM 54

Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARG 262
             +RHPN+VQ LG V Q +P+ IVTEY+ KG L  +L+ +G   +  +  + FALD+  G
Sbjct: 55  TTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEG 114

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CR 319
           M YL E      +HRDL   N+L  +    KV+DFG++K  +         QD+     +
Sbjct: 115 MEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQG-------QDSGKLPVK 164

Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPF 374
           + APE  + +++ TK DV+SF ++L E+   G  P+      +V     K Y  R   P 
Sbjct: 165 WTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGY--RMEAPE 222

Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
             P ++Y     +++++CW   PAKRPTF+Q+  +L  I
Sbjct: 223 GCPPEVY-----KVMKDCWELDPAKRPTFKQLREQLALI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score =  154 bits (390), Expect = 9e-44
 Identities = 95/271 (35%), Positives = 147/271 (54%), Gaps = 26/271 (9%)

Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP EL F    E+  G F    L  WRG I VA+K + E  +S+DD    F +E  ++ 
Sbjct: 1   IDPSELTFLK--ELGSGQFGVVHLGKWRGKIDVAIKMIREGAMSEDD----FIEEAKVMM 54

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
           K+ HPN+VQ  G  T+  P+ IVTEY+  G L  +L+ RKG L     +    D+   M 
Sbjct: 55  KLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME 114

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS--CRYVA 322
           YL  N     IHRDL   N L  +   +KV+DFG+++   V +D+  + Q T    ++  
Sbjct: 115 YLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARY--VLDDQYTSSQGTKFPVKWAP 169

Query: 323 PEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAA--RQRPPFKAPAK 379
           PEVF    + +K DV+SF +++ E+  EG  P+    ++EV ++ +A  R   P  AP +
Sbjct: 170 PEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYRPKLAPTE 229

Query: 380 LYARGLKELIEECWNEKPAKRPTFRQIITRL 410
           +Y      ++  CW+EKP  RP F++++++L
Sbjct: 230 VY-----TIMYSCWHEKPEDRPAFKKLLSQL 255

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  148 bits (377), Expect = 6e-42
 Identities = 78/259 (30%), Positives = 128/259 (49%), Gaps = 27/259 (10%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
            F    +I KG F     A  +  G +VA+K +  E     +++     E+ +L+K +HP
Sbjct: 1   LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIIN---EIQILKKCKHP 57

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHEN 269
           N+V++ G+  +   + IV E+   G L+  LK     L  S       ++ +G+ YLH N
Sbjct: 58  NIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSN 117

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVF 326
               IIHRD++ +NIL    G +K+ DFG+S  L+  + R     +T      ++APEV 
Sbjct: 118 G---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKAR-----NTMVGTPYWMAPEVI 169

Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA--YAARQRPP-FKAPAKLYAR 383
             + YD K D++S  +   E+ EG PP+    +    KA    A   PP  + P K ++ 
Sbjct: 170 NGKPYDYKADIWSLGITAIELAEGKPPY---SELPPMKALFKIATNGPPGLRNPEK-WSD 225

Query: 384 GLKELIEECWNEKPAKRPT 402
             K+ +++C  + P KRPT
Sbjct: 226 EFKDFLKKCLQKNPEKRPT 244

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score =  148 bits (375), Expect = 9e-42
 Identities = 91/266 (34%), Positives = 139/266 (52%), Gaps = 22/266 (8%)

Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           I+P EL F    E+  G F    L  WR  I+VA+K + E  +S++D    F +E  ++ 
Sbjct: 1   INPSELTFMK--ELGSGQFGVVHLGKWRAQIKVAIKAINEGAMSEED----FIEEAKVMM 54

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
           K+ HP +VQ  G  TQ  P+ IVTE++  G L  +L+ R+G L     +    D+  GM 
Sbjct: 55  KLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGME 114

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
           YL  N     IHRDL   N L   +G +KV+DFG+++ +   E    +      ++  PE
Sbjct: 115 YLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPE 171

Query: 325 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
           VF   +Y +K DV+SF +++ E+  EG  PF  K + EV +  +   R   P  A   +Y
Sbjct: 172 VFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRPKLASMTVY 231

Query: 382 ARGLKELIEECWNEKPAKRPTFRQII 407
                E++  CW+EKP  RPTF +++
Sbjct: 232 -----EVMYSCWHEKPEGRPTFAELL 252

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score =  143 bits (363), Expect = 5e-40
 Identities = 85/270 (31%), Positives = 141/270 (52%), Gaps = 24/270 (8%)

Query: 150 IDPHELDFTNSVEITKGTFILAFWRGI-----QVAVKKLGEEVISDDDRVRAFRDELALL 204
           I P EL      EI  G F L  W G      +VA+K + E  +S++D    F +E  ++
Sbjct: 1   IHPSELTL--VQEIGSGQFGLV-WLGYWLEKRKVAIKTIREGAMSEED----FIEEAQVM 53

Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGM 263
            K+ HP +VQ  G  T+ SP+ +V E++  G L  +L+ ++G     T +   LD+  GM
Sbjct: 54  MKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGM 113

Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 323
            YL  +    +IHRDL   N L  ++  +KV+DFG+++ +   +    T      ++ +P
Sbjct: 114 AYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSP 170

Query: 324 EVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKL 380
           EVF   +Y +K DV+SF +++ E+  EG  P+  + ++EV +   A  R   P  A   +
Sbjct: 171 EVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKPRLASQSV 230

Query: 381 YARGLKELIEECWNEKPAKRPTFRQIITRL 410
           Y     EL++ CW E+P  RP+F  ++ +L
Sbjct: 231 Y-----ELMQHCWKERPEDRPSFSLLLHQL 255

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  139 bits (352), Expect = 3e-38
 Identities = 67/239 (28%), Positives = 119/239 (49%), Gaps = 12/239 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G    +K++    +S+ +R  A   E+ +L+K+ HPN++++  +  +   + IV EY   
Sbjct: 25  GKLYVLKEIDLSNMSEKEREDALN-EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADG 83

Query: 235 GDLRAFLKRKGALKPSTAVRFALD----IARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           GDL   +K++            LD    +   + YLH  K   I+HRD++P NI    +G
Sbjct: 84  GDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNG 140

Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
            +K+ DFG+SK+L+   D   T   T   Y++PE+ +N+ Y+ K D++S   +L E+   
Sbjct: 141 LVKLGDFGISKVLSSTVDLAKTVVGTPY-YLSPELCQNKPYNYKSDIWSLGCVLYELCTL 199

Query: 351 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409
             PF  ++  E+       Q PP  +    Y+  L+ L+     + P +RP+  QI+  
Sbjct: 200 KHPFEGENLLELALKILKGQYPPIPSQ---YSSELRNLVSSLLQKDPEERPSIAQILQS 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score =  137 bits (347), Expect = 9e-38
 Identities = 79/244 (32%), Positives = 129/244 (52%), Gaps = 23/244 (9%)

Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
           + G +VAVK      I  D   +AF +E A++ K+ H N+V+ LG +  +  + IV E +
Sbjct: 27  YTGQKVAVK-----NIKCDVTAQAFLEETAVMTKLHHKNLVRLLGVILHNG-LYIVMELM 80

Query: 233 PKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            KG+L  FL+ +G    S    ++F+LD+A GM YL   K   ++HRDL   NIL  + G
Sbjct: 81  SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDG 137

Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 349
             KV+DFG++++        +       ++ APE  K++++ +K DV+S+ ++L E+   
Sbjct: 138 VAKVSDFGLARV----GSMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSY 193

Query: 350 GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           G  P+      EV +      R  PP   PA +Y      L+  CW  +P KRP+F ++ 
Sbjct: 194 GRAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYV-----LMTSCWETEPKKRPSFHKLR 248

Query: 408 TRLE 411
            +LE
Sbjct: 249 EKLE 252

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score =  137 bits (348), Expect = 1e-37
 Identities = 84/258 (32%), Positives = 124/258 (48%), Gaps = 23/258 (8%)

Query: 162 EITKGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220
           E+  GT     W G  +VAVK L    +S      AF  E  +++K+RH  +VQ     +
Sbjct: 21  EVWMGT-----WNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCS 71

Query: 221 QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
           +  P+ IVTEY+ KG L  FLK      L+    V  A  IA GM YL        IHRD
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRD 128

Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
           L   NIL  ++   K+ADFG+++L+   E           ++ APE      +  K DV+
Sbjct: 129 LAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVW 188

Query: 339 SFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKA--PAKLYARGLKELIEECWNE 395
           SF ++L E++  G  P+    + EV +      R P     P +LY     +L+ +CW++
Sbjct: 189 SFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPRPPNCPEELY-----DLMLQCWDK 243

Query: 396 KPAKRPTFRQIITRLESI 413
            P +RPTF  + + LE  
Sbjct: 244 DPEERPTFEYLQSFLEDY 261

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score =  136 bits (344), Expect = 5e-37
 Identities = 88/257 (34%), Positives = 130/257 (50%), Gaps = 19/257 (7%)

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+ +G   L   + I VA+K L +   SD  R   F  E +++ +  HPN+++  G VT+
Sbjct: 19  EVCRGRLKLPGKKEIDVAIKTL-KAGSSDKQR-LDFLTEASIMGQFDHPNIIRLEGVVTK 76

Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MI+TEY+  G L  FL+   G       V     IA GM YL E   V   HRDL 
Sbjct: 77  SRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYV---HRDLA 133

Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFS 339
             NIL + +   KV+DFG+S+ L   E    T       R+ APE     ++ +  DV+S
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWS 193

Query: 340 FALILQE-MIEGCPPFTMKHDNEVPKA----YAARQRPPFKAPAKLYARGLKELIEECWN 394
           F +++ E M  G  P+    + +V KA    Y  R  PP   P+ LY     +L+ +CW 
Sbjct: 194 FGIVMWEVMSYGERPYWDMSNQDVIKAVEDGY--RLPPPMDCPSALY-----QLMLDCWQ 246

Query: 395 EKPAKRPTFRQIITRLE 411
           +   +RPTF QI++ L+
Sbjct: 247 KDRNERPTFSQIVSTLD 263

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score =  134 bits (338), Expect = 2e-36
 Identities = 87/270 (32%), Positives = 139/270 (51%), Gaps = 22/270 (8%)

Query: 150 IDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP +L F    E+  G F       WRG   VA+K + E  +S+D+    F +E  ++ 
Sbjct: 1   IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMN 264
           K+ H  +VQ  G  T+  P+ IVTEY+  G L  +L+  G   +PS  +    D+  GM 
Sbjct: 55  KLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMA 114

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
           YL   +    IHRDL   N L DD G +KV+DFG+S+ +   E           R+  PE
Sbjct: 115 YLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171

Query: 325 VFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
           V    ++ +K DV++F +++ E+   G  P+   +++E  +  +   R   P  A  K+Y
Sbjct: 172 VLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPHLASEKVY 231

Query: 382 ARGLKELIEECWNEKPAKRPTFRQIITRLE 411
           A     ++  CW+EK  +RPTF+Q+++ +E
Sbjct: 232 A-----IMYSCWHEKAEERPTFQQLLSSIE 256

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score =  134 bits (338), Expect = 5e-36
 Identities = 76/253 (30%), Positives = 123/253 (48%), Gaps = 24/253 (9%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
              +VA+K + E   S  +R   F +E +++++    +VV+ LG V+   P ++V E + 
Sbjct: 35  PETRVAIKTVNENA-SMRER-IEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMA 92

Query: 234 KGDLRAFLKRK-------GALKPSTAVRF---ALDIARGMNYLHENKPVPIIHRDLEPSN 283
           KGDL+++L+ +         L P T  +F   A +IA GM YL   K    +HRDL   N
Sbjct: 93  KGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARN 149

Query: 284 ILRDDSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
            +  +   +K+ DFG+++ +   +  R         R++APE  K+  + TK DV+SF +
Sbjct: 150 CMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGV 209

Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKELIEECWNEKPAK 399
           +L EM      P+    + EV K          P   P KL      EL+  CW   P  
Sbjct: 210 VLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPENCPDKLL-----ELMRMCWQYNPKM 264

Query: 400 RPTFRQIITRLES 412
           RPTF +I++ L+ 
Sbjct: 265 RPTFLEIVSSLKD 277

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  133 bits (336), Expect = 5e-36
 Identities = 71/229 (31%), Positives = 112/229 (48%), Gaps = 14/229 (6%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L ++ I     V     E  +L +I HP +V+   A      + +V EY P G+L 
Sbjct: 22  AMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELF 81

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           + L ++G      A  +A +I   + YLH      II+RDL+P NIL D  G++K+ DFG
Sbjct: 82  SHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFG 138

Query: 299 VSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
           ++K L+ +  R     +T C    Y+APEV   + Y   VD +S  ++L EM+ G PPF 
Sbjct: 139 LAKELSSEGSRT----NTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPF- 193

Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
             +  +  + Y    + P + P  L +   ++LI     + P KR    
Sbjct: 194 --YAEDRKEIYEKILKDPLRFPEFL-SPEARDLISGLLQKDPTKRLGSG 239

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score =  132 bits (335), Expect = 7e-36
 Identities = 86/275 (31%), Positives = 143/275 (52%), Gaps = 30/275 (10%)

Query: 152 PHELDFTNSVEITKGTFILAF---WRG-IQVAVKKLGEEVISDDDRVRA--FRDELALLQ 205
           P E +FT   ++  G F   +   W+  ++VA+K     ++  DD ++   F+ E+  L+
Sbjct: 4   PRE-EFTLERKLGSGYFGEVWEGLWKNRVRVAIK-----ILKSDDLLKQQDFQKEVQALK 57

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGM 263
           ++RH +++      +   P+ I+TE + KG L AFL+      L  ++ +  A  +A GM
Sbjct: 58  RLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM 117

Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--RYV 321
            YL E      IHRDL   NIL  +    KVADFG+++L+  KED  L+  D     ++ 
Sbjct: 118 AYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLI--KEDVYLS-SDKKIPYKWT 171

Query: 322 APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA--RQRPPFKAPA 378
           APE   +  + TK DV+SF ++L EM   G  P+   +++EV     A  R   P K P 
Sbjct: 172 APEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQ 231

Query: 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           ++Y     +++ ECW  +P  RP+F+ +   L++I
Sbjct: 232 EIY-----KIMLECWAAEPEDRPSFKALREELDNI 261

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score =  132 bits (335), Expect = 1e-35
 Identities = 86/264 (32%), Positives = 127/264 (48%), Gaps = 44/264 (16%)

Query: 176 IQVAVKKLGE--EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
             VA+K L E  E     +    FR E  L+  ++HPN+V  LG  T+  P  ++ EYL 
Sbjct: 36  TSVAIKTLKENAEPKVQQE----FRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLA 91

Query: 234 KGDLRAFLKR----------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
            GDL  FL R                K +L  S  +  A+ IA GM YL  +     +HR
Sbjct: 92  HGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHR 148

Query: 278 DLEPSNILRDDSGNLKVADFGVSKLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEY 331
           DL   N L  +   +K++DFG+S+ +       V+    L       R++ PE     ++
Sbjct: 149 DLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL-----PVRWMPPEAILYGKF 203

Query: 332 DTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKEL 388
            T+ D++SF ++L E+   G  P+    + EV +   +RQ    P   PA++YA     L
Sbjct: 204 TTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCPEDCPARVYA-----L 258

Query: 389 IEECWNEKPAKRPTFRQIITRLES 412
           + ECWNE PA+RP F+ I TRL S
Sbjct: 259 MIECWNEIPARRPRFKDIHTRLRS 282

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score =  131 bits (331), Expect = 3e-35
 Identities = 78/255 (30%), Positives = 126/255 (49%), Gaps = 29/255 (11%)

Query: 171 AFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV 228
             W+   + VAVK L E+ +     V  F  E A++++I+HPN+VQ LG  T+  P  I+
Sbjct: 25  GVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80

Query: 229 TEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
           TE++  G+L  +L+   +  +     +  A  I+  M YL +      IHRDL   N L 
Sbjct: 81  TEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLV 137

Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALI 343
            ++  +KVADFG+S+L+T       T    +    ++ APE     ++  K DV++F ++
Sbjct: 138 GENHLVKVADFGLSRLMT---GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVL 194

Query: 344 LQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 398
           L E+   G  P+     ++V     K Y  R   P   P K+Y     EL+  CW   P+
Sbjct: 195 LWEIATYGMSPYPGIDLSQVYELLEKGY--RMERPEGCPPKVY-----ELMRACWQWNPS 247

Query: 399 KRPTFRQIITRLESI 413
            RP+F +I    E++
Sbjct: 248 DRPSFAEIHQAFETM 262

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  129 bits (327), Expect = 9e-35
 Identities = 71/245 (28%), Positives = 122/245 (49%), Gaps = 23/245 (9%)

Query: 175 GIQVAVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
           G ++AVK++  +  S + +  V A   E+ LL+ ++H  +VQ+ G +     + I  EY+
Sbjct: 27  GRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYM 86

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           P G ++  LK  GAL  +   ++   I  G+ YLH N    I+HRD++ +NILRD +GN+
Sbjct: 87  PGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNV 143

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQ 345
           K+ DFG SK L     + +    T  +       +++PEV   E Y  K DV+S    + 
Sbjct: 144 KLGDFGASKRL-----QTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVV 198

Query: 346 EMIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 403
           EM+   PP+    + E   A    A Q    + P+ + +   +  +   + E   KRP+ 
Sbjct: 199 EMLTEKPPWA---EFEAMAAIFKIATQPTNPQLPSHV-SPDARNFLRRTFVENAKKRPSA 254

Query: 404 RQIIT 408
            +++ 
Sbjct: 255 EELLR 259

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score =  129 bits (326), Expect = 1e-34
 Identities = 75/266 (28%), Positives = 128/266 (48%), Gaps = 16/266 (6%)

Query: 153 HELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV 212
            EL   N   + KG +++   + ++VAVK L +E I+   +   F  E +++ ++ HP +
Sbjct: 1   KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKK--EFLREASVMAQLDHPCI 58

Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
           V+ +G V +  P+M+V E  P G L  +LK++  +  S     A  +A GM YL     V
Sbjct: 59  VRLIG-VCKGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFV 117

Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEE 330
              HRDL   N+L  +    K++DFG+S+ L    D  R  T      ++ APE     +
Sbjct: 118 ---HRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGK 174

Query: 331 YDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKE 387
           + +K DV+S+ + L E    G  P+      EV     + +R   P + P ++Y+     
Sbjct: 175 FSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLPRPEECPQEIYS----- 229

Query: 388 LIEECWNEKPAKRPTFRQIITRLESI 413
           ++  CW  +P  RPTF ++ +     
Sbjct: 230 IMLSCWKYRPEDRPTFSELESTFRRD 255

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score =  129 bits (325), Expect = 1e-34
 Identities = 85/263 (32%), Positives = 138/263 (52%), Gaps = 32/263 (12%)

Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA- 218
           I KG F   +L  +RG +VAVK      I +D   +AF  E +++ ++RH N+VQ LG  
Sbjct: 14  IGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68

Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
           V +   + IVTEY+ KG L  +L+ +G   L     ++F+LD+   M YL  N     +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVH 125

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDT 333
           RDL   N+L  +    KV+DFG++K  +       + QDT     ++ APE  + +++ T
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTKEAS-------STQDTGKLPVKWTAPEALREKKFST 178

Query: 334 KVDVFSFALILQEMIE-GCPPFTMKHDNEV-PKAYAA-RQRPPFKAPAKLYARGLKELIE 390
           K DV+SF ++L E+   G  P+      +V P+     +   P   P  +Y     ++++
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY-----DVMK 233

Query: 391 ECWNEKPAKRPTFRQIITRLESI 413
           +CW+   A RP+F Q+  +LE I
Sbjct: 234 QCWHLDAATRPSFLQLREQLEHI 256

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score =  129 bits (326), Expect = 2e-34
 Identities = 74/270 (27%), Positives = 125/270 (46%), Gaps = 50/270 (18%)

Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--MMIV 228
           G QVAVK L     E+  SD      F  E+ +L+ + H N+V++ G   +     + ++
Sbjct: 33  GEQVAVKSLNHSGEEQHRSD------FEREIEILRTLDHENIVKYKGVCEKPGGRSLRLI 86

Query: 229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
            EYLP G LR +L+R +  +     + F+  I +GM+YL   +    IHRDL   NIL +
Sbjct: 87  MEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVE 143

Query: 288 DSGNLKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
               +K++DFG++K+L        VKE       ++   + APE  +  ++ +  DV+SF
Sbjct: 144 SEDLVKISDFGLAKVLPEDKDYYYVKEPG-----ESPIFWYAPECLRTSKFSSASDVWSF 198

Query: 341 ALILQEMIEGC-----PP--FTMKHDNEVPKAYAAR--------QR--PPFKAPAKLYAR 383
            + L E+         PP  F         +    R        +R   P   P ++Y  
Sbjct: 199 GVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVY-- 256

Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              +L++ CW  +P  RP+F  +I  ++ +
Sbjct: 257 ---DLMKLCWEAEPQDRPSFADLILIVDRL 283

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  128 bits (325), Expect = 2e-34
 Identities = 75/240 (31%), Positives = 115/240 (47%), Gaps = 12/240 (5%)

Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
             G   A+KK+   V  D++  +    EL  L+    P VV+  GA  +   + IV EY+
Sbjct: 24  PTGKIYALKKI--HVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYM 81

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
             G L   LK+ G +        A  I +G++YLH  +   IIHRD++PSN+L +  G +
Sbjct: 82  DGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH--IIHRDIKPSNLLINSKGEV 139

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
           K+ADFG+SK+L    D+  T   T   Y++PE  + E Y    D++S  L L E   G  
Sbjct: 140 KIADFGISKVLENTLDQCNTFVGT-VTYMSPERIQGESYSYAADIWSLGLTLLECALGKF 198

Query: 353 PFTMKHDNEVPK----AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
           PF        P       A    PP   PA+ ++   ++ I  C  + P KRP+  +++ 
Sbjct: 199 PFL---PPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAELLQ 255

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score =  128 bits (323), Expect = 4e-34
 Identities = 76/251 (30%), Positives = 116/251 (46%), Gaps = 26/251 (10%)

Query: 173 WRGI-----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           W G+      VAVK L    +   D    F  E  +++K+RHP ++Q     T   P+ I
Sbjct: 23  WEGLWNNTTPVAVKTLKPGTMDPKD----FLAEAQIMKKLRHPKLIQLYAVCTLEEPIYI 78

Query: 228 VTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           VTE +  G L  +L+     ALK    +  A  +A GM YL        IHRDL   N+L
Sbjct: 79  VTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVL 135

Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
             ++   KVADFG+++++               ++ APE      +  K DV+SF ++L 
Sbjct: 136 VGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLT 195

Query: 346 EMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
           E++  G  P+    + EV     + Y  R   P   P +LY     +++ +CW E P  R
Sbjct: 196 EIVTYGRMPYPGMTNAEVLQQVDQGY--RMPCPPGCPKELY-----DIMLDCWKEDPDDR 248

Query: 401 PTFRQIITRLE 411
           PTF  +  +LE
Sbjct: 249 PTFETLQWKLE 259

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score =  127 bits (321), Expect = 6e-34
 Identities = 76/248 (30%), Positives = 116/248 (46%), Gaps = 25/248 (10%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
             +VAVK     +  D  R   F  E  +L++  HPN+V+ +G   Q  P+ IV E +P 
Sbjct: 19  NTEVAVKTCRSTLPPDLKR--KFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPG 76

Query: 235 GDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G L  FL++K   L     ++ +LD A GM YL E+K    IHRDL   N L  ++  LK
Sbjct: 77  GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYL-ESKNC--IHRDLAARNCLVGENNVLK 133

Query: 294 VADFGVSKLLTVKEDRPLTCQD----TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
           ++DFG+S+    +E    T  D       ++ APE      Y ++ DV+S+ ++L E   
Sbjct: 134 ISDFGMSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFS 190

Query: 350 G--CPPFTMKHD---NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
               P   M +      +   Y  R   P   P ++Y      L+ +CW   P  RP+F 
Sbjct: 191 LGDTPYPGMSNQQTRERIESGY--RMPAPQLCPEEIY-----RLMLQCWAYDPENRPSFS 243

Query: 405 QIITRLES 412
           +I   L+ 
Sbjct: 244 EIYNELQI 251

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  127 bits (323), Expect = 7e-34
 Identities = 67/186 (36%), Positives = 102/186 (54%), Gaps = 16/186 (8%)

Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
           G  VA+KK+     EE I       A R E++LL++++HPN+V+ L  +     + +V E
Sbjct: 24  GEIVALKKIRLDNEEEGIP----STALR-EISLLKELKHPNIVKLLDVIHTERKLYLVFE 78

Query: 231 YLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           Y    DL+ +L KR G L P+        + RG+ Y H ++   I+HRDL+P NIL +  
Sbjct: 79  YCDM-DLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRD 134

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMI 348
           G LK+ADFG+++   +   R  T +  +  Y APE+   ++ Y T VD++S   I  EMI
Sbjct: 135 GVLKLADFGLARAFGIP-LRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMI 193

Query: 349 EGCPPF 354
            G P F
Sbjct: 194 TGKPLF 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  126 bits (319), Expect = 1e-33
 Identities = 68/233 (29%), Positives = 114/233 (48%), Gaps = 14/233 (6%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K++    +S  +R  A  +E+ +L  + HPN++ +  A    + + IV EY P GDL 
Sbjct: 29  ALKEVDLGSMSQKEREDAV-NEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLS 87

Query: 239 AFLKRKGALK---PSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
             + ++   +   P   + R  + + RG+  LHE K   I+HRDL+ +NIL   +  +K+
Sbjct: 88  KAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKI 144

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            D G+SK+L          Q  +  Y+APEV+K   Y  K D++S   +L EM    PPF
Sbjct: 145 GDLGISKVLK---KNMAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPF 201

Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             +   ++       + PP      +Y++ L+  I      KP  RP   +I+
Sbjct: 202 EARSMQDLRYKVQRGKYPPIPP---IYSQDLQNFIRSMLQVKPKLRPNCDKIL 251

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  126 bits (318), Expect = 2e-33
 Identities = 67/234 (28%), Positives = 109/234 (46%), Gaps = 18/234 (7%)

Query: 179 AVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           AVK   E  I D+D   ++   DE+ +L+ ++HPN+V++ G       + I  EY   G 
Sbjct: 29  AVK---EIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGT 85

Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L   L+    L       + L +  G+ YLH +    I+HRD++P+NI  D +G +K+ D
Sbjct: 86  LEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGD 142

Query: 297 FGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTK---VDVFSFALILQEMIEG 350
           FG +  L            +   +  Y+APEV    +        D++S   ++ EM  G
Sbjct: 143 FGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATG 202

Query: 351 CPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402
             P++ + DNE    +   A  +PP     +L   G K+ ++ C    P KRPT
Sbjct: 203 KRPWS-ELDNEFQIMFHVGAGHKPPIPDSLQLSPEG-KDFLDRCLESDPKKRPT 254

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  125 bits (316), Expect = 3e-33
 Identities = 72/259 (27%), Positives = 131/259 (50%), Gaps = 21/259 (8%)

Query: 156 DFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALLQKIRH 209
           ++     I +G F    ++G+       VA+K++  E I ++  +++   E+ LL+ ++H
Sbjct: 1   NYQLGDLIGRGAFG-VVYKGLNLETGDFVAIKQISLEKIKEEA-LKSIMQEIDLLKNLKH 58

Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
           PN+V+++G++  S  + I+ EY   G LR  +K+ G    S    +   + +G+ YLHE 
Sbjct: 59  PNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQ 118

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
               +IHRD++ +NIL    G +K+ADFGV+  L        +   T   ++APEV +  
Sbjct: 119 G---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTP-YWMAPEVIEMS 174

Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAYA--ARQRPPFKAPAKLYARGLK 386
              T  D++S    + E++ G PP+   +D N +   +       PP   P  +    LK
Sbjct: 175 GASTASDIWSLGCTVIELLTGNPPY---YDLNPMAALFRIVQDDHPPL--PEGISPE-LK 228

Query: 387 ELIEECWNEKPAKRPTFRQ 405
           + + +C+ + P  RPT +Q
Sbjct: 229 DFLMQCFQKDPNLRPTAKQ 247

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score =  124 bits (312), Expect = 1e-32
 Identities = 84/261 (32%), Positives = 133/261 (50%), Gaps = 22/261 (8%)

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   R I VA+K L  +    + + R F  E +++ +  HPN++   G VT+
Sbjct: 19  EVCSGRLKLPGKREIPVAIKTL--KAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76

Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L AFL++  G       V     IA GM YL +   +  +HRDL 
Sbjct: 77  SKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 133

Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     T       R+ APE     ++ +  
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 190

Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEEC 392
           DV+S+ +++ E++  G  P+    + +V KA     R   P   PA L+     +L+ +C
Sbjct: 191 DVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPAPMDCPAALH-----QLMLDC 245

Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W +   +RP F QI++ L+ +
Sbjct: 246 WQKDRNERPKFEQIVSILDKL 266

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  124 bits (313), Expect = 2e-32
 Identities = 73/270 (27%), Positives = 124/270 (45%), Gaps = 42/270 (15%)

Query: 157 FTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           FT    I KG+F   + + I       VA+K +  E    +D +   + E+  L + R P
Sbjct: 3   FTLLECIGKGSFGEVY-KAIDKRTNQVVAIKVIDLE--EAEDEIEDIQQEIQFLSQCRSP 59

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
            + ++ G+  + S + I+ EY   G     LK  G L  +       ++  G+ YLHE  
Sbjct: 60  YITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREVLLGLEYLHEEG 118

Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---------YV 321
               IHRD++ +NIL  + G++K+ADFGVS  LT           T  +         ++
Sbjct: 119 K---IHRDIKAANILLSEEGDVKLADFGVSGQLT----------STMSKRNTFVGTPFWM 165

Query: 322 APEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT----MKHDNEVPKAYAARQRPPFKAP 377
           APEV K   YD K D++S  +   E+ +G PP +    M+    +PK        P    
Sbjct: 166 APEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPK------NNPPSLE 219

Query: 378 AKLYARGLKELIEECWNEKPAKRPTFRQII 407
              +++  K+ +  C N+ P +RP+ ++++
Sbjct: 220 GNKFSKPFKDFVSLCLNKDPKERPSAKELL 249

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score =  122 bits (309), Expect = 5e-32
 Identities = 65/256 (25%), Positives = 124/256 (48%), Gaps = 15/256 (5%)

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           ++ +G ++      I VAVK       +       F  E  ++++  HP++V+ +G +T+
Sbjct: 21  DVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE 78

Query: 222 SSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           + P+ IV E  P G+LR++L   K +L  ++ + ++  ++  + YL   + V   HRD+ 
Sbjct: 79  N-PVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFV---HRDIA 134

Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
             N+L      +K+ DFG+S+ L  +     +      +++APE      + +  DV+ F
Sbjct: 135 ARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMF 194

Query: 341 ALILQE-MIEGCPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKP 397
            + + E ++ G  PF    +N+V       +R P     P  LY+     L+ +CW   P
Sbjct: 195 GVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPMPPNCPPTLYS-----LMTKCWAYDP 249

Query: 398 AKRPTFRQIITRLESI 413
           +KRP F ++  +L  I
Sbjct: 250 SKRPRFTELKAQLSDI 265

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  122 bits (307), Expect = 7e-32
 Identities = 69/225 (30%), Positives = 119/225 (52%), Gaps = 14/225 (6%)

Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS 250
           ++ V A R E+ L+ ++ HP++++ LGA  + S   +  E++  G +   L + GA K +
Sbjct: 44  EEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEA 103

Query: 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKEDR 309
             + +   + RG++YLHEN+   IIHRD++ +N+L D +G  L++ADFG +  L  K   
Sbjct: 104 VIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTG 160

Query: 310 PLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM-KHDNEVP-- 363
               Q     +  ++APEV + E+Y    DV+S   ++ EM    PP+   KH N +   
Sbjct: 161 AGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALI 220

Query: 364 -KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            K  +A   P    P  L + GL+++   C   +P  RP  R+++
Sbjct: 221 FKIASATTAPSI--PEHL-SPGLRDVTLRCLELQPEDRPPSRELL 262

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score =  122 bits (309), Expect = 8e-32
 Identities = 77/271 (28%), Positives = 124/271 (45%), Gaps = 55/271 (20%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
             VAVK L ++    D  +     E+ +++ I +H N++  LG  TQ  P+ +V EY   
Sbjct: 43  STVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAH 100

Query: 235 GDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
           G+LR FL+ +                  L     V FA  +ARGM +L   K    IHRD
Sbjct: 101 GNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRD 157

Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----TSCR----YVAPEVFKNE 329
           L   N+L  +   +K+ADFG++        R +   D     T+ R    ++APE   + 
Sbjct: 158 LAARNVLVTEDHVMKIADFGLA--------RDIHHIDYYRKTTNGRLPVKWMAPEALFDR 209

Query: 330 EYDTKVDVFSFALILQEMIE--GCPPFTMKHDNEVPKAYA-----ARQRPPFKAPAKLYA 382
            Y  + DV+SF ++L E+    G P   +     V + +       R   P     +LY 
Sbjct: 210 VYTHQSDVWSFGVLLWEIFTLGGSPYPGIP----VEELFKLLKEGYRMEKPQNCTQELYH 265

Query: 383 RGLKELIEECWNEKPAKRPTFRQIITRLESI 413
                L+ +CW+E P++RPTF+Q++  L+ +
Sbjct: 266 -----LMRDCWHEVPSQRPTFKQLVEDLDRM 291

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  121 bits (305), Expect = 1e-31
 Identities = 73/236 (30%), Positives = 116/236 (49%), Gaps = 18/236 (7%)

Query: 179 AVK--KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           AVK   L ++  +  + V+    E+ALL K++HPN+VQ+LG   +   + I  E +P G 
Sbjct: 29  AVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGS 88

Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L   LK+ G+        +   I  G+ YLH+      +HRD++ +NIL D +G +K+AD
Sbjct: 89  LAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLAD 145

Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFT 355
           FG++K   V E         S  ++APEV   +  Y    D++S    + EM  G PP+ 
Sbjct: 146 FGMAK--QVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW- 202

Query: 356 MKHDNE----VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
                E    V K   +++ PP   P  L     K+ I +C    P+ RPT  +++
Sbjct: 203 --SQLEGVAAVFKIGRSKELPPI--PDHLSDEA-KDFILKCLQRDPSLRPTAAELL 253

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  121 bits (306), Expect = 1e-31
 Identities = 68/239 (28%), Positives = 108/239 (45%), Gaps = 18/239 (7%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
            A+K + +  +   ++V     E  +L + + P VV+   +      + +V EYLP GDL
Sbjct: 21  YAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
            + L+  G+L    A  +  +I   + YLH N    IIHRDL+P NIL D +G+LK+ DF
Sbjct: 81  ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDF 137

Query: 298 GVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
           G+SK+  V+    L   +   +       Y+APEV   + +   VD +S   IL E + G
Sbjct: 138 GLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVG 197

Query: 351 CPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
            PPF   H     + +      +    +           +LI +     P KR   + I
Sbjct: 198 IPPF---HGETPEEIFQNILNGKIEWPEDVEVSDE--AIDLISKLLVPDPEKRLGAKSI 251

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score =  121 bits (305), Expect = 1e-31
 Identities = 87/261 (33%), Positives = 134/261 (51%), Gaps = 22/261 (8%)

Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSS 223
           GT I +  + I  AVK L    I+D + V  F  E  +++   HPNV+  LG    ++ S
Sbjct: 14  GTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGS 71

Query: 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRDLEP 281
           P+ +V  Y+  GDLR F+ R     P+    + F L +A+GM YL   K    +HRDL  
Sbjct: 72  PL-VVLPYMKHGDLRNFI-RSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAA 126

Query: 282 SNILRDDSGNLKVADFGVSKLLTVKE---DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
            N + D+S  +KVADFG+++ +  KE       T      +++A E  + +++ TK DV+
Sbjct: 127 RNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVW 186

Query: 339 SFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395
           SF ++L E M  G PP+      D  V      R   P   P  LY     E++  CW+ 
Sbjct: 187 SFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQPEYCPDPLY-----EVMLSCWHP 241

Query: 396 KPAKRPTFRQIITRLESINNS 416
           KP  RPTF ++++R+E I ++
Sbjct: 242 KPEMRPTFSELVSRIEQIFST 262

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score =  120 bits (303), Expect = 2e-31
 Identities = 86/264 (32%), Positives = 132/264 (50%), Gaps = 30/264 (11%)

Query: 159 NSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
           N  E+ KGT          VAVK   E+ +  + +++ F  E  +L++  HPN+V+ +G 
Sbjct: 7   NFGEVFKGTL----KDKTPVAVKTCKED-LPQELKIK-FLSEARILKQYDHPNIVKLIGV 60

Query: 219 VTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
            TQ  P+ IV E +P GD  +FL K+K  LK    V+FALD A GM YL        IHR
Sbjct: 61  CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117

Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC----QDTSCRYVAPEVFKNEEYDT 333
           DL   N L  ++  LK++DFG+S+    +ED  +      +    ++ APE      Y +
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSR----QEDDGIYSSSGLKQIPIKWTAPEALNYGRYSS 173

Query: 334 KVDVFSFALILQEMIE--GCPPFTMKHDN---EVPKAYAARQRPPFKAPAKLYARGLKEL 388
           + DV+S+ ++L E      CP   M +     +V K Y  R   P K P  +Y     ++
Sbjct: 174 ESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGY--RMSCPQKCPDDVY-----KV 226

Query: 389 IEECWNEKPAKRPTFRQIITRLES 412
           ++ CW+ KP  RP F ++   L +
Sbjct: 227 MQRCWDYKPENRPKFSELQKELAA 250

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  119 bits (301), Expect = 9e-31
 Identities = 65/239 (27%), Positives = 119/239 (49%), Gaps = 18/239 (7%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+KK    +           +E+ +++  +HPN+V +  +      + +V EY+  
Sbjct: 44  GKEVAIKK----MRLRKQNKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDG 99

Query: 235 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G L   + +    +          ++ +G+ YLH      +IHRD++  NIL    G++K
Sbjct: 100 GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVK 156

Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
           +ADFG +  LT ++ +  +   T   ++APEV K ++Y  KVD++S  ++  EM EG PP
Sbjct: 157 LADFGFAAQLTKEKSKRNSVVGTP-YWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPP 215

Query: 354 FTMKHDNEVP-KA-YAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
               +  E P +A +    +  PP K P K  +   K+ + +C  + P KRP+  +++ 
Sbjct: 216 ----YLREPPLRALFLITTKGIPPLKNPEKW-SPEFKDFLNKCLVKDPEKRPSAEELLQ 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  119 bits (299), Expect = 1e-30
 Identities = 71/193 (36%), Positives = 106/193 (54%), Gaps = 18/193 (9%)

Query: 175 GIQVAVKK--LGEEVISDDDRVRAFRD----ELALLQKIRHPNVVQFLGAVTQSSPMMIV 228
           G  +AVK+  L     S  DR R+  D    E+ALL++++H N+VQ+LG+   +  + I 
Sbjct: 25  GELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIF 84

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            EY+P G + A L   GA + +    F   I +G+NYLH      IIHRD++ +NIL D+
Sbjct: 85  LEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDN 141

Query: 289 SGNLKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
            G +K++DFG+SK L            RP + Q  S  ++APEV K   Y  K D++S  
Sbjct: 142 KGGIKISDFGISKKLEANSLSTKTNGARP-SLQG-SVFWMAPEVVKQTSYTRKADIWSLG 199

Query: 342 LILQEMIEGCPPF 354
            ++ EM+ G  PF
Sbjct: 200 CLVVEMLTGKHPF 212

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score =  118 bits (297), Expect = 2e-30
 Identities = 81/245 (33%), Positives = 127/245 (51%), Gaps = 28/245 (11%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VA+K L +  +S +    AF  E  L+++++HP +V+    VTQ  P+ I+TEY+  G 
Sbjct: 32  KVAIKSLKQGSMSPE----AFLAEANLMKQLQHPRLVRLYAVVTQE-PIYIITEYMENGS 86

Query: 237 LRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           L  FLK      L  +  +  A  IA GM ++        IHRDL  +NIL  ++   K+
Sbjct: 87  LVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKI 143

Query: 295 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
           ADFG+++L+   ED   T ++ +    ++ APE      +  K DV+SF ++L E++  G
Sbjct: 144 ADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYG 200

Query: 351 CPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
             P+    + EV     + Y  R   P   P +LY     EL+  CW EKP +RPTF  +
Sbjct: 201 RIPYPGMTNPEVIQNLERGY--RMPRPDNCPEELY-----ELMRLCWKEKPEERPTFEYL 253

Query: 407 ITRLE 411
            + LE
Sbjct: 254 RSVLE 258

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score =  117 bits (295), Expect = 3e-30
 Identities = 77/243 (31%), Positives = 128/243 (52%), Gaps = 23/243 (9%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK L    +S    V+AF +E  L++ ++H  +V+    VT+  P+ I+TEY+ KG 
Sbjct: 32  KVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGS 87

Query: 237 LRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           L  FLK    G +     + F+  IA GM Y+        IHRDL  +N+L  +S   K+
Sbjct: 88  LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKI 144

Query: 295 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
           ADFG+++++   ED   T ++ +    ++ APE      +  K DV+SF ++L E++  G
Sbjct: 145 ADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYG 201

Query: 351 CPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
             P+    +++V  A     R P     P +LY     ++++ CW EK  +RPTF  + +
Sbjct: 202 KIPYPGMSNSDVMSALQRGYRMPRMENCPDELY-----DIMKTCWKEKAEERPTFDYLQS 256

Query: 409 RLE 411
            L+
Sbjct: 257 VLD 259

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  117 bits (296), Expect = 4e-30
 Identities = 71/246 (28%), Positives = 127/246 (51%), Gaps = 16/246 (6%)

Query: 163 ITKGTFILAFWRGIQVAVKK-LGEEVI---SDDDRVRAFRDELALLQKIRH---PNVVQF 215
           I +G +  A +RG  V   + +  ++I   + DD V   + E+ALL ++R    PN+ ++
Sbjct: 9   IGRGAY-GAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKY 67

Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
            G+  +   + I+ EY   G +R  L + G +          ++   + Y+H+   V +I
Sbjct: 68  YGSYLKGPRLWIIMEYAEGGSVRT-LMKAGPIAEKYISVIIREVLVALKYIHK---VGVI 123

Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTK 334
           HRD++ +NIL  ++GN+K+ DFGV+ LL     +  T   T   ++APEV    + YDTK
Sbjct: 124 HRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTP-YWMAPEVITEGKYYDTK 182

Query: 335 VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394
            D++S  + + EM  G PP++   D         + +PP +     Y++ L+E +  C +
Sbjct: 183 ADIWSLGITIYEMATGNPPYS-DVDAFRAMMLIPKSKPP-RLEDNGYSKLLREFVAACLD 240

Query: 395 EKPAKR 400
           E+P +R
Sbjct: 241 EEPKER 246

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score =  118 bits (297), Expect = 4e-30
 Identities = 79/263 (30%), Positives = 114/263 (43%), Gaps = 45/263 (17%)

Query: 177 QVAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
            VAVK L  +     D  R  F  E+ +L ++  PN+ + LG  T   P+ ++ EY+  G
Sbjct: 48  LVAVKVLRPDA---SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENG 104

Query: 236 DLRAFLKR-----------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           DL  FL++             +L  ST +  A  IA GM YL     V   HRDL   N 
Sbjct: 105 DLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFV---HRDLATRNC 161

Query: 285 LRDDSGNLKVADFGVSKLLTVK-----EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           L   +  +K+ADFG+S+ L        + R         R++A E     ++ TK DV++
Sbjct: 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAP----LPIRWMAWESVLLGKFTTKSDVWA 217

Query: 340 FALILQEMIEGC--PPFTMKHDNEV----------PKAYAARQRPPFKAPAKLYARGLKE 387
           F + L E++  C   P+    D +V                  RPP   P  +Y     E
Sbjct: 218 FGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPP-NCPKDIY-----E 271

Query: 388 LIEECWNEKPAKRPTFRQIITRL 410
           L+ ECW      RPTFR+I   L
Sbjct: 272 LMLECWRRDEEDRPTFREIHLFL 294

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score =  116 bits (293), Expect = 8e-30
 Identities = 82/263 (31%), Positives = 130/263 (49%), Gaps = 24/263 (9%)

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+ +G   L   R I VA+K L  +    + + R F  E +++ +  HPN++   G VT+
Sbjct: 19  EVCRGRLKLPGKREIFVAIKTL--KSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 76

Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MI+TE++  G L +FL++  G       V     IA GM YL E   +  +HRDL 
Sbjct: 77  SRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLA 133

Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC-------RYVAPEVFKNEEYDT 333
             NIL + +   KV+DFG+S+ L   ED       TS        R+ APE     ++ +
Sbjct: 134 ARNILVNSNLVCKVSDFGLSRFL---EDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTS 190

Query: 334 KVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIE 390
             DV+S+ +++ E M  G  P+    + +V  A     R  PP   P  L+     +L+ 
Sbjct: 191 ASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPPPMDCPTALH-----QLML 245

Query: 391 ECWNEKPAKRPTFRQIITRLESI 413
           +CW +    RP F QI++ L+ +
Sbjct: 246 DCWQKDRNARPKFGQIVSTLDKM 268

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score =  117 bits (293), Expect = 8e-30
 Identities = 77/256 (30%), Positives = 127/256 (49%), Gaps = 31/256 (12%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K L +  I++  +   F+ E +L+ ++ HPN+V  LG VTQ  P+ ++ EYL +GDL
Sbjct: 37  VAIKTLKD--INNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDL 94

Query: 238 RAFL-----------------KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             FL                   K +L     +  A+ IA GM YL  +     +H+DL 
Sbjct: 95  HEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLA 151

Query: 281 PSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
             NIL  +  ++K++D G+S+ + +    R         R++ PE     ++ +  D++S
Sbjct: 152 ARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWS 211

Query: 340 FALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK--APAKLYARGLKELIEECWNEK 396
           F ++L E+   G  P+    + EV +    RQ  P     P ++Y+     L+ ECW E 
Sbjct: 212 FGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRMYS-----LMTECWQEG 266

Query: 397 PAKRPTFRQIITRLES 412
           P++RP F+ I TRL S
Sbjct: 267 PSRRPRFKDIHTRLRS 282

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score =  116 bits (292), Expect = 1e-29
 Identities = 77/253 (30%), Positives = 110/253 (43%), Gaps = 39/253 (15%)

Query: 176 IQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           I VAVK L  + +SD  DD    F  E A++  + H N+++  G V    P+M+VTE  P
Sbjct: 24  IPVAVKCLKSDKLSDIMDD----FLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP 78

Query: 234 KGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
            G L   L+    G    ST   +A+ IA GM YL   +    IHRDL   NIL      
Sbjct: 79  LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDK 135

Query: 292 LKVADFGVSKLLTVKEDR---------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
           +K+ DFG+ + L   ED          P         + APE  +   +    DV+ F +
Sbjct: 136 VKIGDFGLMRALPQNEDHYVMEEHLKVPFA-------WCAPESLRTRTFSHASDVWMFGV 188

Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAYAAR----QRPPFKAPAKLYARGLKELIEECWNEKP 397
            L EM   G  P+     +++ K         +RP    P  +Y      ++ +CW   P
Sbjct: 189 TLWEMFTYGEEPWAGLSGSQILKKIDKEGERLERPEA-CPQDIY-----NVMLQCWAHNP 242

Query: 398 AKRPTFRQIITRL 410
           A RPTF  +   L
Sbjct: 243 ADRPTFAALREFL 255

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  116 bits (291), Expect = 1e-29
 Identities = 85/291 (29%), Positives = 141/291 (48%), Gaps = 31/291 (10%)

Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALL 204
           DP EL FT    I KG+F   F +GI       VA+K +  E    +D +   + E+ +L
Sbjct: 1   DPEEL-FTKLERIGKGSFGEVF-KGIDNRTQQVVAIKIIDLE--EAEDEIEDIQQEITVL 56

Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN 264
            +   P V ++ G+  + + + I+ EYL  G     L R G            +I +G++
Sbjct: 57  SQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLL-RAGPFDEFQIATMLKEILKGLD 115

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
           YLH  K    IHRD++ +N+L  + G++K+ADFGV+  LT  + +  T   T   ++APE
Sbjct: 116 YLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPE 171

Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL--YA 382
           V +   YD+K D++S  +   E+ +G PP +  H   V         P    P     ++
Sbjct: 172 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-----LFLIPKNNPPTLTGEFS 226

Query: 383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNS---------INHKRRWK 424
           +  KE I+ C N+ P+ RPT ++++     + N+         I+  +RWK
Sbjct: 227 KPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKKTSYLTELIDRFKRWK 277

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score =  116 bits (292), Expect = 1e-29
 Identities = 75/250 (30%), Positives = 120/250 (48%), Gaps = 24/250 (9%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  E  S+ D    F  E  ++ K  H N+V+ +G   +  P  I+ E +  G
Sbjct: 37  LQVAVKTL-PESCSEQDESD-FLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGG 94

Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A D+A+G  YL EN     IHRD+   N L   
Sbjct: 95  DLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTC 151

Query: 289 SGN---LKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
            G     K+ADFG+++ +      R         +++ PE F +  + +K DV+SF ++L
Sbjct: 152 KGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLL 211

Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            E+   G  P+  + + EV +      R  PP   P  +Y      ++ +CW   P  RP
Sbjct: 212 WEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPPKGCPGPVY-----RIMTDCWQHTPEDRP 266

Query: 402 TFRQIITRLE 411
            F  I+ R++
Sbjct: 267 NFATILERIQ 276

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  115 bits (289), Expect = 2e-29
 Identities = 85/287 (29%), Positives = 144/287 (50%), Gaps = 23/287 (8%)

Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQK 206
           DP EL FT   +I KG+F   F +GI    +K+    I D    +D +   + E+ +L +
Sbjct: 1   DPEEL-FTKLEKIGKGSFGEVF-KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58

Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
              P V ++ G+  + + + I+ EYL  G     L+  G L  +       +I +G++YL
Sbjct: 59  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYL 117

Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
           H  K    IHRD++ +N+L  + G +K+ADFGV+  LT  + +  T   T   ++APEV 
Sbjct: 118 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVI 173

Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386
           K   YD+K D++S  +   E+ +G PP +  H  +V         P  +     Y++ LK
Sbjct: 174 KQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEGN---YSKPLK 230

Query: 387 ELIEECWNEKPAKRPTFRQIITRLESINNS---------INHKRRWK 424
           E +E C N++P+ RPT ++++     +  +         I+  +RWK
Sbjct: 231 EFVEACLNKEPSFRPTAKELLKHKFIVRFAKKTSYLTELIDRYKRWK 277

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score =  115 bits (289), Expect = 3e-29
 Identities = 78/247 (31%), Positives = 122/247 (49%), Gaps = 23/247 (9%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           V VK L +    D++    FR EL + +K+ H NVV+ LG   ++ P  ++ EY   GDL
Sbjct: 38  VLVKALQK--TKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL 95

Query: 238 RAFL----KRKGALKP---STAVRFAL--DIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           + FL     +   LKP   ST  + AL   IA GM++L   +    +HRDL   N L   
Sbjct: 96  KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSS 152

Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
              +KV+   +SK +   E   L       R++APE  + +++ TK DV+SF +++ E+ 
Sbjct: 153 QREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVF 212

Query: 349 -EGCPPFTMKHDNEV---PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            +G  PF    D EV    +A       P   P++LY     +L+  CW   P  RP+F 
Sbjct: 213 TQGELPFYGLSDEEVLNRLQAGKLELPVPEGCPSRLY-----KLMTRCWAVNPKDRPSFS 267

Query: 405 QIITRLE 411
           ++++ L 
Sbjct: 268 ELVSALG 274

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score =  115 bits (288), Expect = 3e-29
 Identities = 79/261 (30%), Positives = 130/261 (49%), Gaps = 22/261 (8%)

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+ +G   +   + + VA+K L +   ++  R   F  E +++ +  H N+++  G VT+
Sbjct: 20  EVFRGILKMPGRKEVAVAIKTL-KPGYTEKQRQD-FLSEASIMGQFSHHNIIRLEGVVTK 77

Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             P MI+TEY+  G L  +L+   G       V     IA GM YL +   +  +HRDL 
Sbjct: 78  FKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNYVHRDLA 134

Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     TS      R+ APE     ++ +  
Sbjct: 135 ARNILVNSNLECKVSDFGLSRVL---EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSAS 191

Query: 336 DVFSFALILQE-MIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF +++ E M  G  P+    ++EV KA     R   P   P+ +Y     +L+ +C
Sbjct: 192 DVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPAPMDCPSAVY-----QLMLQC 246

Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W +  A+RP F  I+  L+ +
Sbjct: 247 WQQDRARRPRFVDIVNLLDKL 267

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  114 bits (288), Expect = 4e-29
 Identities = 54/218 (24%), Positives = 104/218 (47%), Gaps = 14/218 (6%)

Query: 199 DELALLQKIRHPNVVQFLG--AVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTA 252
            E+ +L++++HPN+V++        +  + IV EY   GDL   +++    +  ++    
Sbjct: 48  SEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFI 107

Query: 253 VRFALDIARGMNYLH---ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
            R    +   +   H   +     ++HRDL+P+NI  D + N+K+ DFG++K+L      
Sbjct: 108 WRILTQLLLALYECHNRSDPGNT-VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF 166

Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
             T   T   Y++PE   +  YD K D++S   ++ E+    PPFT ++  ++       
Sbjct: 167 AKTYVGTP-YYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG 225

Query: 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           +          Y+  L E+I+   N  P KRP+  +++
Sbjct: 226 KFRRIPY---RYSSELNEVIKSMLNVDPDKRPSTEELL 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score =  114 bits (287), Expect = 5e-29
 Identities = 76/255 (29%), Positives = 122/255 (47%), Gaps = 25/255 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIV 228
             +VAVK L  ++ S  D +  F  E A +++  HPNV++ +G   +S         M++
Sbjct: 27  FQKVAVKMLKADIFSSSD-IEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVI 85

Query: 229 TEYLPKGDLRAFL--KRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
             ++  GDL  FL   R G     L   T VRF +DIA GM YL        IHRDL   
Sbjct: 86  LPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAAR 142

Query: 283 NILRDDSGNLKVADFGVS-KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
           N + +++  + VADFG+S K+ +    R         +++A E   +  Y T  DV++F 
Sbjct: 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFG 202

Query: 342 LILQE-MIEGCPPFTMKHDNEVPKAYAA--RQRPPFKAPAKLYARGLKELIEECWNEKPA 398
           + + E M  G  P+    ++E+        R + P      +Y     EL+ +CW+ +P 
Sbjct: 203 VTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQPPDCLEDVY-----ELMCQCWSPEPK 257

Query: 399 KRPTFRQIITRLESI 413
            RP+F+ +  +LE I
Sbjct: 258 CRPSFQHLRDQLELI 272

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  117 bits (292), Expect = 6e-29
 Identities = 68/276 (24%), Positives = 118/276 (42%), Gaps = 27/276 (9%)

Query: 156 DFTNSVEITKGTFILAF--WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NV 212
            +    ++ +G+F   +       VA+K L +++ S    V  F  E+ +L  + HP N+
Sbjct: 1   SYRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNI 60

Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAVRFALDIARGMNYLHEN 269
           V+          + +V EY+  G L   LK   RKG L  S A+     I   + YLH  
Sbjct: 61  VKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSK 120

Query: 270 KPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLT-----VKEDRPLTCQDTSCRYVAP 323
               IIHRD++P NIL D  G  +K+ DFG++KLL             +    +  Y+AP
Sbjct: 121 G---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAP 177

Query: 324 EVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA---------YAARQR 371
           EV          +  D++S  + L E++ G PPF  + ++                +   
Sbjct: 178 EVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS 237

Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           P   +  +L ++   +L+++   + P  R +    +
Sbjct: 238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDL 273

Length = 384

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score =  114 bits (287), Expect = 7e-29
 Identities = 81/286 (28%), Positives = 132/286 (46%), Gaps = 48/286 (16%)

Query: 162 EITKGT-FILAFWRGIQ-VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           ++ K T F L    G   VAVK L E   +    +R    E  LL+++ HP+V++  GA 
Sbjct: 15  KVVKATAFRLKGRAGYTTVAVKMLKEN--ASSSELRDLLSEFNLLKQVNHPHVIKLYGAC 72

Query: 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPS------------------------TAVRF 255
           +Q  P++++ EY   G LR+FL+    + PS                          + F
Sbjct: 73  SQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISF 132

Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
           A  I+RGM YL E K   ++HRDL   N+L  +   +K++DFG+S+ +  ++      + 
Sbjct: 133 AWQISRGMQYLAEMK---LVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKG 189

Query: 316 -TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-------GCPPFTMKHDNEVPKAYA 367
               +++A E   +  Y T+ DV+SF ++L E++        G  P  +   N +   Y 
Sbjct: 190 RIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF--NLLKTGY- 246

Query: 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
            R   P     ++Y      L+  CW ++P KRPTF  I   LE +
Sbjct: 247 -RMERPENCSEEMYN-----LMLTCWKQEPDKRPTFADISKELEKM 286

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  114 bits (286), Expect = 8e-29
 Identities = 85/287 (29%), Positives = 141/287 (49%), Gaps = 23/287 (8%)

Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQK 206
           DP EL FT    I KG+F    ++GI    K++    I D    +D +   + E+ +L +
Sbjct: 1   DPEEL-FTKLERIGKGSF-GEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQ 58

Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
              P + ++ G+  + + + I+ EYL  G     LK  G L+ +       +I +G++YL
Sbjct: 59  CDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGLDYL 117

Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
           H  +    IHRD++ +N+L  + G++K+ADFGV+  LT  + +  T   T   ++APEV 
Sbjct: 118 HSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEVI 173

Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386
           K   YD K D++S  +   E+ +G PP +  H   V         P  +     Y++  K
Sbjct: 174 KQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQ---YSKPFK 230

Query: 387 ELIEECWNEKPAKRPTFRQI-----ITRLES----INNSINHKRRWK 424
           E +E C N+ P  RPT +++     ITR       +   I+  +RWK
Sbjct: 231 EFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWK 277

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score =  113 bits (284), Expect = 9e-29
 Identities = 88/257 (34%), Positives = 132/257 (51%), Gaps = 29/257 (11%)

Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   +  W G  +VAVK L    +S +    +F +E  +++K+RH  +VQ L AV    P
Sbjct: 20  GEVWMGTWNGNTKVAVKTLKPGTMSPE----SFLEEAQIMKKLRHDKLVQ-LYAVVSEEP 74

Query: 225 MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + IVTEY+ KG L  FLK     ALK    V  A  +A GM Y+     +  IHRDL  +
Sbjct: 75  IYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSA 131

Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
           NIL  D    K+ADFG+++L+   ED   T +  +    ++ APE      +  K DV+S
Sbjct: 132 NILVGDGLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188

Query: 340 FALILQEMI-EGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394
           F ++L E++ +G  P+   ++ E    V + Y  R   P   P  L+     EL+ +CW 
Sbjct: 189 FGILLTELVTKGRVPYPGMNNREVLEQVERGY--RMPCPQDCPISLH-----ELMLQCWK 241

Query: 395 EKPAKRPTFRQIITRLE 411
           + P +RPTF  + + LE
Sbjct: 242 KDPEERPTFEYLQSFLE 258

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  112 bits (282), Expect = 5e-28
 Identities = 62/190 (32%), Positives = 102/190 (53%), Gaps = 7/190 (3%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
            G  VA+KK+    +      +A R E+  LQ  +HP VV+ L      S  ++V EY+P
Sbjct: 24  TGETVALKKVALRRLEGGIPNQALR-EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMP 82

Query: 234 KGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
             DL   L+  +  L  +    +   + +G+ Y+H N    I+HRDL+P+N+L    G L
Sbjct: 83  -SDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVL 138

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGC 351
           K+ADFG+++L + +E R  + Q  +  Y APE+ +   +YD  VD+++   I  E++ G 
Sbjct: 139 KIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGS 198

Query: 352 PPFTMKHDNE 361
           P F  ++D E
Sbjct: 199 PLFPGENDIE 208

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score =  112 bits (281), Expect = 5e-28
 Identities = 67/240 (27%), Positives = 117/240 (48%), Gaps = 16/240 (6%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K L EE  +     +   DE  ++  + HP+VV+ LG +  SS + ++T+ +P G
Sbjct: 37  IPVAIKVLREE--TSPKANKEILDEAYVMASVDHPHVVRLLG-ICLSSQVQLITQLMPLG 93

Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GM+YL E +   ++HRDL   N+L     ++K+
Sbjct: 94  CLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKI 150

Query: 295 ADFGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCP 352
            DFG++KLL V E            +++A E   +  Y  K DV+S+ + + E M  G  
Sbjct: 151 TDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210

Query: 353 PFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
           P+      E+P      +R   P      +Y      ++ +CW      RPTF+++I   
Sbjct: 211 PYEGIPAVEIPDLLEKGERLPQPPICTIDVYM-----VLVKCWMIDAESRPTFKELINEF 265

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score =  112 bits (281), Expect = 6e-28
 Identities = 82/254 (32%), Positives = 125/254 (49%), Gaps = 35/254 (13%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A  K+ +E  S++D  R F  EL +L K+  HPN++  LGA      + I  EY P G+L
Sbjct: 32  AAIKMLKEFASENDH-RDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNL 90

Query: 238 RAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIHRDLEP 281
             FL++   L+   A                ++FA D+A GM YL E +    IHRDL  
Sbjct: 91  LDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAA 147

Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
            N+L  ++   K+ADFG+S+   V   +  T      R++A E      Y TK DV+SF 
Sbjct: 148 RNVLVGENLASKIADFGLSRGEEVYVKK--TMGRLPVRWMAIESLNYSVYTTKSDVWSFG 205

Query: 342 LILQEMIE--GCPPFTM---KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 396
           ++L E++   G P   M   +   ++P+ Y  R   P     ++Y     EL+ +CW ++
Sbjct: 206 VLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RMEKPRNCDDEVY-----ELMRQCWRDR 258

Query: 397 PAKRPTFRQIITRL 410
           P +RP F QI  +L
Sbjct: 259 PYERPPFAQISVQL 272

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score =  112 bits (280), Expect = 9e-28
 Identities = 82/257 (31%), Positives = 128/257 (49%), Gaps = 36/257 (14%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           +  A+K++ E    DD R   F  EL +L K+  HPN++  LGA      + +  EY P 
Sbjct: 35  MDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 92

Query: 235 GDLRAFLKRKGALK--PSTAV--------------RFALDIARGMNYLHENKPVPIIHRD 278
           G+L  FL++   L+  P+ A+               FA D+ARGM+YL + +    IHRD
Sbjct: 93  GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRD 149

Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
           L   NIL  ++   K+ADFG+S+   V   +  T      R++A E      Y T  DV+
Sbjct: 150 LAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVW 207

Query: 339 SFALILQEMIE--GCPPFTM---KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
           S+ ++L E++   G P   M   +   ++P+ Y  R   P     ++Y     +L+ +CW
Sbjct: 208 SYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVY-----DLMRQCW 260

Query: 394 NEKPAKRPTFRQIITRL 410
            EKP +RP+F QI+  L
Sbjct: 261 REKPYERPSFAQILVSL 277

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score =  110 bits (277), Expect = 1e-27
 Identities = 87/261 (33%), Positives = 133/261 (50%), Gaps = 34/261 (13%)

Query: 162 EITKGTFILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT 220
           E+  GT     W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L AV 
Sbjct: 21  EVWMGT-----WNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-LYAVV 70

Query: 221 QSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
              P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  +HRD
Sbjct: 71  SEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRD 127

Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKV 335
           L  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +  K 
Sbjct: 128 LRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKS 184

Query: 336 DVFSFALILQEM-IEGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYARGLKELIE 390
           DV+SF ++L E+  +G  P+    + E    V + Y  R   P + P  L+     +L+ 
Sbjct: 185 DVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCPPECPESLH-----DLMC 237

Query: 391 ECWNEKPAKRPTFRQIITRLE 411
           +CW ++P +RPTF  +   LE
Sbjct: 238 QCWRKEPEERPTFEYLQAFLE 258

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  110 bits (277), Expect = 1e-27
 Identities = 54/192 (28%), Positives = 89/192 (46%), Gaps = 6/192 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K + ++   +   VR   +E  +LQ++ HP +V    +      M +V + L  GDLR
Sbjct: 29  AMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLR 88

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L +K          +  +I   + YLH      IIHRD++P NIL D+ G++ + DF 
Sbjct: 89  YHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFN 145

Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358
           ++  +T   D   T    +  Y+APEV   + Y   VD +S  +   E + G  P+   H
Sbjct: 146 IATKVT--PDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYR-GH 202

Query: 359 DNEVPKAYAARQ 370
              +     A+Q
Sbjct: 203 SRTIRDQIRAKQ 214

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score =  110 bits (277), Expect = 2e-27
 Identities = 79/267 (29%), Positives = 129/267 (48%), Gaps = 50/267 (18%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS---PMMIVTEYLPK 234
           VAVKKL     S  + +R F  E+ +L+ ++H N+V++ G V  S+    + +V EYLP 
Sbjct: 36  VAVKKLQH---STAEHLRDFEREIEILKSLQHDNIVKYKG-VCYSAGRRNLRLVMEYLPY 91

Query: 235 GDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G LR +L K +  L     + +A  I +GM YL   +    +HRDL   NIL +    +K
Sbjct: 92  GSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVK 148

Query: 294 VADFGVSKLL-------TVKE--DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           + DFG++K+L        V+E  + P+        + APE     ++    DV+SF ++L
Sbjct: 149 IGDFGLTKVLPQDKEYYKVREPGESPIF-------WYAPESLTESKFSVASDVWSFGVVL 201

Query: 345 QEMIEGC-----PP--FTMKHDNEVPKAYAA-----------RQRPPFKAPAKLYARGLK 386
            E+         PP  F     N+                  R   P   PA++YA    
Sbjct: 202 YELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYA---- 257

Query: 387 ELIEECWNEKPAKRPTFRQIITRLESI 413
            +++ECWN  P++RP+F ++  ++E+I
Sbjct: 258 -IMKECWNNDPSQRPSFSELALQVEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  110 bits (276), Expect = 2e-27
 Identities = 65/223 (29%), Positives = 101/223 (45%), Gaps = 20/223 (8%)

Query: 200 ELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
           EL + +  + P +V++ GA     SS + I  EY   G L +  K+          +   
Sbjct: 49  ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLG 108

Query: 258 DIA----RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
            IA    +G++YLH  K   IIHRD++PSNIL    G +K+ DFGVS  L        T 
Sbjct: 109 KIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAGTFT- 164

Query: 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK----AYAAR 369
             TS  Y+APE  + + Y    DV+S  L L E+ +   PF  + +  +      +Y   
Sbjct: 165 -GTS-FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVN 222

Query: 370 QRPP-FKAPAKL---YARGLKELIEECWNEKPAKRPTFRQIIT 408
              P  K        ++   K+ I++C  + P +RPT   ++ 
Sbjct: 223 MPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score =  110 bits (276), Expect = 4e-27
 Identities = 74/249 (29%), Positives = 121/249 (48%), Gaps = 26/249 (10%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L     +      A   EL ++  +  H N+V  LGA T   P++++TEY   
Sbjct: 66  MKVAVKMLKPT--AHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCY 123

Query: 235 GDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           GDL  FL+RK    L     + F+  +A+GM +L        IHRDL   N+L      +
Sbjct: 124 GDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIV 180

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
           K+ DFG+++   +  D     +  +    +++APE   N  Y  + DV+S+ ++L E+  
Sbjct: 181 KICDFGLAR--DIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFS 238

Query: 350 --GCP----PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 403
               P    P   K    + + Y  R   P  APA++Y     ++++ CW+  P KRPTF
Sbjct: 239 LGSNPYPGMPVDSKFYKLIKEGY--RMAQPEHAPAEIY-----DIMKTCWDADPLKRPTF 291

Query: 404 RQIITRLES 412
           +QI+  +  
Sbjct: 292 KQIVQLIGK 300

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score =  109 bits (273), Expect = 4e-27
 Identities = 82/254 (32%), Positives = 124/254 (48%), Gaps = 35/254 (13%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A  K  +E  S DD  R F  EL +L K+  HPN++  LGA      + +  EY P G+L
Sbjct: 25  AAIKRMKEYASKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNL 83

Query: 238 RAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIHRDLEP 281
             FL++   L+   A                + FA D+ARGM+YL + +    IHRDL  
Sbjct: 84  LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAA 140

Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
            NIL  ++   K+ADFG+S+   V   +  T      R++A E      Y T  DV+S+ 
Sbjct: 141 RNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVWSYG 198

Query: 342 LILQEMIE--GCPPFTM---KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 396
           ++L E++   G P   M   +   ++P+ Y  R   P     ++Y     +L+ +CW EK
Sbjct: 199 VLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVY-----DLMRQCWREK 251

Query: 397 PAKRPTFRQIITRL 410
           P +RP+F QI+  L
Sbjct: 252 PYERPSFAQILVSL 265

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  108 bits (272), Expect = 8e-27
 Identities = 72/248 (29%), Positives = 115/248 (46%), Gaps = 34/248 (13%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
              +VA+K++  E       V   R E+  + +  HPNVV++  +      + +V  YL 
Sbjct: 25  NNEKVAIKRIDLEKCQTS--VDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLS 82

Query: 234 KGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            G L   +K     G L  +       ++ +G+ YLH N     IHRD++  NIL  + G
Sbjct: 83  GGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDG 139

Query: 291 NLKVADFGVSKLLTVKEDRPL----TCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQ 345
           ++K+ADFGVS  L    DR      T   T C ++APEV +    YD K D++SF +   
Sbjct: 140 SVKIADFGVSASLADGGDRTRKVRKTFVGTPC-WMAPEVMEQVHGYDFKADIWSFGITAI 198

Query: 346 EMIEGCPPF-----------TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394
           E+  G  P+           T+++D   P +          A  K Y++  +++I  C  
Sbjct: 199 ELATGAAPYSKYPPMKVLMLTLQND---PPSL------ETGADYKKYSKSFRKMISLCLQ 249

Query: 395 EKPAKRPT 402
           + P+KRPT
Sbjct: 250 KDPSKRPT 257

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  108 bits (271), Expect = 8e-27
 Identities = 67/231 (29%), Positives = 112/231 (48%), Gaps = 15/231 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  VA+K +   V  D   +     E+++L++   P +V++ G+  +++ + IV EY   
Sbjct: 28  GQVVAIKVV--PVEEDLQEII---KEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGA 82

Query: 235 GDLRAFLKRKGALKPSTAVRFAL---DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           G +   +K     K  T    A       +G+ YLH NK    IHRD++  NIL ++ G 
Sbjct: 83  GSVSDIMKITN--KTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQ 137

Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
            K+ADFGVS  LT    +  T   T   ++APEV +   Y+ K D++S  +   EM EG 
Sbjct: 138 AKLADFGVSGQLTDTMAKRNTVIGTPF-WMAPEVIQEIGYNNKADIWSLGITAIEMAEGK 196

Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402
           PP++  H          +  P    P K ++    + +++C  + P +RP+
Sbjct: 197 PPYSDIHPMRAIFMIPNKPPPTLSDPEK-WSPEFNDFVKKCLVKDPEERPS 246

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  108 bits (271), Expect = 9e-27
 Identities = 64/214 (29%), Positives = 102/214 (47%), Gaps = 11/214 (5%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
           EL +L K   P +V F GA   +  + I  EY+  G L   LK  +G +      + A+ 
Sbjct: 49  ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           + +G+ YLHE     IIHRD++PSNIL +  G +K+ DFGVS  L        T      
Sbjct: 109 VLKGLTYLHEKHK--IIHRDVKPSNILVNSRGQIKLCDFGVSGQLV--NSLAKT--FVGT 162

Query: 319 R-YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPPFTMKHDNEVPKAYAARQRPPF 374
             Y+APE  +  +Y  K D++S  L L E+  G    PP     D            PP 
Sbjct: 163 SSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPP 222

Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
           + P+  ++   ++ +  C  + P +RP++++++ 
Sbjct: 223 RLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  108 bits (272), Expect = 1e-26
 Identities = 54/184 (29%), Positives = 96/184 (52%), Gaps = 8/184 (4%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KK+     S+     A R E+ LL+++ HPN+++ L        + +V E++   DL
Sbjct: 27  VAIKKIKLRFESEGIPKTALR-EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM-DTDL 84

Query: 238 RAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
              +K +    P + ++ +   + +G+ + H +    I+HRDL+P N+L +  G LK+AD
Sbjct: 85  YKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLAD 141

Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
           FG+++       RP T    +  Y APE+   ++ Y T VD++S   I  E++   P F 
Sbjct: 142 FGLARSFGSPV-RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFP 200

Query: 356 MKHD 359
            K +
Sbjct: 201 GKSE 204

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score =  107 bits (270), Expect = 1e-26
 Identities = 82/277 (29%), Positives = 135/277 (48%), Gaps = 38/277 (13%)

Query: 153 HELDFTNS---VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
           +E ++  +   V + KGT+ + +        +++A+K++ E    D   V+   +E+AL 
Sbjct: 3   YEYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALH 59

Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKP--STAVRFALDIAR 261
             ++H N+VQ+LG+ +++    I  E +P G L A L+ K G LK    T + +   I  
Sbjct: 60  SYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILE 119

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQDT-SCR 319
           G+ YLH+N+   I+HRD++  N+L +  SG +K++DFG SK L      P T   T + +
Sbjct: 120 GLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLA--GINPCTETFTGTLQ 174

Query: 320 YVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-------RQ 370
           Y+APEV       Y    D++S    + EM  G PPF      E+ +  AA       + 
Sbjct: 175 YMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFI-----ELGEPQAAMFKVGMFKI 229

Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            P    P  L A   K  I  C+   P KR +   ++
Sbjct: 230 HPEI--PESLSAEA-KNFILRCFEPDPDKRASAHDLL 263

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score =  107 bits (268), Expect = 1e-26
 Identities = 77/244 (31%), Positives = 118/244 (48%), Gaps = 23/244 (9%)

Query: 178 VAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           VAVK   E +  D   ++A F  E  +L++  HPN+V+ +G  TQ  P+ IV E +  GD
Sbjct: 23  VAVKSCRETLPPD---LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGD 79

Query: 237 LRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
              FL+ +G  LK    ++   + A GM YL E+K    IHRDL   N L  +   LK++
Sbjct: 80  FLTFLRTEGPRLKVKELIQMVENAAAGMEYL-ESKHC--IHRDLAARNCLVTEKNVLKIS 136

Query: 296 DFGVSKLLTVKEDRPLTC----QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
           DFG+S+    +ED         +    ++ APE      Y ++ DV+SF ++L E    G
Sbjct: 137 DFGMSR---EEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLG 193

Query: 351 CPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
             P+    + +  +A     R   P   P  +Y      L+E CW   P +RP+F  +  
Sbjct: 194 AVPYANLSNQQTREAIEQGVRLPCPELCPDAVY-----RLMERCWEYDPGQRPSFSTVHQ 248

Query: 409 RLES 412
            L+S
Sbjct: 249 ELQS 252

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  108 bits (272), Expect = 1e-26
 Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 7/177 (3%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
            A+K L +  I    +V    +E  +LQ IRHP +V   G+    S + +V EY+P G+L
Sbjct: 29  YALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGEL 88

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
            + L++ G      A  +A  +   + YLH      I++RDL+P N+L D  G +K+ DF
Sbjct: 89  FSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDF 145

Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G +K +   + R  T   T   Y+APE+  ++ Y   VD ++  +++ EM+ G PPF
Sbjct: 146 GFAKRV---KGRTYTLCGT-PEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  107 bits (269), Expect = 2e-26
 Identities = 68/225 (30%), Positives = 107/225 (47%), Gaps = 16/225 (7%)

Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           D V+A R E+  L+ + H N+VQ+LG  T    + I  EY+P G + + L+  G  +   
Sbjct: 50  DMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQL 109

Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
              F   +  G+ YLH      I+HRDL+  N+L D  G  K++DFG+SK     +D   
Sbjct: 110 VRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKK---SDDIYD 163

Query: 312 TCQDTSCR----YVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPK 364
             Q+ S +    ++APEV  +    Y  KVD++S   ++ EM  G  P+   +    + K
Sbjct: 164 NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFK 223

Query: 365 AYAARQRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
               R  PP        L    L + +  C+   P  RPT R+++
Sbjct: 224 LGNKRSAPPIPPDVSMNLSPVAL-DFLNACFTINPDNRPTARELL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score =  107 bits (269), Expect = 2e-26
 Identities = 76/263 (28%), Positives = 118/263 (44%), Gaps = 42/263 (15%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L EE  +  D    F+ E AL+ +  HPN+V+ LG      PM ++ EY+  GDL
Sbjct: 38  VAVKMLKEE--ASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDL 95

Query: 238 RAFLKRKGALKPSTAVR----------------------FALDIARGMNYLHENKPVPII 275
             FL+ +      +                          A  +A GM YL E K    +
Sbjct: 96  NEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FV 152

Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTK 334
           HRDL   N L  ++  +K+ADFG+S+ +   +    +  D    R++ PE      Y T+
Sbjct: 153 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTE 212

Query: 335 VDVFSFALILQEMIE-GCPP-FTMKHDNEVPKAYAARQ----RPPFKAPAKLYARGLKEL 388
            DV+++ ++L E+   G  P + M H+  +   Y  R       P   P +LY      L
Sbjct: 213 SDVWAYGVVLWEIFSYGMQPYYGMAHEEVI---YYVRDGNVLSCPDNCPLELYN-----L 264

Query: 389 IEECWNEKPAKRPTFRQIITRLE 411
           +  CW++ P+ RP+F  I   L+
Sbjct: 265 MRLCWSKLPSDRPSFASINRILQ 287

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  107 bits (268), Expect = 4e-26
 Identities = 57/178 (32%), Positives = 92/178 (51%), Gaps = 5/178 (2%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KK  E    +D +  A R E+ +L+++RH N+V    A  +   + +V EY+ +  L
Sbjct: 29  VAIKKFKESEDDEDVKKTALR-EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLL 87

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
                  G L P     +   + + + Y H +    IIHRD++P NIL  +SG LK+ DF
Sbjct: 88  ELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDF 144

Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G ++ L  +   PLT    +  Y APE+   +  Y   VDV++   I+ E+++G P F
Sbjct: 145 GFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLF 202

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score =  106 bits (267), Expect = 4e-26
 Identities = 74/259 (28%), Positives = 115/259 (44%), Gaps = 38/259 (14%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
             VAVK L E   + +D  + F  E  LL   +H N+V+F G  T+  P ++V EY+  G
Sbjct: 36  ELVAVKTLKE--TASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHG 93

Query: 236 DLRAFLKR--------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           DL  FL+                G L  S  ++ A+ IA GM YL     V   HRDL  
Sbjct: 94  DLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFV---HRDLAT 150

Query: 282 SNILRDDSGNLKVADFGVSK------LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
            N L      +K+ DFG+S+         V     L       R++ PE     ++ T+ 
Sbjct: 151 RNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTML-----PIRWMPPESIMYRKFTTES 205

Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E+   G  P+    + EV +     +  + P   P+++Y     +++  C
Sbjct: 206 DVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRPRTCPSEVY-----DIMLGC 260

Query: 393 WNEKPAKRPTFRQIITRLE 411
           W   P +R   + I  RL+
Sbjct: 261 WKRDPQQRINIKDIHERLQ 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  106 bits (267), Expect = 6e-26
 Identities = 60/185 (32%), Positives = 94/185 (50%), Gaps = 17/185 (9%)

Query: 178 VAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEY 231
           VA+KK    +  ++++    + A R E+ LLQK+RHPN+V+    VT      + +V EY
Sbjct: 27  VALKK----IRMENEKEGFPITAIR-EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEY 81

Query: 232 LPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           +   DL   L         S    +   +  G+ YLH N    I+HRD++ SNIL ++ G
Sbjct: 82  MDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDG 137

Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIE 349
            LK+ADFG+++  T +     T +  +  Y  PE+      Y  +VD++S   IL E+  
Sbjct: 138 VLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFL 197

Query: 350 GCPPF 354
           G P F
Sbjct: 198 GKPIF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score =  105 bits (264), Expect = 6e-26
 Identities = 84/253 (33%), Positives = 125/253 (49%), Gaps = 21/253 (8%)

Query: 166 GTFILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   +  W G  +VA+K L    +  +    AF  E  +++K+RH  +V  L AV    P
Sbjct: 20  GEVWMGTWNGTTKVAIKTLKPGTMMPE----AFLQEAQIMKKLRHDKLVP-LYAVVSEEP 74

Query: 225 MMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + IVTE++ KG L  FLK      LK    V  A  IA GM Y+     +  IHRDL  +
Sbjct: 75  IYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAA 131

Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
           NIL  D+   K+ADFG+++L+   ED   T +  +    ++ APE      +  K DV+S
Sbjct: 132 NILVGDNLVCKIADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 188

Query: 340 FALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 398
           F ++L E++ +G  P+    + EV +      R P           L EL++ CW + P 
Sbjct: 189 FGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPCPQGC---PESLHELMKLCWKKDPD 245

Query: 399 KRPTFRQIITRLE 411
           +RPTF  I + LE
Sbjct: 246 ERPTFEYIQSFLE 258

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score =  105 bits (263), Expect = 9e-26
 Identities = 70/253 (27%), Positives = 119/253 (47%), Gaps = 15/253 (5%)

Query: 156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF    +I KG+F + F           A+K++    ++  +R  A  DE  +L K+   
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAI-DEARVLAKLDSS 59

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
            ++++  +      + IV EY   GDL   LK  R   L      RF + I  G+ +LH 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
            K   I+HRD++  N+  D   N+K+ D GV+KLL+   +   T   T   Y++PE+ ++
Sbjct: 120 KK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANTIVGTP-YYLSPELCED 175

Query: 329 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388
           + Y+ K DV++  ++L E   G  PF   +   +         PP       Y++ L +L
Sbjct: 176 KPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPVSQM---YSQQLAQL 232

Query: 389 IEECWNEKPAKRP 401
           I++C  +   +RP
Sbjct: 233 IDQCLTKDYRQRP 245

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  105 bits (263), Expect = 1e-25
 Identities = 69/272 (25%), Positives = 130/272 (47%), Gaps = 19/272 (6%)

Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGE-EVISDDDRVRAFRDELALLQKIRH 209
           +F    +I KG F + +       G  VA+KK+   E++    R    + E+ LL+++ H
Sbjct: 3   NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLK-EIDLLKQLDH 61

Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAV-RFALDIARGMNY 265
           PNV+++L +  +++ + IV E    GDL   +K   ++  L P   + ++ + +   + +
Sbjct: 62  PNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEH 121

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
           +H  +   I+HRD++P+N+    +G +K+ D G+ +  + K     +   T   Y++PE 
Sbjct: 122 MHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP-YYMSPER 177

Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYAR 383
                Y+ K D++S   +L EM     PF     N   + K       PP   PA  Y+ 
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL--PADHYSE 235

Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESINN 415
            L++L+  C N  P KRP    ++   + ++ 
Sbjct: 236 ELRDLVSRCINPDPEKRPDISYVLQVAKEMHA 267

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score =  104 bits (261), Expect = 1e-25
 Identities = 77/243 (31%), Positives = 127/243 (52%), Gaps = 24/243 (9%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK +    +S    V AF  E  +++ ++H  +V+ L AV    P+ I+TE++ KG 
Sbjct: 32  KVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGS 86

Query: 237 LRAFLKR-KGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           L  FLK  +G+ +P    + F+  IA GM ++ +      IHRDL  +NIL   S   K+
Sbjct: 87  LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKI 143

Query: 295 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
           ADFG+++++   ED   T ++ +    ++ APE      +  K DV+SF ++L E++  G
Sbjct: 144 ADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 200

Query: 351 CPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
             P+    + EV +A     R P     P +LY      ++  CW  +P +RPTF  I +
Sbjct: 201 RIPYPGMSNPEVIRALERGYRMPRPENCPEELY-----NIMMRCWKNRPEERPTFEYIQS 255

Query: 409 RLE 411
            L+
Sbjct: 256 VLD 258

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  105 bits (265), Expect = 2e-25
 Identities = 70/246 (28%), Positives = 112/246 (45%), Gaps = 21/246 (8%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K++ + ++   + VR    E  +L   +   +V+ L A      + +  EY+P GD 
Sbjct: 29  VALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDF 88

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
           R  L   G L    A  +  ++   ++ LHE   +  IHRDL+P N L D SG++K+ DF
Sbjct: 89  RTLLNNLGVLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDF 145

Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
           G+SK +    +  +   D    Y+APEV + + YD  VD +S   +L E + G PPF+  
Sbjct: 146 GLSKGIVTYANSVVGSPD----YMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGS 201

Query: 358 HDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
             NE            QRP +  P    +    +LI +  N+             R  S+
Sbjct: 202 TPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPS----------RRFGSL 251

Query: 414 NNSINH 419
            +  NH
Sbjct: 252 EDIKNH 257

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score =  104 bits (261), Expect = 2e-25
 Identities = 69/255 (27%), Positives = 120/255 (47%), Gaps = 30/255 (11%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K L ++   +      F+ E  +  +++HPN+V  LG VT+  P+ ++  Y    DL
Sbjct: 38  VAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95

Query: 238 RAFL----------------KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
             FL                  K  L+P+  V     IA GM +L  +    ++H+DL  
Sbjct: 96  HEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLAT 152

Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSF 340
            N+L  D  N+K++D G+ + +   +   L        R+++PE     ++    D++S+
Sbjct: 153 RNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSY 212

Query: 341 ALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKELIEECWNEKP 397
            ++L E+   G  P+    + +V +    RQ    P   PA +Y      L+ ECWNE P
Sbjct: 213 GVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCPDDCPAWVYT-----LMLECWNEFP 267

Query: 398 AKRPTFRQIITRLES 412
           ++RP F+ I +RL +
Sbjct: 268 SRRPRFKDIHSRLRT 282

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  103 bits (259), Expect = 3e-25
 Identities = 60/170 (35%), Positives = 91/170 (53%), Gaps = 17/170 (10%)

Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALKPST 251
           V A   E+ LL+ ++H  +VQ+ G +   +   + I  EY+P G ++  LK  GAL  S 
Sbjct: 48  VSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESV 107

Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
             ++   I  GM+YLH N    I+HRD++ +NILRD +GN+K+ DFG SK L     + +
Sbjct: 108 TRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRL-----QTI 159

Query: 312 TCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
               T  R       +++PEV   E Y  K DV+S    + EM+   PP+
Sbjct: 160 CMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score =  104 bits (260), Expect = 4e-25
 Identities = 61/220 (27%), Positives = 108/220 (49%), Gaps = 16/220 (7%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL ++ + R P +V F GA    + + +  E++  G L    K+ G +      + A+ +
Sbjct: 53  ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS-KLLTVKEDRPLTCQDTSC 318
             G+ YL+      I+HRD++PSNIL +  G +K+ DFGVS +L+    D   T   TS 
Sbjct: 113 VEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIAD---TFVGTST 167

Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--------- 369
            Y++PE  +  +Y  K DV+S  + + E+  G  PF   + ++  +              
Sbjct: 168 -YMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIV 226

Query: 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409
           Q PP + P+  +   L++ ++ C  + P +RPT +Q+   
Sbjct: 227 QEPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score =  103 bits (259), Expect = 4e-25
 Identities = 72/255 (28%), Positives = 122/255 (47%), Gaps = 27/255 (10%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVT 229
           ++VAVK +  ++ +  + +  F  E A ++   HPNV++ +G   ++S +      M++ 
Sbjct: 28  LKVAVKTMKLDIHTYSE-IEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVIL 86

Query: 230 EYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
            ++  GDL +FL   R G     L   T ++F +DIA GM YL        IHRDL   N
Sbjct: 87  PFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARN 143

Query: 284 ILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
            +  +   + VADFG+SK +    D  R         +++A E   +  Y +K DV++F 
Sbjct: 144 CMLREDMTVCVADFGLSKKI-YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFG 202

Query: 342 LILQE-MIEGCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 398
           + + E    G  P+    ++E+     +  R + P     +LY     +L+  CW   P 
Sbjct: 203 VTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQPEDCLDELY-----DLMYSCWRADPK 257

Query: 399 KRPTFRQIITRLESI 413
            RPTF ++   LE+I
Sbjct: 258 DRPTFTKLREVLENI 272

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  103 bits (258), Expect = 5e-25
 Identities = 71/241 (29%), Positives = 112/241 (46%), Gaps = 34/241 (14%)

Query: 178 VAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+K     VI     D     + E+++L++ RHPN+V + G+  +   + IV EY   G
Sbjct: 31  VAIK-----VIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGG 85

Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L+   +  +G L          +  +G+ YLHE      IHRD++ +NIL  + G++K+
Sbjct: 86  SLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKL 142

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGC 351
           ADFGVS  LT    +  +   T   ++APEV   E    YD K D+++  +   E+ E  
Sbjct: 143 ADFGVSAQLTATIAKRKSFIGTP-YWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQ 201

Query: 352 PP----------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           PP          F +   N  P        P  K   K ++    + I++C  + P KRP
Sbjct: 202 PPMFDLHPMRALFLISKSNFPP--------PKLKDKEK-WSPVFHDFIKKCLTKDPKKRP 252

Query: 402 T 402
           T
Sbjct: 253 T 253

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  103 bits (257), Expect = 6e-25
 Identities = 66/234 (28%), Positives = 122/234 (52%), Gaps = 12/234 (5%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           V +K++  E ++ D+R+ A ++E  +L+ + HPN++++     +   +MIV EY P G L
Sbjct: 28  VIIKQIPVEQMTKDERLAA-QNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTL 86

Query: 238 RAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKV 294
             +++++    L   T + F + I   ++++H      I+HRDL+  NIL D     +K+
Sbjct: 87  AEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKI 143

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG+SK+L+ K  +  T   T C Y++PE+ + + Y+ K D+++   +L E+      F
Sbjct: 144 GDFGISKILSSKS-KAYTVVGTPC-YISPELCEGKPYNQKSDIWALGCVLYELASLKRAF 201

Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
              +   +P          F   +  Y+  L++LI    N  P+KRP   QI+ 
Sbjct: 202 EAAN---LPALVLKIMSGTFAPISDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score =  103 bits (259), Expect = 1e-24
 Identities = 74/261 (28%), Positives = 126/261 (48%), Gaps = 31/261 (11%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           + + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 43  KPVTVAVKMLKDDATDKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYA 100

Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 101 SKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH 157

Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
           RDL   N+L  +   +K+ADFG+++ +  +   +  T      +++APE   +  Y  + 
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQS 217

Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E+   G  P+      E+ K      R   P     +LY      ++ EC
Sbjct: 218 DVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTHELYM-----IMREC 272

Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+  P++RPTF+Q++  L+ +
Sbjct: 273 WHAVPSQRPTFKQLVEDLDRV 293

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  102 bits (255), Expect = 1e-24
 Identities = 58/166 (34%), Positives = 91/166 (54%), Gaps = 7/166 (4%)

Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           V A   E+ LL+ +RH  +VQ+ G +   +   + I  EY+P G ++  LK  GAL  + 
Sbjct: 48  VNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENV 107

Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV--KEDR 309
             R+   I +G++YLH N    I+HRD++ +NILRD +GN+K+ DFG SK +        
Sbjct: 108 TRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGT 164

Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
            +     +  +++PEV   E Y  K DV+S A  + EM+   PP+ 
Sbjct: 165 GIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score =  101 bits (254), Expect = 2e-24
 Identities = 76/267 (28%), Positives = 131/267 (49%), Gaps = 44/267 (16%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYL 232
           G QVAVK L  E  S  + +   + E+ +L+ + H N+V++ G  T+   + + ++ E+L
Sbjct: 33  GEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 90

Query: 233 PKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G L+ +L R K  +     +++A+ I +GM+YL   +    +HRDL   N+L +    
Sbjct: 91  PSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 147

Query: 292 LKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           +K+ DFG++K +       TVK+D      D+   + APE     ++    DV+SF + L
Sbjct: 148 VKIGDFGLTKAIETDKEYYTVKDDL-----DSPVFWYAPECLIQSKFYIASDVWSFGVTL 202

Query: 345 QEMIEGC----PPFTM-------KHDN-------EVPKAYAARQRPPFKAPAKLYARGLK 386
            E++  C     P T+        H          V +      RPP   P ++Y     
Sbjct: 203 YELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPRPP-NCPEEVY----- 256

Query: 387 ELIEECWNEKPAKRPTFRQIITRLESI 413
           +L+ +CW  +P+KR TF+ +I   E+I
Sbjct: 257 QLMRKCWEFQPSKRTTFQNLIEGFEAI 283

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  100 bits (251), Expect = 3e-24
 Identities = 74/236 (31%), Positives = 118/236 (50%), Gaps = 11/236 (4%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-IVTEYLP 233
           G Q  +KKL     S  +R +A   E  LL +++HPN+V +  +      ++ IV  +  
Sbjct: 25  GKQYVIKKLNLRNASRRER-KAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCE 83

Query: 234 KGDLRAFLK-RKGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
            GDL   LK +KG L P +  V + + IA  + YLHE     I+HRDL+  N+    +  
Sbjct: 84  GGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNI 140

Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +KV D G++++L  + D   T   T   Y++PE+F N+ Y+ K DV++    + EM    
Sbjct: 141 IKVGDLGIARVLENQCDMASTLIGTP-YYMSPELFSNKPYNYKSDVWALGCCVYEMATLK 199

Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             F  K  N +       + PP     K Y+  L ELI    +++P KRP+ + I+
Sbjct: 200 HAFNAKDMNSLVYRIIEGKLPPM---PKDYSPELGELIATMLSKRPEKRPSVKSIL 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score =  101 bits (252), Expect = 4e-24
 Identities = 80/270 (29%), Positives = 131/270 (48%), Gaps = 31/270 (11%)

Query: 162 EITKGTF--ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
           E+ +GT   IL    G I+VAVK L +     D   + F  E  L+    HPN+V+ LG 
Sbjct: 10  EVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGV 67

Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA-------VRFALDIARGMNYLHENKP 271
              + P  I+ E +  GDL ++L+     +           +   LD+A+G  YL +   
Sbjct: 68  CLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH- 126

Query: 272 VPIIHRDLEPSNILRDDSGN-----LKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPE 324
              IHRDL   N L  + G      +K+ DFG+++ +  K D  R         R++APE
Sbjct: 127 --FIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDI-YKSDYYRKEGEGLLPVRWMAPE 183

Query: 325 VFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA--RQRPPFKAPAKLY 381
              + ++ T+ DV+SF +++ E++  G  P+   ++ EV +   A  R + P   P K+Y
Sbjct: 184 SLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKPENCPDKIY 243

Query: 382 ARGLKELIEECWNEKPAKRPTFRQIITRLE 411
                +L+  CW + P++RPTF +I   L+
Sbjct: 244 -----QLMTNCWAQDPSERPTFDRIQEILQ 268

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  101 bits (254), Expect = 4e-24
 Identities = 65/184 (35%), Positives = 98/184 (53%), Gaps = 13/184 (7%)

Query: 175 GIQVAVKK--LGEEVISDD--DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
           G  VA+KK  LGE   + D  +   A R E+ LLQ+++HPN++  L      S + +V E
Sbjct: 25  GRIVAIKKIKLGERKEAKDGINFT-ALR-EIKLLQELKHPNIIGLLDVFGHKSNINLVFE 82

Query: 231 YLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           ++   DL   +K K   L P+    + L   RG+ YLH N    I+HRDL+P+N+L    
Sbjct: 83  FME-TDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASD 138

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMI 348
           G LK+ADFG+++      +R +T Q  +  Y APE+ F    Y   VD++S   I  E++
Sbjct: 139 GVLKLADFGLAR-SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELL 197

Query: 349 EGCP 352
              P
Sbjct: 198 LRVP 201

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score =  101 bits (252), Expect = 6e-24
 Identities = 72/259 (27%), Positives = 125/259 (48%), Gaps = 31/259 (11%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  K
Sbjct: 48  VTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASK 105

Query: 235 GDLRAFLKRKGALK----------PSTAVRF------ALDIARGMNYLHENKPVPIIHRD 278
           G+LR +L+ +              P   + F         +ARGM YL   K    IHRD
Sbjct: 106 GNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRD 162

Query: 279 LEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 337
           L   N+L  ++  +K+ADFG+++ +  +   +  T      +++APE   +  Y  + DV
Sbjct: 163 LAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222

Query: 338 FSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWN 394
           +SF +++ E+   G  P+      E+ K      R   P     +LY      ++ +CW+
Sbjct: 223 WSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-----MMRDCWH 277

Query: 395 EKPAKRPTFRQIITRLESI 413
             P+ RPTF+Q++  L+ I
Sbjct: 278 AIPSHRPTFKQLVEDLDRI 296

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score =  101 bits (252), Expect = 7e-24
 Identities = 73/266 (27%), Positives = 127/266 (47%), Gaps = 31/266 (11%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           + + VAVK L +   + D  +     E+ L++ I +H N++  LG  TQ  P+ ++ EY 
Sbjct: 43  QTVTVAVKMLKDN--ATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYA 100

Query: 233 PKGDLRAFLKRKGALKPSTA----------------VRFALDIARGMNYLHENKPVPIIH 276
            KG+LR FL+ +    P                   V  A  +ARGM YL   +    IH
Sbjct: 101 AKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIH 157

Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
           RDL   N+L  +   +K+ADFG+++ +  +   +  +      +++APE   +  Y  + 
Sbjct: 158 RDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQS 217

Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF +++ E+   G  P+      E+ K      R   P     +LY      L+ EC
Sbjct: 218 DVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKPSNCTHELYM-----LMREC 272

Query: 393 WNEKPAKRPTFRQIITRLESINNSIN 418
           W+  P +RPTF+Q++  L+ +  +++
Sbjct: 273 WHAVPTQRPTFKQLVEALDKVLAAVS 298

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score =  100 bits (250), Expect = 1e-23
 Identities = 76/261 (29%), Positives = 128/261 (49%), Gaps = 31/261 (11%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 49  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 106

Query: 233 PKGDLRAFL--KRKGALK----PSTA----------VRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L  +R   ++    P+            V  A  +ARGM YL   K    IH
Sbjct: 107 SKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIH 163

Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
           RDL   N+L  +   +K+ADFG+++ +  +   +  T      +++APE   +  Y  + 
Sbjct: 164 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 223

Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E+   G  P+      E+ K      R   P     +LY      ++ +C
Sbjct: 224 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYM-----MMRDC 278

Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+  P++RPTF+Q++  L+ I
Sbjct: 279 WHAVPSQRPTFKQLVEDLDRI 299

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 99.4 bits (248), Expect = 2e-23
 Identities = 63/229 (27%), Positives = 109/229 (47%), Gaps = 17/229 (7%)

Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KG 245
           I  ++ +  F  E+ +L + +HPN+V    A    + + I+ E+   G L + +    +G
Sbjct: 40  IESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG 99

Query: 246 ALKPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
             +P      R  L+    +N+LH +K   +IHRDL+  NIL    G++K+ADFGVS   
Sbjct: 100 LTEPQIRYVCRQMLE---ALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKN 153

Query: 304 TVKEDRPLTCQDTSCRYVAPEV-----FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358
                +  T   T   ++APEV     FK+  YD K D++S  + L E+ +  PP    +
Sbjct: 154 KSTLQKRDTFIGTP-YWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELN 212

Query: 359 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
              V       + P    P+K ++    + ++ C  + P  RPT  +++
Sbjct: 213 PMRVLLKILKSEPPTLDQPSK-WSSSFNDFLKSCLVKDPDDRPTAAELL 260

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 99.3 bits (248), Expect = 2e-23
 Identities = 71/251 (28%), Positives = 112/251 (44%), Gaps = 33/251 (13%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP------MMIVTE 230
           VA+K +       +D     ++E  +L+K   HPN+  F GA  + +P      + +V E
Sbjct: 34  VAIKIMD----IIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVME 89

Query: 231 YLPKG---DL-RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
               G   DL +   K+   LK         +  RG+ YLHENK   +IHRD++  NIL 
Sbjct: 90  LCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILL 146

Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTKVDVFSFA 341
             +  +K+ DFGVS  L     R  T   T   ++APEV   +E     YD + DV+S  
Sbjct: 147 TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPY-WMAPEVIACDEQPDASYDARSDVWSLG 205

Query: 342 LILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 397
           +   E+ +G PP    H       +P     R  PP     + +++   + I EC  +  
Sbjct: 206 ITAIELADGKPPLCDMHPMRALFKIP-----RNPPPTLKSPENWSKKFNDFISECLIKNY 260

Query: 398 AKRPTFRQIIT 408
            +RP   +++ 
Sbjct: 261 EQRPFMEELLE 271

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 98.6 bits (245), Expect = 2e-23
 Identities = 59/186 (31%), Positives = 95/186 (51%), Gaps = 9/186 (4%)

Query: 175 GIQVAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSSPMMIVTE 230
           G ++AVK++    E       V A   E+ LL+ + H  +VQ+ G +       + I  E
Sbjct: 27  GRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFME 86

Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           ++P G ++  LK  GAL  +   ++   I  G++YLH N    I+HRD++ +NILRD  G
Sbjct: 87  HMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVG 143

Query: 291 NLKVADFGVSKLLTV--KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
           N+K+ DFG SK L         +     +  +++PEV   E Y  K D++S    + EM+
Sbjct: 144 NVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEML 203

Query: 349 EGCPPF 354
              PP+
Sbjct: 204 TEKPPW 209

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 99.4 bits (248), Expect = 3e-23
 Identities = 60/185 (32%), Positives = 92/185 (49%), Gaps = 5/185 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           AVK L ++VI  DD V     E  +L    +HP + Q          +  V EY+  GDL
Sbjct: 24  AVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDL 83

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R G      A  +A +I  G+ +LHE     II+RDL+  N+L D  G++K+ADF
Sbjct: 84  MFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADF 140

Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
           G+ K   +      T   T   Y+APE+   + Y   VD ++  ++L EM+ G  PF   
Sbjct: 141 GMCKEGILGGVTTSTFCGTP-DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199

Query: 358 HDNEV 362
            ++E+
Sbjct: 200 DEDEL 204

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 98.7 bits (246), Expect = 3e-23
 Identities = 51/156 (32%), Positives = 91/156 (58%), Gaps = 7/156 (4%)

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
           +E  +L+++ HP +++          + ++ EY+P G+L ++L+  G    ST + +A +
Sbjct: 50  NEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASE 109

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           I   + YLH  +   I++RDL+P NIL D  G++K+ DFG +K L    DR  T   T  
Sbjct: 110 IVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLR---DRTWTLCGTP- 162

Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            Y+APEV +++ ++  VD ++  +++ EM+ G PPF
Sbjct: 163 EYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPF 198

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 97.9 bits (244), Expect = 4e-23
 Identities = 58/238 (24%), Positives = 112/238 (47%), Gaps = 14/238 (5%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
            V  K++    +S+ +R R   +E+ +L  ++HPN++ +       + ++I  EY   G 
Sbjct: 27  LVVWKEVNLTRLSEKER-RDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGT 85

Query: 237 L-RAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           L    +++KG L     V + L  I   ++Y+H+     I+HRD++  NI    +G +K+
Sbjct: 86  LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKL 142

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG+SK+L  +     T   T   Y++PE+ +  +Y+ K D+++   +L E++      
Sbjct: 143 GDFGISKILGSEYSMAETVVGTP-YYMSPELCQGVKYNFKSDIWALGCVLYELL--TLKR 199

Query: 355 TMKHDN--EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
           T    N   +          P  +    Y+  L  L+     + P KRPT  +++ + 
Sbjct: 200 TFDATNPLNLVVKIVQGNYTPVVSV---YSSELISLVHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 97.7 bits (243), Expect = 5e-23
 Identities = 72/254 (28%), Positives = 116/254 (45%), Gaps = 24/254 (9%)

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+ +G   L   R + VA+  L     SD  R R F  E   L +  H N+V+  G +T+
Sbjct: 20  ELCRGCLKLPSKRELPVAIHTL-RAGCSDKQR-RGFLAEALTLGQFDHSNIVRLEGVITR 77

Query: 222 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
            + MMIVTEY+  G L +FL++ +G L     +     +A GM YL E   +  +H+ L 
Sbjct: 78  GNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLA 134

Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKV 335
              +L +     K++ F       ++ED+      T        + APE  +   + +  
Sbjct: 135 AHKVLVNSDLVCKISGFR-----RLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSAS 189

Query: 336 DVFSFALILQE-MIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF +++ E M  G  P+      +V KA     R   P   P  L+     +L+ +C
Sbjct: 190 DVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLPAPRNCPNLLH-----QLMLDC 244

Query: 393 WNEKPAKRPTFRQI 406
           W ++  +RP F QI
Sbjct: 245 WQKERGERPRFSQI 258

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 93.2 bits (232), Expect = 7e-23
 Identities = 48/104 (46%), Positives = 64/104 (61%), Gaps = 5/104 (4%)

Query: 29  NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
           N  D+DG        L   A+   +E +K LL++G DVN +D D RT LH+AA  G  E+
Sbjct: 1   NARDEDGRTP-----LHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEI 55

Query: 89  VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           V LLLE+GADV+ +D+ G+TPL  A    N +V+KLL KHGA  
Sbjct: 56  VKLLLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGADV 99

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 97.4 bits (242), Expect = 8e-23
 Identities = 76/253 (30%), Positives = 118/253 (46%), Gaps = 23/253 (9%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-------SPMMIV 228
           ++VAVK + +  I     +  F  E   +++  HPNV++ +G   Q+       SP++I+
Sbjct: 27  LKVAVKTM-KIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVIL 85

Query: 229 TEYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
             ++  GDL +FL   R G     L     V+F  DIA GM YL        IHRDL   
Sbjct: 86  P-FMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAAR 141

Query: 283 NILRDDSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
           N + +++ N+ VADFG+SK +   +  R         +++A E   +  Y TK DV+SF 
Sbjct: 142 NCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFG 201

Query: 342 LILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
           + + E+   G  P+    ++E+      RQ    K P      GL  L+  CW   P  R
Sbjct: 202 VTMWEIATRGQTPYPGVENSEIYDYL--RQGNRLKQPPDCL-DGLYSLMSSCWLLNPKDR 258

Query: 401 PTFRQIITRLESI 413
           P+F  +   LE  
Sbjct: 259 PSFETLRCELEKA 271

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies)

 Score = 91.2 bits (227), Expect = 1e-22
 Identities = 42/89 (47%), Positives = 54/89 (60%), Gaps = 2/89 (2%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A   ++E +K LL+ G DVN  D    TALH+AA  G  E+V LLLE GADV+ KD
Sbjct: 1   LHLAAKNGNLELVKLLLEKGADVNLGD--TDTALHLAARNGNLEIVKLLLEHGADVNAKD 58

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           + G+T L  A    N E++KLL +HGA  
Sbjct: 59  KDGNTALHLAARNGNLEIVKLLLEHGADI 87

Length = 91

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score = 96.8 bits (241), Expect = 1e-22
 Identities = 51/166 (30%), Positives = 98/166 (59%), Gaps = 9/166 (5%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---RKGALKPSTAVRFA 256
           E++L+++++H N+V+    +   + +M+V EY+ K DL+ ++     +GAL P+T   F 
Sbjct: 48  EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
             + +G+ + HEN+   ++HRDL+P N+L +  G LK+ADFG+++   +  +   + +  
Sbjct: 107 YQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNT-FSNEVV 162

Query: 317 SCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361
           +  Y AP+V   +  Y T +D++S   I+ EMI G P F   ++ +
Sbjct: 163 TLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 96.1 bits (239), Expect = 1e-22
 Identities = 65/244 (26%), Positives = 122/244 (50%), Gaps = 24/244 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G Q  +K++    +S  +R  + R E+A+L  ++HPN+VQ+  +  ++  + IV +Y   
Sbjct: 25  GKQYVIKEINISKMSPKEREES-RKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEG 83

Query: 235 GDLRAFL-KRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           GDL   +  ++G L P   +  + + I   + ++H+ K   I+HRD++  NI     G +
Sbjct: 84  GDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTI 140

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
           K+ DFG++++L    +   TC  T   Y++PE+ +N  Y+ K D+++   +L EM     
Sbjct: 141 KLGDFGIARVLNSTVELARTCIGTP-YYLSPEICENRPYNNKSDIWALGCVLYEMC---- 195

Query: 353 PFTMKH-------DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
             T+KH        N V K      R  +   +  Y+  L+ L+ + +   P  RP+   
Sbjct: 196 --TLKHAFEAGNMKNLVLKII----RGSYPPVSSHYSYDLRNLVSQLFKRNPRDRPSVNS 249

Query: 406 IITR 409
           I+ +
Sbjct: 250 ILEK 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score = 96.1 bits (240), Expect = 2e-22
 Identities = 49/200 (24%), Positives = 89/200 (44%), Gaps = 23/200 (11%)

Query: 175 GIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
             + A+K L +  +  + +V+    ++  L +   HP +++          +  V EY P
Sbjct: 26  NKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAP 85

Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            G+L  ++++ G+L       +A +I   + YLH      IIHRDL+P NIL D   ++K
Sbjct: 86  NGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIK 142

Query: 294 VADFGVSKLL---------------TVKEDRPLTCQDTS----CRYVAPEVFKNEEYDTK 334
           + DFG +K+L                  +      +  S      YV+PE+   +     
Sbjct: 143 ITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKS 202

Query: 335 VDVFSFALILQEMIEGCPPF 354
            D+++   I+ +M+ G PPF
Sbjct: 203 SDLWALGCIIYQMLTGKPPF 222

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 96.2 bits (239), Expect = 3e-22
 Identities = 65/252 (25%), Positives = 120/252 (47%), Gaps = 24/252 (9%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           + + VAVK L  +V         F  E+ ++ ++++PN+++ LG      P+ ++TEY+ 
Sbjct: 43  QPVLVAVKMLRADVTKTARN--DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYME 100

Query: 234 KGDLRAFLKRKG------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
            GDL  FL ++             ++  +  +  A+ IA GM YL     +  +HRDL  
Sbjct: 101 NGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYL---ASLNFVHRDLAT 157

Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSF 340
            N L  +   +K+ADFG+S+ L   +   +  +     R++A E     ++ T  DV++F
Sbjct: 158 RNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAF 217

Query: 341 ALILQEMIEGCP--PFTMKHDNEVPKA----YAARQRPPFKAPAKLYARGLKELIEECWN 394
            + L EM   C   P+++  D +V +     +  + R  + +   L    + +L+  CW+
Sbjct: 218 GVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWS 277

Query: 395 EKPAKRPTFRQI 406
                RPTF +I
Sbjct: 278 RDIKDRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 95.7 bits (238), Expect = 3e-22
 Identities = 71/267 (26%), Positives = 117/267 (43%), Gaps = 42/267 (15%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--MMIVTEYL 232
           G  VAVK L  E          ++ E+ +L+ + H N+V++ G  ++     + ++ EY+
Sbjct: 33  GEMVAVKTLKRE--CGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYV 90

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           P G LR +L +   L  +  + FA  I  GM YLH       IHRDL   N+L D+   +
Sbjct: 91  PLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLV 146

Query: 293 KVADFGVSKLLT-------VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
           K+ DFG++K +        V+ED      D+   + A E  K  ++    DV+SF + L 
Sbjct: 147 KIGDFGLAKAVPEGHEYYRVRED-----GDSPVFWYAVECLKENKFSYASDVWSFGVTLY 201

Query: 346 EMIEGCPPF-------------TMKHDNEVP--KAYAARQRPPF--KAPAKLYARGLKEL 388
           E++  C                       V   +      R P     P ++Y      L
Sbjct: 202 ELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVY-----IL 256

Query: 389 IEECWNEKPAKRPTFRQIITRLESINN 415
           ++ CW  +   RPTFR +I  L+ +++
Sbjct: 257 MKNCWETEAKFRPTFRSLIPILKEMHH 283

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 95.0 bits (236), Expect = 4e-22
 Identities = 67/215 (31%), Positives = 111/215 (51%), Gaps = 11/215 (5%)

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPS-TAVRF 255
           R E  LL K++HPN+V F  +      + IV EY   GDL   +K ++G L P  T +++
Sbjct: 46  RKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQW 105

Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
            + +  G+ ++HE +   ++HRD++  NI    +G +K+ DFG ++LLT       T   
Sbjct: 106 FVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVG 162

Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH-DNEVPKAYAARQRPPF 374
           T   YV PE+++N  Y+ K D++S   IL E+     PF      N + K      +P  
Sbjct: 163 TP-YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP-- 219

Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409
             P+  Y+  L+ LI++ +   P  RP+   I++R
Sbjct: 220 -LPSH-YSYELRSLIKQMFKRNPRSRPSATTILSR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 96.4 bits (240), Expect = 4e-22
 Identities = 71/215 (33%), Positives = 109/215 (50%), Gaps = 14/215 (6%)

Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
           DF   + + KG+F   +LA  +G     A+K L ++VI  DD V     E   LAL  K 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGK- 59

Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
             P + Q          +  V EY+  GDL   +++ G  K   AV +A +IA G+ +LH
Sbjct: 60  -PPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLH 118

Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
                 II+RDL+  N++ D  G++K+ADFG+ K          T   T   Y+APE+  
Sbjct: 119 SKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTP-DYIAPEIIA 174

Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
            + Y   VD ++F ++L EM+ G PPF  + ++E+
Sbjct: 175 YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score = 95.1 bits (237), Expect = 5e-22
 Identities = 60/182 (32%), Positives = 101/182 (55%), Gaps = 13/182 (7%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+KK+  E  ++D+ V   A R E++LL+++ HPN+V+ L  V   + + +V E+L   
Sbjct: 27  VALKKIRLE--TEDEGVPSTAIR-EISLLKELNHPNIVRLLDVVHSENKLYLVFEFLDL- 82

Query: 236 DLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           DL+ ++       L P     +   + +G+ Y H ++   ++HRDL+P N+L D  G LK
Sbjct: 83  DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALK 139

Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 352
           +ADFG+++   V   R  T +  +  Y APE+   + +Y T VD++S   I  EM+   P
Sbjct: 140 LADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRP 198

Query: 353 PF 354
            F
Sbjct: 199 LF 200

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score = 95.5 bits (238), Expect = 5e-22
 Identities = 60/182 (32%), Positives = 95/182 (52%), Gaps = 10/182 (5%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPK 234
            VA+KK+  +   D   + + R E+ LL  +RHPN+V+    V       + +V EY  +
Sbjct: 34  IVALKKVRMDNERDGIPISSLR-EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ 92

Query: 235 GDLRAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            DL + L         + V+   L + RG+ YLHEN    IIHRDL+ SN+L  D G LK
Sbjct: 93  -DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLK 148

Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 352
           +ADFG+++   +   +P+T +  +  Y APE+      Y T +D+++   IL E++   P
Sbjct: 149 IADFGLARTYGLP-AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKP 207

Query: 353 PF 354
             
Sbjct: 208 LL 209

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score = 96.0 bits (239), Expect = 6e-22
 Identities = 63/191 (32%), Positives = 102/191 (53%), Gaps = 13/191 (6%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA-VTQSSPMMIVTEYL 232
            G  VA+KK+ +   +     R +R EL LL+ +RH N++      ++    +  VTE L
Sbjct: 34  TGQNVAIKKIMKPFSTPVLAKRTYR-ELKLLKHLRHENIISLSDIFISPLEDIYFVTELL 92

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
              DL   L     L+      F   I RG+ Y+H      ++HRDL+PSNIL +++ +L
Sbjct: 93  GT-DLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDL 147

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGC 351
           K+ DFG++++    +D  +T   ++  Y APE+    ++YD +VD++S   I  EM+EG 
Sbjct: 148 KICDFGLARI----QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203

Query: 352 PPFTMK-HDNE 361
           P F  K H N+
Sbjct: 204 PLFPGKDHVNQ 214

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 95.0 bits (237), Expect = 6e-22
 Identities = 57/182 (31%), Positives = 96/182 (52%), Gaps = 21/182 (11%)

Query: 178 VAVKKLGEEVISDDDRVRAF--RDELALLQKIR---HPNVVQFLG-----AVTQSSPMMI 227
           VA+KK+   V   ++ +     R E+ALL+++    HPN+V+ L         +   + +
Sbjct: 27  VALKKV--RVPLSEEGIPLSTLR-EIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTL 83

Query: 228 VTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           V E++ + DL  +L +  K  L P T       + RG+++LH ++   I+HRDL+P NIL
Sbjct: 84  VFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNIL 139

Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
               G +K+ADFG++++ +   +  LT    +  Y APEV     Y T VD++S   I  
Sbjct: 140 VTSDGQVKIADFGLARIYS--FEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFA 197

Query: 346 EM 347
           E+
Sbjct: 198 EL 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 94.6 bits (236), Expect = 6e-22
 Identities = 54/177 (30%), Positives = 88/177 (49%), Gaps = 5/177 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K + +  I +  +      E  +L++  HP +V+          + ++ EY   G+L 
Sbjct: 22  ALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELW 81

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L+ +G     TA  +   +     YLH      II+RDL+P N+L D +G +K+ DFG
Sbjct: 82  TILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFG 138

Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
            +K L   + +  T   T   YVAPE+  N+ YD  VD +S  ++L E++ G PPF 
Sbjct: 139 FAKKLKSGQ-KTWTFCGTP-EYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFG 193

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score = 95.7 bits (239), Expect = 8e-22
 Identities = 65/195 (33%), Positives = 94/195 (48%), Gaps = 27/195 (13%)

Query: 175 GIQVAVKKLGEEVISDD-DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIV 228
           G +VA+KK+   V  D  D  R  R E+ LL+ +RH N++  L  +   SP       IV
Sbjct: 25  GRKVAIKKI-SNVFDDLIDAKRILR-EIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIV 82

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           TE +   DL   +K    L       F   I RG+ YLH      +IHRDL+PSNIL + 
Sbjct: 83  TELMET-DLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNS 138

Query: 289 SGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYV------APEVFKN-EEYDTKVDVFS 339
           + +LK+ DFG+++ +   ED    LT       YV      APE+  +   Y   +D++S
Sbjct: 139 NCDLKICDFGLARGVDPDEDEKGFLT------EYVVTRWYRAPELLLSSSRYTKAIDIWS 192

Query: 340 FALILQEMIEGCPPF 354
              I  E++   P F
Sbjct: 193 VGCIFAELLTRKPLF 207

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 95.2 bits (237), Expect = 8e-22
 Identities = 68/209 (32%), Positives = 108/209 (51%), Gaps = 20/209 (9%)

Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAF---RDELALLQKIRHPNVVQFL 216
           KG+F   +LA  +G     A+K L ++V+ +DD V      R  LAL  +  HP +    
Sbjct: 5   KGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWE--HPFLTHLF 62

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
                   +  V EYL  GDL   ++  G    + A  +A +I  G+ +LH+     II+
Sbjct: 63  CTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIY 119

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDT 333
           RDL+  N+L D  G++K+ADFG+ K     E +      T C    Y+APE+ K ++Y+ 
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGK----ASTFCGTPDYIAPEILKGQKYNE 175

Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEV 362
            VD +SF ++L EM+ G  PF  + ++E+
Sbjct: 176 SVDWWSFGVLLYEMLIGQSPFHGEDEDEL 204

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 93.9 bits (233), Expect = 9e-22
 Identities = 64/220 (29%), Positives = 114/220 (51%), Gaps = 16/220 (7%)

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGAL-KPSTAV 253
           A + E+ LL K++HPN+V F  +  ++  + IV EY   GDL   + R +G L      +
Sbjct: 45  ASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQIL 104

Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL-KVADFGVSKLLTVKEDRPLT 312
            + + I+ G+ ++H+ K   I+HRD++  NI    +G + K+ DFG+++ L    +   T
Sbjct: 105 SWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYT 161

Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH---DNEVPKAYAAR 369
           C  T   Y++PE+ +N  Y+ K D++S   +L E+   C   T+KH    N + +     
Sbjct: 162 CVGTP-YYLSPEICQNRPYNNKTDIWSLGCVLYEL---C---TLKHPFEGNNLHQLVLKI 214

Query: 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409
            +  F   +  ++R L+ LI + +   P  RP+   I+ R
Sbjct: 215 CQGYFAPISPNFSRDLRSLISQLFKVSPRDRPSITSILKR 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 60/211 (28%), Positives = 91/211 (43%), Gaps = 45/211 (21%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  +   +++   R E  +L     P +V+   +      + +V EY+P GDL 
Sbjct: 30  AMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLM 89

Query: 239 AFLKRKGALKPSTAVRF-------ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
             L RK      TA RF       ALD    + +         IHRD++P NIL D  G+
Sbjct: 90  NLLIRKDVFPEETA-RFYIAELVLALDSVHKLGF---------IHRDIKPDNILIDADGH 139

Query: 292 LKVADFGVSKLLTVKEDRPLTCQDT----------------------------SCRYVAP 323
           +K+ADFG+ K +   +DR     D+                            +  Y+AP
Sbjct: 140 IKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP 199

Query: 324 EVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           EV +   Y  + D +S  +IL EM+ G PPF
Sbjct: 200 EVLRGTPYGLECDWWSLGVILYEMLYGFPPF 230

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 93.1 bits (231), Expect = 2e-21
 Identities = 52/190 (27%), Positives = 94/190 (49%), Gaps = 11/190 (5%)

Query: 174 RGIQVAVKKLG---EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
           +G  +AVK++      V++ +      ++E+ LL+ ++H N+VQ+LG     + + I  E
Sbjct: 23  QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFME 82

Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           ++P G + + L R G L      ++   I  G+ YLH N    ++HRD++ +N++   +G
Sbjct: 83  FVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNG 139

Query: 291 NLKVADFGVSKLL-----TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
            +K+ DFG ++ L            L     +  ++APEV     Y  K D++S    + 
Sbjct: 140 IIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVF 199

Query: 346 EMIEGCPPFT 355
           EM  G PP  
Sbjct: 200 EMATGKPPLA 209

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 94.1 bits (234), Expect = 2e-21
 Identities = 58/185 (31%), Positives = 91/185 (49%), Gaps = 5/185 (2%)

Query: 179 AVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           AVK L ++ I      +    E   LL+ ++HP +V    +   +  +  V +Y+  G+L
Sbjct: 24  AVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGEL 83

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              L+R+ +     A  +A +IA  + YLH      II+RDL+P NIL D  G++ + DF
Sbjct: 84  FFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDF 140

Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
           G+ K          T   T   Y+APEV + + YD  VD +    +L EM+ G PPF  +
Sbjct: 141 GLCKEGIEHSKTTSTFCGTP-EYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199

Query: 358 HDNEV 362
              E+
Sbjct: 200 DTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 64/235 (27%), Positives = 108/235 (45%), Gaps = 43/235 (18%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVR-- 254
           E  LL  + H N++  L    +   P  ++  Y+  G+L+ FL+  R G      A+   
Sbjct: 58  ESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQ 117

Query: 255 ----FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK--------L 302
                A+ IA GM+YLH+     +IH+D+   N + D+   +K+ D  +S+         
Sbjct: 118 QLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHC 174

Query: 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCP-----PFT 355
           L   E+RP+       +++A E   N+EY +  DV+SF ++L E++     P     PF 
Sbjct: 175 LGDNENRPV-------KWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFE 227

Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
           M     +   Y   Q  P   P +L+A     ++  CW   P +RP+F Q++  L
Sbjct: 228 MAA--YLKDGYRLAQ--PINCPDELFA-----VMACCWALDPEERPSFSQLVQCL 273

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 96.8 bits (241), Expect = 3e-21
 Identities = 64/252 (25%), Positives = 104/252 (41%), Gaps = 18/252 (7%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL-GAVTQSSPMMIVTEYLP 233
           G +VA+K L  +   ++ +   FR E AL  ++ HPN+V  L         +  V EY+P
Sbjct: 3   GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62

Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 290
              LR  L   GAL      R  L +   +   H      I+HRDL+P NI+        
Sbjct: 63  GRTLREVLAADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIMVSQTGVRP 119

Query: 291 NLKVADFGVSKLLT-VKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           + KV DFG+  LL  V++    T   T     +  Y APE  + E      D++++ LI 
Sbjct: 120 HAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIF 179

Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRP-PFKAPAKLYARGLKELIEECWNEKPAKRP-T 402
            E + G          E+      +  P     P  +    L +++ +  N+ P +R  +
Sbjct: 180 LECLTGQRVVQGASVAEI---LYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAAS 236

Query: 403 FRQIITRLESIN 414
              +  R  ++ 
Sbjct: 237 APALAERFRALE 248

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 93.9 bits (233), Expect = 3e-21
 Identities = 69/218 (31%), Positives = 110/218 (50%), Gaps = 20/218 (9%)

Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
           DF   + + KG+F   +LA  +G     A+K L ++V+  DD V     E   LAL  K 
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDK- 59

Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
             P + Q          +  V EY+  GDL   +++ G  K   AV +A +I+ G+ +LH
Sbjct: 60  -PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLH 118

Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPE 324
                 II+RDL+  N++ D  G++K+ADFG+ K   V          T C    Y+APE
Sbjct: 119 RRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFCGTPDYIAPE 171

Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
           +   + Y   VD +++ ++L EM+ G PPF  + ++E+
Sbjct: 172 IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 93.7 bits (233), Expect = 4e-21
 Identities = 62/227 (27%), Positives = 107/227 (47%), Gaps = 11/227 (4%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
            G   A+K L +  I    +V+    E ++L ++ HP +V  + +    + +  + E++ 
Sbjct: 42  TGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVV 101

Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            G+L   L++ G      A  +  ++     YLH      II+RDL+P N+L D+ G++K
Sbjct: 102 GGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVK 158

Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
           V DFG +K +    DR  T   T   Y+APEV +++ +   VD ++  ++L E I G PP
Sbjct: 159 VTDFGFAKKVP---DRTFTLCGTP-EYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214

Query: 354 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
           F    D+   + Y        K P     R  ++L++        KR
Sbjct: 215 F---FDDTPFRIYEKILAGRLKFPNWFDGRA-RDLVKGLLQTDHTKR 257

Length = 329

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 91.9 bits (228), Expect = 5e-21
 Identities = 66/244 (27%), Positives = 117/244 (47%), Gaps = 23/244 (9%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           VAVK     ++ +D+   A +DEL     ++Q++ +P +V+ +G + ++   M+V E   
Sbjct: 25  VAVK-----ILKNDNNDPALKDELLREANVMQQLDNPYIVRMIG-ICEAESWMLVMELAE 78

Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            G L  FL++   +           ++ GM YL E      +HRDL   N+L       K
Sbjct: 79  LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAK 135

Query: 294 VADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
           ++DFG+SK L   E+  +  T      ++ APE     ++ +K DV+SF +++ E    G
Sbjct: 136 ISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYG 195

Query: 351 CPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
             P+     NEV +   + +R   P + P ++Y     +L++ CW     +RP F  +  
Sbjct: 196 QKPYKGMKGNEVTQMIESGERMECPQRCPPEMY-----DLMKLCWTYGVDERPGFAVVEL 250

Query: 409 RLES 412
           RL +
Sbjct: 251 RLRN 254

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 92.1 bits (229), Expect = 7e-21
 Identities = 70/266 (26%), Positives = 125/266 (46%), Gaps = 23/266 (8%)

Query: 151 DPHELDFTNSVEI---TKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP      N V+I   + G   +A  +  G QVAVKK+    +    R     +E+ +++
Sbjct: 16  DPRS-YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMD---LRKQQRRELLFNEVVIMR 71

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
             +HPN+V+   +      + +V E+L  G L   +      +   A    L + + +++
Sbjct: 72  DYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLAVLKALSF 130

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
           LH      +IHRD++  +IL    G +K++DFG    ++ +  R  +   T   ++APEV
Sbjct: 131 LHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTP-YWMAPEV 186

Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR----PPFKAPAKLY 381
                Y T+VD++S  +++ EM++G PP+     NE P     R R    P  K   K+ 
Sbjct: 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYF----NEPPLQAMKRIRDNLPPKLKNLHKVS 242

Query: 382 ARGLKELIEECWNEKPAKRPTFRQII 407
            R L+  ++      PA+R T  +++
Sbjct: 243 PR-LRSFLDRMLVRDPAQRATAAELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 91.7 bits (227), Expect = 9e-21
 Identities = 72/256 (28%), Positives = 120/256 (46%), Gaps = 30/256 (11%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VAVK L +   + D+  + F  E  LL  ++H ++V+F G   +  P+++V EY+  G
Sbjct: 36  ILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 92

Query: 236 DLRAFLKRKGA-------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           DL  FL+  G              L  S  +  A  IA GM YL        +HRDL   
Sbjct: 93  DLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATR 149

Query: 283 NILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
           N L  ++  +K+ DFG+S+ + +    R         R++ PE     ++ T+ DV+S  
Sbjct: 150 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 209

Query: 342 LILQEMIE-GCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGLKELIEECWNEKP 397
           ++L E+   G  P+    +NEV +        QRP    P ++Y     +L+  CW  +P
Sbjct: 210 VVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR-TCPKEVY-----DLMLGCWQREP 263

Query: 398 AKRPTFRQIITRLESI 413
             R   ++I + L+++
Sbjct: 264 HMRLNIKEIHSLLQNL 279

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 91.2 bits (226), Expect = 9e-21
 Identities = 67/249 (26%), Positives = 121/249 (48%), Gaps = 21/249 (8%)

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGA 218
           E+ + T +L    G+ VA+KK+    I D    +A  D   E+ LL+++ HPNV+++  +
Sbjct: 17  EVYRATCLL---DGVPVALKKVQ---IFDLMDAKARADCIKEIDLLKQLNHPNVIKYYAS 70

Query: 219 VTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPI 274
             + + + IV E    GDL    + F K+K  +   T  ++ + +   + ++H  +   +
Sbjct: 71  FIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---V 127

Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK 334
           +HRD++P+N+    +G +K+ D G+ +  + K     +   T   Y++PE      Y+ K
Sbjct: 128 MHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTP-YYMSPERIHENGYNFK 186

Query: 335 VDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
            D++S   +L EM     PF     N   + K       PP   P+  Y+  L++L+  C
Sbjct: 187 SDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL--PSDHYSEELRQLVNMC 244

Query: 393 WNEKPAKRP 401
            N  P KRP
Sbjct: 245 INPDPEKRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 92.0 bits (228), Expect = 1e-20
 Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 12/202 (5%)

Query: 179 AVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           AVK L ++ I    + + + A R+   LL+ ++HP +V    +   +  +  V +Y+  G
Sbjct: 24  AVKVLQKKTILKKKEQNHIMAERN--VLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG 81

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
           +L   L+R+       A  +A ++A  + YLH    + II+RDL+P NIL D  G++ + 
Sbjct: 82  ELFFHLQRERCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLT 138

Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
           DFG+ K     E+   T   T   Y+APEV + E YD  VD +    +L EM+ G PPF 
Sbjct: 139 DFGLCKEGVEPEETTSTFCGTP-EYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPF- 196

Query: 356 MKHDNEVPKAYAARQRPPFKAP 377
             +  +V + Y      P + P
Sbjct: 197 --YSRDVSQMYDNILHKPLQLP 216

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 91.1 bits (226), Expect = 2e-20
 Identities = 60/236 (25%), Positives = 117/236 (49%), Gaps = 13/236 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+K++    +    +     +E+ ++++ +HPN+V +L +      + +V EYL  
Sbjct: 44  GQEVAIKQMN---LQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAG 100

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +  +  +          +  + + +LH N+   +IHRD++  NIL    G++K+
Sbjct: 101 GSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG    +T ++ +  T   T   ++APEV   + Y  KVD++S  ++  EM+EG PP+
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Query: 355 TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
              ++N +   Y  A    P  + P KL A   ++ +  C      KR + ++++ 
Sbjct: 216 L--NENPLRALYLIATNGTPELQNPEKLSA-IFRDFLNRCLEMDVEKRGSAKELLQ 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 89.8 bits (223), Expect = 2e-20
 Identities = 61/214 (28%), Positives = 96/214 (44%), Gaps = 18/214 (8%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQF 215
            I+KG F    LA  R  G   A+K L +  +   ++V   + E A++      P V + 
Sbjct: 3   PISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKL 62

Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
             +      + +V EYL  GD  + +K  G L    A ++  ++  G+  LH+     II
Sbjct: 63  YYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---II 119

Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
           HRD++P N+L D +G+LK+ DFG+S+     +    T       Y+APE       D   
Sbjct: 120 HRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVGTPD-----YLAPETILGVGDDKMS 174

Query: 336 DVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
           D +S   ++ E + G PPF      E P A    
Sbjct: 175 DWWSLGCVIFEFLFGYPPF----HAETPDAVFDN 204

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 90.3 bits (224), Expect = 2e-20
 Identities = 68/244 (27%), Positives = 116/244 (47%), Gaps = 20/244 (8%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G+ +A+K++  E+  D+ +      EL +L K   P +V F GA      + +  EY+  
Sbjct: 26  GVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDA 83

Query: 235 GDLRAFLKRKGAL--KPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           G L        A    P   +R     + +G+ +L E     IIHRD++P+N+L + +G 
Sbjct: 84  GSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN--IIHRDVKPTNVLVNGNGQ 141

Query: 292 LKVADFGVS-KLLTVKEDRPLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALIL 344
           +K+ DFGVS  L+       + CQ     Y+APE  K+        Y  + DV+S  L +
Sbjct: 142 VKLCDFGVSGNLVASLAKTNIGCQS----YMAPERIKSGGPNQNPTYTVQSDVWSLGLSI 197

Query: 345 QEMIEGCPPFTMK-HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 403
            EM  G  P+  + + N   +  A     P   P+  Y+   ++ + +C N+ P +RPT+
Sbjct: 198 LEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG-YSDDAQDFVAKCLNKIPNRRPTY 256

Query: 404 RQII 407
            Q++
Sbjct: 257 AQLL 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 85.9 bits (213), Expect = 3e-20
 Identities = 39/82 (47%), Positives = 50/82 (60%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A    +E +K LL+ G DVN RD D  T LH+AA  G  +VV LLL+ GADV+ +D
Sbjct: 44  LHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAARNGNLDVVKLLLKHGADVNARD 103

Query: 104 RWGSTPLGDAIYYKNHEVIKLL 125
           + G TPL  A    + EV+KLL
Sbjct: 104 KDGRTPLHLAAKNGHLEVVKLL 125

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 89.8 bits (223), Expect = 4e-20
 Identities = 67/210 (31%), Positives = 114/210 (54%), Gaps = 19/210 (9%)

Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIR 208
           D+T   +I +GT+ + +       G  VA+KK+  E  S+++ V   A R E++LL++++
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLE--SEEEGVPSTAIR-EISLLKELQ 57

Query: 209 HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFAL-DIARGMNY 265
           HPN+V     + Q S + ++ E+L   DL+ +L    KG    +  V+  L  I +G+ +
Sbjct: 58  HPNIVCLQDVLMQESRLYLIFEFLSM-DLKKYLDSLPKGQYMDAELVKSYLYQILQGILF 116

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
            H  +   ++HRDL+P N+L D+ G +K+ADFG+++   +   R  T +  +  Y APEV
Sbjct: 117 CHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV-RVYTHEVVTLWYRAPEV 172

Query: 326 F-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
              +  Y T VD++S   I  EM    P F
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLF 202

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 89.8 bits (223), Expect = 4e-20
 Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 27/246 (10%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  +AVK++   V S + + R   D    ++ +  P  V F GA+ +   + I  E +  
Sbjct: 26  GTIMAVKRIRATVNSQEQK-RLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME-VMD 83

Query: 235 GDLRAFLKR---KGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
             L  F K+   KG   P   + + A+ I + + YLH    V  IHRD++PSN+L + +G
Sbjct: 84  TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSV--IHRDVKPSNVLINRNG 141

Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVF----KNEEYDTKVDVFSFALILQ 345
            +K+ DFG+S  L    D      D  C+ Y+APE        + YD K DV+S  + + 
Sbjct: 142 QVKLCDFGISGYLV---DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMI 198

Query: 346 EMIEGCPPFTMKHD-----NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
           E+  G  P+           +V +       P  + PA+ ++   ++ + +C  +   +R
Sbjct: 199 ELATGRFPYDSWKTPFQQLKQVVEE------PSPQLPAEKFSPEFQDFVNKCLKKNYKER 252

Query: 401 PTFRQI 406
           P + ++
Sbjct: 253 PNYPEL 258

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 89.3 bits (221), Expect = 5e-20
 Identities = 67/252 (26%), Positives = 125/252 (49%), Gaps = 30/252 (11%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VA+K + E   S  +R+  F +E +++++    +VV+ LG V+Q  P +++ E + +GD
Sbjct: 38  RVAIKTVNEAA-SMRERIE-FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGD 95

Query: 237 LRAFLKRKGALKPSTA-------------VRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+ NK    +HRDL   N
Sbjct: 96  LKSYLR---SLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARN 149

Query: 284 ILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
            +  +   +K+ DFG+++ +      R         R+++PE  K+  + T  DV+SF +
Sbjct: 150 CMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGV 209

Query: 343 ILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
           +L E+      P+    + +V +          P   P  L+     EL+  CW   P  
Sbjct: 210 VLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKM 264

Query: 400 RPTFRQIITRLE 411
           RP+F +II+ ++
Sbjct: 265 RPSFLEIISSIK 276

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 89.6 bits (222), Expect = 6e-20
 Identities = 81/295 (27%), Positives = 134/295 (45%), Gaps = 48/295 (16%)

Query: 144 EVPEYEID-PHEL---DFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
           EV   E+  P +L    F  +V   KG       R + VAVK L  +  ++ +    F  
Sbjct: 20  EVHLCEVVNPQDLPTLQFPFNVR--KG-------RPLLVAVKILRPD--ANKNARNDFLK 68

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------- 245
           E+ +L +++ PN+++ LG      P+ ++TEY+  GDL  FL                  
Sbjct: 69  EVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPP 128

Query: 246 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
                A+  S+ +  AL IA GM YL     +  +HRDL   N L  ++  +K+ADFG+S
Sbjct: 129 AHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFGMS 185

Query: 301 KLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC--PPFTMK 357
           + L   +   +  +     R++A E     ++ T  DV++F + L E++  C   P+   
Sbjct: 186 RNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGEL 245

Query: 358 HDNEVPKAYA------ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
            D +V +          RQ   F+ P     +GL EL+ +CW+    +RP+F  I
Sbjct: 246 TDEQVIENAGEFFRDQGRQVYLFRPPP--CPQGLYELMLQCWSRDCRERPSFSDI 298

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 88.3 bits (219), Expect = 1e-19
 Identities = 60/233 (25%), Positives = 106/233 (45%), Gaps = 19/233 (8%)

Query: 183 LGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYL---PKGDLR 238
            G++    D  +     E+ ++ +++RHPN+V++     ++  + IV + +   P G+  
Sbjct: 41  FGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHF 100

Query: 239 AFLKRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
             LK K        +    + +   + YLH+ K   I+HRDL P+NI+  +   + + DF
Sbjct: 101 NSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR--IVHRDLTPNNIMLGEDDKVTITDF 158

Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
           G++K    + +  LT    +  Y  PE+ KNE Y  K DV++F  IL +M    PPF   
Sbjct: 159 GLAK--QKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF--- 213

Query: 358 HDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +   +     K   A   P    P  +Y+  + ++I  C       RP   Q+
Sbjct: 214 YSTNMLSLATKIVEAVYEP---LPEGMYSEDVTDVITSCLTPDAEARPDIIQV 263

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 88.1 bits (218), Expect = 1e-19
 Identities = 63/213 (29%), Positives = 104/213 (48%), Gaps = 14/213 (6%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRF 255
           E  LL K+ HP +V+F  +  +     I+TEY    DL             L  +    +
Sbjct: 52  EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111

Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
            + +  G++Y+H+ +   I+HRDL+  NI L+++   LK+ DFGVS+LL    D   T  
Sbjct: 112 FIQLLLGVHYMHQRR---ILHRDLKAKNIFLKNNL--LKIGDFGVSRLLMGSCDLATTFT 166

Query: 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374
            T   Y++PE  K++ YD+K D++S   IL EM   C     +  N +       + P  
Sbjct: 167 GTP-YYMSPEALKHQGYDSKSDIWSLGCILYEMC--CLAHAFEGQNFLSVVLRIVEGPTP 223

Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             P   Y+R L  +++   N+ P+ RP+  +I+
Sbjct: 224 SLPET-YSRQLNSIMQSMLNKDPSLRPSAAEIL 255

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 89.2 bits (221), Expect = 1e-19
 Identities = 67/232 (28%), Positives = 112/232 (48%), Gaps = 17/232 (7%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVTEYL 232
           +G   AVK L ++V+  DD V     E  +L     +P +            +  V E+L
Sbjct: 19  KGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFL 78

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
             GDL   ++ KG      A  +A +I  G+ +LH      II+RDL+  N++ D  G++
Sbjct: 79  NGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHI 135

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
           K+ADFG+ K     ++R  T   T   Y+APE+ +  +Y   VD +SF ++L EM+ G  
Sbjct: 136 KIADFGMCKENVFGDNRASTFCGTP-DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQS 194

Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL----KELIEECWNEKPAKR 400
           PF    ++E+ +  + R   P       Y R +    K+++E+ +   P +R
Sbjct: 195 PFHGDDEDELFE--SIRVDTPH------YPRWITKESKDILEKLFERDPTRR 238

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 88.0 bits (218), Expect = 1e-19
 Identities = 61/254 (24%), Positives = 110/254 (43%), Gaps = 32/254 (12%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
              +V VK+L     +  D    F  E+   +++ HPNV+Q LG   +S P ++V E+ P
Sbjct: 21  SKARVVVKEL--RASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78

Query: 234 KGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            GDL+ +L+          +     R A ++A G+ +LH+      IH DL   N     
Sbjct: 79  LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTA 135

Query: 289 SGNLKVADFGVSKLLTVKEDRPLT--CQDTSCRYVAPEVFKNEEYDTKV-------DVFS 339
             ++K+ D+G++ L    ED  +T  C     R++APE+ +    D          +++S
Sbjct: 136 DLSVKIGDYGLA-LEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWS 194

Query: 340 FALILQEMIE-GCPPFTMKHDNEVPKAYAARQR------PPFKAPAKLYARGLKELIEEC 392
             + + E+      P+     +E       R++      P        Y+    E+++ C
Sbjct: 195 LGVTMWELFTAADQPYP-DLSDEQVLKQVVREQDIKLPKPQLDLK---YSDRWYEVMQFC 250

Query: 393 WNEKPAKRPTFRQI 406
           W + P  RPT  ++
Sbjct: 251 WLD-PETRPTAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 87.8 bits (217), Expect = 2e-19
 Identities = 55/208 (26%), Positives = 101/208 (48%), Gaps = 12/208 (5%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRF 255
           E+ LL+++ HPNV+++L +  + + + IV E    GDL    + F K+K  +   T  ++
Sbjct: 52  EIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKY 111

Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
            + +   + ++H  +   ++HRD++P+N+    +G +K+ D G+ +  + K     +   
Sbjct: 112 FVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG 168

Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPP 373
           T   Y++PE      Y+ K D++S   +L EM     PF     N         Q   PP
Sbjct: 169 TP-YYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP 227

Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRP 401
              P + Y+  L+EL+  C    P +RP
Sbjct: 228 L--PTEHYSEKLRELVSMCIYPDPDQRP 253

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 88.3 bits (219), Expect = 2e-19
 Identities = 54/189 (28%), Positives = 99/189 (52%), Gaps = 11/189 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K + +E+++DD+ +   + E  +      HP +V         S +  V E++  GDL
Sbjct: 24  AMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDL 83

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  ++ +I+  +N+LHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 84  MFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDY 140

Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G+ K    +  RP     T C    Y+APE+ + E+Y   VD ++  +++ EM+ G  PF
Sbjct: 141 GMCK----EGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Query: 355 TMKHDNEVP 363
            +   ++ P
Sbjct: 197 DIVGMSDNP 205

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 88.5 bits (219), Expect = 2e-19
 Identities = 57/186 (30%), Positives = 98/186 (52%), Gaps = 11/186 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K + +E++ DD+ +   + E  +  Q   +P +V        +S + +V EY+  GDL
Sbjct: 24  AMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDL 83

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  +A +I   +N+LHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 84  MFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDY 140

Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G+ K    +   P     T C    Y+APE+ + EEY   VD ++  +++ EM+ G  PF
Sbjct: 141 GMCK----EGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196

Query: 355 TMKHDN 360
            +  DN
Sbjct: 197 DIITDN 202

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 88.2 bits (218), Expect = 2e-19
 Identities = 57/189 (30%), Positives = 100/189 (52%), Gaps = 11/189 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K + +E+++DD+ +   + E  +  Q   HP +V         S +  V EY+  GDL
Sbjct: 24  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 83

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  ++ +I+  +NYLHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 84  MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 140

Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G+ K    +  RP     T C    Y+APE+ + E+Y   VD ++  +++ EM+ G  PF
Sbjct: 141 GMCK----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196

Query: 355 TMKHDNEVP 363
            +   ++ P
Sbjct: 197 DIVGSSDNP 205

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 87.6 bits (217), Expect = 2e-19
 Identities = 64/231 (27%), Positives = 110/231 (47%), Gaps = 13/231 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A KKL ++ +      +   +E  +L+K+    +V    A      + +V   +  GDL+
Sbjct: 22  ACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLK 81

Query: 239 AFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
             +   G      + A+ +A  I  G+ +LH+ +   I++RDL+P N+L DD GN++++D
Sbjct: 82  YHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISD 138

Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356
            G++  + +K  + +  +  +  Y+APEV + E YD  VD F+    L EMI G  PF  
Sbjct: 139 LGLA--VELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQ 196

Query: 357 ---KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
              K + E  K          + P K ++   K+L E    + P KR   R
Sbjct: 197 RKEKVEKEELKRRTLEM--AVEYPDK-FSPEAKDLCEALLQKDPEKRLGCR 244

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 87.3 bits (216), Expect = 3e-19
 Identities = 64/239 (26%), Positives = 113/239 (47%), Gaps = 22/239 (9%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFR---DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
           I VA+K      I D    + F+   D +  +  + H  +V+ LG    +S + +VT+  
Sbjct: 37  IPVAIK-----TIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICPGAS-LQLVTQLS 90

Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G L   + + + +L P   + + + IA+GM YL E++   ++HR+L   NIL      
Sbjct: 91  PLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSI 147

Query: 292 LKVADFGVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 349
           +++ADFGV+ LL   + +    +  T  +++A E      Y  + DV+S+ + + EM+  
Sbjct: 148 VQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSY 207

Query: 350 GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           G  P+     +EVP      +R   P      +Y   +K     CW      RPTF+++
Sbjct: 208 GAEPYAGMRPHEVPDLLEKGERLAQPQICTIDVYMVMVK-----CWMIDENVRPTFKEL 261

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 87.8 bits (217), Expect = 4e-19
 Identities = 63/209 (30%), Positives = 102/209 (48%), Gaps = 16/209 (7%)

Query: 163 ITKGTF---ILAFWRGIQV--AVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFL 216
           I KG+F   +LA  +  +   AVK L ++ I      +    E   LL+ ++HP +V   
Sbjct: 3   IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            +   +  +  V +Y+  G+L   L+R+       A  +A +IA  + YLH    + I++
Sbjct: 63  FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVY 119

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDT 333
           RDL+P NIL D  G++ + DFG+ K    +         T C    Y+APEV   + YD 
Sbjct: 120 RDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQPYDR 175

Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEV 362
            VD +    +L EM+ G PPF  ++  E+
Sbjct: 176 TVDWWCLGAVLYEMLYGLPPFYSRNTAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score = 87.7 bits (218), Expect = 5e-19
 Identities = 62/188 (32%), Positives = 94/188 (50%), Gaps = 19/188 (10%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
           G +VA+KKL     S     R +R EL LL+ + H NV+  L   T +S +       +V
Sbjct: 40  GRKVAIKKLSRPFQSAIHAKRTYR-ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLV 98

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRD 287
           T  L   DL   +K +  L     ++F +  I RG+ Y+H      IIHRDL+PSNI  +
Sbjct: 99  TH-LMGADLNNIVKCQ-KLSDDH-IQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVN 152

Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQE 346
           +   LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E
Sbjct: 153 EDCELKILDFGLARHT----DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208

Query: 347 MIEGCPPF 354
           ++ G   F
Sbjct: 209 LLTGKTLF 216

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 86.8 bits (215), Expect = 6e-19
 Identities = 65/205 (31%), Positives = 100/205 (48%), Gaps = 16/205 (7%)

Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDE---LALLQKIRHPNVVQFL 216
           KG+F   +LA  +G     A+K L ++VI  DD V     E   LAL  K  HP +    
Sbjct: 5   KGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAK--HPFLTALH 62

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
                   +  V EY+  GDL   ++R        +  +A ++   + +LH +    +I+
Sbjct: 63  CCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIY 119

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           RDL+  NIL D  G+ K+ADFG+ K   +      T   T   Y+APE+ +  EY   VD
Sbjct: 120 RDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP-DYIAPEILQELEYGPSVD 178

Query: 337 VFSFALILQEMIEGCPPFTMKHDNE 361
            ++  +++ EM+ G PPF  + DNE
Sbjct: 179 WWALGVLMYEMMAGQPPF--EADNE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 87.0 bits (215), Expect = 8e-19
 Identities = 57/187 (30%), Positives = 98/187 (52%), Gaps = 9/187 (4%)

Query: 179 AVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           AVK L ++++    +   + A R+   LL+ ++HP +V    +   +  +  V +++  G
Sbjct: 24  AVKVLQKKIVLNRKEQKHIMAERN--VLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGG 81

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
           +L   L+R+ +     A  +A +IA  + YLH    + I++RDL+P NIL D  G++ + 
Sbjct: 82  ELFFHLQRERSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLT 138

Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
           DFG+ K    + D   T   T   Y+APEV + + YD  VD +    +L EM+ G PPF 
Sbjct: 139 DFGLCKEGIAQSDTTTTFCGTP-EYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFY 197

Query: 356 MKHDNEV 362
            +   E+
Sbjct: 198 CRDVAEM 204

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 86.3 bits (214), Expect = 8e-19
 Identities = 62/243 (25%), Positives = 105/243 (43%), Gaps = 39/243 (16%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +  +   + ++ +
Sbjct: 49  ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            RG+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L    D        +  
Sbjct: 109 LRGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 163

Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPPFTMK------------------- 357
           Y++PE  +   Y  + D++S  L L EM  G    PP   K                   
Sbjct: 164 YMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESH 223

Query: 358 -----HDNEVPKAYAARQ-------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
                H  + P+  A  +        PP K P+  ++   ++ +++C  + P +R   ++
Sbjct: 224 RPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKE 283

Query: 406 IIT 408
           +  
Sbjct: 284 LTK 286

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 86.3 bits (213), Expect = 9e-19
 Identities = 56/233 (24%), Positives = 115/233 (49%), Gaps = 9/233 (3%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+K++    +    +     +E+ +++++++PN+V FL +      + +V EYL  
Sbjct: 44  GQEVAIKQIN---LQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAG 100

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +     +  +       +  + + +LH N+   +IHRD++  N+L    G++K+
Sbjct: 101 GSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKL 156

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG    +T ++ +  T   T   ++APEV   + Y  KVD++S  ++  EM+EG PP+
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             ++        A    P  + P KL +   ++ +  C      KR + ++++
Sbjct: 216 LNENPLRALYLIATNGTPELQNPEKL-SPIFRDFLNRCLEMDVEKRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 86.2 bits (214), Expect = 1e-18
 Identities = 64/205 (31%), Positives = 96/205 (46%), Gaps = 25/205 (12%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MM 226
           G  VA+KK+      D   + A R E+ +L+K++HPNVV  +    +           + 
Sbjct: 33  GRVVALKKILMHNEKDGFPITALR-EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVY 91

Query: 227 IVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           +VT Y+   DL   L+     L  S    + L +  G+NYLHEN    I+HRD++ +NIL
Sbjct: 92  MVTPYM-DHDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANIL 147

Query: 286 RDDSGNLKVADFGVSKLLTVKEDRP------LTCQDTSC---R-YVAPEVFKNE-EYDTK 334
            D+ G LK+ADFG+++        P       T + T+    R Y  PE+   E  Y T 
Sbjct: 148 IDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTA 207

Query: 335 VDVFSFALILQEMIEGCPPFTMKHD 359
           VD++    +  EM    P    K D
Sbjct: 208 VDIWGIGCVFAEMFTRRPILQGKSD 232

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 85.5 bits (211), Expect = 1e-18
 Identities = 67/254 (26%), Positives = 123/254 (48%), Gaps = 28/254 (11%)

Query: 173 WRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP----- 224
           ++G  V   +L    + D   D     + E+ +L+K   H N+  + GA  + +P     
Sbjct: 23  YKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82

Query: 225 -MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
            + +V E+   G +   +K  +   LK         +I RG+++LH++K   +IHRD++ 
Sbjct: 83  QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKG 139

Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEE-----YDT 333
            N+L  ++  +K+ DFGVS  L    DR +  ++T   +  ++APEV   +E     YD 
Sbjct: 140 QNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDF 195

Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
           K D++S  +   EM EG PP    H   +   +   + P  +  +K +++  +  IE C 
Sbjct: 196 KSDLWSLGITAIEMAEGAPPLCDMH--PMRALFLIPRNPAPRLKSKKWSKKFQSFIESCL 253

Query: 394 NEKPAKRPTFRQII 407
            +  ++RPT  Q++
Sbjct: 254 VKNHSQRPTTEQLM 267

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 60/187 (32%), Positives = 87/187 (46%), Gaps = 8/187 (4%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQ---KIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           A+K L +  I   D V +   E  + +     RHP +V           +  V EY   G
Sbjct: 28  AIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGG 87

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
           DL   +      +P  AV +A  +  G+ YLHENK   I++RDL+  N+L D  G +K+A
Sbjct: 88  DLMMHIHTDVFSEPR-AVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIA 143

Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
           DFG+ K      DR  T   T   ++APEV     Y   VD +   +++ EM+ G  PF 
Sbjct: 144 DFGLCKEGMGFGDRTSTFCGTP-EFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFP 202

Query: 356 MKHDNEV 362
              + EV
Sbjct: 203 GDDEEEV 209

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 85.6 bits (212), Expect = 1e-18
 Identities = 51/183 (27%), Positives = 95/183 (51%), Gaps = 18/183 (9%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+K++  +   DD+ V   A R E+ LL++++H N+V+    +     + +V EY  + 
Sbjct: 28  VALKRVRLD--DDDEGVPSSALR-EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ- 83

Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           DL+ +     G + P     F   + +G+ + H +    ++HRDL+P N+L + +G LK+
Sbjct: 84  DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKL 140

Query: 295 ADFGVSKLLTVKEDRPLTC---QDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEG 350
           ADFG+++   +    P+ C   +  +  Y  P+V F  + Y T +D++S   I  E+   
Sbjct: 141 ADFGLARAFGI----PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 196

Query: 351 CPP 353
             P
Sbjct: 197 GRP 199

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 86.2 bits (213), Expect = 1e-18
 Identities = 56/192 (29%), Positives = 92/192 (47%), Gaps = 10/192 (5%)

Query: 166 GTFILAFWRGIQ---VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           G  ILA ++      VA+K+  +  I    +V     E  +L  I HP  V   G+    
Sbjct: 44  GRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDE 103

Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           S + +V E++  G+   FL+R           +A  I     YL   + + I++RDL+P 
Sbjct: 104 SYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYL---QSLNIVYRDLKPE 160

Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
           N+L D  G +K+ DFG +K++   + R  T   T   Y+APE+  N  +    D ++  +
Sbjct: 161 NLLLDKDGFIKMTDFGFAKVV---DTRTYTLCGTP-EYIAPEILLNVGHGKAADWWTLGI 216

Query: 343 ILQEMIEGCPPF 354
            + E++ GCPPF
Sbjct: 217 FIYEILVGCPPF 228

Length = 340

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 74/258 (28%), Positives = 120/258 (46%), Gaps = 24/258 (9%)

Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGA 218
           KG+F    LA  +G     A+K L ++V+  DD V     E  +L     HP +      
Sbjct: 5   KGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCT 64

Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
                 +  V EYL  GDL   ++         A  +A +I  G+ +LH      I++RD
Sbjct: 65  FQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRD 121

Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
           L+  NIL D  G++K+ADFG+ K   + + +  T   T   Y+APE+   ++Y+T VD +
Sbjct: 122 LKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP-DYIAPEILLGQKYNTSVDWW 180

Query: 339 SFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 398
           SF ++L EM+ G  PF    + E+    + R   P     +   R  K+++ + +  +P 
Sbjct: 181 SFGVLLYEMLIGQSPFHGHDEEEL--FQSIRMDNPCY--PRWLTREAKDILVKLFVREPE 236

Query: 399 KR----------PTFRQI 406
           +R          P FR+I
Sbjct: 237 RRLGVKGDIRQHPFFREI 254

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 85.4 bits (211), Expect = 2e-18
 Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 14/204 (6%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E  +L ++  P +V    +      + +V  ++  G+L   L+R+G    S A  +  ++
Sbjct: 43  ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 318
              +  LH+     +I+RDL+P NIL D  G++ + DFG+ KL    +D+     +T C 
Sbjct: 103 LCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDK----TNTFCG 155

Query: 319 --RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376
              Y+APE+     Y   VD ++  ++L EM+ G PPF   +D  V + Y    + P + 
Sbjct: 156 TPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPF---YDENVNEMYRKILQEPLRF 212

Query: 377 PAKLYARGLKELIEECWNEKPAKR 400
           P     R  K+L+    +  P +R
Sbjct: 213 PDGF-DRDAKDLLIGLLSRDPTRR 235

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 85.8 bits (212), Expect = 2e-18
 Identities = 69/221 (31%), Positives = 112/221 (50%), Gaps = 26/221 (11%)

Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF   + + KG+F   +LA  +G     A+K L ++V+  DD V     E  +L     P
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 211 NVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
             +  L +  Q+   +  V EY+  GDL   +++ G  K   AV +A +IA G+ +LH  
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL-----LTVKEDRPLTCQDTSC---RYV 321
               II+RDL+  N++ D  G++K+ADFG+ K      +T K         T C    Y+
Sbjct: 121 G---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK---------TFCGTPDYI 168

Query: 322 APEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
           APE+   + Y   VD ++F ++L EM+ G  PF  + ++E+
Sbjct: 169 APEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 209

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 85.1 bits (210), Expect = 2e-18
 Identities = 52/157 (33%), Positives = 87/157 (55%), Gaps = 7/157 (4%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
           E++LL+ ++H N+V     +     + +V EYL   DL+ +L   G L     V+ F   
Sbjct: 53  EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           + RG++Y H+ K   I+HRDL+P N+L ++ G LK+ADFG+++  +V   +  + +  + 
Sbjct: 112 LLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-KTYSNEVVTL 167

Query: 319 RYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            Y  P+V   + EY T +D++    IL EM  G P F
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMF 204

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 85.6 bits (212), Expect = 2e-18
 Identities = 59/184 (32%), Positives = 97/184 (52%), Gaps = 7/184 (3%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  +   DRVR  + E  +L ++ HP +V+   A      + ++ ++L  GDL 
Sbjct: 28  AMKVLKKATLKVRDRVRT-KMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 86

Query: 239 AFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
             L  K  +     V+F L ++A  +++LH    + II+RDL+P NIL D+ G++K+ DF
Sbjct: 87  TRLS-KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDF 142

Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
           G+SK     E +  +   T   Y+APEV     +    D +SF +++ EM+ G  PF  K
Sbjct: 143 GLSKESIDHEKKAYSFCGT-VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGK 201

Query: 358 HDNE 361
              E
Sbjct: 202 DRKE 205

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 84.7 bits (209), Expect = 2e-18
 Identities = 66/226 (29%), Positives = 109/226 (48%), Gaps = 17/226 (7%)

Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKP 249
           ++ +  +  E+ +L    HPN+V+ L A    + + I+ E+   G + A  L+ +  L  
Sbjct: 43  EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTE 102

Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
                        +NYLHENK   IIHRDL+  NIL    G++K+ADFGVS     K  R
Sbjct: 103 PQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVS----AKNTR 155

Query: 310 PLTCQDT---SCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361
            +  +D+   +  ++APEV      K+  YD K DV+S  + L EM +  PP    +   
Sbjct: 156 TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR 215

Query: 362 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           V    A  + P    P++ ++   K+ +++C  +    R T  Q++
Sbjct: 216 VLLKIAKSEPPTLAQPSR-WSSEFKDFLKKCLEKNVDARWTTTQLL 260

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 84.7 bits (209), Expect = 3e-18
 Identities = 61/219 (27%), Positives = 104/219 (47%), Gaps = 18/219 (8%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A KKL ++ I          +E  +L+K+    VV    A      + +V   +  
Sbjct: 25  GKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84

Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           GDL+  +   G    +   AV +A +I  G+  LH+ +   I++RDL+P NIL DD G++
Sbjct: 85  GDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHI 141

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
           +++D G++  + V E + +  +  +  Y+APEV KNE Y    D ++   +L EMI G  
Sbjct: 142 RISDLGLA--VHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 199

Query: 353 PFTMKHD-----------NEVPKAYAARQRPPFKAPAKL 380
           PF  +              EV + Y+ +  P  ++  K+
Sbjct: 200 PFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKM 238

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 85.1 bits (210), Expect = 3e-18
 Identities = 71/272 (26%), Positives = 125/272 (45%), Gaps = 21/272 (7%)

Query: 148 YEIDPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELA 202
           ++ DP +L FT+  EI  G+F  + F R ++    VA+KK+       +++ +    E+ 
Sbjct: 19  FKEDPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
            LQ+I+HPN +++ G   +     +V EY            K  L+            +G
Sbjct: 78  FLQRIKHPNSIEYKGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 137

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
           + YLH +    +IHRD++  NIL  + G +K+ADFG + + +     P      +  ++A
Sbjct: 138 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIAS-----PANSFVGTPYWMA 189

Query: 323 PEV---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFKAPA 378
           PEV       +YD KVDV+S  +   E+ E  PP F M   N +   Y   Q       +
Sbjct: 190 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESPTLQS 246

Query: 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
             ++   +  ++ C  + P  RPT  +++  +
Sbjct: 247 NEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 84.3 bits (208), Expect = 3e-18
 Identities = 71/254 (27%), Positives = 123/254 (48%), Gaps = 28/254 (11%)

Query: 173 WRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP----- 224
           ++G  V   +L    + D  +D     + E+ +L+K   H N+  + GA  + SP     
Sbjct: 33  YKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDD 92

Query: 225 -MMIVTEYLPKGDLRAFLKR-KG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
            + +V E+   G +   +K  KG ALK         +I RG+ +LH +K   +IHRD++ 
Sbjct: 93  QLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKG 149

Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEE-----YDT 333
            N+L  ++  +K+ DFGVS  L    DR +  ++T   +  ++APEV   +E     YD 
Sbjct: 150 QNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDY 205

Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
           + D++S  +   EM EG PP    H   +   +   + PP K  +K +++   + IE C 
Sbjct: 206 RSDIWSLGITAIEMAEGAPPLCDMH--PMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCL 263

Query: 394 NEKPAKRPTFRQII 407
            +    RP+  Q++
Sbjct: 264 VKNYLSRPSTEQLL 277

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 59/227 (25%), Positives = 102/227 (44%), Gaps = 27/227 (11%)

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
           AF +  +L+ ++ H ++V+  G V      ++V EY+  G L  FL R+     S   + 
Sbjct: 47  AFFETASLMSQLSHKHLVKLYG-VCVRDENIMVEEYVKFGPLDVFLHREKN-NVSLHWKL 104

Query: 256 --ALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGN---LKVADFGVSKLLTVK 306
             A  +A  ++YL + K   ++H ++   NIL      + G    +K++D G+   +  +
Sbjct: 105 DVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLSR 161

Query: 307 EDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCP-PFTMKHDNEVP 363
           E+R          ++APE  +N +       D +SF   L E+      P +    +E  
Sbjct: 162 EERVERIP-----WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKE 216

Query: 364 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
           + Y  + R P    A+L       LI +CW   P KRP+FR I+  L
Sbjct: 217 RFYQDQHRLPMPDCAELA-----NLINQCWTYDPTKRPSFRAILRDL 258

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 68/253 (26%), Positives = 121/253 (47%), Gaps = 30/253 (11%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
            +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  G
Sbjct: 37  TRVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHG 94

Query: 236 DLRAFLK--------RKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           DL+++L+          G   P+    ++ A +IA GM YL+  K    +HRDL   N +
Sbjct: 95  DLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCM 151

Query: 286 RDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
                 +K+ DFG+++ +      R         R++APE  K+  + T  D++SF ++L
Sbjct: 152 VAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211

Query: 345 QEMIE-GCPPFTMKHDNEVPK-----AYAARQRPPFKAPAKLYARGLKELIEECWNEKPA 398
            E+      P+    + +V K      Y  +   P   P ++      +L+  CW   P 
Sbjct: 212 WEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ---PDNCPERVT-----DLMRMCWQFNPK 263

Query: 399 KRPTFRQIITRLE 411
            RPTF +I+  L+
Sbjct: 264 MRPTFLEIVNLLK 276

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 83.9 bits (207), Expect = 5e-18
 Identities = 71/261 (27%), Positives = 118/261 (45%), Gaps = 21/261 (8%)

Query: 151 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP +L F++  EI  G+F  + F R ++    VA+KK+       +++ +    E+  LQ
Sbjct: 12  DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           K+RHPN +Q+ G   +     +V EY            K  L+            +G+ Y
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
           LH +    +IHRD++  NIL  + G +K+ DFG + ++      P      +  ++APEV
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAPEV 182

Query: 326 ---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFKAPAKLY 381
                  +YD KVDV+S  +   E+ E  PP F M   N +   Y   Q       +  +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESPALQSGHW 239

Query: 382 ARGLKELIEECWNEKPAKRPT 402
           +   +  ++ C  + P  RPT
Sbjct: 240 SEYFRNFVDSCLQKIPQDRPT 260

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 83.5 bits (206), Expect = 6e-18
 Identities = 70/254 (27%), Positives = 118/254 (46%), Gaps = 30/254 (11%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L E   S+  R + F+ E  LL  ++H ++V+F G  T+  P+++V EY+  GDL
Sbjct: 38  VAVKALKE--ASESAR-QDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDL 94

Query: 238 RAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
             FL+                 G L     +  A  IA GM YL     +  +HRDL   
Sbjct: 95  NRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYL---ASLHFVHRDLATR 151

Query: 283 NILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
           N L      +K+ DFG+S+ + +    R         R++ PE     ++ T+ D++SF 
Sbjct: 152 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFG 211

Query: 342 LILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKELIEECWNEKPA 398
           ++L E+   G  P+    + E  +     +    P   P ++YA     +++ CW  +P 
Sbjct: 212 VVLWEIFTYGKQPWYQLSNTEAIECITQGRELERPRTCPPEVYA-----IMQGCWQREPQ 266

Query: 399 KRPTFRQIITRLES 412
           +R   + I +RL++
Sbjct: 267 QRMVIKDIHSRLQA 280

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 82.7 bits (204), Expect = 7e-18
 Identities = 69/267 (25%), Positives = 122/267 (45%), Gaps = 22/267 (8%)

Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVK--KLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           EL   N   + KG + +   + I VA+K  K   E    D+ +R    E  ++ ++ +P 
Sbjct: 2   ELGSGNFGCVKKGVYKMRK-KQIDVAIKVLKNENEKSVRDEMMR----EAEIMHQLDNPY 56

Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENK 270
           +V+ +G V ++  +M+V E    G L  FL  +K  +  S  V     ++ GM YL    
Sbjct: 57  IVRMIG-VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115

Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKN 328
               +HRDL   N+L  +    K++DFG+SK L   +   +  +      ++ APE    
Sbjct: 116 ---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINF 172

Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGL 385
            ++ ++ DV+S+ + + E    G  P+      EV        R   P + P ++YA   
Sbjct: 173 RKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDCPAECPPEMYA--- 229

Query: 386 KELIEECWNEKPAKRPTFRQIITRLES 412
             L+++CW  K   RP F ++  R+ +
Sbjct: 230 --LMKDCWIYKWEDRPNFAKVEERMRT 254

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 83.6 bits (206), Expect = 7e-18
 Identities = 55/233 (23%), Positives = 114/233 (48%), Gaps = 9/233 (3%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+K++    +    +     +E+ ++++ ++PN+V +L +      + +V EYL  
Sbjct: 44  GQEVAIKQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 100

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +     +          +  + +++LH N+   +IHRD++  NIL    G++K+
Sbjct: 101 GSLTDVVTET-CMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKL 156

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG    +T ++ +  T   T   ++APEV   + Y  KVD++S  ++  EM+EG PP+
Sbjct: 157 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY 215

Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             ++        A    P  + P +L A   ++ +  C      +R + ++++
Sbjct: 216 LNENPLRALYLIATNGTPELQNPERLSAV-FRDFLNRCLEMDVDRRGSAKELL 267

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 83.4 bits (206), Expect = 8e-18
 Identities = 67/251 (26%), Positives = 119/251 (47%), Gaps = 23/251 (9%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L E+  ++ +    F  E+ ++ +++ PN+++ L     S P+ ++TEY+  GDL
Sbjct: 49  VAVKMLRED--ANKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDL 106

Query: 238 RAFLKRKGALKP-----------STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
             FL R    +            ST +  A  IA GM YL     +  +HRDL   N L 
Sbjct: 107 NQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLV 163

Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
             +  +K+ADFG+S+ L   +   +  +     R+++ E     ++ T  DV++F + L 
Sbjct: 164 GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLW 223

Query: 346 EMIEGCP--PFTMKHDNEVPKA----YAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
           E++  C   P++   D +V +     +  + R  +     L    L +L+  CW     +
Sbjct: 224 EILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKE 283

Query: 400 RPTFRQIITRL 410
           RP+F++I   L
Sbjct: 284 RPSFQEIHATL 294

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 83.7 bits (207), Expect = 8e-18
 Identities = 52/161 (32%), Positives = 87/161 (54%), Gaps = 10/161 (6%)

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
           + E  +L+ ++HP +V  + A      + ++ EYL  G+L   L+R+G     TA  +  
Sbjct: 48  KAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLS 107

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
           +I+  + +LH+     II+RDL+P NIL D  G++K+ DFG+ K  ++ E    T   T 
Sbjct: 108 EISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCK-ESIHEG---TVTHTF 160

Query: 318 C---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
           C    Y+APE+     +   VD +S   ++ +M+ G PPFT
Sbjct: 161 CGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFT 201

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 83.1 bits (205), Expect = 8e-18
 Identities = 62/231 (26%), Positives = 109/231 (47%), Gaps = 24/231 (10%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFAL 257
           E  +L+K+  P +V    A    + + +V   +  GDL+  +   G   L+    + ++ 
Sbjct: 43  EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
            I  G+ +LH    + I++RD++P N+L DD GN +++D G++  + +K+ + +T +  +
Sbjct: 103 QITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLA--VELKDGKTITQRAGT 157

Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------- 369
             Y+APE+ K E Y   VD F+    + EM+ G  PF   H  +V K    R        
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFK-DHKEKVAKEELKRRTLEDEVK 216

Query: 370 -QRPPFKAPAKLYAR-GLKELIEE-----CWNEKPAKRPTFRQI-ITRLES 412
            +   F   +K   R  L +  E+       N+ P K   F+ I   RLE+
Sbjct: 217 FEHQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKTINFPRLEA 267

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 83.3 bits (206), Expect = 9e-18
 Identities = 75/272 (27%), Positives = 127/272 (46%), Gaps = 31/272 (11%)

Query: 151 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP +L FT+  EI  G+F  + F R ++    VA+KK+       +++ +    E+  LQ
Sbjct: 12  DPEKL-FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYL--PKGDLRAFLKRKGALKPSTAVRFA---LDIA 260
           ++RHPN +++ G   +     +V EY      D+    K     KP   V  A       
Sbjct: 71  QLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDILEVHK-----KPLQEVEIAAICHGAL 125

Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
           +G+ YLH ++    IHRD++  NIL  + G +K+ADFG + L++     P      +  +
Sbjct: 126 QGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVS-----PANSFVGTPYW 177

Query: 321 VAPEV---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFKA 376
           +APEV       +YD KVDV+S  +   E+ E  PP F M   N +   Y   Q      
Sbjct: 178 MAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNDSPTL 234

Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
            +  ++   +  ++ C  + P  RP+  +++ 
Sbjct: 235 SSNDWSDYFRNFVDSCLQKIPQDRPSSEELLK 266

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 83.2 bits (205), Expect = 1e-17
 Identities = 57/233 (24%), Positives = 114/233 (48%), Gaps = 9/233 (3%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA++++    +    +     +E+ ++++ ++PN+V +L +      + +V EYL  
Sbjct: 45  GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +     +          +  + + +LH N+   +IHRD++  NIL    G++K+
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG    +T ++ +  T   T   ++APEV   + Y  KVD++S  ++  EMIEG PP+
Sbjct: 158 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216

Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             ++        A    P  + P KL A   ++ +  C +    KR + ++++
Sbjct: 217 LNENPLRALYLIATNGTPELQNPEKLSAI-FRDFLNRCLDMDVEKRGSAKELL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score = 82.6 bits (205), Expect = 1e-17
 Identities = 77/283 (27%), Positives = 135/283 (47%), Gaps = 56/283 (19%)

Query: 164 TKGTFILAFWR--GIQVAVKKLGEEVISDDD--RVRAFRDELALLQKI-RHPNVVQFLGA 218
           T G+  LA  +  G  VA+KK+ ++  S ++   +R    E+  L+K+  HPN+V+    
Sbjct: 11  TFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLR----EVKSLRKLNEHPNIVKLKEV 66

Query: 219 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIH 276
             ++  +  V EY+ +G+L   +K RKG     + +R  +  I +G+ ++H++      H
Sbjct: 67  FRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFH 122

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-TSCR-YVAPEVF-KNEEYDT 333
           RDL+P N+L      +K+ADFG+++   ++   P T  D  S R Y APE+  ++  Y +
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAR--EIRSRPPYT--DYVSTRWYRAPEILLRSTSYSS 178

Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEV------------------PKAYA-ARQ---R 371
            VD+++   I+ E+    P F     +E+                  P+ Y  A +   R
Sbjct: 179 PVDIWALGCIMAELYTLRPLF--PGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFR 236

Query: 372 PPFKAPAKLY------ARGLKELIEEC--WNEKPAKRPTFRQI 406
            P  AP  L+      +    +LI++   W+  P KRPT  Q 
Sbjct: 237 FPQFAPTSLHQLIPNASPEAIDLIKDMLRWD--PKKRPTASQA 277

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 82.8 bits (204), Expect = 1e-17
 Identities = 63/228 (27%), Positives = 110/228 (48%), Gaps = 19/228 (8%)

Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KGAL 247
            ++ +  +  E+ +L    HP +V+ LGA      + I+ E+ P G + A +    +G  
Sbjct: 49  SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLT 108

Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           +P   V     +   + YLH  K   IIHRDL+  N+L    G++K+ADFGVS     K 
Sbjct: 109 EPQIQV-ICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVS----AKN 160

Query: 308 DRPLTCQDT---SCRYVAPEV-----FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359
            + L  +D+   +  ++APEV      K+  YD K D++S  + L EM +  PP    + 
Sbjct: 161 VKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNP 220

Query: 360 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             V    A  + P    P+K ++   ++ ++   ++ P  RP+  Q++
Sbjct: 221 MRVLLKIAKSEPPTLSQPSK-WSMEFRDFLKTALDKHPETRPSAAQLL 267

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 55/188 (29%), Positives = 88/188 (46%), Gaps = 18/188 (9%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K + + V+   + V  F +E  +L     P + Q   A      + +V EY P GDL 
Sbjct: 30  AMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLL 89

Query: 239 AFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
           + L R          +F L ++   ++ +H+   +  +HRD++P N+L D +G++K+ADF
Sbjct: 90  SLLNRYEDQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADF 146

Query: 298 GVSKLLT----VKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEM 347
           G +  LT    V    P+   D    Y+APEV           Y  + D +S  +I  EM
Sbjct: 147 GSAARLTANKMVNSKLPVGTPD----YIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEM 202

Query: 348 IEGCPPFT 355
           I G  PF 
Sbjct: 203 IYGRSPFH 210

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 74/251 (29%), Positives = 111/251 (44%), Gaps = 30/251 (11%)

Query: 175 GIQVAVKKLGEEVISD-DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS-----PMMI 227
           G   AVK L  + ISD D+ + A   E  +LQ +  HPNVV+F G   ++       + +
Sbjct: 47  GSLAAVKIL--DPISDVDEEIEA---EYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWL 101

Query: 228 VTEYLPKGD----LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           V E    G     ++  L     L  +           G+ +LH N+   IIHRD++ +N
Sbjct: 102 VLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNN 158

Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTKVDVF 338
           IL    G +K+ DFGVS  LT    R  T   T   ++APEV   E+     YD + DV+
Sbjct: 159 ILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF-WMAPEVIACEQQYDYSYDARCDVW 217

Query: 339 SFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP--FKAPAKLYARGLKELIEECWNEK 396
           S  +   E+ +G PP    H   V   +   + PP     P K + R     I +C  + 
Sbjct: 218 SLGITAIELGDGDPPLFDMH--PVKTLFKIPRNPPPTLLHPEK-WCRSFNHFISQCLIKD 274

Query: 397 PAKRPTFRQII 407
              RP+   ++
Sbjct: 275 FEARPSVTHLL 285

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 51/177 (28%), Positives = 96/177 (54%), Gaps = 9/177 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  VA+KK+  +  ++     A R E++LL+++ HPN+V+ L  +   + + +V E+L +
Sbjct: 25  GEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ 83

Query: 235 GDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
            DL+ F+       +       +   + +G+ + H ++   ++HRDL+P N+L +  G +
Sbjct: 84  -DLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAI 139

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMI 348
           K+ADFG+++   V   R  T +  +  Y APE+    + Y T VD++S   I  EM+
Sbjct: 140 KLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 195

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 81.8 bits (202), Expect = 2e-17
 Identities = 55/182 (30%), Positives = 89/182 (48%), Gaps = 7/182 (3%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A KKL ++ I          +E  +L+K+    VV    A      + +V   +  
Sbjct: 25  GKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNG 84

Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           GDL+  +   G        AV +A +I  G+  LH  +   I++RDL+P NIL DD G++
Sbjct: 85  GDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHI 141

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
           +++D G++  + + E   +  +  +  Y+APEV KNE Y    D +    ++ EMIEG  
Sbjct: 142 RISDLGLA--VEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKS 199

Query: 353 PF 354
           PF
Sbjct: 200 PF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 82.0 bits (202), Expect = 2e-17
 Identities = 79/268 (29%), Positives = 121/268 (45%), Gaps = 35/268 (13%)

Query: 163 ITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
           I KGT+     +L    G + AVK L + +   D+ + A  + L  L    HPNVV+F G
Sbjct: 26  IGKGTYGKVFKVLNKKNGSKAAVKIL-DPIHDIDEEIEAEYNILKALSD--HPNVVKFYG 82

Query: 218 A-----VTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
                 V     + +V E    G +    + FLKR   ++         +   G+ +LH 
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142

Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           NK    IHRD++ +NIL    G +K+ DFGVS  LT    R  T   T   ++APEV   
Sbjct: 143 NK---TIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPF-WMAPEVIAC 198

Query: 329 EE-----YDTKVDVFSFALILQEMIEGCPPFT----MKHDNEVPKAYAARQRPPFKAPAK 379
           E+     YD + DV+S  +   E+ +G PP      M+   ++P     R  PP     +
Sbjct: 199 EQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIP-----RNPPPTLHQPE 253

Query: 380 LYARGLKELIEECWNEKPAKRPTFRQII 407
           L++    + I +C  +   KRPT   ++
Sbjct: 254 LWSNEFNDFIRKCLTKDYEKRPTVSDLL 281

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 82.9 bits (205), Expect = 2e-17
 Identities = 65/229 (28%), Positives = 108/229 (47%), Gaps = 25/229 (10%)

Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
           +D   R    E+ +L+ + HPNVV+       +  + ++ E++  G L        A + 
Sbjct: 112 EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEG---THIADEQ 168

Query: 250 STAVRFALDIAR----GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
             A     D+AR    G+ YLH      I+HRD++PSN+L + + N+K+ADFGVS++L  
Sbjct: 169 FLA-----DVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220

Query: 306 KEDRPLTCQDTSCRYVAPEVFKNE----EYDTKV-DVFSFALILQEMIEGCPPFTMKHDN 360
             D P      +  Y++PE    +     YD    D++S  + + E   G  PF +    
Sbjct: 221 TMD-PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQG 279

Query: 361 EVPKAYAA--RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           +      A    +PP +APA   +R  +  I  C   +PAKR +  Q++
Sbjct: 280 DWASLMCAICMSQPP-EAPATA-SREFRHFISCCLQREPAKRWSAMQLL 326

Length = 353

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 65/249 (26%), Positives = 113/249 (45%), Gaps = 26/249 (10%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEY-- 231
           G  +AVK++      D+   +    +L ++ +    P +V+F GA+ +     I  E   
Sbjct: 29  GTIMAVKRI--RSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD 86

Query: 232 --LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
             L K     +   K  +      + A+   + +NYL E   + IIHRD++PSNIL D +
Sbjct: 87  ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRN 144

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPE---VFKNEEYDTKVDVFSFALILQ 345
           GN+K+ DFG+S  L    D     +D  CR Y+APE       + YD + DV+S  + L 
Sbjct: 145 GNIKLCDFGISGQL---VDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLY 201

Query: 346 EMIEGCPPFTMKHDN------EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
           E+  G  P+  K ++      +V K           +  + ++      I  C  +  +K
Sbjct: 202 EVATGKFPYP-KWNSVFDQLTQVVKGDPPILSN---SEEREFSPSFVNFINLCLIKDESK 257

Query: 400 RPTFRQIIT 408
           RP +++++ 
Sbjct: 258 RPKYKELLE 266

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 81.6 bits (201), Expect = 3e-17
 Identities = 69/250 (27%), Positives = 114/250 (45%), Gaps = 33/250 (13%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L +  ++     + F+ E  LL  ++H ++V+F G      P+++V EY+  GDL
Sbjct: 38  VAVKALKDPTLAAR---KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL 94

Query: 238 RAFLK----------------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
             FL+                 KG L  S  +  A  IA GM YL        +HRDL  
Sbjct: 95  NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLAT 151

Query: 282 SNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
            N L   +  +K+ DFG+S+ + +    R         R++ PE     ++ T+ DV+SF
Sbjct: 152 RNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 211

Query: 341 ALILQEMIE-GCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGLKELIEECWNEK 396
            +IL E+   G  P+    + EV +        +RP    P ++Y     +++  CW  +
Sbjct: 212 GVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRV-CPKEVY-----DIMLGCWQRE 265

Query: 397 PAKRPTFRQI 406
           P +R   ++I
Sbjct: 266 PQQRLNIKEI 275

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 80.7 bits (199), Expect = 4e-17
 Identities = 61/231 (26%), Positives = 101/231 (43%), Gaps = 10/231 (4%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A KKL ++ +           E  +L K+    +V    A    + + +V   +  GDLR
Sbjct: 22  ACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLR 81

Query: 239 AFL----KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
             +    +         A  +   I  G+ +LH+ +   II+RDL+P N+L D+ GN+++
Sbjct: 82  YHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRI 138

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           +D G++  L   + +      T   ++APE+ + EEYD  VD F+  + L EMI    PF
Sbjct: 139 SDLGLAVELKDGQSKTKGYAGTP-GFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPF 197

Query: 355 TMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
             + +    K    R        P K ++   K   E    + P KR  FR
Sbjct: 198 RARGEKVENKELKQRILNDSVTYPDK-FSPASKSFCEALLAKDPEKRLGFR 247

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 81.6 bits (201), Expect = 5e-17
 Identities = 62/250 (24%), Positives = 105/250 (42%), Gaps = 47/250 (18%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L    D        +  
Sbjct: 113 IKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 167

Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEM-----------------IEGCPPFTMKHDNEV 362
           Y++PE  +   Y  + D++S  L L EM                 + GCP      ++E 
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESET 227

Query: 363 P----------KAYAARQRPPF---------------KAPAKLYARGLKELIEECWNEKP 397
                       +Y    RPP                K P+ ++    ++ + +C  + P
Sbjct: 228 SPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNP 287

Query: 398 AKRPTFRQII 407
           A+R   +Q++
Sbjct: 288 AERADLKQLM 297

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 81.2 bits (200), Expect = 5e-17
 Identities = 51/157 (32%), Positives = 86/157 (54%), Gaps = 7/157 (4%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
           E++LL+ ++H N+V     V     + +V EYL K DL+ ++   G +     V+ F   
Sbjct: 54  EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCGNIMSMHNVKIFLYQ 112

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           I RG+ Y H  K   ++HRDL+P N+L ++ G LK+ADFG+++  +V   +  + +  + 
Sbjct: 113 ILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-KTYSNEVVTL 168

Query: 319 RYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            Y  P+V   + EY T++D++    I  EM  G P F
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 80.4 bits (198), Expect = 5e-17
 Identities = 72/251 (28%), Positives = 120/251 (47%), Gaps = 32/251 (12%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           QV VK+L       +     F +E    + ++H N++Q LG  T+ +P ++V E+ P GD
Sbjct: 24  QVVVKELRVSASVQEQM--KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81

Query: 237 LRAFLK--RKGAL---KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L+ +L+  RK  L    P+T  R A +IA G+ +LH+N     IH DL   N L      
Sbjct: 82  LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLT 138

Query: 292 LKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKV-------DVFSFAL 342
           +K+ D+G+S     KED  +T        R++APE+      +  V       +V+S  +
Sbjct: 139 VKIGDYGLSH-NKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGV 197

Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAYAARQ------RPPFKAPAKLYARGLKELIEECWNE 395
            + E+ E G  P+    D +V   Y  R+      +P  K P    +    E+++ CW  
Sbjct: 198 TIWELFELGSQPYRHLSDEQV-LTYTVREQQLKLPKPRLKLP---LSDRWYEVMQFCW-L 252

Query: 396 KPAKRPTFRQI 406
           +P +RP+  ++
Sbjct: 253 QPEQRPSAEEV 263

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 80.8 bits (199), Expect = 6e-17
 Identities = 48/157 (30%), Positives = 86/157 (54%), Gaps = 7/157 (4%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
           E++LL+ ++H N+V     +     + +V EYL K DL+ +L   G       V+ F   
Sbjct: 54  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNSINMHNVKLFLFQ 112

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           + RG+NY H  K   ++HRDL+P N+L ++ G LK+ADFG+++  ++   +  + +  + 
Sbjct: 113 LLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-KTYSNEVVTL 168

Query: 319 RYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            Y  P++   + +Y T++D++    I  EM  G P F
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLF 205

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 81.2 bits (201), Expect = 6e-17
 Identities = 49/181 (27%), Positives = 82/181 (45%), Gaps = 11/181 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI---VTEY 231
           G +VA+KK+           R  R EL +L+  +H N++     +           V   
Sbjct: 30  GKKVAIKKIPHAFDVPTLAKRTLR-ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMD 88

Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L + DL   +     L       F   + RG+ Y+H      +IHRDL+PSN+L ++   
Sbjct: 89  LMESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCE 145

Query: 292 LKVADFGVSKLLT---VKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEM 347
           L++ DFG+++ L+    +    +T    +  Y APE+     EY T +D++S   I  EM
Sbjct: 146 LRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEM 205

Query: 348 I 348
           +
Sbjct: 206 L 206

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 80.9 bits (199), Expect = 6e-17
 Identities = 48/156 (30%), Positives = 81/156 (51%), Gaps = 5/156 (3%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E +LL+ ++H N+V     +     + +V EY+     +   K  G L P     F   +
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQL 112

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            RG++Y+H+     I+HRDL+P N+L  D+G LK+ADFG+++  +V      + +  +  
Sbjct: 113 LRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS-HTYSNEVVTLW 168

Query: 320 YVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           Y  P+V   + EY T +D++    I  EMI+G   F
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 82.4 bits (203), Expect = 8e-17
 Identities = 76/300 (25%), Positives = 131/300 (43%), Gaps = 25/300 (8%)

Query: 123 KLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELD-------FTNSVEITKGTFILAFWRG 175
           +  EK+ A   + P   K   ++PE E  P   +        T  V     T      RG
Sbjct: 32  EAFEKYCAD--LDPEAYKKCVDLPEGEEVPESNNPREHMYVLTTLVGRNPTTAAFVATRG 89

Query: 176 IQVAVKKLGEEVISDDDRVRAF-RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
                K + + V+ +D+R  A+ R EL  L    H  +V+          ++++ EY   
Sbjct: 90  SDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSG 149

Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           GDL    +  LK     +          I   ++ +H  K   ++HRDL+ +NI    +G
Sbjct: 150 GDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTG 206

Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEM 347
            +K+ DFG SK  +  +   L    + C    Y+APE+++ + Y  K D++S  +IL E+
Sbjct: 207 IIKLGDFGFSKQYS--DSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYEL 264

Query: 348 IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           +    PF      E+ +     +  PF  P    + G+K L++   ++ PA RPT +Q++
Sbjct: 265 LTLHRPFKGPSQREIMQQVLYGKYDPFPCPV---SSGMKALLDPLLSKNPALRPTTQQLL 321

Length = 478

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 80.7 bits (199), Expect = 9e-17
 Identities = 56/191 (29%), Positives = 94/191 (49%), Gaps = 11/191 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           AVK L ++VI  DD V     E  +L   R HP + Q          +  V E++  GDL
Sbjct: 24  AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDL 83

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              +++      + A  +A +I   + +LH+     II+RDL+  N+L D  G+ K+ADF
Sbjct: 84  MFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 140

Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G+ K    +         T C    Y+APE+ +   Y   VD ++  ++L EM+ G  PF
Sbjct: 141 GMCK----EGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPF 196

Query: 355 TMKHDNEVPKA 365
             ++++++ +A
Sbjct: 197 EAENEDDLFEA 207

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score = 79.8 bits (197), Expect = 1e-16
 Identities = 56/182 (30%), Positives = 92/182 (50%), Gaps = 14/182 (7%)

Query: 178 VAVKKLGEEVISDDDRVR--AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+KK  E    DD  V+  A R E+ +L+++RH N+V  +    +   + +V E++   
Sbjct: 29  VAIKKFLES--EDDKMVKKIAMR-EIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHT 85

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
            L    K    L  S   ++   I RG+ + H +    IIHRD++P NIL   SG +K+ 
Sbjct: 86  VLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLC 142

Query: 296 DFGVSKLLTVKEDRPLTCQD-TSCR-YVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCP 352
           DFG ++ L    +      D  + R Y APE +  + +Y   VD+++   ++ EM+ G P
Sbjct: 143 DFGFARTLAAPGE---VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199

Query: 353 PF 354
            F
Sbjct: 200 LF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 79.5 bits (196), Expect = 1e-16
 Identities = 57/214 (26%), Positives = 95/214 (44%), Gaps = 17/214 (7%)

Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR 254
           +    EL +L K   P ++ F GA    + + I TE++  G L  +      +      R
Sbjct: 44  KQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGR 99

Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
            A+ + +G+ YL   K   I+HRD++PSN+L +  G +K+ DFGVS  L     +     
Sbjct: 100 IAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSIAKTYVGT 156

Query: 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---VPKAY---AA 368
           +    Y+APE    E+Y    DV+S  +   E+  G  P+     N+   +P        
Sbjct: 157 NA---YMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIV 213

Query: 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402
            + PP   P   ++      I +C  ++P +RP 
Sbjct: 214 DEDPP-VLPVGQFSEKFVHFITQCMRKQPKERPA 246

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 79.2 bits (196), Expect = 2e-16
 Identities = 57/181 (31%), Positives = 96/181 (53%), Gaps = 10/181 (5%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKG 235
           VA+KKL  E   +   + + R E+ +L K++HPN+V     V  S+   + +V EY+ + 
Sbjct: 33  VALKKLKMEKEKEGFPITSLR-EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYV-EH 90

Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           DL++ ++  K     S      L +  G+ +LH+N    I+HRDL+ SN+L ++ G LK+
Sbjct: 91  DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKI 147

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPP 353
            DFG+++       +P T    +  Y APE+     EY T +D++S   I  E++   P 
Sbjct: 148 CDFGLAREYGSPL-KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPL 206

Query: 354 F 354
           F
Sbjct: 207 F 207

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 79.1 bits (195), Expect = 3e-16
 Identities = 56/190 (29%), Positives = 91/190 (47%), Gaps = 17/190 (8%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+KK+ ++ +   ++++    E  +L    +P VV    +      + +V EY+  GD  
Sbjct: 30  AMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCA 89

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             LK  GAL    A  +  +    + YLH      I+HRDL+P N+L    G++K+ DFG
Sbjct: 90  TLLKNIGALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFG 146

Query: 299 VSKL----LTV--------KEDRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           +SK+    LT         K+ R    +    +  Y+APEV   + Y   VD ++  +IL
Sbjct: 147 LSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIIL 206

Query: 345 QEMIEGCPPF 354
            E + GC PF
Sbjct: 207 YEFLVGCVPF 216

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 79.3 bits (195), Expect = 3e-16
 Identities = 68/264 (25%), Positives = 114/264 (43%), Gaps = 21/264 (7%)

Query: 148 YEIDPHELDFTNSVEITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVRAFRDELA 202
           Y+ DP E+ F    EI  G+F   ++         VAVKK+       +++ +    E+ 
Sbjct: 15  YKDDPEEI-FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
            LQ+++HPN +++ G   +     +V EY            K  L+            +G
Sbjct: 74  FLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQG 133

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
           + YLH +    +IHRD++  NIL  + G +K+ADFG +   +     P      +  ++A
Sbjct: 134 LAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS-----PANSFVGTPYWMA 185

Query: 323 PEV---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFKAPA 378
           PEV       +YD KVDV+S  +   E+ E  PP F M   N +   Y   Q       +
Sbjct: 186 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNDSPTLQS 242

Query: 379 KLYARGLKELIEECWNEKPAKRPT 402
             +    +  ++ C  + P +RP 
Sbjct: 243 NEWTDSFRGFVDYCLQKIPQERPA 266

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 78.6 bits (194), Expect = 3e-16
 Identities = 65/219 (29%), Positives = 103/219 (47%), Gaps = 17/219 (7%)

Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE 268
           P +V+  G     S + I  E L    L   LKR +G +      +  + I + ++YL E
Sbjct: 74  PYIVKCYGYFITDSDVFICME-LMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKE 132

Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF-- 326
              V  IHRD++PSNIL D SGN+K+ DFG+S  L   + +  T       Y+APE    
Sbjct: 133 KHGV--IHRDVKPSNILLDASGNVKLCDFGISGRLV--DSKAKTRSAGCAAYMAPERIDP 188

Query: 327 --KNEEYDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
              N +YD + DV+S  + L E+  G  P+   K + EV      ++ PP   P + ++ 
Sbjct: 189 PDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEV-LTKILQEEPPSLPPNEGFSP 247

Query: 384 GLKELIEECWNEKPAKRPTFRQI-----ITRLESINNSI 417
                ++ C  +   KRP +R++     I R E+    +
Sbjct: 248 DFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEVDV 286

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 78.9 bits (194), Expect = 4e-16
 Identities = 61/235 (25%), Positives = 117/235 (49%), Gaps = 12/235 (5%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 37  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 93

Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL E +   ++HRDL   N+L     ++K+
Sbjct: 94  CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKI 150

Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCP 352
            DFG++KLL   E +          +++A E   +  Y  + DV+S+ + + E M  G  
Sbjct: 151 TDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 210

Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I
Sbjct: 211 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELI 262

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 78.5 bits (193), Expect = 5e-16
 Identities = 59/195 (30%), Positives = 90/195 (46%), Gaps = 9/195 (4%)

Query: 165 KGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           KGTF   IL   +  G   A+K L +EVI   D V     E  +LQ  RHP +     A 
Sbjct: 5   KGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAF 64

Query: 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
                +  V EY   G+L   L R+       A  +  +I   + YLH      +++RD+
Sbjct: 65  QTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDI 121

Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           +  N++ D  G++K+ DFG+ K          T   T   Y+APEV ++ +Y   VD + 
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP-EYLAPEVLEDNDYGRAVDWWG 180

Query: 340 FALILQEMIEGCPPF 354
             +++ EM+ G  PF
Sbjct: 181 LGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 77.7 bits (191), Expect = 5e-16
 Identities = 59/241 (24%), Positives = 117/241 (48%), Gaps = 12/241 (4%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K L E      ++     DE  ++  +  P V + LG +  +S + +VT+ +P G
Sbjct: 37  IPVAIKVLRENTSPKANK--EILDEAYVMAGVGSPYVCRLLG-ICLTSTVQLVTQLMPYG 93

Query: 236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GM+YL E   V ++HRDL   N+L     ++K+
Sbjct: 94  CLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKI 150

Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG+++LL + E +          +++A E   +  +  + DV+S+ + + E++  G  
Sbjct: 151 TDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAK 210

Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+      E+P      +R P + P  +    +  ++ +CW      RP FR+++     
Sbjct: 211 PYDGIPAREIPDLLEKGERLP-QPP--ICTIDVYMIMVKCWMIDSECRPRFRELVDEFSR 267

Query: 413 I 413
           +
Sbjct: 268 M 268

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 78.1 bits (193), Expect = 5e-16
 Identities = 57/253 (22%), Positives = 111/253 (43%), Gaps = 37/253 (14%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L ++ +   ++V+    E  +L  + HP +     +    + + +V +Y P G+L 
Sbjct: 30  ALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELF 89

Query: 239 AFL-KRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
             L ++ G        RF A ++   + YLH      I++RDL+P NIL  +SG++ ++D
Sbjct: 90  RLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSD 146

Query: 297 FGVSKLLTVK--------------------EDRPLTCQDT----SC----RYVAPEVFKN 328
           F +SK   V+                         + + +    S      Y+APEV   
Sbjct: 147 FDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISG 206

Query: 329 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL-YARGLKE 387
           + + + VD ++  ++L EM+ G  PF   + +E    ++   +     P     +   ++
Sbjct: 207 DGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDET---FSNILKKEVTFPGSPPVSSSARD 263

Query: 388 LIEECWNEKPAKR 400
           LI +   + P+KR
Sbjct: 264 LIRKLLVKDPSKR 276

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 51/177 (28%), Positives = 85/177 (48%), Gaps = 20/177 (11%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL ++ +I+H N++  +    +   + +V + +   DL+  + RK  L  S      L I
Sbjct: 70  ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIRLTESQVKCILLQI 128

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV-------------SKLLTVK 306
             G+N LH+      +HRDL P+NI  +  G  K+ADFG+             SK  T++
Sbjct: 129 LNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185

Query: 307 EDRPLTCQDTSCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
               +T +  +  Y APE +   E+Y   VD++S   I  E++ G P F    +NE+
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFP--GENEI 240

Length = 335

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 78.1 bits (192), Expect = 6e-16
 Identities = 53/176 (30%), Positives = 87/176 (49%), Gaps = 3/176 (1%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +EVI   D V     E  +LQ  RHP +     +      +  V EY   G+L 
Sbjct: 24  AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 83

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L R+       A  +  +I   ++YLH  K V  ++RDL+  N++ D  G++K+ DFG
Sbjct: 84  FHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFG 141

Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           + K   +K+   +     +  Y+APEV ++ +Y   VD +   +++ EM+ G  PF
Sbjct: 142 LCK-EGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 196

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 47/157 (29%), Positives = 81/157 (51%), Gaps = 7/157 (4%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
           E +LL+ ++H N+V     +     + +V EYL   DL+ ++    G L       F   
Sbjct: 53  EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           + RG+ Y H+ +   ++HRDL+P N+L  + G LK+ADFG+++  +V   +  + +  + 
Sbjct: 112 LLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-KTYSNEVVTL 167

Query: 319 RYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
            Y  P+V   + EY T +D++    I  EM  G P F
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLF 204

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 77.4 bits (190), Expect = 7e-16
 Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 13/163 (7%)

Query: 204 LQKIRHPNVVQFLGAVTQS-----SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFA 256
           L+   HPNVV+     T S     + + +V E++ + DL  +L +  +  +   T     
Sbjct: 58  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 116

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
             + RG+++LH ++   ++HRDL+P NIL   SG +K+ADFG++++ + +    LT    
Sbjct: 117 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM--ALTSVVV 171

Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359
           +  Y APEV     Y T VD++S   I  EM    P F    D
Sbjct: 172 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 78.2 bits (192), Expect = 7e-16
 Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 27/223 (12%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK    +      + ++ +
Sbjct: 53  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            RG+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L    D        +  
Sbjct: 113 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 167

Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPPFTMKHDNEV------------PK 364
           Y++PE  +   Y  + D++S  L L E+  G    PP   K    +            P 
Sbjct: 168 YMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPH 227

Query: 365 AYAARQRPPFKAPAKLY------ARGLKELIEECWNEKPAKRP 401
           + + R RPP + P   +      A  + EL++   NE P K P
Sbjct: 228 SISPRPRPPGR-PVSGHGMDSRPAMAIFELLDYIVNEPPPKLP 269

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 77.1 bits (190), Expect = 9e-16
 Identities = 57/210 (27%), Positives = 104/210 (49%), Gaps = 14/210 (6%)

Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
           R E  +L+ +R  P +V    A    + + ++ +Y+  G+L   L ++     S    + 
Sbjct: 52  RTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYI 111

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQD 315
            +I   +++LH+     II+RD++  NIL D  G++ + DFG+SK  L  +E+R  +   
Sbjct: 112 AEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCG 168

Query: 316 TSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---Q 370
           T   Y+APEV +     +D  VD +S  ++  E++ G  PFT+  +       + R    
Sbjct: 169 T-IEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS 227

Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKR 400
           +PPF  P  + A   ++ I++   + P KR
Sbjct: 228 KPPF--PKTMSAEA-RDFIQKLLEKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 76.9 bits (189), Expect = 1e-15
 Identities = 50/182 (27%), Positives = 87/182 (47%), Gaps = 7/182 (3%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A K+L ++ I          +E  +L+K+    VV    A      + +V   +  
Sbjct: 25  GKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNG 84

Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           GDL+  +   G    +   A+ +A +I  G+  LH       ++RDL+P NIL DD G++
Sbjct: 85  GDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHI 141

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
           +++D G++  + + E   +  +  +  Y+APEV  N+ Y    D +    ++ EMIEG  
Sbjct: 142 RISDLGLA--VKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQS 199

Query: 353 PF 354
           PF
Sbjct: 200 PF 201

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 1e-15
 Identities = 59/197 (29%), Positives = 97/197 (49%), Gaps = 23/197 (11%)

Query: 174 RGIQVAVKKLGEEVISDDDR----VRAFRDELALLQKIRHPNVVQFLGAVTQSS-----P 224
            G++VA+KK     IS  +      R  R E+ +L++ +H N++  L  +   S      
Sbjct: 29  TGVKVAIKK-----ISPFEHQTFCQRTLR-EIKILRRFKHENIIGILDIIRPPSFESFND 82

Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + IV E +   DL   +K +  L       F   I RG+ Y+H      ++HRDL+PSN+
Sbjct: 83  VYIVQELMET-DLYKLIKTQ-HLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNL 137

Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFA 341
           L + + +LK+ DFG++++   + D    LT    +  Y APE+  N + Y   +D++S  
Sbjct: 138 LLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVG 197

Query: 342 LILQEMIEGCPPFTMKH 358
            IL EM+   P F  K 
Sbjct: 198 CILAEMLSNRPLFPGKD 214

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 58/195 (29%), Positives = 94/195 (48%), Gaps = 29/195 (14%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRH-PNVVQFLGA--VTQSSP---MMIVT 229
           VA+KK   E   D++ +   A R E++LLQ +     +V+ L    V + +    + +V 
Sbjct: 29  VALKKTRLE--MDEEGIPPTALR-EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVF 85

Query: 230 EYLPKGDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           EYL   DL+ F+   G      L   T   F   + +G+ + H++    ++HRDL+P N+
Sbjct: 86  EYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNL 141

Query: 285 LRDDSGN-LKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEV-FKNEEYDTKVDVFS 339
           L D     LK+AD G+ +  ++    P+   T +  +  Y APEV   +  Y T VD++S
Sbjct: 142 LVDKQKGLLKIADLGLGRAFSI----PVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWS 197

Query: 340 FALILQEMIEGCPPF 354
              I  EM    P F
Sbjct: 198 VGCIFAEMSRKQPLF 212

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 77.2 bits (190), Expect = 1e-15
 Identities = 60/203 (29%), Positives = 93/203 (45%), Gaps = 10/203 (4%)

Query: 165 KGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           KGTF   IL   +      A+K L +EVI   D V     E  +LQ  RHP +     + 
Sbjct: 5   KGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSF 64

Query: 220 TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
                +  V EY   G+L   L R+       A  +  +I   + YLH      +++RDL
Sbjct: 65  QTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDL 121

Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           +  N++ D  G++K+ DFG+ K          T   T   Y+APEV ++ +Y   VD + 
Sbjct: 122 KLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP-EYLAPEVLEDNDYGRAVDWWG 180

Query: 340 FALILQEMIEGCPPFTMKHDNEV 362
             +++ EM+ G  PF  + D+E 
Sbjct: 181 LGVVMYEMMCGRLPFYNQ-DHEK 202

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 4/180 (2%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +EVI   D V     E  +L+  RHP +     +      +  V EY+  
Sbjct: 20  GKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNG 79

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L R+          +  +I   ++YLH  K   I++RDL+  N++ D  G++K+
Sbjct: 80  GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKI 136

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG+ K   + +   +     +  Y+APEV ++ +Y   VD +   +++ EM+ G  PF
Sbjct: 137 TDFGLCK-EGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 195

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 76.6 bits (188), Expect = 2e-15
 Identities = 62/236 (26%), Positives = 112/236 (47%), Gaps = 15/236 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G QVAVKK+    +    R     +E+ +++   H NVV    +      + +V E+L  
Sbjct: 47  GKQVAVKKMD---LRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEG 103

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +      +   A    L + R ++YLH      +IHRD++  +IL    G +K+
Sbjct: 104 GALTDIVTHTRMNEEQIAT-VCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKL 159

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           +DFG    ++ +  +  +   T   ++APEV     Y T+VD++S  +++ EMI+G PP+
Sbjct: 160 SDFGFCAQVSKEVPKRKSLVGTP-YWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218

Query: 355 TMKHDNEVPKAYAARQR---PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
                NE P     R R   PP    +   +  L+  ++     +P++R T ++++
Sbjct: 219 F----NEPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRATAQELL 270

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 76.2 bits (187), Expect = 2e-15
 Identities = 47/162 (29%), Positives = 78/162 (48%), Gaps = 17/162 (10%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
           E +LL+ ++H N+V     +     +  V EY+   DL  ++ +  G L P     F   
Sbjct: 53  EASLLKGLKHANIVLLHDIIHTKETLTFVFEYM-HTDLAQYMIQHPGGLHPYNVRLFMFQ 111

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           + RG+ Y+H      I+HRDL+P N+L    G LK+ADFG+++       + +  Q  S 
Sbjct: 112 LLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLAR------AKSIPSQTYSS 162

Query: 319 R-----YVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
                 Y  P+V     +Y + +D++    I  EM++G P F
Sbjct: 163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAF 204

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|205076 pfam12796, Ank_2, Ankyrin repeats (3 copies)

 Score = 70.7 bits (174), Expect = 3e-15
 Identities = 30/60 (50%), Positives = 39/60 (65%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A   ++E +K LL+ G DVN +D D  TALH+AA  G  E+V LLLE GAD++ KD
Sbjct: 32  LHLAARNGNLEIVKLLLEHGADVNAKDKDGNTALHLAARNGNLEIVKLLLEHGADINLKD 91

Length = 91

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 76.0 bits (187), Expect = 3e-15
 Identities = 63/203 (31%), Positives = 96/203 (47%), Gaps = 39/203 (19%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  VA+KK+  +   +   + A R E+ +L+++ H N+V             IVT+   K
Sbjct: 32  GELVALKKVRLDNEKEGFPITAIR-EIKILRQLNHRNIVNL---------KEIVTD---K 78

Query: 235 GDLRAFLKRKGA--------------LKPSTAVRFALD--------IARGMNYLHENKPV 272
            D   F K KGA              L  S  V F+ D        +  G+NY H+    
Sbjct: 79  QDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN-- 136

Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-Y 331
             +HRD++ SNIL ++ G +K+ADFG+++L   +E RP T +  +  Y  PE+   EE Y
Sbjct: 137 -FLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERY 195

Query: 332 DTKVDVFSFALILQEMIEGCPPF 354
              +DV+S   IL E+    P F
Sbjct: 196 GPAIDVWSCGCILGELFTKKPIF 218

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 75.4 bits (185), Expect = 3e-15
 Identities = 53/165 (32%), Positives = 85/165 (51%), Gaps = 16/165 (9%)

Query: 200 ELALLQKIR---HPNVVQFLGAVT-----QSSPMMIVTEYLPKGDLRAFLKRKGA--LKP 249
           E+ALL+++    HPN+V+ +         + + + +V E++ + DLR +L +     L  
Sbjct: 49  EVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DLRTYLDKVPPPGLPA 107

Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
            T         RG+++LH N    I+HRDL+P NIL    G +K+ADFG++++ + +   
Sbjct: 108 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYSCQ--M 162

Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            LT    +  Y APEV     Y T VD++S   I  EM    P F
Sbjct: 163 ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 207

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 76.3 bits (188), Expect = 3e-15
 Identities = 55/205 (26%), Positives = 84/205 (40%), Gaps = 57/205 (27%)

Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
           VRA RD LA   +  +P VV+   +    + + ++ EYLP GD+   L +K         
Sbjct: 48  VRAERDILA---EADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEET- 103

Query: 254 RF-------ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL--- 303
           RF       A+D    + Y         IHRD++P N+L D  G++K++DFG+   L   
Sbjct: 104 RFYIAETILAIDSIHKLGY---------IHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154

Query: 304 -------TVKEDRPLTCQDTSCR---------------------------YVAPEVFKNE 329
                   +    P    D   +                           Y+APEVF   
Sbjct: 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQT 214

Query: 330 EYDTKVDVFSFALILQEMIEGCPPF 354
            Y+ + D +S  +I+ EM+ G PPF
Sbjct: 215 GYNKECDWWSLGVIMYEMLVGYPPF 239

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (185), Expect = 5e-15
 Identities = 52/180 (28%), Positives = 89/180 (49%), Gaps = 8/180 (4%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           A+K L ++ I     V     E  +L +      P +V    +    S + +VT+Y+  G
Sbjct: 22  AMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGG 81

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
           +L   L+++G      A  +  ++   + +LH+     I++RDL+P NIL D +G++ + 
Sbjct: 82  ELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALC 138

Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPF 354
           DFG+SK          T   T+  Y+APEV  +E+ Y   VD +S  +++ EM  G  PF
Sbjct: 139 DFGLSKANLTDNKTTNTFCGTT-EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPF 197

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 74.3 bits (182), Expect = 7e-15
 Identities = 54/215 (25%), Positives = 99/215 (46%), Gaps = 10/215 (4%)

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
           + E+ +++  +H N+V + G+  +   + I  E+   G L+      G L  S     + 
Sbjct: 54  QQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSR 113

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
           +  +G+ YLH       +HRD++ +NIL  D+G++K+ADFGVS  +T    +  +   T 
Sbjct: 114 ETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSFIGTP 170

Query: 318 CRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEV--PKAYAARQRP 372
             ++APEV   E    Y+   D+++  +   E+ E  PP    H          +  Q P
Sbjct: 171 -YWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPP 229

Query: 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             K   K ++      ++    + P KRPT  +++
Sbjct: 230 KLKDKMK-WSNSFHHFVKMALTKNPKKRPTAEKLL 263

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 74.7 bits (183), Expect = 8e-15
 Identities = 60/234 (25%), Positives = 115/234 (49%), Gaps = 12/234 (5%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K L E      +    F DE  ++  + HP++V+ LG V  S  + +VT+ +P G
Sbjct: 37  IPVAIKILNETTGPKANV--EFMDEALIMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHG 93

Query: 236 DLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  ++ + K  +     + + + IA+GM YL E +   ++HRDL   N+L     ++K+
Sbjct: 94  CLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKI 150

Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG+++LL   E +          +++A E     ++  + DV+S+ + + E++  G  
Sbjct: 151 TDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGK 210

Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           P+      E+P      +R P + P  +    +  ++ +CW      RP F+++
Sbjct: 211 PYDGIPTREIPDLLEKGERLP-QPP--ICTIDVYMVMVKCWMIDADSRPKFKEL 261

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 75.6 bits (186), Expect = 8e-15
 Identities = 55/185 (29%), Positives = 89/185 (48%), Gaps = 17/185 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MM 226
           G +VA+KK+     +     R FR EL +L   +H NV   L A+    P        + 
Sbjct: 25  GKRVALKKMPNVFQNLVSCKRVFR-ELKMLCFFKHDNV---LSALDILQPPHIDPFEEIY 80

Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
           +VTE L + DL   +     L       F   I RG+ YLH      I+HRD++P N+L 
Sbjct: 81  VVTE-LMQSDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLV 136

Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQ 345
           + +  LK+ DFG++++    E + +T +  +  Y APE+   +  Y + VD++S   I  
Sbjct: 137 NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA 196

Query: 346 EMIEG 350
           E++  
Sbjct: 197 ELLGR 201

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 74.1 bits (182), Expect = 1e-14
 Identities = 59/183 (32%), Positives = 96/183 (52%), Gaps = 14/183 (7%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +A+KK+  E   +D+ V   A R E++LL++++H N+V+    V     + +V EYL   
Sbjct: 30  IALKKIRLE--QEDEGVPSTAIR-EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL- 85

Query: 236 DLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-L 292
           DL+  +      A  P     +   I RG+ Y H ++   ++HRDL+P N+L D   N L
Sbjct: 86  DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNAL 142

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGC 351
           K+ADFG+++   +   R  T +  +  Y APE+   +  Y T VD++S   I  EM+   
Sbjct: 143 KLADFGLARAFGIPV-RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQK 201

Query: 352 PPF 354
           P F
Sbjct: 202 PLF 204

Length = 294

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 62/253 (24%), Positives = 113/253 (44%), Gaps = 12/253 (4%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A KKL ++ I          +E  +L+K+    VV    A      + +V   +  
Sbjct: 25  GKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNG 84

Query: 235 GDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           GDL+  +   G        A+ +A ++  G+  L   +   I++RDL+P NIL DD G++
Sbjct: 85  GDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHI 141

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
           +++D G++  + + E   +  +  +  Y+APEV  NE+Y    D +    ++ EMI+G  
Sbjct: 142 RISDLGLA--VQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQS 199

Query: 353 PFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ---IIT 408
           PF  K    V +    R+ +   +  ++ ++   K +      + P +R   R       
Sbjct: 200 PFR-KRKERVKREEVDRRVKEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGV 258

Query: 409 RLESINNSINHKR 421
           +   I  +IN KR
Sbjct: 259 KQHPIFKNINFKR 271

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 23/228 (10%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY--- 231
           G +VA+KKL     S+    RA+R EL LL+ ++H NV+  L   T    +    ++   
Sbjct: 40  GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLV 98

Query: 232 LP--KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +P    DL   +K +  L           + +G+ Y+H      IIHRDL+P N+  ++ 
Sbjct: 99  MPFMGTDLGKLMKHE-KLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNED 154

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++    + D  +T    +  Y APEV  N   Y   VD++S   I+ EM+
Sbjct: 155 CELKILDFGLAR----QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEML 210

Query: 349 EGCPPFT-MKHDNEVPKAYAARQRPPFKAPAKL-------YARGLKEL 388
            G P F    H +++ +       P  +   KL       Y + L   
Sbjct: 211 TGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRF 258

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 51/173 (29%), Positives = 88/173 (50%), Gaps = 17/173 (9%)

Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           AL     + F+  +A+GM++L        IHRDL   NIL       K+ DFG+++   +
Sbjct: 210 ALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLAR--DI 264

Query: 306 KEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT-MKHDN 360
           + D     +  +    +++APE   N  Y  + DV+S+ ++L E+   G  P+  M  D+
Sbjct: 265 RNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS 324

Query: 361 EVPKAYAA--RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
           +  K      R   P  AP+++Y     ++++ CW+  P KRPTF+QI+  +E
Sbjct: 325 KFYKMIKEGYRMLSPECAPSEMY-----DIMKSCWDADPLKRPTFKQIVQLIE 372

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 46/152 (30%), Positives = 73/152 (48%), Gaps = 11/152 (7%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP--KGDLRAFL-KRKGALKPSTAVRFA 256
           E  LLQ + HP+V++    +   +   +V   LP    DL  +L KR   L    A+   
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
             I  G+ YLH  +   IIHRD++  NI  +D   + + D G ++   V     L    T
Sbjct: 164 KQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQF-PVVAPAFLGLAGT 219

Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
                APEV   ++Y++K D++S  ++L EM+
Sbjct: 220 -VETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score = 73.0 bits (180), Expect = 3e-14
 Identities = 64/194 (32%), Positives = 101/194 (52%), Gaps = 30/194 (15%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM---IVTEYLP 233
           VA+KK+ +   +  D  R FR E+  LQ++  HPN+V+ L  V ++       +V EY+ 
Sbjct: 35  VALKKIFDAFRNATDAQRTFR-EIMFLQELGDHPNIVKLL-NVIKAENDKDIYLVFEYM- 91

Query: 234 KGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           + DL A + R   L+     R+ +  + + + Y+H      +IHRDL+PSNIL +    +
Sbjct: 92  ETDLHAVI-RANILED-VHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRV 146

Query: 293 KVADFGVSKLLTVKEDRP----LTCQDTSCRYVA------PEV-FKNEEYDTKVDVFSFA 341
           K+ADFG+++ L+  E+ P    LT       YVA      PE+   +  Y   VD++S  
Sbjct: 147 KLADFGLARSLSELEENPENPVLT------DYVATRWYRAPEILLGSTRYTKGVDMWSVG 200

Query: 342 LILQEMIEGCPPFT 355
            IL EM+ G P F 
Sbjct: 201 CILGEMLLGKPLFP 214

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 73.2 bits (179), Expect = 4e-14
 Identities = 58/183 (31%), Positives = 93/183 (50%), Gaps = 17/183 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 42  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 100

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            +L   DL   +K +        V+F +  I RG+ Y+H      IIHRDL+PSN+  ++
Sbjct: 101 THLMGADLNNIVKCQKL--TDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 155

Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEM 347
              LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E+
Sbjct: 156 DCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211

Query: 348 IEG 350
           + G
Sbjct: 212 LTG 214

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 72.0 bits (176), Expect = 5e-14
 Identities = 46/177 (25%), Positives = 88/177 (49%), Gaps = 4/177 (2%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KK  +   +++ +    R EL +L+ ++  N+V+   A  +   + +V EY+ K  L
Sbjct: 29  VAIKKFKDSEENEEVKETTLR-ELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNML 87

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
               +    + P     +   + + +++ H+N    I+HRD++P N+L   +  LK+ DF
Sbjct: 88  ELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDF 144

Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G ++ L+   +   T    +  Y +PE+     Y   VD++S   IL E+ +G P F
Sbjct: 145 GFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLF 201

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 72.4 bits (178), Expect = 6e-14
 Identities = 56/184 (30%), Positives = 91/184 (49%), Gaps = 12/184 (6%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-----QSSPMMIVTEY 231
           +VA+KK+     +  D  R  R E+ LL+ + H NV+     +        + + IV E 
Sbjct: 32  KVAIKKIANAFDNRIDAKRTLR-EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYE- 89

Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   DL   ++    L       F   + RG+ Y+H      ++HRDL+PSN+L + + +
Sbjct: 90  LMDTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCD 146

Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG 350
           LK+ DFG+++  + K D  +T    +  Y APE+  N  EY T +DV+S   I  E++  
Sbjct: 147 LKICDFGLARTTSEKGDF-MTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGR 205

Query: 351 CPPF 354
            P F
Sbjct: 206 KPLF 209

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 72.0 bits (176), Expect = 6e-14
 Identities = 69/264 (26%), Positives = 122/264 (46%), Gaps = 19/264 (7%)

Query: 151 DPHELDFTNSVEITKG-TFILAFWR----GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP  L   N ++I +G T I+   R    G QVAVK +    +    R     +E+ +++
Sbjct: 18  DPRSL-LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 73

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
             +H NVV+   +      + ++ E+L  G L   + +   L           + + + Y
Sbjct: 74  DYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCY 132

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY-VAPE 324
           LH      +IHRD++  +IL    G +K++DFG      + +D P         Y +APE
Sbjct: 133 LHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKSLVGTPYWMAPE 187

Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP-AKLYAR 383
           V     Y T+VD++S  +++ EM++G PP+    D+ V      R  PP K   A   + 
Sbjct: 188 VISRTPYGTEVDIWSLGIMVIEMVDGEPPYF--SDSPVQAMKRLRDSPPPKLKNAHKISP 245

Query: 384 GLKELIEECWNEKPAKRPTFRQII 407
            L++ +E     +P +R T ++++
Sbjct: 246 VLRDFLERMLTREPQERATAQELL 269

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 71.2 bits (174), Expect = 7e-14
 Identities = 56/223 (25%), Positives = 100/223 (44%), Gaps = 8/223 (3%)

Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           D     + E+ ++++ +H N+V + G+      + I  EY   G L+      G L    
Sbjct: 48  DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQ 107

Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
                 +  +G+ YLH       +HRD++ +NIL  D+G++K+ADFGV+  +T    +  
Sbjct: 108 IAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRK 164

Query: 312 TCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368
           +   T   ++APEV    KN  Y+   D+++  +   E+ E  PP    H        + 
Sbjct: 165 SFIGTP-YWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSK 223

Query: 369 RQRPPFKAPAKL-YARGLKELIEECWNEKPAKRPTFRQIITRL 410
               P K   K  ++      ++    + P KRPT  +++T L
Sbjct: 224 SNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 71.2 bits (174), Expect = 1e-13
 Identities = 53/209 (25%), Positives = 103/209 (49%), Gaps = 12/209 (5%)

Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
           R E  +L+ IR  P +V    A    + + ++ +Y+  G+L   L ++   K      ++
Sbjct: 52  RTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYS 111

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            +I   + +LH+   + II+RD++  NIL D +G++ + DFG+SK     E         
Sbjct: 112 GEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCG 168

Query: 317 SCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---QR 371
           +  Y+AP++ +  +  +D  VD +S  +++ E++ G  PFT+  +       + R     
Sbjct: 169 TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 228

Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKR 400
           PP+  P ++ A   K++I+    + P KR
Sbjct: 229 PPY--PQEMSALA-KDIIQRLLMKDPKKR 254

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 73.0 bits (179), Expect = 1e-13
 Identities = 43/123 (34%), Positives = 71/123 (57%), Gaps = 9/123 (7%)

Query: 193 RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA 252
           +V+A RD LAL    + P +V    ++  ++ + +V EYL  GD+++ L   G      A
Sbjct: 50  QVQAERDALAL---SKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMA 106

Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
           V++  ++A  ++YLH +    IIHRDL+P N+L  + G++K+ DFG+SK   V  +R L 
Sbjct: 107 VKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK---VTLNRELN 160

Query: 313 CQD 315
             D
Sbjct: 161 MMD 163

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score = 70.9 bits (174), Expect = 1e-13
 Identities = 51/179 (28%), Positives = 87/179 (48%), Gaps = 12/179 (6%)

Query: 178 VAVKKLGEEVISDDD---RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           VA+KK  E   S+DD   +  A R E+ +L++++HPN+V  +    +   + +V EY   
Sbjct: 29  VAIKKFVE---SEDDPVIKKIALR-EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDH 84

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
             L    K    +      +      + +N+ H++     IHRD++P NIL    G +K+
Sbjct: 85  TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKL 141

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCP 352
            DFG +++LT   D       T   Y APE+   + +Y   VDV++   +  E++ G P
Sbjct: 142 CDFGFARILTGPGDDYTDYVATRW-YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQP 199

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 71.6 bits (175), Expect = 1e-13
 Identities = 48/168 (28%), Positives = 83/168 (49%), Gaps = 27/168 (16%)

Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR----- 309
           ++  +A+GM +L   K    IHRDL   NIL  ++  +K+ DFG+++ +    D      
Sbjct: 184 YSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 240

Query: 310 ---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT-MKHDNEVPK 364
              PL       +++APE   +  Y  + DV+SF ++L E+   G  P+  +K D E  +
Sbjct: 241 ARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 293

Query: 365 AY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
                 R R P     ++Y   L     +CW+ +P++RPTF +++  L
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTML-----DCWHGEPSQRPTFSELVEHL 336

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional

 Score = 71.2 bits (175), Expect = 2e-13
 Identities = 40/107 (37%), Positives = 58/107 (54%), Gaps = 7/107 (6%)

Query: 31  LDDDGEEIKPE---FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHV---AACQG 84
            +D+  +I  E   +  +  A+   VE ++ LL +G DVNFR    +T LH+    + + 
Sbjct: 2   EEDESVDIIMEAALYDYLLNASNVTVEEVRRLLAAGADVNFRGEYGKTPLHLYLHYSSEK 61

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE-VIKLLEKHGA 130
             ++V LLLE GADV+  +R G TPL   +Y      VIKLL K GA
Sbjct: 62  VKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGA 108

Length = 471

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 70.8 bits (173), Expect = 3e-13
 Identities = 51/193 (26%), Positives = 90/193 (46%), Gaps = 23/193 (11%)

Query: 232 LPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
               +++  L   G+  L     + F   +ARGM +L     V   HRDL   N+L    
Sbjct: 217 SNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCV---HRDLAARNVLLAQG 273

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQE 346
             +K+ DFG+++   +  D     + ++    +++APE   +  Y T  DV+S+ ++L E
Sbjct: 274 KIVKICDFGLAR--DIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWE 331

Query: 347 MIE--GCPPFTMKHD----NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
           +    G P   M  D    N++   Y  R   P  A  ++Y     +++ +CWN +P KR
Sbjct: 332 IFSLGGTPYPGMIVDSTFYNKIKSGY--RMAKPDHATQEVY-----DIMVKCWNSEPEKR 384

Query: 401 PTFRQIITRLESI 413
           P+F  +   +ES+
Sbjct: 385 PSFLHLSDIVESL 397

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 70.1 bits (171), Expect = 4e-13
 Identities = 58/186 (31%), Positives = 87/186 (46%), Gaps = 23/186 (12%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           GI VAVKKL     +     RA+R EL LL+ + H N++  L   T   P   + E+   
Sbjct: 46  GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFT---PQKSLEEF--- 98

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNI 284
            D+   ++   A      +   LD  R          G+ +LH      IIHRDL+PSNI
Sbjct: 99  QDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNI 154

Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           +      LK+ DFG+++  T   +  +T    +  Y APEV     Y   VD++S   I+
Sbjct: 155 VVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 212

Query: 345 QEMIEG 350
            E+++G
Sbjct: 213 GELVKG 218

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 69.4 bits (170), Expect = 6e-13
 Identities = 57/196 (29%), Positives = 90/196 (45%), Gaps = 22/196 (11%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-----MMIVT 229
           G +VA+KK+ +      D  R  R E+ LL+ +RHP++V+    +   S      + +V 
Sbjct: 25  GEKVAIKKINDVFEHVSDATRILR-EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVF 83

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           E L + DL   +K    L P     F   + R + Y+H      + HRDL+P NIL +  
Sbjct: 84  E-LMESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANAD 139

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE--------YDTKVDVFSFA 341
             LK+ DFG++++     D P     T   YVA   ++  E        Y   +D++S  
Sbjct: 140 CKLKICDFGLARVAF--NDTPTAIFWTD--YVATRWYRAPELCGSFFSKYTPAIDIWSIG 195

Query: 342 LILQEMIEGCPPFTMK 357
            I  E++ G P F  K
Sbjct: 196 CIFAEVLTGKPLFPGK 211

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 69.3 bits (169), Expect = 7e-13
 Identities = 55/180 (30%), Positives = 89/180 (49%), Gaps = 15/180 (8%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY----- 231
           +VAVKKL     S     R +R EL LL+ ++H NV+  L   T ++ +    E      
Sbjct: 42  KVAVKKLSRPFQSLIHARRTYR-ELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN 100

Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   DL   +K +  L           + RG+ Y+H      IIHRDL+PSN+  ++   
Sbjct: 101 LMGADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCE 156

Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG 350
           L++ DFG+++    + D  +T    +  Y APE+  N   Y+  VD++S   I+ E+++G
Sbjct: 157 LRILDFGLAR----QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 68.7 bits (168), Expect = 8e-13
 Identities = 50/168 (29%), Positives = 84/168 (50%), Gaps = 27/168 (16%)

Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR----- 309
           ++  +ARGM +L   K    IHRDL   NIL  ++  +K+ DFG+++ +    D      
Sbjct: 178 YSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD 234

Query: 310 ---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT-MKHDNEVPK 364
              PL       +++APE   ++ Y T+ DV+SF ++L E+   G  P+  ++ D E  +
Sbjct: 235 ARLPL-------KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR 287

Query: 365 AY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
                 R R P  A  ++Y+  L     +CW+  P  RPTF +++  L
Sbjct: 288 RLKEGTRMRAPEYATPEIYSIML-----DCWHNNPEDRPTFSELVEIL 330

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 69.3 bits (169), Expect = 9e-13
 Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 24/170 (14%)

Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPST 251
           F +E  ++     P VVQ   A      + +V EY+P GDL   +       K A   + 
Sbjct: 90  FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 149

Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
            V  ALD    M +         IHRD++P N+L D SG+LK+ADFG    + + ++  +
Sbjct: 150 EVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMV 198

Query: 312 TCQDTSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 354
            C DT+     Y++PEV K++     Y  + D +S  + L EM+ G  PF
Sbjct: 199 RC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 53/199 (26%), Positives = 87/199 (43%), Gaps = 34/199 (17%)

Query: 175 GIQVAVKKL----GEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT 229
              VA+KK+     +++++     RA R EL LL+  R H N+            M IV 
Sbjct: 27  EETVAIKKITNVFSKKILAK----RALR-ELKLLRHFRGHKNITCLYD-------MDIVF 74

Query: 230 ----------EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
                     E L + DL   ++    L  +    F   I  G+ Y+H      ++HRDL
Sbjct: 75  PGNFNELYLYEELMEADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDL 131

Query: 280 EPSNILRDDSGNLKVADFGVSKLLT---VKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKV 335
           +P N+L +    LK+ DFG+++  +    +    +T    +  Y APE+    + Y   +
Sbjct: 132 KPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAI 191

Query: 336 DVFSFALILQEMIEGCPPF 354
           DV+S   IL E++   P F
Sbjct: 192 DVWSVGCILAELLGRKPVF 210

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional

 Score = 67.8 bits (166), Expect = 1e-12
 Identities = 61/281 (21%), Positives = 122/281 (43%), Gaps = 37/281 (13%)

Query: 150 IDPHELDFTNSVEITKGT--FILAFWRGI----QVAVKKLGEEVISDDDRVRAFRDELAL 203
           I+  ++D   SV I +     I   ++GI    +V ++   +        +    +E+  
Sbjct: 15  IESDDIDKYTSVLIKENDQNSI---YKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKN 71

Query: 204 LQKIRHPNVVQFLG---AVTQSSP-MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           L++I   N+++  G    +    P + ++ EY  +G LR  L ++  L   T +  A+D 
Sbjct: 72  LRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDC 131

Query: 260 ARGMNYLHE--NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
            +G+  L++  NKP    +++L   + L  ++  LK+   G+ K+L+     P       
Sbjct: 132 CKGLYNLYKYTNKP----YKNLTSVSFLVTENYKLKIICHGLEKILSS----PPFKNVNF 183

Query: 318 CRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPF-----TMKHDNEVPKAYAARQ 370
             Y + ++  +   EY  K D++S  ++L E+  G  PF        +D  + K  +   
Sbjct: 184 MVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNS--L 241

Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
           + P   P       +K ++E C +    KRP  ++I+  L 
Sbjct: 242 KLPLDCP-----LEIKCIVEACTSHDSIKRPNIKEILYNLS 277

Length = 283

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 68.7 bits (168), Expect = 1e-12
 Identities = 53/203 (26%), Positives = 101/203 (49%), Gaps = 26/203 (12%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF--------------LGAVTQS 222
           +VAVKK+   V++D   V+    E+ +++++ H N+V+               +G++T+ 
Sbjct: 32  RVAVKKI---VLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTEL 88

Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + + IV EY+ + DL   L+ +G L    A  F   + RG+ Y+H      ++HRDL+P+
Sbjct: 89  NSVYIVQEYM-ETDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPA 143

Query: 283 NIL-RDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE-VFKNEEYDTKVDVF 338
           N+    +   LK+ DFG+++++         L+    +  Y +P  +     Y   +D++
Sbjct: 144 NVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMW 203

Query: 339 SFALILQEMIEGCPPFTMKHDNE 361
           +   I  EM+ G P F   H+ E
Sbjct: 204 AAGCIFAEMLTGKPLFAGAHELE 226

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 68.6 bits (168), Expect = 1e-12
 Identities = 59/188 (31%), Positives = 83/188 (44%), Gaps = 25/188 (13%)

Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYL 232
            G  VA+KKL     +     RA+R EL L++ + H N++  L   T Q S       YL
Sbjct: 40  TGQNVAIKKLSRPFQNVTHAKRAYR-ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYL 98

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPS 282
               + A L           ++  LD  R          G+ +LH      IIHRDL+PS
Sbjct: 99  VMELMDANL--------CQVIQMDLDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPS 147

Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
           NI+      LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   
Sbjct: 148 NIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGC 205

Query: 343 ILQEMIEG 350
           I+ EMI G
Sbjct: 206 IMGEMIRG 213

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 67.7 bits (165), Expect = 1e-12
 Identities = 58/242 (23%), Positives = 107/242 (44%), Gaps = 27/242 (11%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  VAVKK+    +    R     +E+ +++  +H NVV+   +      + +V E+L  
Sbjct: 45  GKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG 101

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +      +   A    L + + ++ LH      +IHRD++  +IL    G +K+
Sbjct: 102 GALTDIVTHTRMNEEQIAA-VCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKL 157

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           +DFG    ++ +  R  +   T   ++APE+     Y  +VD++S  +++ EM++G PP+
Sbjct: 158 SDFGFCAQVSKEVPRRKSLVGTP-YWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216

Query: 355 ---------TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
                     M  DN  PK     +  P           LK  ++      PA+R T  +
Sbjct: 217 FNEPPLKAMKMIRDNLPPKLKNLHKVSPS----------LKGFLDRLLVRDPAQRATAAE 266

Query: 406 II 407
           ++
Sbjct: 267 LL 268

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 48/161 (29%), Positives = 83/161 (51%), Gaps = 19/161 (11%)

Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
           ++  +ARGM +L   K    IHRDL   NIL  ++  +K+ DFG+++   + +D P   +
Sbjct: 179 YSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLAR--DIYKD-PDYVR 232

Query: 315 DTSCR----YVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT-MKHDNEVPKAY-- 366
             S R    ++APE   ++ Y T+ DV+SF ++L E+   G  P+  ++ + E  +    
Sbjct: 233 KGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKD 292

Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             R R P  A  ++Y      ++  CW   P +RPTF  ++
Sbjct: 293 GTRMRAPENATPEIY-----RIMLACWQGDPKERPTFSALV 328

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 68.1 bits (166), Expect = 2e-12
 Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 26/210 (12%)

Query: 218 AVTQSSPMMI-VTEYLP----KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
           A  +SS       +YLP    +      +    AL     V F+  +A GM +L     V
Sbjct: 202 ADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCV 261

Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNE 329
              HRDL   N+L  +   +K+ DFG+++   +  D     + ++    +++APE   N 
Sbjct: 262 ---HRDLAARNVLICEGKLVKICDFGLAR--DIMRDSNYISKGSTFLPLKWMAPESIFNN 316

Query: 330 EYDTKVDVFSFALILQEM--IEGCP----PFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
            Y T  DV+SF ++L E+  + G P    P   +  N + + Y  R   P  A  ++Y  
Sbjct: 317 LYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGY--RMAKPAHASDEIY-- 372

Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              E++++CW EK   RP F Q++  +  +
Sbjct: 373 ---EIMQKCWEEKFEIRPDFSQLVHLVGDL 399

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score = 67.6 bits (165), Expect = 2e-12
 Identities = 57/180 (31%), Positives = 90/180 (50%), Gaps = 12/180 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYLP 233
           G +VA+KKL     S+    RA+R EL LL+ ++H NV+  L   T   S       YL 
Sbjct: 40  GEKVAIKKLSRPFQSEIFAKRAYR-ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLV 98

Query: 234 KGDLRAFLKRKGALKPST-AVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
              ++  L++      S   V++ +  +  G+ Y+H      IIHRDL+P N+  ++   
Sbjct: 99  MPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCE 155

Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG 350
           LK+ DFG+++      D  +T    +  Y APEV  N   Y+  VD++S   I+ EM+ G
Sbjct: 156 LKILDFGLAR----HADAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTG 211

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 67.0 bits (164), Expect = 2e-12
 Identities = 53/191 (27%), Positives = 90/191 (47%), Gaps = 34/191 (17%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM---------IV 228
           VA+KK+  E   +   + A R E+ +LQ ++H NVV  L  + ++             +V
Sbjct: 40  VALKKVLMENEKEGFPITALR-EIKILQLLKHENVVN-LIEICRTKATPYNRYKGSFYLV 97

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIAR-------GMNYLHENKPVPIIHRDLE 280
            E+    DL   L  K        V+F L +I +       G+ Y+H NK   I+HRD++
Sbjct: 98  FEFCEH-DLAGLLSNK-------NVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMK 146

Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNE-EYDTKVD 336
            +NIL    G LK+ADFG+++  ++ ++           +  Y  PE+   E +Y   +D
Sbjct: 147 AANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPID 206

Query: 337 VFSFALILQEM 347
           ++    I+ EM
Sbjct: 207 MWGAGCIMAEM 217

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 67.4 bits (164), Expect = 3e-12
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 16/166 (9%)

Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF- 255
           F +E  ++     P VVQ   A      + +V EY+P GDL   +       P    +F 
Sbjct: 90  FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDV--PEKWAKFY 147

Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             ++   ++ +H    + +IHRD++P N+L D  G+LK+ADFG    + + E   + C D
Sbjct: 148 TAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMVRC-D 201

Query: 316 TSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 354
           T+     Y++PEV K++     Y  + D +S  + L EM+ G  PF
Sbjct: 202 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 67.1 bits (164), Expect = 4e-12
 Identities = 50/157 (31%), Positives = 75/157 (47%), Gaps = 24/157 (15%)

Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMN 264
             +VQ   A      + +V EY+P GDL   +       K A   +  V  ALD    M 
Sbjct: 103 EWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEVVLALDAIHSMG 162

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYV 321
           +         IHRD++P N+L D SG+LK+ADFG    + +  +  + C DT+     Y+
Sbjct: 163 F---------IHRDVKPDNMLLDKSGHLKLADFGTC--MKMDANGMVRC-DTAVGTPDYI 210

Query: 322 APEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 354
           +PEV K++     Y  + D +S  + L EM+ G  PF
Sbjct: 211 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 65.7 bits (160), Expect = 6e-12
 Identities = 58/217 (26%), Positives = 105/217 (48%), Gaps = 23/217 (10%)

Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV----RFALDIARG 262
           ++HPN++Q LG   ++ P ++V EY   GDL+++L ++   + ++ +    R A +IA G
Sbjct: 52  LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---R 319
           + ++H++     +H DL   N        +KV D+G+      KED  +  +D  C   R
Sbjct: 112 VTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIG-PSRYKEDY-IETEDDKCVPLR 166

Query: 320 YVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV-PKAYAARQ 370
           ++APE+           E     +V++  + L E+ E    P++   D EV       +Q
Sbjct: 167 WLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQ 226

Query: 371 RPPFKAPAKL-YARGLKELIEECWNEKPAKRPTFRQI 406
              FK   +L Y+    E+++ CW   P KR T  ++
Sbjct: 227 VKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEV 262

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|140343 PTZ00322, PTZ00322, 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional

 Score = 67.2 bits (164), Expect = 6e-12
 Identities = 37/82 (45%), Positives = 45/82 (54%)

Query: 47  LANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
           LA   D  G + LL  G D N RD D RT LH+A   G  +VV +LLE GAD    D+ G
Sbjct: 89  LAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDG 148

Query: 107 STPLGDAIYYKNHEVIKLLEKH 128
            TPL  A      EV++LL +H
Sbjct: 149 KTPLELAEENGFREVVQLLSRH 170

Length = 664

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 65.8 bits (160), Expect = 9e-12
 Identities = 52/210 (24%), Positives = 92/210 (43%), Gaps = 37/210 (17%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  + + ++V   R E  +L +     VV+   +      + ++ E+LP GD+ 
Sbjct: 30  AMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMM 89

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L +K  L       +  +    ++ +H+   +  IHRD++P N+L D  G++K++DFG
Sbjct: 90  TLLMKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFG 146

Query: 299 V--------------------------------SKLLTVKEDRPLTCQDT--SCRYVAPE 324
           +                                 K  T K++R      T  +  Y+APE
Sbjct: 147 LCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPE 206

Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           VF    Y+   D +S  +I+ EM+ G PPF
Sbjct: 207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 66.0 bits (161), Expect = 1e-11
 Identities = 63/243 (25%), Positives = 109/243 (44%), Gaps = 46/243 (18%)

Query: 225 MMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           + +V +Y   GDLR  +K +       +   A    + +   ++++H      +IHRD++
Sbjct: 114 IALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIK 170

Query: 281 PSNILRDDSGNLKVADFGVSKLL--TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
            +NIL   +G +K+ DFG SK+   TV +D   T   T   YVAPE+++ + Y  K D+F
Sbjct: 171 SANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTP-YYVAPEIWRRKPYSKKADMF 229

Query: 339 SFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRP--------------------PFKAP 377
           S  ++L E++    PF  ++  EV  K  A R  P                    P + P
Sbjct: 230 SLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRP 289

Query: 378 A----------KLYARGLKELIEECWNEKPAKRPTFRQIITR-LESINNSINHKRRWKIR 426
           +          KL+  GL E+++     +P      R  I+R ++     +  +RR  +R
Sbjct: 290 SSSKLLNMPICKLFISGLLEIVQ----TQPGFSGPLRDTISRQIQQTKQLLQVERRRIVR 345

Query: 427 TMK 429
            M+
Sbjct: 346 QME 348

Length = 496

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 65.0 bits (159), Expect = 1e-11
 Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 20/170 (11%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYLPKGDLRAFLK-----RKGALKPSTA 252
           E+ALL++++H NVV  +    + +   +  + +Y  + DL   +K     ++ ++ PS  
Sbjct: 52  EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMV 110

Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKLLTVKED 308
                 I  G++YLH N    ++HRDL+P+NIL      + G +K+ D G+++L      
Sbjct: 111 KSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDLGLARLF-NAPL 166

Query: 309 RPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPF 354
           +PL   D    +  Y APE+     + TK +D+++   I  E++   P F
Sbjct: 167 KPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIF 216

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 65.3 bits (159), Expect = 2e-11
 Identities = 50/171 (29%), Positives = 86/171 (50%), Gaps = 27/171 (15%)

Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL------TVK 306
           +RF+  +A+GM++L        IHRD+   N+L  D    K+ DFG+++ +       VK
Sbjct: 215 LRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271

Query: 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF-----TMKHDN 360
            +  L       +++APE   +  Y  + DV+S+ ++L E+   G  P+       K   
Sbjct: 272 GNARL-----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYK 326

Query: 361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
            V + Y    RP F AP ++Y+     +++ CWN +P +RPTF QI   ++
Sbjct: 327 MVKRGYQM-SRPDF-APPEIYS-----IMKMCWNLEPTERPTFSQISQLIQ 370

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 51/209 (24%), Positives = 105/209 (50%), Gaps = 13/209 (6%)

Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
           R E  +L+ +R  P +V    A    + + ++ +Y+  G++   L ++          ++
Sbjct: 52  RTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYS 111

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQD 315
            +I   + +LH+   + I++RD++  NIL D  G++ + DFG+SK  L+ +++R  +   
Sbjct: 112 GEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYSFCG 168

Query: 316 TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---QR 371
           T   Y+APE+ + +    K VD +S  +++ E++ G  PFT++ +       + R     
Sbjct: 169 TI-EYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCD 227

Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKR 400
           PPF +     A+   +L+ +   + P KR
Sbjct: 228 PPFPSFIGPEAQ---DLLHKLLRKDPKKR 253

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 65.1 bits (158), Expect = 2e-11
 Identities = 54/220 (24%), Positives = 94/220 (42%), Gaps = 37/220 (16%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  + + ++V   R E  +L +     VV+   +      + ++ E+LP GD+ 
Sbjct: 30  AMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMM 89

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L +K  L       +  +    ++ +H+   +  IHRD++P N+L D  G++K++DFG
Sbjct: 90  TLLMKKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFG 146

Query: 299 V--------------------------------SKLLTVKEDRPLTCQDT--SCRYVAPE 324
           +                                 K  T K +R      T  +  Y+APE
Sbjct: 147 LCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPE 206

Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK 364
           VF    Y+   D +S  +I+ EM+ G PPF  +   E  K
Sbjct: 207 VFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYK 246

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 52/203 (25%), Positives = 83/203 (40%), Gaps = 48/203 (23%)

Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
           V+A RD LA   +  +  VV+   +      +  V +Y+P GD+ + L R G  +   A 
Sbjct: 48  VKAERDILA---EADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLAR 104

Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV-------------- 299
            +  ++   +  +H+   +  IHRD++P NIL D  G++K+ DFG+              
Sbjct: 105 FYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQ 161

Query: 300 ------------SKLLTVKEDRPLTC-------QDTSCR---------YVAPEVFKNEEY 331
                       S+  +  +   L         Q   C          Y+APEV     Y
Sbjct: 162 KGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGY 221

Query: 332 DTKVDVFSFALILQEMIEGCPPF 354
               D +S  +IL EM+ G PPF
Sbjct: 222 TQLCDWWSVGVILYEMLVGQPPF 244

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional

 Score = 65.0 bits (158), Expect = 2e-11
 Identities = 33/77 (42%), Positives = 48/77 (62%)

Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
           + IK +LD GIDVN +D + +T LH A  +G  E + +L E GADV+ +D  G  P+  A
Sbjct: 105 DMIKTILDCGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIA 164

Query: 114 IYYKNHEVIKLLEKHGA 130
           I +   ++IKLL + GA
Sbjct: 165 IKHNFFDIIKLLLEKGA 181

Length = 434

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 63.8 bits (155), Expect = 3e-11
 Identities = 40/121 (33%), Positives = 68/121 (56%), Gaps = 7/121 (5%)

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           GDL   L + G    +    +A +I  G+ ++H N+ V  ++RDL+P+NIL D+ G++++
Sbjct: 82  GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMH-NRFV--VYRDLKPANILLDEHGHVRI 138

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPP 353
           +D G++   + K  +P     T   Y+APEV  K   YD+  D FS   +L +++ G  P
Sbjct: 139 SDLGLACDFSKK--KPHASVGTH-GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSP 195

Query: 354 F 354
           F
Sbjct: 196 F 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|165205 PHA02874, PHA02874, ankyrin repeat protein; Provisional

 Score = 64.2 bits (156), Expect = 4e-11
 Identities = 42/138 (30%), Positives = 70/138 (50%), Gaps = 8/138 (5%)

Query: 30  GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89
           G+D + ++ + +  L +   + D+E IK L + G DVN  D +    +H+A    F +++
Sbjct: 114 GIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDII 173

Query: 90  SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA------KPLMAPMH--VKH 141
            LLLE+GA  + KD  G +PL +A  Y ++  IKLL  HG       K    P+H  + H
Sbjct: 174 KLLLEKGAYANVKDNNGESPLHNAAEYGDYACIKLLIDHGNHIMNKCKNGFTPLHNAIIH 233

Query: 142 AREVPEYEIDPHELDFTN 159
            R   E  I+   ++  +
Sbjct: 234 NRSAIELLINNASINDQD 251

Length = 434

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 44/158 (27%), Positives = 78/158 (49%), Gaps = 7/158 (4%)

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
           R  L+L+     P +V    A      +  + + +  GDL   L + G         +A 
Sbjct: 45  RIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYAT 104

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
           +I  G+ ++H      +++RDL+P+NIL D+ G+++++D G++   + K  +P     T 
Sbjct: 105 EIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTH 159

Query: 318 CRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
             Y+APEV  K   YD+  D FS   +L +++ G  PF
Sbjct: 160 -GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 63.9 bits (155), Expect = 5e-11
 Identities = 43/154 (27%), Positives = 74/154 (48%), Gaps = 10/154 (6%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP--KGDLRAFLKRKGALKPSTAVRFAL 257
           E  +L+ I HP+++Q  G  T +    ++   LP  K DL  +L  K  +     +    
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILAIER 189

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL-LTVKEDRPLTCQDT 316
            + R + YLHEN+   IIHRD++  NI  +  G++ + DFG +   + +  ++      T
Sbjct: 190 SVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAGT 246

Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
                APE+   + Y   VD++S  ++L EM   
Sbjct: 247 IATN-APELLARDPYGPAVDIWSAGIVLFEMATC 279

Length = 391

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 62.8 bits (152), Expect = 1e-10
 Identities = 56/184 (30%), Positives = 85/184 (46%), Gaps = 23/184 (12%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
            VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D
Sbjct: 51  NVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFT---PQKSLEEF---QD 103

Query: 237 LRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILR 286
           +   ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+ 
Sbjct: 104 VYIVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVV 159

Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
                LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ E
Sbjct: 160 KSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 217

Query: 347 MIEG 350
           MI+G
Sbjct: 218 MIKG 221

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 62.6 bits (152), Expect = 1e-10
 Identities = 56/214 (26%), Positives = 86/214 (40%), Gaps = 46/214 (21%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPM-MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
           E+ +L+ I H  ++  + A    S + M++ +Y  K DL  ++ R G L    A+     
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKY--KCDLFTYVDRSGPLPLEQAITIQRR 193

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL------T 312
           +   + YLH      IIHRD++  NI  D+  N  + DFG +  L    D P       T
Sbjct: 194 LLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGT 250

Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM-IEGCPPFTMK-------------- 357
            +  S     PE+   + Y  K D++S  L+L EM ++    F  +              
Sbjct: 251 LETNS-----PELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRC 305

Query: 358 ---HDNEVP-----------KAYAARQRPPFKAP 377
              H  E P           K YA   RPP+  P
Sbjct: 306 MQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIP 339

Length = 392

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 42/190 (22%), Positives = 86/190 (45%), Gaps = 18/190 (9%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVKK+  +     + ++  + E+   ++++HPN++ ++ +    S + +V+  +  G  
Sbjct: 28  VAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86

Query: 238 RAFLKR--KGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
              LK      L P  A+ F L D+   ++Y+H       IHR ++ S+IL    G + +
Sbjct: 87  EDLLKTHFPEGL-PELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVL 142

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRY-------VAPEVFKN--EEYDTKVDVFSFALILQ 345
           +    S  + +K  +         +        ++PEV +   + Y+ K D++S  +   
Sbjct: 143 SGLRYSVSM-IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITAC 201

Query: 346 EMIEGCPPFT 355
           E+  G  PF 
Sbjct: 202 ELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 60.9 bits (147), Expect = 3e-10
 Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKSLEEF---QDV 97

Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 98  YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 153

Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 154 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211

Query: 348 I 348
           +
Sbjct: 212 V 212

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 60.3 bits (146), Expect = 7e-10
 Identities = 51/207 (24%), Positives = 86/207 (41%), Gaps = 52/207 (25%)

Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
           V+A RD LA   +   P VV    +   +  + ++ E+LP GDL   L +          
Sbjct: 48  VKAERDVLA---ESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTR 104

Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS------------- 300
            +  +    +  +H+   +  IHRD++P NIL D  G++K++DFG+S             
Sbjct: 105 FYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQ 161

Query: 301 KLLTVKEDRP----------------LTCQDT-----------------SCRYVAPEVFK 327
           KLL  K ++                 ++ +D                  +  Y+APE+F 
Sbjct: 162 KLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFL 221

Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPF 354
            + Y  + D +S   I+ E + G PPF
Sbjct: 222 QQGYGQECDWWSLGAIMFECLIGWPPF 248

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 53/222 (23%), Positives = 94/222 (42%), Gaps = 49/222 (22%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L ++ + + ++V   + E  +L +  +  VV+   +      +  V +Y+P GD+ 
Sbjct: 30  AMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMM 89

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           + L R        A  +  ++   +  +H+   +  IHRD++P NIL D  G++K+ DFG
Sbjct: 90  SLLIRMEVFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFG 146

Query: 299 V-------------SKLLTVKED--RPLTCQD--TSCR---------------------- 319
           +              K   +++D   P    D  ++CR                      
Sbjct: 147 LCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAH 206

Query: 320 -------YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
                  Y+APEV   + Y    D +S  +IL EM+ G PPF
Sbjct: 207 SLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 59.6 bits (144), Expect = 1e-09
 Identities = 56/222 (25%), Positives = 92/222 (41%), Gaps = 49/222 (22%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L ++ +   ++V   + E  +L +  +  VV+   +      +  V +Y+P GD+ 
Sbjct: 30  AMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMM 89

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           + L R G      A  +  ++   +  +H+   +  IHRD++P NIL D  G++K+ DFG
Sbjct: 90  SLLIRMGIFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFG 146

Query: 299 V---------SKLLT----VKEDR---------PLTC---------------QDTSC--- 318
           +         SK       V++D          P  C               Q   C   
Sbjct: 147 LCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAH 206

Query: 319 ------RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
                  Y+APEV     Y    D +S  +IL EM+ G PPF
Sbjct: 207 SLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPF 248

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional

 Score = 58.5 bits (142), Expect = 3e-09
 Identities = 36/108 (33%), Positives = 55/108 (50%), Gaps = 15/108 (13%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE-VVSLLLERGADVDPK 102
            +  ++E+  + ++ LL++G DVN  +    T LH+      T  V+ LL++ GADV+ K
Sbjct: 54  YLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAK 113

Query: 103 DRWGSTPL-----GDAIYYKNHEVIKLLEKHGAKP------LMAPMHV 139
           D+ G TPL     G  I  K   VI+LL + GA         M P+ V
Sbjct: 114 DKVGRTPLHVYLSGFNINPK---VIRLLLRKGADVNALDLYGMTPLAV 158

Length = 471

>gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 57.2 bits (138), Expect = 4e-09
 Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 23/232 (9%)

Query: 189 SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGAL 247
           S  D   AF +  +L+ ++ H ++    G   + S  ++V E++  G L   L++ KG +
Sbjct: 55  SHRDIALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRV 114

Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-------NLKVADFGVS 300
             +  +  A  +A  ++YL E+K   ++H ++   NIL    G        +K++D GVS
Sbjct: 115 PVAWKITVAQQLASALSYL-EDKN--LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVS 171

Query: 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEM-IEGCPPFTMKH 358
                +E+R          ++APE         T  D +SF   L E+  +G  P   + 
Sbjct: 172 FTALSREERV-----ERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226

Query: 359 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
            +E  + Y  + R P   P+    + L  LI +C   +P +RP+FR I+  L
Sbjct: 227 PSEKERFYEKKHRLP--EPS---CKELATLISQCLTYEPTQRPSFRTILRDL 273

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 57.4 bits (138), Expect = 5e-09
 Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 18/204 (8%)

Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
           FR+E  +L    +  +     A    + + +V +Y   GDL   L +     P    RF 
Sbjct: 48  FREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFY 107

Query: 257 L-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
           L ++   ++ +H+   +  +HRD++P NIL D +G++++ADFG    L + ED   T Q 
Sbjct: 108 LAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFG--SCLKLMEDG--TVQS 160

Query: 316 T----SCRYVAPEVFKNEE-----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKA 365
           +    +  Y++PE+ +  E     Y  + D +S  + + EM+ G  PF  +   E   K 
Sbjct: 161 SVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKI 220

Query: 366 YAARQRPPFKAPAKLYARGLKELI 389
              ++R  F A     +   K+LI
Sbjct: 221 MNHKERFQFPAQVTDVSEDAKDLI 244

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 56.4 bits (137), Expect = 5e-09
 Identities = 42/174 (24%), Positives = 83/174 (47%), Gaps = 10/174 (5%)

Query: 209 HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
           +PN ++   +VT     +++ +Y+  GDL   LK++G L  +   +    +   +N LH+
Sbjct: 68  NPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHK 127

Query: 269 NKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
           +    IIH D++  N+L D +   + + D+G+ K++        +C D +  Y +PE  K
Sbjct: 128 HN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYDGTLDYFSPEKIK 179

Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKL 380
              YD   D ++  ++  E++ G  PF    D E+  ++   RQ+        +
Sbjct: 180 GHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQQKKLPFIKNV 233

Length = 267

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 52/180 (28%), Positives = 90/180 (50%), Gaps = 24/180 (13%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALK--------P 249
           E+ALL++++HPNV+         S   + ++ +Y  + DL   +K   A K        P
Sbjct: 48  EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLP 106

Query: 250 STAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKLLT 304
            + V+  L  I  G++YLH N    ++HRDL+P+NIL      + G +K+AD G ++L  
Sbjct: 107 RSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Query: 305 VKEDRPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDN 360
               +PL   D    +  Y APE+     + TK +D+++   I  E++   P F  + ++
Sbjct: 164 -SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only]

 Score = 55.2 bits (132), Expect = 1e-08
 Identities = 32/77 (41%), Positives = 42/77 (54%), Gaps = 3/77 (3%)

Query: 56  IKELLDSGI--DVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112
            K LL++G   DVN   D D  T LH AA  G  ++V LLLE GAD + ++ +G T L  
Sbjct: 127 AKLLLEAGADLDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADPNSRNSYGVTALDP 186

Query: 113 AIYYKNHEVIKLLEKHG 129
           A      E++KLL   G
Sbjct: 187 AAKNGRIELVKLLLDKG 203

Length = 235

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 57.1 bits (137), Expect = 1e-08
 Identities = 62/239 (25%), Positives = 106/239 (44%), Gaps = 38/239 (15%)

Query: 200 ELALLQKIRHPNVVQ----FLGAVTQSSPMMIVTEYLPKGDL----RAFLKRKGALKPST 251
           E+ ++++++H N+V+    FL    Q   + I+ E+   GDL    +   K  G ++   
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQK--LYILMEFCDAGDLSRNIQKCYKMFGKIEEHA 119

Query: 252 AVRFALDIARGMNYLHENKPVP----IIHRDLEPSNI-----------LRDDSGNL---- 292
            V     +   + Y H  K  P    ++HRDL+P NI           +   + NL    
Sbjct: 120 IVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRP 179

Query: 293 --KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMI 348
             K+ DFG+SK + + E    +C  T   Y +PE+  +E   YD K D+++   I+ E+ 
Sbjct: 180 IAKIGDFGLSKNIGI-ESMAHSCVGTP-YYWSPELLLHETKSYDDKSDMWALGCIIYELC 237

Query: 349 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            G  PF     N   +  +  +R P   P K  ++ L  LI+   N    +RP+  Q +
Sbjct: 238 SGKTPF--HKANNFSQLISELKRGP-DLPIKGKSKELNILIKNLLNLSAKERPSALQCL 293

Length = 1021

>gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional

 Score = 56.2 bits (136), Expect = 1e-08
 Identities = 28/95 (29%), Positives = 48/95 (50%), Gaps = 18/95 (18%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAA--CQGFTEVVSLLLERGADVDPKDR--------- 104
           ++ LLD+G +VN ++ D    LH+     +   +++ LL+++G D++ K+R         
Sbjct: 124 VEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRVNYLLSYGV 183

Query: 105 -------WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
                  +G TPL  A+Y  N E +K L   GA P
Sbjct: 184 PINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANP 218

Length = 422

>gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional

 Score = 56.4 bits (136), Expect = 1e-08
 Identities = 39/134 (29%), Positives = 64/134 (47%), Gaps = 13/134 (9%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L +    +D    + LL  G +VN  D  N + LH A       +V +LLE GA  D +D
Sbjct: 172 LHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARD 231

Query: 104 RWGSTPLGDAI-YYKNHEVIKLLEKHG----AKPL---MAPMHVKHARE-----VPEYEI 150
           + G+TPL  ++ Y K+++++KLL +HG    AK     +  +H     E     + EY  
Sbjct: 232 KCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYILGLTALHSSIKSERKLKLLLEYGA 291

Query: 151 DPHELDFTNSVEIT 164
           D + L+      ++
Sbjct: 292 DINSLNSYKLTPLS 305

Length = 477

>gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional

 Score = 56.4 bits (136), Expect = 2e-08
 Identities = 31/96 (32%), Positives = 56/96 (58%), Gaps = 2/96 (2%)

Query: 32  DDDGEEIKP--EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89
           D+ GE   P     L+ +A+  +   ++ELL + +D +  D   RT LH+AA +G+ + V
Sbjct: 515 DNGGEHDDPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCV 574

Query: 90  SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
            +LL+   +V  +D  G+T L +AI  K+H++ ++L
Sbjct: 575 LVLLKHACNVHIRDANGNTALWNAISAKHHKIFRIL 610

Length = 823

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 55.8 bits (134), Expect = 2e-08
 Identities = 54/194 (27%), Positives = 94/194 (48%), Gaps = 29/194 (14%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV-----QFLGAVTQSSP---MMIV 228
           +VA+KK    V+ D    +    EL +++ + H N++      +     ++     + +V
Sbjct: 93  KVAIKK----VLQDP---QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVV 145

Query: 229 TEYLPKGDLRAFLK---RKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNI 284
            E++P+  +  ++K   R     P   V+ ++  + R + Y+H      I HRDL+P N+
Sbjct: 146 MEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNL 201

Query: 285 LRD-DSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFA 341
           L D ++  LK+ DFG +K LL  +      C   S  Y APE+      Y T +D++S  
Sbjct: 202 LIDPNTHTLKLCDFGSAKNLLAGQRSVSYIC---SRFYRAPELMLGATNYTTHIDLWSLG 258

Query: 342 LILQEMIEGCPPFT 355
            I+ EMI G P F+
Sbjct: 259 CIIAEMILGYPIFS 272

Length = 440

>gnl|CDD|238125 cd00204, ANK, ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

 Score = 51.6 bits (124), Expect = 3e-08
 Identities = 25/50 (50%), Positives = 30/50 (60%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93
           L   A   +++ +K LL  G DVN RD D RT LH+AA  G  EVV LLL
Sbjct: 77  LHLAARNGNLDVVKLLLKHGADVNARDKDGRTPLHLAAKNGHLEVVKLLL 126

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats. Length = 126

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 55.2 bits (133), Expect = 3e-08
 Identities = 27/70 (38%), Positives = 41/70 (58%), Gaps = 3/70 (4%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L  +  +  D   A   EL +L  + +H N+V  LGA T   P++++TEY   
Sbjct: 69  LRVAVKML--KASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCY 126

Query: 235 GDLRAFLKRK 244
           GDL  FL++K
Sbjct: 127 GDLLNFLRKK 136

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional

 Score = 55.1 bits (133), Expect = 3e-08
 Identities = 27/75 (36%), Positives = 40/75 (53%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           +  LL  G+ +N +D+   T LH A      E V  LL+ GA+ +  +++G TPL  AI 
Sbjct: 175 VNYLLSYGVPINIKDVYGFTPLHYAVYNNNPEFVKYLLDLGANPNLVNKYGDTPLHIAIL 234

Query: 116 YKNHEVIKLLEKHGA 130
             N E+ KLL  +G 
Sbjct: 235 NNNKEIFKLLLNNGP 249

Length = 422

>gnl|CDD|200936 pfam00023, Ank, Ankyrin repeat

 Score = 49.1 bits (118), Expect = 3e-08
 Identities = 19/33 (57%), Positives = 23/33 (69%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDR 104
           D  T LH+AA  G  EVV LLLE GADV+ +D+
Sbjct: 1   DGNTPLHLAARNGHLEVVKLLLEAGADVNARDK 33

Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Repeats 13-24 are especially active, with known sites of interaction for the Na/K ATPase, Cl/HCO(3) anion exchanger, voltage-gated sodium channel, clathrin heavy chain and L1 family cell adhesion molecules. The ANK repeats are found to form a contiguous spiral stack such that ion transporters like the anion exchanger associate in a large central cavity formed by the ANK repeat spiral, while clathrin and cell adhesion molecules associate with specific regions outside this cavity. Length = 33

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 54.7 bits (131), Expect = 3e-08
 Identities = 51/180 (28%), Positives = 89/180 (49%), Gaps = 24/180 (13%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKRKGALK--------P 249
           E+ALL++++HPNV+         +   + ++ +Y  + DL   +K   A K        P
Sbjct: 48  EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 106

Query: 250 STAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSGNLKVADFGVSKLLT 304
              V+  L  I  G++YLH N    ++HRDL+P+NIL      + G +K+AD G ++L  
Sbjct: 107 RGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFARLFN 163

Query: 305 VKEDRPLTCQD---TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDN 360
               +PL   D    +  Y APE+     + TK +D+++   I  E++   P F  + ++
Sbjct: 164 -SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score = 53.0 bits (128), Expect = 8e-08
 Identities = 50/191 (26%), Positives = 92/191 (48%), Gaps = 18/191 (9%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP--MMIVTEYLPK 234
            A+K + ++     ++V   R E+  L+++  HPN+++ +  +       + +V E L  
Sbjct: 27  YAIKCM-KKHFKSLEQVNNLR-EIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE-LMD 83

Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            +L   +K RK  L       +   + + ++++H N    I HRD++P NIL  D   LK
Sbjct: 84  MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILK 139

Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCR-YVAPE-VFKNEEYDTKVDVFSFALILQEMIEGC 351
           +ADFG  +   +    P T +  S R Y APE +  +  Y  K+D+++   +  E++   
Sbjct: 140 LADFGSCR--GIYSKPPYT-EYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLF 196

Query: 352 PPFTMKHDNEV 362
           P F     NE+
Sbjct: 197 PLFPGT--NEL 205

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional

 Score = 53.9 bits (130), Expect = 9e-08
 Identities = 31/83 (37%), Positives = 46/83 (55%), Gaps = 7/83 (8%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFT-----EVVSLLLERGADVDPKDRWGSTPL 110
           +K LLD+G D+N    +N T LH  +   +      E+V LLLE GA+V+  D  G TPL
Sbjct: 51  VKILLDNGADINSSTKNNSTPLHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPL 110

Query: 111 GDAIYYK--NHEVIKLLEKHGAK 131
             AI  K  ++ +++ L  +GA 
Sbjct: 111 LYAISKKSNSYSIVEYLLDNGAN 133

Length = 422

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 53.5 bits (128), Expect = 1e-07
 Identities = 38/140 (27%), Positives = 71/140 (50%), Gaps = 17/140 (12%)

Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSN 283
           + +V +Y   GDL   L +     P    RF + ++   ++ +H+   V   HRD++P N
Sbjct: 76  LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYV---HRDIKPDN 132

Query: 284 ILRDDSGNLKVADFG----VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTK 334
           +L D +G++++ADFG    +++  TV+    +   D    Y++PE+ +  E     Y  +
Sbjct: 133 VLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPD----YISPEILQAMEDGMGKYGPE 188

Query: 335 VDVFSFALILQEMIEGCPPF 354
            D +S  + + EM+ G  PF
Sbjct: 189 CDWWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 53.2 bits (128), Expect = 1e-07
 Identities = 40/138 (28%), Positives = 72/138 (52%), Gaps = 17/138 (12%)

Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNIL 285
           +V +Y   GDL   L +     P    RF L ++   ++ +H+   +  +HRD++P N+L
Sbjct: 78  LVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVL 134

Query: 286 RDDSGNLKVADFGVS-KLL---TVKEDRPLTCQDTSCRYVAPEVFKNEE-----YDTKVD 336
            D +G++++ADFG   +LL   TV+ +  +   D    Y++PE+ +  E     Y  + D
Sbjct: 135 LDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPD----YISPEILQAMEDGKGRYGPECD 190

Query: 337 VFSFALILQEMIEGCPPF 354
            +S  + + EM+ G  PF
Sbjct: 191 WWSLGVCMYEMLYGETPF 208

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 52.2 bits (125), Expect = 1e-07
 Identities = 66/267 (24%), Positives = 116/267 (43%), Gaps = 35/267 (13%)

Query: 165 KGTFILAFWRGIQVAVKKLGE----EVI------SDDDRVRAFRDELALLQKIRHPNVVQ 214
           +GTF   F +GI+  V   GE    EV+      S  +   +F +  +++ ++ H ++V 
Sbjct: 5   QGTFTKIF-KGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVL 63

Query: 215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST-AVRFALDIARGMNYLHENKPVP 273
             G        ++V EY+  G L  +LK+   L   +  +  A  +A  +++L +     
Sbjct: 64  NYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG--- 120

Query: 274 IIHRDLEPSNIL-----RDDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
           + H ++   N+L        +GN   +K++D G+S  +TV     L        +V PE 
Sbjct: 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS--ITVLPKEILL---ERIPWVPPEC 175

Query: 326 FKN-EEYDTKVDVFSFALILQEMIEGCP-PFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
            +N +      D +SF   L E+  G   P +     +  + Y  R     + PA  +  
Sbjct: 176 IENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYEDRH----QLPAPKWTE 231

Query: 384 GLKELIEECWNEKPAKRPTFRQIITRL 410
            L  LI +C + +P  RP+FR II  L
Sbjct: 232 -LANLINQCMDYEPDFRPSFRAIIRDL 257

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 52.7 bits (126), Expect = 2e-07
 Identities = 49/192 (25%), Positives = 90/192 (46%), Gaps = 18/192 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  V V+    E  +++  ++A ++E+ L    RHPN++      T  S + +++ ++  
Sbjct: 25  GTLVTVRITDLENCTEE-HLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83

Query: 235 GDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           G   + LK       S A+         RG+NYLH+N     IHR+++ S+IL    G +
Sbjct: 84  GSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLV 140

Query: 293 KVADFGVSKL--LTVKEDRPLTCQD-----TSCR-YVAPEVFKNE--EYDTKVDVFSFAL 342
            ++  G+S L  L     +     D     TS   +++PE+ + +   Y+ K D++S  +
Sbjct: 141 SLS--GLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGI 198

Query: 343 ILQEMIEGCPPF 354
              E+  G  PF
Sbjct: 199 TACELATGRVPF 210

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies)

 Score = 47.2 bits (113), Expect = 2e-07
 Identities = 26/53 (49%), Positives = 32/53 (60%)

Query: 73  NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
            RTALH AA  G  E+V  LLE+G D++  D  G+T L  A    N EV+KLL
Sbjct: 1   GRTALHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLL 53

Length = 54

>gnl|CDD|222277 pfam13637, Ank_4, Ankyrin repeats (many copies)

 Score = 46.8 bits (112), Expect = 2e-07
 Identities = 23/50 (46%), Positives = 30/50 (60%)

Query: 44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL 93
          L   A    +E +K LL+ G+D+N  D D  TALH+AA  G  EV+ LLL
Sbjct: 5  LHKAAISGRLELVKYLLEKGVDINRTDEDGNTALHIAAENGNLEVLKLLL 54

Length = 54

>gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 51.5 bits (123), Expect = 3e-07
 Identities = 61/245 (24%), Positives = 112/245 (45%), Gaps = 32/245 (13%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I+V +K L     S  D   AF +  ++++++ H ++V   G   +    ++V E++  G
Sbjct: 33  IKVILKVLDP---SHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFG 89

Query: 236 DLRAFLKRKGALKPSTAVRF--ALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGN 291
            L  F+ RK  +  +T  +F  A  +A  ++YL +     ++H ++   NIL  R+    
Sbjct: 90  PLDLFMHRKSDVL-TTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDG 145

Query: 292 -----LKVADFGVSKLLTVKEDRPLTCQDTSCR--YVAPEVFKNEE-YDTKVDVFSFALI 343
                +K++D G+   +TV     L+ Q+   R  ++APE  ++ +      D +SF   
Sbjct: 146 ECGPFIKLSDPGIP--ITV-----LSRQECVERIPWIAPECVEDSKNLSIAADKWSFGTT 198

Query: 344 LQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402
           L E+   G  P   K   E  + Y  +       P+    + L +L+  C N  P +RP 
Sbjct: 199 LWEICYNGEIPLKDKTLAEKERFYEGQCML--VTPS---CKELADLMTHCMNYDPNQRPF 253

Query: 403 FRQII 407
           FR I+
Sbjct: 254 FRAIM 258

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262

>gnl|CDD|206028 pfam13857, Ank_5, Ankyrin repeats (many copies)

 Score = 46.6 bits (111), Expect = 3e-07
 Identities = 20/47 (42%), Positives = 28/47 (59%)

Query: 64  IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
           ID+N  D +  T LH+AA  G  E+V  LL+ G D++ +D  G T L
Sbjct: 7   IDLNATDGNGNTPLHLAAKYGALELVQWLLKPGVDLNLRDSDGLTAL 53

Length = 56

>gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional

 Score = 52.4 bits (125), Expect = 4e-07
 Identities = 44/128 (34%), Positives = 61/128 (47%), Gaps = 4/128 (3%)

Query: 8   RTTLLKQSSLAPDRERKEAEL--NGLDDDGEEIKPEFRLMFLA-NERDVEGIKELLDSGI 64
           + T L  +S AP   R   +L   G D + + IK E  L  +A N  D E I+ L+  G 
Sbjct: 273 KNTPLHHASQAPSLSRLVPKLLERGADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGA 332

Query: 65  DVNFRDIDNRTALHVAAC-QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
           DVN  D    T LH A+      ++V  LLE GA+V+ +D    TP+  A    N  +I 
Sbjct: 333 DVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIIN 392

Query: 124 LLEKHGAK 131
            L  +GA 
Sbjct: 393 TLLDYGAD 400

Length = 682

>gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only]

 Score = 50.2 bits (119), Expect = 5e-07
 Identities = 39/97 (40%), Positives = 55/97 (56%), Gaps = 8/97 (8%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA-----CQGFTEVVSLLLERGAD 98
           L   A++ D + +K LL SG DVN +D D  T LH+AA      +G  EV  LLLE GAD
Sbjct: 77  LHSAASKGDDKIVKLLLASGADVNAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGAD 136

Query: 99  VDPKDRW---GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           +D  +     G+TPL  A    + ++++LL + GA P
Sbjct: 137 LDVNNLRDEDGNTPLHWAALNGDADIVELLLEAGADP 173

Length = 235

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 50.2 bits (120), Expect = 6e-07
 Identities = 35/142 (24%), Positives = 60/142 (42%), Gaps = 9/142 (6%)

Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
           PN+V     +     + +V ++   G L + + +   +      R+A ++   ++ LH  
Sbjct: 45  PNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHRE 104

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVFKN 328
               I+ RDL P+NIL DD G++++  F         E       +     Y APEV   
Sbjct: 105 G---IVCRDLNPNNILLDDRGHIQLTYFS-----RWSEVEDSCDGEAVENMYCAPEVGGI 156

Query: 329 EEYDTKVDVFSFALILQEMIEG 350
            E     D +S   IL E++ G
Sbjct: 157 SEETEACDWWSLGAILFELLTG 178

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional

 Score = 51.4 bits (123), Expect = 7e-07
 Identities = 50/185 (27%), Positives = 88/185 (47%), Gaps = 28/185 (15%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G+Q  VK+     I+D + + +   E+A + K++HPN+V+ +G         ++ EY+  
Sbjct: 715 GMQFVVKE-----INDVNSIPS--SEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEG 767

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNL 292
            +L   L+    L      + A+ IA+ + +LH      ++  +L P  I+ D  D  +L
Sbjct: 768 KNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHL 824

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCR----YVAPEVFKNEEYDTKVDVFSFALILQEMI 348
           +++  G            L C DT C     YVAPE  + ++   K D++ F LIL E++
Sbjct: 825 RLSLPG------------LLCTDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELL 872

Query: 349 EGCPP 353
            G  P
Sbjct: 873 TGKSP 877

Length = 968

>gnl|CDD|215625 PLN03192, PLN03192, Voltage-dependent potassium channel; Provisional

 Score = 50.6 bits (121), Expect = 1e-06
 Identities = 23/57 (40%), Positives = 32/57 (56%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
           L   A   D+  +KELL  G++V+  D    TAL VA  +   ++V LL+  GADVD
Sbjct: 626 LCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVD 682

Length = 823

>gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 23/82 (28%), Positives = 42/82 (51%)

Query: 51  RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
           + ++ +K L+  G D +  + D  + LH+A   G  + + LL++  A +D +D  G TPL
Sbjct: 113 KKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPL 172

Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
             A+   +  + K+L   GA  
Sbjct: 173 IIAMAKGDIAICKMLLDSGANI 194

Length = 413

>gnl|CDD|223738 COG0666, Arp, FOG: Ankyrin repeat [General function prediction only]

 Score = 48.3 bits (114), Expect = 3e-06
 Identities = 34/98 (34%), Positives = 45/98 (45%), Gaps = 5/98 (5%)

Query: 40  PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99
             +  + L     +  +   L     +  RD+D R  LH AA +G  ++V LLL  GADV
Sbjct: 40  NLYLELALLPAASLSELLLKLIVDRHLAARDLDGRLPLHSAASKGDDKIVKLLLASGADV 99

Query: 100 DPKDRWGSTPLGDAIYYKN-----HEVIKLLEKHGAKP 132
           + KD  G TPL  A    N      EV KLL + GA  
Sbjct: 100 NAKDADGDTPLHLAALNGNPPEGNIEVAKLLLEAGADL 137

Length = 235

>gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional

 Score = 48.3 bits (115), Expect = 5e-06
 Identities = 27/80 (33%), Positives = 43/80 (53%), Gaps = 1/80 (1%)

Query: 52  DVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
           + E  K LL  G D+N +D     TALH A       +  LLL  GA+V+  D+  ++PL
Sbjct: 146 EAEITKLLLSYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPL 205

Query: 111 GDAIYYKNHEVIKLLEKHGA 130
             A+ + N  ++ +L ++GA
Sbjct: 206 HHAVKHYNKPIVHILLENGA 225

Length = 477

>gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 40/104 (38%), Positives = 55/104 (52%), Gaps = 5/104 (4%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANER---DVEGIKE-LLDSGIDVNFRDIDNRTALHV 79
           KEA ++G D   ++I      M L  ER   D   I E LL+ G DVN +DI   T +H 
Sbjct: 126 KEA-ISGNDIHYDKINESIEYMKLIKERIQQDELLIAEMLLEGGADVNAKDIYCITPIHY 184

Query: 80  AACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
           AA +G  ++V+LLL  GADV+       + L  A+  KN + IK
Sbjct: 185 AAERGNAKMVNLLLSYGADVNIIALDDLSVLECAVDSKNIDTIK 228

Length = 682

>gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional

 Score = 46.2 bits (110), Expect = 2e-05
 Identities = 23/79 (29%), Positives = 37/79 (46%), Gaps = 2/79 (2%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTE--VVSLLLERGADVDPKDRWGSTPLGDA 113
           ++EL+ +G D    D+   T LH  A     +  +V  LL  G  ++ ++R+G TPL  A
Sbjct: 205 VRELIRAGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYA 264

Query: 114 IYYKNHEVIKLLEKHGAKP 132
             + N    + L   GA  
Sbjct: 265 AVFNNPRACRRLIALGADI 283

Length = 471

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 45.8 bits (108), Expect = 3e-05
 Identities = 44/163 (26%), Positives = 68/163 (41%), Gaps = 28/163 (17%)

Query: 150 IDPHELDFTNSVEITKGTFIL-------AFWR--------------GIQVAVKKLGEEVI 188
           +DP +L + ++ E+ +   +L       AF R               ++VAVK L     
Sbjct: 21  VDPMQLPYDSAWEMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTAR 80

Query: 189 SDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
           S + +  A   EL ++  +  H N+V  LGA T+  P+ I+TEY   GDL  +L R    
Sbjct: 81  SSEKQ--ALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHR---- 134

Query: 248 KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
              T +++ LD  R    L      P+  R    S     D G
Sbjct: 135 NKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGG 177

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|205784 pfam13606, Ank_3, Ankyrin repeat

 Score = 40.3 bits (95), Expect = 3e-05
 Identities = 16/29 (55%), Positives = 20/29 (68%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVD 100
           D  T LH+AA  G  E+V LLLE GAD++
Sbjct: 1   DGNTPLHLAARNGNLELVKLLLEHGADIN 29

Ankyrins are multifunctional adaptors that link specific proteins to the membrane-associated, spectrin- actin cytoskeleton. This repeat-domain is a 'membrane-binding' domain of up to 24 repeated units, and it mediates most of the protein's binding activities. Length = 30

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 45.5 bits (108), Expect = 5e-05
 Identities = 58/262 (22%), Positives = 103/262 (39%), Gaps = 51/262 (19%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VA+KK+ E++  +    + F  E  +   + HP +V      +   P+     Y+    
Sbjct: 29  RVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYT 88

Query: 237 LRAFLKR-------KGALKPSTAVRFALDI----ARGMNYLHENKPVPIIHRDLEPSNIL 285
           L++ LK           L   T+V   L I       + Y+H      ++HRDL+P NIL
Sbjct: 89  LKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNIL 145

Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTC---QDTSC--------------RYVAPEVFKN 328
               G + + D+G +    ++E+  L     +   C               Y+APE    
Sbjct: 146 LGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLG 205

Query: 329 EEYDTKVDVFSFALILQEMIEGCPPF--------TMKHDNEVPKAYAA-RQRPPF----- 374
                  D+++  +IL +M+    P+        + +     P   A  R+ PPF     
Sbjct: 206 VPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIA 265

Query: 375 -KA----PAKLYARGLKELIEE 391
            KA    PA+ Y   ++EL ++
Sbjct: 266 MKALAVDPAERY-SSVQELKQD 286

Length = 932

>gnl|CDD|197603 smart00248, ANK, ankyrin repeats

 Score = 39.9 bits (94), Expect = 5e-05
 Identities = 17/29 (58%), Positives = 22/29 (75%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVD 100
           D RT LH+AA  G  EVV LLL++GAD++
Sbjct: 1   DGRTPLHLAAENGNLEVVKLLLDKGADIN 29

Ankyrin repeats are about 33 amino acids long and occur in at least four consecutive copies. They are involved in protein-protein interactions. The core of the repeat seems to be an helix-loop-helix structure. Length = 30

>gnl|CDD|222980 PHA03095, PHA03095, ankyrin-like protein; Provisional

 Score = 44.6 bits (106), Expect = 7e-05
 Identities = 20/61 (32%), Positives = 29/61 (47%)

Query: 59  LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
           LL +GI +N R+   +T LH AA          L+  GAD++     G+TPL   +   N
Sbjct: 243 LLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSDGNTPLSLMVRNNN 302

Query: 119 H 119
            
Sbjct: 303 G 303

Length = 471

>gnl|CDD|222984 PHA03100, PHA03100, ankyrin repeat protein; Provisional

 Score = 44.7 bits (106), Expect = 7e-05
 Identities = 27/97 (27%), Positives = 43/97 (44%), Gaps = 9/97 (9%)

Query: 44  LMFLANE-----RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ--GFTEVVSLLLERG 96
           L +L+N         E +K LL+ G +VN  D +  T L  A  +      +V  LL+ G
Sbjct: 72  LHYLSNIKYNLTDVKEIVKLLLEYGANVNAPDNNGITPLLYAISKKSNSYSIVEYLLDNG 131

Query: 97  ADVDPKDRWGSTPLGDAIYYKNH--EVIKLLEKHGAK 131
           A+V+ K+  G   L   +       +++KLL   G  
Sbjct: 132 ANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVD 168

Length = 422

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 43.7 bits (103), Expect = 1e-04
 Identities = 27/68 (39%), Positives = 35/68 (51%), Gaps = 3/68 (4%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           VAVK L       +    A   EL +L  +  H N+V  LGA T   P +++TEY   GD
Sbjct: 68  VAVKMLKPSAHLTERE--ALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGD 125

Query: 237 LRAFLKRK 244
           L  FL+RK
Sbjct: 126 LLNFLRRK 133

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional

 Score = 44.2 bits (104), Expect = 1e-04
 Identities = 32/85 (37%), Positives = 42/85 (49%), Gaps = 5/85 (5%)

Query: 51  RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA---DVDPKDRWGS 107
           RD E IK L+  G   + +  D  + LH A  +G  + V  LL+ G    DV  KD  G 
Sbjct: 46  RDSEAIKLLMKHGAIPDVKYPDIESELHDAVEEGDVKAVEELLDLGKFADDVFYKD--GM 103

Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132
           TPL  A   K  +++KLL   GA P
Sbjct: 104 TPLHLATILKKLDIMKLLIARGADP 128

Length = 413

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 27/69 (39%), Positives = 39/69 (56%), Gaps = 4/69 (5%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E   + + +  A   EL +L  I  H NVV  LGA T+ + P+M++ E+   G
Sbjct: 40  VAVKMLKEGATASEHK--ALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYG 97

Query: 236 DLRAFLKRK 244
           +L  FL+ K
Sbjct: 98  NLSNFLRAK 106

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional

 Score = 42.9 bits (101), Expect = 2e-04
 Identities = 33/106 (31%), Positives = 50/106 (47%), Gaps = 11/106 (10%)

Query: 49  NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-TEVVSLLLERGADVDPKDR-WG 106
           N R+VE  K +L +    N + ID       +       E+  LLL  GAD++ KDR  G
Sbjct: 110 NNRNVEIFKIILTNRYK-NIQTIDLVYIDKKSKDDIIEAEITKLLLSYGADINMKDRHKG 168

Query: 107 STPLGDAIYYKNHEVIKLLEKHGAKPLM------APMH--VKHARE 144
           +T L  A   K+  + +LL  +GA   +      +P+H  VKH  +
Sbjct: 169 NTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNK 214

Length = 477

>gnl|CDD|165206 PHA02875, PHA02875, ankyrin repeat protein; Provisional

 Score = 43.4 bits (102), Expect = 2e-04
 Identities = 30/84 (35%), Positives = 46/84 (54%), Gaps = 5/84 (5%)

Query: 50  ERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
           E DV+ ++ELLD G    DV ++D    T LH+A      +++ LL+ RGAD D  +   
Sbjct: 78  EGDVKAVEELLDLGKFADDVFYKD--GMTPLHLATILKKLDIMKLLIARGADPDIPNTDK 135

Query: 107 STPLGDAIYYKNHEVIKLLEKHGA 130
            +PL  A+   + + I+LL  H A
Sbjct: 136 FSPLHLAVMMGDIKGIELLIDHKA 159

Length = 413

>gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional

 Score = 43.1 bits (101), Expect = 3e-04
 Identities = 28/73 (38%), Positives = 37/73 (50%), Gaps = 1/73 (1%)

Query: 39  KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA-CQGFTEVVSLLLERGA 97
           K +  L+      D+E    L D+G  VN  D    T LH A+     + +V  LLERGA
Sbjct: 239 KNDLSLLKAIRNEDLETSLLLYDAGFSVNSIDDCKNTPLHHASQAPSLSRLVPKLLERGA 298

Query: 98  DVDPKDRWGSTPL 110
           DV+ K+  G TPL
Sbjct: 299 DVNAKNIKGETPL 311

Length = 682

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 43.0 bits (101), Expect = 3e-04
 Identities = 42/155 (27%), Positives = 67/155 (43%), Gaps = 18/155 (11%)

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK--GDLRAFL-KRKGALKPSTAVRFA 256
           E  LL+++ HP V+  L          +V   LPK   DL  +L  R   L  +     A
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLV---LPKYRSDLYTYLGARLRPLGLAQVTAVA 266

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT---- 312
             +   ++Y+H      IIHRD++  N+L +   ++ + DFG +         P      
Sbjct: 267 RQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA 323

Query: 313 -CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
              DT+    APEV   + Y   VD++S  L++ E
Sbjct: 324 GTVDTN----APEVLAGDPYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 26/69 (37%), Positives = 39/69 (56%), Gaps = 3/69 (4%)

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L     S + +  A   EL ++  +  H N+V  LGA T+S P+ I+TEY   
Sbjct: 68  MKVAVKMLKPTARSSEKQ--ALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFY 125

Query: 235 GDLRAFLKR 243
           GDL  +L +
Sbjct: 126 GDLVNYLHK 134

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional

 Score = 41.6 bits (97), Expect = 8e-04
 Identities = 27/79 (34%), Positives = 45/79 (56%), Gaps = 7/79 (8%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAA---CQGFTEVVSLLLERGADVDPKDRWGSTPLGD 112
           +K L+D G +VN ++ D  T LH A    C+   +V+ +LL+ GADV+  +     PL  
Sbjct: 425 VKTLIDRGANVNSKNKDLSTPLHYACKKNCK--LDVIEMLLDNGADVNAINIQNQYPLLI 482

Query: 113 AIYYKNHEVIKLLEKHGAK 131
           A+ Y  H ++ +L  +GA+
Sbjct: 483 ALEY--HGIVNILLHYGAE 499

Length = 682

>gnl|CDD|222939 PHA02878, PHA02878, ankyrin repeat protein; Provisional

 Score = 39.9 bits (93), Expect = 0.002
 Identities = 26/79 (32%), Positives = 42/79 (53%), Gaps = 4/79 (5%)

Query: 52  DVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
           D + +K LL+ G+DVN +  I   TALH +        + LLLE GAD++  + +  TPL
Sbjct: 247 DYDILKLLLEHGVDVNAKSYILGLTALHSSIKS--ERKLKLLLEYGADINSLNSYKLTPL 304

Query: 111 GDAIY-YKNHEVIKLLEKH 128
             A+  Y    + ++L  +
Sbjct: 305 SSAVKQYLCINIGRILISN 323

Length = 477

>gnl|CDD|165207 PHA02876, PHA02876, ankyrin repeat protein; Provisional

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 29/96 (30%), Positives = 50/96 (52%), Gaps = 7/96 (7%)

Query: 50  ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
           +R+ + +  LL+ G +VN RD  ++T +H AA +    +++ LL+ GAD++   +   T 
Sbjct: 352 DRNKDIVITLLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTA 411

Query: 110 LGDAIYYKN-HEVIKLLEKHGA------KPLMAPMH 138
           L  A+   N +  +K L   GA      K L  P+H
Sbjct: 412 LHFALCGTNPYMSVKTLIDRGANVNSKNKDLSTPLH 447

Length = 682

>gnl|CDD|165256 PHA02946, PHA02946, ankyin-like protein; Provisional

 Score = 40.4 bits (94), Expect = 0.002
 Identities = 34/89 (38%), Positives = 46/89 (51%), Gaps = 13/89 (14%)

Query: 49  NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108
           +ER VE   ELL  G   N  D D    LH+A+      +V++LL  GAD +  D+   T
Sbjct: 51  DERFVE---ELLHRGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKT 107

Query: 109 PLGDAIYY---KNHEVIK---LLEKHGAK 131
           PL    YY    + EVI+   LL ++GAK
Sbjct: 108 PL----YYLSGTDDEVIERINLLVQYGAK 132

Length = 446

>gnl|CDD|233161 TIGR00870, trp, transient-receptor-potential calcium channel protein

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 26/83 (31%), Positives = 38/83 (45%), Gaps = 19/83 (22%)

Query: 68  FRDIDNRTALHVAA-CQGFTEVVSLLLERGADVDPK---DRWGSTPLGDAIYY------- 116
              I   TALH+AA  Q + E+V LLLERGA V  +   D +  +   D+ Y+       
Sbjct: 126 TPGI---TALHLAAHRQNY-EIVKLLLERGASVPARACGDFFVKSQGVDSFYHGESPLNA 181

Query: 117 ----KNHEVIKLLEKHGAKPLMA 135
                +  ++ LL +  A  L A
Sbjct: 182 AACLGSPSIVALLSEDPADILTA 204

The Transient Receptor Potential Ca2+ Channel (TRP-CC) Family (TC. 1.A.4)The TRP-CC family has also been called the store-operated calcium channel (SOC) family. The prototypical members include the Drosophila retinal proteinsTRP and TRPL (Montell and Rubin, 1989; Hardie and Minke, 1993). SOC members of the family mediate the entry of extracellular Ca2+ into cells in responseto depletion of intracellular Ca2+ stores (Clapham, 1996) and agonist stimulated production of inositol-1,4,5 trisphosphate (IP3). One member of the TRP-CCfamily, mammalian Htrp3, has been shown to form a tight complex with the IP3 receptor (TC #1.A.3.2.1). This interaction is apparently required for IP3 tostimulate Ca2+ release via Htrp3. The vanilloid receptor subtype 1 (VR1), which is the receptor for capsaicin (the ?hot? ingredient in chili peppers) and servesas a heat-activated ion channel in the pain pathway (Caterina et al., 1997), is also a member of this family. The stretch-inhibitable non-selective cation channel(SIC) is identical to the vanilloid receptor throughout all of its first 700 residues, but it exhibits a different sequence in its last 100 residues. VR1 and SICtransport monovalent cations as well as Ca2+. VR1 is about 10x more permeable to Ca2+ than to monovalent ions. Ca2+ overload probably causes cell deathafter chronic exposure to capsaicin. (McCleskey and Gold, 1999) [Transport and binding proteins, Cations and iron carrying compounds]. Length = 743

>gnl|CDD|165089 PHA02716, PHA02716, CPXV016; CPX019; EVM010; Provisional

 Score = 39.9 bits (93), Expect = 0.003
 Identities = 24/95 (25%), Positives = 43/95 (45%), Gaps = 4/95 (4%)

Query: 20  DRERKEAELNGLDDDGEEIKPEFRLMF--LANERDVEGIKELLDSGIDVNFRDIDNRTAL 77
           + E     +  LD +  +  P     +  LA   D+  +   L  G+ ++++D   RT L
Sbjct: 262 NPEITNIYIESLDGNKVKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCL 321

Query: 78  HVAACQGF--TEVVSLLLERGADVDPKDRWGSTPL 110
           H    +    T+++ LL E G D++  D  G+T L
Sbjct: 322 HQYILRHNISTDIIKLLHEYGNDLNEPDNIGNTVL 356

Length = 764

>gnl|CDD|165103 PHA02736, PHA02736, Viral ankyrin protein; Provisional

 Score = 37.9 bits (88), Expect = 0.003
 Identities = 19/58 (32%), Positives = 34/58 (58%), Gaps = 4/58 (6%)

Query: 72  DNRTALHVAACQGFT---EVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLL 125
             +  +H+ +        E + LL+E GAD++ K+R +G+TPL  A+Y +N+E+   L
Sbjct: 54  HGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWL 111

Length = 154

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 38.2 bits (89), Expect = 0.003
 Identities = 29/155 (18%), Positives = 53/155 (34%), Gaps = 27/155 (17%)

Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
            L     +  LH            +  NIL   + +  +   G     T ++ RP    D
Sbjct: 23  CLQCLGALRELHRQA---------KSGNIL--LTWDGLLKLDGSVAFKTPEQSRP----D 67

Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY-------AA 368
               ++APEV + + Y  K D++S  + L E ++   P+    + E+            A
Sbjct: 68  PY--FMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYN--EERELSAILEILLNGMPA 123

Query: 369 RQRPPFKAPAK-LYARGLKELIEECWNEKPAKRPT 402
                         AR  ++ +  C +  P +R  
Sbjct: 124 DDPRDRSNLEGVSAARSFEDFMRLCASRLPQRREA 158

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|222931 PHA02798, PHA02798, ankyrin-like protein; Provisional

 Score = 39.4 bits (92), Expect = 0.003
 Identities = 23/84 (27%), Positives = 44/84 (52%), Gaps = 8/84 (9%)

Query: 56  IKELLDSGIDVNFRDIDNRTAL-----HVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
           +K  ++ G +VN  D +  T L     ++   +   ++V +L+E GAD++ K+  G TPL
Sbjct: 54  VKLFINLGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPL 113

Query: 111 GDAI---YYKNHEVIKLLEKHGAK 131
              +   Y  N E++  + ++GA 
Sbjct: 114 YCLLSNGYINNLEILLFMIENGAD 137

Length = 489

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	458
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	99.98
KOG3653	534	consensus Transforming growth factor beta/activin	99.98
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	99.97
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.97
KOG1027	903	consensus Serine/threonine protein kinase and endo	99.97
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.97
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.97
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	99.97
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	99.97
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	99.97
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	99.96
KOG0576	829	consensus Mitogen-activated protein kinase kinase	99.96
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.96
KOG1152	772	consensus Signal transduction serine/threonine kin	99.96
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.96
KOG1290	590	consensus Serine/threonine protein kinase [Signal	99.96
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.95
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.95
KOG1167	418	consensus Serine/threonine protein kinase of the C	99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
PLN00181	793	protein SPA1-RELATED; Provisional	99.94
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.94
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.9
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.9
PRK09188	365	serine/threonine protein kinase; Provisional	99.89
KOG4412	226	consensus 26S proteasome regulatory complex, subun	99.86
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.85
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.85
KOG4412	226	consensus 26S proteasome regulatory complex, subun	99.85
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.84
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.83
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.83
PRK12274	218	serine/threonine protein kinase; Provisional	99.82
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.81
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.81
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.81
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.8
PRK10345	210	hypothetical protein; Provisional	99.79
KOG0509	600	consensus Ankyrin repeat and DHHC-type Zn-finger d	99.79
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.78
PHA02743	166	Viral ankyrin protein; Provisional	99.77
PF12796	89	Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02	99.74
PHA02859	209	ankyrin repeat protein; Provisional	99.73
PHA02791	284	ankyrin-like protein; Provisional	99.73
PHA02791	284	ankyrin-like protein; Provisional	99.73
PHA02741	169	hypothetical protein; Provisional	99.72
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.72
PHA02741	169	hypothetical protein; Provisional	99.72
PHA02736	154	Viral ankyrin protein; Provisional	99.72
KOG0509	600	consensus Ankyrin repeat and DHHC-type Zn-finger d	99.71
PHA02878	477	ankyrin repeat protein; Provisional	99.71
PRK14879	211	serine/threonine protein kinase; Provisional	99.7
PHA02874	434	ankyrin repeat protein; Provisional	99.7
KOG0502	296	consensus Integral membrane ankyrin-repeat protein	99.7
PHA02875	413	ankyrin repeat protein; Provisional	99.7
KOG0512	228	consensus Fetal globin-inducing factor (contains a	99.7
PLN03192	823	Voltage-dependent potassium channel; Provisional	99.69
PHA02859	209	ankyrin repeat protein; Provisional	99.69
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.69
PHA02875	413	ankyrin repeat protein; Provisional	99.69
PHA02743	166	Viral ankyrin protein; Provisional	99.69
smart00090	237	RIO RIO-like kinase.	99.68
PHA02946	446	ankyin-like protein; Provisional	99.68
KOG0512	228	consensus Fetal globin-inducing factor (contains a	99.68
PHA02716	764	CPXV016; CPX019; EVM010; Provisional	99.67
PHA03095	471	ankyrin-like protein; Provisional	99.67
PHA02884	300	ankyrin repeat protein; Provisional	99.67
PHA02798	489	ankyrin-like protein; Provisional	99.67
PHA02884	300	ankyrin repeat protein; Provisional	99.67
PHA02795	437	ankyrin-like protein; Provisional	99.67
PHA02878	477	ankyrin repeat protein; Provisional	99.67
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.67
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.66
PHA03095	471	ankyrin-like protein; Provisional	99.66
KOG0508	615	consensus Ankyrin repeat protein [General function	99.66
PHA03100	480	ankyrin repeat protein; Provisional	99.66
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.65
PHA03100	480	ankyrin repeat protein; Provisional	99.64
PHA02798	489	ankyrin-like protein; Provisional	99.64
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.64
PHA02716	764	CPXV016; CPX019; EVM010; Provisional	99.63
KOG4177	1143	consensus Ankyrin [Cell wall/membrane/envelope bio	99.62
PHA02874	434	ankyrin repeat protein; Provisional	99.62
KOG0514	452	consensus Ankyrin repeat protein [General function	99.62
PHA02876	682	ankyrin repeat protein; Provisional	99.62
KOG4214	117	consensus Myotrophin and similar proteins [Transcr	99.61
KOG0510	929	consensus Ankyrin repeat protein [General function	99.6
KOG0510	929	consensus Ankyrin repeat protein [General function	99.6
KOG0505	527	consensus Myosin phosphatase, regulatory subunit [	99.59
PHA02730	672	ankyrin-like protein; Provisional	99.59
PHA02795	437	ankyrin-like protein; Provisional	99.59
PHA02989	494	ankyrin repeat protein; Provisional	99.58
PHA02989	494	ankyrin repeat protein; Provisional	99.57
PHA02736	154	Viral ankyrin protein; Provisional	99.57
KOG4214	117	consensus Myotrophin and similar proteins [Transcr	99.57
PHA02917	661	ankyrin-like protein; Provisional	99.56
PHA02917	661	ankyrin-like protein; Provisional	99.56
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.56
PHA02946	446	ankyin-like protein; Provisional	99.55
PHA02876	682	ankyrin repeat protein; Provisional	99.55
KOG0508	615	consensus Ankyrin repeat protein [General function	99.54
PHA02730	672	ankyrin-like protein; Provisional	99.53
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.52
cd00204	126	ANK ankyrin repeats; ankyrin repeats mediate prote	99.51
PF12796	89	Ank_2: Ankyrin repeats (3 copies); InterPro: IPR02	99.5
PF13857	56	Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A	99.5
KOG4177	1143	consensus Ankyrin [Cell wall/membrane/envelope bio	99.49
KOG0515	752	consensus p53-interacting protein 53BP/ASPP, conta	99.49
KOG0514	452	consensus Ankyrin repeat protein [General function	99.49
PLN03192	823	Voltage-dependent potassium channel; Provisional	99.49
PF13637	54	Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A	99.48
PTZ00322	664	6-phosphofructo-2-kinase/fructose-2,6-biphosphatas	99.48
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.47

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9e-50  Score=388.30  Aligned_cols=258  Identities=27%  Similarity=0.468  Sum_probs=235.1

Q ss_pred             CCCCcccCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeE
Q 012684          144 EVPEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA  218 (458)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~  218 (458)
                      +++..-.++...+|...+.||+|+|..+|.     +|+.||+|++.+.........+.+.+|+++.+.++|||||+++++
T Consensus         7 ~ip~~i~D~~~~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~   86 (592)
T KOG0575|consen    7 EIPEVIEDPRSKRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHF   86 (592)
T ss_pred             CCCCeeecCCcceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeE
Confidence            556666677778899999999999998873     799999999998888888888999999999999999999999999


Q ss_pred             EEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecC
Q 012684          219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (458)
Q Consensus       219 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg  298 (458)
                      |++.+.+|||.|+|..++|..++++++++++.++..+++||+.||.|||+++   |+|||||..|+|++++.+|||+|||
T Consensus        87 FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFG  163 (592)
T KOG0575|consen   87 FEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFG  163 (592)
T ss_pred             eecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccc
Confidence            9999999999999999999999999999999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCCh
Q 012684          299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA  378 (458)
Q Consensus       299 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  378 (458)
                      +|..+..... .....+|||.|.|||++....++..+||||+||++|.|+.|++||...+..++...++.....-    |
T Consensus       164 LAt~le~~~E-rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~----P  238 (592)
T KOG0575|consen  164 LATQLEYDGE-RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM----P  238 (592)
T ss_pred             eeeeecCccc-ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc----c
Confidence            9998865433 3345789999999999999999999999999999999999999999998888888885554332    3


Q ss_pred             hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          379 KLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       379 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ..++.+.++||.++|+.||.+|||+.+++.+
T Consensus       239 ~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h  269 (592)
T KOG0575|consen  239 SHLSAEAKDLIRKLLRPNPSERPSLDEVLDH  269 (592)
T ss_pred             cccCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            4788999999999999999999999999987

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.6e-50  Score=375.52  Aligned_cols=251  Identities=25%  Similarity=0.363  Sum_probs=221.4

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHH----HHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDD----RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~----~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      .|.+.+.||.|+||.|.     .+|+.||||++++.......    .....++|+++|++++|||||+++++|......|
T Consensus       173 ~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~Y  252 (475)
T KOG0615|consen  173 YYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSY  252 (475)
T ss_pred             eeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceE
Confidence            47788999999999886     38999999999876554322    3344679999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC---CCEEEeecCCcccc
Q 012684          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLL  303 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~---~~vkl~Dfg~~~~~  303 (458)
                      |||||++||+|.+++-.++.+.+.....+++|++.|+.|||+.|   |+||||||+|||+..+   ..+||+|||+|+..
T Consensus       253 mVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDFGlAK~~  329 (475)
T KOG0615|consen  253 MVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDFGLAKVS  329 (475)
T ss_pred             EEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEecccchhhcc
Confidence            99999999999999999999999999999999999999999999   9999999999999976   67999999999987


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCC--C-CchhHHHHHHHHHHHHcCCCCCCCCCCCc-HHHHHHhcCCCCCCCChh
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEY--D-TKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPFKAPAK  379 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~-~~~DiwslG~~l~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~  379 (458)
                      .  ........+|||.|.|||++.+..+  . .+.||||+||+||-+++|.+||.+..... ..+++........+..+.
T Consensus       330 g--~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~  407 (475)
T KOG0615|consen  330 G--EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD  407 (475)
T ss_pred             c--cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh
Confidence            5  3455567889999999999977643  2 47899999999999999999999887776 777776666666667889


Q ss_pred             hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          380 LYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       380 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      .++.+..+||.+||..||++|||+.++|+|-+
T Consensus       408 ~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW  439 (475)
T KOG0615|consen  408 RISEEALDLINWMLVVDPENRPSADEALNHPW  439 (475)
T ss_pred             hhhHHHHHHHHHhhEeCcccCcCHHHHhcChh
Confidence            99999999999999999999999999999843

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-49  Score=367.08  Aligned_cols=247  Identities=28%  Similarity=0.445  Sum_probs=213.5

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc-eEEEE
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVT  229 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~-~~lv~  229 (458)
                      +++....||+|..|.|+     .+++.+|+|.+...  .++...+++.+|+++++.++|||||++|+.|..++. ++|+|
T Consensus        80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~m  157 (364)
T KOG0581|consen   80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICM  157 (364)
T ss_pred             HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeeh
Confidence            45566789999999887     47999999999543  456677889999999999999999999999999985 99999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |||+||+|.+++...+++++...-+++.++++||.|||. ++   |+||||||+|||++..|.|||||||.+..+.+.  
T Consensus       158 EYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~---IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS--  232 (364)
T KOG0581|consen  158 EYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERK---IIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS--  232 (364)
T ss_pred             hhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccC---eeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence            999999999999998999999999999999999999996 76   999999999999999999999999999876543  


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCC--CCCcHHHHHHhcCCCCCCCChhh-hHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK--HDNEVPKAYAARQRPPFKAPAKL-YARGL  385 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~--~~~~~~~~~~~~~~~~~~~~~~~-~~~~l  385 (458)
                       ....+.||..|||||.+.+..|+.++||||||++++|+++|+.||...  ........+......+.+..+.. +|+++
T Consensus       233 -~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~~fS~ef  311 (364)
T KOG0581|consen  233 -IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEGEFSPEF  311 (364)
T ss_pred             -hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcccCCHHH
Confidence             446678999999999999999999999999999999999999999874  22333333323233233334454 99999


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      +.|+..||++||.+|||+++++.|-
T Consensus       312 ~~FV~~CL~Kdp~~R~s~~qLl~Hp  336 (364)
T KOG0581|consen  312 RSFVSCCLRKDPSERPSAKQLLQHP  336 (364)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCH
Confidence            9999999999999999999999983

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-48  Score=372.02  Aligned_cols=273  Identities=42%  Similarity=0.730  Sum_probs=233.4

Q ss_pred             CCCCCcccCcCCccccCceeeccceEEEEE---EcCeE-EEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeE
Q 012684          143 REVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQ-VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA  218 (458)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~lg~G~~~~v~---~~g~~-vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~  218 (458)
                      ...+.+++++.++.+..  .||.|+||.||   |.|+. ||+|++......... .+.|.+|+.+|.+++|||||+++|+
T Consensus        31 ~~~~~~~i~~~~l~~~~--~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~  107 (362)
T KOG0192|consen   31 DELPEEEIDPDELPIEE--VLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGA  107 (362)
T ss_pred             ccccceecChHHhhhhh--hcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEE
Confidence            34567777777665443  49999999887   88998 999999876655544 7789999999999999999999999


Q ss_pred             EEeCC-ceEEEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC-CEEE
Q 012684          219 VTQSS-PMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKV  294 (458)
Q Consensus       219 ~~~~~-~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~-~vkl  294 (458)
                      +.+.. ..++||||+++|+|.+++..  ...++...++.++.||+.|+.|||+.+|  |+||||||+|||++.++ ++||
T Consensus       108 ~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI  185 (362)
T KOG0192|consen  108 CTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKI  185 (362)
T ss_pred             EcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEE
Confidence            99887 79999999999999999987  5779999999999999999999999986  99999999999999997 9999


Q ss_pred             eecCCccccccCCCCCcccCCCCCcccCCcccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-C
Q 012684          295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R  371 (458)
Q Consensus       295 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~  371 (458)
                      +|||+++...... ...+...||+.|||||++.  ...++.|+||||||+++|||+||+.||...........+.... +
T Consensus       186 ~DFGlsr~~~~~~-~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~R  264 (362)
T KOG0192|consen  186 ADFGLSREKVISK-TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLR  264 (362)
T ss_pred             CCCccceeecccc-ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCC
Confidence            9999998765432 3334467999999999999  5689999999999999999999999999998866666654444 5


Q ss_pred             CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccccc
Q 012684          372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWK  424 (458)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~~  424 (458)
                      +.++.   .+++.+..+|..||..||..||++.+++..|+.+.........+.
T Consensus       265 p~~p~---~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~~~~~~~~~~  314 (362)
T KOG0192|consen  265 PPIPK---ECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMSHISSAGPED  314 (362)
T ss_pred             CCCCc---cCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHHhhcccCccc
Confidence            55543   377899999999999999999999999999999987666544444

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-48  Score=344.30  Aligned_cols=369  Identities=29%  Similarity=0.436  Sum_probs=302.0

Q ss_pred             CCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 012684           30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP  109 (458)
Q Consensus        30 ~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp  109 (458)
                      +-|.|.-|..|+.||||||+.|+..+++.|+..|+.+|..|.-..||||+||..|+.++|+.|++..+|+|..|..|.||
T Consensus        24 ehdln~gddhgfsplhwaakegh~aivemll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgntp  103 (448)
T KOG0195|consen   24 EHDLNVGDDHGFSPLHWAAKEGHVAIVEMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTP  103 (448)
T ss_pred             ccccccccccCcchhhhhhhcccHHHHHHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCc
Confidence            44666677788999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hHHHhhcchHHHHHHHHHhCCCCCCCccccc-----------------------cCCCCCCc------------------
Q 012684          110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK-----------------------HAREVPEY------------------  148 (458)
Q Consensus       110 l~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~-----------------------~~~~~~~~------------------  148 (458)
                      |||||.+|...+++-|+..|+...+-.-.+.                       .+.++|.-                  
T Consensus       104 lhyacfwgydqiaedli~~ga~v~icnk~g~tpldkakp~l~~~l~e~aek~gq~~nripfkdt~wkgtktr~rdatlsr  183 (448)
T KOG0195|consen  104 LHYACFWGYDQIAEDLISCGAAVNICNKKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFKDTTWKGTKTRTRDATLSR  183 (448)
T ss_pred             hhhhhhhcHHHHHHHHHhccceeeecccCCCCchhhhchHHHHHHHHHHHHhCCCCCccccccccccccccccccccccc
Confidence            9999999999999999999997654333322                       22333211                  


Q ss_pred             --ccCcCCccccCceeec---cceEEEEEEcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          149 --EIDPHELDFTNSVEIT---KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       149 --~~~~~~~~~~~~~~lg---~G~~~~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                        .++..++++.  .+|.   +|..+.+.|.|.+++.|++..... ..+.-.+|..|...|+.+.||||+++++.|.+..
T Consensus       184 ~~gid~~~lnl~--tkl~e~hsgelwrgrwqgndivakil~vr~~-t~risrdfneefp~lrifshpnilpvlgacnspp  260 (448)
T KOG0195|consen  184 YTGIDVSSLNLI--TKLAESHSGELWRGRWQGNDIVAKILNVREV-TARISRDFNEEFPALRIFSHPNILPVLGACNSPP  260 (448)
T ss_pred             ccCcchhhhhhh--hhhccCCCcccccccccCcchhhhhhhhhhc-chhhcchhhhhCcceeeecCCchhhhhhhccCCC
Confidence              2222222221  1222   466677889999999999976543 3334467899999999999999999999999999


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeee-CCCCCCCEEecCCCCEEE--eecC
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIH-RDLEPSNILRDDSGNLKV--ADFG  298 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H-~Dikp~Nil~~~~~~vkl--~Dfg  298 (458)
                      .+.++.+|++.|+|+.++.+...  ++..++.+++.+++.|++|||+..|  ++- --+....+++|++.+.+|  +|--
T Consensus       261 nlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep--~ipr~~lns~hvmidedltarismad~k  338 (448)
T KOG0195|consen  261 NLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEP--MIPRFYLNSKHVMIDEDLTARISMADTK  338 (448)
T ss_pred             CceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcch--hhhhhhcccceEEecchhhhheecccce
Confidence            99999999999999999987654  6788999999999999999999885  444 468899999999876555  3443


Q ss_pred             CccccccCCCCCcccCCCCCcccCCcccCCCCCC---CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCC
Q 012684          299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD---TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPF  374 (458)
Q Consensus       299 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~  374 (458)
                      ++...        ....-.|.|++||.+...+.+   ..+|+|||+++++||.|+..||.+.++.+....+...+ ++.+
T Consensus       339 fsfqe--------~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglrv~i  410 (448)
T KOG0195|consen  339 FSFQE--------VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLRVHI  410 (448)
T ss_pred             eeeec--------cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhccccccC
Confidence            33321        112236789999999876544   47999999999999999999999999999988886666 4444


Q ss_pred             CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       375 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                         ++++++.+..++.-||+.||.+||.+..++-.|+++.
T Consensus       411 ---ppgis~hm~klm~icmnedpgkrpkfdmivpilekm~  447 (448)
T KOG0195|consen  411 ---PPGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI  447 (448)
T ss_pred             ---CCCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence               5678899999999999999999999999999888763

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-49  Score=352.73  Aligned_cols=252  Identities=27%  Similarity=0.480  Sum_probs=215.2

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeee-EEEeCCc-eEEE
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG-AVTQSSP-MMIV  228 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~-~~~~~~~-~~lv  228 (458)
                      .|++.++||.|+||.||     ++|..+|.|.+.-. ..+....+.+..|+.+|++++||||+++++ .|.+++. ++||
T Consensus        20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlniv   98 (375)
T KOG0591|consen   20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIV   98 (375)
T ss_pred             HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHH
Confidence            58899999999999887     58999999999844 346667778899999999999999999999 5655555 8999


Q ss_pred             EEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPV-PIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~-~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ||+|.+|+|.+.++.    +..+++..+|+++.|++.||..+|+..|+ .|+||||||.||+++.+|.|||+|||+++++
T Consensus        99 mE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l  178 (375)
T KOG0591|consen   99 MELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFL  178 (375)
T ss_pred             HHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHh
Confidence            999999999998864    45599999999999999999999994433 4899999999999999999999999999987


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      .... ......+|||.||+||.+.+.+|++++||||+||++|||+.-++||.+.+-.+....+.....++.  +...||.
T Consensus       179 ~s~~-tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~--p~~~YS~  255 (375)
T KOG0591|consen  179 SSKT-TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL--PDEHYST  255 (375)
T ss_pred             cchh-HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC--cHHHhhh
Confidence            6442 233567899999999999999999999999999999999999999999876666666654444433  2378999


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      .+..||..|+..||+.||+...++..+.
T Consensus       256 ~l~~li~~ci~vd~~~RP~t~~~v~di~  283 (375)
T KOG0591|consen  256 DLRELINMCIAVDPEQRPDTVPYVQDIQ  283 (375)
T ss_pred             HHHHHHHHHccCCcccCCCcchHHHHHH
Confidence            9999999999999999999655554443

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-47  Score=356.35  Aligned_cols=248  Identities=31%  Similarity=0.540  Sum_probs=217.9

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|...++||.|+|++||.     ++..||||.+.+... .....+.+..|+.+|+.++|||||++++++..++.+|+||
T Consensus        10 ~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM   88 (429)
T KOG0595|consen   10 GDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM   88 (429)
T ss_pred             ccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence            4677778899999999984     689999999987654 5566778899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC------CCEEEeecCCcccc
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS------GNLKVADFGVSKLL  303 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~------~~vkl~Dfg~~~~~  303 (458)
                      |||+||+|.+++++.+.+++.++..++.||+.||++||+++   |+||||||+|||++..      ..+||+|||+++.+
T Consensus        89 EyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L  165 (429)
T KOG0595|consen   89 EYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFL  165 (429)
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchhhhC
Confidence            99999999999999999999999999999999999999999   9999999999999975      46999999999987


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      ..  .......+|+|-|||||++..++|+.|+|+||+|+++|++++|+.||...+..+....+ +.+....+..+...+.
T Consensus       166 ~~--~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~-~k~~~~~~~~~~~~s~  242 (429)
T KOG0595|consen  166 QP--GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYI-KKGNEIVPVLPAELSN  242 (429)
T ss_pred             Cc--hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHH-hccccccCchhhhccC
Confidence            63  33445678999999999999999999999999999999999999999999999888866 3443334444566677


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+.+++...+..+|..|-+..+-..+
T Consensus       243 ~~~~Ll~~ll~~~~~~~~~~~~~~~~  268 (429)
T KOG0595|consen  243 PLRELLISLLQRNPKDRISFEDFFDH  268 (429)
T ss_pred             chhhhhhHHHhcCccccCchHHhhhh
Confidence            78899999999999999888776654

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=3.6e-47  Score=350.72  Aligned_cols=248  Identities=29%  Similarity=0.466  Sum_probs=221.8

Q ss_pred             ccccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      ..|++.+.||+|+||.|+     .+++.||+|++++..+......+....|..+|..++||.||+++..|++...+|+|+
T Consensus        25 ~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVl  104 (357)
T KOG0598|consen   25 DDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVL  104 (357)
T ss_pred             hheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEE
Confidence            368889999999999887     378999999999888777777888999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||+.||.|...|++.+.|++..+.-++..|+.||.|||++|   |+||||||+|||++.+|+++|+|||++...-.. ..
T Consensus       105 d~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~-~~  180 (357)
T KOG0598|consen  105 DYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD-GD  180 (357)
T ss_pred             eccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcccC-CC
Confidence            99999999999999999999999999999999999999999   999999999999999999999999999854333 33


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      .....+||+.|||||++.+.+++..+|.||||+++|+|++|.+||...+...+...+.....+.   .+..++.+.++++
T Consensus       181 ~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~---~p~~ls~~ardll  257 (357)
T KOG0598|consen  181 ATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPL---PPGYLSEEARDLL  257 (357)
T ss_pred             ccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCC---CCccCCHHHHHHH
Confidence            4455789999999999999999999999999999999999999999999888888875554233   3455789999999


Q ss_pred             HHHcccCCCCCC----CHHHHHHH
Q 012684          390 EECWNEKPAKRP----TFRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rp----s~~~ll~~  409 (458)
                      +++|.+||++|.    ++.++.+|
T Consensus       258 ~~LL~rdp~~RLg~~~d~~~ik~H  281 (357)
T KOG0598|consen  258 KKLLKRDPRQRLGGPGDAEEIKRH  281 (357)
T ss_pred             HHHhccCHHHhcCCCCChHHhhcC
Confidence            999999999996    45555544

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-45  Score=356.22  Aligned_cols=260  Identities=34%  Similarity=0.586  Sum_probs=228.8

Q ss_pred             CCCcccCcCCccccCceeeccceEEEEE---EcCe-EEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE
Q 012684          145 VPEYEIDPHELDFTNSVEITKGTFILAF---WRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT  220 (458)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~---~~g~-~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~  220 (458)
                      ...|+++..+++  ..++||+|.||.|+   |+|. +||+|.++.....+    +.|.+|+.+|++++|++||+++++|.
T Consensus       198 ~d~wei~r~~l~--l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~  271 (468)
T KOG0197|consen  198 RDPWEIPREELK--LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCT  271 (468)
T ss_pred             cCCeeecHHHHH--HHHHhcCCccceEEEEEEcCCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEe
Confidence            345666665544  45789999999875   6776 99999998653333    46779999999999999999999999


Q ss_pred             eCCceEEEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecC
Q 012684          221 QSSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (458)
Q Consensus       221 ~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg  298 (458)
                      .+..+||||||++.|+|.++|+.  +..+...+.+.++.|||+|++||++++   +|||||-.+|||++++..+||+|||
T Consensus       272 ~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFG  348 (468)
T KOG0197|consen  272 KQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFG  348 (468)
T ss_pred             cCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccc
Confidence            98899999999999999999987  456999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCC
Q 012684          299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP  377 (458)
Q Consensus       299 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  377 (458)
                      +++...............+..|.|||.+..+.++.++|||||||+|+||+| |+.||...+..++...+....+.+.|  
T Consensus       349 LAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P--  426 (468)
T KOG0197|consen  349 LARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRP--  426 (468)
T ss_pred             cccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCC--
Confidence            999665544445555566889999999999999999999999999999999 99999999999999999888888764  


Q ss_pred             hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       378 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                       ..+|+++.+++..||+.+|++|||+..+...|+++...
T Consensus       427 -~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~~  464 (468)
T KOG0197|consen  427 -EGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFTS  464 (468)
T ss_pred             -CCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhhc
Confidence             45779999999999999999999999999999888654

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=352.25  Aligned_cols=247  Identities=28%  Similarity=0.493  Sum_probs=221.4

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      +|..++.||+|+|..|+.     +++.||||++.+..+..+..++-+..|-..|.+| +||+|+++|..|.++..+|+|+
T Consensus        74 DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvL  153 (604)
T KOG0592|consen   74 DFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVL  153 (604)
T ss_pred             hcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEE
Confidence            688889999999998874     7899999999988776666666678899999999 8999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||+++|+|.+++++.|.|++..+..++.||+.||+|||++|   ||||||||+|||++++|+++|+|||.++.++.....
T Consensus       154 e~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~  230 (604)
T KOG0592|consen  154 EYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKS  230 (604)
T ss_pred             EecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeeccccccCChhhcc
Confidence            99999999999999999999999999999999999999999   999999999999999999999999999877533211


Q ss_pred             ------------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCC
Q 012684          310 ------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP  377 (458)
Q Consensus       310 ------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  377 (458)
                                  ....++||..|.+||++.....++.+|||+|||+||+|+.|++||.+.+.--+...+.......    
T Consensus       231 ~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~f----  306 (604)
T KOG0592|consen  231 QENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEF----  306 (604)
T ss_pred             ccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccC----
Confidence                        1145789999999999999999999999999999999999999999988887777775544332    


Q ss_pred             hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          378 AKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       378 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++++++.+.+||+++|..||.+|+|.++|..|
T Consensus       307 p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~H  338 (604)
T KOG0592|consen  307 PEGFPEDARDLIKKLLVRDPSDRLTSQQIKAH  338 (604)
T ss_pred             CCCCCHHHHHHHHHHHccCccccccHHHHhhC
Confidence            45677999999999999999999999999887

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.5e-45  Score=341.42  Aligned_cols=253  Identities=27%  Similarity=0.495  Sum_probs=208.4

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC--ceE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMM  226 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--~~~  226 (458)
                      ..+|...+.||+|+||.|+.     +|+..|||.+....  . ...+.+.+|+.+|++++|||||++++......  .++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~--~-~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~   92 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED--S-PTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYN   92 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc--c-hhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeE
Confidence            45677888999999999983     47899999997552  1 12677899999999999999999999854443  689


Q ss_pred             EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC-CCCEEEeecCCccccc
Q 012684          227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLT  304 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~-~~~vkl~Dfg~~~~~~  304 (458)
                      +.|||+++|+|.+++.+.+ .+++..+..+.+|+++||.|||++|   |+||||||+|||++. ++.+||+|||++....
T Consensus        93 i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~  169 (313)
T KOG0198|consen   93 IFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLE  169 (313)
T ss_pred             eeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccc
Confidence            9999999999999999876 7999999999999999999999999   999999999999999 7999999999988765


Q ss_pred             c--CCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCC-CCCcHHHHHHhcCCCCCCCChhh
Q 012684          305 V--KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMK-HDNEVPKAYAARQRPPFKAPAKL  380 (458)
Q Consensus       305 ~--~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~-~~~~~~~~~~~~~~~~~~~~~~~  380 (458)
                      .  ..........||+.|||||++..+ ...+++|||||||++.||+||+.||... ........+....  ..+..+..
T Consensus       170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~--~~P~ip~~  247 (313)
T KOG0198|consen  170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGRED--SLPEIPDS  247 (313)
T ss_pred             cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccC--CCCCCCcc
Confidence            3  112223457799999999999853 3445999999999999999999999984 3222222222222  23355667


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          381 YARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      ++++.++||..|+.+||.+||||.++++|.-...
T Consensus       248 ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~  281 (313)
T KOG0198|consen  248 LSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQ  281 (313)
T ss_pred             cCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhc
Confidence            8999999999999999999999999999865543

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-44  Score=322.54  Aligned_cols=234  Identities=27%  Similarity=0.508  Sum_probs=213.8

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||.|+||.|..     +|..||+|++.+..+-...+.+...+|..+|+.+.||.++++++.|.+...+|||||
T Consensus        45 dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvme  124 (355)
T KOG0616|consen   45 DFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVME  124 (355)
T ss_pred             hhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEe
Confidence            677888999999998863     789999999998777777888889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |++||.|..++++.++|++..+..++.|++.||+|||+.+   |++||+||+|||+|.+|.+||+|||+++.+..   . 
T Consensus       125 yv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~---r-  197 (355)
T KOG0616|consen  125 YVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG---R-  197 (355)
T ss_pred             ccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC---c-
Confidence            9999999999999999999999999999999999999999   99999999999999999999999999997642   2 


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      ....+|||.|+|||++...++..++|.|+|||++|||+.|.+||...++..+...+.... ..+   |..+++.+++||+
T Consensus       198 T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~-v~f---P~~fs~~~kdLl~  273 (355)
T KOG0616|consen  198 TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGK-VKF---PSYFSSDAKDLLK  273 (355)
T ss_pred             EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCc-ccC---CcccCHHHHHHHH
Confidence            445789999999999999999999999999999999999999999999877777774433 333   4568899999999


Q ss_pred             HHcccCCCCC
Q 012684          391 ECWNEKPAKR  400 (458)
Q Consensus       391 ~~l~~dp~~R  400 (458)
                      .+|+.|-.+|
T Consensus       274 ~LL~vD~t~R  283 (355)
T KOG0616|consen  274 KLLQVDLTKR  283 (355)
T ss_pred             HHHhhhhHhh
Confidence            9999999999

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.2e-44  Score=353.88  Aligned_cols=245  Identities=27%  Similarity=0.423  Sum_probs=217.4

Q ss_pred             ccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |..++.||.|+.|.|.     .+|+..|||++.+...........+.+|+-+|+.+.||||+++|+++..+.++|+|.||
T Consensus        14 wkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEy   93 (786)
T KOG0588|consen   14 WKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEY   93 (786)
T ss_pred             eeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEe
Confidence            5667889999999886     48999999999876444555567789999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCc
Q 012684          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL  311 (458)
Q Consensus       232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~  311 (458)
                      ++||-|++++-+.|++++.++.++++||+.|+.|+|..+   |+|||+||+|+|++..+++||+|||+|....  ++...
T Consensus        94 v~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~--~gklL  168 (786)
T KOG0588|consen   94 VPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV--PGKLL  168 (786)
T ss_pred             cCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--CCccc
Confidence            999999999999999999999999999999999999999   9999999999999999999999999998642  45566


Q ss_pred             ccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          312 TCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      ...+|+|+|+|||++.|.+|. .++||||.||+||.|++|++||++.+-......+..+.   +.. |..+++++++||+
T Consensus       169 eTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~---f~M-Ps~Is~eaQdLLr  244 (786)
T KOG0588|consen  169 ETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGV---FEM-PSNISSEAQDLLR  244 (786)
T ss_pred             cccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCc---ccC-CCcCCHHHHHHHH
Confidence            778899999999999999886 58999999999999999999999776665555553333   221 3678899999999


Q ss_pred             HHcccCCCCCCCHHHHHHHH
Q 012684          391 ECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~L  410 (458)
                      +|+..||.+|.|..++++|-
T Consensus       245 ~ml~VDp~~RiT~~eI~kHP  264 (786)
T KOG0588|consen  245 RMLDVDPSTRITTEEILKHP  264 (786)
T ss_pred             HHhccCccccccHHHHhhCc
Confidence            99999999999999999984

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-44  Score=347.22  Aligned_cols=249  Identities=29%  Similarity=0.471  Sum_probs=214.6

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCC-C-HHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCc
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-D-DDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP  224 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~  224 (458)
                      ...+|...+.||+|+||.|+.     +|+.||+|++...... . ....+.+.+|+.+++.+. ||||+++++++.....
T Consensus        15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~   94 (370)
T KOG0583|consen   15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK   94 (370)
T ss_pred             ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence            345789999999999998873     6899999988764222 1 134456778999999998 9999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC-CCEEEeecCCcccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLL  303 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~-~~vkl~Dfg~~~~~  303 (458)
                      +++||||+.||+|.+++.+.+++.+..+..+++|++.|++|+|++|   |+||||||+|||++.+ +++||+|||++...
T Consensus        95 ~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s~~~  171 (370)
T KOG0583|consen   95 IYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLSAIS  171 (370)
T ss_pred             EEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEecccccccc
Confidence            9999999999999999999999999999999999999999999999   9999999999999999 99999999999876


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCC-CC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhh
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEE-YD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY  381 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (458)
                      . .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||.+.+...+...+ ..+...+   +..+
T Consensus       172 ~-~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki-~~~~~~~---p~~~  246 (370)
T KOG0583|consen  172 P-GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKI-RKGEFKI---PSYL  246 (370)
T ss_pred             C-CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHH-hcCCccC---CCCc
Confidence            4 2344556778999999999999977 76 6899999999999999999999997666666654 3333333   2334


Q ss_pred             -HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          382 -ARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       382 -~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                       +++++.+|.+||..||.+|+|+.+++.+
T Consensus       247 ~S~~~~~Li~~mL~~~P~~R~t~~~i~~h  275 (370)
T KOG0583|consen  247 LSPEARSLIEKMLVPDPSTRITLLEILEH  275 (370)
T ss_pred             CCHHHHHHHHHHcCCCcccCCCHHHHhhC
Confidence             8999999999999999999999999955

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-44  Score=333.87  Aligned_cols=248  Identities=25%  Similarity=0.450  Sum_probs=225.0

Q ss_pred             CccccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|++.+.||+|+||.|.     ..|+.||||.+++..+.++..+-.+++|+++|..++||||+++|.+|+..+.+.||
T Consensus        52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIviv  131 (668)
T KOG0611|consen   52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIV  131 (668)
T ss_pred             hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEE
Confidence            3478899999999999886     47999999999999998888888999999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |||..+|.|++++.+++.+++.++..+++||+.|+.|+|.++   ++|||||.+|||+|.++++||+|||++..+..  .
T Consensus       132 MEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~--~  206 (668)
T KOG0611|consen  132 MEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYAD--K  206 (668)
T ss_pred             EEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhcc--c
Confidence            999999999999999999999999999999999999999999   99999999999999999999999999987653  3


Q ss_pred             CCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      .....++|+|-|.+||++++.+|. +..|.||||++||.|+.|.+||++.+...+..++........+     -+....-
T Consensus       207 kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~-----~PSdA~g  281 (668)
T KOG0611|consen  207 KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREPE-----TPSDASG  281 (668)
T ss_pred             cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCCC-----CCchHHH
Confidence            455778899999999999999885 6899999999999999999999999988888888665533221     2346778


Q ss_pred             HHHHHcccCCCCCCCHHHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      ||++||..||++|.|+.++..|++
T Consensus       282 LIRwmLmVNP~RRATieDiAsHWW  305 (668)
T KOG0611|consen  282 LIRWMLMVNPERRATIEDIASHWW  305 (668)
T ss_pred             HHHHHHhcCcccchhHHHHhhhhe
Confidence            999999999999999999999974

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.9e-43  Score=329.39  Aligned_cols=258  Identities=29%  Similarity=0.475  Sum_probs=217.7

Q ss_pred             CCcccCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE
Q 012684          146 PEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT  220 (458)
Q Consensus       146 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~  220 (458)
                      +..++......|+..+.||.|.-+.|+.     .++.||||++..+.....  +..+++|+..++.++||||++++..|.
T Consensus        17 ~~~~~p~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~--ld~l~kE~~~msl~~HPNIv~~~~sFv   94 (516)
T KOG0582|consen   17 SEKEFPLNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNND--LDALRKEVQTMSLIDHPNIVTYHCSFV   94 (516)
T ss_pred             ccccCCCCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhh--HHHHHHHHHHhhhcCCCCcceEEEEEE
Confidence            4555666677889999999998877763     689999999987765443  788999999999999999999999999


Q ss_pred             eCCceEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecC
Q 012684          221 QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (458)
Q Consensus       221 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg  298 (458)
                      .+..+|+||.||.+|++.++++..-  .+++..+..|++++++||.|||++|   .||||||+.|||++.+|.|||+|||
T Consensus        95 v~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFg  171 (516)
T KOG0582|consen   95 VDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFG  171 (516)
T ss_pred             ecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCce
Confidence            9999999999999999999998642  3899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCCCCc---ccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCC
Q 012684          299 VSKLLTVKEDRPL---TCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP  373 (458)
Q Consensus       299 ~~~~~~~~~~~~~---~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~  373 (458)
                      .+..+.....+..   ....||++|||||++..  ..|+.|+||||||++.+||.+|..||....+.++....... .++
T Consensus       172 vsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn-~pp  250 (516)
T KOG0582|consen  172 VSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQN-DPP  250 (516)
T ss_pred             eeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcC-CCC
Confidence            8766544322211   45689999999999644  37899999999999999999999999998877665554333 332


Q ss_pred             C-------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 F-------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ~-------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .       .+....++..++++|..||.+||.+|||+++++++
T Consensus       251 ~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh  293 (516)
T KOG0582|consen  251 TLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKH  293 (516)
T ss_pred             CcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhcc
Confidence            1       12234577899999999999999999999999985

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-45  Score=342.48  Aligned_cols=249  Identities=29%  Similarity=0.487  Sum_probs=219.6

Q ss_pred             cCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      +....|+..+.||+|+||.||.     +++.||+|++....  ..+..++++.|+.++.+++++||.++|+.+..+..++
T Consensus        10 ~~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lw   87 (467)
T KOG0201|consen   10 DPELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLW   87 (467)
T ss_pred             CcccccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHH
Confidence            3455677778999999999984     68899999998664  4556788999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ++||||.||++.+.++..+.+.+..+..++++++.||.|||..+   .+|||||+.|||+..+|.|||+|||.+......
T Consensus        88 iiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~  164 (467)
T KOG0201|consen   88 IIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNT  164 (467)
T ss_pred             HHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeech
Confidence            99999999999999998877788999999999999999999999   999999999999999999999999999887766


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                      .... ....|||.|||||++.+..|+.|+||||||++.+||++|.+||....+......+-+...|   ....++++.++
T Consensus       165 ~~rr-~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP---~L~~~~S~~~k  240 (467)
T KOG0201|consen  165 VKRR-KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPP---RLDGDFSPPFK  240 (467)
T ss_pred             hhcc-ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCC---ccccccCHHHH
Confidence            5444 6678999999999999989999999999999999999999999998885544433222222   23448899999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +|+..||.+||+.||+|.+|++|
T Consensus       241 EFV~~CL~k~P~~RpsA~~LLKh  263 (467)
T KOG0201|consen  241 EFVEACLDKNPEFRPSAKELLKH  263 (467)
T ss_pred             HHHHHHhhcCcccCcCHHHHhhh
Confidence            99999999999999999999987

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-44  Score=345.70  Aligned_cols=245  Identities=23%  Similarity=0.462  Sum_probs=218.6

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .|+.-.+||+|..|.||     .+++.||||.+....   +...+.+.+|+.+|+..+|+|||.+++.|...+.+|+|||
T Consensus       274 ~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~---Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVME  350 (550)
T KOG0578|consen  274 KYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRK---QPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVME  350 (550)
T ss_pred             hhcchhhhccccccceeeeeeccCCceEEEEEEEecc---CCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEe
Confidence            57777899999998887     378899999997653   3334668899999999999999999999998899999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |++||+|.+.+... .+++.++..|++++++||+|||.+|   |+|||||.+|||++.+|.+||+|||++..+..... .
T Consensus       351 ym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~-K  425 (550)
T KOG0578|consen  351 YMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS-K  425 (550)
T ss_pred             ecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccC-c
Confidence            99999999988764 4999999999999999999999999   99999999999999999999999999988765533 4


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....|||.|||||+.....|+++.||||||++++||+-|.+||-..++-.....+...+.+.+.. +..+|+.+++|+.
T Consensus       426 R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk~-~~klS~~~kdFL~  504 (550)
T KOG0578|consen  426 RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLKN-PEKLSPELKDFLD  504 (550)
T ss_pred             cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcCC-ccccCHHHHHHHH
Confidence            455779999999999999999999999999999999999999999888877777777777777654 5668999999999


Q ss_pred             HHcccCCCCCCCHHHHHHH
Q 012684          391 ECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~  409 (458)
                      +||+.||.+|+++++||+|
T Consensus       505 ~cL~~dv~~RasA~eLL~H  523 (550)
T KOG0578|consen  505 RCLVVDVEQRASAKELLEH  523 (550)
T ss_pred             HHhhcchhcCCCHHHHhcC
Confidence            9999999999999999987

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-44  Score=339.58  Aligned_cols=247  Identities=25%  Similarity=0.378  Sum_probs=208.1

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCC-ceEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS-PMMI  227 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~-~~~l  227 (458)
                      .+|+..++||.|+||.|+.     +|..||||.++......++...  .+|+..|++++ ||||+++.+++.+++ .+|+
T Consensus        10 ~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~n--LREvksL~kln~hpniikL~Evi~d~~~~L~f   87 (538)
T KOG0661|consen   10 DRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMN--LREVKSLRKLNPHPNIIKLKEVIRDNDRILYF   87 (538)
T ss_pred             HHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHH--HHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence            4788999999999999984     7889999999887765443322  46999999998 999999999998887 8999


Q ss_pred             EEEccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ||||| ..+|+++++.+++ |+++.+..|+.||++||+|+|.+|   +.|||+||+|||+.+...|||+|||+|+.+.. 
T Consensus        88 VfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~S-  162 (538)
T KOG0661|consen   88 VFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVRS-  162 (538)
T ss_pred             eHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEeccccccccccc-
Confidence            99999 6799999987654 999999999999999999999999   99999999999999999999999999998753 


Q ss_pred             CCCCcccCCCCCcccCCcccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH-HhcCCCCCC---------
Q 012684          307 EDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY-AARQRPPFK---------  375 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~-~~~~~~~~~---------  375 (458)
                       ..+.+.++.|.+|+|||++. .+.|+.+.|||++||+++|+.+-++.|.+.+.-+....+ ...+.|...         
T Consensus       163 -kpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La  241 (538)
T KOG0661|consen  163 -KPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLA  241 (538)
T ss_pred             -CCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHH
Confidence             46778889999999999875 457899999999999999999999999987654322222 112222111         


Q ss_pred             ----------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          376 ----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       376 ----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                      ...+..+.++.++|.+|+..||.+||||++++++
T Consensus       242 ~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~  291 (538)
T KOG0661|consen  242 SAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH  291 (538)
T ss_pred             HHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence                            1123467889999999999999999999999987

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=5.3e-44  Score=343.05  Aligned_cols=244  Identities=27%  Similarity=0.505  Sum_probs=216.9

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|-+-+.||+|+||.||.     +.+.||+|.+.+... .+..+..+.+|+++++.++||||+.+++.|+...++|+|+|
T Consensus         3 ~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte   81 (808)
T KOG0597|consen    3 QYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE   81 (808)
T ss_pred             chhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence            466778999999999983     678999999987543 55667889999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+.| +|.+++...+.++++.+..++.|++.||.|||+.+   |+|||+||+|||++..|.+|+||||+++.++. ....
T Consensus        82 ~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~-~t~v  156 (808)
T KOG0597|consen   82 YAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMST-NTSV  156 (808)
T ss_pred             hhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhccc-Ccee
Confidence            9966 99999999999999999999999999999999999   99999999999999999999999999997754 3445


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .+...|||.|||||+..+++|+..+|+|||||++||+++|++||...+-....+.+......+    +...+..+.+|++
T Consensus       157 ltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~----p~~~S~~f~nfl~  232 (808)
T KOG0597|consen  157 LTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKP----PSTASSSFVNFLQ  232 (808)
T ss_pred             eeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCC----cccccHHHHHHHH
Confidence            567789999999999999999999999999999999999999999776655555553333222    3467899999999


Q ss_pred             HHcccCCCCCCCHHHHHHH
Q 012684          391 ECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+|.+||..|.|..+++.|
T Consensus       233 gLL~kdP~~RltW~~Ll~H  251 (808)
T KOG0597|consen  233 GLLIKDPAQRLTWTDLLGH  251 (808)
T ss_pred             HHhhcChhhcccHHHHhcC
Confidence            9999999999999999987

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=1.1e-43  Score=317.88  Aligned_cols=248  Identities=22%  Similarity=0.410  Sum_probs=204.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .|+...++|+|+||+|+.     +|+-||||++..+. .++...+-..+|+++|++++|||+|.++.+|.....+++|+|
T Consensus         3 kYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE   81 (396)
T KOG0593|consen    3 KYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE   81 (396)
T ss_pred             HHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence            466677899999999984     79999999997543 234445556889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||+. ++.+-+.+ ...++...+..+++|++.|+.|+|+++   ++||||||+|||++.+|.+||||||+|+.+.. +..
T Consensus        82 ~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-pgd  156 (396)
T KOG0593|consen   82 YCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSA-PGD  156 (396)
T ss_pred             ecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcC-Ccc
Confidence            9966 55555554 445899999999999999999999999   99999999999999999999999999998764 455


Q ss_pred             CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-C------------CC---
Q 012684          310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-Q------------RP---  372 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~------------~~---  372 (458)
                      ..+.+..|.+|+|||++.+ .+|+...|||++||++.||++|.+.|.+.++-+....+.+. +            .+   
T Consensus       157 ~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~  236 (396)
T KOG0593|consen  157 NYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFH  236 (396)
T ss_pred             hhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCcee
Confidence            6677888999999999988 68999999999999999999999999998775432222111 0            00   


Q ss_pred             ----CCCC-------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 ----PFKA-------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 ----~~~~-------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                          +-+.       .-+.++.-+.+|++.||..||++|++-++++.|
T Consensus       237 Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H  284 (396)
T KOG0593|consen  237 GVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHH  284 (396)
T ss_pred             eeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcC
Confidence                1000       112355678899999999999999999999975

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=4.7e-43  Score=336.31  Aligned_cols=252  Identities=27%  Similarity=0.378  Sum_probs=217.4

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      -..|+..+.||+|+||.|+.     +|..+|+|++++........++.++.|-++|....+|+||++|..|.+..++|||
T Consensus       140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi  219 (550)
T KOG0605|consen  140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI  219 (550)
T ss_pred             cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence            34678889999999999984     8999999999988777788888899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc---
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV---  305 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~---  305 (458)
                      |||++||++.++|.+.+.+++..+..++.+++-|+..+|+.|   ++||||||+|+|||..|++||+|||++.-+..   
T Consensus       220 MEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~  296 (550)
T KOG0605|consen  220 MEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHR  296 (550)
T ss_pred             EEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhhhhhh
Confidence            999999999999999999999999999999999999999999   99999999999999999999999999843210   


Q ss_pred             -------------------CCCC----Cc--------------------ccCCCCCcccCCcccCCCCCCCchhHHHHHH
Q 012684          306 -------------------KEDR----PL--------------------TCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL  342 (458)
Q Consensus       306 -------------------~~~~----~~--------------------~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~  342 (458)
                                         ....    ..                    ....|||.|+|||++.+..|+...|.|||||
T Consensus       297 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~  376 (550)
T KOG0605|consen  297 IESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGC  376 (550)
T ss_pred             hhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHH
Confidence                               0000    00                    1446999999999999999999999999999


Q ss_pred             HHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 012684          343 ILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR  409 (458)
Q Consensus       343 ~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~  409 (458)
                      ++||||.|.+||...++.++...+.........+.....+++..+||.+||. ||++|..   ++||.+|
T Consensus       377 ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~H  445 (550)
T KOG0605|consen  377 IMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKH  445 (550)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcC
Confidence            9999999999999999999888775444221112234467999999999999 9999976   5666554

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=314.81  Aligned_cols=251  Identities=23%  Similarity=0.374  Sum_probs=223.4

Q ss_pred             CccccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      +.+|++.+.||+|.|+.|+     -+|+.+|+|++....+... ..+++.+|+.+-+.++||||+++.+.+.+.+..|+|
T Consensus        10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv   88 (355)
T KOG0033|consen   10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   88 (355)
T ss_pred             chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence            3467888899999998776     4899999999987655443 567899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC---CEEEeecCCcccccc
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTV  305 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~---~vkl~Dfg~~~~~~~  305 (458)
                      +|+++|++|..-+-.+..+++..+...++||+++|.|+|.++   |+|||+||.|+++-...   -+||+|||++..+. 
T Consensus        89 Fe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~-  164 (355)
T KOG0033|consen   89 FDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN-  164 (355)
T ss_pred             EecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEEeC-
Confidence            999999999766665567899999999999999999999999   99999999999997533   49999999999876 


Q ss_pred             CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHH
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL  385 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (458)
                       .........|||+|||||++...+|+..+|||+.||+||-|+.|++||.+.+...+.+.++.....-.+..+.+++++.
T Consensus       165 -~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~A  243 (355)
T KOG0033|consen  165 -DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEA  243 (355)
T ss_pred             -CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHH
Confidence             4566677889999999999999999999999999999999999999999999999999987666555555788999999


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      ++|+++||..||.+|.|+.|+|+|-
T Consensus       244 k~LvrrML~~dP~kRIta~EAL~Hp  268 (355)
T KOG0033|consen  244 KSLIRRMLTVNPKKRITADEALKHP  268 (355)
T ss_pred             HHHHHHHhccChhhhccHHHHhCCc
Confidence            9999999999999999999999874

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.1e-41  Score=324.96  Aligned_cols=258  Identities=19%  Similarity=0.312  Sum_probs=215.0

Q ss_pred             cccCcCCccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe---
Q 012684          148 YEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ---  221 (458)
Q Consensus       148 ~~~~~~~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~---  221 (458)
                      ..+++.+++......||+|+++.++   ++|+.||||.+...........+.+.+|+.++++++||||+++++++.+   
T Consensus        13 ~~i~~~~i~~~~~~~i~~g~~~~v~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~   92 (283)
T PHA02988         13 KCIESDDIDKYTSVLIKENDQNSIYKGIFNNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVD   92 (283)
T ss_pred             eecCHHHcCCCCCeEEeeCCceEEEEEEECCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEeccc
Confidence            3445555555555678999888765   6899999999986654455556778899999999999999999999876   


Q ss_pred             -CCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCEEecCCCCEEEeecCC
Q 012684          222 -SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (458)
Q Consensus       222 -~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~  299 (458)
                       ....++||||+++|+|.+++.+.+.+++.....++.|++.||.|||+. +   ++||||||+||+++.++.+||+|||+
T Consensus        93 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~  169 (283)
T PHA02988         93 DLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGL  169 (283)
T ss_pred             CCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccch
Confidence             356899999999999999999888899999999999999999999985 6   88999999999999999999999999


Q ss_pred             ccccccCCCCCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCC
Q 012684          300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKA  376 (458)
Q Consensus       300 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~  376 (458)
                      +.......    ....++..|+|||.+.+  ..++.++|||||||++|+|++|+.||...+..+....+.... ++..  
T Consensus       170 ~~~~~~~~----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--  243 (283)
T PHA02988        170 EKILSSPP----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL--  243 (283)
T ss_pred             Hhhhcccc----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC--
Confidence            87653221    23457889999999876  678999999999999999999999999877666655553333 3222  


Q ss_pred             ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       377 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                       +..+++.++++|.+||+.||.+|||++++++.|+.+..
T Consensus       244 -~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~  281 (283)
T PHA02988        244 -PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF  281 (283)
T ss_pred             -CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence             23467899999999999999999999999999998753

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-42  Score=330.24  Aligned_cols=252  Identities=26%  Similarity=0.417  Sum_probs=212.9

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--Cce
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM  225 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~  225 (458)
                      ....|+..++||+|+||.||.     +|+.||+|.+...... +.......+|+.+|++++||||+++.+...+.  +.+
T Consensus       115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~-~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si  193 (560)
T KOG0600|consen  115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEK-EGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI  193 (560)
T ss_pred             chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCC-CcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence            334577888999999999984     7899999999876543 33445677899999999999999999999876  689


Q ss_pred             EEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      |||+|||+ -+|.-++...+ .|++.++..+++||+.||+|+|.+|   |+|||||.+|||+|.+|.+||+|||+|.++.
T Consensus       194 YlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~  269 (560)
T KOG0600|consen  194 YLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT  269 (560)
T ss_pred             EEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence            99999995 49999888744 5999999999999999999999999   9999999999999999999999999999887


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCC-------
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA-------  376 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-------  376 (458)
                      .......+..+.|.+|+|||++.|. .|+...|+||+||+|.||++|++.|.+.+..+....+.+..-.+.+.       
T Consensus       270 ~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kL  349 (560)
T KOG0600|consen  270 PSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKL  349 (560)
T ss_pred             CCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccC
Confidence            7777778888899999999998875 79999999999999999999999999987765544443322111110       


Q ss_pred             ------------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          377 ------------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       377 ------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                        ....++....+|+..+|..||.+|.||.+++..
T Consensus       350 P~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~s  400 (560)
T KOG0600|consen  350 PHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQS  400 (560)
T ss_pred             CcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcC
Confidence                              012356778899999999999999999999874

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=4e-42  Score=302.83  Aligned_cols=248  Identities=27%  Similarity=0.445  Sum_probs=204.3

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|...+.||+|+||.||.     +|+.||||.++.....+.-.. ...+|++.|+.++|+||+.++++|.....+.+|+|
T Consensus         3 rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~-talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE   81 (318)
T KOG0659|consen    3 RYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINR-TALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE   81 (318)
T ss_pred             hhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccH-HHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence            577778999999999984     799999999987654433333 45679999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |+ ..+|+..++... .+++.++..++.++++||+|||+++   |+||||||.|+|++.+|.+||+|||+++.+.... .
T Consensus        82 fm-~tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~-~  156 (318)
T KOG0659|consen   82 FM-PTDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN-R  156 (318)
T ss_pred             ec-cccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC-c
Confidence            99 459999998644 5899999999999999999999999   9999999999999999999999999999886543 3


Q ss_pred             CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-CCCC--------------
Q 012684          310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPP--------------  373 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~~~~--------------  373 (458)
                      .......|.+|+|||++.|. .|+...||||+||++.||+.|.+-|.+.++-+....+... +.|.              
T Consensus       157 ~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~  236 (318)
T KOG0659|consen  157 IQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYV  236 (318)
T ss_pred             ccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHH
Confidence            33444678999999998775 7899999999999999999999888887764433333211 1111              


Q ss_pred             ---------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 ---------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ---------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                               .....+..+....+|+..|+..||.+|+|+.|++++
T Consensus       237 ~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~  281 (318)
T KOG0659|consen  237 KIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH  281 (318)
T ss_pred             HHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence                     111122345678999999999999999999999987

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-42  Score=326.08  Aligned_cols=253  Identities=26%  Similarity=0.401  Sum_probs=206.3

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCC-----------CHHHHHHHHHHHHHHhcCCCCcceeeeeEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-----------DDDRVRAFRDELALLQKIRHPNVVQFLGAV  219 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~-----------~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~  219 (458)
                      +|++.+.||+|.||.|..     +++.||||++.+....           .....+..++|+.+|+++.|||||+++.+.
T Consensus        98 qy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvL  177 (576)
T KOG0585|consen   98 QYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVL  177 (576)
T ss_pred             heehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEee
Confidence            699999999999998863     7899999999764321           112245788999999999999999999998


Q ss_pred             Ee--CCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeec
Q 012684          220 TQ--SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (458)
Q Consensus       220 ~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Df  297 (458)
                      .+  ...+|||+|||..|.+...=.....+++.+++.++++++.||+|||.+|   |+||||||+|+|++++|+|||+||
T Consensus       178 DDP~s~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g~VKIsDF  254 (576)
T KOG0585|consen  178 DDPESDKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDGTVKISDF  254 (576)
T ss_pred             cCcccCceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCCcEEeecc
Confidence            65  4679999999998887653222233899999999999999999999999   999999999999999999999999


Q ss_pred             CCccccccCCCCC----cccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc
Q 012684          298 GVSKLLTVKEDRP----LTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR  369 (458)
Q Consensus       298 g~~~~~~~~~~~~----~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~  369 (458)
                      |.+..........    .....|||.|+|||...++    ..+.+.||||+||+||+|+.|+.||-+....+....++..
T Consensus       255 GVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~KIvn~  334 (576)
T KOG0585|consen  255 GVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFDKIVND  334 (576)
T ss_pred             ceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHHHHhcC
Confidence            9998764332221    2346799999999998773    2346899999999999999999999988777777666333


Q ss_pred             CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                       ...++. .+.+.+.+++||.+||++||+.|.+..++..|.+..
T Consensus       335 -pL~fP~-~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt  376 (576)
T KOG0585|consen  335 -PLEFPE-NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVT  376 (576)
T ss_pred             -cccCCC-cccccHHHHHHHHHHhhcChhheeehhhheecceec
Confidence             223322 234678999999999999999999999999987654

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.8e-42  Score=328.34  Aligned_cols=243  Identities=24%  Similarity=0.409  Sum_probs=208.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.||.     +|+.||+|++...........+.+.+|+.+++.++||||+++++++.++...++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e   81 (291)
T cd05612           2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME   81 (291)
T ss_pred             CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence            577889999999998873     588999999975433333455678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+++++|.+++...+.+++..+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||++......    
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~----  154 (291)
T cd05612          82 YVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR----  154 (291)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC----
Confidence            9999999999998888999999999999999999999999   999999999999999999999999998765322    


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....|++.|+|||++.+..++.++|||||||++|+|++|+.||......+....+... ...+   +..+++.++++|.
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~-~~~~---~~~~~~~~~~li~  230 (291)
T cd05612         155 TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAG-KLEF---PRHLDLYAKDLIK  230 (291)
T ss_pred             cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CcCC---CccCCHHHHHHHH
Confidence            12345889999999999888999999999999999999999999887665555554322 2222   3446789999999


Q ss_pred             HHcccCCCCCCC-----HHHHHHH
Q 012684          391 ECWNEKPAKRPT-----FRQIITR  409 (458)
Q Consensus       391 ~~l~~dp~~Rps-----~~~ll~~  409 (458)
                      +||+.||.+||+     +++++++
T Consensus       231 ~~l~~dp~~R~~~~~~~~~~~l~h  254 (291)
T cd05612         231 KLLVVDRTRRLGNMKNGADDVKNH  254 (291)
T ss_pred             HHcCCCHHHccCCccCCHHHHhcC
Confidence            999999999995     8888877

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=4.3e-41  Score=329.32  Aligned_cols=255  Identities=28%  Similarity=0.463  Sum_probs=205.4

Q ss_pred             CccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC
Q 012684          154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS  222 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~  222 (458)
                      ..+|++.+.||.|+||.||.          .+..||+|++....  .......+.+|+.+++.+ +||||+++++++...
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACTKP   83 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEecCC
Confidence            34688889999999999873          23679999987432  334456788999999999 899999999988754


Q ss_pred             -CceEEEEEccCCCCHHHHHHhc---------------------------------------------------------
Q 012684          223 -SPMMIVTEYLPKGDLRAFLKRK---------------------------------------------------------  244 (458)
Q Consensus       223 -~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------  244 (458)
                       ..++++|||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (338)
T cd05102          84 NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQET  163 (338)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhc
Confidence             4689999999999999998752                                                         


Q ss_pred             -----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC-CcccCCCCC
Q 012684          245 -----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSC  318 (458)
Q Consensus       245 -----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~  318 (458)
                           ..+++.++..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++......... ......+++
T Consensus       164 ~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~  240 (338)
T cd05102         164 DDLWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL  240 (338)
T ss_pred             cccccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCc
Confidence                 23677888899999999999999999   999999999999999999999999999765322111 112234567


Q ss_pred             cccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCC
Q 012684          319 RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP  397 (458)
Q Consensus       319 ~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp  397 (458)
                      .|+|||++.+..++.++||||||+++|+|++ |..||......+........+...  ..+..+++.+.++|.+||+.||
T Consensus       241 ~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~l~~li~~cl~~dp  318 (338)
T cd05102         241 KWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRM--RAPENATPEIYRIMLACWQGDP  318 (338)
T ss_pred             cccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCC--CCCCCCCHHHHHHHHHHccCCh
Confidence            8999999988889999999999999999997 999998765544333322222211  1234577899999999999999


Q ss_pred             CCCCCHHHHHHHHHHHHh
Q 012684          398 AKRPTFRQIITRLESINN  415 (458)
Q Consensus       398 ~~Rps~~~ll~~L~~~~~  415 (458)
                      .+|||+.++++.|+++..
T Consensus       319 ~~RPs~~el~~~l~~~~~  336 (338)
T cd05102         319 KERPTFSALVEILGDLLQ  336 (338)
T ss_pred             hhCcCHHHHHHHHHHHHh
Confidence            999999999999998764

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=2.5e-41  Score=322.95  Aligned_cols=248  Identities=23%  Similarity=0.359  Sum_probs=204.7

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |+..+.||+|+||.|+.     +|+.||+|.+.............+.+|+.+++.++|++|+++++++..++..++||||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~   81 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence            66778999999998863     6899999998755433333445678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       232 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      +++|+|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......  .
T Consensus        82 ~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~--~  156 (285)
T cd05631          82 MNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEG--E  156 (285)
T ss_pred             cCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCC--C
Confidence            9999999887643  35889999999999999999999999   999999999999999999999999998765322  2


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+...........+..+++.+.+||
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  236 (285)
T cd05631         157 TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSEKFSEDAKSIC  236 (285)
T ss_pred             eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccccCCccCCHHHHHHH
Confidence            22345689999999999998999999999999999999999999987665443333322222222223455788999999


Q ss_pred             HHHcccCCCCCCC-----HHHHHHH
Q 012684          390 EECWNEKPAKRPT-----FRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps-----~~~ll~~  409 (458)
                      .+||+.||.+||+     +.+++++
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~~~~h  261 (285)
T cd05631         237 RMLLTKNPKERLGCRGNGAAGVKQH  261 (285)
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHhcC
Confidence            9999999999997     7888876

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=8.3e-42  Score=332.10  Aligned_cols=241  Identities=25%  Similarity=0.401  Sum_probs=205.2

Q ss_pred             eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCC
Q 012684          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~  235 (458)
                      +.||+|+||.||.     +|+.||+|++.............+.+|+.+++.++||||+++++++..++..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~   80 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999873     68899999997654434455567788999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCC
Q 012684          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (458)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~  315 (458)
                      +|.+++...+.+++..+..++.|++.||+|||+.|   |+||||||+||+++.++.+||+|||++...... ........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~-~~~~~~~~  156 (323)
T cd05571          81 ELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFC  156 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccC-CCccccee
Confidence            99999988888999999999999999999999999   999999999999999999999999998753222 12223456


Q ss_pred             CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 012684          316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE  395 (458)
Q Consensus       316 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  395 (458)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.. ....+   +..+++++.++|.+||+.
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~-~~~~~---p~~~~~~~~~li~~~L~~  232 (323)
T cd05571         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-EEIRF---PRTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             cCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHc-CCCCC---CCCCCHHHHHHHHHHccC
Confidence            89999999999998999999999999999999999999987665554444422 22222   345788999999999999


Q ss_pred             CCCCCC-----CHHHHHHH
Q 012684          396 KPAKRP-----TFRQIITR  409 (458)
Q Consensus       396 dp~~Rp-----s~~~ll~~  409 (458)
                      ||.+||     ++.+++++
T Consensus       233 dP~~R~~~~~~~~~~ll~h  251 (323)
T cd05571         233 DPKQRLGGGPEDAKEIMEH  251 (323)
T ss_pred             CHHHcCCCCCCCHHHHHcC
Confidence            999999     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-41  Score=331.99  Aligned_cols=244  Identities=24%  Similarity=0.410  Sum_probs=209.0

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     +|+.||+|++...........+.+.+|+.+++.++||||+++++++..++..++||
T Consensus        18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   97 (329)
T PTZ00263         18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL   97 (329)
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence            3678889999999998873     57899999997543333445567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||+.+++|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......   
T Consensus        98 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~---  171 (329)
T PTZ00263         98 EFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR---  171 (329)
T ss_pred             cCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC---
Confidence            99999999999998888999999999999999999999999   999999999999999999999999998765322   


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                       .....||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+. .+...+   +..++..+++||
T Consensus       172 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~-~~~~~~---p~~~~~~~~~li  246 (329)
T PTZ00263        172 -TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL-AGRLKF---PNWFDGRARDLV  246 (329)
T ss_pred             -cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh-cCCcCC---CCCCCHHHHHHH
Confidence             123468999999999999889999999999999999999999998766555544442 233332   334678899999


Q ss_pred             HHHcccCCCCCCC-----HHHHHHH
Q 012684          390 EECWNEKPAKRPT-----FRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps-----~~~ll~~  409 (458)
                      .+||+.||.+||+     +.+++.|
T Consensus       247 ~~~L~~dP~~R~~~~~~~~~~ll~h  271 (329)
T PTZ00263        247 KGLLQTDHTKRLGTLKGGVADVKNH  271 (329)
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            9999999999997     6888876

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.1e-41  Score=330.81  Aligned_cols=247  Identities=29%  Similarity=0.453  Sum_probs=211.1

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.||.     +|+.||+|++.............+..|+.+++.++||||+++++++...+..|+|||
T Consensus         2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e   81 (333)
T cd05600           2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME   81 (333)
T ss_pred             CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence            578889999999998873     578999999976543334455678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |++|++|.+++...+.+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.....    .
T Consensus        82 ~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~----~  154 (333)
T cd05600          82 YVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT----Y  154 (333)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc----c
Confidence            9999999999998888999999999999999999999999   99999999999999999999999999876532    2


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC----CCCCCCChhhhHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFKAPAKLYARGLK  386 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~l~  386 (458)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+....    .+........++.++.
T Consensus       155 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~  234 (333)
T cd05600         155 ANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAW  234 (333)
T ss_pred             cCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHH
Confidence            234568999999999998899999999999999999999999998877665555443222    1222112235688999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++|.+||..+|.+||++.+++++
T Consensus       235 ~li~~~l~~~~~rr~s~~~ll~h  257 (333)
T cd05600         235 DLITKLINDPSRRFGSLEDIKNH  257 (333)
T ss_pred             HHHHHHhhChhhhcCCHHHHHhC
Confidence            99999999999999999999987

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1e-41  Score=327.77  Aligned_cols=247  Identities=25%  Similarity=0.464  Sum_probs=218.2

Q ss_pred             ccccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc-eEEE
Q 012684          155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIV  228 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~-~~lv  228 (458)
                      .+|...+.+|+|+||.++     ..+..|++|.+......... .+...+|+.+++++.||||+.+.+.|..++. .+||
T Consensus         4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~-r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv   82 (426)
T KOG0589|consen    4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPE-RRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV   82 (426)
T ss_pred             chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchh-hHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence            367888999999999775     36789999999876654433 3467789999999999999999999998888 9999


Q ss_pred             EEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          229 TEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      |+||+||+|.+.+.+..  .|+++.++.++.|++.|+.|||+++   |+|||||++|||++.++.|+|+|||+++.....
T Consensus        83 m~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~  159 (426)
T KOG0589|consen   83 MEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE  159 (426)
T ss_pred             EeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence            99999999999997643  4999999999999999999999998   999999999999999999999999999987654


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                      . .......|||.|++||.+.+-+|..|+|||||||++|||++-+++|...+.......+....   ..+.+..++.+++
T Consensus       160 ~-~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~---~~Plp~~ys~el~  235 (426)
T KOG0589|consen  160 D-SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGL---YSPLPSMYSSELR  235 (426)
T ss_pred             h-hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhcc---CCCCCccccHHHH
Confidence            3 23345789999999999999999999999999999999999999999988887777775555   3334778999999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+|..||.++|..||++.+|+.+
T Consensus       236 ~lv~~~l~~~P~~RPsa~~LL~~  258 (426)
T KOG0589|consen  236 SLVKSMLRKNPEHRPSALELLRR  258 (426)
T ss_pred             HHHHHHhhcCCccCCCHHHHhhC
Confidence            99999999999999999999987

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-41  Score=334.28  Aligned_cols=243  Identities=26%  Similarity=0.401  Sum_probs=216.7

Q ss_pred             cCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCce
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~  225 (458)
                      ....+|...+.||+|+||.|..     +++.||||++++..+-..+.++..+.|.+++... +||.++.++.+|....++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            3445788899999999999874     6889999999998888888899999999999988 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      |+||||+.||++.. +...+.|++..+..++..++.||+|||++|   |||||||.+|||+|.+|.+||+|||+++....
T Consensus       445 ~fvmey~~Ggdm~~-~~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~  520 (694)
T KOG0694|consen  445 FFVMEYVAGGDLMH-HIHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG  520 (694)
T ss_pred             EEEEEecCCCcEEE-EEecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccccCC
Confidence            99999999999543 344567999999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHH
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL  385 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (458)
                      ..+ .....+|||.|+|||++.+..|+...|.|||||+||+|+.|..||.+.+.+++...+.... +.+   |..+|.+.
T Consensus       521 ~g~-~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~-~~y---P~~ls~ea  595 (694)
T KOG0694|consen  521 QGD-RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE-VRY---PRFLSKEA  595 (694)
T ss_pred             CCC-ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC-CCC---CCcccHHH
Confidence            333 4456889999999999999999999999999999999999999999999999999884443 333   45678999


Q ss_pred             HHHHHHHcccCCCCCCCH
Q 012684          386 KELIEECWNEKPAKRPTF  403 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~  403 (458)
                      .+|++++|.+||++|..+
T Consensus       596 ~~il~~ll~k~p~kRLG~  613 (694)
T KOG0694|consen  596 IAIMRRLLRKNPEKRLGS  613 (694)
T ss_pred             HHHHHHHhccCcccccCC
Confidence            999999999999999876

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-41  Score=327.09  Aligned_cols=252  Identities=27%  Similarity=0.425  Sum_probs=225.9

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~l  227 (458)
                      ...|++.+.||.|.||.|+.     +|+.+|+|.+.+...........+.+|+.+|+++. ||||+.+++.|+....+++
T Consensus        34 ~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~l  113 (382)
T KOG0032|consen   34 KEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYL  113 (382)
T ss_pred             cccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEE
Confidence            34688889999999999874     69999999998876655556678999999999997 9999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC----CCEEEeecCCcccc
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVADFGVSKLL  303 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~----~~vkl~Dfg~~~~~  303 (458)
                      |||+++||.|.+.+... .+++..+..++.|++.++.|||+.|   ++||||||+|+|+...    +.++++|||++...
T Consensus       114 vmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~  189 (382)
T KOG0032|consen  114 VMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFI  189 (382)
T ss_pred             EEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCCCceEc
Confidence            99999999999999876 4999999999999999999999999   9999999999999843    47999999999987


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      ..  ........||+.|+|||++....++...||||+|+++|.|++|..||.+.+.......+...........+..++.
T Consensus       190 ~~--~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~  267 (382)
T KOG0032|consen  190 KP--GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISE  267 (382)
T ss_pred             cC--CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCH
Confidence            65  4456677899999999999999999999999999999999999999999998888887766555555567788999


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      .++++|+.||..||.+|+|+.++++|-+
T Consensus       268 ~akd~i~~ll~~dp~~R~ta~~~L~HpW  295 (382)
T KOG0032|consen  268 SAKDFIRKLLEFDPRKRLTAAQALQHPW  295 (382)
T ss_pred             HHHHHHHHhcccCcccCCCHHHHhcCcc
Confidence            9999999999999999999999999843

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.7e-41  Score=329.13  Aligned_cols=292  Identities=27%  Similarity=0.508  Sum_probs=248.1

Q ss_pred             hHHHHHHHHHhCCCCCCCccccccCCCCCCcccCcCCccccCceeeccceEEEEEE-----c-C---eEEEEEEcCCCCC
Q 012684          118 NHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW-----R-G---IQVAVKKLGEEVI  188 (458)
Q Consensus       118 ~~~~~~~l~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~-----~-g---~~vavK~~~~~~~  188 (458)
                      -.+++.+....-..+.........|...+.|++...++.+.  ++||+|.||.|+.     . +   ..||+|.......
T Consensus       122 i~~li~~~~~~~~~~~~~~~~L~~PI~r~~Wel~H~~v~l~--kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~  199 (474)
T KOG0194|consen  122 ISELVNYYKFSKLEITGKNFFLKRPIPRQKWELSHSDIELG--KKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSE  199 (474)
T ss_pred             HHHHHHHHHhcccceeccceeecccccccccEEeccCcccc--ceeecccccEEEEEEEEecCCceeeeeEEEeeccccc
Confidence            34677777776666666666677777888999998888777  8999999998873     1 2   2389999986555


Q ss_pred             CCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH
Q 012684          189 SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLH  267 (458)
Q Consensus       189 ~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH  267 (458)
                      .......++..|.+++++++||||+++||+...+..+++|||+|.||+|.++|++.+. ++..+...++.+.+.||+|||
T Consensus       200 ~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh  279 (474)
T KOG0194|consen  200 LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH  279 (474)
T ss_pred             ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH
Confidence            6778888999999999999999999999999999999999999999999999998774 999999999999999999999


Q ss_pred             hCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHH
Q 012684          268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM  347 (458)
Q Consensus       268 ~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~l  347 (458)
                      +++   ++||||-.+|+|++.++.+||+|||++.......... ....-+..|+|||.+....+++++|||||||++||+
T Consensus       280 ~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~~~~~-~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Ei  355 (474)
T KOG0194|consen  280 SKN---CIHRDIAARNCLYSKKGVVKISDFGLSRAGSQYVMKK-FLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEI  355 (474)
T ss_pred             HCC---CcchhHhHHHheecCCCeEEeCccccccCCcceeecc-ccccCcceecChhhhccCccccccchhheeeeEEee
Confidence            999   9999999999999999999999999987654221111 122357799999999999999999999999999999


Q ss_pred             Hc-CCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          348 IE-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       348 lt-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      ++ |..||.+....++...+...+ +.+.+.   ..+..+..++..|+..+|++||++.++.+.|+.+.....
T Consensus       356 f~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~---~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~~~~  425 (474)
T KOG0194|consen  356 FENGAEPYPGMKNYEVKAKIVKNGYRMPIPS---KTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEKKKE  425 (474)
T ss_pred             eccCCCCCCCCCHHHHHHHHHhcCccCCCCC---CCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHhccc
Confidence            98 888999999988888885544 444433   456889999999999999999999999999999876644

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=4.8e-41  Score=326.67  Aligned_cols=241  Identities=24%  Similarity=0.387  Sum_probs=204.9

Q ss_pred             eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCC
Q 012684          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~  235 (458)
                      +.||+|+||.||.     +|..||+|++.............+.+|+.+++.++||||+++++++..++..|+||||++++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG   80 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence            3689999999873     68899999997654434455667788999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCC
Q 012684          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (458)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~  315 (458)
                      +|..++...+.+++..+..++.|++.||.|||+++   ++||||||+|||++.++.++|+|||++...... ........
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~  156 (323)
T cd05595          81 ELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GATMKTFC  156 (323)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCC-CCcccccc
Confidence            99999988888999999999999999999999999   999999999999999999999999998753221 12223456


Q ss_pred             CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 012684          316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE  395 (458)
Q Consensus       316 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  395 (458)
                      ||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.... ..   .+..+++++.++|..||+.
T Consensus       157 gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~-~~---~p~~~~~~~~~li~~~L~~  232 (323)
T cd05595         157 GTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEE-IR---FPRTLSPEAKSLLAGLLKK  232 (323)
T ss_pred             CCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCC-CC---CCCCCCHHHHHHHHHHccC
Confidence            8999999999998889999999999999999999999998776655555443222 22   2345788999999999999


Q ss_pred             CCCCCC-----CHHHHHHH
Q 012684          396 KPAKRP-----TFRQIITR  409 (458)
Q Consensus       396 dp~~Rp-----s~~~ll~~  409 (458)
                      ||.+||     ++.+++++
T Consensus       233 dP~~R~~~~~~~~~~~l~h  251 (323)
T cd05595         233 DPKQRLGGGPSDAKEVMEH  251 (323)
T ss_pred             CHHHhCCCCCCCHHHHHcC
Confidence            999998     89999876

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=5.3e-42  Score=302.77  Aligned_cols=250  Identities=25%  Similarity=0.419  Sum_probs=216.6

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCC--C---CHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCc
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVI--S---DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~--~---~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~  224 (458)
                      +|...+.||.|..+.|.     .+|..+|+|++.....  +   .....+.-..|+.+|+++ .||+|+++.++++.+..
T Consensus        18 ~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF   97 (411)
T KOG0599|consen   18 KYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAF   97 (411)
T ss_pred             hcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcch
Confidence            46667789999887553     4788999999864221  1   223344456799999999 79999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      +++|+|.|+.|.|.+++.+.-.+++....+|++|+++|++|||.++   |+||||||+|||++++.+++|+|||++..+.
T Consensus        98 ~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   98 VFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             hhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEeccceeeccC
Confidence            9999999999999999999888999999999999999999999999   9999999999999999999999999999875


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCC------CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCCh
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA  378 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  378 (458)
                      .  .......+|||+|+|||.+.+.      .|+...|+|++||++|.|+.|++||....+.-+...+.........+.+
T Consensus       175 ~--GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speW  252 (411)
T KOG0599|consen  175 P--GEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEW  252 (411)
T ss_pred             C--chhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcch
Confidence            3  4566778999999999998653      6778899999999999999999999987776666766566666666788


Q ss_pred             hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          379 KLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       379 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      .+++...++||.+||+.||++|.|+++++.|-
T Consensus       253 adis~~~KdLIsrlLqVdp~~Ritake~LaHp  284 (411)
T KOG0599|consen  253 ADISATVKDLISRLLQVDPTKRITAKEALAHP  284 (411)
T ss_pred             hhccccHHHHHHHHHeeCchhcccHHHHhcCh
Confidence            99999999999999999999999999999873

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.7e-42  Score=297.21  Aligned_cols=248  Identities=26%  Similarity=0.438  Sum_probs=220.2

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|.+.+.||+|-||.||.     ++--||+|++.++.+.......++.+|+++-..++||||+++|++|.+...+|+++|
T Consensus        23 dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilE  102 (281)
T KOG0580|consen   23 DFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILE  102 (281)
T ss_pred             hccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEE
Confidence            677889999999999984     677899999987766666666788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |..+|.|...|+  ...++++...+.++.|++.||.|+|.++   ++||||||+|+|++..+.+|++|||-+...+   .
T Consensus       103 ya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p---~  176 (281)
T KOG0580|consen  103 YAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP---S  176 (281)
T ss_pred             ecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC---C
Confidence            999999999999  4567999999999999999999999999   9999999999999999999999999987654   3


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      ......+||..|.+||...+..++...|+|++|++.||++.|..||...+..+....+.+.. ..+   +..++.+.+++
T Consensus       177 ~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~-~~~---p~~is~~a~dl  252 (281)
T KOG0580|consen  177 NKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVD-LKF---PSTISGGAADL  252 (281)
T ss_pred             CCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHcc-ccC---CcccChhHHHH
Confidence            34455689999999999999999999999999999999999999999988777776663333 232   36788999999


Q ss_pred             HHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      |.+|+.++|.+|.+..+++.+-.-.
T Consensus       253 I~~ll~~~p~~r~~l~~v~~hpwI~  277 (281)
T KOG0580|consen  253 ISRLLVKNPIERLALTEVMDHPWIV  277 (281)
T ss_pred             HHHHhccCccccccHHHHhhhHHHH
Confidence            9999999999999999999986554

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=6.1e-41  Score=326.61  Aligned_cols=240  Identities=25%  Similarity=0.401  Sum_probs=204.6

Q ss_pred             eeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCC
Q 012684          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD  236 (458)
Q Consensus       162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~  236 (458)
                      .||+|+||.||.     +|..||+|++.............+.+|+.+++.++||||+++++++..++..++||||+++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~   81 (328)
T cd05593           2 LLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGE   81 (328)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCC
Confidence            689999999873     688999999976544444556778889999999999999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCCC
Q 012684          237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT  316 (458)
Q Consensus       237 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~g  316 (458)
                      |.+++...+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++...... ........|
T Consensus        82 L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~~g  157 (328)
T cd05593          82 LFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITD-AATMKTFCG  157 (328)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCc-ccccccccC
Confidence            9999988888999999999999999999999999   999999999999999999999999998753221 122234568


Q ss_pred             CCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccC
Q 012684          317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK  396 (458)
Q Consensus       317 t~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~d  396 (458)
                      |+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+.. ....   .+..+++.+.++|.+||..|
T Consensus       158 t~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~-~~~~---~p~~~~~~~~~li~~~L~~d  233 (328)
T cd05593         158 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-EDIK---FPRTLSADAKSLLSGLLIKD  233 (328)
T ss_pred             CcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhcc-CCcc---CCCCCCHHHHHHHHHHcCCC
Confidence            9999999999988899999999999999999999999987665544444322 2222   23457889999999999999


Q ss_pred             CCCCC-----CHHHHHHH
Q 012684          397 PAKRP-----TFRQIITR  409 (458)
Q Consensus       397 p~~Rp-----s~~~ll~~  409 (458)
                      |.+||     ++.+++++
T Consensus       234 P~~R~~~~~~~~~~il~h  251 (328)
T cd05593         234 PNKRLGGGPDDAKEIMRH  251 (328)
T ss_pred             HHHcCCCCCCCHHHHhcC
Confidence            99997     89999987

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=6.3e-41  Score=327.70  Aligned_cols=244  Identities=24%  Similarity=0.397  Sum_probs=208.2

Q ss_pred             ccccCceeeccceEEEEEE---c---CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          155 LDFTNSVEITKGTFILAFW---R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~---~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      .+|++.+.||+|+||.|+.   .   +..||+|.+...........+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus        30 ~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv  109 (340)
T PTZ00426         30 EDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLV  109 (340)
T ss_pred             hhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEE
Confidence            3688889999999998873   1   258999998754433445566788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |||+++|+|.+++...+.+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++......  
T Consensus       110 ~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--  184 (340)
T PTZ00426        110 LEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--  184 (340)
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence            999999999999998888999999999999999999999999   999999999999999999999999998765321  


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                        .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.. ....+   +..+++.+.++
T Consensus       185 --~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~-~~~~~---p~~~~~~~~~l  258 (340)
T PTZ00426        185 --TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILE-GIIYF---PKFLDNNCKHL  258 (340)
T ss_pred             --cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhc-CCCCC---CCCCCHHHHHH
Confidence              2335689999999999988899999999999999999999999998766554444432 22222   34567889999


Q ss_pred             HHHHcccCCCCCC-----CHHHHHHH
Q 012684          389 IEECWNEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rp-----s~~~ll~~  409 (458)
                      |++||+.||.+|+     ++++++++
T Consensus       259 i~~~l~~dp~~R~~~~~~~~~~~~~h  284 (340)
T PTZ00426        259 MKKLLSHDLTKRYGNLKKGAQNVKEH  284 (340)
T ss_pred             HHHHcccCHHHcCCCCCCCHHHHHcC
Confidence            9999999999995     89999887

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-40  Score=323.25  Aligned_cols=266  Identities=33%  Similarity=0.520  Sum_probs=211.1

Q ss_pred             CCCcccCcCCccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE
Q 012684          145 VPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT  220 (458)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~  220 (458)
                      ...-++..++.+|.....||+|+||.||.    +|..||||.+......  . ..+|.+|+.++.+++|||+++++|||.
T Consensus        65 fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~--~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~  141 (361)
T KOG1187|consen   65 FSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQ--G-EREFLNEVEILSRLRHPNLVKLLGYCL  141 (361)
T ss_pred             eeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCc--c-hhHHHHHHHHHhcCCCcCcccEEEEEe
Confidence            34556667777899999999999999983    5589999988654322  1 345999999999999999999999999


Q ss_pred             eCC-ceEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeec
Q 012684          221 QSS-PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (458)
Q Consensus       221 ~~~-~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Df  297 (458)
                      +.+ ..+||+||++.|+|.+++....  .++|..+++|+.++++||+|||+..+.+|+||||||+|||+|++...||+||
T Consensus       142 e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDF  221 (361)
T KOG1187|consen  142 EGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDF  221 (361)
T ss_pred             cCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCc
Confidence            988 4999999999999999998754  7999999999999999999999988667999999999999999999999999


Q ss_pred             CCccccccCCCCCcccC-CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--c-HHHH---HHhcC
Q 012684          298 GVSKLLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--E-VPKA---YAARQ  370 (458)
Q Consensus       298 g~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~--~-~~~~---~~~~~  370 (458)
                      |++...+.. ....... .||.+|+|||++..+..+.|+||||||+++.||+||+.|.+...+.  . ...+   .....
T Consensus       222 GLa~~~~~~-~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~  300 (361)
T KOG1187|consen  222 GLAKLGPEG-DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEG  300 (361)
T ss_pred             cCcccCCcc-ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCc
Confidence            999765431 1111122 7899999999999889999999999999999999999888754311  1 2221   11111


Q ss_pred             ------CCCCC--CChh-hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          371 ------RPPFK--APAK-LYARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       371 ------~~~~~--~~~~-~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                            .+.+.  .... ..-..+..+...|++.+|.+||++.++++.|+.+.
T Consensus       301 ~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~  353 (361)
T KOG1187|consen  301 KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL  353 (361)
T ss_pred             chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence                  11111  1110 12234778889999999999999999988885543

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.1e-40  Score=329.54  Aligned_cols=250  Identities=26%  Similarity=0.391  Sum_probs=206.2

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.|+.     +|+.||+|++.............+..|+.++..++||+|+++++.+.+...+|+|||
T Consensus         2 ~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E   81 (363)
T cd05628           2 DFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIME   81 (363)
T ss_pred             CceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEc
Confidence            577889999999999873     578999999975433344455678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC--
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~--  308 (458)
                      |++||+|.+++.+.+.+++..+..++.|++.||.|||++|   |+||||||+|||++.++.++|+|||++........  
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~  158 (363)
T cd05628          82 FLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE  158 (363)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccccccc
Confidence            9999999999998888999999999999999999999999   99999999999999999999999999875432110  


Q ss_pred             --------------------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 012684          309 --------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM  356 (458)
Q Consensus       309 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~  356 (458)
                                                      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~  238 (363)
T cd05628         159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (363)
T ss_pred             ccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCC
Confidence                                            001234689999999999998999999999999999999999999998


Q ss_pred             CCCCcHHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcc--cCCCCCCCHHHHHHH
Q 012684          357 KHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWN--EKPAKRPTFRQIITR  409 (458)
Q Consensus       357 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~--~dp~~Rps~~~ll~~  409 (458)
                      ....+....+.... ...++. ...++++++++|.+|+.  .++..||++.++++|
T Consensus       239 ~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~~~~~~r~~r~~~~ei~~h  293 (363)
T cd05628         239 ETPQETYKKVMNWKETLIFPP-EVPISEKAKDLILRFCCEWEHRIGAPGVEEIKTN  293 (363)
T ss_pred             CCHHHHHHHHHcCcCcccCCC-cCCCCHHHHHHHHHHcCChhhcCCCCCHHHHhCC
Confidence            77666655554322 222222 22367889999998765  233346899999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.6e-41  Score=324.22  Aligned_cols=239  Identities=25%  Similarity=0.383  Sum_probs=201.6

Q ss_pred             eccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012684          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (458)
Q Consensus       163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L  237 (458)
                      ||+|+||.||.     +++.||+|.+.............+..|+.++++++||||+++++++...+..++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L   80 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL   80 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence            69999998873     5788999999754433445566788899999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCCCC
Q 012684          238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS  317 (458)
Q Consensus       238 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt  317 (458)
                      .+++...+.+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++....... .......||
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt  156 (312)
T cd05585          81 FHHLQREGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD-DKTNTFCGT  156 (312)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC-CccccccCC
Confidence            999988888999999999999999999999999   9999999999999999999999999987532221 222345689


Q ss_pred             CcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCC
Q 012684          318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP  397 (458)
Q Consensus       318 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp  397 (458)
                      +.|+|||++.+..++.++|||||||++|+|++|+.||......+....+.. ....   .+..+++.+.++|.+||+.||
T Consensus       157 ~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~~li~~~L~~dp  232 (312)
T cd05585         157 PEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQ-EPLR---FPDGFDRDAKDLLIGLLSRDP  232 (312)
T ss_pred             cccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHc-CCCC---CCCcCCHHHHHHHHHHcCCCH
Confidence            999999999998999999999999999999999999987665554444422 2222   234578899999999999999


Q ss_pred             CCCCC---HHHHHHH
Q 012684          398 AKRPT---FRQIITR  409 (458)
Q Consensus       398 ~~Rps---~~~ll~~  409 (458)
                      .+||+   +.+++.+
T Consensus       233 ~~R~~~~~~~e~l~h  247 (312)
T cd05585         233 TRRLGYNGAQEIKNH  247 (312)
T ss_pred             HHcCCCCCHHHHHcC
Confidence            99975   6777765

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=8.3e-41  Score=326.44  Aligned_cols=248  Identities=21%  Similarity=0.383  Sum_probs=203.8

Q ss_pred             cccCceeeccceEEEEEE--------cCeEEEEEEcCCCCC-CCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCce
Q 012684          156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVI-SDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~  225 (458)
                      +|++.+.||+|+||.||.        +|..||+|++..... ......+.+..|+.+++.+ +||+|+++++++..++.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            477889999999999873        578999999865322 1233445678899999999 599999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      ++||||+++++|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~  157 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKEFLS  157 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCccccc
Confidence            999999999999999988888999999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH---hcCCCCCCCChhhh
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLY  381 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~~~  381 (458)
                      ..........||+.|+|||++.+. .++.++|||||||++|+|++|+.||...........+.   ....+.   .+..+
T Consensus       158 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~~  234 (332)
T cd05614         158 EEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPP---FPSFI  234 (332)
T ss_pred             cCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC---CCCCC
Confidence            333333345689999999998765 47889999999999999999999997654332222221   122222   23457


Q ss_pred             HHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012684          382 ARGLKELIEECWNEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  409 (458)
                      ++.+.++|.+||+.||.+||     ++++++++
T Consensus       235 ~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h  267 (332)
T cd05614         235 GPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEH  267 (332)
T ss_pred             CHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcC
Confidence            88999999999999999999     78888876

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-41  Score=331.98  Aligned_cols=249  Identities=27%  Similarity=0.424  Sum_probs=210.7

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|.+.+.||+|+||.||.     +|+.||+|++.............+..|+.++..++||||+++++++.+++..++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (350)
T cd05573           2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME   81 (350)
T ss_pred             CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence            578889999999998873     589999999976543333455678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC---
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE---  307 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~---  307 (458)
                      |+++++|.+++.+.+.+++..+..++.|++.||.|||+.|   ++||||||+||+++.++.++|+|||++.......   
T Consensus        82 ~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~  158 (350)
T cd05573          82 YMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE  158 (350)
T ss_pred             CCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCcccCccc
Confidence            9999999999998888999999999999999999999999   9999999999999999999999999987654332   


Q ss_pred             -------------------------CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 012684          308 -------------------------DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV  362 (458)
Q Consensus       308 -------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~  362 (458)
                                               ........||+.|+|||++.+..++.++|||||||++|+|++|+.||......+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~  238 (350)
T cd05573         159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQET  238 (350)
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHH
Confidence                                     0122345689999999999998999999999999999999999999998776555


Q ss_pred             HHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCC-HHHHHHH
Q 012684          363 PKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPT-FRQIITR  409 (458)
Q Consensus       363 ~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~  409 (458)
                      ...+.... ...++. ...+++.+.++|..||. ||.+||+ +++++++
T Consensus       239 ~~~i~~~~~~~~~p~-~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h  285 (350)
T cd05573         239 YNKIINWKESLRFPP-DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH  285 (350)
T ss_pred             HHHHhccCCcccCCC-CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence            54443311 112221 22378999999999997 9999999 9999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=4.7e-40  Score=310.92  Aligned_cols=251  Identities=26%  Similarity=0.437  Sum_probs=208.3

Q ss_pred             ccccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      .+|++.+.||+|+||.|+.        .+..||+|.++...  .......+.+|+.+++.++||||+++++++..++..+
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~   82 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMM   82 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcE
Confidence            3577888999999998862        35689999997542  3344567889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      +||||+++++|.+++... +.+++..++.++.|++.||+|||+.+   ++||||||+||+++.++.++++|||.+.....
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~  159 (266)
T cd05064          83 IVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS  159 (266)
T ss_pred             EEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence            999999999999999764 56899999999999999999999999   99999999999999999999999998765322


Q ss_pred             CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      ..........++..|+|||.+.+..++.++|||||||++|++++ |..||......+....+......+   .+..++..
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  236 (266)
T cd05064         160 EAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP---APRNCPNL  236 (266)
T ss_pred             cchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHH
Confidence            21111122334678999999988899999999999999999775 999998877666555553332222   24567889


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      +.+++.+||+.+|.+||++.++++.|.++
T Consensus       237 ~~~li~~c~~~~p~~RP~~~~i~~~l~~~  265 (266)
T cd05064         237 LHQLMLDCWQKERGERPRFSQIHSILSKM  265 (266)
T ss_pred             HHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence            99999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=7.7e-42  Score=328.12  Aligned_cols=281  Identities=32%  Similarity=0.478  Sum_probs=224.0

Q ss_pred             CCCcccCcCCccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe
Q 012684          145 VPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ  221 (458)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~  221 (458)
                      ...|+|.+.++  +..+-||.|+-|.|+   +.++.||||+++.-          -..+++.|++|+||||+.+.++|..
T Consensus       116 ~e~WeiPFe~I--sELeWlGSGaQGAVF~Grl~netVAVKKV~el----------kETdIKHLRkLkH~NII~FkGVCtq  183 (904)
T KOG4721|consen  116 EELWEIPFEEI--SELEWLGSGAQGAVFLGRLHNETVAVKKVREL----------KETDIKHLRKLKHPNIITFKGVCTQ  183 (904)
T ss_pred             hhhccCCHHHh--hhhhhhccCcccceeeeeccCceehhHHHhhh----------hhhhHHHHHhccCcceeeEeeeecC
Confidence            34777776654  233458988887766   57899999988521          2347889999999999999999999


Q ss_pred             CCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          222 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       222 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                      ...+|||||||..|.|.++|+....+++.....|..+|+.|+.|||.+.   |||||||.-||||+.+..|||+|||.++
T Consensus       184 sPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~  260 (904)
T KOG4721|consen  184 SPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSK  260 (904)
T ss_pred             CceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchH
Confidence            9999999999999999999999999999999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhh
Q 012684          302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY  381 (458)
Q Consensus       302 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (458)
                      .....  ...-.+.||..|||||+++..+++.|.|||||||+||||+||..||.+.+...++--+  ......-..+..+
T Consensus       261 e~~~~--STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGV--GsNsL~LpvPstc  336 (904)
T KOG4721|consen  261 ELSDK--STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGV--GSNSLHLPVPSTC  336 (904)
T ss_pred             hhhhh--hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEec--cCCcccccCcccC
Confidence            76543  2334567999999999999999999999999999999999999999876654332111  1111111235567


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccccccccchhhhhHHHHHhcCCCCCC
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSSPS  446 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  446 (458)
                      ++.++-||+.||+..|..||++.+++.||+.....+-..+.  ..=|+...++.+..+..+..-+
T Consensus       337 P~GfklL~Kqcw~sKpRNRPSFrqil~HldIa~pell~~te--e~yf~sq~swrEevk~h~~~it  399 (904)
T KOG4721|consen  337 PDGFKLLLKQCWNSKPRNRPSFRQILLHLDIASPELLSTTE--ETYFKSQASWREEVKLHFEKIT  399 (904)
T ss_pred             chHHHHHHHHHHhcCCCCCccHHHHHHHHhhcCHHHhcccH--HHHHHHHHHHHHHHHHhhhhhc
Confidence            89999999999999999999999999999776443332211  1124455556666665554333

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=2.2e-41  Score=295.32  Aligned_cols=260  Identities=23%  Similarity=0.394  Sum_probs=208.8

Q ss_pred             ccCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-
Q 012684          149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-  222 (458)
Q Consensus       149 ~~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-  222 (458)
                      .+...+.+|++++.||+|||..|+.     ++..||+|++...   ..+..+..++|++..++++||||++++++...+ 
T Consensus        15 tv~In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~   91 (302)
T KOG2345|consen   15 TVIINNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREE   91 (302)
T ss_pred             cEEEcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhh
Confidence            3445677899999999999998874     7899999999754   355667889999999999999999999987533 


Q ss_pred             ----CceEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEE
Q 012684          223 ----SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV  294 (458)
Q Consensus       223 ----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl  294 (458)
                          ...|++++|...|+|.+.+..    +..+++.+.+.|+.++++||++||+..| +++||||||.|||+++++.++|
T Consensus        92 ~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~-~yAH~DiKP~NILls~~~~~vl  170 (302)
T KOG2345|consen   92 KDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEP-PYAHRDIKPANILLSDSGLPVL  170 (302)
T ss_pred             ccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCC-cccccCCCcceeEecCCCceEE
Confidence                348999999999999999875    2359999999999999999999999985 6999999999999999999999


Q ss_pred             eecCCccccccCCCCC--------cccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHH
Q 012684          295 ADFGVSKLLTVKEDRP--------LTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP  363 (458)
Q Consensus       295 ~Dfg~~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~  363 (458)
                      .|||.+....-.....        ...-.+|..|+|||++.-.   ..+.++|||||||+||.|+.|..||.......-.
T Consensus       171 ~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgS  250 (302)
T KOG2345|consen  171 MDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGS  250 (302)
T ss_pred             EeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCe
Confidence            9999987653221111        1233578899999998654   5678999999999999999999999764432211


Q ss_pred             HHHH-hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          364 KAYA-ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       364 ~~~~-~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      .... ......++...+ +|+.+.++|++||+.||.+||++.+++.+++.+
T Consensus       251 laLAv~n~q~s~P~~~~-yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~L  300 (302)
T KOG2345|consen  251 LALAVQNAQISIPNSSR-YSEALHQLIKSMLQVDPNQRPTIPELLSKLDDL  300 (302)
T ss_pred             EEEeeeccccccCCCCC-ccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhh
Confidence            1111 111223333233 899999999999999999999999999998875

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=1.3e-40  Score=331.01  Aligned_cols=250  Identities=23%  Similarity=0.337  Sum_probs=206.0

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .|+..+.||+|+||.||.     +++.||+|++...........+.+..|+.+++.++||||+++++++.+...+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E   81 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence            467788999999999974     678999999976544455566778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC-
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~-  309 (458)
                      |++||+|.+++.+.+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++......... 
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~  158 (381)
T cd05626          82 YIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSK  158 (381)
T ss_pred             cCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCcccccccccc
Confidence            9999999999988888999999999999999999999999   999999999999999999999999987533110000 


Q ss_pred             ---------------------------------------------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHH
Q 012684          310 ---------------------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL  344 (458)
Q Consensus       310 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l  344 (458)
                                                                   ......||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il  238 (381)
T cd05626         159 YYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVIL  238 (381)
T ss_pred             cccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHH
Confidence                                                         00234689999999999988899999999999999


Q ss_pred             HHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHc--ccCCCCCCCHHHHHHH
Q 012684          345 QEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECW--NEKPAKRPTFRQIITR  409 (458)
Q Consensus       345 ~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l--~~dp~~Rps~~~ll~~  409 (458)
                      |+|++|+.||......+....+.... .... .....+++++.++|.+|+  ..+|..||++.+++.|
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~h  305 (381)
T cd05626         239 FEMLVGQPPFLAPTPTETQLKVINWENTLHI-PPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAH  305 (381)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHHccccccCC-CCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            99999999998876655444443222 2222 123357889999999855  4555569999999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-41  Score=331.39  Aligned_cols=249  Identities=25%  Similarity=0.420  Sum_probs=207.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||.|+||.|+.     +|+.||||++.............+.+|+.+++.++||||+++++++..+...|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (364)
T cd05599           2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME   81 (364)
T ss_pred             CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence            577889999999999873     688999999975433334455678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC-
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~-  309 (458)
                      |+++|+|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++..+...... 
T Consensus        82 ~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~  158 (364)
T cd05599          82 YLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTE  158 (364)
T ss_pred             CCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccccccc
Confidence            9999999999998888999999999999999999999999   999999999999999999999999998654321100 


Q ss_pred             ------------------------------------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCC
Q 012684          310 ------------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP  353 (458)
Q Consensus       310 ------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p  353 (458)
                                                          ......||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~P  238 (364)
T cd05599         159 FYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPP  238 (364)
T ss_pred             ccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCC
Confidence                                                00123589999999999988999999999999999999999999


Q ss_pred             CCCCCCCcHHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 012684          354 FTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR  409 (458)
Q Consensus       354 f~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~  409 (458)
                      |...+..+....+.... ...++ ....+++.+.++|.+|+. +|.+|++   +.+++.+
T Consensus       239 f~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h  296 (364)
T cd05599         239 FCSDNPQETYRKIINWKETLQFP-DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH  296 (364)
T ss_pred             CCCCCHHHHHHHHHcCCCccCCC-CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcC
Confidence            98877655544443222 11222 123468899999999997 9999998   9999886

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.4e-40  Score=317.92  Aligned_cols=250  Identities=22%  Similarity=0.366  Sum_probs=202.1

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.|+.     +++.||+|++..... .....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (287)
T cd07848           2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE   80 (287)
T ss_pred             CceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence            578889999999998873     578999999975432 23344567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |++++.+..+......+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++..........
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  157 (287)
T cd07848          81 YVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN  157 (287)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCccccccccccc
Confidence            9988777665555567999999999999999999999999   9999999999999999999999999998764433333


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-------------CC-----
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-------------RP-----  372 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-------------~~-----  372 (458)
                      .....+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+....             .+     
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (287)
T cd07848         158 YTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGL  237 (287)
T ss_pred             ccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccc
Confidence            344568899999999988889999999999999999999999998765433221111100             00     


Q ss_pred             CCCC----------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 PFKA----------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 ~~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ..+.          ....++..+.+||++||+.||++|||++++++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~h  284 (287)
T cd07848         238 RFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNH  284 (287)
T ss_pred             ccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence            0000          012357789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.8e-40  Score=309.08  Aligned_cols=249  Identities=24%  Similarity=0.387  Sum_probs=216.4

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .|...+.||+|..|.||+     ++..+|+|++.+......+...+.+.|.++|+.++||.++.+|+.|+.+...|++||
T Consensus        78 ~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~me  157 (459)
T KOG0610|consen   78 HFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVME  157 (459)
T ss_pred             HHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEe
Confidence            467788999999999984     458999999998877777778888999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC-
Q 012684          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-  307 (458)
Q Consensus       231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~-  307 (458)
                      ||+||+|..+++++  +.|++..+..++.+++-||+|||..|   ||+|||||+|||+-++|+|-|+||.++......+ 
T Consensus       158 yCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt  234 (459)
T KOG0610|consen  158 YCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPT  234 (459)
T ss_pred             cCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCCCe
Confidence            99999999999875  34999999999999999999999999   9999999999999999999999999875431100 


Q ss_pred             --------------------------------C----------------------CCcccCCCCCcccCCcccCCCCCCC
Q 012684          308 --------------------------------D----------------------RPLTCQDTSCRYVAPEVFKNEEYDT  333 (458)
Q Consensus       308 --------------------------------~----------------------~~~~~~~gt~~y~aPE~~~~~~~~~  333 (458)
                                                      .                      .....++||-.|+|||++.|..++.
T Consensus       235 ~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgs  314 (459)
T KOG0610|consen  235 LVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGS  314 (459)
T ss_pred             eeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCc
Confidence                                            0                      0013456899999999999999999


Q ss_pred             chhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC----HHHHHHH
Q 012684          334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT----FRQIITR  409 (458)
Q Consensus       334 ~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~~  409 (458)
                      +.|.|+||+++|||+.|+-||.+.+..+....+.. +.+.++..+ .++..+++||+++|.+||.+|..    |.+|-+|
T Consensus       315 AVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~-~~l~Fp~~~-~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~H  392 (459)
T KOG0610|consen  315 AVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG-QPLKFPEEP-EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRH  392 (459)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc-CCCcCCCCC-cchhHHHHHHHHHhccChhhhhccccchHHhhcC
Confidence            99999999999999999999999999998888743 444444433 67889999999999999999998    7777765

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=4.8e-41  Score=327.85  Aligned_cols=249  Identities=25%  Similarity=0.372  Sum_probs=208.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|.+.+.||+|+||.||.     +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+....++|||
T Consensus         2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (330)
T cd05601           2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME   81 (330)
T ss_pred             CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence            577889999999999873     688999999986544344556678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |+++++|.+++.+. +.+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++.........
T Consensus        82 ~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~  158 (330)
T cd05601          82 YQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV  158 (330)
T ss_pred             CCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCCCce
Confidence            99999999999875 67999999999999999999999999   999999999999999999999999999866433222


Q ss_pred             CcccCCCCCcccCCcccC------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCC-CCCCCChhhhH
Q 012684          310 PLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-PPFKAPAKLYA  382 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  382 (458)
                      ......+|+.|+|||++.      +..++.++|||||||++|+|++|+.||...........+..... ..++ ....++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~~  237 (330)
T cd05601         159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFP-EDPKVS  237 (330)
T ss_pred             eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCC-CCCCCC
Confidence            223346899999999986      44677899999999999999999999987766555554433222 2222 223478


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.+.++|..||. +|.+||++.+++.+
T Consensus       238 ~~~~~li~~ll~-~p~~R~t~~~l~~h  263 (330)
T cd05601         238 SDFLDLIQSLLC-GQKERLGYEGLCCH  263 (330)
T ss_pred             HHHHHHHHHHcc-ChhhCCCHHHHhCC
Confidence            899999999998 99999999999976

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=4e-41  Score=326.56  Aligned_cols=263  Identities=29%  Similarity=0.533  Sum_probs=217.9

Q ss_pred             CCcccCcCCccccCceeeccceEEEEEEc--CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          146 PEYEIDPHELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       146 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      .+|+|.+.+  +.+...||+|+||.||..  .-+||||++..... .++.++.|++|+.++++-+|.||+-+.|+|....
T Consensus       385 ~~WeIp~~e--v~l~~rIGsGsFGtV~Rg~whGdVAVK~Lnv~~p-t~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~  461 (678)
T KOG0193|consen  385 EEWEIPPEE--VLLGERIGSGSFGTVYRGRWHGDVAVKLLNVDDP-TPEQLQAFKNEVAVLKKTRHENILLFMGACMNPP  461 (678)
T ss_pred             cccccCHHH--hhccceeccccccceeecccccceEEEEEecCCC-CHHHHHHHHHHHHHHhhcchhhheeeehhhcCCc
Confidence            466666654  456679999999999832  23799999988765 4458899999999999999999999999998876


Q ss_pred             ceEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      . .||+.+|+|-+|+.+++- ..+|...+.+.|++|+++|+.|||.++   |+|+|||..|||+.+++.|||+|||++..
T Consensus       462 ~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatv  537 (678)
T KOG0193|consen  462 L-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATV  537 (678)
T ss_pred             e-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceee
Confidence            6 999999999999999975 345888999999999999999999999   99999999999999999999999999864


Q ss_pred             cccC-CCCCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC--CCCCCC
Q 012684          303 LTVK-EDRPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKA  376 (458)
Q Consensus       303 ~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--~~~~~~  376 (458)
                      -... .........|...|||||+++-+   +|++.+||||||+++|||++|..||.....+.+. ..+..+  .+....
T Consensus       538 k~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIi-fmVGrG~l~pd~s~  616 (678)
T KOG0193|consen  538 KTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQII-FMVGRGYLMPDLSK  616 (678)
T ss_pred             eeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheE-EEecccccCccchh
Confidence            3322 22333445677889999998654   7889999999999999999999999954444433 322333  455555


Q ss_pred             ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       377 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      .....++++++|+..||.+++++||.+.+|+..|+.+..+
T Consensus       617 ~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~~  656 (678)
T KOG0193|consen  617 IRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLPS  656 (678)
T ss_pred             hhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhhc
Confidence            5667788999999999999999999999999998888664

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1e-40  Score=331.48  Aligned_cols=249  Identities=24%  Similarity=0.375  Sum_probs=205.3

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||.|+||.||.     +|+.||||++...........+.+.+|+.+++.++||||+++++++.++..+|+|||
T Consensus         2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E   81 (377)
T cd05629           2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME   81 (377)
T ss_pred             CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence            577889999999999884     688999999865433334456778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC-
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~-  309 (458)
                      |++||+|.+++...+.+++..+..++.|++.||+|||+.|   |+||||||+|||++.++.++|+|||++..+...... 
T Consensus        82 ~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~  158 (377)
T cd05629          82 FLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA  158 (377)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccccccc
Confidence            9999999999988888999999999999999999999999   999999999999999999999999998632110000 


Q ss_pred             ---------------------------------------------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHH
Q 012684          310 ---------------------------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL  344 (458)
Q Consensus       310 ---------------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l  344 (458)
                                                                   ......||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil  238 (377)
T cd05629         159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM  238 (377)
T ss_pred             cccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhh
Confidence                                                         00124589999999999988899999999999999


Q ss_pred             HHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCC---CCHHHHHHH
Q 012684          345 QEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKR---PTFRQIITR  409 (458)
Q Consensus       345 ~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~R---ps~~~ll~~  409 (458)
                      |+|++|..||......+....+.... ...++ ....++.+++++|.+||. +|.+|   +++.+++.+
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~h  305 (377)
T cd05629         239 FECLIGWPPFCSENSHETYRKIINWRETLYFP-DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSH  305 (377)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHHHccCCccCCC-CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcC
Confidence            99999999998776655544443222 12221 223578899999999998 67765   599999987

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=9.7e-40  Score=318.69  Aligned_cols=251  Identities=26%  Similarity=0.444  Sum_probs=206.4

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|++.+.||+|+||.|+.     +|..||+|.+....  .....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence            45788889999999998874     68899999997542  344556789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+.+  .|+||||||+||+++.++.++|+|||++......  
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~--  157 (331)
T cd06649          82 MEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS--  157 (331)
T ss_pred             eecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc--
Confidence            999999999999998888999999999999999999999853  2999999999999999999999999998765322  


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh--------------------
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA--------------------  368 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~--------------------  368 (458)
                       ......+++.|+|||++.+..++.++|||||||++|+|++|+.||......+....+..                    
T Consensus       158 -~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (331)
T cd06649         158 -MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPP  236 (331)
T ss_pred             -ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccc
Confidence             22334689999999999988899999999999999999999999976543322111100                    


Q ss_pred             ------------------------cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          369 ------------------------RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       369 ------------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                                              ............+++++++||.+||..||++|||+++++++..
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~  303 (331)
T cd06649         237 GRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTF  303 (331)
T ss_pred             cccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChH
Confidence                                    0000001112246789999999999999999999999999843

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=5.5e-41  Score=338.90  Aligned_cols=251  Identities=31%  Similarity=0.554  Sum_probs=217.8

Q ss_pred             cccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      +....++||+|.||.|+.          ....||||.++..  .+.+..++|++|++++..++|||||+++|.|..++.+
T Consensus       487 ~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~  564 (774)
T KOG1026|consen  487 DIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLAELQHPNIVRLLGVCREGDPL  564 (774)
T ss_pred             heeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCee
Confidence            344557899999999973          3478999999865  3455778899999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC
Q 012684          226 MIVTEYLPKGDLRAFLKRK--------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~  291 (458)
                      |+|+|||..|+|.+||...              ++++..+.+.|+.||+.|+.||-++.   ++||||-.+|+|++++..
T Consensus       565 ~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~  641 (774)
T KOG1026|consen  565 CMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLV  641 (774)
T ss_pred             EEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceE
Confidence            9999999999999999742              23788999999999999999999999   999999999999999999


Q ss_pred             EEEeecCCccccccCCCCCcc-cCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhc
Q 012684          292 LKVADFGVSKLLTVKEDRPLT-CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR  369 (458)
Q Consensus       292 vkl~Dfg~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~  369 (458)
                      |||+|||+++.+-..+..... ...-+.+|||||.+..++++.++||||+||+|||+++ |+.||.+.+.+++.+.+...
T Consensus       642 VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g  721 (774)
T KOG1026|consen  642 VKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAG  721 (774)
T ss_pred             EEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcC
Confidence            999999999865433322221 2234789999999999999999999999999999998 99999999999999988555


Q ss_pred             CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      ...+.   +.++|.++.+|+..||+.+|.+||++++|-..|+..-
T Consensus       722 ~lL~~---Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~  763 (774)
T KOG1026|consen  722 QLLSC---PENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWA  763 (774)
T ss_pred             CcccC---CCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHH
Confidence            54333   5668899999999999999999999999999998874

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=1.9e-40  Score=328.30  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=207.6

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|++.+.||+|+||.||.     +|..||+|.+.............+.+|+.+++.++||||+++++++..+...|+|
T Consensus        42 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv  121 (370)
T cd05596          42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMV  121 (370)
T ss_pred             HHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEE
Confidence            34688889999999999873     6889999999754333334445678899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |||++||+|.+++.. ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus       122 ~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~  197 (370)
T cd05596         122 MEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM  197 (370)
T ss_pred             EcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc
Confidence            999999999998875 35888999999999999999999999   99999999999999999999999999876543322


Q ss_pred             CCcccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR  383 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  383 (458)
                      .......||+.|+|||++.+.    .++.++|||||||++|+|++|+.||...+.......+.... ...++ ....++.
T Consensus       198 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s~  276 (370)
T cd05596         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFP-DDIEISK  276 (370)
T ss_pred             ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCC-CcCCCCH
Confidence            223345689999999998653    37789999999999999999999999877655555553322 12222 2235789


Q ss_pred             HHHHHHHHHcccCCCC--CCCHHHHHHH
Q 012684          384 GLKELIEECWNEKPAK--RPTFRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~--Rps~~~ll~~  409 (458)
                      ++.++|..||+.+|.+  |+++.+++++
T Consensus       277 ~~~~li~~~L~~~p~r~~R~s~~ell~h  304 (370)
T cd05596         277 QAKDLICAFLTDREVRLGRNGVDEIKSH  304 (370)
T ss_pred             HHHHHHHHHccChhhccCCCCHHHHhcC
Confidence            9999999999999998  9999999987

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.3e-40  Score=301.87  Aligned_cols=248  Identities=28%  Similarity=0.407  Sum_probs=203.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV  228 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv  228 (458)
                      +|+...+|++|+||.||.     +++-||+|+++.+.....-- -...+|+.+|.+++|||||.+-.+....  +.+|+|
T Consensus        77 efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFP-ItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~V  155 (419)
T KOG0663|consen   77 EFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFP-ITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIV  155 (419)
T ss_pred             HHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCc-chhHHHHHHHHhcCCCCeeeeEEEEeccccceeeee
Confidence            577888999999999984     68899999998654322211 2346799999999999999999988643  569999


Q ss_pred             EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||||+ .+|..++..-+ +|+..++..++.|++.|++|||.++   |+||||||+|+|++..|.+|++|||+|+.++.. 
T Consensus       156 Me~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp-  230 (419)
T KOG0663|consen  156 MEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYGSP-  230 (419)
T ss_pred             HHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhcCC-
Confidence            99995 59999998754 7999999999999999999999999   999999999999999999999999999988755 


Q ss_pred             CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-CCC------CCCCCh-
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP------PFKAPA-  378 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~~~------~~~~~~-  378 (458)
                      ..+.+...-|.+|+|||++.+. .|+...|+||+||++.||+++++.|.+.+.......+... +.|      .+...+ 
T Consensus       231 ~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~  310 (419)
T KOG0663|consen  231 LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPA  310 (419)
T ss_pred             cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccch
Confidence            4556667789999999998875 6899999999999999999999999988765544444221 111      110000 


Q ss_pred             --------------------hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          379 --------------------KLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       379 --------------------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                          ..++..-.+|+..+|..||.+|.||++.|++
T Consensus       311 ~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h  361 (419)
T KOG0663|consen  311 VKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKH  361 (419)
T ss_pred             hhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcc
Confidence                                1134667899999999999999999999987

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=9.3e-41  Score=325.08  Aligned_cols=241  Identities=25%  Similarity=0.405  Sum_probs=203.9

Q ss_pred             eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCC
Q 012684          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~  235 (458)
                      +.||+|+||.|+.     +|..||+|++.............+..|+.+++.++||||+++++++..+...|+||||++++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   80 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG   80 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence            3689999999873     68899999997654444445567788999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccC
Q 012684          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ  314 (458)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~  314 (458)
                      +|.+++...+.+++..+..++.|++.||.|||+ .+   |+||||||+|||++.++.+||+|||++...... .......
T Consensus        81 ~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~-~~~~~~~  156 (325)
T cd05594          81 ELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-GATMKTF  156 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCC-Ccccccc
Confidence            999999888889999999999999999999997 78   999999999999999999999999998753221 1222345


Q ss_pred             CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 012684          315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN  394 (458)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  394 (458)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.. ....+   +..+++++.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~-~~~~~---p~~~~~~~~~li~~~L~  232 (325)
T cd05594         157 CGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILM-EEIRF---PRTLSPEAKSLLSGLLK  232 (325)
T ss_pred             cCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhc-CCCCC---CCCCCHHHHHHHHHHhh
Confidence            689999999999988899999999999999999999999987665554444422 22222   34578899999999999


Q ss_pred             cCCCCCC-----CHHHHHHH
Q 012684          395 EKPAKRP-----TFRQIITR  409 (458)
Q Consensus       395 ~dp~~Rp-----s~~~ll~~  409 (458)
                      .||.+|+     ++.+++++
T Consensus       233 ~dP~~R~~~~~~~~~~il~h  252 (325)
T cd05594         233 KDPKQRLGGGPDDAKEIMQH  252 (325)
T ss_pred             cCHHHhCCCCCCCHHHHhcC
Confidence            9999996     89999987

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2e-40  Score=315.09  Aligned_cols=243  Identities=24%  Similarity=0.460  Sum_probs=212.5

Q ss_pred             ccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |...+.||+|-|.+|.     ++|+.||||++.+..... .....+..|+..|+.++|||||++|.+...+..+|||+|+
T Consensus        20 YDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL   98 (864)
T KOG4717|consen   20 YDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL   98 (864)
T ss_pred             ehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence            6677889999999875     699999999998876543 3445677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec-CCCCEEEeecCCccccccCCCC
Q 012684          232 LPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       232 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~-~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      -++|+|++|+.+.. .+.++.+.+++.||+.|+.|+|+.+   ++||||||+|+++- .-|.|||.|||++..+.  +..
T Consensus        99 GD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~--PG~  173 (864)
T KOG4717|consen   99 GDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ--PGK  173 (864)
T ss_pred             cCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCC--Ccc
Confidence            99999999997654 4999999999999999999999999   99999999998765 67899999999997653  445


Q ss_pred             CcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      .....+|+..|-|||++.+..|+ ++.|||||||+||.|++|+.||...++.+....+..... .   .|.+++.++++|
T Consensus       174 kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKY-t---vPshvS~eCrdL  249 (864)
T KOG4717|consen  174 KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKY-T---VPSHVSKECRDL  249 (864)
T ss_pred             hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccc-c---CchhhhHHHHHH
Confidence            66778899999999999998887 689999999999999999999999988887766633332 2   257899999999


Q ss_pred             HHHHcccCCCCCCCHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~  409 (458)
                      |..||..||++|.+.+++...
T Consensus       250 I~sMLvRdPkkRAslEeI~s~  270 (864)
T KOG4717|consen  250 IQSMLVRDPKKRASLEEIVST  270 (864)
T ss_pred             HHHHHhcCchhhccHHHHhcc
Confidence            999999999999999999864

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=2.1e-40  Score=329.76  Aligned_cols=250  Identities=24%  Similarity=0.349  Sum_probs=205.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .|+..+.||+|+||.|+.     +++.||+|++.............+.+|+.+++.++||||+++++.+.++..+|+|||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E   81 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD   81 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence            477889999999999874     678999999975443344556778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC--
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~--  308 (458)
                      |+++|+|.+++.+.+.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||++........  
T Consensus        82 ~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~  158 (382)
T cd05625          82 YIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (382)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCcccccccccc
Confidence            9999999999988888999999999999999999999999   99999999999999999999999999753210000  


Q ss_pred             --------------------------------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHH
Q 012684          309 --------------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL  344 (458)
Q Consensus       309 --------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l  344 (458)
                                                                  .......||+.|+|||++.+..++.++|||||||++
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil  238 (382)
T cd05625         159 YYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVIL  238 (382)
T ss_pred             ccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHH
Confidence                                                        001124689999999999998999999999999999


Q ss_pred             HHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 012684          345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR  409 (458)
Q Consensus       345 ~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~  409 (458)
                      |+|++|+.||...++.+....+..............+++++.++|.+|+ .+|.+|++   +.+++.|
T Consensus       239 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  305 (382)
T cd05625         239 YEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAH  305 (382)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcC
Confidence            9999999999987665554444332221111223457889999998876 59999987   8888876

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=4.2e-39  Score=328.67  Aligned_cols=249  Identities=24%  Similarity=0.361  Sum_probs=208.6

Q ss_pred             cCCccccCceeeccceEEEEEE-----c-CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----R-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~-g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      +....|.+.+.||+|+||.||.     + +..||+|.+...   .......+.+|+.+++.++||||+++++++..++..
T Consensus        64 ~~~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~  140 (478)
T PTZ00267         64 PREHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKL  140 (478)
T ss_pred             CcceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEE
Confidence            4445689999999999998873     3 678999987533   344556678899999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          226 MIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                      |+||||++||+|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus       141 ~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~  217 (478)
T PTZ00267        141 LLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSK  217 (478)
T ss_pred             EEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCce
Confidence            999999999999988754    346889999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhh
Q 012684          302 LLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL  380 (458)
Q Consensus       302 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (458)
                      ........ ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+......+   .+..
T Consensus       218 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~---~~~~  294 (478)
T PTZ00267        218 QYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDP---FPCP  294 (478)
T ss_pred             ecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC---CCcc
Confidence            66432211 1234568999999999998889999999999999999999999998776655555543333332   2345


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          381 YARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++.++.++|..||..||.+||++.+++.+
T Consensus       295 ~s~~~~~li~~~L~~dP~~Rps~~~~l~~  323 (478)
T PTZ00267        295 VSSGMKALLDPLLSKNPALRPTTQQLLHT  323 (478)
T ss_pred             CCHHHHHHHHHHhccChhhCcCHHHHHhC
Confidence            77899999999999999999999999864

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.8e-40  Score=320.36  Aligned_cols=240  Identities=29%  Similarity=0.484  Sum_probs=198.7

Q ss_pred             eeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCCC
Q 012684          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (458)
Q Consensus       162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~  235 (458)
                      .||+|+||.||.     +++.||+|.+...........+.+..|..++... +||||+++++++..+...++||||++|+
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg   81 (316)
T cd05592           2 VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGG   81 (316)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            689999999873     5778999999765433334445556677776654 8999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCC
Q 012684          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (458)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~  315 (458)
                      +|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....... .......
T Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~-~~~~~~~  157 (316)
T cd05592          82 DLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE-GKASTFC  157 (316)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC-Ccccccc
Confidence            99999988888999999999999999999999999   9999999999999999999999999987543222 2233456


Q ss_pred             CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 012684          316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE  395 (458)
Q Consensus       316 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  395 (458)
                      ||+.|+|||.+.+..++.++|||||||++|+|++|+.||.+.+..+....+. ...+.+   +..++.++.++|..||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~-~~~~~~---~~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         158 GTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSIL-NDRPHF---PRWISKEAKDCLSKLFER  233 (316)
T ss_pred             CCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCC---CCCCCHHHHHHHHHHccC
Confidence            8999999999998889999999999999999999999999876655554442 223322   345778999999999999


Q ss_pred             CCCCCCCHH-HHHHH
Q 012684          396 KPAKRPTFR-QIITR  409 (458)
Q Consensus       396 dp~~Rps~~-~ll~~  409 (458)
                      ||.+||++. +++++
T Consensus       234 ~P~~R~~~~~~l~~h  248 (316)
T cd05592         234 DPTKRLGVDGDIRQH  248 (316)
T ss_pred             CHHHcCCChHHHHcC
Confidence            999999975 55553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.2e-40  Score=330.98  Aligned_cols=250  Identities=23%  Similarity=0.333  Sum_probs=205.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .|++.+.||+|+||.|+.     +|+.||+|++...........+.+.+|+.+++.++||||+++++.+.+++.+|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E   81 (376)
T cd05598           2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD   81 (376)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence            578889999999999873     588999999975433333445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC--
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~--  308 (458)
                      |+++|+|.+++...+.+++..+..++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++..+.....  
T Consensus        82 ~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~  158 (376)
T cd05598          82 YIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSK  158 (376)
T ss_pred             CCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCcccccccccc
Confidence            9999999999988888999999999999999999999999   99999999999999999999999999743210000  


Q ss_pred             ----------------------------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHH
Q 012684          309 ----------------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI  348 (458)
Q Consensus       309 ----------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll  348 (458)
                                                              .......||+.|+|||++.+..++.++|||||||++|+|+
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell  238 (376)
T cd05598         159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML  238 (376)
T ss_pred             ccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehh
Confidence                                                    0011346899999999999989999999999999999999


Q ss_pred             cCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCC---CHHHHHHH
Q 012684          349 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP---TFRQIITR  409 (458)
Q Consensus       349 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp---s~~~ll~~  409 (458)
                      +|+.||......+....+..............+++.+.++|.+|+ .+|.+|+   ++.+++++
T Consensus       239 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h  301 (376)
T cd05598         239 VGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAH  301 (376)
T ss_pred             hCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCC
Confidence            999999987765544444222211111123357889999999976 5999999   89999987

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2.5e-40  Score=321.20  Aligned_cols=240  Identities=25%  Similarity=0.421  Sum_probs=201.0

Q ss_pred             eeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCCC
Q 012684          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (458)
Q Consensus       162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~  235 (458)
                      .||+|+||.||.     +++.||+|++...........+.+..|..++..+ +||||+++++++...+.+|+||||++++
T Consensus         2 ~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g   81 (320)
T cd05590           2 VLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGG   81 (320)
T ss_pred             eeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCc
Confidence            689999999873     5789999999754333334456677788888776 7999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCC
Q 012684          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (458)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~  315 (458)
                      +|.+++...+.+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++...... ........
T Consensus        82 ~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~-~~~~~~~~  157 (320)
T cd05590          82 DLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFN-GKTTSTFC  157 (320)
T ss_pred             hHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcC-CCcccccc
Confidence            99999988888999999999999999999999999   999999999999999999999999998753221 12223456


Q ss_pred             CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 012684          316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE  395 (458)
Q Consensus       316 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  395 (458)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.. .....   +..++.++.++|..||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~-~~~~~---~~~~~~~~~~li~~~L~~  233 (320)
T cd05590         158 GTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN-DEVVY---PTWLSQDAVDILKAFMTK  233 (320)
T ss_pred             cCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhc-CCCCC---CCCCCHHHHHHHHHHccc
Confidence            89999999999988899999999999999999999999998776665555532 22222   345778999999999999


Q ss_pred             CCCCCCCH------HHHHHH
Q 012684          396 KPAKRPTF------RQIITR  409 (458)
Q Consensus       396 dp~~Rps~------~~ll~~  409 (458)
                      ||.+||++      ++++.+
T Consensus       234 dP~~R~~~~~~~~~~~~~~h  253 (320)
T cd05590         234 NPTMRLGSLTLGGEEAILRH  253 (320)
T ss_pred             CHHHCCCCCCCCCHHHHHcC
Confidence            99999998      666654

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=1.7e-39  Score=313.13  Aligned_cols=253  Identities=28%  Similarity=0.461  Sum_probs=203.0

Q ss_pred             CccccCceeeccceEEEEEE---------------------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcc
Q 012684          154 ELDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV  212 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~---------------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i  212 (458)
                      ..+|.+.+.||+|+||.||.                     ++..||+|.+....  .......+.+|+.++..++||||
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~ni   81 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILSRLKDPNI   81 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHhhcCCCCe
Confidence            34678889999999999873                     23479999987542  34456678999999999999999


Q ss_pred             eeeeeEEEeCCceEEEEEccCCCCHHHHHHhcC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 012684          213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------------------ALKPSTAVRFALDIARGMNYLHENKPVP  273 (458)
Q Consensus       213 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~  273 (458)
                      +++++++...+..++||||+++++|.+++....                   .+++..++.++.|++.||.|||+.+   
T Consensus        82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---  158 (304)
T cd05096          82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---  158 (304)
T ss_pred             eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---
Confidence            999999999999999999999999999986531                   3567788999999999999999999   


Q ss_pred             eeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc--C
Q 012684          274 IIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--G  350 (458)
Q Consensus       274 i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt--g  350 (458)
                      ++||||||+|||++.++.+||+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++  +
T Consensus       159 ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~  238 (304)
T cd05096         159 FVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCK  238 (304)
T ss_pred             ccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccC
Confidence            999999999999999999999999998765332211 1122345778999999988889999999999999999986  5


Q ss_pred             CCCCCCCCCCcHHHHHHhc----CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          351 CPPFTMKHDNEVPKAYAAR----QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       351 ~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      ..||......+........    ........++.+++.+.++|.+||+.||.+|||+.++.+.|+
T Consensus       239 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~  303 (304)
T cd05096         239 EQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLT  303 (304)
T ss_pred             CCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHh
Confidence            6788876655544333211    111111223456789999999999999999999999988875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=4.1e-40  Score=320.20  Aligned_cols=241  Identities=24%  Similarity=0.424  Sum_probs=202.0

Q ss_pred             eeeccceEEEEEE--------cCeEEEEEEcCCCCC-CCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          161 VEITKGTFILAFW--------RGIQVAVKKLGEEVI-SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       161 ~~lg~G~~~~v~~--------~g~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      +.||+|+||.||.        .++.||+|++..... ........+..|+.+++.++||||+++++++..++..|+||||
T Consensus         2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~   81 (323)
T cd05584           2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY   81 (323)
T ss_pred             ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence            5799999998873        578899999875322 1223345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCc
Q 012684          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL  311 (458)
Q Consensus       232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~  311 (458)
                      +++++|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++...... ....
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~  157 (323)
T cd05584          82 LSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHE-GTVT  157 (323)
T ss_pred             CCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccC-CCcc
Confidence            999999999998888999999999999999999999999   999999999999999999999999998643222 1222


Q ss_pred             ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHH
Q 012684          312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE  391 (458)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  391 (458)
                      ....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.. ....+   +..+++.+.++|.+
T Consensus       158 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~li~~  233 (323)
T cd05584         158 HTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILK-GKLNL---PPYLTPEARDLLKK  233 (323)
T ss_pred             cccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCC---CCCCCHHHHHHHHH
Confidence            345689999999999988889999999999999999999999987665544444422 22222   34567899999999


Q ss_pred             HcccCCCCCC-----CHHHHHHH
Q 012684          392 CWNEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       392 ~l~~dp~~Rp-----s~~~ll~~  409 (458)
                      ||+.||.+||     ++.+++++
T Consensus       234 ~l~~~p~~R~~~~~~~~~~l~~h  256 (323)
T cd05584         234 LLKRNPSSRLGAGPGDAAEVQSH  256 (323)
T ss_pred             HcccCHhHcCCCCCCCHHHHhcC
Confidence            9999999999     89998886

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=7.7e-40  Score=312.67  Aligned_cols=249  Identities=24%  Similarity=0.375  Sum_probs=204.9

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.|+.     +++.||+|.+.............+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence            477888999999998863     578999999975443333334557789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......  
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~--  155 (285)
T cd05605          81 LMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEG--  155 (285)
T ss_pred             ccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCC--
Confidence            99999999888653  35899999999999999999999999   999999999999999999999999998765322  


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      .......|++.|+|||++.+..++.++|+||+|+++|+|++|+.||...........+...........+..++..+.+|
T Consensus       156 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  235 (285)
T cd05605         156 ETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSI  235 (285)
T ss_pred             CccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHH
Confidence            12233467899999999988889999999999999999999999998766544333332221222222344578899999


Q ss_pred             HHHHcccCCCCCC-----CHHHHHHH
Q 012684          389 IEECWNEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rp-----s~~~ll~~  409 (458)
                      |.+||..||.+||     ++.+++++
T Consensus       236 i~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05605         236 CRQLLTKDPGFRLGCRGEGAEEVKAH  261 (285)
T ss_pred             HHHHccCCHHHhcCCCCCCHHHHhcC
Confidence            9999999999999     88888776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.8e-40  Score=311.48  Aligned_cols=243  Identities=25%  Similarity=0.362  Sum_probs=198.2

Q ss_pred             eccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012684          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (458)
Q Consensus       163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L  237 (458)
                      ||+|+||.||.     +|+.||+|.+...........+.+..|+.+++.++||||+++.+++..+...++||||+++++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L   80 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL   80 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence            68999998873     6789999999755443334446678899999999999999999999999999999999999999


Q ss_pred             HHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCccc
Q 012684          238 RAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC  313 (458)
Q Consensus       238 ~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~  313 (458)
                      .+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++........ ....
T Consensus        81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~-~~~~  156 (280)
T cd05608          81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS-KTKG  156 (280)
T ss_pred             HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc-cccc
Confidence            887743    345899999999999999999999999   99999999999999999999999999876543322 2233


Q ss_pred             CCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHc
Q 012684          314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW  393 (458)
Q Consensus       314 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  393 (458)
                      ..||+.|+|||.+.+..++.++|+||||+++|+|++|+.||.......................+..+++.+.+++..||
T Consensus       157 ~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         157 YAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSVTYPDKFSPASKSFCEALL  236 (280)
T ss_pred             cCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCCCCcccCCHHHHHHHHHHh
Confidence            46889999999999989999999999999999999999999875443222222111111112234457889999999999


Q ss_pred             ccCCCCCC-----CHHHHHHH
Q 012684          394 NEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       394 ~~dp~~Rp-----s~~~ll~~  409 (458)
                      +.||.+||     ++++++++
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h  257 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTH  257 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcC
Confidence            99999999     67778776

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.3e-39  Score=322.52  Aligned_cols=254  Identities=28%  Similarity=0.458  Sum_probs=205.6

Q ss_pred             CccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC
Q 012684          154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS  222 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~  222 (458)
                      ..+|++.+.||+|+||.|+.          ++..||+|++....  .......+.+|+.+++.+ +||||+++++++...
T Consensus        37 ~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~  114 (374)
T cd05106          37 RDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGACTHG  114 (374)
T ss_pred             HHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEecCC
Confidence            33688889999999998863          22479999997543  334456788999999999 899999999999999


Q ss_pred             CceEEEEEccCCCCHHHHHHhc----------------------------------------------------------
Q 012684          223 SPMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------  244 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~~----------------------------------------------------------  244 (458)
                      +..++||||+++|+|.+++...                                                          
T Consensus       115 ~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  194 (374)
T cd05106         115 GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQS  194 (374)
T ss_pred             CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCcccccccc
Confidence            9999999999999999998542                                                          


Q ss_pred             ------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC-c
Q 012684          245 ------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-L  311 (458)
Q Consensus       245 ------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~-~  311 (458)
                                  .++++..++.++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++.......... .
T Consensus       195 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~  271 (374)
T cd05106         195 SDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK  271 (374)
T ss_pred             ccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence                        13677888999999999999999999   9999999999999999999999999987653322111 1


Q ss_pred             ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||....................  .+..+++++.++|.
T Consensus       272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~  349 (374)
T cd05106         272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS--RPDFAPPEIYSIMK  349 (374)
T ss_pred             cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc--CCCCCCHHHHHHHH
Confidence            12234567999999988889999999999999999997 9999987665443333322221111  12345789999999


Q ss_pred             HHcccCCCCCCCHHHHHHHHHHHH
Q 012684          391 ECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      +||+.||.+|||+.++++.|+++.
T Consensus       350 ~cl~~dp~~RPs~~~l~~~l~~~~  373 (374)
T cd05106         350 MCWNLEPTERPTFSQISQLIQRQL  373 (374)
T ss_pred             HHcCCChhhCcCHHHHHHHHHHHh
Confidence            999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.6e-39  Score=322.19  Aligned_cols=251  Identities=28%  Similarity=0.471  Sum_probs=203.4

Q ss_pred             cccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCc
Q 012684          156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~  224 (458)
                      +|++.+.||+|+||.|+.          ++..||||++....  .....+.+.+|+.+++.+ +||||+++++++...+.
T Consensus        36 ~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          36 RLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             HeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            688889999999999863          34589999997442  233446788899999999 89999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcC-----------------------------------------------------------
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG-----------------------------------------------------------  245 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~-----------------------------------------------------------  245 (458)
                      .++||||+++|+|.+++.+..                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999986421                                                           


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          246 ----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       246 ----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                                      .+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++.........
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  270 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY  270 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence                            3677888999999999999999999   999999999999999999999999998765432211


Q ss_pred             C-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          310 P-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       310 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      . .....++..|+|||.+.+..++.++||||||+++|+|++ |..||....................  .+...+.++++
T Consensus       271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~  348 (375)
T cd05104         271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRML--SPECAPSEMYD  348 (375)
T ss_pred             cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCC--CCCCCCHHHHH
Confidence            1 122334567999999999899999999999999999998 8999987654433333323322111  12345678999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      ||..||+.||.+|||+.++++.|++.
T Consensus       349 li~~cl~~dP~~RPs~~eil~~l~~~  374 (375)
T cd05104         349 IMKSCWDADPLKRPTFKQIVQLIEQQ  374 (375)
T ss_pred             HHHHHccCChhHCcCHHHHHHHHHhh
Confidence            99999999999999999999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-40  Score=306.42  Aligned_cols=253  Identities=28%  Similarity=0.425  Sum_probs=206.6

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe-----CCce
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-----SSPM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-----~~~~  225 (458)
                      .|...+.||.|+||.|-     .+|+.||||.+...+ ...-..++..+|+.+|+.++|+||+.+++.+..     -+.+
T Consensus        23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F-~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~Dv  101 (359)
T KOG0660|consen   23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPF-ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDV  101 (359)
T ss_pred             eecccccccCcceeeEEEEEEcCCCCEeehhhhhhhh-hchHHHHHHHHHHHHHHHhcCCCcceEEeeccccccccccee
Confidence            34446789999999774     378999999997543 455566777889999999999999999999864     3568


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      |+|+|+| +.+|.+.++.+..++...+..++.|++.||+|+|+.+   |+||||||+|++++.+..+|++|||+|+....
T Consensus       102 YiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~  177 (359)
T KOG0660|consen  102 YLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLARYLDK  177 (359)
T ss_pred             EEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEeccccceeeccc
Confidence            9999999 7799999998888999999999999999999999999   99999999999999999999999999997753


Q ss_pred             C-CCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH-----------------
Q 012684          306 K-EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY-----------------  366 (458)
Q Consensus       306 ~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~-----------------  366 (458)
                      . .....+.+..|.+|.|||++.. ..|+...||||+||++.||++|+..|.+.+.-.....+                 
T Consensus       178 ~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s  257 (359)
T KOG0660|consen  178 FFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRS  257 (359)
T ss_pred             cCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhcc
Confidence            2 1233467788999999998754 57999999999999999999999999887653211111                 


Q ss_pred             ------Hh-cC---CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHH
Q 012684          367 ------AA-RQ---RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESI  413 (458)
Q Consensus       367 ------~~-~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~  413 (458)
                            .. ..   ..++....++.++...+|+.+||..||.+|+|+++++.|  |..+
T Consensus       258 ~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~  316 (359)
T KOG0660|consen  258 EKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPY  316 (359)
T ss_pred             HHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhh
Confidence                  01 11   112222334677899999999999999999999999987  4444

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=3.6e-40  Score=320.35  Aligned_cols=240  Identities=25%  Similarity=0.401  Sum_probs=202.5

Q ss_pred             eeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCCC
Q 012684          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (458)
Q Consensus       162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~  235 (458)
                      .||+|+||.||.     +|+.||+|++...........+.+..|..++..+ +||||+++++++..++..|+||||++++
T Consensus         2 ~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~   81 (321)
T cd05591           2 VLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGG   81 (321)
T ss_pred             ccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCC
Confidence            589999998873     4789999999765443444556677888888866 7999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCC
Q 012684          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (458)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~  315 (458)
                      +|..++...+.+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++...... ........
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~  157 (321)
T cd05591          82 DLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILN-GVTTTTFC  157 (321)
T ss_pred             cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccC-Cccccccc
Confidence            99999988888999999999999999999999999   999999999999999999999999998754322 12223456


Q ss_pred             CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 012684          316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE  395 (458)
Q Consensus       316 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  395 (458)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... ..+   +..+++++.++|..||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~-~~~---p~~~~~~~~~ll~~~L~~  233 (321)
T cd05591         158 GTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDD-VLY---PVWLSKEAVSILKAFMTK  233 (321)
T ss_pred             cCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCC-CCC---CCCCCHHHHHHHHHHhcc
Confidence            8999999999998889999999999999999999999999877666555543322 222   234678999999999999


Q ss_pred             CCCCCC-------CHHHHHHH
Q 012684          396 KPAKRP-------TFRQIITR  409 (458)
Q Consensus       396 dp~~Rp-------s~~~ll~~  409 (458)
                      ||.+||       ++.+++++
T Consensus       234 dp~~R~~~~~~~~~~~~~~~h  254 (321)
T cd05591         234 NPNKRLGCVASQGGEDAIKQH  254 (321)
T ss_pred             CHHHcCCCCCCCCCHHHHhcC
Confidence            999999       88888876

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=4.1e-40  Score=325.57  Aligned_cols=251  Identities=23%  Similarity=0.330  Sum_probs=205.9

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|++.+.||+|+||.|+.     +++.||+|++.............+.+|+.+++.++||||+++++++..+...|+|
T Consensus        42 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv  121 (370)
T cd05621          42 AEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMV  121 (370)
T ss_pred             HHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEE
Confidence            34688889999999998873     5789999998754333334455678899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |||+++|+|.+++... .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++........
T Consensus       122 ~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~  197 (370)
T cd05621         122 MEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGM  197 (370)
T ss_pred             EcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceecccCCc
Confidence            9999999999998754 5889999999999999999999999   99999999999999999999999999986543322


Q ss_pred             CCcccCCCCCcccCCcccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR  383 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  383 (458)
                      .......||+.|+|||++.+..    ++.++|+|||||++|+|++|+.||...+.......+.... ...++. ...++.
T Consensus       198 ~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~s~  276 (370)
T cd05621         198 VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPE-DVEISK  276 (370)
T ss_pred             eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCC-cccCCH
Confidence            2223456899999999987543    6789999999999999999999998876655555543322 222222 235688


Q ss_pred             HHHHHHHHHcccCCCC--CCCHHHHHHH
Q 012684          384 GLKELIEECWNEKPAK--RPTFRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~--Rps~~~ll~~  409 (458)
                      .++++|..||..++.+  |+++.++++|
T Consensus       277 ~~~~li~~~L~~~~~r~~R~~~~e~l~h  304 (370)
T cd05621         277 HAKNLICAFLTDREVRLGRNGVEEIKQH  304 (370)
T ss_pred             HHHHHHHHHccCchhccCCCCHHHHhcC
Confidence            9999999999865544  8999999998

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=7.2e-40  Score=318.67  Aligned_cols=246  Identities=28%  Similarity=0.442  Sum_probs=204.7

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCC-CcceeeeeEEEeCCceEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~i~~~~~~~~~~~~~~lv~  229 (458)
                      +|++.+.||+|+||.||.     +++.||+|++...........+.+..|..++..+.| ++|+++++++...+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            467788999999999874     567899999976543344455677889999999965 56889999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++...... ..
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~~  156 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG-GK  156 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC-CC
Confidence            99999999999988888999999999999999999999999   999999999999999999999999998643221 12


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......||+.|+|||++.+..++.++||||+||++|+|++|+.||......+....+. .....+   +..+++.+.+++
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~-~~~~~~---~~~~~~~~~~li  232 (324)
T cd05587         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIM-EHNVSY---PKSLSKEAVSIC  232 (324)
T ss_pred             ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCC---CCCCCHHHHHHH
Confidence            2234568999999999999889999999999999999999999998776655555442 222222   345788999999


Q ss_pred             HHHcccCCCCCCCH-----HHHHHH
Q 012684          390 EECWNEKPAKRPTF-----RQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps~-----~~ll~~  409 (458)
                      .+||..||.+|++.     .+++++
T Consensus       233 ~~~l~~~P~~R~~~~~~~~~~~~~h  257 (324)
T cd05587         233 KGLLTKHPAKRLGCGPTGERDIREH  257 (324)
T ss_pred             HHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            99999999999986     566654

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=7.4e-40  Score=319.20  Aligned_cols=242  Identities=24%  Similarity=0.411  Sum_probs=199.7

Q ss_pred             eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      +.||+|+||.|+.     ++..||+|++.............+..|..+++.+ +||||+++++++......|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            3689999998873     6789999999865544555566788899999988 799999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccC
Q 012684          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ  314 (458)
Q Consensus       235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~  314 (458)
                      ++|.+++...+.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++...... .......
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~~~~~  156 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP-GDTTSTF  156 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccC-CCccccc
Confidence            999999988888999999999999999999999999   999999999999999999999999998643211 1222345


Q ss_pred             CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc--------HHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE--------VPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                      .||+.|+|||++.+..++.++|+|||||++|+|++|+.||.......        ............   .+..++..+.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~p~~~~~~~~  233 (329)
T cd05588         157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIR---IPRSLSVKAS  233 (329)
T ss_pred             cCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCC---CCCCCCHHHH
Confidence            68999999999999899999999999999999999999996432211        111111222222   2345778999


Q ss_pred             HHHHHHcccCCCCCCC------HHHHHHH
Q 012684          387 ELIEECWNEKPAKRPT------FRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps------~~~ll~~  409 (458)
                      ++|.+||+.||.+||+      +.++++|
T Consensus       234 ~li~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05588         234 SVLKGFLNKDPKERLGCHPQTGFRDIKSH  262 (329)
T ss_pred             HHHHHHhccCHHHcCCCCCCCCHHHHhcC
Confidence            9999999999999997      6777765

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.2e-39  Score=311.95  Aligned_cols=247  Identities=26%  Similarity=0.415  Sum_probs=198.0

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||.|+||.||.     ++..||+|.+.....  ......+.+|+.+++.++||||+++++++..+...++|||
T Consensus         6 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           6 TYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             cceEeeEEecCCCEEEEEEEECCCCCEEEEEEeccccc--CCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEe
Confidence            588889999999999874     678999999975432  1223456789999999999999999999999889999999


Q ss_pred             ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |+. ++|.+++...+ .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++....... .
T Consensus        84 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~-~  158 (288)
T cd07871          84 YLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPT-K  158 (288)
T ss_pred             CCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCC-c
Confidence            996 59999887654 4788999999999999999999999   9999999999999999999999999987543221 2


Q ss_pred             CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCC---------------
Q 012684          310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP---------------  373 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~---------------  373 (458)
                      ......+++.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+..+....+......+               
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T cd07871         159 TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFR  238 (288)
T ss_pred             cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhh
Confidence            2233457889999999865 467899999999999999999999998766544333221111000               


Q ss_pred             ---CC--------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 ---FK--------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ---~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                         ++        .....+++++.++|.+||+.||.+|||++++++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~h  285 (288)
T cd07871         239 SYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRH  285 (288)
T ss_pred             ccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence               00        0112356789999999999999999999999875

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=8.2e-40  Score=318.27  Aligned_cols=244  Identities=25%  Similarity=0.406  Sum_probs=200.9

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHH---hcCCCCcceeeeeEEEeCCceEEE
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL---QKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      |++.+.||+|+||.||.     +|+.||||++...........+.+..|..++   +.++||||+++++++...+..|+|
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv   80 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV   80 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence            56678999999998873     5889999999755433334455677776655   456799999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |||+++++|..++.. +.+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...... .
T Consensus        81 ~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~-~  155 (324)
T cd05589          81 MEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF-G  155 (324)
T ss_pred             EcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCCC-C
Confidence            999999999988765 56999999999999999999999999   999999999999999999999999998653222 1


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      .......|++.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+... ...+   +..+++.+.++
T Consensus       156 ~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~-~~~~---p~~~~~~~~~l  231 (324)
T cd05589         156 DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVND-EVRY---PRFLSREAISI  231 (324)
T ss_pred             CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCC---CCCCCHHHHHH
Confidence            2223456899999999999988999999999999999999999999887665555544322 2222   34578899999


Q ss_pred             HHHHcccCCCCCC-----CHHHHHHH
Q 012684          389 IEECWNEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rp-----s~~~ll~~  409 (458)
                      |.+||+.||.+||     ++.+++++
T Consensus       232 i~~~L~~dP~~R~~~~~~~~~~l~~~  257 (324)
T cd05589         232 MRRLLRRNPERRLGSGEKDAEDVKKQ  257 (324)
T ss_pred             HHHHhhcCHhHcCCCCCCCHHHHhhC
Confidence            9999999999999     57777765

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=3e-39  Score=308.11  Aligned_cols=249  Identities=33%  Similarity=0.557  Sum_probs=208.2

Q ss_pred             cccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      +|++.+.||+|+||.||.          ....||+|.+....  .......+.+|+.+++.++||||+++++++......
T Consensus         6 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           6 AVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCce
Confidence            567788999999998873          12579999987542  344556789999999999999999999999988899


Q ss_pred             EEEEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC
Q 012684          226 MIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS  289 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~  289 (458)
                      +++|||+++++|.+++...                ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.+
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~  160 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEG  160 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCC
Confidence            9999999999999999764                34778889999999999999999999   9999999999999999


Q ss_pred             CCEEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHH
Q 012684          290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA  367 (458)
Q Consensus       290 ~~vkl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~  367 (458)
                      +.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||.+....+....+.
T Consensus       161 ~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05048         161 LTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR  240 (283)
T ss_pred             CcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999875432221 11223345788999999988889999999999999999998 999999877766655553


Q ss_pred             hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012684          368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      ....+.   .+..+++++.+|+.+||+.||.+||++.+++++|+.
T Consensus       241 ~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05048         241 SRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRS  282 (283)
T ss_pred             cCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhc
Confidence            333222   345678999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=6e-39  Score=303.25  Aligned_cols=252  Identities=24%  Similarity=0.459  Sum_probs=208.4

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||.|+||.||     .+++.||+|.+.............+.+|+.+++.++||||+++++++...+..+++||
T Consensus         3 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08228           3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEE
Confidence            57888999999999886     2689999998875444455666778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       231 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      |+++++|.+++..    ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~  159 (267)
T cd08228          83 LADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccch
Confidence            9999999988853    344888999999999999999999999   999999999999999999999999998765432


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--cHHHHHHhcCCCCCCCChhhhHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      . .......+++.|+|||.+.+..++.++|+||+|+++|+|++|+.||......  .....+.....++  .....++..
T Consensus       160 ~-~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  236 (267)
T cd08228         160 T-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPP--LPTEHYSEK  236 (267)
T ss_pred             h-HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCCCCC--CChhhcCHH
Confidence            1 1122345788999999998888899999999999999999999999765432  2222221112222  223456788


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      +.++|.+||..+|.+||++.++++.|+++
T Consensus       237 ~~~li~~cl~~~p~~Rp~~~~vl~~~~~~  265 (267)
T cd08228         237 LRELVSMCIYPDPDQRPDIGYVHQIAKQM  265 (267)
T ss_pred             HHHHHHHHCCCCcccCcCHHHHHHHHHHh
Confidence            99999999999999999999999999876

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=4e-39  Score=303.95  Aligned_cols=248  Identities=29%  Similarity=0.514  Sum_probs=206.3

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .|++.+.||.|+||.++.     .+..||+|.+...    ......+.+|+.+++.++||||+++++++..+...+++||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (263)
T cd05052           7 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITE   82 (263)
T ss_pred             HeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEE
Confidence            466778999999998763     5789999998643    2234678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+++++|.+++...  ..+++..+..++.|+++||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~  159 (263)
T cd05052          83 FMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY  159 (263)
T ss_pred             eCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCcccccccccee
Confidence            99999999998763  34888999999999999999999999   99999999999999999999999999876643322


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      ........+..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.....+.   .+..+++.+.+
T Consensus       160 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  236 (263)
T cd05052         160 TAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYRME---RPEGCPPKVYE  236 (263)
T ss_pred             eccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC---CCCCCCHHHHH
Confidence            22222234567999999988889999999999999999998 999998766555544443222222   24557889999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      +|.+||+.||.+||++.++++.|+++
T Consensus       237 li~~cl~~~p~~Rp~~~~l~~~l~~~  262 (263)
T cd05052         237 LMRACWQWNPSDRPSFAEIHQAFETM  262 (263)
T ss_pred             HHHHHccCCcccCCCHHHHHHHHHhh
Confidence            99999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=5.8e-40  Score=318.10  Aligned_cols=241  Identities=27%  Similarity=0.454  Sum_probs=198.8

Q ss_pred             eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      +.||+|+||.|+.     +|..||+|.+...........+.+..|..++... +||+|+++++++..++..|+||||+.+
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            3689999998873     6789999999754332223345566777777654 899999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccC
Q 012684          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ  314 (458)
Q Consensus       235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~  314 (458)
                      ++|.+++...+.+++..+..++.|++.||+|||+.|   |+||||||+||+++.++.++|+|||++...... .......
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~  156 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTF  156 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccC-CCceecc
Confidence            999999988888999999999999999999999999   999999999999999999999999998643221 1222345


Q ss_pred             CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 012684          315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN  394 (458)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  394 (458)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+. ...+.+   +..++.+++++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~-~~~~~~---~~~~~~~~~~li~~~l~  232 (316)
T cd05620         157 CGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIR-VDTPHY---PRWITKESKDILEKLFE  232 (316)
T ss_pred             CCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCCC---CCCCCHHHHHHHHHHcc
Confidence            68999999999999899999999999999999999999998776555544442 222222   34477899999999999


Q ss_pred             cCCCCCCCHH-HHHHH
Q 012684          395 EKPAKRPTFR-QIITR  409 (458)
Q Consensus       395 ~dp~~Rps~~-~ll~~  409 (458)
                      .||.+||++. ++++|
T Consensus       233 ~dP~~R~~~~~~~~~h  248 (316)
T cd05620         233 RDPTRRLGVVGNIRGH  248 (316)
T ss_pred             CCHHHcCCChHHHHcC
Confidence            9999999985 56644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=9.3e-40  Score=317.77  Aligned_cols=246  Identities=27%  Similarity=0.420  Sum_probs=204.9

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      +|.+.+.||+|+||.||.     ++..||+|++.............+..|..++..+ +||+|+++++++...+..++||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            467788999999999873     5679999999765433444455667788888777 5899999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||+++|+|.+++...+.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||++...... ..
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~-~~  156 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD-GV  156 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC-CC
Confidence            99999999999988888999999999999999999999999   999999999999999999999999998754322 12


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.. ....+   +..+++++.+++
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~-~~~~~---p~~~s~~~~~li  232 (323)
T cd05616         157 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-HNVAY---PKSMSKEAVAIC  232 (323)
T ss_pred             ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHh-CCCCC---CCcCCHHHHHHH
Confidence            22345689999999999999999999999999999999999999988766555555432 22222   345788999999


Q ss_pred             HHHcccCCCCCCCH-----HHHHHH
Q 012684          390 EECWNEKPAKRPTF-----RQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps~-----~~ll~~  409 (458)
                      .+||+.||.+|++.     .+++++
T Consensus       233 ~~~l~~~p~~R~~~~~~~~~~i~~h  257 (323)
T cd05616         233 KGLMTKHPGKRLGCGPEGERDIKEH  257 (323)
T ss_pred             HHHcccCHHhcCCCCCCCHHHHhcC
Confidence            99999999999985     566544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=1.3e-39  Score=318.65  Aligned_cols=249  Identities=25%  Similarity=0.396  Sum_probs=197.4

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----Cce
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SPM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~~  225 (458)
                      +|++.+.||+|+||.|+.     +|..||||.+..... .......+.+|+.+++.++||||+++++++...     ...
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence            478889999999998873     689999999874322 223345678899999999999999999988543     247


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      |+||||+ +++|.+++...+.+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus        80 ~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~  155 (338)
T cd07859          80 YVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFN  155 (338)
T ss_pred             EEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccccc
Confidence            9999999 5799999988888999999999999999999999999   99999999999999999999999999875432


Q ss_pred             CCC--CCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh-------------
Q 012684          306 KED--RPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-------------  368 (458)
Q Consensus       306 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~-------------  368 (458)
                      ...  .......+|+.|+|||++.+  ..++.++|||||||++|+|++|+.||...+.......+..             
T Consensus       156 ~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i  235 (338)
T cd07859         156 DTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRV  235 (338)
T ss_pred             ccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHh
Confidence            211  12234568999999999865  5788999999999999999999999976543221111100             


Q ss_pred             ----------c----CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          369 ----------R----QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       369 ----------~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                .    ...++....+.+++.+.++|.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h  290 (338)
T cd07859         236 RNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD  290 (338)
T ss_pred             hhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                      0    0001111112456788999999999999999999999987

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=9.3e-40  Score=323.29  Aligned_cols=253  Identities=24%  Similarity=0.337  Sum_probs=206.5

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      ...+|++.+.||+|+||.|+.     +++.||+|++.............+.+|..+++.++||||+++++.+..+...++
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l  120 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYM  120 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEE
Confidence            345788999999999998873     678999999865333333445567889999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||||++||+|.+++... .+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus       121 v~Ey~~gg~L~~~~~~~-~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~  196 (371)
T cd05622         121 VMEYMPGGDLVNLMSNY-DVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG  196 (371)
T ss_pred             EEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCC
Confidence            99999999999998764 5888999999999999999999999   9999999999999999999999999998664332


Q ss_pred             CCCcccCCCCCcccCCcccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYA  382 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  382 (458)
                      ........||+.|+|||++.+..    ++.++|||||||++|+|++|+.||...+.......+.... ...++ ....++
T Consensus       197 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~-~~~~~s  275 (371)
T cd05622         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP-DDNDIS  275 (371)
T ss_pred             cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCC-CcCCCC
Confidence            22233456899999999987543    7789999999999999999999999876655555543322 22222 234678


Q ss_pred             HHHHHHHHHHcccCCCC--CCCHHHHHHHH
Q 012684          383 RGLKELIEECWNEKPAK--RPTFRQIITRL  410 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~--Rps~~~ll~~L  410 (458)
                      ..++++|..||..++.+  |+++.+++++.
T Consensus       276 ~~~~~li~~~L~~~~~r~~r~~~~ei~~h~  305 (371)
T cd05622         276 KEAKNLICAFLTDREVRLGRNGVEEIKRHL  305 (371)
T ss_pred             HHHHHHHHHHcCChhhhcCCCCHHHHhcCc
Confidence            99999999999844443  78999999875

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=7.5e-40  Score=317.66  Aligned_cols=241  Identities=27%  Similarity=0.449  Sum_probs=202.1

Q ss_pred             eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      +.||+|+||.||.     ++..||+|++.............+..|..+++.+ +||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            3689999998873     5789999999765433444556677888888888 799999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccC
Q 012684          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ  314 (458)
Q Consensus       235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~  314 (458)
                      ++|.+++.+.+.+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++...... .......
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-~~~~~~~  156 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG-GVTTSTF  156 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcC-CCcccce
Confidence            999999988888999999999999999999999999   999999999999999999999999998653221 1122334


Q ss_pred             CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 012684          315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN  394 (458)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  394 (458)
                      .+++.|+|||++.+..++.++|+|||||++|+|++|+.||...+.......+.. ....+   +..++..+.+||.+||.
T Consensus       157 ~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~-~~~~~---~~~~~~~~~~li~~~l~  232 (318)
T cd05570         157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILE-DEVRY---PRWLSKEAKSILKSFLT  232 (318)
T ss_pred             ecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHc-CCCCC---CCcCCHHHHHHHHHHcc
Confidence            578999999999998999999999999999999999999987665554444422 22222   34577899999999999


Q ss_pred             cCCCCCCCH-----HHHHHH
Q 012684          395 EKPAKRPTF-----RQIITR  409 (458)
Q Consensus       395 ~dp~~Rps~-----~~ll~~  409 (458)
                      .||.+||++     .+++++
T Consensus       233 ~dP~~R~s~~~~~~~~ll~~  252 (318)
T cd05570         233 KNPEKRLGCLPTGEQDIKGH  252 (318)
T ss_pred             CCHHHcCCCCCCCHHHHhcC
Confidence            999999999     888765

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=4.8e-39  Score=302.17  Aligned_cols=245  Identities=32%  Similarity=0.578  Sum_probs=203.8

Q ss_pred             cccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      +|++.+.||+|+||.||.    .+..+|+|.+.....    ....+.+|+.+++.++||||+++++++......++||||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~   80 (256)
T cd05114           5 ELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAM----SEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEF   80 (256)
T ss_pred             HcEEeeEecCCcCceEEEEEeccCceEEEEecccCCc----cHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEc
Confidence            366678999999998873    456899998864322    234678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       232 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      +++++|.+++.. .+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||.+..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05114          81 MENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS  157 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence            999999999875 356899999999999999999999999   9999999999999999999999999987654322222


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||...+..+....+.....+..   +...+..+.+++
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~~~~li  234 (256)
T cd05114         158 SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYR---PKLASMTVYEVM  234 (256)
T ss_pred             cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCHHHHHHH
Confidence            223345668999999988889999999999999999999 8999988776666665544333322   234567899999


Q ss_pred             HHHcccCCCCCCCHHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      .+||..+|++||++.++++.|
T Consensus       235 ~~c~~~~p~~Rps~~~l~~~l  255 (256)
T cd05114         235 YSCWHEKPEGRPTFAELLRAI  255 (256)
T ss_pred             HHHccCCcccCcCHHHHHHhh
Confidence            999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-39  Score=329.25  Aligned_cols=261  Identities=22%  Similarity=0.390  Sum_probs=212.1

Q ss_pred             ccCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEE-E-
Q 012684          149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAV-T-  220 (458)
Q Consensus       149 ~~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~-~-  220 (458)
                      .+.....++++.+.|.+|||+.||.     .|..||+|++-..   ++..++.+.+|+.+|++| +|+|||.+++.. . 
T Consensus        31 ~~~Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~  107 (738)
T KOG1989|consen   31 TFTVGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAIN  107 (738)
T ss_pred             EEEECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEecccccc
Confidence            4445566888999999999999984     3489999999644   677888999999999999 599999999932 1 


Q ss_pred             --eC---CceEEEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEE
Q 012684          221 --QS---SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK  293 (458)
Q Consensus       221 --~~---~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vk  293 (458)
                        .+   -.++|+||||.||.|-+++..  ...|++.++++|+.|+++|+++||...| +|||||||.+|||++.+|..|
T Consensus       108 ~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~p-PiIHRDLKiENvLls~~g~~K  186 (738)
T KOG1989|consen  108 RSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKP-PIIHRDLKIENVLLSADGNYK  186 (738)
T ss_pred             ccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCC-ccchhhhhhhheEEcCCCCEE
Confidence              11   357899999999999999985  3459999999999999999999999984 699999999999999999999


Q ss_pred             EeecCCccccccCCCCCc--------ccCCCCCcccCCccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 012684          294 VADFGVSKLLTVKEDRPL--------TCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV  362 (458)
Q Consensus       294 l~Dfg~~~~~~~~~~~~~--------~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~  362 (458)
                      |||||.+...........        -....|+.|+|||.+   .+.+.+.|+|||+|||+||.|+..+.||.....-.+
T Consensus       187 LCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~laI  266 (738)
T KOG1989|consen  187 LCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLAI  266 (738)
T ss_pred             eCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcceeE
Confidence            999999865432221111        122469999999975   566889999999999999999999999997644332


Q ss_pred             HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012684          363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH  419 (458)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  419 (458)
                      .     .+.-.++. .+.|+..+++||+.||+.||.+||++-+++.++..+...-..
T Consensus       267 l-----ng~Y~~P~-~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~~~~~  317 (738)
T KOG1989|consen  267 L-----NGNYSFPP-FPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELANKPCP  317 (738)
T ss_pred             E-----eccccCCC-CccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhcCCCC
Confidence            1     12222222 256899999999999999999999999999999988766443

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=1.4e-39  Score=317.13  Aligned_cols=242  Identities=24%  Similarity=0.400  Sum_probs=198.1

Q ss_pred             eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      +.||+|+||.|+.     +++.||+|++.............+..|..++.++ +||||+++++++..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            3689999998873     5789999999866544555566788899888777 899999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccC
Q 012684          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ  314 (458)
Q Consensus       235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~  314 (458)
                      ++|..++...+.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.++|+|||++...... .......
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~-~~~~~~~  156 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-GDTTSTF  156 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCC-CCccccc
Confidence            999999988888999999999999999999999999   999999999999999999999999998753221 1222345


Q ss_pred             CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-----cH---HHHHHhcCCCCCCCChhhhHHHHH
Q 012684          315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-----EV---PKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~-----~~---~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                      .||+.|+|||++.+..++.++|+|||||++|+|++|+.||......     ..   ...........   .+..++..+.
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~---~p~~~~~~~~  233 (329)
T cd05618         157 CGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIR---IPRSLSVKAA  233 (329)
T ss_pred             cCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCC---CCCCCCHHHH
Confidence            6899999999999989999999999999999999999999632111     11   11111222222   2345778999


Q ss_pred             HHHHHHcccCCCCCCCH------HHHHHH
Q 012684          387 ELIEECWNEKPAKRPTF------RQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~------~~ll~~  409 (458)
                      ++|.+||+.||.+||++      .++++|
T Consensus       234 ~ll~~~L~~dP~~R~~~~~~~~~~~i~~h  262 (329)
T cd05618         234 SVLKSFLNKDPKERLGCHPQTGFADIQGH  262 (329)
T ss_pred             HHHHHHhcCCHHHcCCCCCCCCHHHHhcC
Confidence            99999999999999984      566665

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3.6e-39  Score=320.66  Aligned_cols=244  Identities=23%  Similarity=0.302  Sum_probs=196.6

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      ...+|++.+.||+|+||.||.     +++.||+|....         ..+.+|+.+++.++||||+++++++..+...++
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l  160 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL  160 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence            345799999999999999874     688999997532         246789999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |||++ +++|.+++.....+++.++..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.......
T Consensus       161 v~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~  236 (391)
T PHA03212        161 ILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN  236 (391)
T ss_pred             EEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc
Confidence            99999 5799999988778999999999999999999999999   9999999999999999999999999987543222


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-------cHHHHH-HhcC---------
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-------EVPKAY-AARQ---------  370 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~-------~~~~~~-~~~~---------  370 (458)
                      ........||+.|+|||++.+..++.++|||||||++|+|++|+.||......       .....+ ...+         
T Consensus       237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~  316 (391)
T PHA03212        237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPID  316 (391)
T ss_pred             ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcc
Confidence            22333456899999999999889999999999999999999999887543210       000000 0000         


Q ss_pred             ------------------CCCCCCC---hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          371 ------------------RPPFKAP---AKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       371 ------------------~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                        .+.....   ...++.++.+||.+||+.||.+|||+++++++
T Consensus       317 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~h  376 (391)
T PHA03212        317 AQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDF  376 (391)
T ss_pred             hhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                              0000001   11346689999999999999999999999986

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=6.1e-39  Score=313.21  Aligned_cols=248  Identities=27%  Similarity=0.490  Sum_probs=203.8

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|++.+.||.|+||.||.     +|..+|+|.+....  .......+.+|+.+++.++||||++++++|..++..++|
T Consensus         4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEE
Confidence            45788899999999999874     67899999987542  334556788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |||+.+++|.+++...+.+++..+..++.|++.||.|||+. +   ++|+||||+||+++.++.++|+|||++...... 
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-  157 (333)
T cd06650          82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  157 (333)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence            99999999999998888899999999999999999999985 6   999999999999999999999999998755322 


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh-------------------
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-------------------  368 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~-------------------  368 (458)
                        ......+++.|+|||++.+..++.++|+|||||++|+|++|+.||..............                   
T Consensus       158 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (333)
T cd06650         158 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPG  235 (333)
T ss_pred             --ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCcc
Confidence              22334678899999999988899999999999999999999999976543322111100                   


Q ss_pred             -----------------------cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          369 -----------------------RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       369 -----------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                             ............++.++++||.+||+.||.+|||+.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h  299 (333)
T cd06650         236 RPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVH  299 (333)
T ss_pred             chhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhC
Confidence                                   00000000112356789999999999999999999999987

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.4e-39  Score=317.39  Aligned_cols=251  Identities=20%  Similarity=0.305  Sum_probs=205.7

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|.+.+.||+|+||.|+.     +++.||+|++.............+.+|..++..++|++|+++++++..++..|+|||
T Consensus         2 ~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~E   81 (331)
T cd05624           2 DFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMD   81 (331)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            578889999999998873     678899999875333333445567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |++||+|.+++.+ .+.+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.++|+|||++.........
T Consensus        82 y~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~  158 (331)
T cd05624          82 YYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV  158 (331)
T ss_pred             CCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCCCce
Confidence            9999999999987 467899999999999999999999999   999999999999999999999999998765433222


Q ss_pred             CcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHH
Q 012684          310 PLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR  383 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  383 (458)
                      ......||+.|+|||++.+     ..++.++|+||||+++|+|++|+.||...+..+....+.... +.+++.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~  238 (331)
T cd05624         159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSE  238 (331)
T ss_pred             eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCH
Confidence            2233568999999999875     457889999999999999999999998776655554443322 3334444455788


Q ss_pred             HHHHHHHHHcccCCCC--CCCHHHHHHH
Q 012684          384 GLKELIEECWNEKPAK--RPTFRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~--Rps~~~ll~~  409 (458)
                      +++++|.+||..++.+  |+++.+++++
T Consensus       239 ~~~~li~~ll~~~~~~~~~~~~~~~~~h  266 (331)
T cd05624         239 EAKDLIQRLICSRERRLGQNGIEDFKKH  266 (331)
T ss_pred             HHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence            9999999999876554  4688888877

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=1e-39  Score=317.49  Aligned_cols=241  Identities=27%  Similarity=0.415  Sum_probs=197.3

Q ss_pred             eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHH-HHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      +.||+|+||.||.     +|+.||+|++.............+..|.. +++.++||||+++++.+......++||||+++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG   80 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence            3689999998873     68999999997543323333344555554 56788999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccC
Q 012684          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ  314 (458)
Q Consensus       235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~  314 (458)
                      ++|.+++...+.+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||++...... .......
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~  156 (323)
T cd05575          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH-SKTTSTF  156 (323)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC-CCccccc
Confidence            999999988888999999999999999999999999   999999999999999999999999998753222 1222345


Q ss_pred             CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 012684          315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN  394 (458)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  394 (458)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... ..   .+..+++.+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~---~~~~~~~~~~~li~~~l~  232 (323)
T cd05575         157 CGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKP-LR---LKPNISVSARHLLEGLLQ  232 (323)
T ss_pred             cCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCC-CC---CCCCCCHHHHHHHHHHhh
Confidence            68999999999999899999999999999999999999998776555544443222 11   234568899999999999


Q ss_pred             cCCCCCCCHH----HHHHH
Q 012684          395 EKPAKRPTFR----QIITR  409 (458)
Q Consensus       395 ~dp~~Rps~~----~ll~~  409 (458)
                      .||.+||++.    +++++
T Consensus       233 ~~p~~R~~~~~~~~~il~~  251 (323)
T cd05575         233 KDRTKRLGAKDDFLEIKNH  251 (323)
T ss_pred             cCHHhCCCCCCCHHHHHcC
Confidence            9999999984    55543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=4.9e-39  Score=302.91  Aligned_cols=248  Identities=30%  Similarity=0.526  Sum_probs=207.1

Q ss_pred             ccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .+|++.++||+|+||.||.    ++..||+|.+....    ...+.+.+|+.+++.++||||+++++.+......+++||
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05072           6 ESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITE   81 (261)
T ss_pred             HHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEe
Confidence            3677889999999998873    56789999886432    234678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+++++|.+++...  ..++...+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05072          82 YMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY  158 (261)
T ss_pred             cCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCce
Confidence            99999999998753  45888899999999999999999999   99999999999999999999999999986543322


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+......+   ....++..+.+
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  235 (261)
T cd05072         159 TAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMP---RMENCPDELYD  235 (261)
T ss_pred             eccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHH
Confidence            22223345678999999988888999999999999999998 999998776655555543332222   23457789999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      ++.+||+.+|++||+++++++.|++
T Consensus       236 li~~~l~~~p~~Rp~~~~i~~~l~~  260 (261)
T cd05072         236 IMKTCWKEKAEERPTFDYLQSVLDD  260 (261)
T ss_pred             HHHHHccCCcccCcCHHHHHHHHhc
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=1.4e-39  Score=315.29  Aligned_cols=241  Identities=27%  Similarity=0.449  Sum_probs=198.5

Q ss_pred             eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      +.||+|+||.||.     +++.||+|++................|..++... +||||+++++++......++||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            3689999998873     5789999999764332233345566677777764 899999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccC
Q 012684          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ  314 (458)
Q Consensus       235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~  314 (458)
                      |+|.+++.....+++.++..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++....... ......
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~  156 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD-AKTCTF  156 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC-Cceeee
Confidence            999999988778999999999999999999999999   9999999999999999999999999987532221 122334


Q ss_pred             CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 012684          315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN  394 (458)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  394 (458)
                      .||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+. ...+.+   +..++..++++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~-~~~~~~---~~~~~~~~~~li~~~l~  232 (316)
T cd05619         157 CGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIR-MDNPCY---PRWLTREAKDILVKLFV  232 (316)
T ss_pred             cCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCCCC---CccCCHHHHHHHHHHhc
Confidence            68999999999998889999999999999999999999998876655554442 222222   33477899999999999


Q ss_pred             cCCCCCCCHH-HHHHH
Q 012684          395 EKPAKRPTFR-QIITR  409 (458)
Q Consensus       395 ~dp~~Rps~~-~ll~~  409 (458)
                      .||.+||++. +++.+
T Consensus       233 ~~P~~R~~~~~~l~~h  248 (316)
T cd05619         233 REPERRLGVKGDIRQH  248 (316)
T ss_pred             cCHhhcCCChHHHHcC
Confidence            9999999997 66553

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-39  Score=316.37  Aligned_cols=251  Identities=21%  Similarity=0.319  Sum_probs=205.2

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.|+.     +++.||+|++...........+.+.+|..+++.++||||+++++++..++.+|+|||
T Consensus         2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (331)
T cd05597           2 DFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMD   81 (331)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEe
Confidence            577889999999998873     578999999975333334445668889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |++|++|.+++.+ ...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.++|+|||++.........
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~  158 (331)
T cd05597          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV  158 (331)
T ss_pred             cCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc
Confidence            9999999999976 456899999999999999999999999   999999999999999999999999998765433222


Q ss_pred             CcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHH
Q 012684          310 PLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR  383 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  383 (458)
                      ......||+.|+|||++.+     ..++.++|||||||++|+|++|+.||......+....+.... ...++.....++.
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  238 (331)
T cd05597         159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDVTDVSE  238 (331)
T ss_pred             cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCCccCCCCH
Confidence            2233458999999999863     356789999999999999999999998766555544443322 2333333445788


Q ss_pred             HHHHHHHHHcccCCCC--CCCHHHHHHH
Q 012684          384 GLKELIEECWNEKPAK--RPTFRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~--Rps~~~ll~~  409 (458)
                      .++++|++||..++++  ||++.+++++
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~l~h  266 (331)
T cd05597         239 EAKDLIRRLICSPETRLGRNGLQDFKDH  266 (331)
T ss_pred             HHHHHHHHHccCcccccCCCCHHHHhcC
Confidence            9999999998764444  7899999998

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1e-38  Score=300.74  Aligned_cols=248  Identities=29%  Similarity=0.493  Sum_probs=206.0

Q ss_pred             ccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .+|++.+.||.|++|.||.    ++..||+|.+.....    ..+.+.+|+.++++++||||+++++++...+..+++||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (261)
T cd05068           6 TSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTM----DPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTE   81 (261)
T ss_pred             hheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCcc----cHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeee
Confidence            3577889999999998763    567899999875432    23568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+++++|.+++....  .+++..+..++.|++.||.+||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~  158 (261)
T cd05068          82 LMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIY  158 (261)
T ss_pred             cccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCcc
Confidence            999999999997644  5899999999999999999999999   99999999999999999999999999887642211


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      ........+..|+|||.+.+..++.++|+||||+++++|++ |+.||...........+......+   .+..++..+.+
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  235 (261)
T cd05068         159 EAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP---CPPGCPKELYD  235 (261)
T ss_pred             cccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCcCCHHHHH
Confidence            11112223457999999988889999999999999999999 999998776655555443332222   23456789999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      ++.+||+.+|.+||++.++++.|+.
T Consensus       236 li~~~l~~~P~~Rp~~~~l~~~l~~  260 (261)
T cd05068         236 IMLDCWKEDPDDRPTFETLQWKLED  260 (261)
T ss_pred             HHHHHhhcCcccCCCHHHHHHHHhc
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.2e-38  Score=304.88  Aligned_cols=254  Identities=28%  Similarity=0.502  Sum_probs=210.8

Q ss_pred             CccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      ..+|.+.+.||.|+||.||.          ++..+|+|.+...   .......+.+|+.+++.++||||+++++++...+
T Consensus         4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   80 (288)
T cd05093           4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGD   80 (288)
T ss_pred             hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence            34678889999999998874          2356899988643   3445667899999999999999999999999999


Q ss_pred             ceEEEEEccCCCCHHHHHHhcC-------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKG-------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG  290 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~  290 (458)
                      ..++||||+++++|.+++...+             .+++..++.++.|++.||+|||+.+   ++||||||+||+++.++
T Consensus        81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~  157 (288)
T cd05093          81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENL  157 (288)
T ss_pred             ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCC
Confidence            9999999999999999997543             3899999999999999999999999   99999999999999999


Q ss_pred             CEEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHh
Q 012684          291 NLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA  368 (458)
Q Consensus       291 ~vkl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~  368 (458)
                      .++|+|||++........ .......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+..
T Consensus       158 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~  237 (288)
T cd05093         158 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQ  237 (288)
T ss_pred             cEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc
Confidence            999999999876532211 11122335678999999998889999999999999999998 9999988776655555533


Q ss_pred             cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      .....   .+..++.++.+|+.+||+.||.+|||+.++++.|+.+...
T Consensus       238 ~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~~  282 (288)
T cd05093         238 GRVLQ---RPRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAKA  282 (288)
T ss_pred             CCcCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHHh
Confidence            33222   2345678999999999999999999999999999988644

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=4.2e-39  Score=316.98  Aligned_cols=244  Identities=24%  Similarity=0.385  Sum_probs=197.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||+|+||.||.     +|+.||||++....  .......+.+|+.+++.++|+||+++++++..++.+++|||
T Consensus        75 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e  152 (353)
T PLN00034         75 ELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLE  152 (353)
T ss_pred             HHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEe
Confidence            567778999999999873     57899999986442  34455678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+++++|.+.    ...++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++..+.... ..
T Consensus       153 ~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~-~~  224 (353)
T PLN00034        153 FMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM-DP  224 (353)
T ss_pred             cCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceeccccc-cc
Confidence            9999998653    33567778889999999999999999   9999999999999999999999999987654321 12


Q ss_pred             cccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL  385 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (458)
                      .....||..|+|||.+..     ...+.++|||||||++|+|++|+.||.......................+..++.++
T Consensus       225 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  304 (353)
T PLN00034        225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREF  304 (353)
T ss_pred             ccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHH
Confidence            234568999999998743     234568999999999999999999998554444333322222222223345678899


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+||.+||+.||.+|||+.+++++
T Consensus       305 ~~li~~~l~~~P~~Rpt~~ell~h  328 (353)
T PLN00034        305 RHFISCCLQREPAKRWSAMQLLQH  328 (353)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcC
Confidence            999999999999999999999987

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=6.1e-39  Score=327.85  Aligned_cols=254  Identities=22%  Similarity=0.340  Sum_probs=209.9

Q ss_pred             ccCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          149 EIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       149 ~~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      +......+|++.+.||+|+||.||.     +|+.||||++..... .......+.+|+.++..++|+||+++++.+....
T Consensus        26 ~~~~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~  104 (496)
T PTZ00283         26 TAKEQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKD  104 (496)
T ss_pred             cccccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHhcCCCCcEEEeecceeccc
Confidence            3344456899999999999999873     689999999976544 3445567888999999999999999988775332


Q ss_pred             --------ceEEEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC
Q 012684          224 --------PMMIVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (458)
Q Consensus       224 --------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~  291 (458)
                              .+++||||+++|+|.+++...    ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus       105 ~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~  181 (496)
T PTZ00283        105 PRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGL  181 (496)
T ss_pred             ccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCC
Confidence                    368999999999999998652    45899999999999999999999999   999999999999999999


Q ss_pred             EEEeecCCccccccCC-CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC
Q 012684          292 LKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ  370 (458)
Q Consensus       292 vkl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~  370 (458)
                      +||+|||++..+.... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+.........
T Consensus       182 vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~  261 (496)
T PTZ00283        182 VKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGR  261 (496)
T ss_pred             EEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCC
Confidence            9999999987654321 112234568999999999999899999999999999999999999998766555544443333


Q ss_pred             CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ..+   .+..+++.+.+++..||+.||.+||++.+++.+
T Consensus       262 ~~~---~~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~  297 (496)
T PTZ00283        262 YDP---LPPSISPEMQEIVTALLSSDPKRRPSSSKLLNM  297 (496)
T ss_pred             CCC---CCCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence            322   345678999999999999999999999999875

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=7.7e-39  Score=304.41  Aligned_cols=251  Identities=26%  Similarity=0.450  Sum_probs=204.1

Q ss_pred             CCccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC
Q 012684          153 HELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS  222 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~  222 (458)
                      ...+|+..+.||+|+||.||.          .+..||+|.+...  ........+.+|+.+++.++||||+++++++..+
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~--~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~   81 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQG   81 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence            345688899999999998873          2467999998643  2333455688999999999999999999999999


Q ss_pred             CceEEEEEccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCE
Q 012684          223 SPMMIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL  292 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~v  292 (458)
                      ...++||||+++++|.+++....          .++...+..++.|++.||.|||+.+   ++|+||||+||+++.++.+
T Consensus        82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~  158 (277)
T cd05062          82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTV  158 (277)
T ss_pred             CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCE
Confidence            99999999999999999987532          2466788889999999999999999   9999999999999999999


Q ss_pred             EEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcC
Q 012684          293 KVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ  370 (458)
Q Consensus       293 kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~  370 (458)
                      +|+|||++.......... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+.........
T Consensus       159 ~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~  238 (277)
T cd05062         159 KIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG  238 (277)
T ss_pred             EECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999987543221111 112234678999999988889999999999999999998 789998776655554443333


Q ss_pred             CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      .+.   .+...+..+.+++.+||+.||.+|||+.++++.|+
T Consensus       239 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  276 (277)
T cd05062         239 LLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIK  276 (277)
T ss_pred             cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhh
Confidence            222   23456788999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-38  Score=299.93  Aligned_cols=250  Identities=32%  Similarity=0.529  Sum_probs=208.5

Q ss_pred             cccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      +|++.+.||+|+||.||.        +...||+|.+....  .......+..|+.+++.++||||+++++++..+...++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           5 YVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             HceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEE
Confidence            577889999999998873        13589999987542  34445678889999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      +|||+++++|.+++... +.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~  159 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDS  159 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhccccc
Confidence            99999999999998763 46899999999999999999999999   999999999999999999999999999876422


Q ss_pred             CCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          307 EDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       307 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      ... ......+++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+......+.   +..++..
T Consensus       160 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  236 (266)
T cd05033         160 EATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLPP---PMDCPSA  236 (266)
T ss_pred             ccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHH
Confidence            111 1122334678999999998889999999999999999998 9999987666555555533322222   3456789


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      +.+++.+||+.+|.+||++.+++++|+++
T Consensus       237 l~~li~~cl~~~p~~Rp~~~ei~~~l~~~  265 (266)
T cd05033         237 LYQLMLDCWQKDRNERPTFSQIVSTLDKM  265 (266)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            99999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=9.8e-40  Score=322.37  Aligned_cols=249  Identities=24%  Similarity=0.393  Sum_probs=205.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||+|+||.|+.     +|+.||+|++.............+..|+.++..++||+|+++++.+..+..+|+|||
T Consensus         2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E   81 (360)
T cd05627           2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME   81 (360)
T ss_pred             CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence            467788999999999873     688999999975433344456678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC--
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~--  308 (458)
                      |++||+|.+++.+.+.+++..+..++.|++.||.|||+.|   |+||||||+|||++.++.++|+|||++........  
T Consensus        82 ~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~  158 (360)
T cd05627          82 FLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE  158 (360)
T ss_pred             CCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccccccc
Confidence            9999999999988888999999999999999999999999   99999999999999999999999999865421100  


Q ss_pred             --------------------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 012684          309 --------------------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM  356 (458)
Q Consensus       309 --------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~  356 (458)
                                                      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~  238 (360)
T cd05627         159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCS  238 (360)
T ss_pred             cccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCC
Confidence                                            001134689999999999998999999999999999999999999998


Q ss_pred             CCCCcHHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 012684          357 KHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPT---FRQIITR  409 (458)
Q Consensus       357 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps---~~~ll~~  409 (458)
                      .+.......+.... ...++. ...++++++++|.+|+ .||.+|++   +.++++|
T Consensus       239 ~~~~~~~~~i~~~~~~~~~p~-~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~h  293 (360)
T cd05627         239 ETPQETYRKVMNWKETLVFPP-EVPISEKAKDLILRFC-TDSENRIGSNGVEEIKSH  293 (360)
T ss_pred             CCHHHHHHHHHcCCCceecCC-CCCCCHHHHHHHHHhc-cChhhcCCCCCHHHHhcC
Confidence            77766555543222 222221 1236789999999977 49999985   6777766

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.7e-39  Score=314.36  Aligned_cols=240  Identities=27%  Similarity=0.436  Sum_probs=200.4

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      +|+..+.||+|+||.|+.     +|+.||+|++...........+.+..|..++..+. |++|+++++++...+..|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            356778999999999874     58899999997643333444566778888888885 678889999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||++|++|.+++...+.+++.++..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||++...... ..
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~-~~  156 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD-GV  156 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC-Cc
Confidence            99999999999988888999999999999999999999999   999999999999999999999999998754322 11


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......||+.|+|||++.+..++.++|+||+||++|+|++|+.||...........+... ...+   +..+++.+.+++
T Consensus       157 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~-~~~~---p~~~~~~~~~li  232 (323)
T cd05615         157 TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEH-NVSY---PKSLSKEAVSIC  232 (323)
T ss_pred             cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCC---CccCCHHHHHHH
Confidence            223445899999999999888999999999999999999999999887665555544322 2222   345778999999


Q ss_pred             HHHcccCCCCCCCH
Q 012684          390 EECWNEKPAKRPTF  403 (458)
Q Consensus       390 ~~~l~~dp~~Rps~  403 (458)
                      .+||+.+|.+|++.
T Consensus       233 ~~~l~~~p~~R~~~  246 (323)
T cd05615         233 KGLMTKHPSKRLGC  246 (323)
T ss_pred             HHHcccCHhhCCCC
Confidence            99999999999985

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=2.4e-39  Score=314.66  Aligned_cols=235  Identities=26%  Similarity=0.390  Sum_probs=193.1

Q ss_pred             eeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHH-HHhcCCCCcceeeeeEEEeCCceEEEEEccCCC
Q 012684          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (458)
Q Consensus       162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~  235 (458)
                      .||+|+||.||.     +|+.||+|++.............+..|.. +++.++||||+++++++...+..|+||||++++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~   81 (321)
T cd05603           2 VIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGG   81 (321)
T ss_pred             eeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCC
Confidence            689999999873     57899999997543323333344555554 678889999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCC
Q 012684          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (458)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~  315 (458)
                      +|...+.....+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++...... ........
T Consensus        82 ~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~  157 (321)
T cd05603          82 ELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEP-EETTSTFC  157 (321)
T ss_pred             CHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCC-CCcccccc
Confidence            99999988788999999999999999999999999   999999999999999999999999998753222 12223456


Q ss_pred             CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 012684          316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE  395 (458)
Q Consensus       316 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  395 (458)
                      ||+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+.. ....   .+...+..+.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~-~~~~---~~~~~~~~~~~li~~~l~~  233 (321)
T cd05603         158 GTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILH-KPLQ---LPGGKTVAACDLLVGLLHK  233 (321)
T ss_pred             CCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhc-CCCC---CCCCCCHHHHHHHHHHccC
Confidence            89999999999988899999999999999999999999987765544444422 2222   2345678899999999999


Q ss_pred             CCCCCCCHH
Q 012684          396 KPAKRPTFR  404 (458)
Q Consensus       396 dp~~Rps~~  404 (458)
                      ||.+||++.
T Consensus       234 ~p~~R~~~~  242 (321)
T cd05603         234 DQRRRLGAK  242 (321)
T ss_pred             CHhhcCCCC
Confidence            999999864

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-40  Score=319.43  Aligned_cols=245  Identities=26%  Similarity=0.485  Sum_probs=214.5

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      +..|+..+.||.|+||.||+     +.+.||||.+.-..-...+.-+++..|+..|+++.|||++.+.++|..+...|+|
T Consensus        25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV  104 (948)
T KOG0577|consen   25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV  104 (948)
T ss_pred             HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence            44577788999999999985     6789999999876655556667788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |||| -|+..|++.- ..++.+.++..|..+.+.||.|||+.+   .||||||.-|||+++.|.|||+|||.+....   
T Consensus       105 MEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~---  177 (948)
T KOG0577|consen  105 MEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMA---  177 (948)
T ss_pred             HHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcC---
Confidence            9999 5689888864 456899999999999999999999999   9999999999999999999999999998653   


Q ss_pred             CCCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                        +...++|||.|||||++.   .+.|+-++||||||+++.+|.-+++|+..++......-+.....|.+.  .+.|+..
T Consensus       178 --PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLq--s~eWS~~  253 (948)
T KOG0577|consen  178 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQ--SNEWSDY  253 (948)
T ss_pred             --chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCC--CchhHHH
Confidence              445678999999999985   458999999999999999999999999888776666666544455543  5779999


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +++|+..||++=|.+|||..++++|
T Consensus       254 F~~Fvd~CLqKipqeRptse~ll~H  278 (948)
T KOG0577|consen  254 FRNFVDSCLQKIPQERPTSEELLKH  278 (948)
T ss_pred             HHHHHHHHHhhCcccCCcHHHHhhc
Confidence            9999999999999999999999886

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-38  Score=299.55  Aligned_cols=249  Identities=27%  Similarity=0.472  Sum_probs=206.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCC--CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      +|.+.+.||.|++|.+|.     ++..||+|.+......  .......+.+|+.++++++||||+++++++..+...++|
T Consensus         3 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v   82 (263)
T cd06625           3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIF   82 (263)
T ss_pred             cccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEE
Confidence            577889999999998873     5789999998654322  223456788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      +||+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        83 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~  159 (263)
T cd06625          83 MEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS  159 (263)
T ss_pred             EEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecccccc
Confidence            999999999999988888999999999999999999999999   99999999999999999999999999875532211


Q ss_pred             CCc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          309 RPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       309 ~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                      ...  ....++..|+|||.+.+..++.++||||||+++|+|++|+.||................  .....+..++..+.
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  237 (263)
T cd06625         160 SGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQP--TNPQLPSHVSPDAR  237 (263)
T ss_pred             ccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccC--CCCCCCccCCHHHH
Confidence            111  23456788999999999889999999999999999999999998765443333332221  12223456788999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++|..||..+|.+|||+.+++++
T Consensus       238 ~li~~~l~~~p~~Rpt~~~ll~~  260 (263)
T cd06625         238 NFLRRTFVENAKKRPSAEELLRH  260 (263)
T ss_pred             HHHHHHhhcCcccCCCHHHHhhC
Confidence            99999999999999999999876

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=6.8e-39  Score=304.86  Aligned_cols=243  Identities=25%  Similarity=0.386  Sum_probs=195.3

Q ss_pred             eccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012684          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (458)
Q Consensus       163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L  237 (458)
                      ||+|+||.||.     +|+.||+|.+.............+..|+.+++.++||||+++++++..+...++||||++|++|
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L   80 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL   80 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence            68999998873     5899999999754332222334456799999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCC
Q 012684          238 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (458)
Q Consensus       238 ~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~  315 (458)
                      .+++...+  .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++......  .......
T Consensus        81 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~--~~~~~~~  155 (277)
T cd05607          81 KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDG--KTITQRA  155 (277)
T ss_pred             HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCC--ceeeccC
Confidence            98886543  4788889999999999999999999   999999999999999999999999998765432  1223346


Q ss_pred             CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcc
Q 012684          316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWN  394 (458)
Q Consensus       316 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~  394 (458)
                      +++.|+|||++.+..++.++|+|||||++|+|++|+.||................ ..........+++++.++|.+||+
T Consensus       156 ~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  235 (277)
T cd05607         156 GTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICRLFLA  235 (277)
T ss_pred             CCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccccccCCHHHHHHHHHHhc
Confidence            7889999999988889999999999999999999999998654332222221111 112222234578899999999999


Q ss_pred             cCCCCCCCHHHHHHHH
Q 012684          395 EKPAKRPTFRQIITRL  410 (458)
Q Consensus       395 ~dp~~Rps~~~ll~~L  410 (458)
                      .||.+||+++++++.+
T Consensus       236 ~~P~~R~~~~~~~~~~  251 (277)
T cd05607         236 KKPEDRLGSREKNDDP  251 (277)
T ss_pred             cCHhhCCCCccchhhh
Confidence            9999999998776443

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.4e-38  Score=300.74  Aligned_cols=252  Identities=25%  Similarity=0.483  Sum_probs=208.1

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||.|+||.|+.     +|..+|||.+.............+.+|+.+++.++||||+++++++..++..+++||
T Consensus         3 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   82 (267)
T cd08229           3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLE   82 (267)
T ss_pred             hhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEE
Confidence            577788999999998863     789999998876544455556778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       231 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      |+++++|.+++..    ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd08229          83 LADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             ecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhccccC
Confidence            9999999998863    345899999999999999999999999   999999999999999999999999998765433


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--cHHHHHHhcCCCCCCCChhhhHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      .. ......++..|+|||.+.+..++.++|+||||+++|+|++|..||......  .....+.....++  .....+++.
T Consensus       160 ~~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  236 (267)
T cd08229         160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP--LPSDHYSEE  236 (267)
T ss_pred             Cc-ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCCCCC--CCcccccHH
Confidence            21 122345788999999998888899999999999999999999999764432  1112221111111  223457889


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      ++++|.+||..||.+|||+.++++.++++
T Consensus       237 ~~~li~~~l~~~p~~Rpt~~~i~~~~~~~  265 (267)
T cd08229         237 LRQLVNMCINPDPEKRPDITYVYDVAKRM  265 (267)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHHHHHhhh
Confidence            99999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.7e-38  Score=298.69  Aligned_cols=244  Identities=26%  Similarity=0.435  Sum_probs=203.4

Q ss_pred             eeccceEEEEEE-------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       162 ~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      +||+|+||.|+.       ++..+|+|++.... ......+.+..|+.+++.++||||+++++++.. ...++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCC
Confidence            589999998873       46899999987543 244556778899999999999999999998864 467899999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC--cc
Q 012684          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LT  312 (458)
Q Consensus       235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~--~~  312 (458)
                      ++|.+++.....+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..........  ..
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  156 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKT  156 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecC
Confidence            999999988778999999999999999999999999   9999999999999999999999999987654332211  11


Q ss_pred             cCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHH
Q 012684          313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE  391 (458)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  391 (458)
                      ...++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+.....++.   +..+++++.++|.+
T Consensus       157 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~  233 (257)
T cd05116         157 HGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERMEC---PQRCPPEMYDLMKL  233 (257)
T ss_pred             CCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCCCHHHHHHHHH
Confidence            2233578999999988888999999999999999998 9999988766655555543333332   34578899999999


Q ss_pred             HcccCCCCCCCHHHHHHHHHHH
Q 012684          392 CWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       392 ~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      ||+.||.+||++.+|...|++.
T Consensus       234 ~~~~~p~~Rp~~~~i~~~l~~~  255 (257)
T cd05116         234 CWTYGVDERPGFAVVELRLRNY  255 (257)
T ss_pred             HhccCchhCcCHHHHHHHHhcc
Confidence            9999999999999999998764

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=1e-38  Score=300.10  Aligned_cols=246  Identities=30%  Similarity=0.543  Sum_probs=202.6

Q ss_pred             cccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      +|++.+.||+|+||.+|.    .+..+|+|.+.....    ..+.+.+|+.+++.++||||+++++++......+++|||
T Consensus         5 ~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05113           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSM----SEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEY   80 (256)
T ss_pred             HeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCcc----cHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEc
Confidence            467778999999998763    234699999875432    235688899999999999999999999988899999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      +.+++|.+++... ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||.+..........
T Consensus        81 ~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~  157 (256)
T cd05113          81 MSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS  157 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence            9999999999764 46899999999999999999999999   9999999999999999999999999987654322211


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+........   +...+..+.+++
T Consensus       158 ~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li  234 (256)
T cd05113         158 SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYR---PHLASEKVYAIM  234 (256)
T ss_pred             cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCC---CCCCCHHHHHHH
Confidence            122335667999999988889999999999999999998 9999987766555555433333222   234578999999


Q ss_pred             HHHcccCCCCCCCHHHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      .+||+.||.+||++.++++.|+
T Consensus       235 ~~cl~~~p~~Rp~~~~ll~~~~  256 (256)
T cd05113         235 YSCWHEKAEERPTFQQLLSSIE  256 (256)
T ss_pred             HHHcCCCcccCCCHHHHHHhhC
Confidence            9999999999999999998763

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=1.7e-38  Score=306.78  Aligned_cols=265  Identities=28%  Similarity=0.514  Sum_probs=213.7

Q ss_pred             CCCcccCcCCccccCceeeccceEEEEEEc------------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCc
Q 012684          145 VPEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPN  211 (458)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~  211 (458)
                      .+.|++.  ..+|.+.+.||+|+||.|+..            +..+|+|.+....  .......+..|+.+++.+ +|||
T Consensus        10 ~~~~~~~--~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~   85 (307)
T cd05098          10 DPRWEVP--RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKN   85 (307)
T ss_pred             CCcceee--hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCC
Confidence            3445444  347899999999999988731            2469999997542  234456788899999999 7999


Q ss_pred             ceeeeeEEEeCCceEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCee
Q 012684          212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPII  275 (458)
Q Consensus       212 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~  275 (458)
                      |+++++++..++..++||||+.+++|.+++....                .+++.++..++.|++.||+|||+.+   ++
T Consensus        86 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~  162 (307)
T cd05098          86 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CI  162 (307)
T ss_pred             EeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cc
Confidence            9999999999999999999999999999997632                3788899999999999999999999   99


Q ss_pred             eCCCCCCCEEecCCCCEEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCC
Q 012684          276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPP  353 (458)
Q Consensus       276 H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~p  353 (458)
                      |+||||+||+++.++.++|+|||++.......... .....+++.|+|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus       163 H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p  242 (307)
T cd05098         163 HRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSP  242 (307)
T ss_pred             cccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCC
Confidence            99999999999999999999999987654321111 112234568999999988889999999999999999998 8899


Q ss_pred             CCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012684          354 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH  419 (458)
Q Consensus       354 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  419 (458)
                      |......+....+.......   .+..++.++.++|.+||..+|.+|||+.++++.|+++.....+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~~~~~  305 (307)
T cd05098         243 YPGVPVEELFKLLKEGHRMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILALTSN  305 (307)
T ss_pred             CCcCCHHHHHHHHHcCCCCC---CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHHHhhc
Confidence            97765544444443222222   2345678999999999999999999999999999998776443

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=7.7e-40  Score=317.67  Aligned_cols=236  Identities=25%  Similarity=0.373  Sum_probs=197.6

Q ss_pred             eeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012684          161 VEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (458)
Q Consensus       161 ~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~  232 (458)
                      +.||+|+||.||.        +|+.||+|++...... ......+..|+.++++++||||+++++++..++..|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence            5799999998872        5789999999754322 223345678999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcc
Q 012684          233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT  312 (458)
Q Consensus       233 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~  312 (458)
                      ++++|.+++.+...+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++....... ....
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-~~~~  156 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE-KKAY  156 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC-Ccee
Confidence            99999999988888999999999999999999999999   9999999999999999999999999987643321 2223


Q ss_pred             cCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHH
Q 012684          313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC  392 (458)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  392 (458)
                      ...|++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+.. ....   .+..+++.+.++|..|
T Consensus       157 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~-~~~~---~p~~~~~~~~~li~~~  232 (318)
T cd05582         157 SFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILK-AKLG---MPQFLSPEAQSLLRAL  232 (318)
T ss_pred             cccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHc-CCCC---CCCCCCHHHHHHHHHH
Confidence            45689999999999988889999999999999999999999987665554444422 2222   2345778999999999


Q ss_pred             cccCCCCCCCHHH
Q 012684          393 WNEKPAKRPTFRQ  405 (458)
Q Consensus       393 l~~dp~~Rps~~~  405 (458)
                      |+.||.+||++.+
T Consensus       233 l~~~P~~R~~a~~  245 (318)
T cd05582         233 FKRNPANRLGAGP  245 (318)
T ss_pred             hhcCHhHcCCCCC
Confidence            9999999999544

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=7.3e-39  Score=306.57  Aligned_cols=247  Identities=28%  Similarity=0.434  Sum_probs=194.4

Q ss_pred             cccCceeeccceEEEEEE------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC---CCCcceeeeeEEE-----e
Q 012684          156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVT-----Q  221 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~i~~~~~~~~-----~  221 (458)
                      +|++.+.||+|+||.||.      +|..||+|.+........ ....+.+|+.+++.+   +||||+++++++.     .
T Consensus         2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEG-MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCC-chHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            688889999999998873      367899999875432221 223345576666655   6999999999985     2


Q ss_pred             CCceEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCC
Q 012684          222 SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (458)
Q Consensus       222 ~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~  299 (458)
                      ....++||||+. ++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.++|+|||+
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg~  156 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGL  156 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEccccc
Confidence            456899999995 6999998753  34889999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCC----
Q 012684          300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK----  375 (458)
Q Consensus       300 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~----  375 (458)
                      +......  .......+++.|+|||.+.+..++.++|||||||++|+|++|+.||.+....+....+......+.+    
T Consensus       157 ~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~  234 (290)
T cd07862         157 ARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP  234 (290)
T ss_pred             eEeccCC--cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhch
Confidence            8765432  2223456789999999998888999999999999999999999999887655444333221110000    


Q ss_pred             -------------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          376 -------------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       376 -------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                         ...+.+++.++++|.+||+.||++|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~h  287 (290)
T cd07862         235 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  287 (290)
T ss_pred             hhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcC
Confidence                               0112456788999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=7.5e-39  Score=308.60  Aligned_cols=249  Identities=24%  Similarity=0.442  Sum_probs=195.3

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|++.+.||.|+||.|+.     +|+.||+|++.....  ......+.+|+.+++.++||||+++++++..+...++|
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv   81 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV   81 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence            34688899999999998873     688999999975432  12223567899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |||+ +++|.+++... +.+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++...... 
T Consensus        82 ~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~-  156 (303)
T cd07869          82 FEYV-HTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVP-  156 (303)
T ss_pred             EECC-CcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCC-
Confidence            9999 46888877653 56899999999999999999999999   999999999999999999999999998754322 


Q ss_pred             CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH-HHHHHh-cCCCC-----------
Q 012684          308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAA-RQRPP-----------  373 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~-~~~~~~-~~~~~-----------  373 (458)
                      ........+++.|+|||++.+ ..++.++|||||||++|+|++|+.||.+...... ...+.. .+.+.           
T Consensus       157 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (303)
T cd07869         157 SHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLP  236 (303)
T ss_pred             CccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhcc
Confidence            122234567899999999865 4578899999999999999999999987543211 111100 00000           


Q ss_pred             -C---------CC------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 -F---------KA------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 -~---------~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                       +         +.      ....+++.+.+++.+||+.||.+|||++++++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h  288 (303)
T cd07869         237 HFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSH  288 (303)
T ss_pred             ccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcC
Confidence             0         00      001234678999999999999999999999986

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1e-38  Score=304.92  Aligned_cols=248  Identities=25%  Similarity=0.380  Sum_probs=202.8

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |+..+.||+|+||.|+.     +++.||+|.+.............+..|+.++++++|++|+++++.+..++..++||||
T Consensus         2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05630           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL   81 (285)
T ss_pred             ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence            56678899999998874     6789999998765444444445677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       232 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ++|++|.+++...+  .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......  .
T Consensus        82 ~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~--~  156 (285)
T cd05630          82 MNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG--Q  156 (285)
T ss_pred             cCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCC--c
Confidence            99999999886533  4889999999999999999999999   999999999999999999999999998754322  1


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......|++.|+|||.+.+..++.++|+||+|+++|+|++|+.||.......................+..+++.+.+|+
T Consensus       157 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05630         157 TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLC  236 (285)
T ss_pred             cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhhhhhhhcCccCCHHHHHHH
Confidence            22334688999999999988899999999999999999999999987554322222211111111122345778999999


Q ss_pred             HHHcccCCCCCCC-----HHHHHHH
Q 012684          390 EECWNEKPAKRPT-----FRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps-----~~~ll~~  409 (458)
                      ..||+.||.+|||     +.+++++
T Consensus       237 ~~~l~~~p~~R~s~~~~~~~~~~~h  261 (285)
T cd05630         237 KMLLCKDPKERLGCQGGGAREVKEH  261 (285)
T ss_pred             HHHhhcCHHHccCCCCCchHHHHcC
Confidence            9999999999999     8899886

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=1.4e-38  Score=302.99  Aligned_cols=249  Identities=29%  Similarity=0.490  Sum_probs=206.7

Q ss_pred             ccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      .+|.+.+.||+|+||.||.          ++..||+|.+....  .....+.+.+|+.+++.++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   82 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLTNFQHENIVKFYGVCTEGDP   82 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCC
Confidence            4577888999999998873          13689999987542  33345788999999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcC--------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG--------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG  290 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~  290 (458)
                      .++||||+++++|.+++...+              .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~  159 (280)
T cd05049          83 PIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDL  159 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCC
Confidence            999999999999999997542              3778889999999999999999999   99999999999999999


Q ss_pred             CEEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHh
Q 012684          291 NLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA  368 (458)
Q Consensus       291 ~vkl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~  368 (458)
                      .++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+..
T Consensus       160 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~  239 (280)
T cd05049         160 VVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQ  239 (280)
T ss_pred             eEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence            999999999875432211 11122335678999999999899999999999999999998 9999987776665555532


Q ss_pred             cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      ....   ..+..++..+.+++.+||..||.+||++.++++.|+
T Consensus       240 ~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~  279 (280)
T cd05049         240 GRLL---QRPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQ  279 (280)
T ss_pred             CCcC---CCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhh
Confidence            2222   223457789999999999999999999999999885

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.2e-39  Score=315.38  Aligned_cols=238  Identities=26%  Similarity=0.403  Sum_probs=194.8

Q ss_pred             eeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHH-HHHhcCCCCcceeeeeEEEeCCceEEEEEccCCC
Q 012684          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL-ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (458)
Q Consensus       162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~-~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~  235 (458)
                      .||+|+||.||.     ++..||+|++.............+..|. .+++.++||||+++++++...+..++||||++++
T Consensus         2 ~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~   81 (325)
T cd05602           2 VIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGG   81 (325)
T ss_pred             eeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCC
Confidence            689999998873     5688999999754322222233444444 4567889999999999999999999999999999


Q ss_pred             CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCC
Q 012684          236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (458)
Q Consensus       236 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~  315 (458)
                      +|.+++...+.+++..+..++.|++.||.|||+.|   |+||||||+|||++.++.++|+|||++...... ........
T Consensus        82 ~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~-~~~~~~~~  157 (325)
T cd05602          82 ELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-NGTTSTFC  157 (325)
T ss_pred             cHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccC-CCCccccc
Confidence            99999988888999999999999999999999999   999999999999999999999999998754322 12223456


Q ss_pred             CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 012684          316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE  395 (458)
Q Consensus       316 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  395 (458)
                      ||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... ..   ..+.+++.+.++|.+||+.
T Consensus       158 gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~-~~---~~~~~~~~~~~li~~~l~~  233 (325)
T cd05602         158 GTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQ---LKPNITNSARHLLEGLLQK  233 (325)
T ss_pred             CCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCC-cC---CCCCCCHHHHHHHHHHccc
Confidence            8999999999999899999999999999999999999998776655544443221 11   2345788999999999999


Q ss_pred             CCCCCCCHHHHH
Q 012684          396 KPAKRPTFRQII  407 (458)
Q Consensus       396 dp~~Rps~~~ll  407 (458)
                      ||.+||++.+.+
T Consensus       234 ~p~~R~~~~~~~  245 (325)
T cd05602         234 DRTKRLGAKDDF  245 (325)
T ss_pred             CHHHCCCCCCCH
Confidence            999999987543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=4e-39  Score=314.45  Aligned_cols=251  Identities=22%  Similarity=0.319  Sum_probs=205.7

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.|+.     +++.||+|++.............+..|+.++..++|++|+++++++..+...++|||
T Consensus         2 ~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (332)
T cd05623           2 DFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMD   81 (332)
T ss_pred             CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEe
Confidence            577889999999998873     567899999865333233444568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |+++|+|.+++.+ ...+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++.........
T Consensus        82 y~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~  158 (332)
T cd05623          82 YYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV  158 (332)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccCCcc
Confidence            9999999999987 456899999999999999999999999   999999999999999999999999998755332222


Q ss_pred             CcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHH
Q 012684          310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR  383 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  383 (458)
                      ......||+.|+|||++.     ...++.++|||||||++|+|++|+.||...+..+....+.... ...++.....+++
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~  238 (332)
T cd05623         159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSE  238 (332)
T ss_pred             eecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCH
Confidence            223456899999999986     3457889999999999999999999998876655555553332 2334444456789


Q ss_pred             HHHHHHHHHcccCCCC--CCCHHHHHHH
Q 012684          384 GLKELIEECWNEKPAK--RPTFRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~--Rps~~~ll~~  409 (458)
                      .+.++|++||..++.+  |+++.+++++
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~~~h  266 (332)
T cd05623         239 DAKDLIRRLICSREHRLGQNGIEDFKQH  266 (332)
T ss_pred             HHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence            9999999999765554  6899999988

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-38  Score=298.50  Aligned_cols=245  Identities=31%  Similarity=0.562  Sum_probs=202.4

Q ss_pred             cccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      +|++.+.||+|+||.|+.    .+..+|+|.+......    ...+..|+.+++.++||||+++++++...+..++||||
T Consensus         5 ~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~   80 (256)
T cd05059           5 ELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEY   80 (256)
T ss_pred             HcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEec
Confidence            467788999999998873    4568999998654321    24577899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      +++++|.+++... +.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~  157 (256)
T cd05059          81 MANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS  157 (256)
T ss_pred             CCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence            9999999999763 46899999999999999999999999   9999999999999999999999999987654322111


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......+....+........   +..++..+.+++
T Consensus       158 ~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li  234 (256)
T cd05059         158 SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRLYR---PKLAPTEVYTIM  234 (256)
T ss_pred             cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCHHHHHHH
Confidence            112223457999999988889999999999999999998 8999987766665555533323222   334788999999


Q ss_pred             HHHcccCCCCCCCHHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      .+||..+|++|||+.++++.|
T Consensus       235 ~~cl~~~p~~Rpt~~~~l~~l  255 (256)
T cd05059         235 YSCWHEKPEDRPAFKKLLSQL  255 (256)
T ss_pred             HHHhcCChhhCcCHHHHHHHh
Confidence            999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=5.5e-39  Score=312.77  Aligned_cols=242  Identities=24%  Similarity=0.407  Sum_probs=199.1

Q ss_pred             eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      +.||+|+||.|+.     +++.||+|++...........+.+..|..++.++ +||+|+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            3699999998873     6789999999866544555667788899999888 699999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccC
Q 012684          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ  314 (458)
Q Consensus       235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~  314 (458)
                      ++|..++...+.+++..+..++.|++.||+|||+++   ++||||||+|||++.++.++|+|||++...... .......
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~-~~~~~~~  156 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGP-GDTTSTF  156 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCC-CCceecc
Confidence            999999988888999999999999999999999999   999999999999999999999999998753221 1222345


Q ss_pred             CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc------HHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE------VPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||.......      ............   .+..++..+.++
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~---~p~~~~~~~~~l  233 (327)
T cd05617         157 CGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIR---IPRFLSVKASHV  233 (327)
T ss_pred             cCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCC---CCCCCCHHHHHH
Confidence            68999999999999899999999999999999999999996533211      111111122112   244577899999


Q ss_pred             HHHHcccCCCCCCCH------HHHHHH
Q 012684          389 IEECWNEKPAKRPTF------RQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rps~------~~ll~~  409 (458)
                      |.+||+.||.+|+++      .++++|
T Consensus       234 i~~~L~~dP~~R~~~~~~~~~~~i~~h  260 (327)
T cd05617         234 LKGFLNKDPKERLGCQPQTGFSDIKSH  260 (327)
T ss_pred             HHHHhccCHHHcCCCCCCCCHHHHHcC
Confidence            999999999999985      566655

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=2.4e-38  Score=303.84  Aligned_cols=253  Identities=29%  Similarity=0.459  Sum_probs=206.8

Q ss_pred             CccccCceeeccceEEEEEE---------------------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcc
Q 012684          154 ELDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV  212 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~---------------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i  212 (458)
                      ..+|++.+.||+|+||.|+.                     .+..||+|.+....  .....+.+.+|+.+++.++||||
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i   81 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILSRLSDPNI   81 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhcCCCCE
Confidence            34688889999999998874                     23568999987543  33556778999999999999999


Q ss_pred             eeeeeEEEeCCceEEEEEccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 012684          213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP  281 (458)
Q Consensus       213 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp  281 (458)
                      +++++++..+...+++||++.+++|.+++.+..           .+++..++.++.|++.||.|||+.+   ++|+||||
T Consensus        82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp  158 (296)
T cd05051          82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLAT  158 (296)
T ss_pred             eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccch
Confidence            999999999999999999999999999998755           6899999999999999999999999   99999999


Q ss_pred             CCEEecCCCCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCC
Q 012684          282 SNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKH  358 (458)
Q Consensus       282 ~Nil~~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt--g~~pf~~~~  358 (458)
                      +||+++.++.++|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++  |..||....
T Consensus       159 ~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~  238 (296)
T cd05051         159 RNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLT  238 (296)
T ss_pred             hceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcC
Confidence            9999999999999999998754322211 1223345778999999988889999999999999999998  778887766


Q ss_pred             CCcHHHHHHhc----CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          359 DNEVPKAYAAR----QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       359 ~~~~~~~~~~~----~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      ...........    ........+..++.++.+++.+||+.||.+|||+.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~  295 (296)
T cd05051         239 DQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQ  295 (296)
T ss_pred             hHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhc
Confidence            55544433222    111112223456789999999999999999999999998876

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.6e-38  Score=296.35  Aligned_cols=243  Identities=30%  Similarity=0.541  Sum_probs=199.9

Q ss_pred             eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCC
Q 012684          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~  235 (458)
                      +.||.|+||.||.     +|+.||+|.+....  .......+.+|+.+++.++||||+++++++......++||||++++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~   78 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG   78 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence            3689999998873     68899999886432  3445567889999999999999999999999999999999999999


Q ss_pred             CHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCc-cc
Q 012684          236 DLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-TC  313 (458)
Q Consensus       236 ~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~-~~  313 (458)
                      +|.+++...+ .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........... ..
T Consensus        79 ~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  155 (252)
T cd05084          79 DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM  155 (252)
T ss_pred             cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence            9999997644 5899999999999999999999999   99999999999999999999999999875432211111 11


Q ss_pred             CCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHH
Q 012684          314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC  392 (458)
Q Consensus       314 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  392 (458)
                      ...+..|+|||.+.+..++.++|+||||+++|+|++ |..||....................   +..++..+.+++.+|
T Consensus       156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~  232 (252)
T cd05084         156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLPC---PELCPDAVYRLMERC  232 (252)
T ss_pred             CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---cccCCHHHHHHHHHH
Confidence            123456999999988889999999999999999997 8999987665544444433222222   345678999999999


Q ss_pred             cccCCCCCCCHHHHHHHHH
Q 012684          393 WNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       393 l~~dp~~Rps~~~ll~~L~  411 (458)
                      |+.+|.+|||+.++++.|+
T Consensus       233 l~~~p~~Rps~~~~~~~l~  251 (252)
T cd05084         233 WEYDPGQRPSFSTVHQELQ  251 (252)
T ss_pred             cCCChhhCcCHHHHHHHHh
Confidence            9999999999999998876

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.7e-38  Score=301.62  Aligned_cols=249  Identities=30%  Similarity=0.525  Sum_probs=204.2

Q ss_pred             cccCceeeccceEEEEEE---------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      .|++.+.||+|+||.||.         .+..||+|.+...  ........+.+|+.+++.++||||+++++++..+...|
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           6 AVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceE
Confidence            356678999999998873         3478999999743  23445567889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHhc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC
Q 012684          227 IVTEYLPKGDLRAFLKRK-----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS  289 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~-----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~  289 (458)
                      ++|||+++++|.+++...                 ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~  160 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQ  160 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCC
Confidence            999999999999998532                 13678888999999999999999999   9999999999999999


Q ss_pred             CCEEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHH
Q 012684          290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA  367 (458)
Q Consensus       290 ~~vkl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~  367 (458)
                      +.++|+|||++........ .......++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.
T Consensus       161 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~  240 (283)
T cd05090         161 LHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVR  240 (283)
T ss_pred             CcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            9999999999876532211 11123345677999999988889999999999999999998 999998766544444443


Q ss_pred             hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012684          368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      .....+   .+..+++.+.+++.+||+.||.+||++.+++++|..
T Consensus       241 ~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  282 (283)
T cd05090         241 KRQLLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS  282 (283)
T ss_pred             cCCcCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence            323222   244577899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=3.6e-38  Score=302.03  Aligned_cols=253  Identities=27%  Similarity=0.479  Sum_probs=208.8

Q ss_pred             ccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      .+|.+.+.||.|+||.+|.          ++..+++|.+...   .....+.+.+|+.+++.++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP---TLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDP   81 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCc---cHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCc
Confidence            3577778999999998873          2356899988643   33444678899999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD  288 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~  288 (458)
                      .++||||+++++|.+++...+                .+++..++.++.|++.||+|||+++   ++|+||||+||+++.
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~  158 (291)
T cd05094          82 LIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGA  158 (291)
T ss_pred             eEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEcc
Confidence            999999999999999997532                3788999999999999999999999   999999999999999


Q ss_pred             CCCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHH
Q 012684          289 SGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY  366 (458)
Q Consensus       289 ~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~  366 (458)
                      ++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+
T Consensus       159 ~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~  238 (291)
T cd05094         159 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECI  238 (291)
T ss_pred             CCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            999999999998755332111 1123345778999999998889999999999999999998 99999877666555544


Q ss_pred             HhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      .....+.   .+..++..+.+++.+||+.||.+||++.++++.|+++...
T Consensus       239 ~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~~  285 (291)
T cd05094         239 TQGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGKA  285 (291)
T ss_pred             hCCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHhh
Confidence            3322222   2344678899999999999999999999999999998654

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.2e-38  Score=301.17  Aligned_cols=249  Identities=24%  Similarity=0.397  Sum_probs=202.8

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     +|+.||+|++....   ......+.+|+.+++.++||||+++++++..+...++||
T Consensus         9 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           9 HDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             hhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEE
Confidence            3688899999999998873     67899999986432   223456788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... .
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~-~  161 (267)
T cd06646          86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATI-A  161 (267)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeecccc-c
Confidence            99999999999988888999999999999999999999999   9999999999999999999999999987653221 1


Q ss_pred             CcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGL  385 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l  385 (458)
                      ......+++.|+|||.+.   ...++.++|+||+|+++|+|++|+.||....+......+.... .++.......++..+
T Consensus       162 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (267)
T cd06646         162 KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTF  241 (267)
T ss_pred             ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHH
Confidence            123345788999999874   3356789999999999999999999997655433222221111 112112234577899


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      .++|.+||..+|.+|||+++++++|
T Consensus       242 ~~li~~~l~~~P~~Rp~~~~il~~l  266 (267)
T cd06646         242 HNFVKISLTKNPKKRPTAERLLTHL  266 (267)
T ss_pred             HHHHHHHhhCChhhCcCHHHHhcCC
Confidence            9999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.6e-39  Score=304.59  Aligned_cols=244  Identities=37%  Similarity=0.707  Sum_probs=198.5

Q ss_pred             CceeeccceEEEEE---Ec------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          159 NSVEITKGTFILAF---WR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       159 ~~~~lg~G~~~~v~---~~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      ..+.||.|.||.|+   +.      +..|+||.+...  ...+..+.+.+|+..+++++||||+++++++...+..++||
T Consensus         3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred             EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeecccccccccccccccccccccccccccccc
Confidence            45789999999887   34      688999999643  34555788999999999999999999999999888899999


Q ss_pred             EccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       230 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||+++|+|.+++...  ..+++..++.++.|++.||.|||+++   ++|++|+++||+++.++.+||+|||++.......
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~  157 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS  157 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccccc
Confidence            999999999999986  67999999999999999999999999   9999999999999999999999999998762221


Q ss_pred             C-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHH
Q 012684          308 D-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL  385 (458)
Q Consensus       308 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (458)
                      . ...........|+|||.+.+..++.++||||||+++||+++ |+.||......+....+....+.+.   +..++..+
T Consensus       158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  234 (259)
T PF07714_consen  158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI---PDNCPKDI  234 (259)
T ss_dssp             SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS---BTTSBHHH
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee---ccchhHHH
Confidence            1 11122345678999999988889999999999999999999 7899988866666666633334332   45578899


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      .++|..||+.||.+|||+.++++.|
T Consensus       235 ~~li~~C~~~~p~~RPs~~~i~~~L  259 (259)
T PF07714_consen  235 YSLIQQCWSHDPEKRPSFQEILQEL  259 (259)
T ss_dssp             HHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHhcC
Confidence            9999999999999999999999876

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=1.5e-38  Score=299.44  Aligned_cols=248  Identities=29%  Similarity=0.519  Sum_probs=209.2

Q ss_pred             ccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .+|+..+.||.|+||.||.    .+..+|+|.+....   ......+..|+.+++.++||||+++++++......++|||
T Consensus         6 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           6 EEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDD---LLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             HHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccc---hhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEe
Confidence            4688889999999998873    47889999987542   3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~  159 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVY  159 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCccc
Confidence            99999999999753  45889999999999999999999999   99999999999999999999999999976543221


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      . .....++..|+|||.+.+..++.++|+||||+++|+|++ |+.||......+....+......+.   +..+++.+.+
T Consensus       160 ~-~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  235 (261)
T cd05148         160 L-SSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPC---PAKCPQEIYK  235 (261)
T ss_pred             c-ccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCCC---CCCCCHHHHH
Confidence            1 123345678999999988889999999999999999998 8999988776666655543323322   3456789999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      +|.+||+.||.+|||+.++++.|+.
T Consensus       236 ~i~~~l~~~p~~Rpt~~~l~~~L~~  260 (261)
T cd05148         236 IMLECWAAEPEDRPSFKALREELDN  260 (261)
T ss_pred             HHHHHcCCCchhCcCHHHHHHHHhc
Confidence            9999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=1.9e-38  Score=302.99  Aligned_cols=248  Identities=23%  Similarity=0.350  Sum_probs=203.1

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |+..+.||.|+||.||.     +|+.||+|.+.............+.+|+.+++.++|++|+++++.+..++..+++|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~   81 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI   81 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence            56678899999998874     5789999999765443344445677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       232 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      +.+++|.+++...  ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++......  .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~--~  156 (285)
T cd05632          82 MNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEG--E  156 (285)
T ss_pred             ccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCC--C
Confidence            9999999888653  35999999999999999999999999   999999999999999999999999998754322  1


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...........+...........+..+++.+.+|+
T Consensus       157 ~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  236 (285)
T cd05632         157 SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSIC  236 (285)
T ss_pred             cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHH
Confidence            22334688999999999888899999999999999999999999987655433333322221111223445778899999


Q ss_pred             HHHcccCCCCCCC-----HHHHHHH
Q 012684          390 EECWNEKPAKRPT-----FRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps-----~~~ll~~  409 (458)
                      ..||+.||.+||+     +.+++.+
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~l~~~  261 (285)
T cd05632         237 KMLLTKDPKQRLGCQEEGAGEVKRH  261 (285)
T ss_pred             HHHccCCHhHcCCCcccChHHHHcC
Confidence            9999999999999     6666665

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=2.9e-38  Score=314.48  Aligned_cols=253  Identities=26%  Similarity=0.449  Sum_probs=205.1

Q ss_pred             CccccCceeeccceEEEEEEc----------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeC
Q 012684          154 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS  222 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~  222 (458)
                      ..+|++.+.||+|+||.||..          +..||||++....  .....+.+.+|+.+++++. ||||+++++++...
T Consensus        36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~  113 (400)
T cd05105          36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTA--RSSEKQALMSELKIMTHLGPHLNIVNLLGACTKS  113 (400)
T ss_pred             ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence            446788899999999998731          2469999997542  3344567899999999995 99999999999999


Q ss_pred             CceEEEEEccCCCCHHHHHHhc----------------------------------------------------------
Q 012684          223 SPMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------  244 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~~----------------------------------------------------------  244 (458)
                      ...|+||||+++|+|.+++...                                                          
T Consensus       114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (400)
T cd05105         114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE  193 (400)
T ss_pred             CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence            9999999999999999988642                                                          


Q ss_pred             --------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe
Q 012684          245 --------------------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR  286 (458)
Q Consensus       245 --------------------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~  286 (458)
                                                            ..+++..+..++.|++.||.|||+.+   ++|+||||+||++
T Consensus       194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill  270 (400)
T cd05105         194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLL  270 (400)
T ss_pred             hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEE
Confidence                                                  13677778899999999999999999   9999999999999


Q ss_pred             cCCCCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHH
Q 012684          287 DDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK  364 (458)
Q Consensus       287 ~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~  364 (458)
                      +.++.++|+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus       271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~  350 (400)
T cd05105         271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY  350 (400)
T ss_pred             eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence            99999999999998765332211 1122345678999999988889999999999999999997 999998765443332


Q ss_pred             HHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          365 AYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       365 ~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      ...... ...   .+..++..+.++|.+||+.||++||++.++.+.|+++.
T Consensus       351 ~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~  398 (400)
T cd05105         351 NKIKSGYRMA---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLL  398 (400)
T ss_pred             HHHhcCCCCC---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHc
Confidence            222222 222   23457789999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.1e-38  Score=301.48  Aligned_cols=252  Identities=29%  Similarity=0.525  Sum_probs=207.0

Q ss_pred             cccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      +|++.+.||+|+||.||.          ....+++|.+....  .......+.+|+.+++.++||||+++++.+..++..
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   78 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL   78 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence            467788999999998874          12468999887542  334456788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCC
Q 012684          226 MIVTEYLPKGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP  281 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp  281 (458)
                      +++|||+.+++|.+++...                        ..+++..++.++.|++.||.|||+.+   ++||||||
T Consensus        79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp  155 (290)
T cd05045          79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAA  155 (290)
T ss_pred             EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhh
Confidence            9999999999999998642                        23778889999999999999999999   99999999


Q ss_pred             CCEEecCCCCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCC
Q 012684          282 SNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHD  359 (458)
Q Consensus       282 ~Nil~~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~  359 (458)
                      +||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++++|++ |+.||....+
T Consensus       156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~  235 (290)
T cd05045         156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP  235 (290)
T ss_pred             heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence            9999999999999999998755322211 1122234678999999988889999999999999999998 9999988766


Q ss_pred             CcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          360 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       360 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      .+...........+   .+..++.++.+++..||+.+|.+||++.++++.|+++..
T Consensus       236 ~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~  288 (290)
T cd05045         236 ERLFNLLKTGYRME---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV  288 (290)
T ss_pred             HHHHHHHhCCCCCC---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence            66555543332222   234567899999999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=3.3e-39  Score=314.16  Aligned_cols=237  Identities=26%  Similarity=0.406  Sum_probs=195.9

Q ss_pred             eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHH-HHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      +.||+|+||.||.     +|+.||+|++.............+..|.. +++.++||||+++++.+..++..++||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~   80 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG   80 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence            3689999999873     68899999997543333334445555654 46778999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccC
Q 012684          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ  314 (458)
Q Consensus       235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~  314 (458)
                      ++|..++...+.+++..+..++.|++.||.|||+.|   ++||||||+|||++.++.++|+|||++...... .......
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~-~~~~~~~  156 (325)
T cd05604          81 GELFFHLQRERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ-SDTTTTF  156 (325)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC-CCCcccc
Confidence            999999988888999999999999999999999999   999999999999999999999999998753222 1222345


Q ss_pred             CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 012684          315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN  394 (458)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  394 (458)
                      .||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.... ...   .+..+..+.++|.+||+
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~-~~~---~~~~~~~~~~ll~~ll~  232 (325)
T cd05604         157 CGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKP-LVL---RPGASLTAWSILEELLE  232 (325)
T ss_pred             cCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCC-ccC---CCCCCHHHHHHHHHHhc
Confidence            68999999999999889999999999999999999999998876655555543322 111   23467889999999999


Q ss_pred             cCCCCCCCHHH
Q 012684          395 EKPAKRPTFRQ  405 (458)
Q Consensus       395 ~dp~~Rps~~~  405 (458)
                      .||.+||++.+
T Consensus       233 ~~p~~R~~~~~  243 (325)
T cd05604         233 KDRQRRLGAKE  243 (325)
T ss_pred             cCHHhcCCCCC
Confidence            99999998853

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.3e-38  Score=315.84  Aligned_cols=249  Identities=24%  Similarity=0.374  Sum_probs=200.9

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-----ce
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-----~~  225 (458)
                      +|+..+.||+|+||.||.     +|+.||+|.+.... ........+.+|+.+++.++||||+++++++....     ..
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence            367788999999999873     68999999986532 23344567888999999999999999999998766     78


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      |+||||+. ++|.+++...+.+++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+||+|||++.....
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~  155 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVEEP  155 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeeccc
Confidence            99999994 689998888788999999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc---------------
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---------------  369 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~---------------  369 (458)
                      ..........+++.|+|||.+.+. .++.++|||||||++|+|++|+.||...+.......+...               
T Consensus       156 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  235 (372)
T cd07853         156 DESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG  235 (372)
T ss_pred             CccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHH
Confidence            333333344678899999998774 4788999999999999999999999876654332222110               


Q ss_pred             --------C-CCCC----CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          370 --------Q-RPPF----KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       370 --------~-~~~~----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                              . .++.    .......++++.+||.+||+.||.+|||+.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h  288 (372)
T cd07853         236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH  288 (372)
T ss_pred             HHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence                    0 0000    01112346789999999999999999999999987

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=5.4e-38  Score=306.84  Aligned_cols=254  Identities=28%  Similarity=0.482  Sum_probs=204.7

Q ss_pred             ccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEe-C
Q 012684          155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-S  222 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~-~  222 (458)
                      .+|++.+.||.|+||.||.          +++.||+|++....  .....+.+..|+.+++++ +||||+++++++.. +
T Consensus         7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~   84 (337)
T cd05054           7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTKPG   84 (337)
T ss_pred             HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEecCC
Confidence            3688889999999999974          23689999987542  234456678899999999 79999999998864 4


Q ss_pred             CceEEEEEccCCCCHHHHHHhc----------------------------------------------------------
Q 012684          223 SPMMIVTEYLPKGDLRAFLKRK----------------------------------------------------------  244 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~~----------------------------------------------------------  244 (458)
                      ..++++|||+++++|.+++...                                                          
T Consensus        85 ~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  164 (337)
T cd05054          85 GPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDE  164 (337)
T ss_pred             CCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhH
Confidence            5688999999999999998642                                                          


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC-CcccCCCCCcc
Q 012684          245 ---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRY  320 (458)
Q Consensus       245 ---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y  320 (458)
                         ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++..+...... ......++..|
T Consensus       165 ~~~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y  241 (337)
T cd05054         165 LYKEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKW  241 (337)
T ss_pred             HhhcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccc
Confidence               25788889999999999999999999   999999999999999999999999999865332211 11233456789


Q ss_pred             cCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCC
Q 012684          321 VAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK  399 (458)
Q Consensus       321 ~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~  399 (458)
                      +|||++.+..++.++|||||||++|+|++ |..||......+............  ..+..+++++.+++.+||+.+|.+
T Consensus       242 ~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l~~~cl~~~p~~  319 (337)
T cd05054         242 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRM--RAPEYATPEIYSIMLDCWHNNPED  319 (337)
T ss_pred             cCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCC--CCCccCCHHHHHHHHHHccCChhh
Confidence            99999999899999999999999999997 999998765544333322222111  123456788999999999999999


Q ss_pred             CCCHHHHHHHHHHHHh
Q 012684          400 RPTFRQIITRLESINN  415 (458)
Q Consensus       400 Rps~~~ll~~L~~~~~  415 (458)
                      ||++.+++++|+++..
T Consensus       320 RPs~~ell~~l~~~~~  335 (337)
T cd05054         320 RPTFSELVEILGDLLQ  335 (337)
T ss_pred             CcCHHHHHHHHHHHHh
Confidence            9999999999998754

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6.8e-39  Score=295.76  Aligned_cols=248  Identities=28%  Similarity=0.453  Sum_probs=200.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCc-ceeeeeEEEeCC------
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSS------  223 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-i~~~~~~~~~~~------  223 (458)
                      .|+..++||+|+||.||.     +|..||+|+++.....+ -.-....+|+.+++.++|+| |+++++++....      
T Consensus        12 ~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~E-G~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~   90 (323)
T KOG0594|consen   12 DYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEE-GVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG   90 (323)
T ss_pred             HHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccccc-CCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence            466677899999999983     78999999998664321 12234578999999999999 999999998776      


Q ss_pred             ceEEEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCC
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~  299 (458)
                      .+++|+||+ .-+|.+++...+    .++...+..+++||+.||.|||+++   |+||||||+|||++++|.+||+|||+
T Consensus        91 ~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl  166 (323)
T KOG0594|consen   91 KLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL  166 (323)
T ss_pred             eEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence            789999999 569999998755    4777889999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-CCCC----
Q 012684          300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPP----  373 (458)
Q Consensus       300 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~~~~----  373 (458)
                      ++..... ....+...+|.+|+|||++.+. .|+...||||+||+++||++++..|.+.+..+....+... +.|.    
T Consensus       167 Ara~~ip-~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~W  245 (323)
T KOG0594|consen  167 ARAFSIP-MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDW  245 (323)
T ss_pred             HHHhcCC-cccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCC
Confidence            9865432 3335556789999999999886 7899999999999999999999999988765443333221 1110    


Q ss_pred             ------------CCCC--h-------hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 ------------FKAP--A-------KLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ------------~~~~--~-------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                  ++..  +       +..++...+++..||+.+|.+|.|++.++.|
T Consensus       246 p~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h  302 (323)
T KOG0594|consen  246 PGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH  302 (323)
T ss_pred             CCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence                        0000  1       1122478899999999999999999999997

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=7e-38  Score=303.37  Aligned_cols=258  Identities=28%  Similarity=0.524  Sum_probs=210.8

Q ss_pred             CccccCceeeccceEEEEEE------------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT  220 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~  220 (458)
                      ..+|.+.+.||+|+||.||.            .+..+|+|.+....  .......+..|+.+++++ +||||+++++++.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~   88 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGVCT   88 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEEEc
Confidence            34778889999999998874            13579999987542  344566788899999999 6999999999999


Q ss_pred             eCCceEEEEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCE
Q 012684          221 QSSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI  284 (458)
Q Consensus       221 ~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Ni  284 (458)
                      .++..+++|||+++++|.+++...                ..+++.++..++.|++.||.|||++|   ++|+||||+||
T Consensus        89 ~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Ni  165 (314)
T cd05099          89 QEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNV  165 (314)
T ss_pred             cCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeE
Confidence            999999999999999999999753                23788889999999999999999999   99999999999


Q ss_pred             EecCCCCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcH
Q 012684          285 LRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV  362 (458)
Q Consensus       285 l~~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~  362 (458)
                      +++.++.++|+|||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+.
T Consensus       166 ll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~  245 (314)
T cd05099         166 LVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEEL  245 (314)
T ss_pred             EEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            9999999999999999765432111 1122234467999999988889999999999999999999 8999987766555


Q ss_pred             HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012684          363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH  419 (458)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  419 (458)
                      ...+.......   .+..++..+.++|.+||..||.+|||+.++++.|+.+......
T Consensus       246 ~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~~~~~  299 (314)
T cd05099         246 FKLLREGHRMD---KPSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLAAVSE  299 (314)
T ss_pred             HHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHHhcC
Confidence            55543332222   2345678899999999999999999999999999998766543

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.2e-37  Score=294.20  Aligned_cols=253  Identities=26%  Similarity=0.502  Sum_probs=208.4

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||.|+||.++.     +|..||+|.+...........+.+.+|+.++++++|++|+++++++..++..++|||
T Consensus         3 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   82 (267)
T cd08224           3 NFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLE   82 (267)
T ss_pred             ceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEe
Confidence            688889999999998873     688999999875444455556778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       231 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      |+++++|.+++..    ...+++.++..++.|++.||.|||+.|   ++|+||+|+||+++.++.++|+|||++......
T Consensus        83 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~  159 (267)
T cd08224          83 LADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSSK  159 (267)
T ss_pred             cCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccCC
Confidence            9999999998864    244889999999999999999999999   999999999999999999999999998765432


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--cHHHHHHhcCCCCCCCChhhhHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      .. ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||......  ...........++.  +...++..
T Consensus       160 ~~-~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  236 (267)
T cd08224         160 TT-AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYPPL--PADHYSEE  236 (267)
T ss_pred             Cc-ccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCCCC--ChhhcCHH
Confidence            21 122345788899999998888999999999999999999999999654322  11222211112222  22367789


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      +.++|.+||..+|.+|||+.++++.|+.+.
T Consensus       237 ~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~  266 (267)
T cd08224         237 LRDLVSRCINPDPEKRPDISYVLQVAKEMH  266 (267)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence            999999999999999999999999998763

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=9.5e-38  Score=297.82  Aligned_cols=252  Identities=27%  Similarity=0.466  Sum_probs=199.7

Q ss_pred             ccCceeeccceEEEEEE---------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--Cce
Q 012684          157 FTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM  225 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~  225 (458)
                      |+..+.||+|+||.|+.         ++..||+|.+....  .......+.+|+.+++.++||||+++++++...  ...
T Consensus         6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   83 (283)
T cd05080           6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL   83 (283)
T ss_pred             ceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence            47788999999998852         46789999997542  233456688899999999999999999988653  458


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      +++|||+++++|.+++... .+++.++..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.....
T Consensus        84 ~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~  159 (283)
T cd05080          84 QLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPE  159 (283)
T ss_pred             EEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccCC
Confidence            9999999999999998764 5999999999999999999999999   99999999999999999999999999886543


Q ss_pred             CCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH------------HHHHHhcCC
Q 012684          306 KEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV------------PKAYAARQR  371 (458)
Q Consensus       306 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~------------~~~~~~~~~  371 (458)
                      ....  ......++..|+|||.+.+..++.++||||||+++|+|++|+.||........            .........
T Consensus       160 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd05080         160 GHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLER  239 (283)
T ss_pred             cchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhc
Confidence            2211  11223456679999999888899999999999999999999999865432110            000000000


Q ss_pred             CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      ......+..++..+.+++..||+.+|.+|||+++++..|+++.
T Consensus       240 ~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~  282 (283)
T cd05080         240 GMRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMH  282 (283)
T ss_pred             CCCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhh
Confidence            0011123456789999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=5.2e-38  Score=296.29  Aligned_cols=249  Identities=31%  Similarity=0.507  Sum_probs=204.2

Q ss_pred             ccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .+|++.++||+|+||.|+.    .+..||+|.+.....    ..+.+.+|+.+++.++||||+++++.+. ....++|||
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e   80 (262)
T cd05071           6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM----SPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTE   80 (262)
T ss_pred             HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCcc----CHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEE
Confidence            4588899999999998863    345799999975432    1246788999999999999999999875 456799999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+++++|.+++.+.  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||.+........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~  157 (262)
T cd05071          81 YMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEY  157 (262)
T ss_pred             cCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeecccccc
Confidence            99999999999763  34788999999999999999999999   99999999999999999999999999976543332


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      .......++..|+|||...+..++.++|+||||+++|+|++ |..||......+....+......+.   ...++..+.+
T Consensus       158 ~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~  234 (262)
T cd05071         158 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPESLHD  234 (262)
T ss_pred             ccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCCCCC---ccccCHHHHH
Confidence            22223345678999999988889999999999999999999 8889987766555444432222222   3457789999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      +|.+|++.||.+||+++++++.|+.++
T Consensus       235 li~~~l~~~p~~Rp~~~~~~~~l~~~~  261 (262)
T cd05071         235 LMCQCWRKEPEERPTFEYLQAFLEDYF  261 (262)
T ss_pred             HHHHHccCCcccCCCHHHHHHHHHHhc
Confidence            999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=7.1e-38  Score=305.98  Aligned_cols=261  Identities=30%  Similarity=0.541  Sum_probs=211.3

Q ss_pred             CCcccCcCCccccCceeeccceEEEEEEc------------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcc
Q 012684          146 PEYEIDPHELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNV  212 (458)
Q Consensus       146 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i  212 (458)
                      +.|++.  ..+|++.+.||+|+||.||.-            +..||+|.+...  ......+.+.+|+.+++++ +||||
T Consensus         5 ~~~~~~--~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i   80 (334)
T cd05100           5 PKWELS--RTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNI   80 (334)
T ss_pred             cccccC--HhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCe
Confidence            455544  447888999999999988631            236899988743  2344567788999999999 79999


Q ss_pred             eeeeeEEEeCCceEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 012684          213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIH  276 (458)
Q Consensus       213 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H  276 (458)
                      +++++++..++..+++|||+++++|.+++.+..                .++..++..++.|++.||.|||+++   ++|
T Consensus        81 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH  157 (334)
T cd05100          81 INLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIH  157 (334)
T ss_pred             eeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eec
Confidence            999999999999999999999999999997532                3677888899999999999999999   999


Q ss_pred             CCCCCCCEEecCCCCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 012684          277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF  354 (458)
Q Consensus       277 ~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf  354 (458)
                      |||||+||+++.++.++|+|||++......... ......++..|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus       158 ~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~  237 (334)
T cd05100         158 RDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPY  237 (334)
T ss_pred             cccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCC
Confidence            999999999999999999999998765432111 1122234567999999998889999999999999999998 88999


Q ss_pred             CCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ......+....+........   +..++..+.+++.+||+.+|.+||++.++++.|+.+...
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~~~  296 (334)
T cd05100         238 PGIPVEELFKLLKEGHRMDK---PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVLTV  296 (334)
T ss_pred             CCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHhhh
Confidence            87766555554433322222   345678899999999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=6e-38  Score=302.41  Aligned_cols=257  Identities=28%  Similarity=0.511  Sum_probs=211.2

Q ss_pred             cCCccccCceeeccceEEEEEE------------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeE
Q 012684          152 PHELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGA  218 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~  218 (458)
                      ....+|.+.+.||+|+||.||.            .+..||+|.+....  .....+.+.+|+.+++.+ +||||++++++
T Consensus        12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~   89 (304)
T cd05101          12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGA   89 (304)
T ss_pred             ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeeccccc--chHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence            4456788889999999998872            23479999987432  334556788999999999 89999999999


Q ss_pred             EEeCCceEEEEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 012684          219 VTQSSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS  282 (458)
Q Consensus       219 ~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~  282 (458)
                      +......+++|||+.+++|.+++...                ..++..++..++.|+++||.|||++|   ++|+||||+
T Consensus        90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~  166 (304)
T cd05101          90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAAR  166 (304)
T ss_pred             EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccc
Confidence            99999999999999999999999763                23677888999999999999999999   999999999


Q ss_pred             CEEecCCCCEEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 012684          283 NILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDN  360 (458)
Q Consensus       283 Nil~~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~  360 (458)
                      ||+++.++.++|+|||++.......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||......
T Consensus       167 Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~  246 (304)
T cd05101         167 NVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE  246 (304)
T ss_pred             eEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence            9999999999999999998664332211 122335678999999988889999999999999999998 78899877665


Q ss_pred             cHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      +....+........   +..++..+.++|.+||..+|.+|||+.++++.|+++...
T Consensus       247 ~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~~~  299 (304)
T cd05101         247 ELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRILTL  299 (304)
T ss_pred             HHHHHHHcCCcCCC---CCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHHHh
Confidence            55555433332222   345678999999999999999999999999999988655

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=5.4e-38  Score=294.66  Aligned_cols=246  Identities=27%  Similarity=0.464  Sum_probs=206.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||+|+||.+|.     +|..|++|.+..... .......+.+|+.+++.++||||+++++++..++..++|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence            366778999999998763     678999999875433 34456678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+++++|.+++...  ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~  156 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN  156 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence            99999999999764  46889999999999999999999999   99999999999999999999999999876543321


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                       ......+++.|+|||++.+..++.++|+||||+++++|++|+.||.................+..   +..++..+.++
T Consensus       157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  232 (256)
T cd08529         157 -FANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV---SQMYSQQLAQL  232 (256)
T ss_pred             -hhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHHHHH
Confidence             22334578899999999988889999999999999999999999987765444444433333332   33678899999


Q ss_pred             HHHHcccCCCCCCCHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~  409 (458)
                      |.+||+.+|++||++.+++++
T Consensus       233 i~~~l~~~p~~Rp~~~~ll~~  253 (256)
T cd08529         233 IDQCLTKDYRQRPDTFQLLRN  253 (256)
T ss_pred             HHHHccCCcccCcCHHHHhhC
Confidence            999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=5.4e-38  Score=299.10  Aligned_cols=248  Identities=28%  Similarity=0.495  Sum_probs=204.4

Q ss_pred             ccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      .++...++||+|+||.||.          ++..+|+|.+...   .......+.+|+.+++.++||||+++++++.....
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   81 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRP   81 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCc
Confidence            3567788999999998874          3568999988643   34556678999999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcC---------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG---------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS  289 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~  289 (458)
                      .+++|||+++++|.+++...+               .+++..+..++.|++.||+|||+.+   ++|+||||+||+++.+
T Consensus        82 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~  158 (280)
T cd05092          82 LLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQG  158 (280)
T ss_pred             eEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCC
Confidence            999999999999999997643               3788999999999999999999999   9999999999999999


Q ss_pred             CCEEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHH
Q 012684          290 GNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA  367 (458)
Q Consensus       290 ~~vkl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~  367 (458)
                      +.++|+|||++........ .......+++.|+|||.+.+..++.++|||||||++|+|++ |..||......+......
T Consensus       159 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~  238 (280)
T cd05092         159 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT  238 (280)
T ss_pred             CCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHH
Confidence            9999999999875432211 11122234678999999988889999999999999999998 999998766555544443


Q ss_pred             hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      ......   .+..+++.+.++|.+||+.||.+||++.++++.|+
T Consensus       239 ~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~  279 (280)
T cd05092         239 QGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQ  279 (280)
T ss_pred             cCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHh
Confidence            222222   23457789999999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.7e-38  Score=294.13  Aligned_cols=244  Identities=28%  Similarity=0.509  Sum_probs=202.0

Q ss_pred             eeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012684          161 VEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (458)
Q Consensus       161 ~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~  232 (458)
                      ++||+|+||.|+.        .+..+|+|.+......  ...+.+..|+.+++.+.||||+++++++.. ...++||||+
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~   77 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKG-EPLMLVMELA   77 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcC-CceEEEEEeC
Confidence            3689999998862        2268999999765432  445678899999999999999999998764 5679999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCc-
Q 012684          233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-  311 (458)
Q Consensus       233 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~-  311 (458)
                      ++++|.+++...+.+++..+..++.|++.||.|||..+   ++|+||||+||+++.++.++|+|||++........... 
T Consensus        78 ~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~  154 (257)
T cd05060          78 PLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRA  154 (257)
T ss_pred             CCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCccccc
Confidence            99999999988778999999999999999999999999   99999999999999999999999999876643322111 


Q ss_pred             -ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          312 -TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       312 -~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                       ....++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+......+   .+..++..+.++|
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li  231 (257)
T cd05060         155 TTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP---RPEECPQEIYSIM  231 (257)
T ss_pred             ccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCC---CCCCCCHHHHHHH
Confidence             11123457999999988889999999999999999998 999998876655555543332222   2445778999999


Q ss_pred             HHHcccCCCCCCCHHHHHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      .+||..+|.+||++.++++.|+.+
T Consensus       232 ~~cl~~~p~~Rp~~~~l~~~l~~~  255 (257)
T cd05060         232 LSCWKYRPEDRPTFSELESTFRRD  255 (257)
T ss_pred             HHHhcCChhhCcCHHHHHHHHHhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=5.2e-38  Score=295.78  Aligned_cols=247  Identities=31%  Similarity=0.524  Sum_probs=204.4

Q ss_pred             ccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .+|++.++||.|+||.||.    ++..||+|.+.....    ....+.+|+.++++++||||+++++++. ....+++||
T Consensus         6 ~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           6 ETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSM----SPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             HHceeeeeeccCccceEEeeecCCCceEEEEEecCCCC----cHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEE
Confidence            3577788999999998873    678999999875432    2356888999999999999999999874 456899999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+.+++|.+++...  ..+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~  157 (260)
T cd05067          81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEY  157 (260)
T ss_pred             cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCc
Confidence            99999999998653  35888999999999999999999999   99999999999999999999999999876543222


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      .......++..|+|||.+.+..++.++||||||+++|++++ |+.||...+..+....+......+   .+..++.++.+
T Consensus       158 ~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  234 (260)
T cd05067         158 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP---RPDNCPEELYE  234 (260)
T ss_pred             ccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCCCC---CCCCCCHHHHH
Confidence            22223345678999999988888999999999999999998 999998877665555543332222   23456789999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      +|.+||+.+|++||++++++..|+.
T Consensus       235 li~~~l~~~p~~Rp~~~~l~~~l~~  259 (260)
T cd05067         235 LMRLCWKEKPEERPTFEYLRSVLED  259 (260)
T ss_pred             HHHHHccCChhhCCCHHHHHHHhhc
Confidence            9999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.2e-38  Score=294.07  Aligned_cols=244  Identities=34%  Similarity=0.612  Sum_probs=207.0

Q ss_pred             ccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      .+|++.+.||.|+||.|+   ..|+.||+|.+....    ...+.+.+|+.+++.++|+||+++++++......++||||
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~~~~v~iK~~~~~~----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   81 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYRGQKVAVKCLKDDS----TAAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEY   81 (256)
T ss_pred             hhccceeeeecCCCceEEEEEecCcEEEEEEeccch----hHHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEe
Confidence            357778899999999886   478999999997542    1456788999999999999999999999988999999999


Q ss_pred             cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       232 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      +++++|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||.+........ 
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-  157 (256)
T cd05039          82 MAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-  157 (256)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence            99999999998765  6899999999999999999999999   99999999999999999999999999987632211 


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                         ....+..|+|||.+.+..++.++|+||||++++++++ |..||......+............   .+..+++.+.++
T Consensus       158 ---~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  231 (256)
T cd05039         158 ---SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYRME---APEGCPPEVYKV  231 (256)
T ss_pred             ---cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCC---CccCCCHHHHHH
Confidence               2234567999999988889999999999999999997 999998776555544443322222   234567899999


Q ss_pred             HHHHcccCCCCCCCHHHHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      |.+||..+|.+|||+.++++.|++
T Consensus       232 i~~~l~~~p~~Rp~~~~l~~~l~~  255 (256)
T cd05039         232 MKDCWELDPAKRPTFKQLREQLAL  255 (256)
T ss_pred             HHHHhccChhhCcCHHHHHHHHhc
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=5.9e-38  Score=296.22  Aligned_cols=250  Identities=24%  Similarity=0.467  Sum_probs=206.7

Q ss_pred             cccCceeeccceEEEEEE----cCeEEEEEEcCCCCCC---CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      +|+..+.||.|+||.||.    +|+.+|+|.+......   .......+.+|+.+++.++|+||+++++++.+....+++
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv   80 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF   80 (265)
T ss_pred             CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence            477888999999998874    6788999998754321   233446688999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC-
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-  307 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~-  307 (458)
                      |||+++++|.+++.+.+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  157 (265)
T cd06631          81 MEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGL  157 (265)
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhhccc
Confidence            999999999999988788999999999999999999999999   9999999999999999999999999987643211 


Q ss_pred             ----CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          308 ----DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       308 ----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                          ........++..|+|||.+.+..++.++|+||||+++|+|++|..||.............. .....+..+..++.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  236 (265)
T cd06631         158 HGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGA-HRGLMPRLPDSFSA  236 (265)
T ss_pred             cccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhh-ccCCCCCCCCCCCH
Confidence                1112334578899999999988889999999999999999999999986554433322222 21223334456889


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++.++|.+||..+|.+||++.+++.+
T Consensus       237 ~~~~~i~~~l~~~p~~Rp~~~~~l~~  262 (265)
T cd06631         237 AAIDFVTSCLTRDQHERPSALQLLRH  262 (265)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            99999999999999999999999864

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=4.9e-38  Score=302.89  Aligned_cols=252  Identities=32%  Similarity=0.541  Sum_probs=203.8

Q ss_pred             cccCceeeccceEEEEEE-----cCe--EEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~l  227 (458)
                      +|++.+.||+|+||.|+.     +|.  .+++|.+...  ........+.+|+.++.++ +||||+++++++..++..++
T Consensus         8 ~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~l   85 (303)
T cd05088           8 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   85 (303)
T ss_pred             hceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceE
Confidence            567778999999998873     343  4577776532  2344556788899999999 89999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC
Q 012684          228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~  291 (458)
                      ||||+++++|.+++...+                .+++.++..++.|++.||+|||+.|   ++||||||+||+++.++.
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~  162 (303)
T cd05088          86 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  162 (303)
T ss_pred             EEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCc
Confidence            999999999999997542                4788899999999999999999999   999999999999999999


Q ss_pred             EEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcC
Q 012684          292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ  370 (458)
Q Consensus       292 vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~  370 (458)
                      ++|+|||++.......  .......+..|+|||.+.+..++.++||||||+++|+|++ |..||......+.........
T Consensus       163 ~kl~dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~  240 (303)
T cd05088         163 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  240 (303)
T ss_pred             EEeCccccCcccchhh--hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC
Confidence            9999999986432111  1111223567999999988888999999999999999998 999998766655544442221


Q ss_pred             CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      ...   .+..+++.+.++|.+||+.+|.+||++.+++..|+++....
T Consensus       241 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~~~  284 (303)
T cd05088         241 RLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  284 (303)
T ss_pred             cCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            222   23346788999999999999999999999999998876553

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-39  Score=313.98  Aligned_cols=240  Identities=25%  Similarity=0.415  Sum_probs=195.1

Q ss_pred             eccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC---CCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      ||+|+||.||.     +|+.||+|++................|..++...   +||+|+++++.+......|+||||+++
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            69999999873     5889999999754333333344455566666555   699999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccC
Q 012684          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ  314 (458)
Q Consensus       235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~  314 (458)
                      ++|.+++...+.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.++|+|||++...... .......
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~-~~~~~~~  156 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTD-NKTTNTF  156 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCC-CCCccCc
Confidence            999999988888999999999999999999999999   999999999999999999999999998753222 2223345


Q ss_pred             CCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHc
Q 012684          315 DTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW  393 (458)
Q Consensus       315 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  393 (458)
                      .||+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+... ...+  ....+++.+.++|.+||
T Consensus       157 ~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~-~~~~--~~~~~~~~~~~li~~~L  233 (330)
T cd05586         157 CGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFG-KVRF--PKNVLSDEGRQFVKGLL  233 (330)
T ss_pred             cCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcC-CCCC--CCccCCHHHHHHHHHHc
Confidence            689999999998754 4788999999999999999999999887665555444322 2222  22346789999999999


Q ss_pred             ccCCCCCC----CHHHHHHH
Q 012684          394 NEKPAKRP----TFRQIITR  409 (458)
Q Consensus       394 ~~dp~~Rp----s~~~ll~~  409 (458)
                      +.||.+||    ++.+++++
T Consensus       234 ~~~P~~R~~~~~~~~~ll~h  253 (330)
T cd05586         234 NRNPQHRLGAHRDAVELKEH  253 (330)
T ss_pred             CCCHHHCCCCCCCHHHHhcC
Confidence            99999998    57777765

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=6.9e-38  Score=294.96  Aligned_cols=246  Identities=33%  Similarity=0.539  Sum_probs=203.3

Q ss_pred             cccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      +|++.+.||+|+||.||.    .+..+|+|.+......    .+.+.+|+.+++.++||+++++++++. ....+++|||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~   81 (260)
T cd05070           7 SLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEY   81 (260)
T ss_pred             HhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEe
Confidence            578889999999998873    4578999998754332    245888999999999999999999875 4568999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       232 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05070          82 MSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             cCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCcccc
Confidence            9999999998763  34889999999999999999999999   999999999999999999999999999765432222


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      ......++..|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+......+.   +...+..+.++
T Consensus       159 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  235 (260)
T cd05070         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC---PQDCPISLHEL  235 (260)
T ss_pred             cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCHHHHHH
Confidence            2222335667999999988889999999999999999999 8999988766665555533323322   34567899999


Q ss_pred             HHHHcccCCCCCCCHHHHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      +.+||..+|.+|||+.++.+.|++
T Consensus       236 i~~~l~~~p~~Rpt~~~l~~~l~~  259 (260)
T cd05070         236 MLQCWKKDPEERPTFEYLQSFLED  259 (260)
T ss_pred             HHHHcccCcccCcCHHHHHHHHhc
Confidence            999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=9.8e-38  Score=293.55  Aligned_cols=243  Identities=25%  Similarity=0.443  Sum_probs=200.3

Q ss_pred             eeccceEEEEEE-------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       162 ~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      .||+|+||.|+.       .+..||+|++....  .....+.+.+|+.++++++||||+++++++.. ...++||||+++
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~   78 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASG   78 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCC
Confidence            489999998863       24579999987542  34445678899999999999999999998864 578999999999


Q ss_pred             CCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC--c
Q 012684          235 GDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--L  311 (458)
Q Consensus       235 ~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~--~  311 (458)
                      ++|.+++.. ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++..........  .
T Consensus        79 ~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~  155 (257)
T cd05115          79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR  155 (257)
T ss_pred             CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence            999999875 456899999999999999999999999   9999999999999999999999999987553322111  1


Q ss_pred             ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      ....+++.|+|||.+.+..++.++||||||+++|++++ |..||......+....+.....+..   +...++++.++|.
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~  232 (257)
T cd05115         156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLDC---PAECPPEMYALMK  232 (257)
T ss_pred             CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC---CCCCCHHHHHHHH
Confidence            22233568999999988888999999999999999996 9999988776665555533333333   3456789999999


Q ss_pred             HHcccCCCCCCCHHHHHHHHHHH
Q 012684          391 ECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      +||..+|++||++.++.+.|+.+
T Consensus       233 ~c~~~~~~~Rp~~~~i~~~l~~~  255 (257)
T cd05115         233 DCWIYKWEDRPNFAKVEERMRTY  255 (257)
T ss_pred             HHcCCChhhCcCHHHHHHHHhhh
Confidence            99999999999999999998875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=7.4e-38  Score=297.69  Aligned_cols=249  Identities=29%  Similarity=0.486  Sum_probs=203.5

Q ss_pred             ccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      .+|++.+.||+|+||.||.          .+..||+|.+....  .......+..|+.+++.++||||+++++++.+...
T Consensus         6 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~   83 (277)
T cd05036           6 DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESC--SEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCC
Confidence            4678889999999998762          35689999886432  33444668889999999999999999999998889


Q ss_pred             eEEEEEccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC---CEEE
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKV  294 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~---~vkl  294 (458)
                      .++||||++|++|.+++...+       .+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++   .++|
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl  160 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEe
Confidence            999999999999999997643       4788999999999999999999999   99999999999998755   5999


Q ss_pred             eecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCC
Q 012684          295 ADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP  372 (458)
Q Consensus       295 ~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~  372 (458)
                      +|||++.......... ......+..|+|||++.+..++.++|||||||++|+|++ |..||......+....+......
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~  240 (277)
T cd05036         161 ADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL  240 (277)
T ss_pred             ccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC
Confidence            9999998653221111 112223567999999988889999999999999999997 99999887666555544333332


Q ss_pred             CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       373 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      .   .+..++..+.+++.+||+.+|++|||+.+++++|+
T Consensus       241 ~---~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~  276 (277)
T cd05036         241 D---PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ  276 (277)
T ss_pred             C---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence            2   23456789999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=7.7e-38  Score=303.35  Aligned_cols=254  Identities=24%  Similarity=0.492  Sum_probs=206.1

Q ss_pred             CccccCceeeccceEEEEEE-----cCe----EEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      ..+|+..+.||+|+||.||.     +|.    .||+|.+...  ......+.+.+|+.+++.++||||+++++++... .
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~   82 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-T   82 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence            34688889999999998873     233    4899998643  2344556788999999999999999999998764 5


Q ss_pred             eEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      .++++||+++|+|.+++... ..++...++.++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        83 ~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~  159 (316)
T cd05108          83 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLL  159 (316)
T ss_pred             ceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEccccccccc
Confidence            68999999999999999874 35888999999999999999999999   999999999999999999999999999866


Q ss_pred             ccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhh
Q 012684          304 TVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY  381 (458)
Q Consensus       304 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (458)
                      ....... .....++..|+|||.+.+..++.++||||||+++|+|++ |+.||.+....+...........+.   +..+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~  236 (316)
T cd05108         160 GADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPIC  236 (316)
T ss_pred             cCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCCCCCC---CCCC
Confidence            4322211 122234668999999998899999999999999999997 9999987665554443332223222   3346


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      +..+.+++..||..||.+||++.+++..|..+...
T Consensus       237 ~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~~  271 (316)
T cd05108         237 TIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  271 (316)
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHcC
Confidence            78899999999999999999999999998887543

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1e-37  Score=294.81  Aligned_cols=248  Identities=29%  Similarity=0.501  Sum_probs=204.9

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCC------HHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      +|++...||.|+||.++.     ++..||+|.+.......      ....+.+.+|+.++++++||||+++++++.....
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH   80 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence            467788999999998863     57899999886543322      1234568889999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      .+++|||+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        81 ~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~~~~  157 (267)
T cd06628          81 LNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLE  157 (267)
T ss_pred             cEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCcccc
Confidence            9999999999999999988888999999999999999999999999   9999999999999999999999999987664


Q ss_pred             cCCC-----CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChh
Q 012684          305 VKED-----RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK  379 (458)
Q Consensus       305 ~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  379 (458)
                      ....     .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.................+.   .+.
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~  234 (267)
T cd06628         158 ANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPE---IPS  234 (267)
T ss_pred             cccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCCCc---CCc
Confidence            2111     11122347788999999988888999999999999999999999998765433333322222222   344


Q ss_pred             hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          380 LYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       380 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .++..+.++|.+||+.||.+||++.+++++
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  264 (267)
T cd06628         235 NISSEAIDFLEKTFEIDHNKRPTAAELLKH  264 (267)
T ss_pred             ccCHHHHHHHHHHccCCchhCcCHHHHhhC
Confidence            577899999999999999999999999874

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.4e-37  Score=299.46  Aligned_cols=254  Identities=27%  Similarity=0.459  Sum_probs=207.3

Q ss_pred             CCccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEe
Q 012684          153 HELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ  221 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~  221 (458)
                      ...+|.+.+.||+|+||.|+.          .+..||+|.+....  .....+.+.+|+.+++++ +||||+++++++..
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~  110 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGACTI  110 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence            344688889999999998863          23579999987542  234456788999999999 79999999999999


Q ss_pred             CCceEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCC
Q 012684          222 SSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (458)
Q Consensus       222 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~  299 (458)
                      .+..+++|||+.+++|.+++....  .+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+
T Consensus       111 ~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~  187 (302)
T cd05055         111 GGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGL  187 (302)
T ss_pred             CCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCcc
Confidence            999999999999999999997643  3899999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCC
Q 012684          300 SKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP  377 (458)
Q Consensus       300 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  377 (458)
                      +......... ......+++.|+|||.+.+..++.++||||+|+++|+|++ |..||......+............  ..
T Consensus       188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~  265 (302)
T cd05055         188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM--AQ  265 (302)
T ss_pred             cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC--CC
Confidence            8765432211 1122345678999999988889999999999999999998 999998766554433332322211  12


Q ss_pred             hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       378 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      +...++.+.+++.+||..+|++|||+.++++.|+++
T Consensus       266 ~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~  301 (302)
T cd05055         266 PEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ  301 (302)
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence            334678999999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=6.5e-38  Score=294.19  Aligned_cols=245  Identities=27%  Similarity=0.442  Sum_probs=204.6

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||.|+||.++     .++..||+|.+....  .....+.+..|+.+++.++||||+++++.+..++..+++||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME   78 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            46778999999999876     268899999986442  23455678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+++++|.+++..  ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        79 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~-  154 (255)
T cd08219          79 YCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPG-  154 (255)
T ss_pred             eCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeecccc-
Confidence            9999999998865  234889999999999999999999999   9999999999999999999999999987654321 


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      .......+++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+......+   .+..++..+.++
T Consensus       155 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  231 (255)
T cd08219         155 AYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKP---LPSHYSYELRSL  231 (255)
T ss_pred             cccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCC---CCcccCHHHHHH
Confidence            12233457889999999988889999999999999999999999998765544444443222322   234577889999


Q ss_pred             HHHHcccCCCCCCCHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~  409 (458)
                      |.+||+.||.+||++.+++..
T Consensus       232 i~~~l~~~P~~Rp~~~~il~~  252 (255)
T cd08219         232 IKQMFKRNPRSRPSATTILSR  252 (255)
T ss_pred             HHHHHhCCcccCCCHHHHhhc
Confidence            999999999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-37  Score=299.21  Aligned_cols=253  Identities=26%  Similarity=0.462  Sum_probs=203.6

Q ss_pred             CccccCceeeccceEEEEEEc-------------------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCccee
Q 012684          154 ELDFTNSVEITKGTFILAFWR-------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ  214 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~~-------------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~  214 (458)
                      ..+|++.+.||+|+||.||.-                   ...||+|.+....  .......+.+|++++++++||||++
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~i~~   81 (295)
T cd05097           4 RQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADV--TKTARNDFLKEIKIMSRLKNPNIIR   81 (295)
T ss_pred             hHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCcCe
Confidence            346888899999999998741                   1358999997542  3445567899999999999999999


Q ss_pred             eeeEEEeCCceEEEEEccCCCCHHHHHHhcC------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 012684          215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS  282 (458)
Q Consensus       215 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~  282 (458)
                      +++++......++||||+.+++|.+++....            .+++..++.++.|++.||.|||+.+   ++|+||||+
T Consensus        82 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~  158 (295)
T cd05097          82 LLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATR  158 (295)
T ss_pred             EEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChh
Confidence            9999999999999999999999999986532            3677888999999999999999999   999999999


Q ss_pred             CEEecCCCCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCC
Q 012684          283 NILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHD  359 (458)
Q Consensus       283 Nil~~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt--g~~pf~~~~~  359 (458)
                      ||+++.++.+||+|||++......... ......++..|+|||.+.+..++.++|+||||+++|+|++  +..||...+.
T Consensus       159 Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~  238 (295)
T cd05097         159 NCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSD  238 (295)
T ss_pred             hEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccCh
Confidence            999999999999999998754322111 1122344678999999988889999999999999999988  6778887665


Q ss_pred             CcHHHHHHh----cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          360 NEVPKAYAA----RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       360 ~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      .+.......    .........+..+++.+.+||.+||..||.+|||+.++++.|+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~  294 (295)
T cd05097         239 EQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLR  294 (295)
T ss_pred             HHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHh
Confidence            554433221    1122222234456789999999999999999999999999886

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=5.2e-38  Score=296.91  Aligned_cols=247  Identities=24%  Similarity=0.403  Sum_probs=202.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.++.     +++.||+|.++...   ......+.+|+.+++.++||||+++++.+...+..++|||
T Consensus        10 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645          10 DFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEe
Confidence            688889999999998873     68899999986542   2334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+++++|.+++...+.+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....... ..
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~-~~  162 (267)
T cd06645          87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATI-AK  162 (267)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCcc-cc
Confidence            9999999999988888999999999999999999999999   9999999999999999999999999987654321 12


Q ss_pred             cccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLK  386 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~  386 (458)
                      .....+++.|+|||.+.   ...++.++|+|||||++|+|++|..||....+........... .++.......++..+.
T Consensus       163 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (267)
T cd06645         163 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFH  242 (267)
T ss_pred             cccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHH
Confidence            23446788999999874   4457889999999999999999999997655433332221221 1111111224678899


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++|.+||..+|++||++.+++++
T Consensus       243 ~li~~~l~~~P~~R~~~~~ll~~  265 (267)
T cd06645         243 HFVKMALTKNPKKRPTAEKLLQH  265 (267)
T ss_pred             HHHHHHccCCchhCcCHHHHhcC
Confidence            99999999999999999999865

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4.8e-38  Score=299.80  Aligned_cols=249  Identities=27%  Similarity=0.492  Sum_probs=205.3

Q ss_pred             cccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      .|.+.+.||+|+||.||.          .+..||+|.+....  .....+.+..|+.++..++||||+++++++......
T Consensus         6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCce
Confidence            366778999999998874          14789999997542  333456688999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC
Q 012684          226 MIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS  289 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~  289 (458)
                      ++++||+.+++|.+++...                ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.+
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~  160 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDK  160 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCC
Confidence            9999999999999998532                24778889999999999999999999   9999999999999999


Q ss_pred             CCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHH
Q 012684          290 GNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA  367 (458)
Q Consensus       290 ~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~  367 (458)
                      +.+||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.+....+....+.
T Consensus       161 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~  240 (283)
T cd05091         161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIR  240 (283)
T ss_pred             CceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHH
Confidence            99999999998765332211 1123345678999999988889999999999999999998 888998876666555554


Q ss_pred             hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012684          368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      .....+   .+..++..+.+++..||+.+|.+||++++++..|+.
T Consensus       241 ~~~~~~---~~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~  282 (283)
T cd05091         241 NRQVLP---CPDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT  282 (283)
T ss_pred             cCCcCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence            333332   245678899999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=8.8e-38  Score=296.92  Aligned_cols=249  Identities=29%  Similarity=0.485  Sum_probs=205.8

Q ss_pred             ccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      .+|++...||+|+||.|+.          .+..||+|.+....  .......+.+|+.+++.++||||+++++++.....
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~   83 (277)
T cd05032           6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQP   83 (277)
T ss_pred             HHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCC
Confidence            3677889999999998873          23689999986442  33445668889999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEE
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV  294 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl  294 (458)
                      .++||||+++++|.+++....          .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|
T Consensus        84 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl  160 (277)
T cd05032          84 TLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKI  160 (277)
T ss_pred             cEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEE
Confidence            999999999999999986532          3677889999999999999999999   999999999999999999999


Q ss_pred             eecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCC
Q 012684          295 ADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP  372 (458)
Q Consensus       295 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~  372 (458)
                      +|||++........ .......++..|+|||.+.+..++.++||||||+++|++++ |..||...+..+...........
T Consensus       161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~  240 (277)
T cd05032         161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHL  240 (277)
T ss_pred             CCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCC
Confidence            99999876543221 11223345778999999988889999999999999999998 99999877766666655433333


Q ss_pred             CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       373 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      ..   +..++..+.++|.+||+.+|.+|||+.++++.|+
T Consensus       241 ~~---~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~  276 (277)
T cd05032         241 DL---PENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLK  276 (277)
T ss_pred             CC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhc
Confidence            32   3345789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=1.7e-37  Score=290.35  Aligned_cols=242  Identities=31%  Similarity=0.541  Sum_probs=200.0

Q ss_pred             eeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012684          162 EITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (458)
Q Consensus       162 ~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L  237 (458)
                      .||.|+||.||.    ++..+|+|.+....  .......+.+|+.+++.++||||+++++++......++||||+++++|
T Consensus         2 ~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   79 (250)
T cd05085           2 LLGKGNFGEVFKGTLKDKTPVAVKTCKEDL--PQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDF   79 (250)
T ss_pred             ccCCCCCceEEEEEecCCcEEEEEecCCcC--CHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcH
Confidence            589999998873    57789999987542  344455688999999999999999999999999999999999999999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCCC
Q 012684          238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT  316 (458)
Q Consensus       238 ~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~g  316 (458)
                      .+++... ..+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++...............+
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~  156 (250)
T cd05085          80 LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI  156 (250)
T ss_pred             HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCC
Confidence            9998753 45789999999999999999999999   9999999999999999999999999987543222111122234


Q ss_pred             CCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 012684          317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE  395 (458)
Q Consensus       317 t~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  395 (458)
                      ++.|+|||.+.+..++.++|+||||+++|++++ |..||...........+....+...   +..++..+.+++.+|++.
T Consensus       157 ~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~  233 (250)
T cd05085         157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC---PQKCPDDVYKVMQRCWDY  233 (250)
T ss_pred             cccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHHHHccc
Confidence            567999999988888999999999999999998 9999987765555444433222222   334678999999999999


Q ss_pred             CCCCCCCHHHHHHHHH
Q 012684          396 KPAKRPTFRQIITRLE  411 (458)
Q Consensus       396 dp~~Rps~~~ll~~L~  411 (458)
                      +|++||++.++++.|.
T Consensus       234 ~p~~Rp~~~~l~~~l~  249 (250)
T cd05085         234 KPENRPKFSELQKELA  249 (250)
T ss_pred             CcccCCCHHHHHHHhc
Confidence            9999999999998874

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=6.4e-38  Score=300.48  Aligned_cols=253  Identities=30%  Similarity=0.534  Sum_probs=207.6

Q ss_pred             CccccCceeeccceEEEEEEc----------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC
Q 012684          154 ELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS  222 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~  222 (458)
                      ..+|+..+.||+|+||.|+..          ...+|+|.+....  .......+.+|+.+++++ +||||+++++++..+
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~   88 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQE   88 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCC
Confidence            346778889999999988731          2679999987542  234456688999999999 799999999999999


Q ss_pred             CceEEEEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe
Q 012684          223 SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR  286 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~  286 (458)
                      +..+++|||+++++|.+++...                +.+++..++.++.|++.||.|||+.+   ++|+||||+||++
T Consensus        89 ~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~  165 (293)
T cd05053          89 GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLV  165 (293)
T ss_pred             CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEE
Confidence            9999999999999999999642                35788899999999999999999999   9999999999999


Q ss_pred             cCCCCEEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHH
Q 012684          287 DDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK  364 (458)
Q Consensus       287 ~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~  364 (458)
                      +.++.++|+|||++..+....... .....++..|+|||.+.+..++.++|||||||++|+|++ |..||......+...
T Consensus       166 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~  245 (293)
T cd05053         166 TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFK  245 (293)
T ss_pred             cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHH
Confidence            999999999999998654322111 122234567999999988889999999999999999997 999998776665555


Q ss_pred             HHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      ..........   +...+..+.+|+.+||..||++|||+.++++.|+++.
T Consensus       246 ~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~  292 (293)
T cd05053         246 LLKEGYRMEK---PQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML  292 (293)
T ss_pred             HHHcCCcCCC---CCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence            5433332222   3345788999999999999999999999999998764

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=1.5e-37  Score=294.00  Aligned_cols=250  Identities=31%  Similarity=0.538  Sum_probs=206.6

Q ss_pred             cccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      +|.+.+.||+|+||.|+.        .+..+|+|.+....  .....+.+.+|+.++++++||||+++++++..++..++
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           5 CIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence            567788999999998763        23379999987542  23445678999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ||||+++++|.+++... +.+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  159 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCcccccccc
Confidence            99999999999999764 45899999999999999999999999   999999999999999999999999999866433


Q ss_pred             CCCCc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          307 EDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       307 ~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      .....  ....++..|+|||.+.+..++.++|+||||+++|++++ |..||......+....+......+.   +..+++
T Consensus       160 ~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~  236 (267)
T cd05066         160 PEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA---PMDCPA  236 (267)
T ss_pred             cceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCcCCC---CCCCCH
Confidence            22111  11223567999999998889999999999999999886 9999987766555555533322222   345678


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      .+.+++.+|++.+|.+||++.++++.|+++
T Consensus       237 ~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  266 (267)
T cd05066         237 ALHQLMLDCWQKDRNERPKFEQIVSILDKL  266 (267)
T ss_pred             HHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence            999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=8.9e-38  Score=293.66  Aligned_cols=243  Identities=33%  Similarity=0.606  Sum_probs=205.8

Q ss_pred             eeeccceEEEEEE-----c---CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012684          161 VEITKGTFILAFW-----R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~  232 (458)
                      +.||+|+||.++.     .   +..|++|.+.....  ....+.+..|+.+++.++|+||+++++++......+++|||+
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~   78 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM   78 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence            3689999998763     2   78999999976533  224677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          233 PKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       233 ~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ++++|.+++...         ..+++..++.++.|++.||.|||+++   ++|+||+|+||+++.++.++|+|||.+...
T Consensus        79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~  155 (262)
T cd00192          79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDV  155 (262)
T ss_pred             cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccc
Confidence            999999999875         67999999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhh
Q 012684          304 TVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY  381 (458)
Q Consensus       304 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (458)
                      ..... .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.......   .+..+
T Consensus       156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~  232 (262)
T cd00192         156 YDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRLP---KPEYC  232 (262)
T ss_pred             ccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCccC
Confidence            54321 11233456788999999988888999999999999999999 699999886666655554433322   24456


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      ++.+.+++.+||..+|.+|||+.+++++|+
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~l~~~l~  262 (262)
T cd00192         233 PDELYELMLSCWQLDPEDRPTFSELVERLE  262 (262)
T ss_pred             ChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence            889999999999999999999999999873

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=6.2e-38  Score=309.45  Aligned_cols=247  Identities=25%  Similarity=0.376  Sum_probs=195.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC------
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~------  223 (458)
                      .+|++.+.||+|+||.|+.     +|..||+|.+..... .......+.+|+.+++.++||||+++++++....      
T Consensus        21 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   99 (359)
T cd07876          21 KRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQ   99 (359)
T ss_pred             hceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccc
Confidence            4788899999999998873     588999999975432 3344566788999999999999999999986443      


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ..|+||||+. ++|.+.+..  .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++...
T Consensus       100 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876         100 DVYLVMELMD-ANLCQVIHM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             eeEEEEeCCC-cCHHHHHhc--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence            4799999995 567766643  4888999999999999999999999   999999999999999999999999998754


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh---------------
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---------------  368 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~---------------  368 (458)
                      ..  ........+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+.......+..               
T Consensus       174 ~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  251 (359)
T cd07876         174 CT--NFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQP  251 (359)
T ss_pred             cc--CccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHH
Confidence            32  1222345678999999999998999999999999999999999999987653221111100               


Q ss_pred             ------cCCCCCC-----------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          369 ------RQRPPFK-----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       369 ------~~~~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                            ...+..+                 ......++.+++||.+||..||.+|||+.+++.+-
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  316 (359)
T cd07876         252 TVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHP  316 (359)
T ss_pred             HHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCc
Confidence                  0011100                 01112356789999999999999999999999874

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-37  Score=294.20  Aligned_cols=250  Identities=27%  Similarity=0.468  Sum_probs=204.1

Q ss_pred             ccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc----
Q 012684          157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----  224 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~----  224 (458)
                      |.+.+.||+|+||.|+.        .+..||+|.+..... .......+.+|+..++.++||||+++++++.....    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence            45678899999998873        236799999875432 34456678999999999999999999998865443    


Q ss_pred             --eEEEEEccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEee
Q 012684          225 --MMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (458)
Q Consensus       225 --~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~D  296 (458)
                        .+++|||+++++|..++...      ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~d  156 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVAD  156 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECC
Confidence              79999999999999988542      25888999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCC
Q 012684          297 FGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF  374 (458)
Q Consensus       297 fg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  374 (458)
                      ||++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+....... 
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-  235 (273)
T cd05035         157 FGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK-  235 (273)
T ss_pred             ccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-
Confidence            9998765433211 1112234668999999988889999999999999999999 899998876666555553333332 


Q ss_pred             CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       375 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                        .+..+++.+.+++.+||+.||.+|||+.++++.|+++
T Consensus       236 --~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~  272 (273)
T cd05035         236 --QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI  272 (273)
T ss_pred             --CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence              2446788999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=4e-39  Score=296.87  Aligned_cols=244  Identities=27%  Similarity=0.429  Sum_probs=198.0

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC----
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----  223 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~----  223 (458)
                      .++.|...+.+|.|+||.|+.     +++.||||..-.+..       --.+|+.+|+.+.|||||++..+|....    
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r-------~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~   94 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR-------YKNRELQIMRKLDHPNIVRLLYFFSSSTESDE   94 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC-------cCcHHHHHHHhcCCcCeeeEEEEEEecCCCch
Confidence            455788889999999999984     678999998854321       1235999999999999999999986432    


Q ss_pred             -ceEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC-CCEEEeec
Q 012684          224 -PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADF  297 (458)
Q Consensus       224 -~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~-~~vkl~Df  297 (458)
                       ...+||||++ .+|.++++.    +.+++...+.-+.+||++||.|||+.|   |+||||||+|+|+|.+ |.+|||||
T Consensus        95 ~~lnlVleymP-~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDF  170 (364)
T KOG0658|consen   95 VYLNLVLEYMP-ETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDF  170 (364)
T ss_pred             hHHHHHHHhch-HHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccC
Confidence             4578999995 599999874    466888899999999999999999999   9999999999999965 99999999


Q ss_pred             CCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh-cCCC---
Q 012684          298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRP---  372 (458)
Q Consensus       298 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~-~~~~---  372 (458)
                      |+|+.+..  +.+...+.+|..|+|||.+.+. .|+.+.||||.||++.||+.|++-|.+.+.......+.+ .+.|   
T Consensus       171 GSAK~L~~--~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e  248 (364)
T KOG0658|consen  171 GSAKVLVK--GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTRE  248 (364)
T ss_pred             Ccceeecc--CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHH
Confidence            99997753  3444567789999999998775 799999999999999999999999998776543333311 1111   


Q ss_pred             ---------------CCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 ---------------PFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 ---------------~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                     .+.      ......+++..+|+.++|..+|.+|.++.+++.+
T Consensus       249 ~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h  306 (364)
T KOG0658|consen  249 DIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAH  306 (364)
T ss_pred             HHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcc
Confidence                           110      0223457899999999999999999999999976

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.7e-37  Score=294.22  Aligned_cols=249  Identities=27%  Similarity=0.463  Sum_probs=200.8

Q ss_pred             cCceeeccceEEEEEE-----cC--eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------Cc
Q 012684          158 TNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------SP  224 (458)
Q Consensus       158 ~~~~~lg~G~~~~v~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~------~~  224 (458)
                      .+.+.||+|+||.||.     .+  ..+|+|.+.... ......+.+..|+.+++.++||||+++++++...      ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCC
Confidence            4567899999998873     22  269999987543 2445567788999999999999999999987432      24


Q ss_pred             eEEEEEccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecC
Q 012684          225 MMIVTEYLPKGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg  298 (458)
                      .+++|||+.+++|.+++..      ...+++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg  157 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFG  157 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCC
Confidence            6899999999999988742      234788999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCC
Q 012684          299 VSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA  376 (458)
Q Consensus       299 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  376 (458)
                      ++..+...... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+........  
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~--  235 (272)
T cd05075         158 LSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQ--  235 (272)
T ss_pred             cccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence            98865432211 1122345678999999998889999999999999999999 8999987666555555433333222  


Q ss_pred             ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       377 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                       +..++..+.++|.+||+.||++|||+.++++.|+++
T Consensus       236 -~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~  271 (272)
T cd05075         236 -PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA  271 (272)
T ss_pred             -CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence             345678899999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=1.2e-37  Score=327.59  Aligned_cols=256  Identities=20%  Similarity=0.299  Sum_probs=206.0

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.|+.     +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+++..+++||
T Consensus         3 rYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVME   82 (932)
T PRK13184          3 RYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMP   82 (932)
T ss_pred             CeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEE
Confidence            688889999999999874     588999999986554455556778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCC
Q 012684          231 YLPKGDLRAFLKRK-----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (458)
Q Consensus       231 ~~~~~~L~~~l~~~-----------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~  299 (458)
                      |++|++|.+++...           ..++...++.++.|+++||+|||+.|   |+||||||+||+++.++.++|+|||+
T Consensus        83 Y~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFGL  159 (932)
T PRK13184         83 YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWGA  159 (932)
T ss_pred             cCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecCc
Confidence            99999999998641           22456678889999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCC-----------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH
Q 012684          300 SKLLTVKED-----------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV  362 (458)
Q Consensus       300 ~~~~~~~~~-----------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~  362 (458)
                      +........                 .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||........
T Consensus       160 Ak~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki  239 (932)
T PRK13184        160 AIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI  239 (932)
T ss_pred             ceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhh
Confidence            976521110                 001224689999999999998999999999999999999999999987554433


Q ss_pred             HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC-HHHHHHHHHHHHh
Q 012684          363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT-FRQIITRLESINN  415 (458)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps-~~~ll~~L~~~~~  415 (458)
                      .... ....+........+++.+.+++.+||+.||++||+ ++++++.|+....
T Consensus       240 ~~~~-~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~lq  292 (932)
T PRK13184        240 SYRD-VILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHLQ  292 (932)
T ss_pred             hhhh-hccChhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence            2221 11111111123457788999999999999999965 6667777777654

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=1.5e-37  Score=292.63  Aligned_cols=246  Identities=33%  Similarity=0.524  Sum_probs=201.6

Q ss_pred             cccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      +|.+...||.|+||.+|.    .+..+|+|.+.....    ..+.+.+|+.+++.++|||++++++++. .+..+++|||
T Consensus         7 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05069           7 SLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEF   81 (260)
T ss_pred             HeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEc
Confidence            577888999999998873    345799998864322    2356788999999999999999999875 4568999999


Q ss_pred             cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       232 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      +.+++|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.........
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~  158 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT  158 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCccc
Confidence            99999999997633  4788999999999999999999999   999999999999999999999999999765433222


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      ......++..|+|||...+..++.++|+||||+++|+|++ |..||......+....+......+   .+..++..+.++
T Consensus       159 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  235 (260)
T cd05069         159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMP---CPQGCPESLHEL  235 (260)
T ss_pred             ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCcccCHHHHHH
Confidence            2223345678999999988889999999999999999999 999998876655555443322222   234577899999


Q ss_pred             HHHHcccCCCCCCCHHHHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      +.+||..||.+||+++++++.|++
T Consensus       236 i~~~l~~~p~~Rp~~~~i~~~l~~  259 (260)
T cd05069         236 MKLCWKKDPDERPTFEYIQSFLED  259 (260)
T ss_pred             HHHHccCCcccCcCHHHHHHHHhc
Confidence            999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=2.3e-37  Score=293.12  Aligned_cols=254  Identities=26%  Similarity=0.490  Sum_probs=207.9

Q ss_pred             CccccCceeeccceEEEEEE----c----CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          154 ELDFTNSVEITKGTFILAFW----R----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~----~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      ..+|++.+.||.|+||.|+.    .    ...||+|.....  ......+.+.+|+.+++.++||||+++++++.. ...
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~   81 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNC--TSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV   81 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCc--CCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence            34577889999999998873    1    236899988644  234556678999999999999999999998875 457


Q ss_pred             EEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      ++||||+++++|.+++.... .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        82 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~  158 (270)
T cd05056          82 WIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLE  158 (270)
T ss_pred             EEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeecc
Confidence            89999999999999998644 4899999999999999999999999   9999999999999999999999999987654


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      ...........+++.|+|||.+.+..++.++||||||+++|++++ |..||......+....+......+.   +..++.
T Consensus       159 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~  235 (270)
T cd05056         159 DESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERLPM---PPNCPP  235 (270)
T ss_pred             cccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcCCC---CCCCCH
Confidence            332212222334567999999988889999999999999999986 9999988776655555433333332   345678


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      .+.++|.+|+..+|.+|||+.++++.|+.+...
T Consensus       236 ~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~~  268 (270)
T cd05056         236 TLYSLMTKCWAYDPSKRPRFTELKAQLSDILQE  268 (270)
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            999999999999999999999999999987543

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.8e-37  Score=291.23  Aligned_cols=247  Identities=22%  Similarity=0.393  Sum_probs=208.2

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||.|+||.++     .++..+++|.+...... ......+.+|+.++++++|+||+++++++.+....+++||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence            47888999999999665     36889999998755433 3445668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+++++|.+++...  ..+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~  156 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS  156 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence            99999999999764  45899999999999999999999999   99999999999999999999999999876543321


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                       ......+++.|+|||.+.+..++.++|+||||+++++|++|..||......+....+......+   ....++..+.++
T Consensus       157 -~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  232 (256)
T cd08221         157 -MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP---VVSVYSSELISL  232 (256)
T ss_pred             -cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCC---CccccCHHHHHH
Confidence             2233457889999999988888899999999999999999999998766655555553332222   235678899999


Q ss_pred             HHHHcccCCCCCCCHHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      |.+||+.+|.+||+++++++++
T Consensus       233 i~~~l~~~p~~R~s~~~ll~~~  254 (256)
T cd08221         233 VHSLLQQDPEKRPTADEVLDQP  254 (256)
T ss_pred             HHHHcccCcccCCCHHHHhhCc
Confidence            9999999999999999999863

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=1.2e-37  Score=292.67  Aligned_cols=242  Identities=30%  Similarity=0.562  Sum_probs=200.9

Q ss_pred             cccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE-eCCceEEEEEc
Q 012684          156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEY  231 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-~~~~~~lv~e~  231 (458)
                      +|.+.+.||+|+||.+|   ..|..||+|.+...     ...+.+.+|+.++++++|++++++++++. .+...+++|||
T Consensus         7 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~   81 (256)
T cd05082           7 ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY   81 (256)
T ss_pred             hCeeeeeecccCCCeEEEEEEcCCcEEEEEeCCC-----chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEEC
Confidence            57777899999998776   47889999998643     22456888999999999999999999764 45678999999


Q ss_pred             cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       232 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      +++++|.+++.+.+  .+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.......  
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--  156 (256)
T cd05082          82 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--  156 (256)
T ss_pred             CCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence            99999999997644  3788999999999999999999999   9999999999999999999999999987543221  


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                        ....++..|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.....+.   .+..+++.+.++
T Consensus       157 --~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  231 (256)
T cd05082         157 --DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCPPVVYDV  231 (256)
T ss_pred             --CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CCCCCCHHHHHH
Confidence              22334567999999988889999999999999999997 999998766555444443222222   234577899999


Q ss_pred             HHHHcccCCCCCCCHHHHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      |.+|++.+|.+|||+.++++.|+.
T Consensus       232 i~~~l~~~p~~Rpt~~~l~~~l~~  255 (256)
T cd05082         232 MKQCWHLDAATRPSFLQLREQLEH  255 (256)
T ss_pred             HHHHhcCChhhCcCHHHHHHHHhc
Confidence            999999999999999999998875

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.3e-37  Score=295.95  Aligned_cols=253  Identities=25%  Similarity=0.421  Sum_probs=204.7

Q ss_pred             CccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      ..+|++.+.||+|+||.||.          .+..||+|.+....  .......+.+|+.+++.++||||+++++++....
T Consensus         5 ~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~   82 (288)
T cd05061           5 REKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQ   82 (288)
T ss_pred             HHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCC
Confidence            34688889999999999884          13489999986442  2333456788999999999999999999999999


Q ss_pred             ceEEEEEccCCCCHHHHHHhcC----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEE
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKG----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK  293 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vk  293 (458)
                      ..++||||+.+|+|.+++....          ..+...+..++.|++.||.|||+++   ++||||||+||+++.++.++
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~  159 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVK  159 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEE
Confidence            9999999999999999997532          2455678889999999999999999   99999999999999999999


Q ss_pred             EeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCC
Q 012684          294 VADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR  371 (458)
Q Consensus       294 l~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~  371 (458)
                      |+|||++.......... .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||......+....+.....
T Consensus       160 L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~  239 (288)
T cd05061         160 IGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGY  239 (288)
T ss_pred             ECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999987553322111 112234667999999988889999999999999999998 7899987666555544433333


Q ss_pred             CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      ...   +...++.+.+++.+||+.||.+|||+.++++.|+...
T Consensus       240 ~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~  279 (288)
T cd05061         240 LDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDL  279 (288)
T ss_pred             CCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhc
Confidence            322   3345689999999999999999999999999888753

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-38  Score=329.65  Aligned_cols=254  Identities=33%  Similarity=0.560  Sum_probs=219.1

Q ss_pred             cccCceeeccceEEEEEE------cC----eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          156 DFTNSVEITKGTFILAFW------RG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~------~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      +.+..+.||+|.||.||.      .|    ..||+|.+...  .+.....+|.+|..+|+.++||||++++|++.+....
T Consensus       693 ~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  693 NVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             heEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCc
Confidence            455667899999999983      23    35888888754  5677788999999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecC
Q 012684          226 MIVTEYLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg  298 (458)
                      +|++|||+||+|..+|++.       ..++..+.+.++.|+++|+.||++++   +|||||..+|+|++....|||+|||
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFG  847 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFG  847 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccc
Confidence            9999999999999999875       23889999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCCCCcc-cCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCC
Q 012684          299 VSKLLTVKEDRPLT-CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA  376 (458)
Q Consensus       299 ~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  376 (458)
                      +|+.+-........ ...-+..|||||.+..+.++.|+|||||||+|||++| |..||...+..++...+...++.+.  
T Consensus       848 lArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~--  925 (1025)
T KOG1095|consen  848 LARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDP--  925 (1025)
T ss_pred             hhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCC--
Confidence            99844322222221 2234678999999999999999999999999999998 9999999999999887777776665  


Q ss_pred             ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       377 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                       +..++..+.++|..||+.+|++||++..|++.+..+.+..
T Consensus       926 -P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~~~  965 (1025)
T KOG1095|consen  926 -PSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISNAA  965 (1025)
T ss_pred             -CCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhhhh
Confidence             4567788999999999999999999999999988876543

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=1e-38  Score=300.12  Aligned_cols=248  Identities=28%  Similarity=0.547  Sum_probs=200.9

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |++.+.||+|+||.|+.     +++.||+|.+...... ........+|+.++++++||||+++++++......++|||+
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIE-EEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHH-HHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEecccccc-ccccchhhhhhhccccccccccccccccccccccccccccc
Confidence            56788999999999984     5678999999865322 22222345699999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCc
Q 012684          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL  311 (458)
Q Consensus       232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~  311 (458)
                      +.+++|.+++...+.+++..+..++.|+++||.+||+.+   ++|+||||+||+++.++.++|+|||.+.... ......
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~-~~~~~~  155 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLS-ENNENF  155 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEEST-STTSEB
T ss_pred             ccccccccccccccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccc-cccccc
Confidence            998899999997788999999999999999999999999   9999999999999999999999999987541 122334


Q ss_pred             ccCCCCCcccCCcccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCC---CCChhhhHHHHHH
Q 012684          312 TCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF---KAPAKLYARGLKE  387 (458)
Q Consensus       312 ~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~  387 (458)
                      ....+++.|+|||++. +...+.++|+||||+++++|++|..||....................   .......++.+.+
T Consensus       156 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  235 (260)
T PF00069_consen  156 NPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRD  235 (260)
T ss_dssp             SSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHH
Confidence            4566789999999998 77899999999999999999999999997632222222211111111   0011112479999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +|..||+.||++||++.+++++
T Consensus       236 li~~~l~~~p~~R~~~~~l~~~  257 (260)
T PF00069_consen  236 LIKKMLSKDPEQRPSAEELLKH  257 (260)
T ss_dssp             HHHHHSSSSGGGSTTHHHHHTS
T ss_pred             HHHHHccCChhHCcCHHHHhcC
Confidence            9999999999999999999875

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.4e-37  Score=299.99  Aligned_cols=252  Identities=24%  Similarity=0.376  Sum_probs=205.1

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|...+.||.|+||.++.     +++.|++|.+.............+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   81 (305)
T cd05609           2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME   81 (305)
T ss_pred             CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence            577788999999998873     578999999876543344455678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC--
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~--  308 (458)
                      |++|++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........  
T Consensus        82 ~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~  158 (305)
T cd05609          82 YVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN  158 (305)
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcCcccc
Confidence            9999999999988888999999999999999999999999   99999999999999999999999998763210000  


Q ss_pred             ------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCC
Q 012684          309 ------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA  376 (458)
Q Consensus       309 ------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  376 (458)
                                  .......++..|+|||.+.+..++.++|+||||+++|+|++|..||.+....+......... ...+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~-~~~~~  237 (305)
T cd05609         159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-IEWPE  237 (305)
T ss_pred             ccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcc-cCCCC
Confidence                        00112346778999999988889999999999999999999999998776655544443222 22222


Q ss_pred             ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       377 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      ....++..+.++|.+||+.||.+||+...+.+.|+
T Consensus       238 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~  272 (305)
T cd05609         238 GDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ  272 (305)
T ss_pred             ccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence            23357889999999999999999999654444443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2.1e-37  Score=297.65  Aligned_cols=252  Identities=32%  Similarity=0.531  Sum_probs=205.2

Q ss_pred             cccCceeeccceEEEEEE-----cC--eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~l  227 (458)
                      +|++.+.||.|+||.|+.     +|  ..+++|.+...  ......+.+.+|+.++.++ +||||+++++++...+..++
T Consensus         3 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l   80 (297)
T cd05089           3 DIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYI   80 (297)
T ss_pred             cceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceE
Confidence            577788999999998873     23  24788887632  2334456788899999999 79999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC
Q 012684          228 VTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~  291 (458)
                      +|||+++++|.+++....                .+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~  157 (297)
T cd05089          81 AIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLA  157 (297)
T ss_pred             EEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCe
Confidence            999999999999997532                4778899999999999999999999   999999999999999999


Q ss_pred             EEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcC
Q 012684          292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ  370 (458)
Q Consensus       292 vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~  370 (458)
                      ++|+|||++......  ........+..|+|||.+.+..++.++|||||||++|+|++ |..||................
T Consensus       158 ~kl~dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~  235 (297)
T cd05089         158 SKIADFGLSRGEEVY--VKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  235 (297)
T ss_pred             EEECCcCCCccccce--eccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCC
Confidence            999999998643211  11111223557999999988889999999999999999997 999998876665555443222


Q ss_pred             CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      ...   .+..++..+.+||.+||+.+|.+||++.++++.|+.+.+..
T Consensus       236 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~~~  279 (297)
T cd05089         236 RME---KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLEAR  279 (297)
T ss_pred             CCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhh
Confidence            222   23457789999999999999999999999999999887654

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-37  Score=291.33  Aligned_cols=248  Identities=29%  Similarity=0.462  Sum_probs=205.6

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|+..+.||.|+||.++.     ++..+++|.+....   ....+.+.+|+.++++++||||+++++++..+...+++|
T Consensus         3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~   79 (262)
T cd06613           3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM   79 (262)
T ss_pred             cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence            4678889999999998863     56889999997542   234577889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      ||+++++|.+++... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        80 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~-  155 (262)
T cd06613          80 EYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATI-  155 (262)
T ss_pred             eCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhh-
Confidence            999999999998775 67999999999999999999999999   9999999999999999999999999987654321 


Q ss_pred             CCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARG  384 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  384 (458)
                      .......++..|+|||.+.+.   .++.++|+||||+++|+|++|+.||................ .+........++.+
T Consensus       156 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (262)
T cd06613         156 AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPV  235 (262)
T ss_pred             hccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHH
Confidence            122334578889999998776   78889999999999999999999998766544433332221 22222234457789


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.+++.+||..+|.+|||+.+++.+
T Consensus       236 ~~~li~~~l~~~p~~Rpt~~~il~~  260 (262)
T cd06613         236 FHDFIKKCLTKDPKKRPTATKLLQH  260 (262)
T ss_pred             HHHHHHHHcCCChhhCCCHHHHhcC
Confidence            9999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.6e-38  Score=302.08  Aligned_cols=247  Identities=26%  Similarity=0.419  Sum_probs=197.2

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|...+.||+|+||.||.     ++..||+|.+......  .....+.+|+.+++.++||||+++++++..++..++|||
T Consensus         7 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           7 TYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             ceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccC--CcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEe
Confidence            588889999999999874     6788999998754321  222356779999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |++ ++|.+++...+ .++...+..++.|++.||.|||+.+   |+||||||+||+++.++.++|+|||++....... .
T Consensus        85 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~-~  159 (309)
T cd07872          85 YLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPT-K  159 (309)
T ss_pred             CCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCc-c
Confidence            996 58888887644 4788999999999999999999999   9999999999999999999999999987543221 1


Q ss_pred             CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC------------------
Q 012684          310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------  370 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~------------------  370 (458)
                      ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...+..+....+....                  
T Consensus       160 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (309)
T cd07872         160 TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFK  239 (309)
T ss_pred             ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhh
Confidence            2223456889999998865 457889999999999999999999998766544332221110                  


Q ss_pred             ---CCCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          371 ---RPPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       371 ---~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                         .+...     .....+++++.++|.+||+.||.+|||+.+++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  286 (309)
T cd07872         240 NYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKH  286 (309)
T ss_pred             hhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcC
Confidence               00000     0112457789999999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.9e-37  Score=294.64  Aligned_cols=255  Identities=25%  Similarity=0.494  Sum_probs=201.6

Q ss_pred             CccccCceeeccceEEEEEE---------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--
Q 012684          154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--  222 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--  222 (458)
                      +..|++.+.||+|+||.|+.         ++..||+|.+...  ........+.+|+.+++.++||||+++++++...  
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~   80 (284)
T cd05079           3 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGG   80 (284)
T ss_pred             hhhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCC
Confidence            34578889999999998863         4788999998644  2344556789999999999999999999998765  


Q ss_pred             CceEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          223 SPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                      ...++||||++|++|.+++.+.. .+++..+..++.|++.||+|||++|   ++||||||+||+++.++.++|+|||++.
T Consensus        81 ~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~  157 (284)
T cd05079          81 NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTK  157 (284)
T ss_pred             CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCcccc
Confidence            56899999999999999997643 5899999999999999999999999   9999999999999999999999999987


Q ss_pred             ccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-----------C-cHHHHHH
Q 012684          302 LLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-----------N-EVPKAYA  367 (458)
Q Consensus       302 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~-----------~-~~~~~~~  367 (458)
                      ........  ......++..|+|||.+.+..++.++||||||+++|+|++++.|+.....           . .......
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (284)
T cd05079         158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVR  237 (284)
T ss_pred             ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHH
Confidence            65432211  11234466789999999888899999999999999999998776532111           0 0011110


Q ss_pred             hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      ..........+..++..+.+|+.+||+.||.+|||++++++.|+.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~  283 (284)
T cd05079         238 VLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI  283 (284)
T ss_pred             HHHcCccCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence            0011111122345788999999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=2.3e-37  Score=297.20  Aligned_cols=253  Identities=27%  Similarity=0.474  Sum_probs=203.1

Q ss_pred             ccccCceeeccceEEEEEE---------------------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcce
Q 012684          155 LDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV  213 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~---------------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~  213 (458)
                      .+|++.+.||+|+||.||.                     ++..||+|.+....  .......+.+|+.+++.++||||+
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~~l~~~~i~   82 (296)
T cd05095           5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMSRLKDPNII   82 (296)
T ss_pred             hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcc
Confidence            3588889999999999984                     23469999997542  344556788999999999999999


Q ss_pred             eeeeEEEeCCceEEEEEccCCCCHHHHHHhcC-----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 012684          214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-----------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS  282 (458)
Q Consensus       214 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~  282 (458)
                      ++++++..++..+++|||+++++|.+++....           .+++.++..++.|++.||+|||+.+   ++|+||||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~  159 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATR  159 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChh
Confidence            99999999999999999999999999987632           3567789999999999999999999   999999999


Q ss_pred             CEEecCCCCEEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCC
Q 012684          283 NILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHD  359 (458)
Q Consensus       283 Nil~~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt--g~~pf~~~~~  359 (458)
                      ||+++.++.++|+|||++..+....... .....+++.|++||...+..++.++|+|||||++|+|++  |..||.....
T Consensus       160 Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~  239 (296)
T cd05095         160 NCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSD  239 (296)
T ss_pred             eEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccCh
Confidence            9999999999999999987653322111 122234678999999888889999999999999999998  7789987665


Q ss_pred             CcHHHHHHh----cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012684          360 NEVPKAYAA----RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       360 ~~~~~~~~~----~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      .+.......    .........+..+++.+.+++..||+.||.+||++.++++.|++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~  296 (296)
T cd05095         240 EQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE  296 (296)
T ss_pred             HHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence            554332211    11111112234567899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1e-38  Score=312.58  Aligned_cols=241  Identities=31%  Similarity=0.533  Sum_probs=205.4

Q ss_pred             eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCC
Q 012684          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG  235 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~  235 (458)
                      -.||+|+||.||.     +...+|||.+...   ..+..+-+..|+.+.++++|.|||+++|.+.+++.+-|.||-++||
T Consensus       581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGG  657 (1226)
T KOG4279|consen  581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGG  657 (1226)
T ss_pred             EEeecCceeEEEeeccccceeEEEeeecccc---cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCC
Confidence            3699999999984     4578999999754   3344566888999999999999999999999999999999999999


Q ss_pred             CHHHHHHh-cCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec-CCCCEEEeecCCccccccCCCCCc
Q 012684          236 DLRAFLKR-KGAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPL  311 (458)
Q Consensus       236 ~L~~~l~~-~~~~--~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~-~~~~vkl~Dfg~~~~~~~~~~~~~  311 (458)
                      +|.+++.. .|++  .+.++-.+.+||++||.|||...   |+|||||-+|+|++ -.|.+||+|||.++.+..- ....
T Consensus       658 SLSsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgi-nP~T  733 (1226)
T KOG4279|consen  658 SLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGI-NPCT  733 (1226)
T ss_pred             cHHHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhccC-Cccc
Confidence            99999975 5777  77888889999999999999999   99999999999998 5789999999999876532 2334


Q ss_pred             ccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          312 TCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ..+.||..|||||++..+  .|+.++|||||||++.||.||++||............ .+-....++.|..++.+.+.||
T Consensus       734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk-VGmyKvHP~iPeelsaeak~Fi  812 (1226)
T KOG4279|consen  734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK-VGMYKVHPPIPEELSAEAKNFI  812 (1226)
T ss_pred             cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh-hcceecCCCCcHHHHHHHHHHH
Confidence            567799999999999765  6888999999999999999999999987666554433 2223344445778899999999


Q ss_pred             HHHcccCCCCCCCHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+|+..||.+||+|++++..
T Consensus       813 lrcFepd~~~R~sA~~LL~D  832 (1226)
T KOG4279|consen  813 LRCFEPDPCDRPSAKDLLQD  832 (1226)
T ss_pred             HHHcCCCcccCccHHHhccC
Confidence            99999999999999999864

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=3.2e-37  Score=291.69  Aligned_cols=250  Identities=30%  Similarity=0.533  Sum_probs=206.5

Q ss_pred             cccCceeeccceEEEEEE-----cC---eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      +|+..+.||+|+||.||.     ++   ..+|+|.+....  .....+.+..|+.+++.++||||+++++++...+..++
T Consensus         6 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l   83 (268)
T cd05063           6 HITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMI   83 (268)
T ss_pred             HceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEE
Confidence            677789999999998872     22   379999986542  33445678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ||||+++++|.+++... +.+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~  160 (268)
T cd05063          84 ITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLEDD  160 (268)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceecccc
Confidence            99999999999999764 56899999999999999999999999   999999999999999999999999998765433


Q ss_pred             CCCCcc--cCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          307 EDRPLT--CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       307 ~~~~~~--~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      ......  ....++.|+|||.+.+..++.++|+||||+++|+|++ |..||......+....+......+.   +..++.
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~  237 (268)
T cd05063         161 PEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLPA---PMDCPS  237 (268)
T ss_pred             cccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC---CCCCCH
Confidence            221111  1223457999999988888999999999999999997 9999987766555555533322222   234678


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      .+.+++.+||..+|.+||++.++++.|+++
T Consensus       238 ~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~  267 (268)
T cd05063         238 AVYQLMLQCWQQDRARRPRFVDIVNLLDKL  267 (268)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence            899999999999999999999999998765

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.4e-37  Score=298.83  Aligned_cols=248  Identities=27%  Similarity=0.467  Sum_probs=203.1

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.|+.     +|..+|+|.+....  .......+.+|+.++++++||||+++++++..++..++|||
T Consensus         2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence            578889999999998873     57889999987542  34445668889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |+++++|.+++...+.+++..+..++.|+++||.|||+ .+   ++|+||||+||+++.++.++|+|||++......   
T Consensus        80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~---  153 (308)
T cd06615          80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS---  153 (308)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EEECCCChHHEEEecCCcEEEccCCCccccccc---
Confidence            99999999999888889999999999999999999998 47   999999999999999999999999998754322   


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-------------------
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-------------------  370 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-------------------  370 (458)
                      ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+............                   
T Consensus       154 ~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (308)
T cd06615         154 MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDS  233 (308)
T ss_pred             ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCc
Confidence            2233467889999999988888999999999999999999999997554332222111100                   


Q ss_pred             ---------------CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          371 ---------------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       371 ---------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                                     ..........++.++.++|.+||..||++|||+.+++.+..
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~  289 (308)
T cd06615         234 PRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPF  289 (308)
T ss_pred             cchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChh
Confidence                           00000111236778999999999999999999999999843

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=2.8e-37  Score=293.95  Aligned_cols=252  Identities=23%  Similarity=0.487  Sum_probs=205.7

Q ss_pred             ccccCceeeccceEEEEEE-----cCe----EEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      .+|+..+.||.|+||.||.     +|.    .||+|.+....  .......+.+|+.+++.++||||+++++++.. ...
T Consensus         7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STV   83 (279)
T ss_pred             hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCc
Confidence            3577788999999998873     343    58999987542  34445678899999999999999999999875 457


Q ss_pred             EEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          226 MIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      ++++||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++....
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~  160 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD  160 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence            899999999999999976 456899999999999999999999999   9999999999999999999999999988664


Q ss_pred             cCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhH
Q 012684          305 VKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA  382 (458)
Q Consensus       305 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (458)
                      ..... ......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+......+.   +..++
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  237 (279)
T cd05109         161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLPQ---PPICT  237 (279)
T ss_pred             cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CccCC
Confidence            32211 1122234678999999988889999999999999999998 8999987665555554433333322   34577


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      ..+.+++.+||+.||.+||++.++++.|+.+..
T Consensus       238 ~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05109         238 IDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR  270 (279)
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence            899999999999999999999999998887743

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2e-37  Score=291.85  Aligned_cols=249  Identities=31%  Similarity=0.515  Sum_probs=205.6

Q ss_pred             CccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      ..+|++.+.||.|+||.||.    .+..||+|.+.....    ..+.+.+|+.+++.++||||+++++++..+...++||
T Consensus         5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~   80 (261)
T cd05034           5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTM----SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVT   80 (261)
T ss_pred             hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCcc----CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEE
Confidence            34678889999999998873    456799999875432    2356888999999999999999999999889999999


Q ss_pred             EccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          230 EYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||+++++|.+++....  .++...+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        81 e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~  157 (261)
T cd05034          81 EYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDE  157 (261)
T ss_pred             eccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchh
Confidence            9999999999997643  5899999999999999999999999   9999999999999999999999999987654321


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                      .........+..|+|||.+.+..++.++|+||+|++++++++ |+.||...........+......+.   +...+..+.
T Consensus       158 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  234 (261)
T cd05034         158 YTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR---PPNCPEELY  234 (261)
T ss_pred             hhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHH
Confidence            111122234567999999998889999999999999999998 9999987665555555433222222   234578899


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      +++.+||..+|.+||+++++++.|+.
T Consensus       235 ~~i~~~l~~~p~~Rp~~~~l~~~l~~  260 (261)
T cd05034         235 DLMLQCWDKDPEERPTFEYLQSFLED  260 (261)
T ss_pred             HHHHHHcccCcccCCCHHHHHHHHhc
Confidence            99999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=1.7e-37  Score=296.91  Aligned_cols=250  Identities=30%  Similarity=0.483  Sum_probs=205.0

Q ss_pred             ccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      .+|++.+.||.|+||.++.          ++..||+|.+....  .......+.+|+.+++.++||||+++++++..+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~   82 (288)
T cd05050           5 NNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDHPNIVKLLGVCAVGKP   82 (288)
T ss_pred             HhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCc
Confidence            4678888999999998874          46789999987542  34445678899999999999999999999999889


Q ss_pred             eEEEEEccCCCCHHHHHHhcC----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG----------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS  282 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~----------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~  282 (458)
                      .+++|||+++++|.+++....                      .+++.+++.++.|++.||.|||+.+   ++|+||||+
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~  159 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATR  159 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHh
Confidence            999999999999999997432                      3677888999999999999999999   999999999


Q ss_pred             CEEecCCCCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 012684          283 NILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDN  360 (458)
Q Consensus       283 Nil~~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~  360 (458)
                      ||+++.++.++|+|||++..+...... .......+..|+|||.+.+..++.++|+|||||++|+|++ |..||......
T Consensus       160 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~  239 (288)
T cd05050         160 NCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE  239 (288)
T ss_pred             heEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            999999999999999998754322111 1122234667999999988889999999999999999997 88899877666


Q ss_pred             cHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012684          361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      +....+......+   .+..++..+.++|.+||+.||.+|||+.++++.|++
T Consensus       240 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~  288 (288)
T cd05050         240 EVIYYVRDGNVLS---CPDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR  288 (288)
T ss_pred             HHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence            5555543322222   234567899999999999999999999999998863

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=3.1e-37  Score=293.76  Aligned_cols=258  Identities=26%  Similarity=0.417  Sum_probs=210.4

Q ss_pred             CcCCccccCceeeccceEEEEEE----c-----CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe
Q 012684          151 DPHELDFTNSVEITKGTFILAFW----R-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ  221 (458)
Q Consensus       151 ~~~~~~~~~~~~lg~G~~~~v~~----~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~  221 (458)
                      +....+|++.+.||+|+||.|+.    .     +..|++|.+...  ........+.+|+.+++.++||||+++++++..
T Consensus         2 ~~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~   79 (280)
T cd05043           2 AISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIE   79 (280)
T ss_pred             ccchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEec
Confidence            34456788889999999998863    2     588999988643  345556778899999999999999999998765


Q ss_pred             -CCceEEEEEccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCE
Q 012684          222 -SSPMMIVTEYLPKGDLRAFLKRK--------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL  292 (458)
Q Consensus       222 -~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~v  292 (458)
                       +...+++++|+.+++|.+++...        ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+
T Consensus        80 ~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~  156 (280)
T cd05043          80 DGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQV  156 (280)
T ss_pred             CCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcE
Confidence             46789999999999999998753        34889999999999999999999999   9999999999999999999


Q ss_pred             EEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcC
Q 012684          293 KVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ  370 (458)
Q Consensus       293 kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~  370 (458)
                      +|+|||+++.+....... .....++..|+|||.+.+..++.++||||||+++|++++ |+.||....+.+....+....
T Consensus       157 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~  236 (280)
T cd05043         157 KITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY  236 (280)
T ss_pred             EECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC
Confidence            999999987553222111 112234667999999988889999999999999999998 999998776655554443322


Q ss_pred             CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ...   ....+++++.+++.+||..||.+|||+.+++..|+++...
T Consensus       237 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~~  279 (280)
T cd05043         237 RLA---QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHAQ  279 (280)
T ss_pred             CCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhc
Confidence            222   2334678999999999999999999999999999988643

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.9e-37  Score=293.03  Aligned_cols=251  Identities=24%  Similarity=0.474  Sum_probs=203.2

Q ss_pred             cccCceeeccceEEEEEE-----cCe----EEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      +|+..+.||+|+||.||.     +|.    .+++|.+...  ........+..|+..++.++||||+++++++.. ...+
T Consensus         8 ~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~   84 (279)
T cd05111           8 ELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQ   84 (279)
T ss_pred             hceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHhcCCCCCcceEEEEECC-CccE
Confidence            566778999999998873     343    5888887532  233445677888889999999999999998764 4578


Q ss_pred             EEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          227 IVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      +++||+++|+|.+++.. .+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~  161 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYP  161 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceeccC
Confidence            99999999999999976 456899999999999999999999999   99999999999999999999999999976532


Q ss_pred             CCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          306 KED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       306 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      ... .......++..|+|||.+.+..++.++||||||+++|++++ |+.||.+.........+.....+..   +..++.
T Consensus       162 ~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~  238 (279)
T cd05111         162 DDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ---PQICTI  238 (279)
T ss_pred             CCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CCCCCH
Confidence            221 11233456778999999988889999999999999999998 9999988766555444433333332   233567


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      .+.+++.+||..||.+|||+.++++.|..+..
T Consensus       239 ~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~  270 (279)
T cd05111         239 DVYMVMVKCWMIDENVRPTFKELANEFTRMAR  270 (279)
T ss_pred             HHHHHHHHHcCCCcccCcCHHHHHHHHHHHHh
Confidence            88999999999999999999999999888753

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.6e-37  Score=297.47  Aligned_cols=243  Identities=28%  Similarity=0.476  Sum_probs=207.2

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||.|+||.+|.     +++.||+|.+.............+.+|+.++++++||||+++++++..+...++|||
T Consensus         2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   81 (290)
T cd05580           2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME   81 (290)
T ss_pred             ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence            577889999999998862     579999999976544444556778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......    
T Consensus        82 ~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~----  154 (290)
T cd05580          82 YVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR----  154 (290)
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC----
Confidence            9999999999988888999999999999999999999999   999999999999999999999999998765432    


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....+++.|+|||.+.+...+.++|+||||+++|+|++|+.||...........+. .....+   +..++..++++|.
T Consensus       155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-~~~~~~---~~~~~~~l~~li~  230 (290)
T cd05580         155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKIL-EGKVRF---PSFFSPDAKDLIR  230 (290)
T ss_pred             CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-cCCccC---CccCCHHHHHHHH
Confidence            223457889999999988888899999999999999999999998766443334332 223332   3446789999999


Q ss_pred             HHcccCCCCCC-----CHHHHHHH
Q 012684          391 ECWNEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       391 ~~l~~dp~~Rp-----s~~~ll~~  409 (458)
                      +||..||.+|+     ++++++.+
T Consensus       231 ~~l~~~p~~R~~~~~~~~~~l~~~  254 (290)
T cd05580         231 NLLQVDLTKRLGNLKNGVNDIKNH  254 (290)
T ss_pred             HHccCCHHHccCcccCCHHHHHcC
Confidence            99999999999     78888776

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.8e-37  Score=289.95  Aligned_cols=248  Identities=29%  Similarity=0.506  Sum_probs=204.2

Q ss_pred             CccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      ..+|++.+.||+|+||.||.    .+..+|+|.+...    ....+.+.+|+.+++.++|+||+++++.+.. ...+++|
T Consensus         5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~----~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~   79 (260)
T cd05073           5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPG----SMSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIIT   79 (260)
T ss_pred             ccceeEEeEecCccceEEEEEEecCCccEEEEecCCC----hhHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEE
Confidence            34678889999999998873    4567999988643    2345678889999999999999999999887 7789999


Q ss_pred             EccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       230 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||+++++|.+++...  ..++...+..++.|++.||.|||+.+   ++|+||+|+||+++..+.++|+|||.+.......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~  156 (260)
T cd05073          80 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNE  156 (260)
T ss_pred             EeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCC
Confidence            999999999999763  34788889999999999999999999   9999999999999999999999999987654322


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                      ........++..|+|||.+.+..++.++|+||||+++|++++ |..||...+.......+......+   .+..++.++.
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  233 (260)
T cd05073         157 YTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP---RPENCPEELY  233 (260)
T ss_pred             cccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC---CcccCCHHHH
Confidence            222223345667999999988888999999999999999998 999998776655554443222222   2345778999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      +++.+||+.+|.+||++.++++.|+.
T Consensus       234 ~~i~~~l~~~p~~Rp~~~~l~~~L~~  259 (260)
T cd05073         234 NIMMRCWKNRPEERPTFEYIQSVLDD  259 (260)
T ss_pred             HHHHHHcccCcccCcCHHHHHHHHhc
Confidence            99999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=9.9e-38  Score=315.14  Aligned_cols=243  Identities=24%  Similarity=0.362  Sum_probs=191.1

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------  222 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~------  222 (458)
                      ..+|++.+.||+|+||.||.     +++.||||.+....       ....+|+.+++.++||||+++++++...      
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~-------~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~  137 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP-------QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNE  137 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc-------chHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence            34689999999999999873     67899999885431       1235699999999999999999887432      


Q ss_pred             --CceEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC-CEEEe
Q 012684          223 --SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVA  295 (458)
Q Consensus       223 --~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~-~vkl~  295 (458)
                        ..+++||||++ ++|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++ .+||+
T Consensus       138 ~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~  213 (440)
T PTZ00036        138 KNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLC  213 (440)
T ss_pred             CceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeee
Confidence              24679999995 578777653    456899999999999999999999999   99999999999999665 69999


Q ss_pred             ecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-CCC-
Q 012684          296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP-  372 (458)
Q Consensus       296 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~~~-  372 (458)
                      |||++..+...  .......+|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+....+....+... +.+ 
T Consensus       214 DFGla~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~  291 (440)
T PTZ00036        214 DFGSAKNLLAG--QRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPT  291 (440)
T ss_pred             ccccchhccCC--CCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCC
Confidence            99999865432  222345678999999998654 6899999999999999999999999887654433332211 111 


Q ss_pred             --------------CCCC---------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 --------------PFKA---------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 --------------~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                    .++.         .+...++++.+||.+||..||.+|||+.+++.|
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~h  351 (440)
T PTZ00036        292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALAD  351 (440)
T ss_pred             HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCC
Confidence                          0000         112356789999999999999999999999977

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=3.1e-37  Score=307.02  Aligned_cols=258  Identities=28%  Similarity=0.466  Sum_probs=206.8

Q ss_pred             CcccCcCCccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceee
Q 012684          147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQF  215 (458)
Q Consensus       147 ~~~~~~~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~  215 (458)
                      .|++...  +|.+.+.||+|+||.||.          .+..||+|++....  .....+.+..|+.++.++. ||||+++
T Consensus        31 ~~~~~~~--~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~  106 (401)
T cd05107          31 AWEMPRD--NLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNL  106 (401)
T ss_pred             cceecHH--HeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEE
Confidence            3444433  566778999999998873          23589999997543  2333456889999999997 9999999


Q ss_pred             eeEEEeCCceEEEEEccCCCCHHHHHHhcC--------------------------------------------------
Q 012684          216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--------------------------------------------------  245 (458)
Q Consensus       216 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------------------------------------------  245 (458)
                      ++++..++..++||||+.+|+|.+++...+                                                  
T Consensus       107 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  186 (401)
T cd05107         107 LGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDES  186 (401)
T ss_pred             EEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccc
Confidence            999999999999999999999999986532                                                  


Q ss_pred             ------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeC
Q 012684          246 ------------------------------------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR  277 (458)
Q Consensus       246 ------------------------------------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~  277 (458)
                                                                      .+++..++.++.|++.||.|||+.+   ++||
T Consensus       187 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHr  263 (401)
T cd05107         187 ADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHR  263 (401)
T ss_pred             cCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcc
Confidence                                                            2566678889999999999999998   9999


Q ss_pred             CCCCCCEEecCCCCEEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCC
Q 012684          278 DLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT  355 (458)
Q Consensus       278 Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~  355 (458)
                      ||||+|||++.++.++|+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||.
T Consensus       264 dlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~  343 (401)
T cd05107         264 DLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYP  343 (401)
T ss_pred             cCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCC
Confidence            9999999999999999999999876432211 11122345778999999988889999999999999999998 899998


Q ss_pred             CCCCCcHHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          356 MKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       356 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      .....+........+ ++.   .+..++.++.+|+.+||..+|.+||++.+|+..|+.+.
T Consensus       344 ~~~~~~~~~~~~~~~~~~~---~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~  400 (401)
T cd05107         344 ELPMNEQFYNAIKRGYRMA---KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL  400 (401)
T ss_pred             CCCchHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence            765554433332222 222   23456789999999999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=2.9e-37  Score=289.94  Aligned_cols=245  Identities=31%  Similarity=0.595  Sum_probs=202.7

Q ss_pred             cccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      +|++.+.||.|+||.+|.    .+..+|+|.+......    ...+..|+.++++++||+|+++++++......++||||
T Consensus         5 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   80 (256)
T cd05112           5 ELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEF   80 (256)
T ss_pred             HeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEc
Confidence            466678999999998873    4788999998754332    24578899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      +++++|.+++... +.+++..+..++.|++.+|.+||+.+   ++|+||||+||+++.++.++|+|||++..........
T Consensus        81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~  157 (256)
T cd05112          81 MEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS  157 (256)
T ss_pred             CCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence            9999999998764 56899999999999999999999999   9999999999999999999999999987654322222


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+........   +...+..+.+|+
T Consensus       158 ~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~  234 (256)
T cd05112         158 STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK---PRLASQSVYELM  234 (256)
T ss_pred             cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCC---CCCCCHHHHHHH
Confidence            222334668999999988889999999999999999998 9999987666555555433222221   233578899999


Q ss_pred             HHHcccCCCCCCCHHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      .+||+.+|++|||+.++++.|
T Consensus       235 ~~~l~~~p~~Rp~~~~~l~~l  255 (256)
T cd05112         235 QHCWKERPEDRPSFSLLLHQL  255 (256)
T ss_pred             HHHcccChhhCCCHHHHHHhh
Confidence            999999999999999999886

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=3.2e-37  Score=296.24  Aligned_cols=251  Identities=22%  Similarity=0.429  Sum_probs=206.7

Q ss_pred             cCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          150 IDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       150 ~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      +.....+|+..+.||.|+||.+|.     ++..||+|.+.....   ...+.+.+|+.+++.++||||+++++.+..+..
T Consensus        15 ~~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~   91 (296)
T cd06654          15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDE   91 (296)
T ss_pred             cCCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCE
Confidence            334445888899999999998873     578999999875432   234568889999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      .|+||||+++++|.+++.+ ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        92 ~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~  167 (296)
T cd06654          92 LWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQIT  167 (296)
T ss_pred             EEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcc
Confidence            9999999999999999865 45889999999999999999999999   9999999999999999999999999987643


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      ... .......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||.................+.. ..+..++..
T Consensus       168 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  245 (296)
T cd06654         168 PEQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAI  245 (296)
T ss_pred             ccc-cccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCCCCC-CCccccCHH
Confidence            221 112234578899999999888889999999999999999999999987655333322222222222 224457788


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.++|.+||..||++||++.+++.+
T Consensus       246 l~~li~~~l~~~p~~Rpt~~eil~~  270 (296)
T cd06654         246 FRDFLNRCLDMDVEKRGSAKELLQH  270 (296)
T ss_pred             HHHHHHHHCcCCcccCcCHHHHhhC
Confidence            9999999999999999999999985

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=4.6e-37  Score=290.85  Aligned_cols=250  Identities=30%  Similarity=0.536  Sum_probs=204.8

Q ss_pred             cccCceeeccceEEEEEE-----cC---eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      .|.+.+.||+|+||.+|.     ++   ..||+|.+....  .......+..|+.+++.++||||+++++++..+...++
T Consensus         5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEE
Confidence            366788999999998873     22   369999987542  34556789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ||||+++++|.+++.. .+.+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~  159 (269)
T cd05065          83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  159 (269)
T ss_pred             EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence            9999999999999876 356899999999999999999999999   999999999999999999999999998765432


Q ss_pred             CCCCc--ccC--CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhh
Q 012684          307 EDRPL--TCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY  381 (458)
Q Consensus       307 ~~~~~--~~~--~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (458)
                      .....  ...  ..+..|+|||.+.+..++.++|+||||+++|++++ |..||...........+......+.   +..+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~  236 (269)
T cd05065         160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDYRLPP---PMDC  236 (269)
T ss_pred             ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC---cccC
Confidence            22111  111  12457999999988889999999999999999886 9999987766555555433222222   3456


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      +..+.+++.+||..+|.+||++.+++..|+++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~  268 (269)
T cd05065         237 PTALHQLMLDCWQKDRNARPKFGQIVSTLDKM  268 (269)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence            78899999999999999999999999988764

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=3.7e-37  Score=293.57  Aligned_cols=245  Identities=28%  Similarity=0.419  Sum_probs=201.9

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |++.+.||.|+||.++.     ++..+++|.+...   .....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEe
Confidence            56778899999998873     5788999998643   345567788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       232 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      +++++|..++.+ ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....... ..
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~-~~  159 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-QR  159 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEccccccccccccc-cc
Confidence            999999988765 456899999999999999999999999   9999999999999999999999999987643221 12


Q ss_pred             cccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHH
Q 012684          311 LTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL  385 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (458)
                      .....+++.|+|||++.     +..++.++|+||+||++|+|++|+.||...+..+..........+. ...+..++..+
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  238 (282)
T cd06643         160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSSEF  238 (282)
T ss_pred             cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCccccCHHH
Confidence            23345788999999974     3456789999999999999999999998766554444432222222 22344578899


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .++|.+||+.||.+||++.+++++
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~il~~  262 (282)
T cd06643         239 KDFLKKCLEKNVDARWTTTQLLQH  262 (282)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcC
Confidence            999999999999999999999876

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=2.8e-37  Score=296.58  Aligned_cols=252  Identities=22%  Similarity=0.444  Sum_probs=209.2

Q ss_pred             ccCcCCccccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          149 EIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       149 ~~~~~~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      ++.....+|++.+.||.|+||.+|     .+|+.|++|.+....   ....+.+.+|+.+++.++||||+++++++....
T Consensus        13 ~~~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~   89 (296)
T cd06655          13 SIGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMKELKNPNIVNFLDSFLVGD   89 (296)
T ss_pred             hcCCCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHHhcCCCceeeeeeeEecCc
Confidence            444555679999999999999887     368899999986542   223456888999999999999999999999999


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ..++|+||+++++|.+++... .+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++...
T Consensus        90 ~~~lv~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~  165 (296)
T cd06655          90 ELFVVMEYLAGGSLTDVVTET-CMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQI  165 (296)
T ss_pred             eEEEEEEecCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhc
Confidence            999999999999999988754 5899999999999999999999999   999999999999999999999999998765


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      ..... ......+++.|+|||.+.+..++.++|+|||||++|+|++|+.||...........+.....+. ...+..+++
T Consensus       166 ~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  243 (296)
T cd06655         166 TPEQS-KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE-LQNPEKLSP  243 (296)
T ss_pred             ccccc-cCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCcc-cCCcccCCH
Confidence            43221 1223457889999999988888999999999999999999999998766544333332222222 223455788


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+.++|.+||..||.+||++.+++++
T Consensus       244 ~~~~li~~~l~~dp~~Rpt~~~il~~  269 (296)
T cd06655         244 IFRDFLNRCLEMDVEKRGSAKELLQH  269 (296)
T ss_pred             HHHHHHHHHhhcChhhCCCHHHHhhC
Confidence            99999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-39  Score=311.36  Aligned_cols=245  Identities=24%  Similarity=0.417  Sum_probs=211.5

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |.+.-.||.|+||.||.     ++..-|-|++.   ......+++|.-|+++|..+.||+|+++++.|..++.+||+.||
T Consensus        34 WeIiGELGDGAFGKVyKA~nket~~lAAaKvIe---tkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEF  110 (1187)
T KOG0579|consen   34 WEIIGELGDGAFGKVYKAVNKETKLLAAAKVIE---TKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEF  110 (1187)
T ss_pred             HHHHhhhcCccchhhhhhhcccchhhhhhhhhc---ccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEee
Confidence            66667899999999984     34456677774   34677889999999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |.||-+..++-+- ..+++.++..+++|++.||.|||+.+   |+|||||.-|||++-+|.++|+|||.+...... ...
T Consensus       111 C~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t-~qk  186 (1187)
T KOG0579|consen  111 CGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST-RQK  186 (1187)
T ss_pred             cCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH-Hhh
Confidence            9999998887764 45999999999999999999999999   999999999999999999999999998654322 223


Q ss_pred             cccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHH
Q 012684          311 LTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL  385 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (458)
                      ...+.|||+|||||+..     ..+|+.++||||||++|.+|..+.+|....++..+...+ .+..|+.-..|..|+..+
T Consensus       187 RDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi-aKSePPTLlqPS~Ws~~F  265 (1187)
T KOG0579|consen  187 RDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI-AKSEPPTLLQPSHWSRSF  265 (1187)
T ss_pred             hccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH-hhcCCCcccCcchhhhHH
Confidence            35678999999999864     458999999999999999999999999988887776666 344555555678899999


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+|+..||.+||..||++.+|++|
T Consensus       266 ~DfLk~cL~Knp~~Rp~aaqll~H  289 (1187)
T KOG0579|consen  266 SDFLKRCLVKNPRNRPPAAQLLKH  289 (1187)
T ss_pred             HHHHHHHHhcCCccCCCHHHHhhC
Confidence            999999999999999999999987

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=4.6e-38  Score=309.78  Aligned_cols=243  Identities=28%  Similarity=0.371  Sum_probs=197.4

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-C-----CcceeeeeEEEeCCc
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-H-----PNVVQFLGAVTQSSP  224 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----p~i~~~~~~~~~~~~  224 (458)
                      +|.+.+.||+|+||.|.     .+++.||||+++..    .....+-..|+.+|..++ |     -|+|+++++|...++
T Consensus       187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H  262 (586)
T KOG0667|consen  187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH  262 (586)
T ss_pred             EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence            78899999999999875     37899999999743    445566677999999996 3     499999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC--CEEEeecCCc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG--NLKVADFGVS  300 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~--~vkl~Dfg~~  300 (458)
                      +|||+|.+ +-+|+++++.+.  .++...+..++.||+.||.+||+.+   |||+||||+|||+...+  .|||+|||++
T Consensus       263 lciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSS  338 (586)
T KOG0667|consen  263 LCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSS  338 (586)
T ss_pred             eeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccc
Confidence            99999999 679999998754  3889999999999999999999999   99999999999998544  6999999999


Q ss_pred             cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-----------
Q 012684          301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-----------  369 (458)
Q Consensus       301 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-----------  369 (458)
                      .+......    .+..+..|+|||++.|.+|+.+.||||||||++||++|.+.|.+.+..+....+...           
T Consensus       339 c~~~q~vy----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~  414 (586)
T KOG0667|consen  339 CFESQRVY----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDT  414 (586)
T ss_pred             cccCCcce----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHh
Confidence            98654322    455677899999999999999999999999999999999888877653222211000           


Q ss_pred             ------------C-------------------------------CC-CCCCC----hhhhHHHHHHHHHHHcccCCCCCC
Q 012684          370 ------------Q-------------------------------RP-PFKAP----AKLYARGLKELIEECWNEKPAKRP  401 (458)
Q Consensus       370 ------------~-------------------------------~~-~~~~~----~~~~~~~l~~li~~~l~~dp~~Rp  401 (458)
                                  +                               .| .....    ...-...+.+||.+||..||.+|+
T Consensus       415 ~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~  494 (586)
T KOG0667|consen  415 AKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERI  494 (586)
T ss_pred             ccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcC
Confidence                        0                               00 00000    001225689999999999999999


Q ss_pred             CHHHHHHHH
Q 012684          402 TFRQIITRL  410 (458)
Q Consensus       402 s~~~ll~~L  410 (458)
                      |+.++++|-
T Consensus       495 tp~qal~Hp  503 (586)
T KOG0667|consen  495 TPAQALNHP  503 (586)
T ss_pred             CHHHHhcCc
Confidence            999999984

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=4.7e-37  Score=288.54  Aligned_cols=246  Identities=27%  Similarity=0.422  Sum_probs=202.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe-CCceEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVT  229 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~  229 (458)
                      +|++.+.||.|++|.++.     +++.||+|.+..... .....+.+.+|+.+++.++|||++++++.+.. +..++++|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence            477889999999998862     578899999965432 33445668889999999999999999998764 44689999


Q ss_pred             EccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          230 EYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       230 e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||+++++|.+++...  ..+++.++..++.|++.+|.+||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~  156 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC  156 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence            999999999998763  35899999999999999999999999   9999999999999999999999999987654322


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                       .......+++.|+|||++.+..++.++|+||||+++++|++|+.||...+.......+.....+   ..+..+++.+.+
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  232 (257)
T cd08223         157 -DMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLP---PMPKDYSPELGE  232 (257)
T ss_pred             -CccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCC---CCccccCHHHHH
Confidence             2223345788999999999888999999999999999999999999866544433333222222   234567889999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++.+||+.||.+||++.+++++
T Consensus       233 li~~~l~~~p~~Rp~~~~~l~~  254 (257)
T cd08223         233 LIATMLSKRPEKRPSVKSILRQ  254 (257)
T ss_pred             HHHHHhccCcccCCCHHHHhcC
Confidence            9999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=5.4e-37  Score=300.76  Aligned_cols=254  Identities=28%  Similarity=0.475  Sum_probs=202.7

Q ss_pred             CccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEe-
Q 012684          154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-  221 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~-  221 (458)
                      ..+|.+.+.||.|+||.||.          +++.||||++....  .......+.+|+.++.++ +||||+++++++.. 
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~   83 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACTKP   83 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence            34788999999999999873          46789999997542  234456788899999999 68999999998865 


Q ss_pred             CCceEEEEEccCCCCHHHHHHhc---------------------------------------------------------
Q 012684          222 SSPMMIVTEYLPKGDLRAFLKRK---------------------------------------------------------  244 (458)
Q Consensus       222 ~~~~~lv~e~~~~~~L~~~l~~~---------------------------------------------------------  244 (458)
                      +...+++|||+++|+|.+++...                                                         
T Consensus        84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  163 (343)
T cd05103          84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  163 (343)
T ss_pred             CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence            45689999999999999998642                                                         


Q ss_pred             ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC-Cccc
Q 012684          245 ----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTC  313 (458)
Q Consensus       245 ----------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~-~~~~  313 (458)
                                ..++...+..++.|+++||+|||+.+   ++||||||+||+++.++.++|+|||++......... ....
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  240 (343)
T cd05103         164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGD  240 (343)
T ss_pred             hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCC
Confidence                      12567788889999999999999999   999999999999999999999999998765322111 1122


Q ss_pred             CCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHHHHHHHHHH
Q 012684          314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEE  391 (458)
Q Consensus       314 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~  391 (458)
                      ..+++.|+|||.+.+..++.++||||||+++|+|++ |..||................ ....   +...++.+.+++..
T Consensus       241 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  317 (343)
T cd05103         241 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLD  317 (343)
T ss_pred             CCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCC---CCCCCHHHHHHHHH
Confidence            334667999999988889999999999999999996 999998765443332222222 2222   23356789999999


Q ss_pred             HcccCCCCCCCHHHHHHHHHHHHh
Q 012684          392 CWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       392 ~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      ||+.||.+|||+.+++++|+.+.+
T Consensus       318 cl~~~p~~Rps~~eil~~l~~~~~  341 (343)
T cd05103         318 CWHGEPSQRPTFSELVEHLGNLLQ  341 (343)
T ss_pred             HccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999998864

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-37  Score=308.96  Aligned_cols=244  Identities=23%  Similarity=0.334  Sum_probs=198.2

Q ss_pred             CccccCceeeccceEEEEEE-------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          154 ELDFTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      ..+|.+.+.||.|+||.||.       .+..||+|.+...        ....+|+.+++.++||||+++++++......|
T Consensus        91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~--------~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~  162 (392)
T PHA03207         91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG--------KTPGREIDILKTISHRAIINLIHAYRWKSTVC  162 (392)
T ss_pred             cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc--------ccHHHHHHHHHhcCCCCccceeeeEeeCCEEE
Confidence            34699999999999999873       3478999988643        13457999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ++||++ +++|.+++...+.+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++......
T Consensus       163 lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~  238 (392)
T PHA03207        163 MVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH  238 (392)
T ss_pred             EEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence            999999 5789999977788999999999999999999999999   999999999999999999999999998765433


Q ss_pred             CCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH----Hhc------------
Q 012684          307 EDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY----AAR------------  369 (458)
Q Consensus       307 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~----~~~------------  369 (458)
                      ... ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.........+    ...            
T Consensus       239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~  318 (392)
T PHA03207        239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGS  318 (392)
T ss_pred             cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccc
Confidence            222 123456899999999999889999999999999999999999999765543211110    000            


Q ss_pred             -------------CCCCCCCC----hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          370 -------------QRPPFKAP----AKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       370 -------------~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                   .++++...    ...++.+++++|.+||..||++|||+.+++.+
T Consensus       319 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~  375 (392)
T PHA03207        319 TNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL  375 (392)
T ss_pred             hhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence                         01111100    12345678999999999999999999999988

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.9e-38  Score=304.26  Aligned_cols=250  Identities=28%  Similarity=0.514  Sum_probs=217.7

Q ss_pred             ccCceeeccceEEEEEE-------cC--eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          157 FTNSVEITKGTFILAFW-------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-------~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      .+..+.||.|.||.||.       .|  -.||||..+.+.  +.+..+.|..|..+|+.++||||++++|+|.++ ..||
T Consensus       391 Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~Wi  467 (974)
T KOG4257|consen  391 ITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWI  467 (974)
T ss_pred             ccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeE
Confidence            34567899999998872       23  468899887653  344578899999999999999999999999864 6899


Q ss_pred             EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      |||+++-|.|..+++.+. .++......++.||+.||.|||+..   ++||||-.+|||+.....|||+|||+++++...
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~  544 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDD  544 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhcccc
Confidence            999999999999998754 4888999999999999999999999   999999999999999999999999999998765


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL  385 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (458)
                      .....+...-+..|||||-++-+.++.++|||.|||++||++. |..||.+-...++...+..+.+.+.   |+++|+.+
T Consensus       545 ~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~---P~nCPp~L  621 (974)
T KOG4257|consen  545 AYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLPC---PPNCPPAL  621 (974)
T ss_pred             chhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCCC---CCCCChHH
Confidence            5444444455778999999999999999999999999999986 9999999888888877767777776   45678999


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          386 KELIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      ..|+.+||..+|.+||.+.++...|..+..
T Consensus       622 YslmskcWayeP~kRPrftei~~~lsdv~q  651 (974)
T KOG4257|consen  622 YSLMSKCWAYEPSKRPRFTEIKAILSDVLQ  651 (974)
T ss_pred             HHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence            999999999999999999999999988765

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-38  Score=279.27  Aligned_cols=246  Identities=25%  Similarity=0.459  Sum_probs=201.4

Q ss_pred             ccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEE
Q 012684          157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +.....||.|+-|.|.     .+|.-.|||.+...  ...+..+++...++++... .+|+||+++++|..+..+++.||
T Consensus        94 l~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   94 LENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             hhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            4455679999888775     36799999999865  4566677888888887766 48999999999999999999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      .| ..-++.++.+ .+++++..+-++...+++||.||.+++  .|+|||+||+|||+|+.|.+||||||++-++...  .
T Consensus       172 lM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS--k  246 (391)
T KOG0983|consen  172 LM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS--K  246 (391)
T ss_pred             HH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecc--c
Confidence            98 4566776665 456898888899999999999998876  3999999999999999999999999999766433  2


Q ss_pred             CcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                      ..+...|-+.|||||.+.-.   .|+.++||||||++++||.||+.||.+.+.+-..........|+.-.....+|+.++
T Consensus       247 AhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~~gFSp~F~  326 (391)
T KOG0983|consen  247 AHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGHMGFSPDFQ  326 (391)
T ss_pred             ccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCcccCcCHHHH
Confidence            33344577889999998643   688899999999999999999999998655433333333455554444556999999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +|+..||++|+.+||.+.+|++|
T Consensus       327 ~fv~~CL~kd~r~RP~Y~~Ll~h  349 (391)
T KOG0983|consen  327 SFVKDCLTKDHRKRPKYNKLLEH  349 (391)
T ss_pred             HHHHHHhhcCcccCcchHHHhcC
Confidence            99999999999999999999987

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=1.7e-37  Score=316.61  Aligned_cols=248  Identities=21%  Similarity=0.249  Sum_probs=191.2

Q ss_pred             cCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC------CCcceeeeeE
Q 012684          150 IDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR------HPNVVQFLGA  218 (458)
Q Consensus       150 ~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~i~~~~~~  218 (458)
                      ++....+|++.+.||+|+||.||.     +++.||||++....    ........|+.+++.+.      |+++++++++
T Consensus       124 ~~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~  199 (467)
T PTZ00284        124 IDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP----KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRY  199 (467)
T ss_pred             cccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch----hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEE
Confidence            334456799999999999999974     57899999996421    12233455666666554      4568899998


Q ss_pred             EEeC-CceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEecCCC------
Q 012684          219 VTQS-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSG------  290 (458)
Q Consensus       219 ~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dikp~Nil~~~~~------  290 (458)
                      +..+ ...|+|||++ |++|.+++.+.+.+++..+..++.|++.||.|||+ .|   |+||||||+|||++.++      
T Consensus       200 ~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~  275 (467)
T PTZ00284        200 FQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPV  275 (467)
T ss_pred             EEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCcccccc
Confidence            8754 5689999998 88999999888889999999999999999999998 58   99999999999998765      


Q ss_pred             ----------CEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 012684          291 ----------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN  360 (458)
Q Consensus       291 ----------~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~  360 (458)
                                .+||+|||.+....    .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..
T Consensus       276 ~~~~~~~~~~~vkl~DfG~~~~~~----~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~  351 (467)
T PTZ00284        276 TNRALPPDPCRVRICDLGGCCDER----HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL  351 (467)
T ss_pred             cccccCCCCceEEECCCCccccCc----cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence                      49999999876432    2233457899999999999999999999999999999999999999876543


Q ss_pred             cHHHHHHhcC-CCC-----------------------CCCCh--------------hhhHHHHHHHHHHHcccCCCCCCC
Q 012684          361 EVPKAYAARQ-RPP-----------------------FKAPA--------------KLYARGLKELIEECWNEKPAKRPT  402 (458)
Q Consensus       361 ~~~~~~~~~~-~~~-----------------------~~~~~--------------~~~~~~l~~li~~~l~~dp~~Rps  402 (458)
                      +....+.... ..+                       ....+              ...++.+.+||..||+.||++|||
T Consensus       352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t  431 (467)
T PTZ00284        352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN  431 (467)
T ss_pred             HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence            3222221110 000                       00000              011356789999999999999999


Q ss_pred             HHHHHHH
Q 012684          403 FRQIITR  409 (458)
Q Consensus       403 ~~~ll~~  409 (458)
                      ++++++|
T Consensus       432 a~e~L~H  438 (467)
T PTZ00284        432 ARQMTTH  438 (467)
T ss_pred             HHHHhcC
Confidence            9999987

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=8.2e-37  Score=291.46  Aligned_cols=254  Identities=26%  Similarity=0.479  Sum_probs=199.5

Q ss_pred             CccccCceeeccceEEEEEE---------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--C
Q 012684          154 ELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--S  222 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~  222 (458)
                      +..|++.+.||+|+||.|+.         ++..||+|.+...   .....+.+.+|+.+++.++||||+++++++..  .
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~   79 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR   79 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCC
Confidence            44677889999999998874         4778999998643   34556778999999999999999999998753  3


Q ss_pred             CceEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          223 SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                      ...++||||+++++|.+++... ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.
T Consensus        80 ~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~  156 (284)
T cd05081          80 RNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTK  156 (284)
T ss_pred             CceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccc
Confidence            4689999999999999999764 45899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCCCC--cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH------------HHHHH
Q 012684          302 LLTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV------------PKAYA  367 (458)
Q Consensus       302 ~~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~------------~~~~~  367 (458)
                      .........  .....++..|+|||.+.+..++.++||||||+++++|++|+.|+........            .....
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (284)
T cd05081         157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLI  236 (284)
T ss_pred             cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHH
Confidence            664322111  1122234569999999888899999999999999999998877653321100            00000


Q ss_pred             -hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          368 -ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       368 -~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                       .............++..+.++|.+||..+|++|||+.++++.|+.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~  283 (284)
T cd05081         237 ELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAI  283 (284)
T ss_pred             HHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhc
Confidence             0000111112345678999999999999999999999999998865

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=7e-37  Score=288.45  Aligned_cols=249  Identities=25%  Similarity=0.458  Sum_probs=205.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||.|+||.++.     ++..|++|.+...... ....+.+..|+.+++.++|+||+++++.+...+..++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence            577889999999998763     6789999999765432 4567789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||+|.||+++.++.++|+|||++..........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~  156 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTM  156 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCCcc
Confidence            9999999999988777899999999999999999999999   9999999999999999999999999987764332211


Q ss_pred             c---ccCCCCCcccCCcccCCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHH
Q 012684          311 L---TCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR  383 (458)
Q Consensus       311 ~---~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  383 (458)
                      .   ....+++.|+|||.+.+..   .+.++||||||++++++++|+.||................ .+.++ ....+++
T Consensus       157 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~  235 (264)
T cd06626         157 GEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAGHKPPIP-DSLQLSP  235 (264)
T ss_pred             cccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcCCCCCCC-cccccCH
Confidence            1   1345688999999998765   7889999999999999999999997654333222222222 22222 2233578


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+.++|.+||+.+|.+||++.+++.+
T Consensus       236 ~~~~li~~~l~~~p~~R~~~~~i~~~  261 (264)
T cd06626         236 EGKDFLDRCLESDPKKRPTASELLQH  261 (264)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhcC
Confidence            89999999999999999999998864

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=1.9e-37  Score=306.63  Aligned_cols=246  Identities=25%  Similarity=0.355  Sum_probs=196.0

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------C
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~------~  223 (458)
                      .+|++.+.||+|+||.|+.     .++.||||.+..... .......+.+|+.+++.++||||+++++++...      .
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~  102 (364)
T cd07875          24 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  102 (364)
T ss_pred             cceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence            4788999999999998863     678999999975432 334456678899999999999999999987543      3


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ..|+||||+. ++|.+.+..  .+++..+..++.|++.||.|||+++   |+||||||+||+++.++.++|+|||++...
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  176 (364)
T cd07875         103 DVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  176 (364)
T ss_pred             eEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence            5799999995 578877754  4788999999999999999999999   999999999999999999999999999765


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-------------
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-------------  370 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-------------  370 (458)
                      ...  .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+....             
T Consensus       177 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (364)
T cd07875         177 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  254 (364)
T ss_pred             CCC--CcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhH
Confidence            322  22234567899999999999899999999999999999999999998765433322221110             


Q ss_pred             --------CCCCC-----------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          371 --------RPPFK-----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       371 --------~~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                              ++.+.                 ......+..++++|.+||+.||.+|||+.+++++
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h  318 (364)
T cd07875         255 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH  318 (364)
T ss_pred             HHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                    11000                 0011124578999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.1e-39  Score=289.28  Aligned_cols=246  Identities=27%  Similarity=0.401  Sum_probs=217.8

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|...+.||+|.||.|..     +|+.||+|++++..+...+.+..-..|-++|+..+||.+..+...|+.++++|+|||
T Consensus       169 dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMe  248 (516)
T KOG0690|consen  169 DFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVME  248 (516)
T ss_pred             hhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEE
Confidence            467778999999998864     789999999999888777777888889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |..||.|.-++.+...+++..+..+...|+.||.|||+++   |++||||.+|.|+|.+|++||+|||+++.--.. ...
T Consensus       249 yanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~-g~t  324 (516)
T KOG0690|consen  249 YANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY-GDT  324 (516)
T ss_pred             EccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhcccc-cce
Confidence            9999999999998888999999999999999999999999   999999999999999999999999999764322 334


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      ....+|||.|+|||++....|+...|.|.+||++|||++|+.||...+.......+...... +   |..++++.+.|+.
T Consensus       325 ~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~k-F---Pr~ls~eAktLLs  400 (516)
T KOG0690|consen  325 TKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLK-F---PRTLSPEAKTLLS  400 (516)
T ss_pred             eccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhcc-C---CccCCHHHHHHHH
Confidence            45678999999999999999999999999999999999999999999988888877544422 2   4568899999999


Q ss_pred             HHcccCCCCCCC-----HHHHHHH
Q 012684          391 ECWNEKPAKRPT-----FRQIITR  409 (458)
Q Consensus       391 ~~l~~dp~~Rps-----~~~ll~~  409 (458)
                      .+|.+||++|..     ++++..+
T Consensus       401 GLL~kdP~kRLGgGpdDakEi~~h  424 (516)
T KOG0690|consen  401 GLLKKDPKKRLGGGPDDAKEIMRH  424 (516)
T ss_pred             HHhhcChHhhcCCCchhHHHHHhh
Confidence            999999999953     5555554

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=7.5e-37  Score=293.04  Aligned_cols=247  Identities=25%  Similarity=0.415  Sum_probs=202.8

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      ..|++.+.||.|+||.||.     ++..|++|.+...   .....+.+.+|+.+++.++||||+++++.+..++..++||
T Consensus        12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   88 (292)
T cd06644          12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMI   88 (292)
T ss_pred             hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEE
Confidence            4688889999999998873     5789999998643   4455677889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      ||+++++|..++.+ ...+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        89 e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-  164 (292)
T cd06644          89 EFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL-  164 (292)
T ss_pred             ecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceeccccc-
Confidence            99999999988765 456899999999999999999999999   9999999999999999999999999886543221 


Q ss_pred             CCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          309 RPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      .......+++.|+|||++.     ...++.++|+|||||++|+|++|..||.............. ...+....+..++.
T Consensus       165 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  243 (292)
T cd06644         165 QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAK-SEPPTLSQPSKWSM  243 (292)
T ss_pred             cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhc-CCCccCCCCcccCH
Confidence            1122345788999999984     33567799999999999999999999987665443333322 22222223446778


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+.++|.+||..||++||++.+++++
T Consensus       244 ~~~~li~~~l~~~p~~Rp~~~~il~~  269 (292)
T cd06644         244 EFRDFLKTALDKHPETRPSAAQLLEH  269 (292)
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            99999999999999999999999876

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.6e-37  Score=294.22  Aligned_cols=247  Identities=26%  Similarity=0.464  Sum_probs=202.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.++.     +|..||+|.+....  .......+.+|+.++++++||||+++++.+..++..++|||
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence            577888999999998863     58999999986432  34445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       231 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      |+++++|..++...   ..+++..+..++.|++.||.|||+ .+   ++|+||||+||+++.++.++|+|||++......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  156 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHN---IIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS  156 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCC---EeeCCCCHHHEEECCCCCEEEeecCCcccccCC
Confidence            99999999988763   368999999999999999999997 47   999999999999999999999999998765322


Q ss_pred             CCCCcccCCCCCcccCCcccCCCC------CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhh
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL  380 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (458)
                         ......+++.|+|||.+.+..      ++.++|+|||||++|+|++|+.||....................+..+..
T Consensus       157 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (286)
T cd06622         157 ---LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSG  233 (286)
T ss_pred             ---ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcc
Confidence               122345778899999985543      47899999999999999999999987655444443322222222233445


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          381 YARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      +++++.++|.+||..+|.+||++.+++.+-
T Consensus       234 ~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~  263 (286)
T cd06622         234 YSDDAQDFVAKCLNKIPNRRPTYAQLLEHP  263 (286)
T ss_pred             cCHHHHHHHHHHcccCcccCCCHHHHhcCh
Confidence            889999999999999999999999999863

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=5.2e-37  Score=290.10  Aligned_cols=251  Identities=26%  Similarity=0.518  Sum_probs=205.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCC---CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      +|+..+.||+|+||.+|.     ++..||+|.+......   .....+.+..|+.++++++||||+++++++.+.+..++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~   80 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL   80 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence            467788999999998873     6889999998754321   12345778999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC-CEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~-~vkl~Dfg~~~~~~~~  306 (458)
                      ||||+++++|.+++.+.+.+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++ .++|+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~  157 (268)
T cd06630          81 FVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARLAAK  157 (268)
T ss_pred             EEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEcccccccccccc
Confidence            9999999999999988888999999999999999999999999   99999999999998776 5999999998766433


Q ss_pred             CCC---CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhH
Q 012684          307 EDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYA  382 (458)
Q Consensus       307 ~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  382 (458)
                      ...   ......++..|+|||.+.+..++.++|+||+|+++++|++|..||...........+.... ....+..+..++
T Consensus       158 ~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (268)
T cd06630         158 GTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLS  237 (268)
T ss_pred             cccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhC
Confidence            111   1123456889999999988888999999999999999999999997655433322221111 112223345678


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.+.+++.+||..+|.+||++.+++++
T Consensus       238 ~~~~~~i~~~l~~~p~~R~~~~~ll~~  264 (268)
T cd06630         238 PGLRDVTLRCLELQPEDRPPSRELLKH  264 (268)
T ss_pred             HHHHHHHHHHcCCCcccCcCHHHHhcC
Confidence            899999999999999999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=6.1e-37  Score=290.91  Aligned_cols=250  Identities=29%  Similarity=0.495  Sum_probs=205.7

Q ss_pred             ccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      .+|+....||.|+||.||.          ....|++|.+...  ......+.+.+|+.++++++||||+++++++.+...
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   82 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKT--KDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEP   82 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCc--cchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCc
Confidence            4577888999999998873          2467999988643  233356678999999999999999999999999899


Q ss_pred             eEEEEEccCCCCHHHHHHhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEe
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA  295 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~  295 (458)
                      .++||||+++++|.+++....         .+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++++
T Consensus        83 ~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~  159 (275)
T cd05046          83 HYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVS  159 (275)
T ss_pred             ceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEc
Confidence            999999999999999998655         6899999999999999999999999   9999999999999999999999


Q ss_pred             ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCC
Q 012684          296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF  374 (458)
Q Consensus       296 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  374 (458)
                      |||++...............++..|+|||.+.+...+.++||||||+++|+|++ |..||.............. +....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~-~~~~~  238 (275)
T cd05046         160 LLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA-GKLEL  238 (275)
T ss_pred             ccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHc-CCcCC
Confidence            999986543322222333445778999999988888899999999999999998 8889987665554444422 22222


Q ss_pred             CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       375 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      . .+..++..+.+++.+||+.+|.+|||+.++++.|.
T Consensus       239 ~-~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~  274 (275)
T cd05046         239 P-VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG  274 (275)
T ss_pred             C-CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence            1 23356789999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=1.3e-37  Score=292.68  Aligned_cols=247  Identities=25%  Similarity=0.366  Sum_probs=206.9

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||.|+||.++.     ++..||+|.+...........+.+.+|+.++++++||||+++++++..+...++|+|
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD   80 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence            477889999999987763     589999999986554454566789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+.|++|.+++.....+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  .
T Consensus        81 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~--~  155 (258)
T cd05578          81 LLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT--L  155 (258)
T ss_pred             CCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc--c
Confidence            9999999999988778999999999999999999999999   9999999999999999999999999987654322  2


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|..||...+........ ..........+..++..+.++|.
T Consensus       156 ~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~  234 (258)
T cd05578         156 TTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR-AKQETADVLYPATWSTEAIDAIN  234 (258)
T ss_pred             ccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH-HHhccccccCcccCcHHHHHHHH
Confidence            23345778899999998888899999999999999999999999987653222211 11111222334557789999999


Q ss_pred             HHcccCCCCCCCH--HHHHH
Q 012684          391 ECWNEKPAKRPTF--RQIIT  408 (458)
Q Consensus       391 ~~l~~dp~~Rps~--~~ll~  408 (458)
                      +||+.||.+||++  +++++
T Consensus       235 ~~l~~~p~~R~~~~~~~l~~  254 (258)
T cd05578         235 KLLERDPQKRLGDNLKDLKN  254 (258)
T ss_pred             HHccCChhHcCCccHHHHhc
Confidence            9999999999999  66554

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=2.1e-37  Score=296.13  Aligned_cols=247  Identities=28%  Similarity=0.426  Sum_probs=191.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC---CCCcceeeeeEEEe-----C
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQ-----S  222 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~i~~~~~~~~~-----~  222 (458)
                      +|++.+.||+|+||.|+.     +|+.||+|.+........ ....+.+|+.+++.+   +||||+++++++..     .
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~-~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~   79 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDG-LPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE   79 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCC-CchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence            477889999999999874     678999999875432221 112344566666555   79999999998864     2


Q ss_pred             CceEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCc
Q 012684          223 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~  300 (458)
                      ...+++||++. ++|.+++...  ..+++..+..++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++
T Consensus        80 ~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~  155 (288)
T cd07863          80 TKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA  155 (288)
T ss_pred             ceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence            45799999996 5899888764  34899999999999999999999999   999999999999999999999999998


Q ss_pred             cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CC-------
Q 012684          301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP-------  372 (458)
Q Consensus       301 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~-------  372 (458)
                      ......  .......+++.|+|||++.+..++.++|||||||++|+|++|+.||...........+.... .+       
T Consensus       156 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (288)
T cd07863         156 RIYSCQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  233 (288)
T ss_pred             ccccCc--ccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcc
Confidence            765422  22233457889999999988889999999999999999999999997765443322221100 00       


Q ss_pred             ---------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 ---------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 ---------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                     ......+.++..+.++|.+||+.||.+|||+.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~h  285 (288)
T cd07863         234 DVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQH  285 (288)
T ss_pred             cccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                           0000113456788999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=6.3e-37  Score=287.48  Aligned_cols=246  Identities=34%  Similarity=0.608  Sum_probs=204.0

Q ss_pred             ccCceeeccceEEEEEE---c------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          157 FTNSVEITKGTFILAFW---R------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~---~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      +++.+.||.|+||.++.   .      +..||+|.+....  .....+.+..|+.+++.++||||+++++++...+..++
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~   78 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI   78 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence            34667899999998763   2      3889999996542  22255678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          228 VTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      +|||+++++|.+++.....  +++..+..++.|++.||++||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        79 i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~  155 (258)
T smart00219       79 VMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYD  155 (258)
T ss_pred             EEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccc
Confidence            9999999999999976544  899999999999999999999999   99999999999999999999999999976654


Q ss_pred             CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      ..........+++.|+|||.+.+..++.++|+||||+++++|++ |..||....................   +..++..
T Consensus       156 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  232 (258)
T smart00219      156 DDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPPE  232 (258)
T ss_pred             ccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHH
Confidence            32222112336788999999988889999999999999999998 8899987665555555433333322   3447889


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      +.+++.+||..||.+|||+.++++.|
T Consensus       233 ~~~~i~~~l~~~p~~Rpt~~~ll~~l  258 (258)
T smart00219      233 IYKLMLQCWAEDPEDRPTFSELVEIL  258 (258)
T ss_pred             HHHHHHHHCcCChhhCcCHHHHHhhC
Confidence            99999999999999999999998764

Phosphotransferases. Tyrosine-specific kinase subfamily.

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=8.5e-38  Score=304.94  Aligned_cols=251  Identities=27%  Similarity=0.460  Sum_probs=218.9

Q ss_pred             cCcCCccccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          150 IDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       150 ~~~~~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      .......|.+...||+|.|+.|.     .+|..||+|.+.+...... ..+.+.+|+++|+.++||||++++.+...+..
T Consensus        51 ~~~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~  129 (596)
T KOG0586|consen   51 DSNSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMKSLNHPNIVKLFSVIETEAT  129 (596)
T ss_pred             ccccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHHhcCCcceeeeeeeeeecce
Confidence            34445568888999999999886     3799999999988765443 44458899999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      +|+||||+.+|.+++++.+.++..+..+..++.|++.|++|||+++   |+|||||++|||++.+..+||+|||++.++.
T Consensus       130 lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~  206 (596)
T KOG0586|consen  130 LYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFD  206 (596)
T ss_pred             eEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeec
Confidence            9999999999999999999999999999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhH
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYA  382 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~  382 (458)
                      .  ........|++.|.|||++.+.++. +..|+||+|+++|.|+.|.+||++.+-.+......... +.++     -++
T Consensus       207 ~--~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp~-----~ms  279 (596)
T KOG0586|consen  207 Y--GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIPF-----YMS  279 (596)
T ss_pred             c--cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeecccc-----eee
Confidence            3  3455667899999999999988664 78999999999999999999999988777666654443 3332     356


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      .++.++|+++|..+|.+|++.+++.++-+
T Consensus       280 ~dce~lLrk~lvl~Pskr~~~dqim~~~W  308 (596)
T KOG0586|consen  280 CDCEDLLRKFLVLNPSKRGPCDQIMKDRW  308 (596)
T ss_pred             chhHHHHHHhhccCccccCCHHHhhhhcc
Confidence            78999999999999999999999998743

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=6.7e-37  Score=288.96  Aligned_cols=249  Identities=29%  Similarity=0.505  Sum_probs=206.9

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||.|+||.++.     ++..+|+|++......  .....+.+|+.+++.++|+||+++++.+......+++||
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           2 DYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQ--TSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             cceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcc--hHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEe
Confidence            578889999999998862     6789999999754332  256778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       231 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ++++++|.+++...   ..+++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~  156 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGG  156 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence            99999999999763   45899999999999999999999999   9999999999999999999999999987664432


Q ss_pred             CC---CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCCh--hhh
Q 012684          308 DR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA--KLY  381 (458)
Q Consensus       308 ~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~--~~~  381 (458)
                      ..   ......++..|+|||.+... .++.++|+||||+++++|++|+.||...+.............+.+....  ..+
T Consensus       157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (267)
T cd06610         157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKY  236 (267)
T ss_pred             cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccc
Confidence            22   11334578899999998776 7888999999999999999999999877665544444333322222222  367


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++.+.+++.+||..||.+||++++++++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~ll~~  264 (267)
T cd06610         237 SKSFRKMISLCLQKDPSKRPTAEELLKH  264 (267)
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence            8899999999999999999999999875

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-37  Score=286.37  Aligned_cols=243  Identities=30%  Similarity=0.534  Sum_probs=199.9

Q ss_pred             eeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCC
Q 012684          161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD  236 (458)
Q Consensus       161 ~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~  236 (458)
                      +.||.|+||.++.    .+..||+|.+.....  ......+.+|+.++++++||||+++++++......++||||+++++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLP--PDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeCCCcEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            3689999987762    389999999876532  2455678899999999999999999999999999999999999999


Q ss_pred             HHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCc-ccC
Q 012684          237 LRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL-TCQ  314 (458)
Q Consensus       237 L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~-~~~  314 (458)
                      |.+++.. ...++......++.+++.+|.|||+++   ++|+||+|+||+++.++.++|+|||++........... ...
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~  155 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK  155 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence            9999865 345888999999999999999999999   99999999999999999999999999876532211111 112


Q ss_pred             CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHc
Q 012684          315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW  393 (458)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  393 (458)
                      ..+..|+|||.+.+..++.++|+||||+++|+|++ |..||...........+.......   .+..++..+.+++.+||
T Consensus       156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l  232 (251)
T cd05041         156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP---APQLCPEEIYRLMLQCW  232 (251)
T ss_pred             cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC---CCccCCHHHHHHHHHHh
Confidence            23567999999988889999999999999999999 899998776655554443322222   23456789999999999


Q ss_pred             ccCCCCCCCHHHHHHHHH
Q 012684          394 NEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       394 ~~dp~~Rps~~~ll~~L~  411 (458)
                      +.+|.+|||+.++++.|+
T Consensus       233 ~~~p~~Rp~~~ell~~l~  250 (251)
T cd05041         233 AYDPENRPSFSEIYNELQ  250 (251)
T ss_pred             ccChhhCcCHHHHHHHhh
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=6e-37  Score=298.58  Aligned_cols=247  Identities=17%  Similarity=0.359  Sum_probs=192.4

Q ss_pred             Cceeeccc--eEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          159 NSVEITKG--TFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       159 ~~~~lg~G--~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      +.+.||+|  +|+.|+.     +|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence            34679999  5666652     689999999976533 334556788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          232 LPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       232 ~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      +++++|.+++...  ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++||+...........
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~  157 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR  157 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence            9999999998653  45899999999999999999999999   999999999999999999999999865433211110


Q ss_pred             ------CcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCC---------
Q 012684          310 ------PLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP---------  372 (458)
Q Consensus       310 ------~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~---------  372 (458)
                            ......++..|+|||++.+  ..++.++|||||||++|+|++|+.||.................+         
T Consensus       158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (327)
T cd08227         158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIP  237 (327)
T ss_pred             ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchh
Confidence                  0112245677999999876  35889999999999999999999999865443322211111000         


Q ss_pred             ---------------------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 ---------------------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 ---------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                                       ........+++.+.+||..||+.||.+|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~  307 (327)
T cd08227         238 AEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNH  307 (327)
T ss_pred             hhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcC
Confidence                                             0000112356789999999999999999999999986

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.6e-37  Score=297.32  Aligned_cols=249  Identities=25%  Similarity=0.407  Sum_probs=205.9

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||.|+||.+|.     ++..||+|.+...........+.+..|+.+++.++||||+++++.+..+...|+|||
T Consensus         2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   81 (316)
T cd05574           2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD   81 (316)
T ss_pred             ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence            577788999999998873     578999999987654444566778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+.+++|.+++...  ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        82 ~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~  158 (316)
T cd05574          82 YCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP  158 (316)
T ss_pred             ecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence            99999999998764  45899999999999999999999999   99999999999999999999999999875432211


Q ss_pred             C----------------------------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 012684          309 R----------------------------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN  360 (458)
Q Consensus       309 ~----------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~  360 (458)
                      .                            ......|+..|+|||.+.+..++.++||||||+++|+|++|+.||...+..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~  238 (316)
T cd05574         159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD  238 (316)
T ss_pred             ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence            0                            111235788899999999888999999999999999999999999877665


Q ss_pred             cHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC----HHHHHHH
Q 012684          361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT----FRQIITR  409 (458)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps----~~~ll~~  409 (458)
                      .....+. .....++. ...++..+.++|.+||..||++|||    +.+++.+
T Consensus       239 ~~~~~~~-~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~  289 (316)
T cd05574         239 ETFSNIL-KKEVTFPG-SPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQH  289 (316)
T ss_pred             HHHHHHh-cCCccCCC-ccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcC
Confidence            4444432 22222221 2226889999999999999999999    7777775

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=4.1e-37  Score=288.85  Aligned_cols=246  Identities=23%  Similarity=0.460  Sum_probs=206.4

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||.|+||.++.     +|..||+|.+..... .......+.+|+.+++.++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence            477889999999998774     688999999875433 23345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+.+++|.+++....  .+++.++..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~  156 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE  156 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence            999999999987643  4788999999999999999999999   99999999999999999999999999876543211


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                       ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||......+....+.....+.   .+..++..+.++
T Consensus       157 -~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  232 (256)
T cd08218         157 -LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPP---VSSHYSYDLRNL  232 (256)
T ss_pred             -hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCC---CcccCCHHHHHH
Confidence             1123457888999999988888999999999999999999999998766555554443333332   244577899999


Q ss_pred             HHHHcccCCCCCCCHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~  409 (458)
                      |.+||+.+|.+||++.+++++
T Consensus       233 i~~~l~~~p~~Rp~~~~vl~~  253 (256)
T cd08218         233 VSQLFKRNPRDRPSVNSILEK  253 (256)
T ss_pred             HHHHhhCChhhCcCHHHHhhC
Confidence            999999999999999999975

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.5e-37  Score=304.67  Aligned_cols=246  Identities=25%  Similarity=0.356  Sum_probs=195.2

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------C
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~------~  223 (458)
                      .+|++.+.||+|+||.|+.     .++.||+|.+..... .......+.+|+.+++.++||||+++++++...      .
T Consensus        17 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   95 (355)
T cd07874          17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQ   95 (355)
T ss_pred             hceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccc
Confidence            4788999999999999873     578999999975432 334456677899999999999999999988643      3


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ..++||||++ ++|.+.+..  .+++..+..++.|++.||.|||+.|   |+||||||+||+++.++.+||+|||++...
T Consensus        96 ~~~lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          96 DVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             eeEEEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcccccC
Confidence            4799999995 577777654  4888999999999999999999999   999999999999999999999999999765


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc--------------
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--------------  369 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------------  369 (458)
                      ...  .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||.+.............              
T Consensus       170 ~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (355)
T cd07874         170 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  247 (355)
T ss_pred             CCc--cccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcH
Confidence            322  2223456789999999999888999999999999999999999999865432211111000              


Q ss_pred             -------CCCCC-----------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          370 -------QRPPF-----------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       370 -------~~~~~-----------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                             ..+..                 .......+..+++||.+||..||.+|||+.+++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h  311 (355)
T cd07874         248 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH  311 (355)
T ss_pred             HHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence                   00000                 00112235678999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-39  Score=290.43  Aligned_cols=244  Identities=27%  Similarity=0.441  Sum_probs=211.2

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      -|.+..+||+|+||.|+     -+|.-+|||.+...     ..++++..|+.++++++.|+||++|+.+.....+|+|||
T Consensus        34 VFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVME  108 (502)
T KOG0574|consen   34 VFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVME  108 (502)
T ss_pred             HHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehh
Confidence            47788899999999886     48999999998743     346788899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||..|++.+++.. +.++++.++..+++.-++||+|||...   -+|||||.-|||++.+|..||+|||.+-.+...- .
T Consensus       109 YCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM-A  184 (502)
T KOG0574|consen  109 YCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM-A  184 (502)
T ss_pred             hcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhH-H
Confidence            9999999999875 456999999999999999999999988   8999999999999999999999999987665331 2


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......|||-|||||++..-.|..++||||||++..||.-|++||.+..+....-.+-....|.+ ..+..+|.++-+|+
T Consensus       185 KRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF-~KPE~WS~~F~DFi  263 (502)
T KOG0574|consen  185 KRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTF-KKPEEWSSEFNDFI  263 (502)
T ss_pred             hhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCC-CChHhhhhHHHHHH
Confidence            23567899999999999888899999999999999999999999998877654333322222222 34677899999999


Q ss_pred             HHHcccCCCCCCCHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.||-++|++|-|+.++++|
T Consensus       264 ~~CLiK~PE~R~TA~~L~~H  283 (502)
T KOG0574|consen  264 RSCLIKKPEERKTALRLCEH  283 (502)
T ss_pred             HHHhcCCHHHHHHHHHHhhh
Confidence            99999999999999999987

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-37  Score=293.15  Aligned_cols=246  Identities=24%  Similarity=0.411  Sum_probs=204.9

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||.|+||.|+.     ++..+|+|.+...   .....+.+..|+.+++.++||||+++++.+..+...++|||
T Consensus         6 ~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           6 IWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             HHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEee
Confidence            588889999999998863     5789999998643   45556778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... .
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~-~  158 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL-Q  158 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhcccc-c
Confidence            99999999998764 46899999999999999999999999   9999999999999999999999999886543221 1


Q ss_pred             CcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      ......+++.|+|||.+.     ...++.++|+||||+++|+|++|+.||...........+.....+.+ ..+..++.+
T Consensus       159 ~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  237 (280)
T cd06611         159 KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPSKWSSS  237 (280)
T ss_pred             ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcccCCHH
Confidence            223345788999999874     33567799999999999999999999987765554444432222222 234567889


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.++|..||..+|.+||++.+++++
T Consensus       238 ~~~li~~~l~~~p~~Rps~~~il~~  262 (280)
T cd06611         238 FNDFLKSCLVKDPDDRPTAAELLKH  262 (280)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhcC
Confidence            9999999999999999999999987

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=5.9e-37  Score=287.61  Aligned_cols=241  Identities=32%  Similarity=0.601  Sum_probs=201.2

Q ss_pred             cccCceeeccceEEEEEE---cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012684          156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~---~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~  232 (458)
                      +|++.+.||+|+||.++.   .+..||+|.+....     ..+.+.+|+.+++.++||||+++++++..+ ..+++|||+
T Consensus         7 ~~~~~~~lg~g~~g~v~~~~~~~~~~~iK~~~~~~-----~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~   80 (254)
T cd05083           7 KLTLGEIIGEGEFGAVLQGEYTGQKVAVKNIKCDV-----TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELM   80 (254)
T ss_pred             HceeeeeeccCCCCceEecccCCCceEEEeecCcc-----hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECC
Confidence            578889999999998874   78899999986432     235688899999999999999999998765 479999999


Q ss_pred             CCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          233 PKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       233 ~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      .+++|.+++....  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......    
T Consensus        81 ~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~----  153 (254)
T cd05083          81 SKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMG----  153 (254)
T ss_pred             CCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceecccc----
Confidence            9999999997643  4788999999999999999999999   999999999999999999999999998754322    


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......+..|+|||.+.+..++.++|+||||+++|+|++ |+.||......+....+.....+.   .+..++..+.+++
T Consensus       154 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li  230 (254)
T cd05083         154 VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRME---PPEGCPADVYVLM  230 (254)
T ss_pred             CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC---CCCcCCHHHHHHH
Confidence            112234567999999988889999999999999999997 999998876655555543332222   2345788999999


Q ss_pred             HHHcccCCCCCCCHHHHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      .+||+.+|++||++++++..|+.
T Consensus       231 ~~~l~~~p~~Rp~~~~l~~~l~~  253 (254)
T cd05083         231 TSCWETEPKKRPSFHKLREKLEK  253 (254)
T ss_pred             HHHcCCChhhCcCHHHHHHHHcc
Confidence            99999999999999999998753

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6e-37  Score=290.88  Aligned_cols=245  Identities=28%  Similarity=0.484  Sum_probs=205.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||.|+||.++.     +++.||+|.+....  .......+.+|+.+++.++||||+++++++..+...++|+|
T Consensus         2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence            577778999999998873     68899999987543  23345668889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+++++|.+++... ++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........ .
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~-~  154 (274)
T cd06609          80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS-K  154 (274)
T ss_pred             eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc-c
Confidence            99999999998865 7899999999999999999999999   99999999999999999999999999987654321 2


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....+++.|+|||.+.+..++.++|+||||+++|+|++|+.||....+......+.....+...  ...++..+.+++.
T Consensus       155 ~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~  232 (274)
T cd06609         155 RNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPFKDFVS  232 (274)
T ss_pred             cccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHHHHHHH
Confidence            23345788899999999888999999999999999999999999876654444333222222221  1227889999999


Q ss_pred             HHcccCCCCCCCHHHHHHH
Q 012684          391 ECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~  409 (458)
                      +||..+|.+|||+++++++
T Consensus       233 ~~l~~~p~~Rpt~~~il~~  251 (274)
T cd06609         233 LCLNKDPKERPSAKELLKH  251 (274)
T ss_pred             HHhhCChhhCcCHHHHhhC
Confidence            9999999999999999986

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=1e-36  Score=288.07  Aligned_cols=249  Identities=28%  Similarity=0.495  Sum_probs=202.4

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCC--CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CCce
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPM  225 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~  225 (458)
                      .+|+..+.||+|+||.+|.     +|..||+|.+......  .......+.+|+.+++.++||||+++++++..  +...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL   81 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence            4688889999999998873     5789999998654322  23445678899999999999999999999875  3568


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      +++|||+++++|.+++...+.+++...+.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        82 ~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~  158 (266)
T cd06651          82 TIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQT  158 (266)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCcccccc
Confidence            899999999999999988778999999999999999999999999   99999999999999999999999999875532


Q ss_pred             CC--CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          306 KE--DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       306 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      ..  ........++..|+|||.+.+..++.++|+||+|+++|+|++|+.||...............  ...+..+..+++
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~--~~~~~~~~~~~~  236 (266)
T cd06651         159 ICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQ--PTNPQLPSHISE  236 (266)
T ss_pred             ccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcC--CCCCCCchhcCH
Confidence            11  11122345788999999998888899999999999999999999999876544433332221  122223455678


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .++.+| .||..+|++||++++++++
T Consensus       237 ~~~~li-~~~~~~p~~Rp~~~eil~h  261 (266)
T cd06651         237 HARDFL-GCIFVEARHRPSAEELLRH  261 (266)
T ss_pred             HHHHHH-HHhcCChhhCcCHHHHhcC
Confidence            889999 6888899999999999875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.2e-36  Score=289.75  Aligned_cols=243  Identities=25%  Similarity=0.421  Sum_probs=197.4

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||+|+||.||.     ++..||+|.+....  .......+.+|+.++++++||||+++++++...+..++|||
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence            466778999999998873     67899999986542  33445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+++++|..+    ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......   .
T Consensus        80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~---~  149 (279)
T cd06619          80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS---I  149 (279)
T ss_pred             cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc---c
Confidence            9999999754    34788889999999999999999999   999999999999999999999999998765322   2


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH----HHHHHh-cCCCCCCCChhhhHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV----PKAYAA-RQRPPFKAPAKLYARGL  385 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~----~~~~~~-~~~~~~~~~~~~~~~~l  385 (458)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||........    ...... ............+++++
T Consensus       150 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (279)
T cd06619         150 AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKF  229 (279)
T ss_pred             ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCCCCCCCcCCHHH
Confidence            2334678899999999988899999999999999999999999975432211    111111 01111111233467889


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      .++|.+||+.+|.+||++.+++++-
T Consensus       230 ~~li~~~l~~~P~~Rp~~~eil~~~  254 (279)
T cd06619         230 VHFITQCMRKQPKERPAPENLMDHP  254 (279)
T ss_pred             HHHHHHHhhCChhhCCCHHHHhcCc
Confidence            9999999999999999999999873

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.3e-36  Score=286.57  Aligned_cols=246  Identities=31%  Similarity=0.558  Sum_probs=195.8

Q ss_pred             eeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE-eCCceEEEEEcc
Q 012684          162 EITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYL  232 (458)
Q Consensus       162 ~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~-~~~~~~lv~e~~  232 (458)
                      .||+|+||.||.        .+..||+|.+...  ......+.+.+|+.+++.++||||+++++++. .++..+++|||+
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           2 VIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             cccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecC
Confidence            589999998872        2357999988532  23445667888999999999999999999775 456689999999


Q ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC---
Q 012684          233 PKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED---  308 (458)
Q Consensus       233 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~---  308 (458)
                      .+++|.+++... ...++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........   
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~  156 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV  156 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCcceee
Confidence            999999999764 34677788889999999999999999   99999999999999999999999999875432111   


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      .......+++.|+|||.+.+..++.++||||||+++|+|++ |.+||......+..........+..   +..+++.+.+
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  233 (262)
T cd05058         157 HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPLYE  233 (262)
T ss_pred             cccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHHHH
Confidence            11122345678999999988889999999999999999999 4667776555444444432222222   3346788999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          388 LIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      ++..||..+|++||++.++++.|+++..
T Consensus       234 li~~cl~~~p~~Rp~~~~il~~l~~~~~  261 (262)
T cd05058         234 VMLSCWHPKPEMRPTFSELVSRIEQIFS  261 (262)
T ss_pred             HHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence            9999999999999999999999998753

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=5.2e-37  Score=291.85  Aligned_cols=242  Identities=26%  Similarity=0.406  Sum_probs=197.3

Q ss_pred             eccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012684          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (458)
Q Consensus       163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L  237 (458)
                      ||+|+||.||.     +|+.||+|.+.............+..|+.++++++||||+++++.+...+..|+||||+++++|
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL   80 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence            68999998873     5889999999754433333445667899999999999999999999999999999999999999


Q ss_pred             HHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCC
Q 012684          238 RAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD  315 (458)
Q Consensus       238 ~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~  315 (458)
                      .+++...+  .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+.....  ........
T Consensus        81 ~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~--~~~~~~~~  155 (277)
T cd05577          81 KYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKG--GKKIKGRA  155 (277)
T ss_pred             HHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhcc--CCcccccc
Confidence            99997755  6899999999999999999999999   99999999999999999999999999876543  22223345


Q ss_pred             CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHccc
Q 012684          316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE  395 (458)
Q Consensus       316 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~  395 (458)
                      ++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+...........+..+++.+.++|.+||+.
T Consensus       156 ~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  235 (277)
T cd05577         156 GTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQK  235 (277)
T ss_pred             CCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccC
Confidence            67889999999888889999999999999999999999987655332222222222112223445788999999999999


Q ss_pred             CCCCCC-----CHHHHHHH
Q 012684          396 KPAKRP-----TFRQIITR  409 (458)
Q Consensus       396 dp~~Rp-----s~~~ll~~  409 (458)
                      ||.+||     ++.+++.+
T Consensus       236 ~p~~R~~~~~~~~~~ll~h  254 (277)
T cd05577         236 DPEKRLGCRGGSADEVREH  254 (277)
T ss_pred             ChhHccCCCcccHHHHHhC
Confidence            999999     66667664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-36  Score=288.60  Aligned_cols=243  Identities=33%  Similarity=0.562  Sum_probs=196.8

Q ss_pred             eeccceEEEEEE-----cC--eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccC
Q 012684          162 EITKGTFILAFW-----RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP  233 (458)
Q Consensus       162 ~lg~G~~~~v~~-----~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~  233 (458)
                      .||+|+||.|+.     +|  ..+++|.+...  ......+.+.+|+.+++++ +||||+++++++...+..+++|||++
T Consensus         2 ~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~   79 (270)
T cd05047           2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAP   79 (270)
T ss_pred             cCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCC
Confidence            589999998863     23  35788888643  2344556788999999999 79999999999999999999999999


Q ss_pred             CCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeec
Q 012684          234 KGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (458)
Q Consensus       234 ~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Df  297 (458)
                      +++|.+++....                .+++.++..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+||
T Consensus        80 ~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~df  156 (270)
T cd05047          80 HGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADF  156 (270)
T ss_pred             CCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCC
Confidence            999999997532                3788899999999999999999999   999999999999999999999999


Q ss_pred             CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCC
Q 012684          298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA  376 (458)
Q Consensus       298 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  376 (458)
                      |++.......  .......+..|+|||.+.+..++.++|+||||+++|+|++ |..||...+..+....+.......   
T Consensus       157 gl~~~~~~~~--~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~---  231 (270)
T cd05047         157 GLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLE---  231 (270)
T ss_pred             CCccccchhh--hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCC---
Confidence            9985322111  1111233567999999988889999999999999999997 999998766555444443222222   


Q ss_pred             ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       377 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      .+...+..+.+++.+|+..||.+|||+.+++..|+++.
T Consensus       232 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~  269 (270)
T cd05047         232 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML  269 (270)
T ss_pred             CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence            22346678999999999999999999999999998874

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=1.3e-36  Score=288.60  Aligned_cols=233  Identities=24%  Similarity=0.428  Sum_probs=187.8

Q ss_pred             eeccceEEEEEEc-----------------------------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcc
Q 012684          162 EITKGTFILAFWR-----------------------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV  212 (458)
Q Consensus       162 ~lg~G~~~~v~~~-----------------------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i  212 (458)
                      .||+|+||.||..                             ...|++|++...   .......+.+|+.+++.++||||
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~~~~l~h~ni   78 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPS---HRDIALAFFETASLMSQVSHIHL   78 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChH---HHHHHHHHHHHHHHHhcCCCCCe
Confidence            5899999988832                             135899998643   23344567889999999999999


Q ss_pred             eeeeeEEEeCCceEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC-
Q 012684          213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-  290 (458)
Q Consensus       213 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~-  290 (458)
                      +++++++..+...++||||+++++|..++.. .+.+++..+..++.|++.||+|||+++   ++||||||+||+++..+ 
T Consensus        79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~  155 (274)
T cd05076          79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGL  155 (274)
T ss_pred             eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCc
Confidence            9999999999999999999999999999865 456899999999999999999999999   99999999999998644 


Q ss_pred             ------CEEEeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHH-cCCCCCCCCCCCcH
Q 012684          291 ------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEV  362 (458)
Q Consensus       291 ------~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~ll-tg~~pf~~~~~~~~  362 (458)
                            .++++|||++......     ....++..|+|||.+.+ ..++.++||||||+++|+++ +|..||......+.
T Consensus       156 ~~~~~~~~kl~d~g~~~~~~~~-----~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~  230 (274)
T cd05076         156 AEGTSPFIKLSDPGVSFTALSR-----EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEK  230 (274)
T ss_pred             ccCccceeeecCCccccccccc-----cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHH
Confidence                  3899999987643211     22346778999998865 46789999999999999985 69999987665544


Q ss_pred             HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      ........  ..   +...++.+.++|.+||+.+|.+|||+.++++.|
T Consensus       231 ~~~~~~~~--~~---~~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L  273 (274)
T cd05076         231 ERFYEKKH--RL---PEPSCKELATLISQCLTYEPTQRPSFRTILRDL  273 (274)
T ss_pred             HHHHHhcc--CC---CCCCChHHHHHHHHHcccChhhCcCHHHHHHhh
Confidence            33322211  11   122346799999999999999999999999887

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=5.5e-37  Score=323.93  Aligned_cols=249  Identities=22%  Similarity=0.369  Sum_probs=198.4

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CCceEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMI  227 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~l  227 (458)
                      .+|.+.+.||.|+||.||.     ++..||+|.+..... .......+..|+.+++.++||||++++++|..  ...+||
T Consensus        13 ~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyI   91 (1021)
T PTZ00266         13 NEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYI   91 (1021)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEE
Confidence            3788999999999999984     578999999875543 33455678899999999999999999998854  356899


Q ss_pred             EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeeeCCCCCCCEEecC-----------
Q 012684          228 VTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP----VPIIHRDLEPSNILRDD-----------  288 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~----~~i~H~Dikp~Nil~~~-----------  288 (458)
                      ||||+++++|.+++..    .+.+++..++.|+.||+.||.|||+.++    .+|+|+||||+|||++.           
T Consensus        92 VMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~  171 (1021)
T PTZ00266         92 LMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQ  171 (1021)
T ss_pred             EEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccccc
Confidence            9999999999999875    3569999999999999999999998431    12999999999999964           


Q ss_pred             ------CCCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 012684          289 ------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN  360 (458)
Q Consensus       289 ------~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~  360 (458)
                            .+.+||+|||++..+...  .......+|+.|+|||++.+  ..++.++|||||||+||+|++|+.||......
T Consensus       172 ~~n~ng~~iVKLsDFGlAr~l~~~--s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~  249 (1021)
T PTZ00266        172 ANNLNGRPIAKIGDFGLSKNIGIE--SMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNF  249 (1021)
T ss_pred             ccccCCCCceEEccCCcccccccc--ccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcH
Confidence                  335899999999765322  12234568999999999854  35788999999999999999999999865443


Q ss_pred             cHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ......... .+.+  ....++..+.+||..||..+|.+||++.+++.+
T Consensus       250 ~qli~~lk~-~p~l--pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h  295 (1021)
T PTZ00266        250 SQLISELKR-GPDL--PIKGKSKELNILIKNLLNLSAKERPSALQCLGY  295 (1021)
T ss_pred             HHHHHHHhc-CCCC--CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhcc
Confidence            222222111 1222  224567899999999999999999999999964

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=1.3e-36  Score=289.13  Aligned_cols=245  Identities=28%  Similarity=0.488  Sum_probs=205.3

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .|+..+.||.|+||.+|.     ++..||+|.+....  .......+.+|+.+++.+.||||+++++++.++...++|||
T Consensus         5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06640           5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIME   82 (277)
T ss_pred             hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEe
Confidence            466778899999998863     57899999987542  23456778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+++++|.+++.. +++++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        83 ~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-~~  157 (277)
T cd06640          83 YLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK  157 (277)
T ss_pred             cCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCc-cc
Confidence            9999999998875 56899999999999999999999999   9999999999999999999999999987654322 12


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....++..|+|||.+.+..++.++|+||||+++|+|++|..||....+......+.....   +.....++..+.++|.
T Consensus       158 ~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~  234 (277)
T cd06640         158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFSKPFKEFID  234 (277)
T ss_pred             cccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhhHHHHHHHH
Confidence            2234567889999999888899999999999999999999999987665544433322212   2234567889999999


Q ss_pred             HHcccCCCCCCCHHHHHHHH
Q 012684          391 ECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~L  410 (458)
                      +||+.+|.+||++.+++.+-
T Consensus       235 ~~l~~~p~~Rp~~~~il~~~  254 (277)
T cd06640         235 ACLNKDPSFRPTAKELLKHK  254 (277)
T ss_pred             HHcccCcccCcCHHHHHhCh
Confidence            99999999999999999884

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=8.1e-37  Score=286.66  Aligned_cols=245  Identities=26%  Similarity=0.457  Sum_probs=204.3

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|+..+.||.|+||.++.     ++..|++|.+...     ...+.+.+|+.+++.++||||+++++.+..+...|+++
T Consensus         3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~-----~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~   77 (256)
T cd06612           3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVE-----EDLQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM   77 (256)
T ss_pred             ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecH-----HHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence            4678888999999997763     4789999998643     12567899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      ||+++++|.+++.. ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        78 e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~  154 (256)
T cd06612          78 EYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA  154 (256)
T ss_pred             ecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc
Confidence            99999999999975 446899999999999999999999999   99999999999999999999999999887654321


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                       ......++..|+|||.+.+..++.++||||||+++++|++|+.||................. .....+..++..+.++
T Consensus       155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  232 (256)
T cd06612         155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPP-PTLSDPEKWSPEFNDF  232 (256)
T ss_pred             -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCC-CCCCchhhcCHHHHHH
Confidence             22334468899999999888899999999999999999999999987655443333222112 2222344577899999


Q ss_pred             HHHHcccCCCCCCCHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~  409 (458)
                      |.+||+.||.+|||+++++.+
T Consensus       233 i~~~l~~~P~~Rps~~~il~~  253 (256)
T cd06612         233 VKKCLVKDPEERPSAIQLLQH  253 (256)
T ss_pred             HHHHHhcChhhCcCHHHHhcC
Confidence            999999999999999999874

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=9.1e-37  Score=286.67  Aligned_cols=242  Identities=30%  Similarity=0.526  Sum_probs=200.3

Q ss_pred             eeccceEEEEEE------cC--eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccC
Q 012684          162 EITKGTFILAFW------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP  233 (458)
Q Consensus       162 ~lg~G~~~~v~~------~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~  233 (458)
                      .||.|++|.||.      .+  ..||+|.+......  ...+.+.+|+.++++++||||+++++.+.. ...+++|||++
T Consensus         2 ~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             cCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecC
Confidence            589999998863      22  36999999865432  566789999999999999999999999988 88999999999


Q ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC--
Q 012684          234 KGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--  309 (458)
Q Consensus       234 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~--  309 (458)
                      +++|.+++....  .+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++..+......  
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  155 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV  155 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence            999999998754  5899999999999999999999999   999999999999999999999999998876432211  


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      ......++..|+|||.+.+..++.++||||||+++|+|++ |+.||...+..+....+..... .. ..+..++..+.++
T Consensus       156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~~-~~~~~~~~~~~~l  233 (257)
T cd05040         156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGE-RL-ERPEACPQDIYNV  233 (257)
T ss_pred             cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCC-cC-CCCccCCHHHHHH
Confidence            1122346778999999988889999999999999999998 9999987666555444432221 11 1234567899999


Q ss_pred             HHHHcccCCCCCCCHHHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      +.+||+.+|++||++.++++.|.
T Consensus       234 i~~~l~~~p~~Rps~~~~~~~l~  256 (257)
T cd05040         234 MLQCWAHNPADRPTFAALREFLP  256 (257)
T ss_pred             HHHHCCCCcccCCCHHHHHHHhc
Confidence            99999999999999999998874

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=6.5e-37  Score=294.22  Aligned_cols=250  Identities=21%  Similarity=0.421  Sum_probs=206.3

Q ss_pred             CcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       151 ~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      .....+|++.+.||.|+||.+|.     +|..||+|.+.....   ...+.+.+|+.+++.++||||+++++++..+...
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~   91 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMRENKNPNIVNYLDSYLVGDEL   91 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEE
Confidence            34456788999999999998873     689999999865432   2345678899999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      ++||||+++++|.+++.+ ..+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        92 ~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~  167 (297)
T cd06656          92 WVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITP  167 (297)
T ss_pred             EEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccC
Confidence            999999999999999865 45888999999999999999999999   99999999999999999999999999876532


Q ss_pred             CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHH
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL  385 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (458)
                      .. .......+++.|+|||.+.+..++.++|+||||+++|++++|+.||.................+. ...+..++..+
T Consensus       168 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  245 (297)
T cd06656         168 EQ-SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPE-LQNPERLSAVF  245 (297)
T ss_pred             Cc-cCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCCC-CCCccccCHHH
Confidence            21 12233457889999999988888999999999999999999999998765533322222222222 22345577889


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+++.+||..||.+||++.+++++
T Consensus       246 ~~li~~~l~~~p~~Rps~~~il~~  269 (297)
T cd06656         246 RDFLNRCLEMDVDRRGSAKELLQH  269 (297)
T ss_pred             HHHHHHHccCChhhCcCHHHHhcC
Confidence            999999999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=2.5e-36  Score=285.14  Aligned_cols=248  Identities=26%  Similarity=0.445  Sum_probs=201.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCC--CCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM  226 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~  226 (458)
                      +|++.+.||+|+||.+|.     +|..||+|.+.....  ......+.+.+|+.+++.+.||||+++++++.+.  ..++
T Consensus         3 ~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   82 (265)
T cd06652           3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLS   82 (265)
T ss_pred             cceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEE
Confidence            577889999999998873     578999998864321  2234567788999999999999999999998763  4678


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ++|||+++++|.+++.+.+.+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~  159 (265)
T cd06652          83 IFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKRLQTI  159 (265)
T ss_pred             EEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccccccc
Confidence            99999999999999988777899999999999999999999999   999999999999999999999999998754321


Q ss_pred             CC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          307 ED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       307 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      ..  .......++..|+|||.+.+..++.++|+||||+++|+|++|+.||.............  ..+..+..+..++..
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~  237 (265)
T cd06652         160 CLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA--TQPTNPVLPPHVSDH  237 (265)
T ss_pred             cccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHh--cCCCCCCCchhhCHH
Confidence            11  11223457889999999988888999999999999999999999998654433333222  122223335567788


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.++|.+|+. +|.+||++++++++
T Consensus       238 ~~~~i~~~l~-~p~~Rp~~~~il~~  261 (265)
T cd06652         238 CRDFLKRIFV-EAKLRPSADELLRH  261 (265)
T ss_pred             HHHHHHHHhc-ChhhCCCHHHHhcC
Confidence            9999999995 89999999999865

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=6.7e-37  Score=294.72  Aligned_cols=247  Identities=23%  Similarity=0.413  Sum_probs=196.7

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||.|+||.||.     ++..||+|.+......  .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus         7 ~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e   84 (301)
T cd07873           7 TYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEE--GAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   84 (301)
T ss_pred             ceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEeccccc--CchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEe
Confidence            588889999999998873     5789999998754322  223356789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |+. ++|.+++... ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....... .
T Consensus        85 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-~  159 (301)
T cd07873          85 YLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPT-K  159 (301)
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCC-C
Confidence            995 5898888764 45889999999999999999999999   9999999999999999999999999987543221 1


Q ss_pred             CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC------------------
Q 012684          310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------------  370 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~------------------  370 (458)
                      ......+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...+..+....+....                  
T Consensus       160 ~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (301)
T cd07873         160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  239 (301)
T ss_pred             cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhcccccc
Confidence            22233568899999988654 57789999999999999999999998765433222211100                  


Q ss_pred             ---CCCC-----CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          371 ---RPPF-----KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       371 ---~~~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                         .+..     ......+++.+++||.+||+.||.+|||+++++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h  286 (301)
T cd07873         240 SYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKH  286 (301)
T ss_pred             ccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence               0000     00113467789999999999999999999999986

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=1.9e-36  Score=286.70  Aligned_cols=244  Identities=27%  Similarity=0.419  Sum_probs=190.9

Q ss_pred             eeccceEEEEEE-------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       162 ~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      .||+|+||.||.       ++..+|+|.+....  .......+.+|+.+++.++||||+++++++.+....++||||+++
T Consensus         2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             cccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            589999998873       23579999987543  233345688899999999999999999999998899999999999


Q ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC-
Q 012684          235 GDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-  308 (458)
Q Consensus       235 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~-  308 (458)
                      ++|.+++....     ..++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........ 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~  156 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYY  156 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCccee
Confidence            99999987532     3556777889999999999999999   99999999999999999999999999865432211 


Q ss_pred             CCcccCCCCCcccCCcccCCC-------CCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCC--CCCh
Q 012684          309 RPLTCQDTSCRYVAPEVFKNE-------EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF--KAPA  378 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~  378 (458)
                      .......++..|+|||++.+.       .++.++|+||||+++|+|++ |+.||......+.............  +...
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05087         157 VTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLK  236 (269)
T ss_pred             ecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccC
Confidence            111233467789999998642       35779999999999999996 9999987665554333322222211  2222


Q ss_pred             hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       379 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      ...++.+.+++..|+ .+|++|||+++|+..|.
T Consensus       237 ~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~  268 (269)
T cd05087         237 LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS  268 (269)
T ss_pred             CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence            346778999999998 68999999999998763

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.3e-36  Score=285.41  Aligned_cols=247  Identities=27%  Similarity=0.462  Sum_probs=205.4

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCC--CCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      +|+..+.||+|+||.+|.     ++..|++|.+.....  ...+..+.+.+|+.+++.++||||+++++++..+...+++
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF   80 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence            466778999999998863     688999999864321  2234567789999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-  156 (258)
T cd06632          81 LELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-  156 (258)
T ss_pred             EEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccccc-
Confidence            999999999999988878999999999999999999999999   9999999999999999999999999987654332 


Q ss_pred             CCcccCCCCCcccCCcccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                       ......+++.|+|||.+.... ++.++|+||||+++|+|++|+.||..............  ....+..+..+++.+.+
T Consensus       157 -~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  233 (258)
T cd06632         157 -FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGR--SKELPPIPDHLSDEAKD  233 (258)
T ss_pred             -cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHh--cccCCCcCCCcCHHHHH
Confidence             223455788999999987766 88999999999999999999999987654333333222  12222334557889999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++.+||..+|.+||++.+++.+
T Consensus       234 li~~~l~~~p~~Rp~~~~~l~~  255 (258)
T cd06632         234 FILKCLQRDPSLRPTAAELLEH  255 (258)
T ss_pred             HHHHHhhcCcccCcCHHHHhcC
Confidence            9999999999999999999864

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=5.5e-39  Score=334.07  Aligned_cols=252  Identities=24%  Similarity=0.397  Sum_probs=214.2

Q ss_pred             CcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       151 ~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      ...+.+|+....||.|.||.||.     +|+--|+|-+...... ......+.+|..++..++|||+|++|++-......
T Consensus      1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv 1309 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKV 1309 (1509)
T ss_pred             ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHH
Confidence            34456788888999999999984     7899999998754332 44556688999999999999999999999998999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      +|.||||+||+|.+++...+..++.-...+..|++.|+.|||++|   |+||||||+||+++.+|.+|++|||.|..+..
T Consensus      1310 ~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~ 1386 (1509)
T KOG4645|consen 1310 YIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKIKN 1386 (1509)
T ss_pred             HHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEecC
Confidence            999999999999999988776777777779999999999999999   99999999999999999999999999987754


Q ss_pred             CC---CCCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCCh
Q 012684          306 KE---DRPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPA  378 (458)
Q Consensus       306 ~~---~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~  378 (458)
                      ..   ........||+.|||||++.+.   ....++|||||||++.||+||+.||...+.+-.......-+ .|++   |
T Consensus      1387 ~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~---P 1463 (1509)
T KOG4645|consen 1387 NAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQI---P 1463 (1509)
T ss_pred             chhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCC---c
Confidence            42   1122566799999999999765   45678999999999999999999999988776665554444 4444   4


Q ss_pred             hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          379 KLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       379 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ..++++-++||..||..||++|.++.||+++
T Consensus      1464 ~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1464 ERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred             hhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence            4489999999999999999999999988876

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.4e-37  Score=292.82  Aligned_cols=248  Identities=24%  Similarity=0.433  Sum_probs=204.1

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.++.     +|..||+|++....  .......+.+|+.+++.++||||+++++++......++||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCM   82 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEE
Confidence            4678889999999998873     48899999886442  2344567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      ||+++++|.+++...+.+++..+..++.+++.+|.|||+ .+   ++|+||+|+||+++.++.++|+|||++......  
T Consensus        83 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~---i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~--  157 (284)
T cd06620          83 EFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHR---IMHRDIKPSNILVNSRGQIKLCDFGVSGELINS--  157 (284)
T ss_pred             ecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcC---eeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence            999999999999888889999999999999999999997 56   999999999999999999999999998654222  


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--------cHHH---HHHhcCCCCCCCC
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--------EVPK---AYAARQRPPFKAP  377 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~--------~~~~---~~~~~~~~~~~~~  377 (458)
                       ......++..|+|||.+.+..++.++|+|||||++|+|++|+.||......        ....   .......+.+  .
T Consensus       158 -~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~  234 (284)
T cd06620         158 -IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRL--P  234 (284)
T ss_pred             -ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCC--C
Confidence             112345788999999998888899999999999999999999999865542        1111   1111111111  1


Q ss_pred             hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012684          378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       378 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      ...++..+.++|.+||..||.+|||+.+++++..-
T Consensus       235 ~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~  269 (284)
T cd06620         235 SSDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPF  269 (284)
T ss_pred             chhcCHHHHHHHHHHhcCCcccCcCHHHHhcCccc
Confidence            22367889999999999999999999999987543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=1.6e-36  Score=287.09  Aligned_cols=243  Identities=26%  Similarity=0.448  Sum_probs=191.8

Q ss_pred             eeccceEEEEEE-------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       162 ~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      +||+|+||.|+.       ....+++|.+...  ........+.+|+..++.++||||+++++.+......++||||+++
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRAS--ATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPL   79 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCcc--CChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCC
Confidence            589999998873       2357888887643  2344456688899999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC-
Q 012684          235 GDLRAFLKRKG-----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-  308 (458)
Q Consensus       235 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~-  308 (458)
                      ++|.+++....     ..++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++........ 
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~  156 (269)
T cd05042          80 GDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYY  156 (269)
T ss_pred             CcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchhe
Confidence            99999997642     2456778899999999999999999   99999999999999999999999999865322211 


Q ss_pred             CCcccCCCCCcccCCcccCC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCC--CCCh
Q 012684          309 RPLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF--KAPA  378 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~--~~~~  378 (458)
                      .......+++.|+|||++..       ..++.++||||||+++|+|++ |..||......+.............  +..+
T Consensus       157 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (269)
T cd05042         157 ITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLD  236 (269)
T ss_pred             eccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCccc
Confidence            11122345677999998643       356789999999999999998 7889987765555444434333222  2234


Q ss_pred             hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          379 KLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       379 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      ..+++.+.+++..|+ .||.+|||++++++.|
T Consensus       237 ~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l  267 (269)
T cd05042         237 LKYSDRWYEVMQFCW-LDPETRPTAEEVHELL  267 (269)
T ss_pred             ccCCHHHHHHHHHHh-cCcccccCHHHHHHHh
Confidence            467888999999998 5999999999999876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-36  Score=287.71  Aligned_cols=252  Identities=26%  Similarity=0.515  Sum_probs=207.4

Q ss_pred             ccccCceeeccceEEEEEE-----cC----eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          155 LDFTNSVEITKGTFILAFW-----RG----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      .+|++.+.||+|+||.++.     +|    ..+|+|.+....  .......+.+|+.+++.++||||+++++++.. ...
T Consensus         7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREET--SPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cce
Confidence            4677888999999998874     23    269999887543  34455678899999999999999999999987 788


Q ss_pred             EEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      ++||||+++++|.+++... ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~  160 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD  160 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence            9999999999999999864 45899999999999999999999999   9999999999999999999999999998654


Q ss_pred             cCCCCCc-ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhH
Q 012684          305 VKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA  382 (458)
Q Consensus       305 ~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (458)
                      ....... ....++..|+|||.+....++.++|+||||+++|++++ |+.||......+....+......+.   +...+
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~  237 (279)
T cd05057         161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ---PPICT  237 (279)
T ss_pred             CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC---CCCCC
Confidence            3221111 11223567999999988888999999999999999998 9999998776665555533322222   23456


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      ..+.+++.+||..||.+||++.++++.|+++..
T Consensus       238 ~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~  270 (279)
T cd05057         238 IDVYMVLVKCWMIDAESRPTFKELINEFSKMAR  270 (279)
T ss_pred             HHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence            789999999999999999999999999998854

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.5e-36  Score=286.19  Aligned_cols=239  Identities=26%  Similarity=0.416  Sum_probs=199.7

Q ss_pred             eccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012684          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (458)
Q Consensus       163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L  237 (458)
                      ||.|+||.++.     ++..||+|.+...........+.+.+|+.+++.++||||+++++.+.++...+++|||+++++|
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL   80 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence            58888887762     4889999999866555555567799999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCCCC
Q 012684          238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS  317 (458)
Q Consensus       238 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt  317 (458)
                      .+++.+...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......  ......++
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~--~~~~~~~~  155 (262)
T cd05572          81 WTILRDRGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ--KTWTFCGT  155 (262)
T ss_pred             HHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc--ccccccCC
Confidence            999988777999999999999999999999999   9999999999999999999999999988764432  12234578


Q ss_pred             CcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--CcHHHHHHh-cCCCCCCCChhhhHHHHHHHHHHHcc
Q 012684          318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWN  394 (458)
Q Consensus       318 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~--~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~  394 (458)
                      +.|+|||.+.+..++.++|+||+|+++|+|++|..||.....  ......+.. .....   .+...++.+.++|.+||+
T Consensus       156 ~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~~l~  232 (262)
T cd05572         156 PEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE---FPNYIDKAAKDLIKQLLR  232 (262)
T ss_pred             cCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC---CCcccCHHHHHHHHHHcc
Confidence            899999999888889999999999999999999999987663  223333221 11222   233347899999999999


Q ss_pred             cCCCCCCC-----HHHHHHH
Q 012684          395 EKPAKRPT-----FRQIITR  409 (458)
Q Consensus       395 ~dp~~Rps-----~~~ll~~  409 (458)
                      .||.+||+     +++++++
T Consensus       233 ~~p~~R~~~~~~~~~~l~~~  252 (262)
T cd05572         233 RNPEERLGNLKGGIKDIKKH  252 (262)
T ss_pred             CChhhCcCCcccCHHHHhcC
Confidence            99999999     7777775

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.6e-36  Score=287.55  Aligned_cols=251  Identities=28%  Similarity=0.483  Sum_probs=201.8

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCC-------CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-------DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      +|...+.||.|+||.||.     +|+.||+|.+......       .....+.+..|+.+++.++||||+++++++....
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~   81 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE   81 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence            577888999999998873     6889999988642211       1122456788999999999999999999999999


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ..++||||+.+++|.+++.+.+.++...+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~~~~  158 (272)
T cd06629          82 YLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGISKKS  158 (272)
T ss_pred             ceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeeccccccc
Confidence            99999999999999999988888999999999999999999999999   999999999999999999999999998754


Q ss_pred             ccCCCC-CcccCCCCCcccCCcccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-CCCCCC-CCh
Q 012684          304 TVKEDR-PLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPPFK-APA  378 (458)
Q Consensus       304 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~-~~~  378 (458)
                      ...... ......++..|+|||.+.+..  ++.++|+||||++++++++|..||......+........ ....++ ...
T Consensus       159 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (272)
T cd06629         159 DDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVS  238 (272)
T ss_pred             cccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccc
Confidence            322111 122345788999999987654  788999999999999999999999754433222222111 122222 223


Q ss_pred             hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          379 KLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       379 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ..++..+.++|..||..+|.+||++.+++.+
T Consensus       239 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  269 (272)
T cd06629         239 MNLSPVALDFLNACFTINPDNRPTARELLQH  269 (272)
T ss_pred             ccCCHHHHHHHHHHhcCChhhCCCHHHHhhC
Confidence            4568899999999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=3.8e-36  Score=284.41  Aligned_cols=247  Identities=28%  Similarity=0.495  Sum_probs=197.0

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .++.....||+|+||.||.     ++..||+|.+...   .....+.+.+|+.+++.++|+||+++++++..++..++|+
T Consensus         8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~   84 (268)
T cd06624           8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM   84 (268)
T ss_pred             ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence            3444556899999998873     4678999988644   3345567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC-CCCEEEeecCCcccccc
Q 012684          230 EYLPKGDLRAFLKRK-GAL--KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTV  305 (458)
Q Consensus       230 e~~~~~~L~~~l~~~-~~~--~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~-~~~vkl~Dfg~~~~~~~  305 (458)
                      ||+++++|.+++... ..+  ++..+..++.|++.||.|||+.+   ++|+||||+||+++. .+.++|+|||++.....
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~  161 (268)
T cd06624          85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG  161 (268)
T ss_pred             ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence            999999999999764 445  77888889999999999999999   999999999999986 67899999999876532


Q ss_pred             CCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      .. .......+++.|+|||.+.+.  .++.++|+||||+++|+|++|+.||............ .......+..+..+++
T Consensus       162 ~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  239 (268)
T cd06624         162 IN-PCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK-VGMFKIHPEIPESLSA  239 (268)
T ss_pred             CC-CccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh-hhhhccCCCCCcccCH
Confidence            21 222334578899999998654  3778999999999999999999999764432222111 1111112223456778


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+.+++.+||+.+|.+|||+.+++.+
T Consensus       240 ~~~~li~~~l~~~p~~Rpt~~~ll~~  265 (268)
T cd06624         240 EAKNFILRCFEPDPDKRASAHDLLQD  265 (268)
T ss_pred             HHHHHHHHHcCCCchhCCCHHHHHhC
Confidence            99999999999999999999999875

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.6e-36  Score=284.40  Aligned_cols=248  Identities=28%  Similarity=0.461  Sum_probs=207.0

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||.|++|.++.     +|..|++|++.....  ......+.+|+..+..++||||+++++++......++|||
T Consensus         2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence            467778999999997763     589999999976532  2456778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |+++++|.+++.....+++...+.++.|+++||.|||+ .+   ++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~  156 (264)
T cd06623          80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQ  156 (264)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCCCc
Confidence            99999999999887889999999999999999999999 99   999999999999999999999999998866433221


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhh-hHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL-YARGLKEL  388 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~l~~l  388 (458)
                       .....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.......................+.. ++..+.++
T Consensus       157 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  235 (264)
T cd06623         157 -CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPSLPAEEFSPEFRDF  235 (264)
T ss_pred             -ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCCCCcccCCHHHHHH
Confidence             1234567889999999988889999999999999999999999987753222222222222222223344 78899999


Q ss_pred             HHHHcccCCCCCCCHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~  409 (458)
                      |..||..+|++||++.+++++
T Consensus       236 i~~~l~~~p~~R~~~~~ll~~  256 (264)
T cd06623         236 ISACLQKDPKKRPSAAELLQH  256 (264)
T ss_pred             HHHHccCChhhCCCHHHHHhC
Confidence            999999999999999999986

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.6e-37  Score=300.78  Aligned_cols=245  Identities=25%  Similarity=0.355  Sum_probs=194.1

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------C
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~------~  223 (458)
                      .+|++.+.||.|+||.|+.     ++..||+|.+..... .......+.+|+.+++.++||||+++++++...      .
T Consensus        15 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   93 (343)
T cd07878          15 ERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFN   93 (343)
T ss_pred             hhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccC
Confidence            4688889999999998873     578999999875432 223345677899999999999999999987533      3


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ..|++|+++ +++|.+++.. +.+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        94 ~~~~~~~~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          94 EVYLVTNLM-GADLNNIVKC-QKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             cEEEEeecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCccceec
Confidence            578999998 8899987754 56999999999999999999999999   999999999999999999999999998765


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-C----------
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R----------  371 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~----------  371 (458)
                      ..    ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||...........+.... .          
T Consensus       169 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (343)
T cd07878         169 DD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKIS  244 (343)
T ss_pred             CC----CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence            32    2234467899999999876 467889999999999999999999998654332222211100 0          


Q ss_pred             -----------CCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 -----------PPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 -----------~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                 +..+     ......++.+.+||.+||..||.+|||+.+++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h  298 (343)
T cd07878         245 SEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH  298 (343)
T ss_pred             hhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                       0000     0012345678899999999999999999999987

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=8.5e-37  Score=291.39  Aligned_cols=248  Identities=27%  Similarity=0.440  Sum_probs=195.2

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||.|++|.|+.     +|..||+|.+..... .......+.+|+.+++.++||||+++++++..+...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence            467788999999998874     588999999875432 22233567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          231 YLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       231 ~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |++ ++|.+++...   ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++...... 
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-  154 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP-  154 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCC-
Confidence            996 6898888652   45899999999999999999999999   999999999999999999999999998754322 


Q ss_pred             CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-C---------------
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-Q---------------  370 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~---------------  370 (458)
                      ........+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||............... .               
T Consensus       155 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (285)
T cd07861         155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPD  234 (285)
T ss_pred             cccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHH
Confidence            1122233467889999988654 4688999999999999999999999865432211111000 0               


Q ss_pred             ---------CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          371 ---------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       371 ---------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                               ..........+++++.++|.+||..||.+|||+.+++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~  282 (285)
T cd07861         235 YKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNH  282 (285)
T ss_pred             HHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcC
Confidence                     000111123467889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.5e-36  Score=294.41  Aligned_cols=241  Identities=23%  Similarity=0.385  Sum_probs=182.5

Q ss_pred             ceeeccceEEEEEE-------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CCceEEEEE
Q 012684          160 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE  230 (458)
Q Consensus       160 ~~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e  230 (458)
                      .++||+|+||.||.       ++..||+|.+.....     ...+.+|+.+++.++||||+++++++..  +...+++||
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD   80 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence            35899999999873       357899999865422     1346789999999999999999999854  456899999


Q ss_pred             ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe----cCCCCEEEeec
Q 012684          231 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADF  297 (458)
Q Consensus       231 ~~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~----~~~~~vkl~Df  297 (458)
                      |+ +++|.+++...         ..+++..+..++.|++.||.|||+.+   |+||||||+|||+    +..+.+||+||
T Consensus        81 ~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07868          81 YA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             cc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeec
Confidence            99 56898887532         24888899999999999999999999   9999999999999    45678999999


Q ss_pred             CCccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc---------HHHH
Q 012684          298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---------VPKA  365 (458)
Q Consensus       298 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~---------~~~~  365 (458)
                      |++........  .......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||.......         ....
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07868         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDR  236 (317)
T ss_pred             CceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHH
Confidence            99976543211  122345679999999998764 57889999999999999999999997543211         0000


Q ss_pred             HHh-cCCCC------------------------CC---------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          366 YAA-RQRPP------------------------FK---------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       366 ~~~-~~~~~------------------------~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.. .+.+.                        ..         ......+..+.++|.+||+.||.+|||+++++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~h  314 (317)
T cd07868         237 IFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQD  314 (317)
T ss_pred             HHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcC
Confidence            000 00000                        00         0000123467899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=2.9e-36  Score=282.86  Aligned_cols=245  Identities=26%  Similarity=0.466  Sum_probs=204.9

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||+|+||.++.     ++..+|+|.+..... .......+.+|+.+++.++||||+++++.+..++..++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence            477889999999998873     688999999976543 33446778899999999999999999999998999999999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC-CEEEeecCCccccccCC
Q 012684          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKE  307 (458)
Q Consensus       231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~-~vkl~Dfg~~~~~~~~~  307 (458)
                      |+++++|.+++...  ..+++..+..++.|++.+|.|||+++   ++|+||+|+||+++.++ .++|+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS  156 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence            99999999999764  34889999999999999999999999   99999999999998654 58999999998664332


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                        ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+..............+.   +..+++.+.+
T Consensus       157 --~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~  231 (256)
T cd08220         157 --KAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPI---SDRYSPDLRQ  231 (256)
T ss_pred             --cccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCCC---CCCcCHHHHH
Confidence              22234578899999999888889999999999999999999999987766555444433322222   3457789999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++..||..+|.+|||+.+++.+
T Consensus       232 li~~~l~~~p~~Rpt~~~ll~~  253 (256)
T cd08220         232 LILSMLNLDPSKRPQLSQIMAQ  253 (256)
T ss_pred             HHHHHccCChhhCCCHHHHhhC
Confidence            9999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=2.5e-36  Score=284.46  Aligned_cols=246  Identities=25%  Similarity=0.458  Sum_probs=204.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CCceEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIV  228 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv  228 (458)
                      +|++.+.||.|+||.+|.     +|..||+|.+..... .....+.+..|+.+++.++||||+++++++..  +...+++
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence            467778999999998873     678999999875543 34555678899999999999999999998764  4567999


Q ss_pred             EEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeeeCCCCCCCEEecCCCCEEEeecCC
Q 012684          229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLH-----ENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH-----~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~  299 (458)
                      |||+++++|.+++..    ...+++..++.++.|++.||.|||     +.+   ++|+||+|+||+++.++.++|+|||+
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~---i~h~dl~p~nili~~~~~~kl~d~g~  156 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNT---VLHRDLKPANIFLDANNNVKLGDFGL  156 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCc---ceecCCCHHHEEEecCCCEEEecccc
Confidence            999999999999875    356899999999999999999999     777   99999999999999999999999999


Q ss_pred             ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChh
Q 012684          300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK  379 (458)
Q Consensus       300 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  379 (458)
                      +........ ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||...........+...   ..+..+.
T Consensus       157 ~~~~~~~~~-~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~~~~~  232 (265)
T cd08217         157 AKILGHDSS-FAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEG---KFRRIPY  232 (265)
T ss_pred             cccccCCcc-cccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcC---CCCCCcc
Confidence            887654321 122345788999999998888899999999999999999999999887644444443222   2223355


Q ss_pred             hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          380 LYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       380 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .++..+.+++.+||+.+|.+||++.+++++
T Consensus       233 ~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~  262 (265)
T cd08217         233 RYSSELNEVIKSMLNVDPDKRPSTEELLQL  262 (265)
T ss_pred             ccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence            678899999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.2e-36  Score=287.89  Aligned_cols=242  Identities=29%  Similarity=0.518  Sum_probs=196.7

Q ss_pred             eeccceEEEEEEc-----------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          162 EITKGTFILAFWR-----------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       162 ~lg~G~~~~v~~~-----------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .||.|+||.||..           +..+|+|.+....  .......+.+|+.+++.++||||+++++++..+...++|||
T Consensus         2 ~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           2 FLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             ccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEe
Confidence            5899999988731           2579999886432  23345678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC-----CEEEeecC
Q 012684          231 YLPKGDLRAFLKRK-------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFG  298 (458)
Q Consensus       231 ~~~~~~L~~~l~~~-------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~-----~vkl~Dfg  298 (458)
                      |+++++|.+++...       ..+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++     .++|+|||
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg  156 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFG  156 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCcc
Confidence            99999999998642       23788899999999999999999999   99999999999999877     89999999


Q ss_pred             CccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCC
Q 012684          299 VSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA  376 (458)
Q Consensus       299 ~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  376 (458)
                      ++......... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||......+....+.......   
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---  233 (269)
T cd05044         157 LARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQ---  233 (269)
T ss_pred             cccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCccC---
Confidence            98755322111 1122234678999999998889999999999999999998 999998766554444432222222   


Q ss_pred             ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       377 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      .+..++..+.++|.+||..+|.+||++.++++.|+
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~  268 (269)
T cd05044         234 KPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQ  268 (269)
T ss_pred             CcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHh
Confidence            23457889999999999999999999999999886

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=3.6e-36  Score=283.73  Aligned_cols=233  Identities=24%  Similarity=0.405  Sum_probs=187.3

Q ss_pred             eeccceEEEEEEc-----------------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          162 EITKGTFILAFWR-----------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       162 ~lg~G~~~~v~~~-----------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      .||+|+||.||..                 ...|++|.+...   .......+.+|+.+++.++||||+++++++..+..
T Consensus         2 ~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~   78 (262)
T cd05077           2 HLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVE   78 (262)
T ss_pred             ccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCC
Confidence            6899999988742                 235899987643   23344567889999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC-------EEEee
Q 012684          225 MMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-------LKVAD  296 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~-------vkl~D  296 (458)
                      .+++|||+++++|..++.. .+.+++..++.++.|+++||+|||+.+   ++||||||+|||++.++.       ++++|
T Consensus        79 ~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d  155 (262)
T cd05077          79 NIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD  155 (262)
T ss_pred             CEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence            9999999999999998875 356899999999999999999999999   999999999999987664       89999


Q ss_pred             cCCccccccCCCCCcccCCCCCcccCCcccC-CCCCCCchhHHHHHHHHHHHH-cCCCCCCCCCCCcHHHHHHhcCCCCC
Q 012684          297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF  374 (458)
Q Consensus       297 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~~ll-tg~~pf~~~~~~~~~~~~~~~~~~~~  374 (458)
                      ||++......     ....++..|+|||.+. +..++.++||||||+++|+|+ +|..||......+..... ...... 
T Consensus       156 ~g~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~~~~~-  228 (262)
T cd05077         156 PGIPITVLSR-----QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-EGQCML-  228 (262)
T ss_pred             CCCCccccCc-----ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-hcCccC-
Confidence            9998654321     2345678899999886 456888999999999999997 588898765544332222 111111 


Q ss_pred             CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       375 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                         ....+..+.+||.+||+.||.+||++.+++.++
T Consensus       229 ---~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~  261 (262)
T cd05077         229 ---VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI  261 (262)
T ss_pred             ---CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence               112356899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=1.4e-36  Score=289.97  Aligned_cols=249  Identities=23%  Similarity=0.391  Sum_probs=199.9

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+....||+|+||.++.     +|+.||+|++..... .....+.+.+|+.++++++||||+++++++......++|||
T Consensus         2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e   80 (286)
T cd07847           2 KYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE   80 (286)
T ss_pred             ceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence            577888999999998874     588999999864432 12223457889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+++++|..++.....+++..+..++.|++.+|.|||+.+   ++|+||||+||+++.++.++|+|||++........ .
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~-~  156 (286)
T cd07847          81 YCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPGD-D  156 (286)
T ss_pred             ccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCcc-c
Confidence            9999888888777677999999999999999999999999   99999999999999999999999999987643321 2


Q ss_pred             cccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-------------------
Q 012684          311 LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-------------------  370 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-------------------  370 (458)
                      .....++..|+|||.+.+ ..++.++|+||||+++++|++|+.||.+....+....+....                   
T Consensus       157 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07847         157 YTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKG  236 (286)
T ss_pred             ccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccccccc
Confidence            233456788999999866 457889999999999999999999998766543322221100                   


Q ss_pred             --CCCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          371 --RPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       371 --~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                        .+...      .....++..+.+||.+||+.+|++||++.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~  283 (286)
T cd07847         237 LSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEH  283 (286)
T ss_pred             ccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcC
Confidence              00000      0012457889999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2.2e-36  Score=288.59  Aligned_cols=249  Identities=27%  Similarity=0.435  Sum_probs=201.0

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||.|+||.++.     +|..||+|.+...... ......+.+|+.++++++||||+++++++..+...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence            477888999999998873     6889999999765322 2334678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |+ +++|.+++.. ...+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.........
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~  155 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEPR  155 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCC
Confidence            99 9999999865 456899999999999999999999999   999999999999999999999999998876543322


Q ss_pred             CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCC--------------
Q 012684          310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP--------------  373 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~--------------  373 (458)
                      ......++..|+|||.+.+. .++.++||||+|+++++|++|.+||................ .+.              
T Consensus       156 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (286)
T cd07832         156 LYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYN  235 (286)
T ss_pred             ccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhh
Confidence            33445678899999998654 46889999999999999999988887655433322221111 000              


Q ss_pred             ---C--------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 ---F--------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ---~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                         +        ....+..+..+.++|.+||..||.+|||+++++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h  282 (286)
T cd07832         236 KITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRH  282 (286)
T ss_pred             cccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence               0        00112356889999999999999999999999876

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.7e-36  Score=285.36  Aligned_cols=241  Identities=26%  Similarity=0.376  Sum_probs=193.8

Q ss_pred             eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHH-hcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      +.||.|+||.+|.     +|+.||+|.+.............+..|..++ ...+|||++++++++..++..++||||+++
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            4689999998874     5789999998754332233333445555444 445899999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccC
Q 012684          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ  314 (458)
Q Consensus       235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~  314 (458)
                      ++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....     ....
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~-----~~~~  153 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE-----NKKF  153 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc-----cccC
Confidence            999999988888999999999999999999999999   99999999999999999999999999875432     1233


Q ss_pred             CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 012684          315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN  394 (458)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  394 (458)
                      .+++.|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+..............+++.+.++|.+||+
T Consensus       154 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  233 (260)
T cd05611         154 VGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLC  233 (260)
T ss_pred             CCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHcc
Confidence            46788999999988888999999999999999999999998776655544443222211122233578899999999999


Q ss_pred             cCCCCCCCHH---HHHHH
Q 012684          395 EKPAKRPTFR---QIITR  409 (458)
Q Consensus       395 ~dp~~Rps~~---~ll~~  409 (458)
                      .+|.+||++.   +++++
T Consensus       234 ~~p~~R~~~~~~~~~l~~  251 (260)
T cd05611         234 MDPAKRLGANGYQEIKSH  251 (260)
T ss_pred             CCHHHccCCCcHHHHHcC
Confidence            9999999765   55444

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.2e-36  Score=289.27  Aligned_cols=244  Identities=29%  Similarity=0.503  Sum_probs=202.8

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .|+..+.||.|+||.||.     ++..||+|.+....  .....+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus         5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (277)
T cd06642           5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIME   82 (277)
T ss_pred             HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEE
Confidence            366677899999998873     57899999987442  23445678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+++++|.+++.. +.+++..+..++.|++.|+.|||+.+   ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        83 ~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~-~~  157 (277)
T cd06642          83 YLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IK  157 (277)
T ss_pred             ccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcc-hh
Confidence            9999999998864 56899999999999999999999999   9999999999999999999999999987654321 11


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....++..|+|||.+.+..++.++|+||||+++++|++|+.||...........+.....+   .....++..+.++|.
T Consensus       158 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~  234 (277)
T cd06642         158 RNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPP---TLEGQYSKPFKEFVE  234 (277)
T ss_pred             hhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCC---CCCcccCHHHHHHHH
Confidence            22335678899999999888899999999999999999999999876555444333222222   223456788999999


Q ss_pred             HHcccCCCCCCCHHHHHHH
Q 012684          391 ECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~  409 (458)
                      +||..+|.+||++.+++.+
T Consensus       235 ~~l~~~p~~Rp~~~~il~~  253 (277)
T cd06642         235 ACLNKDPRFRPTAKELLKH  253 (277)
T ss_pred             HHccCCcccCcCHHHHHHh
Confidence            9999999999999999987

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=2.5e-36  Score=287.47  Aligned_cols=241  Identities=22%  Similarity=0.341  Sum_probs=191.3

Q ss_pred             eeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhc---CCCCcceeeeeEEEeCCceEEEEEccC
Q 012684          162 EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK---IRHPNVVQFLGAVTQSSPMMIVTEYLP  233 (458)
Q Consensus       162 ~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~---l~hp~i~~~~~~~~~~~~~~lv~e~~~  233 (458)
                      .||+|+||.||.     +|+.+|+|.+.............+.+|..+++.   ..||+|+.+++.+..++..++||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            379999998873     578999999876543333323334445444443   479999999999999899999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCccc
Q 012684          234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC  313 (458)
Q Consensus       234 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~  313 (458)
                      +++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......   ....
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~  154 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHA  154 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceecccc---CccC
Confidence            9999999988888999999999999999999999999   999999999999999999999999998754322   1223


Q ss_pred             CCCCCcccCCcccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHH
Q 012684          314 QDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC  392 (458)
Q Consensus       314 ~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~  392 (458)
                      ..+++.|+|||.+. +..++.++|+||+||++|+|++|..||.................. ....+..++.++.++|.+|
T Consensus       155 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~  233 (279)
T cd05633         155 SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTV-NVELPDSFSPELKSLLEGL  233 (279)
T ss_pred             cCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcC-CcCCccccCHHHHHHHHHH
Confidence            45889999999986 456789999999999999999999999865543322211111111 1123455788999999999


Q ss_pred             cccCCCCCC-----CHHHHHHH
Q 012684          393 WNEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       393 l~~dp~~Rp-----s~~~ll~~  409 (458)
                      |..||.+||     |+++++++
T Consensus       234 l~~~p~~R~~~~~~~~~~~~~h  255 (279)
T cd05633         234 LQRDVSKRLGCLGRGAQEVKEH  255 (279)
T ss_pred             hcCCHHHhcCCCCCCHHHHHhC
Confidence            999999999     59988887

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=1.6e-36  Score=287.39  Aligned_cols=247  Identities=26%  Similarity=0.416  Sum_probs=197.9

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC----
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----  222 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~----  222 (458)
                      .+..|+..+.||.|+||.||.     +++.||+|.+....    .....+..|+.+++.+ +||||+++++++...    
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPG   79 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCC
Confidence            445688888999999998873     57899999986442    2234678899999998 799999999998753    


Q ss_pred             --CceEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecC
Q 012684          223 --SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (458)
Q Consensus       223 --~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg  298 (458)
                        ...+++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||
T Consensus        80 ~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg  156 (272)
T cd06637          80 MDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFG  156 (272)
T ss_pred             CCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCC
Confidence              4589999999999999998863  35889999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCCCCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCC
Q 012684          299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP  373 (458)
Q Consensus       299 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~  373 (458)
                      ++....... .......+++.|+|||++.+     ..++.++|+||+||++|+|++|+.||................  .
T Consensus       157 ~~~~~~~~~-~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~  233 (272)
T cd06637         157 VSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--A  233 (272)
T ss_pred             Cceeccccc-ccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--C
Confidence            987653221 12234567889999999863     357789999999999999999999997655433332222211  1


Q ss_pred             CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .......++..+.+||.+||..||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  269 (272)
T cd06637         234 PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKH  269 (272)
T ss_pred             CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhC
Confidence            112234567899999999999999999999999875

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=3.5e-36  Score=286.81  Aligned_cols=254  Identities=25%  Similarity=0.465  Sum_probs=202.0

Q ss_pred             ccccCceeeccceEEEEEE---------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CC
Q 012684          155 LDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SS  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~  223 (458)
                      ..|+..+.||+|+||.|+.         ++..||+|.+.....  ....+.+.+|+.+++.+.||||+++++++..  ..
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~   81 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE--EQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGR   81 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccc--hHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCC
Confidence            4566778999999998873         267899999975532  2356778999999999999999999999877  55


Q ss_pred             ceEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      ..+++|||+++++|.+++.... .+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||.+..
T Consensus        82 ~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~  158 (284)
T cd05038          82 SLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV  158 (284)
T ss_pred             ceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence            7899999999999999997654 5899999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCCCC--cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH-----------HHHHHhc
Q 012684          303 LTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-----------PKAYAAR  369 (458)
Q Consensus       303 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~-----------~~~~~~~  369 (458)
                      ........  .....++..|+|||.+.+..++.++|+||||+++++|++|+.||........           .......
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd05038         159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLEL  238 (284)
T ss_pred             cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHH
Confidence            65222111  1122345579999999888899999999999999999999999875433221           1111000


Q ss_pred             -CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          370 -QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       370 -~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                       ........+..++.++.+++.+||+.+|.+|||+.++++.|+.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i  283 (284)
T cd05038         239 LKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRL  283 (284)
T ss_pred             HHcCCcCCCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhc
Confidence             01111112344668899999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=1.1e-36  Score=291.87  Aligned_cols=244  Identities=23%  Similarity=0.432  Sum_probs=200.4

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |.....||.|+||.++.     ++..||||.+...   .....+.+.+|+.+++.++||||+++++.+..++..++||||
T Consensus        24 ~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~  100 (292)
T cd06658          24 LDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEF  100 (292)
T ss_pred             HhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeC
Confidence            33446799999998873     5789999998643   234456688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCc
Q 012684          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL  311 (458)
Q Consensus       232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~  311 (458)
                      +++++|.+++.. +.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....... ...
T Consensus       101 ~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~-~~~  175 (292)
T cd06658         101 LEGGALTDIVTH-TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV-PKR  175 (292)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhccccc-ccC
Confidence            999999998754 46899999999999999999999999   9999999999999999999999999987543222 122


Q ss_pred             ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHH
Q 012684          312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE  391 (458)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  391 (458)
                      ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.. ..+........++..+.+++..
T Consensus       176 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~  254 (292)
T cd06658         176 KSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRD-NLPPRVKDSHKVSSVLRGFLDL  254 (292)
T ss_pred             ceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cCCCccccccccCHHHHHHHHH
Confidence            234578899999999888899999999999999999999999987655443333322 2222222233467889999999


Q ss_pred             HcccCCCCCCCHHHHHHH
Q 012684          392 CWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       392 ~l~~dp~~Rps~~~ll~~  409 (458)
                      ||..||.+|||+++++++
T Consensus       255 ~l~~~P~~Rpt~~~il~~  272 (292)
T cd06658         255 MLVREPSQRATAQELLQH  272 (292)
T ss_pred             HccCChhHCcCHHHHhhC
Confidence            999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=3.4e-36  Score=287.41  Aligned_cols=250  Identities=27%  Similarity=0.415  Sum_probs=198.2

Q ss_pred             cCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEE-----
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT-----  220 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~-----  220 (458)
                      ....+|++.+.||+|+||.+|.     +++.+|+|.+....    .....+.+|+.+++.+ +||||+++++++.     
T Consensus        15 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~   90 (286)
T cd06638          15 DPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK   90 (286)
T ss_pred             CcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence            3456788999999999998873     67899999876421    1234577899999999 7999999999874     


Q ss_pred             eCCceEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEee
Q 012684          221 QSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (458)
Q Consensus       221 ~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~D  296 (458)
                      .+...++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|
T Consensus        91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~d  167 (286)
T cd06638          91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVD  167 (286)
T ss_pred             CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEcc
Confidence            34568999999999999998753    345888899999999999999999999   99999999999999999999999


Q ss_pred             cCCccccccCCCCCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCC
Q 012684          297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR  371 (458)
Q Consensus       297 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~  371 (458)
                      ||++....... .......+++.|+|||.+..     ..++.++|+||+||++|+|++|+.||............... .
T Consensus       168 fg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~-~  245 (286)
T cd06638         168 FGVSAQLTSTR-LRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRN-P  245 (286)
T ss_pred             CCceeecccCC-CccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhcccc-C
Confidence            99987654321 12233457889999998753     34788999999999999999999999876543332222111 1


Q ss_pred             CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      .+....+..++..+.++|.+||+.||++|||+.++++++
T Consensus       246 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~  284 (286)
T cd06638         246 PPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHV  284 (286)
T ss_pred             CCcccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcc
Confidence            111122344677899999999999999999999999864

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=4.3e-36  Score=286.77  Aligned_cols=245  Identities=24%  Similarity=0.434  Sum_probs=202.3

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .|...+.||.|++|.++.     ++..+++|.+...   .....+.+.+|+.+++.++||||+++++++...+..++++|
T Consensus        20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e   96 (285)
T cd06648          20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVME   96 (285)
T ss_pred             hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEe
Confidence            344557899999998863     5788999988533   23344568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+++++|.+++.. +++++..+..++.|++.||.|||+.+   ++||||+|+||+++.++.++|+|||.+........ .
T Consensus        97 ~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~-~  171 (285)
T cd06648          97 FLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP-R  171 (285)
T ss_pred             ccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc-c
Confidence            9999999999887 67899999999999999999999999   99999999999999999999999998765433211 1


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+........... .++.......++..+.++|.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~  250 (285)
T cd06648         172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDN-LPPKLKNLHKVSPRLRSFLD  250 (285)
T ss_pred             cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhc-CCCCCcccccCCHHHHHHHH
Confidence            22345788999999998888899999999999999999999999876654444443222 22222223346789999999


Q ss_pred             HHcccCCCCCCCHHHHHHH
Q 012684          391 ECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~  409 (458)
                      +||+.+|++||++.+++++
T Consensus       251 ~~l~~~p~~Rpt~~~il~~  269 (285)
T cd06648         251 RMLVRDPAQRATAAELLNH  269 (285)
T ss_pred             HHcccChhhCcCHHHHccC
Confidence            9999999999999999975

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=4e-36  Score=289.62  Aligned_cols=254  Identities=23%  Similarity=0.491  Sum_probs=204.7

Q ss_pred             CccccCceeeccceEEEEEE-----cCe----EEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      ..+|+..+.||+|+||.||.     +|.    .||+|.+....  .......+.+|+.+++.++||||+++++++... .
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~   82 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-T   82 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-C
Confidence            34567778999999998874     343    57999886442  234445688899999999999999999998754 4


Q ss_pred             eEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      .++++||+++|+|.+++.... .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.+||+|||++...
T Consensus        83 ~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~  159 (303)
T cd05110          83 IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLL  159 (303)
T ss_pred             ceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEccccccccc
Confidence            679999999999999987644 5889999999999999999999999   999999999999999999999999999865


Q ss_pred             ccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhh
Q 012684          304 TVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY  381 (458)
Q Consensus       304 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (458)
                      ...... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+................+.   +..+
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~  236 (303)
T cd05110         160 EGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLPQ---PPIC  236 (303)
T ss_pred             cCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCCC---CCCC
Confidence            432211 1122334678999999988889999999999999999997 9999987655444444433323322   3346


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      +..+.+++..|+..+|++||++.++++.|+++...
T Consensus       237 ~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~~  271 (303)
T cd05110         237 TIDVYMVMVKCWMIDADSRPKFKELAAEFSRMARD  271 (303)
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            67899999999999999999999999999987544

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=1.7e-36  Score=286.14  Aligned_cols=246  Identities=28%  Similarity=0.499  Sum_probs=201.4

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||.|+||.++.     +++.+|+|.+....  .......+.+|+.+++.++||||+++++.+..++..++++|
T Consensus         2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence            466778899999998763     58899999987543  23455678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+.+++|.+++... ..+++.....++.|++.||.|||+ .+   ++|+||||+||+++.++.++|+|||.+........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~  156 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA  156 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHHh
Confidence            99999999999875 678999999999999999999999 88   99999999999999999999999999876532211


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC--CcHHHHHHhcCCCCCCCChh-hhHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD--NEVPKAYAARQRPPFKAPAK-LYARGL  385 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~--~~~~~~~~~~~~~~~~~~~~-~~~~~l  385 (458)
                      .   ...++..|+|||.+.+..++.++|+||||+++++|++|+.||.....  ...............+..+. .++..+
T Consensus       157 ~---~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (265)
T cd06605         157 K---TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLPSGKFSPDF  233 (265)
T ss_pred             h---cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCChhhcCHHH
Confidence            1   15578889999999888899999999999999999999999976531  11222221111111111222 278899


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .++|..||..||.+|||+.+++.+
T Consensus       234 ~~li~~~l~~~p~~Rpt~~~ll~~  257 (265)
T cd06605         234 QDFVNLCLIKDPRERPSYKELLEH  257 (265)
T ss_pred             HHHHHHHcCCCchhCcCHHHHhhC
Confidence            999999999999999999999876

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=1e-36  Score=290.77  Aligned_cols=248  Identities=22%  Similarity=0.421  Sum_probs=194.2

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||.|+||.+|.     +|..||+|.+..... .......+.+|+.+++.++||||+++++++.+....++++|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence            477788999999998873     688999999975432 22223457789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |++ ++|.+++.. .+.+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++....... .
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-~  154 (284)
T cd07839          80 YCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPV-R  154 (284)
T ss_pred             cCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCC-C
Confidence            995 588887765 566999999999999999999999999   9999999999999999999999999987653321 2


Q ss_pred             CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-cHHHHHHhc-------------C----
Q 012684          310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAAR-------------Q----  370 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~-~~~~~~~~~-------------~----  370 (458)
                      ......+++.|+|||.+.+. .++.++||||||+++|+|++|..||...... +....+...             .    
T Consensus       155 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07839         155 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDY  234 (284)
T ss_pred             CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccc
Confidence            22334568899999998764 4688999999999999999999886443322 111111000             0    


Q ss_pred             --CCCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          371 --RPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       371 --~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                        .+...      ...+.+++++.++|.+||+.||.+|||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h  281 (284)
T cd07839         235 KPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQH  281 (284)
T ss_pred             cccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcC
Confidence              00000      1113467889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4e-36  Score=284.78  Aligned_cols=248  Identities=27%  Similarity=0.431  Sum_probs=200.2

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCC---
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS---  223 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~---  223 (458)
                      ...+|++.+.||.|+||.++.     +++.+++|++....    ...+.+.+|+.+++++ +||||+++++++....   
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~   79 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIE----DEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPG   79 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCc----hhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCC
Confidence            456789999999999988763     57889999986432    2345688999999999 7999999999997644   


Q ss_pred             ---ceEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEee
Q 012684          224 ---PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (458)
Q Consensus       224 ---~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~D  296 (458)
                         ..++||||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|
T Consensus        80 ~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d  156 (275)
T cd06608          80 NDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVD  156 (275)
T ss_pred             cceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECC
Confidence               48999999999999998865    346899999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccccCCCCCcccCCCCCcccCCcccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCC
Q 012684          297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR  371 (458)
Q Consensus       297 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~  371 (458)
                      ||++....... .......+++.|+|||.+...     .++.++||||||+++|+|++|+.||...........+.....
T Consensus       157 ~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~  235 (275)
T cd06608         157 FGVSAQLDSTL-GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPP  235 (275)
T ss_pred             Cccceecccch-hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCC
Confidence            99987654322 122334578899999987542     467789999999999999999999986655444444322222


Q ss_pred             CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.. ..+..++..+.++|.+||..||.+|||+.+++++
T Consensus       236 ~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~  272 (275)
T cd06608         236 PTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLEH  272 (275)
T ss_pred             CCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            222 2233477899999999999999999999999874

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=3e-36  Score=303.67  Aligned_cols=244  Identities=20%  Similarity=0.274  Sum_probs=192.4

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      ...+|.+.+.||+|+||.||.     .++.||||....         ..+.+|+.++++++||||+++++++..++..++
T Consensus       167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~l  237 (461)
T PHA03211        167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCL  237 (461)
T ss_pred             ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEE
Confidence            355799999999999999884     578899996431         235679999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      |||++ .++|.+++... ..+++.++..++.|++.||.|||++|   |+||||||+|||++.++.++|+|||++......
T Consensus       238 v~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~  313 (461)
T PHA03211        238 VLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGS  313 (461)
T ss_pred             EEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence            99999 56898888764 46999999999999999999999999   999999999999999999999999999765432


Q ss_pred             CCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--------cHHHHHHhcCC--CCCC
Q 012684          307 EDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--------EVPKAYAARQR--PPFK  375 (458)
Q Consensus       307 ~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~--------~~~~~~~~~~~--~~~~  375 (458)
                      .... .....||+.|+|||++.+..++.++|||||||++|+|++|..|+......        .+...+...+.  ..++
T Consensus       314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~  393 (461)
T PHA03211        314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP  393 (461)
T ss_pred             cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence            2111 12346899999999999989999999999999999999987655332211        11111111110  0000


Q ss_pred             C-------------------------Ch---hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          376 A-------------------------PA---KLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       376 ~-------------------------~~---~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .                         .+   ..++..+.+||.+||+.||.+|||+.+++++
T Consensus       394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h  455 (461)
T PHA03211        394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL  455 (461)
T ss_pred             CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence            0                         00   1234578999999999999999999999987

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=3.4e-36  Score=286.94  Aligned_cols=254  Identities=26%  Similarity=0.420  Sum_probs=201.5

Q ss_pred             CCcccCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEE
Q 012684          146 PEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAV  219 (458)
Q Consensus       146 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~  219 (458)
                      +..++......|++.+.||.|+||.+|.     +++.+|+|.+...    ......+..|+.+++++ +||||+++++++
T Consensus         7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~   82 (282)
T cd06636           7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAF   82 (282)
T ss_pred             hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeeh
Confidence            3444445556788899999999998874     6789999998643    23345678899999998 799999999998


Q ss_pred             Ee------CCceEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC
Q 012684          220 TQ------SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (458)
Q Consensus       220 ~~------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~  291 (458)
                      ..      ....+++|||+.+++|.+++...  ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.
T Consensus        83 ~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~  159 (282)
T cd06636          83 IKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAE  159 (282)
T ss_pred             hcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCC
Confidence            53      45789999999999999998753  34788888999999999999999999   999999999999999999


Q ss_pred             EEEeecCCccccccCCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 012684          292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY  366 (458)
Q Consensus       292 vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~  366 (458)
                      ++|+|||++....... .......+++.|+|||.+.     +..++.++|+||||+++|+|++|+.||....+.......
T Consensus       160 ~~l~dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~  238 (282)
T cd06636         160 VKLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLI  238 (282)
T ss_pred             EEEeeCcchhhhhccc-cCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhH
Confidence            9999999987553221 1223345788999999875     345778999999999999999999999765543322222


Q ss_pred             HhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .  ...........++..+.++|.+||..||.+||++.+++++
T Consensus       239 ~--~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~  279 (282)
T cd06636         239 P--RNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKH  279 (282)
T ss_pred             h--hCCCCCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcC
Confidence            1  1122222344578899999999999999999999999864

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=1.6e-36  Score=291.45  Aligned_cols=244  Identities=23%  Similarity=0.419  Sum_probs=200.2

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |.....||.|+||.++.     ++..||+|.+.....   ...+.+.+|+.+++.++||||+++++++..++..+++|||
T Consensus        23 ~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~   99 (297)
T cd06659          23 LENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEF   99 (297)
T ss_pred             HHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEec
Confidence            33445799999998762     588999999864322   2345678899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCc
Q 012684          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL  311 (458)
Q Consensus       232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~  311 (458)
                      +++++|.+++.. ..+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... ...
T Consensus       100 ~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~-~~~  174 (297)
T cd06659         100 LQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PKR  174 (297)
T ss_pred             CCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhccccc-ccc
Confidence            999999997765 56899999999999999999999999   9999999999999999999999999986543221 122


Q ss_pred             ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHH
Q 012684          312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE  391 (458)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  391 (458)
                      ....++..|+|||.+.+..++.++|+||||+++++|++|+.||......+....+. ............++..+.++|..
T Consensus       175 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~~i~~  253 (297)
T cd06659         175 KSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLR-DSPPPKLKNAHKISPVLRDFLER  253 (297)
T ss_pred             cceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHh-ccCCCCccccCCCCHHHHHHHHH
Confidence            33457889999999988889999999999999999999999998765444433332 22222222334567889999999


Q ss_pred             HcccCCCCCCCHHHHHHH
Q 012684          392 CWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       392 ~l~~dp~~Rps~~~ll~~  409 (458)
                      ||+.+|.+||++++++++
T Consensus       254 ~l~~~P~~Rps~~~ll~~  271 (297)
T cd06659         254 MLTREPQERATAQELLDH  271 (297)
T ss_pred             HhcCCcccCcCHHHHhhC
Confidence            999999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=1e-35  Score=281.55  Aligned_cols=243  Identities=25%  Similarity=0.395  Sum_probs=188.1

Q ss_pred             eeccceEEEEEE----cC---eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          162 EITKGTFILAFW----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       162 ~lg~G~~~~v~~----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      +||+|+||.||.    ++   ..+++|.+....  .....+.+.+|+.+++.++||||+++++.+......++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCEL   79 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCC
Confidence            589999998874    22   346677665432  234456788999999999999999999999999999999999999


Q ss_pred             CCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC-C
Q 012684          235 GDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-R  309 (458)
Q Consensus       235 ~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~-~  309 (458)
                      ++|.+++.+.    ...+...+..++.|++.||+|||+.+   ++|+||||+|||++.++.++|+|||++........ .
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~  156 (268)
T cd05086          80 GDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE  156 (268)
T ss_pred             CcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhh
Confidence            9999999753    23566777889999999999999999   99999999999999999999999998754221111 1


Q ss_pred             CcccCCCCCcccCCcccCC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCC--CCCCChh
Q 012684          310 PLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP--PFKAPAK  379 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~  379 (458)
                      ......++..|+|||++.+       ..++.++||||||+++|+|++ |..||......+...........  ..+....
T Consensus       157 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (268)
T cd05086         157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLEL  236 (268)
T ss_pred             cccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCC
Confidence            1123456788999998743       245679999999999999997 57788776655544443333221  1122234


Q ss_pred             hhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          380 LYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       380 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      .+++.+.+++..|+ .+|++||++.++++.|
T Consensus       237 ~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l  266 (268)
T cd05086         237 PYSERWYEVLQFCW-LSPEKRATAEEVHRLL  266 (268)
T ss_pred             CCcHHHHHHHHHHh-hCcccCCCHHHHHHHh
Confidence            47788999999999 6799999999998876

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-37  Score=296.64  Aligned_cols=253  Identities=28%  Similarity=0.466  Sum_probs=212.2

Q ss_pred             cccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      .+.++++||+|.||.+..    .+..||||.++...  .......|..|+++|.+++||||++++++|..++.+|+|+||
T Consensus       539 ~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EY  616 (807)
T KOG1094|consen  539 RLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDA--TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEY  616 (807)
T ss_pred             heehhhhhcCcccceeEEEEecCceEEEEeecCccc--chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHH
Confidence            466788999999998864    45999999998654  344457899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       232 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ++.|+|.+++.+..  ........+|+.||+.|++||.+.+   ++||||.+.|+|+++++++||+|||+++.+-..+..
T Consensus       617 mEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  617 MENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence            99999999998863  3466778889999999999999999   999999999999999999999999999855333222


Q ss_pred             C-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc--CCCCCCCCCCCcHHHHHHhc----CCCCCCCChhhhH
Q 012684          310 P-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCPPFTMKHDNEVPKAYAAR----QRPPFKAPAKLYA  382 (458)
Q Consensus       310 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt--g~~pf~~~~~~~~~~~~~~~----~~~~~~~~~~~~~  382 (458)
                      . .....-+.+|||+|.+.-++++.++|+|+||+++||+++  ...||.....+.+.+..-..    +......-|..++
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp  773 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP  773 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence            2 123345789999999998999999999999999999865  78899988887765554222    2233334466788


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      .++.++|.+||+.+-.+||+++++-..|++.
T Consensus       774 ~~lyelml~Cw~~es~~RPsFe~lh~~lq~~  804 (807)
T KOG1094|consen  774 QGLYELMLRCWRRESEQRPSFEQLHLFLQED  804 (807)
T ss_pred             HHHHHHHHHHhchhhhcCCCHHHHHHHHHHh
Confidence            8999999999999999999999999998764

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=3.9e-36  Score=288.80  Aligned_cols=249  Identities=29%  Similarity=0.460  Sum_probs=198.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCC--CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      +|+..+.||.|+||.+|.     +|+.||+|.+......  .......+..|+.+++.++|+||+++++++..+...++|
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv   80 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV   80 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence            466778899999998873     5789999999765432  122334567899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |||+ +++|.+++.... .+++..+..++.|+++||.|||+++   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~  156 (298)
T cd07841          81 FEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN  156 (298)
T ss_pred             Eccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccCCC
Confidence            9999 899999998766 7999999999999999999999999   9999999999999999999999999998664432


Q ss_pred             CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CC-------------
Q 012684          308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP-------------  372 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~-------------  372 (458)
                       .......+++.|+|||.+.+ ..++.++|+||||+++++|++|..||......+......... .+             
T Consensus       157 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (298)
T cd07841         157 -RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPD  235 (298)
T ss_pred             -ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccc
Confidence             22223345778999998854 457889999999999999999988887665433322221110 00             


Q ss_pred             ----------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 ----------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 ----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                +........+..+.++|.+||+.||++|||+++++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~  282 (298)
T cd07841         236 YVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH  282 (298)
T ss_pred             cccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence                      0000113346789999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=5.9e-36  Score=281.31  Aligned_cols=232  Identities=27%  Similarity=0.491  Sum_probs=188.0

Q ss_pred             eeeccceEEEEEE-----cC----------eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          161 VEITKGTFILAFW-----RG----------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      +.||+|+||.||.     ++          ..+++|.+....    .....+.+|+.+++.++||||+++++++.. ...
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~   75 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMSQLSHKHLVKLYGVCVR-DEN   75 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence            3689999998862     22          247888775432    115678889999999999999999999987 778


Q ss_pred             EEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC-------CEEEeec
Q 012684          226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-------NLKVADF  297 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~-------~vkl~Df  297 (458)
                      ++||||+++++|.+++...+ .++...+..++.|++.||.|||+.+   ++|+||||+||+++.++       .++|+||
T Consensus        76 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Df  152 (259)
T cd05037          76 IMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDP  152 (259)
T ss_pred             EEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCC
Confidence            99999999999999998765 6899999999999999999999999   99999999999999887       7999999


Q ss_pred             CCccccccCCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCC
Q 012684          298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF  374 (458)
Q Consensus       298 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  374 (458)
                      |++.....     .....++..|+|||.+.+.  .++.++|+||||+++++|++ |..||......+...........+.
T Consensus       153 g~a~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~  227 (259)
T cd05037         153 GIPITVLS-----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQHRLPM  227 (259)
T ss_pred             Cccccccc-----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCCCCCC
Confidence            99876533     1223456789999998876  78889999999999999999 6888877764444333322111111


Q ss_pred             CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       375 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      +     ....+.++|.+||..+|.+|||+.++++.|
T Consensus       228 ~-----~~~~~~~li~~~l~~~p~~Rpt~~~il~~l  258 (259)
T cd05037         228 P-----DCAELANLINQCWTYDPTKRPSFRAILRDL  258 (259)
T ss_pred             C-----CchHHHHHHHHHhccChhhCCCHHHHHHhc
Confidence            1     126899999999999999999999999876

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-36  Score=287.86  Aligned_cols=250  Identities=26%  Similarity=0.437  Sum_probs=200.8

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||+|+||.++.     +++.||+|.+..... .....+.+.+|+.+++.++|+||+++++++..++..+++||
T Consensus         2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e   80 (288)
T cd07833           2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE   80 (288)
T ss_pred             ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence            578889999999998764     578999999875432 23344678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |++++.+..+......+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++..........
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~  157 (288)
T cd07833          81 YVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARPASP  157 (288)
T ss_pred             cCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCcccc
Confidence            9988777766666667999999999999999999999999   9999999999999999999999999988765443323


Q ss_pred             cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc--------------------
Q 012684          311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--------------------  369 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------------------  369 (458)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||......+........                    
T Consensus       158 ~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd07833         158 LTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAG  237 (288)
T ss_pred             ccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccc
Confidence            3445678889999999887 7889999999999999999999999865433221111100                    


Q ss_pred             -CCCCCC-------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          370 -QRPPFK-------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       370 -~~~~~~-------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                       ..+...       ..+..++..+.++|++||..+|++||++++++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~  285 (288)
T cd07833         238 VAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQH  285 (288)
T ss_pred             cccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcC
Confidence             000000       0112247889999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.3e-37  Score=277.18  Aligned_cols=244  Identities=23%  Similarity=0.370  Sum_probs=203.0

Q ss_pred             ceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccC
Q 012684          160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP  233 (458)
Q Consensus       160 ~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~  233 (458)
                      .+.||+|+|+.|.     .+|..||||++.+.   +.....++.+|++++.++ .|+||++++++|+++..+|||||.+.
T Consensus        83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~  159 (463)
T KOG0607|consen   83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR  159 (463)
T ss_pred             HHHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence            4579999998774     68999999999765   444567788899999999 69999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC---EEEeecCCccccccCC---
Q 012684          234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTVKE---  307 (458)
Q Consensus       234 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~---vkl~Dfg~~~~~~~~~---  307 (458)
                      ||+|...++++..|++.++.++.++|+.||.+||.+|   |.|||+||+|||-.....   ||||||.+..-+....   
T Consensus       160 GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~s  236 (463)
T KOG0607|consen  160 GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCS  236 (463)
T ss_pred             CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCC
Confidence            9999999999999999999999999999999999999   999999999999886554   8999998875432211   


Q ss_pred             ---CCCcccCCCCCcccCCcccC---C--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-------c--------HHH
Q 012684          308 ---DRPLTCQDTSCRYVAPEVFK---N--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-------E--------VPK  364 (458)
Q Consensus       308 ---~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~-------~--------~~~  364 (458)
                         ........|+..|||||+..   +  ..|+.+.|.|||||++|-|++|.+||.+.-..       +        .+.
T Consensus       237 pastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFe  316 (463)
T KOG0607|consen  237 PASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFE  316 (463)
T ss_pred             CCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHH
Confidence               11224456888999999752   2  36788999999999999999999999764332       1        234


Q ss_pred             HHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+...........+.++|.+.+++|+.+|..|+..|.++.+++.+
T Consensus       317 sIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnh  361 (463)
T KOG0607|consen  317 SIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNH  361 (463)
T ss_pred             HHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCC
Confidence            443333444456788999999999999999999999999999985

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=1.1e-35  Score=284.85  Aligned_cols=253  Identities=26%  Similarity=0.399  Sum_probs=201.4

Q ss_pred             cccCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEe
Q 012684          148 YEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ  221 (458)
Q Consensus       148 ~~~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~  221 (458)
                      .++.....+|++.+.||.|+||.+|.     +++.+|+|.+....    .....+..|+.+++.+ +|||++++++++..
T Consensus        15 ~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~   90 (291)
T cd06639          15 ESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYK   90 (291)
T ss_pred             ccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEe
Confidence            34444567899999999999998873     68899999986432    2235577899999988 89999999999865


Q ss_pred             C-----CceEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCE
Q 012684          222 S-----SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL  292 (458)
Q Consensus       222 ~-----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~v  292 (458)
                      .     ...++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+
T Consensus        91 ~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~  167 (291)
T cd06639          91 ADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGV  167 (291)
T ss_pred             ccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCE
Confidence            3     358999999999999998863    356899999999999999999999999   9999999999999999999


Q ss_pred             EEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 012684          293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA  367 (458)
Q Consensus       293 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~  367 (458)
                      +|+|||++........ ......++..|+|||.+...     .++.++|+|||||++|+|++|+.||...........+.
T Consensus       168 kl~dfg~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~  246 (291)
T cd06639         168 KLVDFGVSAQLTSTRL-RRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIP  246 (291)
T ss_pred             EEeecccchhcccccc-cccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHh
Confidence            9999999876543221 11234578889999987643     25789999999999999999999998765544433332


Q ss_pred             hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ....+.. ..+..++..+.++|.+||+.+|++||++.+++.+
T Consensus       247 ~~~~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~  287 (291)
T cd06639         247 RNPPPTL-LHPEKWCRSFNHFISQCLIKDFEARPSVTHLLEH  287 (291)
T ss_pred             cCCCCCC-CcccccCHHHHHHHHHHhhcChhhCcCHHHHhcC
Confidence            2222222 1233466789999999999999999999999876

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=7.7e-36  Score=288.15  Aligned_cols=246  Identities=26%  Similarity=0.464  Sum_probs=202.2

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      +..|...+.||.|+||.+|.     +|+.||+|.+...........+.+.+|+.+++.++||||+++++++..++..++|
T Consensus        14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv   93 (307)
T cd06607          14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV   93 (307)
T ss_pred             chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence            34588889999999998873     6899999998755444555667788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |||+. |+|.+++.. ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++...... 
T Consensus        94 ~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~-  168 (307)
T cd06607          94 MEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA-  168 (307)
T ss_pred             HHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC-
Confidence            99995 578777754 456899999999999999999999999   999999999999999999999999998754321 


Q ss_pred             CCCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                          ....+++.|+|||.+.   ...++.++||||||+++|+|++|+.||.................+.  .....++..
T Consensus       169 ----~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  242 (307)
T cd06607         169 ----NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPT--LSSNDWSDY  242 (307)
T ss_pred             ----CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCC--CCchhhCHH
Confidence                2345678899999874   3467889999999999999999999998765443333322222222  223457789


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      +.++|.+||+.||.+||++.+++.+.
T Consensus       243 ~~~li~~~l~~~p~~Rp~~~~il~~~  268 (307)
T cd06607         243 FRNFVDSCLQKIPQDRPSSEELLKHR  268 (307)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhcCh
Confidence            99999999999999999999999864

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.3e-37  Score=295.25  Aligned_cols=251  Identities=24%  Similarity=0.363  Sum_probs=201.2

Q ss_pred             ccCcCCccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCC
Q 012684          149 EIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS  223 (458)
Q Consensus       149 ~~~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~  223 (458)
                      -|......|++.+.||+||-..||.    +.+.||+|.+.... .+...+.-|.+|+..|.+| .|.+|+++++|-..++
T Consensus       355 ~i~Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~  433 (677)
T KOG0596|consen  355 IIKVKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDG  433 (677)
T ss_pred             eEEECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCc
Confidence            3455667899999999999988873    44788888876543 3667788899999999999 6999999999999999


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCH-HHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~-~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      .+|||||+- ..+|..+|+......+ ..+..+..|++.|+.++|++|   |||.||||+|+|+-. |.+||+|||+|..
T Consensus       434 ~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~a  508 (677)
T KOG0596|consen  434 YLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANA  508 (677)
T ss_pred             eEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcc
Confidence            999999986 6799999998765443 466778999999999999999   999999999998864 7899999999987


Q ss_pred             cccCCCC-CcccCCCCCcccCCcccCCC-----------CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC
Q 012684          303 LTVKEDR-PLTCQDTSCRYVAPEVFKNE-----------EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ  370 (458)
Q Consensus       303 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~  370 (458)
                      +...... ......||+.||+||.+...           +.++++|||||||+||+|+-|+.||......  ...+....
T Consensus       509 I~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~--~aKl~aI~  586 (677)
T KOG0596|consen  509 IQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQ--IAKLHAIT  586 (677)
T ss_pred             cCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHH--HHHHHhhc
Confidence            7544322 23556899999999998532           3668999999999999999999999865422  22222222


Q ss_pred             CC----CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          371 RP----PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       371 ~~----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .|    +++..++.+  ++.++++.||..||++|||..+||++
T Consensus       587 ~P~~~Iefp~~~~~~--~li~~mK~CL~rdPkkR~si~eLLqh  627 (677)
T KOG0596|consen  587 DPNHEIEFPDIPEND--ELIDVMKCCLARDPKKRWSIPELLQH  627 (677)
T ss_pred             CCCccccccCCCCch--HHHHHHHHHHhcCcccCCCcHHHhcC
Confidence            33    344333332  39999999999999999999999986

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=308.08  Aligned_cols=258  Identities=31%  Similarity=0.544  Sum_probs=225.4

Q ss_pred             ccCcCCccccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE
Q 012684          149 EIDPHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT  220 (458)
Q Consensus       149 ~~~~~~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~  220 (458)
                      ||++.-  ..+.+.||.|.||.|..        +...||||.++...  .+....+|..|..+|-+++||||+++.|+..
T Consensus       625 EId~s~--i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVT  700 (996)
T KOG0196|consen  625 EIDPSC--VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVT  700 (996)
T ss_pred             hcChhh--eEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEe
Confidence            444443  45667899999999873        34789999998653  4666778999999999999999999999999


Q ss_pred             eCCceEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCC
Q 012684          221 QSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (458)
Q Consensus       221 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~  299 (458)
                      ....+.||+|||++|+|+.||.. .+.|+..+...+++.|+.|++||-+.+   ++||||-..|||++.+-..|++|||+
T Consensus       701 ks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGL  777 (996)
T KOG0196|consen  701 KSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGL  777 (996)
T ss_pred             cCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccc
Confidence            99999999999999999999976 467999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCCcccCC--CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCC
Q 012684          300 SKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA  376 (458)
Q Consensus       300 ~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  376 (458)
                      ++.+........+...  -+.+|.|||.+..++++.++|+||+|+++||.++ |..||-+++..++...+...-+.+.  
T Consensus       778 SRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPp--  855 (996)
T KOG0196|consen  778 SRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPP--  855 (996)
T ss_pred             eeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCCC--
Confidence            9987655433333333  3678999999999999999999999999999887 9999999999999999977667665  


Q ss_pred             ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       377 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                       |.++|..+.+|+..||++|..+||.+.+|+..|.++..+
T Consensus       856 -PmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn  894 (996)
T KOG0196|consen  856 -PMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN  894 (996)
T ss_pred             -CCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence             456778999999999999999999999999999987543

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.9e-37  Score=300.72  Aligned_cols=258  Identities=25%  Similarity=0.483  Sum_probs=209.2

Q ss_pred             CCCCcccCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCC-CCCCCHHHHHHHHHHHHHHhcCCCCcceeeee
Q 012684          144 EVPEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGE-EVISDDDRVRAFRDELALLQKIRHPNVVQFLG  217 (458)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~-~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~  217 (458)
                      .....+.++...-......||+|+|-.||.     .|..||=-.++. .....+...+.|..|+.+|+.|+||||+++|+
T Consensus        29 ~~~~ve~~p~gRy~k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~  108 (632)
T KOG0584|consen   29 ESEFVEKDPTGRYLKFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYD  108 (632)
T ss_pred             cccccccCCCCceeehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeee
Confidence            334567777777667778999999998884     455555222211 12245667789999999999999999999999


Q ss_pred             EEEeCCc--eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC-CCCEEE
Q 012684          218 AVTQSSP--MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKV  294 (458)
Q Consensus       218 ~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~-~~~vkl  294 (458)
                      ++.+...  +.+|+|++..|+|..|+++.++++...+..|++||++||.|||++.| ||+|||||.+|||+++ .|.|||
T Consensus       109 SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~P-PIIHRDLKCDNIFinG~~G~VKI  187 (632)
T KOG0584|consen  109 SWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDP-PIIHRDLKCDNIFVNGNLGEVKI  187 (632)
T ss_pred             heecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCC-CccccccccceEEEcCCcCceee
Confidence            9987544  88999999999999999999999999999999999999999999996 7999999999999995 689999


Q ss_pred             eecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-HHHHHHhcCCCC
Q 012684          295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPP  373 (458)
Q Consensus       295 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~-~~~~~~~~~~~~  373 (458)
                      +|+|+|......   ......|||.|||||.+- ..|+...||||||++++||+|+.+||....... +.+.+ ..+..|
T Consensus       188 GDLGLAtl~r~s---~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV-~SGiKP  262 (632)
T KOG0584|consen  188 GDLGLATLLRKS---HAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKV-TSGIKP  262 (632)
T ss_pred             cchhHHHHhhcc---ccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHH-HcCCCH
Confidence            999999876432   233478999999999987 579999999999999999999999999866554 44444 344332


Q ss_pred             CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      -. ...--.+++++||.+||.. ..+|||+.+||++
T Consensus       263 ~s-l~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d  296 (632)
T KOG0584|consen  263 AA-LSKVKDPEVREFIEKCLAT-KSERLSAKELLKD  296 (632)
T ss_pred             HH-hhccCCHHHHHHHHHHhcC-chhccCHHHHhhC
Confidence            11 1112257999999999999 9999999999975

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-36  Score=284.75  Aligned_cols=245  Identities=27%  Similarity=0.505  Sum_probs=200.4

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC---CCcceeeeeEEEeCCceEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~i~~~~~~~~~~~~~~l  227 (458)
                      .|+..+.||.|+||.++.     +|..||+|.+....  .....+.+.+|+.+++.++   |||++++++++..+...++
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l   79 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI   79 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence            366778899999998873     68899999987542  2344567888999999986   9999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||||+++++|.+++.. +.+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 v~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  155 (277)
T cd06917          80 IMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS  155 (277)
T ss_pred             EEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCCc
Confidence            9999999999999866 47899999999999999999999999   9999999999999999999999999987765432


Q ss_pred             CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                       .......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.................+.+  ....++.++.
T Consensus       156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  232 (277)
T cd06917         156 -SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRL--EDNGYSKLLR  232 (277)
T ss_pred             -cccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCCCCC--CcccCCHHHH
Confidence             222334578899999988653 568899999999999999999999987654433322211111111  1223778999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +++.+||+.||.+||++.+++.+
T Consensus       233 ~~i~~~l~~~p~~R~~~~~il~~  255 (277)
T cd06917         233 EFVAACLDEEPKERLSAEELLKS  255 (277)
T ss_pred             HHHHHHcCCCcccCcCHHHHhhC
Confidence            99999999999999999999986

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=5.8e-36  Score=286.55  Aligned_cols=248  Identities=23%  Similarity=0.395  Sum_probs=199.7

Q ss_pred             cccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCC-CHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCce
Q 012684          156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~  225 (458)
                      +|++.+.||.|+||.+|.        +|..||+|++...... .....+.+.+|+.+++++ +||+|+++++.+..+...
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            467788999999998773        6789999998753221 223345678899999999 699999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      ++||||+++++|.+++.....+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~  157 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFHE  157 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCccceeccc
Confidence            999999999999999988888999999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh---cCCCCCCCChhh
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---RQRPPFKAPAKL  380 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~---~~~~~~~~~~~~  380 (458)
                      ..........++..|+|||.+.+.  .++.++|+||||+++|+|++|..||...........+..   ...+++   +..
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~  234 (290)
T cd05613         158 DEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY---PQE  234 (290)
T ss_pred             ccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCC---Ccc
Confidence            322222344578899999998753  467899999999999999999999975433322222211   122222   345


Q ss_pred             hHHHHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012684          381 YARGLKELIEECWNEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~  409 (458)
                      +++.+.+++.+||..||.+||     ++.+++.+
T Consensus       235 ~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~  268 (290)
T cd05613         235 MSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKH  268 (290)
T ss_pred             CCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcC
Confidence            778999999999999999997     66777665

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-37  Score=276.79  Aligned_cols=238  Identities=25%  Similarity=0.366  Sum_probs=199.2

Q ss_pred             eeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEe----CCceEEEEE
Q 012684          161 VEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ----SSPMMIVTE  230 (458)
Q Consensus       161 ~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~----~~~~~lv~e  230 (458)
                      ..||-|--|.|.     .+|+.+|+|++...        ...++|+++--.. .|||||.++++|..    ...+.+|||
T Consensus        68 qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE  139 (400)
T KOG0604|consen   68 QVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVME  139 (400)
T ss_pred             hhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeee
Confidence            368888777553     58999999998632        3456788765545 79999999999853    345789999


Q ss_pred             ccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC---CCEEEeecCCcccccc
Q 012684          231 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTV  305 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~---~~vkl~Dfg~~~~~~~  305 (458)
                      .++||.|...+++++.  |++.++..|++||+.|+.|||+.+   |.||||||+|+|+...   ..+||+|||+++....
T Consensus       140 ~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~  216 (400)
T KOG0604|consen  140 CMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQE  216 (400)
T ss_pred             cccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEecccccccccCC
Confidence            9999999999998765  999999999999999999999999   9999999999999854   4699999999987543


Q ss_pred             CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC----cHHHHHHhcCCCCCCCChhhh
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN----EVPKAYAARQRPPFKAPAKLY  381 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~----~~~~~~~~~~~~~~~~~~~~~  381 (458)
                        .........||.|.|||++....|+...|+||+||++|-|++|.+||......    .+...+...+.....+.+..+
T Consensus       217 --~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~V  294 (400)
T KOG0604|consen  217 --PGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSCV  294 (400)
T ss_pred             --CccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhHH
Confidence              23344556799999999999999999999999999999999999999876543    345566555555555678899


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      |+..+++|+.+|..+|.+|.|+.+++++-+
T Consensus       295 Se~aKdlIR~LLkt~PteRlTI~~~m~hpw  324 (400)
T KOG0604|consen  295 SEAAKDLIRKLLKTEPTERLTIEEVMDHPW  324 (400)
T ss_pred             HHHHHHHHHHHhcCCchhheeHHHhhcCch
Confidence            999999999999999999999999999743

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=9.9e-36  Score=282.19  Aligned_cols=250  Identities=29%  Similarity=0.476  Sum_probs=200.1

Q ss_pred             ccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-----
Q 012684          157 FTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----  223 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-----  223 (458)
                      |.+.+.||+|+||.|+.        ++..||||++..... .....+.+.+|+.+++.++||||+++++++....     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence            45667899999998762        368899999976543 3344667889999999999999999999886432     


Q ss_pred             -ceEEEEEccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEee
Q 012684          224 -PMMIVTEYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (458)
Q Consensus       224 -~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~D  296 (458)
                       ..+++++|+.+++|.+++...      ..++...+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~d  156 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVAD  156 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECc
Confidence             247889999999999887532      24788889999999999999999999   99999999999999999999999


Q ss_pred             cCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCC
Q 012684          297 FGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF  374 (458)
Q Consensus       297 fg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  374 (458)
                      ||++......... ......+++.|++||.+.+..++.++||||||+++|+|++ |+.||......+....+........
T Consensus       157 fg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~  236 (273)
T cd05074         157 FGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ  236 (273)
T ss_pred             ccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence            9998765332211 1122345678999999988888999999999999999999 8999987665554444433322221


Q ss_pred             CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       375 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                         +..+++.+.+++.+||..+|.+|||+.+++..|+.+
T Consensus       237 ---~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~  272 (273)
T cd05074         237 ---PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI  272 (273)
T ss_pred             ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence               234678999999999999999999999999999865

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=4.6e-36  Score=295.66  Aligned_cols=241  Identities=23%  Similarity=0.326  Sum_probs=188.1

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|++.+.||+|+||.||.     ++..||+|.....         ....|+.+++.++||||+++++++......++|
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  135 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMV  135 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEE
Confidence            44699999999999999874     5678999986432         234589999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||++ .++|.+++.. ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++...... 
T Consensus       136 ~e~~-~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-  210 (357)
T PHA03209        136 LPHY-SSDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-  210 (357)
T ss_pred             EEcc-CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence            9999 5688888865 456899999999999999999999999   999999999999999999999999998753221 


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCC-CCCCCCc----------HHHHHHhcCC-C-CC
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF-TMKHDNE----------VPKAYAARQR-P-PF  374 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf-~~~~~~~----------~~~~~~~~~~-~-~~  374 (458)
                       .......||+.|+|||++.+..++.++|||||||++|+|+++..|+ .......          ....+...+. + .+
T Consensus       211 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~  289 (357)
T PHA03209        211 -PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEF  289 (357)
T ss_pred             -cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhc
Confidence             1223346899999999999989999999999999999999865544 3322110          0000000000 0 00


Q ss_pred             C-----------------------C----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          375 K-----------------------A----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       375 ~-----------------------~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +                       .    ....++..+.++|.+||+.||.+|||+.++++|
T Consensus       290 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~h  351 (357)
T PHA03209        290 PRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNY  351 (357)
T ss_pred             CCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcC
Confidence            0                       0    011345567789999999999999999999987

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=8.9e-36  Score=284.68  Aligned_cols=250  Identities=24%  Similarity=0.473  Sum_probs=208.0

Q ss_pred             CcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       151 ~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      ......|+....||.|+||.++.     ++..|++|.+.....    ..+.+.+|+.+++.++|+||+++++++......
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~   90 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDEL   90 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEE
Confidence            34455688888999999987763     588999999975422    456788899999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      ++++||+++++|.+++.... .++...+..++.|++.||.|||+.|   ++|+||+|+||+++.++.++|+|||++....
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~  167 (286)
T cd06614          91 WVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLT  167 (286)
T ss_pred             EEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhc
Confidence            99999999999999998876 7999999999999999999999999   9999999999999999999999999887554


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      .... ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||...........+.....+.. .....++..
T Consensus       168 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  245 (286)
T cd06614         168 KEKS-KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPL-KNPEKWSPE  245 (286)
T ss_pred             cchh-hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC-cchhhCCHH
Confidence            3221 22233467889999999888889999999999999999999999987655444443333223222 223447889


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.++|.+||+.+|.+||++.+++.+
T Consensus       246 l~~li~~~l~~~p~~Rpt~~~il~~  270 (286)
T cd06614         246 FKDFLNKCLVKDPEKRPSAEELLQH  270 (286)
T ss_pred             HHHHHHHHhccChhhCcCHHHHhhC
Confidence            9999999999999999999999875

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=1.3e-35  Score=282.19  Aligned_cols=243  Identities=30%  Similarity=0.529  Sum_probs=202.8

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |+..+.||.|+||.||.     ++..||+|.+....  .......+.+|+.+++.++||||+++++++..+...++||||
T Consensus         6 ~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   83 (277)
T cd06641           6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEY   83 (277)
T ss_pred             hhhheeEeecCCeEEEEEEECCCCcEEEEEEecccc--chHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEe
Confidence            56778899999998873     57899999986432  234456788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCc
Q 012684          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL  311 (458)
Q Consensus       232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~  311 (458)
                      +++++|.+++.. +.+++..+..++.|++.++.+||+.+   ++|+||+|.||+++.++.++|+|||++....... ...
T Consensus        84 ~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~-~~~  158 (277)
T cd06641          84 LGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKR  158 (277)
T ss_pred             CCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccch-hhh
Confidence            999999998865 46899999999999999999999999   9999999999999999999999999987654321 112


Q ss_pred             ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHH
Q 012684          312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE  391 (458)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  391 (458)
                      ....++..|+|||.+.+..++.++|+||||+++++|++|..||...........+.....+.   ....++.++.++|.+
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~  235 (277)
T cd06641         159 NTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSKPLKEFVEA  235 (277)
T ss_pred             ccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC---CCcccCHHHHHHHHH
Confidence            23456788999999988888899999999999999999999998765544444332222222   234567889999999


Q ss_pred             HcccCCCCCCCHHHHHHH
Q 012684          392 CWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       392 ~l~~dp~~Rps~~~ll~~  409 (458)
                      ||..+|.+||++.+++.+
T Consensus       236 ~l~~~p~~Rp~~~~~l~~  253 (277)
T cd06641         236 CLNKEPSFRPTAKELLKH  253 (277)
T ss_pred             HccCChhhCcCHHHHHhC
Confidence            999999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-35  Score=277.81  Aligned_cols=246  Identities=27%  Similarity=0.524  Sum_probs=207.7

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||.|++|.++.     ++..|++|.+..... .......+.+|++++++++|||++++++++.++...+++||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence            467788999999998874     678999999976543 23556789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      ++++++|.+++...+.+++..+..++.|++.+|.+||+.|   ++|+||+|+||+++.++.++|+|||++......... 
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-  155 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD-  155 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCccc-
Confidence            9999999999988888999999999999999999999999   999999999999999999999999999876543221 


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....++..|+|||...+..++.++|+|++|+++++|++|+.||.................+   ..+..++..+.+++.
T Consensus       156 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~  232 (254)
T cd06627         156 DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP---PLPEGISPELKDFLM  232 (254)
T ss_pred             ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC---CCCCCCCHHHHHHHH
Confidence            23345788999999998878889999999999999999999999876543333333222222   234557889999999


Q ss_pred             HHcccCCCCCCCHHHHHHH
Q 012684          391 ECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~  409 (458)
                      +||..+|++|||+.+++.+
T Consensus       233 ~~l~~~p~~R~~~~~~l~~  251 (254)
T cd06627         233 QCFQKDPNLRPTAKQLLKH  251 (254)
T ss_pred             HHHhCChhhCcCHHHHhcC
Confidence            9999999999999999864

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2.8e-36  Score=287.90  Aligned_cols=249  Identities=25%  Similarity=0.419  Sum_probs=198.8

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||.|+||.||.     +++.||+|.+....... ...+.+.+|+.+++.++||||+++++++..+...++|||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   80 (286)
T cd07846           2 KYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE   80 (286)
T ss_pred             ceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence            577788999999998863     57899999987543322 344567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+++++|.++....+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        81 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~-~~  156 (286)
T cd07846          81 FVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EV  156 (286)
T ss_pred             cCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc-cc
Confidence            9999999888776667999999999999999999999999   9999999999999999999999999987654322 22


Q ss_pred             cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc--------------------
Q 012684          311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--------------------  369 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------------------  369 (458)
                      .....++..|+|||.+.+. .++.++||||||+++++|++|+.||......+....+...                    
T Consensus       157 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (286)
T cd07846         157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAG  236 (286)
T ss_pred             cCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhc
Confidence            2334578899999998653 4678999999999999999999999765432211111100                    


Q ss_pred             -CCCCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          370 -QRPPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       370 -~~~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                       ..+...      ...+.++..+.+++.+||..+|.+||++.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  283 (286)
T cd07846         237 MRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHH  283 (286)
T ss_pred             cccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcC
Confidence             000000      0123467889999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.3e-35  Score=277.11  Aligned_cols=244  Identities=29%  Similarity=0.529  Sum_probs=204.7

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |+..+.||.|++|.++.     ++..+++|++.....   .....+.+|+.+++.++||+|+++++++..+...++++||
T Consensus         2 y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~   78 (253)
T cd05122           2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEF   78 (253)
T ss_pred             ceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEec
Confidence            66778999999998763     488999999975432   3556788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      +++++|.+++... ..+++..+..++.|++.+|.+||+.+   ++|+||+|+||+++.++.++|+|||.+........  
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--  153 (253)
T cd05122          79 CSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA--  153 (253)
T ss_pred             CCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence            9999999998875 57899999999999999999999999   99999999999999999999999999877654321  


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....++..|+|||.+.+..++.++|+||||+++++|++|+.||...+.............+... ....++..+.++|.
T Consensus       154 ~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~  232 (253)
T cd05122         154 RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLR-NPEKWSDEFKDFLK  232 (253)
T ss_pred             ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCcC-cccccCHHHHHHHH
Confidence            23345788899999998888889999999999999999999999876554444333332222222 22234788999999


Q ss_pred             HHcccCCCCCCCHHHHHHH
Q 012684          391 ECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~  409 (458)
                      +||+.||.+|||+.+++++
T Consensus       233 ~~l~~~p~~R~t~~~~l~~  251 (253)
T cd05122         233 KCLQKNPEKRPTAEQLLKH  251 (253)
T ss_pred             HHccCChhhCCCHHHHhcC
Confidence            9999999999999999875

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-35  Score=279.06  Aligned_cols=249  Identities=28%  Similarity=0.485  Sum_probs=203.7

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCC--CCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--Cce
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPM  225 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~  225 (458)
                      .+|.+.+.||+|+||.+|.     +|..||+|.+.....  ........+.+|+.++++++||||+++++++.+.  ...
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~   81 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL   81 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence            3678889999999998873     588999998753221  2334556788999999999999999999998764  458


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      +++|||+++++|.+++...+.+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        82 ~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~  158 (264)
T cd06653          82 SIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRIQT  158 (264)
T ss_pred             EEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcccccccccc
Confidence            899999999999999988778999999999999999999999999   99999999999999999999999999876532


Q ss_pred             CC--CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          306 KE--DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       306 ~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      ..  ........++..|+|||.+.+..++.++|+||||+++++|++|+.||.............  ..+..+..+..+++
T Consensus       159 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~--~~~~~~~~p~~~~~  236 (264)
T cd06653         159 ICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA--TQPTKPMLPDGVSD  236 (264)
T ss_pred             ccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHH--cCCCCCCCCcccCH
Confidence            11  111223457889999999988888999999999999999999999998765444333322  22222334567889


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+.++|.+||. +|..||++.+++.|
T Consensus       237 ~~~~~i~~~l~-~~~~r~~~~~~~~~  261 (264)
T cd06653         237 ACRDFLKQIFV-EEKRRPTAEFLLRH  261 (264)
T ss_pred             HHHHHHHHHhc-CcccCccHHHHhcC
Confidence            99999999999 57999999998875

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-37  Score=292.00  Aligned_cols=258  Identities=27%  Similarity=0.410  Sum_probs=214.6

Q ss_pred             CcccCcCCc-cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE
Q 012684          147 EYEIDPHEL-DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT  220 (458)
Q Consensus       147 ~~~~~~~~~-~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~  220 (458)
                      .+|.-+.+. .|+.-+.||+|+||.|+     .+|..||.|.+.+..+..........+|-.+|.+++.+.||.+-.+|+
T Consensus       176 ~lE~qpvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfe  255 (591)
T KOG0986|consen  176 WLELQPVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFE  255 (591)
T ss_pred             HHHhhhccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeec
Confidence            444444433 57788899999999776     589999999998766554444455678999999999999999999999


Q ss_pred             eCCceEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecC
Q 012684          221 QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (458)
Q Consensus       221 ~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg  298 (458)
                      ..+.+|+||..|+||+|.-+|.+-+  .|++..+..++.+|+.||++||+.+   |++||+||+|||+|+.|+|+|+|+|
T Consensus       256 Tkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLG  332 (591)
T KOG0986|consen  256 TKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLG  332 (591)
T ss_pred             CCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccc
Confidence            9999999999999999988887655  5999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCCh
Q 012684          299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA  378 (458)
Q Consensus       299 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  378 (458)
                      +|..+..  ..+.....||.+|||||++.++.|+...|.|||||++|+|+.|+.||.........+.+...-.......+
T Consensus       333 LAvei~~--g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey~  410 (591)
T KOG0986|consen  333 LAVEIPE--GKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEYS  410 (591)
T ss_pred             eEEecCC--CCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhcc
Confidence            9998764  45566678999999999999999999999999999999999999999876554333333222222223345


Q ss_pred             hhhHHHHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 012684          379 KLYARGLKELIEECWNEKPAKRPT-----FRQIITR  409 (458)
Q Consensus       379 ~~~~~~l~~li~~~l~~dp~~Rps-----~~~ll~~  409 (458)
                      ..+|+++++|.+.+|++||.+|..     +.++.+|
T Consensus       411 ~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~H  446 (591)
T KOG0986|consen  411 DKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEH  446 (591)
T ss_pred             cccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhC
Confidence            678999999999999999999954     4455554

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=2e-35  Score=282.53  Aligned_cols=247  Identities=27%  Similarity=0.448  Sum_probs=198.0

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV  228 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv  228 (458)
                      +|...+.||.|++|.++.     +++.+|+|.+....  .......+.+|++++++++||||+++++++...  +.+++|
T Consensus         2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence            467788999999998762     67899999987542  234556788999999999999999999998653  468999


Q ss_pred             EEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      |||+++++|.+++..    ...++...+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~  156 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELV  156 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeecccccccc
Confidence            999999999988753    345888999999999999999999999   9999999999999999999999999987543


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-----CcHHHHHHhcCCCCCCCC--
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-----NEVPKAYAARQRPPFKAP--  377 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~-----~~~~~~~~~~~~~~~~~~--  377 (458)
                      ....   ....++..|+|||.+.+..++.++|+||||+++|+|++|+.||.....     .+..........+.....  
T Consensus       157 ~~~~---~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd06621         157 NSLA---GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPG  233 (287)
T ss_pred             cccc---ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCC
Confidence            2211   233467789999999888899999999999999999999999986632     112222211111211111  


Q ss_pred             -hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          378 -AKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       378 -~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                       ...+++.+.++|.+||+.+|.+|||+.+++++-
T Consensus       234 ~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~  267 (287)
T cd06621         234 NGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHP  267 (287)
T ss_pred             CCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCc
Confidence             123578899999999999999999999999873

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4.4e-36  Score=282.81  Aligned_cols=241  Identities=30%  Similarity=0.455  Sum_probs=199.5

Q ss_pred             eccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012684          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (458)
Q Consensus       163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L  237 (458)
                      ||.|+||.+|.     +|+.+++|.+...........+.+.+|+.++++++||||+++++.+..+...|++|||+.+++|
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L   80 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL   80 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence            57888887763     4899999999765444445667789999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC-------CC
Q 012684          238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-------RP  310 (458)
Q Consensus       238 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~-------~~  310 (458)
                      .+++.+.+.+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++........       ..
T Consensus        81 ~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  157 (265)
T cd05579          81 ASLLENVGSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKE  157 (265)
T ss_pred             HHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccc
Confidence            999988778999999999999999999999999   99999999999999999999999999875432211       12


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....++..|+|||...+...+.++|+||||+++++|++|..||......+....... +....+. ...++..+.+++.
T Consensus       158 ~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~~~-~~~~~~~~~~~i~  235 (265)
T cd05579         158 DKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILN-GKIEWPE-DVEVSDEAIDLIS  235 (265)
T ss_pred             ccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc-CCcCCCc-cccCCHHHHHHHH
Confidence            2334567889999999888888999999999999999999999988776655555433 2222222 1124789999999


Q ss_pred             HHcccCCCCCCCHHHHHH
Q 012684          391 ECWNEKPAKRPTFRQIIT  408 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~  408 (458)
                      +||+.+|.+|||+..+.+
T Consensus       236 ~~l~~~p~~Rpt~~~~~~  253 (265)
T cd05579         236 KLLVPDPEKRLGAKSIEE  253 (265)
T ss_pred             HHhcCCHhhcCCCccHHH
Confidence            999999999999944443

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=3.8e-36  Score=285.83  Aligned_cols=247  Identities=25%  Similarity=0.457  Sum_probs=207.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      +|...+.||.|+||.+|.     +|..||+|++.............+..|..+++++. ||||+++++++..+...++||
T Consensus         2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   81 (280)
T cd05581           2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL   81 (280)
T ss_pred             CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence            577888999999998873     68999999997654444555677889999999998 999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC-
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~-  308 (458)
                      |++++++|.+++.+.+.+++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++........ 
T Consensus        82 e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~  158 (280)
T cd05581          82 EYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSP  158 (280)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCCcccc
Confidence            99999999999998888999999999999999999999999   99999999999999999999999999876543321 


Q ss_pred             ------------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC
Q 012684          309 ------------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ  370 (458)
Q Consensus       309 ------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~  370 (458)
                                        .......++..|+|||...+..++.++|+||||++++++++|+.||............. ..
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~-~~  237 (280)
T cd05581         159 ESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKIL-KL  237 (280)
T ss_pred             ccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH-hc
Confidence                              11223456788999999988888999999999999999999999999776444333332 11


Q ss_pred             CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCH----HHHHHH
Q 012684          371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTF----RQIITR  409 (458)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~----~~ll~~  409 (458)
                      ...   .+..+++.+.++|..||+.+|.+||++    .+++++
T Consensus       238 ~~~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~  277 (280)
T cd05581         238 EYS---FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAH  277 (280)
T ss_pred             CCC---CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcC
Confidence            112   234567899999999999999999999    777754

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1e-35  Score=285.43  Aligned_cols=247  Identities=22%  Similarity=0.449  Sum_probs=203.9

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|.+.+.||.|+||.++.     ++..||+|.+...   .....+.+.+|+.+++.++||||+++++++......++|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv   94 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV   94 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence            45788889999999998873     5788999998643   223346688899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      +||+++++|.+++.+. .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        95 ~e~~~~~~L~~~~~~~-~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~-  169 (293)
T cd06647          95 MEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ-  169 (293)
T ss_pred             EecCCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceecccccc-
Confidence            9999999999998753 5788999999999999999999999   9999999999999999999999999887554322 


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      .......+++.|+|||.+.+..++.++|+||||+++|++++|+.||...+.............+.+. .+..++..+.++
T Consensus       170 ~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~l~~l  248 (293)
T cd06647         170 SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQ-NPEKLSAIFRDF  248 (293)
T ss_pred             cccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCCCCCC-CccccCHHHHHH
Confidence            1223345788899999998888899999999999999999999999876543332222222222222 234467889999


Q ss_pred             HHHHcccCCCCCCCHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~  409 (458)
                      |..||..+|.+||++.+++.+
T Consensus       249 i~~~l~~~p~~Rp~~~~il~h  269 (293)
T cd06647         249 LNRCLEMDVEKRGSAKELLQH  269 (293)
T ss_pred             HHHHccCChhhCcCHHHHhcC
Confidence            999999999999999999987

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.3e-35  Score=287.68  Aligned_cols=241  Identities=24%  Similarity=0.391  Sum_probs=181.6

Q ss_pred             ceeeccceEEEEEE-------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CCceEEEEE
Q 012684          160 SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTE  230 (458)
Q Consensus       160 ~~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~lv~e  230 (458)
                      ..+||+|+||.||.       .+..||+|.+.....     ...+.+|+.+++.++||||+++++++..  +...++|||
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e   80 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD   80 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence            35899999999873       346899999865422     2346789999999999999999999853  567899999


Q ss_pred             ccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe----cCCCCEEEeec
Q 012684          231 YLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADF  297 (458)
Q Consensus       231 ~~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~----~~~~~vkl~Df  297 (458)
                      |+. ++|.+++...         ..+++..+..++.|++.||.|||+.+   ++||||||+||++    +.++.++|+||
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~Df  156 (317)
T cd07867          81 YAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADM  156 (317)
T ss_pred             eeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeec
Confidence            994 5888877531         24788889999999999999999999   9999999999999    46678999999


Q ss_pred             CCccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH---------HHH
Q 012684          298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV---------PKA  365 (458)
Q Consensus       298 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~---------~~~  365 (458)
                      |++........  .......+|+.|+|||.+.+. .++.++|||||||++|+|++|+.||........         ...
T Consensus       157 G~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~  236 (317)
T cd07867         157 GFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDR  236 (317)
T ss_pred             cceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHH
Confidence            99986543221  122345678899999998764 578899999999999999999999975432110         000


Q ss_pred             H-HhcC------------CCCCC---------------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          366 Y-AARQ------------RPPFK---------------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       366 ~-~~~~------------~~~~~---------------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      + ...+            .+.+.                     ......+..+.++|.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~h  314 (317)
T cd07867         237 IFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQD  314 (317)
T ss_pred             HHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcC
Confidence            0 0000            00000                     0001123568889999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=3.1e-35  Score=275.73  Aligned_cols=249  Identities=27%  Similarity=0.484  Sum_probs=206.9

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV  228 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv  228 (458)
                      +|...+.||.|++|.++.     ++..|++|++..... .....+.+.+|+.++++++||||+++++.+...  ...+++
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGD-SEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeecccc-chHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence            366778999999998873     588999999976533 245567889999999999999999999999988  889999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      +||+++++|.+++.+...+++..++.++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||.+........
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~  156 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET  156 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccccc
Confidence            999999999999988778999999999999999999999999   99999999999999999999999999887654322


Q ss_pred             C-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          309 R-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       309 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      . ......++..|+|||.+.+...+.++|+||||+++++|++|..||............ ..........+..++..+.+
T Consensus       157 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~  235 (260)
T cd06606         157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYK-IGSSGEPPEIPEHLSEEAKD  235 (260)
T ss_pred             cccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHh-ccccCCCcCCCcccCHHHHH
Confidence            1 123345788999999998888899999999999999999999999876622111111 11112223334556889999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +|.+|++.||.+||++.+++.+
T Consensus       236 ~i~~~l~~~p~~Rp~~~~ll~~  257 (260)
T cd06606         236 FLRKCLRRDPKKRPTADELLQH  257 (260)
T ss_pred             HHHHhCcCChhhCCCHHHHhhC
Confidence            9999999999999999999875

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=6.4e-36  Score=285.94  Aligned_cols=254  Identities=23%  Similarity=0.344  Sum_probs=200.3

Q ss_pred             cccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCC-CHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCce
Q 012684          156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~  225 (458)
                      +|++.+.||.|+||.+|.        +++.||+|.+...... .....+.+..|+.+++++ +||+|+++++.+..+...
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            366778999999998873        4678999998743221 223345678899999999 699999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      ++||||+.+++|.+++.....+++..+..++.|++++|.|||+.+   ++|+||+|.||+++.++.++|+|||++.....
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~  157 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKEFLA  157 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECcccccccc
Confidence            999999999999999987777999999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCCCCcccCCCCCcccCCcccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      ..........++..|+|||.+.+..  .+.++|+||||+++++|++|..||...........+...........+..++.
T Consensus       158 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (288)
T cd05583         158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSA  237 (288)
T ss_pred             ccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCCCcccCH
Confidence            3222222345788999999987654  67899999999999999999999975433222222111111111122445778


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      .+.++|.+||+.||++|||+.++.+.|+.
T Consensus       238 ~l~~li~~~l~~~p~~R~t~~~~~~~l~~  266 (288)
T cd05583         238 EARDFIQKLLEKDPKKRLGANGADEIKNH  266 (288)
T ss_pred             HHHHHHHHHhcCCHhhccCcchHHHHhcC
Confidence            99999999999999999998877665544

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=1.4e-35  Score=280.49  Aligned_cols=230  Identities=23%  Similarity=0.411  Sum_probs=186.5

Q ss_pred             eccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCCCC
Q 012684          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD  236 (458)
Q Consensus       163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~  236 (458)
                      ||.|+||.|+.     ++..+|+|.+.......      .  |......+ +||||+++++.+..++..++||||+++++
T Consensus        24 lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~------~--e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~   95 (267)
T PHA03390         24 LIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA------I--EPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGD   95 (267)
T ss_pred             ecCCCceEEEEEEEcCCCcEEEEEEEehhhcch------h--hHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCc
Confidence            59999998863     67889999986542211      1  22222222 79999999999999999999999999999


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC-CEEEeecCCccccccCCCCCcccCC
Q 012684          237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKEDRPLTCQD  315 (458)
Q Consensus       237 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~-~vkl~Dfg~~~~~~~~~~~~~~~~~  315 (458)
                      |.+++.....+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++ .++|+|||++......     ....
T Consensus        96 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~-----~~~~  167 (267)
T PHA03390         96 LFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP-----SCYD  167 (267)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccceecCCC-----ccCC
Confidence            9999988778999999999999999999999999   99999999999999998 9999999998765322     2235


Q ss_pred             CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHH-HHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 012684          316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-KAYAARQRPPFKAPAKLYARGLKELIEECWN  394 (458)
Q Consensus       316 gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  394 (458)
                      ++..|+|||++.+..++.++|+||+|+++|+|++|+.||......... ....... ......+..+++.++++|.+||+
T Consensus       168 ~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~  246 (267)
T PHA03390        168 GTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDFVQSMLK  246 (267)
T ss_pred             CCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHHHHHHhc
Confidence            788999999999888999999999999999999999999865544321 1121111 11222344688999999999999


Q ss_pred             cCCCCCCC-HHHHHHH
Q 012684          395 EKPAKRPT-FRQIITR  409 (458)
Q Consensus       395 ~dp~~Rps-~~~ll~~  409 (458)
                      .+|.+||+ +++++++
T Consensus       247 ~~p~~R~~~~~~~l~h  262 (267)
T PHA03390        247 YNINYRLTNYNEIIKH  262 (267)
T ss_pred             cChhhCCchHHHHhcC
Confidence            99999996 5998865

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.6e-36  Score=282.32  Aligned_cols=234  Identities=23%  Similarity=0.392  Sum_probs=187.0

Q ss_pred             eeccceEEEEEEc------------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          162 EITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       162 ~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .||.|+||.||..            ...||+|.+...   .....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus         2 ~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~   78 (258)
T cd05078           2 SLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKS---HRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQ   78 (258)
T ss_pred             CCCcccchhheeeeecccccccccccchhhHHhhcch---hHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEE
Confidence            5899999988731            234888887533   2334567888999999999999999999999988999999


Q ss_pred             EccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC--------EEEeecCCc
Q 012684          230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--------LKVADFGVS  300 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~--------vkl~Dfg~~  300 (458)
                      ||+++|+|.+++...+ .+++.....++.|++.||.|||+.+   ++||||||+||+++.++.        ++++|||++
T Consensus        79 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~  155 (258)
T cd05078          79 EYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS  155 (258)
T ss_pred             ecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence            9999999999997654 4889999999999999999999999   999999999999987765        699999988


Q ss_pred             cccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCC-CCCCCCCCCcHHHHHHhcCCCCCCCCh
Q 012684          301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGC-PPFTMKHDNEVPKAYAARQRPPFKAPA  378 (458)
Q Consensus       301 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~-~pf~~~~~~~~~~~~~~~~~~~~~~~~  378 (458)
                      .....     .....+++.|+|||.+.+. .++.++||||||+++|+|++|. .||............  .....+   +
T Consensus       156 ~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~--~~~~~~---~  225 (258)
T cd05078         156 ITVLP-----KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFY--EDRHQL---P  225 (258)
T ss_pred             cccCC-----chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHH--HccccC---C
Confidence            65432     1234567889999999764 5788999999999999999984 666654443322222  222222   2


Q ss_pred             hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       379 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      ...+..+.++|.+||+.||++|||+.++++.|+
T Consensus       226 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~  258 (258)
T cd05078         226 APKWTELANLINQCMDYEPDFRPSFRAIIRDLN  258 (258)
T ss_pred             CCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence            234578999999999999999999999998763

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=1.8e-35  Score=281.89  Aligned_cols=244  Identities=25%  Similarity=0.480  Sum_probs=192.1

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHH-HhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      +|++.+.||+|+||.||.     +|..||+|.+...... .. ...+..|+.. ++..+||||+++++++..++..+++|
T Consensus         2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~-~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~   79 (283)
T cd06617           2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNS-QE-QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM   79 (283)
T ss_pred             CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCc-HH-HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence            577888999999998874     6899999998765322 22 2344456554 66678999999999999999999999


Q ss_pred             EccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       230 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      ||++ ++|.+++..    ...+++..++.++.|++.||+|||++ +   ++||||||+||+++.++.+||+|||++....
T Consensus        80 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~  155 (283)
T cd06617          80 EVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLV  155 (283)
T ss_pred             hhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecccccccc
Confidence            9995 688888764    24589999999999999999999997 7   9999999999999999999999999987653


Q ss_pred             cCCCCCcccCCCCCcccCCcccCC----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-cHHHHHHhcCCCCCCCChh
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKN----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPAK  379 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~  379 (458)
                      ...  ......++..|+|||.+.+    ..++.++|+||||+++|+|++|+.||...... +..........+..  ...
T Consensus       156 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~  231 (283)
T cd06617         156 DSV--AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQL--PAE  231 (283)
T ss_pred             ccc--ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCC--Ccc
Confidence            221  1122356788999998865    35678999999999999999999999754322 22222222222222  233


Q ss_pred             hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          380 LYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       380 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .++.++.++|.+||..+|.+||++.+++++
T Consensus       232 ~~~~~l~~li~~~l~~~p~~Rp~~~~il~~  261 (283)
T cd06617         232 KFSPEFQDFVNKCLKKNYKERPNYPELLQH  261 (283)
T ss_pred             ccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            578899999999999999999999999986

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.7e-36  Score=293.79  Aligned_cols=249  Identities=30%  Similarity=0.520  Sum_probs=218.8

Q ss_pred             ccCceeeccceEEEEE---Ec--CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAF---WR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~---~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      ++...+||-|.||.||   |.  ...||||.++..    ...+++|..|..+|+.++|||+|+++++|..+..+|||+||
T Consensus       269 ItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEf  344 (1157)
T KOG4278|consen  269 ITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEF  344 (1157)
T ss_pred             eeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEec
Confidence            4566789999999876   43  568999999743    45678899999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          232 LPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       232 ~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |..|+|.++|.+..+  ++.-..+.++.||..|++||..++   +|||||-..|+|+.++..||++|||+++.+......
T Consensus       345 M~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYT  421 (1157)
T KOG4278|consen  345 MCYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYT  421 (1157)
T ss_pred             ccCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCcee
Confidence            999999999998654  777788889999999999999999   999999999999999999999999999988655444


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      .......++.|.|||-+....++.|+|||+|||+|||+.| |-.||.+.+...+...+....+..-   +.++++...+|
T Consensus       422 AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~---PeGCPpkVYeL  498 (1157)
T KOG4278|consen  422 AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDG---PEGCPPKVYEL  498 (1157)
T ss_pred             cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccccccC---CCCCCHHHHHH
Confidence            4444456788999999999899999999999999999998 8889999888888887766667665   45678999999


Q ss_pred             HHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          389 IEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      ++.||+.+|.+||++.++-+.++.++.
T Consensus       499 MraCW~WsPsDRPsFaeiHqafEtmf~  525 (1157)
T KOG4278|consen  499 MRACWNWSPSDRPSFAEIHQAFETMFS  525 (1157)
T ss_pred             HHHHhcCCcccCccHHHHHHHHHHHhc
Confidence            999999999999999999999988754

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=3.5e-35  Score=284.86  Aligned_cols=247  Identities=26%  Similarity=0.477  Sum_probs=204.2

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |...+.||+|+||.++.     +|..||+|.+.............+..|+.+++.++|||++++++++.++...++||||
T Consensus        27 f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  106 (317)
T cd06635          27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEY  106 (317)
T ss_pred             hhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeC
Confidence            77788999999998763     6789999998765444555566788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       232 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      +. |+|.+++.. ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.....     
T Consensus       107 ~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-----  177 (317)
T cd06635         107 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-----  177 (317)
T ss_pred             CC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC-----
Confidence            96 578777754 456899999999999999999999999   99999999999999999999999998865432     


Q ss_pred             cccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      .....+++.|+|||.+.   +..++.++|+||||+++|+|++|+.||...........+.....+..  ....+++.+.+
T Consensus       178 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~  255 (317)
T cd06635         178 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSDYFRN  255 (317)
T ss_pred             cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCccccHHHHH
Confidence            12345788899999973   45678899999999999999999999987655444444433333222  23457788999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      +|.+||+.+|.+||++.++++++....
T Consensus       256 li~~~l~~~p~~Rpt~~~il~~~~~~~  282 (317)
T cd06635         256 FVDSCLQKIPQDRPTSEELLKHMFVLR  282 (317)
T ss_pred             HHHHHccCCcccCcCHHHHHhChhhhc
Confidence            999999999999999999999865543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=1.8e-35  Score=279.82  Aligned_cols=249  Identities=23%  Similarity=0.452  Sum_probs=202.3

Q ss_pred             cccCceeeccceEEEEEE------cCeEEEEEEcCCCCC-------CCHHHHHHHHHHHHHHhc-CCCCcceeeeeEEEe
Q 012684          156 DFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVI-------SDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQ  221 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~hp~i~~~~~~~~~  221 (458)
                      +|++...||+|+||.++.      .+..+|+|.+.....       ........+..|+.++.. ++||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            367788999999998863      368899998864221       233445667788888765 699999999999999


Q ss_pred             CCceEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEecCCCCEEEee
Q 012684          222 SSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (458)
Q Consensus       222 ~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dikp~Nil~~~~~~vkl~D  296 (458)
                      ++..+++|||+++++|.+++..    ...+++..++.++.|++.+|.|||+ .+   ++|+||+|.||+++.++.++|+|
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~---i~H~dl~~~nil~~~~~~~~l~d  157 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKR---IVHRDLTPNNIMLGEDDKVTITD  157 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCc---eeecCCCHHHEEECCCCcEEEec
Confidence            9999999999999999988743    3458999999999999999999996 66   99999999999999999999999


Q ss_pred             cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCC
Q 012684          297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA  376 (458)
Q Consensus       297 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  376 (458)
                      ||.+.......  ......++..|+|||.+.+..++.++|+||||+++|+|++|+.||..................+.  
T Consensus       158 fg~~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--  233 (269)
T cd08528         158 FGLAKQKQPES--KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL--  233 (269)
T ss_pred             ccceeeccccc--ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--
Confidence            99987654332  23345678899999999988899999999999999999999999986655444444332222221  


Q ss_pred             ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       377 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      ....+++.+.++|.+||+.||.+||++.++..+++
T Consensus       234 ~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~  268 (269)
T cd08528         234 PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS  268 (269)
T ss_pred             CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence            22356789999999999999999999999998875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=1.1e-35  Score=278.77  Aligned_cols=244  Identities=27%  Similarity=0.475  Sum_probs=206.0

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||.|+||.++.     +|..+|+|.+..... .......+..|+.+++.++||||+++++++......++|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence            467788999999988763     678999999875443 23445667889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       231 ~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      |+++++|.+++..    ...+++..++.++.|++.||.|||+.|   ++|+||+|.||+++.++.++|+|||++......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~  156 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN  156 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC
Confidence            9999999999876    345889999999999999999999999   999999999999999999999999998766433


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                         ......+++.|+|||.+.+..++.++|+||||+++++|++|+.||...+..+....+.....+   ..+..++.++.
T Consensus       157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  230 (256)
T cd08530         157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP---PIPPIYSQDLQ  230 (256)
T ss_pred             ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC---CCchhhCHHHH
Confidence               222345788999999998888899999999999999999999999877665554444332223   23446788999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +++.+||+.+|.+||++.+++++
T Consensus       231 ~li~~~l~~~p~~Rp~~~~~l~~  253 (256)
T cd08530         231 NFIRSMLQVKPKLRPNCDKILAS  253 (256)
T ss_pred             HHHHHHcCCCcccCCCHHHHhcC
Confidence            99999999999999999999875

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.4e-35  Score=276.44  Aligned_cols=246  Identities=25%  Similarity=0.467  Sum_probs=207.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|.+.+.||.|+||.++.     ++..|++|.+..... .......+..|+++++.++|||++++++.+..+...++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence            467788999999998762     588999999976433 33455678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          231 YLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       231 ~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ++++++|.+++.+.    ..+++..+..++.+++.||.+||+.+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~  156 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSST  156 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccC
Confidence            99999999999864    66999999999999999999999999   999999999999999999999999998765433


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                      . .......+++.|+|||.+.+..++.++|+||+|+++++|++|+.||................   ....+..++..+.
T Consensus       157 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  232 (258)
T cd08215         157 V-DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ---YPPIPSQYSSELR  232 (258)
T ss_pred             c-ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCC---CCCCCCCCCHHHH
Confidence            2 12233457888999999988889999999999999999999999998776555544443322   2233446788999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +++..||..+|.+|||+.+++++
T Consensus       233 ~~i~~~l~~~p~~Rp~~~~ll~~  255 (258)
T cd08215         233 NLVSSLLQKDPEERPSIAQILQS  255 (258)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcC
Confidence            99999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=1e-35  Score=283.81  Aligned_cols=248  Identities=24%  Similarity=0.450  Sum_probs=195.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||.|+||.++.     +|..||||.+..... .......+.+|+.++++++||||+++++++.++...++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence            467788999999998863     688999999875432 22233568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+. ++|.+++..  ...+++..+..++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++....... 
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~-  154 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-  154 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCc-
Confidence            995 689988865  345899999999999999999999999   9999999999999999999999999987653321 


Q ss_pred             CCcccCCCCCcccCCcccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CC--------------
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP--------------  372 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~--------------  372 (458)
                      .......+++.|+|||.+.+.. ++.++|+||||+++|+|++|+.||................ .+              
T Consensus       155 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (284)
T cd07860         155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDY  234 (284)
T ss_pred             cccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHH
Confidence            2223334678899999886644 5789999999999999999999998654432222211111 00              


Q ss_pred             ----------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 ----------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 ----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                .+....+.+++.+.++|.+||+.||.+|||+++++++
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~  281 (284)
T cd07860         235 KPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAH  281 (284)
T ss_pred             HhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcC
Confidence                      0000112356788999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.2e-35  Score=284.90  Aligned_cols=248  Identities=27%  Similarity=0.418  Sum_probs=196.7

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIV  228 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv  228 (458)
                      +|+..+.||.|+||.|+.     +++.+|+|.+...... ......+.+|+.++++++||||+++++++...  ...|+|
T Consensus         6 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv   84 (293)
T cd07843           6 EYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV   84 (293)
T ss_pred             hhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence            678888999999998873     5789999999754332 22334567799999999999999999998877  889999


Q ss_pred             EEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          229 TEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |||+. ++|.+++.... .+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        85 ~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~  160 (293)
T cd07843          85 MEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL  160 (293)
T ss_pred             ehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccCCc
Confidence            99996 59999887644 4899999999999999999999999   9999999999999999999999999988665432


Q ss_pred             CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCC--------------
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP--------------  372 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~--------------  372 (458)
                       .......+++.|+|||.+.+. .++.++|+||||+++++|++|..||...........+......              
T Consensus       161 -~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (293)
T cd07843         161 -KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPG  239 (293)
T ss_pred             -cccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccch
Confidence             222334567889999998764 4588999999999999999999999876554333222111000              


Q ss_pred             ---------CC---CC-Chhh-hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 ---------PF---KA-PAKL-YARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 ---------~~---~~-~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                               ..   .. .+.. +++.+.++|..||+.||.+|||+.+++.+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~  290 (293)
T cd07843         240 AKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKH  290 (293)
T ss_pred             hcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcC
Confidence                     00   00 0111 47789999999999999999999999875

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=1.4e-35  Score=292.02  Aligned_cols=246  Identities=26%  Similarity=0.379  Sum_probs=195.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------C
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~------~  223 (458)
                      .+|+..+.||+|+||.|+.     +|..||+|.+..... .......+.+|+.++++++||||+++++++...      .
T Consensus        16 ~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   94 (353)
T cd07850          16 KRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQ   94 (353)
T ss_pred             cceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccC
Confidence            4688889999999998863     788999999875432 333445677899999999999999999988643      3


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ..|+||||+. ++|.+.+...  ++...+..++.|++.||+|||+.|   ++|+||||+||+++.++.++|+|||++...
T Consensus        95 ~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          95 DVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             cEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence            5799999994 5898887654  889999999999999999999999   999999999999999999999999999865


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc--------------
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR--------------  369 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~--------------  369 (458)
                      ...  .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...+.......+...              
T Consensus       169 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (353)
T cd07850         169 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQP  246 (353)
T ss_pred             CCC--CCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            432  1223345788999999999989999999999999999999999999765432211111100              


Q ss_pred             -------CCCCC------------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          370 -------QRPPF------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       370 -------~~~~~------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                             .++..                  .......++.+.++|.+||+.||.+|||+.+++.+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~  311 (353)
T cd07850         247 TVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH  311 (353)
T ss_pred             hhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                   00000                  00012346678999999999999999999999987

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=1.1e-35  Score=279.04  Aligned_cols=246  Identities=24%  Similarity=0.455  Sum_probs=202.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||.|+||.+|.     +|..+|+|.+..... .....+.+.+|+.+++.++||||+++++.+..+...++|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence            477788999999998873     678999999875432 22334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC-EEEeecCCccccccCC
Q 012684          231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKE  307 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~-vkl~Dfg~~~~~~~~~  307 (458)
                      |+++++|.+++....  .+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++. ++|+|||.+.......
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~  156 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM  156 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence            999999999987643  4789999999999999999999999   999999999999998864 6999999987654322


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      . ......+++.|+|||.+.+..++.++|+||||+++++|++|..||......+.........   .....+.++..+.+
T Consensus       157 ~-~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~  232 (257)
T cd08225         157 E-LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGY---FAPISPNFSRDLRS  232 (257)
T ss_pred             c-cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccc---CCCCCCCCCHHHHH
Confidence            1 2223457889999999988889999999999999999999999998765544444332222   22223456789999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +|.+||..+|.+|||+.+++++
T Consensus       233 ~i~~~l~~~p~~Rpt~~~ll~~  254 (257)
T cd08225         233 LISQLFKVSPRDRPSITSILKR  254 (257)
T ss_pred             HHHHHhccChhhCcCHHHHhhC
Confidence            9999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7e-36  Score=306.16  Aligned_cols=251  Identities=16%  Similarity=0.207  Sum_probs=185.0

Q ss_pred             ccccCceeeccceEEEEEE------cCeEEEEE--------------EcCCCCCCCHHHHHHHHHHHHHHhcCCCCccee
Q 012684          155 LDFTNSVEITKGTFILAFW------RGIQVAVK--------------KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ  214 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~------~g~~vavK--------------~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~  214 (458)
                      .+|++.+.||+|+||.||.      .+...+.|              .+.+...........+.+|+.++++++||||++
T Consensus       148 ~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~HpnIv~  227 (501)
T PHA03210        148 AHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNHENILK  227 (501)
T ss_pred             hccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCCCCcCc
Confidence            3699999999999999884      11122222              111111122334566889999999999999999


Q ss_pred             eeeEEEeCCceEEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC
Q 012684          215 FLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS  289 (458)
Q Consensus       215 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~  289 (458)
                      +++++...+..|+|++++ +++|.+++...     .......+..++.|++.||.|||+++   |+||||||+|||++.+
T Consensus       228 l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl~~~  303 (501)
T PHA03210        228 IEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFLNCD  303 (501)
T ss_pred             EeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCC
Confidence            999999999999999999 56888776542     22345677789999999999999999   9999999999999999


Q ss_pred             CCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCC-CCCCCCCcH---HHH
Q 012684          290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEV---PKA  365 (458)
Q Consensus       290 ~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p-f~~~~~~~~---~~~  365 (458)
                      +.+||+|||++..+............||+.|+|||++.+..++.++|||||||++|+|++|..+ |........   ...
T Consensus       304 ~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~~~~  383 (501)
T PHA03210        304 GKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI  383 (501)
T ss_pred             CCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHHHHH
Confidence            9999999999987643322222345689999999999998999999999999999999998764 433222111   111


Q ss_pred             HHhcC--CCCCCC-------------------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          366 YAARQ--RPPFKA-------------------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       366 ~~~~~--~~~~~~-------------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +....  ...++.                         ....++..+.++|.+||+.||.+|||+.+++.+
T Consensus       384 ~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~h  454 (501)
T PHA03210        384 IDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLAL  454 (501)
T ss_pred             HHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhC
Confidence            10000  000000                         001234567788999999999999999999986

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.4e-35  Score=280.58  Aligned_cols=240  Identities=22%  Similarity=0.351  Sum_probs=189.7

Q ss_pred             eccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHH---HHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL---ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      ||+|+||.||.     +|+.||+|.+.............+..|.   ..++...||+|+++++++...+..++||||+.|
T Consensus         2 ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g   81 (278)
T cd05606           2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNG   81 (278)
T ss_pred             cccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCC
Confidence            79999998872     5789999998765433222222233343   344455799999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccC
Q 012684          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ  314 (458)
Q Consensus       235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~  314 (458)
                      ++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......   .....
T Consensus        82 ~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~---~~~~~  155 (278)
T cd05606          82 GDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK---KPHAS  155 (278)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCcc---CCcCc
Confidence            999999988888999999999999999999999999   999999999999999999999999998755322   11234


Q ss_pred             CCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHc
Q 012684          315 DTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW  393 (458)
Q Consensus       315 ~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  393 (458)
                      .|+..|+|||.+.++ .++.++||||+|+++|+|++|+.||................... ...+..+++.+.+++.+||
T Consensus       156 ~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~s~~~~~li~~~l  234 (278)
T cd05606         156 VGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-VELPDSFSPELRSLLEGLL  234 (278)
T ss_pred             CCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccC-CCCCCcCCHHHHHHHHHHh
Confidence            678999999998754 68899999999999999999999998764332222111111111 1123446889999999999


Q ss_pred             ccCCCCCC-----CHHHHHHH
Q 012684          394 NEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       394 ~~dp~~Rp-----s~~~ll~~  409 (458)
                      ..+|.+||     ++.+++++
T Consensus       235 ~~~p~~R~~~~~~~~~~ll~~  255 (278)
T cd05606         235 QRDVNRRLGCLGRGAQEVKEH  255 (278)
T ss_pred             hcCHHhccCCCCCCHHHHHhC
Confidence            99999999     99999864

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=9.8e-37  Score=290.70  Aligned_cols=242  Identities=24%  Similarity=0.385  Sum_probs=211.2

Q ss_pred             ceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          160 SVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       160 ~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      .+.||.|.||.||     .+|+.||||++.+..+.... .+.+++|+.+|+.+.||+||.+---|+..+.++.|||.+. 
T Consensus       569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~-  646 (888)
T KOG4236|consen  569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLH-  646 (888)
T ss_pred             HhhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhc-
Confidence            4679999999998     48999999999987775433 3779999999999999999999999999999999999995 


Q ss_pred             CCHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC---CCEEEeecCCccccccCCCC
Q 012684          235 GDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       235 ~~L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~---~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |++.+.+-  +.+++++.....++.||+.||.|||-++   |+|+||||+|||+...   ..+||||||+++.++..  .
T Consensus       647 GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk--s  721 (888)
T KOG4236|consen  647 GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK--S  721 (888)
T ss_pred             chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchh--h
Confidence            56655553  4678999999999999999999999999   9999999999999864   36999999999998754  3


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......|||.|+|||+++...|...-|+||+||++|.-++|..||..  .+++..++......-.+.++..++++..+||
T Consensus       722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaFMyPp~PW~eis~~AidlI  799 (888)
T KOG4236|consen  722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAFMYPPNPWSEISPEAIDLI  799 (888)
T ss_pred             hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhccccccCCCchhhcCHHHHHHH
Confidence            34567899999999999999999999999999999999999999975  4556677755556666677899999999999


Q ss_pred             HHHcccCCCCCCCHHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      ..+|+..=.+|-|....+.+-
T Consensus       800 n~LLqVkm~kRysvdk~lsh~  820 (888)
T KOG4236|consen  800 NNLLQVKMRKRYSVDKSLSHP  820 (888)
T ss_pred             HHHHHHHHHHhcchHhhccch
Confidence            999999999999999998874

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-37  Score=317.73  Aligned_cols=253  Identities=24%  Similarity=0.324  Sum_probs=217.9

Q ss_pred             cCCccccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          152 PHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      ...-+|.+.+.||+|+||.|.     .+++-||+|++++...........|..|-++|..-+.+-|++++..|.++.++|
T Consensus        72 l~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   72 LKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceE
Confidence            334468888999999999775     378999999998755444555678999999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      +||||++||+|-.++.+.+++++.-+..++..|+-||.-+|+.|   +|||||||+|||+|..|++||+|||.+-.+...
T Consensus       152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGsClkm~~d  228 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGSCLKMDAD  228 (1317)
T ss_pred             EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchhHHhcCCC
Confidence            99999999999999998888999999999999999999999999   999999999999999999999999999887644


Q ss_pred             CCCCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhh
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKL  380 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~  380 (458)
                      ..-.....+|||.|.+||++..     +.|++..|.||+||++|||+.|.-||...+..+.+..+.... ...+| ....
T Consensus       229 G~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP-~~~~  307 (1317)
T KOG0612|consen  229 GTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP-DETD  307 (1317)
T ss_pred             CcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC-cccc
Confidence            4444566789999999999843     468899999999999999999999999988888777775553 44454 2345


Q ss_pred             hHHHHHHHHHHHcccCCCCCCC---HHHHHHH
Q 012684          381 YARGLKELIEECWNEKPAKRPT---FRQIITR  409 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps---~~~ll~~  409 (458)
                      +|++.++||.+.+.- |+.|..   +.++..|
T Consensus       308 VSeeakdLI~~ll~~-~e~RLgrngiedik~H  338 (1317)
T KOG0612|consen  308 VSEEAKDLIEALLCD-REVRLGRNGIEDIKNH  338 (1317)
T ss_pred             cCHHHHHHHHHHhcC-hhhhcccccHHHHHhC
Confidence            899999999988875 888887   8888776

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-37  Score=293.90  Aligned_cols=248  Identities=23%  Similarity=0.354  Sum_probs=220.4

Q ss_pred             cccCceeeccceEEEEE---EcCeE--EEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAF---WRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~---~~g~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      ++.....||.|+||.|.   ..++.  +|+|++++.++.+....+.+..|-.+|..++.|.||++|..|.++.++|++||
T Consensus       421 dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmE  500 (732)
T KOG0614|consen  421 DLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLME  500 (732)
T ss_pred             hhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHH
Confidence            45566679999999764   45555  89999999888888888999999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      -|-||.||+.+..++.|...++..++..+++|++|||++|   |++|||||+|.+++.+|-+||.|||+++.+...  ..
T Consensus       501 aClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g--~K  575 (732)
T KOG0614|consen  501 ACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG--RK  575 (732)
T ss_pred             hhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC--Cc
Confidence            9999999999999999999999999999999999999999   999999999999999999999999999988643  45


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      ...++|||.|.|||++.+..++..+|.||||+++|||++|.+||.+.++......+.+.... + ..|..++....++|+
T Consensus       576 TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~-i-~~Pr~I~k~a~~Lik  653 (732)
T KOG0614|consen  576 TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDK-I-EFPRRITKTATDLIK  653 (732)
T ss_pred             eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhh-h-hcccccchhHHHHHH
Confidence            56688999999999999999999999999999999999999999999998888777554421 1 124667889999999


Q ss_pred             HHcccCCCCCCC-----HHHHHHHH
Q 012684          391 ECWNEKPAKRPT-----FRQIITRL  410 (458)
Q Consensus       391 ~~l~~dp~~Rps-----~~~ll~~L  410 (458)
                      ++...+|.+|..     +.++.+|-
T Consensus       654 ~LCr~~P~ERLG~~~~gI~DIkkH~  678 (732)
T KOG0614|consen  654 KLCRDNPTERLGYQKGGINDIKKHR  678 (732)
T ss_pred             HHHhcCcHhhhccccCChHHHHhhh
Confidence            999999999976     66666663

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=2.8e-35  Score=280.74  Aligned_cols=247  Identities=25%  Similarity=0.479  Sum_probs=196.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||.|++|.+|.     +|..||+|.+.....  ......+.+|+.++++++||||+++++++...+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   78 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE   78 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence            477889999999998873     688999999975432  2223456789999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          231 YLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |++ ++|.+++...+   .+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.......
T Consensus        79 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~  154 (284)
T cd07836          79 YMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPV  154 (284)
T ss_pred             cCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc
Confidence            996 48988887543   5899999999999999999999999   9999999999999999999999999987543321


Q ss_pred             CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCC-------------
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP-------------  373 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~-------------  373 (458)
                       .......+++.|++||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+......+             
T Consensus       155 -~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (284)
T cd07836         155 -NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPE  233 (284)
T ss_pred             -cccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCch
Confidence             122233467889999988654 46889999999999999999999998776554433322111000             


Q ss_pred             ----CCC--------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 ----FKA--------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ----~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                          .+.        ..+..++.+.++|.+||+.||.+||++++++++
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~  281 (284)
T cd07836         234 YKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQH  281 (284)
T ss_pred             hcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence                000        012346788999999999999999999999864

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=2.4e-35  Score=281.35  Aligned_cols=248  Identities=29%  Similarity=0.419  Sum_probs=197.8

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceEEEE
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVT  229 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~  229 (458)
                      |++.+.||.|+||.+|.     +|..+|+|.+.... ........+.+|+.+++.++|||++++++++...  +..++||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence            56678999999998874     57899999998653 2233345678899999999999999999999887  8899999


Q ss_pred             EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      ||++ ++|.+++... ..+++..++.++.|++.||+|||+.+   ++|+||+|+||+++.++.++|+|||++........
T Consensus        80 e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~  155 (287)
T cd07840          80 EYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS  155 (287)
T ss_pred             cccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCCc
Confidence            9996 5899888765 56999999999999999999999999   99999999999999999999999999987654432


Q ss_pred             CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCC-CCCC-----------
Q 012684          309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-PPFK-----------  375 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~-~~~~-----------  375 (458)
                      .......++..|+|||.+.+ ..++.++||||||+++++|++|+.||...........+..... +...           
T Consensus       156 ~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (287)
T cd07840         156 ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWF  235 (287)
T ss_pred             ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhh
Confidence            23334456788999998765 3578899999999999999999999987665433332221110 0000           


Q ss_pred             --------------CChhh-hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          376 --------------APAKL-YARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       376 --------------~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                    ..... +++.+.++|.+||..+|.+||++++++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  284 (287)
T cd07840         236 ENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQH  284 (287)
T ss_pred             hhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhC
Confidence                          00011 26789999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=2.3e-35  Score=285.03  Aligned_cols=249  Identities=29%  Similarity=0.435  Sum_probs=195.9

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMI  227 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~l  227 (458)
                      .+|+..+.||.|+||.++.     +|+.||+|.+....... .....+.+|+.++++++|+||+++++++...  +..++
T Consensus         7 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l   85 (309)
T cd07845           7 TEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL   85 (309)
T ss_pred             cceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence            3688888999999998873     58899999987543222 1122456799999999999999999998755  46899


Q ss_pred             EEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ||||+. ++|.+++.. ...+++.++..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        86 v~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~  161 (309)
T cd07845          86 VMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP  161 (309)
T ss_pred             EEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecCCc
Confidence            999995 589888875 356899999999999999999999999   999999999999999999999999998866432


Q ss_pred             CCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCC------------
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP------------  373 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~------------  373 (458)
                      . .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+..+....+......+            
T Consensus       162 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (309)
T cd07845         162 A-KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLP  240 (309)
T ss_pred             c-CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccc
Confidence            2 22223345778999999865 457889999999999999999999998766554443332211000            


Q ss_pred             ------CCC--------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 ------FKA--------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ------~~~--------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                            ...        ....+++.+.++|.+||+.||.+|||+++++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h  290 (309)
T cd07845         241 LVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALES  290 (309)
T ss_pred             ccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                  000        011247888999999999999999999999986

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=2.2e-35  Score=282.15  Aligned_cols=244  Identities=28%  Similarity=0.465  Sum_probs=193.2

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      +|...+.||.|+||.||.     +|..||+|.+.....  ......+.+|+.++.++. ||||+++++++..+...+++|
T Consensus         5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~   82 (288)
T cd06616           5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICM   82 (288)
T ss_pred             HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEE
Confidence            455667899999998873     678999999875432  244567888999999995 999999999999888999999


Q ss_pred             EccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          230 EYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       230 e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ||+. +++.++..     ..+.+++..+..++.|++.||+|||+. +   ++||||||+||+++.++.++|+|||++...
T Consensus        83 e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~  158 (288)
T cd06616          83 ELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELK---IIHRDVKPSNILLDRNGNIKLCDFGISGQL  158 (288)
T ss_pred             eccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---eeccCCCHHHEEEccCCcEEEeecchhHHh
Confidence            9984 56665432     235689999999999999999999975 7   999999999999999999999999998765


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh---cCCCCCC-C
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---RQRPPFK-A  376 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~---~~~~~~~-~  376 (458)
                      ....  ......+++.|+|||.+.+.   .++.++||||+|+++|+|++|+.||.....  .......   ...+... .
T Consensus       159 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~~  234 (288)
T cd06616         159 VDSI--AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPILSNS  234 (288)
T ss_pred             ccCC--ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcCCCc
Confidence            3221  11233578889999998775   688899999999999999999999986542  2222211   1111211 1


Q ss_pred             ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       377 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+..++..+.+||.+||+.||.+|||+++++.+
T Consensus       235 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~  267 (288)
T cd06616         235 EEREFSPSFVNFINLCLIKDESKRPKYKELLEH  267 (288)
T ss_pred             CCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            223478899999999999999999999999987

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.3e-35  Score=281.61  Aligned_cols=241  Identities=22%  Similarity=0.405  Sum_probs=198.5

Q ss_pred             ceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       160 ~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      ...||.|+||.++.     +|..||+|.+...   .......+.+|+.+++.++||||+++++.+..++..+++|||+++
T Consensus        25 ~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~  101 (292)
T cd06657          25 FIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEG  101 (292)
T ss_pred             HHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCC
Confidence            35799999998763     6889999988533   233456688899999999999999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccC
Q 012684          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ  314 (458)
Q Consensus       235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~  314 (458)
                      ++|.+++.. +.+++..+..++.|++.+|+|||+.|   ++|+||+|+||+++.++.++|+|||++....... ......
T Consensus       102 ~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~-~~~~~~  176 (292)
T cd06657         102 GALTDIVTH-TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PRRKSL  176 (292)
T ss_pred             CcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceeccccc-cccccc
Confidence            999998754 46899999999999999999999999   9999999999999999999999999887654321 122334


Q ss_pred             CCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 012684          315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN  394 (458)
Q Consensus       315 ~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  394 (458)
                      .+++.|+|||.+.+..++.++|+||+|+++|+|++|..||......+...... ...+........+++.+.+++.+||.
T Consensus       177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~  255 (292)
T cd06657         177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIR-DNLPPKLKNLHKVSPSLKGFLDRLLV  255 (292)
T ss_pred             ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hhCCcccCCcccCCHHHHHHHHHHHh
Confidence            57889999999988888999999999999999999999998755544333332 22222212234567889999999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 012684          395 EKPAKRPTFRQIITR  409 (458)
Q Consensus       395 ~dp~~Rps~~~ll~~  409 (458)
                      .||.+||++.+++.+
T Consensus       256 ~~P~~R~~~~~ll~~  270 (292)
T cd06657         256 RDPAQRATAAELLKH  270 (292)
T ss_pred             CCcccCcCHHHHhcC
Confidence            999999999999986

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=7.3e-35  Score=279.53  Aligned_cols=254  Identities=15%  Similarity=0.144  Sum_probs=187.0

Q ss_pred             CCccccCceeeccceEEEEEE-----c---CeEEEEEEcCCCCCCCHHHH--------HHHHHHHHHHhcCCCCcceeee
Q 012684          153 HELDFTNSVEITKGTFILAFW-----R---GIQVAVKKLGEEVISDDDRV--------RAFRDELALLQKIRHPNVVQFL  216 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~---g~~vavK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~hp~i~~~~  216 (458)
                      ...+|.+.+.||+|+||.||.     +   +..+|+|+............        .....+...+..+.|++|++++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~   89 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY   89 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence            345799999999999999874     2   34667776543221110000        1112233455667899999999


Q ss_pred             eEEEeCC----ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCE
Q 012684          217 GAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL  292 (458)
Q Consensus       217 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~v  292 (458)
                      +++....    ..+++++++ ..++.+.+......++..+..++.|++.||.|||+.+   ++||||||+|||++.++.+
T Consensus        90 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~~~~  165 (294)
T PHA02882         90 GCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGNNRG  165 (294)
T ss_pred             EeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCcE
Confidence            9875443    347888887 5578887776656788889999999999999999999   9999999999999999999


Q ss_pred             EEeecCCccccccCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH-HHH
Q 012684          293 KVADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKA  365 (458)
Q Consensus       293 kl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~-~~~  365 (458)
                      +|+|||++........      .......||+.|+|||++.+..++.++|||||||++++|++|+.||........ ...
T Consensus       166 ~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~  245 (294)
T PHA02882        166 YIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHA  245 (294)
T ss_pred             EEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHH
Confidence            9999999876532111      112234689999999999999999999999999999999999999987743322 111


Q ss_pred             HHh---cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          366 YAA---RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       366 ~~~---~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      ...   .............++.+.+++..|+..+|++||++.++++.|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~  293 (294)
T PHA02882        246 AKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIKIF  293 (294)
T ss_pred             hHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence            110   000011112234578899999999999999999999999875

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-36  Score=282.17  Aligned_cols=239  Identities=29%  Similarity=0.447  Sum_probs=211.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .|.....||+|+||.|.+     +.+.||||++++..+...+.++.-..|-++|... +-|.+++++.+|+.-+++|+||
T Consensus       350 DFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVM  429 (683)
T KOG0696|consen  350 DFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVM  429 (683)
T ss_pred             ccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEE
Confidence            466677999999998864     4578999999988877777777777888888877 4678999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||+.||+|--.+++-+++.+..+..++..|+-||-+||++|   |++||||.+||+++.+|++||+|||++..-- ....
T Consensus       430 EyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni-~~~~  505 (683)
T KOG0696|consen  430 EYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENI-FDGV  505 (683)
T ss_pred             EEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeecccccccc-cCCc
Confidence            99999999999999999999999999999999999999999   9999999999999999999999999997532 2344


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......|||.|+|||++..++|+..+|.||+||+||||+.|+.||++.+..+....+.... ..+   +..+|.+...++
T Consensus       506 TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehn-vsy---PKslSkEAv~ic  581 (683)
T KOG0696|consen  506 TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHN-VSY---PKSLSKEAVAIC  581 (683)
T ss_pred             ceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHcc-CcC---cccccHHHHHHH
Confidence            4567889999999999999999999999999999999999999999999999888884443 232   567889999999


Q ss_pred             HHHcccCCCCCCC
Q 012684          390 EECWNEKPAKRPT  402 (458)
Q Consensus       390 ~~~l~~dp~~Rps  402 (458)
                      ...|.+.|.+|..
T Consensus       582 kg~ltK~P~kRLG  594 (683)
T KOG0696|consen  582 KGLLTKHPGKRLG  594 (683)
T ss_pred             HHHhhcCCccccC
Confidence            9999999999954

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-35  Score=280.64  Aligned_cols=247  Identities=27%  Similarity=0.460  Sum_probs=196.1

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |++.+.||.|++|.+|.     +|..||+|++...... ......+.+|+.+++.++|||++++++++..++..+++|||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETED-EGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeeccccc-ccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence            56678999999998873     6899999998754322 22335677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          232 LPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       232 ~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      + +++|.+++....  .+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++...... ..
T Consensus        80 ~-~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~-~~  154 (283)
T cd07835          80 L-DLDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVP-VR  154 (283)
T ss_pred             c-CcCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCC-cc
Confidence            9 569999988765  6899999999999999999999999   999999999999999999999999998755322 11


Q ss_pred             CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-------------------
Q 012684          310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------------------  369 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-------------------  369 (458)
                      ......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+...                   
T Consensus       155 ~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd07835         155 TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYK  234 (283)
T ss_pred             ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhh
Confidence            22233457889999987654 5688999999999999999999999765432221111110                   


Q ss_pred             ------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          370 ------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       370 ------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                            ...........++..+.++|.+||+.||.+|||+++++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~  280 (283)
T cd07835         235 PTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQH  280 (283)
T ss_pred             hhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence                  0011111234566889999999999999999999999865

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=5.6e-35  Score=279.89  Aligned_cols=248  Identities=23%  Similarity=0.400  Sum_probs=191.0

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|.+.+.||+|+||.|+.     +|..||+|.+.......  ....+.+|+.+++.++|+||+++++++..+...++||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~   82 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF   82 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence            4688889999999998874     58899999986543211  2234677999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      ||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-  157 (291)
T cd07870          83 EYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIPS-  157 (291)
T ss_pred             eccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCCC-
Confidence            9995 677776654 345788888999999999999999999   9999999999999999999999999987543221 


Q ss_pred             CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH-HHHHHh-cCC------------CC
Q 012684          309 RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAA-RQR------------PP  373 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~-~~~~~~-~~~------------~~  373 (458)
                      .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||........ ...... .+.            +.
T Consensus       158 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07870         158 QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPN  237 (291)
T ss_pred             CCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhccc
Confidence            122333468899999998754 578899999999999999999999986543211 000000 000            00


Q ss_pred             C---------C----CC--hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 F---------K----AP--AKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ~---------~----~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .         +    ..  ....+..+.+++.+|+..||.+|||+.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h  288 (291)
T cd07870         238 YKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLH  288 (291)
T ss_pred             ccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcC
Confidence            0         0    00  00124678999999999999999999999865

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-35  Score=273.90  Aligned_cols=238  Identities=29%  Similarity=0.459  Sum_probs=200.3

Q ss_pred             eccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012684          163 ITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (458)
Q Consensus       163 lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L  237 (458)
                      ||.|+||.++.     +++.+|+|.+.............+..|+.++++++||||+++++.+..+...+++|||+++++|
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L   80 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL   80 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence            68899987763     4899999999876555555677889999999999999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCCCC
Q 012684          238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS  317 (458)
Q Consensus       238 ~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt  317 (458)
                      .+++.....+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||++....... .......++
T Consensus        81 ~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~-~~~~~~~~~  156 (250)
T cd05123          81 FSHLSKEGRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG-SRTNTFCGT  156 (250)
T ss_pred             HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC-CcccCCcCC
Confidence            999998878999999999999999999999999   9999999999999999999999999987654322 122344578


Q ss_pred             CcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCC
Q 012684          318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP  397 (458)
Q Consensus       318 ~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp  397 (458)
                      ..|+|||.+.+...+.++|+||||+++|++++|..||...........+.. ....   .+...+..+.++|.+||..||
T Consensus       157 ~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~-~~~~---~~~~~~~~l~~~i~~~l~~~p  232 (250)
T cd05123         157 PEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILK-DPLR---FPEFLSPEARDLISGLLQKDP  232 (250)
T ss_pred             ccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhc-CCCC---CCCCCCHHHHHHHHHHhcCCH
Confidence            889999999888888999999999999999999999987665444444322 2222   233457889999999999999


Q ss_pred             CCCCCH---HHHHH
Q 012684          398 AKRPTF---RQIIT  408 (458)
Q Consensus       398 ~~Rps~---~~ll~  408 (458)
                      .+||++   .++++
T Consensus       233 ~~R~~~~~~~~l~~  246 (250)
T cd05123         233 TKRLGSGGAEEIKA  246 (250)
T ss_pred             hhCCCcccHHHHHh
Confidence            999999   55554

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.6e-35  Score=289.43  Aligned_cols=251  Identities=23%  Similarity=0.366  Sum_probs=198.4

Q ss_pred             ccccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe----CCce
Q 012684          155 LDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPM  225 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~----~~~~  225 (458)
                      .+|++.+.||.|+||.++     .+|..||+|.+..... .......+.+|+.+++.++||||+++++++..    ....
T Consensus         5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~   83 (334)
T cd07855           5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV   83 (334)
T ss_pred             hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence            578888899999999886     3689999999975432 22344567789999999999999999998753    3468


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      ++||||+ +++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        84 ~lv~e~~-~~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~  159 (334)
T cd07855          84 YVVMDLM-ESDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSS  159 (334)
T ss_pred             EEEEehh-hhhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEecccccceeecc
Confidence            9999999 5699999987778999999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCCCC---cccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh-------------
Q 012684          306 KEDRP---LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-------------  368 (458)
Q Consensus       306 ~~~~~---~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~-------------  368 (458)
                      .....   .....++..|+|||.+.+ ..++.++||||||+++|+|++|+.||...+.......+..             
T Consensus       160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~  239 (334)
T cd07855         160 SPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRI  239 (334)
T ss_pred             cCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhh
Confidence            22111   123467889999999765 4578899999999999999999999976543221111100             


Q ss_pred             -----------cC-CCCC--CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          369 -----------RQ-RPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       369 -----------~~-~~~~--~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                                 .. ....  ....+..+..+.++|..||+.+|.+||++.+++.+-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~  295 (334)
T cd07855         240 GSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHP  295 (334)
T ss_pred             chhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhCh
Confidence                       00 0010  001134578899999999999999999999999873

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=1.5e-34  Score=280.01  Aligned_cols=242  Identities=26%  Similarity=0.477  Sum_probs=199.1

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |.....||.|+||.+|.     +|..|++|.+.............+.+|+.+++.++|||++++++++.++...|+||||
T Consensus        23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~  102 (313)
T cd06633          23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY  102 (313)
T ss_pred             hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence            55556799999998874     6889999999765444555566788899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       232 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      +. ++|.+++.. ...+++.++..++.|++.+|.|||+.|   ++|+||+|+||+++.++.++|+|||++....     .
T Consensus       103 ~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~-----~  173 (313)
T cd06633         103 CL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSS-----P  173 (313)
T ss_pred             CC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccC-----C
Confidence            95 578877765 456899999999999999999999999   9999999999999999999999999886432     1


Q ss_pred             cccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      .....++..|+|||.+.   ...++.++|+||||+++|+|++|..||.................+..  ....++..+++
T Consensus       174 ~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~  251 (313)
T cd06633         174 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTL--QSNEWTDSFRG  251 (313)
T ss_pred             CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CccccCHHHHH
Confidence            22345788999999974   35678899999999999999999999987665444443322222222  23456778999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++.+||+.+|.+||++.+++.+
T Consensus       252 li~~~l~~~P~~Rp~~~~~l~~  273 (313)
T cd06633         252 FVDYCLQKIPQERPASAELLRH  273 (313)
T ss_pred             HHHHHccCChhhCcCHHHHhcC
Confidence            9999999999999999999976

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-35  Score=280.66  Aligned_cols=248  Identities=25%  Similarity=0.420  Sum_probs=191.4

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|+..+.||.|++|.||.     +++.||+|.+.......  ....+.+|+.+++.++||||+++++++..+...++||
T Consensus         5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence            3678889999999998873     67899999987543211  1234567999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      ||+. ++|.+++... ..+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||++....... 
T Consensus        83 e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~-  157 (291)
T cd07844          83 EYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPS-  157 (291)
T ss_pred             ecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCC-
Confidence            9996 5999988764 45889999999999999999999999   9999999999999999999999999986543211 


Q ss_pred             CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-cHHHHHHhc-CCC-------------
Q 012684          309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAAR-QRP-------------  372 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~-~~~~~~~~~-~~~-------------  372 (458)
                      .......++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||...... +....+... ..+             
T Consensus       158 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (291)
T cd07844         158 KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPE  237 (291)
T ss_pred             ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccc
Confidence            11122235778999999865 45788999999999999999999999765421 111111000 000             


Q ss_pred             -------CCC-----CChhhhH--HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 -------PFK-----APAKLYA--RGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 -------~~~-----~~~~~~~--~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                             ...     .....++  ..+.+++.+||+.+|++|||+.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~  288 (291)
T cd07844         238 FKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKH  288 (291)
T ss_pred             cccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcC
Confidence                   000     0001223  678899999999999999999998864

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2.8e-35  Score=288.00  Aligned_cols=253  Identities=26%  Similarity=0.394  Sum_probs=199.8

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----Cc
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~  224 (458)
                      .+|.+.+.||.|+||.++.     +|..||||.+..... .......+.+|+.+++.++||||+++++++...     ..
T Consensus         5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~   83 (337)
T cd07858           5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND   83 (337)
T ss_pred             cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence            4688889999999998873     688999999875432 223345667899999999999999999988644     34


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      .++++||+ +++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus        84 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~  159 (337)
T cd07858          84 VYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLARTTS  159 (337)
T ss_pred             EEEEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCccccccC
Confidence            79999999 5799999988888999999999999999999999999   9999999999999999999999999988654


Q ss_pred             cCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh---------------
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---------------  368 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~---------------  368 (458)
                      ... .......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+..               
T Consensus       160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (337)
T cd07858         160 EKG-DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRN  238 (337)
T ss_pred             CCc-ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCc
Confidence            322 22233457889999998765 4688899999999999999999999976542211111100               


Q ss_pred             ---------cC---CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHH
Q 012684          369 ---------RQ---RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESI  413 (458)
Q Consensus       369 ---------~~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~  413 (458)
                               ..   .+......+.+++.+.++|.+||+.+|.+|||+++++++  ++.+
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~~  297 (337)
T cd07858         239 EKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLASL  297 (337)
T ss_pred             hhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhhh
Confidence                     00   011111123567889999999999999999999999988  5443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-35  Score=291.97  Aligned_cols=246  Identities=28%  Similarity=0.526  Sum_probs=211.0

Q ss_pred             ccccCceeeccceEEEEE---E-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          155 LDFTNSVEITKGTFILAF---W-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~---~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      .+....++||+|+||.|+   |     +...||||.++.....  ....+|.+|+.+|.+++|||++++||++.+ ....
T Consensus       110 e~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~--~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  110 EQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLN--AIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccc--hhHHHHHHHHHHHHhccCcceeEEeeeecc-chhh
Confidence            356677899999999887   3     2358999999865432  267889999999999999999999999987 6788


Q ss_pred             EEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          227 IVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      +|||+++.|+|.+.|.+  ...|.......++.||+.|+.||.+++   +|||||-..|+++-....|||+|||+.+-+.
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg  263 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALG  263 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccC
Confidence            99999999999999987  345888899999999999999999999   9999999999999999999999999998776


Q ss_pred             cCCCCCc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhh
Q 012684          305 VKEDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY  381 (458)
Q Consensus       305 ~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (458)
                      ..++...  ....-+..|+|||.++...++.++|+|++||++|||++ |..||.+.....+...+....+.+.   ++.+
T Consensus       264 ~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR---Pk~c  340 (1039)
T KOG0199|consen  264 ENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR---PKYC  340 (1039)
T ss_pred             CCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC---CCCC
Confidence            5543321  23344678999999999999999999999999999998 8999999999888888865555554   4457


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++.+.+++..||..+|.+|||+..|.+.
T Consensus       341 sedIY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  341 SEDIYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             hHHHHHHHHHhccCCccccccHHHHHHh
Confidence            7999999999999999999999999744

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=7e-35  Score=279.61  Aligned_cols=248  Identities=26%  Similarity=0.430  Sum_probs=193.9

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|+..+.||.|++|.+|.     +|+.||+|.+..... .......+.+|+.++++++||||+++++++..+...++|||
T Consensus         3 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   81 (294)
T PLN00009          3 QYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE   81 (294)
T ss_pred             ceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence            577889999999998863     678999999865432 22334567889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC-CCCEEEeecCCccccccCC
Q 012684          231 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~-~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |++ ++|.+++.....  +++..+..++.|++.||+|||+++   ++|+||+|+||+++. ++.+||+|||++...... 
T Consensus        82 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~-  156 (294)
T PLN00009         82 YLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP-  156 (294)
T ss_pred             ccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC-
Confidence            995 588888765443  577888899999999999999999   999999999999985 557999999998765322 


Q ss_pred             CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-CCC-------------
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP-------------  372 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~~~-------------  372 (458)
                      ........+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||......+........ ..+             
T Consensus       157 ~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (294)
T PLN00009        157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD  236 (294)
T ss_pred             ccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchh
Confidence            1122334567889999988664 5788999999999999999999999876543332222111 000             


Q ss_pred             ------CCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 ------PFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 ------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                            ...     ...+.+++.+.+++.+||+.+|++||++.+++.+
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~  284 (294)
T PLN00009        237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEH  284 (294)
T ss_pred             hhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcC
Confidence                  000     0123457889999999999999999999999975

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=5.7e-35  Score=280.24  Aligned_cols=248  Identities=26%  Similarity=0.397  Sum_probs=192.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCc-----
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP-----  224 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~-----  224 (458)
                      +|+..+.||.|+||.||.     +|+.||+|.+..... .......+.+|+.+++.+ +||||+++++++.....     
T Consensus         2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            577889999999998873     688999999865432 222334677899999999 46999999999877655     


Q ss_pred             eEEEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC-CCCEEEeecC
Q 012684          225 MMIVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFG  298 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~-~~~vkl~Dfg  298 (458)
                      .|+||||+++ +|.+++...     ..+++..++.++.|++.||.|||+.+   ++|+||+|+||+++. ++.++|+|||
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg  156 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG  156 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence            8999999975 898887642     34799999999999999999999999   999999999999998 8899999999


Q ss_pred             CccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CC----
Q 012684          299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP----  372 (458)
Q Consensus       299 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~----  372 (458)
                      ++....... .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||...+.......+.... .+    
T Consensus       157 ~~~~~~~~~-~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (295)
T cd07837         157 LGRAFSIPV-KSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQV  235 (295)
T ss_pred             cceecCCCc-cccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            987653221 12223346788999998765 457889999999999999999999998765433222211110 00    


Q ss_pred             --------------CCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 --------------PFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 --------------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                    ...     ...+.+++.+.++|.+||..||.+||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~  291 (295)
T cd07837         236 WPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH  291 (295)
T ss_pred             CcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence                          000     0113467889999999999999999999999875

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9.8e-35  Score=281.26  Aligned_cols=249  Identities=18%  Similarity=0.337  Sum_probs=195.2

Q ss_pred             ccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccC
Q 012684          157 FTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP  233 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~  233 (458)
                      +.+.+.+|.|+++.++   .+|..||+|++..... .......+..|+.+++.++||||+++++++..+...+++|||++
T Consensus         4 ~~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~   82 (314)
T cd08216           4 TLIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMA   82 (314)
T ss_pred             hhhhHhhcCCceEEEEEecCCCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccC
Confidence            4445556666665544   3789999999976532 34566789999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC--
Q 012684          234 KGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--  309 (458)
Q Consensus       234 ~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~--  309 (458)
                      +++|.+++...  ..+++..+..++.|++.||.|||+++   |+|+||||+||+++.++.++|+|||.+.........  
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~  159 (314)
T cd08216          83 YGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQR  159 (314)
T ss_pred             CCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccc
Confidence            99999999763  45889999999999999999999999   999999999999999999999999988654322111  


Q ss_pred             ----CcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCC-----------
Q 012684          310 ----PLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP-----------  372 (458)
Q Consensus       310 ----~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~-----------  372 (458)
                          ......++..|+|||.+.+.  .++.++|+||+|+++++|++|+.||.................+           
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (314)
T cd08216         160 VVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLY  239 (314)
T ss_pred             ccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhh
Confidence                11233467789999998663  5788999999999999999999999875443322111110000           


Q ss_pred             -------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 -------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 -------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                         ........++..+.+++..||..||.+|||+++++++
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  295 (314)
T cd08216         240 EDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNH  295 (314)
T ss_pred             cCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcC
Confidence                               0001123456789999999999999999999999987

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=8.2e-35  Score=277.16  Aligned_cols=244  Identities=22%  Similarity=0.336  Sum_probs=190.5

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC--CceEEE
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS--SPMMIV  228 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~--~~~~lv  228 (458)
                      |++.+.||.|+||.++.     ++..||+|.+..... ..... ....|+.++.++ +||||+++++++.++  +..++|
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~-~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv   78 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK-SLEQV-NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV   78 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC-Cchhh-hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence            56678899999998763     688999999875432 22222 334688888888 599999999999887  889999


Q ss_pred             EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |||++ ++|.+++.. ...+++.++..++.|++.||+|||+.+   ++|+||+|+||+++. +.++|+|||++.......
T Consensus        79 ~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~  153 (282)
T cd07831          79 FELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP  153 (282)
T ss_pred             EecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence            99996 588888775 356899999999999999999999999   999999999999999 999999999997654322


Q ss_pred             CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC---------------C
Q 012684          308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ---------------R  371 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~---------------~  371 (458)
                        ......++..|+|||.+.+ ..++.++|+|||||++|+|++|..||...+..+.........               .
T Consensus       154 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (282)
T cd07831         154 --PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRH  231 (282)
T ss_pred             --CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccccc
Confidence              2223456889999997644 456889999999999999999999998765433222221100               0


Q ss_pred             CCC--C--------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 PPF--K--------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 ~~~--~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ..+  +        .....++..+.++|.+||+.+|.+||++.+++.+
T Consensus       232 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~  279 (282)
T cd07831         232 MNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRH  279 (282)
T ss_pred             ccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhC
Confidence            000  0        0113467899999999999999999999999875

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.2e-35  Score=286.73  Aligned_cols=249  Identities=27%  Similarity=0.406  Sum_probs=202.4

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-----ce
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-----~~  225 (458)
                      +|++.+.||.|+||.++.     +|..||+|.+.... ......+.+.+|+.+++.++||||+++++++....     ..
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence            477888999999998863     47899999997543 22344567888999999999999999999987765     78


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      |++|||+. ++|.+++.+...+++..+..++.|++.||.+||+.|   ++|+||||.||+++.++.++|+|||++.....
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~~~  155 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGVDP  155 (330)
T ss_pred             EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEeecc
Confidence            99999995 589999988778999999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCC---------
Q 012684          306 KED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP---------  373 (458)
Q Consensus       306 ~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~---------  373 (458)
                      ...  .......+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||......+....+......+         
T Consensus       156 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  235 (330)
T cd07834         156 DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFIT  235 (330)
T ss_pred             cccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhcc
Confidence            321  122344578889999999887 78899999999999999999999998766544333222211100         


Q ss_pred             ------------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 ------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                        .....+.++..+.++|.+||+.+|.+||++.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~  289 (330)
T cd07834         236 SEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH  289 (330)
T ss_pred             ccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence                              000112356789999999999999999999999987

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=7.4e-35  Score=281.36  Aligned_cols=249  Identities=24%  Similarity=0.355  Sum_probs=191.1

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-------
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-------  223 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-------  223 (458)
                      +|+..+.||.|+||.|+.     ++..||+|.+....... .....+.+|+.+++.++||||+++++++....       
T Consensus        13 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~   91 (310)
T cd07865          13 KYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYK   91 (310)
T ss_pred             heEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcC-CchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCC
Confidence            688899999999998873     68899999986543222 12234567999999999999999999986543       


Q ss_pred             -ceEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          224 -PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       224 -~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                       ..++||||+. ++|.+++.... .+++.++..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++.
T Consensus        92 ~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          92 GSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             ceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCCCcc
Confidence             3599999994 58888887643 6899999999999999999999999   9999999999999999999999999987


Q ss_pred             ccccCCCC---CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCC---
Q 012684          302 LLTVKEDR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP---  373 (458)
Q Consensus       302 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~---  373 (458)
                      ........   ......++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...........+.... ..+   
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV  247 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            65432211   11233467889999987664 46789999999999999999999998765433222221110 000   


Q ss_pred             --------------CCC----------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 --------------FKA----------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 --------------~~~----------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                    .+.          .....++.+.++|.+||..||.+|||+.+++++
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h  307 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNH  307 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcC
Confidence                          000          001124567899999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=8.8e-35  Score=280.90  Aligned_cols=247  Identities=26%  Similarity=0.453  Sum_probs=201.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      ..|+..+.||.|+||.++.     ++..+|+|.+.............+.+|+.+++.++|||++++++++......++||
T Consensus        15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   94 (308)
T cd06634          15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM   94 (308)
T ss_pred             HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEE
Confidence            3477778999999998862     67889999987543344455567888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      ||+. ++|.+++.. ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++......  
T Consensus        95 e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          95 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9995 688877754 445899999999999999999999999   999999999999999999999999998764321  


Q ss_pred             CCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL  385 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (458)
                         ....+++.|+|||.+.   ...++.++|||||||++|+|++|+.||...........+.....+..  ....++..+
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  243 (308)
T cd06634         169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYF  243 (308)
T ss_pred             ---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc--CcccccHHH
Confidence               2345788999999874   34578899999999999999999999977655444443333222222  234577889


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      .++|.+||..+|.+||++.+++.+...
T Consensus       244 ~~li~~cl~~~P~~Rp~~~~ll~~~~~  270 (308)
T cd06634         244 RNFVDSCLQKIPQDRPTSEVLLKHRFV  270 (308)
T ss_pred             HHHHHHHhhCCcccCCCHHHHhhCccc
Confidence            999999999999999999999988543

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=4.4e-35  Score=286.53  Aligned_cols=248  Identities=26%  Similarity=0.428  Sum_probs=193.1

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----Cc
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~  224 (458)
                      .+|++.+.||+|+||.||.     +|+.||+|.+...  ........+..|+.+++.++||||+++++++...     ..
T Consensus         5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~   82 (336)
T cd07849           5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFND   82 (336)
T ss_pred             cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccce
Confidence            4788899999999998873     6889999998642  2233445677899999999999999999987644     35


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      .++++||+. ++|.+++.. ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++....
T Consensus        83 ~~lv~e~~~-~~l~~~~~~-~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~  157 (336)
T cd07849          83 VYIVQELME-TDLYKLIKT-QHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARIAD  157 (336)
T ss_pred             EEEEehhcc-cCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceeecc
Confidence            799999995 588887754 56899999999999999999999999   9999999999999999999999999987654


Q ss_pred             cCCCC--CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-----------
Q 012684          305 VKEDR--PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-----------  370 (458)
Q Consensus       305 ~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-----------  370 (458)
                      .....  ......+++.|+|||.+.+ ..++.++||||||+++|+|++|+.||...........+....           
T Consensus       158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (336)
T cd07849         158 PEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCI  237 (336)
T ss_pred             ccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence            32211  1123457889999998654 467889999999999999999999997654221111110000           


Q ss_pred             -----------CC-----CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          371 -----------RP-----PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       371 -----------~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                 .+     +.....+.+++.+.++|.+||+.||.+|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h  292 (336)
T cd07849         238 ISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH  292 (336)
T ss_pred             hchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence                       00     0000112356789999999999999999999999998

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=9.1e-35  Score=281.57  Aligned_cols=250  Identities=23%  Similarity=0.364  Sum_probs=192.9

Q ss_pred             cccCceeeccceEEEEEE-------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceE
Q 012684          156 DFTNSVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMM  226 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~  226 (458)
                      +|++.+.||.|+||.++.       .+..||+|.+.............+.+|+.+++.++||||+++++++...  ...+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY   80 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence            467788999999998873       5789999999864322233335677899999999999999999999887  7899


Q ss_pred             EEEEccCCCCHHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC----CCCEEEeec
Q 012684          227 IVTEYLPKGDLRAFLKRK-----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD----SGNLKVADF  297 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~----~~~vkl~Df  297 (458)
                      +||||++ ++|.+++...     ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.    ++.+||+||
T Consensus        81 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df  156 (316)
T cd07842          81 LLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL  156 (316)
T ss_pred             EEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence            9999995 5787776532     25889999999999999999999999   999999999999999    899999999


Q ss_pred             CCccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH---------HHH
Q 012684          298 GVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV---------PKA  365 (458)
Q Consensus       298 g~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~---------~~~  365 (458)
                      |++........  .......+++.|+|||.+.+. .++.++|+||||+++++|++|+.||........         ...
T Consensus       157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (316)
T cd07842         157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLER  236 (316)
T ss_pred             ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHH
Confidence            99886543322  112334568889999987664 578899999999999999999999986554320         000


Q ss_pred             H-H------------------------hcCCCCCC--CCh------hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          366 Y-A------------------------ARQRPPFK--APA------KLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       366 ~-~------------------------~~~~~~~~--~~~------~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      + .                        .......+  ...      ...+..+.++|.+||+.||++|||+.+++.+
T Consensus       237 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~  313 (316)
T cd07842         237 IFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEH  313 (316)
T ss_pred             HHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence            0 0                        00011111  000      1345679999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.2e-34  Score=282.38  Aligned_cols=246  Identities=22%  Similarity=0.407  Sum_probs=190.6

Q ss_pred             eeeccc--eEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccC
Q 012684          161 VEITKG--TFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP  233 (458)
Q Consensus       161 ~~lg~G--~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~  233 (458)
                      ..||.|  +|+.|+.     +|+.||+|++..... .....+.+.+|+.+++.++||||++++++|..+...++||||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence            456666  7777752     689999999875533 34456788999999999999999999999999999999999999


Q ss_pred             CCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC-
Q 012684          234 KGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-  310 (458)
Q Consensus       234 ~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~-  310 (458)
                      +++|.+++.+..  .+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.++++||+.+.......... 
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~  159 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK  159 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence            999999988643  4888999999999999999999999   9999999999999999999999998654322111100 


Q ss_pred             -----cccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CC----------
Q 012684          311 -----LTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP----------  372 (458)
Q Consensus       311 -----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~----------  372 (458)
                           .....++..|+|||++.+.  .++.++|||||||++|+|++|+.||................ ..          
T Consensus       160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (328)
T cd08226         160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCE  239 (328)
T ss_pred             ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchh
Confidence                 0112345679999998764  46789999999999999999999998765433222111100 00          


Q ss_pred             -------------------------------C-CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          373 -------------------------------P-FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       373 -------------------------------~-~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                                                     . .......+++.+.+||++||+.||.+|||+.+++++-
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~  309 (328)
T cd08226         240 ESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHA  309 (328)
T ss_pred             hhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCH
Confidence                                           0 0011234678899999999999999999999999873

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=4e-37  Score=271.08  Aligned_cols=247  Identities=26%  Similarity=0.392  Sum_probs=196.1

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEE
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      +++....||.|.||.|.     -+|+..|||.++....  ....+++..|.+...+- +.||||++||.+..++..|+.|
T Consensus        65 ~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCM  142 (361)
T KOG1006|consen   65 NLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICM  142 (361)
T ss_pred             hHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeH
Confidence            45566789999999886     3799999999987643  45566788888765444 7999999999999999999999


Q ss_pred             EccCCCCHHHHHH-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          230 EYLPKGDLRAFLK-----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       230 e~~~~~~L~~~l~-----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      |+| ..+|..+-+     ....+++...-.|....+.||.||-..-+  |+|||+||+|||++..|.|||||||++-.+-
T Consensus       143 ELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lk--iIHRDvKPSNILldr~G~vKLCDFGIcGqLv  219 (361)
T KOG1006|consen  143 ELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELK--IIHRDVKPSNILLDRHGDVKLCDFGICGQLV  219 (361)
T ss_pred             HHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhh--hhhccCChhheEEecCCCEeeecccchHhHH
Confidence            999 567766543     24568888888899999999999987653  9999999999999999999999999986553


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCC---Chh
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA---PAK  379 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~  379 (458)
                      ..  ...+.-.|-..|||||.+...  .|+.++|+||||++|||+.||+.||...+..-........+.++.-.   ..-
T Consensus       220 ~S--iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~  297 (361)
T KOG1006|consen  220 DS--IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECV  297 (361)
T ss_pred             HH--HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCccccc
Confidence            22  222334466679999998653  58889999999999999999999999877632222223344443322   234


Q ss_pred             hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          380 LYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       380 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +++..+..+|..||.+|-..||.+.+|+++
T Consensus       298 ~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~  327 (361)
T KOG1006|consen  298 HYSFSMVRFINTCLIKDRSDRPKYDDLKKF  327 (361)
T ss_pred             ccCHHHHHHHHHHhhcccccCcchhhhhcC
Confidence            588999999999999999999999999875

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=2.5e-34  Score=276.10  Aligned_cols=247  Identities=28%  Similarity=0.469  Sum_probs=193.0

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      .+|++.+.||.|+||.++.     +|..||||.+.....  ......+..|+.++... .||||+++++++..+...+++
T Consensus        15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v   92 (296)
T cd06618          15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC   92 (296)
T ss_pred             chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence            4578889999999998763     389999999975432  22344556677666666 599999999999999999999


Q ss_pred             EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      |||+ +++|.+++.. .+.+++..+..++.|++.||.|||+ .+   ++|+||+|+||+++.++.++|+|||++......
T Consensus        93 ~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~  168 (296)
T cd06618          93 MELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVDS  168 (296)
T ss_pred             eecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccCC
Confidence            9998 5578877765 4568899999999999999999997 47   999999999999999999999999998765432


Q ss_pred             CCCCcccCCCCCcccCCcccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCC-cHHHHHHhcCCCCCCCChhhh
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPAKLY  381 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~~  381 (458)
                      ..  .....+++.|+|||.+.+..    ++.++|+||||+++|+|++|+.||...... +..........+..+ ....+
T Consensus       169 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~  245 (296)
T cd06618         169 KA--KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLP-PNEGF  245 (296)
T ss_pred             Cc--ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCCC-CCCCC
Confidence            21  12234677899999987543    778999999999999999999999764332 222222222222222 22347


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      +.++.++|.+||..||.+||++.+++.+.
T Consensus       246 ~~~l~~li~~~l~~~p~~Rp~~~~il~~~  274 (296)
T cd06618         246 SPDFCSFVDLCLTKDHRKRPKYRELLQHP  274 (296)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCh
Confidence            78999999999999999999999999874

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=9.9e-35  Score=279.55  Aligned_cols=250  Identities=26%  Similarity=0.406  Sum_probs=195.4

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC------
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~------  223 (458)
                      .+|++.+.||+|+||.|+.     +|+.||+|.+...... ......+.+|+.+++.++||||+++++++.+..      
T Consensus         7 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~   85 (302)
T cd07864           7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFK   85 (302)
T ss_pred             hhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhcc
Confidence            4688889999999998873     5789999999754321 122345678999999999999999999987654      


Q ss_pred             ----ceEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecC
Q 012684          224 ----PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (458)
Q Consensus       224 ----~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg  298 (458)
                          ..++|+||+++ ++.+++... ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||
T Consensus        86 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl~dfg  161 (302)
T cd07864          86 KDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKLADFG  161 (302)
T ss_pred             ccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEeCccc
Confidence                78999999965 777777653 46899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCC---
Q 012684          299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP---  373 (458)
Q Consensus       299 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~---  373 (458)
                      ++...............++..|+|||.+.+. .++.++|||||||++++|++|+.||......+....+.... .+.   
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (302)
T cd07864         162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAV  241 (302)
T ss_pred             ccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh
Confidence            9886644332233333457789999988653 56889999999999999999999998655433322222211 100   


Q ss_pred             ---C-------------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 ---F-------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ---~-------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                         .                   ......++..+.+++..||+.||.+||++++++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~  299 (302)
T cd07864         242 WPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNS  299 (302)
T ss_pred             cccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence               0                   01122457889999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.6e-34  Score=275.11  Aligned_cols=247  Identities=26%  Similarity=0.425  Sum_probs=198.6

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |...+.||.|++|.++.     +|+.+++|.+...... ......+..|+.+++.++||||+++++++..+...++||||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence            45678899999998863     6889999998765432 23446778899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       232 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      +++ +|.+++.. ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||.+....... ..
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-~~  154 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RP  154 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc-cc
Confidence            964 88888876 357899999999999999999999999   9999999999999999999999999987664332 12


Q ss_pred             cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-C-----------------
Q 012684          311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R-----------------  371 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~-----------------  371 (458)
                      .....++..|+|||.+.+. .++.++|+||||+++|+|++|+.||...+..+....+.... .                 
T Consensus       155 ~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (283)
T cd05118         155 YTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYK  234 (283)
T ss_pred             ccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhh
Confidence            2334567889999998776 78889999999999999999999997765433322221110 0                 


Q ss_pred             --------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 --------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                              .......+.++..+.++|..||+.||.+||++.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~  280 (283)
T cd05118         235 FSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAH  280 (283)
T ss_pred             hhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhC
Confidence                    00011123467889999999999999999999999875

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.1e-34  Score=272.28  Aligned_cols=246  Identities=27%  Similarity=0.435  Sum_probs=193.8

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC---CCCcceeeeeEEEeCCc----
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSSP----  224 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~i~~~~~~~~~~~~----  224 (458)
                      |++.+.||.|+||.+|.     ++..||+|.+....... .....+.+|+.+++++   +||||+++++++.....    
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~   79 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL   79 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence            56678999999998863     47899999997543322 2234456677777666   59999999999988776    


Q ss_pred             -eEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          225 -MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       225 -~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                       .+++|||+. ++|.+++....  .+++..++.++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||++.
T Consensus        80 ~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~  155 (287)
T cd07838          80 KLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR  155 (287)
T ss_pred             eeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence             999999995 58999887643  4899999999999999999999999   9999999999999999999999999987


Q ss_pred             ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCC----------
Q 012684          302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR----------  371 (458)
Q Consensus       302 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~----------  371 (458)
                      ......  ......+++.|+|||.+.+..++.++|+||||+++|+|++|+.||......+....+.....          
T Consensus       156 ~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  233 (287)
T cd07838         156 IYSFEM--ALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRN  233 (287)
T ss_pred             eccCCc--ccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCC
Confidence            664331  22233468889999999988899999999999999999999999987665544333321100          


Q ss_pred             -------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 -------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 -------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                   .........+++.+.++|.+||+.||.+||++.+++.+
T Consensus       234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~  284 (287)
T cd07838         234 VSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQH  284 (287)
T ss_pred             cccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcC
Confidence                         00001112456788999999999999999999999864

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=1.7e-34  Score=282.45  Aligned_cols=249  Identities=26%  Similarity=0.406  Sum_probs=196.1

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC--CceE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS--SPMM  226 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~--~~~~  226 (458)
                      .+|++.+.||.|+||.++.     +|..+|+|.+..... .......+..|+.+++++ +||||+++++++...  ...+
T Consensus         7 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~   85 (337)
T cd07852           7 RKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFR-NATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIY   85 (337)
T ss_pred             hHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccC-cchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEE
Confidence            4688889999999998763     578999998865432 223345677899999999 999999999998654  3589


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      +||||+. ++|.+++... .+++.....++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......
T Consensus        86 lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~  160 (337)
T cd07852          86 LVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARSLSEL  160 (337)
T ss_pred             EEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhccccc
Confidence            9999995 5999988765 7888899999999999999999999   999999999999999999999999998765433


Q ss_pred             CC----CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc------------
Q 012684          307 ED----RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR------------  369 (458)
Q Consensus       307 ~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~------------  369 (458)
                      ..    .......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+...            
T Consensus       161 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07852         161 EENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESI  240 (337)
T ss_pred             cccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHH
Confidence            21    12233457889999998755 45778999999999999999999999765543322221111            


Q ss_pred             ---------------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          370 ---------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       370 ---------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                     .........+.++..+.++|.+||+.||.+|||+.+++.+
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~  295 (337)
T cd07852         241 KSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH  295 (337)
T ss_pred             HhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence                           0111111223367889999999999999999999999986

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=3.7e-34  Score=302.37  Aligned_cols=144  Identities=29%  Similarity=0.516  Sum_probs=131.4

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|.+.+.||+|+||.||.     +++.||||++.............+..|+.+++.++||||+++++.+.....+|+||
T Consensus         4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm   83 (669)
T cd05610           4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM   83 (669)
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence            3688889999999998873     48899999997655555566677889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                      ||+.|++|.+++...+.+++..++.++.||+.||.|||+.+   |+||||||+|||++.++.++|+|||++.
T Consensus        84 Ey~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          84 EYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999988788999999999999999999999999   9999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.6e-34  Score=280.00  Aligned_cols=250  Identities=24%  Similarity=0.354  Sum_probs=195.9

Q ss_pred             ccc-CceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHH-----------HHHHHHHHHHHHhcCCCCcceeeeeE
Q 012684          156 DFT-NSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDD-----------RVRAFRDELALLQKIRHPNVVQFLGA  218 (458)
Q Consensus       156 ~~~-~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~hp~i~~~~~~  218 (458)
                      +|. +.+.||.|+||.||.     +|+.||+|.+.........           ....+.+|+.+++.++||||++++++
T Consensus         9 ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~   88 (335)
T PTZ00024          9 RYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDV   88 (335)
T ss_pred             chhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEE
Confidence            444 456799999998873     6889999998654322100           01246789999999999999999999


Q ss_pred             EEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecC
Q 012684          219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (458)
Q Consensus       219 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg  298 (458)
                      +..+...++||||+. ++|.+++.....+++.....++.|++.||.|||+.+   ++|+||+|+||+++.++.++|+|||
T Consensus        89 ~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl~dfg  164 (335)
T PTZ00024         89 YVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFG  164 (335)
T ss_pred             EecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEECCcc
Confidence            999999999999995 699999988778999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCC-------------CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHH
Q 012684          299 VSKLLTVKE-------------DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK  364 (458)
Q Consensus       299 ~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~  364 (458)
                      ++.......             ........+++.|+|||.+.+. .++.++|+||||+++|+|++|+.||......+...
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~~  244 (335)
T PTZ00024        165 LARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLG  244 (335)
T ss_pred             ceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence            987654110             1111223457789999998764 46889999999999999999999998776544332


Q ss_pred             HHHhcC-CCCC-----------------------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          365 AYAARQ-RPPF-----------------------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       365 ~~~~~~-~~~~-----------------------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+.... .+..                       .......+..+.++|..||+.+|.+|||+.+++.+
T Consensus       245 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~  313 (335)
T PTZ00024        245 RIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKH  313 (335)
T ss_pred             HHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcC
Confidence            221111 0000                       00112346789999999999999999999999986

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=3.3e-34  Score=279.84  Aligned_cols=249  Identities=22%  Similarity=0.345  Sum_probs=193.8

Q ss_pred             cccCceeeccceEEEEEE-----c--CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC----C
Q 012684          156 DFTNSVEITKGTFILAFW-----R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS----S  223 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~----~  223 (458)
                      +|++.+.||.|+||.++.     +  +..||+|.+..... .....+.+.+|+.+++++ +||||+++++.+...    .
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~   79 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFS-KKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN   79 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence            467788999999998863     3  67899999875332 223345677899999999 599999999875432    4


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ..+++++++ +++|.+++.....+++..+..++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++...
T Consensus        80 ~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~~~  155 (332)
T cd07857          80 ELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGF  155 (332)
T ss_pred             cEEEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCceec
Confidence            578999998 5799999988788999999999999999999999999   999999999999999999999999999765


Q ss_pred             ccCCC---CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc----------
Q 012684          304 TVKED---RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR----------  369 (458)
Q Consensus       304 ~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~----------  369 (458)
                      .....   .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|+.||...+...........          
T Consensus       156 ~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  235 (332)
T cd07857         156 SENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLS  235 (332)
T ss_pred             ccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHH
Confidence            43211   11233467889999998765 46889999999999999999999999875532222111100          


Q ss_pred             --------------C---CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          370 --------------Q---RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       370 --------------~---~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                    .   ...+....+..+..+.+++.+||+.||.+|||+.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~  292 (332)
T cd07857         236 RIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEH  292 (332)
T ss_pred             hhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence                          0   111111122356789999999999999999999999976

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=4.4e-35  Score=303.77  Aligned_cols=245  Identities=30%  Similarity=0.457  Sum_probs=187.8

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe---------
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ---------  221 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~---------  221 (458)
                      +|++...||+|+||.|+     .+|+.||||+|....  .......+.+|+..+.+++|||||++|..+.+         
T Consensus       480 DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~~e  557 (1351)
T KOG1035|consen  480 DFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTVLE  557 (1351)
T ss_pred             hhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccccc
Confidence            46777889999999887     489999999998765  45666788999999999999999999832100         


Q ss_pred             --------------------------------------------------------------------------------
Q 012684          222 --------------------------------------------------------------------------------  221 (458)
Q Consensus       222 --------------------------------------------------------------------------------  221 (458)
                                                                                                      
T Consensus       558 i~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~~e  637 (1351)
T KOG1035|consen  558 IVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSDSE  637 (1351)
T ss_pred             ccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccccC
Confidence                                                                                            


Q ss_pred             ----------------------C--------CceEEEEEccCCCCHHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCC
Q 012684          222 ----------------------S--------SPMMIVTEYLPKGDLRAFLKRKGAL-KPSTAVRFALDIARGMNYLHENK  270 (458)
Q Consensus       222 ----------------------~--------~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~i~~qi~~~l~~LH~~~  270 (458)
                                            +        ..+||-||||+..+|.+++.++... .....|+++++|++||.|+|+.|
T Consensus       638 ~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~g  717 (1351)
T KOG1035|consen  638 GSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQG  717 (1351)
T ss_pred             CccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCc
Confidence                                  0        1368999999887777777665443 47889999999999999999999


Q ss_pred             CCCeeeCCCCCCCEEecCCCCEEEeecCCccccc-----------------cCCCCCcccCCCCCcccCCcccCCCC---
Q 012684          271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT-----------------VKEDRPLTCQDTSCRYVAPEVFKNEE---  330 (458)
Q Consensus       271 ~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~-----------------~~~~~~~~~~~gt~~y~aPE~~~~~~---  330 (458)
                         ++||||||.|||+++++.|||+|||++....                 .......+...||.-|+|||++.+..   
T Consensus       718 ---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~  794 (1351)
T KOG1035|consen  718 ---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK  794 (1351)
T ss_pred             ---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence               9999999999999999999999999998621                 01112335678999999999997764   


Q ss_pred             CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCC-CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 012684          331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK-APAKLYARGLKELIEECWNEKPAKRPTFRQIIT  408 (458)
Q Consensus       331 ~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  408 (458)
                      |+.|.||||||++++||+   +||...-.......-.+.+..+.+ .....--+.-..+|++|++.||.+||||.+||+
T Consensus       795 Yn~KiDmYSLGIVlFEM~---yPF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  795 YNSKIDMYSLGIVLFEML---YPFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             ccchhhhHHHHHHHHHHh---ccCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            899999999999999997   556653332221111222222222 001112245678999999999999999999996

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=3.4e-34  Score=272.83  Aligned_cols=247  Identities=28%  Similarity=0.478  Sum_probs=197.5

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |+..+.||.|+||.+|.     +++.||+|.+.... ......+.+..|+.+++.++||||+++++++.+....++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence            45567899999998874     58999999997653 2233345677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      +. ++|.+++.+. ..+++..+..++.|++.||.+||+.+   ++|+||+|+||+++.++.++|+|||.+........ .
T Consensus        80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~-~  154 (282)
T cd07829          80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-T  154 (282)
T ss_pred             cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-c
Confidence            96 5999999876 57999999999999999999999999   99999999999999999999999999876543321 2


Q ss_pred             cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-------------------
Q 012684          311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-------------------  370 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-------------------  370 (458)
                      .....++..|+|||.+.+. .++.++|+||||++++++++|+.||...........+....                   
T Consensus       155 ~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  234 (282)
T cd07829         155 YTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKP  234 (282)
T ss_pred             cCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccc
Confidence            2333456789999998766 78889999999999999999999998765433222221100                   


Q ss_pred             -CCCCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          371 -RPPFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       371 -~~~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                       .+...     ...+.++..+.++|..||..||.+||++.+++.+
T Consensus       235 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~  279 (282)
T cd07829         235 TFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKH  279 (282)
T ss_pred             cccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhC
Confidence             00000     1112346789999999999999999999999875

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.5e-35  Score=285.83  Aligned_cols=239  Identities=26%  Similarity=0.400  Sum_probs=197.6

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~l  227 (458)
                      ...|.....+|.|+|+.+.+     ++...++|++....       .+-.+|+.++... +||||+++.+.+.++...|+
T Consensus       321 ~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~-------~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~  393 (612)
T KOG0603|consen  321 TESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRA-------DDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYL  393 (612)
T ss_pred             chhhccccccCCCCccceeeeeccccccchhheeccccc-------cccccccchhhhhcCCCcceeecceecCCceeee
Confidence            34577778899999987764     67899999997652       1234577666666 79999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe-cCCCCEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR-DDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~-~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      |||++.|+-|.+.+...+.+. ..+..|+.+|+.|+.|||++|   ++||||||+|||+ +..++++|+|||.++.....
T Consensus       394 v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~  469 (612)
T KOG0603|consen  394 VMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS  469 (612)
T ss_pred             eehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCchh
Confidence            999999998888877665555 777889999999999999999   9999999999999 68899999999999876533


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                          .....-|..|.|||++....+++++|+||||++||+|++|+.||......  .....+.+.+.+.   ..+|...+
T Consensus       470 ----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~--~ei~~~i~~~~~s---~~vS~~AK  540 (612)
T KOG0603|consen  470 ----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG--IEIHTRIQMPKFS---ECVSDEAK  540 (612)
T ss_pred             ----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch--HHHHHhhcCCccc---cccCHHHH
Confidence                22223478899999999999999999999999999999999999876655  2222233344332   66899999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      +||..||+.||.+||++.++..+-.-
T Consensus       541 dLl~~LL~~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  541 DLLQQLLQVDPALRLGADEIGAHPWF  566 (612)
T ss_pred             HHHHHhccCChhhCcChhhhccCcch
Confidence            99999999999999999999988544

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=4.4e-34  Score=269.00  Aligned_cols=246  Identities=27%  Similarity=0.435  Sum_probs=195.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCC--CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      +|.+.+.||.|+||.++.     .+..+++|.+......  .......+..|+.+++.++||||+++++++.+....++|
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   80 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII   80 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence            477889999999998873     3445666666532221  122234566789999999999999999999988899999


Q ss_pred             EEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          229 TEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      |||+++++|.+++..    ...+++..+..++.|++.||.|||+.+   ++|+||+|+||+++. +.++|+|||++....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~  156 (260)
T cd08222          81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM  156 (260)
T ss_pred             EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence            999999999988864    346899999999999999999999999   999999999999975 579999999987653


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      ... .......+++.|+|||.+.+..++.++|+||||+++++|++|..||..............   ...+..+..++..
T Consensus       157 ~~~-~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~  232 (260)
T cd08222         157 GSC-DLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVE---GPTPSLPETYSRQ  232 (260)
T ss_pred             CCc-ccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHc---CCCCCCcchhcHH
Confidence            321 122234578889999999888888999999999999999999999976544333333322   2222334567889


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.++|.+||..+|.+||++.+++++
T Consensus       233 ~~~li~~~l~~~p~~Rp~~~~il~~  257 (260)
T cd08222         233 LNSIMQSMLNKDPSLRPSAAEILRN  257 (260)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhhC
Confidence            9999999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.3e-34  Score=279.07  Aligned_cols=246  Identities=24%  Similarity=0.369  Sum_probs=195.0

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-----
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----  223 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-----  223 (458)
                      ..+|++.+.||.|+||.|+.     +|..||+|.+.... ........+.+|+.+++.++||||+++++++..+.     
T Consensus        14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07880          14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRF   92 (343)
T ss_pred             ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccccc
Confidence            34688899999999998863     68899999986543 23334456788999999999999999999987543     


Q ss_pred             -ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          224 -PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       224 -~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                       ..++||||+ +++|.+++.. ..+++..+..++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++..
T Consensus        93 ~~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~dfg~~~~  167 (343)
T cd07880          93 HDFYLVMPFM-GTDLGKLMKH-EKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQ  167 (343)
T ss_pred             ceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccccc
Confidence             358999999 7899988764 56899999999999999999999999   99999999999999999999999999876


Q ss_pred             cccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCC----------
Q 012684          303 LTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR----------  371 (458)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~----------  371 (458)
                      ...    ......+++.|+|||.+.+ ..++.++|+||||+++|++++|+.||...........+.....          
T Consensus       168 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (343)
T cd07880         168 TDS----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKL  243 (343)
T ss_pred             ccc----CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhh
Confidence            532    1223456888999998876 3578899999999999999999999986554322221111000          


Q ss_pred             ------------C-----CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 ------------P-----PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 ------------~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                  +     .+......+++.+.++|.+||+.||.+|||+.+++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~  298 (343)
T cd07880         244 QSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAH  298 (343)
T ss_pred             cchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                        0     0001113456789999999999999999999999965

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=7.9e-34  Score=276.58  Aligned_cols=247  Identities=28%  Similarity=0.421  Sum_probs=195.2

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe-CCceE
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMM  226 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~~~~  226 (458)
                      .+.+|++.+.||.|+||.++.     +|..||+|.+..... .....+.+..|+.+++.++||||+++++++.. ....+
T Consensus         8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~   86 (328)
T cd07856           8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY   86 (328)
T ss_pred             cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence            455799999999999998873     688999998865432 22334567789999999999999999999865 45789


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ++|||+ +++|.+++.. ..+++..+..++.|+++||.|||+.+   ++|+||+|+||+++.++.++|+|||.+..... 
T Consensus        87 lv~e~~-~~~L~~~~~~-~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-  160 (328)
T cd07856          87 FVTELL-GTDLHRLLTS-RPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQDP-  160 (328)
T ss_pred             EEeehh-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCccccccccCC-
Confidence            999999 6799988764 45888888899999999999999999   99999999999999999999999999875422 


Q ss_pred             CCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh-----------------
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-----------------  368 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~-----------------  368 (458)
                         ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+..                 
T Consensus       161 ---~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (328)
T cd07856         161 ---QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSEN  237 (328)
T ss_pred             ---CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchh
Confidence               1223456788999998765 5688999999999999999999999976543211111000                 


Q ss_pred             ------cC----CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          369 ------RQ----RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       369 ------~~----~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                            ..    ..+.....+.++..+.++|.+||+.+|.+||++.+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~  288 (328)
T cd07856         238 TLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH  288 (328)
T ss_pred             hHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                  00    001111123467889999999999999999999999987

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-34  Score=281.31  Aligned_cols=246  Identities=27%  Similarity=0.380  Sum_probs=196.6

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc----
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----  224 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~----  224 (458)
                      ..+|++...||.|+||.+|.     ++..||+|.+..... .......+.+|+.+++.++||||+++++++.....    
T Consensus        14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   92 (343)
T cd07851          14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQ-SAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF   92 (343)
T ss_pred             cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccc-hhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence            44688899999999998873     578999999875432 22334567789999999999999999998866554    


Q ss_pred             --eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          225 --MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       225 --~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                        .++|+||+ +++|.+++.. ..+++..+..++.|++.||.|||+.|   ++|+||+|+||+++.++.++|+|||++..
T Consensus        93 ~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~~~~  167 (343)
T cd07851          93 QDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGLARH  167 (343)
T ss_pred             ccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEcccccccc
Confidence              89999999 7799998875 46999999999999999999999999   99999999999999999999999999876


Q ss_pred             cccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCC---------
Q 012684          303 LTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP---------  372 (458)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~---------  372 (458)
                      ....    .....++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+......         
T Consensus       168 ~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (343)
T cd07851         168 TDDE----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKI  243 (343)
T ss_pred             cccc----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhc
Confidence            5322    233456888999998765 36788999999999999999999999866544332222111100         


Q ss_pred             ------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 ------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 ------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                        .+......+++.+.++|.+||+.||.+|||+.+++.+
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h  298 (343)
T cd07851         244 SSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAH  298 (343)
T ss_pred             cchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcC
Confidence                              0001112357889999999999999999999999986

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.6e-34  Score=278.32  Aligned_cols=247  Identities=26%  Similarity=0.358  Sum_probs=194.1

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----  222 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----  222 (458)
                      ...+|++.+.||+|+||.++.     +|..||+|.+..... .....+.+.+|+.++++++||||+++++++...     
T Consensus        15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~   93 (345)
T cd07877          15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE   93 (345)
T ss_pred             ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence            345788899999999998762     688999999875422 223345677899999999999999999988543     


Q ss_pred             -CceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          223 -SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       223 -~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                       ...+++++++ +++|.+++.. ..+++..+..++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++.
T Consensus        94 ~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~dfg~~~  168 (345)
T cd07877          94 FNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR  168 (345)
T ss_pred             cccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEEEecccccc
Confidence             3478888887 8899988765 46899999999999999999999999   9999999999999999999999999987


Q ss_pred             ccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCC---------
Q 012684          302 LLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR---------  371 (458)
Q Consensus       302 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~---------  371 (458)
                      ....    ......++..|+|||.+.+ ..++.++|+||||+++|+|++|+.||...........+.....         
T Consensus       169 ~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (345)
T cd07877         169 HTDD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKK  244 (345)
T ss_pred             cccc----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhh
Confidence            5432    2233457888999998866 4678899999999999999999999976544322221111000         


Q ss_pred             ------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 ------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 ------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                        ..+.......++.+.++|..||+.||.+||++.+++.+
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h  300 (345)
T cd07877         245 ISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  300 (345)
T ss_pred             cccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence                              00001111346789999999999999999999999987

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=5.6e-34  Score=275.32  Aligned_cols=251  Identities=28%  Similarity=0.404  Sum_probs=192.1

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------  222 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~------  222 (458)
                      ..+|++.+.||.|+||.+|.     +++.+|+|.+........ ....+.+|+.+++.++||||+++++++...      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~-~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDG-FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCC-cchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence            35788999999999998873     578999999865432221 123466799999999999999999987543      


Q ss_pred             --CceEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCC
Q 012684          223 --SPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (458)
Q Consensus       223 --~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~  299 (458)
                        ..+++||||+. ++|...+.. ...+++..+..++.|+++||.|||+.+   ++|+||||+||+++.++.++|+|||+
T Consensus        86 ~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~  161 (311)
T cd07866          86 KRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFGL  161 (311)
T ss_pred             cCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCcc
Confidence              34699999995 577777664 446999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCC----------cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh
Q 012684          300 SKLLTVKEDRP----------LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA  368 (458)
Q Consensus       300 ~~~~~~~~~~~----------~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~  368 (458)
                      +..........          .....+++.|+|||.+.+. .++.++||||||+++|+|++|+.||...+.......+..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~  241 (311)
T cd07866         162 ARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFK  241 (311)
T ss_pred             chhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence            87654322111          1223457789999987654 578899999999999999999999987665433332221


Q ss_pred             cCCCC----------------------CCC----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          369 RQRPP----------------------FKA----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       369 ~~~~~----------------------~~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ....+                      .+.    ....+++.+.++|.+||+.||.+|||+.+++.+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~  308 (311)
T cd07866         242 LCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEH  308 (311)
T ss_pred             HhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcC
Confidence            11100                      000    001234678899999999999999999999865

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.8e-33  Score=268.08  Aligned_cols=245  Identities=24%  Similarity=0.403  Sum_probs=192.5

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEE
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      |++.+.||.|+||.++.     +++.|++|.+.......  ......+|+..++.+. ||||+++++++..++..++|||
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e   78 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE   78 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence            56678999999998863     57889999987543221  1223456889999998 9999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+ +++|.+++....  .+++..+..++.|++.+|.|||+.+   ++|+||+|+||+++.++.++|+|||++......  
T Consensus        79 ~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~--  152 (283)
T cd07830          79 YM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSR--  152 (283)
T ss_pred             cC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCC--
Confidence            99 789999887754  6899999999999999999999999   999999999999999999999999998765432  


Q ss_pred             CCcccCCCCCcccCCcccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CC--------------
Q 012684          309 RPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP--------------  372 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~--------------  372 (458)
                      .......++..|+|||.+. +..++.++|+||||+++++|++|+.||................ .+              
T Consensus       153 ~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (283)
T cd07830         153 PPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK  232 (283)
T ss_pred             CCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhcc
Confidence            1223345788899999874 4457889999999999999999999997665433222211100 00              


Q ss_pred             ---C--------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 ---P--------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 ---~--------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                         .        ........+..+.++|.+||..||.+|||+++++.+
T Consensus       233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~  280 (283)
T cd07830         233 LGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQH  280 (283)
T ss_pred             ccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhC
Confidence               0        000011225789999999999999999999999865

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=7.2e-34  Score=278.58  Aligned_cols=249  Identities=25%  Similarity=0.385  Sum_probs=193.9

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC------
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~------  223 (458)
                      .+|.....||.|+||.++.     +|+.||+|.+..... .......+.+|+.+++.++||||+++++++....      
T Consensus        15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~   93 (342)
T cd07879          15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ   93 (342)
T ss_pred             cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence            4688889999999998863     588999999875432 2223455788999999999999999999986543      


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ..++|+||+. .+|.+++.  ..+++..+..++.|++.||+|||+.+   ++||||||+||+++.++.++|+|||++...
T Consensus        94 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          94 DFYLVMPYMQ-TDLQKIMG--HPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             eEEEEecccc-cCHHHHHc--CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence            4699999994 57877653  35899999999999999999999999   999999999999999999999999998754


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC------------
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------  370 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~------------  370 (458)
                      ..    ......+++.|+|||.+.+ ..++.++|+||||+++|+|++|+.||...+.......+....            
T Consensus       168 ~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (342)
T cd07879         168 DA----EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLE  243 (342)
T ss_pred             CC----CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhc
Confidence            32    1223456788999999876 467889999999999999999999998765332222211100            


Q ss_pred             ----------CC-----CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHHH
Q 012684          371 ----------RP-----PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESIN  414 (458)
Q Consensus       371 ----------~~-----~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~  414 (458)
                                .+     .+....+..++.+.++|.+||+.||.+||++.+++.+  ++.+.
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         244 DKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             ccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhcc
Confidence                      00     0001112356789999999999999999999999976  55553

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=6.6e-34  Score=278.83  Aligned_cols=248  Identities=23%  Similarity=0.390  Sum_probs=191.9

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------  222 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~------  222 (458)
                      ..+|++.+.||.|+||.|+.     +|..||+|.+.....   ...+.+.+|+.+++.++||||+++++++...      
T Consensus         4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~   80 (342)
T cd07854           4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTE   80 (342)
T ss_pred             CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhccccccccc
Confidence            46789999999999998873     588999999865432   3345678899999999999999999876543      


Q ss_pred             --------CceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC-CCCEE
Q 012684          223 --------SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLK  293 (458)
Q Consensus       223 --------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~-~~~vk  293 (458)
                              ...++||||++ ++|.+++.. +.+++..+..++.|+++||.|||+.|   ++||||||+||+++. ++.++
T Consensus        81 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k  155 (342)
T cd07854          81 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK  155 (342)
T ss_pred             ccccccccceEEEEeeccc-ccHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence                    35789999995 589888764 46899999999999999999999999   999999999999984 55789


Q ss_pred             EeecCCccccccCCCC--CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-
Q 012684          294 VADFGVSKLLTVKEDR--PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-  369 (458)
Q Consensus       294 l~Dfg~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-  369 (458)
                      |+|||++.........  ......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||......+........ 
T Consensus       156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~  235 (342)
T cd07854         156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESV  235 (342)
T ss_pred             ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            9999998765322111  1122346788999998654 46778999999999999999999999766543322221110 


Q ss_pred             ----------------------CCCC---CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          370 ----------------------QRPP---FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       370 ----------------------~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                            ....   .....+.++.++.++|..||..||.+|||+.+++.+
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h  300 (342)
T cd07854         236 PVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMH  300 (342)
T ss_pred             CCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCC
Confidence                                  0000   000112466789999999999999999999999976

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=7.7e-35  Score=261.83  Aligned_cols=250  Identities=25%  Similarity=0.392  Sum_probs=190.7

Q ss_pred             cccCceeeccceEEEEEEc---------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe-CCce
Q 012684          156 DFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~~~  225 (458)
                      .|+...+||+|+||.||..         ...+|+|.+..+...+.-.. ..-+|+.+++-++||||+.+..+|.. +..+
T Consensus        25 ~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~-SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v  103 (438)
T KOG0666|consen   25 EYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISM-SACREIALLRELKHPNVISLVKVFLSHDKKV  103 (438)
T ss_pred             HhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCH-HHHHHHHHHHHhcCCcchhHHHHHhccCceE
Confidence            5778889999999999852         34799999976533222222 34569999999999999999999877 7789


Q ss_pred             EEEEEccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC----CCEEEee
Q 012684          226 MIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVAD  296 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~----~~vkl~D  296 (458)
                      ++++||.+ -+|+.+++-     ...++...+..|++||+.|+.|||+++   |+||||||+|||+..+    |+|||+|
T Consensus       104 ~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  104 WLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             EEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEeec
Confidence            99999995 499998863     234888999999999999999999999   9999999999999988    8999999


Q ss_pred             cCCccccccCC--CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCC----------cHH
Q 012684          297 FGVSKLLTVKE--DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDN----------EVP  363 (458)
Q Consensus       297 fg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~----------~~~  363 (458)
                      ||+++.+...-  .......+.|.+|+|||++.|. .|+++.|+|++||++.||++-.+.|.+....          ...
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            99998875431  1122445569999999998875 6889999999999999999988877643221          011


Q ss_pred             HHHHhcCCCCCCC---------C-----------------------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          364 KAYAARQRPPFKA---------P-----------------------AKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       364 ~~~~~~~~~~~~~---------~-----------------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      ......+.|.-..         .                       ...-++...+|+.+||+.||.+|.|+++++++.
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~  338 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHP  338 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhccc
Confidence            1111111111000         0                       001123467899999999999999999999874

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.6e-33  Score=291.76  Aligned_cols=258  Identities=30%  Similarity=0.522  Sum_probs=215.0

Q ss_pred             CcccCcCCccccCceeeccceEEEEEE------------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcce
Q 012684          147 EYEIDPHELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVV  213 (458)
Q Consensus       147 ~~~~~~~~~~~~~~~~lg~G~~~~v~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~  213 (458)
                      .||++...+.  +.+.||.|.||.|+.            ....||||.++....  ....+.+..|+.+|+.+ .||||+
T Consensus       290 ~~e~~~~~l~--~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~--~~~~~~~~~El~~m~~~g~H~niv  365 (609)
T KOG0200|consen  290 KWEIPRENLK--LGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENAS--SSEKKDLMSELNVLKELGKHPNIV  365 (609)
T ss_pred             ceeechhhcc--ccceeecccccceEeEEEeecccccccceEEEEEEecccccC--cHHHHHHHHHHHHHHHhcCCcchh
Confidence            7787777664  444999999997752            146899999986643  36678899999999999 599999


Q ss_pred             eeeeEEEeCCceEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeC
Q 012684          214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR  277 (458)
Q Consensus       214 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~  277 (458)
                      .++++|...+.+++|+||+..|+|.+++...+                .++..+.+.+++||+.|++||++..   ++||
T Consensus       366 ~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHR  442 (609)
T KOG0200|consen  366 NLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHR  442 (609)
T ss_pred             hheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccch
Confidence            99999999999999999999999999998755                3888899999999999999999998   9999


Q ss_pred             CCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCC--CCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 012684          278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF  354 (458)
Q Consensus       278 Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf  354 (458)
                      ||-.+|||+..+..+|++|||+++..............  -+..|||||.+....++.++||||+|++|||+++ |..||
T Consensus       443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY  522 (609)
T KOG0200|consen  443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY  522 (609)
T ss_pred             hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence            99999999999999999999999865433322212122  3556999999999999999999999999999998 99999


Q ss_pred             CCCC-CCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          355 TMKH-DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       355 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      .+.. ..+....+....+...   |.++++++.++++.||+.+|++||++.++.+.++...
T Consensus       523 p~~~~~~~l~~~l~~G~r~~~---P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~l  580 (609)
T KOG0200|consen  523 PGIPPTEELLEFLKEGNRMEQ---PEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKHL  580 (609)
T ss_pred             CCCCcHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHHH
Confidence            9855 4444444433335454   4556889999999999999999999999999998854

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1.9e-33  Score=261.18  Aligned_cols=215  Identities=19%  Similarity=0.252  Sum_probs=173.5

Q ss_pred             ceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCHHHH
Q 012684          166 GTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAF  240 (458)
Q Consensus       166 G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~  240 (458)
                      |.|+.|+     .+|+.||+|.+....        ....|...+....||||+++++++......+++|||++|++|.++
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~   75 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH   75 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence            5666555     378999999997542        123344445555799999999999999999999999999999999


Q ss_pred             HHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCCCCCcc
Q 012684          241 LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY  320 (458)
Q Consensus       241 l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y  320 (458)
                      +.+...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++++|||.+......    .....++..|
T Consensus        76 l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~----~~~~~~~~~y  148 (237)
T cd05576          76 ISKFLNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS----CDGEAVENMY  148 (237)
T ss_pred             HHHhcCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhccccc----cccCCcCccc
Confidence            988778999999999999999999999999   999999999999999999999999987654322    1223346679


Q ss_pred             cCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCC
Q 012684          321 VAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR  400 (458)
Q Consensus       321 ~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R  400 (458)
                      +|||.+.+..++.++|+||+|+++|+|++|+.||......     .......   ..+..+++.++++|.+||+.||.+|
T Consensus       149 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~R  220 (237)
T cd05576         149 CAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-----INTHTTL---NIPEWVSEEARSLLQQLLQFNPTER  220 (237)
T ss_pred             cCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-----ccccccc---CCcccCCHHHHHHHHHHccCCHHHh
Confidence            9999998888899999999999999999999887643211     0000111   1234577899999999999999999


Q ss_pred             CCH
Q 012684          401 PTF  403 (458)
Q Consensus       401 ps~  403 (458)
                      |++
T Consensus       221 ~~~  223 (237)
T cd05576         221 LGA  223 (237)
T ss_pred             cCC
Confidence            997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1e-33  Score=280.08  Aligned_cols=252  Identities=25%  Similarity=0.398  Sum_probs=198.2

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC------
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~------  223 (458)
                      ..|...+.||+|+||.|+.     +|+.||||.++...  .....+...+|++++++++|||||++++.-....      
T Consensus        13 y~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~   90 (732)
T KOG4250|consen   13 YLWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTR   90 (732)
T ss_pred             cceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccc
Confidence            3466677899999999983     79999999998653  3445677889999999999999999999865433      


Q ss_pred             ceEEEEEccCCCCHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC--CC--CEEEee
Q 012684          224 PMMIVTEYLPKGDLRAFLKRK---GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SG--NLKVAD  296 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~--~~--~vkl~D  296 (458)
                      ...+|||||.||+|...+++.   ..+++.+.+.++.+++.||.|||++|   |+||||||.||++-.  +|  ..||+|
T Consensus        91 ~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtD  167 (732)
T KOG4250|consen   91 LPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTD  167 (732)
T ss_pred             cceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeec
Confidence            468999999999999999863   34999999999999999999999999   999999999998753  33  479999


Q ss_pred             cCCccccccCCCCCcccCCCCCcccCCcccC-CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc----HHHHHHhcC-
Q 012684          297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYAARQ-  370 (458)
Q Consensus       297 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~----~~~~~~~~~-  370 (458)
                      ||.|+.+..  +.......||+.|++||++- ...|+...|.|||||++|+++||..||.......    +.-.+..+. 
T Consensus       168 fG~Arel~d--~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp  245 (732)
T KOG4250|consen  168 FGAARELDD--NSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKP  245 (732)
T ss_pred             ccccccCCC--CCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCC
Confidence            999998754  34667889999999999987 4788889999999999999999999997543331    221111111 


Q ss_pred             C-----------------CCCCCChhhhH----HHHHHHHHHHcccCCCCCC--CHHHHHHHHHHHH
Q 012684          371 R-----------------PPFKAPAKLYA----RGLKELIEECWNEKPAKRP--TFRQIITRLESIN  414 (458)
Q Consensus       371 ~-----------------~~~~~~~~~~~----~~l~~li~~~l~~dp~~Rp--s~~~ll~~L~~~~  414 (458)
                      .                 ..++. +.+++    ..+-.++..+|..+|.+|.  ...+....+..+.
T Consensus       246 ~~v~i~~~~~eNgpv~~s~~lP~-p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL  311 (732)
T KOG4250|consen  246 SGVAIGAQEEENGPVEWSSTLPQ-PNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL  311 (732)
T ss_pred             CceeEeeecccCCceeeeccCCC-cccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence            0                 01111 22333    3456788999999999999  7777766666654

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-33  Score=280.58  Aligned_cols=249  Identities=27%  Similarity=0.417  Sum_probs=205.0

Q ss_pred             cCCccccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEe----
Q 012684          152 PHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ----  221 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~----  221 (458)
                      ..+..|++.+.+|.|.+|.|+     .+|+-.|+|+......    ..++++.|.++++.+ .|||++.+|++|..    
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d----~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~   91 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTED----EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPG   91 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCcc----ccHHHHHHHHHHHhccCCCCcceEEEEEEEecCC
Confidence            334456777899999998887     3788899999875432    234677899999988 69999999999853    


Q ss_pred             -CCceEEEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecC
Q 012684          222 -SSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (458)
Q Consensus       222 -~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg  298 (458)
                       ++.+|||||||.||+.-|+++.  ..++.++.+..|++.++.||.+||.+.   ++|||||-.|||++.++.|||+|||
T Consensus        92 ~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKLvDFG  168 (953)
T KOG0587|consen   92 NGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKLVDFG  168 (953)
T ss_pred             CCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEEeeee
Confidence             4679999999999999999875  456899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCCCCcccCCCCCcccCCcccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCC
Q 012684          299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP  373 (458)
Q Consensus       299 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~  373 (458)
                      .+..+...... .....|||.|||||++...     .|+.++|+||||++..||.-|.+|+.+.-+....-.+... -|+
T Consensus       169 vSaQldsT~gr-RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRN-PPP  246 (953)
T KOG0587|consen  169 VSAQLDSTVGR-RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRN-PPP  246 (953)
T ss_pred             eeeeeeccccc-ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCC-CCc
Confidence            99887665433 3456799999999999664     4667899999999999999999999987764433222111 111


Q ss_pred             CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .-.-+..++.++.+||..||.+|..+||+..++++|
T Consensus       247 kLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~h  282 (953)
T KOG0587|consen  247 KLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKH  282 (953)
T ss_pred             cccchhhHHHHHHHHHHHHHhhccccCcchhhhccC
Confidence            122367789999999999999999999999999986

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-33  Score=262.24  Aligned_cols=256  Identities=30%  Similarity=0.476  Sum_probs=201.8

Q ss_pred             CccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC--CCCcceeeeeEEEeCC----c
Q 012684          154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQSS----P  224 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~i~~~~~~~~~~~----~  224 (458)
                      ..+.+..+.||+|.||.|+   |.|+.||||++....      ...+.+|.++.+..  +|+||+.+++.-..+.    .
T Consensus       210 arqI~L~e~IGkGRyGEVwrG~wrGe~VAVKiF~srd------E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQ  283 (513)
T KOG2052|consen  210 ARQIVLQEIIGKGRFGEVWRGRWRGEDVAVKIFSSRD------ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQ  283 (513)
T ss_pred             hheeEEEEEecCccccceeeccccCCceEEEEecccc------hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEE
Confidence            4467788999999999876   899999999996431      13466677776655  9999999999865432    5


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeeeCCCCCCCEEecCCCCEEEeecCC
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-----NKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-----~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~  299 (458)
                      +|||++|-+.|+|+|+|.+ ..++....++++..++.||++||.     +|+..|+|||||..|||+..++..-|+|+|+
T Consensus       284 LwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL  362 (513)
T KOG2052|consen  284 LWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL  362 (513)
T ss_pred             EEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence            8999999999999999998 569999999999999999999993     4566799999999999999999999999999


Q ss_pred             ccccccCC---CCCcccCCCCCcccCCcccCCCC------CCCchhHHHHHHHHHHHHcC----------CCCCCCCCCC
Q 012684          300 SKLLTVKE---DRPLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEG----------CPPFTMKHDN  360 (458)
Q Consensus       300 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~~l~~lltg----------~~pf~~~~~~  360 (458)
                      |.......   +...+...||.+|||||++...-      .-..+||||||.++||++.+          +.||.+..+.
T Consensus       363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~  442 (513)
T KOG2052|consen  363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPS  442 (513)
T ss_pred             eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCC
Confidence            97665432   23446778999999999997642      11369999999999999763          5788765443


Q ss_pred             c-----HHHHH-HhcCCCCCCCChhhhH--HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          361 E-----VPKAY-AARQRPPFKAPAKLYA--RGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       361 ~-----~~~~~-~~~~~~~~~~~~~~~~--~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      +     +.+-+ ....+|.++..+...+  ..+.++|+.||..||.-|.|+-.+.+.|.++.+.
T Consensus       443 DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~~~  506 (513)
T KOG2052|consen  443 DPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLSNS  506 (513)
T ss_pred             CCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHhcC
Confidence            2     11111 2233666655444433  4688999999999999999999999999988754

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-33  Score=255.73  Aligned_cols=240  Identities=24%  Similarity=0.399  Sum_probs=202.6

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEE
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .|...+.||+|+|..|.     .+.+-||+|+++++.+.+.+...-.+.|-.++.+. +||.+|.+..+|..+.++++|.
T Consensus       251 df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvi  330 (593)
T KOG0695|consen  251 DFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVI  330 (593)
T ss_pred             cceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEE
Confidence            57788899999998653     47889999999988887777777788899998888 7999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||++||+|--.+++..+++++.+..+...|+-||.|||++|   |++||||.+|+|++..|.+||.|||+++.-- .+..
T Consensus       331 eyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l-~~gd  406 (593)
T KOG0695|consen  331 EYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL-GPGD  406 (593)
T ss_pred             EEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC-CCCc
Confidence            99999999888888889999999999999999999999999   9999999999999999999999999997533 2334


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC---CCCCcH----HHHHHhcCCCCCCCChhhhH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM---KHDNEV----PKAYAARQRPPFKAPAKLYA  382 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~---~~~~~~----~~~~~~~~~~~~~~~~~~~~  382 (458)
                      ....+.|||.|.|||++++..|....|.|+|||+++||+.|+.||+.   .++++.    .-++.......   .+..+|
T Consensus       407 ~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqir---iprsls  483 (593)
T KOG0695|consen  407 TTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIR---IPRSLS  483 (593)
T ss_pred             ccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccc---ccceee
Confidence            44567899999999999999999999999999999999999999973   222221    11111111111   234567


Q ss_pred             HHHHHHHHHHcccCCCCCCC
Q 012684          383 RGLKELIEECWNEKPAKRPT  402 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps  402 (458)
                      .....+++.-|++||++|..
T Consensus       484 vkas~vlkgflnkdp~erlg  503 (593)
T KOG0695|consen  484 VKASHVLKGFLNKDPKERLG  503 (593)
T ss_pred             hhhHHHHHHhhcCCcHHhcC
Confidence            77889999999999999954

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=9.3e-33  Score=275.62  Aligned_cols=251  Identities=24%  Similarity=0.492  Sum_probs=215.0

Q ss_pred             cccCceeeccceEEEEEEc---------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          156 DFTNSVEITKGTFILAFWR---------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~~---------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      .....+.||.|+||.||..         ..+||+|++...  .....-.++.+|+.+|..++|||++++++++.... +.
T Consensus       697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~--t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q  773 (1177)
T KOG1025|consen  697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEF--TSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ  773 (1177)
T ss_pred             hhhhhceeccccceeEEeeeEecCCceecceeEEEEeecc--CCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence            4455678999999999842         358999998754  34445567889999999999999999999998655 78


Q ss_pred             EEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          227 IVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      ||++|+++|+|.++++. +..+-....+.|..||++|+.|||.+.   ++||||-.+|||+..-..+|+.|||+++....
T Consensus       774 lvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~  850 (1177)
T KOG1025|consen  774 LVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAP  850 (1177)
T ss_pred             HHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCc
Confidence            99999999999999986 456888999999999999999999999   99999999999999999999999999987754


Q ss_pred             CCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          306 KEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       306 ~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      .... ......-.+.|||-|.+..+.++.++||||+||++||++| |..|+.+...+++...+....+...   ++.++.
T Consensus       851 d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geRLsq---PpiCti  927 (1177)
T KOG1025|consen  851 DEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGERLSQ---PPICTI  927 (1177)
T ss_pred             ccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhccccCCC---CCCccH
Confidence            4322 2233344678999999999999999999999999999998 9999999999999988876666443   455778


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      ++..++.+||..|+..||+++++...+.++..
T Consensus       928 DVy~~mvkCwmid~~~rp~fkel~~~fs~~ar  959 (1177)
T KOG1025|consen  928 DVYMVMVKCWMIDADSRPTFKELAEEFSRMAR  959 (1177)
T ss_pred             HHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence            99999999999999999999999999988653

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-33  Score=231.84  Aligned_cols=248  Identities=24%  Similarity=0.438  Sum_probs=196.7

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|.--++||+|+||.|+.     +++-||+|.++..... +-.-....+|+-+++.++|.|||++++...++..+-+|+|
T Consensus         3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvfe   81 (292)
T KOG0662|consen    3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_pred             chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence            344557899999999984     6789999999765432 2223456779999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      || ..+|..+... ++.++.+.+..++.|++.||.++|+++   +.|||+||+|.+++.+|.+||+|||+++-++... .
T Consensus        82 ~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipv-r  156 (292)
T KOG0662|consen   82 FC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-R  156 (292)
T ss_pred             Hh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCce-E
Confidence            99 5699999876 577999999999999999999999999   9999999999999999999999999998664321 1


Q ss_pred             CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcC-CC--------------
Q 012684          310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RP--------------  372 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~-~~--------------  372 (458)
                      -......|.+|.+|.++.+. -|+...|+||-||++.|+.. |++.|.+.+..+....+...- .+              
T Consensus       157 cysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdy  236 (292)
T KOG0662|consen  157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDY  236 (292)
T ss_pred             eeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCC
Confidence            22333568899999998876 57889999999999999985 888888877665544442221 11              


Q ss_pred             -CCCCC-----h----hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 -PFKAP-----A----KLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 -~~~~~-----~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                       +++..     +    +.++..=+++++.+|.-+|..|.+++..+++
T Consensus       237 k~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqh  283 (292)
T KOG0662|consen  237 KPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQH  283 (292)
T ss_pred             cccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcC
Confidence             11110     1    1122345789999999999999999998875

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.4e-33  Score=269.74  Aligned_cols=242  Identities=24%  Similarity=0.351  Sum_probs=199.9

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |...+.||-|+||.|-+     +...||.|.+.+..+...+.+...+.|-++|.--+.+-||++|..|.+++.+|+||+|
T Consensus       631 Fvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdY  710 (1034)
T KOG0608|consen  631 FVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDY  710 (1034)
T ss_pred             eEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEec
Confidence            55567899999997753     4567999999877666677777888999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC--
Q 012684          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--  309 (458)
Q Consensus       232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~--  309 (458)
                      ++||++-.+|-+-+-|.+..+..++..+..|+++.|..|   +|||||||+|||||.+|++||.|||++.-+....+.  
T Consensus       711 IPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  711 IPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             cCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            999999999999899999999999999999999999999   999999999999999999999999998432111000  


Q ss_pred             ----------C-----------------------------cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcC
Q 012684          310 ----------P-----------------------------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG  350 (458)
Q Consensus       310 ----------~-----------------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg  350 (458)
                                +                             .....||+.|+|||++....++...|.||.||+||+|+.|
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG  867 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence                      0                             0245689999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC
Q 012684          351 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT  402 (458)
Q Consensus       351 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  402 (458)
                      +.||...++.+....++....-..-.....+++++.++|.++.. +++.|..
T Consensus       868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLG  918 (1034)
T KOG0608|consen  868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLG  918 (1034)
T ss_pred             CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhhc
Confidence            99999988887665553322111122356788999999877554 3666644

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=1e-31  Score=248.94  Aligned_cols=238  Identities=34%  Similarity=0.538  Sum_probs=193.8

Q ss_pred             cceEEEEEE--cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCHHHHHH
Q 012684          165 KGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK  242 (458)
Q Consensus       165 ~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~  242 (458)
                      .|....+..  +|+.+|+|++........  .+.+.+|+..+++++|+||+++++++......++++|++.+++|.+++.
T Consensus         2 ~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        2 FGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             ceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            344545554  469999999975433221  5788899999999999999999999999899999999998889999998


Q ss_pred             hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCCCCCcccC
Q 012684          243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA  322 (458)
Q Consensus       243 ~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~a  322 (458)
                      ....++...++.++.+++.++.+||+.+   ++|+||+|+||+++.++.++|+|||.+.......  ......++..|++
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~  154 (244)
T smart00220       80 KRGRLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG--LLTTFVGTPEYMA  154 (244)
T ss_pred             hccCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc--ccccccCCcCCCC
Confidence            7666899999999999999999999999   9999999999999999999999999998765432  2334457788999


Q ss_pred             CcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC
Q 012684          323 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT  402 (458)
Q Consensus       323 PE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  402 (458)
                      ||.+.+..++.++|+|+||++++++++|..||..........................++..+.+++.+|+..+|.+||+
T Consensus       155 pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~  234 (244)
T smart00220      155 PEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISPEAKDLIRKLLVKDPEKRLT  234 (244)
T ss_pred             HHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCHHHHHHHHHHccCCchhccC
Confidence            99998888899999999999999999999999874333332222222222222222227789999999999999999999


Q ss_pred             HHHHHHH
Q 012684          403 FRQIITR  409 (458)
Q Consensus       403 ~~~ll~~  409 (458)
                      +.+++++
T Consensus       235 ~~~~~~~  241 (244)
T smart00220      235 AEEALQH  241 (244)
T ss_pred             HHHHhhC
Confidence            9999873

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=8.2e-32  Score=298.53  Aligned_cols=244  Identities=23%  Similarity=0.371  Sum_probs=188.0

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .+.....||+|+||.||.     +|..||+|.+.....       ....|+..+++++||||+++++++.+....++|||
T Consensus       691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E  763 (968)
T PLN00113        691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE  763 (968)
T ss_pred             hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence            355667899999998873     678999999864321       11246788999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+++|+|.++++.   +++..+..++.|+++||+|||...+.+++||||||+||+++.++..++. ||.......     
T Consensus       764 y~~~g~L~~~l~~---l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~-----  834 (968)
T PLN00113        764 YIEGKNLSEVLRN---LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT-----  834 (968)
T ss_pred             CCCCCcHHHHHhc---CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc-----
Confidence            9999999999963   7899999999999999999994422239999999999999998887775 655433211     


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--cHHHHHHhc---------CCCCCC---C
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--EVPKAYAAR---------QRPPFK---A  376 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~--~~~~~~~~~---------~~~~~~---~  376 (458)
                      .....+|+.|+|||++.+..++.++|||||||++|||++|+.||......  .........         ..+...   .
T Consensus       835 ~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  914 (968)
T PLN00113        835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVS  914 (968)
T ss_pred             CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCC
Confidence            11235788999999999989999999999999999999999999643221  111111000         011110   1


Q ss_pred             ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       377 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      .......++.+++.+||+.||.+|||+.++++.|+++..
T Consensus       915 ~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~L~~~~~  953 (968)
T PLN00113        915 VNQNEIVEVMNLALHCTATDPTARPCANDVLKTLESASR  953 (968)
T ss_pred             ccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHHHHHhhc
Confidence            112234567889999999999999999999999998754

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.5e-33  Score=260.93  Aligned_cols=298  Identities=24%  Similarity=0.357  Sum_probs=221.8

Q ss_pred             hHHHhhcchHHHHHHHHHhC----CCCCCCcccc-----ccCCCC------CCcccCc---CCccccCceeeccceEEEE
Q 012684          110 LGDAIYYKNHEVIKLLEKHG----AKPLMAPMHV-----KHAREV------PEYEIDP---HELDFTNSVEITKGTFILA  171 (458)
Q Consensus       110 l~~A~~~~~~~~~~~l~~~g----~~~~~~~~~~-----~~~~~~------~~~~~~~---~~~~~~~~~~lg~G~~~~v  171 (458)
                      |.+|-++...++.++-+.+-    +++.+.-...     .+.+++      ....+..   ...+|.....||+|+|..|
T Consensus       400 ltlaEYhEqeEIfKLRlgHLkKEEaeiqaElERLErvrnlHiRELKRi~NEdnSQFkDHptLn~RYLlLhLLGrGGFSEV  479 (775)
T KOG1151|consen  400 LTLAEYHEQEEIFKLRLGHLKKEEAEIQAELERLERVRNLHIRELKRIHNEDNSQFKDHPTLNDRYLLLHLLGRGGFSEV  479 (775)
T ss_pred             ccHHHHHhHHHHHHHHHhhhhhhHHHHHHHHHHHHHHHHHHHHHHHhhcccchhhhccCcchHHHHHHHHHhccccHHHH
Confidence            67888888888887766553    3443211111     111111      1112221   2236888889999999877


Q ss_pred             E-----EcCeEEEEEEcCCCCCCCHHHH----HHHHHHHHHHhcCCCCcceeeeeEEEe-CCceEEEEEccCCCCHHHHH
Q 012684          172 F-----WRGIQVAVKKLGEEVISDDDRV----RAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTEYLPKGDLRAFL  241 (458)
Q Consensus       172 ~-----~~g~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l  241 (458)
                      |     ...+.||+|+-..+..+.++..    +...+|.++-+.+.||.||++|++|.- .+.+|.|+|||+|.+|.-+|
T Consensus       480 yKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYL  559 (775)
T KOG1151|consen  480 YKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYL  559 (775)
T ss_pred             HHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHH
Confidence            6     3578999998876554443333    334679999999999999999999964 56789999999999999999


Q ss_pred             HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC---CCCEEEeecCCccccccCCCCC------cc
Q 012684          242 KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTVKEDRP------LT  312 (458)
Q Consensus       242 ~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~---~~~vkl~Dfg~~~~~~~~~~~~------~~  312 (458)
                      +...-+++.++..|+.||+.||.||.+..| +|+|-||||.|||+-.   -|.+||.|||++..+.......      ..
T Consensus       560 KQhklmSEKEARSIiMQiVnAL~YLNEikp-PIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTS  638 (775)
T KOG1151|consen  560 KQHKLMSEKEARSIIMQIVNALKYLNEIKP-PIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTS  638 (775)
T ss_pred             HhhhhhhHHHHHHHHHHHHHHHHHHhccCC-CeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeec
Confidence            998889999999999999999999999874 6999999999999864   4689999999999875443221      14


Q ss_pred             cCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHH---HHhcCCCCCCCChhhhHHHH
Q 012684          313 CQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA---YAARQRPPFKAPAKLYARGL  385 (458)
Q Consensus       313 ~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~l  385 (458)
                      ...||.+|++||.+.-+    ..+.+.||||+||++|+++-|+.||...........   +.......++ ..+.++++.
T Consensus       639 QgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP-~KPvVsseA  717 (775)
T KOG1151|consen  639 QGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFP-PKPVVSSEA  717 (775)
T ss_pred             ccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCC-CCCccCHHH
Confidence            45789999999987533    467799999999999999999999987544332211   1111123333 245688999


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.||++||...-++|....+|..+
T Consensus       718 kaFIRRCLaYRKeDR~DV~qLA~d  741 (775)
T KOG1151|consen  718 KAFIRRCLAYRKEDRIDVQQLACD  741 (775)
T ss_pred             HHHHHHHHHhhhhhhhhHHHHccC
Confidence            999999999999999988877654

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-33  Score=258.20  Aligned_cols=244  Identities=26%  Similarity=0.311  Sum_probs=191.3

Q ss_pred             CccccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC--CC----cceeeeeEEEeC
Q 012684          154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HP----NVVQFLGAVTQS  222 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp----~i~~~~~~~~~~  222 (458)
                      .-+|.+...+|+|+||.|.     .++..||||+++.-    ....+...-|+++++++.  .|    -++++.++|.-.
T Consensus        88 ~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyr  163 (415)
T KOG0671|consen   88 TNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYR  163 (415)
T ss_pred             ccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhcc
Confidence            5689999999999999775     25789999999732    233345566999999993  23    367888889999


Q ss_pred             CceEEEEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC------------
Q 012684          223 SPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD------------  288 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~------------  288 (458)
                      ++.|||+|.+ |-++++++.+++.  ++...+..+++|+++++++||+.+   ++|-||||+|||+..            
T Consensus       164 ghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  164 GHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             CceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCc
Confidence            9999999998 8899999988654  888999999999999999999999   999999999999753            


Q ss_pred             --------CCCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 012684          289 --------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN  360 (458)
Q Consensus       289 --------~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~  360 (458)
                              +..|+++|||.+.+....    ......|..|.|||++.+-+++.+.||||+||+|+|+++|...|.+-.+.
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~e~----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~  315 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDHEH----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENL  315 (415)
T ss_pred             cceeccCCCcceEEEecCCcceeccC----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcH
Confidence                    224899999999875433    24556789999999999999999999999999999999999999876644


Q ss_pred             cH---HHHH-----------------HhcCCCCCCC---------------Ch-------hhhHHHHHHHHHHHcccCCC
Q 012684          361 EV---PKAY-----------------AARQRPPFKA---------------PA-------KLYARGLKELIEECWNEKPA  398 (458)
Q Consensus       361 ~~---~~~~-----------------~~~~~~~~~~---------------~~-------~~~~~~l~~li~~~l~~dp~  398 (458)
                      +-   .+.+                 ...++..++.               +.       ..-...+.+||+.||..||.
T Consensus       316 EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~  395 (415)
T KOG0671|consen  316 EHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPA  395 (415)
T ss_pred             HHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcc
Confidence            31   1111                 0001111100               00       00113588999999999999


Q ss_pred             CCCCHHHHHHH
Q 012684          399 KRPTFRQIITR  409 (458)
Q Consensus       399 ~Rps~~~ll~~  409 (458)
                      +|+|+.|++.|
T Consensus       396 ~RiTl~EAL~H  406 (415)
T KOG0671|consen  396 RRITLREALSH  406 (415)
T ss_pred             ccccHHHHhcC
Confidence            99999999986

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.98  E-value=9.1e-34  Score=248.04  Aligned_cols=249  Identities=24%  Similarity=0.388  Sum_probs=191.3

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--------C
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------S  222 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--------~  222 (458)
                      .|.-..++|+|.||.|+     .+|+.||+|++-.+..... .-....+|+++|..++|+|++.++..|..        .
T Consensus        18 ~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeG-fpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r   96 (376)
T KOG0669|consen   18 KYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEG-FPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR   96 (376)
T ss_pred             HHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccC-CcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence            45566789999999775     4788899997754221111 11234579999999999999999988753        2


Q ss_pred             CceEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          223 SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                      ..+|+||++|+ .+|.-++... -+++..++.+++.++..||.|+|+..   |+|||+||+|+||+.+|.++|+|||+++
T Consensus        97 ~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGlar  172 (376)
T KOG0669|consen   97 ATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGLAR  172 (376)
T ss_pred             ceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccccc
Confidence            34899999995 5899988765 56999999999999999999999999   9999999999999999999999999997


Q ss_pred             ccccCCCC---CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC---C---
Q 012684          302 LLTVKEDR---PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ---R---  371 (458)
Q Consensus       302 ~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~---~---  371 (458)
                      .+......   ..+....|.+|++||.+.+. .++++.|||.-||++.+|+||.+-+.+.+.......+....   .   
T Consensus       173 ~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkev  252 (376)
T KOG0669|consen  173 AFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEV  252 (376)
T ss_pred             ceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCccc
Confidence            65443222   23455669999999998774 78999999999999999999999888766544333331111   0   


Q ss_pred             ---------------CCCCCCh----h------hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 ---------------PPFKAPA----K------LYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 ---------------~~~~~~~----~------~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                     ++++...    +      .-.++..+|+..+|..||++|+++.+++.+
T Consensus       253 WP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh  315 (376)
T KOG0669|consen  253 WPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH  315 (376)
T ss_pred             CCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence                           0010000    0      012467899999999999999999999986

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=99.98  E-value=8.5e-31  Score=248.11  Aligned_cols=254  Identities=29%  Similarity=0.431  Sum_probs=201.2

Q ss_pred             cccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC--CCCcceeeeeEEEeCC----ceE
Q 012684          156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQSS----PMM  226 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~i~~~~~~~~~~~----~~~  226 (458)
                      ..+....+|+|.||.|+   +.++.||||++.      ....+.|++|.++++..  +|+||++++++-....    .++
T Consensus       211 pl~l~eli~~Grfg~V~KaqL~~~~VAVKifp------~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw  284 (534)
T KOG3653|consen  211 PLQLLELIGRGRFGCVWKAQLDNRLVAVKIFP------EQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW  284 (534)
T ss_pred             chhhHHHhhcCccceeehhhccCceeEEEecC------HHHHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence            35556789999999997   588999999995      45567899999988876  7999999999876544    789


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCC------CCeeeCCCCCCCEEecCCCCEEEeecCCc
Q 012684          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKP------VPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~------~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~  300 (458)
                      ||++|.+.|+|.++|..+ .+++....+++..+++||+|||+..|      .+|+|||||.+|||+..+++.-|+|||++
T Consensus       285 LVt~fh~kGsL~dyL~~n-tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLA  363 (534)
T KOG3653|consen  285 LVTEFHPKGSLCDYLKAN-TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLA  363 (534)
T ss_pred             EEeeeccCCcHHHHHHhc-cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecccee
Confidence            999999999999999874 58999999999999999999997653      46999999999999999999999999999


Q ss_pred             cccccCC-CCCcccCCCCCcccCCcccCCCC-C-----CCchhHHHHHHHHHHHHcCCCCCC-CCC--------------
Q 012684          301 KLLTVKE-DRPLTCQDTSCRYVAPEVFKNEE-Y-----DTKVDVFSFALILQEMIEGCPPFT-MKH--------------  358 (458)
Q Consensus       301 ~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~-~-----~~~~DiwslG~~l~~lltg~~pf~-~~~--------------  358 (458)
                      ..+.... ........||.+|||||++-+.- .     -.+.||||+|.+||||++++..+. +..              
T Consensus       364 l~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~h  443 (534)
T KOG3653|consen  364 LRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNH  443 (534)
T ss_pred             EEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCC
Confidence            8775332 22233467999999999986641 1     136999999999999998765442 111              


Q ss_pred             --CCcHHHHHHh-cCCCCCCCChhh--hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          359 --DNEVPKAYAA-RQRPPFKAPAKL--YARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       359 --~~~~~~~~~~-~~~~~~~~~~~~--~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                        .+++...+.. +.+|.++..+..  ...-+++.+..||..||+-|.|+.=+-+.+.++...
T Consensus       444 Pt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~~~  506 (534)
T KOG3653|consen  444 PTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELMML  506 (534)
T ss_pred             CCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHhcc
Confidence              1223333333 346766654432  235689999999999999999999998888887654

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=99.97  E-value=8e-32  Score=229.44  Aligned_cols=216  Identities=25%  Similarity=0.420  Sum_probs=171.3

Q ss_pred             CcCCccccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCc
Q 012684          151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       151 ~~~~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~  224 (458)
                      +.....+.-...||+|+||.+.     .+|.-.|+|.++...  +.+..+++.+|+++..+. .+|.+|.+|+.+..+..
T Consensus        42 eV~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tv--n~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regd  119 (282)
T KOG0984|consen   42 EVPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATV--NSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGD  119 (282)
T ss_pred             ccchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhc--ChHHHHHHHHhhhhhccCCCCCeEEEeehhhhcccc
Confidence            3334445556789999999763     589999999998653  345566788899887766 79999999999999999


Q ss_pred             eEEEEEccCCCCHHHHH----HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCc
Q 012684          225 MMIVTEYLPKGDLRAFL----KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l----~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~  300 (458)
                      +|+.||.| ..+|..+-    +.++.+++..+-+|+..++.||.|||++-  .++|||+||+|||++.+|.||+||||.+
T Consensus       120 vwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIs  196 (282)
T KOG0984|consen  120 VWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGIS  196 (282)
T ss_pred             EEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccc
Confidence            99999999 56887654    45677999999999999999999999975  3999999999999999999999999998


Q ss_pred             cccccCCCCCcccCCCCCcccCCcccCCC----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-cHHHHHHhcCCCC
Q 012684          301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPP  373 (458)
Q Consensus       301 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwslG~~l~~lltg~~pf~~~~~~-~~~~~~~~~~~~~  373 (458)
                      -.+.+.-  ..+...|-..|||||.+..+    .|+.++||||||+++.||.++++||+....+ +...++.....|.
T Consensus       197 G~L~dSi--Akt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~  272 (282)
T KOG0984|consen  197 GYLVDSI--AKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQ  272 (282)
T ss_pred             eeehhhh--HHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCCCCC
Confidence            7764332  22223455679999998543    6889999999999999999999999875443 3344443333333

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.97  E-value=3.3e-30  Score=234.16  Aligned_cols=261  Identities=15%  Similarity=0.258  Sum_probs=222.7

Q ss_pred             cCCccccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCce
Q 012684          152 PHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~  225 (458)
                      .....|.+.++||+|+||..+     +++++||||.-.....     .-++..|....+.| ..++|+..|.+...+.+-
T Consensus        25 ~VG~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~N   99 (449)
T KOG1165|consen   25 MVGPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYN   99 (449)
T ss_pred             EecccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchh
Confidence            456789999999999999765     5899999998865432     23577899999999 579999999999988889


Q ss_pred             EEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC-----CEEEeecCC
Q 012684          226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFGV  299 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~-----~vkl~Dfg~  299 (458)
                      .||||++ |.+|+|++.-++ +|+..++..++.|++.-++|+|++.   +|+|||||+|+||...+     .|.++|||+
T Consensus       100 iLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGm  175 (449)
T KOG1165|consen  100 ILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGM  175 (449)
T ss_pred             hhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccc
Confidence            9999999 999999998655 4999999999999999999999999   99999999999999654     499999999


Q ss_pred             ccccccCCCCC------cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC---
Q 012684          300 SKLLTVKEDRP------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ---  370 (458)
Q Consensus       300 ~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~---  370 (458)
                      ++.+.......      .....||.+||+-..+.+.+.+.+.|+-|||-++.+++.|.+||.+.........+.+.+   
T Consensus       176 AK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~K  255 (449)
T KOG1165|consen  176 AKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETK  255 (449)
T ss_pred             hhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhcccc
Confidence            99875543222      245579999999999999999999999999999999999999999988877666665544   


Q ss_pred             -CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhccc
Q 012684          371 -RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKR  421 (458)
Q Consensus       371 -~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~  421 (458)
                       ..++...+.++|.++...+...-+.+-.+-|.+..+...+.+++.......
T Consensus       256 r~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dvldr~g~t~  307 (449)
T KOG1165|consen  256 RSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDVLDRLGETD  307 (449)
T ss_pred             ccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHhcCCcc
Confidence             334455678899999999999999999999999999999988877665543

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=99.97  E-value=5.1e-32  Score=271.79  Aligned_cols=240  Identities=26%  Similarity=0.391  Sum_probs=187.3

Q ss_pred             ccCceeeccceEEEE----EEcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILA----FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v----~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |...+.+|.|+-|.+    .+.|+.||||++-...      .....+|+..|+.- +||||+++|+.-.++...||..|+
T Consensus       511 ~~~~eilG~Gs~Gt~Vf~G~ye~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalEL  584 (903)
T KOG1027|consen  511 FSPKEILGYGSNGTVVFRGVYEGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALEL  584 (903)
T ss_pred             eccHHHcccCCCCcEEEEEeeCCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehH
Confidence            445567888877643    3688999999986432      34567899999998 699999999998888999999999


Q ss_pred             cCCCCHHHHHHhcCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC---C--CCEEEeecCCccc
Q 012684          232 LPKGDLRAFLKRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---S--GNLKVADFGVSKL  302 (458)
Q Consensus       232 ~~~~~L~~~l~~~~~----~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~---~--~~vkl~Dfg~~~~  302 (458)
                      | ..+|.+++...+.    ......+.++.|+++||++||+.+   |+||||||+||||+.   +  .+++|+|||+++.
T Consensus       585 C-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKk  660 (903)
T KOG1027|consen  585 C-ACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKK  660 (903)
T ss_pred             h-hhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccc
Confidence            9 6799999987421    122456788999999999999999   999999999999986   3  4689999999998


Q ss_pred             cccCCCCC--cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCcHHHHHHhcCCCCCCCChh
Q 012684          303 LTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKAYAARQRPPFKAPAK  379 (458)
Q Consensus       303 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg-~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  379 (458)
                      +.......  .....||-+|+|||++.....+.++||||+||++|+.++| .+||.+....+.  .+...... +....+
T Consensus       661 l~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl~~~~~-L~~L~~  737 (903)
T KOG1027|consen  661 LAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NILTGNYT-LVHLEP  737 (903)
T ss_pred             cCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhh--hhhcCccc-eeeecc
Confidence            76543322  3456789999999999988888899999999999999985 999997654432  22222211 111111


Q ss_pred             hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          380 LYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       380 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .-..+..+||.+|++.+|..||+|.+++.|
T Consensus       738 ~~d~eA~dLI~~ml~~dP~~RPsa~~VL~H  767 (903)
T KOG1027|consen  738 LPDCEAKDLISRMLNPDPQLRPSATDVLNH  767 (903)
T ss_pred             CchHHHHHHHHHhcCCCcccCCCHHHHhCC
Confidence            111288999999999999999999999986

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.97  E-value=2.5e-30  Score=266.88  Aligned_cols=246  Identities=19%  Similarity=0.234  Sum_probs=163.3

Q ss_pred             CCccccCceeeccceEEEEEE-----c----CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeE-----
Q 012684          153 HELDFTNSVEITKGTFILAFW-----R----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA-----  218 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~-----  218 (458)
                      ...+|+..+.||+|+||.||.     +    +..||+|.+.....     .+....|  .++...+.++..++..     
T Consensus       130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~-----~e~~~~e--~l~~~~~~~~~~~~~~~~~~~  202 (566)
T PLN03225        130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA-----VEIWMNE--RVRRACPNSCADFVYGFLEPV  202 (566)
T ss_pred             ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch-----hHHHHHH--HHHhhchhhHHHHHHhhhccc
Confidence            345788999999999999984     3    78999998764321     1111111  1111122222222211     


Q ss_pred             -EEeCCceEEEEEccCCCCHHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeC
Q 012684          219 -VTQSSPMMIVTEYLPKGDLRAFLKRKGA--------------------LKPSTAVRFALDIARGMNYLHENKPVPIIHR  277 (458)
Q Consensus       219 -~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~  277 (458)
                       ...+...++||||+.+++|.+++.....                    .....+..++.|++.||.|||+.+   |+||
T Consensus       203 ~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHR  279 (566)
T PLN03225        203 SSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHR  279 (566)
T ss_pred             ccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeC
Confidence             2355678999999999999999875421                    112345579999999999999999   9999


Q ss_pred             CCCCCCEEecC-CCCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC----------------------CCCCc
Q 012684          278 DLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE----------------------EYDTK  334 (458)
Q Consensus       278 Dikp~Nil~~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~  334 (458)
                      ||||+|||++. ++.+||+|||++..+............+++.|+|||.+...                      .++.+
T Consensus       280 DLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k  359 (566)
T PLN03225        280 DVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDR  359 (566)
T ss_pred             cCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCC
Confidence            99999999996 57999999999986544333333456789999999965322                      12345


Q ss_pred             hhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC----------CCCCCCC-h------hhhHHHHHHHHHHHcccCC
Q 012684          335 VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----------RPPFKAP-A------KLYARGLKELIEECWNEKP  397 (458)
Q Consensus       335 ~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~----------~~~~~~~-~------~~~~~~l~~li~~~l~~dp  397 (458)
                      +|||||||++|+|+++..|+..... .....+....          ....... .      ........+||.+||+.||
T Consensus       360 ~DVwSlGviL~el~~~~~~~~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP  438 (566)
T PLN03225        360 FDIYSAGLIFLQMAFPNLRSDSNLI-QFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKG  438 (566)
T ss_pred             cccHHHHHHHHHHHhCcCCCchHHH-HHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCc
Confidence            6999999999999987766442110 0001110000          0000000 0      0012234589999999999


Q ss_pred             CCCCCHHHHHHH
Q 012684          398 AKRPTFRQIITR  409 (458)
Q Consensus       398 ~~Rps~~~ll~~  409 (458)
                      .+|||+.++++|
T Consensus       439 ~kR~ta~e~L~H  450 (566)
T PLN03225        439 RQRISAKAALAH  450 (566)
T ss_pred             ccCCCHHHHhCC
Confidence            999999999997

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.97  E-value=9.5e-30  Score=256.47  Aligned_cols=253  Identities=18%  Similarity=0.196  Sum_probs=177.6

Q ss_pred             CCccccCceeeccceEEEEEE---------------------cCeEEEEEEcCCCCCCCHH-----------HHHHHHHH
Q 012684          153 HELDFTNSVEITKGTFILAFW---------------------RGIQVAVKKLGEEVISDDD-----------RVRAFRDE  200 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~---------------------~g~~vavK~~~~~~~~~~~-----------~~~~~~~E  200 (458)
                      ...+|.+.++||+|+||.||.                     .++.||||.+.........           ..+....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            455789999999999999983                     3467999998643211000           01122346


Q ss_pred             HHHHhcCCCCc-----ceeeeeEEEe--------CCceEEEEEccCCCCHHHHHHhcC----------------------
Q 012684          201 LALLQKIRHPN-----VVQFLGAVTQ--------SSPMMIVTEYLPKGDLRAFLKRKG----------------------  245 (458)
Q Consensus       201 ~~~l~~l~hp~-----i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~----------------------  245 (458)
                      +.++.+++|.+     +++++++|..        .+..++||||+++++|.+++....                      
T Consensus       223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~  302 (507)
T PLN03224        223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP  302 (507)
T ss_pred             HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence            66666675544     4677777643        356899999999999999886421                      


Q ss_pred             --CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCCCCCcccCC
Q 012684          246 --ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP  323 (458)
Q Consensus       246 --~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aP  323 (458)
                        .+++..+..++.|++.+|.|||+.+   |+||||||+||+++.++.++|+|||++...............+++.|+||
T Consensus       303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aP  379 (507)
T PLN03224        303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPP  379 (507)
T ss_pred             cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeCh
Confidence              1345677889999999999999999   99999999999999999999999999875533222222223457899999


Q ss_pred             cccCCCCC----------------------CCchhHHHHHHHHHHHHcCCC-CCCCCCCCc--------HHHHHH--hcC
Q 012684          324 EVFKNEEY----------------------DTKVDVFSFALILQEMIEGCP-PFTMKHDNE--------VPKAYA--ARQ  370 (458)
Q Consensus       324 E~~~~~~~----------------------~~~~DiwslG~~l~~lltg~~-pf~~~~~~~--------~~~~~~--~~~  370 (458)
                      |.+.....                      ..+.|+||+||++++|++|.. ||.......        ....+.  ...
T Consensus       380 E~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~  459 (507)
T PLN03224        380 EELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQ  459 (507)
T ss_pred             hhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhccc
Confidence            98754321                      124799999999999999876 775422111        011110  111


Q ss_pred             CCCCCCChhhhHHHHHHHHHHHcccCC---CCCCCHHHHHHH
Q 012684          371 RPPFKAPAKLYARGLKELIEECWNEKP---AKRPTFRQIITR  409 (458)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~~l~~dp---~~Rps~~~ll~~  409 (458)
                      ...++ .....++...+|+.+||..+|   .+|+|++++++|
T Consensus       460 ~~~~~-~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~H  500 (507)
T PLN03224        460 KYDFS-LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSH  500 (507)
T ss_pred             CCCcc-cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCC
Confidence            22222 234467889999999999876   689999999987

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=99.97  E-value=1.7e-31  Score=254.81  Aligned_cols=243  Identities=24%  Similarity=0.357  Sum_probs=195.5

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC------CCcceeeeeEEEeCCc
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR------HPNVVQFLGAVTQSSP  224 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hp~i~~~~~~~~~~~~  224 (458)
                      +|.+....|+|.|+.|.     ..|..||||+|..+....    +.=..|+.+|++|+      --|+++++..|...++
T Consensus       433 RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~----KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknH  508 (752)
T KOG0670|consen  433 RYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMH----KTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNH  508 (752)
T ss_pred             eeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHh----hhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcce
Confidence            67788889999999775     367899999998654332    34456999999995      2489999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC-CEEEeecCCc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVS  300 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~-~vkl~Dfg~~  300 (458)
                      +|||+|.+ ..+|.++|+..|.   +....+..++.|++-||..|-..|   |+|.||||.|||+++.. .+||||||.|
T Consensus       509 LClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLKLCDfGSA  584 (752)
T KOG0670|consen  509 LCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILKLCDFGSA  584 (752)
T ss_pred             eEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceeeeccCccc
Confidence            99999998 6799999998664   788899999999999999999999   99999999999999654 6899999999


Q ss_pred             cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-C-CC------
Q 012684          301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-Q-RP------  372 (458)
Q Consensus       301 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~-~~------  372 (458)
                      ...+..   ..+.+..+.-|.|||++.|-+|+...|+||+||+||||+||+..|.+.+...+....... + .|      
T Consensus       585 ~~~~en---eitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRK  661 (752)
T KOG0670|consen  585 SFASEN---EITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRK  661 (752)
T ss_pred             cccccc---cccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhh
Confidence            876533   333344456799999999999999999999999999999999999998876544333111 0 00      


Q ss_pred             ------------------------------------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHH
Q 012684          373 ------------------------------------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFR  404 (458)
Q Consensus       373 ------------------------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~  404 (458)
                                                                      .++......-..+.+|+..||..||.+|.|.+
T Consensus       662 gqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~n  741 (752)
T KOG0670|consen  662 GQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVN  741 (752)
T ss_pred             cchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHH
Confidence                                                            01111111225688999999999999999999


Q ss_pred             HHHHH
Q 012684          405 QIITR  409 (458)
Q Consensus       405 ~ll~~  409 (458)
                      ++|.|
T Consensus       742 qAL~H  746 (752)
T KOG0670|consen  742 QALKH  746 (752)
T ss_pred             HHhcC
Confidence            99986

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=99.97  E-value=1.9e-30  Score=234.78  Aligned_cols=247  Identities=26%  Similarity=0.370  Sum_probs=191.8

Q ss_pred             CccccCceeeccceEEEEE----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------C
Q 012684          154 ELDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S  223 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~------~  223 (458)
                      ..+|...+.+|.|.=..+.    ..+++||+|....+... ..-.+...+|+.++..++|+||++++.+|.-.      .
T Consensus        16 ~~Ry~nL~p~~~g~~~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~   94 (369)
T KOG0665|consen   16 PKRYVNLKPIGSGAQIVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQ   94 (369)
T ss_pred             eeeeeeecccCCCCceEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHH
Confidence            4466666777777553222    47899999999876433 33345567799999999999999999999643      3


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ..|+|||++ ..+|.+++..  .++.+++..++.|++.|++|||+.|   |+||||||+||++..++.+|+.|||++...
T Consensus        95 e~y~v~e~m-~~nl~~vi~~--elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   95 EVYLVMELM-DANLCQVILM--ELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             hHHHHHHhh-hhHHHHHHHH--hcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhccc
Confidence            579999999 5699988874  3788999999999999999999999   999999999999999999999999999864


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-CC-----------
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QR-----------  371 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~~-----------  371 (458)
                      ..  ....+.+..|..|.|||++.+..+...+||||+||++.||++|+..|.+.+.-.....+... +.           
T Consensus       169 ~~--~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~  246 (369)
T KOG0665|consen  169 DT--DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQP  246 (369)
T ss_pred             Cc--ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhH
Confidence            32  24556677899999999999999999999999999999999999998866542211111000 00           


Q ss_pred             ---------C---------CCC--------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 ---------P---------PFK--------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 ---------~---------~~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                               +         .++        +..+.-+..+++++.+||..||++|.|+.++|.|
T Consensus       247 ~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~H  310 (369)
T KOG0665|consen  247 TVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRH  310 (369)
T ss_pred             HHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcC
Confidence                     0         000        0001112457899999999999999999999987

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=99.97  E-value=2.8e-30  Score=223.22  Aligned_cols=242  Identities=20%  Similarity=0.406  Sum_probs=189.1

Q ss_pred             CccccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeC--Cce
Q 012684          154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQS--SPM  225 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~--~~~  225 (458)
                      ..+|++.+++|+|.|+.|+     .+.+.++||+++.      -..+.+.+|+.+|+.+ .||||+++++...+.  ...
T Consensus        37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKP------VkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp  110 (338)
T KOG0668|consen   37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKP------VKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP  110 (338)
T ss_pred             cchHHHHHHHcCccHhhHhcccccCCCceEEEeeech------HHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence            3369999999999998765     4778999999963      3457899999999999 499999999998754  457


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC-CCEEEeecCCccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLT  304 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~-~~vkl~Dfg~~~~~~  304 (458)
                      .+|+|+++..+...+-   ..++..++..++.++++||.|+|+.|   |.|||+||.|++++.. -.++|+|+|++.++.
T Consensus       111 aLiFE~v~n~Dfk~ly---~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYH  184 (338)
T KOG0668|consen  111 SLIFEYVNNTDFKQLY---PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFYH  184 (338)
T ss_pred             hhHhhhhccccHHHHh---hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhcC
Confidence            8999999887766553   34888899999999999999999999   9999999999999965 469999999999875


Q ss_pred             cCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-CcHHHHH-------------Hhc
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHD-NEVPKAY-------------AAR  369 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~-~~~~~~~-------------~~~  369 (458)
                      .  .........+..|.-||++.. +.++..-|+|||||++..|+..+.||-.... .+....+             .+.
T Consensus       185 p--~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY  262 (338)
T KOG0668|consen  185 P--GKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKY  262 (338)
T ss_pred             C--CceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHH
Confidence            3  344445566778899999865 4678899999999999999999998754332 2111111             000


Q ss_pred             C---CC------------CC-----CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          370 Q---RP------------PF-----KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       370 ~---~~------------~~-----~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .   .+            ++     +.....++++..+|+..+|..|..+|||++|++.|
T Consensus       263 ~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~H  322 (338)
T KOG0668|consen  263 QIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAH  322 (338)
T ss_pred             ccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcC
Confidence            0   01            00     00112245899999999999999999999999987

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-31  Score=236.86  Aligned_cols=250  Identities=24%  Similarity=0.418  Sum_probs=194.7

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-----ce
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-----~~  225 (458)
                      +.+-.+.||.|.||.|+     .+|+.||+|++..- ....-.-+.+.+|+.++..++|.|++..++...-..     .+
T Consensus        54 Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEi  132 (449)
T KOG0664|consen   54 DIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQEL  132 (449)
T ss_pred             cCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHH
Confidence            34445789999999888     47999999998643 233444566788999999999999999888765332     46


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      |.++|++ ..+|..++-....++...+.-+++||+.||+|||+.+   |.||||||-|.|++.+..+||||||+++....
T Consensus       133 YV~TELm-QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~  208 (449)
T KOG0664|consen  133 YVLTELM-QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ  208 (449)
T ss_pred             HHHHHHH-HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence            7889988 5689998888888999999999999999999999999   99999999999999999999999999987655


Q ss_pred             CCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh--------------cC
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA--------------RQ  370 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~--------------~~  370 (458)
                      ......+....|-.|.|||++.|. .|+...||||+||++.||+.++..|...++-+....+..              ++
T Consensus       209 d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEG  288 (449)
T KOG0664|consen  209 RDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEG  288 (449)
T ss_pred             hhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhh
Confidence            444444444567789999999775 688999999999999999999999887665432222211              00


Q ss_pred             ------C-----CCCCC-----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          371 ------R-----PPFKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       371 ------~-----~~~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                            +     +.++.     .+..-..+...++..++..||.+|.+..+.+.++
T Consensus       289 Ak~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~  344 (449)
T KOG0664|consen  289 AKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHR  344 (449)
T ss_pred             hHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhcccc
Confidence                  0     01100     0111224566788899999999999999998875

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=99.96  E-value=7.1e-31  Score=257.35  Aligned_cols=247  Identities=26%  Similarity=0.424  Sum_probs=207.9

Q ss_pred             cccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|.....+|.|+||.||     .+++..|+|+++..   ..+..+-++.|+-+++.++||||+.+++.+.....+|+.||
T Consensus        16 dyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME   92 (829)
T KOG0576|consen   16 DYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME   92 (829)
T ss_pred             chhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence            56667789999999987     37899999999764   34456678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      ||.||+|.+.-.-.+++++.++..+++..+++|+|||+.|   -+|||||-.||+++..|.+|++|||.+..++-... .
T Consensus        93 ycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati~-K  168 (829)
T KOG0576|consen   93 YCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATIA-K  168 (829)
T ss_pred             ecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhhh-h
Confidence            9999999998777889999999999999999999999999   89999999999999999999999999877654322 2


Q ss_pred             cccCCCCCcccCCccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHHHHH
Q 012684          311 LTCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLK  386 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~  386 (458)
                      ...+.||+.|||||+.   +.+.|....|||++|++..|+---+.|..+.-+........+.+ .++.......+++.+.
T Consensus       169 rksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh  248 (829)
T KOG0576|consen  169 RKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFH  248 (829)
T ss_pred             hhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHH
Confidence            3457899999999975   44578889999999999999877677765555544444433333 4444455667889999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +|++.++.++|++||+++.++.|
T Consensus       249 ~fvK~altknpKkRptaeklL~h  271 (829)
T KOG0576|consen  249 NFVKGALTKNPKKRPTAEKLLQH  271 (829)
T ss_pred             HHHHHHhcCCCccCCChhhheec
Confidence            99999999999999999998874

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.96  E-value=5.5e-29  Score=216.84  Aligned_cols=263  Identities=17%  Similarity=0.222  Sum_probs=218.6

Q ss_pred             CccccCceeeccceEEEEE-----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEE
Q 012684          154 ELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~-----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~l  227 (458)
                      ..+|.+.++||+|+||..|     .+|+.||||+-+...-.+     .+..|..+.+.++ ..+|+.+..++.+..+-.+
T Consensus        14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hp-----qL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvl   88 (341)
T KOG1163|consen   14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHP-----QLLYESKVYRILQGGVGIPHIRHYGTEKDYNVL   88 (341)
T ss_pred             ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCc-----chhHHHHHHHHhccCCCCchhhhhcccccccee
Confidence            4578999999999999776     379999999987654333     4677889999995 5799999999999999999


Q ss_pred             EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC---CCCEEEeecCCcccc
Q 012684          228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLL  303 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~---~~~vkl~Dfg~~~~~  303 (458)
                      ||+++ |.+|++++.-. ..++..+++.++-|++.-++|+|.++   ++||||||+|+|..-   -..+.|+|||+++.+
T Consensus        89 VMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky  164 (341)
T KOG1163|consen   89 VMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKY  164 (341)
T ss_pred             eeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhh
Confidence            99999 99999998754 45999999999999999999999999   999999999999873   346999999999876


Q ss_pred             ccCCCCC------cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC----CCC
Q 012684          304 TVKEDRP------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPP  373 (458)
Q Consensus       304 ~~~~~~~------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~----~~~  373 (458)
                      .......      -....||.+|.+-..+.+-..+.++|+-|+|++|.++..|..||.+...........+..    ..+
T Consensus       165 ~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~  244 (341)
T KOG1163|consen  165 RDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTP  244 (341)
T ss_pred             ccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCC
Confidence            4332211      134568999999999988888999999999999999999999999987765443332222    334


Q ss_pred             CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhccccccc
Q 012684          374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKI  425 (458)
Q Consensus       374 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~~~~  425 (458)
                      ....+.++|.++...+..|-..--++-|.+..+.+.+..++..++.+.++-.
T Consensus       245 ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLfr~ln~~~d~iy  296 (341)
T KOG1163|consen  245 IEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILFRTLNHQYDYIY  296 (341)
T ss_pred             HHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHHhhccccCCeEe
Confidence            4456788899999999999999999999999999999999999998765543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=99.96  E-value=1.4e-29  Score=244.53  Aligned_cols=204  Identities=23%  Similarity=0.378  Sum_probs=175.4

Q ss_pred             CcccCcCCc-cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHH-----HHHHHHHHHHhcCC---CCcc
Q 012684          147 EYEIDPHEL-DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRV-----RAFRDELALLQKIR---HPNV  212 (458)
Q Consensus       147 ~~~~~~~~~-~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~-----~~~~~E~~~l~~l~---hp~i  212 (458)
                      .+|..+... .|+..+.+|.|+||.|..     +...|+||++.++.+-...++     -.+-.|+.+|..++   |+||
T Consensus       552 ~~e~~~~k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NI  631 (772)
T KOG1152|consen  552 GCEKEYKKFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENI  631 (772)
T ss_pred             cceeeecccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccch
Confidence            444445544 588899999999998863     567899999988765433332     23556999999996   9999


Q ss_pred             eeeeeEEEeCCceEEEEEcc-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC
Q 012684          213 VQFLGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (458)
Q Consensus       213 ~~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~  291 (458)
                      ++++++|++++++||+||.- +|.+|.+++...+.+++.++..|++|++-|+++||+.|   |+|||||-+|+.++.+|-
T Consensus       632 lKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~  708 (772)
T KOG1152|consen  632 LKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGF  708 (772)
T ss_pred             hhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCe
Confidence            99999999999999999975 56699999999999999999999999999999999999   999999999999999999


Q ss_pred             EEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHcCCCCCCC
Q 012684          292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTM  356 (458)
Q Consensus       292 vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~lltg~~pf~~  356 (458)
                      +||+|||.+.+..+   .+...+.||..|.|||++.|.+|- ..-|||+||++||.++....||..
T Consensus       709 ~klidfgsaa~~ks---gpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  709 VKLIDFGSAAYTKS---GPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             EEEeeccchhhhcC---CCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence            99999999988654   355567899999999999998875 468999999999999999999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.96  E-value=9.4e-28  Score=216.99  Aligned_cols=207  Identities=38%  Similarity=0.653  Sum_probs=177.6

Q ss_pred             eccceEEEEE---Ec--CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012684          163 ITKGTFILAF---WR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (458)
Q Consensus       163 lg~G~~~~v~---~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L  237 (458)
                      ||.|++|.++   ..  |+.+++|.+.......  ..+.+.+|+..++.+.|++|+++++++......+++||++.+++|
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l   78 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL   78 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence            5778887665   33  8999999997543211  346788999999999999999999999998999999999998999


Q ss_pred             HHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC-CCCEEEeecCCccccccCCCCCcccCC
Q 012684          238 RAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQD  315 (458)
Q Consensus       238 ~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~-~~~vkl~Dfg~~~~~~~~~~~~~~~~~  315 (458)
                      .+++... ..++...+..++.+++.++.+||+.+   ++|+||+|.||+++. ++.++|+|||.+........ ......
T Consensus        79 ~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~-~~~~~~  154 (215)
T cd00180          79 KDLLKENEGKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS-LLKTIV  154 (215)
T ss_pred             HHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc-hhhccc
Confidence            9999875 46899999999999999999999999   999999999999999 89999999999876543321 122344


Q ss_pred             CCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcc
Q 012684          316 TSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN  394 (458)
Q Consensus       316 gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~  394 (458)
                      +...|++||.+... ..+.++|+|++|++++++                                   ..+.+++..|+.
T Consensus       155 ~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~  199 (215)
T cd00180         155 GTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQ  199 (215)
T ss_pred             CCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhh
Confidence            67789999998877 778899999999999998                                   578899999999


Q ss_pred             cCCCCCCCHHHHHHHH
Q 012684          395 EKPAKRPTFRQIITRL  410 (458)
Q Consensus       395 ~dp~~Rps~~~ll~~L  410 (458)
                      .||.+||++.++++++
T Consensus       200 ~~p~~R~~~~~l~~~~  215 (215)
T cd00180         200 KDPEKRPSAKEILEHL  215 (215)
T ss_pred             CCcccCcCHHHHhhCC
Confidence            9999999999998753

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.96  E-value=8.5e-29  Score=229.15  Aligned_cols=254  Identities=23%  Similarity=0.368  Sum_probs=208.4

Q ss_pred             cccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-Cc
Q 012684          156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SP  224 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-~~  224 (458)
                      +++....+-+|.||.+|.          +.+.|.+|.++...  ++-+...+..|--++..+.|||+.++.+++.++ ..
T Consensus       285 Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~A--S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~  362 (563)
T KOG1024|consen  285 RVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHA--SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYAT  362 (563)
T ss_pred             heechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcc--cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCc
Confidence            456666788999998763          23567777776542  455667788888888888999999999998654 45


Q ss_pred             eEEEEEccCCCCHHHHHHhc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEee
Q 012684          225 MMIVTEYLPKGDLRAFLKRK--------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~D  296 (458)
                      .+.++.+..-|+|..++...        ..++..+...++.|++.|++|||+++   ++|.||-.+|.+|++.-.|||+|
T Consensus       363 P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~LqVkltD  439 (563)
T KOG1024|consen  363 PFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQLQVKLTD  439 (563)
T ss_pred             ceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhheeEEecc
Confidence            68888999899999999731        23677788899999999999999999   99999999999999999999999


Q ss_pred             cCCccccccCCCCCc-ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCC
Q 012684          297 FGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF  374 (458)
Q Consensus       297 fg~~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  374 (458)
                      =.+++.+-..+..-. ..-..+..||+||.+....++..+|+|||||++|||+| |+.|+...++.++...++.+.+...
T Consensus       440 saLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQ  519 (563)
T KOG1024|consen  440 SALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQ  519 (563)
T ss_pred             chhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceecC
Confidence            998876532221111 11234678999999999999999999999999999998 9999999999998888866666554


Q ss_pred             CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       375 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                         |.++|.++..++..||...|++||+++++...|.+...++
T Consensus       520 ---P~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~~ql  559 (563)
T KOG1024|consen  520 ---PFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFHTQL  559 (563)
T ss_pred             ---CCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHHHHH
Confidence               4567899999999999999999999999999998876654

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.96  E-value=7.6e-28  Score=228.68  Aligned_cols=129  Identities=27%  Similarity=0.363  Sum_probs=109.1

Q ss_pred             cCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-----C---CcceeeeeE
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----H---PNVVQFLGA  218 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----h---p~i~~~~~~  218 (458)
                      +...+|-+.++||.|-|.+|++     ..+.||+|+.+.    .+...+....|+.+|+++.     |   .+||++++.
T Consensus        75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKS----AqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~  150 (590)
T KOG1290|consen   75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKS----AQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH  150 (590)
T ss_pred             ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEeh----hhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence            4457899999999999998873     578999999973    3445566788999999983     2   489999999


Q ss_pred             EEe----CCceEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec
Q 012684          219 VTQ----SSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD  287 (458)
Q Consensus       219 ~~~----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~  287 (458)
                      |..    +.++|||+|++ |.+|..++....  .++...+..|++|++.||.|||...  +|||-||||+|||+.
T Consensus       151 FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  151 FKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC  222 (590)
T ss_pred             ceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence            964    45799999999 889999998754  3999999999999999999999976  499999999999964

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.95  E-value=2.6e-28  Score=216.10  Aligned_cols=245  Identities=18%  Similarity=0.339  Sum_probs=189.0

Q ss_pred             CCCcccCcCCc--cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeee
Q 012684          145 VPEYEIDPHEL--DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFL  216 (458)
Q Consensus       145 ~~~~~~~~~~~--~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~  216 (458)
                      ++..++.-.++  .|.+.+.||+|.||....     +.+.+++|.+..+    .-...+|.+|...--.+ .|.||+..|
T Consensus        12 I~~~el~kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p----~tt~~dF~rEfhY~~~Ls~H~hIi~tY   87 (378)
T KOG1345|consen   12 IPMEELKKVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP----QTTQADFVREFHYSFFLSPHQHIIDTY   87 (378)
T ss_pred             cccccccccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc----hhhHHHHHHHhccceeeccchhhhHHH
Confidence            34444444333  688999999999996653     6789999999754    44567899998876666 589999887


Q ss_pred             eE-EEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC--CCCEE
Q 012684          217 GA-VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLK  293 (458)
Q Consensus       217 ~~-~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~--~~~vk  293 (458)
                      +. |+..+..+++|||++.|+|..-+...| +-+.....++.|+++|+.|||+++   ++|||||.+|||+-.  .-+||
T Consensus        88 ~vaFqt~d~YvF~qE~aP~gdL~snv~~~G-igE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvK  163 (378)
T KOG1345|consen   88 EVAFQTSDAYVFVQEFAPRGDLRSNVEAAG-IGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVK  163 (378)
T ss_pred             HHHhhcCceEEEeeccCccchhhhhcCccc-ccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEE
Confidence            75 666778889999999999988765533 777888899999999999999999   999999999999863  33799


Q ss_pred             EeecCCccccccCCCCCcccCCCCCcccCCcccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc----HHH
Q 012684          294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPK  364 (458)
Q Consensus       294 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~----~~~  364 (458)
                      |||||.+...+...    ....-+..|.+||....-     ...+.+|+|.||+++|.++||++||.......    ...
T Consensus       164 lcDFG~t~k~g~tV----~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~  239 (378)
T KOG1345|consen  164 LCDFGLTRKVGTTV----KYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWE  239 (378)
T ss_pred             eeecccccccCcee----hhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHH
Confidence            99999988654322    112235569999875322     45678999999999999999999998543322    233


Q ss_pred             HHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCC
Q 012684          365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP  401 (458)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp  401 (458)
                      ++.....+..+.....+++.+..+.++-|..+|++|-
T Consensus       240 ~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drc  276 (378)
T KOG1345|consen  240 QWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDRC  276 (378)
T ss_pred             HHhcccCccCchhhcccCHHHHHHHHHhcCCcccccc
Confidence            3334445566666677889999999999999999993

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.95  E-value=7.8e-27  Score=214.02  Aligned_cols=199  Identities=33%  Similarity=0.564  Sum_probs=169.3

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      |...+.||.|+++.++.     ++..+++|.+......  ...+.+..|+..++.++|+|++++++++......++++|+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~   78 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY   78 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence            45667899999987763     4789999999765332  2567888999999999999999999999988999999999


Q ss_pred             cCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          232 LPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       232 ~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      +++++|.+++..... +++.....++.+++.++.+||+.+   ++|+||+|.||+++.++.++|+|||.+..........
T Consensus        79 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~  155 (225)
T smart00221       79 CEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAAL  155 (225)
T ss_pred             cCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCccccc
Confidence            999999999988666 899999999999999999999999   9999999999999999999999999988765432112


Q ss_pred             cccCCCCCcccCCccc-CCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCCC
Q 012684          311 LTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPFTM-KHDN  360 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~~lltg~~pf~~-~~~~  360 (458)
                      .....++..|++||.+ ....++.++|+|+||+++++|++|+.||.. ..+.
T Consensus       156 ~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      156 LKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             ccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhH
Confidence            2334567789999998 666778899999999999999999999977 4444

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=99.94  E-value=2.8e-27  Score=221.89  Aligned_cols=245  Identities=22%  Similarity=0.365  Sum_probs=189.2

Q ss_pred             CccccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCc
Q 012684          154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~  224 (458)
                      ...|....+||.|+|+.|+.        ..+.||+|.+....  .   ...+.+|+++|..+ .+.||+++.+++..++.
T Consensus        35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~---p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~  109 (418)
T KOG1167|consen   35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--S---PSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ  109 (418)
T ss_pred             hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--C---chHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence            33577788999999998872        57899999997543  2   24588899999999 69999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec-CCCCEEEeecCCcccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLL  303 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~-~~~~vkl~Dfg~~~~~  303 (458)
                      .++||||++.....++...   ++..++..+++.++.||.++|.+|   |+||||||+|+|++ ..+.-.|+|||++...
T Consensus       110 v~ivlp~~~H~~f~~l~~~---l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~  183 (418)
T KOG1167|consen  110 VAIVLPYFEHDRFRDLYRS---LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGLAQRY  183 (418)
T ss_pred             eEEEecccCccCHHHHHhc---CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechhHHHH
Confidence            9999999999888888755   678899999999999999999999   99999999999999 4678899999999721


Q ss_pred             ccCC------C------CC-------------------------------cccCCCCCcccCCcccCCC-CCCCchhHHH
Q 012684          304 TVKE------D------RP-------------------------------LTCQDTSCRYVAPEVFKNE-EYDTKVDVFS  339 (458)
Q Consensus       304 ~~~~------~------~~-------------------------------~~~~~gt~~y~aPE~~~~~-~~~~~~Diws  339 (458)
                      ....      .      .+                               .-...||++|.|||++... ..+++.||||
T Consensus       184 d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws  263 (418)
T KOG1167|consen  184 DGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWS  263 (418)
T ss_pred             HhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceee
Confidence            1000      0      00                               0134589999999998654 5788999999


Q ss_pred             HHHHHHHHHcCCCCCCCCCCCc--------------HHHHHHhcCC---------------------C------------
Q 012684          340 FALILQEMIEGCPPFTMKHDNE--------------VPKAYAARQR---------------------P------------  372 (458)
Q Consensus       340 lG~~l~~lltg~~pf~~~~~~~--------------~~~~~~~~~~---------------------~------------  372 (458)
                      .|++++.++++++||......-              +...-...++                     .            
T Consensus       264 ~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n  343 (418)
T KOG1167|consen  264 AGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPN  343 (418)
T ss_pred             ccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccc
Confidence            9999999999999997544321              0000000000                     0            


Q ss_pred             -CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 -PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 -~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                       ........++..+.+++++|++.||.+|.|++++|+|
T Consensus       344 ~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkH  381 (418)
T KOG1167|consen  344 TEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKH  381 (418)
T ss_pred             eeeccccccccHHHHHHHHHHccCChhhcccHHHHhcC
Confidence             0000111234578899999999999999999999987

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=2.5e-26  Score=203.12  Aligned_cols=164  Identities=18%  Similarity=0.282  Sum_probs=130.7

Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCccc
Q 012684          235 GDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC  313 (458)
Q Consensus       235 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~  313 (458)
                      |+|.+++... ..+++.+++.++.|++.||.|||+.+         ||+||+++.++.+++  ||++......      .
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~------~   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPE------Q   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeeccc------c
Confidence            6899999874 45999999999999999999999875         999999999999999  9998765432      1


Q ss_pred             CCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-HHHHHHhcCCCC---CCCChhhhHH--HHHH
Q 012684          314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPP---FKAPAKLYAR--GLKE  387 (458)
Q Consensus       314 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~-~~~~~~~~~~~~---~~~~~~~~~~--~l~~  387 (458)
                      ..||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+.......   .......++.  .+.+
T Consensus        64 ~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  143 (176)
T smart00750       64 SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFAD  143 (176)
T ss_pred             CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHH
Confidence            257899999999999999999999999999999999999997654432 222221111111   1112334454  6999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          388 LIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      +|.+||..||.+||++.++++++.....
T Consensus       144 ~i~~cl~~~p~~Rp~~~~ll~~~~~~~~  171 (176)
T smart00750      144 FMRVCASRLPQRREAANHYLAHCRALFA  171 (176)
T ss_pred             HHHHHHhcccccccCHHHHHHHHHHHHH
Confidence            9999999999999999999999877643

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.94  E-value=2.3e-27  Score=256.51  Aligned_cols=195  Identities=16%  Similarity=0.210  Sum_probs=141.1

Q ss_pred             cCCC-CcceeeeeEE-------EeCCceEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 012684          206 KIRH-PNVVQFLGAV-------TQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIH  276 (458)
Q Consensus       206 ~l~h-p~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H  276 (458)
                      .++| +||++++++|       .....++++||++ +++|.+++... ..+++.++..++.||++||.|||++|   |+|
T Consensus        28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---IvH  103 (793)
T PLN00181         28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQG---IVV  103 (793)
T ss_pred             hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCC---eee
Confidence            3455 5788888877       2234577888988 67999999753 45999999999999999999999999   999


Q ss_pred             CCCCCCCEEecCCCC-------------------EEEeecCCccccccCCC---------------CCcccCCCCCcccC
Q 012684          277 RDLEPSNILRDDSGN-------------------LKVADFGVSKLLTVKED---------------RPLTCQDTSCRYVA  322 (458)
Q Consensus       277 ~Dikp~Nil~~~~~~-------------------vkl~Dfg~~~~~~~~~~---------------~~~~~~~gt~~y~a  322 (458)
                      |||||+|||++..+.                   +|++|||+++.......               .......||+.|+|
T Consensus       104 rDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~A  183 (793)
T PLN00181        104 HNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTS  183 (793)
T ss_pred             ccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEC
Confidence            999999999965444                   55556665543211000               00011347888999


Q ss_pred             CcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCC
Q 012684          323 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT  402 (458)
Q Consensus       323 PE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps  402 (458)
                      ||++.+..++.++|||||||+||||++|..|+....  .....+.....++.   .....+....++..||+.+|.+||+
T Consensus       184 PE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~L~~~P~~Rps  258 (793)
T PLN00181        184 PEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQ---ILLNWPKEASFCLWLLHPEPSCRPS  258 (793)
T ss_pred             hhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChh---hhhcCHHHHHHHHHhCCCChhhCcC
Confidence            999999899999999999999999999988865322  11122211111111   1112345678899999999999999


Q ss_pred             HHHHHHH
Q 012684          403 FRQIITR  409 (458)
Q Consensus       403 ~~~ll~~  409 (458)
                      +.+++++
T Consensus       259 ~~eil~h  265 (793)
T PLN00181        259 MSELLQS  265 (793)
T ss_pred             hHHHhhc
Confidence            9999875

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.94  E-value=1.1e-25  Score=218.18  Aligned_cols=255  Identities=20%  Similarity=0.306  Sum_probs=200.4

Q ss_pred             cccCceeeccceEEEEEE----c--CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC----CCcceeeeeEE-EeCCc
Q 012684          156 DFTNSVEITKGTFILAFW----R--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR----HPNVVQFLGAV-TQSSP  224 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----hp~i~~~~~~~-~~~~~  224 (458)
                      +|.+.+.||+|+||.||.    .  ...+|+|..........   ..+..|..++..+.    .++++.+++.+ ..+..
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~   95 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF   95 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence            799999999999999884    1  24799998875432221   14667888888885    36999999999 57778


Q ss_pred             eEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC-----CCEEEeec
Q 012684          225 MMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-----GNLKVADF  297 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~-----~~vkl~Df  297 (458)
                      .++||+.+ |.+|.++....  +.++..++..++.|++.+|++||+.|   ++||||||+|+++...     ..++|.||
T Consensus        96 ~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDf  171 (322)
T KOG1164|consen   96 NFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDF  171 (322)
T ss_pred             eEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEec
Confidence            99999999 99999988654  46999999999999999999999999   9999999999999965     35999999


Q ss_pred             CCcc--ccccCCC---C---C-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh
Q 012684          298 GVSK--LLTVKED---R---P-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA  368 (458)
Q Consensus       298 g~~~--~~~~~~~---~---~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~  368 (458)
                      |+++  .+.....   .   . .....||..|+++..+.+...+++.|+||+++++.+++.|..||..............
T Consensus       172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~  251 (322)
T KOG1164|consen  172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEK  251 (322)
T ss_pred             CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHH
Confidence            9998  3221111   1   1 2345599999999999999999999999999999999999999987665443333322


Q ss_pred             cCCCCCCC-ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          369 RQRPPFKA-PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       369 ~~~~~~~~-~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      ........ .....+..+.++...+-..+...+|.+..+...|+......
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~~~~  301 (322)
T KOG1164|consen  252 DPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAELLKDVFDSE  301 (322)
T ss_pred             HhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHHHHHHHHhc
Confidence            22111111 22334578888988888899999999999999998886654

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.90  E-value=7.3e-25  Score=225.76  Aligned_cols=247  Identities=27%  Similarity=0.375  Sum_probs=186.5

Q ss_pred             CceeeccceEEEEEE-----cCeEEEEEEcCC---CCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          159 NSVEITKGTFILAFW-----RGIQVAVKKLGE---EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       159 ~~~~lg~G~~~~v~~-----~g~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      ....+|.|.+|.++.     ....++.|....   ...........+..|+-+-..+.|||++..+..+.+.....-.||
T Consensus       322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE  401 (601)
T KOG0590|consen  322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME  401 (601)
T ss_pred             ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence            456788888884432     222333333321   111222222336668878888899999888887776666555699


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC--
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~--  308 (458)
                      ||++ +|+.++...+.++..++..+++|++.|+.|||..|   +.|||+|++|+++..+|.+|++|||.+......-.  
T Consensus       402 ~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~  477 (601)
T KOG0590|consen  402 YCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKN  477 (601)
T ss_pred             cccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCcchh
Confidence            9999 99999998878999999999999999999999999   99999999999999999999999999876543322  


Q ss_pred             -CCcccCCCCCcccCCcccCCCCCCC-chhHHHHHHHHHHHHcCCCCCCCCCCCcHH-HHH-HhcCC---CCCCCChhhh
Q 012684          309 -RPLTCQDTSCRYVAPEVFKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEVP-KAY-AARQR---PPFKAPAKLY  381 (458)
Q Consensus       309 -~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwslG~~l~~lltg~~pf~~~~~~~~~-~~~-~~~~~---~~~~~~~~~~  381 (458)
                       .......|+..|+|||++.+..|.+ ..||||.|++++.|.+|+.||......+.. ... ...+.   .........+
T Consensus       478 ~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  557 (601)
T KOG0590|consen  478 IHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLL  557 (601)
T ss_pred             hhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChHHHHHhc
Confidence             2234567889999999999999987 589999999999999999999866554332 111 11111   1111234556


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.+.+.+|.+||+.||.+|.|++++++.
T Consensus       558 p~~~~~~~~~~l~~~P~~R~ti~~i~~d  585 (601)
T KOG0590|consen  558 PRETRIIIYRMLQLDPTKRITIEQILND  585 (601)
T ss_pred             hhhHHHHHHHHccCChhheecHHHHhhC
Confidence            7889999999999999999999999975

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.90  E-value=6e-22  Score=191.33  Aligned_cols=250  Identities=26%  Similarity=0.452  Sum_probs=199.6

Q ss_pred             ccCceeeccceEEEEEE--cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCC-cceeeeeEEEeCCceEEEEEccC
Q 012684          157 FTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP-NVVQFLGAVTQSSPMMIVTEYLP  233 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-~i~~~~~~~~~~~~~~lv~e~~~  233 (458)
                      |.....||.|+|+.++.  .-..+++|.+.............+.+|..++..+.|+ +++++++.+......+++++++.
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~   81 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVD   81 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEeccEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCC
Confidence            56778899999987763  2367899999876554444567789999999999887 79999999977777899999999


Q ss_pred             CCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC-CEEEeecCCccccccCCCC
Q 012684          234 KGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       234 ~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~-~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ++++.+++....   .++......++.|++.++.|+|+.+   ++|||+||+||+++..+ .++++|||.+.........
T Consensus        82 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~  158 (384)
T COG0515          82 GGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST  158 (384)
T ss_pred             CCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCCcc
Confidence            999998877764   6899999999999999999999999   99999999999999988 7999999998755433221


Q ss_pred             -----CcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC----CcHHHHHHhcCCC-CCCC
Q 012684          310 -----PLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHD----NEVPKAYAARQRP-PFKA  376 (458)
Q Consensus       310 -----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~pf~~~~~----~~~~~~~~~~~~~-~~~~  376 (458)
                           ......++..|++||.+.+   .......|+|++|++++++++|..||.....    ......+.....+ ....
T Consensus       159 ~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (384)
T COG0515         159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASP  238 (384)
T ss_pred             ccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccc
Confidence                 2356678999999999987   5788899999999999999999999877664    2333333222222 1111


Q ss_pred             Chhh----hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          377 PAKL----YARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       377 ~~~~----~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ....    ....+.+++..++..+|..|.+.......
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~  275 (384)
T COG0515         239 LSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSH  275 (384)
T ss_pred             cCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence            1111    12578899999999999999999988875

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.89  E-value=1.8e-22  Score=195.56  Aligned_cols=170  Identities=21%  Similarity=0.238  Sum_probs=128.6

Q ss_pred             CCcccCcCCccccCceeeccceEEEEEE------cCeEEEEEEcCCCCC--CCHHHHHHHHHHHHHHhcCCCCccee-ee
Q 012684          146 PEYEIDPHELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQ-FL  216 (458)
Q Consensus       146 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~-~~  216 (458)
                      |.-.+.+...+|+..+.||+|+||.||.      +++.||||.+.....  ......+.+.+|+.++++++|+|+++ ++
T Consensus         9 ~~~~~~~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~   88 (365)
T PRK09188          9 PGDQIPALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLL   88 (365)
T ss_pred             cccccccccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEE
Confidence            3444556667899999999999999883      467789998753311  12334567899999999999999985 44


Q ss_pred             eEEEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCCEEecCCCCEEEe
Q 012684          217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSNILRDDSGNLKVA  295 (458)
Q Consensus       217 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Di-kp~Nil~~~~~~vkl~  295 (458)
                      +.    +..|+||||++|++|... ..   ..   ...++.|++++|.|||+.|   |+|||| ||+|||++.++.++|+
T Consensus        89 ~~----~~~~LVmE~~~G~~L~~~-~~---~~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLi  154 (365)
T PRK09188         89 AT----GKDGLVRGWTEGVPLHLA-RP---HG---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVI  154 (365)
T ss_pred             Ec----CCcEEEEEccCCCCHHHh-Cc---cc---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEE
Confidence            32    457999999999999732 11   11   1467899999999999999   999999 9999999999999999


Q ss_pred             ecCCccccccCCCC-------CcccCCCCCcccCCcccCCC
Q 012684          296 DFGVSKLLTVKEDR-------PLTCQDTSCRYVAPEVFKNE  329 (458)
Q Consensus       296 Dfg~~~~~~~~~~~-------~~~~~~gt~~y~aPE~~~~~  329 (458)
                      |||++..+......       ......+++.|+|||.+...
T Consensus       155 DFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        155 DFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             ECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99999866433211       11344577889999998653

>KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones]

Probab=99.86  E-value=1.4e-21  Score=162.40  Aligned_cols=111  Identities=33%  Similarity=0.338  Sum_probs=82.5

Q ss_pred             CCCCCCcCccchHHHHHHHhCCHHHHHHHHHc-CCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 012684           31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP  109 (458)
Q Consensus        31 ~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~-g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp  109 (458)
                      ..+|.+|..|+||||+||..|+.++|+.|+.+ |+|+|..+..|.|||||||..|..+|+++|+++|+.++++|..|.||
T Consensus        63 v~~ddkDdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~G~T~LHyAagK~r~eIaqlLle~ga~i~~kD~~~qtp  142 (226)
T KOG4412|consen   63 VKPDDKDDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNGGQTCLHYAAGKGRLEIAQLLLEKGALIRIKDKQGQTP  142 (226)
T ss_pred             CCCCCccccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCCCcceehhhhcCChhhHHHHHHhcCCCCcccccccCch
Confidence            34455566677777777777777777777776 77777777777777777777777777777777777777777777777


Q ss_pred             hHHHhhcchHHHHHHHHHhCCCCCCCcccccc
Q 012684          110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH  141 (458)
Q Consensus       110 l~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~  141 (458)
                      ||-|+.-|..+++++|+..|+.++++.-.+-+
T Consensus       143 lHRAAavGklkvie~Li~~~a~~n~qDk~G~T  174 (226)
T KOG4412|consen  143 LHRAAAVGKLKVIEYLISQGAPLNTQDKYGFT  174 (226)
T ss_pred             hHHHHhccchhhHHHHHhcCCCCCcccccCcc
Confidence            77777777777777777777766555444333

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.85  E-value=1.4e-21  Score=176.31  Aligned_cols=170  Identities=10%  Similarity=0.175  Sum_probs=132.6

Q ss_pred             CccccCceeeccceEEEEEE---cCeEEEEEEcCCCCCCCHHHHHH------HHHHHHHHhcCCCCcceeeeeEEEeC--
Q 012684          154 ELDFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDRVRA------FRDELALLQKIRHPNVVQFLGAVTQS--  222 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~---~g~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~hp~i~~~~~~~~~~--  222 (458)
                      +.+|...+.+|.|+||.|+.   ++..+|||++.......+...+.      +.+|+..+.++.||+|+.+.+++...  
T Consensus        30 ~~~y~~~~~l~~~~f~~v~l~~~~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~~~  109 (232)
T PRK10359         30 SYNIKTIKVFRNIDDTKVSLIDTDYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLAER  109 (232)
T ss_pred             hCceEEEEEecCCCceEEEEEecCCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeeccc
Confidence            45788999999999998874   56689999998766555555444      57899999999999999999886533  


Q ss_pred             ------CceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEee
Q 012684          223 ------SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (458)
Q Consensus       223 ------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~D  296 (458)
                            +..+++|||++|.+|.++..    +++    ....+++.++..+|+.|   ++|||++|+||+++.+| ++|+|
T Consensus       110 ~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g-i~liD  177 (232)
T PRK10359        110 KTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG-LRIID  177 (232)
T ss_pred             ccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-EEEEE
Confidence                  35799999999999988732    332    34569999999999999   99999999999999988 99999


Q ss_pred             cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHH
Q 012684          297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI  348 (458)
Q Consensus       297 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~ll  348 (458)
                      ||...........             ........+..++|+|+||+++..+.
T Consensus       178 fg~~~~~~e~~a~-------------d~~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        178 LSGKRCTAQRKAK-------------DRIDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             CCCcccccchhhH-------------HHHHHHhHhcccccccceeEeehHHH
Confidence            9987654211100             01333445667999999999987654

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.85  E-value=2.4e-22  Score=198.08  Aligned_cols=222  Identities=22%  Similarity=0.324  Sum_probs=184.4

Q ss_pred             eccceEEEEE--------EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEccC
Q 012684          163 ITKGTFILAF--------WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP  233 (458)
Q Consensus       163 lg~G~~~~v~--------~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~  233 (458)
                      +|.|+||.|+        ..|.-||+|+.++......... ....|..++...+ ||.++++...++.+...++++++..
T Consensus         2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            6888888765        2567899999876554333332 4556778888885 9999999999999999999999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCccc
Q 012684          234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC  313 (458)
Q Consensus       234 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~  313 (458)
                      ||.|...+.....+.+.....+...++-++..+|+.+   ++|||+|++||+++.+|++++.|||+++..-...     .
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~-----~  152 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK-----I  152 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh-----h
Confidence            9999999988888888888889999999999999999   9999999999999999999999999998653221     1


Q ss_pred             CCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHc
Q 012684          314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW  393 (458)
Q Consensus       314 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  393 (458)
                      .+||..|||||+++  .+....|.||+|+++++|++|..||..    ++...+.+...+    .+..++..++.++..++
T Consensus       153 ~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~----~p~~l~~~a~~~~~~l~  222 (612)
T KOG0603|consen  153 ACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELE----MPRELSAEARSLFRQLF  222 (612)
T ss_pred             cccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccC----CchhhhHHHHHHHHHHH
Confidence            27899999999998  467899999999999999999999998    444444332222    24667889999999999


Q ss_pred             ccCCCCCCCH
Q 012684          394 NEKPAKRPTF  403 (458)
Q Consensus       394 ~~dp~~Rps~  403 (458)
                      ..+|..|...
T Consensus       223 ~r~p~nrLg~  232 (612)
T KOG0603|consen  223 KRNPENRLGA  232 (612)
T ss_pred             hhCHHHHhcc
Confidence            9999999776

>KOG4412 consensus 26S proteasome regulatory complex, subunit PSMD10 [Posttranslational modification, protein turnover, chaperones]

Probab=99.85  E-value=2.6e-21  Score=160.77  Aligned_cols=106  Identities=29%  Similarity=0.266  Sum_probs=95.5

Q ss_pred             CCCCCCcC-ccchHHHHHHHhCCHHHHHHHHH-cCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHC-CCCCCCCCCCCC
Q 012684           31 LDDDGEEI-KPEFRLMFLANERDVEGIKELLD-SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGS  107 (458)
Q Consensus        31 ~d~~~~~~-~g~t~l~~a~~~~~~~~~~~ll~-~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~-ga~~~~~~~~g~  107 (458)
                      +..+.++. +|+|||||||..|+.+++.+|+. .+..+|.+|..||||||+||..|+.++|+.|+.+ |+|+|..++.|.
T Consensus        28 kSL~~r~dqD~Rt~LHwa~S~g~~eiv~fLlsq~nv~~ddkDdaGWtPlhia~s~g~~evVk~Ll~r~~advna~tn~G~  107 (226)
T KOG4412|consen   28 KSLNARDDQDGRTPLHWACSFGHVEIVYFLLSQPNVKPDDKDDAGWTPLHIAASNGNDEVVKELLNRSGADVNATTNGGQ  107 (226)
T ss_pred             hhhhccccccCCceeeeeeecCchhHHHHHHhcCCCCCCCccccCCchhhhhhhcCcHHHHHHHhcCCCCCcceecCCCc
Confidence            34555555 89999999999999999999994 5888999999999999999999999999999999 999999999999


Q ss_pred             ChhHHHhhcchHHHHHHHHHhCCCCCCCc
Q 012684          108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      ||||||+..|+.+++++|+++|+.+.+..
T Consensus       108 T~LHyAagK~r~eIaqlLle~ga~i~~kD  136 (226)
T KOG4412|consen  108 TCLHYAAGKGRLEIAQLLLEKGALIRIKD  136 (226)
T ss_pred             ceehhhhcCChhhHHHHHHhcCCCCcccc
Confidence            99999999999999999999999885533

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.84  E-value=1e-21  Score=202.95  Aligned_cols=244  Identities=20%  Similarity=0.271  Sum_probs=173.8

Q ss_pred             cccCceeeccceEEEEE---EcCeEEEEEEcCCCC-CCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      ++...+.||.+.|-.+.   -..-.|+||++-+.. ..+.+...+-..|++ ...+++||++++.-....+...|||-+|
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~eG~vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqy  102 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDREGLVVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQY  102 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCCceEEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence            46667789999996443   233349999986543 112222222223444 5556899999998887778888999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc--ccCCCC
Q 012684          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL--TVKEDR  309 (458)
Q Consensus       232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~--~~~~~~  309 (458)
                      + ..+|+|.+..++-+..-+...|+.|++.||.-+|..|   |+|||||.+|||++.=+-+.|+||..-+..  +..+..
T Consensus       103 v-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  103 V-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             H-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            9 5699999998888888889999999999999999999   999999999999999889999999876533  222222


Q ss_pred             Cc-----ccCCCCCcccCCcccCCC----------C-CCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCC
Q 012684          310 PL-----TCQDTSCRYVAPEVFKNE----------E-YDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP  372 (458)
Q Consensus       310 ~~-----~~~~gt~~y~aPE~~~~~----------~-~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~  372 (458)
                      ..     +....| .|.|||.+...          + .+++-||||+||++.||++ |++||.-..   . -.+......
T Consensus       179 df~fFFDTSrRRt-CYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LSQ---L-~aYr~~~~~  253 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRT-CYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLSQ---L-LAYRSGNAD  253 (1431)
T ss_pred             cceEEEecCCcee-eecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHHH---H-HhHhccCcc
Confidence            22     222233 69999987541          2 5678999999999999998 788875211   0 011111100


Q ss_pred             CCCCChhh-hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 PFKAPAKL-YARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 ~~~~~~~~-~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ........ -+..++++|..|++.||.+|.++++.|+.
T Consensus       254 ~~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  254 DPEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             CHHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            00000000 12468999999999999999999999987

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.83  E-value=3.9e-21  Score=178.57  Aligned_cols=233  Identities=18%  Similarity=0.310  Sum_probs=150.9

Q ss_pred             cCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC----------CCcceeee
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR----------HPNVVQFL  216 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~----------hp~i~~~~  216 (458)
                      ....++.....||.|+++.|+.     +|+.+|||+............+.+++|.-....+.          |-.++..+
T Consensus         9 ~~~r~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~   88 (288)
T PF14531_consen    9 QRPRTLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPL   88 (288)
T ss_dssp             --EEEEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---S
T ss_pred             CCceEEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeee
Confidence            3344667788999999998873     78999999987655445556777877775555432          22333333


Q ss_pred             eEEEe---------C---C-----ceEEEEEccCCCCHHHHHHh---cCCC----CHHHHHHHHHHHHHHHHHHHhCCCC
Q 012684          217 GAVTQ---------S---S-----PMMIVTEYLPKGDLRAFLKR---KGAL----KPSTAVRFALDIARGMNYLHENKPV  272 (458)
Q Consensus       217 ~~~~~---------~---~-----~~~lv~e~~~~~~L~~~l~~---~~~~----~~~~~~~i~~qi~~~l~~LH~~~~~  272 (458)
                      +...-         .   .     ..+++|+.+ .++|.+++..   ....    .......+..|+++.+++||..|  
T Consensus        89 d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G--  165 (288)
T PF14531_consen   89 DLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG--  165 (288)
T ss_dssp             EEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             EEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc--
Confidence            33221         1   1     236788887 5699888652   2222    22234456689999999999999  


Q ss_pred             CeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCC--------CCCCCchhHHHHHHHH
Q 012684          273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--------EEYDTKVDVFSFALIL  344 (458)
Q Consensus       273 ~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l  344 (458)
                       ++|+||+|+|++++.+|.++|+||+.....+..    ......+..|.+||....        -.++.+.|.|+||+++
T Consensus       166 -lVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~----~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~l  240 (288)
T PF14531_consen  166 -LVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTR----YRCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITL  240 (288)
T ss_dssp             -EEEST-SGGGEEE-TTS-EEE--GGGEEETTEE----EEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHH
T ss_pred             -eEecccceeeEEEcCCCCEEEcChHHHeecCce----eeccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHH
Confidence             999999999999999999999999887654322    111234567899997633        2467899999999999


Q ss_pred             HHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCC
Q 012684          345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR  400 (458)
Q Consensus       345 ~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R  400 (458)
                      |.|+++..||....+......       .+. .+.+++..++.||..+|+.||.+|
T Consensus       241 y~lWC~~lPf~~~~~~~~~~~-------~f~-~C~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  241 YSLWCGRLPFGLSSPEADPEW-------DFS-RCRDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             HHHHHSS-STCCCGGGSTSGG-------GGT-TSS---HHHHHHHHHHT-SSGGGS
T ss_pred             HHHHHccCCCCCCCccccccc-------cch-hcCCcCHHHHHHHHHHccCCcccC
Confidence            999999999997655433221       111 233678899999999999999988

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.83  E-value=1.9e-20  Score=166.87  Aligned_cols=137  Identities=19%  Similarity=0.217  Sum_probs=105.5

Q ss_pred             eeeccceEEEEEE----cCeEEEEEEcCCCCCCCHH-----------------------HHHHHHHHHHHHhcCCCCcce
Q 012684          161 VEITKGTFILAFW----RGIQVAVKKLGEEVISDDD-----------------------RVRAFRDELALLQKIRHPNVV  213 (458)
Q Consensus       161 ~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~hp~i~  213 (458)
                      ..||+|+||.||.    +|+.||||+++........                       .......|+..+..+.++++.
T Consensus         3 ~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v~   82 (190)
T cd05147           3 GCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGIP   82 (190)
T ss_pred             CccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCCC
Confidence            4799999999874    6899999999754321111                       012234599999999877764


Q ss_pred             eeeeEEEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeCCCCCCCEEecCCCCE
Q 012684          214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL-HENKPVPIIHRDLEPSNILRDDSGNL  292 (458)
Q Consensus       214 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~i~H~Dikp~Nil~~~~~~v  292 (458)
                      ....+...  ..++||||++|+++.......+.++...+..++.|++.+|.++ |+.|   |+||||||+||+++ ++.+
T Consensus        83 ~p~~~~~~--~~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~-~~~v  156 (190)
T cd05147          83 CPEPILLK--SHVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH-DGKL  156 (190)
T ss_pred             CCcEEEec--CCEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-CCcE
Confidence            43332222  2389999998887766544456799999999999999999999 7889   99999999999998 4789


Q ss_pred             EEeecCCcccc
Q 012684          293 KVADFGVSKLL  303 (458)
Q Consensus       293 kl~Dfg~~~~~  303 (458)
                      +|+|||++...
T Consensus       157 ~LiDFG~a~~~  167 (190)
T cd05147         157 YIIDVSQSVEH  167 (190)
T ss_pred             EEEEccccccC
Confidence            99999998754

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.82  E-value=1.3e-19  Score=160.09  Aligned_cols=186  Identities=13%  Similarity=0.064  Sum_probs=135.0

Q ss_pred             CceeeccceEEEEEE---cCeEEEEEEcCCCCCCCHHH-HHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEccC
Q 012684          159 NSVEITKGTFILAFW---RGIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP  233 (458)
Q Consensus       159 ~~~~lg~G~~~~v~~---~g~~vavK~~~~~~~~~~~~-~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~  233 (458)
                      +...|++|+||.|++   .+.+++.+.+.......... ...+.+|+++|+++. +++|++++++    +..+++|||+.
T Consensus         6 ~~~~l~~~~f~~v~~~~~~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~   81 (218)
T PRK12274          6 VNEPLKSDTFGRILLVRGGERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLA   81 (218)
T ss_pred             cceeecCCCcceEEEeecCCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeec
Confidence            456899999999986   46677777665332111111 125788999999995 5889999886    34699999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCC-CCCCEEecCCCCEEEeecCCccccccCCCC---
Q 012684          234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL-EPSNILRDDSGNLKVADFGVSKLLTVKEDR---  309 (458)
Q Consensus       234 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Di-kp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~---  309 (458)
                      |.+|.+....       ....++.|++.+|.++|+.|   |+|||| ||+|||++.++.++|+|||++.........   
T Consensus        82 G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~  151 (218)
T PRK12274         82 GAAMYQRPPR-------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL  151 (218)
T ss_pred             CccHHhhhhh-------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence            9999764322       12357889999999999999   999999 799999999999999999999854322110   


Q ss_pred             -C--------cccCCCCCcccCCcccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCC
Q 012684          310 -P--------LTCQDTSCRYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKH  358 (458)
Q Consensus       310 -~--------~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~~lltg~~pf~~~~  358 (458)
                       .        ......++.|++|+...  ...--.+.+.++.|+.+|.++|+..|+-+..
T Consensus       152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence             0        00112456777776532  2222357899999999999999998865543

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.81  E-value=1.8e-19  Score=168.13  Aligned_cols=196  Identities=20%  Similarity=0.270  Sum_probs=145.8

Q ss_pred             CCCcceeeeeEEEe---------------------------CCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHH
Q 012684          208 RHPNVVQFLGAVTQ---------------------------SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA  260 (458)
Q Consensus       208 ~hp~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~  260 (458)
                      .||||+++..+|.+                           +..+|+||..+ ..+|..++..+. .+.-...-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~-~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRH-RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCC-CchHHHHHHHHHHH
Confidence            59999999887742                           23579999988 569999998754 45666777899999


Q ss_pred             HHHHHHHhCCCCCeeeCCCCCCCEEecC--CC--CEEEeecCCccccccCC-----CCCcccCCCCCcccCCcccCCCC-
Q 012684          261 RGMNYLHENKPVPIIHRDLEPSNILRDD--SG--NLKVADFGVSKLLTVKE-----DRPLTCQDTSCRYVAPEVFKNEE-  330 (458)
Q Consensus       261 ~~l~~LH~~~~~~i~H~Dikp~Nil~~~--~~--~vkl~Dfg~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~-  330 (458)
                      +|+.|||++|   |.|||+|.+|||+.-  ++  .+.++|||.+---....     ........|....||||+....+ 
T Consensus       352 Eav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PG  428 (598)
T KOG4158|consen  352 EAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPG  428 (598)
T ss_pred             HHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCC
Confidence            9999999999   999999999999863  32  47899999864322110     11112335677899999986542 


Q ss_pred             ----C-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHH
Q 012684          331 ----Y-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ  405 (458)
Q Consensus       331 ----~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  405 (458)
                          . -.|+|.|+.|.+.||++....||........  .....+...++..+..+++.+++++..+|+.||.+|+++.-
T Consensus       429 p~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L--~~r~Yqe~qLPalp~~vpp~~rqlV~~lL~r~pskRvsp~i  506 (598)
T KOG4158|consen  429 PNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLL--DTRTYQESQLPALPSRVPPVARQLVFDLLKRDPSKRVSPNI  506 (598)
T ss_pred             CceeeccchhhhhhhhhhHHHHhccCCcccccchhee--chhhhhhhhCCCCcccCChHHHHHHHHHhcCCccccCCccH
Confidence                1 1489999999999999999999997432221  11123344455567778899999999999999999999775


Q ss_pred             HHHHH
Q 012684          406 IITRL  410 (458)
Q Consensus       406 ll~~L  410 (458)
                      ....|
T Consensus       507 AANvl  511 (598)
T KOG4158|consen  507 AANVL  511 (598)
T ss_pred             HHhHH
Confidence            55543

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.81  E-value=2.8e-19  Score=188.29  Aligned_cols=254  Identities=20%  Similarity=0.235  Sum_probs=189.8

Q ss_pred             CCCcccCcCCccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC---CCcceeeee
Q 012684          145 VPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLG  217 (458)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~i~~~~~  217 (458)
                      -+..++......|.+.++||+|+||.||+    +|+.||||+-+....++-      .-=..++.+|+   -+.|..+..
T Consensus       688 ~~~~~~~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WEf------YI~~q~~~RLk~~~~~~~~~~~~  761 (974)
T KOG1166|consen  688 NPNTEFEVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWEF------YICLQVMERLKPQMLPSIMHISS  761 (974)
T ss_pred             CccceeeecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCceee------eehHHHHHhhchhhhcchHHHHH
Confidence            34556666677899999999999999986    689999999876544321      11122333333   345666666


Q ss_pred             EEEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC-------CC
Q 012684          218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-------SG  290 (458)
Q Consensus       218 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~-------~~  290 (458)
                      +..-.+.-++|+||.+.|+|.++++..+.+++..++.++.|++..++.||..+   |||+||||+|+++..       ..
T Consensus       762 a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~  838 (974)
T KOG1166|consen  762 AHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSK  838 (974)
T ss_pred             HHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCccc
Confidence            66666778899999999999999998888999999999999999999999999   999999999999973       23


Q ss_pred             CEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc
Q 012684          291 NLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR  369 (458)
Q Consensus       291 ~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~  369 (458)
                      -++|+|||.+..+....+. .......|-.+-.+|...|++++...|.|.|+.+++.|+.|++--           ....
T Consensus       839 ~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q-----------~~~g  907 (974)
T KOG1166|consen  839 GLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME-----------VKNG  907 (974)
T ss_pred             ceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH-----------hcCC
Confidence            5999999999876554443 445667788999999999999999999999999999999997632           1111


Q ss_pred             CCCCCCC-ChhhhH-HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          370 QRPPFKA-PAKLYA-RGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       370 ~~~~~~~-~~~~~~-~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      ..-.... .+..+. .-.-+|+..+|+.|-..=|...+|...|+.+...-.
T Consensus       908 ~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~lr~~~~~~~~~~~  958 (974)
T KOG1166|consen  908 SSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQELRTELEEVLAEHF  958 (974)
T ss_pred             cceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHHHHHHHHHHHHHH
Confidence            1100101 111122 234578888888555556888888888888765533

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.81  E-value=1.9e-19  Score=177.62  Aligned_cols=210  Identities=30%  Similarity=0.506  Sum_probs=163.8

Q ss_pred             HhcCCCCcceeeeeEEEeCCceEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 012684          204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS  282 (458)
Q Consensus       204 l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~  282 (458)
                      |+.+.|.|+.++++.+.++...+.|.+||..|+|.+.+.. .-.++......++++++.||.|+|... . ..|+.+++.
T Consensus         1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~-i-~~hg~l~s~   78 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSP-I-GYHGALKSS   78 (484)
T ss_pred             CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCc-c-eeeeeeccc
Confidence            4567899999999999999999999999999999999987 345888888899999999999999976 2 399999999


Q ss_pred             CEEecCCCCEEEeecCCccccccC-CCCCcccCCCCCcccCCcccCCCC-------CCCchhHHHHHHHHHHHHcCCCCC
Q 012684          283 NILRDDSGNLKVADFGVSKLLTVK-EDRPLTCQDTSCRYVAPEVFKNEE-------YDTKVDVFSFALILQEMIEGCPPF  354 (458)
Q Consensus       283 Nil~~~~~~vkl~Dfg~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwslG~~l~~lltg~~pf  354 (458)
                      |.+++....+||.|||+....... .............|.|||.+.+..       .+.+.|+||+|++++|++++..||
T Consensus        79 nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~  158 (484)
T KOG1023|consen   79 NCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPF  158 (484)
T ss_pred             cceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcc
Confidence            999999999999999998765321 111111122344699999987641       356799999999999999999999


Q ss_pred             CCCCCC----cHHHHHHhcCCCCCCCC-h--hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          355 TMKHDN----EVPKAYAARQRPPFKAP-A--KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       355 ~~~~~~----~~~~~~~~~~~~~~~~~-~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      +.....    ++...+...+..++.+. .  ....+++..++..||..+|.+||++.++-..++.+..
T Consensus       159 ~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~~  226 (484)
T KOG1023|consen  159 DLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTINK  226 (484)
T ss_pred             ccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhcc
Confidence            874433    34444433233222221 1  1455679999999999999999999999988877654

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.80  E-value=4.8e-19  Score=158.39  Aligned_cols=139  Identities=19%  Similarity=0.163  Sum_probs=107.1

Q ss_pred             ceeeccceEEEEEE----cCeEEEEEEcCCCCCCCH-----------------------HHHHHHHHHHHHHhcCCCCcc
Q 012684          160 SVEITKGTFILAFW----RGIQVAVKKLGEEVISDD-----------------------DRVRAFRDELALLQKIRHPNV  212 (458)
Q Consensus       160 ~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~-----------------------~~~~~~~~E~~~l~~l~hp~i  212 (458)
                      ...||+|+||.||.    +|+.||||+++.......                       .....+..|...+.++.++++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   81 (190)
T cd05145           2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV   81 (190)
T ss_pred             CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence            35799999998874    589999999986532110                       002234678999999998887


Q ss_pred             eeeeeEEEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEecCCCC
Q 012684          213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGN  291 (458)
Q Consensus       213 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dikp~Nil~~~~~~  291 (458)
                      .....+...  ..++||||++|+++.........++......++.|++.++.++|+ .|   |+||||||+||+++ ++.
T Consensus        82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~-~~~  155 (190)
T cd05145          82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH-DGK  155 (190)
T ss_pred             CCceEEEec--CCEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-CCC
Confidence            544443333  248999999887554433334568888999999999999999999 98   99999999999999 889


Q ss_pred             EEEeecCCccccc
Q 012684          292 LKVADFGVSKLLT  304 (458)
Q Consensus       292 vkl~Dfg~~~~~~  304 (458)
                      ++|+|||++....
T Consensus       156 ~~liDFG~a~~~~  168 (190)
T cd05145         156 PYIIDVSQAVELD  168 (190)
T ss_pred             EEEEEcccceecC
Confidence            9999999987653

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PRK10345 hypothetical protein; Provisional

Probab=99.79  E-value=6.4e-19  Score=158.55  Aligned_cols=135  Identities=18%  Similarity=0.275  Sum_probs=103.8

Q ss_pred             ccCceeeccceEEEEEEc--CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-----CCCcceeeeeEEEeCC---ce-
Q 012684          157 FTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-----RHPNVVQFLGAVTQSS---PM-  225 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~~--g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hp~i~~~~~~~~~~~---~~-  225 (458)
                      +.....||+|+|+.||..  ....+||++....   ....+.+.+|+.+++.+     .||||+++++++..+.   .+ 
T Consensus         4 L~~~~~LG~G~~~~Vy~hp~~~~k~IKv~~~~~---~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~   80 (210)
T PRK10345          4 LSEQSPLGTGRHRKCYAHPEDAQRCIKIVYHRG---DGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVY   80 (210)
T ss_pred             cCCcceecCCCceEEEECCCCcCeEEEEEeccc---cchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEE
Confidence            455678999999999851  1223678775432   22346789999999999     5799999999998763   33 


Q ss_pred             EEEEEc--cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeeeCCCCCCCEEecC----CCCEEEeecC
Q 012684          226 MIVTEY--LPKGDLRAFLKRKGALKPSTAVRFALDIARGM-NYLHENKPVPIIHRDLEPSNILRDD----SGNLKVADFG  298 (458)
Q Consensus       226 ~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l-~~LH~~~~~~i~H~Dikp~Nil~~~----~~~vkl~Dfg  298 (458)
                      .+||||  +.+++|.+++++. .+++.  ..++.|++.++ +|||+++   |+||||||+|||++.    ++.++|+||+
T Consensus        81 ~~I~e~~G~~~~tL~~~l~~~-~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg~  154 (210)
T PRK10345         81 DVIADFDGKPSITLTEFAEQC-RYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDNI  154 (210)
T ss_pred             EEEecCCCCcchhHHHHHHcc-cccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEECC
Confidence            378999  5578999999764 46555  35678888777 9999999   999999999999974    3379999954


Q ss_pred             Cc
Q 012684          299 VS  300 (458)
Q Consensus       299 ~~  300 (458)
                      .+
T Consensus       155 G~  156 (210)
T PRK10345        155 GE  156 (210)
T ss_pred             CC
Confidence            43

>KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only]

Probab=99.79  E-value=4.2e-19  Score=174.59  Aligned_cols=125  Identities=26%  Similarity=0.296  Sum_probs=113.4

Q ss_pred             CchhhhhhhhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccC-CCCCCHHHHHHHcCCHHHHHHHHHCC
Q 012684           18 APDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERG   96 (458)
Q Consensus        18 ~~~~~~~~~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~-~~g~t~l~~A~~~~~~~~~~~Ll~~g   96 (458)
                      +-++-+.-++-++.+++..|.+|.|+|||||.+|+++++++|+++||++|..+ .-|.||||+||++|+..+|.+|+++|
T Consensus        56 ~l~~v~~lve~~g~~v~~~D~~g~tlLHWAAiNNrl~v~r~li~~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhG  135 (600)
T KOG0509|consen   56 ELETVKELVESEGESVNNPDREGVTLLHWAAINNRLDVARYLISHGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHG  135 (600)
T ss_pred             hHHHHHHHHhhcCcCCCCCCcCCccceeHHHHcCcHHHHHHHHHcCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcC
Confidence            33444455566689999999999999999999999999999999999999998 55889999999999999999999999


Q ss_pred             CCCCCCCCCCCChhHHHhhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684           97 ADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus        97 a~~~~~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      ||++.+|.+|.+|+|+|+..|+..++-+|+.+|+|+++..-.+.++
T Consensus       136 Adpt~~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~D~~grTp  181 (600)
T KOG0509|consen  136 ADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLRDNNGRTP  181 (600)
T ss_pred             CCCceecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCcCCCCCCH
Confidence            9999999999999999999999999999999999998877666655

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.78  E-value=2.6e-19  Score=185.16  Aligned_cols=227  Identities=26%  Similarity=0.404  Sum_probs=165.7

Q ss_pred             ccccccCCCCCCcccCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCC
Q 012684          136 PMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP  210 (458)
Q Consensus       136 ~~~~~~~~~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp  210 (458)
                      +|...++....-+...+.+..|...+.+..|+||.||+     +-+++|+| +++...       -+++   ++.....|
T Consensus        64 p~~~~s~~~~~as~~~p~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~l-------ilRn---ilt~a~np  132 (1205)
T KOG0606|consen   64 PMTDESPESRGASRRAPSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNL-------ILRN---ILTFAGNP  132 (1205)
T ss_pred             CCCCCCcccccccccCCCccccceeEeeccCCCCceeeeeccccccchhhc-ccccch-------hhhc---cccccCCc
Confidence            55555554444455667778888889999999998875     35677874 332211       0111   22222344


Q ss_pred             cceeeeeEEEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC
Q 012684          211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG  290 (458)
Q Consensus       211 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~  290 (458)
                      .+|                     |+-.+.++.-+.++..-        +.+++|||+.+   |+|||+||+|.+|+.-|
T Consensus       133 fvv---------------------gDc~tllk~~g~lPvdm--------vla~Eylh~yg---ivhrdlkpdnllIT~mG  180 (1205)
T KOG0606|consen  133 FVV---------------------GDCATLLKNIGPLPVDM--------VLAVEYLHSYG---IVHRDLKPDNLLITSMG  180 (1205)
T ss_pred             cee---------------------chhhhhcccCCCCcchh--------hHHhHhhccCC---eecCCCCCCcceeeecc
Confidence            433                     56666666656555432        77899999999   99999999999999999


Q ss_pred             CEEEeecCCccccccCCC--------------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 012684          291 NLKVADFGVSKLLTVKED--------------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM  356 (458)
Q Consensus       291 ~vkl~Dfg~~~~~~~~~~--------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~  356 (458)
                      ++|+.|||+++.......              ..-...+|||.|.|||++..+.|....|.|++|+++|+++-|+.||.+
T Consensus       181 hiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffG  260 (1205)
T KOG0606|consen  181 HIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG  260 (1205)
T ss_pred             cccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccC
Confidence            999999999865321100              001345799999999999999999999999999999999999999999


Q ss_pred             CCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHH
Q 012684          357 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI  406 (458)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l  406 (458)
                      .++++.+..+..... .+++....++++.+++|.++|+.+|..|.-....
T Consensus       261 dtpeelfg~visd~i-~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~ga  309 (1205)
T KOG0606|consen  261 DTPEELFGQVISDDI-EWPEEDEALPPEAQDLIEQLLRQNPLCRLGTGGA  309 (1205)
T ss_pred             CCHHHHHhhhhhhhc-cccccCcCCCHHHHHHHHHHHHhChHhhcccchh
Confidence            999998887754443 3333345577899999999999999999554433

>PHA02743 Viral ankyrin protein; Provisional

Probab=99.77  E-value=1.9e-18  Score=150.77  Aligned_cols=107  Identities=20%  Similarity=0.152  Sum_probs=98.0

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHH---HHHHHHHcCCCCCccC-CCCCCHHHHHHHcCCHHHHHHHHH-CCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVE---GIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLE-RGADVDPK  102 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~---~~~~ll~~g~~in~~~-~~g~t~l~~A~~~~~~~~~~~Ll~-~ga~~~~~  102 (458)
                      -.+.+.+.+|..|.||||+||..|+.+   ++++|++.|+++|.++ ..|.||||+|+..++.+++++|+. .|++++.+
T Consensus        45 ~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~  124 (166)
T PHA02743         45 GDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINARELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAI  124 (166)
T ss_pred             hcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCCCCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCc
Confidence            356677888889999999999998865   4899999999999998 589999999999999999999995 79999999


Q ss_pred             CCCCCChhHHHhhcchHHHHHHHHHhCCCCCC
Q 012684          103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       103 ~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~  134 (458)
                      |..|.||||+|+..++.+++++|+++|+++..
T Consensus       125 d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~  156 (166)
T PHA02743        125 NYQHETAYHIAYKMRDRRMMEILRANGAVCDD  156 (166)
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCC
Confidence            99999999999999999999999999999744

>PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain

Probab=99.74  E-value=1.5e-17  Score=129.43  Aligned_cols=87  Identities=44%  Similarity=0.583  Sum_probs=82.2

Q ss_pred             HHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcchHHHHH
Q 012684           44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK  123 (458)
Q Consensus        44 l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~~  123 (458)
                      ||+||..|+.++++.|++.+.+++.    |.||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..|+.++++
T Consensus         1 L~~A~~~~~~~~~~~ll~~~~~~~~----~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~   76 (89)
T PF12796_consen    1 LHIAAQNGNLEILKFLLEKGADINL----GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVK   76 (89)
T ss_dssp             HHHHHHTTTHHHHHHHHHTTSTTTS----SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHH
T ss_pred             CHHHHHcCCHHHHHHHHHCcCCCCC----CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHH
Confidence            7999999999999999999999887    889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhCCCCCC
Q 012684          124 LLEKHGAKPLM  134 (458)
Q Consensus       124 ~l~~~g~~~~~  134 (458)
                      +|+++|+++..
T Consensus        77 ~Ll~~g~~~~~   87 (89)
T PF12796_consen   77 LLLEHGADVNI   87 (89)
T ss_dssp             HHHHTTT-TTS
T ss_pred             HHHHcCCCCCC
Confidence            99999999864

These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B ....

>PHA02859 ankyrin repeat protein; Provisional

Probab=99.73  E-value=2.8e-17  Score=148.93  Aligned_cols=105  Identities=22%  Similarity=0.242  Sum_probs=50.7

Q ss_pred             CCCCCCCc-CccchHHHHHHHh---CCHHHHHHHHHcCCCCCccCCCCCCHHHHHHH--cCCHHHHHHHHHCCCCCCCCC
Q 012684           30 GLDDDGEE-IKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAAC--QGFTEVVSLLLERGADVDPKD  103 (458)
Q Consensus        30 ~~d~~~~~-~~g~t~l~~a~~~---~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~--~~~~~~~~~Ll~~ga~~~~~~  103 (458)
                      |+|++.++ ..|.||||+|+..   ++.+++++|+++|+++|.+|..|.||||+|+.  .++.+++++|+++|++++.+|
T Consensus        76 gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G~TpLh~a~~~~~~~~~iv~~Li~~gadin~~d  155 (209)
T PHA02859         76 GADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDGKNLLHMYMCNFNVRINVIKLLIDSGVSFLNKD  155 (209)
T ss_pred             CCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccccc
Confidence            44444443 2445555554432   23455555555555555555555555555443  234555555555555555555


Q ss_pred             CCCCChhHH-HhhcchHHHHHHHHHhCCCCCC
Q 012684          104 RWGSTPLGD-AIYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       104 ~~g~tpl~~-A~~~~~~~~~~~l~~~g~~~~~  134 (458)
                      ..|.||||. |+..++.+++++|+++|+++..
T Consensus       156 ~~g~t~Lh~~a~~~~~~~iv~~Ll~~Gadi~~  187 (209)
T PHA02859        156 FDNNNILYSYILFHSDKKIFDFLTSLGIDINE  187 (209)
T ss_pred             CCCCcHHHHHHHhcCCHHHHHHHHHcCCCCCC
Confidence            555555552 3334445555555555555443

>PHA02791 ankyrin-like protein; Provisional

Probab=99.73  E-value=3e-17  Score=154.41  Aligned_cols=103  Identities=16%  Similarity=0.114  Sum_probs=50.3

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCC-CHHHHHHHcCCHHHHHHHHHCCCCCCCCC-CCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNR-TALHVAACQGFTEVVSLLLERGADVDPKD-RWG  106 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~-t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~-~~g  106 (458)
                      .|+|++.++..|+||||+||..|+.+++++|++.|+++|.++..|+ ||||+||..|+.+++++|+++|++.  .| ..|
T Consensus        83 ~Gadvn~~d~~G~TpLh~Aa~~g~~eivk~Ll~~gadin~~~~~g~~TpL~~Aa~~g~~eivk~LL~~~~~~--~d~~~g  160 (284)
T PHA02791         83 SGMDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKTSFYHAVMLNDVSIVSYFLSEIPST--FDLAIL  160 (284)
T ss_pred             CCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccCCCCCcHHHHHHHHcCCHHHHHHHHhcCCcc--cccccC
Confidence            3444444444555555555555555555555555555554444443 4555555555555555555444322  11 124


Q ss_pred             CChhHHHhhcchHHHHHHHHHhCCCCC
Q 012684          107 STPLGDAIYYKNHEVIKLLEKHGAKPL  133 (458)
Q Consensus       107 ~tpl~~A~~~~~~~~~~~l~~~g~~~~  133 (458)
                      .||||+|+..|+.+++++|+++|+++.
T Consensus       161 ~TpLh~Aa~~g~~eiv~lLL~~gAd~n  187 (284)
T PHA02791        161 LSCIHITIKNGHVDMMILLLDYMTSTN  187 (284)
T ss_pred             ccHHHHHHHcCCHHHHHHHHHCCCCCC
Confidence            555555555555555555555555543

>PHA02791 ankyrin-like protein; Provisional

Probab=99.73  E-value=4.4e-17  Score=153.34  Aligned_cols=101  Identities=27%  Similarity=0.291  Sum_probs=94.4

Q ss_pred             CCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhH
Q 012684           32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG  111 (458)
Q Consensus        32 d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~  111 (458)
                      +.+..|.+|.||||+||..|+.+++++|++.|+++|.++  |.||||+|+..|+.+++++|+.+|++++.+|..|+||||
T Consensus        22 ~a~~~D~~G~TpLh~Aa~~g~~eiv~~Ll~~ga~~n~~d--~~TpLh~Aa~~g~~eiV~lLL~~Gadvn~~d~~G~TpLh   99 (284)
T PHA02791         22 DAFKADVHGHSALYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGMDDSQFDDKGNTALY   99 (284)
T ss_pred             CCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCcCCCcCCC--CCCHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHH
Confidence            335678889999999999999999999999999998864  799999999999999999999999999999999999999


Q ss_pred             HHhhcchHHHHHHHHHhCCCCCC
Q 012684          112 DAIYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       112 ~A~~~~~~~~~~~l~~~g~~~~~  134 (458)
                      +|+..|+.+++++|+++|+++..
T Consensus       100 ~Aa~~g~~eivk~Ll~~gadin~  122 (284)
T PHA02791        100 YAVDSGNMQTVKLFVKKNWRLMF  122 (284)
T ss_pred             HHHHcCCHHHHHHHHHCCCCcCc
Confidence            99999999999999999998744

>PHA02741 hypothetical protein; Provisional

Probab=99.72  E-value=3e-17  Score=143.79  Aligned_cols=103  Identities=20%  Similarity=0.275  Sum_probs=95.7

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCC----HHHHHHHHHcCCCCCccCC-CCCCHHHHHHHcCCHHHHHHHHH-CCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDI-DNRTALHVAACQGFTEVVSLLLE-RGADVDPK  102 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~----~~~~~~ll~~g~~in~~~~-~g~t~l~~A~~~~~~~~~~~Ll~-~ga~~~~~  102 (458)
                      .+++.+.+|..|.||||+|+..|+    .+++++|++.|+++|.++. +|+||||+|+..++.+++++|+. .|++++.+
T Consensus        49 ~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~  128 (169)
T PHA02741         49 HAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQEMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFC  128 (169)
T ss_pred             hhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCCCcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcC
Confidence            457778888889999999999998    5899999999999999985 89999999999999999999997 59999999


Q ss_pred             CCCCCChhHHHhhcchHHHHHHHHHhCCC
Q 012684          103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAK  131 (458)
Q Consensus       103 ~~~g~tpl~~A~~~~~~~~~~~l~~~g~~  131 (458)
                      |..|.||||+|+..++.+++++|++.++.
T Consensus       129 n~~g~tpL~~A~~~~~~~iv~~L~~~~~~  157 (169)
T PHA02741        129 NADNKSPFELAIDNEDVAMMQILREIVAT  157 (169)
T ss_pred             CCCCCCHHHHHHHCCCHHHHHHHHHHHHH
Confidence            99999999999999999999999998765

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.72  E-value=2.5e-18  Score=166.75  Aligned_cols=170  Identities=26%  Similarity=0.404  Sum_probs=127.6

Q ss_pred             ceEEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~  300 (458)
                      ++||.|++|+..+|.+++..+.   .-+......++.|+..++.|   ++   .+|+|+||.||+...+..+||.|||+.
T Consensus       330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~  403 (516)
T KOG1033|consen  330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV  403 (516)
T ss_pred             chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence            5789999999999999997543   36677888999999999999   77   999999999999999999999999998


Q ss_pred             cccccCC-----CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCC
Q 012684          301 KLLTVKE-----DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK  375 (458)
Q Consensus       301 ~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  375 (458)
                      .......     ....+...||..||+||.+.+..|+.++|||+||++|+|++.-   |..  ..+............++
T Consensus       404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~---f~T--~~er~~t~~d~r~g~ip  478 (516)
T KOG1033|consen  404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQ---FST--QFERIATLTDIRDGIIP  478 (516)
T ss_pred             eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHH---hcc--HHHHHHhhhhhhcCCCC
Confidence            7665443     2234566799999999999999999999999999999999862   211  11111111111111111


Q ss_pred             -CChhhhHHHHHHHHHHHcccCCCCCCCHHH
Q 012684          376 -APAKLYARGLKELIEECWNEKPAKRPTFRQ  405 (458)
Q Consensus       376 -~~~~~~~~~l~~li~~~l~~dp~~Rps~~~  405 (458)
                       .....+ +.-..|+..++...|.+||++.+
T Consensus       479 ~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~  508 (516)
T KOG1033|consen  479 PEFLQDY-PEEYTLLQQLLSPSPEERPSAIE  508 (516)
T ss_pred             hHHhhcC-cHHHHHHHHhcCCCcccCchHHH
Confidence             111122 34458999999999999995443

>PHA02741 hypothetical protein; Provisional

Probab=99.72  E-value=3.8e-17  Score=143.12  Aligned_cols=110  Identities=20%  Similarity=0.176  Sum_probs=96.0

Q ss_pred             CCCCcCccchHHHHHHHhCCHHHHHHHHH------cCCCCCccCCCCCCHHHHHHHcCC----HHHHHHHHHCCCCCCCC
Q 012684           33 DDGEEIKPEFRLMFLANERDVEGIKELLD------SGIDVNFRDIDNRTALHVAACQGF----TEVVSLLLERGADVDPK  102 (458)
Q Consensus        33 ~~~~~~~g~t~l~~a~~~~~~~~~~~ll~------~g~~in~~~~~g~t~l~~A~~~~~----~~~~~~Ll~~ga~~~~~  102 (458)
                      .+.++..|.||||+||..|+.++++.|+.      .|+++|.+|..|+||||+|+..|+    .+++++|+++|+++|.+
T Consensus        14 ~~~~~~~g~t~Lh~Aa~~g~~~~v~~l~~~~~~~~~ga~in~~d~~g~T~Lh~A~~~g~~~~~~~ii~~Ll~~gadin~~   93 (169)
T PHA02741         14 IAEKNSEGENFFHEAARCGCFDIIARFTPFIRGDCHAAALNATDDAGQMCIHIAAEKHEAQLAAEIIDHLIELGADINAQ   93 (169)
T ss_pred             hhccccCCCCHHHHHHHcCCHHHHHHHHHHhccchhhhhhhccCCCCCcHHHHHHHcCChHHHHHHHHHHHHcCCCCCCC
Confidence            44566778999999999999999999864      368999999999999999999998    58999999999999999


Q ss_pred             CC-CCCChhHHHhhcchHHHHHHHHH-hCCCCCCCccccccC
Q 012684          103 DR-WGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHVKHA  142 (458)
Q Consensus       103 ~~-~g~tpl~~A~~~~~~~~~~~l~~-~g~~~~~~~~~~~~~  142 (458)
                      +. .|+||||+|+..++.+++++|+. .|+++......+.++
T Consensus        94 ~~~~g~TpLh~A~~~~~~~iv~~Ll~~~g~~~~~~n~~g~tp  135 (169)
T PHA02741         94 EMLEGDTALHLAAHRRDHDLAEWLCCQPGIDLHFCNADNKSP  135 (169)
T ss_pred             CcCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCcCCCCCCCH
Confidence            85 99999999999999999999997 589886655444433

>PHA02736 Viral ankyrin protein; Provisional

Probab=99.72  E-value=9.8e-18  Score=144.67  Aligned_cols=100  Identities=20%  Similarity=0.218  Sum_probs=92.4

Q ss_pred             CCCcCccchHHHHHHHhCCH---HHHHHHHHcCCCCCccC-CCCCCHHHHHHHcCCHHHHHHHHH-CCCCCCCCCCCCCC
Q 012684           34 DGEEIKPEFRLMFLANERDV---EGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDRWGST  108 (458)
Q Consensus        34 ~~~~~~g~t~l~~a~~~~~~---~~~~~ll~~g~~in~~~-~~g~t~l~~A~~~~~~~~~~~Ll~-~ga~~~~~~~~g~t  108 (458)
                      +..|.+|.||||+||..|+.   +++++|++.|+++|.++ .+|+||||+|+..|+.+++++|+. .|++++.+|..|.|
T Consensus        49 ~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~t  128 (154)
T PHA02736         49 LEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGKERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFKT  128 (154)
T ss_pred             HHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCccccCCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCCC
Confidence            34577899999999999987   46889999999999998 589999999999999999999998 49999999999999


Q ss_pred             hhHHHhhcchHHHHHHHHHhCCCCC
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGAKPL  133 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~~~~  133 (458)
                      |||+|+..|+.+++++|+..|++..
T Consensus       129 pL~~A~~~~~~~i~~~Ll~~ga~~~  153 (154)
T PHA02736        129 PYYVACERHDAKMMNILRAKGAQCK  153 (154)
T ss_pred             HHHHHHHcCCHHHHHHHHHcCCCCC
Confidence            9999999999999999999999864

>KOG0509 consensus Ankyrin repeat and DHHC-type Zn-finger domain containing proteins [General function prediction only]

Probab=99.71  E-value=2.8e-17  Score=161.88  Aligned_cols=114  Identities=32%  Similarity=0.397  Sum_probs=101.2

Q ss_pred             cCCCCCCCc-CccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEE-IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (458)
Q Consensus        29 n~~d~~~~~-~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~  107 (458)
                      -|+|+|... .-+-|||||||.+|++.++.+|+++|||++.+|..|.||||+||+.|+..+|.+|+..|+|++.+|..|+
T Consensus       100 ~gadvn~~gG~l~stPLHWAar~G~~~vv~lLlqhGAdpt~~D~~G~~~lHla~~~~~~~~vayll~~~~d~d~~D~~gr  179 (600)
T KOG0509|consen  100 HGADVNAIGGVLGSTPLHWAARNGHISVVDLLLQHGADPTLKDKQGLTPLHLAAQFGHTALVAYLLSKGADIDLRDNNGR  179 (600)
T ss_pred             cCCCccccCCCCCCCcchHHHHcCcHHHHHHHHHcCCCCceecCCCCcHHHHHHHhCchHHHHHHHHhcccCCCcCCCCC
Confidence            345555554 3577999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChhHHHhhcchHHHHHHHHHhCCCCCCCc-cccccC
Q 012684          108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAP-MHVKHA  142 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l~~~g~~~~~~~-~~~~~~  142 (458)
                      ||||||++.|....+..|+..|+.+.... -++.+|
T Consensus       180 TpLmwAaykg~~~~v~~LL~f~a~~~~~d~~~g~Tp  215 (600)
T KOG0509|consen  180 TPLMWAAYKGFALFVRRLLKFGASLLLTDDNHGNTP  215 (600)
T ss_pred             CHHHHHHHhcccHHHHHHHHhcccccccccccCCch
Confidence            99999999999888999999999987655 343333

>PHA02878 ankyrin repeat protein; Provisional

Probab=99.71  E-value=5.1e-17  Score=166.33  Aligned_cols=108  Identities=31%  Similarity=0.428  Sum_probs=102.1

Q ss_pred             hcCCCCCCCcCc-cchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIK-PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG  106 (458)
Q Consensus        28 ~n~~d~~~~~~~-g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g  106 (458)
                      -.|+|++..+.. |.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|
T Consensus       155 ~~gadin~~~~~~g~tpLh~A~~~~~~~iv~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g  234 (477)
T PHA02878        155 SYGADINMKDRHKGNTALHYATENKDQRLTELLLSYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCG  234 (477)
T ss_pred             HcCCCCCccCCCCCCCHHHHHHhCCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCC
Confidence            468888888888 9999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CChhHHHhhc-chHHHHHHHHHhCCCCCCC
Q 012684          107 STPLGDAIYY-KNHEVIKLLEKHGAKPLMA  135 (458)
Q Consensus       107 ~tpl~~A~~~-~~~~~~~~l~~~g~~~~~~  135 (458)
                      .||||+|+.. ++.+++++|+++|+++...
T Consensus       235 ~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~  264 (477)
T PHA02878        235 NTPLHISVGYCKDYDILKLLLEHGVDVNAK  264 (477)
T ss_pred             CCHHHHHHHhcCCHHHHHHHHHcCCCCCcc
Confidence            9999999975 6899999999999998653

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.70  E-value=2.3e-16  Score=143.55  Aligned_cols=134  Identities=23%  Similarity=0.362  Sum_probs=110.7

Q ss_pred             eeeccceEEEEE---EcCeEEEEEEcCCCCCCCH-----HHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012684          161 VEITKGTFILAF---WRGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (458)
Q Consensus       161 ~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~  232 (458)
                      +.||+|++|.||   +.|..+++|..........     .....+.+|+.++..+.|++|+....++......+++|||+
T Consensus         2 ~~l~~G~~~~vy~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~   81 (211)
T PRK14879          2 KLIKRGAEAEIYLGDFLGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYI   81 (211)
T ss_pred             cccccCceEEEEEEeeCCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEe
Confidence            468999999886   4689999998764332221     12345778999999999998887777777777889999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       233 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      +|++|.+++.....    ....++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++|+|||.+..
T Consensus        82 ~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         82 EGEPLKDLINSNGM----EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             CCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999875432    77889999999999999999   99999999999999 78899999998763

>PHA02874 ankyrin repeat protein; Provisional

Probab=99.70  E-value=8.9e-17  Score=162.59  Aligned_cols=107  Identities=33%  Similarity=0.483  Sum_probs=102.2

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~  107 (458)
                      -.|+|++.++..|.||||+||..|+.+++++|++.|+++|.+|.+|.||||+|+..|+.+++++|+++|++++..+..|.
T Consensus       112 ~~g~d~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~g~~~n~~~~~g~  191 (434)
T PHA02874        112 DCGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNIEDDNGCYPIHIAIKHNFFDIIKLLLEKGAYANVKDNNGE  191 (434)
T ss_pred             HCcCCCCCCCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCC
Confidence            35678888899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChhHHHhhcchHHHHHHHHHhCCCCCC
Q 012684          108 TPLGDAIYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l~~~g~~~~~  134 (458)
                      ||||+|+..|+.+++++|++.|+++..
T Consensus       192 tpL~~A~~~g~~~iv~~Ll~~g~~i~~  218 (434)
T PHA02874        192 SPLHNAAEYGDYACIKLLIDHGNHIMN  218 (434)
T ss_pred             CHHHHHHHcCCHHHHHHHHhCCCCCcC
Confidence            999999999999999999999998754

>KOG0502 consensus Integral membrane ankyrin-repeat protein Kidins220 (protein kinase D substrate) [General function prediction only]

Probab=99.70  E-value=2.1e-17  Score=141.62  Aligned_cols=105  Identities=27%  Similarity=0.287  Sum_probs=99.9

Q ss_pred             CCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhH
Q 012684           32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG  111 (458)
Q Consensus        32 d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~  111 (458)
                      -+|..|..|+|||+||+..|++.+|++|++.|||++...+...|+|.+|++.|..++|++|+.++.|+|..|.+|-|||-
T Consensus       152 ~VN~~De~GfTpLiWAaa~G~i~vV~fLL~~GAdp~~lgk~resALsLAt~ggytdiV~lLL~r~vdVNvyDwNGgTpLl  231 (296)
T KOG0502|consen  152 KVNACDEFGFTPLIWAAAKGHIPVVQFLLNSGADPDALGKYRESALSLATRGGYTDIVELLLTREVDVNVYDWNGGTPLL  231 (296)
T ss_pred             cccCccccCchHhHHHHhcCchHHHHHHHHcCCChhhhhhhhhhhHhHHhcCChHHHHHHHHhcCCCcceeccCCCceee
Confidence            36777889999999999999999999999999999999888899999999999999999999999999999999999999


Q ss_pred             HHhhcchHHHHHHHHHhCCCCCCCc
Q 012684          112 DAIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       112 ~A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      +|+..|+.++++.|+..||++....
T Consensus       232 yAvrgnhvkcve~Ll~sGAd~t~e~  256 (296)
T KOG0502|consen  232 YAVRGNHVKCVESLLNSGADVTQED  256 (296)
T ss_pred             eeecCChHHHHHHHHhcCCCccccc
Confidence            9999999999999999999986644

>PHA02875 ankyrin repeat protein; Provisional

Probab=99.70  E-value=1.5e-16  Score=159.94  Aligned_cols=101  Identities=24%  Similarity=0.218  Sum_probs=90.8

Q ss_pred             CCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHh
Q 012684           35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI  114 (458)
Q Consensus        35 ~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~  114 (458)
                      ..+.+|.||||+||..|+.+++++|++.|+++|.++.+|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus        97 ~~~~~g~tpL~~A~~~~~~~iv~~Ll~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~  176 (413)
T PHA02875         97 VFYKDGMTPLHLATILKKLDIMKLLIARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAM  176 (413)
T ss_pred             cccCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHH
Confidence            34557889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hcchHHHHHHHHHhCCCCCCC
Q 012684          115 YYKNHEVIKLLEKHGAKPLMA  135 (458)
Q Consensus       115 ~~~~~~~~~~l~~~g~~~~~~  135 (458)
                      ..|+.+++++|+++|+++...
T Consensus       177 ~~g~~eiv~~Ll~~ga~~n~~  197 (413)
T PHA02875        177 AKGDIAICKMLLDSGANIDYF  197 (413)
T ss_pred             HcCCHHHHHHHHhCCCCCCcC
Confidence            999999999999999987653

>KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription]

Probab=99.70  E-value=5.1e-17  Score=134.28  Aligned_cols=92  Identities=36%  Similarity=0.464  Sum_probs=68.1

Q ss_pred             HHHHHHhCCHHHHHHHHHcCCC-CCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcchHHHH
Q 012684           44 LMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI  122 (458)
Q Consensus        44 l~~a~~~~~~~~~~~ll~~g~~-in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~  122 (458)
                      +.+|+..+.+..|+.|++..++ +|.+|.+|.||||+|+.+|+.+|++.|+..||+++.+-..|+||||-|+.|++.+++
T Consensus        67 ~lwaae~nrl~eV~~lL~e~an~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va  146 (228)
T KOG0512|consen   67 LLWAAEKNRLTEVQRLLSEKANHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVA  146 (228)
T ss_pred             HHHHHhhccHHHHHHHHHhccccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHH
Confidence            6677777777777777766554 677777777777777777777777777777777777777777777777777777777


Q ss_pred             HHHHHhCCCCCCC
Q 012684          123 KLLEKHGAKPLMA  135 (458)
Q Consensus       123 ~~l~~~g~~~~~~  135 (458)
                      -.|+.+|+|+...
T Consensus       147 ~~LLqhgaDVnA~  159 (228)
T KOG0512|consen  147 GRLLQHGADVNAQ  159 (228)
T ss_pred             HHHHhccCccccc
Confidence            7777777776443

>PLN03192 Voltage-dependent potassium channel; Provisional

Probab=99.69  E-value=1.1e-16  Score=173.46  Aligned_cols=117  Identities=26%  Similarity=0.249  Sum_probs=103.1

Q ss_pred             hhhhhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHH---------------------
Q 012684           23 RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA---------------------   81 (458)
Q Consensus        23 ~~~~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~---------------------   81 (458)
                      -+...-.|+|+|..|..|.||||+||..|+.+++++|+++|+|+|.+|.+|+||||.|+                     
T Consensus       541 l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~~g~~~iv~~L~~~~~~~~~~  620 (823)
T PLN03192        541 LEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAISAKHHKIFRILYHFASISDPH  620 (823)
T ss_pred             HHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHhcCcccCcc
Confidence            34444578899999999999999999999999999999999999999999999988554                     


Q ss_pred             ----------HcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcchHHHHHHHHHhCCCCCCCcccc
Q 012684           82 ----------CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV  139 (458)
Q Consensus        82 ----------~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~  139 (458)
                                ..|+.+++++|+++|+|+|.+|..|.||||+|+..|+.+++++|+++|+++.....++
T Consensus       621 ~~~~~L~~Aa~~g~~~~v~~Ll~~Gadin~~d~~G~TpLh~A~~~g~~~iv~~Ll~~GAdv~~~~~~g  688 (823)
T PLN03192        621 AAGDLLCTAAKRNDLTAMKELLKQGLNVDSEDHQGATALQVAMAEDHVDMVRLLIMNGADVDKANTDD  688 (823)
T ss_pred             cCchHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHHHHHHHHcCCCCCCCCCCC
Confidence                      5555666777889999999999999999999999999999999999999987655443

>PHA02859 ankyrin repeat protein; Provisional

Probab=99.69  E-value=1.6e-16  Score=143.98  Aligned_cols=104  Identities=26%  Similarity=0.276  Sum_probs=92.3

Q ss_pred             CCCCcCccchHHHHHHHhC--CHHHHHHHHHcCCCCCccC-CCCCCHHHHHHHc---CCHHHHHHHHHCCCCCCCCCCCC
Q 012684           33 DDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRD-IDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWG  106 (458)
Q Consensus        33 ~~~~~~~g~t~l~~a~~~~--~~~~~~~ll~~g~~in~~~-~~g~t~l~~A~~~---~~~~~~~~Ll~~ga~~~~~~~~g  106 (458)
                      .+..+..|.||||+|+..+  +.+++++|++.|+++|.++ ..|+||||+|+..   ++.+++++|+++|+++|.+|..|
T Consensus        44 ~n~~~~~g~TpLh~a~~~~~~~~eiv~~Ll~~gadvn~~~~~~g~TpLh~a~~~~~~~~~eiv~~Ll~~gadin~~d~~G  123 (209)
T PHA02859         44 VNDCNDLYETPIFSCLEKDKVNVEILKFLIENGADVNFKTRDNNLSALHHYLSFNKNVEPEILKILIDSGSSITEEDEDG  123 (209)
T ss_pred             hhccCccCCCHHHHHHHcCCCCHHHHHHHHHCCCCCCccCCCCCCCHHHHHHHhCccccHHHHHHHHHCCCCCCCcCCCC
Confidence            4556778999999999865  8999999999999999997 5899999998864   47999999999999999999999


Q ss_pred             CChhHHHhh--cchHHHHHHHHHhCCCCCCCc
Q 012684          107 STPLGDAIY--YKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       107 ~tpl~~A~~--~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      .||||+|+.  .++.+++++|+++|+++....
T Consensus       124 ~TpLh~a~~~~~~~~~iv~~Li~~gadin~~d  155 (209)
T PHA02859        124 KNLLHMYMCNFNVRINVIKLLIDSGVSFLNKD  155 (209)
T ss_pred             CCHHHHHHHhccCCHHHHHHHHHcCCCccccc
Confidence            999999876  468999999999999986543

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.69  E-value=2.6e-16  Score=141.88  Aligned_cols=129  Identities=26%  Similarity=0.375  Sum_probs=104.1

Q ss_pred             eccceEEEEE---EcCeEEEEEEcCCCCCCC-----HHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          163 ITKGTFILAF---WRGIQVAVKKLGEEVISD-----DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       163 lg~G~~~~v~---~~g~~vavK~~~~~~~~~-----~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      ||+|+||.||   ++|..+++|.........     ......+.+|+.+++.+.|+++....-++......++||||++|
T Consensus         2 ig~G~~~~vy~~~~~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g   81 (199)
T TIGR03724         2 IAKGAEAIIYLGDFLGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEG   81 (199)
T ss_pred             CCCCceEEEEEeecCCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECC
Confidence            7999999876   578899999965432211     12245677899999999887765555555566677999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      ++|.+++.....       .++.+++.+|.+||+.+   ++|+|++|.||+++ ++.++++|||++..
T Consensus        82 ~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        82 KPLKDVIEEGND-------ELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             ccHHHHHhhcHH-------HHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            999998765321       78999999999999999   99999999999999 78999999998764

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PHA02875 ankyrin repeat protein; Provisional

Probab=99.69  E-value=1.7e-16  Score=159.62  Aligned_cols=107  Identities=25%  Similarity=0.318  Sum_probs=101.7

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~  107 (458)
                      -.|+|++..+.+|.||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++..+..|.
T Consensus       123 ~~gad~~~~~~~g~tpLh~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~TpL~~A~~~g~~eiv~~Ll~~ga~~n~~~~~~~  202 (413)
T PHA02875        123 ARGADPDIPNTDKFSPLHLAVMMGDIKGIELLIDHKACLDIEDCCGCTPLIIAMAKGDIAICKMLLDSGANIDYFGKNGC  202 (413)
T ss_pred             hCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCcCCCCCC
Confidence            36889999999999999999999999999999999999999999999999999999999999999999999999998875


Q ss_pred             -ChhHHHhhcchHHHHHHHHHhCCCCCC
Q 012684          108 -TPLGDAIYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       108 -tpl~~A~~~~~~~~~~~l~~~g~~~~~  134 (458)
                       ||+|+|+..|+.+++++|+++|+++..
T Consensus       203 ~t~l~~A~~~~~~~iv~~Ll~~gad~n~  230 (413)
T PHA02875        203 VAALCYAIENNKIDIVRLFIKRGADCNI  230 (413)
T ss_pred             chHHHHHHHcCCHHHHHHHHHCCcCcch
Confidence             789999999999999999999999864

>PHA02743 Viral ankyrin protein; Provisional

Probab=99.69  E-value=1.1e-16  Score=139.66  Aligned_cols=111  Identities=20%  Similarity=0.186  Sum_probs=93.8

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCH----HHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHH---HHHHHHHCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDV----EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTE---VVSLLLERGADVDP  101 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~----~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~---~~~~Ll~~ga~~~~  101 (458)
                      |++|.+..+.++.++||.||..|++    +++++|++.|+++|.+|..|+||||+|+..|+.+   ++++|+++|+++|.
T Consensus         9 ~~~~~~~~~~~~~~~l~~a~~~g~~~~l~~~~~~l~~~g~~~~~~d~~g~t~Lh~Aa~~g~~~~~~~i~~Ll~~Gadin~   88 (166)
T PHA02743          9 NNLGAVEIDEDEQNTFLRICRTGNIYELMEVAPFISGDGHLLHRYDHHGRQCTHMVAWYDRANAVMKIELLVNMGADINA   88 (166)
T ss_pred             cchHHhhhccCCCcHHHHHHHcCCHHHHHHHHHHHhhcchhhhccCCCCCcHHHHHHHhCccCHHHHHHHHHHcCCCCCC
Confidence            4445555555666779999999998    6666788899999999999999999999998765   48999999999999


Q ss_pred             CC-CCCCChhHHHhhcchHHHHHHHHH-hCCCCCCCcccc
Q 012684          102 KD-RWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHV  139 (458)
Q Consensus       102 ~~-~~g~tpl~~A~~~~~~~~~~~l~~-~g~~~~~~~~~~  139 (458)
                      ++ ..|.||||+|+..++.+++++|+. .|+++......+
T Consensus        89 ~d~~~g~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g  128 (166)
T PHA02743         89 RELGTGNTLLHIAASTKNYELAEWLCRQLGVNLGAINYQH  128 (166)
T ss_pred             CCCCCCCcHHHHHHHhCCHHHHHHHHhccCCCccCcCCCC
Confidence            98 589999999999999999999995 899986654333

>smart00090 RIO RIO-like kinase

Probab=99.68  E-value=1.9e-16  Score=146.01  Aligned_cols=142  Identities=20%  Similarity=0.139  Sum_probs=107.9

Q ss_pred             ccccCceeeccceEEEEE------EcCeEEEEEEcCCCCCCC-------------------HH--HHHHHHHHHHHHhcC
Q 012684          155 LDFTNSVEITKGTFILAF------WRGIQVAVKKLGEEVISD-------------------DD--RVRAFRDELALLQKI  207 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~------~~g~~vavK~~~~~~~~~-------------------~~--~~~~~~~E~~~l~~l  207 (458)
                      .-|.+.+.||+|+||.||      .+|+.||+|.++......                   ..  ....+..|+..++++
T Consensus        28 ~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L  107 (237)
T smart00090       28 ILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRL  107 (237)
T ss_pred             chHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            346677899999999875      267899999987542110                   00  113356899999999


Q ss_pred             CC--CcceeeeeEEEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEE
Q 012684          208 RH--PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL  285 (458)
Q Consensus       208 ~h--p~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil  285 (458)
                      .+  ..++++++.    ...++||||++|.+|.........+...+...++.|++.++++||+.|.  ++|+||||+||+
T Consensus       108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~--iiH~Dikp~NIl  181 (237)
T smart00090      108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGE--LVHGDLSEYNIL  181 (237)
T ss_pred             HhcCCCCCeeeEe----cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCC--EEeCCCChhhEE
Confidence            65  345555543    2358999999988887665444556666778899999999999999873  999999999999


Q ss_pred             ecCCCCEEEeecCCcccc
Q 012684          286 RDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       286 ~~~~~~vkl~Dfg~~~~~  303 (458)
                      ++ ++.++|+|||.+...
T Consensus       182 i~-~~~i~LiDFg~a~~~  198 (237)
T smart00090      182 VH-DGKVVIIDVSQSVEL  198 (237)
T ss_pred             EE-CCCEEEEEChhhhcc
Confidence            99 889999999988753

>PHA02946 ankyin-like protein; Provisional

Probab=99.68  E-value=2.2e-16  Score=159.06  Aligned_cols=111  Identities=21%  Similarity=0.230  Sum_probs=99.0

Q ss_pred             hhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcC--CHHHHHHHHHCCCCCCC-CC
Q 012684           27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDP-KD  103 (458)
Q Consensus        27 ~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~--~~~~~~~Ll~~ga~~~~-~~  103 (458)
                      .-+|+|+|.++.+|.||||+||..|+.+++++|+++|+++|.+|.+|.||||+|+..+  ..+++++|+++|++++. .|
T Consensus        59 l~~Gadvn~~d~~G~TpLh~Aa~~g~~eiv~lLL~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d  138 (446)
T PHA02946         59 LHRGYSPNETDDDGNYPLHIASKINNNRIVAMLLTHGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVD  138 (446)
T ss_pred             HHCcCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccC
Confidence            3478889999999999999999999999999999999999999999999999998866  48899999999999996 68


Q ss_pred             CCCCChhHHHhhcchHHHHHHHHHhCCCCCCCccc
Q 012684          104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH  138 (458)
Q Consensus       104 ~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~  138 (458)
                      ..|.|||| |+..+..+++++|+++|+++......
T Consensus       139 ~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~~  172 (446)
T PHA02946        139 EEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDKF  172 (446)
T ss_pred             CCCCcHHH-HHHCCChHHHHHHHhccccccccCCC
Confidence            89999997 66678899999999999988654433

>KOG0512 consensus Fetal globin-inducing factor (contains ankyrin repeats) [Transcription]

Probab=99.68  E-value=1.7e-16  Score=131.17  Aligned_cols=96  Identities=27%  Similarity=0.223  Sum_probs=88.4

Q ss_pred             CCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChh
Q 012684           31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL  110 (458)
Q Consensus        31 ~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl  110 (458)
                      --+|.+|.+|.||||-|+.+|++++|..|+..|||.+++...||||||-||.-++.+++-+|+++|||+|.+.....|||
T Consensus        88 n~vNtrD~D~YTpLHRAaYn~h~div~~ll~~gAn~~a~T~~GWTPLhSAckWnN~~va~~LLqhgaDVnA~t~g~ltpL  167 (228)
T KOG0512|consen   88 NHVNTRDEDEYTPLHRAAYNGHLDIVHELLLSGANKEAKTNEGWTPLHSACKWNNFEVAGRLLQHGADVNAQTKGLLTPL  167 (228)
T ss_pred             ccccccccccccHHHHHHhcCchHHHHHHHHccCCcccccccCccchhhhhcccchhHHHHHHhccCcccccccccchhh
Confidence            34788999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhcchHH-HHHHHH
Q 012684          111 GDAIYYKNHE-VIKLLE  126 (458)
Q Consensus       111 ~~A~~~~~~~-~~~~l~  126 (458)
                      |+|+...+.. .+.+|+
T Consensus       168 hlaa~~rn~r~t~~~Ll  184 (228)
T KOG0512|consen  168 HLAAGNRNSRDTLELLL  184 (228)
T ss_pred             HHhhcccchHHHHHHHh
Confidence            9999887754 444444

>PHA02716 CPXV016; CPX019; EVM010; Provisional

Probab=99.67  E-value=2.2e-16  Score=164.66  Aligned_cols=108  Identities=21%  Similarity=0.208  Sum_probs=82.4

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCC--HHHHHHHHHcCCCCCccCCCCCCHHHHH--------------------------
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERD--VEGIKELLDSGIDVNFRDIDNRTALHVA--------------------------   80 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~--~~~~~~ll~~g~~in~~~~~g~t~l~~A--------------------------   80 (458)
                      +|+|+|.++..|.||||+||..|+  .+++++|+++|||+|.+|..|+||||+|                          
T Consensus       201 ~GADVN~kD~~G~TPLH~Aa~~g~~~~eIVklLLe~GADVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~~  280 (764)
T PHA02716        201 NGVNVNLQNNHLITPLHTYLITGNVCASVIKKIIELGGDMDMKCVNGMSPIMTYIINIDNINPEITNIYIESLDGNKVKN  280 (764)
T ss_pred             cCCCCCCCCCCCCCHHHHHHHcCCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhcccccccc
Confidence            677777777788888888888774  4788888888888888888888888764                          


Q ss_pred             -----------HHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhh--cchHHHHHHHHHhCCCCCCCc
Q 012684           81 -----------ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY--YKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus        81 -----------~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~--~~~~~~~~~l~~~g~~~~~~~  136 (458)
                                 +..|+.+++++|+++|++++.+|..|+||||+|+.  .++.+++++|+++|+++....
T Consensus       281 ~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~kD  349 (764)
T PHA02716        281 IPMILHSYITLARNIDISVVYSFLQPGVKLHYKDSAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEPD  349 (764)
T ss_pred             chhhhHHHHHHHHcCCHHHHHHHHhCCCceeccCCCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccCC
Confidence                       34567778888888888888888888888887654  346788888888888775443

>PHA03095 ankyrin-like protein; Provisional

Probab=99.67  E-value=3.4e-16  Score=160.28  Aligned_cols=113  Identities=28%  Similarity=0.318  Sum_probs=103.1

Q ss_pred             hhcCCCCCCCcCccchHHHHHHHhC---CHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcC-CHHHHHHHHHCCCCCCCC
Q 012684           27 ELNGLDDDGEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPK  102 (458)
Q Consensus        27 ~~n~~d~~~~~~~g~t~l~~a~~~~---~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~-~~~~~~~Ll~~ga~~~~~  102 (458)
                      .-.|+|++.++..|.||||+|+..+   +.++++.|++.|+++|.++..|.||||+|+..| ..+++++|+++|++++.+
T Consensus        34 l~~ga~vn~~~~~g~t~Lh~a~~~~~~~~~~iv~~Ll~~Gadin~~~~~g~TpLh~A~~~~~~~~iv~lLl~~ga~in~~  113 (471)
T PHA03095         34 LAAGADVNFRGEYGKTPLHLYLHYSSEKVKDIVRLLLEAGADVNAPERCGFTPLHLYLYNATTLDVIKLLIKAGADVNAK  113 (471)
T ss_pred             HHcCCCcccCCCCCCCHHHHHHHhcCCChHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCcHHHHHHHHHcCCCCCCC
Confidence            3467888888889999999999999   999999999999999999999999999999999 599999999999999999


Q ss_pred             CCCCCChhHHHh--hcchHHHHHHHHHhCCCCCCCcccc
Q 012684          103 DRWGSTPLGDAI--YYKNHEVIKLLEKHGAKPLMAPMHV  139 (458)
Q Consensus       103 ~~~g~tpl~~A~--~~~~~~~~~~l~~~g~~~~~~~~~~  139 (458)
                      |..|.||||+|+  ..++.+++++|+++|+++......+
T Consensus       114 ~~~g~tpLh~a~~~~~~~~~iv~~Ll~~gad~~~~d~~g  152 (471)
T PHA03095        114 DKVGRTPLHVYLSGFNINPKVIRLLLRKGADVNALDLYG  152 (471)
T ss_pred             CCCCCCHHHHHhhCCcCCHHHHHHHHHcCCCCCccCCCC
Confidence            999999999999  5668999999999999986644433

>PHA02884 ankyrin repeat protein; Provisional

Probab=99.67  E-value=4.8e-16  Score=146.31  Aligned_cols=97  Identities=20%  Similarity=0.112  Sum_probs=80.8

Q ss_pred             HHHHHHHhCCHHHHHHHHHcCCCCCccC----CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC-CCCCChhHHHhhcc
Q 012684           43 RLMFLANERDVEGIKELLDSGIDVNFRD----IDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIYYK  117 (458)
Q Consensus        43 ~l~~a~~~~~~~~~~~ll~~g~~in~~~----~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~-~~g~tpl~~A~~~~  117 (458)
                      +||.|++.|+.+++++|+++|+|+|.++    ..|.||||+|+..++.+++++|+++||++|.++ ..|.||||+|+..+
T Consensus        36 lL~~A~~~~~~eivk~LL~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~  115 (300)
T PHA02884         36 ILYSSIKFHYTDIIDAILKLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHG  115 (300)
T ss_pred             HHHHHHHcCCHHHHHHHHHCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcC
Confidence            5666777788999999999999988874    578999999999999999999999999999864 57889999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCcccc
Q 012684          118 NHEVIKLLEKHGAKPLMAPMHV  139 (458)
Q Consensus       118 ~~~~~~~l~~~g~~~~~~~~~~  139 (458)
                      +.+++++|++.|+++......+
T Consensus       116 ~~eivklLL~~GAdin~kd~~G  137 (300)
T PHA02884        116 CLKCLEILLSYGADINIQTNDM  137 (300)
T ss_pred             CHHHHHHHHHCCCCCCCCCCCC
Confidence            9999999999998886644333

>PHA02798 ankyrin-like protein; Provisional

Probab=99.67  E-value=2.4e-16  Score=161.76  Aligned_cols=111  Identities=24%  Similarity=0.263  Sum_probs=101.6

Q ss_pred             hhhhcCCCCCCCcCccchHHHHHHHh-----CCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcC---CHHHHHHHHHCC
Q 012684           25 EAELNGLDDDGEEIKPEFRLMFLANE-----RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG---FTEVVSLLLERG   96 (458)
Q Consensus        25 ~~~~n~~d~~~~~~~g~t~l~~a~~~-----~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~---~~~~~~~Ll~~g   96 (458)
                      -..-+|+|+|..+..|.||||+|+.+     ++.+++++|+++|+|+|.+|.+|.||||+|+..+   +.+++++|+++|
T Consensus        56 ~Ll~~Gadvn~~d~~g~TpL~~~~~n~~~~~~~~~iv~~Ll~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~G  135 (489)
T PHA02798         56 LFINLGANVNGLDNEYSTPLCTILSNIKDYKHMLDIVKILIENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENG  135 (489)
T ss_pred             HHHHCCCCCCCCCCCCCChHHHHHHhHHhHHhHHHHHHHHHHCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcC
Confidence            33457889999999999999999865     6789999999999999999999999999999875   789999999999


Q ss_pred             CCCCCCCCCCCChhHHHhhcch---HHHHHHHHHhCCCCCCC
Q 012684           97 ADVDPKDRWGSTPLGDAIYYKN---HEVIKLLEKHGAKPLMA  135 (458)
Q Consensus        97 a~~~~~~~~g~tpl~~A~~~~~---~~~~~~l~~~g~~~~~~  135 (458)
                      |+++.+|..|.||||+|+..++   .+++++|++.|+++...
T Consensus       136 advn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~~  177 (489)
T PHA02798        136 ADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINTH  177 (489)
T ss_pred             CCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCcccc
Confidence            9999999999999999999887   99999999999998643

>PHA02884 ankyrin repeat protein; Provisional

Probab=99.67  E-value=3.7e-16  Score=147.10  Aligned_cols=101  Identities=21%  Similarity=0.227  Sum_probs=90.3

Q ss_pred             hcCCCCCCCc----CccchHHHHHHHhCCHHHHHHHHHcCCCCCcc-CCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Q 012684           28 LNGLDDDGEE----IKPEFRLMFLANERDVEGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPK  102 (458)
Q Consensus        28 ~n~~d~~~~~----~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~-~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~  102 (458)
                      -.|+|++.++    ..|.||||+||..++.+++++|+++|||+|.+ +..|.||||+|+..|+.+++++|+.+||+++.+
T Consensus        54 ~~GAdiN~~~~~sd~~g~TpLh~Aa~~~~~eivklLL~~GADVN~~~~~~g~TpLh~Aa~~~~~eivklLL~~GAdin~k  133 (300)
T PHA02884         54 KLGADPEAPFPLSENSKTNPLIYAIDCDNDDAAKLLIRYGADVNRYAEEAKITPLYISVLHGCLKCLEILLSYGADINIQ  133 (300)
T ss_pred             HCCCCccccCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Confidence            4566666653    47999999999999999999999999999996 467999999999999999999999999999999


Q ss_pred             CCCCCChhHHHhhcchHHHHHHHHHh
Q 012684          103 DRWGSTPLGDAIYYKNHEVIKLLEKH  128 (458)
Q Consensus       103 ~~~g~tpl~~A~~~~~~~~~~~l~~~  128 (458)
                      |..|.||||+|+..++.+++..+.+.
T Consensus       134 d~~G~TpL~~A~~~~~~~~~~~~~~~  159 (300)
T PHA02884        134 TNDMVTPIELALMICNNFLAFMICDN  159 (300)
T ss_pred             CCCCCCHHHHHHHhCChhHHHHhcCC
Confidence            99999999999998888887666543

>PHA02795 ankyrin-like protein; Provisional

Probab=99.67  E-value=2.5e-16  Score=154.02  Aligned_cols=97  Identities=26%  Similarity=0.208  Sum_probs=87.9

Q ss_pred             CccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcc
Q 012684           38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK  117 (458)
Q Consensus        38 ~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~  117 (458)
                      ..+.|++|.|+..++.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++||+++.+|..|.||||+|+..|
T Consensus       186 ~~~~t~l~~a~~~~~~eIve~LIs~GADIN~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G~TpLh~Aa~~g  265 (437)
T PHA02795        186 IIQYTRGFLVDEPTVLEIYKLCIPYIEDINQLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNGYTCLDVAVDRG  265 (437)
T ss_pred             hhccchhHHHHhcCHHHHHHHHHhCcCCcCcCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcC
Confidence            45778899999999999999999999999999999999999999999999999999999999999999999999999888


Q ss_pred             --------hHHHHHHHHHhCCCCCC
Q 012684          118 --------NHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       118 --------~~~~~~~l~~~g~~~~~  134 (458)
                              +.+++++|+++|+++..
T Consensus       266 ~~~~~~~~~~eIvelLL~~gadI~~  290 (437)
T PHA02795        266 SVIARRETHLKILEILLREPLSIDC  290 (437)
T ss_pred             CcccccccHHHHHHHHHhCCCCCCc
Confidence                    46899999999998754

>PHA02878 ankyrin repeat protein; Provisional

Probab=99.67  E-value=4.4e-16  Score=159.41  Aligned_cols=113  Identities=24%  Similarity=0.240  Sum_probs=102.2

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHc-CCHHHHHHHHHCCCCCCCCCC-C
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ-GFTEVVSLLLERGADVDPKDR-W  105 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~-~~~~~~~~Ll~~ga~~~~~~~-~  105 (458)
                      -.|+|++..+..|.||||+|+..|+.+++++|++.|+++|.+|..|.||||+|+.. ++.+++++|+++|+++|.++. .
T Consensus       189 ~~gad~n~~d~~g~tpLh~A~~~~~~~iv~~Ll~~ga~in~~d~~g~TpLh~A~~~~~~~~iv~~Ll~~gadvn~~~~~~  268 (477)
T PHA02878        189 SYGANVNIPDKTNNSPLHHAVKHYNKPIVHILLENGASTDARDKCGNTPLHISVGYCKDYDILKLLLEHGVDVNAKSYIL  268 (477)
T ss_pred             HCCCCCCCcCCCCCCHHHHHHHhCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHhcCCHHHHHHHHHcCCCCCccCCCC
Confidence            35788888899999999999999999999999999999999999999999999975 799999999999999999986 8


Q ss_pred             CCChhHHHhhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684          106 GSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus       106 g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      |.||||+|  .++.+++++|+++|+|+......+.+|
T Consensus       269 g~TpLh~A--~~~~~~v~~Ll~~gadin~~d~~g~Tp  303 (477)
T PHA02878        269 GLTALHSS--IKSERKLKLLLEYGADINSLNSYKLTP  303 (477)
T ss_pred             CCCHHHHH--ccCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence            99999999  467899999999999997765544444

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.67  E-value=6.3e-18  Score=174.58  Aligned_cols=252  Identities=24%  Similarity=0.396  Sum_probs=197.5

Q ss_pred             CccccCceeeccceEEEEEE------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceE
Q 012684          154 ELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~  226 (458)
                      ...|...+.||+|+|+.+..      ....+|+|.+.... ...........|..+-+.+. |+|++.+++...+....+
T Consensus        19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~   97 (601)
T KOG0590|consen   19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL   97 (601)
T ss_pred             cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence            44566777899999986642      34567777766543 23445556677888888886 999999999999999999


Q ss_pred             EEEEccCCCCHHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeeCCCCCCCEEecCCC-CEEEeecCCccc
Q 012684          227 IVTEYLPKGDLRAFL-KRKG-ALKPSTAVRFALDIARGMNYLH-ENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKL  302 (458)
Q Consensus       227 lv~e~~~~~~L~~~l-~~~~-~~~~~~~~~i~~qi~~~l~~LH-~~~~~~i~H~Dikp~Nil~~~~~-~vkl~Dfg~~~~  302 (458)
                      +.+++..|+++.+.+ .... ..+...+-.++.|+..++.|+| ..+   +.|+||||+|.+++..+ .+++.|||++..
T Consensus        98 ~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~  174 (601)
T KOG0590|consen   98 LSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATA  174 (601)
T ss_pred             cccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhcc
Confidence            999999999999888 4444 5777888899999999999999 888   99999999999999999 999999999987


Q ss_pred             ccc--CCCCCcccCCC-CCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHH-HHHhcCCCCCCCC
Q 012684          303 LTV--KEDRPLTCQDT-SCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK-AYAARQRPPFKAP  377 (458)
Q Consensus       303 ~~~--~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~-~~~~~~~~~~~~~  377 (458)
                      +..  ..........| ++.|+|||...+. ...+..|+||.|+++..+++|..||.......... .............
T Consensus       175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  254 (601)
T KOG0590|consen  175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLP  254 (601)
T ss_pred             ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCc
Confidence            765  22333345566 9999999999884 45678999999999999999999998765544221 1111111212334


Q ss_pred             hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          378 AKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       378 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +...+....+++.+++..+|..|.+.+++-..
T Consensus       255 ~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d  286 (601)
T KOG0590|consen  255 WNSISDQAHDLLHKILKENPSNRLSIEELKLD  286 (601)
T ss_pred             cccCChhhhhcccccccCCchhcccccccccc
Confidence            56677889999999999999999999987654

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.66  E-value=1.1e-15  Score=158.18  Aligned_cols=135  Identities=24%  Similarity=0.237  Sum_probs=109.6

Q ss_pred             cccCceeeccceEEEEEE---cCeEEEEEEcCCCCCC-----CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          156 DFTNSVEITKGTFILAFW---RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~---~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      .|...+.||+|+||.||.   .+..+++|+.......     .....+.+.+|+.+++.++|++++....++......++
T Consensus       334 ~~~~~~~iG~G~~g~Vy~~~~~~~~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~l  413 (535)
T PRK09605        334 RKIPDHLIGKGAEADIKKGEYLGRDAVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEEKTI  413 (535)
T ss_pred             ccCccceeccCCcEEEEEEeecCccceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEE
Confidence            345678999999999985   5666666654322111     11234568899999999999999988877777777899


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      ||||++|++|.+++.        ....++.+++.+|.+||+.+   ++||||||+||++ .++.++|+|||++..
T Consensus       414 v~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        414 VMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             EEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            999999999999875        34678999999999999999   9999999999999 678899999999864

>PHA03095 ankyrin-like protein; Provisional

Probab=99.66  E-value=4.1e-16  Score=159.71  Aligned_cols=105  Identities=23%  Similarity=0.260  Sum_probs=78.5

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCH--HHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDV--EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW  105 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~--~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~  105 (458)
                      -.|+|++.++..|.||||+||..|+.  .+++.|++.|+++|.+|..|.||||+|+..|+.+++++|+++||+++.+|..
T Consensus       210 ~~g~~~~~~d~~g~tpLh~Aa~~~~~~~~~v~~ll~~g~din~~d~~g~TpLh~A~~~~~~~~v~~LL~~gad~n~~~~~  289 (471)
T PHA03095        210 RAGCDPAATDMLGNTPLHSMATGSSCKRSLVLPLLIAGISINARNRYGQTPLHYAAVFNNPRACRRLIALGADINAVSSD  289 (471)
T ss_pred             HcCCCCcccCCCCCCHHHHHHhcCCchHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCC
Confidence            35667777777777777777777764  4667777777777777777777777777777777777777777777777777


Q ss_pred             CCChhHHHhhcchHHHHHHHHHhCCCC
Q 012684          106 GSTPLGDAIYYKNHEVIKLLEKHGAKP  132 (458)
Q Consensus       106 g~tpl~~A~~~~~~~~~~~l~~~g~~~  132 (458)
                      |.||||+|+..|+.++++.|+..++++
T Consensus       290 g~tpl~~A~~~~~~~~v~~LL~~~~~~  316 (471)
T PHA03095        290 GNTPLSLMVRNNNGRAVRAALAKNPSA  316 (471)
T ss_pred             CCCHHHHHHHhCCHHHHHHHHHhCCCH
Confidence            777777777777777777777777665

>KOG0508 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.66  E-value=1.1e-16  Score=151.58  Aligned_cols=106  Identities=28%  Similarity=0.372  Sum_probs=99.6

Q ss_pred             hhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Q 012684           27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG  106 (458)
Q Consensus        27 ~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g  106 (458)
                      .--|+++|..+.-.-|||--||..|+++++++|+++|+|++..|..|.|+||+||.+|+.+|+++|++.|||+|.++..|
T Consensus       104 ~~~ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmIa~ykGh~~I~qyLle~gADvn~ks~kG  183 (615)
T KOG0508|consen  104 LRRGASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMIACYKGHVDIAQYLLEQGADVNAKSYKG  183 (615)
T ss_pred             HHhcCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEeeeccCchHHHHHHHHhCCCcchhcccC
Confidence            34467777777777799999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CChhHHHhhcchHHHHHHHHHhCCCC
Q 012684          107 STPLGDAIYYKNHEVIKLLEKHGAKP  132 (458)
Q Consensus       107 ~tpl~~A~~~~~~~~~~~l~~~g~~~  132 (458)
                      .|+||.++..|+.+++++|+.+|+.+
T Consensus       184 NTALH~caEsG~vdivq~Ll~~ga~i  209 (615)
T KOG0508|consen  184 NTALHDCAESGSVDIVQLLLKHGAKI  209 (615)
T ss_pred             chHHHhhhhcccHHHHHHHHhCCcee
Confidence            99999999999999999999999876

>PHA03100 ankyrin repeat protein; Provisional

Probab=99.66  E-value=5.4e-16  Score=159.15  Aligned_cols=105  Identities=30%  Similarity=0.412  Sum_probs=52.1

Q ss_pred             cCCCCCCCcCccchHHHHHHHhC--CHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG  106 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~--~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g  106 (458)
                      +|+|.+..+..|.||||+|+..|  +.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++..+..|
T Consensus       130 ~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~~d~~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~~~~~~~  209 (480)
T PHA03100        130 NGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNRYGYTPLHIAVEKGNIDVIKFLLDNGADINAGDIET  209 (480)
T ss_pred             cCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCcccccCCCCCHHHHHHHhCCHHHHHHHHHcCCCccCCCCCC
Confidence            34444444444555555555555  4555555555555555555555555555555555555555555554444444444


Q ss_pred             ------CChhHHHhhcch--HHHHHHHHHhCCCCC
Q 012684          107 ------STPLGDAIYYKN--HEVIKLLEKHGAKPL  133 (458)
Q Consensus       107 ------~tpl~~A~~~~~--~~~~~~l~~~g~~~~  133 (458)
                            .||||+|+..++  .+++++|++.|+++.
T Consensus       210 ~~~~~~~t~l~~a~~~~~~~~~iv~~Ll~~g~din  244 (480)
T PHA03100        210 LLFTIFETPLHIAACYNEITLEVVNYLLSYGVPIN  244 (480)
T ss_pred             CcHHHHHhHHHHHHHhCcCcHHHHHHHHHcCCCCC
Confidence                  444444444444  444444444444443

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.65  E-value=8.2e-16  Score=138.52  Aligned_cols=135  Identities=21%  Similarity=0.111  Sum_probs=103.6

Q ss_pred             cccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCH-------------------HHHHHHHHHHHHHhcCCCC--
Q 012684          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDD-------------------DRVRAFRDELALLQKIRHP--  210 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~hp--  210 (458)
                      .|.+.+.||.|+||.||.    +|+.||||++........                   ........|+.++..+.++  
T Consensus        16 ~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i   95 (198)
T cd05144          16 VESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGF   95 (198)
T ss_pred             hhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCC
Confidence            466678899999998873    589999998764321100                   1112356788888888776  


Q ss_pred             cceeeeeEEEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC
Q 012684          211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG  290 (458)
Q Consensus       211 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~  290 (458)
                      .+++.++.    ...++||||++|++|.++...      .....++.+++.++.++|+.+   ++|+||+|.||+++.++
T Consensus        96 ~v~~~~~~----~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p~Nill~~~~  162 (198)
T cd05144          96 PVPKPIDW----NRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHG---IIHGDLSEFNILVDDDE  162 (198)
T ss_pred             CCCceeec----CCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCC---CCcCCCCcccEEEcCCC
Confidence            45555542    456899999999998765321      345678899999999999999   99999999999999999


Q ss_pred             CEEEeecCCcccc
Q 012684          291 NLKVADFGVSKLL  303 (458)
Q Consensus       291 ~vkl~Dfg~~~~~  303 (458)
                      .++|+|||++...
T Consensus       163 ~~~liDfg~~~~~  175 (198)
T cd05144         163 KIYIIDWPQMVST  175 (198)
T ss_pred             cEEEEECCccccC
Confidence            9999999998644

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>PHA03100 ankyrin repeat protein; Provisional

Probab=99.64  E-value=9.1e-16  Score=157.51  Aligned_cols=105  Identities=28%  Similarity=0.430  Sum_probs=59.7

Q ss_pred             cCCCCCCCcCccchHHHHHH--HhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcC--CHHHHHHHHHCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLA--NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDPKDR  104 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~--~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~--~~~~~~~Ll~~ga~~~~~~~  104 (458)
                      +|+|++..+..|.||||+||  ..|+.+++++|++.|++++.++..|.||||+|+..|  +.+++++|+++|++++.++.
T Consensus        95 ~ga~i~~~d~~g~tpL~~A~~~~~~~~~iv~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~iv~~Ll~~g~din~~d~  174 (480)
T PHA03100         95 YGANVNAPDNNGITPLLYAISKKSNSYSIVEYLLDNGANVNIKNSDGENLLHLYLESNKIDLKILKLLIDKGVDINAKNR  174 (480)
T ss_pred             CCCCCCCCCCCCCchhhHHHhcccChHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCChHHHHHHHHHCCCCcccccC
Confidence            34445555555555555555  555555555555555555555555555555555555  55555555555555555555


Q ss_pred             CCCChhHHHhhcchHHHHHHHHHhCCCCC
Q 012684          105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPL  133 (458)
Q Consensus       105 ~g~tpl~~A~~~~~~~~~~~l~~~g~~~~  133 (458)
                      .|.||||+|+..|+.+++++|+++|+++.
T Consensus       175 ~g~tpL~~A~~~~~~~iv~~Ll~~ga~~~  203 (480)
T PHA03100        175 YGYTPLHIAVEKGNIDVIKFLLDNGADIN  203 (480)
T ss_pred             CCCCHHHHHHHhCCHHHHHHHHHcCCCcc
Confidence            55555555555555555555555555543

>PHA02798 ankyrin-like protein; Provisional

Probab=99.64  E-value=1e-15  Score=157.07  Aligned_cols=106  Identities=25%  Similarity=0.329  Sum_probs=85.6

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhC---CHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC---HHHHHHHHHCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---TEVVSLLLERGADVDP  101 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~---~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~---~~~~~~Ll~~ga~~~~  101 (458)
                      -+|+|+|..+..|.||||+|+.++   +.+++++|+++|+++|.+|.+|.||||+|+..++   .+++++|+++|++++.
T Consensus        97 ~~GadiN~~d~~G~TpLh~a~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~tpL~~a~~~~~~~~~~vv~~Ll~~gadin~  176 (489)
T PHA02798         97 ENGADINKKNSDGETPLYCLLSNGYINNLEILLFMIENGADTTLLDKDGFTMLQVYLQSNHHIDIEIIKLLLEKGVDINT  176 (489)
T ss_pred             HCCCCCCCCCCCcCcHHHHHHHcCCcChHHHHHHHHHcCCCccccCCCCCcHHHHHHHcCCcchHHHHHHHHHhCCCccc
Confidence            367888888888999999999875   6899999999999999999999999999999887   8899999988888887


Q ss_pred             CC-CCCCChhHHHhhc----chHHHHHHHHHhCCCCC
Q 012684          102 KD-RWGSTPLGDAIYY----KNHEVIKLLEKHGAKPL  133 (458)
Q Consensus       102 ~~-~~g~tpl~~A~~~----~~~~~~~~l~~~g~~~~  133 (458)
                      ++ ..|.||||.++..    ++.+++++|+++|+++.
T Consensus       177 ~~~~~~~t~Lh~~~~~~~~~~~~~ivk~Li~~Ga~i~  213 (489)
T PHA02798        177 HNNKEKYDTLHCYFKYNIDRIDADILKLFVDNGFIIN  213 (489)
T ss_pred             ccCcCCCcHHHHHHHhccccCCHHHHHHHHHCCCCcc
Confidence            64 4567777766543    35677777777776654

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.64  E-value=3.3e-15  Score=138.07  Aligned_cols=138  Identities=20%  Similarity=0.209  Sum_probs=106.1

Q ss_pred             ccCceeeccceEEEEEEcCeEEEEEEcCCCCC----------CCHHHHHHHHHHHHHHhcCCCCcc--eeeeeEEEeCC-
Q 012684          157 FTNSVEITKGTFILAFWRGIQVAVKKLGEEVI----------SDDDRVRAFRDELALLQKIRHPNV--VQFLGAVTQSS-  223 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~~g~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~hp~i--~~~~~~~~~~~-  223 (458)
                      +.+.+..|.|+++.|+..+..++||.+.....          .+......+.+|+.++..+.|++|  ++.+++..... 
T Consensus        37 ~~lg~~~g~gtv~~v~~~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~  116 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTPGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG  116 (239)
T ss_pred             ceeecCCCCccEEEEEeCCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC
Confidence            44445677888888888999999998853211          012234567889999999988775  67777654322 


Q ss_pred             c---eEEEEEccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCC
Q 012684          224 P---MMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (458)
Q Consensus       224 ~---~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~  299 (458)
                      .   .++|||+++| .+|.+++.. ..++..    .+.+++.+|.+||+.|   |+|+||||.|||++.++.++|+|||.
T Consensus       117 ~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        117 LFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             cceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEEECCC
Confidence            2   3599999987 699988765 345543    3578999999999999   99999999999999999999999998


Q ss_pred             ccc
Q 012684          300 SKL  302 (458)
Q Consensus       300 ~~~  302 (458)
                      +..
T Consensus       189 ~~~  191 (239)
T PRK01723        189 GEL  191 (239)
T ss_pred             ccc
Confidence            764

>PHA02716 CPXV016; CPX019; EVM010; Provisional

Probab=99.63  E-value=1.8e-15  Score=157.86  Aligned_cols=115  Identities=24%  Similarity=0.255  Sum_probs=100.6

Q ss_pred             hcCCCCCCCcCccchHHHHH-------------------------------------HHhCCHHHHHHHHHcCCCCCccC
Q 012684           28 LNGLDDDGEEIKPEFRLMFL-------------------------------------ANERDVEGIKELLDSGIDVNFRD   70 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a-------------------------------------~~~~~~~~~~~ll~~g~~in~~~   70 (458)
                      -.|+|+|.++..|.||||+|                                     |..|+.+++++|++.|+++|.+|
T Consensus       235 e~GADVN~kD~~G~TPLh~Ai~~a~n~~~EIvkiLie~~d~n~~~~~~~~L~~~i~AA~~g~leiVklLLe~GAdIN~kD  314 (764)
T PHA02716        235 ELGGDMDMKCVNGMSPIMTYIINIDNINPEITNIYIESLDGNKVKNIPMILHSYITLARNIDISVVYSFLQPGVKLHYKD  314 (764)
T ss_pred             HcCCCCCCCCCCCCCHHHHHHHhhhccCHHHHHHHHHhccccccccchhhhHHHHHHHHcCCHHHHHHHHhCCCceeccC
Confidence            46889999999999999975                                     44578899999999999999999


Q ss_pred             CCCCCHHHHHHH--cCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhh--------------cchHHHHHHHHHhCCCCCC
Q 012684           71 IDNRTALHVAAC--QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY--------------YKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus        71 ~~g~t~l~~A~~--~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~--------------~~~~~~~~~l~~~g~~~~~  134 (458)
                      .+|+||||+|+.  .++.+++++|+++|++++.+|..|+||||+|+.              .++.+++++|+++|+++..
T Consensus       315 ~~G~TPLH~Aaa~~~~~~eIVklLLe~GADIN~kD~~G~TPLH~A~~~lav~~~ld~~~~~~~~~eVVklLL~~GADIn~  394 (764)
T PHA02716        315 SAGRTCLHQYILRHNISTDIIKLLHEYGNDLNEPDNIGNTVLHTYLSMLSVVNILDPETDNDIRLDVIQCLISLGADITA  394 (764)
T ss_pred             CCCCCHHHHHHHHhCCCchHHHHHHHcCCCCccCCCCCCCHHHHHHHhhhhhccccccccccChHHHHHHHHHCCCCCCC
Confidence            999999999875  468999999999999999999999999999875              3688999999999999976


Q ss_pred             CccccccC
Q 012684          135 APMHVKHA  142 (458)
Q Consensus       135 ~~~~~~~~  142 (458)
                      ....+.+|
T Consensus       395 kn~~G~TP  402 (764)
T PHA02716        395 VNCLGYTP  402 (764)
T ss_pred             cCCCCCCh
Confidence            65555444

>KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis]

Probab=99.62  E-value=7.2e-16  Score=163.97  Aligned_cols=108  Identities=34%  Similarity=0.331  Sum_probs=103.6

Q ss_pred             hhhhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Q 012684           24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD  103 (458)
Q Consensus        24 ~~~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~  103 (458)
                      ....-.|++.+.++..|+||||.||..|++++|++|+++|+|+|+++..|+||||.||..|+.+|+.+|+++||++|..|
T Consensus       524 ~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH~Aa~~G~~~i~~LLlk~GA~vna~d  603 (1143)
T KOG4177|consen  524 KILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLHQAAQQGHNDIAELLLKHGASVNAAD  603 (1143)
T ss_pred             HHHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhhHHHHcChHHHHHHHHHcCCCCCccc
Confidence            34445689999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCChhHHHhhcchHHHHHHHHHhCCC
Q 012684          104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK  131 (458)
Q Consensus       104 ~~g~tpl~~A~~~~~~~~~~~l~~~g~~  131 (458)
                      .+|.|||++|+..|+.++++.|...+++
T Consensus       604 ~~g~TpL~iA~~lg~~~~~k~l~~~~~~  631 (1143)
T KOG4177|consen  604 LDGFTPLHIAVRLGYLSVVKLLKVVTAT  631 (1143)
T ss_pred             ccCcchhHHHHHhcccchhhHHHhccCc
Confidence            9999999999999999999999999999

>PHA02874 ankyrin repeat protein; Provisional

Probab=99.62  E-value=3.2e-15  Score=151.22  Aligned_cols=104  Identities=24%  Similarity=0.191  Sum_probs=56.3

Q ss_pred             CCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCC-------------
Q 012684           31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-------------   97 (458)
Q Consensus        31 ~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga-------------   97 (458)
                      .+.+..+.+|.||||.|+..|+.+++++|++.|+++|..+..|.||||+|+..|+.+++++|+++|+             
T Consensus        26 ~~~n~~~~~~~tpL~~A~~~g~~~iv~~Ll~~Ga~~n~~~~~~~t~L~~A~~~~~~~iv~~Ll~~g~~~~~~~~~~~~~~  105 (434)
T PHA02874         26 NCINISVDETTTPLIDAIRSGDAKIVELFIKHGADINHINTKIPHPLLTAIKIGAHDIIKLLIDNGVDTSILPIPCIEKD  105 (434)
T ss_pred             CCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcchhccCCHH
Confidence            3344444455555555555555555555555555555555555555555555555555555554432             


Q ss_pred             ----------CCCCCCCCCCChhHHHhhcchHHHHHHHHHhCCCCCC
Q 012684           98 ----------DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus        98 ----------~~~~~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~  134 (458)
                                +++.++..|.||||+|+..|+.+++++|++.|+++..
T Consensus       106 ~i~~ll~~g~d~n~~~~~g~T~Lh~A~~~~~~~~v~~Ll~~gad~n~  152 (434)
T PHA02874        106 MIKTILDCGIDVNIKDAELKTFLHYAIKKGDLESIKMLFEYGADVNI  152 (434)
T ss_pred             HHHHHHHCcCCCCCCCCCCccHHHHHHHCCCHHHHHHHHhCCCCCCC
Confidence                      3344555555555555555555555555555555543

>KOG0514 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.62  E-value=3.9e-16  Score=143.39  Aligned_cols=115  Identities=29%  Similarity=0.291  Sum_probs=82.5

Q ss_pred             hhcCCCCCCCcCccchHHHHHHHhC-----CHHHHHHHHHcCCCCCccC-CCCCCHHHHHHHcCCHHHHHHHHHCCCCCC
Q 012684           27 ELNGLDDDGEEIKPEFRLMFLANER-----DVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVD  100 (458)
Q Consensus        27 ~~n~~d~~~~~~~g~t~l~~a~~~~-----~~~~~~~ll~~g~~in~~~-~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~  100 (458)
                      +...+|+|..+.-|+||++++|...     +.++|+.|++.| |||++- ..|+|+|++|+..|+.++|+.||..|||+|
T Consensus       289 DSgvC~VD~qNrAGYtpiMLaALA~lk~~~d~~vV~~LF~mg-nVNaKAsQ~gQTALMLAVSHGr~d~vk~LLacgAdVN  367 (452)
T KOG0514|consen  289 DSGVCDVDQQNRAGYTPVMLAALAKLKQPADRTVVERLFKMG-DVNAKASQHGQTALMLAVSHGRVDMVKALLACGADVN  367 (452)
T ss_pred             ccCcccccccccccccHHHHHHHHhhcchhhHHHHHHHHhcc-CcchhhhhhcchhhhhhhhcCcHHHHHHHHHccCCCc
Confidence            3445555555555555555555432     345555555554 566553 347999999999999999999999999999


Q ss_pred             CCCCCCCChhHHHhhcchHHHHHHHHHh-CCCCCCCccccccC
Q 012684          101 PKDRWGSTPLGDAIYYKNHEVIKLLEKH-GAKPLMAPMHVKHA  142 (458)
Q Consensus       101 ~~~~~g~tpl~~A~~~~~~~~~~~l~~~-g~~~~~~~~~~~~~  142 (458)
                      ++|.+|-|+|++|+.+|++|++++|+.. +.|+..+...++++
T Consensus       368 iQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~DgSTA  410 (452)
T KOG0514|consen  368 IQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDVDGSTA  410 (452)
T ss_pred             cccCCccHHHhhhhhhChHHHHHHHhccCcccceeecCCCchh
Confidence            9999999999999999999999999865 23444443333333

>PHA02876 ankyrin repeat protein; Provisional

Probab=99.62  E-value=2.4e-15  Score=160.74  Aligned_cols=117  Identities=27%  Similarity=0.286  Sum_probs=98.8

Q ss_pred             hhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC-HHHHHHHHHCCCCCCCCCC
Q 012684           26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-TEVVSLLLERGADVDPKDR  104 (458)
Q Consensus        26 ~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~-~~~~~~Ll~~ga~~~~~~~  104 (458)
                      ..-.|+|++.++..|.||||+||..|+.+++++|++.|++++..+..|.||||+|+..++ ..++++|+++|+++|.+|.
T Consensus       361 Ll~~gadin~~d~~G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~~~~~g~T~Lh~A~~~~~~~~~vk~Ll~~gadin~~d~  440 (682)
T PHA02876        361 LLELGANVNARDYCDKTPIHYAAVRNNVVIINTLLDYGADIEALSQKIGTALHFALCGTNPYMSVKTLIDRGANVNSKNK  440 (682)
T ss_pred             HHHcCCCCccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCccccCCCCCchHHHHHHcCCHHHHHHHHHhCCCCCCcCCC
Confidence            344677888888889999999999999999999999999999999999999999987665 5678899999999999999


Q ss_pred             CCCChhHHHhhcc-hHHHHHHHHHhCCCCCCCccccccC
Q 012684          105 WGSTPLGDAIYYK-NHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus       105 ~g~tpl~~A~~~~-~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      .|+||||+|+..| +.+++++|++.|+++......+.++
T Consensus       441 ~G~TpLh~Aa~~~~~~~iv~lLl~~Gad~n~~d~~g~tp  479 (682)
T PHA02876        441 DLSTPLHYACKKNCKLDVIEMLLDNGADVNAINIQNQYP  479 (682)
T ss_pred             CCChHHHHHHHhCCcHHHHHHHHHCCCCCCCCCCCCCCH
Confidence            9999999999876 6799999999999987665444444

>KOG4214 consensus Myotrophin and similar proteins [Transcription]

Probab=99.61  E-value=1.9e-15  Score=111.78  Aligned_cols=92  Identities=28%  Similarity=0.506  Sum_probs=79.9

Q ss_pred             HHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcchHHHHH
Q 012684           44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK  123 (458)
Q Consensus        44 l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~~  123 (458)
                      +.|++++|.++-|+..+..|.|+|..- .|+||||+||-+|.++++.+|+..||+++.+|+.|.|||-.|++.|+..+++
T Consensus         6 ~~W~vkNG~~DeVk~~v~~g~nVn~~~-ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVk   84 (117)
T KOG4214|consen    6 VAWNVKNGEIDEVKQSVNEGLNVNEIY-GGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVK   84 (117)
T ss_pred             HhhhhccCcHHHHHHHHHccccHHHHh-CCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHH
Confidence            688889999999999998888887664 7889999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCc
Q 012684          124 LLEKHGAKPLMAP  136 (458)
Q Consensus       124 ~l~~~g~~~~~~~  136 (458)
                      +|+..|++-....
T Consensus        85 lLL~~GAdrt~~~   97 (117)
T KOG4214|consen   85 LLLQNGADRTIHA   97 (117)
T ss_pred             HHHHcCcccceeC
Confidence            9999998865443

>KOG0510 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.60  E-value=1.9e-15  Score=152.03  Aligned_cols=97  Identities=34%  Similarity=0.349  Sum_probs=51.2

Q ss_pred             CccchHHHHHHHhCCHHHHHHHHH-cC-CCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCC---CCCCCCCChhHH
Q 012684           38 IKPEFRLMFLANERDVEGIKELLD-SG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD---PKDRWGSTPLGD  112 (458)
Q Consensus        38 ~~g~t~l~~a~~~~~~~~~~~ll~-~g-~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~---~~~~~g~tpl~~  112 (458)
                      .+++||||+||..|++++++.|++ .| ..+|..|..|.||||+|+..||.++++.|++.||+.+   ..|.+|.||||.
T Consensus       304 ~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLHlaa~~gH~~v~qlLl~~GA~~~~~~e~D~dg~TaLH~  383 (929)
T KOG0510|consen  304 KDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLHLAAKSGHDRVVQLLLNKGALFLNMSEADSDGNTALHL  383 (929)
T ss_pred             CCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchhhhhhcCHHHHHHHHHhcChhhhcccccccCCchhhhH
Confidence            344444555555555555555554 22 2344555555555555555555555555555555554   335555555555


Q ss_pred             HhhcchHHHHHHHHHhCCCCCC
Q 012684          113 AIYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       113 A~~~~~~~~~~~l~~~g~~~~~  134 (458)
                      |+..|+..+++.|+.+|+++..
T Consensus       384 Aa~~g~~~av~~Li~~Ga~I~~  405 (929)
T KOG0510|consen  384 AAKYGNTSAVQKLISHGADIGV  405 (929)
T ss_pred             HHHhccHHHHHHHHHcCCceee
Confidence            5555555555555555555533

>KOG0510 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.60  E-value=2.3e-15  Score=151.45  Aligned_cols=100  Identities=29%  Similarity=0.342  Sum_probs=93.9

Q ss_pred             CCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHH-C-CCCCCCCCCCCCChhH
Q 012684           34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-R-GADVDPKDRWGSTPLG  111 (458)
Q Consensus        34 ~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~-~-ga~~~~~~~~g~tpl~  111 (458)
                      +..|.+|+||||+||..|+.++++.|+..|++||.++.++.||||.||.+|+.+.|+-|++ . -...|..|..|.||||
T Consensus       267 ~~~d~dg~tpLH~a~r~G~~~svd~Ll~~Ga~I~~kn~d~~spLH~AA~yg~~ntv~rLL~~~~~rllne~D~~g~tpLH  346 (929)
T KOG0510|consen  267 NDEDNDGCTPLHYAARQGGPESVDNLLGFGASINSKNKDEESPLHFAAIYGRINTVERLLQESDTRLLNESDLHGMTPLH  346 (929)
T ss_pred             hcccccCCchHHHHHHcCChhHHHHHHHcCCcccccCCCCCCchHHHHHcccHHHHHHHHhCcCccccccccccCCCchh
Confidence            4456678999999999999999999999999999999999999999999999999999998 4 4678889999999999


Q ss_pred             HHhhcchHHHHHHHHHhCCCCC
Q 012684          112 DAIYYKNHEVIKLLEKHGAKPL  133 (458)
Q Consensus       112 ~A~~~~~~~~~~~l~~~g~~~~  133 (458)
                      +|+..|+..++++|++.||...
T Consensus       347 laa~~gH~~v~qlLl~~GA~~~  368 (929)
T KOG0510|consen  347 LAAKSGHDRVVQLLLNKGALFL  368 (929)
T ss_pred             hhhhcCHHHHHHHHHhcChhhh
Confidence            9999999999999999999876

>KOG0505 consensus Myosin phosphatase, regulatory subunit [Posttranslational modification, protein turnover, chaperones; Signal transduction mechanisms]

Probab=99.59  E-value=2.8e-15  Score=144.79  Aligned_cols=68  Identities=28%  Similarity=0.401  Sum_probs=40.2

Q ss_pred             CCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCC
Q 012684           30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA   97 (458)
Q Consensus        30 ~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga   97 (458)
                      |++++..+.+|.|+||-||...+.++|++|+++|++||.+|.+||||||-|+..|+.+++.+|+++||
T Consensus        63 ga~~~~~n~DglTalhq~~id~~~e~v~~l~e~ga~Vn~~d~e~wtPlhaaascg~~~i~~~li~~gA  130 (527)
T KOG0505|consen   63 GASPNLCNVDGLTALHQACIDDNLEMVKFLVENGANVNAQDNEGWTPLHAAASCGYLNIVEYLIQHGA  130 (527)
T ss_pred             CCCccccCCccchhHHHHHhcccHHHHHHHHHhcCCccccccccCCcchhhcccccHHHHHHHHHhhh
Confidence            34455555555666666666666666666666666666666666666666555555555555555555

>PHA02730 ankyrin-like protein; Provisional

Probab=99.59  E-value=6.6e-15  Score=150.89  Aligned_cols=107  Identities=18%  Similarity=0.158  Sum_probs=92.6

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCC----HHHHHHHHHcCC--CCCccCCCCCCHHHH---HHHcC---------CHHHHH
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGI--DVNFRDIDNRTALHV---AACQG---------FTEVVS   90 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~----~~~~~~ll~~g~--~in~~~~~g~t~l~~---A~~~~---------~~~~~~   90 (458)
                      +|+|+|.. ..|.||||+||..++    .+++++|+++|+  ++|.+|.+|.||||.   |+..+         ..++++
T Consensus       368 ~GAdIN~k-~~G~TpLH~Aa~~nnn~i~~eIvelLIs~Ga~~dIN~kd~~G~T~Lh~~i~a~~~n~~~~~~e~~~~~ivk  446 (672)
T PHA02730        368 NGATMDKT-TDNNYPLHDYFVNNNNIVDVNVVRFIVENNGHMAINHVSNNGRLCMYGLILSRFNNCGYHCYETILIDVFD  446 (672)
T ss_pred             CCCCCCcC-CCCCcHHHHHHHHcCCcchHHHHHHHHHcCCCccccccccCCCchHhHHHHHHhccccccccchhHHHHHH
Confidence            67777765 689999999998885    899999999997  699999999999984   33332         235799


Q ss_pred             HHHHCCCCCCCCCCCCCChhHHHhhcchHHHHHHHHHhCCCCCCCc
Q 012684           91 LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus        91 ~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      +|+.+||++|.+|..|.||||+|+..++.+++++|+++||++....
T Consensus       447 ~LIs~GADINakD~~G~TPLh~Aa~~~~~eive~LI~~GAdIN~~d  492 (672)
T PHA02730        447 ILSKYMDDIDMIDNENKTLLYYAVDVNNIQFARRLLEYGASVNTTS  492 (672)
T ss_pred             HHHhcccchhccCCCCCCHHHHHHHhCCHHHHHHHHHCCCCCCCCC
Confidence            9999999999999999999999999999999999999999986544

>PHA02795 ankyrin-like protein; Provisional

Probab=99.59  E-value=7.3e-15  Score=143.81  Aligned_cols=111  Identities=17%  Similarity=0.036  Sum_probs=93.3

Q ss_pred             hhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccC------CCCCCHHHHHHHcCCHHHHHHHHHCCCCCC
Q 012684           27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD------IDNRTALHVAACQGFTEVVSLLLERGADVD  100 (458)
Q Consensus        27 ~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~------~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~  100 (458)
                      ..+|+|++..  ++.||||+|+..++.+++++|+++|++.+...      ..|.|++|.|+..++.+++++|+++||++|
T Consensus       138 I~~GADIn~~--~~~t~lh~A~~~~~~eIVk~Lls~Ga~~~n~~~~~l~~~~~~t~l~~a~~~~~~eIve~LIs~GADIN  215 (437)
T PHA02795        138 VDHGAVIYKI--ECLNAYFRGICKKESSVVEFILNCGIPDENDVKLDLYKIIQYTRGFLVDEPTVLEIYKLCIPYIEDIN  215 (437)
T ss_pred             HHCCCCCCCC--CCCCHHHHHHHcCcHHHHHHHHhcCCcccccccchhhhhhccchhHHHHhcCHHHHHHHHHhCcCCcC
Confidence            3466666653  34789999999999999999999998543322      347789999999999999999999999999


Q ss_pred             CCCCCCCChhHHHhhcchHHHHHHHHHhCCCCCCCcccc
Q 012684          101 PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV  139 (458)
Q Consensus       101 ~~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~  139 (458)
                      .+|..|.||||+|+..|+.+++++|+++|+++......+
T Consensus       216 ~kD~~G~TpLh~Aa~~g~~eiVelLL~~GAdIN~~d~~G  254 (437)
T PHA02795        216 QLDAGGRTLLYRAIYAGYIDLVSWLLENGANVNAVMSNG  254 (437)
T ss_pred             cCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCC
Confidence            999999999999999999999999999999987654433

>PHA02989 ankyrin repeat protein; Provisional

Probab=99.58  E-value=8.8e-15  Score=150.40  Aligned_cols=106  Identities=24%  Similarity=0.274  Sum_probs=88.5

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhC------CHHHHHHHHHcCCCCCccCCCCCCHHHHHHHc---CCHHHHHHHHHCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANER------DVEGIKELLDSGIDVNFRDIDNRTALHVAACQ---GFTEVVSLLLERGAD   98 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~------~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~---~~~~~~~~Ll~~ga~   98 (458)
                      -+|+|+|.++ .+.||||.|+.++      +.+++++|+++|+|+|.+|.+|.||||.|+..   |+.+++++|+++|||
T Consensus        58 ~~GAdvn~~~-~~~tpL~~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gad  136 (494)
T PHA02989         58 DNGADVNYKG-YIETPLCAVLRNREITSNKIKKIVKLLLKFGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGIN  136 (494)
T ss_pred             HcCCCccCCC-CCCCcHHHHHhccCcchhhHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCC
Confidence            3577777665 4689999887654      46799999999999999999999999987764   678999999999999


Q ss_pred             C-CCCCCCCCChhHHHhhc--chHHHHHHHHHhCCCCCC
Q 012684           99 V-DPKDRWGSTPLGDAIYY--KNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus        99 ~-~~~~~~g~tpl~~A~~~--~~~~~~~~l~~~g~~~~~  134 (458)
                      + +.+|..|.||||+|+..  ++.+++++|+++|+++..
T Consensus       137 in~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~  175 (494)
T PHA02989        137 VNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFE  175 (494)
T ss_pred             cccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccc
Confidence            9 78899999999988754  578999999999998765

>PHA02989 ankyrin repeat protein; Provisional

Probab=99.57  E-value=1.2e-14  Score=149.50  Aligned_cols=109  Identities=20%  Similarity=0.252  Sum_probs=98.0

Q ss_pred             hcCCCCCCCcCccchHHHHHHHh---CCHHHHHHHHHcCCCC-CccCCCCCCHHHHHHHc--CCHHHHHHHHHCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDV-NFRDIDNRTALHVAACQ--GFTEVVSLLLERGADVDP  101 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~---~~~~~~~~ll~~g~~i-n~~~~~g~t~l~~A~~~--~~~~~~~~Ll~~ga~~~~  101 (458)
                      -+|+|+|.++..|.||||.|+..   |+.+++++|+++|+|+ +.+|..|.||||+|+..  ++.+++++|+++|++++.
T Consensus        96 ~~Gadin~~d~~g~tpL~~a~~~~~~~~~eiv~~Ll~~Gadin~~~d~~g~tpLh~a~~~~~~~~~iv~~Ll~~Gadi~~  175 (494)
T PHA02989         96 KFGADINLKTFNGVSPIVCFIYNSNINNCDMLRFLLSKGINVNDVKNSRGYNLLHMYLESFSVKKDVIKILLSFGVNLFE  175 (494)
T ss_pred             HCCCCCCCCCCCCCcHHHHHHHhcccCcHHHHHHHHHCCCCcccccCCCCCCHHHHHHHhccCCHHHHHHHHHcCCCccc
Confidence            57899999999999999988766   6799999999999999 89999999999998764  689999999999999998


Q ss_pred             -CCCCCCChhHHHhhcc----hHHHHHHHHHhCCCCCCCc
Q 012684          102 -KDRWGSTPLGDAIYYK----NHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       102 -~~~~g~tpl~~A~~~~----~~~~~~~l~~~g~~~~~~~  136 (458)
                       .+..|.||||+|+..+    +.+++++|++.|+++....
T Consensus       176 ~~~~~g~tpL~~a~~~~~~~~~~~iv~~Ll~~Ga~vn~~~  215 (494)
T PHA02989        176 KTSLYGLTPMNIYLRNDIDVISIKVIKYLIKKGVNIETNN  215 (494)
T ss_pred             cccccCCChHHHHHhcccccccHHHHHHHHhCCCCccccC
Confidence             6889999999998764    8899999999999986543

>PHA02736 Viral ankyrin protein; Provisional

Probab=99.57  E-value=3.4e-15  Score=128.77  Aligned_cols=106  Identities=25%  Similarity=0.336  Sum_probs=84.5

Q ss_pred             CCCCcCccchHHHHHHHhCCHHHHHHHHHcCC--C-----CCccCCCCCCHHHHHHHcCCHH---HHHHHHHCCCCCCCC
Q 012684           33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGI--D-----VNFRDIDNRTALHVAACQGFTE---VVSLLLERGADVDPK  102 (458)
Q Consensus        33 ~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~--~-----in~~~~~g~t~l~~A~~~~~~~---~~~~Ll~~ga~~~~~  102 (458)
                      .+.++.+|.||||+||..|+.  ++++...+.  +     ++.+|.+|+||||+|+..|+.+   ++++|+++|++++.+
T Consensus        10 ~~~~d~~g~tpLh~A~~~g~~--~~l~~~~~~~~~~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~e~v~~Ll~~gadin~~   87 (154)
T PHA02736         10 ASEPDIEGENILHYLCRNGGV--TDLLAFKNAISDENRYLVLEYNRHGKQCVHIVSNPDKADPQEKLKLLMEWGADINGK   87 (154)
T ss_pred             HHhcCCCCCCHHHHHHHhCCH--HHHHHHHHHhcchhHHHHHHhcCCCCEEEEeecccCchhHHHHHHHHHHcCCCcccc
Confidence            345567799999999999984  333332222  2     3456889999999999999874   689999999999999


Q ss_pred             C-CCCCChhHHHhhcchHHHHHHHHH-hCCCCCCCccccc
Q 012684          103 D-RWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHVK  140 (458)
Q Consensus       103 ~-~~g~tpl~~A~~~~~~~~~~~l~~-~g~~~~~~~~~~~  140 (458)
                      + ..|.||||+|+..++.+++++|+. .|+++......+.
T Consensus        88 ~~~~g~T~Lh~A~~~~~~~i~~~Ll~~~g~d~n~~~~~g~  127 (154)
T PHA02736         88 ERVFGNTPLHIAVYTQNYELATWLCNQPGVNMEILNYAFK  127 (154)
T ss_pred             CCCCCCcHHHHHHHhCCHHHHHHHHhCCCCCCccccCCCC
Confidence            8 499999999999999999999997 4888865544333

>KOG4214 consensus Myotrophin and similar proteins [Transcription]

Probab=99.57  E-value=4.9e-15  Score=109.60  Aligned_cols=86  Identities=22%  Similarity=0.241  Sum_probs=77.0

Q ss_pred             hhcCC-CCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCC
Q 012684           27 ELNGL-DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW  105 (458)
Q Consensus        27 ~~n~~-d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~  105 (458)
                      .+|.. |+| +...|+|||||||..|.++++++|+..||+|+.+|..|.|||.-|+..||.++|++|++.||+-....++
T Consensus        21 ~v~~g~nVn-~~~ggR~plhyAAD~GQl~ilefli~iGA~i~~kDKygITPLLsAvwEGH~~cVklLL~~GAdrt~~~Pd   99 (117)
T KOG4214|consen   21 SVNEGLNVN-EIYGGRTPLHYAADYGQLSILEFLISIGANIQDKDKYGITPLLSAVWEGHRDCVKLLLQNGADRTIHAPD   99 (117)
T ss_pred             HHHccccHH-HHhCCcccchHhhhcchHHHHHHHHHhccccCCccccCCcHHHHHHHHhhHHHHHHHHHcCcccceeCCC
Confidence            34444 443 4458999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCChhHHH
Q 012684          106 GSTPLGDA  113 (458)
Q Consensus       106 g~tpl~~A  113 (458)
                      |.+.+..+
T Consensus       100 G~~~~eat  107 (117)
T KOG4214|consen  100 GTALIEAT  107 (117)
T ss_pred             chhHHhhc
Confidence            98877755

>PHA02917 ankyrin-like protein; Provisional

Probab=99.56  E-value=1.4e-14  Score=151.92  Aligned_cols=107  Identities=21%  Similarity=0.181  Sum_probs=92.4

Q ss_pred             hcCCCCCCCcCccchHHHHHHHh---CCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcC--------------------
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--------------------   84 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~---~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~--------------------   84 (458)
                      .++.+++.+|.+|+||||+||..   |+.+++++|++.|++++.++.+|+||||.|+..|                    
T Consensus        20 ~~~~~~~~~d~~g~t~Lh~a~~~~~~~~~~~v~~Ll~~ga~v~~~~~~g~TpL~~Aa~~g~~~v~~~~~~~Ll~~~~~~n   99 (661)
T PHA02917         20 RDRDPNDTRNQFKNNALHAYLFNEHCNNVEVVKLLLDSGTNPLHKNWRQLTPLEEYTNSRHVKVNKDIAMALLEATGYSN   99 (661)
T ss_pred             hccCcccccCCCCCcHHHHHHHhhhcCcHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCChhHHHHHHHHHHhccCCCC
Confidence            46777777788999999997666   7799999999999999999999999999777644                    


Q ss_pred             ---------------CHHHHHHHHHCCCCCCCCCCCCCChhHHH--hhcchHHHHHHHHHhCCCCCC
Q 012684           85 ---------------FTEVVSLLLERGADVDPKDRWGSTPLGDA--IYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus        85 ---------------~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A--~~~~~~~~~~~l~~~g~~~~~  134 (458)
                                     +.+++++|+++|||+|.+|..|.||||.|  +..|+.+++++|+++|+++..
T Consensus       100 ~~~~~~~~~~a~~~~~~e~vk~Ll~~Gadin~~d~~g~T~L~~~~a~~~~~~eivklLi~~Ga~vn~  166 (661)
T PHA02917        100 INDFNIFSYMKSKNVDVDLIKVLVEHGFDLSVKCENHRSVIENYVMTDDPVPEIIDLFIENGCSVLY  166 (661)
T ss_pred             CCCcchHHHHHhhcCCHHHHHHHHHcCCCCCccCCCCccHHHHHHHccCCCHHHHHHHHHcCCCccc
Confidence                           45788999999999999999999999954  457899999999999999864

>PHA02917 ankyrin-like protein; Provisional

Probab=99.56  E-value=1.6e-14  Score=151.35  Aligned_cols=105  Identities=30%  Similarity=0.253  Sum_probs=96.1

Q ss_pred             cCCCCCCCcCccchHHHHHHHhC-----------------------CHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANER-----------------------DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF   85 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~-----------------------~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~   85 (458)
                      +|++.+..+.+|.||||.||..+                       ..+++++|+.+|+|+|.+|..|+||||+|+..++
T Consensus       385 ~ga~~~~~~~~G~TpL~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~Ll~~GAdIN~kd~~G~TpLh~Aa~~~~  464 (661)
T PHA02917        385 EGGDAVNHLDDGEIPIGHLCKSNYGCYNFYTYTYKKGLCDMSYACPILSTINICLPYLKDINMIDKRGETLLHKAVRYNK  464 (661)
T ss_pred             cCCCccccCCCCCChhHHHHHhcccchhhhhhhhhhccchhhhhhhhHHHHHHHHHCCCCCCCCCCCCcCHHHHHHHcCC
Confidence            67887777778999999998543                       3568899999999999999999999999999999


Q ss_pred             HHHHHHHHHCCCCCCCCCCCCCChhHHHhh-cchHHHHHHHHHhCCCCC
Q 012684           86 TEVVSLLLERGADVDPKDRWGSTPLGDAIY-YKNHEVIKLLEKHGAKPL  133 (458)
Q Consensus        86 ~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~-~~~~~~~~~l~~~g~~~~  133 (458)
                      .+++++|+++|++++.+|..|.||||+|+. .++.+++++|+.+|+++.
T Consensus       465 ~~~v~~Ll~~GAdin~~d~~G~T~L~~A~~~~~~~~iv~~LL~~ga~i~  513 (661)
T PHA02917        465 QSLVSLLLESGSDVNIRSNNGYTCIAIAINESRNIELLKMLLCHKPTLD  513 (661)
T ss_pred             HHHHHHHHHCcCCCCCCCCCCCCHHHHHHHhCCCHHHHHHHHHcCCChh
Confidence            999999999999999999999999999996 678999999999999874

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.56  E-value=2.5e-14  Score=127.54  Aligned_cols=134  Identities=23%  Similarity=0.223  Sum_probs=94.1

Q ss_pred             ceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHH---------------------HHHHHHHHhcCCCC--cc
Q 012684          160 SVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRA---------------------FRDELALLQKIRHP--NV  212 (458)
Q Consensus       160 ~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~---------------------~~~E~~~l~~l~hp--~i  212 (458)
                      .+.||+|+||.||.    +|+.||||++.............                     ...|...+..+.+.  .+
T Consensus         2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~   81 (187)
T cd05119           2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV   81 (187)
T ss_pred             CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence            35799999998874    58999999987543221111111                     13566666666433  35


Q ss_pred             eeeeeEEEeCCceEEEEEccCCCCHHH-HHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEecCCC
Q 012684          213 VQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSG  290 (458)
Q Consensus       213 ~~~~~~~~~~~~~~lv~e~~~~~~L~~-~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dikp~Nil~~~~~  290 (458)
                      +++++.    ...++||||++++++.. .+.... .. ..+..++.+++.++.++|. .+   ++|+||||+||+++ ++
T Consensus        82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~-~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~-~~  151 (187)
T cd05119          82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR-LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD-DG  151 (187)
T ss_pred             CceEec----CCCEEEEEEeCCCCccChhhhhhh-hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-CC
Confidence            555554    24589999998854321 111111 11 6678899999999999999 88   99999999999999 89


Q ss_pred             CEEEeecCCcccc
Q 012684          291 NLKVADFGVSKLL  303 (458)
Q Consensus       291 ~vkl~Dfg~~~~~  303 (458)
                      .++|+|||.+...
T Consensus       152 ~~~liDfg~a~~~  164 (187)
T cd05119         152 KVYIIDVPQAVEI  164 (187)
T ss_pred             cEEEEECcccccc
Confidence            9999999998654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>PHA02946 ankyin-like protein; Provisional

Probab=99.55  E-value=2.2e-14  Score=144.60  Aligned_cols=112  Identities=19%  Similarity=0.266  Sum_probs=96.7

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCC--HHHHHHHHHcCCCCCc-cCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERD--VEGIKELLDSGIDVNF-RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR  104 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~--~~~~~~ll~~g~~in~-~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~  104 (458)
                      -+|+|++.+|..|.||||+|+..++  .+++++|+++|+++|. .|.+|.|||| ||..++.+++++|+++|++++.+|.
T Consensus        93 ~~GAdin~~d~~g~TpLh~A~~~~~~~~e~v~lLl~~Gadin~~~d~~g~tpL~-aa~~~~~~vv~~Ll~~gad~~~~d~  171 (446)
T PHA02946         93 THGADPNACDKQHKTPLYYLSGTDDEVIERINLLVQYGAKINNSVDEEGCGPLL-ACTDPSERVFKKIMSIGFEARIVDK  171 (446)
T ss_pred             HCcCCCCCCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCcccccCCCCCcHHH-HHHCCChHHHHHHHhccccccccCC
Confidence            4678888899999999999988764  8999999999999995 6889999997 6778999999999999999999999


Q ss_pred             CCCChhHHHhhcc--hHHHHHHHHHhCCCCCCCccccc
Q 012684          105 WGSTPLGDAIYYK--NHEVIKLLEKHGAKPLMAPMHVK  140 (458)
Q Consensus       105 ~g~tpl~~A~~~~--~~~~~~~l~~~g~~~~~~~~~~~  140 (458)
                      .|+||||+|+..+  +.+++++|+++|+++......+.
T Consensus       172 ~G~t~Lh~A~~~~~~~~~~v~~Ll~~Gadin~~d~~G~  209 (446)
T PHA02946        172 FGKNHIHRHLMSDNPKASTISWMMKLGISPSKPDHDGN  209 (446)
T ss_pred             CCCCHHHHHHHhcCCCHHHHHHHHHcCCCCcccCCCCC
Confidence            9999999988755  46899999999999876544443

>PHA02876 ankyrin repeat protein; Provisional

Probab=99.55  E-value=2.9e-14  Score=152.42  Aligned_cols=107  Identities=34%  Similarity=0.367  Sum_probs=82.3

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhC-CHHHHHHHHHcCCCCCccCCCCCCHHHHHHHc-CCHHHHHHHHHCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANER-DVEGIKELLDSGIDVNFRDIDNRTALHVAACQ-GFTEVVSLLLERGADVDPKDRW  105 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~-~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~-~~~~~~~~Ll~~ga~~~~~~~~  105 (458)
                      -.|+|++.++..|.||||+|+..| +.+.++.|+..|+++|.+|..|.||||+|+.. ++.+++++|++.|++++.+|..
T Consensus       295 ~~gadin~~d~~g~TpLh~Aa~~g~~~~~v~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~iv~lLl~~gadin~~d~~  374 (682)
T PHA02876        295 ERGADVNAKNIKGETPLYLMAKNGYDTENIRTLIMLGADVNAADRLYITPLHQASTLDRNKDIVITLLELGANVNARDYC  374 (682)
T ss_pred             HCCCCCCCcCCCCCCHHHHHHHhCCCHHHHHHHHHcCCCCCCcccCCCcHHHHHHHhCCcHHHHHHHHHcCCCCccCCCC
Confidence            356666777777777777777777 47777777777777777777777777777774 4677778888888888888888


Q ss_pred             CCChhHHHhhcchHHHHHHHHHhCCCCCC
Q 012684          106 GSTPLGDAIYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       106 g~tpl~~A~~~~~~~~~~~l~~~g~~~~~  134 (458)
                      |.||||+|+..|+.+++++|+++|+++..
T Consensus       375 G~TpLh~Aa~~~~~~iv~~Ll~~gad~~~  403 (682)
T PHA02876        375 DKTPIHYAAVRNNVVIINTLLDYGADIEA  403 (682)
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHCCCCccc
Confidence            88888888888888888888888887754

>KOG0508 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.54  E-value=1.2e-14  Score=137.77  Aligned_cols=110  Identities=31%  Similarity=0.327  Sum_probs=102.0

Q ss_pred             CCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHH
Q 012684           33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD  112 (458)
Q Consensus        33 ~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~  112 (458)
                      -|+.+.+|-+||-.|+..||+++|+.|+++|+++|.......|||.-||.-|+++++++|+++|||+++.|..|.|.||+
T Consensus        77 FDge~IegappLWaAsaAGHl~vVk~L~~~ga~VN~tT~TNStPLraACfDG~leivKyLvE~gad~~IanrhGhTcLmI  156 (615)
T KOG0508|consen   77 FDGETIEGAPPLWAASAAGHLEVVKLLLRRGASVNDTTRTNSTPLRAACFDGHLEIVKYLVEHGADPEIANRHGHTCLMI  156 (615)
T ss_pred             eCCcccCCCchhhHHhccCcHHHHHHHHHhcCccccccccCCccHHHHHhcchhHHHHHHHHcCCCCcccccCCCeeEEe
Confidence            34566788899999999999999999999999999988888999999999999999999999999999999999999999


Q ss_pred             HhhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684          113 AIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus       113 A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      |++.|+.+++++|++.|+|++.....+.++
T Consensus       157 a~ykGh~~I~qyLle~gADvn~ks~kGNTA  186 (615)
T KOG0508|consen  157 ACYKGHVDIAQYLLEQGADVNAKSYKGNTA  186 (615)
T ss_pred             eeccCchHHHHHHHHhCCCcchhcccCchH
Confidence            999999999999999999998877666554

>PHA02730 ankyrin-like protein; Provisional

Probab=99.53  E-value=3.6e-14  Score=145.51  Aligned_cols=103  Identities=17%  Similarity=0.172  Sum_probs=91.1

Q ss_pred             CCC-CCcCccchHHHHHHHhC---CHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcC--CHHHHHHHHHCC--CCCCCCC
Q 012684           32 DDD-GEEIKPEFRLMFLANER---DVEGIKELLDSGIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERG--ADVDPKD  103 (458)
Q Consensus        32 d~~-~~~~~g~t~l~~a~~~~---~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~--~~~~~~~Ll~~g--a~~~~~~  103 (458)
                      +.| .+|.+|+||||+|+..|   +.+++++|+++|||+|++|.+|+||||+|+..+  +.+++++|+++|  |+++..+
T Consensus        32 ~in~~kd~~G~TaLh~A~~~~~~~~~eivklLLs~GAdin~kD~~G~TPLh~Aa~~~~~~~eIv~~Ll~~~~~~~~~~~~  111 (672)
T PHA02730         32 NLSKHIDRRGNNALHCYVSNKCDTDIKIVRLLLSRGVERLCRNNEGLTPLGVYSKRKYVKSQIVHLLISSYSNASNELTS  111 (672)
T ss_pred             chhhhcCCCCCcHHHHHHHcCCcCcHHHHHHHHhCCCCCcccCCCCCChHHHHHHcCCCcHHHHHHHHhcCCCCCccccc
Confidence            555 66778999999999997   599999999999999999999999999999977  799999999995  4558888


Q ss_pred             CCCCChhHHHhh--cchHHHHHHHHH-hCCCCCC
Q 012684          104 RWGSTPLGDAIY--YKNHEVIKLLEK-HGAKPLM  134 (458)
Q Consensus       104 ~~g~tpl~~A~~--~~~~~~~~~l~~-~g~~~~~  134 (458)
                      ..+.+||+.++.  +++.+++++|+. .++++..
T Consensus       112 ~~~d~~l~~y~~s~n~~~~~vk~Li~~~~~~~~~  145 (672)
T PHA02730        112 NINDFDLYSYMSSDNIDLRLLKYLIVDKRIRPSK  145 (672)
T ss_pred             ccCCchHHHHHHhcCCcHHHHHHHHHhcCCChhh
Confidence            889999999888  889999999996 6667653

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.52  E-value=7.9e-14  Score=119.18  Aligned_cols=132  Identities=19%  Similarity=0.182  Sum_probs=107.5

Q ss_pred             CceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCC--CcceeeeeEEEeCCceEEEEEccC
Q 012684          159 NSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYLP  233 (458)
Q Consensus       159 ~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~i~~~~~~~~~~~~~~lv~e~~~  233 (458)
                      +.+.||.|.++.++   ..+..+++|.......     ...+..|+..++.+.+  +++++++.++..++..+++|||+.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~   76 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKDEDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIE   76 (155)
T ss_pred             cceecccccccceEEEEecCCeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecC
Confidence            34678999998776   4567999999865432     3568889999999965  589999999888888999999998


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       234 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      |+.+..+       +......++.++++++.+||.....+++|+|++|.||+++..+.++++|||.+..
T Consensus        77 g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          77 GETLDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             CeecccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            8777654       4566677899999999999985222399999999999999989999999998764

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>cd00204 ANK ankyrin repeats; ankyrin repeats mediate protein-protein interactions in very diverse families of proteins

Probab=99.51  E-value=2.1e-13  Score=112.32  Aligned_cols=99  Identities=44%  Similarity=0.581  Sum_probs=92.8

Q ss_pred             CcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhh
Q 012684           36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY  115 (458)
Q Consensus        36 ~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~  115 (458)
                      ++.+|.||||+|+..++.++++.|++.|.+++.++..|.||||+|+..++.+++++|+..|++++..+..|.||+|+|+.
T Consensus         3 ~~~~g~t~l~~a~~~~~~~~i~~li~~~~~~~~~~~~g~~~l~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~l~~a~~   82 (126)
T cd00204           3 RDEDGRTPLHLAASNGHLEVVKLLLENGADVNAKDNDGRTPLHLAAKNGHLEIVKLLLEKGADVNARDKDGNTPLHLAAR   82 (126)
T ss_pred             cCcCCCCHHHHHHHcCcHHHHHHHHHcCCCCCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHH
Confidence            34678999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cchHHHHHHHHHhCCCCCC
Q 012684          116 YKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       116 ~~~~~~~~~l~~~g~~~~~  134 (458)
                      .++.+++++|+..|.++..
T Consensus        83 ~~~~~~~~~L~~~~~~~~~  101 (126)
T cd00204          83 NGNLDVVKLLLKHGADVNA  101 (126)
T ss_pred             cCcHHHHHHHHHcCCCCcc
Confidence            9999999999999866544

The number of ANK repeats in a protein can range from 2 to over 20 (ankyrins, for example). ANK repeats may occur in combinations with other types of domains. The structural repeat unit contains two antiparallel helices and a beta-hairpin, repeats are stacked in a superhelical arrangement; this alignment contains 4 consecutive repeats.

>PF12796 Ank_2: Ankyrin repeats (3 copies); InterPro: IPR020683 This entry represents the ankyrin repeat-containing domain

Probab=99.50  E-value=7.6e-14  Score=108.41  Aligned_cols=64  Identities=42%  Similarity=0.587  Sum_probs=59.8

Q ss_pred             cchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Q 012684           40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD  103 (458)
Q Consensus        40 g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~  103 (458)
                      |.||||+||..|+.+++++|++.|+++|.+|.+|+||||+|+..|+.+++++|+++|++++.+|
T Consensus        26 ~~~~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~n   89 (89)
T PF12796_consen   26 GNTALHYAAENGNLEIVKLLLENGADINSQDKNGNTALHYAAENGNLEIVKLLLEHGADVNIRN   89 (89)
T ss_dssp             SSBHHHHHHHTTTHHHHHHHHHTTTCTT-BSTTSSBHHHHHHHTTHHHHHHHHHHTTT-TTSS-
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHhcccccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence            8899999999999999999999999999999999999999999999999999999999999875

These domains contain multiple repeats of a beta(2)-alpha(2) motif. The ankyrin repeat is one of the most common protein-protein interaction motifs in nature. Ankyrin repeats are tandemly repeated modules of about 33 amino acids. They occur in a large number of functionally diverse proteins mainly from eukaryotes. The few known examples from prokaryotes and viruses may be the result of horizontal gene transfers []. The repeat has been found in proteins of diverse function such as transcriptional initiators, cell-cycle regulators, cytoskeletal, ion transporters and signal transducers. The ankyrin fold appears to be defined by its structure rather than its function since there is no specific sequence or structure which is universally recognised by it. The conserved fold of the ankyrin repeat unit is known from several crystal and solution structures [, , , ]. Each repeat folds into a helix-loop-helix structure with a beta-hairpin/loop region projecting out from the helices at a 90o angle. The repeats stack together to form an L-shaped structure [, ].; PDB: 3AAA_C 3F6Q_A 2KBX_A 3IXE_A 3TWR_D 3TWV_A 3TWT_B 3TWQ_A 3TWS_A 3TWX_B ....

>PF13857 Ank_5: Ankyrin repeats (many copies); PDB: 1SW6_A 3EHR_B 3EHQ_A

Probab=99.50  E-value=2.2e-14  Score=100.47  Aligned_cols=55  Identities=53%  Similarity=0.668  Sum_probs=29.2

Q ss_pred             HHHcC-CCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHH
Q 012684           59 LLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA  113 (458)
Q Consensus        59 ll~~g-~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A  113 (458)
                      |++.| +++|.+|..|.||||+||.+|+.+++++|++.|++++.+|..|+||+|+|
T Consensus         1 LL~~~~~~~n~~d~~G~T~LH~A~~~g~~~~v~~Ll~~g~d~~~~d~~G~Tpl~~A   56 (56)
T PF13857_consen    1 LLEHGPADVNAQDKYGNTPLHWAARYGHSEVVRLLLQNGADPNAKDKDGQTPLHYA   56 (56)
T ss_dssp             -----T--TT---TTS--HHHHHHHHT-HHHHHHHHHCT--TT---TTS--HHHH-
T ss_pred             CCccCcCCCcCcCCCCCcHHHHHHHcCcHHHHHHHHHCcCCCCCCcCCCCCHHHhC
Confidence            56677 78888888888888888888888888888888888888888888888876

>KOG4177 consensus Ankyrin [Cell wall/membrane/envelope biogenesis]

Probab=99.49  E-value=6.6e-14  Score=149.23  Aligned_cols=111  Identities=36%  Similarity=0.449  Sum_probs=97.5

Q ss_pred             CCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhH
Q 012684           32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG  111 (458)
Q Consensus        32 d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~  111 (458)
                      +.+-....|.|+||.|+..+...++..+++.|++++.++..|.||||.||.+|+.++|++|+++|||++.+++.|+||||
T Consensus       499 ~~~~~~~~~l~~lhla~~~~~v~~~~~l~~~ga~v~~~~~r~~TpLh~A~~~g~v~~VkfLLe~gAdv~ak~~~G~TPLH  578 (1143)
T KOG4177|consen  499 NDNLDAKKGLTPLHLAADEDTVKVAKILLEHGANVDLRTGRGYTPLHVAVHYGNVDLVKFLLEHGADVNAKDKLGYTPLH  578 (1143)
T ss_pred             ccCccchhccchhhhhhhhhhHHHHHHHhhcCCceehhcccccchHHHHHhcCCchHHHHhhhCCccccccCCCCCChhh
Confidence            33444445667777777777777888888888999999999999999999999999999999999999999999999999


Q ss_pred             HHhhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684          112 DAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus       112 ~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      .|+..|+.+++.+|+++|++++.....+..+
T Consensus       579 ~Aa~~G~~~i~~LLlk~GA~vna~d~~g~Tp  609 (1143)
T KOG4177|consen  579 QAAQQGHNDIAELLLKHGASVNAADLDGFTP  609 (1143)
T ss_pred             HHHHcChHHHHHHHHHcCCCCCcccccCcch
Confidence            9999999999999999999998877666655

>KOG0515 consensus p53-interacting protein 53BP/ASPP, contains ankyrin and SH3 domains [Cell cycle control, cell division, chromosome partitioning]

Probab=99.49  E-value=5.4e-14  Score=134.81  Aligned_cols=93  Identities=31%  Similarity=0.373  Sum_probs=87.6

Q ss_pred             HHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcchHHHHH
Q 012684           44 LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK  123 (458)
Q Consensus        44 l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~~  123 (458)
                      |.-|+..|.+++|+.++..-.|+...|.+|.||||-|+..||++||++|++.|+|+|..|.+||||||+|+.+++.-||+
T Consensus       554 LLDaaLeGEldlVq~~i~ev~DpSqpNdEGITaLHNAiCaghyeIVkFLi~~ganVNa~DSdGWTPLHCAASCNnv~~ck  633 (752)
T KOG0515|consen  554 LLDAALEGELDLVQRIIYEVTDPSQPNDEGITALHNAICAGHYEIVKFLIEFGANVNAADSDGWTPLHCAASCNNVPMCK  633 (752)
T ss_pred             HHhhhhcchHHHHHHHHHhhcCCCCCCccchhHHhhhhhcchhHHHHHHHhcCCcccCccCCCCchhhhhhhcCchHHHH
Confidence            45699999999999999887899999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHhCCCCCCCc
Q 012684          124 LLEKHGAKPLMAP  136 (458)
Q Consensus       124 ~l~~~g~~~~~~~  136 (458)
                      .|+++|+.++...
T Consensus       634 qLVe~GaavfAsT  646 (752)
T KOG0515|consen  634 QLVESGAAVFAST  646 (752)
T ss_pred             HHHhccceEEeee
Confidence            9999999886543

>KOG0514 consensus Ankyrin repeat protein [General function prediction only]

Probab=99.49  E-value=6.4e-14  Score=128.98  Aligned_cols=102  Identities=33%  Similarity=0.376  Sum_probs=92.7

Q ss_pred             hhcCCCCCCCc-CccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHC-CCCCCCCCC
Q 012684           27 ELNGLDDDGEE-IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDR  104 (458)
Q Consensus        27 ~~n~~d~~~~~-~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~-ga~~~~~~~  104 (458)
                      ...-.|+|.+- ..|.|+|++|+.+|+.++|+.||..|||||.+|.+|.|+|+.||..||.+|+++||.. ++|+...|.
T Consensus       326 LF~mgnVNaKAsQ~gQTALMLAVSHGr~d~vk~LLacgAdVNiQDdDGSTALMCA~EHGhkEivklLLA~p~cd~sLtD~  405 (452)
T KOG0514|consen  326 LFKMGDVNAKASQHGQTALMLAVSHGRVDMVKALLACGADVNIQDDDGSTALMCAAEHGHKEIVKLLLAVPSCDISLTDV  405 (452)
T ss_pred             HHhccCcchhhhhhcchhhhhhhhcCcHHHHHHHHHccCCCccccCCccHHHhhhhhhChHHHHHHHhccCcccceeecC
Confidence            33445666663 3699999999999999999999999999999999999999999999999999999986 999999999


Q ss_pred             CCCChhHHHhhcchHHHHHHHHHh
Q 012684          105 WGSTPLGDAIYYKNHEVIKLLEKH  128 (458)
Q Consensus       105 ~g~tpl~~A~~~~~~~~~~~l~~~  128 (458)
                      +|-|+|.+|...|+.++.-+|-.+
T Consensus       406 DgSTAl~IAleagh~eIa~mlYa~  429 (452)
T KOG0514|consen  406 DGSTALSIALEAGHREIAVMLYAH  429 (452)
T ss_pred             CCchhhhhHHhcCchHHHHHHHHH
Confidence            999999999999999999888755

>PLN03192 Voltage-dependent potassium channel; Provisional

Probab=99.49  E-value=1.8e-13  Score=148.60  Aligned_cols=97  Identities=28%  Similarity=0.456  Sum_probs=90.3

Q ss_pred             CcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhh
Q 012684           36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY  115 (458)
Q Consensus        36 ~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~  115 (458)
                      .+.++.++||.||..|+.++++.|++.|+|+|..|.+|.||||+||..|+.+++++|+++|+++|.+|.+|.||||+|+.
T Consensus       521 ~~~~~~~~L~~Aa~~g~~~~l~~Ll~~G~d~n~~d~~G~TpLh~Aa~~g~~~~v~~Ll~~gadin~~d~~G~TpL~~A~~  600 (823)
T PLN03192        521 DDPNMASNLLTVASTGNAALLEELLKAKLDPDIGDSKGRTPLHIAASKGYEDCVLVLLKHACNVHIRDANGNTALWNAIS  600 (823)
T ss_pred             CCccchhHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHhcCCCCCCcCCCCCCHHHHHHH
Confidence            34456789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cchHHHHHHHHHhCCCC
Q 012684          116 YKNHEVIKLLEKHGAKP  132 (458)
Q Consensus       116 ~~~~~~~~~l~~~g~~~  132 (458)
                      .|+.+++++|++.++..
T Consensus       601 ~g~~~iv~~L~~~~~~~  617 (823)
T PLN03192        601 AKHHKIFRILYHFASIS  617 (823)
T ss_pred             hCCHHHHHHHHhcCccc
Confidence            99999999888777653

>PF13637 Ank_4: Ankyrin repeats (many copies); PDB: 3B95_A 3B7B_A 3F6Q_A 2KBX_A 3IXE_A 2DWZ_C 2DVW_A 3AJI_A 1S70_B 2HE0_A

Probab=99.48  E-value=8e-14  Score=97.11  Aligned_cols=54  Identities=39%  Similarity=0.524  Sum_probs=40.2

Q ss_pred             cchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHH
Q 012684           40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL   93 (458)
Q Consensus        40 g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll   93 (458)
                      |.||||+||..|+.+++++|++.|+++|.+|.+|.||||+|+..|+.+++++|+
T Consensus         1 g~t~lh~A~~~g~~~~~~~Ll~~~~din~~d~~g~t~lh~A~~~g~~~~~~~Ll   54 (54)
T PF13637_consen    1 GRTPLHWAARSGNLEIVKLLLEHGADINAQDEDGRTPLHYAAKNGNIDIVKFLL   54 (54)
T ss_dssp             SSBHHHHHHHTT-HHHHHHHHHTTSGTT-B-TTS--HHHHHHHTT-HHHHHHHH
T ss_pred             CChHHHHHHHhCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHccCHHHHHHHC
Confidence            568888888888888888888888888888888888888888888888888875

...

>PTZ00322 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase; Provisional

Probab=99.48  E-value=3e-13  Score=142.74  Aligned_cols=96  Identities=42%  Similarity=0.529  Sum_probs=90.2

Q ss_pred             hHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcchHHH
Q 012684           42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV  121 (458)
Q Consensus        42 t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~  121 (458)
                      +.||.||..|+.+.++.|++.|+++|.+|.+|+||||+||..|+.+++++|+++|++++.+|..|.||||+|+..|+.++
T Consensus        84 ~~L~~aa~~G~~~~vk~LL~~Gadin~~d~~G~TpLh~Aa~~g~~eiv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~i  163 (664)
T PTZ00322         84 VELCQLAASGDAVGARILLTGGADPNCRDYDGRTPLHIACANGHVQVVRVLLEFGADPTLLDKDGKTPLELAEENGFREV  163 (664)
T ss_pred             HHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHCCcHHH
Confidence            45899999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHh-------CCCCCCCcc
Q 012684          122 IKLLEKH-------GAKPLMAPM  137 (458)
Q Consensus       122 ~~~l~~~-------g~~~~~~~~  137 (458)
                      +++|+++       |+++.....
T Consensus       164 v~~Ll~~~~~~~~~ga~~~~~~~  186 (664)
T PTZ00322        164 VQLLSRHSQCHFELGANAKPDSF  186 (664)
T ss_pred             HHHHHhCCCcccccCCCCCcccc
Confidence            9999999       776655444

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.47  E-value=1.4e-13  Score=122.84  Aligned_cols=115  Identities=24%  Similarity=0.337  Sum_probs=101.5

Q ss_pred             hhhhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Q 012684           24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD  103 (458)
Q Consensus        24 ~~~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~  103 (458)
                      .....-|+.+|..+....||||+||.+|+.++|..|++..+|+|+.|..|.|||||||.-|.-.+++-|+..||-+++.|
T Consensus        51 emll~rgarvn~tnmgddtplhlaaahghrdivqkll~~kadvnavnehgntplhyacfwgydqiaedli~~ga~v~icn  130 (448)
T KOG0195|consen   51 EMLLSRGARVNSTNMGDDTPLHLAAAHGHRDIVQKLLSRKADVNAVNEHGNTPLHYACFWGYDQIAEDLISCGAAVNICN  130 (448)
T ss_pred             HHHHhcccccccccCCCCcchhhhhhcccHHHHHHHHHHhcccchhhccCCCchhhhhhhcHHHHHHHHHhccceeeecc
Confidence            44556677888888888899999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCChhHHHhhcchHHHHHHHHHhCCCCCCCccc
Q 012684          104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH  138 (458)
Q Consensus       104 ~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~  138 (458)
                      +.|.||+..|.-.-...+.+.-.++|..+...+++
T Consensus       131 k~g~tpldkakp~l~~~l~e~aek~gq~~nripfk  165 (448)
T KOG0195|consen  131 KKGMTPLDKAKPMLKNTLLEIAEKHGQSPNRIPFK  165 (448)
T ss_pred             cCCCCchhhhchHHHHHHHHHHHHhCCCCCccccc
Confidence            99999999886666666777778888877655544

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	458
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		1e-36
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		2e-36
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-32
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		6e-32
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		9e-32
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-31
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		2e-31
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		2e-31
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		4e-31
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		4e-29
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		5e-29
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		5e-29
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		5e-29
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		5e-29
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		5e-29
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		6e-29
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-29
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-29
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		8e-29
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		1e-28
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-28
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-28
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-28
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		2e-28
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		5e-28
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		5e-28
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-28
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		7e-28
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		8e-28
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		9e-28
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		1e-27
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		2e-27
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		2e-27
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		2e-27
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		3e-27
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		3e-27
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		6e-27
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-27
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		8e-27
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		8e-27
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		9e-27
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		1e-26
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-26
1fvr_A	327	Tie2 Kinase Domain Length = 327		2e-26
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		3e-26
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-26
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		3e-26
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		3e-26
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		3e-26
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		4e-26
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		4e-26
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		4e-26
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		4e-26
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		4e-26
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		4e-26
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-26
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		4e-26
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		4e-26
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		4e-26
3zzw_A	289	Crystal Structure Of The Kinase Domain Of Ror2 Leng		4e-26
4gt4_A	308	Structure Of Unliganded, Inactive Ror2 Kinase Domai		4e-26
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		5e-26
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-26
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-26
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-26
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-26
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		5e-26
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		5e-26
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		5e-26
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-26
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		6e-26
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		6e-26
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		6e-26
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		6e-26
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		6e-26
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		7e-26
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		7e-26
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-26
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		7e-26
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		8e-26
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		8e-26
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		8e-26
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		8e-26
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-25
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		1e-25
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-25
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-25
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-25
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-25
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		1e-25
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-25
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		1e-25
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-25
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-25
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-25
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		2e-25
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-25
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		2e-25
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		2e-25
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-25
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		2e-25
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		2e-25
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-25
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		2e-25
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		2e-25
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		2e-25
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		3e-25
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-25
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		4e-25
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		4e-25
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-25
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		6e-25
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		8e-25
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		8e-25
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-25
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		9e-25
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-24
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-24
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		1e-24
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		1e-24
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		1e-24
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-24
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-24
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		2e-24
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-24
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		2e-24
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		2e-24
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		2e-24
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-24
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-24
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		2e-24
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		3e-24
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		3e-24
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		4e-24
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		5e-24
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		5e-24
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-24
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		5e-24
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		6e-24
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		7e-24
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		8e-24
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		8e-24
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		9e-24
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		1e-23
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-23
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		1e-23
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		1e-23
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		2e-23
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-23
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		2e-23
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-23
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-23
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		2e-23
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		2e-23
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		2e-23
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-23
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		3e-23
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-23
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-23
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		3e-23
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-23
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		3e-23
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-23
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-23
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		4e-23
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		4e-23
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-23
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		6e-23
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		6e-23
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		7e-23
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		7e-23
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-23
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-23
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		8e-23
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		9e-23
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-22
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-22
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-22
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-22
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-22
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-22
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-22
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-22
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		1e-22
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		2e-22
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		2e-22
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		2e-22
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-22
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		2e-22
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		3e-22
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-22
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		3e-22
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-22
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		3e-22
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		3e-22
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		3e-22
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		3e-22
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		3e-22
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		4e-22
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		4e-22
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		5e-22
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-22
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		6e-22
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		7e-22
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		7e-22
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		7e-22
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		7e-22
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-22
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		8e-22
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		8e-22
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		8e-22
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		8e-22
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		9e-22
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		9e-22
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		9e-22
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		9e-22
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		9e-22
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		9e-22
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-21
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		1e-21
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		1e-21
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-21
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-21
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		1e-21
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		1e-21
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		1e-21
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		2e-21
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-21
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		2e-21
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		2e-21
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		2e-21
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		2e-21
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		2e-21
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		2e-21
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		2e-21
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-21
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		2e-21
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		3e-21
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-21
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		3e-21
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-21
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		4e-21
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		4e-21
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		4e-21
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		4e-21
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		5e-21
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-21
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-21
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-21
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-21
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-21
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		5e-21
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		5e-21
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		5e-21
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		5e-21
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		5e-21
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		5e-21
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		6e-21
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		6e-21
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		7e-21
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-21
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-21
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		7e-21
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		7e-21
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-21
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-21
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-21
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		8e-21
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-21
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		8e-21
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		8e-21
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		9e-21
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-21
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		9e-21
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		9e-21
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		1e-20
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-20
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		1e-20
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-20
4h58_A	275	Braf In Complex With Compound 3 Length = 275		1e-20
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-20
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-20
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		1e-20
3qup_A	323	Inhibitor Bound Structure Of The Kinase Domain Of T		1e-20
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-20
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-20
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-20
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		2e-20
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-20
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		3e-20
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-20
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		3e-20
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-20
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		3e-20
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		3e-20
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		3e-20
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		4e-20
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-20
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-20
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		4e-20
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		4e-20
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		5e-20
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		5e-20
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		5e-20
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-20
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-20
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-20
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		6e-20
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		7e-20
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		7e-20
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		7e-20
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		7e-20
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-20
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		7e-20
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		7e-20
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		7e-20
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		7e-20
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		7e-20
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		8e-20
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		9e-20
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		9e-20
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		9e-20
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		1e-19
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-19
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		1e-19
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		1e-19
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-19
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		1e-19
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		1e-19
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		1e-19
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-19
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-19
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		2e-19
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		2e-19
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		2e-19
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		2e-19
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		2e-19
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-19
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		3e-19
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		3e-19
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		4e-19
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		4e-19
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		4e-19
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		4e-19
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		4e-19
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		5e-19
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		5e-19
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		5e-19
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-19
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-19
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		6e-19
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		6e-19
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		6e-19
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		6e-19
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		6e-19
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		6e-19
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-19
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		7e-19
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		8e-19
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		8e-19
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		8e-19
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-19
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		8e-19
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		9e-19
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		9e-19
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		9e-19
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		9e-19
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		1e-18
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-18
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		1e-18
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-18
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		1e-18
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-18
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		1e-18
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		1e-18
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		1e-18
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		1e-18
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-18
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		1e-18
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		1e-18
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		1e-18
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		1e-18
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-18
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		2e-18
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		2e-18
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		2e-18
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-18
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		2e-18
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-18
3kmw_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		2e-18
2p0c_A	313	Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro		2e-18
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		2e-18
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		2e-18
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-18
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-18
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		2e-18
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-18
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-18
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-18
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-18
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-18
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-18
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-18
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		3e-18
4ae6_A	343	Structure And Function Of The Human Sperm-specific		3e-18
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		3e-18
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-18
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-18
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		3e-18
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		3e-18
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-18
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-18
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		3e-18
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		3e-18
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		3e-18
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		4e-18
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		4e-18
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		4e-18
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-18
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		4e-18
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		4e-18
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		4e-18
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-18
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		6e-18
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		6e-18
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		8e-18
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		8e-18
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		8e-18
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		8e-18
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		8e-18
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		8e-18
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		9e-18
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		9e-18
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		9e-18
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		1e-17
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		1e-17
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		1e-17
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-17
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-17
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-17
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-17
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-17
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-17
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-17
2z8c_A	303	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-17
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		2e-17
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		2e-17
3my0_A	305	Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai		2e-17
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		2e-17
1ir3_A	306	Phosphorylated Insulin Receptor Tyrosine Kinase In		2e-17
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		2e-17
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-17
1rqq_A	306	Crystal Structure Of The Insulin Receptor Kinase In		2e-17
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		2e-17
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-17
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-17
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		2e-17
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		2e-17
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		2e-17
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		2e-17
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		2e-17
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		2e-17
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		2e-17
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		2e-17
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-17
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		3e-17
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-17
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-17
3eta_A	317	Kinase Domain Of Insulin Receptor Complexed With A		3e-17
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-17
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		3e-17
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		3e-17
1i44_A	306	Crystallographic Studies Of An Activation Loop Muta		3e-17
3g51_A	325	Structural Diversity Of The Active Conformation Of		3e-17
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-17
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		3e-17
1irk_A	306	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-17
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		3e-17
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-17
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		4e-17
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		4e-17
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		4e-17
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		4e-17
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		4e-17
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		4e-17
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		5e-17
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		5e-17
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		5e-17
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		5e-17
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		5e-17
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		5e-17
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-17
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		5e-17
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		5e-17
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		5e-17
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-17
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		5e-17
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		5e-17
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-17
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		6e-17
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		6e-17
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		6e-17
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		6e-17
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		6e-17
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		6e-17
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		6e-17
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-17
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		6e-17
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-17
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		7e-17
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		7e-17
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		7e-17
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		7e-17
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		7e-17
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		7e-17
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		7e-17
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		7e-17
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		7e-17
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		8e-17
4fl2_A	636	Structural And Biophysical Characterization Of The		8e-17
4fl3_A	635	Structural And Biophysical Characterization Of The		9e-17
3g2f_A	336	Crystal Structure Of The Kinase Domain Of Bone Morp		9e-17
3ekk_A	307	Insulin Receptor Kinase Complexed With An Inhibitor		1e-16
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		1e-16
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		1e-16
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		1e-16
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		1e-16
1p14_A	306	Crystal Structure Of A Catalytic-Loop Mutant Of The		1e-16
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		1e-16
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		1e-16
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		1e-16
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		2e-16
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		2e-16
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		2e-16
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		2e-16
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		2e-16
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		2e-16
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-16
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-16
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		3e-16
3kmu_A	271	Crystal Structure Of The IlkALPHA-Parvin Core Compl		3e-16
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		3e-16
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		4e-16
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-16
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		6e-16
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		6e-16
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		7e-16
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		7e-16
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		7e-16
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		8e-16
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		8e-16
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		8e-16
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		8e-16
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		9e-16
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		9e-16
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		9e-16
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		9e-16
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		9e-16
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-16
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		9e-16
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		1e-15
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		1e-15
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		1e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		1e-15
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-15
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-15
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-15
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-15
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-15
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		2e-15
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		2e-15
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		2e-15
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		2e-15
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		2e-15
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-15
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-15
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		2e-15
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		2e-15
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		2e-15
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-15
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-15
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		3e-15
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		3e-15
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-15
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		3e-15
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		3e-15
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		3e-15
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		3e-15
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-15
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-15
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-15
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		3e-15
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		3e-15
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		3e-15
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		3e-15
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		3e-15
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		4e-15
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		4e-15
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		4e-15
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		4e-15
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		4e-15
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		4e-15
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		4e-15
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		4e-15
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		4e-15
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		4e-15
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		4e-15
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-15
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		4e-15
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		4e-15
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		4e-15
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		4e-15
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		4e-15
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		4e-15
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		4e-15
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		4e-15
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		4e-15
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		4e-15
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		4e-15
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		4e-15
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		4e-15
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		4e-15
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		4e-15
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		5e-15
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-15
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		5e-15
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		5e-15
3bbt_B	328	Crystal Structure Of The Erbb4 Kinase In Complex Wi		5e-15
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		5e-15
2r4b_A	321	Erbb4 Kinase Domain Complexed With A Thienopyrimidi		5e-15
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		5e-15
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		6e-15
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-15
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		6e-15
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		7e-15
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		7e-15
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		7e-15
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		7e-15
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-15
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		7e-15
4hqd_A	169	Crystal Structure Of Engineered Protein. Northeast		8e-15
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-15
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		8e-15
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-15
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		9e-15
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-14
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		1e-14
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		1e-14
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		1e-14
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		1e-14
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-14
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-14
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-14
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		1e-14
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-14
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-14
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-14
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		1e-14
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-14
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		1e-14
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-14
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-14
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		1e-14
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-14
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-14
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-14
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-14
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-14
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		1e-14
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		1e-14
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		1e-14
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-14
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-14
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		1e-14
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		1e-14
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		1e-14
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		1e-14
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		2e-14
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-14
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		2e-14
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-14
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		2e-14
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-14
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		2e-14
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		2e-14
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-14
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		2e-14
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-14
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-14
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		2e-14
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-14
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		2e-14
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		2e-14
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-14
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		2e-14
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		2e-14
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		2e-14
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		3e-14
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-14
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		3e-14
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-14
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		3e-14
3hec_A	348	P38 In Complex With Imatinib Length = 348		3e-14
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		3e-14
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		3e-14
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-14
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		3e-14
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		3e-14
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		3e-14
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-14
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		3e-14
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-14
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		3e-14
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		3e-14
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		3e-14
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		3e-14
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		3e-14
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		3e-14
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		3e-14
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		3e-14
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		3e-14
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		3e-14
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		3e-14
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		3e-14
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		3e-14
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		3e-14
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		3e-14
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-14
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		3e-14
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		3e-14
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-14
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		4e-14
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-14
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-14
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		4e-14
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		4e-14
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		4e-14
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		4e-14
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		5e-14
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		5e-14
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		5e-14
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		5e-14
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		5e-14
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		6e-14
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		6e-14
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		7e-14
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		7e-14
2oza_B	366	Structure Of P38alpha Complex Length = 366		8e-14
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		9e-14
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		9e-14
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		1e-13
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		1e-13
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-13
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		1e-13
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		1e-13
4gpm_A	169	Crystal Structure Of Engineered Protein. Northeast		1e-13
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		1e-13
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		1e-13
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		1e-13
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-13
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		1e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-13
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-13
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		1e-13
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		2e-13
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-13
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		2e-13
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-13
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-13
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		2e-13
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-13
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		2e-13
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		2e-13
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		2e-13
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		2e-13
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		2e-13
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		2e-13
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-13
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		2e-13
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-13
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		2e-13
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-13
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		3e-13
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		3e-13
4gmr_A	169	Crystal Structure Of Engineered Protein. Northeast		3e-13
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		3e-13
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		3e-13
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		3e-13
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		3e-13
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-13
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-13
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		3e-13
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-13
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-13
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		3e-13
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		3e-13
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		3e-13
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		3e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-13
1n0r_A	126	4ank: A Designed Ankyrin Repeat Protein With Four I		3e-13
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		3e-13
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		3e-13
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		3e-13
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-13
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		4e-13
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		4e-13
1n0q_A	93	3ank: A Designed Ankyrin Repeat Protein With Three		4e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		4e-13
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		4e-13
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		4e-13
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-13
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		5e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		5e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		5e-13
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-13
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		6e-13
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		6e-13
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		6e-13
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-13
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		7e-13
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		7e-13
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		7e-13
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		7e-13
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-13
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-13
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		8e-13
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		9e-13
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		1e-12
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-12
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-12
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		1e-12
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		1e-12
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		1e-12
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		1e-12
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		1e-12
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		1e-12
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-12
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-12
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-12
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		1e-12
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-12
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-12
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		1e-12
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-12
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-12
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-12
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		1e-12
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-12
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		1e-12
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-12
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-12
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-12
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-12
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		1e-12
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		1e-12
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		1e-12
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		1e-12
4dui_A	169	Darpin D1 Binding To Tubulin Beta Chain (not In Com		1e-12
4hb5_A	169	Crystal Structure Of Engineered Protein. Northeast		2e-12
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-12
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-12
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		2e-12
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		2e-12
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-12
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		2e-12
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		2e-12
2oza_A	356	Structure Of P38alpha Complex Length = 356		2e-12
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		2e-12
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		2e-12
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		2e-12
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		2e-12
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		2e-12
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		2e-12
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		2e-12
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		2e-12
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		2e-12
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		2e-12
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		2e-12
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		2e-12
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		2e-12
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-12
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		2e-12
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		2e-12
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-12
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		2e-12
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-12
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		2e-12
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		2e-12
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-12
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-12
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-12
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		2e-12
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		2e-12
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		2e-12
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		2e-12
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		2e-12
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		2e-12
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-12
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		2e-12
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-12
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-12
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		2e-12
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		2e-12
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-12
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		2e-12
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		2e-12
4drx_E	169	Gtp-Tubulin In Complex With A Darpin Length = 169		2e-12
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-12
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		3e-12
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		3e-12
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		3e-12
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-12
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		3e-12
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		3e-12
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		3e-12
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-12
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		3e-12
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		4e-12
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-12
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-12
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		4e-12
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		4e-12
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-12
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		4e-12
4atz_D	154	Ad5 Knob In Complex With A Designed Ankyrin Repeat		4e-12
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-12
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		4e-12
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		5e-12
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-12
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		5e-12
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		5e-12
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-12
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		6e-12
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		6e-12
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		6e-12
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		6e-12
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		6e-12
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		7e-12
2y0b_G	136	Caspase-3 In Complex With An Inhibitory Darpin-3.4_		7e-12
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		8e-12
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		9e-12
2l6b_A	115	Nrc Consensus Ankyrin Repeat Protein Solution Struc		9e-12
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		1e-11
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-11
1mj0_A	166	Sank E3_5: An Artificial Ankyrin Repeat Protein Len		1e-11
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-11
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		1e-11
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		2e-11
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-11
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		2e-11
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-11
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-11
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		2e-11
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		2e-11
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		2e-11
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		2e-11
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-11
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		2e-11
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-11
2xzd_G	136	Caspase-3 In Complex With An Inhibitory Darpin-3.4		3e-11
2xeh_A	157	Structural Determinants For Improved Thermal Stabil		3e-11
2xee_A	157	Structural Determinants For Improved Thermal Stabil		4e-11
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-11
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		6e-11
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		7e-11
2qyj_A	166	Crystal Structure Of A Designed Full Consensus Anky		7e-11
3zu7_B	169	Crystal Structure Of A Designed Selected Ankyrin Re		7e-11
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		7e-11
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		7e-11
3q9u_C	158	In Silico And In Vitro Co-Evolution Of A High Affin		8e-11
1svx_A	169	Crystal Structure Of A Designed Selected Ankyrin Re		9e-11
2bkg_A	166	Crystal Structure Of E3_19 An Designed Ankyrin Repe		1e-10
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		1e-10
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		1e-10
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		1e-10
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-10
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		1e-10
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-10
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-10
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-10
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-10
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-10
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-10
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-10
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-10
4f6r_D	169	Tubulin:stathmin-Like Domain Complex Length = 169		1e-10
2xzt_G	136	Caspase-3 In Complex With Darpin-3.4_i78s Length =		2e-10
2v4h_C	136	Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 13		2e-10
4fvp_A	289	Crystal Structure Of The Jak2 Pseudokinase Domain (		2e-10
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		3e-10
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-10

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  150 bits (379), Expect = 1e-36,   Method: Compositional matrix adjust.
 Identities = 97/256 (37%), Positives = 142/256 (55%), Gaps = 12/256 (4%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
           GT   A W G  VAVK L E+    + RV  F  E+A+++++RHPN+V F+GAVTQ   +
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109
Query: 226 MIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
            IVTEYL +G L   L + GA   L     +  A D+A+GMNYLH   P PI+HRDL+  
Sbjct: 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRDLKSP 168
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--RYVAPEVFKNEEYDTKVDVFSF 340
           N+L D    +KV DFG+S+L   K    L  +  +    ++APEV ++E  + K DV+SF
Sbjct: 169 NLLVDKKYTVKVCDFGLSRL---KASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSDVYSF 225
Query: 341 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
            +IL E+     P+   +  +V  A   + +   + P  L  + +  +IE CW  +P KR
Sbjct: 226 GVILWELATLQQPWGNLNPAQVVAAVGFKCK-RLEIPRNLNPQ-VAAIIEGCWTNEPWKR 283
Query: 401 PTFRQIITRLESINNS 416
           P+F  I+  L  +  S
Sbjct: 284 PSFATIMDLLRPLIKS 299

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score =  150 bits (378), Expect = 2e-36,   Method: Compositional matrix adjust.
 Identities = 96/256 (37%), Positives = 143/256 (55%), Gaps = 12/256 (4%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
           GT   A W G  VAVK L E+    + RV  F  E+A+++++RHPN+V F+GAVTQ   +
Sbjct: 51  GTVHRAEWHGSDVAVKILMEQDFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNL 109
Query: 226 MIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
            IVTEYL +G L   L + GA   L     +  A D+A+GMNYLH   P PI+HR+L+  
Sbjct: 110 SIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSP 168
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--RYVAPEVFKNEEYDTKVDVFSF 340
           N+L D    +KV DFG+S+L   K    L+ +  +    ++APEV ++E  + K DV+SF
Sbjct: 169 NLLVDKKYTVKVCDFGLSRL---KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSF 225
Query: 341 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
            +IL E+     P+   +  +V  A   + +   + P  L  + +  +IE CW  +P KR
Sbjct: 226 GVILWELATLQQPWGNLNPAQVVAAVGFKCK-RLEIPRNLNPQ-VAAIIEGCWTNEPWKR 283
Query: 401 PTFRQIITRLESINNS 416
           P+F  I+  L  +  S
Sbjct: 284 PSFATIMDLLRPLIKS 299

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 85/278 (30%), Positives = 145/278 (52%), Gaps = 22/278 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTFIL---AFWRGI-QVAVKKLGEEVISDDDRVRAFRDELA 202
           ++ IDP EL F    EI  G F L    +W    +VA+K + E  +S++D    F +E  
Sbjct: 2   KWVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAE 55
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 261
           ++ K+ HP +VQ  G   + +P+ +VTE++  G L  +L+ ++G     T +   LD+  
Sbjct: 56  VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
           GM YL E     +IHRDL   N L  ++  +KV+DFG+++ +   +    T      ++ 
Sbjct: 116 GMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 172
Query: 322 APEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPK--AYAARQRPPFKAPA 378
           +PEVF    Y +K DV+SF +++ E+  EG  P+  + ++EV +  +   R   P  A  
Sbjct: 173 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 232
Query: 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
            +Y     +++  CW E+P  RP F +++ +L  I  S
Sbjct: 233 HVY-----QIMNHCWRERPEDRPAFSRLLRQLAEIAES 265

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score =  135 bits (339), Expect = 6e-32,   Method: Compositional matrix adjust.
 Identities = 85/275 (30%), Positives = 142/275 (51%), Gaps = 22/275 (8%)
Query: 150 IDPHELDFTNSVEITKGTFIL---AFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP EL F    EI  G F L    +W    +VA+K + E  +S+DD    F +E  ++ 
Sbjct: 24  IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSEDD----FIEEAEVMM 77
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
           K+ HP +VQ  G   + +P+ +V E++  G L  +L+ ++G     T +   LD+  GM 
Sbjct: 78  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 137
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
           YL E     +IHRDL   N L  ++  +KV+DFG+++ +   +    T      ++ +PE
Sbjct: 138 YLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 194
Query: 325 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLY 381
           VF    Y +K DV+SF +++ E+  EG  P+  + ++EV +  +   R   P  A   +Y
Sbjct: 195 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 254
Query: 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
                +++  CW E+P  RP F +++ +L  I  S
Sbjct: 255 -----QIMNHCWKERPEDRPAFSRLLRQLAEIAES 284

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score =  134 bits (338), Expect = 9e-32,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 143/275 (52%), Gaps = 22/275 (8%)
Query: 150 IDPHELDFTNSVEITKGTFIL---AFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP EL F    EI  G F L    +W    +VA+K + E  +S++D    F +E  ++ 
Sbjct: 4   IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMM 57
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
           K+ HP +VQ  G   + +P+ +V E++  G L  +L+ ++G     T +   LD+  GM 
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 117
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
           YL E     +IHRDL   N L  ++  +KV+DFG+++ +   +    T      ++ +PE
Sbjct: 118 YLEE---ASVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 174
Query: 325 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLY 381
           VF    Y +K DV+SF +++ E+  EG  P+  + ++EV +  +   R   P  A   +Y
Sbjct: 175 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 234
Query: 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
                +++  CW E+P  RP F +++ +L +I  S
Sbjct: 235 -----QIMNHCWKERPEDRPAFSRLLRQLAAIAAS 264

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/278 (30%), Positives = 144/278 (51%), Gaps = 22/278 (7%)
Query: 147 EYEIDPHELDFTNSVEITKGTFIL---AFWRGI-QVAVKKLGEEVISDDDRVRAFRDELA 202
           ++ IDP EL F    EI  G F L    +W    +VA+K + E  +S++D    F +E  
Sbjct: 4   KWVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAE 57
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 261
           ++ K+ HP +VQ  G   + +P+ +V E++  G L  +L+ ++G     T +   LD+  
Sbjct: 58  VMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 117
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
           GM YL E     +IHRDL   N L  ++  +KV+DFG+++ +   +    T      ++ 
Sbjct: 118 GMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWA 174
Query: 322 APEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPK--AYAARQRPPFKAPA 378
           +PEVF    Y +K DV+SF +++ E+  EG  P+  + ++EV +  +   R   P  A  
Sbjct: 175 SPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLAST 234
Query: 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
            +Y     +++  CW E+P  RP F +++ +L  I  S
Sbjct: 235 HVY-----QIMNHCWRERPEDRPAFSRLLRQLAEIAES 267

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 142/275 (51%), Gaps = 22/275 (8%)
Query: 150 IDPHELDFTNSVEITKGTFIL---AFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP EL F    EI  G F L    +W    +VA+K + E  +S++D    F +E  ++ 
Sbjct: 4   IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMM 57
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
           K+ HP +VQ  G   + +P+ +V E++  G L  +L+ ++G     T +   LD+  GM 
Sbjct: 58  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 117
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
           YL E     +IHRDL   N L  ++  +KV+DFG+++ +   +    T      ++ +PE
Sbjct: 118 YLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 174
Query: 325 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLY 381
           VF    Y +K DV+SF +++ E+  EG  P+  + ++EV +  +   R   P  A   +Y
Sbjct: 175 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 234
Query: 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
                +++  CW E+P  RP F +++ +L  I  S
Sbjct: 235 -----QIMNHCWKERPEDRPAFSRLLRQLAEIAES 264

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 84/275 (30%), Positives = 142/275 (51%), Gaps = 22/275 (8%)
Query: 150 IDPHELDFTNSVEITKGTFIL---AFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP EL F    EI  G F L    +W    +VA+K + E  +S++D    F +E  ++ 
Sbjct: 2   IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMM 55
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
           K+ HP +VQ  G   + +P+ +V E++  G L  +L+ ++G     T +   LD+  GM 
Sbjct: 56  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
           YL E     +IHRDL   N L  ++  +KV+DFG+++ +   +    T      ++ +PE
Sbjct: 116 YLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172
Query: 325 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLY 381
           VF    Y +K DV+SF +++ E+  EG  P+  + ++EV +  +   R   P  A   +Y
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRLASTHVY 232
Query: 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
                +++  CW E+P  RP F +++ +L  I  S
Sbjct: 233 -----QIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 139/261 (53%), Gaps = 21/261 (8%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   L  W+G   VAVK + E  +S+D+    F  E   + K+ HP +V+F G  ++  P
Sbjct: 22  GVVKLGKWKGQYDVAVKMIKEGSMSEDE----FFQEAQTMMKLSHPKLVKFYGVCSKEYP 77
Query: 225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           + IVTEY+  G L  +L+  G  L+PS  +    D+  GM +L  ++    IHRDL   N
Sbjct: 78  IYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARN 134
Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS--CRYVAPEVFKNEEYDTKVDVFSFA 341
            L D    +KV+DFG+++   V +D+ ++   T    ++ APEVF   +Y +K DV++F 
Sbjct: 135 CLVDRDLCVKVSDFGMTRY--VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFG 192
Query: 342 LILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPA 398
           +++ E+   G  P+ +  ++EV    +   R   P  A   +Y     +++  CW+E P 
Sbjct: 193 ILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLASDTIY-----QIMYSCWHELPE 247
Query: 399 KRPTFRQIITRLESINNSINH 419
           KRPTF+Q+++ +E +     H
Sbjct: 248 KRPTFQQLLSSIEPLREKDKH 268

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 22/261 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGFVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     T       R+ +PE     ++ +  
Sbjct: 175 ARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+S+ ++L E++  G  P+    + +V KA     R  PP   PA LY     +L+ +C
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY-----QLMLDC 286
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W +    RP F QI++ L+ +
Sbjct: 287 WQKDRNNRPKFEQIVSILDKL 307

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 22/261 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     T       R+ +PE     ++ +  
Sbjct: 175 ARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+S+ ++L E++  G  P+    + +V KA     R  PP   PA LY     +L+ +C
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY-----QLMLDC 286
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W +    RP F QI++ L+ +
Sbjct: 287 WQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 22/261 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 31  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 88
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 89  SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 145
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     T       R+ +PE     ++ +  
Sbjct: 146 ARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 202
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+S+ ++L E++  G  P+    + +V KA     R  PP   PA LY     +L+ +C
Sbjct: 203 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY-----QLMLDC 257
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W +    RP F QI++ L+ +
Sbjct: 258 WQKDRNNRPKFEQIVSILDKL 278

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 22/261 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 58  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 115
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 116 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 172
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     T       R+ +PE     ++ +  
Sbjct: 173 ARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 229
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+S+ ++L E++  G  P+    + +V KA     R  PP   PA LY     +L+ +C
Sbjct: 230 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY-----QLMLDC 284
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W +    RP F QI++ L+ +
Sbjct: 285 WQKDRNNRPKFEQIVSILDKL 305

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 22/261 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     T       R+ +PE     ++ +  
Sbjct: 175 ARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+S+ ++L E++  G  P+    + +V KA     R  PP   PA LY     +L+ +C
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY-----QLMLDC 286
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W +    RP F QI++ L+ +
Sbjct: 287 WQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 22/261 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     T       R+ +PE     ++ +  
Sbjct: 175 ARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+S+ ++L E++  G  P+    + +V KA     R  PP   PA LY     +L+ +C
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY-----QLMLDC 286
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W +    RP F QI++ L+ +
Sbjct: 287 WQKDRNNRPKFEQIVSILDKL 307

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 22/261 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 48  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 105
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 106 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 162
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     T       R+ +PE     ++ +  
Sbjct: 163 ARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 219
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+S+ ++L E++  G  P+    + +V KA     R  PP   PA LY     +L+ +C
Sbjct: 220 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY-----QLMLDC 274
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W +    RP F QI++ L+ +
Sbjct: 275 WQKDRNNRPKFEQIVSILDKL 295

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 22/261 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     T       R+ +PE     ++ +  
Sbjct: 175 ARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+S+ ++L E++  G  P+    + +V KA     R  PP   PA LY     +L+ +C
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY-----QLMLDC 286
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W +    RP F QI++ L+ +
Sbjct: 287 WQKDRNNRPKFEQIVSILDKL 307

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 137/263 (52%), Gaps = 32/263 (12%)
Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           I KG F   +L  +RG +VAVK      I +D   +AF  E +++ ++RH N+VQ LG +
Sbjct: 29  IGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 83
Query: 220 T-QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
             +   + IVTEY+ KG L  +L+ +G   L     ++F+LD+   M YL  N     +H
Sbjct: 84  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 140
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDT 333
           RDL   N+L  +    KV+DFG++K          + QDT     ++ APE  + +++ T
Sbjct: 141 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFST 193
Query: 334 KVDVFSFALILQEMIE-GCPPF-TMKHDNEVPKA-YAARQRPPFKAPAKLYARGLKELIE 390
           K DV+SF ++L E+   G  P+  +   + VP+     +   P   P  +Y     E+++
Sbjct: 194 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY-----EVMK 248
Query: 391 ECWNEKPAKRPTFRQIITRLESI 413
            CW+   A RP+F Q+  +LE I
Sbjct: 249 NCWHLDAAMRPSFLQLREQLEHI 271

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 137/263 (52%), Gaps = 32/263 (12%)
Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           I KG F   +L  +RG +VAVK      I +D   +AF  E +++ ++RH N+VQ LG +
Sbjct: 14  IGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 68
Query: 220 T-QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
             +   + IVTEY+ KG L  +L+ +G   L     ++F+LD+   M YL  N     +H
Sbjct: 69  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 125
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDT 333
           RDL   N+L  +    KV+DFG++K          + QDT     ++ APE  + +++ T
Sbjct: 126 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFST 178
Query: 334 KVDVFSFALILQEMIE-GCPPF-TMKHDNEVPKA-YAARQRPPFKAPAKLYARGLKELIE 390
           K DV+SF ++L E+   G  P+  +   + VP+     +   P   P  +Y     E+++
Sbjct: 179 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY-----EVMK 233
Query: 391 ECWNEKPAKRPTFRQIITRLESI 413
            CW+   A RP+F Q+  +LE I
Sbjct: 234 NCWHLDAAMRPSFLQLREQLEHI 256

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 137/263 (52%), Gaps = 32/263 (12%)
Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           I KG F   +L  +RG +VAVK      I +D   +AF  E +++ ++RH N+VQ LG +
Sbjct: 201 IGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 255
Query: 220 T-QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
             +   + IVTEY+ KG L  +L+ +G   L     ++F+LD+   M YL  N     +H
Sbjct: 256 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 312
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDT 333
           RDL   N+L  +    KV+DFG++K          + QDT     ++ APE  + +++ T
Sbjct: 313 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREKKFST 365
Query: 334 KVDVFSFALILQEMIE-GCPPF-TMKHDNEVPKA-YAARQRPPFKAPAKLYARGLKELIE 390
           K DV+SF ++L E+   G  P+  +   + VP+     +   P   P  +Y     ++++
Sbjct: 366 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY-----DVMK 420
Query: 391 ECWNEKPAKRPTFRQIITRLESI 413
            CW+   A RPTF Q+  +LE I
Sbjct: 421 NCWHLDAATRPTFLQLREQLEHI 443

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score =  124 bits (310), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 135/261 (51%), Gaps = 22/261 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG++++L   ED P     T       R+ +PE     ++ +  
Sbjct: 175 ARNILINSNLVCKVSDFGLARVL---EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+S+ ++L E++  G  P+    + +V KA     R  PP   PA LY     +L+ +C
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY-----QLMLDC 286
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W +    RP F QI++ L+ +
Sbjct: 287 WQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 134/261 (51%), Gaps = 22/261 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+ ++L   ED P     T       R+ +PE     ++ +  
Sbjct: 175 ARNILINSNLVCKVSDFGLGRVL---EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+S+ ++L E++  G  P+    + +V KA     R  PP   PA LY     +L+ +C
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY-----QLMLDC 286
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W +    RP F QI++ L+ +
Sbjct: 287 WQKDRNNRPKFEQIVSILDKL 307

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 135/263 (51%), Gaps = 32/263 (12%)
Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           I KG F   +L  +RG +VAVK      I +D   +AF  E +++ ++RH N+VQ LG +
Sbjct: 20  IGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVI 74
Query: 220 T-QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
             +   + IVTEY+ KG L  +L+ +G   L     ++F+LD+   M YL  N     +H
Sbjct: 75  VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVH 131
Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDT 333
           RDL   N+L  +    KV+DFG++K          + QDT     ++ APE  +   + T
Sbjct: 132 RDLAARNVLVSEDNVAKVSDFGLTK-------EASSTQDTGKLPVKWTAPEALREAAFST 184
Query: 334 KVDVFSFALILQEMIE-GCPPF-TMKHDNEVPKA-YAARQRPPFKAPAKLYARGLKELIE 390
           K DV+SF ++L E+   G  P+  +   + VP+     +   P   P  +Y     E+++
Sbjct: 185 KSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPAVY-----EVMK 239
Query: 391 ECWNEKPAKRPTFRQIITRLESI 413
            CW+   A RP+F Q+  +LE I
Sbjct: 240 NCWHLDAAMRPSFLQLREQLEHI 262

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score =  123 bits (309), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 91/278 (32%), Positives = 134/278 (48%), Gaps = 22/278 (7%)
Query: 149 EIDPHELDFTNSVEITK-GTFILAFWRGIQVAVKKLGEEVISD-DDRVRAFRDELALLQK 206
           EID  EL     + I   G    AFW G +VAVK    +   D    +   R E  L   
Sbjct: 3   EIDFAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAM 62
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++HPN++   G   +   + +V E+   G L   L  K  + P   V +A+ IARGMNYL
Sbjct: 63  LKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMNYL 121
Query: 267 HENKPVPIIHRDLEPSNIL------RDDSGN--LKVADFGVSKLLTVKEDRPLTCQDTSC 318
           H+   VPIIHRDL+ SNIL        D  N  LK+ DFG++     +E    T    + 
Sbjct: 122 HDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-----REWHRTTKMSAAG 176
Query: 319 RY--VAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQRPPFK 375
            Y  +APEV +   +    DV+S+ ++L E++ G  PF  +  + +  AY  A  +    
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPF--RGIDGLAVAYGVAMNKLALP 234
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
            P+        +L+E+CWN  P  RP+F  I+ +L +I
Sbjct: 235 IPSTC-PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI 271

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 134/261 (51%), Gaps = 22/261 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTE +  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     T       R+ +PE     ++ +  
Sbjct: 175 ARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+S+ ++L E++  G  P+    + +V KA     R  PP   PA LY     +L+ +C
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY-----QLMLDC 286
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W +    RP F QI++ L+ +
Sbjct: 287 WQKDRNNRPKFEQIVSILDKL 307

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 134/261 (51%), Gaps = 22/261 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 31  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 88
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTE +  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 89  SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLA 145
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     T       R+ +PE     ++ +  
Sbjct: 146 ARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 202
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+S+ ++L E++  G  P+    + +V KA     R  PP   PA LY     +L+ +C
Sbjct: 203 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY-----QLMLDC 257
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W +    RP F QI++ L+ +
Sbjct: 258 WQKDRNNRPKFEQIVSILDKL 278

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score =  121 bits (304), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 84/261 (32%), Positives = 134/261 (51%), Gaps = 22/261 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   + I VA+K L  +V   + + R F  E +++ +  HPN+++  G VT+
Sbjct: 60  EVCSGRLKLPSKKEISVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTK 117
Query: 222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTE +  G L +FL++  A       V     IA GM YL +   +  +HRDL 
Sbjct: 118 SKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGAVHRDLA 174
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     T       R+ +PE     ++ +  
Sbjct: 175 ARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSAS 231
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+S+ ++L E++  G  P+    + +V KA     R  PP   PA LY     +L+ +C
Sbjct: 232 DVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDCPAALY-----QLMLDC 286
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W +    RP F QI++ L+ +
Sbjct: 287 WQKDRNNRPKFEQIVSILDKL 307

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 135/270 (50%), Gaps = 22/270 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   +   R I VA+K L  +    D + R F  E +++ +  HPN++   G VT+
Sbjct: 29  EVCSGRLKVPGKREICVAIKTL--KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 86
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             P+MI+TEY+  G L AFL++  G       V     I  GM YL +   +  +HRDL 
Sbjct: 87  CKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSYVHRDLA 143
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     T       R+ APE     ++ +  
Sbjct: 144 ARNILVNSNLVCKVSDFGMSRVL---EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 200
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEEC 392
           DV+S+ +++ E++  G  P+    + +V KA     R  PP   P  L+     +L+ +C
Sbjct: 201 DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALH-----QLMLDC 255
Query: 393 WNEKPAKRPTFRQIITRLESINNSINHKRR 422
           W ++ + RP F QI+  L+ +  + N  +R
Sbjct: 256 WQKERSDRPKFGQIVNMLDKLIRNPNSLKR 285

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 135/270 (50%), Gaps = 22/270 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   +   R I VA+K L  +    D + R F  E +++ +  HPN++   G VT+
Sbjct: 23  EVCSGRLKVPGKREICVAIKTL--KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 80
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             P+MI+TEY+  G L AFL++  G       V     I  GM YL +   +  +HRDL 
Sbjct: 81  CKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSYVHRDLA 137
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     T       R+ APE     ++ +  
Sbjct: 138 ARNILVNSNLVCKVSDFGMSRVL---EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 194
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+S+ +++ E++  G  P+    + +V KA     R  PP   P  L+     +L+ +C
Sbjct: 195 DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALH-----QLMLDC 249
Query: 393 WNEKPAKRPTFRQIITRLESINNSINHKRR 422
           W ++ + RP F QI+  L+ +  + N  +R
Sbjct: 250 WQKERSDRPKFGQIVNMLDKLIRNPNSLKR 279

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 135/270 (50%), Gaps = 22/270 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   +   R I VA+K L  +    D + R F  E +++ +  HPN++   G VT+
Sbjct: 44  EVCSGRLKVPGKREICVAIKTL--KAGYTDKQRRDFLSEASIMGQFDHPNIIHLEGVVTK 101
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             P+MI+TEY+  G L AFL++  G       V     I  GM YL +   +  +HRDL 
Sbjct: 102 CKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLSD---MSAVHRDLA 158
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     T       R+ APE     ++ +  
Sbjct: 159 ARNILVNSNLVCKVSDFGMSRVL---EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSAS 215
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+S+ +++ E++  G  P+    + +V KA     R  PP   P  L+     +L+ +C
Sbjct: 216 DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLPPPMDCPIALH-----QLMLDC 270
Query: 393 WNEKPAKRPTFRQIITRLESINNSINHKRR 422
           W ++ + RP F QI+  L+ +  + N  +R
Sbjct: 271 WQKERSDRPKFGQIVNMLDKLIRNPNSLKR 300

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 87/264 (32%), Positives = 137/264 (51%), Gaps = 18/264 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   R + VA+K L  +V   + + R F  E +++ +  HPNVV   G VT+
Sbjct: 58  EVCSGRLKLPGKRDVAVAIKTL--KVGYTEKQRRDFLCEASIMGQFDHPNVVHLEGVVTR 115
Query: 222 SSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             P+MIV E++  G L AFL K  G       V     IA GM YL +   +  +HRDL 
Sbjct: 116 GKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLAD---MGYVHRDLA 172
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S+++   ED P     T+      R+ APE  +  ++ +  
Sbjct: 173 ARNILVNSNLVCKVSDFGLSRVI---EDDPEAVYTTTGGKIPVRWTAPEAIQYRKFTSAS 229
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWN 394
           DV+S+ +++ E++  G  P+    + +V KA     R P  AP    A GL +L+ +CW 
Sbjct: 230 DVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEEGYRLP--APMDCPA-GLHQLMLDCWQ 286
Query: 395 EKPAKRPTFRQIITRLESINNSIN 418
           ++ A+RP F QI+  L+ +  + N
Sbjct: 287 KERAERPKFEQIVGILDKMIRNPN 310

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 132/261 (50%), Gaps = 22/261 (8%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   R + VA+K L  +V   + + R F  E +++ +  HPN++   G VT+
Sbjct: 37  EVCSGRLKLPGKRELPVAIKTL--KVGYTEKQRRDFLGEASIMGQFDHPNIIHLEGVVTK 94
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S P+MIVTEY+  G L  FLK+  G       V     I+ GM YL +   +  +HRDL 
Sbjct: 95  SKPVMIVTEYMENGSLDTFLKKNDGQFTVIQLVGMLRGISAGMKYLSD---MGYVHRDLA 151
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKV 335
             NIL + +   KV+DFG+S++L   ED P     T       R+ APE     ++ +  
Sbjct: 152 ARNILINSNLVCKVSDFGLSRVL---EDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTSAS 208
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+S+ +++ E++  G  P+    + +V KA     R   P   PA LY     +L+ +C
Sbjct: 209 DVWSYGIVMWEVVSYGERPYWEMTNQDVIKAVEEGYRLPSPMDCPAALY-----QLMLDC 263
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W ++   RP F +I+  L+ +
Sbjct: 264 WQKERNSRPKFDEIVNMLDKL 284

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/248 (32%), Positives = 122/248 (49%), Gaps = 20/248 (8%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
           G    A WR   VA+K+     I  +   +AF  EL  L ++ HPN+V+  GA    +P+
Sbjct: 22  GVVCKAKWRAKDVAIKQ-----IESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPV 74
Query: 226 MIVTEYLPKGDLRAFLKRKGALKPSTA---VRFALDIARGMNYLHENKPVPIIHRDLEPS 282
            +V EY   G L   L     L   TA   + + L  ++G+ YLH  +P  +IHRDL+P 
Sbjct: 75  CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP 134
Query: 283 NILRDDSGN-LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
           N+L    G  LK+ DFG +  +       +T    S  ++APEVF+   Y  K DVFS+ 
Sbjct: 135 NLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWG 190
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKELIEECWNEKPAK 399
           +IL E+I    PF           +A     RPP     K   + ++ L+  CW++ P++
Sbjct: 191 IILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL---IKNLPKPIESLMTRCWSKDPSQ 247
Query: 400 RPTFRQII 407
           RP+  +I+
Sbjct: 248 RPSMEEIV 255

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 80/248 (32%), Positives = 122/248 (49%), Gaps = 20/248 (8%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
           G    A WR   VA+K+     I  +   +AF  EL  L ++ HPN+V+  GA    +P+
Sbjct: 23  GVVCKAKWRAKDVAIKQ-----IESESERKAFIVELRQLSRVNHPNIVKLYGACL--NPV 75
Query: 226 MIVTEYLPKGDLRAFLKRKGALKPSTA---VRFALDIARGMNYLHENKPVPIIHRDLEPS 282
            +V EY   G L   L     L   TA   + + L  ++G+ YLH  +P  +IHRDL+P 
Sbjct: 76  CLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPP 135
Query: 283 NILRDDSGN-LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
           N+L    G  LK+ DFG +  +       +T    S  ++APEVF+   Y  K DVFS+ 
Sbjct: 136 NLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWG 191
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKELIEECWNEKPAK 399
           +IL E+I    PF           +A     RPP     K   + ++ L+  CW++ P++
Sbjct: 192 IILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL---IKNLPKPIESLMTRCWSKDPSQ 248
Query: 400 RPTFRQII 407
           RP+  +I+
Sbjct: 249 RPSMEEIV 256

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 86/258 (33%), Positives = 125/258 (48%), Gaps = 25/258 (9%)
Query: 166 GTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
           G   +  W+   + VAVK L E    D   V  F  E A++++I+HPN+VQ LG  T   
Sbjct: 46  GEVYVGVWKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTLEP 101
Query: 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAV---RFALDIARGMNYLHENKPVPIIHRDLE 280
           P  IVTEY+P G+L  +L R+   +  TAV     A  I+  M YL +      IHRDL 
Sbjct: 102 PFYIVTEYMPYGNLLDYL-RECNREEVTAVVLLYMATQISSAMEYLEKKN---FIHRDLA 157
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
             N L  ++  +KVADFG+S+L+T              ++ APE      +  K DV++F
Sbjct: 158 ARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAF 217
Query: 341 ALILQEM-IEGCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395
            ++L E+   G  P+     ++V     K Y  R   P   P K+Y     EL+  CW  
Sbjct: 218 GVLLWEIATYGMSPYPGIDLSQVYDLLEKGY--RMEQPEGCPPKVY-----ELMRACWKW 270
Query: 396 KPAKRPTFRQIITRLESI 413
            PA RP+F +     E++
Sbjct: 271 SPADRPSFAETHQAFETM 288

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 137/271 (50%), Gaps = 22/271 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF-ILAF--WRG-IQVAVKKLGEEVISDDDRVRAFRDELAL 203
           +EIDP +L F    E+  G F ++ +  WRG   VA+K + E  +S+D+    F +E  +
Sbjct: 19  WEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKV 72
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARG 262
           +  + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+   
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
           M YL   +    +HRDL   N L +D G +KV+DFG+S+ +   E+          R+  
Sbjct: 133 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSP 189
Query: 323 PEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAK 379
           PEV    ++ +K D+++F +++ E+   G  P+    ++E  +  A   R   P  A  K
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 249
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQIITRL 410
           +Y      ++  CW+EK  +RPTF+ +++ +
Sbjct: 250 VYT-----IMYSCWHEKADERPTFKILLSNI 275

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 86/269 (31%), Positives = 135/269 (50%), Gaps = 36/269 (13%)
Query: 171 AFWRGIQVAVKKLGEEVIS------DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
            F + I+V  ++ GE ++       D++  R F  E+ +++ + HPNV++F+G + +   
Sbjct: 22  CFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKR 81
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           +  +TEY+  G LR  +K   +  P S  V FA DIA GM YLH    + IIHRDL   N
Sbjct: 82  LNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHN 138
Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRP-----LTCQDTSCRY--------VAPEVFKNEE 330
            L  ++ N+ VADFG+++L+  ++ +P     L   D   RY        +APE+     
Sbjct: 139 CLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS 198
Query: 331 YDTKVDVFSFALILQEMIEGCP------PFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384
           YD KVDVFSF ++L E+I          P TM     V + +  R  PP   P   +   
Sbjct: 199 YDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNV-RGFLDRYCPP-NCPPSFFP-- 254
Query: 385 LKELIEECWNEKPAKRPTFRQIITRLESI 413
              +   C +  P KRP+F ++   LE++
Sbjct: 255 ---ITVRCCDLDPEKRPSFVKLEHWLETL 280

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 136/271 (50%), Gaps = 22/271 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF-ILAF--WRG-IQVAVKKLGEEVISDDDRVRAFRDELAL 203
           +EIDP +L F    E+  G F ++ +  WRG   VA+K + E  +S+D+    F +E  +
Sbjct: 3   WEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKV 56
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARG 262
           +  + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+   
Sbjct: 57  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 116
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
           M YL   +    +HRDL   N L +D G +KV+DFG+S+ +   E           R+  
Sbjct: 117 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 173
Query: 323 PEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAK 379
           PEV    ++ +K D+++F +++ E+   G  P+    ++E  +  A   R   P  A  K
Sbjct: 174 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 233
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQIITRL 410
           +Y      ++  CW+EK  +RPTF+ +++ +
Sbjct: 234 VYT-----IMYSCWHEKADERPTFKILLSNI 259

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 136/271 (50%), Gaps = 22/271 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF-ILAF--WRG-IQVAVKKLGEEVISDDDRVRAFRDELAL 203
           +EIDP +L F    E+  G F ++ +  WRG   VA+K + E  +S+D+    F +E  +
Sbjct: 4   WEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKV 57
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARG 262
           +  + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+   
Sbjct: 58  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 117
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
           M YL   +    +HRDL   N L +D G +KV+DFG+S+ +   E           R+  
Sbjct: 118 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 174
Query: 323 PEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAK 379
           PEV    ++ +K D+++F +++ E+   G  P+    ++E  +  A   R   P  A  K
Sbjct: 175 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 234
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQIITRL 410
           +Y      ++  CW+EK  +RPTF+ +++ +
Sbjct: 235 VYT-----IMYSCWHEKADERPTFKILLSNI 260

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 136/271 (50%), Gaps = 22/271 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF-ILAF--WRG-IQVAVKKLGEEVISDDDRVRAFRDELAL 203
           +EIDP +L F    E+  G F ++ +  WRG   VA+K + E  +S+D+    F +E  +
Sbjct: 10  WEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKV 63
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARG 262
           +  + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+   
Sbjct: 64  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 123
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
           M YL   +    +HRDL   N L +D G +KV+DFG+S+ +   E           R+  
Sbjct: 124 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 180
Query: 323 PEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAK 379
           PEV    ++ +K D+++F +++ E+   G  P+    ++E  +  A   R   P  A  K
Sbjct: 181 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 240
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQIITRL 410
           +Y      ++  CW+EK  +RPTF+ +++ +
Sbjct: 241 VYT-----IMYSCWHEKADERPTFKILLSNI 266

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score =  118 bits (295), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 136/271 (50%), Gaps = 22/271 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF-ILAF--WRG-IQVAVKKLGEEVISDDDRVRAFRDELAL 203
           +EIDP +L F    E+  G F ++ +  WRG   VA+K + E  +S+D+    F +E  +
Sbjct: 19  WEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKV 72
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARG 262
           +  + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+   
Sbjct: 73  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 132
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
           M YL   +    +HRDL   N L +D G +KV+DFG+S+ +   E           R+  
Sbjct: 133 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSP 189
Query: 323 PEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAK 379
           PEV    ++ +K D+++F +++ E+   G  P+    ++E  +  A   R   P  A  K
Sbjct: 190 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 249
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQIITRL 410
           +Y      ++  CW+EK  +RPTF+ +++ +
Sbjct: 250 VYT-----IMYSCWHEKADERPTFKILLSNI 275

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 77/271 (28%), Positives = 136/271 (50%), Gaps = 22/271 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTF-ILAF--WRG-IQVAVKKLGEEVISDDDRVRAFRDELAL 203
           +EIDP +L F    E+  G F ++ +  WRG   VA+K + E  +S+D+    F +E  +
Sbjct: 4   WEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKV 57
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARG 262
           +  + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+   
Sbjct: 58  MMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA 117
Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
           M YL   +    +HRDL   N L +D G +KV+DFG+S+ +   E           R+  
Sbjct: 118 MEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSP 174
Query: 323 PEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAK 379
           PEV    ++ +K D+++F +++ E+   G  P+    ++E  +  A   R   P  A  K
Sbjct: 175 PEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEK 234
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQIITRL 410
           +Y      ++  CW+EK  +RPTF+ +++ +
Sbjct: 235 VYT-----IMYSCWHEKADERPTFKILLSNI 260

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 145/288 (50%), Gaps = 23/288 (7%)
Query: 150 IDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQ 205
           +DP EL FT   +I KG+F   F +GI    +K+    I D    +D +   + E+ +L 
Sbjct: 3   LDPEEL-FTKLEKIGKGSFGEVF-KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           +   P V ++ G+  + + + I+ EYL  G     L+  G L  +       +I +G++Y
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDY 119
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
           LH  K    IHRD++ +N+L  + G +K+ADFGV+  LT  + +  T   T   ++APEV
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEV 175
Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385
            K   YD+K D++S  +   E+  G PP +  H  +V         P  +     Y++ L
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGN---YSKPL 232
Query: 386 KELIEECWNEKPAKRPTFRQIITRLESINNS---------INHKRRWK 424
           KE +E C N++P+ RPT ++++     + N+         I+  +RWK
Sbjct: 233 KEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWK 280

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 82/257 (31%), Positives = 127/257 (49%), Gaps = 36/257 (14%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           +  A+K++ E    DD R   F  EL +L K+  HPN++  LGA      + +  EY P 
Sbjct: 53  MDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 110
Query: 235 GDLRAFLKRKGALK--PSTAV--------------RFALDIARGMNYLHENKPVPIIHRD 278
           G+L  FL++   L+  P+ A+               FA D+ARGM+YL + +    IHRD
Sbjct: 111 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRD 167
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
           L   NIL  ++   K+ADFG+S+   V   +  T      R++A E      Y T  DV+
Sbjct: 168 LAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVW 225
Query: 339 SFALILQEMIE-GCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
           S+ ++L E++  G  P+      E    +P+ Y  R   P     ++Y     +L+ +CW
Sbjct: 226 SYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVY-----DLMRQCW 278
Query: 394 NEKPAKRPTFRQIITRL 410
            EKP +RP+F QI+  L
Sbjct: 279 REKPYERPSFAQILVSL 295

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 82/257 (31%), Positives = 127/257 (49%), Gaps = 36/257 (14%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           +  A+K++ E    DD R   F  EL +L K+  HPN++  LGA      + +  EY P 
Sbjct: 43  MDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 100
Query: 235 GDLRAFLKRKGALK--PSTAV--------------RFALDIARGMNYLHENKPVPIIHRD 278
           G+L  FL++   L+  P+ A+               FA D+ARGM+YL + +    IHRD
Sbjct: 101 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRD 157
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
           L   NIL  ++   K+ADFG+S+   V   +  T      R++A E      Y T  DV+
Sbjct: 158 LAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVW 215
Query: 339 SFALILQEMIE-GCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
           S+ ++L E++  G  P+      E    +P+ Y  R   P     ++Y     +L+ +CW
Sbjct: 216 SYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVY-----DLMRQCW 268
Query: 394 NEKPAKRPTFRQIITRL 410
            EKP +RP+F QI+  L
Sbjct: 269 REKPYERPSFAQILVSL 285

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 45  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 102
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM YL   K    +HRD
Sbjct: 103 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRD 157
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 158 LAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQKFTTKS 217
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 218 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 272
Query: 393 WNEKPAKRPTFRQIITRLESINNSI 417
           W+ K   RP+F ++++R+ +I ++ 
Sbjct: 273 WHPKAEMRPSFSELVSRISAIFSTF 297

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 41  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 98
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM YL   K    +HRD
Sbjct: 99  EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRD 153
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 154 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKS 213
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 214 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 268
Query: 393 WNEKPAKRPTFRQIITRLESINNSI 417
           W+ K   RP+F ++++R+ +I ++ 
Sbjct: 269 WHPKAEMRPSFSELVSRISAIFSTF 293

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 17  HKLGGGQFGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 67
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 68  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 128 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDY--RMERPEGCPEKVY-- 240
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 241 ---ELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 43  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 100
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM YL   K    +HRD
Sbjct: 101 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRD 155
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 156 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKS 215
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 216 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 270
Query: 393 WNEKPAKRPTFRQIITRLESINNSI 417
           W+ K   RP+F ++++R+ +I ++ 
Sbjct: 271 WHPKAEMRPSFSELVSRISAIFSTF 295

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/261 (31%), Positives = 131/261 (50%), Gaps = 22/261 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 64  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 121
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM YL   K    +HRD
Sbjct: 122 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRD 176
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 177 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKS 236
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 237 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 291
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+ K   RP+F ++++R+ +I
Sbjct: 292 WHPKAEMRPSFSELVSRISAI 312

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 44  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 101
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM YL   K    +HRD
Sbjct: 102 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRD 156
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 157 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKS 216
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 217 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 271
Query: 393 WNEKPAKRPTFRQIITRLESINNSI 417
           W+ K   RP+F ++++R+ +I ++ 
Sbjct: 272 WHPKAEMRPSFSELVSRISAIFSTF 296

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 22  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 76
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 77  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 133
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
           NIL  D+ + K+ADFG+++L+   ED   T ++ +    ++ APE      +  K DV+S
Sbjct: 134 NILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 190
Query: 340 FALILQEMI-EGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEK 396
           F ++L E++  G  P+    + EV +      R   P   P +LY     +L+  CW E+
Sbjct: 191 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY-----QLMRLCWKER 245
Query: 397 PAKRPTFRQIITRLE 411
           P  RPTF  + + LE
Sbjct: 246 PEDRPTFDYLRSVLE 260

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 46  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 103
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM YL   K    +HRD
Sbjct: 104 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRD 158
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 159 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKS 218
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 219 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 273
Query: 393 WNEKPAKRPTFRQIITRLESINNSI 417
           W+ K   RP+F ++++R+ +I ++ 
Sbjct: 274 WHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 86/276 (31%), Positives = 140/276 (50%), Gaps = 26/276 (9%)
Query: 146 PEYEIDPHELDFTNSVEITK-GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELAL 203
           PE+E+    L     +   + G   + ++ G  +VAVK L +  +S D    AF  E  L
Sbjct: 2   PEWEVPRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANL 57
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIAR 261
           +++++H  +V+    VTQ  P+ I+TEY+  G L  FLK    +K +    +  A  IA 
Sbjct: 58  MKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAE 116
Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---C 318
           GM ++ E      IHR+L  +NIL  D+ + K+ADFG+++L+   ED   T ++ +    
Sbjct: 117 GMAFIEERN---YIHRNLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPI 170
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAY--AARQRPPFK 375
           ++ APE      +  K DV+SF ++L E++  G  P+    + EV +      R   P  
Sbjct: 171 KWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDN 230
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
            P +LY     +L+  CW E+P  RPTF  + + LE
Sbjct: 231 CPEELY-----QLMRLCWKERPEDRPTFDYLRSVLE 261

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 45  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 102
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM YL   K    +HRD
Sbjct: 103 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRD 157
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 158 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKS 217
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 218 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 272
Query: 393 WNEKPAKRPTFRQIITRLESINNSI 417
           W+ K   RP+F ++++R+ +I ++ 
Sbjct: 273 WHPKAEMRPSFSELVSRISAIFSTF 297

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 17  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 67
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 68  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 128 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAY 184
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDY--RMERPEGCPEKVY-- 240
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 241 ---ELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 65  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 122
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM YL   K    +HRD
Sbjct: 123 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRD 177
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 178 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKS 237
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 238 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 292
Query: 393 WNEKPAKRPTFRQIITRLESINNSI 417
           W+ K   RP+F ++++R+ +I ++ 
Sbjct: 293 WHPKAEMRPSFSELVSRISAIFSTF 317

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 81
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 138
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
           NIL  D+ + K+ADFG+++L+   ED   T ++ +    ++ APE      +  K DV+S
Sbjct: 139 NILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 340 FALILQEMI-EGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEK 396
           F ++L E++  G  P+    + EV +      R   P   P +LY     +L+  CW E+
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY-----QLMRLCWKER 250
Query: 397 PAKRPTFRQIITRLE 411
           P  RPTF  + + LE
Sbjct: 251 PEDRPTFDYLRSVLE 265

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 46  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 103
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM YL   K    +HRD
Sbjct: 104 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRD 158
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 159 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKS 218
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 219 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 273
Query: 393 WNEKPAKRPTFRQIITRLESINNSI 417
           W+ K   RP+F ++++R+ +I ++ 
Sbjct: 274 WHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 115/239 (48%), Gaps = 28/239 (11%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL--------------- 241
           FR E  L  +++HPNVV  LG VT+  P+ ++  Y   GDL  FL               
Sbjct: 59  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 118
Query: 242 -KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
              K AL+P   V     IA GM YL  +    ++H+DL   N+L  D  N+K++D G+ 
Sbjct: 119 RTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLF 175
Query: 301 KLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKH 358
           + +   +   L        R++APE     ++    D++S+ ++L E+   G  P+    
Sbjct: 176 REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 235
Query: 359 DNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
           + +V +    RQ  P     PA +YA     L+ ECWNE P++RP F+ I +RL +  N
Sbjct: 236 NQDVVEMIRNRQVLPCPDDCPAWVYA-----LMIECWNEFPSRRPRFKDIHSRLRAWGN 289

>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 74/239 (30%), Positives = 115/239 (48%), Gaps = 28/239 (11%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL--------------- 241
           FR E  L  +++HPNVV  LG VT+  P+ ++  Y   GDL  FL               
Sbjct: 76  FRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDD 135
Query: 242 -KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
              K AL+P   V     IA GM YL  +    ++H+DL   N+L  D  N+K++D G+ 
Sbjct: 136 RTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLF 192
Query: 301 KLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKH 358
           + +   +   L        R++APE     ++    D++S+ ++L E+   G  P+    
Sbjct: 193 REVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252
Query: 359 DNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
           + +V +    RQ  P     PA +YA     L+ ECWNE P++RP F+ I +RL +  N
Sbjct: 253 NQDVVEMIRNRQVLPCPDDCPAWVYA-----LMIECWNEFPSRRPRFKDIHSRLRAWGN 306

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/265 (31%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 38  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 95
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM YL   K    +HRD
Sbjct: 96  EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRD 150
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 151 LAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKS 210
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 211 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 265
Query: 393 WNEKPAKRPTFRQIITRLESINNSI 417
           W+ K   RP+F ++++R+ +I ++ 
Sbjct: 266 WHPKAEMRPSFSELVSRISAIFSTF 290

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 32  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 86
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 87  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 143
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
           NIL  D+ + K+ADFG+++L+   ED   T ++ +    ++ APE      +  K DV+S
Sbjct: 144 NILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 200
Query: 340 FALILQEMI-EGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEK 396
           F ++L E++  G  P+    + EV +      R   P   P +LY     +L+  CW E+
Sbjct: 201 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY-----QLMRLCWKER 255
Query: 397 PAKRPTFRQIITRLE 411
           P  RPTF  + + LE
Sbjct: 256 PEDRPTFDYLRSVLE 270

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 81
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 138
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
           NIL  D+ + K+ADFG+++L+   ED   T ++ +    ++ APE      +  K DV+S
Sbjct: 139 NILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 340 FALILQEMI-EGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEK 396
           F ++L E++  G  P+    + EV +      R   P   P +LY     +L+  CW E+
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY-----QLMRLCWKER 250
Query: 397 PAKRPTFRQIITRLE 411
           P  RPTF  + + LE
Sbjct: 251 PEDRPTFDYLRSVLE 265

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 19  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 69
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 242
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 243 ---ELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 37  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 91
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 92  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 148
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
           NIL  D+ + K+ADFG+++L+   ED   T ++ +    ++ APE      +  K DV+S
Sbjct: 149 NILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 205
Query: 340 FALILQEMI-EGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEK 396
           F ++L E++  G  P+    + EV +      R   P   P +LY     +L+  CW E+
Sbjct: 206 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY-----QLMRLCWKER 260
Query: 397 PAKRPTFRQIITRLE 411
           P  RPTF  + + LE
Sbjct: 261 PEDRPTFDYLRSVLE 275

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 84/270 (31%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 19  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 69
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 242
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 243 ---ELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 28  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 83  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 139
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
           NIL  D+ + K+ADFG+++L+   ED   T ++ +    ++ APE      +  K DV+S
Sbjct: 140 NILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 196
Query: 340 FALILQEMI-EGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEK 396
           F ++L E++  G  P+    + EV +      R   P   P +LY     +L+  CW E+
Sbjct: 197 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY-----QLMRLCWKER 251
Query: 397 PAKRPTFRQIITRLE 411
           P  RPTF  + + LE
Sbjct: 252 PEDRPTFDYLRSVLE 266

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 131/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E+ +     V  F  E A++++I+HP
Sbjct: 24  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 74
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 134
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 135 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 247
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 248 ---ELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 33  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 87
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 144
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
           NIL  D+ + K+ADFG+++L+   ED   T ++ +    ++ APE      +  K DV+S
Sbjct: 145 NILVSDTLSCKIADFGLARLI---EDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 340 FALILQEMI-EGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEK 396
           F ++L E++  G  P+    + EV +      R   P   P +LY     +L+  CW E+
Sbjct: 202 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY-----QLMRLCWKER 256
Query: 397 PAKRPTFRQIITRLE 411
           P  RPTF  + + LE
Sbjct: 257 PEDRPTFDYLRSVLE 271

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 76/269 (28%), Positives = 134/269 (49%), Gaps = 22/269 (8%)
Query: 150 IDPHELDFTNSVEITKGTF-ILAF--WRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP +L F    E+  G F ++ +  WRG   VA+K + E  +S+D+    F +E  ++ 
Sbjct: 1   IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMN 264
            + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+   M 
Sbjct: 55  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
           YL   +    +HRDL   N L +D G +KV+DFG+S+ +   E           R+  PE
Sbjct: 115 YLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171
Query: 325 VFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLY 381
           V    ++ +K D+++F +++ E+   G  P+    ++E  +  A   R   P  A  K+Y
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHLASEKVY 231
Query: 382 ARGLKELIEECWNEKPAKRPTFRQIITRL 410
                 ++  CW+EK  +RPTF+ +++ +
Sbjct: 232 T-----IMYSCWHEKADERPTFKILLSNI 255

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 79/247 (31%), Positives = 127/247 (51%), Gaps = 22/247 (8%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           + VA+K L +   ++  RV  F  E  ++ +  H N+++  G +++  PMMI+TEY+  G
Sbjct: 74  VPVAIKTL-KAGYTEKQRVD-FLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENG 131
Query: 236 DLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  FL+ K G       V     IA GM YL     +  +HRDL   NIL + +   KV
Sbjct: 132 ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKV 188
Query: 295 ADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKVDVFSFALILQE-MI 348
           +DFG+S++L   ED P     TS      R+ APE     ++ +  DV+SF +++ E M 
Sbjct: 189 SDFGLSRVL---EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMT 245
Query: 349 EGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
            G  P+    ++EV KA     R   P   P+ +Y     +L+ +CW ++ A+RP F  I
Sbjct: 246 YGERPYWELSNHEVMKAINDGFRLPTPMDCPSAIY-----QLMMQCWQQERARRPKFADI 300
Query: 407 ITRLESI 413
           ++ L+ +
Sbjct: 301 VSILDKL 307

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 78/260 (30%), Positives = 128/260 (49%), Gaps = 18/260 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   R I VA+K L       + + R F  E +++ +  HPNV+   G VT+
Sbjct: 48  EVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 105
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S+P+MI+TE++  G L +FL++  G       V     IA GM YL +   +  +HRDL 
Sbjct: 106 STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLA 162
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS----CRYVAPEVFKNEEYDTKVD 336
             NIL + +   KV+DFG+S+ L      P            R+ APE  +  ++ +  D
Sbjct: 163 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASD 222
Query: 337 VFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECW 393
           V+S+ +++ E++  G  P+    + +V  A     R  PP   P+ L+     +L+ +CW
Sbjct: 223 VWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH-----QLMLDCW 277
Query: 394 NEKPAKRPTFRQIITRLESI 413
            +    RP F QI+  L+ +
Sbjct: 278 QKDRNHRPKFGQIVNTLDKM 297

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 29  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 83
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 84  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 140
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
           NIL  D+ + K+ADFG+++L+   ED   T ++ +    ++ APE      +  K DV+S
Sbjct: 141 NILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 197
Query: 340 FALILQEMI-EGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEK 396
           F ++L E++  G  P+    + EV +      R   P   P +LY     +L+  CW E+
Sbjct: 198 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY-----QLMRLCWKER 252
Query: 397 PAKRPTFRQIITRLE 411
           P  RPTF  + + LE
Sbjct: 253 PEDRPTFDYLRSVLE 267

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  115 bits (287), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 81
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 138
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
           NIL  D+ + K+ADFG+++L+   ED   T ++ +    ++ APE      +  K DV+S
Sbjct: 139 NILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 340 FALILQEMI-EGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEK 396
           F ++L E++  G  P+    + EV +      R   P   P +LY     +L+  CW E+
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY-----QLMRLCWKER 250
Query: 397 PAKRPTFRQIITRLE 411
           P  RPTF  + + LE
Sbjct: 251 PEDRPTFDYLRSVLE 265

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 35  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 89
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 90  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 146
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
           NIL  D+ + K+ADFG+++L+   ED   T ++ +    ++ APE      +  K DV+S
Sbjct: 147 NILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 203
Query: 340 FALILQEMI-EGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEK 396
           F ++L E++  G  P+    + EV +      R   P   P +LY     +L+  CW E+
Sbjct: 204 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY-----QLMRLCWKER 258
Query: 397 PAKRPTFRQIITRLE 411
           P  RPTF  + + LE
Sbjct: 259 PEDRPTFDYLRSVLE 273

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 127/257 (49%), Gaps = 36/257 (14%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           +  A+K++ E    DD R   F  EL +L K+  HPN++  LGA      + +  EY P 
Sbjct: 50  MDAAIKRMKEYASKDDHR--DFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 107
Query: 235 GDLRAFLKRKGALK--PSTAV--------------RFALDIARGMNYLHENKPVPIIHRD 278
           G+L  FL++   L+  P+ A+               FA D+ARGM+YL + +    IHR+
Sbjct: 108 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRN 164
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
           L   NIL  ++   K+ADFG+S+   V   +  T      R++A E      Y T  DV+
Sbjct: 165 LAARNILVGENYVAKIADFGLSRGQEVYVKK--TMGRLPVRWMAIESLNYSVYTTNSDVW 222
Query: 339 SFALILQEMIE-GCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
           S+ ++L E++  G  P+      E    +P+ Y  R   P     ++Y     +L+ +CW
Sbjct: 223 SYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY--RLEKPLNCDDEVY-----DLMRQCW 275
Query: 394 NEKPAKRPTFRQIITRL 410
            EKP +RP+F QI+  L
Sbjct: 276 REKPYERPSFAQILVSL 292

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 144/288 (50%), Gaps = 23/288 (7%)
Query: 150 IDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQ 205
           +DP EL FT   +I KG+F   F +GI    +K+    I D    +D +   + E+ +L 
Sbjct: 3   LDPEEL-FTKLEKIGKGSFGEVF-KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 60
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           +   P V ++ G+  + + + I+ EYL  G     L+  G L  +       +I +G++Y
Sbjct: 61  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDY 119
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
           LH  K    IHRD++ +N+L  + G +K+ADFGV+  LT  + +      T   ++APEV
Sbjct: 120 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPF-WMAPEV 175
Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385
            K   YD+K D++S  +   E+  G PP +  H  +V         P  +     Y++ L
Sbjct: 176 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGN---YSKPL 232
Query: 386 KELIEECWNEKPAKRPTFRQIITRLESINNS---------INHKRRWK 424
           KE +E C N++P+ RPT ++++     + N+         I+  +RWK
Sbjct: 233 KEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWK 280

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 33  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 87
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 88  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 144
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
           NIL  D+ + K+ADFG+++L+   ED   T ++ +    ++ APE      +  K DV+S
Sbjct: 145 NILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 340 FALILQEMI-EGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEK 396
           F ++L E++  G  P+    + EV +      R   P   P +LY     +L+  CW E+
Sbjct: 202 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY-----QLMRLCWKER 256
Query: 397 PAKRPTFRQIITRLE 411
           P  RPTF  + + LE
Sbjct: 257 PEDRPTFDYLRSVLE 271

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 86/284 (30%), Positives = 142/284 (50%), Gaps = 29/284 (10%)
Query: 152 PHELDFTNSVE-ITKGTFILAF--------WRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
           PHE   T+S   I KG F + +           IQ A+K L    I++  +V AF  E  
Sbjct: 17  PHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVEAFLREGL 74
Query: 203 LLQKIRHPNVVQFLGAVTQSSPM-MIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDI 259
           L++ + HPNV+  +G +     +  ++  Y+  GDL  F+ R     P+    + F L +
Sbjct: 75  LMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI-RSPQRNPTVKDLISFGLQV 133
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-- 317
           ARGM YL E K    +HRDL   N + D+S  +KVADFG+++ +  +E   +     +  
Sbjct: 134 ARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARL 190
Query: 318 -CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PP 373
             ++ A E  +   + TK DV+SF ++L E++  G PP+      ++    A  +R   P
Sbjct: 191 PVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQP 250
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
              P  LY     +++++CW   PA RPTFR ++  +E I +++
Sbjct: 251 EYCPDSLY-----QVMQQCWEADPAVRPTFRVLVGEVEQIVSAL 289

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 36  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 90
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 91  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 147
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
           NIL  D+ + K+ADFG+++L+   ED   T ++ +    ++ APE      +  K DV+S
Sbjct: 148 NILVSDTLSCKIADFGLARLI---EDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 204
Query: 340 FALILQEMI-EGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEK 396
           F ++L E++  G  P+    + EV +      R   P   P +LY     +L+  CW E+
Sbjct: 205 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY-----QLMRLCWKER 259
Query: 397 PAKRPTFRQIITRLE 411
           P  RPTF  + + LE
Sbjct: 260 PEDRPTFDYLRSVLE 274

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 83/255 (32%), Positives = 132/255 (51%), Gaps = 25/255 (9%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   + ++ G  +VAVK L +  +S D    AF  E  L+++++H  +V+    VTQ  P
Sbjct: 27  GEVWMGYYNGHTKVAVKSLKQGSMSPD----AFLAEANLMKQLQHQRLVRLYAVVTQE-P 81
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST--AVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + I+TEY+  G L  FLK    +K +    +  A  IA GM ++ E      IHRDL  +
Sbjct: 82  IYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAA 138
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFS 339
           NIL  D+ + K+ADFG+++L+   ED   T ++ +    ++ APE      +  K DV+S
Sbjct: 139 NILVSDTLSCKIADFGLARLI---EDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 340 FALILQEMI-EGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEK 396
           F ++L E++  G  P+    + EV +      R   P   P +LY     +L+  CW E+
Sbjct: 196 FGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRPDNCPEELY-----QLMRLCWKER 250
Query: 397 PAKRPTFRQIITRLE 411
           P  RPTF  + + LE
Sbjct: 251 PEDRPTFDYLRSVLE 265

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E+ +     V  F  E A++++I+HP
Sbjct: 24  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 74
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 135 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 191
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 247
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 248 ---ELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 21  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 71
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 132 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 188
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 244
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 245 ---ELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E+ +     V  F  E A++++I+HP
Sbjct: 21  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 71
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 132 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 188
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 244
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 245 ---ELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 129/270 (47%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 17  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 67
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+ E++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 68  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 127
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 128 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 184
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 185 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDPSQVYELLEKDY--RMERPEGCPEKVY-- 240
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 241 ---ELMRACWQWNPSDRPSFAEIHQAFETM 267

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 19  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 69
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 242
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 243 ---ELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 32  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 82
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 83  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 142
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 143 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 199
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 200 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 255
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 256 ---ELMRACWQWNPSDRPSFAEIHQAFETM 282

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/262 (30%), Positives = 136/262 (51%), Gaps = 14/262 (5%)
Query: 150 IDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQ 205
           +DP EL FT   +I KG+F   F +GI    +K+    I D    +D +   + E+ +L 
Sbjct: 23  MDPEEL-FTKLEKIGKGSFGEVF-KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLS 80
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           +   P V ++ G+  + + + I+ EYL  G     L+  G L  +       +I +G++Y
Sbjct: 81  QCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDY 139
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
           LH  K    IHRD++ +N+L  + G +K+ADFGV+  LT  + +  T   T   ++APEV
Sbjct: 140 LHSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPF-WMAPEV 195
Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385
            K   YD+K D++S  +   E+  G PP +  H  +V         P  +     Y++ L
Sbjct: 196 IKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGN---YSKPL 252
Query: 386 KELIEECWNEKPAKRPTFRQII 407
           KE +E C N++P+ RPT ++++
Sbjct: 253 KEFVEACLNKEPSFRPTAKELL 274

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E+ +     V  F  E A++++I+HP
Sbjct: 24  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 74
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 135 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 247
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 248 ---ELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 19  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 69
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 70  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 129
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 329 EEYDTKVDVFSFALILQEM-IEGCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 242
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 243 ---ELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E+ +     V  F  E A++++I+HP
Sbjct: 23  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 73
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 74  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 133
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 134 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 190
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 246
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 247 ---ELMRACWQWNPSDRPSFAEIHQAFETM 273

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 85/287 (29%), Positives = 143/287 (49%), Gaps = 23/287 (8%)
Query: 151 DPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISD----DDRVRAFRDELALLQK 206
           DP EL FT   +I KG+F   F +GI    +K+    I D    +D +   + E+ +L +
Sbjct: 19  DPEEL-FTKLEKIGKGSFGEVF-KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQ 76
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
              P V ++ G+  + + + I+ EYL  G     L+  G L  +       +I +G++YL
Sbjct: 77  CDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYL 135
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
           H  K    IHRD++ +N+L  + G +K+ADFGV+  LT  + +      T   ++APEV 
Sbjct: 136 HSEKK---IHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPF-WMAPEVI 191
Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386
           K   YD+K D++S  +   E+  G PP +  H  +V         P  +     Y++ LK
Sbjct: 192 KQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGN---YSKPLK 248
Query: 387 ELIEECWNEKPAKRPTFRQIITRLESINNS---------INHKRRWK 424
           E +E C N++P+ RPT ++++     + N+         I+  +RWK
Sbjct: 249 EFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYLTELIDRYKRWK 295

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 131/261 (50%), Gaps = 22/261 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 51  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 108
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM +L   K    +HRD
Sbjct: 109 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRD 163
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 164 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 223
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 224 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 278
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+ K   RP+F ++++R+ +I
Sbjct: 279 WHPKAEMRPSFSELVSRISAI 299

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 21  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 71
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 72  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 131
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 132 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAY 188
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 189 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 244
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 245 ---ELMRACWQWNPSDRPSFAEIHQAFETM 271

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 131/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E+ +     V  F  E A++++I+HP
Sbjct: 24  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 74
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 75  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 135 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 329 EEYDTKVDVFSFALILQEM-IEGCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 247
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 248 ---ELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 131/261 (50%), Gaps = 22/261 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 44  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 101
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM +L   K    +HRD
Sbjct: 102 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRD 156
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 157 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 216
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 217 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 271
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+ K   RP+F ++++R+ +I
Sbjct: 272 WHPKAEMRPSFSELVSRISAI 292

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 130/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 20  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 70
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 71  NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 131 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAY 187
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 243
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 244 ---ELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 131/261 (50%), Gaps = 22/261 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 47  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 104
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM +L   K    +HRD
Sbjct: 105 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRD 159
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 160 LAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 219
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 220 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 274
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+ K   RP+F ++++R+ +I
Sbjct: 275 WHPKAEMRPSFSELVSRISAI 295

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/270 (30%), Positives = 131/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E+ +     V  F  E A++++I+HP
Sbjct: 226 HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 276
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 277 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 336
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHR+L   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 337 KN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 393
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 394 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 449
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 450 ---ELMRACWQWNPSDRPSFAEIHQAFETM 476

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 131/261 (50%), Gaps = 22/261 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 47  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 104
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM +L   K    +HRD
Sbjct: 105 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRD 159
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 160 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 219
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 220 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 274
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+ K   RP+F ++++R+ +I
Sbjct: 275 WHPKAEMRPSFSELVSRISAI 295

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/265 (30%), Positives = 133/265 (50%), Gaps = 22/265 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 46  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 103
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM +L   K    +HRD
Sbjct: 104 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRD 158
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 159 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 218
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 219 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 273
Query: 393 WNEKPAKRPTFRQIITRLESINNSI 417
           W+ K   RP+F ++++R+ +I ++ 
Sbjct: 274 WHPKAEMRPSFSELVSRISAIFSTF 298

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 131/261 (50%), Gaps = 22/261 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 46  VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 103
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM +L   K    +HRD
Sbjct: 104 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRD 158
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 159 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 218
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 219 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 273
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+ K   RP+F ++++R+ +I
Sbjct: 274 WHPKAEMRPSFSELVSRISAI 294

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/261 (31%), Positives = 131/261 (50%), Gaps = 22/261 (8%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS 222
           +  GT +    + I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S
Sbjct: 105 VYHGTLLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRS 162
Query: 223 --SPMMIVTEYLPKGDLRAFLKRKGALKPSTA--VRFALDIARGMNYLHENKPVPIIHRD 278
             SP+ +V  Y+  GDLR F+ R     P+    + F L +A+GM +L   K    +HRD
Sbjct: 163 EGSPL-VVLPYMKHGDLRNFI-RNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRD 217
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL---TCQDTSCRYVAPEVFKNEEYDTKV 335
           L   N + D+   +KVADFG+++ +  KE   +   T      +++A E  + +++ TK 
Sbjct: 218 LAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKS 277
Query: 336 DVFSFALILQE-MIEGCPPF--TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E M  G PP+      D  V      R   P   P  LY     E++ +C
Sbjct: 278 DVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKC 332
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+ K   RP+F ++++R+ +I
Sbjct: 333 WHPKAEMRPSFSELVSRISAI 353

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 129/270 (47%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 19  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 69
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+ E++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 70  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 242
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 243 ---ELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score =  113 bits (282), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 83/270 (30%), Positives = 129/270 (47%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 19  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 69
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV--RFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+ E++  G+L  +L+     + S  V    A  I+  M YL +
Sbjct: 70  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEK 129
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 130 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 186
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 187 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 242
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 243 ---ELMRACWQWNPSDRPSFAEIHQAFETM 269

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 127/260 (48%), Gaps = 18/260 (6%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+  G   L   R I VA+K L       + + R F  E +++ +  HPNV+   G VT+
Sbjct: 22  EVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNVIHLEGVVTK 79
Query: 222 SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           S+P+MI+TE++  G L +FL++  G       V     IA GM YL +   +  +HR L 
Sbjct: 80  STPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRALA 136
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS----CRYVAPEVFKNEEYDTKVD 336
             NIL + +   KV+DFG+S+ L      P            R+ APE  +  ++ +  D
Sbjct: 137 ARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASD 196
Query: 337 VFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECW 393
           V+S+ +++ E++  G  P+    + +V  A     R  PP   P+ L+     +L+ +CW
Sbjct: 197 VWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPPPMDCPSALH-----QLMLDCW 251
Query: 394 NEKPAKRPTFRQIITRLESI 413
            +    RP F QI+  L+ +
Sbjct: 252 QKDRNHRPKFGQIVNTLDKM 271

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 129/270 (47%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 20  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 70
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+ E++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 71  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 130
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 131 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAY 187
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 188 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 243
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 244 ---ELMRACWQWNPSDRPSFAEIHQAFETM 270

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 80/270 (29%), Positives = 131/270 (48%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E+ +     V  F  E A++++I+HP
Sbjct: 265 HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHP 315
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 316 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 375
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHR+L   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 376 KN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 432
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 433 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 488
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 489 ---ELMRACWQWNPSDRPSFAEIHQAFETM 515

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/248 (31%), Positives = 130/248 (52%), Gaps = 23/248 (9%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK L    +S    V+AF +E  L++ ++H  +V+    VT+  P+ I+TEY+ KG 
Sbjct: 39  KVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGS 94
Query: 237 LRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           L  FLK    G +     + F+  IA GM Y+        IHRDL  +N+L  +S   K+
Sbjct: 95  LLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKI 151
Query: 295 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
           ADFG+++++   ED   T ++ +    ++ APE      +  K DV+SF ++L E++  G
Sbjct: 152 ADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWSFGILLYEIVTYG 208
Query: 351 CPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
             P+  + + +V  A +   R P     P +LY     ++++ CW EK  +RPTF  + +
Sbjct: 209 KIPYPGRTNADVMTALSQGYRMPRVENCPDELY-----DIMKMCWKEKAEERPTFDYLQS 263
Query: 409 RLESINNS 416
            L+    +
Sbjct: 264 VLDDFYTA 271

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 81/270 (30%), Positives = 129/270 (47%), Gaps = 28/270 (10%)
Query: 153 HELDFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           H+L      E+ +G      W+   + VAVK L E    D   V  F  E A++++I+HP
Sbjct: 24  HKLGGGQYGEVYEGV-----WKKYSLTVAVKTLKE----DTMEVEEFLKEAAVMKEIKHP 74
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHE 268
           N+VQ LG  T+  P  I+ E++  G+L  +L+   +  +     +  A  I+  M YL +
Sbjct: 75  NLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEK 134
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                 IHRDL   N L  ++  +KVADFG+S+L+T              ++ APE    
Sbjct: 135 KN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 191
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV----PKAYAARQRPPFKAPAKLYAR 383
            ++  K DV++F ++L E+   G  P+     ++V     K Y  R   P   P K+Y  
Sbjct: 192 NKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY--RMERPEGCPEKVY-- 247
Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
              EL+  CW   P+ RP+F +I    E++
Sbjct: 248 ---ELMRACWQWNPSDRPSFAEIHQAFETM 274

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 139/295 (47%), Gaps = 24/295 (8%)
Query: 131 KPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQ-----VAVKKLGE 185
           +PL     V   R VP+ +   +  D     +I +G F   F   ++     VAVK    
Sbjct: 90  QPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-R 148
Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG 245
           E +  D + + F  E  +L++  HPN+V+ +G  TQ  P+ IV E +  GD   FL+ +G
Sbjct: 149 ETLPPDLKAK-FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG 207
Query: 246 A-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           A L+  T ++   D A GM YL E+K    IHRDL   N L  +   LK++DFG+S+   
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYL-ESKCC--IHRDLAARNCLVTEKNVLKISDFGMSR--- 261
Query: 305 VKEDRPLTCQDTSCR-----YVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKH 358
            +E   +       R     + APE      Y ++ DV+SF ++L E    G  P+    
Sbjct: 262 -EEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320
Query: 359 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           + +  +      R P     +L    +  L+E+CW  +P +RP+F  I   L+SI
Sbjct: 321 NQQTREFVEKGGRLPC---PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score =  111 bits (278), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 89/295 (30%), Positives = 139/295 (47%), Gaps = 24/295 (8%)
Query: 131 KPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQ-----VAVKKLGE 185
           +PL     V   R VP+ +   +  D     +I +G F   F   ++     VAVK    
Sbjct: 90  QPLTKKSGVVLHRAVPKDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSC-R 148
Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG 245
           E +  D + + F  E  +L++  HPN+V+ +G  TQ  P+ IV E +  GD   FL+ +G
Sbjct: 149 ETLPPDLKAK-FLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG 207
Query: 246 A-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           A L+  T ++   D A GM YL E+K    IHRDL   N L  +   LK++DFG+S+   
Sbjct: 208 ARLRVKTLLQMVGDAAAGMEYL-ESKCC--IHRDLAARNCLVTEKNVLKISDFGMSR--- 261
Query: 305 VKEDRPLTCQDTSCR-----YVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKH 358
            +E   +       R     + APE      Y ++ DV+SF ++L E    G  P+    
Sbjct: 262 -EEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLS 320
Query: 359 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           + +  +      R P     +L    +  L+E+CW  +P +RP+F  I   L+SI
Sbjct: 321 NQQTREFVEKGGRLPC---PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSI 372

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score =  111 bits (277), Expect = 8e-25,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 125/250 (50%), Gaps = 15/250 (6%)
Query: 166 GTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G   +  W G  +VA+K L    +S +    +F +E  +++K++H  +VQ L AV    P
Sbjct: 23  GEVWMGTWNGNTKVAIKTLKPGTMSPE----SFLEEAQIMKKLKHDKLVQ-LYAVVSEEP 77
Query: 225 MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + IVTEY+ KG L  FLK     ALK    V  A  +A GM Y+     +  IHRDL  +
Sbjct: 78  IYIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSA 134
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
           NIL  +    K+ADFG+++L+   E           ++ APE      +  K DV+SF +
Sbjct: 135 NILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGI 194
Query: 343 ILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           +L E++ +G  P+   ++ EV +      R P      +    L EL+  CW + P +RP
Sbjct: 195 LLTELVTKGRVPYPGMNNREVLEQVERGYRMPCPQDCPI---SLHELMIHCWKKDPEERP 251
Query: 402 TFRQIITRLE 411
           TF  + + LE
Sbjct: 252 TFEYLQSFLE 261

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  111 bits (277), Expect = 9e-25,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 123/250 (49%), Gaps = 24/250 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K+ H N+V+ +G   QS P  I+ E +  G
Sbjct: 76  LQVAVKTL-PEVCSEQDELD-FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGG 133
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 134 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 190
Query: 289 SGNLKVA---DFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
            G  +VA   DFG+++ +      R   C     +++ PE F    + +K D +SF ++L
Sbjct: 191 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 250
Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            E+   G  P+  K + EV +      R  PP   P  +Y      ++ +CW  +P  RP
Sbjct: 251 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRP 305
Query: 402 TFRQIITRLE 411
            F  I+ R+E
Sbjct: 306 NFAIILERIE 315

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  111 bits (277), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 123/250 (49%), Gaps = 24/250 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K+ H N+V+ +G   QS P  I+ E +  G
Sbjct: 62  LQVAVKTL-PEVCSEQDELD-FLMEALIISKLNHQNIVRCIGVSLQSLPRFILLELMAGG 119
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 120 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 176
Query: 289 SGNLKVA---DFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
            G  +VA   DFG+++ +      R   C     +++ PE F    + +K D +SF ++L
Sbjct: 177 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 236
Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            E+   G  P+  K + EV +      R  PP   P  +Y      ++ +CW  +P  RP
Sbjct: 237 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRP 291
Query: 402 TFRQIITRLE 411
            F  I+ R+E
Sbjct: 292 NFAIILERIE 301

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 132/265 (49%), Gaps = 18/265 (6%)
Query: 159 NSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
           +S E+  G   +   R + VA+K L  +    + + R F  E +++ +  HPN+++  G 
Sbjct: 61  DSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGV 118
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
           VT+    MIVTEY+  G L  FL+   G       V     +  GM YL +   +  +HR
Sbjct: 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHR 175
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYD 332
           DL   N+L D +   KV+DFG+S++L   ED P     T+      R+ APE      + 
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLSRVL---EDDPDAAXTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 333 TKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 391
           +  DV+SF +++ E++  G  P+    + +V  +     R P  AP       L +L+ +
Sbjct: 233 SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP--APMGC-PHALHQLMLD 289
Query: 392 CWNEKPAKRPTFRQIITRLESINNS 416
           CW++  A+RP F QI++ L+++  S
Sbjct: 290 CWHKDRAQRPRFSQIVSVLDALIRS 314

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 132/265 (49%), Gaps = 18/265 (6%)
Query: 159 NSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
           +S E+  G   +   R + VA+K L  +    + + R F  E +++ +  HPN+++  G 
Sbjct: 61  DSGEVCYGRLRVPGQRDVPVAIKAL--KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGV 118
Query: 219 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
           VT+    MIVTEY+  G L  FL+   G       V     +  GM YL +   +  +HR
Sbjct: 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHR 175
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYD 332
           DL   N+L D +   KV+DFG+S++L   ED P     T+      R+ APE      + 
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLSRVL---EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFS 232
Query: 333 TKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 391
           +  DV+SF +++ E++  G  P+    + +V  +     R P  AP       L +L+ +
Sbjct: 233 SASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP--APMGC-PHALHQLMLD 289
Query: 392 CWNEKPAKRPTFRQIITRLESINNS 416
           CW++  A+RP F QI++ L+++  S
Sbjct: 290 CWHKDRAQRPRFSQIVSVLDALIRS 314

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 122/250 (48%), Gaps = 24/250 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 76  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGG 133
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 134 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 190
Query: 289 SGNLKVA---DFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
            G  +VA   DFG+++ +      R   C     +++ PE F    + +K D +SF ++L
Sbjct: 191 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 250
Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            E+   G  P+  K + EV +      R  PP   P  +Y      ++ +CW  +P  RP
Sbjct: 251 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRP 305
Query: 402 TFRQIITRLE 411
            F  I+ R+E
Sbjct: 306 NFAIILERIE 315

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score =  110 bits (276), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 122/250 (48%), Gaps = 24/250 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 53  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 110
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 111 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 167
Query: 289 SGNLKVA---DFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
            G  +VA   DFG+++ +      R   C     +++ PE F    + +K D +SF ++L
Sbjct: 168 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 227
Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            E+   G  P+  K + EV +      R  PP   P  +Y      ++ +CW  +P  RP
Sbjct: 228 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRP 282
Query: 402 TFRQIITRLE 411
            F  I+ R+E
Sbjct: 283 NFAIILERIE 292

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 122/250 (48%), Gaps = 24/250 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 61  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGG 118
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 119 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 175
Query: 289 SGNLKVA---DFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
            G  +VA   DFG+++ +      R   C     +++ PE F    + +K D +SF ++L
Sbjct: 176 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235
Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            E+   G  P+  K + EV +      R  PP   P  +Y      ++ +CW  +P  RP
Sbjct: 236 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRP 290
Query: 402 TFRQIITRLE 411
            F  I+ R+E
Sbjct: 291 NFAIILERIE 300

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 122/250 (48%), Gaps = 24/250 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 62  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 119
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 120 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 176
Query: 289 SGNLKVA---DFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
            G  +VA   DFG+++ +      R   C     +++ PE F    + +K D +SF ++L
Sbjct: 177 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 236
Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            E+   G  P+  K + EV +      R  PP   P  +Y      ++ +CW  +P  RP
Sbjct: 237 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRP 291
Query: 402 TFRQIITRLE 411
            F  I+ R+E
Sbjct: 292 NFAIILERIE 301

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 122/250 (48%), Gaps = 24/250 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 78  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 135
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 136 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 192
Query: 289 SGNLKVA---DFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
            G  +VA   DFG+++ +      R   C     +++ PE F    + +K D +SF ++L
Sbjct: 193 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 252
Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            E+   G  P+  K + EV +      R  PP   P  +Y      ++ +CW  +P  RP
Sbjct: 253 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRP 307
Query: 402 TFRQIITRLE 411
            F  I+ R+E
Sbjct: 308 NFAIILERIE 317

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 122/250 (48%), Gaps = 24/250 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 88  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 145
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 146 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 202
Query: 289 SGNLKVA---DFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
            G  +VA   DFG+++ +      R   C     +++ PE F    + +K D +SF ++L
Sbjct: 203 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 262
Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            E+   G  P+  K + EV +      R  PP   P  +Y      ++ +CW  +P  RP
Sbjct: 263 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRP 317
Query: 402 TFRQIITRLE 411
            F  I+ R+E
Sbjct: 318 NFAIILERIE 327

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 122/250 (48%), Gaps = 24/250 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 61  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 118
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 119 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 175
Query: 289 SGNLKVA---DFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
            G  +VA   DFG+++ +      R   C     +++ PE F    + +K D +SF ++L
Sbjct: 176 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 235
Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            E+   G  P+  K + EV +      R  PP   P  +Y      ++ +CW  +P  RP
Sbjct: 236 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRP 290
Query: 402 TFRQIITRLE 411
            F  I+ R+E
Sbjct: 291 NFAIILERIE 300

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 122/250 (48%), Gaps = 24/250 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 68  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 125
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 126 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 182
Query: 289 SGNLKVA---DFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
            G  +VA   DFG+++ +      R   C     +++ PE F    + +K D +SF ++L
Sbjct: 183 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 242
Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            E+   G  P+  K + EV +      R  PP   P  +Y      ++ +CW  +P  RP
Sbjct: 243 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRP 297
Query: 402 TFRQIITRLE 411
            F  I+ R+E
Sbjct: 298 NFAIILERIE 307

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 122/250 (48%), Gaps = 24/250 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 76  LQVAVKTL-PEVYSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 133
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 134 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 190
Query: 289 SGNLKVA---DFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
            G  +VA   DFG+++ +      R   C     +++ PE F    + +K D +SF ++L
Sbjct: 191 PGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 250
Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            E+   G  P+  K + EV +      R  PP   P  +Y      ++ +CW  +P  RP
Sbjct: 251 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRP 305
Query: 402 TFRQIITRLE 411
            F  I+ R+E
Sbjct: 306 NFAIILERIE 315

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 122/250 (48%), Gaps = 24/250 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 62  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 119
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 120 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 176
Query: 289 SGNLKVA---DFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
            G  +VA   DFG+++ +      R   C     +++ PE F    + +K D +SF ++L
Sbjct: 177 PGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 236
Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            E+   G  P+  K + EV +      R  PP   P  +Y      ++ +CW  +P  RP
Sbjct: 237 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRP 291
Query: 402 TFRQIITRLE 411
            F  I+ R+E
Sbjct: 292 NFAIILERIE 301

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 122/250 (48%), Gaps = 24/250 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 79  LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 136
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 137 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 193
Query: 289 SGNLKVA---DFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
            G  +VA   DFG+++ +      R   C     +++ PE F    + +K D +SF ++L
Sbjct: 194 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 253
Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            E+   G  P+  K + EV +      R  PP   P  +Y      ++ +CW  +P  RP
Sbjct: 254 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRP 308
Query: 402 TFRQIITRLE 411
            F  I+ R+E
Sbjct: 309 NFAIILERIE 318

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 81/250 (32%), Positives = 122/250 (48%), Gaps = 24/250 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           +QVAVK L  EV S+ D +  F  E  ++ K  H N+V+ +G   QS P  I+ E +  G
Sbjct: 102 LQVAVKTL-PEVCSEQDELD-FLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGG 159
Query: 236 DLRAFLK--RKGALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           DL++FL+  R    +PS+      +  A DIA G  YL EN     IHRD+   N L   
Sbjct: 160 DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTC 216
Query: 289 SGNLKVA---DFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
            G  +VA   DFG+++ +      R   C     +++ PE F    + +K D +SF ++L
Sbjct: 217 PGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLL 276
Query: 345 QEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            E+   G  P+  K + EV +      R  PP   P  +Y      ++ +CW  +P  RP
Sbjct: 277 WEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRP 331
Query: 402 TFRQIITRLE 411
            F  I+ R+E
Sbjct: 332 NFAIILERIE 341

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 89/305 (29%), Positives = 147/305 (48%), Gaps = 30/305 (9%)
Query: 138 HVKHAREVPEYE---IDPHELDFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVI 188
           H   A +VP  +    DP EL FT    I KG+F   F +GI       VA+K +  ++ 
Sbjct: 4   HSPVAVQVPGMQNNIADPEEL-FTKLERIGKGSFGEVF-KGIDNRTQQVVAIKII--DLE 59
Query: 189 SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK 248
             +D +   + E+ +L +     V ++ G+  + S + I+ EYL  G     L R G   
Sbjct: 60  EAEDEIEDIQQEITVLSQCDSSYVTKYYGSYLKGSKLWIIMEYLGGGSALDLL-RAGPFD 118
Query: 249 PSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
                    +I +G++YLH  K    IHRD++ +N+L  + G++K+ADFGV+  LT  + 
Sbjct: 119 EFQIATMLKEILKGLDYLHSEKK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI 175
Query: 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA 368
           +  T   T   ++APEV +   YD+K D++S  +   E+ +G PP +  H   V      
Sbjct: 176 KRNTFVGTPF-WMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV-LFLIP 233
Query: 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS---------INH 419
           +  PP       + +  KE I+ C N+ P+ RPT ++++     + NS         I+ 
Sbjct: 234 KNNPP--TLVGDFTKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKNSKKTSYLTELIDR 291
Query: 420 KRRWK 424
            +RWK
Sbjct: 292 FKRWK 296

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 77/252 (30%), Positives = 131/252 (51%), Gaps = 28/252 (11%)
Query: 173 WRG-----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           W G      +VAVK L    +S    V+AF +E  L++ ++H  +V+    VT+  P+ I
Sbjct: 29  WMGYYNNSTKVAVKTLKPGTMS----VQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYI 84
Query: 228 VTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           +TE++ KG L  FLK    G +     + F+  IA GM Y+        IHRDL  +N+L
Sbjct: 85  ITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVL 141
Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFAL 342
             +S   K+ADFG+++++   ED   T ++ +    ++ APE      +  K +V+SF +
Sbjct: 142 VSESLMCKIADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWSFGI 198
Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKPAK 399
           +L E++  G  P+  + + +V  A +   R P     P +LY     ++++ CW EK  +
Sbjct: 199 LLYEIVTYGKIPYPGRTNADVMSALSQGYRMPRMENCPDELY-----DIMKMCWKEKAEE 253
Query: 400 RPTFRQIITRLE 411
           RPTF  + + L+
Sbjct: 254 RPTFDYLQSVLD 265

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score =  108 bits (271), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 121/251 (48%), Gaps = 37/251 (14%)
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPS 250
           A   EL +L  +  H N+V  LGA T   P +++TEY   GDL  FL+RK       K S
Sbjct: 88  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 147
Query: 251 TAV--------------RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
            A+               F+  +A+GM +L        IHRDL   NIL       K+ D
Sbjct: 148 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 204
Query: 297 FGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
           FG+++   +K D     +  +    +++APE   N  Y  + DV+S+ + L E+   G  
Sbjct: 205 FGLAR--DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 262
Query: 353 PF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409
           P+  M  D++  K      R   P  APA++Y     ++++ CW+  P KRPTF+QI+  
Sbjct: 263 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY-----DIMKTCWDADPLKRPTFKQIVQL 317
Query: 410 LE-SINNSINH 419
           +E  I+ S NH
Sbjct: 318 IEKQISESTNH 328

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 121/251 (48%), Gaps = 37/251 (14%)
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPS 250
           A   EL +L  +  H N+V  LGA T   P +++TEY   GDL  FL+RK       K S
Sbjct: 90  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 149
Query: 251 TAV--------------RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
            A+               F+  +A+GM +L        IHRDL   NIL       K+ D
Sbjct: 150 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 206
Query: 297 FGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
           FG+++   +K D     +  +    +++APE   N  Y  + DV+S+ + L E+   G  
Sbjct: 207 FGLAR--DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 264
Query: 353 PF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409
           P+  M  D++  K      R   P  APA++Y     ++++ CW+  P KRPTF+QI+  
Sbjct: 265 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY-----DIMKTCWDADPLKRPTFKQIVQL 319
Query: 410 LE-SINNSINH 419
           +E  I+ S NH
Sbjct: 320 IEKQISESTNH 330

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 121/251 (48%), Gaps = 37/251 (14%)
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPS 250
           A   EL +L  +  H N+V  LGA T   P +++TEY   GDL  FL+RK       K S
Sbjct: 72  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131
Query: 251 TAV--------------RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
            A+               F+  +A+GM +L        IHRDL   NIL       K+ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188
Query: 297 FGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
           FG+++   +K D     +  +    +++APE   N  Y  + DV+S+ + L E+   G  
Sbjct: 189 FGLAR--DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 246
Query: 353 PF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409
           P+  M  D++  K      R   P  APA++Y     ++++ CW+  P KRPTF+QI+  
Sbjct: 247 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY-----DIMKTCWDADPLKRPTFKQIVQL 301
Query: 410 LE-SINNSINH 419
           +E  I+ S NH
Sbjct: 302 IEKQISESTNH 312

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 84/290 (28%), Positives = 144/290 (49%), Gaps = 27/290 (9%)
Query: 150 IDPHELDFTNSVEITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELAL 203
           +DP EL FT    I KG+F    ++GI       VA+K +  ++   +D +   + E+ +
Sbjct: 15  VDPEEL-FTKLDRIGKGSF-GEVYKGIDNHTKEVVAIKII--DLEEAEDEIEDIQQEITV 70
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGM 263
           L +   P + ++ G+  +S+ + I+ EYL  G     LK  G L+ +       +I +G+
Sbjct: 71  LSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREILKGL 129
Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 323
           +YLH  +    IHRD++ +N+L  + G++K+ADFGV+  LT  + +      T   ++AP
Sbjct: 130 DYLHSERK---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPF-WMAP 185
Query: 324 EVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
           EV K   YD K D++S  +   E+ +G PP +  H   V         P  +     +++
Sbjct: 186 EVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQ---HSK 242
Query: 384 GLKELIEECWNEKPAKRPTFRQI-----ITRLES----INNSINHKRRWK 424
             KE +E C N+ P  RPT +++     ITR       +   I+  +RWK
Sbjct: 243 PFKEFVEACLNKDPRFRPTAKELLKHKFITRYTKKTSFLTELIDRYKRWK 292

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  108 bits (271), Expect = 5e-24,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 121/251 (48%), Gaps = 37/251 (14%)
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPS 250
           A   EL +L  +  H N+V  LGA T   P +++TEY   GDL  FL+RK       K S
Sbjct: 95  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 154
Query: 251 TAV--------------RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
            A+               F+  +A+GM +L        IHRDL   NIL       K+ D
Sbjct: 155 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 211
Query: 297 FGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
           FG+++   +K D     +  +    +++APE   N  Y  + DV+S+ + L E+   G  
Sbjct: 212 FGLAR--HIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 269
Query: 353 PF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409
           P+  M  D++  K      R   P  APA++Y     ++++ CW+  P KRPTF+QI+  
Sbjct: 270 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY-----DIMKTCWDADPLKRPTFKQIVQL 324
Query: 410 LE-SINNSINH 419
           +E  I+ S NH
Sbjct: 325 IEKQISESTNH 335

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score =  108 bits (270), Expect = 6e-24,   Method: Compositional matrix adjust.
 Identities = 80/251 (31%), Positives = 121/251 (48%), Gaps = 37/251 (14%)
Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPS 250
           A   EL +L  +  H N+V  LGA T   P +++TEY   GDL  FL+RK       K S
Sbjct: 95  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 154
Query: 251 TAV--------------RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
            A+               F+  +A+GM +L        IHRDL   NIL       K+ D
Sbjct: 155 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 211
Query: 297 FGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
           FG+++   +K D     +  +    +++APE   N  Y  + DV+S+ + L E+   G  
Sbjct: 212 FGLAR--DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSS 269
Query: 353 PF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR 409
           P+  M  D++  K      R   P  APA++Y     ++++ CW+  P KRPTF+QI+  
Sbjct: 270 PYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY-----DIMKTCWDADPLKRPTFKQIVQL 324
Query: 410 LE-SINNSINH 419
           +E  I+ S NH
Sbjct: 325 IEKQISESTNH 335

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score =  108 bits (270), Expect = 7e-24,   Method: Compositional matrix adjust.
 Identities = 81/283 (28%), Positives = 149/283 (52%), Gaps = 24/283 (8%)
Query: 148 YEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
           +EI+  E+    S  I  G+F   +   W G  VAVK L + V    ++ +AFR+E+A+L
Sbjct: 31  WEIEASEVML--STRIGSGSFGTVYKGKWHG-DVAVKIL-KVVDPTPEQFQAFRNEVAVL 86
Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGM 263
           +K RH N++ F+G +T+ + + IVT++     L   L  ++   +    +  A   A+GM
Sbjct: 87  RKTRHVNILLFMGYMTKDN-LAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGM 145
Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVA 322
           +YLH      IIHRD++ +NI   +   +K+ DFG++ + +         Q T S  ++A
Sbjct: 146 DYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMA 202
Query: 323 PEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-----VPKAYAARQRPPF 374
           PEV +   N  +  + DV+S+ ++L E++ G  P++  ++ +     V + YA+   P  
Sbjct: 203 PEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYAS---PDL 259
Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
               K   + +K L+ +C  +   +RP F QI++ +E + +S+
Sbjct: 260 SKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 134/266 (50%), Gaps = 24/266 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 244
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 245 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 301
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
             K DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ 
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMC 415
Query: 391 ECWNEKPAKRPTFRQIITRLESINNS 416
           +CW ++P +RPTF  +   LE    S
Sbjct: 416 QCWRKEPEERPTFEYLQAFLEDYFTS 441

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 134/266 (50%), Gaps = 24/266 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 244
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 245 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 301
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
             K DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ 
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMC 415
Query: 391 ECWNEKPAKRPTFRQIITRLESINNS 416
           +CW ++P +RPTF  +   LE    S
Sbjct: 416 QCWRKEPEERPTFEYLQAFLEDYFTS 441

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score =  107 bits (268), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 88/266 (33%), Positives = 133/266 (50%), Gaps = 24/266 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++KIRH  +VQ L
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKIRHEKLVQ-L 78
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 79  YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
             K DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ 
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMC 249
Query: 391 ECWNEKPAKRPTFRQIITRLESINNS 416
           +CW + P +RPTF  +   LE    S
Sbjct: 250 QCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 130/263 (49%), Gaps = 18/263 (6%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 14  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 68
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 69  YAVVSEEPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 125
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK 334
           +HRDL  +NIL  ++   KVADFG+++L+   E           ++ APE      +  K
Sbjct: 126 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 185
Query: 335 VDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
            DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ +CW
Sbjct: 186 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMCQCW 242
Query: 394 NEKPAKRPTFRQIITRLESINNS 416
            ++P +RPTF  +   LE    S
Sbjct: 243 RKEPEERPTFEYLQAFLEDYFTS 265

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 87/265 (32%), Positives = 136/265 (51%), Gaps = 32/265 (12%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 273 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 327
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 328 YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 384
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +
Sbjct: 385 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 441
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKLYARGLK 386
             K DV+SF ++L E+  +G  P+    + E    V + Y  R   P + P  L+     
Sbjct: 442 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGY--RMPCPPECPESLH----- 494
Query: 387 ELIEECWNEKPAKRPTFRQIITRLE 411
           +L+ +CW ++P +RPTF  +   LE
Sbjct: 495 DLMCQCWRKEPEERPTFEYLQAFLE 519

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 134/266 (50%), Gaps = 24/266 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 17  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 71
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 72  YAVVSEEPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 128
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +
Sbjct: 129 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 185
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
             K DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ 
Sbjct: 186 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMC 242
Query: 391 ECWNEKPAKRPTFRQIITRLESINNS 416
           +CW ++P +RPTF  +   LE    S
Sbjct: 243 QCWRKEPEERPTFEYLQAFLEDYFTS 268

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 127/261 (48%), Gaps = 31/261 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 59  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 116
Query: 233 PKGDLRAFLKRKG------ALKPS----------TAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +       +  PS            V  A  +ARGM YL   K    IH
Sbjct: 117 SKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 173
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
           RDL   N+L  +   +K+ADFG+++ +  +   +  T      +++APE   +  Y  + 
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLPVKWMAPEALFDRIYTHQS 233
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E+   G  P+      E+ K      R   P     +LY      ++ +C
Sbjct: 234 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYM-----MMRDC 288
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+  P++RPTF+Q++  L+ I
Sbjct: 289 WHAVPSQRPTFKQLVEDLDRI 309

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 133/266 (50%), Gaps = 24/266 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 78
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 79  YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
             K DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ 
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMC 249
Query: 391 ECWNEKPAKRPTFRQIITRLESINNS 416
           +CW + P +RPTF  +   LE    S
Sbjct: 250 QCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 133/266 (50%), Gaps = 24/266 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 78
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 79  YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +
Sbjct: 136 VHRDLAAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
             K DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ 
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMC 249
Query: 391 ECWNEKPAKRPTFRQIITRLESINNS 416
           +CW + P +RPTF  +   LE    S
Sbjct: 250 QCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 133/266 (50%), Gaps = 24/266 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 15  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 69
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 70  YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 126
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +
Sbjct: 127 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 183
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
             K DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ 
Sbjct: 184 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMC 240
Query: 391 ECWNEKPAKRPTFRQIITRLESINNS 416
           +CW + P +RPTF  +   LE    S
Sbjct: 241 QCWRKDPEERPTFEYLQAFLEDYFTS 266

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 16/227 (7%)
Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAV 253
           R F  E +++ +  HPN+++  G VT S P+MI+TE++  G L +FL+   G       V
Sbjct: 62  REFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLV 121
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
                IA GM YL E   +  +HRDL   NIL + +   KV+DFG+S+ L      P   
Sbjct: 122 GMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTET 178
Query: 314 QDTS----CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA 368
                    R+ APE     ++ +  D +S+ +++ E++  G  P+    + +V  A   
Sbjct: 179 SSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQ 238
Query: 369 RQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
             R  PP   P  L+     +L+ +CW +    RP F Q+++ L+ +
Sbjct: 239 DYRLPPPPDCPTSLH-----QLMLDCWQKDRNARPRFPQVVSALDKM 280

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 67/227 (29%), Positives = 111/227 (48%), Gaps = 16/227 (7%)
Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAV 253
           R F  E +++ +  HPN+++  G VT S P+MI+TE++  G L +FL+   G       V
Sbjct: 60  REFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLV 119
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
                IA GM YL E   +  +HRDL   NIL + +   KV+DFG+S+ L      P   
Sbjct: 120 GMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYT 176
Query: 314 QDTS----CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA 368
                    R+ APE     ++ +  D +S+ +++ E++  G  P+    + +V  A   
Sbjct: 177 SSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMSFGERPYWDMSNQDVINAIEQ 236
Query: 369 RQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
             R  PP   P  L+     +L+ +CW +    RP F Q+++ L+ +
Sbjct: 237 DYRLPPPPDCPTSLH-----QLMLDCWQKDRNARPRFPQVVSALDKM 278

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 72/233 (30%), Positives = 115/233 (49%), Gaps = 10/233 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VAVK L  + I   D V   R E+  L+  RHP++++    ++  S + +V EY+  
Sbjct: 41  GHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSG 100
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L  ++ + G L    + R    I  G++Y H +    ++HRDL+P N+L D   N K+
Sbjct: 101 GELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKI 157
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPP 353
           ADFG+S +++  E    +C   S  Y APEV     Y   +VD++S  +IL  ++ G  P
Sbjct: 158 ADFGLSNMMSDGEFLRXSC--GSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215
Query: 354 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           F    D+ VP  +       F  P  L    +  L++      P KR T + I
Sbjct: 216 FD---DDHVPTLFKKICDGIFYTPQYLNP-SVISLLKHMLQVDPMKRATIKDI 264

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 31/261 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 51  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 108
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 109 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 165
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
           RDL   N+L  +   +K+ADFG+++ +  +   +  T      +++APE   +  Y  + 
Sbjct: 166 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 225
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E+   G  P+      E+ K      R   P     +LY      ++ +C
Sbjct: 226 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYM-----MMRDC 280
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+  P++RPTF+Q++  L+ I
Sbjct: 281 WHAVPSQRPTFKQLVEDLDRI 301

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 31/261 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 59  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 116
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 117 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 173
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
           RDL   N+L  +   +K+ADFG+++ +  +   +  T      +++APE   +  Y  + 
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 233
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E+   G  P+      E+ K      R   P     +LY      ++ +C
Sbjct: 234 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYM-----MMRDC 288
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+  P++RPTF+Q++  L+ I
Sbjct: 289 WHAVPSQRPTFKQLVEDLDRI 309

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 133/266 (50%), Gaps = 24/266 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 13  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 67
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 68  YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 124
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +
Sbjct: 125 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 181
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
             K DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ 
Sbjct: 182 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMC 238
Query: 391 ECWNEKPAKRPTFRQIITRLESINNS 416
           +CW + P +RPTF  +   LE    S
Sbjct: 239 QCWRKDPEERPTFEYLQAFLEDYFTS 264

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 31/261 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 59  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 116
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 117 SKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 173
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
           RDL   N+L  +   +K+ADFG+++ +  +   +  T      +++APE   +  Y  + 
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 233
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E+   G  P+      E+ K      R   P     +LY      ++ +C
Sbjct: 234 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYM-----MMRDC 288
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+  P++RPTF+Q++  L+ I
Sbjct: 289 WHAVPSQRPTFKQLVEDLDRI 309

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 31/261 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 48  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 105
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 106 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 162
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
           RDL   N+L  +   +K+ADFG+++ +  +   +  T      +++APE   +  Y  + 
Sbjct: 163 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 222
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E+   G  P+      E+ K      R   P     +LY      ++ +C
Sbjct: 223 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYM-----MMRDC 277
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+  P++RPTF+Q++  L+ I
Sbjct: 278 WHAVPSQRPTFKQLVEDLDRI 298

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 31/261 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 59  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 116
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 117 SKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 173
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
           RDL   N+L  +   +K+ADFG+++ +  +   +  T      +++APE   +  Y  + 
Sbjct: 174 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 233
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E+   G  P+      E+ K      R   P     +LY      ++ +C
Sbjct: 234 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYM-----MMRDC 288
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+  P++RPTF+Q++  L+ I
Sbjct: 289 WHAVPSQRPTFKQLVEDLDRI 309

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score =  106 bits (265), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 31/261 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 44  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 101
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 102 SKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 158
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
           RDL   N+L  +   +K+ADFG+++ +  +   +  T      +++APE   +  Y  + 
Sbjct: 159 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 218
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E+   G  P+      E+ K      R   P     +LY      ++ +C
Sbjct: 219 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYM-----MMRDC 273
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+  P++RPTF+Q++  L+ I
Sbjct: 274 WHAVPSQRPTFKQLVEDLDRI 294

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 31/261 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 52  RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 109
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 110 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 166
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
           RDL   N+L  +   +K+ADFG+++ +  +   +  T      +++APE   +  Y  + 
Sbjct: 167 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 226
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E+   G  P+      E+ K      R   P     +LY      ++ +C
Sbjct: 227 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYM-----MMRDC 281
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+  P++RPTF+Q++  L+ I
Sbjct: 282 WHAVPSQRPTFKQLVEDLDRI 302

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 31/261 (11%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL 232
           R  +VAVK L  +    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY 
Sbjct: 100 RVTKVAVKMLKSDATEKD--LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYA 157
Query: 233 PKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            KG+LR +L+ +                  L     V  A  +ARGM YL   K    IH
Sbjct: 158 SKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIH 214
Query: 277 RDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
           RDL   N+L  +   +K+ADFG+++ +  +   +  T      +++APE   +  Y  + 
Sbjct: 215 RDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQS 274
Query: 336 DVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEEC 392
           DV+SF ++L E+   G  P+      E+ K      R   P     +LY      ++ +C
Sbjct: 275 DVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYM-----MMRDC 329
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W+  P++RPTF+Q++  L+ I
Sbjct: 330 WHAVPSQRPTFKQLVEDLDRI 350

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 134/266 (50%), Gaps = 24/266 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 21  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 75
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  +  IA GM Y+     +  
Sbjct: 76  YAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNY 132
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEWTARQGAKFPIKWTAPEAALYGRF 189
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
             K DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ 
Sbjct: 190 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMC 246
Query: 391 ECWNEKPAKRPTFRQIITRLESINNS 416
           +CW ++P +RPTF  +   LE    S
Sbjct: 247 QCWRKEPEERPTFEYLQAFLEDYFTS 272

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 134/266 (50%), Gaps = 24/266 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 21  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 75
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  +  IA GM Y+     +  
Sbjct: 76  YAVVSEEPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNY 132
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +
Sbjct: 133 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 189
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
             K DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ 
Sbjct: 190 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMC 246
Query: 391 ECWNEKPAKRPTFRQIITRLESINNS 416
           +CW ++P +RPTF  +   LE    S
Sbjct: 247 QCWRKEPEERPTFEYLQAFLEDYFTS 272

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 133/266 (50%), Gaps = 24/266 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 78
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 79  YAVVSEEPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
             K DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ 
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMC 249
Query: 391 ECWNEKPAKRPTFRQIITRLESINNS 416
           +CW + P +RPTF  +   LE    S
Sbjct: 250 QCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 133/266 (50%), Gaps = 24/266 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 190 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 244
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IV EY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 245 YAVVSEEPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNY 301
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +
Sbjct: 302 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 358
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
             K DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ 
Sbjct: 359 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMC 415
Query: 391 ECWNEKPAKRPTFRQIITRLESINNS 416
           +CW ++P +RPTF  +   LE    S
Sbjct: 416 QCWRKEPEERPTFEYLQAFLEDYFTS 441

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 132/266 (49%), Gaps = 24/266 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 191 VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGNMSPE----AFLQEAQVMKKLRHEKLVQ-L 245
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IVTEY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 246 YAVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 302
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+ +L+   ED   T +  +    ++ APE      +
Sbjct: 303 VHRDLRAANILVGENLVCKVADFGLGRLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 359
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
             K DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ 
Sbjct: 360 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMC 416
Query: 391 ECWNEKPAKRPTFRQIITRLESINNS 416
           +CW + P +RPTF  +   LE    S
Sbjct: 417 QCWRKDPEERPTFEYLQAFLEDYFTS 442

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 31/260 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 67  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           DL   N+L  ++  +K+ADFG+++ +  +   +  T      +++APE   +  Y  + D
Sbjct: 182 DLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSD 241
Query: 337 VFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECW 393
           V+SF +++ E+   G  P+      E+ K      R   P     +LY      ++ +CW
Sbjct: 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-----MMRDCW 296
Query: 394 NEKPAKRPTFRQIITRLESI 413
           +  P++RPTF+Q++  L+ I
Sbjct: 297 HAVPSQRPTFKQLVEDLDRI 316

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 77/260 (29%), Positives = 127/260 (48%), Gaps = 38/260 (14%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L     +D+    A   EL ++  + +H N+V  LGA T   P++++TEY   
Sbjct: 77  LKVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY 134
Query: 235 GDLRAFLKRKG---------ALKPSTA-----VRFALDIARGMNYLHENKPVPIIHRDLE 280
           GDL  FL+RK          A+  STA     + F+  +A+GM +L        IHRD+ 
Sbjct: 135 GDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVA 191
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDV 337
             N+L  +    K+ DFG+++   +  D     +  +    +++APE   +  Y  + DV
Sbjct: 192 ARNVLLTNGHVAKIGDFGLAR--DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249
Query: 338 FSFALILQEMIE-GCPPF-----TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 391
           +S+ ++L E+   G  P+       K    V   Y   Q P F AP  +Y+     +++ 
Sbjct: 250 WSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ-PAF-APKNIYS-----IMQA 302
Query: 392 CWNEKPAKRPTFRQIITRLE 411
           CW  +P  RPTF+QI + L+
Sbjct: 303 CWALEPTHRPTFQQICSFLQ 322

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 84/263 (31%), Positives = 128/263 (48%), Gaps = 18/263 (6%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 78
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IV EY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 79  YAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK 334
           +HRDL  +NIL  ++   KVADFG+++L+   E           ++ APE      +  K
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIK 195
Query: 335 VDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
            DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ +CW
Sbjct: 196 SDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMCQCW 252
Query: 394 NEKPAKRPTFRQIITRLESINNS 416
            + P +RPTF  +   LE    S
Sbjct: 253 RKDPEERPTFEYLQAFLEDYFTS 275

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 128/260 (49%), Gaps = 31/260 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++   +D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 67  AVTVAVKMLKDDATEED--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           DL   N+L  ++  +K+ADFG+++ +  +   +  T      +++APE   +  Y  + D
Sbjct: 182 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241
Query: 337 VFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECW 393
           V+SF +++ E+   G  P+      E+ K      R   P     +LY      ++ +CW
Sbjct: 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-----MMRDCW 296
Query: 394 NEKPAKRPTFRQIITRLESI 413
           +  P++RPTF+Q++  L+ I
Sbjct: 297 HAVPSQRPTFKQLVEDLDRI 316

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 31/260 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 67  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           DL   N+L  ++  +K+ADFG+++ +  +   +  T      +++APE   +  Y  + D
Sbjct: 182 DLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGRLPVKWMAPEALFDRVYTHQSD 241
Query: 337 VFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECW 393
           V+SF +++ E+   G  P+      E+ K      R   P     +LY      ++ +CW
Sbjct: 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-----MMRDCW 296
Query: 394 NEKPAKRPTFRQIITRLESI 413
           +  P++RPTF+Q++  L+ I
Sbjct: 297 HAVPSQRPTFKQLVEDLDRI 316

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 132/266 (49%), Gaps = 24/266 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 78
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IV EY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 79  YAVVSEEPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
             K DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ 
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMC 249
Query: 391 ECWNEKPAKRPTFRQIITRLESINNS 416
           +CW + P +RPTF  +   LE    S
Sbjct: 250 QCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 114/233 (48%), Gaps = 10/233 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VAVK L  + I   D V   + E+  L+  RHP++++    ++  +   +V EY+  
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L  ++ + G ++   A R    I   ++Y H +    ++HRDL+P N+L D   N K+
Sbjct: 96  GELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKI 152
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPP 353
           ADFG+S +++  E    +C   S  Y APEV     Y   +VD++S  +IL  ++ G  P
Sbjct: 153 ADFGLSNMMSDGEFLRTSC--GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
Query: 354 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           F    D  VP  +   +   F  P  L  R +  L+       P KR T + I
Sbjct: 211 FD---DEHVPTLFKKIRGGVFYIPEYL-NRSVATLLMHMLQVDPLKRATIKDI 259

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score =  104 bits (260), Expect = 9e-23,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 132/266 (49%), Gaps = 24/266 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 78
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IV EY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 79  YAVVSEEPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
             K DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ 
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMC 249
Query: 391 ECWNEKPAKRPTFRQIITRLESINNS 416
           +CW + P +RPTF  +   LE    S
Sbjct: 250 QCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 116/246 (47%), Gaps = 24/246 (9%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 36  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 87
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P+G++   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 88  VYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 144
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFA 341
           L   +G LK+ADFG S         P + + T C    Y+ PE+ +   +D KVD++S  
Sbjct: 145 LLGSAGELKIADFGWSV------HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           ++  E + G PPF     N   + Y    R  F  P      G ++LI       P++RP
Sbjct: 199 VLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRP 254
Query: 402 TFRQII 407
             R+++
Sbjct: 255 MLREVL 260

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 31/260 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 67  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           DL   N+L  ++  +K+ADFG+++ +  +   +  T      +++APE   +  Y  + D
Sbjct: 182 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241
Query: 337 VFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECW 393
           V+SF +++ E+   G  P+      E+ K      R   P     +LY      ++ +CW
Sbjct: 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-----MMRDCW 296
Query: 394 NEKPAKRPTFRQIITRLESI 413
           +  P++RPTF+Q++  L+ I
Sbjct: 297 HAVPSQRPTFKQLVEDLDRI 316

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 31/260 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 54  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 111
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 112 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 168
Query: 278 DLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           DL   N+L  ++  +K+ADFG+++ +  +   +  T      +++APE   +  Y  + D
Sbjct: 169 DLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 228
Query: 337 VFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECW 393
           V+SF +++ E+   G  P+      E+ K      R   P     +LY      ++ +CW
Sbjct: 229 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-----MMRDCW 283
Query: 394 NEKPAKRPTFRQIITRLESI 413
           +  P++RPTF+Q++  L+ I
Sbjct: 284 HAVPSQRPTFKQLVEDLDRI 303

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 66/246 (26%), Positives = 115/246 (46%), Gaps = 24/246 (9%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 32  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 83
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 84  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 140
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFA 341
           L   +G LK+ADFG S         P + +DT C    Y+ PE+ +   +D KVD++S  
Sbjct: 141 LLGSAGELKIADFGWSV------HAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 194
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           ++  E + G PPF     N   + Y    R  F  P      G ++LI       P++RP
Sbjct: 195 VLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRP 250
Query: 402 TFRQII 407
             R+++
Sbjct: 251 MLREVL 256

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 31/260 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 59  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 116
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 117 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 173
Query: 278 DLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           DL   N+L  ++  +K+ADFG+++ +  +   +  T      +++APE   +  Y  + D
Sbjct: 174 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 233
Query: 337 VFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECW 393
           V+SF +++ E+   G  P+      E+ K      R   P     +LY      ++ +CW
Sbjct: 234 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-----MMRDCW 288
Query: 394 NEKPAKRPTFRQIITRLESI 413
           +  P++RPTF+Q++  L+ I
Sbjct: 289 HAVPSQRPTFKQLVEDLDRI 308

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 31/260 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 67  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           DL   N+L  ++  +K+ADFG+++ +  +   +  T      +++APE   +  Y  + D
Sbjct: 182 DLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGRLPVKWMAPEALFDRVYTHQSD 241
Query: 337 VFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECW 393
           V+SF +++ E+   G  P+      E+ K      R   P     +LY      ++ +CW
Sbjct: 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-----MMRDCW 296
Query: 394 NEKPAKRPTFRQIITRLESI 413
           +  P++RPTF+Q++  L+ I
Sbjct: 297 HAVPSQRPTFKQLVEDLDRI 316

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 31/260 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 56  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 113
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 114 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 170
Query: 278 DLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           DL   N+L  ++  +K+ADFG+++ +  +   +  T      +++APE   +  Y  + D
Sbjct: 171 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 230
Query: 337 VFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECW 393
           V+SF +++ E+   G  P+      E+ K      R   P     +LY      ++ +CW
Sbjct: 231 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-----MMRDCW 285
Query: 394 NEKPAKRPTFRQIITRLESI 413
           +  P++RPTF+Q++  L+ I
Sbjct: 286 HAVPSQRPTFKQLVEDLDRI 305

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 31/260 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 67  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           DL   N+L  ++  +K+ADFG+++ +  +   +  T      +++APE   +  Y  + D
Sbjct: 182 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241
Query: 337 VFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECW 393
           V+SF +++ E+   G  P+      E+ K      R   P     +LY      ++ +CW
Sbjct: 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-----MMRDCW 296
Query: 394 NEKPAKRPTFRQIITRLESI 413
           +  P++RPTF+Q++  L+ I
Sbjct: 297 HAVPSQRPTFKQLVEDLDRI 316

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 127/243 (52%), Gaps = 24/243 (9%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK +    +S    V AF  E  +++ ++H  +V+ L AV    P+ I+TE++ KG 
Sbjct: 214 KVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGS 268
Query: 237 LRAFLKR-KGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           L  FLK  +G+ +P    + F+  IA GM ++ +      IHRDL  +NIL   S   K+
Sbjct: 269 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKI 325
Query: 295 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
           ADFG+++++   ED   T ++ +    ++ APE      +  K DV+SF ++L E++  G
Sbjct: 326 ADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 382
Query: 351 CPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
             P+    + EV +A     R   P   P +LY      ++  CW  +P +RPTF  I +
Sbjct: 383 RIPYPGMSNPEVIRALERGYRMPRPENCPEELY-----NIMMRCWKNRPEERPTFEYIQS 437
Query: 409 RLE 411
            L+
Sbjct: 438 VLD 440

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 77/243 (31%), Positives = 127/243 (52%), Gaps = 24/243 (9%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK +    +S    V AF  E  +++ ++H  +V+ L AV    P+ I+TE++ KG 
Sbjct: 41  KVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGS 95
Query: 237 LRAFLKR-KGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           L  FLK  +G+ +P    + F+  IA GM ++ +      IHRDL  +NIL   S   K+
Sbjct: 96  LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKI 152
Query: 295 ADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G 350
           ADFG+++++   ED   T ++ +    ++ APE      +  K DV+SF ++L E++  G
Sbjct: 153 ADFGLARVI---EDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYG 209
Query: 351 CPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
             P+    + EV +A     R   P   P +LY      ++  CW  +P +RPTF  I +
Sbjct: 210 RIPYPGMSNPEVIRALERGYRMPRPENCPEELY-----NIMMRCWKNRPEERPTFEYIQS 264
Query: 409 RLE 411
            L+
Sbjct: 265 VLD 267

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 132/266 (49%), Gaps = 24/266 (9%)
Query: 161 VEITKGTF---ILAFWRGI-QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           V++ +G F    +  W G  +VA+K L    +S +    AF  E  +++K+RH  +VQ L
Sbjct: 24  VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPE----AFLQEAQVMKKLRHEKLVQ-L 78
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPI 274
            AV    P+ IV EY+ KG L  FLK +    L+    V  A  IA GM Y+     +  
Sbjct: 79  YAVVSEEPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNY 135
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEY 331
           +HRDL  +NIL  ++   KVADFG+++L+   ED   T +  +    ++ APE      +
Sbjct: 136 VHRDLRAANILVGENLVCKVADFGLARLI---EDNEYTARQGAKFPIKWTAPEAALYGRF 192
Query: 332 DTKVDVFSFALILQEM-IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
             K DV+SF ++L E+  +G  P+    + EV        R P   P +     L +L+ 
Sbjct: 193 TIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP--CPPEC-PESLHDLMC 249
Query: 391 ECWNEKPAKRPTFRQIITRLESINNS 416
           +CW + P +RPTF  +   LE    S
Sbjct: 250 QCWRKDPEERPTFEYLQAFLEDYFTS 275

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 73/260 (28%), Positives = 127/260 (48%), Gaps = 31/260 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 113 AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 170
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 171 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 227
Query: 278 DLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           DL   N+L  ++  +K+ADFG+++ +  +   +  T      +++APE   +  Y  + D
Sbjct: 228 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 287
Query: 337 VFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECW 393
           V+SF +++ E+   G  P+      E+ K      R   P     +LY      ++ +CW
Sbjct: 288 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-----MMRDCW 342
Query: 394 NEKPAKRPTFRQIITRLESI 413
           +  P++RPTF+Q++  L+ I
Sbjct: 343 HAVPSQRPTFKQLVEDLDRI 362

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 70/233 (30%), Positives = 114/233 (48%), Gaps = 10/233 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VAVK L  + I   D V   + E+  L+  RHP++++    ++  +   +V EY+  
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L  ++ + G ++   A R    I   ++Y H +    ++HRDL+P N+L D   N K+
Sbjct: 96  GELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKI 152
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPP 353
           ADFG+S +++  E    +C   S  Y APEV     Y   +VD++S  +IL  ++ G  P
Sbjct: 153 ADFGLSNMMSDGEFLRDSC--GSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210
Query: 354 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           F    D  VP  +   +   F  P  L  R +  L+       P KR T + I
Sbjct: 211 FD---DEHVPTLFKKIRGGVFYIPEYL-NRSVATLLMHMLQVDPLKRATIKDI 259

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/235 (31%), Positives = 120/235 (51%), Gaps = 25/235 (10%)
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGALKPS 250
           ++ + F+ E+ ++  + HPN+V+  G +   +P  +V E++P GDL    L +   +K S
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNL--KVADFGVSKLLTV 305
             +R  LDIA G+ Y+    P PI+HRDL   NI     D++  +  KVADFG+S+    
Sbjct: 123 VKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ---- 177
Query: 306 KEDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
           +    ++    + +++APE    EE  Y  K D +SFA+IL  ++ G  PF      ++ 
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 364 KAYAARQ---RP--PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
                R+   RP  P   P +L     + +IE CW+  P KRP F  I+  L  +
Sbjct: 238 FINMIREEGLRPTIPEDCPPRL-----RNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/235 (31%), Positives = 119/235 (50%), Gaps = 25/235 (10%)
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGALKPS 250
           ++ + F+ E+ ++  + HPN+V+  G +   +P  +V E++P GDL    L +   +K S
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNL--KVADFGVSKLLTV 305
             +R  LDIA G+ Y+    P PI+HRDL   NI     D++  +  KVADFG S+    
Sbjct: 123 VKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ---- 177
Query: 306 KEDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
           +    ++    + +++APE    EE  Y  K D +SFA+IL  ++ G  PF      ++ 
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 364 KAYAARQ---RP--PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
                R+   RP  P   P +L     + +IE CW+  P KRP F  I+  L  +
Sbjct: 238 FINMIREEGLRPTIPEDCPPRL-----RNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 126/260 (48%), Gaps = 38/260 (14%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L     +D+    A   EL ++  + +H N+V  LGA T   P++++TEY   
Sbjct: 77  LKVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY 134
Query: 235 GDLRAFLKRKG---------ALKPST-----AVRFALDIARGMNYLHENKPVPIIHRDLE 280
           GDL  FL+RK          A+  ST      + F+  +A+GM +L        IHRD+ 
Sbjct: 135 GDLLNFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLASKN---CIHRDVA 191
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDV 337
             N+L  +    K+ DFG+++   +  D     +  +    +++APE   +  Y  + DV
Sbjct: 192 ARNVLLTNGHVAKIGDFGLAR--DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDV 249
Query: 338 FSFALILQEMIE-GCPPF-----TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 391
           +S+ ++L E+   G  P+       K    V   Y   Q P F AP  +Y+     +++ 
Sbjct: 250 WSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ-PAF-APKNIYS-----IMQA 302
Query: 392 CWNEKPAKRPTFRQIITRLE 411
           CW  +P  RPTF+QI + L+
Sbjct: 303 CWALEPTHRPTFQQICSFLQ 322

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 124/256 (48%), Gaps = 34/256 (13%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L     +D+    A   EL ++  + +H N+V  LGA T   P++++TEY   
Sbjct: 69  LKVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY 126
Query: 235 GDLRAFLKRKGA----------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           GDL  FL+RK            L+    + F+  +A+GM +L        IHRD+   N+
Sbjct: 127 GDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV 183
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFA 341
           L  +    K+ DFG+++   +  D     +  +    +++APE   +  Y  + DV+S+ 
Sbjct: 184 LLTNGHVAKIGDFGLAR--DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 241
Query: 342 LILQEMIE-GCPPF-----TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395
           ++L E+   G  P+       K    V   Y   Q P F AP  +Y+     +++ CW  
Sbjct: 242 ILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ-PAF-APKNIYS-----IMQACWAL 294
Query: 396 KPAKRPTFRQIITRLE 411
           +P  RPTF+QI + L+
Sbjct: 295 EPTHRPTFQQICSFLQ 310

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 127/260 (48%), Gaps = 31/260 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  
Sbjct: 67  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           DL   N+L  ++  +++ADFG+++ +  +   +  T      +++APE   +  Y  + D
Sbjct: 182 DLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241
Query: 337 VFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECW 393
           V+SF +++ E+   G  P+      E+ K      R   P     +LY      ++ +CW
Sbjct: 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-----MMRDCW 296
Query: 394 NEKPAKRPTFRQIITRLESI 413
           +  P++RPTF+Q++  L+ I
Sbjct: 297 HAVPSQRPTFKQLVEDLDRI 316

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 129/266 (48%), Gaps = 42/266 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTEYL 232
           G QVAVK L  E  S  + +   + E+ +L+ + H N+V++ G  T+   + + ++ E+L
Sbjct: 38  GEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 95
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G L+ +L K K  +     +++A+ I +GM+YL   +    +HRDL   N+L +    
Sbjct: 96  PSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 152
Query: 292 LKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           +K+ DFG++K +       TVK+DR     D+   + APE     ++    DV+SF + L
Sbjct: 153 VKIGDFGLTKAIETDKEXXTVKDDR-----DSPVFWYAPECLMQSKFYIASDVWSFGVTL 207
Query: 345 QEMIEGC----PPFT------------MKHDNEVPKAYAARQRP-PFKAPAKLYARGLKE 387
            E++  C     P              M     V      ++ P P   P ++Y     +
Sbjct: 208 HELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVY-----Q 262
Query: 388 LIEECWNEKPAKRPTFRQIITRLESI 413
           L+ +CW  +P+ R +F+ +I   E++
Sbjct: 263 LMRKCWEFQPSNRTSFQNLIEGFEAL 288

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 124/256 (48%), Gaps = 34/256 (13%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L     +D+    A   EL ++  + +H N+V  LGA T   P++++TEY   
Sbjct: 77  LKVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY 134
Query: 235 GDLRAFLKRKGA----------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           GDL  FL+RK            L+    + F+  +A+GM +L        IHRD+   N+
Sbjct: 135 GDLLNFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNV 191
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKVDVFSFA 341
           L  +    K+ DFG+++   +  D     +  +    +++APE   +  Y  + DV+S+ 
Sbjct: 192 LLTNGHVAKIGDFGLAR--DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 249
Query: 342 LILQEMIE-GCPPF-----TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395
           ++L E+   G  P+       K    V   Y   Q P F AP  +Y+     +++ CW  
Sbjct: 250 ILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ-PAF-APKNIYS-----IMQACWAL 302
Query: 396 KPAKRPTFRQIITRLE 411
           +P  RPTF+QI + L+
Sbjct: 303 EPTHRPTFQQICSFLQ 318

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 123/268 (45%), Gaps = 46/268 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L E   +    +R    E  +L+++ HP+V++  GA +Q  P++++ EY   G L
Sbjct: 56  VAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 238 RAFLKRKGALKPST------------------------AVRFALDIARGMNYLHENKPVP 273
           R FL+    + P                           + FA  I++GM YL E K   
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--- 170
Query: 274 IIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYD 332
           ++HRDL   NIL  +   +K++DFG+S+ +  ++      Q     +++A E   +  Y 
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYT 230
Query: 333 TKVDVFSFALILQEMIE-------GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385
           T+ DV+SF ++L E++        G PP  + +  +       R   P     ++Y    
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT----GHRMERPDNCSEEMY---- 282
Query: 386 KELIEECWNEKPAKRPTFRQIITRLESI 413
             L+ +CW ++P KRP F  I   LE +
Sbjct: 283 -RLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 114/243 (46%), Gaps = 18/243 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 36  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 87
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P+G++   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 88  VYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 144
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           L   +G LK+ADFG S  +     R      T   Y+ PE+ +   +D KVD++S  ++ 
Sbjct: 145 LLGSAGELKIADFGWS--VHAPSSRRXXLXGT-LDYLPPEMIEGRMHDEKVDLWSLGVLC 201
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            E + G PPF     N   + Y    R  F  P      G ++LI       P++RP  R
Sbjct: 202 YEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLR 257
Query: 405 QII 407
           +++
Sbjct: 258 EVL 260

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 129/266 (48%), Gaps = 42/266 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMIVTEYL 232
           G QVAVK L  E  S  + +   + E+ +L+ + H N+V++ G  T+   + + ++ E+L
Sbjct: 50  GEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFL 107
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G L+ +L K K  +     +++A+ I +GM+YL   +    +HRDL   N+L +    
Sbjct: 108 PSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQ 164
Query: 292 LKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           +K+ DFG++K +       TVK+DR     D+   + APE     ++    DV+SF + L
Sbjct: 165 VKIGDFGLTKAIETDKEXXTVKDDR-----DSPVFWYAPECLMQSKFYIASDVWSFGVTL 219
Query: 345 QEMIEGC----PPFT------------MKHDNEVPKAYAARQRP-PFKAPAKLYARGLKE 387
            E++  C     P              M     V      ++ P P   P ++Y     +
Sbjct: 220 HELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVY-----Q 274
Query: 388 LIEECWNEKPAKRPTFRQIITRLESI 413
           L+ +CW  +P+ R +F+ +I   E++
Sbjct: 275 LMRKCWEFQPSNRTSFQNLIEGFEAL 300

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 66/240 (27%), Positives = 111/240 (46%), Gaps = 18/240 (7%)
Query: 168 FILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           FILA     +  ++K G E           R E+ +   +RHPN+++  G    S+ + +
Sbjct: 34  FILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDSTRVYL 85
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
           + EY P G +   L++           +  ++A  ++Y H  K   +IHRD++P N+L  
Sbjct: 86  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKK---VIHRDIKPENLLLG 142
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
            +G LK+ADFG S +      R   C   +  Y+ PE+ +   +D KVD++S  ++  E 
Sbjct: 143 SAGELKIADFGWS-VHAPSSRRAALC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEF 199
Query: 348 IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           + G PPF     N     Y    R  F  P      G ++LI       P++RP  R+++
Sbjct: 200 LVGKPPFEA---NTYQDTYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLREVL 255

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score =  102 bits (254), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 123/268 (45%), Gaps = 46/268 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L E   +    +R    E  +L+++ HP+V++  GA +Q  P++++ EY   G L
Sbjct: 56  VAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 238 RAFLKRKGALKPST------------------------AVRFALDIARGMNYLHENKPVP 273
           R FL+    + P                           + FA  I++GM YL E K   
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK--- 170
Query: 274 IIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYD 332
           ++HRDL   NIL  +   +K++DFG+S+ +  ++      Q     +++A E   +  Y 
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYT 230
Query: 333 TKVDVFSFALILQEMIE-------GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385
           T+ DV+SF ++L E++        G PP  + +  +       R   P     ++Y    
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKT----GHRMERPDNCSEEMY---- 282
Query: 386 KELIEECWNEKPAKRPTFRQIITRLESI 413
             L+ +CW ++P KRP F  I   LE +
Sbjct: 283 -RLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 15/218 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L    D        +  
Sbjct: 114 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 168
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPPFTMKHDNEVPKA------YAARQ 370
           Y++PE  +   Y  + D++S  L L EM  G    PP   K D+  P A      Y   +
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNE 228
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
            PP K P+ +++   ++ + +C  + PA+R   +Q++ 
Sbjct: 229 PPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 265

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 126/260 (48%), Gaps = 31/260 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++  Y  
Sbjct: 67  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           DL   N+L  ++  +K+ADFG+++ +  +   +  T      +++APE   +  Y  + D
Sbjct: 182 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241
Query: 337 VFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECW 393
           V+SF +++ E+   G  P+      E+ K      R   P     +LY      ++ +CW
Sbjct: 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-----MMRDCW 296
Query: 394 NEKPAKRPTFRQIITRLESI 413
           +  P++RPTF+Q++  L+ I
Sbjct: 297 HAVPSQRPTFKQLVEDLDRI 316

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 122/271 (45%), Gaps = 52/271 (19%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L E   +    +R    E  +L+++ HP+V++  GA +Q  P++++ EY   G L
Sbjct: 56  VAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSL 113
Query: 238 RAFLKRKGALKPST------------------------AVRFALDIARGMNYLHENKPVP 273
           R FL+    + P                           + FA  I++GM YL E   + 
Sbjct: 114 RGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MS 170
Query: 274 IIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYD 332
           ++HRDL   NIL  +   +K++DFG+S+ +  ++      Q     +++A E   +  Y 
Sbjct: 171 LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYT 230
Query: 333 TKVDVFSFALILQEMIE-------GCPP---FTMKHDNEVPKAYAARQRPPFKAPAKLYA 382
           T+ DV+SF ++L E++        G PP   F +            R   P     ++Y 
Sbjct: 231 TQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGH-------RMERPDNCSEEMY- 282
Query: 383 RGLKELIEECWNEKPAKRPTFRQIITRLESI 413
                L+ +CW ++P KRP F  I   LE +
Sbjct: 283 ----RLMLQCWKQEPDKRPVFADISKDLEKM 309

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 77/269 (28%), Positives = 126/269 (46%), Gaps = 47/269 (17%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L     +D+    A   EL ++  + +H N+V  LGA T   P++++TEY   
Sbjct: 62  LKVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY 119
Query: 235 GDLRAFLKRK--GALKPSTA---------------------VRFALDIARGMNYLHENKP 271
           GDL  FL+RK    L PS A                     + F+  +A+GM +L     
Sbjct: 120 GDLLNFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKN- 178
Query: 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKN 328
              IHRD+   N+L  +    K+ DFG+++   +  D     +  +    +++APE   +
Sbjct: 179 --CIHRDVAARNVLLTNGHVAKIGDFGLAR--DIMNDSNYIVKGNARLPVKWMAPESIFD 234
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPF-----TMKHDNEVPKAYAARQRPPFKAPAKLYA 382
             Y  + DV+S+ ++L E+   G  P+       K    V   Y   Q P F AP  +Y+
Sbjct: 235 CVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ-PAF-APKNIYS 292
Query: 383 RGLKELIEECWNEKPAKRPTFRQIITRLE 411
                +++ CW  +P  RPTF+QI + L+
Sbjct: 293 -----IMQACWALEPTHRPTFQQICSFLQ 316

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 24/246 (9%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 34  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 85
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 86  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 142
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFA 341
           L   +G LK+ADFG S         P + + T C    Y+ PE+ +   +D KVD++S  
Sbjct: 143 LLGSAGELKIADFGWSV------HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           ++  E + G PPF     N   + Y    R  F  P      G ++LI       P++RP
Sbjct: 197 VLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRP 252
Query: 402 TFRQII 407
             R+++
Sbjct: 253 MLREVL 258

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 113/243 (46%), Gaps = 18/243 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 48  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 99
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 100 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 156
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           L   +G LK+ADFG S +      R   C   +  Y+ PE+ +   +D KVD++S  ++ 
Sbjct: 157 LLGSAGELKIADFGWS-VHAPSSRRTTLC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLC 213
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            E + G PPF     N   + Y    R  F  P      G ++LI       P++RP  R
Sbjct: 214 YEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLR 269
Query: 405 QII 407
           +++
Sbjct: 270 EVL 272

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 112/243 (46%), Gaps = 18/243 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 32  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 83
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 84  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 140
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           L   +G LK+ADFG S        R  T   T   Y+ PE+ +   +D KVD++S  ++ 
Sbjct: 141 LLGSAGELKIADFGWS--CHAPSSRRTTLSGT-LDYLPPEMIEGRMHDEKVDLWSLGVLC 197
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            E + G PPF     N   + Y    R  F  P      G ++LI       P++RP  R
Sbjct: 198 YEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLR 253
Query: 405 QII 407
           +++
Sbjct: 254 EVL 256

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 67/246 (27%), Positives = 120/246 (48%), Gaps = 23/246 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +E++    +V    DE  +L  + HP +++  G    +  + ++ +Y+  
Sbjct: 31  GRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEG 90
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L + L++        A  +A ++   + YLH      II+RDL+P NIL D +G++K+
Sbjct: 91  GELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKI 147
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   V +     C   +  Y+APEV   + Y+  +D +SF +++ EM+ G  PF
Sbjct: 148 TDFGFAKY--VPDVTYXLC--GTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203
Query: 355 TMKHDNEVPKAY-----AARQRPPF------KAPAKLYARGLKELIEECWN--EKPAKRP 401
              +D+   K Y     A  + PPF         ++L  R L + +    N  E     P
Sbjct: 204 ---YDSNTMKTYEKILNAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHP 260
Query: 402 TFRQII 407
            F++++
Sbjct: 261 WFKEVV 266

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 24/246 (9%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 30  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 81
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 82  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 138
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFA 341
           L   +G LK+ADFG S         P + + T C    Y+ PE+ +   +D KVD++S  
Sbjct: 139 LLGSAGELKIADFGWSV------HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 192
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           ++  E + G PPF     N   + Y    R  F  P      G ++LI       P++RP
Sbjct: 193 VLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRP 248
Query: 402 TFRQII 407
             R+++
Sbjct: 249 MLREVL 254

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 65/243 (26%), Positives = 113/243 (46%), Gaps = 24/243 (9%)
Query: 168 FILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ + +
Sbjct: 31  FILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATRVYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
           + EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+L  
Sbjct: 83  ILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLG 139
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFALIL 344
            +G LK+ADFG S         P + + T C    Y+ PE+ +   +D KVD++S  ++ 
Sbjct: 140 SAGELKIADFGWSV------HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLC 193
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            E + G PPF     N   + Y    R  F  P      G ++LI       P++RP  R
Sbjct: 194 YEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLR 249
Query: 405 QII 407
           +++
Sbjct: 250 EVL 252

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 72/260 (27%), Positives = 126/260 (48%), Gaps = 31/260 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLP 233
            + VAVK L ++    D  +     E+ +++ I +H N++  LGA TQ  P+ ++  Y  
Sbjct: 67  AVTVAVKMLKDDATEKD--LSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYAS 124
Query: 234 KGDLRAFL--KRKGALKPST--------------AVRFALDIARGMNYLHENKPVPIIHR 277
           KG+LR +L  +R   ++ S                V     +ARGM YL   K    IHR
Sbjct: 125 KGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHR 181
Query: 278 DLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           DL   N+L  ++  +K+ADFG+++ +  +   +  T      +++APE   +  Y  + D
Sbjct: 182 DLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSD 241
Query: 337 VFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECW 393
           V+SF +++ E+   G  P+      E+ K      R   P     +LY      ++ +CW
Sbjct: 242 VWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYM-----MMRDCW 296
Query: 394 NEKPAKRPTFRQIITRLESI 413
           +  P++RPTF+Q++  L+ I
Sbjct: 297 HAVPSQRPTFKQLVEDLDRI 316

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 24/246 (9%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 34  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 85
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 86  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 142
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFA 341
           L   +G LK+ADFG S         P + + T C    Y+ PE+ +   +D KVD++S  
Sbjct: 143 LLGSAGELKIADFGWSV------HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           ++  E + G PPF     N   + Y    R  F  P      G ++LI       P++RP
Sbjct: 197 VLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRP 252
Query: 402 TFRQII 407
             R+++
Sbjct: 253 MLREVL 258

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 24/246 (9%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 35  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 86
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 87  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 143
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFA 341
           L   +G LK+ADFG S         P + + T C    Y+ PE+ +   +D KVD++S  
Sbjct: 144 LLGSAGELKIADFGWSV------HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 197
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           ++  E + G PPF     N   + Y    R  F  P      G ++LI       P++RP
Sbjct: 198 VLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRP 253
Query: 402 TFRQII 407
             R+++
Sbjct: 254 MLREVL 259

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 24/246 (9%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 34  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 85
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 86  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 142
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFA 341
           L   +G LK+ADFG S         P + +D  C    Y+ PE+ +   +D KVD++S  
Sbjct: 143 LLGSAGELKIADFGWSV------HAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           ++  E + G PPF     N   + Y    R  F  P      G ++LI       P++RP
Sbjct: 197 VLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRP 252
Query: 402 TFRQII 407
             R+++
Sbjct: 253 MLREVL 258

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 113/243 (46%), Gaps = 18/243 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 34  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 85
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 86  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 142
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           L   +G LK+ADFG S +      R   C   +  Y+ PE+ +   +D KVD++S  ++ 
Sbjct: 143 LLGSAGELKIADFGWS-VHAPSSRRXXLC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLC 199
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            E + G PPF     N   + Y    R  F  P      G ++LI       P++RP  R
Sbjct: 200 YEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLR 255
Query: 405 QII 407
           +++
Sbjct: 256 EVL 258

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 113/243 (46%), Gaps = 18/243 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 31  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 83  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 139
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           L   +G LK+ADFG S +      R   C   +  Y+ PE+ +   +D KVD++S  ++ 
Sbjct: 140 LLGSAGELKIADFGWS-VHAPSSRRTXLC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLC 196
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            E + G PPF     N   + Y    R  F  P      G ++LI       P++RP  R
Sbjct: 197 YEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLR 252
Query: 405 QII 407
           +++
Sbjct: 253 EVL 255

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 113/246 (45%), Gaps = 24/246 (9%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 36  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 87
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 88  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 144
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFA 341
           L   +G LK+ADFG S         P + + T C    Y+ PE  +   +D KVD++S  
Sbjct: 145 LLGSAGELKIADFGWSV------HAPSSRRTTLCGTLDYLPPEXIEGRXHDEKVDLWSLG 198
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           ++  E + G PPF     N   + Y    R  F  P      G ++LI       P++RP
Sbjct: 199 VLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRP 254
Query: 402 TFRQII 407
             R+++
Sbjct: 255 XLREVL 260

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 24/246 (9%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 36  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 87
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 88  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 144
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFA 341
           L   +G LK+ADFG S         P + + T C    Y+ PE+ +   +D KVD++S  
Sbjct: 145 LLGSAGELKIADFGWSV------HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           ++  E + G PPF     N   + Y    R  F  P      G ++LI       P++RP
Sbjct: 199 VLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRP 254
Query: 402 TFRQII 407
             R+++
Sbjct: 255 MLREVL 260

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 24/246 (9%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 31  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 83  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 139
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFA 341
           L   +G LK+ADFG S         P + + T C    Y+ PE+ +   +D KVD++S  
Sbjct: 140 LLGSAGELKIADFGWSV------HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           ++  E + G PPF     N   + Y    R  F  P      G ++LI       P++RP
Sbjct: 194 VLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRP 249
Query: 402 TFRQII 407
             R+++
Sbjct: 250 MLREVL 255

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 113/243 (46%), Gaps = 18/243 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 31  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 83  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 139
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           L   +G LK+ADFG S +      R   C   +  Y+ PE+ +   +D KVD++S  ++ 
Sbjct: 140 LLGSAGELKIADFGWS-VHAPSSRRAALC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLC 196
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            E + G PPF     N   + Y    R  F  P      G ++LI       P++RP  R
Sbjct: 197 YEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLR 252
Query: 405 QII 407
           +++
Sbjct: 253 EVL 255

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 113/243 (46%), Gaps = 18/243 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 34  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 85
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 86  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 142
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           L   +G LK+ADFG S +      R   C   +  Y+ PE+ +   +D KVD++S  ++ 
Sbjct: 143 LLGSAGELKIADFGWS-VHAPSSRRAALC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLC 199
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            E + G PPF     N   + Y    R  F  P      G ++LI       P++RP  R
Sbjct: 200 YEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLR 255
Query: 405 QII 407
           +++
Sbjct: 256 EVL 258

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 113/243 (46%), Gaps = 18/243 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 33  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 84
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 85  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 141
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           L   +G LK+ADFG S +      R   C   +  Y+ PE+ +   +D KVD++S  ++ 
Sbjct: 142 LLGSAGELKIADFGWS-VHAPSSRRXXLC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLC 198
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            E + G PPF     N   + Y    R  F  P      G ++LI       P++RP  R
Sbjct: 199 YEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLR 254
Query: 405 QII 407
           +++
Sbjct: 255 EVL 257

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 113/243 (46%), Gaps = 18/243 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 31  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 83  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 139
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           L   +G LK+ADFG S +      R   C   +  Y+ PE+ +   +D KVD++S  ++ 
Sbjct: 140 LLGSAGELKIADFGWS-VHAPSSRRXXLC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLC 196
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            E + G PPF     N   + Y    R  F  P      G ++LI       P++RP  R
Sbjct: 197 YEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLR 252
Query: 405 QII 407
           +++
Sbjct: 253 EVL 255

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 65/246 (26%), Positives = 114/246 (46%), Gaps = 24/246 (9%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 57  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 108
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 109 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 165
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFA 341
           L   +G LK+ADFG S         P + +D  C    Y+ PE+ +   +D KVD++S  
Sbjct: 166 LLGSAGELKIADFGWSV------HAPSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 219
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           ++  E + G PPF     N   + Y    R  F  P      G ++LI       P++RP
Sbjct: 220 VLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRP 275
Query: 402 TFRQII 407
             R+++
Sbjct: 276 MLREVL 281

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 113/243 (46%), Gaps = 18/243 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 57  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 108
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 109 VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 165
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           L   +G LK+ADFG S +      R   C   +  Y+ PE+ +   +D KVD++S  ++ 
Sbjct: 166 LLGSAGELKIADFGWS-VHAPSSRRTTLC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLC 222
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            E + G PPF     N   + Y    R  F  P      G ++LI       P++RP  R
Sbjct: 223 YEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLR 278
Query: 405 QII 407
           +++
Sbjct: 279 EVL 281

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 73/235 (31%), Positives = 119/235 (50%), Gaps = 25/235 (10%)
Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGALKPS 250
           ++ + F+ E+ ++  + HPN+V+  G +   +P  +V E++P GDL    L +   +K S
Sbjct: 65  EKFQEFQREVFIMSNLNHPNIVKLYGLM--HNPPRMVMEFVPCGDLYHRLLDKAHPIKWS 122
Query: 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNL--KVADFGVSKLLTV 305
             +R  LDIA G+ Y+    P PI+HRDL   NI     D++  +  KVADF +S+    
Sbjct: 123 VKLRLMLDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ---- 177
Query: 306 KEDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
           +    ++    + +++APE    EE  Y  K D +SFA+IL  ++ G  PF      ++ 
Sbjct: 178 QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIK 237
Query: 364 KAYAARQ---RP--PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
                R+   RP  P   P +L     + +IE CW+  P KRP F  I+  L  +
Sbjct: 238 FINMIREEGLRPTIPEDCPPRL-----RNVIELCWSGDPKKRPHFSYIVKELSEL 287

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 123/256 (48%), Gaps = 15/256 (5%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+ +G +       I VAVK   ++   D+     F  E  +++ + HP++V+ +G + +
Sbjct: 27  EVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE--KFMSEAVIMKNLDHPHIVKLIG-IIE 83
Query: 222 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             P  I+ E  P G+L  +L+R K +LK  T V ++L I + M YL   + +  +HRD+ 
Sbjct: 84  EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESINCVHRDIA 140
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
             NIL      +K+ DFG+S+ +  ++    +      ++++PE      + T  DV+ F
Sbjct: 141 VRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMF 200
Query: 341 ALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKP 397
           A+ + E++  G  PF    + +V        R   P   P  LY      L+  CW+  P
Sbjct: 201 AVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT-----LMTRCWDYDP 255
Query: 398 AKRPTFRQIITRLESI 413
           + RP F +++  L  +
Sbjct: 256 SDRPRFTELVCSLSDV 271

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 113/243 (46%), Gaps = 18/243 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 36  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 87
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 88  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 144
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           L   +G LK+ADFG S +      R   C   +  Y+ PE+ +   +D KVD++S  ++ 
Sbjct: 145 LLGSAGELKIADFGWS-VHAPSSRRTDLC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLC 201
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            E + G PPF     N   + Y    R  F  P      G ++LI       P++RP  R
Sbjct: 202 YEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLR 257
Query: 405 QII 407
           +++
Sbjct: 258 EVL 260

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 113/243 (46%), Gaps = 18/243 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 31  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 83  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 139
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           L   +G LK+ADFG S +      R   C   +  Y+ PE+ +   +D KVD++S  ++ 
Sbjct: 140 LLGSAGELKIADFGWS-VHAPSSRRTELC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLC 196
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            E + G PPF     N   + Y    R  F  P      G ++LI       P++RP  R
Sbjct: 197 YEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLR 252
Query: 405 QII 407
           +++
Sbjct: 253 EVL 255

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 123/256 (48%), Gaps = 15/256 (5%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+ +G +       I VAVK   ++   D+     F  E  +++ + HP++V+ +G + +
Sbjct: 23  EVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE--KFMSEAVIMKNLDHPHIVKLIG-IIE 79
Query: 222 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             P  I+ E  P G+L  +L+R K +LK  T V ++L I + M YL   + +  +HRD+ 
Sbjct: 80  EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYL---ESINCVHRDIA 136
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
             NIL      +K+ DFG+S+ +  ++    +      ++++PE      + T  DV+ F
Sbjct: 137 VRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMF 196
Query: 341 ALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKP 397
           A+ + E++  G  PF    + +V        R   P   P  LY      L+  CW+  P
Sbjct: 197 AVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT-----LMTRCWDYDP 251
Query: 398 AKRPTFRQIITRLESI 413
           + RP F +++  L  +
Sbjct: 252 SDRPRFTELVCSLSDV 267

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 122/256 (47%), Gaps = 15/256 (5%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ 221
           E+ +G +       I VAVK   ++   D+     F  E  +++ + HP++V+ +G + +
Sbjct: 39  EVYEGVYTNHKGEKINVAVKTCKKDCTLDNKE--KFMSEAVIMKNLDHPHIVKLIG-IIE 95
Query: 222 SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
             P  I+ E  P G+L  +L+R K +LK  T V ++L I + M YL     +  +HRD+ 
Sbjct: 96  EEPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIA 152
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
             NIL      +K+ DFG+S+ +  ++    +      ++++PE      + T  DV+ F
Sbjct: 153 VRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMF 212
Query: 341 ALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKP 397
           A+ + E++  G  PF    + +V        R   P   P  LY      L+  CW+  P
Sbjct: 213 AVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPKPDLCPPVLYT-----LMTRCWDYDP 267
Query: 398 AKRPTFRQIITRLESI 413
           + RP F +++  L  +
Sbjct: 268 SDRPRFTELVCSLSDV 283

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 113/243 (46%), Gaps = 18/243 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 31  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 83  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 139
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           L   +G LK+ADFG S +      R   C   +  Y+ PE+ +   +D KVD++S  ++ 
Sbjct: 140 LLGSAGELKIADFGWS-VHAPSSRRTDLC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLC 196
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            E + G PPF     N   + Y    R  F  P      G ++LI       P++RP  R
Sbjct: 197 YEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLR 252
Query: 405 QII 407
           +++
Sbjct: 253 EVL 255

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 113/243 (46%), Gaps = 18/243 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 32  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 83
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 84  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 140
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           L   +G LK+ADFG S +      R   C   +  Y+ PE+ +   +D KVD++S  ++ 
Sbjct: 141 LLGSAGELKIADFGWS-VHAPSSRRTDLC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLC 197
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            E + G PPF     N   + Y    R  F  P      G ++LI       P++RP  R
Sbjct: 198 YEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLR 253
Query: 405 QII 407
           +++
Sbjct: 254 EVL 256

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/243 (26%), Positives = 113/243 (46%), Gaps = 18/243 (7%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 31  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 82
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 83  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 139
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           L   +G LK+ADFG S +      R   C   +  Y+ PE+ +   +D KVD++S  ++ 
Sbjct: 140 LLGSAGELKIADFGWS-VHAPSSRRTDLC--GTLDYLPPEMIEGRMHDEKVDLWSLGVLC 196
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            E + G PPF     N   + Y    R  F  P      G ++LI       P++RP  R
Sbjct: 197 YEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRPMLR 252
Query: 405 QII 407
           +++
Sbjct: 253 EVL 255

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 24/246 (9%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 34  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 85
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 86  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 142
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFA 341
           L   +G LK+A+FG S         P + + T C    Y+ PE+ +   +D KVD++S  
Sbjct: 143 LLGSAGELKIANFGWSV------HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           ++  E + G PPF     N   + Y    R  F  P      G ++LI       P++RP
Sbjct: 197 VLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRP 252
Query: 402 TFRQII 407
             R+++
Sbjct: 253 MLREVL 258

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 127/261 (48%), Gaps = 33/261 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVK+L     S  D+ R F+ E+ +L+ +    +V++ G         + +V EYL
Sbjct: 39  GALVAVKQLQH---SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 95
Query: 233 PKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR FL+R  A L  S  + ++  I +GM YL   +    +HRDL   NIL +   +
Sbjct: 96  PSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAH 152
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ADFG++KLL + +D  +  +   +   + APE   +  +  + DV+SF ++L E+  
Sbjct: 153 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 212
Query: 349 ---EGCPPFT-----MKHDNEVPK--------AYAARQRPPFKAPAKLYARGLKELIEEC 392
              + C P       M  + +VP             R   P   PA+++     EL++ C
Sbjct: 213 YCDKSCSPSAEFLRMMGSERDVPALSRLLELLEEGQRLPAPPACPAEVH-----ELMKLC 267
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W   P  RP+F  +  +L+ +
Sbjct: 268 WAPSPQDRPSFSALGPQLDML 288

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 125/262 (47%), Gaps = 40/262 (15%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           ++VAVK L     +D+    A   EL ++  + +H N+V  LGA T   P++++TEY   
Sbjct: 77  LKVAVKMLKSTAHADEKE--ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCY 134
Query: 235 GDLRAFLKRK------GALKPS----------TAVRFALDIARGMNYLHENKPVPIIHRD 278
           GDL  FL+RK       +  PS            + F+  +A+GM +L        IHRD
Sbjct: 135 GDLLNFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKN---CIHRD 191
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKNEEYDTKV 335
           +   N+L  +    K+ DFG+++   +  D     +  +    +++APE   +  Y  + 
Sbjct: 192 VAARNVLLTNGHVAKIGDFGLAR--DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQS 249
Query: 336 DVFSFALILQEMIE-GCPPF-----TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389
           DV+S+ ++L E+   G  P+       K    V   Y   Q P F AP  +Y+     ++
Sbjct: 250 DVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQ-PAF-APKNIYS-----IM 302
Query: 390 EECWNEKPAKRPTFRQIITRLE 411
           + CW  +P  RPTF+QI + L+
Sbjct: 303 QACWALEPTHRPTFQQICSFLQ 324

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 114/246 (46%), Gaps = 24/246 (9%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 33  QSKFILALKVLFKAQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 84
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 85  VYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 141
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFA 341
           L   +G LK+A+FG S         P + + T C    Y+ PE+ +   +D KVD++S  
Sbjct: 142 LLGSAGELKIANFGWSV------HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 195
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           ++  E + G PPF     N   + Y    R  F  P      G ++LI       P++RP
Sbjct: 196 VLCYEFLVGKPPFEA---NTYQETYKRISRVEFTFP-DFVTEGARDLISRLLKHNPSQRP 251
Query: 402 TFRQII 407
             R+++
Sbjct: 252 MLREVL 257

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 80/283 (28%), Positives = 136/283 (48%), Gaps = 29/283 (10%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 8   EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 58
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 59  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 117
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ----D 315
           ARGM+YLH      IIHRDL+ +NI   +   +K+ DFG   L TVK     + Q     
Sbjct: 118 ARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFG---LATVKSRWSGSHQFEQLS 171
Query: 316 TSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFT--MKHDNEVPKAYAARQ 370
            S  ++APEV + ++   Y  + DV++F ++L E++ G  P++     D  +        
Sbjct: 172 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 231
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
            P          + +K L+ EC  +K  +RP+F +I+  +E +
Sbjct: 232 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 274

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 99.4 bits (246), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 127/261 (48%), Gaps = 33/261 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVK+L     S  D+ R F+ E+ +L+ +    +V++ G         + +V EYL
Sbjct: 40  GALVAVKQLQH---SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 96
Query: 233 PKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR FL+R  A L  S  + ++  I +GM YL   +    +HRDL   NIL +   +
Sbjct: 97  PSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAH 153
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ADFG++KLL + +D  +  +   +   + APE   +  +  + DV+SF ++L E+  
Sbjct: 154 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 213
Query: 349 ---EGCPPFT-----MKHDNEVPK--------AYAARQRPPFKAPAKLYARGLKELIEEC 392
              + C P       M  + +VP             R   P   PA+++     EL++ C
Sbjct: 214 YCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVH-----ELMKLC 268
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W   P  RP+F  +  +L+ +
Sbjct: 269 WAPSPQDRPSFSALGPQLDML 289

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 77/261 (29%), Positives = 129/261 (49%), Gaps = 33/261 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG-AVTQSSP-MMIVTEYL 232
           G  VAVK+L     S  D+ R F+ E+ +L+ +    +V++ G +     P + +V EYL
Sbjct: 36  GALVAVKQLQH---SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRPELRLVMEYL 92
Query: 233 PKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR FL+R  A L  S  + ++  I +GM YL   +    +HRDL   NIL +   +
Sbjct: 93  PSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAH 149
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ADFG++KLL + +D  +  +   +   + APE   +  +  + DV+SF ++L E+  
Sbjct: 150 VKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 209
Query: 349 ---EGCPPFT-----MKHDNEVPK--------AYAARQRPPFKAPAKLYARGLKELIEEC 392
              + C P       M  + +VP             R   P   PA+++     EL++ C
Sbjct: 210 YCDKSCSPSAEFLRMMGCERDVPALCRLLELLEEGQRLPAPPACPAEVH-----ELMKLC 264
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W   P  RP+F  +  +L+ +
Sbjct: 265 WAPSPQDRPSFSALGPQLDML 285

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/231 (29%), Positives = 117/231 (50%), Gaps = 11/231 (4%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VA+K +  +++   D       E++ L+ +RHP++++    +T  + +++V EY   G+
Sbjct: 36  KVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGE 94
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++  K  +      RF   I   + Y H +K   I+HRDL+P N+L DD+ N+K+AD
Sbjct: 95  LFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIAD 151
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFT 355
           FG+S ++T       +C   S  Y APEV   + Y   +VDV+S  ++L  M+ G  PF 
Sbjct: 152 FGLSNIMTDGNFLKTSC--GSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFD 209
Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
              D  +P  +       +  P  L + G + LI       P +R T ++I
Sbjct: 210 ---DEFIPNLFKKVNSCVYVMPDFL-SPGAQSLIRRMIVADPMQRITIQEI 256

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 76/261 (29%), Positives = 127/261 (48%), Gaps = 33/261 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVK+L     S  D+ R F+ E+ +L+ +    +V++ G         + +V EYL
Sbjct: 52  GALVAVKQLQH---SGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYL 108
Query: 233 PKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR FL+R  A L  S  + ++  I +GM YL   +    +HRDL   NIL +   +
Sbjct: 109 PSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAH 165
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ADFG++KLL + +D  +  +   +   + APE   +  +  + DV+SF ++L E+  
Sbjct: 166 VKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFT 225
Query: 349 ---EGCPPFT-----MKHDNEVPK--------AYAARQRPPFKAPAKLYARGLKELIEEC 392
              + C P       M  + +VP             R   P   PA+++     EL++ C
Sbjct: 226 YCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVH-----ELMKLC 280
Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W   P  RP+F  +  +L+ +
Sbjct: 281 WAPSPQDRPSFSALGPQLDML 301

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 125/263 (47%), Gaps = 18/263 (6%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VA+K + +  ++     + FR E+ +++ 
Sbjct: 9   PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKI 67
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + ++ EY   G++  +L   G +K   A      I   + Y 
Sbjct: 68  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 127
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
           H+ +   I+HRDL+  N+L D   N+K+ADFG S   TV       C   S  Y APE+F
Sbjct: 128 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFC--GSPPYAAPELF 182
Query: 327 KNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKLYARG 384
           + ++YD  +VDV+S  +IL  ++ G  PF  ++  E+  +    + R PF          
Sbjct: 183 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD----- 237
Query: 385 LKELIEECWNEKPAKRPTFRQII 407
            + L++      P KR T  QI+
Sbjct: 238 CENLLKRFLVLNPIKRGTLEQIM 260

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 99.0 bits (245), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 136/277 (49%), Gaps = 21/277 (7%)
Query: 147 EYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           +YEI    ++    +      ++ +G ++      + VA+K   +   SD  R +  ++ 
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEA 62
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           L + Q   HP++V+ +G +T++ P+ I+ E    G+LR+FL+ RK +L  ++ + +A  +
Sbjct: 63  LTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 120
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           +  + YL   +    +HRD+   N+L   +  +K+ DFG+S+ +        +      +
Sbjct: 121 STALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK 177
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAYAARQRPPF--KA 376
           ++APE      + +  DV+ F + + E ++ G  PF    +N+V       +R P     
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 237
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           P  LY+     L+ +CW   P++RP F ++  +L +I
Sbjct: 238 PPTLYS-----LMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 125/263 (47%), Gaps = 18/263 (6%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VAVK + +  ++     + FR E+ +++ 
Sbjct: 11  PHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKV 69
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + +V EY   G++  +L   G +K   A      I   + Y 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
           H+     I+HRDL+  N+L D   N+K+ADFG S   T        C   S  Y APE+F
Sbjct: 130 HQK---FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPELF 184
Query: 327 KNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKLYARG 384
           + ++YD  +VDV+S  +IL  ++ G  PF  ++  E+  +    + R PF          
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD----- 239
Query: 385 LKELIEECWNEKPAKRPTFRQII 407
            + L+++     P+KR T  QI+
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIM 262

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 128/267 (47%), Gaps = 36/267 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 39  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 96  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 152
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ DFG++K+L   ++     +  ++   + APE     ++    DV+SF ++L E+  
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
Query: 349 ----EGCPP--------------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
                  PP                + H  E+ K      RP    P ++Y      ++ 
Sbjct: 213 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYM-----IMT 266
Query: 391 ECWNEKPAKRPTFRQIITRLESINNSI 417
           ECWN    +RP+FR +  R++ I +++
Sbjct: 267 ECWNNNVNQRPSFRDLALRVDQIRDNM 293

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 128/267 (47%), Gaps = 36/267 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 39  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 96  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 152
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ DFG++K+L   ++     +  ++   + APE     ++    DV+SF ++L E+  
Sbjct: 153 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 212
Query: 349 ----EGCPP--------------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
                  PP                + H  E+ K      RP    P ++Y      ++ 
Sbjct: 213 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYM-----IMT 266
Query: 391 ECWNEKPAKRPTFRQIITRLESINNSI 417
           ECWN    +RP+FR +  R++ I +++
Sbjct: 267 ECWNNNVNQRPSFRDLALRVDQIRDNM 293

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 128/267 (47%), Gaps = 36/267 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 57  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 113
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 114 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 170
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ DFG++K+L   ++     +  ++   + APE     ++    DV+SF ++L E+  
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230
Query: 349 ----EGCPP--------------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
                  PP                + H  E+ K      RP    P ++Y      ++ 
Sbjct: 231 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYM-----IMT 284
Query: 391 ECWNEKPAKRPTFRQIITRLESINNSI 417
           ECWN    +RP+FR +  R++ I +++
Sbjct: 285 ECWNNNVNQRPSFRDLALRVDQIRDNM 311

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 128/267 (47%), Gaps = 36/267 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 38  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 94
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 95  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 151
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ DFG++K+L   ++     +  ++   + APE     ++    DV+SF ++L E+  
Sbjct: 152 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 211
Query: 349 ----EGCPP--------------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
                  PP                + H  E+ K      RP    P ++Y      ++ 
Sbjct: 212 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYM-----IMT 265
Query: 391 ECWNEKPAKRPTFRQIITRLESINNSI 417
           ECWN    +RP+FR +  R++ I +++
Sbjct: 266 ECWNNNVNQRPSFRDLALRVDQIRDNM 292

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 128/267 (47%), Gaps = 36/267 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 57  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 113
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 114 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 170
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ DFG++K+L   ++     +  ++   + APE     ++    DV+SF ++L E+  
Sbjct: 171 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 230
Query: 349 ----EGCPP--------------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
                  PP                + H  E+ K      RP    P ++Y      ++ 
Sbjct: 231 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYM-----IMT 284
Query: 391 ECWNEKPAKRPTFRQIITRLESINNSI 417
           ECWN    +RP+FR +  R++ I +++
Sbjct: 285 ECWNNNVNQRPSFRDLALRVDQIRDNM 311

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 125/263 (47%), Gaps = 18/263 (6%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VAVK + +  ++     + FR E+ +++ 
Sbjct: 11  PHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKV 69
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + +V EY   G++  +L   G +K   A      I   + Y 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
           H+     I+HRDL+  N+L D   N+K+ADFG S   T        C   S  Y APE+F
Sbjct: 130 HQK---FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPELF 184
Query: 327 KNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKLYARG 384
           + ++YD  +VDV+S  +IL  ++ G  PF  ++  E+  +    + R PF          
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD----- 239
Query: 385 LKELIEECWNEKPAKRPTFRQII 407
            + L+++     P+KR T  QI+
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIM 262

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 128/267 (47%), Gaps = 36/267 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 46  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 102
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 103 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 159
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ DFG++K+L   ++     +  ++   + APE     ++    DV+SF ++L E+  
Sbjct: 160 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 219
Query: 349 ----EGCPP--------------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
                  PP                + H  E+ K      RP    P ++Y      ++ 
Sbjct: 220 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYM-----IMT 273
Query: 391 ECWNEKPAKRPTFRQIITRLESINNSI 417
           ECWN    +RP+FR +  R++ I +++
Sbjct: 274 ECWNNNVNQRPSFRDLALRVDQIRDNM 300

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 115/235 (48%), Gaps = 13/235 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VAVK + +  ++     + FR E+ +++ + HPN+V+    +     + +V EY   
Sbjct: 32  GKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKVLNHPNIVKLFEVIETEKTLYLVMEYASG 90
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++  +L   G +K   A      I   + Y H+     I+HRDL+  N+L D   N+K+
Sbjct: 91  GEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQK---FIVHRDLKAENLLLDADMNIKI 147
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT-KVDVFSFALILQEMIEGCPP 353
           ADFG S   T        C   S  Y APE+F+ ++YD  +VDV+S  +IL  ++ G  P
Sbjct: 148 ADFGFSNEFTFGNKLDTFC--GSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLP 205
Query: 354 FTMKHDNEV-PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           F  ++  E+  +    + R PF           + L+++     P+KR T  QI+
Sbjct: 206 FDGQNLKELRERVLRGKYRIPFYMSTD-----CENLLKKFLILNPSKRGTLEQIM 255

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 128/267 (47%), Gaps = 36/267 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 44  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 100
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 101 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 157
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ DFG++K+L   ++     +  ++   + APE     ++    DV+SF ++L E+  
Sbjct: 158 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 217
Query: 349 ----EGCPP--------------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
                  PP                + H  E+ K      RP    P ++Y      ++ 
Sbjct: 218 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYM-----IMT 271
Query: 391 ECWNEKPAKRPTFRQIITRLESINNSI 417
           ECWN    +RP+FR +  R++ I +++
Sbjct: 272 ECWNNNVNQRPSFRDLALRVDQIRDNM 298

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 128/267 (47%), Gaps = 36/267 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 42  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 98
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 99  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 155
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ DFG++K+L   ++     +  ++   + APE     ++    DV+SF ++L E+  
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215
Query: 349 ----EGCPP--------------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
                  PP                + H  E+ K      RP    P ++Y      ++ 
Sbjct: 216 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYM-----IMT 269
Query: 391 ECWNEKPAKRPTFRQIITRLESINNSI 417
           ECWN    +RP+FR +  R++ I +++
Sbjct: 270 ECWNNNVNQRPSFRDLALRVDQIRDNM 296

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 128/267 (47%), Gaps = 36/267 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 45  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 101
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 102 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 158
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ DFG++K+L   ++     +  ++   + APE     ++    DV+SF ++L E+  
Sbjct: 159 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 218
Query: 349 ----EGCPP--------------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
                  PP                + H  E+ K      RP    P ++Y      ++ 
Sbjct: 219 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYM-----IMT 272
Query: 391 ECWNEKPAKRPTFRQIITRLESINNSI 417
           ECWN    +RP+FR +  R++ I +++
Sbjct: 273 ECWNNNVNQRPSFRDLALRVDQIRDNM 299

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 127/267 (47%), Gaps = 36/267 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 37  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 93
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 94  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 150
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ DFG++K+L   ++     +  ++   + APE     ++    DV+SF ++L E+  
Sbjct: 151 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 210
Query: 349 ----EGCPP--------------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
                  PP                + H  E+ K      RP    P ++Y      ++ 
Sbjct: 211 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYM-----IMT 264
Query: 391 ECWNEKPAKRPTFRQIITRLESINNSI 417
           ECWN    +RP+FR +  R++ I + +
Sbjct: 265 ECWNNNVNQRPSFRDLALRVDQIRDQM 291

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 98.6 bits (244), Expect = 6e-21,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 128/267 (47%), Gaps = 36/267 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 43  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 99
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 100 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 156
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ DFG++K+L   ++     +  ++   + APE     ++    DV+SF ++L E+  
Sbjct: 157 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 216
Query: 349 ----EGCPP--------------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
                  PP                + H  E+ K      RP    P ++Y      ++ 
Sbjct: 217 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYM-----IMT 270
Query: 391 ECWNEKPAKRPTFRQIITRLESINNSI 417
           ECWN    +RP+FR +  R++ I +++
Sbjct: 271 ECWNNNVNQRPSFRDLALRVDQIRDNM 297

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 127/267 (47%), Gaps = 36/267 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 70  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 126
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 127 PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 183
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ DFG++K+L   ++     +  ++   + APE     ++    DV+SF ++L E+  
Sbjct: 184 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 243
Query: 349 ----EGCPP--------------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
                  PP                + H  E+ K      RP    P ++Y      ++ 
Sbjct: 244 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYM-----IMT 297
Query: 391 ECWNEKPAKRPTFRQIITRLESINNSI 417
           ECWN    +RP+FR +  R++ I + +
Sbjct: 298 ECWNNNVNQRPSFRDLALRVDQIRDQM 324

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 136/277 (49%), Gaps = 21/277 (7%)
Query: 147 EYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           +YEI    ++    +      ++ +G ++      + VA+K   +   SD  R +  ++ 
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEA 62
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           L + Q   HP++V+ +G +T++ P+ I+ E    G+LR+FL+ RK +L  ++ + +A  +
Sbjct: 63  LTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 120
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           +  + YL   +    +HRD+   N+L   +  +K+ DFG+S+ +        +      +
Sbjct: 121 STALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAYAARQRPPF--KA 376
           ++APE      + +  DV+ F + + E ++ G  PF    +N+V       +R P     
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 237
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           P  LY+     L+ +CW   P++RP F ++  +L +I
Sbjct: 238 PPTLYS-----LMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 76/240 (31%), Positives = 122/240 (50%), Gaps = 28/240 (11%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK +    +S    V AF  E  +++ ++H  +V+ L AV    P+ I+TE++ KG 
Sbjct: 208 KVAVKTMKPGSMS----VEAFLAEANVMKTLQHDKLVK-LHAVVTKEPIYIITEFMAKGS 262
Query: 237 LRAFLKR-KGALKP-STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           L  FLK  +G+ +P    + F+  IA GM ++ +      IHRDL  +NIL   S   K+
Sbjct: 263 LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKI 319
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPP 353
           ADFG+++   V    P+       ++ APE      +  K DV+SF ++L E++  G  P
Sbjct: 320 ADFGLAR---VGAKFPI-------KWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 369
Query: 354 FTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
           +    + EV +A     R   P   P +LY      ++  CW  +P +RPTF  I + L+
Sbjct: 370 YPGMSNPEVIRALERGYRMPRPENCPEELY-----NIMMRCWKNRPEERPTFEYIQSVLD 424

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 136/277 (49%), Gaps = 21/277 (7%)
Query: 147 EYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           +YEI    ++    +      ++ +G ++      + VA+K   +   SD  R +  ++ 
Sbjct: 9   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEA 67
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           L + Q   HP++V+ +G +T++ P+ I+ E    G+LR+FL+ RK +L  ++ + +A  +
Sbjct: 68  LTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           +  + YL   +    +HRD+   N+L   +  +K+ DFG+S+ +        +      +
Sbjct: 126 STALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAYAARQRPPF--KA 376
           ++APE      + +  DV+ F + + E ++ G  PF    +N+V       +R P     
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 242
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           P  LY+     L+ +CW   P++RP F ++  +L +I
Sbjct: 243 PPTLYS-----LMTKCWAYDPSRRPRFTELKAQLSTI 274

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 142/290 (48%), Gaps = 35/290 (12%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 31  EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 81
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 82  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 140
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ----D 315
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG   L TVK     + Q     
Sbjct: 141 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG---LATVKSRWSGSHQFEQLS 194
Query: 316 TSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNE-----VPKAYA 367
            S  ++APEV + ++   Y  + DV++F ++L E++ G  P++  ++ +     V + Y 
Sbjct: 195 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 254
Query: 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
           +   P          + +K L+ EC  +K  +RP F QI+  +E +  S+
Sbjct: 255 S---PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 301

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 136/277 (49%), Gaps = 21/277 (7%)
Query: 147 EYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           +YEI    ++    +      ++ +G ++      + VA+K   +   SD  R +  ++ 
Sbjct: 6   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEA 64
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           L + Q   HP++V+ +G +T++ P+ I+ E    G+LR+FL+ RK +L  ++ + +A  +
Sbjct: 65  LTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 122
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           +  + YL   +    +HRD+   N+L   +  +K+ DFG+S+ +        +      +
Sbjct: 123 STALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 179
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAYAARQRPPF--KA 376
           ++APE      + +  DV+ F + + E ++ G  PF    +N+V       +R P     
Sbjct: 180 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 239
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           P  LY+     L+ +CW   P++RP F ++  +L +I
Sbjct: 240 PPTLYS-----LMTKCWAYDPSRRPRFTELKAQLSTI 271

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 98.2 bits (243), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 136/277 (49%), Gaps = 21/277 (7%)
Query: 147 EYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           +YEI    ++    +      ++ +G ++      + VA+K   +   SD  R +  ++ 
Sbjct: 7   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEA 65
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           L + Q   HP++V+ +G +T++ P+ I+ E    G+LR+FL+ RK +L  ++ + +A  +
Sbjct: 66  LTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 123
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           +  + YL   +    +HRD+   N+L   +  +K+ DFG+S+ +        +      +
Sbjct: 124 STALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 180
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAYAARQRPPF--KA 376
           ++APE      + +  DV+ F + + E ++ G  PF    +N+V       +R P     
Sbjct: 181 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 240
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           P  LY+     L+ +CW   P++RP F ++  +L +I
Sbjct: 241 PPTLYS-----LMTKCWAYDPSRRPRFTELKAQLSTI 272

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 136/277 (49%), Gaps = 21/277 (7%)
Query: 147 EYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           +YEI    ++    +      ++ +G ++      + VA+K   +   SD  R +  ++ 
Sbjct: 1   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTC-KNCTSDSVREKFLQEA 59
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           L + Q   HP++V+ +G +T++ P+ I+ E    G+LR+FL+ RK +L  ++ + +A  +
Sbjct: 60  LTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           +  + YL   +    +HRD+   N+L   +  +K+ DFG+S+ +        +      +
Sbjct: 118 STALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAYAARQRPPF--KA 376
           ++APE      + +  DV+ F + + E ++ G  PF    +N+V       +R P     
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 234
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           P  LY+     L+ +CW   P++RP F ++  +L +I
Sbjct: 235 PPTLYS-----LMTKCWAYDPSRRPRFTELKAQLSTI 266

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 123/243 (50%), Gaps = 15/243 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            + VA+K   +   SD  R +  ++ L + Q   HP++V+ +G +T++ P+ I+ E    
Sbjct: 66  ALAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTL 122
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G+LR+FL+ RK +L  ++ + +A  ++  + YL   +    +HRD+   N+L   +  +K
Sbjct: 123 GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVK 179
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCP 352
           + DFG+S+ +        +      +++APE      + +  DV+ F + + E ++ G  
Sbjct: 180 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 239
Query: 353 PFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
           PF    +N+V       +R P     P  LY+     L+ +CW   P++RP F ++  +L
Sbjct: 240 PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS-----LMTKCWAYDPSRRPRFTELKAQL 294
Query: 411 ESI 413
            +I
Sbjct: 295 STI 297

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 136/277 (49%), Gaps = 21/277 (7%)
Query: 147 EYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           +YEI    ++    +      ++ +G ++      + VA+K   +   SD  R +  ++ 
Sbjct: 4   DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEA 62
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           L + Q   HP++V+ +G +T++ P+ I+ E    G+LR+FL+ RK +L  ++ + +A  +
Sbjct: 63  LTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 120
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           +  + YL   +    +HRD+   N+L   +  +K+ DFG+S+ +        +      +
Sbjct: 121 STALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAYAARQRPPF--KA 376
           ++APE      + +  DV+ F + + E ++ G  PF    +N+V       +R P     
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 237
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           P  LY+     L+ +CW   P++RP F ++  +L +I
Sbjct: 238 PPTLYS-----LMTKCWAYDPSRRPRFTELKAQLSTI 269

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 142/290 (48%), Gaps = 35/290 (12%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 32  EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 82
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 83  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 141
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ----D 315
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG   L TVK     + Q     
Sbjct: 142 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG---LATVKSRWSGSHQFEQLS 195
Query: 316 TSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNE-----VPKAYA 367
            S  ++APEV + ++   Y  + DV++F ++L E++ G  P++  ++ +     V + Y 
Sbjct: 196 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 255
Query: 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
           +   P          + +K L+ EC  +K  +RP F QI+  +E +  S+
Sbjct: 256 S---PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 302

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 98.2 bits (243), Expect = 8e-21,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 142/290 (48%), Gaps = 35/290 (12%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 9   EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 59
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 60  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 118
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ----D 315
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG   L TVK     + Q     
Sbjct: 119 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG---LATVKSRWSGSHQFEQLS 172
Query: 316 TSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNE-----VPKAYA 367
            S  ++APEV + ++   Y  + DV++F ++L E++ G  P++  ++ +     V + Y 
Sbjct: 173 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 232
Query: 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
           +   P          + +K L+ EC  +K  +RP F QI+  +E +  S+
Sbjct: 233 S---PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 279

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 136/277 (49%), Gaps = 21/277 (7%)
Query: 147 EYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           +YEI    ++    +      ++ +G ++      + VA+K   +   SD  R +  ++ 
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEA 442
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           L + Q   HP++V+ +G +T++ P+ I+ E    G+LR+FL+ RK +L  ++ + +A  +
Sbjct: 443 LTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 500
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           +  + YL   +    +HRD+   N+L   +  +K+ DFG+S+ +        +      +
Sbjct: 501 STALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAYAARQRPPF--KA 376
           ++APE      + +  DV+ F + + E ++ G  PF    +N+V       +R P     
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 617
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           P  LY+     L+ +CW   P++RP F ++  +L +I
Sbjct: 618 PPTLYS-----LMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 125/263 (47%), Gaps = 18/263 (6%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VAV+ + +  ++     + FR E+ +++ 
Sbjct: 11  PHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKV 69
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + +V EY   G++  +L   G +K   A      I   + Y 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
           H+     I+HRDL+  N+L D   N+K+ADFG S   T        C   S  Y APE+F
Sbjct: 130 HQK---FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFC--GSPPYAAPELF 184
Query: 327 KNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKLYARG 384
           + ++YD  +VDV+S  +IL  ++ G  PF  ++  E+  +    + R PF          
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD----- 239
Query: 385 LKELIEECWNEKPAKRPTFRQII 407
            + L+++     P+KR T  QI+
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIM 262

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 142/290 (48%), Gaps = 35/290 (12%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 6   EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 56
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 57  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 115
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ----D 315
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG   L TVK     + Q     
Sbjct: 116 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG---LATVKSRWSGSHQFEQLS 169
Query: 316 TSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNE-----VPKAYA 367
            S  ++APEV + ++   Y  + DV++F ++L E++ G  P++  ++ +     V + Y 
Sbjct: 170 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 229
Query: 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
           +   P          + +K L+ EC  +K  +RP F QI+  +E +  S+
Sbjct: 230 S---PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 276

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 98.2 bits (243), Expect = 9e-21,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 128/272 (47%), Gaps = 46/272 (16%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 39  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 95
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 96  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 152
Query: 292 LKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           +K+ DFG++K+L        VKE       ++   + APE     ++    DV+SF ++L
Sbjct: 153 VKIGDFGLTKVLPQDKEFFKVKEP-----GESPIFWYAPESLTESKFSVASDVWSFGVVL 207
Query: 345 QEMI-----EGCPP--------------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385
            E+         PP                + H  E+ K      RP    P ++Y    
Sbjct: 208 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYM--- 263
Query: 386 KELIEECWNEKPAKRPTFRQIITRLESINNSI 417
             ++ ECWN    +RP+FR +  R++ I +++
Sbjct: 264 --IMTECWNNNVNQRPSFRDLALRVDQIRDNM 293

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 142/290 (48%), Gaps = 35/290 (12%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 9   EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 59
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 60  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 118
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ----D 315
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG   L TVK     + Q     
Sbjct: 119 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG---LATVKSRWSGSHQFEQLS 172
Query: 316 TSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNE-----VPKAYA 367
            S  ++APEV + ++   Y  + DV++F ++L E++ G  P++  ++ +     V + Y 
Sbjct: 173 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 232
Query: 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
           +   P          + +K L+ EC  +K  +RP F QI+  +E +  S+
Sbjct: 233 S---PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 279

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 67/277 (24%), Positives = 136/277 (49%), Gaps = 21/277 (7%)
Query: 147 EYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           +YEI    ++    +      ++ +G ++      + VA+K   +   SD  R +  ++ 
Sbjct: 384 DYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTC-KNCTSDSVREKFLQEA 442
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           L + Q   HP++V+ +G +T++ P+ I+ E    G+LR+FL+ RK +L  ++ + +A  +
Sbjct: 443 LTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 500
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           +  + YL   +    +HRD+   N+L   +  +K+ DFG+S+ +        +      +
Sbjct: 501 STALAYLESKR---FVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCPPFTMKHDNEVPKAYAARQRPPF--KA 376
           ++APE      + +  DV+ F + + E ++ G  PF    +N+V       +R P     
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMPPNC 617
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           P  LY+     L+ +CW   P++RP F ++  +L +I
Sbjct: 618 PPTLYS-----LMTKCWAYDPSRRPRFTELKAQLSTI 649

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 63/243 (25%), Positives = 123/243 (50%), Gaps = 15/243 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            + VA+K   +   SD  R +  ++ L + Q   HP++V+ +G +T++ P+ I+ E    
Sbjct: 38  AMAVAIKTC-KNCTSDSVREKFLQEALTMRQ-FDHPHIVKLIGVITEN-PVWIIMELCTL 94
Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G+LR+FL+ RK +L  ++ + +A  ++  + YL   +    +HRD+   N+L   +  +K
Sbjct: 95  GELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSATDCVK 151
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE-MIEGCP 352
           + DFG+S+ +        +      +++APE      + +  DV+ F + + E ++ G  
Sbjct: 152 LGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 211
Query: 353 PFTMKHDNEVPKAYAARQRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
           PF    +N+V       +R P     P  LY+     L+ +CW   P++RP F ++  +L
Sbjct: 212 PFQGVKNNDVIGRIENGERLPMPPNCPPTLYS-----LMTKCWAYDPSRRPRFTELKAQL 266
Query: 411 ESI 413
            +I
Sbjct: 267 STI 269

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 142/290 (48%), Gaps = 35/290 (12%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 4   EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 54
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T +  + IVT++     L   L   +   +    +  A   
Sbjct: 55  VGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 113
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ----D 315
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG   L TVK     + Q     
Sbjct: 114 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG---LATVKSRWSGSHQFEQLS 167
Query: 316 TSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNE-----VPKAYA 367
            S  ++APEV + ++   Y  + DV++F ++L E++ G  P++  ++ +     V + Y 
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 227
Query: 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
           +   P          + +K L+ EC  +K  +RP F QI+  +E +  S+
Sbjct: 228 S---PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 82/290 (28%), Positives = 142/290 (48%), Gaps = 35/290 (12%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 4   EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 54
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 55  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 113
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ----D 315
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG   L TVK     + Q     
Sbjct: 114 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG---LATVKSRWSGSHQFEQLS 167
Query: 316 TSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNE-----VPKAYA 367
            S  ++APEV + ++   Y  + DV++F ++L E++ G  P++  ++ +     V + Y 
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 227
Query: 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
           +   P          + +K L+ EC  +K  +RP F QI+  +E +  S+
Sbjct: 228 S---PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 125/263 (47%), Gaps = 18/263 (6%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VAVK + +  ++     + FR E+ +++ 
Sbjct: 11  PHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIMKV 69
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + +V EY   G++  +L   G +K   A      I   + Y 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
           H+     I+HRDL+  N+L D   N+K+ADFG S   T        C   +  Y APE+F
Sbjct: 130 HQK---FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFC--GAPPYAAPELF 184
Query: 327 KNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKLYARG 384
           + ++YD  +VDV+S  +IL  ++ G  PF  ++  E+  +    + R PF          
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD----- 239
Query: 385 LKELIEECWNEKPAKRPTFRQII 407
            + L+++     P+KR T  QI+
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIM 262

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 128/267 (47%), Gaps = 36/267 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ E+L
Sbjct: 42  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEFL 98
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 99  PYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 155
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ DFG++K+L   ++     +  ++   + APE     ++    DV+SF ++L E+  
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215
Query: 349 ----EGCPP--------------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
                  PP                + H  E+ K      RP    P ++Y      ++ 
Sbjct: 216 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYM-----IMT 269
Query: 391 ECWNEKPAKRPTFRQIITRLESINNSI 417
           ECWN    +RP+FR +  R++ I +++
Sbjct: 270 ECWNNNVNQRPSFRDLALRVDQIRDNM 296

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 126/263 (47%), Gaps = 18/263 (6%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VA+K + +  ++     + FR E+ +++ 
Sbjct: 12  PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFR-EVRIMKI 70
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + ++ EY   G++  +L   G +K   A      I   + Y 
Sbjct: 71  LNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYC 130
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
           H+ +   I+HRDL+  N+L D   N+K+ADFG S   TV       C   +  Y APE+F
Sbjct: 131 HQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFC--GAPPYAAPELF 185
Query: 327 KNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKLYARG 384
           + ++YD  +VDV+S  +IL  ++ G  PF  ++  E+  +    + R PF       +  
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF-----YMSTD 240
Query: 385 LKELIEECWNEKPAKRPTFRQII 407
            + L++      P KR T  QI+
Sbjct: 241 CENLLKRFLVLNPIKRGTLEQIM 263

>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 75/252 (29%), Positives = 121/252 (48%), Gaps = 21/252 (8%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-----PM-MIVT 229
           ++VAVK L  ++I+  D +  F  E A +++  HP+V + +G   +S      P+ M++ 
Sbjct: 52  VKVAVKMLKADIIASSD-IEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVIL 110
Query: 230 EYLPKGDLRAFL--KRKGA----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
            ++  GDL AFL   R G     L   T VRF +DIA GM YL        IHRDL   N
Sbjct: 111 PFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARN 167
Query: 284 ILRDDSGNLKVADFGVS-KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
            +  +   + VADFG+S K+ +    R         +++A E   +  Y    DV++F +
Sbjct: 168 CMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGV 227
Query: 343 ILQE-MIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            + E M  G  P+    + E+        R   K P +     + +L+ +CW+  P +RP
Sbjct: 228 TMWEIMTRGQTPYAGIENAEIYNYLIGGNR--LKQPPECMEE-VYDLMYQCWSADPKQRP 284
Query: 402 TFRQIITRLESI 413
           +F  +   LE+I
Sbjct: 285 SFTCLRMELENI 296

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 75/263 (28%), Positives = 125/263 (47%), Gaps = 18/263 (6%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VAV+ + +  ++     + FR E+ +++ 
Sbjct: 11  PHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFR-EVRIMKV 69
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + +V EY   G++  +L   G +K   A      I   + Y 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 129
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
           H+     I+HRDL+  N+L D   N+K+ADFG S   T        C   S  Y APE+F
Sbjct: 130 HQK---FIVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFC--GSPPYAAPELF 184
Query: 327 KNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKLYARG 384
           + ++YD  +VDV+S  +IL  ++ G  PF  ++  E+  +    + R PF          
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYMSTD----- 239
Query: 385 LKELIEECWNEKPAKRPTFRQII 407
            + L+++     P+KR T  QI+
Sbjct: 240 CENLLKKFLILNPSKRGTLEQIM 262

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 135/283 (47%), Gaps = 29/283 (10%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 20  EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 70
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 71  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 129
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ----D 315
           ARGM+YLH      IIHRDL+ +NI   +   +K+ DFG   L T K     + Q     
Sbjct: 130 ARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFG---LATEKSRWSGSHQFEQLS 183
Query: 316 TSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFT--MKHDNEVPKAYAARQ 370
            S  ++APEV + ++   Y  + DV++F ++L E++ G  P++     D  +        
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
            P          + +K L+ EC  +K  +RP+F +I+  +E +
Sbjct: 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 70/230 (30%), Positives = 113/230 (49%), Gaps = 13/230 (5%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VAVK + +  ++     + FR E+ +++ 
Sbjct: 12  PHIGNYRLQKTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFR-EVRIMKI 70
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + +V EY   G++  +L   G +K   A      I   + Y 
Sbjct: 71  LNHPNIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYC 130
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
           H+     I+HRDL+  N+L D   N+K+ADFG S   TV       C   S  Y APE+F
Sbjct: 131 HQKY---IVHRDLKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFC--GSPPYAAPELF 185
Query: 327 KNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPF 374
           + ++YD  +VDV+S  +IL  ++ G  PF  ++  E+  +    + R PF
Sbjct: 186 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPF 235

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 96.7 bits (239), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 72/267 (26%), Positives = 128/267 (47%), Gaps = 36/267 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 40  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 96
Query: 233 PKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L K K  +     +++   I +GM YL   +    IHR+L   NIL ++   
Sbjct: 97  PYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRNLATRNILVENENR 153
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ DFG++K+L   ++     +  ++   + APE     ++    DV+SF ++L E+  
Sbjct: 154 VKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 213
Query: 349 ----EGCPP--------------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
                  PP                + H  E+ K      RP    P ++Y      ++ 
Sbjct: 214 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYM-----IMT 267
Query: 391 ECWNEKPAKRPTFRQIITRLESINNSI 417
           ECWN    +RP+FR +  R++ I +++
Sbjct: 268 ECWNNNVNQRPSFRDLALRVDQIRDNM 294

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 124/266 (46%), Gaps = 47/266 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++TE+   G
Sbjct: 51  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 165
Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEY 331
              NIL  +   +K+ DFG+++ +    D         PL       +++APE   +  Y
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL-------KWMAPETIFDRVY 218
Query: 332 DTKVDVFSFALILQEMIE-GCPPF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKE 387
             + DV+SF ++L E+   G  P+  +K D E  +      R R P     ++Y   L  
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML-- 276
Query: 388 LIEECWNEKPAKRPTFRQIITRLESI 413
              +CW+ +P++RPTF +++  L ++
Sbjct: 277 ---DCWHGEPSQRPTFSELVEHLGNL 299

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/256 (28%), Positives = 119/256 (46%), Gaps = 30/256 (11%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VAVK L +   + D+  + F  E  LL  ++H ++V+F G   +  P+++V EY+  G
Sbjct: 44  ILVAVKTLKD---ASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 100
Query: 236 DLRAFLKRKG-------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           DL  FL+  G              L  S  +  A  IA GM YL        +HRDL   
Sbjct: 101 DLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATR 157
Query: 283 NILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
           N L  ++  +K+ DFG+S+ + +    R         R++ PE     ++ T+ DV+S  
Sbjct: 158 NCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 217
Query: 342 LILQEMIE-GCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARGLKELIEECWNEKP 397
           ++L E+   G  P+    +NEV +        QRP    P ++Y     EL+  CW  +P
Sbjct: 218 VVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR-TCPQEVY-----ELMLGCWQREP 271
Query: 398 AKRPTFRQIITRLESI 413
             R   + I T L+++
Sbjct: 272 HMRKNIKGIHTLLQNL 287

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 96.7 bits (239), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 79/283 (27%), Positives = 135/283 (47%), Gaps = 29/283 (10%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 20  EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 70
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T +  + IVT++     L   L   +   +    +  A   
Sbjct: 71  VGVLRKTRHVNILLFMGYST-APQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQT 129
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ----D 315
           ARGM+YLH      IIHRDL+ +NI   +   +K+ DFG   L T K     + Q     
Sbjct: 130 ARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFG---LATEKSRWSGSHQFEQLS 183
Query: 316 TSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFT--MKHDNEVPKAYAARQ 370
            S  ++APEV + ++   Y  + DV++F ++L E++ G  P++     D  +        
Sbjct: 184 GSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSL 243
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
            P          + +K L+ EC  +K  +RP+F +I+  +E +
Sbjct: 244 SPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 127/267 (47%), Gaps = 36/267 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +    + ++ EYL
Sbjct: 42  GEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYL 98
Query: 233 PKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           P G LR +L+     +     +++   I +GM YL   +    IHRDL   NIL ++   
Sbjct: 99  PYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENR 155
Query: 292 LKVADFGVSKLLTVKEDRPLTCQ--DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI- 348
           +K+ DFG++K+L   ++     +  ++   + APE     ++    DV+SF ++L E+  
Sbjct: 156 VKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFT 215
Query: 349 ----EGCPP--------------FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
                  PP                + H  E+ K      RP    P ++Y      ++ 
Sbjct: 216 YIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPD-GCPDEIYM-----IMT 269
Query: 391 ECWNEKPAKRPTFRQIITRLESINNSI 417
           ECWN    +RP+FR +  R++ I +++
Sbjct: 270 ECWNNNVNQRPSFRDLALRVDQIRDNM 296

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 124/266 (46%), Gaps = 47/266 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++TE+   G
Sbjct: 51  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 165
Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEY 331
              NIL  +   +K+ DFG+++ +    D         PL       +++APE   +  Y
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL-------KWMAPETIFDRVY 218
Query: 332 DTKVDVFSFALILQEMIE-GCPPF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKE 387
             + DV+SF ++L E+   G  P+  +K D E  +      R R P     ++Y   L  
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML-- 276
Query: 388 LIEECWNEKPAKRPTFRQIITRLESI 413
              +CW+ +P++RPTF +++  L ++
Sbjct: 277 ---DCWHGEPSQRPTFSELVEHLGNL 299

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 139/281 (49%), Gaps = 40/281 (14%)
Query: 158 TNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           T S E+ +G+F + +    +G+       +VA+K +  E  S  +R+  F +E +++++ 
Sbjct: 22  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIE-FLNEASVMKEF 79
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-------------STAVR 254
              +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P             S  ++
Sbjct: 80  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPVLAPPSLSKMIQ 136
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTC 313
            A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++ +      R    
Sbjct: 137 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGGK 193
Query: 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQ 370
                R+++PE  K+  + T  DV+SF ++L E+      P+    + +V +        
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 253
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
             P   P  L+     EL+  CW   P  RP+F +II+ ++
Sbjct: 254 DKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 140/281 (49%), Gaps = 40/281 (14%)
Query: 158 TNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  F +E +++++ 
Sbjct: 18  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE-FLNEASVMKEF 75
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA-------------VR 254
              +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P+ A             ++
Sbjct: 76  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPAMANNPVLAPPSLSKMIQ 132
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTC 313
            A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++ +      R    
Sbjct: 133 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 189
Query: 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQ 370
                R+++PE  K+  + T  DV+SF ++L E+      P+    + +V +        
Sbjct: 190 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 249
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
             P   P  L+     EL+  CW   P  RP+F +II+ ++
Sbjct: 250 DKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIISSIK 285

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 96.3 bits (238), Expect = 3e-20,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 132/268 (49%), Gaps = 29/268 (10%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL 201
           +YE D +     + V + KGT+ + +        +++A+K++ E    D    +   +E+
Sbjct: 4   DYEYDEN----GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEI 56
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPS--TAVRFALD 258
           AL + ++H N+VQ+LG+ +++  + I  E +P G L A L+ K G LK +  T   +   
Sbjct: 57  ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 116
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQDT- 316
           I  G+ YLH+N+   I+HRD++  N+L +  SG LK++DFG SK L         C +T 
Sbjct: 117 ILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN----PCTETF 169
Query: 317 --SCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372
             + +Y+APE+       Y    D++S    + EM  G PPF    + +         + 
Sbjct: 170 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV 229
Query: 373 PFKAPAKLYARGLKELIEECWNEKPAKR 400
             + P  + A   K  I +C+   P KR
Sbjct: 230 HPEIPESMSAEA-KAFILKCFEPDPDKR 256

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/268 (28%), Positives = 132/268 (49%), Gaps = 29/268 (10%)
Query: 147 EYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDEL 201
           +YE D +     + V + KGT+ + +        +++A+K++ E    D    +   +E+
Sbjct: 18  DYEYDEN----GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEI 70
Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPS--TAVRFALD 258
           AL + ++H N+VQ+LG+ +++  + I  E +P G L A L+ K G LK +  T   +   
Sbjct: 71  ALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQ 130
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQDT- 316
           I  G+ YLH+N+   I+HRD++  N+L +  SG LK++DFG SK L         C +T 
Sbjct: 131 ILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN----PCTETF 183
Query: 317 --SCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372
             + +Y+APE+       Y    D++S    + EM  G PPF    + +         + 
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV 243
Query: 373 PFKAPAKLYARGLKELIEECWNEKPAKR 400
             + P  + A   K  I +C+   P KR
Sbjct: 244 HPEIPESMSAEA-KAFILKCFEPDPDKR 270

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 96.3 bits (238), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/266 (28%), Positives = 124/266 (46%), Gaps = 47/266 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++TE+   G
Sbjct: 51  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVITEFCKFG 108
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 165
Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEY 331
              NIL  +   +K+ DFG+++ +    D         PL       +++APE   +  Y
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL-------KWMAPETIFDRVY 218
Query: 332 DTKVDVFSFALILQEMIE-GCPPF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKE 387
             + DV+SF ++L E+   G  P+  +K D E  +      R R P     ++Y   L  
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML-- 276
Query: 388 LIEECWNEKPAKRPTFRQIITRLESI 413
              +CW+ +P++RPTF +++  L ++
Sbjct: 277 ---DCWHGEPSQRPTFSELVEHLGNL 299

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/255 (29%), Positives = 121/255 (47%), Gaps = 29/255 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 236 DLRAFLKRK------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           +L  +L+ K              L     + ++  +A+GM +L   K    IHRDL   N
Sbjct: 118 NLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRK---XIHRDLAARN 174
Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDVFSFAL 342
           IL  +   +K+ DFG+++ +    D           +++APE   +  Y  + DV+SF +
Sbjct: 175 ILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 234
Query: 343 ILQEMIE-GCPPF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPA 398
           +L E+   G  P+  +K D E  +      R R P     ++Y   L     +CW+ +P+
Sbjct: 235 LLWEIFSLGASPYPGVKIDEEFXRRLKEGTRMRAPDYTTPEMYQTML-----DCWHGEPS 289
Query: 399 KRPTFRQIITRLESI 413
           +RPTF +++  L ++
Sbjct: 290 QRPTFSELVEHLGNL 304

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 101/212 (47%), Gaps = 9/212 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 73  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 132
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L    D        +  
Sbjct: 133 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 187
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA---YAARQRPPFKA 376
           Y++PE  +   Y  + D++S  L L EM  G  P      +        Y   + PP K 
Sbjct: 188 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPP-KL 246
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
           P+ +++   ++ + +C  + PA+R   +Q++ 
Sbjct: 247 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMV 278

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 140/281 (49%), Gaps = 40/281 (14%)
Query: 158 TNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  F +E +++++ 
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE-FLNEASVMKEF 85
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA-------------VR 254
              +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P+ A             ++
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPAMANNPVLAPPSLSKMIQ 142
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTC 313
            A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++ +      R    
Sbjct: 143 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQ 370
                R+++PE  K+  + T  DV+SF ++L E+      P+    + +V +        
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
             P   P  L+     EL+  CW   P  RP+F +II+ ++
Sbjct: 260 DKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIISSIK 295

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 64/246 (26%), Positives = 112/246 (45%), Gaps = 24/246 (9%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 35  QSKFILALKVLFKTQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 86
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 87  VYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 143
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFA 341
           L   +G LK+ADFG S         P + +DT C    Y+ PE+ +   +D KVD++S  
Sbjct: 144 LLGSNGELKIADFGWSV------HAPSSRRDTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 197
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           ++  E + G PPF      E    Y    R  F  P      G ++LI        ++R 
Sbjct: 198 VLCYEFLVGMPPFEAHTYQET---YRRISRVEFTFP-DFVTEGARDLISRLLKHNASQRL 253
Query: 402 TFRQII 407
           T  +++
Sbjct: 254 TLAEVL 259

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 141/290 (48%), Gaps = 35/290 (12%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 32  EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 82
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 83  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 141
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ----D 315
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG   L T K     + Q     
Sbjct: 142 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG---LATEKSRWSGSHQFEQLS 195
Query: 316 TSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNE-----VPKAYA 367
            S  ++APEV + ++   Y  + DV++F ++L E++ G  P++  ++ +     V + Y 
Sbjct: 196 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 255
Query: 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
           +   P          + +K L+ EC  +K  +RP F QI+  +E +  S+
Sbjct: 256 S---PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 302

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 124/266 (46%), Gaps = 42/266 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSSPMMIVTEYL 232
           G  VAVK L  +  +       ++ E+ +L+ + H +++++ G      ++ + +V EY+
Sbjct: 60  GEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYV 117
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           P G LR +L R  ++  +  + FA  I  GM YLH       IHRDL   N+L D+   +
Sbjct: 118 PLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLV 173
Query: 293 KVADFGVSKLLT-------VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
           K+ DFG++K +        V+ED      D+   + APE  K  ++    DV+SF + L 
Sbjct: 174 KIGDFGLAKAVPEGHEXYRVRED-----GDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 228
Query: 346 EMIEGC-----PPFTMKHDNEVPKAY------------AARQRPPFKAPAKLYARGLKEL 388
           E++  C     PP        + +                R   P K PA++Y      L
Sbjct: 229 ELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVY-----HL 283
Query: 389 IEECWNEKPAKRPTFRQIITRLESIN 414
           ++ CW  + + RPTF  +I  L++++
Sbjct: 284 MKNCWETEASFRPTFENLIPILKTVH 309

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 141/290 (48%), Gaps = 35/290 (12%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 24  EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 74
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 75  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 133
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ----D 315
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG   L T K     + Q     
Sbjct: 134 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG---LATEKSRWSGSHQFEQLS 187
Query: 316 TSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNE-----VPKAYA 367
            S  ++APEV + ++   Y  + DV++F ++L E++ G  P++  ++ +     V + Y 
Sbjct: 188 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 247
Query: 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
           +   P          + +K L+ EC  +K  +RP F QI+  +E +  S+
Sbjct: 248 S---PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 294

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 95.5 bits (236), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 139/281 (49%), Gaps = 40/281 (14%)
Query: 158 TNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           T S E+ +G+F + +    +G+       +VA+K +  E  S  +R+  F +E +++++ 
Sbjct: 15  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTV-NEAASMRERIE-FLNEASVMKEF 72
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-------------STAVR 254
              +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P             S  ++
Sbjct: 73  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPVLAPPSLSKMIQ 129
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTC 313
            A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++ +      R    
Sbjct: 130 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQ 370
                R+++PE  K+  + T  DV+SF ++L E+      P+    + +V +        
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 246
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
             P   P  L+     EL+  CW   P  RP+F +II+ ++
Sbjct: 247 DKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 139/281 (49%), Gaps = 40/281 (14%)
Query: 158 TNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  F +E +++++ 
Sbjct: 50  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE-FLNEASVMKEF 107
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-------------STAVR 254
              +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P             S  ++
Sbjct: 108 NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPVLAPPSLSKMIQ 164
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTC 313
            A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++ +      R    
Sbjct: 165 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 221
Query: 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC-PPFTMKHDNEVPKAY--AARQ 370
                R+++PE  K+  + T  DV+SF ++L E+      P+    + +V +        
Sbjct: 222 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 281
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
             P   P  L+     EL+  CW   P  RP+F +II+ ++
Sbjct: 282 DKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIISSIK 317

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 74/257 (28%), Positives = 121/257 (47%), Gaps = 31/257 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 62  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 119
Query: 236 DLRAFLKRK--------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           +L  +L+ K                L     + ++  +A+GM +L   K    IHRDL  
Sbjct: 120 NLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRK---XIHRDLAA 176
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDVFSF 340
            NIL  +   +K+ DFG+++ +    D           +++APE   +  Y  + DV+SF
Sbjct: 177 RNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKWMAPETIFDRVYTIQSDVWSF 236
Query: 341 ALILQEMIE-GCPPF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEK 396
            ++L E+   G  P+  +K D E  +      R R P     ++Y   L     +CW+ +
Sbjct: 237 GVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML-----DCWHGE 291
Query: 397 PAKRPTFRQIITRLESI 413
           P++RPTF +++  L ++
Sbjct: 292 PSQRPTFSELVEHLGNL 308

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 123/262 (46%), Gaps = 43/262 (16%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 236 DLRAFLKRK------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           +L  +L+ K              L     + ++  +A+GM +L   K    IHRDL   N
Sbjct: 118 NLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRK---XIHRDLAARN 174
Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEYDTKV 335
           IL  +   +K+ DFG+++ +    D         PL       +++APE   +  Y  + 
Sbjct: 175 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL-------KWMAPETIFDRVYTIQS 227
Query: 336 DVFSFALILQEMIE-GCPPF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEE 391
           DV+SF ++L E+   G  P+  +K D E  +      R R P     ++Y   L     +
Sbjct: 228 DVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML-----D 282
Query: 392 CWNEKPAKRPTFRQIITRLESI 413
           CW+ +P++RPTF +++  L ++
Sbjct: 283 CWHGEPSQRPTFSELVEHLGNL 304

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 139/281 (49%), Gaps = 40/281 (14%)
Query: 158 TNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  F +E +++++ 
Sbjct: 22  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE-FLNEASVMKEF 79
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-------------STAVR 254
              +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P             S  ++
Sbjct: 80  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPVLAPPSLSKMIQ 136
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTC 313
            A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++ +      R    
Sbjct: 137 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 193
Query: 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQ 370
                R+++PE  K+  + T  DV+SF ++L E+      P+    + +V +        
Sbjct: 194 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 253
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
             P   P  L+     EL+  CW   P  RP+F +II+ ++
Sbjct: 254 DKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIISSIK 289

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 139/281 (49%), Gaps = 40/281 (14%)
Query: 158 TNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  F +E +++++ 
Sbjct: 19  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE-FLNEASVMKEF 76
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-------------STAVR 254
              +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P             S  ++
Sbjct: 77  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPVLAPPSLSKMIQ 133
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTC 313
            A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++ +      R    
Sbjct: 134 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 190
Query: 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQ 370
                R+++PE  K+  + T  DV+SF ++L E+      P+    + +V +        
Sbjct: 191 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 250
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
             P   P  L+     EL+  CW   P  RP+F +II+ ++
Sbjct: 251 DKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIISSIK 286

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 139/281 (49%), Gaps = 40/281 (14%)
Query: 158 TNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  F +E +++++ 
Sbjct: 21  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE-FLNEASVMKEF 78
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-------------STAVR 254
              +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P             S  ++
Sbjct: 79  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPVLAPPSLSKMIQ 135
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTC 313
            A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++ +      R    
Sbjct: 136 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQ 370
                R+++PE  K+  + T  DV+SF ++L E+      P+    + +V +        
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 252
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
             P   P  L+     EL+  CW   P  RP+F +II+ ++
Sbjct: 253 DKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 95/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           GD+ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G +KV
Sbjct: 126 GDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           ADFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 ADFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 95/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYMPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           GD+ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G +KV
Sbjct: 126 GDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           ADFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 ADFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 139/281 (49%), Gaps = 40/281 (14%)
Query: 158 TNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  F +E +++++ 
Sbjct: 21  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE-FLNEASVMKEF 78
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-------------STAVR 254
              +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P             S  ++
Sbjct: 79  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPVLAPPSLSKMIQ 135
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTC 313
            A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++ +      R    
Sbjct: 136 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 192
Query: 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQ 370
                R+++PE  K+  + T  DV+SF ++L E+      P+    + +V +        
Sbjct: 193 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 252
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
             P   P  L+     EL+  CW   P  RP+F +II+ ++
Sbjct: 253 DKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIISSIK 288

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 141/290 (48%), Gaps = 35/290 (12%)
Query: 144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           E+P+ +I       T    I  G+F   +   W G  VAVK L     +   +++AF++E
Sbjct: 4   EIPDGQI-------TVGQRIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQ-QLQAFKNE 54
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDI 259
           + +L+K RH N++ F+G  T+   + IVT++     L   L   +   +    +  A   
Sbjct: 55  VGVLRKTRHVNILLFMGYSTKPQ-LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQT 113
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ----D 315
           A+GM+YLH      IIHRDL+ +NI   +   +K+ DFG   L T K     + Q     
Sbjct: 114 AQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFG---LATEKSRWSGSHQFEQLS 167
Query: 316 TSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNE-----VPKAYA 367
            S  ++APEV + ++   Y  + DV++F ++L E++ G  P++  ++ +     V + Y 
Sbjct: 168 GSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYL 227
Query: 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
           +   P          + +K L+ EC  +K  +RP F QI+  +E +  S+
Sbjct: 228 S---PDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 76/265 (28%), Positives = 123/265 (46%), Gaps = 46/265 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 61  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 118
Query: 236 DLRAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           +L  +L+ K                 L     + ++  +A+GM +L   K    IHRDL 
Sbjct: 119 NLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLA 175
Query: 281 PSNILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEYD 332
             NIL  +   +K+ DFG+++ +    D         PL       +++APE   +  Y 
Sbjct: 176 ARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL-------KWMAPETIFDRVYT 228
Query: 333 TKVDVFSFALILQEMIE-GCPPF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKEL 388
            + DV+SF ++L E+   G  P+  +K D E  +      R R P     ++Y   L   
Sbjct: 229 IQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML--- 285
Query: 389 IEECWNEKPAKRPTFRQIITRLESI 413
             +CW+ +P++RPTF +++  L ++
Sbjct: 286 --DCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 72/231 (31%), Positives = 121/231 (52%), Gaps = 19/231 (8%)
Query: 143 REVPEYEIDPHEL-DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRA 196
           R+ P   +D  +L DF   + + KG+F   +LA  +G +   A+K L ++V+  DD V  
Sbjct: 6   RKQPSNNLDRVKLTDFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVEC 65
Query: 197 FRDE---LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
              E   LALL K   P + Q          +  V EY+  GDL   +++ G  K   AV
Sbjct: 66  TMVEKRVLALLDK--PPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAV 123
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK--LLTVKEDRPL 311
            +A +I+ G+ +LH+     II+RDL+  N++ D  G++K+ADFG+ K  ++     R  
Sbjct: 124 FYAAEISIGLFFLHKRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREF 180
Query: 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
                +  Y+APE+   + Y   VD +++ ++L EM+ G PPF  + ++E+
Sbjct: 181 C---GTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDEL 228

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 123/266 (46%), Gaps = 47/266 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 51  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 108
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 109 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 165
Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEY 331
              NIL  +   +K+ DFG+++ +    D         PL       +++APE   +  Y
Sbjct: 166 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL-------KWMAPETIFDRVY 218
Query: 332 DTKVDVFSFALILQEMIE-GCPPF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKE 387
             + DV+SF ++L E+   G  P+  +K D E  +      R R P     ++Y   L  
Sbjct: 219 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML-- 276
Query: 388 LIEECWNEKPAKRPTFRQIITRLESI 413
              +CW+ +P++RPTF +++  L ++
Sbjct: 277 ---DCWHGEPSQRPTFSELVEHLGNL 299

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 76/263 (28%), Positives = 116/263 (44%), Gaps = 50/263 (19%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L EE  +  D    F+ E AL+ +  +PN+V+ LG      PM ++ EY+  GDL
Sbjct: 80  VAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDL 137
Query: 238 RAFLKRKGALKPSTAVRF---------------------------ALDIARGMNYLHENK 270
             FL+   ++ P T                               A  +A GM YL E K
Sbjct: 138 NEFLR---SMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK 194
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNE 329
               +HRDL   N L  ++  +K+ADFG+S+ +   +       D    R++ PE     
Sbjct: 195 ---FVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYN 251
Query: 330 EYDTKVDVFSFALILQEMIEGC--PPFTMKHDNEVPKAYAARQ----RPPFKAPAKLYAR 383
            Y T+ DV+++ ++L E+      P + M H+  +   Y  R       P   P +LY  
Sbjct: 252 RYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVI---YYVRDGNILACPENCPLELY-- 306
Query: 384 GLKELIEECWNEKPAKRPTFRQI 406
               L+  CW++ PA RP+F  I
Sbjct: 307 ---NLMRLCWSKLPADRPSFCSI 326

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 122/262 (46%), Gaps = 18/262 (6%)
Query: 152 PHELDFTNSVEITKGTFI---LA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           PH  ++     I KG F    LA     G +VAVK + +  ++     + FR E+ + + 
Sbjct: 11  PHIGNYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFR-EVRIXKV 69
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + HPN+V+    +     + +V EY   G++  +L   G  K   A      I   + Y 
Sbjct: 70  LNHPNIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYC 129
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
           H+     I+HRDL+  N+L D   N+K+ADFG S   T        C   +  Y APE+F
Sbjct: 130 HQK---FIVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFC--GAPPYAAPELF 184
Query: 327 KNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKLYARG 384
           + ++YD  +VDV+S  +IL  ++ G  PF  ++  E+  +    + R PF          
Sbjct: 185 QGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYXSTD----- 239
Query: 385 LKELIEECWNEKPAKRPTFRQI 406
            + L+++     P+KR T  QI
Sbjct: 240 CENLLKKFLILNPSKRGTLEQI 261

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 74/280 (26%), Positives = 138/280 (49%), Gaps = 40/280 (14%)
Query: 158 TNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  F +E +++++ 
Sbjct: 28  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNE-AASMRERIE-FLNEASVMKEF 85
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-------------STAVR 254
              +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P             S  ++
Sbjct: 86  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPVLAPPSLSKMIQ 142
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTC 313
            A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++ +      R    
Sbjct: 143 MAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGK 199
Query: 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQ 370
                R+++PE  K+  + T  DV+SF ++L E+      P+    + +V +        
Sbjct: 200 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 259
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
             P   P  L+     EL+  CW   P  RP+F +II+ +
Sbjct: 260 DKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIISSI 294

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 13/212 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 57  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 116
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L  +         +   
Sbjct: 117 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDEMANEFVGTRS--- 171
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPPFTMKHDNEVPKAYAARQRPPFKA 376
           Y++PE  +   Y  + D++S  L L EM  G    PP  +    +    Y   + PP K 
Sbjct: 172 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFELLD----YIVNEPPP-KL 226
Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
           P+ +++   ++ + +C  + PA+R   +Q++ 
Sbjct: 227 PSAVFSLEFQDFVNKCLIKNPAERADLKQLMV 258

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 101/176 (57%), Gaps = 8/176 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
           E++LL+++ HPN+V  +  +     + +V E++ K DL+  L + K  L+ S    +   
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           + RG+ + H+++   I+HRDL+P N+L +  G LK+ADFG+++   +   R  T +  + 
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RSYTHEVVTL 183
Query: 319 RYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPKAYAARQRP 372
            Y AP+V   +++Y T VD++S   I  EMI G P F  +  D+++PK ++    P
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP 239

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 123/266 (46%), Gaps = 47/266 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174
Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEY 331
              NIL  +   +K+ DFG+++ +    D         PL       +++APE   +  Y
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL-------KWMAPETIFDRVY 227
Query: 332 DTKVDVFSFALILQEMIE-GCPPF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKE 387
             + DV+SF ++L E+   G  P+  +K D E  +      R R P     ++Y   L  
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML-- 285
Query: 388 LIEECWNEKPAKRPTFRQIITRLESI 413
              +CW+ +P++RPTF +++  L ++
Sbjct: 286 ---DCWHGEPSQRPTFSELVEHLGNL 308

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 74/282 (26%), Positives = 138/282 (48%), Gaps = 40/282 (14%)
Query: 157 FTNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRAFRDELALLQK 206
            T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  F +E +++++
Sbjct: 12  ITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE-FLNEASVMKE 69
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-------------STAV 253
               +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P             S  +
Sbjct: 70  FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPVLAPPSLSKMI 126
Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLT 312
           + A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG+++ +      R   
Sbjct: 127 QMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXRKGG 183
Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AAR 369
                 R+++PE  K+  + T  DV+SF ++L E+      P+    + +V +       
Sbjct: 184 KGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGL 243
Query: 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
              P   P  L      EL+  CW   P  RP+F +II+ ++
Sbjct: 244 LDKPDNCPDMLL-----ELMRMCWQYNPKMRPSFLEIISSIK 280

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 129/284 (45%), Gaps = 32/284 (11%)
Query: 143 REVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVRAF 197
           +E P  +I     DF     + KG+F   F    +      A+K L ++V+  DD V   
Sbjct: 5   KERPSLQIKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT 64
Query: 198 RDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
             E  +L     HP +            +  V EYL  GDL   ++       S A  +A
Sbjct: 65  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 124
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            +I  G+ +LH      I++RDL+  NIL D  G++K+ADFG+ K   + + +      T
Sbjct: 125 AEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGT 181
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376
              Y+APE+   ++Y+  VD +SF ++L EM+ G  PF  + + E+   ++ R   PF  
Sbjct: 182 P-DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FHSIRMDNPF-- 236
Query: 377 PAKLYARGL----KELIEECWNEKPAKR----------PTFRQI 406
               Y R L    K+L+ + +  +P KR          P FR+I
Sbjct: 237 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 56/176 (31%), Positives = 101/176 (57%), Gaps = 8/176 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
           E++LL+++ HPN+V  +  +     + +V E++ K DL+  L + K  L+ S    +   
Sbjct: 69  EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           + RG+ + H+++   I+HRDL+P N+L +  G LK+ADFG+++   +   R  T +  + 
Sbjct: 128 LLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIPV-RSYTHEVVTL 183
Query: 319 RYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPKAYAARQRP 372
            Y AP+V   +++Y T VD++S   I  EMI G P F  +  D+++PK ++    P
Sbjct: 184 WYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTP 239

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 123/266 (46%), Gaps = 47/266 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174
Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEY 331
              NIL  +   +K+ DFG+++ +    D         PL       +++APE   +  Y
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL-------KWMAPETIFDRVY 227
Query: 332 DTKVDVFSFALILQEMIE-GCPPF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKE 387
             + DV+SF ++L E+   G  P+  +K D E  +      R R P     ++Y   L  
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML-- 285
Query: 388 LIEECWNEKPAKRPTFRQIITRLESI 413
              +CW+ +P++RPTF +++  L ++
Sbjct: 286 ---DCWHGEPSQRPTFSELVEHLGNL 308

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 123/266 (46%), Gaps = 47/266 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 60  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 117
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 118 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 174
Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEY 331
              NIL  +   +K+ DFG+++ +    D         PL       +++APE   +  Y
Sbjct: 175 AARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPL-------KWMAPETIFDRVY 227
Query: 332 DTKVDVFSFALILQEMIE-GCPPF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKE 387
             + DV+SF ++L E+   G  P+  +K D E  +      R R P     ++Y   L  
Sbjct: 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML-- 285
Query: 388 LIEECWNEKPAKRPTFRQIITRLESI 413
              +CW+ +P++RPTF +++  L ++
Sbjct: 286 ---DCWHGEPSQRPTFSELVEHLGNL 308

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 123/266 (46%), Gaps = 47/266 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 62  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 119
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 120 NLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 176
Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEY 331
              NIL  +   +K+ DFG+++ +    D         PL       +++APE   +  Y
Sbjct: 177 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL-------KWMAPETIFDRVY 229
Query: 332 DTKVDVFSFALILQEMIE-GCPPF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKE 387
             + DV+SF ++L E+   G  P+  +K D E  +      R R P     ++Y   L  
Sbjct: 230 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML-- 287
Query: 388 LIEECWNEKPAKRPTFRQIITRLESI 413
              +CW+ +P++RPTF +++  L ++
Sbjct: 288 ---DCWHGEPSQRPTFSELVEHLGNL 310

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 76/266 (28%), Positives = 123/266 (46%), Gaps = 47/266 (17%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ-SSPMMIVTEYLPKG 235
           VAVK L E     + R  A   EL +L  I  H NVV  LGA T+   P+M++ E+   G
Sbjct: 97  VAVKMLKEGATHSEHR--ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFG 154
Query: 236 DLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDL 279
           +L  +L+ K                  L     + ++  +A+GM +L   K    IHRDL
Sbjct: 155 NLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 211
Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEY 331
              NIL  +   +K+ DFG+++ +    D         PL       +++APE   +  Y
Sbjct: 212 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL-------KWMAPETIFDRVY 264
Query: 332 DTKVDVFSFALILQEMIE-GCPPF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKE 387
             + DV+SF ++L E+   G  P+  +K D E  +      R R P     ++Y   L  
Sbjct: 265 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTML-- 322
Query: 388 LIEECWNEKPAKRPTFRQIITRLESI 413
              +CW+ +P++RPTF +++  L ++
Sbjct: 323 ---DCWHGEPSQRPTFSELVEHLGNL 345

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 81/284 (28%), Positives = 129/284 (45%), Gaps = 32/284 (11%)
Query: 143 REVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVRAF 197
           +E P  +I     DF     + KG+F   F    +      A+K L ++V+  DD V   
Sbjct: 6   KERPSLQIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECT 65
Query: 198 RDELALLQ-KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
             E  +L     HP +            +  V EYL  GDL   ++       S A  +A
Sbjct: 66  MVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYA 125
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            +I  G+ +LH      I++RDL+  NIL D  G++K+ADFG+ K   + + +      T
Sbjct: 126 AEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGT 182
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376
              Y+APE+   ++Y+  VD +SF ++L EM+ G  PF  + + E+   ++ R   PF  
Sbjct: 183 P-DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL--FHSIRMDNPF-- 237
Query: 377 PAKLYARGL----KELIEECWNEKPAKR----------PTFRQI 406
               Y R L    K+L+ + +  +P KR          P FR+I
Sbjct: 238 ----YPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 277

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 116/234 (49%), Gaps = 11/234 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+K + ++V++  D       E++ L+ +RHP++++    +     +++V EY   
Sbjct: 29  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AG 87
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            +L  ++ ++  +    A RF   I   + Y H +K   I+HRDL+P N+L D+  N+K+
Sbjct: 88  NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKI 144
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPP 353
           ADFG+S ++T       +C   S  Y APEV   + Y   +VDV+S  +IL  M+    P
Sbjct: 145 ADFGLSNIMTDGNFLKTSC--GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLP 202
Query: 354 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           F    D  +P  +       +  P K  + G   LI+      P  R +  +I+
Sbjct: 203 FD---DESIPVLFKNISNGVYTLP-KFLSPGAAGLIKRMLIVNPLNRISIHEIM 252

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 116/234 (49%), Gaps = 11/234 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+K + ++V++  D       E++ L+ +RHP++++    +     +++V EY   
Sbjct: 38  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AG 96
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            +L  ++ ++  +    A RF   I   + Y H +K   I+HRDL+P N+L D+  N+K+
Sbjct: 97  NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKI 153
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPP 353
           ADFG+S ++T       +C   S  Y APEV   + Y   +VDV+S  +IL  M+    P
Sbjct: 154 ADFGLSNIMTDGNFLKTSC--GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLP 211
Query: 354 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           F    D  +P  +       +  P K  + G   LI+      P  R +  +I+
Sbjct: 212 FD---DESIPVLFKNISNGVYTLP-KFLSPGAAGLIKRMLIVNPLNRISIHEIM 261

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 116/234 (49%), Gaps = 11/234 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+K + ++V++  D       E++ L+ +RHP++++    +     +++V EY   
Sbjct: 39  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AG 97
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            +L  ++ ++  +    A RF   I   + Y H +K   I+HRDL+P N+L D+  N+K+
Sbjct: 98  NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKI 154
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPP 353
           ADFG+S ++T       +C   S  Y APEV   + Y   +VDV+S  +IL  M+    P
Sbjct: 155 ADFGLSNIMTDGNFLKTSC--GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLP 212
Query: 354 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           F    D  +P  +       +  P K  + G   LI+      P  R +  +I+
Sbjct: 213 FD---DESIPVLFKNISNGVYTLP-KFLSPGAAGLIKRMLIVNPLNRISIHEIM 262

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 66/234 (28%), Positives = 116/234 (49%), Gaps = 11/234 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+K + ++V++  D       E++ L+ +RHP++++    +     +++V EY   
Sbjct: 33  GQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEY-AG 91
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            +L  ++ ++  +    A RF   I   + Y H +K   I+HRDL+P N+L D+  N+K+
Sbjct: 92  NELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKI 148
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPP 353
           ADFG+S ++T       +C   S  Y APEV   + Y   +VDV+S  +IL  M+    P
Sbjct: 149 ADFGLSNIMTDGNFLKTSC--GSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLP 206
Query: 354 FTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           F    D  +P  +       +  P K  + G   LI+      P  R +  +I+
Sbjct: 207 FD---DESIPVLFKNISNGVYTLP-KFLSPGAAGLIKRMLIVNPLNRISIHEIM 256

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 63/246 (25%), Positives = 111/246 (45%), Gaps = 24/246 (9%)
Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +  FILA     +  ++K G E           R E+ +   +RHPN+++  G    ++ 
Sbjct: 35  QSKFILALKVLFKTQLEKAGVE--------HQLRREVEIQSHLRHPNILRLYGYFHDATR 86
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           + ++ EY P G +   L++           +  ++A  ++Y H  +   +IHRD++P N+
Sbjct: 87  VYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKR---VIHRDIKPENL 143
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFA 341
           L   +G LK+ADFG S         P + + T C    Y+ PE+ +   +D KVD++S  
Sbjct: 144 LLGSNGELKIADFGWSV------HAPSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 197
Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           ++  E + G PPF      E    Y    R  F  P      G ++LI        ++R 
Sbjct: 198 VLCYEFLVGMPPFEAHTYQET---YRRISRVEFTFP-DFVTEGARDLISRLLKHNASQRL 253
Query: 402 TFRQII 407
           T  +++
Sbjct: 254 TLAEVL 259

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 95/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G +KV
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           ADFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 ADFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 118/227 (51%), Gaps = 13/227 (5%)
Query: 186 EVISDDDRVRAFR---DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
           +VI D    ++F+   D +  +  + H ++V+ LG    SS + +VT+YLP G L   ++
Sbjct: 48  KVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVR 106
Query: 243 R-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           + +GAL P   + + + IA+GM YL E+    ++HR+L   N+L      ++VADFGV+ 
Sbjct: 107 QHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD 163
Query: 302 LLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 359
           LL   + + L  +  T  +++A E     +Y  + DV+S+ + + E++  G  P+     
Sbjct: 164 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223
Query: 360 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
            EVP      +R    A  ++    +  ++ +CW      RPTF+++
Sbjct: 224 AEVPDLLEKGER---LAQPQICTIDVYMVMVKCWMIDENIRPTFKEL 267

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 49/161 (30%), Positives = 87/161 (54%), Gaps = 10/161 (6%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
           + E  +L++++HP +V  + A      + ++ EYL  G+L   L+R+G     TA  +  
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA 128
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
           +I+  + +LH+     II+RDL+P NI+ +  G++K+ DFG+ K    +     T   T 
Sbjct: 129 EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK----ESIHDGTVTHTF 181
Query: 318 C---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
           C    Y+APE+     ++  VD +S   ++ +M+ G PPFT
Sbjct: 182 CGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 107/235 (45%), Gaps = 16/235 (6%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           + VAVK L  +V+S  + +  F  E+  +  + H N+++  G V  + PM +VTE  P G
Sbjct: 47  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLG 105
Query: 236 DLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L   L K +G     T  R+A+ +A GM YL   +    IHRDL   N+L      +K+
Sbjct: 106 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKI 162
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC--RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GC 351
            DFG+ + L   +D  +  +       + APE  K   +    D + F + L EM   G 
Sbjct: 163 GDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 222
Query: 352 PPFTMKHDNEVPKAY---AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 403
            P+   + +++         R   P   P  +Y      ++ +CW  KP  RPTF
Sbjct: 223 EPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY-----NVMVQCWAHKPEDRPTF 272

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 108/237 (45%), Gaps = 16/237 (6%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           + + VAVK L  +V+S  + +  F  E+  +  + H N+++  G V  + PM +VTE  P
Sbjct: 35  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAP 93
Query: 234 KGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
            G L   L K +G     T  R+A+ +A GM YL   +    IHRDL   N+L      +
Sbjct: 94  LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLV 150
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC--RYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 349
           K+ DFG+ + L   +D  +  +       + APE  K   +    D + F + L EM   
Sbjct: 151 KIGDFGLMRALPQNDDHXVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 210
Query: 350 GCPPFTMKHDNEVPKAY---AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 403
           G  P+   + +++         R   P   P  +Y      ++ +CW  KP  RPTF
Sbjct: 211 GQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY-----NVMVQCWAHKPEDRPTF 262

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 64/227 (28%), Positives = 118/227 (51%), Gaps = 13/227 (5%)
Query: 186 EVISDDDRVRAFR---DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
           +VI D    ++F+   D +  +  + H ++V+ LG    SS + +VT+YLP G L   ++
Sbjct: 66  KVIEDKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSS-LQLVTQYLPLGSLLDHVR 124
Query: 243 R-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           + +GAL P   + + + IA+GM YL E+    ++HR+L   N+L      ++VADFGV+ 
Sbjct: 125 QHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVAD 181
Query: 302 LLTVKEDRPLTCQ-DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHD 359
           LL   + + L  +  T  +++A E     +Y  + DV+S+ + + E++  G  P+     
Sbjct: 182 LLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 241
Query: 360 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
            EVP      +R    A  ++    +  ++ +CW      RPTF+++
Sbjct: 242 AEVPDLLEKGER---LAQPQICTIDVYMVMVKCWMIDENIRPTFKEL 285

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 100/189 (52%), Gaps = 11/189 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A++ + +E+++DD+ +   + E  +  Q   HP +V         S +  V EY+  GDL
Sbjct: 81  AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  ++ +I+  +NYLHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 141 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G+ K    +  RP     T C    Y+APE+ + E+Y   VD ++  +++ EM+ G  PF
Sbjct: 198 GMCK----EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253
Query: 355 TMKHDNEVP 363
            +   ++ P
Sbjct: 254 DIVGSSDNP 262

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 74/281 (26%), Positives = 137/281 (48%), Gaps = 40/281 (14%)
Query: 158 TNSVEITKGTFILAF---WRGI-------QVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           T S E+ +G+F + +    +G+       +VA+K + E   S  +R+  F +E +++++ 
Sbjct: 15  TMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRERIE-FLNEASVMKEF 72
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-------------STAVR 254
              +VV+ LG V+Q  P +++ E + +GDL+++L+   +L+P             S  ++
Sbjct: 73  NCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR---SLRPEMENNPVLAPPSLSKMIQ 129
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK-LLTVKEDRPLTC 313
            A +IA GM YL+ NK    +HRDL   N    +   +K+ DFG+++ +      R    
Sbjct: 130 MAGEIADGMAYLNANK---FVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYRKGGK 186
Query: 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY--AARQ 370
                R+++PE  K+  + T  DV+SF ++L E+      P+    + +V +        
Sbjct: 187 GLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLL 246
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
             P   P  L      EL+  CW   P  RP+F +II+ ++
Sbjct: 247 DKPDNCPDMLL-----ELMRMCWQYNPKMRPSFLEIISSIK 282

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/233 (29%), Positives = 109/233 (46%), Gaps = 13/233 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG---AVTQSSPM-MIVTEYLP 233
           VAVK L  ++  D      FR E      + HP +V       A T + P+  IV EY+ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
              LR  +  +G + P  A+    D  + +N+ H+N    IIHRD++P+NIL   +  +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANILISATNAVK 156
Query: 294 VADFGVSKLLTVKEDRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           V DFG+++ +    +          + +Y++PE  + +  D + DV+S   +L E++ G 
Sbjct: 157 VVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
           PPFT   D+ V  AY   +  P   P      GL   ++    +  AK P  R
Sbjct: 217 PPFT--GDSPVSVAYQHVREDPI--PPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 107/235 (45%), Gaps = 16/235 (6%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           + VAVK L  +V+S  + +  F  E+  +  + H N+++  G V  + PM +VTE  P G
Sbjct: 41  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLG 99
Query: 236 DLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L   L K +G     T  R+A+ +A GM YL   +    IHRDL   N+L      +K+
Sbjct: 100 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKI 156
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC--RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GC 351
            DFG+ + L   +D  +  +       + APE  K   +    D + F + L EM   G 
Sbjct: 157 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 216
Query: 352 PPFTMKHDNEVPKAY---AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 403
            P+   + +++         R   P   P  +Y      ++ +CW  KP  RPTF
Sbjct: 217 EPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY-----NVMVQCWAHKPEDRPTF 266

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 109/233 (46%), Gaps = 13/233 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG---AVTQSSPM-MIVTEYLP 233
           VAVK L  ++  D      FR E      + HP +V       A T + P+  IV EY+ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYATGEAETPAGPLPYIVMEYVD 99
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
              LR  +  +G + P  A+    D  + +N+ H+N    IIHRD++P+NI+   +  +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK 156
Query: 294 VADFGVSKLLTVKEDRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           V DFG+++ +    +          + +Y++PE  + +  D + DV+S   +L E++ G 
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
           PPFT   D+ V  AY   +  P   P      GL   ++    +  AK P  R
Sbjct: 217 PPFT--GDSPVSVAYQHVREDPI--PPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 117/235 (49%), Gaps = 12/235 (5%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + AVK + +    + D     R E+ LL+K+ HPN+++    +  SS   IV E    G+
Sbjct: 49  EYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLK 293
           L   + ++       A R    +  G+ Y+H++    I+HRDL+P NIL   ++   ++K
Sbjct: 108 LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIK 164
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
           + DFG+S     +++  +  +  +  Y+APEV +   YD K DV+S  +IL  ++ G PP
Sbjct: 165 IIDFGLSTCF--QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221
Query: 354 FTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQII 407
           F  K++ ++ K      +  F  P  +  +   K+LI +     P+ R T  Q +
Sbjct: 222 FYGKNEYDILKR-VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/237 (28%), Positives = 108/237 (45%), Gaps = 16/237 (6%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           + + VAVK L  +V+S  + +  F  E+  +  + H N+++  G V  + PM +VTE  P
Sbjct: 35  KTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAP 93
Query: 234 KGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
            G L   L K +G     T  R+A+ +A GM YL   +    IHRDL   N+L      +
Sbjct: 94  LGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLV 150
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC--RYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 349
           K+ DFG+ + L   +D  +  +       + APE  K   +    D + F + L EM   
Sbjct: 151 KIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTY 210
Query: 350 GCPPFTMKHDNEVPKAY---AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 403
           G  P+   + +++         R   P   P  +Y      ++ +CW  KP  RPTF
Sbjct: 211 GQEPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY-----NVMVQCWAHKPEDRPTF 262

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 107/235 (45%), Gaps = 16/235 (6%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           + VAVK L  +V+S  + +  F  E+  +  + H N+++  G V  + PM +VTE  P G
Sbjct: 37  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLG 95
Query: 236 DLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L   L K +G     T  R+A+ +A GM YL   +    IHRDL   N+L      +K+
Sbjct: 96  SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKI 152
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC--RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GC 351
            DFG+ + L   +D  +  +       + APE  K   +    D + F + L EM   G 
Sbjct: 153 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
Query: 352 PPFTMKHDNEVPKAY---AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 403
            P+   + +++         R   P   P  +Y      ++ +CW  KP  RPTF
Sbjct: 213 EPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY-----NVMVQCWAHKPEDRPTF 262

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 107/235 (45%), Gaps = 16/235 (6%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           + VAVK L  +V+S  + +  F  E+  +  + H N+++  G V  + PM +VTE  P G
Sbjct: 41  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLG 99
Query: 236 DLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L   L K +G     T  R+A+ +A GM YL   +    IHRDL   N+L      +K+
Sbjct: 100 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKI 156
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC--RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GC 351
            DFG+ + L   +D  +  +       + APE  K   +    D + F + L EM   G 
Sbjct: 157 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 216
Query: 352 PPFTMKHDNEVPKAY---AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 403
            P+   + +++         R   P   P  +Y      ++ +CW  KP  RPTF
Sbjct: 217 EPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY-----NVMVQCWAHKPEDRPTF 266

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 117/235 (49%), Gaps = 12/235 (5%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + AVK + +    + D     R E+ LL+K+ HPN+++    +  SS   IV E    G+
Sbjct: 49  EYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLK 293
           L   + ++       A R    +  G+ Y+H++    I+HRDL+P NIL   ++   ++K
Sbjct: 108 LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIK 164
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
           + DFG+S     +++  +  +  +  Y+APEV +   YD K DV+S  +IL  ++ G PP
Sbjct: 165 IIDFGLSTCF--QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221
Query: 354 FTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQII 407
           F  K++ ++ K      +  F  P  +  +   K+LI +     P+ R T  Q +
Sbjct: 222 FYGKNEYDILKR-VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 66/235 (28%), Positives = 117/235 (49%), Gaps = 12/235 (5%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + AVK + +    + D     R E+ LL+K+ HPN+++    +  SS   IV E    G+
Sbjct: 49  EYAVKVINKASAKNKDTSTILR-EVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGE 107
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLK 293
           L   + ++       A R    +  G+ Y+H++    I+HRDL+P NIL   ++   ++K
Sbjct: 108 LFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIK 164
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
           + DFG+S     +++  +  +  +  Y+APEV +   YD K DV+S  +IL  ++ G PP
Sbjct: 165 IIDFGLSTCF--QQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221
Query: 354 FTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQII 407
           F  K++ ++ K      +  F  P  +  +   K+LI +     P+ R T  Q +
Sbjct: 222 FYGKNEYDILKR-VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCL 275

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 68/235 (28%), Positives = 107/235 (45%), Gaps = 16/235 (6%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           + VAVK L  +V+S  + +  F  E+  +  + H N+++  G V  + PM +VTE  P G
Sbjct: 47  VSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLG 105
Query: 236 DLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L   L K +G     T  R+A+ +A GM YL   +    IHRDL   N+L      +K+
Sbjct: 106 SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKI 162
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC--RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GC 351
            DFG+ + L   +D  +  +       + APE  K   +    D + F + L EM   G 
Sbjct: 163 GDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ 222
Query: 352 PPFTMKHDNEVPKAY---AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 403
            P+   + +++         R   P   P  +Y      ++ +CW  KP  RPTF
Sbjct: 223 EPWIGLNGSQILHKIDKEGERLPRPEDCPQDIY-----NVMVQCWAHKPEDRPTF 272

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 55/184 (29%), Positives = 99/184 (53%), Gaps = 14/184 (7%)
Query: 189 SDDDR-VRAFR----DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 243
           SDD++ +  F     +E++LL+ + HPN+++            +VTE+   G+L   +  
Sbjct: 80  SDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIIN 139
Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVS 300
           +       A      I  G+ YLH++    I+HRD++P NIL ++     N+K+ DFG+S
Sbjct: 140 RHKFDECDAANIMKQILSGICYLHKH---NIVHRDIKPENILLENKNSLLNIKIVDFGLS 196
Query: 301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN 360
              +  +D  L  +  +  Y+APEV K ++Y+ K DV+S  +I+  ++ G PPF  ++D 
Sbjct: 197 SFFS--KDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253
Query: 361 EVPK 364
           ++ K
Sbjct: 254 DIIK 257

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 92.0 bits (227), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 126/268 (47%), Gaps = 25/268 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + AVK + +  +       +   E+ LL+++ HPN+++            +V E    
Sbjct: 51  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +       A R    +  G+ Y+H+NK   I+HRDL+P N+L   +    N
Sbjct: 111 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDAN 167
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +++ DFG+S     +  + +  +  +  Y+APEV     YD K DV+S  +IL  ++ GC
Sbjct: 168 IRIIDFGLSTHF--EASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGC 224
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFR------ 404
           PPF   ++ ++ K    + +  F+ P  K  +   K+LI +     P+ R + R      
Sbjct: 225 PPFNGANEYDILKK-VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE 283
Query: 405 --------QIITRLESINNSINHKRRWK 424
                   QI   + S++N+I + R+++
Sbjct: 284 WIQTYTKEQISVDVPSLDNAILNIRQFQ 311

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 30/231 (12%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--------RKGALKPST 251
           E+  + +  HPN+V +  +      + +V + L  G +   +K        + G L  ST
Sbjct: 63  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
                 ++  G+ YLH+N     IHRD++  NIL  + G++++ADFGVS  L    D   
Sbjct: 123 IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 179
Query: 312 -----TCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPF---------TM 356
                T   T C ++APEV +    YD K D++SF +   E+  G  P+          +
Sbjct: 180 NKVRKTFVGTPC-WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 238
Query: 357 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
              N+ P      Q    K   K Y +  +++I  C  + P KRPT  +++
Sbjct: 239 TLQNDPPSLETGVQD---KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 286

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 30/231 (12%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--------RKGALKPST 251
           E+  + +  HPN+V +  +      + +V + L  G +   +K        + G L  ST
Sbjct: 58  EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 117
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
                 ++  G+ YLH+N     IHRD++  NIL  + G++++ADFGVS  L    D   
Sbjct: 118 IATILREVLEGLEYLHKNGQ---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITR 174
Query: 312 -----TCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPF---------TM 356
                T   T C ++APEV +    YD K D++SF +   E+  G  P+          +
Sbjct: 175 NKVRKTFVGTPC-WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLML 233
Query: 357 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
              N+ P      Q    K   K Y +  +++I  C  + P KRPT  +++
Sbjct: 234 TLQNDPPSLETGVQD---KEMLKKYGKSFRKMISLCLQKDPEKRPTAAELL 281

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 99/189 (52%), Gaps = 11/189 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K + +E+++DD+ +   + E  +  Q   HP +V         S +  V EY+  GDL
Sbjct: 49  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 108
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  ++ +I+  +NYLHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 109 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 165
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G+ K    +  RP       C    Y+APE+ + E+Y   VD ++  +++ EM+ G  PF
Sbjct: 166 GMCK----EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 221
Query: 355 TMKHDNEVP 363
            +   ++ P
Sbjct: 222 DIVGSSDNP 230

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 109/233 (46%), Gaps = 13/233 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG---AVTQSSPM-MIVTEYLP 233
           VAVK L  ++  D      FR E      + HP +V       A T + P+  IV EY+ 
Sbjct: 57  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 116
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
              LR  +  +G + P  A+    D  + +N+ H+N    IIHRD++P+NI+   +  +K
Sbjct: 117 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK 173
Query: 294 VADFGVSKLLTVKEDRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           V DFG+++ +    +          + +Y++PE  + +  D + DV+S   +L E++ G 
Sbjct: 174 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 233
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
           PPFT   D+ V  AY   +  P   P      GL   ++    +  AK P  R
Sbjct: 234 PPFT--GDSPVSVAYQHVREDPI--PPSARHEGLSADLDAVVLKALAKNPENR 282

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 91.7 bits (226), Expect = 8e-19,   Method: Compositional matrix adjust.
 Identities = 68/261 (26%), Positives = 128/261 (49%), Gaps = 20/261 (7%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF     + KG+F   +       G++VA+K + ++ +     V+  ++E+ +  +++HP
Sbjct: 12  DFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHP 71
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST---AVRFALDIARGMNYLH 267
           ++++       S+ + +V E    G++  +LK +  +KP +   A  F   I  GM YLH
Sbjct: 72  SILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNR--VKPFSENEARHFMHQIITGMLYLH 129
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
            +    I+HRDL  SN+L   + N+K+ADFG++  L +  ++  T   T   Y++PE+  
Sbjct: 130 SHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTP-NYISPEIAT 185
Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386
              +  + DV+S   +   ++ G PPF T    N + K   A     ++ P+ L     K
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA----DYEMPSFLSIEA-K 240
Query: 387 ELIEECWNEKPAKRPTFRQII 407
           +LI +     PA R +   ++
Sbjct: 241 DLIHQLLRRNPADRLSLSSVL 261

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 126/268 (47%), Gaps = 25/268 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + AVK + +  +       +   E+ LL+++ HPN+++            +V E    
Sbjct: 75  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 134
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +       A R    +  G+ Y+H+NK   I+HRDL+P N+L   +    N
Sbjct: 135 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDAN 191
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +++ DFG+S     +  + +  +  +  Y+APEV     YD K DV+S  +IL  ++ GC
Sbjct: 192 IRIIDFGLSTHF--EASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGC 248
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFR------ 404
           PPF   ++ ++ K    + +  F+ P  K  +   K+LI +     P+ R + R      
Sbjct: 249 PPFNGANEYDILKK-VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE 307
Query: 405 --------QIITRLESINNSINHKRRWK 424
                   QI   + S++N+I + R+++
Sbjct: 308 WIQTYTKEQISVDVPSLDNAILNIRQFQ 335

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 126/268 (47%), Gaps = 25/268 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + AVK + +  +       +   E+ LL+++ HPN+++            +V E    
Sbjct: 74  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 133
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +       A R    +  G+ Y+H+NK   I+HRDL+P N+L   +    N
Sbjct: 134 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDAN 190
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +++ DFG+S     +  + +  +  +  Y+APEV     YD K DV+S  +IL  ++ GC
Sbjct: 191 IRIIDFGLSTHF--EASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGC 247
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFR------ 404
           PPF   ++ ++ K    + +  F+ P  K  +   K+LI +     P+ R + R      
Sbjct: 248 PPFNGANEYDILKK-VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHE 306
Query: 405 --------QIITRLESINNSINHKRRWK 424
                   QI   + S++N+I + R+++
Sbjct: 307 WIQTYTKEQISVDVPSLDNAILNIRQFQ 334

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 103/209 (49%), Gaps = 6/209 (2%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALD 258
           E++++Q+   P+VV++ G+  +++ + IV EY   G +   ++ R   L           
Sbjct: 74  EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
             +G+ YLH  +    IHRD++  NIL +  G+ K+ADFGV+  LT    +      T  
Sbjct: 134 TLKGLEYLHFMRK---IHRDIKAGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPF 190
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 378
            ++APEV +   Y+   D++S  +   EM EG PP+   H             P F+ P 
Sbjct: 191 -WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP- 248
Query: 379 KLYARGLKELIEECWNEKPAKRPTFRQII 407
           +L++    + +++C  + P +R T  Q++
Sbjct: 249 ELWSDNFTDFVKQCLVKSPEQRATATQLL 277

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 91.3 bits (225), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 99/189 (52%), Gaps = 11/189 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K + +E+++DD+ +   + E  +  Q   HP +V         S +  V EY+  GDL
Sbjct: 34  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 93
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  ++ +I+  +NYLHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 94  MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 150
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G+ K    +  RP       C    Y+APE+ + E+Y   VD ++  +++ EM+ G  PF
Sbjct: 151 GMCK----EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 206
Query: 355 TMKHDNEVP 363
            +   ++ P
Sbjct: 207 DIVGSSDNP 215

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 109/233 (46%), Gaps = 13/233 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG---AVTQSSPM-MIVTEYLP 233
           VAVK L  ++  D      FR E      + HP +V       A T + P+  IV EY+ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
              LR  +  +G + P  A+    D  + +N+ H+N    IIHRD++P+NI+   +  +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK 156
Query: 294 VADFGVSKLLTVKEDRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           V DFG+++ +    +          + +Y++PE  + +  D + DV+S   +L E++ G 
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
           PPFT   D+ V  AY   +  P   P      GL   ++    +  AK P  R
Sbjct: 217 PPFT--GDSPVSVAYQHVREDPI--PPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/240 (25%), Positives = 121/240 (50%), Gaps = 16/240 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G Q  +K++    +S  +R  + R E+A+L  ++HPN+VQ+  +  ++  + IV +Y   
Sbjct: 49  GRQYVIKEINISRMSSKEREES-RREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107
Query: 235 GDL-RAFLKRKGAL-KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           GDL +    +KG L +    + + + I   + ++H+ K   I+HRD++  NI     G +
Sbjct: 108 GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTV 164
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
           ++ DFG++++L    +    C  T   Y++PE+ +N+ Y+ K D+++   +L E+     
Sbjct: 165 QLGDFGIARVLNSTVELARACIGTP-YYLSPEICENKPYNNKSDIWALGCVLYELC---- 219
Query: 353 PFTMKHDNEVP--KAYAARQRPPFKAPAKL-YARGLKELIEECWNEKPAKRPTFRQIITR 409
             T+KH  E    K    +       P  L Y+  L+ L+ + +   P  RP+   I+ +
Sbjct: 220 --TLKHAFEAGSMKNLVLKIISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRPSVNSILEK 277

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 99/189 (52%), Gaps = 11/189 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K + +E+++DD+ +   + E  +  Q   HP +V         S +  V EY+  GDL
Sbjct: 38  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  ++ +I+  +NYLHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 98  MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 154
Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G+ K    +  RP       C    Y+APE+ + E+Y   VD ++  +++ EM+ G  PF
Sbjct: 155 GMCK----EGLRPGDTTSXFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210
Query: 355 TMKHDNEVP 363
            +   ++ P
Sbjct: 211 DIVGSSDNP 219

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 87/158 (55%), Gaps = 4/158 (2%)
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
           + E  +L++++HP +V  + A      + ++ EYL  G+L   L+R+G     TA  +  
Sbjct: 69  KAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLA 128
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
           +I+  + +LH+     II+RDL+P NI+ +  G++K+ DFG+ K  ++ +         +
Sbjct: 129 EISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCK-ESIHDGTVTHXFCGT 184
Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
             Y+APE+     ++  VD +S   ++ +M+ G PPFT
Sbjct: 185 IEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFT 222

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 67/233 (28%), Positives = 109/233 (46%), Gaps = 13/233 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG---AVTQSSPM-MIVTEYLP 233
           VAVK L  ++  D      FR E      + HP +V       A T + P+  IV EY+ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
              LR  +  +G + P  A+    D  + +N+ H+N    IIHRD++P+NI+   +  +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK 156
Query: 294 VADFGVSKLLTVKEDRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           V DFG+++ +    +          + +Y++PE  + +  D + DV+S   +L E++ G 
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
           PPFT   D+ V  AY   +  P   P      GL   ++    +  AK P  R
Sbjct: 217 PPFT--GDSPVSVAYQHVREDPI--PPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 92/157 (58%), Gaps = 7/157 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
           E+++L++++H N+V+    +     +++V E+L + DL+  L   +G L+  TA  F L 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           +  G+ Y H+ +   ++HRDL+P N+L +  G LK+ADFG+++   +   R  T +  + 
Sbjct: 109 LLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEVVTL 164
Query: 319 RYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
            Y AP+V   +++Y T +D++S   I  EM+ G P F
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLF 201

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 62/234 (26%), Positives = 112/234 (47%), Gaps = 11/234 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + AVK + +  +       +   E+ LL+++ HPN+++            +V E    
Sbjct: 57  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 116
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +       A R    +  G+ Y+H+NK   I+HRDL+P N+L   +    N
Sbjct: 117 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDAN 173
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +++ DFG+S     +  + +  +  +  Y+APEV     YD K DV+S  +IL  ++ GC
Sbjct: 174 IRIIDFGLSTHF--EASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGC 230
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFR 404
           PPF   ++ ++ K    + +  F+ P  K  +   K+LI +     P+ R + R
Sbjct: 231 PPFNGANEYDILKK-VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISAR 283

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 52/179 (29%), Positives = 91/179 (50%), Gaps = 3/179 (1%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I+VA+K +       ++ ++ F  E+    ++ H N+V  +    +     +V EY+   
Sbjct: 37  IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGP 96
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
            L  +++  G L   TA+ F   I  G+ + H+ +   I+HRD++P NIL D +  LK+ 
Sbjct: 97  TLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIF 153
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           DFG++K L+            + +Y +PE  K E  D   D++S  ++L EM+ G PPF
Sbjct: 154 DFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPF 212

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 120/266 (45%), Gaps = 42/266 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVK L  +          ++ E+ +L+ + H +++++ G         + +V EY+
Sbjct: 43  GEMVAVKALKADC--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           P G LR +L R  ++  +  + FA  I  GM YLH       IHR+L   N+L D+   +
Sbjct: 101 PLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHSQH---YIHRNLAARNVLLDNDRLV 156
Query: 293 KVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
           K+ DFG++K +        V+ED      D+   + APE  K  ++    DV+SF + L 
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVRED-----GDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 211
Query: 346 EMIEGC-----PPFTMKHDNEVPKAY------------AARQRPPFKAPAKLYARGLKEL 388
           E++  C     PP        + +                R   P K P ++Y      L
Sbjct: 212 ELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVY-----HL 266
Query: 389 IEECWNEKPAKRPTFRQIITRLESIN 414
           ++ CW  + + RPTF  +I  L++++
Sbjct: 267 MKNCWETEASFRPTFENLIPILKTVH 292

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/233 (26%), Positives = 112/233 (48%), Gaps = 12/233 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G+ VA+KK+    + D         E+ LL+++ HPNV+++  +  + + + IV E    
Sbjct: 57  GVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADA 116
Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           GDL    + F K+K  +   T  ++ + +   + ++H  +   ++HRD++P+N+    +G
Sbjct: 117 GDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATG 173
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
            +K+ D G+ +  + K     +   T   Y++PE      Y+ K D++S   +L EM   
Sbjct: 174 VVKLGDLGLGRFFSSKTTAAHSLVGTP-YYMSPERIHENGYNFKSDIWSLGCLLYEMAAL 232
Query: 351 CPPFTMKHDN--EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
             PF     N   + K       PP   P+  Y+  L++L+  C N  P KRP
Sbjct: 233 QSPFYGDKMNLYSLCKKIEQCDYPPL--PSDHYSEELRQLVNMCINPDPEKRP 283

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 92/157 (58%), Gaps = 7/157 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
           E+++L++++H N+V+    +     +++V E+L + DL+  L   +G L+  TA  F L 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           +  G+ Y H+ +   ++HRDL+P N+L +  G LK+ADFG+++   +   R  T +  + 
Sbjct: 109 LLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEVVTL 164
Query: 319 RYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
            Y AP+V   +++Y T +D++S   I  EM+ G P F
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 50/157 (31%), Positives = 92/157 (58%), Gaps = 7/157 (4%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
           E+++L++++H N+V+    +     +++V E+L + DL+  L   +G L+  TA  F L 
Sbjct: 50  EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           +  G+ Y H+ +   ++HRDL+P N+L +  G LK+ADFG+++   +   R  T +  + 
Sbjct: 109 LLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKYTHEIVTL 164
Query: 319 RYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
            Y AP+V   +++Y T +D++S   I  EM+ G P F
Sbjct: 165 WYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLF 201

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 118/261 (45%), Gaps = 21/261 (8%)
Query: 151 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP +L F++  EI  G+F  + F R ++    VA+KK+       +++ +    E+  LQ
Sbjct: 12  DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 70
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           K+RHPN +Q+ G   +     +V EY            K  L+            +G+ Y
Sbjct: 71  KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 130
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
           LH +    +IHRD++  NIL  + G +K+ DFG + ++      P      +  ++APEV
Sbjct: 131 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAPEV 182
Query: 326 ---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFKAPAKLY 381
                  +YD KVDV+S  +   E+ E  PP F M   N +   Y   Q       +  +
Sbjct: 183 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESPALQSGHW 239
Query: 382 ARGLKELIEECWNEKPAKRPT 402
           +   +  ++ C  + P  RPT
Sbjct: 240 SEYFRNFVDSCLQKIPQDRPT 260

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 70/266 (26%), Positives = 120/266 (45%), Gaps = 42/266 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYL 232
           G  VAVK L  +          ++ E+ +L+ + H +++++ G         + +V EY+
Sbjct: 43  GEMVAVKALKADC--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDQGEKSLQLVMEYV 100
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           P G LR +L R  ++  +  + FA  I  GM YLH       IHR+L   N+L D+   +
Sbjct: 101 PLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRNLAARNVLLDNDRLV 156
Query: 293 KVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
           K+ DFG++K +        V+ED      D+   + APE  K  ++    DV+SF + L 
Sbjct: 157 KIGDFGLAKAVPEGHEYYRVRED-----GDSPVFWYAPECLKEYKFYYASDVWSFGVTLY 211
Query: 346 EMIEGC-----PPFTMKHDNEVPKAY------------AARQRPPFKAPAKLYARGLKEL 388
           E++  C     PP        + +                R   P K P ++Y      L
Sbjct: 212 ELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRPDKCPCEVY-----HL 266
Query: 389 IEECWNEKPAKRPTFRQIITRLESIN 414
           ++ CW  + + RPTF  +I  L++++
Sbjct: 267 MKNCWETEASFRPTFENLIPILKTVH 292

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 97/188 (51%), Gaps = 16/188 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K + +E +  + +  +  +E+A+L KI+HPN+V           + ++ + +  G+L
Sbjct: 46  VAIKCIAKEAL--EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKV 294
              +  KG      A R    +   + YLH+   + I+HRDL+P N+L    D+   + +
Sbjct: 104 FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMI 160
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +DFG+SK+     + P +   T+C    YVAPEV   + Y   VD +S  +I   ++ G 
Sbjct: 161 SDFGLSKM-----EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215
Query: 352 PPFTMKHD 359
           PPF  ++D
Sbjct: 216 PPFYDEND 223

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 64/215 (29%), Positives = 111/215 (51%), Gaps = 14/215 (6%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQV--AVKKLGEEVI---SDDDRVRAFRDELALLQKI 207
           DF     I KG+F   +LA  +  +V  AVK L ++ I    ++  + + R+   LL+ +
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERN--VLLKNV 96
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
           +HP +V    +   +  +  V +Y+  G+L   L+R+       A  +A +IA  + YLH
Sbjct: 97  KHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLH 156
Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
               + I++RDL+P NIL D  G++ + DFG+ K   ++ +   +    +  Y+APEV  
Sbjct: 157 S---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCGTPEYLAPEVLH 212
Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
            + YD  VD +    +L EM+ G PPF  ++  E+
Sbjct: 213 KQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 109/232 (46%), Gaps = 14/232 (6%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           +A+K L +  +  +      R E+ +   +RHPN+++          + ++ E+ P+G+L
Sbjct: 43  MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 102
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              L++ G      +  F  ++A  ++Y HE K   +IHRD++P N+L    G LK+ADF
Sbjct: 103 YKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADF 159
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
           G S        R +     +  Y+ PE+ + + +D KVD++   ++  E + G PPF   
Sbjct: 160 GWSVHAPSLRRRXMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 216
Query: 358 HDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
              E  +       + PPF       + G K+LI +     P +R   + ++
Sbjct: 217 SHTETHRRIVNVDLKFPPF------LSDGSKDLISKLLRYHPPQRLPLKGVM 262

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 109/232 (46%), Gaps = 14/232 (6%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           +A+K L +  +  +      R E+ +   +RHPN+++          + ++ E+ P+G+L
Sbjct: 42  MALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGEL 101
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              L++ G      +  F  ++A  ++Y HE K   +IHRD++P N+L    G LK+ADF
Sbjct: 102 YKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADF 158
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMK 357
           G S        R +     +  Y+ PE+ + + +D KVD++   ++  E + G PPF   
Sbjct: 159 GWSVHAPSLRRRXMC---GTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSP 215
Query: 358 HDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
              E  +       + PPF       + G K+LI +     P +R   + ++
Sbjct: 216 SHTETHRRIVNVDLKFPPF------LSDGSKDLISKLLRYHPPQRLPLKGVM 261

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/191 (28%), Positives = 99/191 (51%), Gaps = 16/191 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K + +E +  + +  +  +E+A+L KI+HPN+V           + ++ + +  G+L
Sbjct: 46  VAIKCIAKEAL--EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKV 294
              +  KG      A R    +   + YLH+   + I+HRDL+P N+L    D+   + +
Sbjct: 104 FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMI 160
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +DFG+SK+     + P +   T+C    YVAPEV   + Y   VD +S  +I   ++ G 
Sbjct: 161 SDFGLSKM-----EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215
Query: 352 PPFTMKHDNEV 362
           PPF  ++D ++
Sbjct: 216 PPFYDENDAKL 226

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 118/261 (45%), Gaps = 21/261 (8%)
Query: 151 DPHELDFTNSVEITKGTF-ILAFWRGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP +L F++  EI  G+F  + F R ++    VA+KK+       +++ +    E+  LQ
Sbjct: 51  DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           K+RHPN +Q+ G   +     +V EY            K  L+            +G+ Y
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
           LH +    +IHRD++  NIL  + G +K+ DFG + ++      P      +  ++APEV
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANXFVGTPYWMAPEV 221
Query: 326 ---FKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFKAPAKLY 381
                  +YD KVDV+S  +   E+ E  PP F M   N +   Y   Q       +  +
Sbjct: 222 ILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM---NAMSALYHIAQNESPALQSGHW 278
Query: 382 ARGLKELIEECWNEKPAKRPT 402
           +   +  ++ C  + P  RPT
Sbjct: 279 SEYFRNFVDSCLQKIPQDRPT 299

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 97/188 (51%), Gaps = 16/188 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K + +E +  + +  +  +E+A+L KI+HPN+V           + ++ + +  G+L
Sbjct: 46  VAIKCIAKEAL--EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKV 294
              +  KG      A R    +   + YLH+   + I+HRDL+P N+L    D+   + +
Sbjct: 104 FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMI 160
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +DFG+SK+     + P +   T+C    YVAPEV   + Y   VD +S  +I   ++ G 
Sbjct: 161 SDFGLSKM-----EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215
Query: 352 PPFTMKHD 359
           PPF  ++D
Sbjct: 216 PPFYDEND 223

>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 81/275 (29%), Positives = 129/275 (46%), Gaps = 20/275 (7%)
Query: 150 IDPHELDFTNSV-EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR 208
           ID  +L+F   + E   G      W+G  + VK L     S   + R F +E   L+   
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPRLRIFS 65
Query: 209 HPNVVQFLGAVTQSSPM---MIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGM 263
           HPNV+  LGA  QS P     ++T ++P G L   L       +  S AV+FALD+ARGM
Sbjct: 66  HPNVLPVLGAC-QSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM 124
Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 323
            +LH  +P+ I    L   +++ D+    +++      +  VK       +  +  +VAP
Sbjct: 125 AFLHTLEPL-IPRHALNSRSVMIDEDMTARIS------MADVKFSFQSPGRMYAPAWVAP 177
Query: 324 EVFKNEEYDT---KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380
           E  + +  DT     D++SFA++L E++    PF    + E+    A     P   P   
Sbjct: 178 EALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTIPPG-- 235
Query: 381 YARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
            +  + +L++ C NE PAKRP F  I+  LE + +
Sbjct: 236 ISPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 69/257 (26%), Positives = 117/257 (45%), Gaps = 24/257 (9%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVTE 230
           ++VAVK +  +  S    +  F  E A ++   HPNV++ LG   + S       M++  
Sbjct: 63  LKVAVKTMKLDN-SSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILP 121
Query: 231 YLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           ++  GDL  +L           +   T ++F +DIA GM YL        +HRDL   N 
Sbjct: 122 FMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNC 178
Query: 285 LRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 343
           +  D   + VADFG+SK + +    R         +++A E   +  Y +K DV++F + 
Sbjct: 179 MLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238
Query: 344 LQEM-IEGCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
           + E+   G  P+    ++E+     +  R + P     +LY     E++  CW   P  R
Sbjct: 239 MWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELY-----EIMYSCWRTDPLDR 293
Query: 401 PTFRQIITRLESINNSI 417
           PTF  +  +LE +  S+
Sbjct: 294 PTFSVLRLQLEKLLESL 310

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 95/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K +   + R  T   T   Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 184 TDFGFAKRV---KGRTWTLCGTP-EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEYSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 95/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 52  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 111
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 112 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 168
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K +   + R  T   T   Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 169 TDFGFAKRV---KGRTWTLCGTP-EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 224

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 184 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 184 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 87  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 146
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 147 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 203
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 204 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 184 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 184 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 59  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 118
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 119 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 175
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 176 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 131/299 (43%), Gaps = 25/299 (8%)
Query: 137 MHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDD 192
           +H+   +     E+     +F+N   + +G F   +      G  VAVK+L EE     +
Sbjct: 20  VHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERXQGGE 79
Query: 193 RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS-- 250
               F+ E+ ++    H N+++  G     +  ++V  Y+  G + + L+ +   +P   
Sbjct: 80  L--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 137
Query: 251 --TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
                R AL  ARG+ YLH++    IIHRD++ +NIL D+     V DFG++KL+  K+ 
Sbjct: 138 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX 197
Query: 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT---MKHDNEV--- 362
                   +  ++APE     +   K DVF + ++L E+I G   F    + +D++V   
Sbjct: 198 HVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 257
Query: 363 --PKAYAARQRPPFKAPAKLYARGLKELIEE-------CWNEKPAKRPTFRQIITRLES 412
              K     ++        L      E +E+       C    P +RP   +++  LE 
Sbjct: 258 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 316

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 127 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 184 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 99/196 (50%), Gaps = 17/196 (8%)
Query: 166 GTFILAFWRGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G     +     VAVKKL   V I+ ++  + F  E+ ++ K +H N+V+ LG  +    
Sbjct: 45  GVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 104
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST---AVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           + +V  Y+P G L   L       P +     + A   A G+N+LHEN     IHRD++ 
Sbjct: 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKS 161
Query: 282 SNILRDDSGNLKVADFGVSK-----LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           +NIL D++   K++DFG+++       TV   R +     +  Y+APE  +  E   K D
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMXSRIV----GTTAYMAPEALRG-EITPKSD 216
Query: 337 VFSFALILQEMIEGCP 352
           ++SF ++L E+I G P
Sbjct: 217 IYSFGVVLLEIITGLP 232

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 118/258 (45%), Gaps = 30/258 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L E   + +   + F+ E  LL  ++H ++V+F G  T+  P+++V EY+  GDL
Sbjct: 51  VAVKALKE---ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL 107
Query: 238 RAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
             FL+                 G L     +  A  +A GM YL     +  +HRDL   
Sbjct: 108 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATR 164
Query: 283 NILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
           N L      +K+ DFG+S+ + +    R         R++ PE     ++ T+ DV+SF 
Sbjct: 165 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFG 224
Query: 342 LILQEMIEGC--PPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPA 398
           ++L E+      P + + +   +      R+   P   P ++YA     ++  CW  +P 
Sbjct: 225 VVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYA-----IMRGCWQREPQ 279
Query: 399 KRPTFRQIITRLESINNS 416
           +R + + +  RL+++  +
Sbjct: 280 QRHSIKDVHARLQALAQA 297

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 59  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 118
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 119 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 175
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 176 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 231

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G +KV
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 118/258 (45%), Gaps = 30/258 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L E   + +   + F+ E  LL  ++H ++V+F G  T+  P+++V EY+  GDL
Sbjct: 74  VAVKALKE---ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL 130
Query: 238 RAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
             FL+                 G L     +  A  +A GM YL     +  +HRDL   
Sbjct: 131 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATR 187
Query: 283 NILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
           N L      +K+ DFG+S+ + +    R         R++ PE     ++ T+ DV+SF 
Sbjct: 188 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFG 247
Query: 342 LILQEMIEGC--PPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPA 398
           ++L E+      P + + +   +      R+   P   P ++YA     ++  CW  +P 
Sbjct: 248 VVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYA-----IMRGCWQREPQ 302
Query: 399 KRPTFRQIITRLESINNS 416
           +R + + +  RL+++  +
Sbjct: 303 QRHSIKDVHARLQALAQA 320

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 89.4 bits (220), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 66/233 (28%), Positives = 108/233 (46%), Gaps = 13/233 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG---AVTQSSPM-MIVTEYLP 233
           VAVK L  ++  D      FR E      + HP +V       A T + P+  IV EY+ 
Sbjct: 40  VAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVD 99
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
              LR  +  +G + P  A+    D  + +N+ H+N    IIHRD++P+NI+   +  +K
Sbjct: 100 GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVK 156
Query: 294 VADFGVSKLLTVKEDRPLTCQDT--SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           V DFG+++ +    +          + +Y++PE  + +  D + DV+S   +L E++ G 
Sbjct: 157 VMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 216
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
           PPFT    + V  AY   +  P   P      GL   ++    +  AK P  R
Sbjct: 217 PPFTGDSPDSV--AYQHVREDPI--PPSARHEGLSADLDAVVLKALAKNPENR 265

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 66/258 (25%), Positives = 118/258 (45%), Gaps = 30/258 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L E   + +   + F+ E  LL  ++H ++V+F G  T+  P+++V EY+  GDL
Sbjct: 45  VAVKALKE---ASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDL 101
Query: 238 RAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
             FL+                 G L     +  A  +A GM YL     +  +HRDL   
Sbjct: 102 NRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATR 158
Query: 283 NILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
           N L      +K+ DFG+S+ + +    R         R++ PE     ++ T+ DV+SF 
Sbjct: 159 NCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFG 218
Query: 342 LILQEMIEGC--PPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPA 398
           ++L E+      P + + +   +      R+   P   P ++YA     ++  CW  +P 
Sbjct: 219 VVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVYA-----IMRGCWQREPQ 273
Query: 399 KRPTFRQIITRLESINNS 416
           +R + + +  RL+++  +
Sbjct: 274 QRHSIKDVHARLQALAQA 291

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 61/196 (31%), Positives = 99/196 (50%), Gaps = 17/196 (8%)
Query: 166 GTFILAFWRGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G     +     VAVKKL   V I+ ++  + F  E+ ++ K +H N+V+ LG  +    
Sbjct: 45  GVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 104
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST---AVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           + +V  Y+P G L   L       P +     + A   A G+N+LHEN     IHRD++ 
Sbjct: 105 LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKS 161
Query: 282 SNILRDDSGNLKVADFGVSK-----LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           +NIL D++   K++DFG+++       TV   R +     +  Y+APE  +  E   K D
Sbjct: 162 ANILLDEAFTAKISDFGLARASEKFAQTVMXXRIV----GTTAYMAPEALRG-EITPKSD 216
Query: 337 VFSFALILQEMIEGCP 352
           ++SF ++L E+I G P
Sbjct: 217 IYSFGVVLLEIITGLP 232

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G +KV
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 184 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +     +    +E  +LQ +  P +V+   +   +S + +V EY P 
Sbjct: 66  GNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G +KV
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG++K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGLAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G +KV
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 57/188 (30%), Positives = 96/188 (51%), Gaps = 5/188 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +  +   DRVR  + E  +L  + HP VV+   A      + ++ ++L  
Sbjct: 56  GHLYAMKVLKKATLKVRDRVRT-KMERDILADVNHPFVVKLHYAFQTEGKLYLILDFLRG 114
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           GDL   L ++          +  ++A G+++LH    + II+RDL+P NIL D+ G++K+
Sbjct: 115 GDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHS---LGIIYRDLKPENILLDEEGHIKL 171
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG+SK     E +  +   T   Y+APEV   + +    D +S+ +++ EM+ G  PF
Sbjct: 172 TDFGLSKEAIDHEKKAYSFCGT-VEYMAPEVVNRQGHSHSADWWSYGVLMFEMLTGSLPF 230
Query: 355 TMKHDNEV 362
             K   E 
Sbjct: 231 QGKDRKET 238

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/180 (30%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  + Q +  P +V+   +   +S + +V EY P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNFPFLVKLEFSFKDNSNLYMVLEYAPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G +KV
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIKV 183
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           ADFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 184 ADFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 54/191 (28%), Positives = 99/191 (51%), Gaps = 16/191 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K + ++ +  + +  +  +E+A+L KI+HPN+V           + ++ + +  G+L
Sbjct: 46  VAIKCIAKKAL--EGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGEL 103
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKV 294
              +  KG      A R    +   + YLH+   + I+HRDL+P N+L    D+   + +
Sbjct: 104 FDRIVEKGFYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMI 160
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +DFG+SK+     + P +   T+C    YVAPEV   + Y   VD +S  +I   ++ G 
Sbjct: 161 SDFGLSKM-----EDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGY 215
Query: 352 PPFTMKHDNEV 362
           PPF  ++D ++
Sbjct: 216 PPFYDENDAKL 226

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 126/264 (47%), Gaps = 29/264 (10%)
Query: 163 ITKGTFILAFWRGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI-RHPNVVQFLGAV 219
           +  GT+   + +G  V   +L    + D   D     + E+ +L+K   H N+  + GA 
Sbjct: 32  VGNGTYGQVY-KGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAF 90
Query: 220 TQSSP------MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKP 271
            + +P      + +V E+   G +   +K  +   LK         +I RG+++LH++K 
Sbjct: 91  IKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK- 149
Query: 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKN 328
             +IHRD++  N+L  ++  +K+ DFGVS  L    DR +  ++T   +  ++APEV   
Sbjct: 150 --VIHRDIKGQNVLLTENAEVKLVDFGVSAQL----DRTVGRRNTFIGTPYWMAPEVIAC 203
Query: 329 EE-----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
           +E     YD K D++S  +   EM EG PP    H   +   +   + P  +  +K +++
Sbjct: 204 DENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH--PMRALFLIPRNPAPRLKSKKWSK 261
Query: 384 GLKELIEECWNEKPAKRPTFRQII 407
             +  IE C  +  ++RP   Q++
Sbjct: 262 KFQSFIESCLVKNHSQRPATEQLM 285

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 89.0 bits (219), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 114/233 (48%), Gaps = 9/233 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA++++    +    +     +E+ ++++ ++PN+V +L +      + +V EYL  
Sbjct: 45  GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +     +          +  + + +LH N+   +IHRD++  NIL    G++K+
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG    +T ++ +  T   T   ++APEV   + Y  KVD++S  ++  EMIEG PP+
Sbjct: 158 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             ++        A    P  + P KL A   ++ +  C +    KR + ++++
Sbjct: 217 LNENPLRALYLIATNGTPELQNPEKLSAI-FRDFLNRCLDMDVEKRGSAKELL 268

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 17/217 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKPSTAVRFALD 258
           E+ +L    HPN+V+ L A    + + I+ E+   G + A  L+ +  L  S        
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-- 316
               +NYLH+NK   IIHRDL+  NIL    G++K+ADFGVS     K  R +  +D+  
Sbjct: 144 TLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRTIQRRDSFI 196
Query: 317 -SCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370
            +  ++APEV      K+  YD K DV+S  + L EM E  PP    +   V    A  +
Sbjct: 197 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE 256
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            P    P++ ++   K+ +++C  +    R T  Q++
Sbjct: 257 PPTLAQPSR-WSSNFKDFLKKCLEKNVDARWTTSQLL 292

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/299 (24%), Positives = 129/299 (43%), Gaps = 25/299 (8%)
Query: 137 MHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDD 192
           +H+   +     E+     +F N   + +G F   +      G  VAVK+L EE     +
Sbjct: 12  VHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVKRLKEERTQGGE 71
Query: 193 RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS-- 250
               F+ E+ ++    H N+++  G     +  ++V  Y+  G + + L+ +   +P   
Sbjct: 72  L--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLD 129
Query: 251 --TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED 308
                R AL  ARG+ YLH++    IIHRD++ +NIL D+     V DFG++KL+  K+ 
Sbjct: 130 WPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDX 189
Query: 309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT---MKHDNEV--- 362
                      ++APE     +   K DVF + ++L E+I G   F    + +D++V   
Sbjct: 190 HVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLL 249
Query: 363 --PKAYAARQRPPFKAPAKLYARGLKELIEE-------CWNEKPAKRPTFRQIITRLES 412
              K     ++        L      E +E+       C    P +RP   +++  LE 
Sbjct: 250 DWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG 308

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 61/179 (34%), Positives = 97/179 (54%), Gaps = 9/179 (5%)
Query: 178 VAVKK--LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+KK  LG    + D   R    E+ LLQ++ HPN++  L A    S + +V +++ + 
Sbjct: 38  VAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ET 96
Query: 236 DLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           DL   +K     L PS    + L   +G+ YLH++    I+HRDL+P+N+L D++G LK+
Sbjct: 97  DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKL 153
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCP 352
           ADFG++K      +R    Q  +  Y APE +F    Y   VD+++   IL E++   P
Sbjct: 154 ADFGLAKSFG-SPNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY P 
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 106/217 (48%), Gaps = 17/217 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKPSTAVRFALD 258
           E+ +L    HPN+V+ L A    + + I+ E+   G + A  L+ +  L  S        
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-- 316
               +NYLH+NK   IIHRDL+  NIL    G++K+ADFGVS     K  R +  +D+  
Sbjct: 144 TLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRXIQRRDSFI 196
Query: 317 -SCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370
            +  ++APEV      K+  YD K DV+S  + L EM E  PP    +   V    A  +
Sbjct: 197 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE 256
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            P    P++ ++   K+ +++C  +    R T  Q++
Sbjct: 257 PPTLAQPSR-WSSNFKDFLKKCLEKNVDARWTTSQLL 292

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +     +    +E  +LQ +  P +V+   +   +S + +V EY P 
Sbjct: 66  GNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYAPG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG++K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGLAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 92/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P + +   +   +S + +V EY P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G +KV
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 184 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 92/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P + +   +   +S + +V EY P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G +KV
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 184 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 88.2 bits (217), Expect = 9e-18,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 117/259 (45%), Gaps = 31/259 (11%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK L +  ++     + F+ E  LL  ++H ++V+F G      P+++V EY+  GDL
Sbjct: 48  VAVKALKDPTLAAR---KDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL 104
Query: 238 RAFLK----------------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
             FL+                 KG L  S  +  A  IA GM YL        +HRDL  
Sbjct: 105 NKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLAT 161
Query: 282 SNILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
            N L   +  +K+ DFG+S+ + +    R         R++ PE     ++ T+ DV+SF
Sbjct: 162 RNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSF 221
Query: 341 ALILQEMIE-GCPPFTMKHDNEVPKAYAARQ--RPPFKAPAKLYARGLKELIEECWNEKP 397
            +IL E+   G  P+    + EV +     +    P   P ++Y     +++  CW  +P
Sbjct: 222 GVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERPRVCPKEVY-----DVMLGCWQREP 276
Query: 398 AKRPTFRQIITRLESINNS 416
            +R   ++I   L ++  +
Sbjct: 277 QQRLNIKEIYKILHALGKA 295

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 88.2 bits (217), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 92/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P + +   +   +S + +V EY P 
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLTKLEFSFKDNSNLYMVMEYAPG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G +KV
Sbjct: 127 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLMIDQQGYIKV 183
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 184 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 68/268 (25%), Positives = 122/268 (45%), Gaps = 25/268 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + AVK + +  +       +   E+ LL+++ HPN+ +            +V E    
Sbjct: 51  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIXKLYEFFEDKGYFYLVGEVYTG 110
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +       A R    +  G+ Y H+NK   I+HRDL+P N+L   +    N
Sbjct: 111 GELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNK---IVHRDLKPENLLLESKSKDAN 167
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +++ DFG+S        +    +  +  Y+APEV     YD K DV+S  +IL  ++ GC
Sbjct: 168 IRIIDFGLSTHFEAS--KKXKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGC 224
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFR------ 404
           PPF   ++ ++ K    + +  F+ P  K  +   K+LI +     P+ R + R      
Sbjct: 225 PPFNGANEYDILKK-VEKGKYTFELPQWKKVSESAKDLIRKXLTYVPSXRISARDALDHE 283
Query: 405 --------QIITRLESINNSINHKRRWK 424
                   QI   + S++N+I + R+++
Sbjct: 284 WIQTYTKEQISVDVPSLDNAILNIRQFQ 311

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 60/216 (27%), Positives = 106/216 (49%), Gaps = 12/216 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFL----KRKGALKPSTAV 253
           E+ LL++++HPN+V++   +    ++ + IV EY   GDL + +    K +  L     +
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 254 RFALDIARGMNYLH--ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
           R    +   +   H   +    ++HRDL+P+N+  D   N+K+ DFG++++L   ED   
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAK 174
Query: 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
               T   Y++PE      Y+ K D++S   +L E+    PPFT     E+  A   R+ 
Sbjct: 175 EFVGTP-YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--AGKIREG 231
Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
              + P + Y+  L E+I    N K   RP+  +I+
Sbjct: 232 KFRRIPYR-YSDELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 107/249 (42%), Gaps = 45/249 (18%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L    D        +  
Sbjct: 114 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 168
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPP---------FTMKHDNEVPK--- 364
           Y++PE  +   Y  + D++S  L L EM  G    PP         F  + + +  +   
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 365 ----------AYAARQRPPF---------------KAPAKLYARGLKELIEECWNEKPAK 399
                     +Y    RPP                K P+ +++   ++ + +C  + PA+
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288
Query: 400 RPTFRQIIT 408
           R   +Q++ 
Sbjct: 289 RADLKQLMV 297

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 107/249 (42%), Gaps = 45/249 (18%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L    D        +  
Sbjct: 114 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 168
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPP---------FTMKHDNEVPK--- 364
           Y++PE  +   Y  + D++S  L L EM  G    PP         F  + + +  +   
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 365 ----------AYAARQRPPF---------------KAPAKLYARGLKELIEECWNEKPAK 399
                     +Y    RPP                K P+ +++   ++ + +C  + PA+
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288
Query: 400 RPTFRQIIT 408
           R   +Q++ 
Sbjct: 289 RADLKQLMV 297

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 107/249 (42%), Gaps = 45/249 (18%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L    D        +  
Sbjct: 114 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 168
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPP---------FTMKHDNEVPK--- 364
           Y++PE  +   Y  + D++S  L L EM  G    PP         F  + + +  +   
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 365 ----------AYAARQRPPF---------------KAPAKLYARGLKELIEECWNEKPAK 399
                     +Y    RPP                K P+ +++   ++ + +C  + PA+
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288
Query: 400 RPTFRQIIT 408
           R   +Q++ 
Sbjct: 289 RADLKQLMV 297

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 107/249 (42%), Gaps = 45/249 (18%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 54  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 113
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L    D        +  
Sbjct: 114 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 168
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPP---------FTMKHDNEVPK--- 364
           Y++PE  +   Y  + D++S  L L EM  G    PP         F  + + +  +   
Sbjct: 169 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 228
Query: 365 ----------AYAARQRPPF---------------KAPAKLYARGLKELIEECWNEKPAK 399
                     +Y    RPP                K P+ +++   ++ + +C  + PA+
Sbjct: 229 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAE 288
Query: 400 RPTFRQIIT 408
           R   +Q++ 
Sbjct: 289 RADLKQLMV 297

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 113/233 (48%), Gaps = 9/233 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA++++    +    +     +E+ ++++ ++PN+V +L +      + +V EYL  
Sbjct: 46  GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 102
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +     +          +  + + +LH N+   +IHR+++  NIL    G++K+
Sbjct: 103 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRNIKSDNILLGMDGSVKL 158
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG    +T ++ +  T   T   ++APEV   + Y  KVD++S  ++  EMIEG PP+
Sbjct: 159 TDFGFCAQITPEQSKRSTMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 217
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             ++        A    P  + P KL A   ++ +  C      KR + +++I
Sbjct: 218 LNENPLRALYLIATNGTPELQNPEKLSAI-FRDFLNRCLEMDVEKRGSAKELI 269

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 94/180 (52%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 53  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 112
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D+ G ++V
Sbjct: 113 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDEQGYIQV 169
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 170 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 225

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 105/217 (48%), Gaps = 17/217 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA-FLKRKGALKPSTAVRFALD 258
           E+ +L    HPN+V+ L A    + + I+ E+   G + A  L+ +  L  S        
Sbjct: 84  EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQ 143
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-- 316
               +NYLH+NK   IIHRDL+  NIL    G++K+ADFGVS     K  R +  +D   
Sbjct: 144 TLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVS----AKNTRXIQRRDXFI 196
Query: 317 -SCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370
            +  ++APEV      K+  YD K DV+S  + L EM E  PP    +   V    A  +
Sbjct: 197 GTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSE 256
Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            P    P++ ++   K+ +++C  +    R T  Q++
Sbjct: 257 PPTLAQPSR-WSSNFKDFLKKCLEKNVDARWTTSQLL 292

>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 120/252 (47%), Gaps = 30/252 (11%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  GD
Sbjct: 46  RVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 103
Query: 237 LRAFLKRKGALKPST-------------AVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+  K    +HRDL   N
Sbjct: 104 LKSYLR---SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARN 157
Query: 284 ILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
            +      +K+ DFG+++ +      R         R++APE  K+  + T  D++SF +
Sbjct: 158 CMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 217
Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
           +L E+      P+    + +V K          P   P ++      +L+  CW   P  
Sbjct: 218 VLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERV-----TDLMRMCWQFNPKM 272
Query: 400 RPTFRQIITRLE 411
           RPTF +I+  L+
Sbjct: 273 RPTFLEIVNLLK 284

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 58/192 (30%), Positives = 97/192 (50%), Gaps = 9/192 (4%)
Query: 166 GTFILAFWRGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G     +     VAVKKL   V I+ ++  + F  E+ ++ K +H N+V+ LG  +    
Sbjct: 39  GVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDD 98
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST---AVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           + +V  Y+P G L   L       P +     + A   A G+N+LHEN     IHRD++ 
Sbjct: 99  LCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKS 155
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEVFKNEEYDTKVDVFSF 340
           +NIL D++   K++DFG+++         +  +   +  Y+APE  +  E   K D++SF
Sbjct: 156 ANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRG-EITPKSDIYSF 214
Query: 341 ALILQEMIEGCP 352
            ++L E+I G P
Sbjct: 215 GVVLLEIITGLP 226

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 57/233 (24%), Positives = 112/233 (48%), Gaps = 9/233 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA++++    +    +     +E+ ++++ ++PN+V +L +      + +V EYL  
Sbjct: 46  GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 102
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +     +          +  + + +LH N+   +IHRD++  NIL    G++K+
Sbjct: 103 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 158
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG    +T ++ +      T   ++APEV   + Y  KVD++S  ++  EMIEG PP+
Sbjct: 159 TDFGFCAQITPEQSKRSXMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 217
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             ++        A    P  + P KL A   ++ +  C      KR + +++I
Sbjct: 218 LNENPLRALYLIATNGTPELQNPEKLSAI-FRDFLNRCLEMDVEKRGSAKELI 269

>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/290 (27%), Positives = 132/290 (45%), Gaps = 47/290 (16%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGA----VT 220
           G      W G  VAVK     + S  D    FR+ E+     +RH N++ F+ +      
Sbjct: 22  GEVWRGLWHGESVAVK-----IFSSRDEQSWFRETEIYNTVLLRHDNILGFIASDMTSRN 76
Query: 221 QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------ENKPVPI 274
            S+ + ++T Y   G L  FL+R+  L+P  A+R A+  A G+ +LH      + KP  I
Sbjct: 77  SSTQLWLITHYHEHGSLYDFLQRQ-TLEPHLALRLAVSAACGLAHLHVEIFGTQGKPA-I 134
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD---TSCRYVAPEVFKNE-- 329
            HRD +  N+L   +    +AD G++ + +   D      +    + RY+APEV   +  
Sbjct: 135 AHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLDIGNNPRVGTKRYMAPEVLDEQIR 194
Query: 330 ----EYDTKVDVFSFALILQEM-----IEGC-----PPF--TMKHD---NEVPKAYAARQ 370
               E     D+++F L+L E+     + G      PPF   + +D    ++ K     Q
Sbjct: 195 TDCFESYKWTDIWAFGLVLWEIARRTIVNGIVEDYRPPFYDVVPNDPSFEDMKKVVCVDQ 254
Query: 371 RPPFKAPAKLYA----RGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
           + P   P +L A     GL +++ ECW   P+ R T  +I   L+ I+NS
Sbjct: 255 QTP-TIPNRLAADPVLSGLAQMMRECWYPNPSARLTALRIKKTLQKISNS 303

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 56/196 (28%), Positives = 104/196 (53%), Gaps = 18/196 (9%)
Query: 175 GIQVAVK--KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
           G+ VA+K  KL  E  +    +R    E++L+++++H N+V+    +   + + +V E++
Sbjct: 30  GVYVALKEVKLDSEEGTPSTAIR----EISLMKELKHENIVRLYDVIHTENKLTLVFEFM 85
Query: 233 PKGDLRAFLKRKG------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
              DL+ ++  +        L+ +    F   + +G+ + HENK   I+HRDL+P N+L 
Sbjct: 86  -DNDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLI 141
Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQ 345
           +  G LK+ DFG+++   +  +   + +  +  Y AP+V   +  Y T +D++S   IL 
Sbjct: 142 NKRGQLKLGDFGLARAFGIPVNT-FSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILA 200
Query: 346 EMIEGCPPFTMKHDNE 361
           EMI G P F   +D E
Sbjct: 201 EMITGKPLFPGTNDEE 216

>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 120/252 (47%), Gaps = 30/252 (11%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  GD
Sbjct: 49  RVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 106
Query: 237 LRAFLKRKGALKPST-------------AVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+  K    +HRDL   N
Sbjct: 107 LKSYLR---SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARN 160
Query: 284 ILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
            +      +K+ DFG+++ +      R         R++APE  K+  + T  D++SF +
Sbjct: 161 CMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 220
Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
           +L E+      P+    + +V K          P   P ++      +L+  CW   P  
Sbjct: 221 VLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERV-----TDLMRMCWQFNPKM 275
Query: 400 RPTFRQIITRLE 411
           RPTF +I+  L+
Sbjct: 276 RPTFLEIVNLLK 287

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 72/266 (27%), Positives = 116/266 (43%), Gaps = 43/266 (16%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           IQVAVK L E+  +D     A   EL ++ ++  H N+V  LGA T S P+ ++ EY   
Sbjct: 76  IQVAVKMLKEK--ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCY 133
Query: 235 GDLRAFLKRK-----------------------GALKPSTAVRFALDIARGMNYLHENKP 271
           GDL  +L+ K                         L     + FA  +A+GM +L     
Sbjct: 134 GDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSC 193
Query: 272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFKN 328
           V   HRDL   N+L      +K+ DFG+++   +  D     +  +    +++APE    
Sbjct: 194 V---HRDLAARNVLVTHGKVVKICDFGLAR--DIMSDSNYVVRGNARLPVKWMAPESLFE 248
Query: 329 EEYDTKVDVFSFALILQEMIE-GCPPF-TMKHDNEVPKAY--AARQRPPFKAPAKLYARG 384
             Y  K DV+S+ ++L E+   G  P+  +  D    K      +   PF A  ++Y   
Sbjct: 249 GIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYI-- 306
Query: 385 LKELIEECWNEKPAKRPTFRQIITRL 410
              +++ CW     KRP+F  + + L
Sbjct: 307 ---IMQSCWAFDSRKRPSFPNLTSFL 329

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 13/224 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  +   DRVR  + E  +L ++ HP +V+   A      + ++ ++L  GDL 
Sbjct: 56  AMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 114
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L ++          +  ++A  +++LH    + II+RDL+P NIL D+ G++K+ DFG
Sbjct: 115 TRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFG 171
Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +SK     E +  +   T   Y+APEV     +    D +SF +++ EM+ G  PF  K 
Sbjct: 172 LSKESIDHEKKAYSFCGT-VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230
Query: 359 DNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
             E       A    P F +P        + L+   +   PA R
Sbjct: 231 RKETMTMILKAKLGMPQFLSPEA------QSLLRMLFKRNPANR 268

>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 120/252 (47%), Gaps = 30/252 (11%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  GD
Sbjct: 49  RVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 106
Query: 237 LRAFLKRKGALKPST-------------AVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+  K    +HRDL   N
Sbjct: 107 LKSYLR---SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARN 160
Query: 284 ILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
            +      +K+ DFG+++ +      R         R++APE  K+  + T  D++SF +
Sbjct: 161 CMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 220
Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
           +L E+      P+    + +V K          P   P +     + +L+  CW   P  
Sbjct: 221 VLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER-----VTDLMRMCWQFNPNM 275
Query: 400 RPTFRQIITRLE 411
           RPTF +I+  L+
Sbjct: 276 RPTFLEIVNLLK 287

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 13/224 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  +   DRVR  + E  +L ++ HP +V+   A      + ++ ++L  GDL 
Sbjct: 57  AMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 115
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L ++          +  ++A  +++LH    + II+RDL+P NIL D+ G++K+ DFG
Sbjct: 116 TRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFG 172
Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +SK     E +  +   T   Y+APEV     +    D +SF +++ EM+ G  PF  K 
Sbjct: 173 LSKESIDHEKKAYSFCGT-VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 231
Query: 359 DNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
             E       A    P F +P        + L+   +   PA R
Sbjct: 232 RKETMTMILKAKLGMPQFLSPEA------QSLLRMLFKRNPANR 269

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 51/182 (28%), Positives = 92/182 (50%), Gaps = 8/182 (4%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K + ++   + + VR    EL ++Q + HP +V    +      M +V + L  GDLR
Sbjct: 44  AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR 103
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L++    K  T   F  ++   ++YL   +   IIHRD++P NIL D+ G++ + DF 
Sbjct: 104 YHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFN 160
Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFT 355
           ++ +L    +  +T    +  Y+APE+F   K   Y   VD +S  +   E++ G  P+ 
Sbjct: 161 IAAMLP--RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYH 218
Query: 356 MK 357
           ++
Sbjct: 219 IR 220

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 67  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 126
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 127 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 183
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 184 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 239

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 87  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 146
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 147 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 203
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 204 TDFGFAK--RVKGATWTLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 62/249 (24%), Positives = 107/249 (42%), Gaps = 45/249 (18%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 116 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 175
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L    D        +  
Sbjct: 176 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 230
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPP---------FTMKHDNEVPK--- 364
           Y++PE  +   Y  + D++S  L L EM  G    PP         F  + + +  +   
Sbjct: 231 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 290
Query: 365 ----------AYAARQRPPF---------------KAPAKLYARGLKELIEECWNEKPAK 399
                     +Y    RPP                K P+ +++   ++ + +C  + PA+
Sbjct: 291 RPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSAVFSLEFQDFVNKCLIKNPAE 350
Query: 400 RPTFRQIIT 408
           R   +Q++ 
Sbjct: 351 RADLKQLMV 359

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 61  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 120
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 121 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 177
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 178 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 233

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 120/252 (47%), Gaps = 30/252 (11%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  GD
Sbjct: 48  RVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 105
Query: 237 LRAFLKRKGALKPST-------------AVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+  K    +HRDL   N
Sbjct: 106 LKSYLR---SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARN 159
Query: 284 ILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
            +      +K+ DFG+++ +      R         R++APE  K+  + T  D++SF +
Sbjct: 160 CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 219
Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
           +L E+      P+    + +V K          P   P ++      +L+  CW   P  
Sbjct: 220 VLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERV-----TDLMRMCWQFNPKM 274
Query: 400 RPTFRQIITRLE 411
           RPTF +I+  L+
Sbjct: 275 RPTFLEIVNLLK 286

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 87  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 146
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 147 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 203
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 204 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 259

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 69/259 (26%), Positives = 130/259 (50%), Gaps = 21/259 (8%)
Query: 161 VEITKGTFILAFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ 214
           +EI +G+F   + +G      ++VA  +L +  ++  +R R F++E   L+ ++HPN+V+
Sbjct: 32  IEIGRGSFKTVY-KGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEXLKGLQHPNIVR 89
Query: 215 FL----GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
           F       V     +++VTE    G L+ +LKR    K      +   I +G+ +LH   
Sbjct: 90  FYDSWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRT 149
Query: 271 PVPIIHRDLEPSNI-LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
           P PIIHRDL+  NI +   +G++K+ D G   L T+K          +  + APE ++ E
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLG---LATLKRASFAKAVIGTPEFXAPEXYE-E 204
Query: 330 EYDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388
           +YD  VDV++F     E      P++  ++  ++ +   +  +P   +  K+    +KE+
Sbjct: 205 KYDESVDVYAFGXCXLEXATSEYPYSECQNAAQIYRRVTSGVKPA--SFDKVAIPEVKEI 262
Query: 389 IEECWNEKPAKRPTFRQII 407
           IE C  +   +R + + ++
Sbjct: 263 IEGCIRQNKDERYSIKDLL 281

>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 120/252 (47%), Gaps = 30/252 (11%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  GD
Sbjct: 49  RVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 106
Query: 237 LRAFLKRKGALKPST-------------AVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+  K    +HRDL   N
Sbjct: 107 LKSYLR---SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARN 160
Query: 284 ILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
            +      +K+ DFG+++ +      R         R++APE  K+  + T  D++SF +
Sbjct: 161 CMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 220
Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
           +L E+      P+    + +V K          P   P ++      +L+  CW   P  
Sbjct: 221 VLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERV-----TDLMRMCWQFNPKM 275
Query: 400 RPTFRQIITRLE 411
           RPTF +I+  L+
Sbjct: 276 RPTFLEIVNLLK 287

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 63/224 (28%), Positives = 106/224 (47%), Gaps = 13/224 (5%)
Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  +   DRVR  + E  +L ++ HP +V+   A      + ++ ++L  GDL 
Sbjct: 56  AMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 114
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L ++          +  ++A  +++LH    + II+RDL+P NIL D+ G++K+ DFG
Sbjct: 115 TRLSKEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFG 171
Query: 299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +SK     E +  +   T   Y+APEV     +    D +SF +++ EM+ G  PF  K 
Sbjct: 172 LSKESIDHEKKAYSFCGT-VEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKD 230
Query: 359 DNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
             E       A    P F +P        + L+   +   PA R
Sbjct: 231 RKETMTMILKAKLGMPQFLSPEA------QSLLRMLFKRNPANR 268

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 18/224 (8%)
Query: 196 AFRDELA----LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 48  ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 106
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--R 309
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+  +
Sbjct: 107 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 163
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY-- 366
             T      ++ APE     ++ +K DV+SF +++ E    G  P+     +EV      
Sbjct: 164 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 223
Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
             R   P   P ++Y     +L+  CW      RP F  +  RL
Sbjct: 224 GERMGCPAGCPREMY-----DLMNLCWTYDVENRPGFAAVELRL 262

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 113/233 (48%), Gaps = 9/233 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA++++    +    +     +E+ ++++ ++PN+V +L +      + +V EYL  
Sbjct: 45  GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +     +          +  + + +LH N+   +IHRD++  NIL    G++K+
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG    +T ++ +      T   ++APEV   + Y  KVD++S  ++  EMIEG PP+
Sbjct: 158 TDFGFCAQITPEQSKRSEMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             ++        A    P  + P KL A   ++ +  C +    KR + ++++
Sbjct: 217 LNENPLRALYLIATNGTPELQNPEKLSAI-FRDFLNRCLDMDVEKRGSAKELL 268

>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/252 (26%), Positives = 120/252 (47%), Gaps = 30/252 (11%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  GD
Sbjct: 49  RVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 106
Query: 237 LRAFLKRKGALKPST-------------AVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+  K    +HRDL   N
Sbjct: 107 LKSYLR---SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARN 160
Query: 284 ILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
            +      +K+ DFG+++ +      R         R++APE  K+  + T  D++SF +
Sbjct: 161 CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 220
Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
           +L E+      P+    + +V K          P   P ++      +L+  CW   P  
Sbjct: 221 VLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPERV-----TDLMRMCWQFNPKM 275
Query: 400 RPTFRQIITRLE 411
           RPTF +I+  L+
Sbjct: 276 RPTFLEIVNLLK 287

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/242 (27%), Positives = 118/242 (48%), Gaps = 16/242 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 346 EMIEGCPPFTMKHDNEVPKAYA-ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
            M+ G  P+    D+   + Y+  +++  +  P K        L+ +   E P+ R T  
Sbjct: 199 AMLAGELPWDQPSDSX--QEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIP 256
Query: 405 QI 406
            I
Sbjct: 257 DI 258

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 18/226 (7%)
Query: 196 AFRDELA----LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 54  ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 112
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--R 309
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+  +
Sbjct: 113 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYK 169
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY-- 366
             T      ++ APE     ++ +K DV+SF +++ E    G  P+     +EV      
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 229
Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
             R   P   P ++Y     +L+  CW      RP F  +  RL +
Sbjct: 230 GERMGCPAGCPREMY-----DLMNLCWTYDVENRPGFAAVELRLRN 270

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/226 (26%), Positives = 105/226 (46%), Gaps = 18/226 (7%)
Query: 196 AFRDELA----LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 54  ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 112
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--R 309
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+  +
Sbjct: 113 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 169
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY-- 366
             T      ++ APE     ++ +K DV+SF +++ E    G  P+     +EV      
Sbjct: 170 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 229
Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
             R   P   P ++Y     +L+  CW      RP F  +  RL +
Sbjct: 230 GERMGCPAGCPREMY-----DLMNLCWTYDVENRPGFAAVELRLRN 270

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 199 AMLAGELPWDQPSDS 213

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 18/224 (8%)
Query: 196 AFRDELA----LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 50  ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 108
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--R 309
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+  +
Sbjct: 109 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY-- 366
             T      ++ APE     ++ +K DV+SF +++ E    G  P+     +EV      
Sbjct: 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 225
Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
             R   P   P ++Y     +L+  CW      RP F  +  RL
Sbjct: 226 GERMGCPAGCPREMY-----DLMNLCWTYDVENRPGFAAVELRL 264

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 56/233 (24%), Positives = 112/233 (48%), Gaps = 9/233 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA++++    +    +     +E+ ++++ ++PN+V +L +      + +V EYL  
Sbjct: 45  GQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAG 101
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   +     +          +  + + +LH N+   +IHRD++  NIL    G++K+
Sbjct: 102 GSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKL 157
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG    +T ++ +      T   ++APEV   + Y  KVD++S  ++  EMIEG PP+
Sbjct: 158 TDFGFCAQITPEQSKRSXMVGTP-YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPY 216
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             ++        A    P  + P KL A   ++ +  C      KR + ++++
Sbjct: 217 LNENPLRALYLIATNGTPELQNPEKLSAI-FRDFLNRCLEMDVEKRGSAKELL 268

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 18/224 (8%)
Query: 196 AFRDELA----LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 60  ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 118
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--R 309
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+  +
Sbjct: 119 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 175
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY-- 366
             T      ++ APE     ++ +K DV+SF +++ E    G  P+     +EV      
Sbjct: 176 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 235
Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
             R   P   P ++Y     +L+  CW      RP F  +  RL
Sbjct: 236 GERMGCPAGCPREMY-----DLMNLCWTYDVENRPGFAAVELRL 274

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 199 AMLAGELPWDQPSDS 213

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 18/224 (8%)
Query: 196 AFRDELA----LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 68  ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 126
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--R 309
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+  +
Sbjct: 127 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 183
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY-- 366
             T      ++ APE     ++ +K DV+SF +++ E    G  P+     +EV      
Sbjct: 184 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 243
Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
             R   P   P ++Y     +L+  CW      RP F  +  RL
Sbjct: 244 GERMGCPAGCPREMY-----DLMNLCWTYDVENRPGFAAVELRL 282

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N++ D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLIIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIIISKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K +   + R      T   Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAKRV---KGRTWXLXGTP-EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 199 AMLAGELPWDQPSDS 213

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 59/216 (27%), Positives = 105/216 (48%), Gaps = 12/216 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFL----KRKGALKPSTAV 253
           E+ LL++++HPN+V++   +    ++ + IV EY   GDL + +    K +  L     +
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 254 RFALDIARGMNYLH--ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
           R    +   +   H   +    ++HRDL+P+N+  D   N+K+ DFG++++L        
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK 174
Query: 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
           T   T   Y++PE      Y+ K D++S   +L E+    PPFT     E+  A   R+ 
Sbjct: 175 TFVGTP-YYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL--AGKIREG 231
Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
              + P + Y+  L E+I    N K   RP+  +I+
Sbjct: 232 KFRRIPYR-YSDELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 106/250 (42%), Gaps = 47/250 (18%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK+ G +      + ++ +
Sbjct: 81  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            +G+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L    D        +  
Sbjct: 141 IKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 195
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEG---CPPFTMKH------------------ 358
           Y++PE  +   Y  + D++S  L L EM  G    PP   K                   
Sbjct: 196 YMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPP 255
Query: 359 --------------DNEVPKA------YAARQRPPFKAPAKLYARGLKELIEECWNEKPA 398
                         D+  P A      Y   + PP K P+ +++   ++ + +C  + PA
Sbjct: 256 RPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPA 314
Query: 399 KRPTFRQIIT 408
           +R   +Q++ 
Sbjct: 315 ERADLKQLMV 324

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 118/260 (45%), Gaps = 34/260 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEY 231
           G  VAVK L E       ++R+ ++ E+ +L+ + H ++V++ G         + +V EY
Sbjct: 37  GEMVAVKALKEGC---GPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEY 93
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           +P G LR +L R   +  +  + FA  I  GM YLH       IHR L   N+L D+   
Sbjct: 94  VPLGSLRDYLPRH-CVGLAQLLLFAQQICEGMAYLHAQH---YIHRALAARNVLLDNDRL 149
Query: 292 LKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           +K+ DFG++K +        V+ED      D+   + APE  K  ++    DV+SF + L
Sbjct: 150 VKIGDFGLAKAVPEGHEYYRVRED-----GDSPVFWYAPECLKECKFYYASDVWSFGVTL 204
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG------------LKELIEEC 392
            E++  C      H          + +       +L  RG            +  L++ C
Sbjct: 205 YELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNC 264
Query: 393 WNEKPAKRPTFRQIITRLES 412
           W  + + RPTF+ ++  L++
Sbjct: 265 WETEASFRPTFQNLVPILQT 284

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 23  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 83  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 200 AMLAGELPWDQPSDS 214

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 18/224 (8%)
Query: 196 AFRDELA----LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 70  ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 128
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--R 309
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+  +
Sbjct: 129 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY-- 366
             T      ++ APE     ++ +K DV+SF +++ E    G  P+     +EV      
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 245
Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
             R   P   P ++Y     +L+  CW      RP F  +  RL
Sbjct: 246 GERMGCPAGCPREMY-----DLMNLCWTYDVENRPGFAAVELRL 284

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 18/224 (8%)
Query: 196 AFRDELA----LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 70  ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 128
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--R 309
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+  +
Sbjct: 129 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 185
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY-- 366
             T      ++ APE     ++ +K DV+SF +++ E    G  P+     +EV      
Sbjct: 186 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 245
Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
             R   P   P ++Y     +L+  CW      RP F  +  RL
Sbjct: 246 GERMGCPAGCPREMY-----DLMNLCWTYDVENRPGFAAVELRL 284

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+APE+  ++ Y+  VD ++  +++ +M  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPEIILSKGYNKAVDWWALGVLIYQMAAGYPPF 238

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 93/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K +   + R      T   Y+APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAKRV---KGRTWXLAGTP-EYLAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 69/260 (26%), Positives = 118/260 (45%), Gaps = 34/260 (13%)
Query: 175 GIQVAVKKLGEEVISDDDRVRA-FRDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEY 231
           G  VAVK L E       ++R+ ++ E+ +L+ + H ++V++ G         + +V EY
Sbjct: 38  GEMVAVKALKEGC---GPQLRSGWQREIEILRTLYHEHIVKYKGCCEDQGEKSVQLVMEY 94
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           +P G LR +L R   +  +  + FA  I  GM YLH       IHR L   N+L D+   
Sbjct: 95  VPLGSLRDYLPRH-CVGLAQLLLFAQQICEGMAYLHAQH---YIHRALAARNVLLDNDRL 150
Query: 292 LKVADFGVSKLL-------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           +K+ DFG++K +        V+ED      D+   + APE  K  ++    DV+SF + L
Sbjct: 151 VKIGDFGLAKAVPEGHEYYRVRED-----GDSPVFWYAPECLKECKFYYASDVWSFGVTL 205
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG------------LKELIEEC 392
            E++  C      H          + +       +L  RG            +  L++ C
Sbjct: 206 YELLTYCDSNQSPHTKFTELIGHTQGQMTVLRLTELLERGERLPRPDRCPCEIYHLMKNC 265
Query: 393 WNEKPAKRPTFRQIITRLES 412
           W  + + RPTF+ ++  L++
Sbjct: 266 WETEASFRPTFQNLVPILQT 285

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 199 AMLAGELPWDQPSDS 213

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 199 AMLAGELPWDQPSDS 213

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 199 AMLAGELPWDQPSDS 213

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 21  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 80
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 81  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 137
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 138 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 197
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 198 AMLAGELPWDQPSDS 212

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 199 AMLAGELPWDQPSDS 213

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 10/213 (4%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF   + + KG+F   +L+  +G     AVK L ++V+  DD V     E  +L     P
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 211 NVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
             +  L +  Q+   +  V EY+  GDL   +++ G  K   AV +A +IA G+ +L   
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
               II+RDL+  N++ D  G++K+ADFG+ K   + +         +  Y+APE+   +
Sbjct: 141 G---IIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKXFCGTPDYIAPEIIAYQ 196
Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
            Y   VD ++F ++L EM+ G  PF  + ++E+
Sbjct: 197 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 229

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 23  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 83  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 200 AMLAGELPWDQPSDS 214

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 23  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 83  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 200 AMLAGELPWDQPSDS 214

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 127/276 (46%), Gaps = 24/276 (8%)
Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVK--KLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           EL   N   + +G + +   + I VA+K  K G E    ++ +R    E  ++ ++ +P 
Sbjct: 17  ELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMR----EAQIMHQLDNPY 71
Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENK 270
           +V+ +G V Q+  +M+V E    G L  FL  K    P + V   L  ++ GM YL E  
Sbjct: 72  IVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 130
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFK 327
               +HRDL   N+L  +    K++DFG+SK L   +D   T +       ++ APE   
Sbjct: 131 ---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPLKWYAPECIN 186
Query: 328 NEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARG 384
             ++ ++ DV+S+ + + E +  G  P+      EV        R   P + P +LYA  
Sbjct: 187 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA-- 244
Query: 385 LKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420
              L+ +CW  K   RP F  +  R+ +   S+  K
Sbjct: 245 ---LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 277

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 85.1 bits (209), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 199 AMLAGELPWDQPSDS 213

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 23  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 83  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 200 AMLAGELPWDQPSDS 214

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 23  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 83  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 200 AMLAGELPWDQPSDS 214

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 199 AMLAGELPWDQPSDS 213

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 23  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 83  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 200 AMLAGELPWDQPSDS 214

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 10/214 (4%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 200
           P++ +  +E ++     + KGTF   IL   +  G   A+K L +EVI   D V     E
Sbjct: 144 PKHRVTMNEFEYLKL--LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 201
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
             +LQ  RHP +     +      +  V EY   G+L   L R+       A  +  +I 
Sbjct: 202 NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 261
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
             ++YLH  K V  ++RDL+  N++ D  G++K+ DFG+ K   +K+   +     +  Y
Sbjct: 262 SALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEY 318
Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           +APEV ++ +Y   VD +   +++ EM+ G  PF
Sbjct: 319 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 352

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 23  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 83  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 200 AMLAGELPWDQPSDS 214

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 199 AMLAGELPWDQPSDS 213

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ + + + H NVV+F G   + +   +
Sbjct: 22  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLNHENVVKFYGHRREGNIQYL 81
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 82  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 138
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 139 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 198
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 199 AMLAGELPWDQPSDS 213

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 64/213 (30%), Positives = 109/213 (51%), Gaps = 10/213 (4%)
Query: 156 DFTNSVEITKGTF---ILAFWRGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF   + + KG+F   +L+  +G     AVK L ++V+  DD V     E  +L     P
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 211 NVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
             +  L +  Q+   +  V EY+  GDL   +++ G  K   AV +A +IA G+ +L   
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
               II+RDL+  N++ D  G++K+ADFG+ K   + +         +  Y+APE+   +
Sbjct: 462 G---IIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKXFCGTPDYIAPEIIAYQ 517
Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
            Y   VD ++F ++L EM+ G  PF  + ++E+
Sbjct: 518 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDEL 550

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 62/214 (28%), Positives = 104/214 (48%), Gaps = 10/214 (4%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 200
           P++ +  +E ++     + KGTF   IL   +  G   A+K L +EVI   D V     E
Sbjct: 141 PKHRVTMNEFEYLKL--LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTE 198
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
             +LQ  RHP +     +      +  V EY   G+L   L R+       A  +  +I 
Sbjct: 199 NRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIV 258
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
             ++YLH  K V  ++RDL+  N++ D  G++K+ DFG+ K   +K+   +     +  Y
Sbjct: 259 SALDYLHSEKNV--VYRDLKLENLMLDKDGHIKITDFGLCK-EGIKDGATMKTFCGTPEY 315
Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           +APEV ++ +Y   VD +   +++ EM+ G  PF
Sbjct: 316 LAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 349

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 18/224 (8%)
Query: 196 AFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 413 ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 471
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--R 309
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+  +
Sbjct: 472 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 528
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY-- 366
             T      ++ APE     ++ +K DV+SF +++ E    G  P+     +EV      
Sbjct: 529 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 588
Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
             R   P   P ++Y     +L+  CW      RP F  +  RL
Sbjct: 589 GERMGCPAGCPREMY-----DLMNLCWTYDVENRPGFAAVELRL 627

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 104/224 (46%), Gaps = 18/224 (8%)
Query: 196 AFRDEL----ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
           A +DEL     ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K   
Sbjct: 412 ALKDELLAEANVMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKN 470
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--R 309
            +     ++ GM YL E+     +HRDL   N+L       K++DFG+SK L   E+  +
Sbjct: 471 IIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 527
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAY-- 366
             T      ++ APE     ++ +K DV+SF +++ E    G  P+     +EV      
Sbjct: 528 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK 587
Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
             R   P   P ++Y     +L+  CW      RP F  +  RL
Sbjct: 588 GERMGCPAGCPREMY-----DLMNLCWTYDVENRPGFAAVELRL 626

>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/254 (28%), Positives = 106/254 (41%), Gaps = 48/254 (18%)
Query: 207 IRHPNVVQFLGA---VTQSSPM--MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 261
           + H N+ +F+     VT    M  ++V EY P G L  +L    +   S+  R A  + R
Sbjct: 64  MEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSC-RLAHSVTR 122
Query: 262 GMNYLHENKPV------PIIHRDLEPSNILRDDSGNLKVADFGVSKLLT-------VKED 308
           G+ YLH   P        I HRDL   N+L  + G   ++DFG+S  LT        +ED
Sbjct: 123 GLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEED 182
Query: 309 RPLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIEGC---------P 352
                +  + RY+APEV +        E    +VD+++  LI  E+   C         P
Sbjct: 183 NAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVP 242
Query: 353 PFTMKHDNEVPK----------AYAARQRPPFKAPAK---LYARGLKELIEECWNEKPAK 399
            + M    EV                +QRP F    K   L  R LKE IE+CW++    
Sbjct: 243 EYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEA 302
Query: 400 RPTFRQIITRLESI 413
           R T +    R+  +
Sbjct: 303 RLTAQXAEERMAEL 316

>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 120/252 (47%), Gaps = 30/252 (11%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  GD
Sbjct: 50  RVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 107
Query: 237 LRAFLKRKGALKPST-------------AVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+  K    +HR+L   N
Sbjct: 108 LKSYLR---SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARN 161
Query: 284 ILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
            +      +K+ DFG+++ +      R         R++APE  K+  + T  D++SF +
Sbjct: 162 CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 221
Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
           +L E+      P+    + +V K          P   P +     + +L+  CW   P  
Sbjct: 222 VLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER-----VTDLMRMCWQFNPNM 276
Query: 400 RPTFRQIITRLE 411
           RPTF +I+  L+
Sbjct: 277 RPTFLEIVNLLK 288

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 58/195 (29%), Positives = 99/195 (50%), Gaps = 13/195 (6%)
Query: 176 IQVAVKKLGEEVISDD--DRVRA------FRDELALLQKIRHPNVVQFLGAVTQSSPMMI 227
           +Q+AV ++ EE ++    D  RA       + E+ +   + H NVV+F G   + +   +
Sbjct: 23  VQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLNHENVVKFYGHRREGNIQYL 82
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
             EY   G+L   ++    +    A RF   +  G+ YLH    + I HRD++P N+L D
Sbjct: 83  FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLD 139
Query: 288 DSGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQ 345
           +  NLK++DFG++ +      +R L     +  YVAPE+ K  E+  + VDV+S  ++L 
Sbjct: 140 ERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLT 199
Query: 346 EMIEGCPPFTMKHDN 360
            M+ G  P+    D+
Sbjct: 200 AMLAGELPWDQPSDS 214

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 19/218 (8%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFAL 257
           E+ +L    HP +V+ LGA      + I+ E+ P G + A +    +G  +P   V    
Sbjct: 66  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCR 124
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT- 316
            +   +N+LH  +   IIHRDL+  N+L    G++++ADFGVS     K  + L  +D+ 
Sbjct: 125 QMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSF 177
Query: 317 --SCRYVAPEV-----FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
             +  ++APEV      K+  YD K D++S  + L EM +  PP    +   V    A  
Sbjct: 178 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 237
Query: 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             P    P+K ++   ++ ++   ++ P  RP+  Q++
Sbjct: 238 DPPTLLTPSK-WSVEFRDFLKIALDKNPETRPSAAQLL 274

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 61/218 (27%), Positives = 106/218 (48%), Gaps = 19/218 (8%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFAL 257
           E+ +L    HP +V+ LGA      + I+ E+ P G + A +    +G  +P   V    
Sbjct: 58  EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQV-VCR 116
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT- 316
            +   +N+LH  +   IIHRDL+  N+L    G++++ADFGVS     K  + L  +D+ 
Sbjct: 117 QMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVS----AKNLKTLQKRDSF 169
Query: 317 --SCRYVAPEV-----FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
             +  ++APEV      K+  YD K D++S  + L EM +  PP    +   V    A  
Sbjct: 170 IGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKS 229
Query: 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             P    P+K ++   ++ ++   ++ P  RP+  Q++
Sbjct: 230 DPPTLLTPSK-WSVEFRDFLKIALDKNPETRPSAAQLL 266

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 92/180 (51%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C   +  Y+AP +  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLC--GTPEYLAPAIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 66/252 (26%), Positives = 120/252 (47%), Gaps = 30/252 (11%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VAVK + E   S  +R+  F +E ++++     +VV+ LG V++  P ++V E +  GD
Sbjct: 49  RVAVKTVNESA-SLRERIE-FLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGD 106
Query: 237 LRAFLKRKGALKPST-------------AVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           L+++L+   +L+P                ++ A +IA GM YL+  K    +HR+L   N
Sbjct: 107 LKSYLR---SLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRNLAARN 160
Query: 284 ILRDDSGNLKVADFGVSK-LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
            +      +K+ DFG+++ +      R         R++APE  K+  + T  D++SF +
Sbjct: 161 CMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 220
Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
           +L E+      P+    + +V K          P   P +     + +L+  CW   P  
Sbjct: 221 VLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPDNCPER-----VTDLMRMCWQFNPNM 275
Query: 400 RPTFRQIITRLE 411
           RPTF +I+  L+
Sbjct: 276 RPTFLEIVNLLK 287

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 92/187 (49%), Gaps = 18/187 (9%)
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFA 256
           +E  +L+K+    VV    A      + +V   +  GDL+  +   G      + AV +A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            +I  G+  LH  +   I++RDL+P NIL DD G+++++D G++  + V E + +  +  
Sbjct: 293 AEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVG 347
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-----------NEVPKA 365
           +  Y+APEV KNE Y    D ++   +L EMI G  PF  +              EVP+ 
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407
Query: 366 YAARQRP 372
           Y+ R  P
Sbjct: 408 YSERFSP 414

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 56/187 (29%), Positives = 92/187 (49%), Gaps = 18/187 (9%)
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFA 256
           +E  +L+K+    VV    A      + +V   +  GDL+  +   G      + AV +A
Sbjct: 233 NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYA 292
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            +I  G+  LH  +   I++RDL+P NIL DD G+++++D G++  + V E + +  +  
Sbjct: 293 AEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLA--VHVPEGQTIKGRVG 347
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD-----------NEVPKA 365
           +  Y+APEV KNE Y    D ++   +L EMI G  PF  +              EVP+ 
Sbjct: 348 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEE 407
Query: 366 YAARQRP 372
           Y+ R  P
Sbjct: 408 YSERFSP 414

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 60/196 (30%), Positives = 95/196 (48%), Gaps = 17/196 (8%)
Query: 166 GTFILAFWRGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           G     +     VAVKKL   V I+ ++  + F  E+ +  K +H N+V+ LG  +    
Sbjct: 36  GVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQHENLVELLGFSSDGDD 95
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPST---AVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           + +V  Y P G L   L       P +     + A   A G+N+LHEN     IHRD++ 
Sbjct: 96  LCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHH---IHRDIKS 152
Query: 282 SNILRDDSGNLKVADFGVSK-----LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           +NIL D++   K++DFG+++        V   R +     +  Y APE  +  E   K D
Sbjct: 153 ANILLDEAFTAKISDFGLARASEKFAQXVXXSRIV----GTTAYXAPEALRG-EITPKSD 207
Query: 337 VFSFALILQEMIEGCP 352
           ++SF ++L E+I G P
Sbjct: 208 IYSFGVVLLEIITGLP 223

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 88/180 (48%), Gaps = 3/180 (1%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +EVI   D V     E  +LQ  RHP +     +      +  V EY   
Sbjct: 33  GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 92
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L R+       A  +  +I   ++YLH  K V  ++RDL+  N++ D  G++K+
Sbjct: 93  GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKI 150
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG+ K   +K+   +     +  Y+APEV ++ +Y   VD +   +++ EM+ G  PF
Sbjct: 151 TDFGLCK-EGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 209

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 60/224 (26%), Positives = 106/224 (47%), Gaps = 28/224 (12%)
Query: 200 ELALLQKIRHPNVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFL----KRKGALKPSTAV 253
           E+ LL++++HPN+V++   +    ++ + IV EY   GDL + +    K +  L     +
Sbjct: 55  EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVL 114
Query: 254 RFALDIARGMNYLH--ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
           R    +   +   H   +    ++HRDL+P+N+  D   N+K+ DFG++++L        
Sbjct: 115 RVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILN------- 167
Query: 312 TCQDTSC--------RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
              DTS          Y++PE      Y+ K D++S   +L E+    PPFT     E+ 
Sbjct: 168 --HDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKEL- 224
Query: 364 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            A   R+    + P + Y+  L E+I    N K   RP+  +I+
Sbjct: 225 -AGKIREGKFRRIPYR-YSDELNEIITRMLNLKDYHRPSVEEIL 266

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 88/180 (48%), Gaps = 3/180 (1%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +EVI   D V     E  +LQ  RHP +     +      +  V EY   
Sbjct: 34  GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 93
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L R+       A  +  +I   ++YLH  K V  ++RDL+  N++ D  G++K+
Sbjct: 94  GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKI 151
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG+ K   +K+   +     +  Y+APEV ++ +Y   VD +   +++ EM+ G  PF
Sbjct: 152 TDFGLCK-EGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 88/180 (48%), Gaps = 3/180 (1%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L +EVI   D V     E  +LQ  RHP +     +      +  V EY   
Sbjct: 35  GRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANG 94
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L R+       A  +  +I   ++YLH  K V  ++RDL+  N++ D  G++K+
Sbjct: 95  GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNV--VYRDLKLENLMLDKDGHIKI 152
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG+ K   +K+   +     +  Y+APEV ++ +Y   VD +   +++ EM+ G  PF
Sbjct: 153 TDFGLCK-EGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPF 211

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 54/171 (31%), Positives = 86/171 (50%), Gaps = 9/171 (5%)
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
           LL+  +HPN++           + +VTE +  G+L   + R+       A      I + 
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 263 MNYLHENKPVPIIHRDLEPSNILR-DDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSC 318
           + YLH      ++HRDL+PSNIL  D+SGN   +++ DFG +K L   E+  L     + 
Sbjct: 129 VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-ENGLLMTPCYTA 184
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
            +VAPEV + + YD   D++S  ++L  M+ G  PF    D + P+   AR
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD-DTPEEILAR 234

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/278 (25%), Positives = 130/278 (46%), Gaps = 30/278 (10%)
Query: 163 ITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           I KG F   +   W G +VA++ +  E   ++D+++AF+ E+   ++ RH NVV F+GA 
Sbjct: 41  IGKGRFGQVYHGRWHG-EVAIRLIDIER-DNEDQLKAFKREVMAYRQTRHENVVLFMGAC 98
Query: 220 TQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
                + I+T       L + ++  K  L  +   + A +I +GM YLH      I+H+D
Sbjct: 99  MSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKD 155
Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTV-----KEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
           L+  N+  D+ G + + DFG+  +  V     +ED+ L  Q+    ++APE+ +    DT
Sbjct: 156 LKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDK-LRIQNGWLCHLAPEIIRQLSPDT 213
Query: 334 K---------VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384
           +          DVF+   I  E+     PF  +    +        +P          + 
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQIG--MGKE 271
Query: 385 LKELIEECWNEKPAKRPTFRQIITRLESI---NNSINH 419
           + +++  CW  +  +RPTF +++  LE +   N  ++H
Sbjct: 272 ISDILLFCWAFEQEERPTFTKLMDMLEKLPKRNRRLSH 309

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 83.2 bits (204), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 52/180 (28%), Positives = 91/180 (50%), Gaps = 7/180 (3%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  
Sbjct: 66  GNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAG 125
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++ + L+R G      A  +A  I     YLH    + +I+RDL+P N+L D  G ++V
Sbjct: 126 GEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQV 182
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            DFG +K   VK      C       +APE+  ++ Y+  VD ++  +++ EM  G PPF
Sbjct: 183 TDFGFAK--RVKGRTWXLCGTPEA--LAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF 238

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 98/187 (52%), Gaps = 16/187 (8%)
Query: 176 IQVAVKKLGEEVISDDDRVR-AFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
           ++V  ++L  E + +   VR A R E  +L+++  HP+++  + +   SS M +V + + 
Sbjct: 127 MEVTAERLSPEQLEE---VREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMR 183
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           KG+L  +L  K AL           +   +++LH N    I+HRDL+P NIL DD+  ++
Sbjct: 184 KGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIR 240
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEM 347
           ++DFG S  L   E     C      Y+APE+ K      +  Y  +VD+++  +IL  +
Sbjct: 241 LSDFGFSCHLEPGEKLRELCGTPG--YLAPEILKCSMDETHPGYGKEVDLWACGVILFTL 298
Query: 348 IEGCPPF 354
           + G PPF
Sbjct: 299 LAGSPPF 305

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
           LL+  +HPN++           + +VTE +  G+L   + R+       A      I + 
Sbjct: 74  LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKT 133
Query: 263 MNYLHENKPVPIIHRDLEPSNILR-DDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSC 318
           + YLH      ++HRDL+PSNIL  D+SGN   L++ DFG +K L   E+  L     + 
Sbjct: 134 VEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRA-ENGLLMTPCYTA 189
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            +VAPEV K + YD   D++S  ++L  M+ G  PF
Sbjct: 190 NFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 82/272 (30%), Positives = 118/272 (43%), Gaps = 22/272 (8%)
Query: 150 IDPHELDFTNSV-EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR 208
           ID  +L+F   + E   G      W+G  + VK L     S   + R F +E   L+   
Sbjct: 7   IDFKQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPRLRIFS 65
Query: 209 HPNVVQFLGAVTQSSPM---MIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGM 263
           HPNV+  LGA  QS P     ++T + P G L   L       +  S AV+FALD ARG 
Sbjct: 66  HPNVLPVLGAC-QSPPAPHPTLITHWXPYGSLYNVLHEGTNFVVDQSQAVKFALDXARGX 124
Query: 264 NYLHENKP-VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
            +LH  +P +P    +     I  D +  +  AD   S     +   P         +VA
Sbjct: 125 AFLHTLEPLIPRHALNSRSVXIDEDXTARISXADVKFSFQSPGRXYAPA--------WVA 176
Query: 323 PEVFKNEEYDT---KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379
           PE  + +  DT     D +SFA++L E++    PF    + E+    A     P   P  
Sbjct: 177 PEALQKKPEDTNRRSADXWSFAVLLWELVTREVPFADLSNXEIGXKVALEGLRPTIPPG- 235
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
             +  + +L + C NE PAKRP F  I+  LE
Sbjct: 236 -ISPHVSKLXKICXNEDPAKRPKFDXIVPILE 266

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 52/156 (33%), Positives = 80/156 (51%), Gaps = 8/156 (5%)
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
           LL+  +HPN++           + +VTE +  G+L   + R+       A      I + 
Sbjct: 74  LLRYGQHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKT 133
Query: 263 MNYLHENKPVPIIHRDLEPSNILR-DDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSC 318
           + YLH      ++HRDL+PSNIL  D+SGN   L++ DFG +K L   E+  L     + 
Sbjct: 134 VEYLHSQG---VVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRA-ENGLLMTPCYTA 189
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            +VAPEV K + YD   D++S  ++L  M+ G  PF
Sbjct: 190 NFVAPEVLKRQGYDEGCDIWSLGILLYTMLAGYTPF 225

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 75/276 (27%), Positives = 127/276 (46%), Gaps = 24/276 (8%)
Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVK--KLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           EL   N   + +G + +   + I VA+K  K G E    ++ +R    E  ++ ++ +P 
Sbjct: 343 ELGCGNFGSVRQGVYRMRK-KQIDVAIKVLKQGTEKADTEEMMR----EAQIMHQLDNPY 397
Query: 212 VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENK 270
           +V+ +G V Q+  +M+V E    G L  FL  K    P + V   L  ++ GM YL E  
Sbjct: 398 IVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRYVAPEVFK 327
               +HR+L   N+L  +    K++DFG+SK L   +D   T +       ++ APE   
Sbjct: 457 ---FVHRNLAARNVLLVNRHYAKISDFGLSKALGA-DDSYYTARSAGKWPLKWYAPECIN 512
Query: 328 NEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK--AYAARQRPPFKAPAKLYARG 384
             ++ ++ DV+S+ + + E +  G  P+      EV        R   P + P +LYA  
Sbjct: 513 FRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMECPPECPPELYA-- 570
Query: 385 LKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420
              L+ +CW  K   RP F  +  R+ +   S+  K
Sbjct: 571 ---LMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 109/201 (54%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+++ H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R  T +  +  Y APE+   
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLG 177
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMV 198

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 101/193 (52%), Gaps = 15/193 (7%)
Query: 220 TQSSPMMIVTEYLPKGDLRAFL-KRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
           +++  + I  E+  KG L  ++ KR+G  L    A+     I +G++Y+H  K   +IHR
Sbjct: 104 SKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LIHR 160
Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 337
           DL+PSNI   D+  +K+ DFG+  + ++K D   T    + RY++PE   +++Y  +VD+
Sbjct: 161 DLKPSNIFLVDTKQVKIGDFGL--VTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDL 218
Query: 338 FSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKP 397
           ++  LIL E++  C         E  K +   +       + ++ +  K L+++  ++KP
Sbjct: 219 YALGLILAELLHVCDTAF-----ETSKFFTDLRDGII---SDIFDKKEKTLLQKLLSKKP 270
Query: 398 AKRPTFRQIITRL 410
             RP   +I+  L
Sbjct: 271 EDRPNTSEILRTL 283

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 94/192 (48%), Gaps = 5/192 (2%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
           G   AVK L ++VI  DD V     E  +L   R HP + Q          +  V E++ 
Sbjct: 48  GDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVN 107
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            GDL   +++      + A  +A +I   + +LH+     II+RDL+  N+L D  G+ K
Sbjct: 108 GGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCK 164
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
           +ADFG+ K          T   T   Y+APE+ +   Y   VD ++  ++L EM+ G  P
Sbjct: 165 LADFGMCKEGICNGVTTATFCGTP-DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAP 223
Query: 354 FTMKHDNEVPKA 365
           F  ++++++ +A
Sbjct: 224 FEAENEDDLFEA 235

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 56/215 (26%), Positives = 100/215 (46%), Gaps = 14/215 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL----KRKGALKPSTAVRF 255
           E+ +L+ + HPN+++          M IV E    G+L   +     R  AL        
Sbjct: 70  EIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVKEDRPLT 312
              +   + Y H      ++H+DL+P NIL  D+     +K+ DFG+++L   K D   T
Sbjct: 130 MKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAELF--KSDEHST 184
Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372
               +  Y+APEVFK  +   K D++S  +++  ++ GC PFT     EV +  A  + P
Sbjct: 185 NAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQK-ATYKEP 242
Query: 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            +    +       +L+++   + P +RP+  Q++
Sbjct: 243 NYAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVL 277

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/213 (26%), Positives = 108/213 (50%), Gaps = 11/213 (5%)
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
           +E+A+L+ + HPN+++            +V E    G+L   +  +       A      
Sbjct: 85  EEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQ 144
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
           +  G+ YLH++    I+HRDL+P N+L   ++    +K+ DFG+S +   +  + +  + 
Sbjct: 145 VLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVF--ENQKKMKERL 199
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
            +  Y+APEV + ++YD K DV+S  +IL  ++ G PPF  + D E+ +    + +  F 
Sbjct: 200 GTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRK-VEKGKYTFD 257
Query: 376 APA-KLYARGLKELIEECWNEKPAKRPTFRQII 407
           +P  K  + G K+LI++       +R + +Q +
Sbjct: 258 SPEWKNVSEGAKDLIKQMLQFDSQRRISAQQAL 290

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 69
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R  T +  +  Y APE+   
Sbjct: 129 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLG 184
Query: 329 EE-YDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 185 XKYYSTAVDIWSLGCIFAEMV 205

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R  T +  +  Y APE+   
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLG 177
Query: 329 EE-YDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 178 XKYYSTAVDIWSLGCIFAEMV 198

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 14/167 (8%)
Query: 196 AFRD-----ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS 250
           AFRD     E+A+L+KI+H N+V        ++   +V + +  G+L   +  +G     
Sbjct: 47  AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEK 106
Query: 251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVKE 307
            A      +   + YLHEN    I+HRDL+P N+L    +++  + + DFG+SK+   ++
Sbjct: 107 DASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKM---EQ 160
Query: 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           +  ++    +  YVAPEV   + Y   VD +S  +I   ++ G PPF
Sbjct: 161 NGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 66
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R  T +  +  Y APE+   
Sbjct: 126 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLG 181
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMV 202

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 69/286 (24%), Positives = 126/286 (44%), Gaps = 19/286 (6%)
Query: 129 GAKPLMAPMHVKHAREVPEYEIDPHELD-FTNSVEITKGTFILAFWRGIQ-----VAVKK 182
           G+ P  AP+     +E+P+  +DP  +  +     + KG F   +           A K 
Sbjct: 4   GSDPKSAPL-----KEIPDVLVDPRTMKRYMRGRFLGKGGFAKCYEITDMDTKEVFAGKV 58
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
           + + ++    +      E+A+ + + +P+VV F G       + +V E   +  L    K
Sbjct: 59  VPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHK 118
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
           R+ A+    A  F     +G+ YLH N+   +IHRDL+  N+  +D  ++K+ DFG++  
Sbjct: 119 RRKAVTEPEARYFMRQTIQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATK 175
Query: 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
           +    +R      T   Y+APEV   + +  +VD++S   IL  ++ G PPF      E 
Sbjct: 176 IEFDGERKKDLCGTP-NYIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE- 233
Query: 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
              Y   ++  +  P  +       LI    +  P  RP+  +++T
Sbjct: 234 --TYIRIKKNEYSVPRHINPVA-SALIRRMLHADPTLRPSVAELLT 276

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 8e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R  T +  +  Y APE+   
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLG 176
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMV 197

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 68/194 (35%), Positives = 99/194 (51%), Gaps = 19/194 (9%)
Query: 178 VAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VAVK +  GE++   D+ V+    E+   + +RHPN+V+F   +   + + IV EY   G
Sbjct: 47  VAVKYIERGEKI---DENVKR---EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 100
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLK 293
           +L   +   G      A  F   +  G++Y H  +   + HRDL+  N L D S    LK
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQ---VAHRDLKLENTLLDGSPAPRLK 157
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV-DVFSFALILQEMIEGCP 352
           +ADFG SK  +V   +P +   T   Y+APEV   +EYD KV DV+S  + L  M+ G  
Sbjct: 158 IADFGYSK-ASVLHSQPKSAVGTPA-YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAY 215
Query: 353 PFTMKHDNEVPKAY 366
           PF    D E PK +
Sbjct: 216 PF---EDPEEPKNF 226

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 11  NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 69
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 70  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 128
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R  T +  +  Y APE+   
Sbjct: 129 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLG 184
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 185 CKYYSTAVDIWSLGCIFAEMV 205

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R  T +  +  Y APE+   
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLG 177
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMV 198

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R  T +  +  Y APE+   
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLG 177
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMV 198

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R  T +  +  Y APE+   
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLG 176
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMV 197

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 59/229 (25%), Positives = 112/229 (48%), Gaps = 31/229 (13%)
Query: 200 ELALLQKIRHPNVVQFLG----------------AVTQSSPMMIVTEYLPKGDLRAFL-K 242
           E+  L K+ H N+V + G                + +++  + I  E+  KG L  ++ K
Sbjct: 54  EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEK 113
Query: 243 RKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK 301
           R+G  L    A+     I +G++Y+H  K   +I+RDL+PSNI   D+  +K+ DFG+  
Sbjct: 114 RRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGL-- 168
Query: 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361
           + ++K D        + RY++PE   +++Y  +VD+++  LIL E++  C         E
Sbjct: 169 VTSLKNDGKRXRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAF-----E 223
Query: 362 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
             K +   +       + ++ +  K L+++  ++KP  RP   +I+  L
Sbjct: 224 TSKFFTDLRDGII---SDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTL 269

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 81.3 bits (199), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 67/217 (30%), Positives = 108/217 (49%), Gaps = 29/217 (13%)
Query: 154 ELDFTNSVEITKGTFILAFWRGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRH 209
           E+ +TN   I  G+F + F   +    +VA+KK     +  D R +    EL +++ ++H
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKK-----VLQDKRFK--NRELQIMRIVKH 91
Query: 210 PNVVQFLGAVTQSSP-------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFALDI 259
           PNVV  L A   S+        + +V EY+P+   RA   + K K  +       +   +
Sbjct: 92  PNVVD-LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQL 150
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
            R + Y+H    + I HRD++P N+L D  SG LK+ DFG +K+L   E  P      S 
Sbjct: 151 LRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE--PNVSXICSR 205
Query: 319 RYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            Y APE +F    Y T +D++S   ++ E+++G P F
Sbjct: 206 YYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLF 242

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 56/201 (27%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 63
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R  T +  +  Y APE+   
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLG 178
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMV 199

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 57/209 (27%), Positives = 99/209 (47%), Gaps = 8/209 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+A+ + + +P+VV F G       + +V E   +  L    KR+ A+    A  F    
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            +G+ YLH N+   +IHRDL+  N+  +D  ++K+ DFG++  +    +R  T   T   
Sbjct: 152 IQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTP-N 207
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379
           Y+APEV   + +  +VD++S   IL  ++ G PPF      E    Y   ++  +  P  
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE---TYIRIKKNEYSVPRH 264
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQIIT 408
           +       LI    +  P  RP+  +++T
Sbjct: 265 INPVA-SALIRRMLHADPTLRPSVAELLT 292

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 100/194 (51%), Gaps = 23/194 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF------LGAVTQSSPMMIV 228
           G QVA+K+  +E +S  +R R +  E+ +++K+ HPNVV        L  +  +   ++ 
Sbjct: 40  GEQVAIKQCRQE-LSPKNRER-WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 97
Query: 229 TEYLPKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI- 284
            EY   GDLR +L +      LK         DI+  + YLHEN+   IIHRDL+P NI 
Sbjct: 98  MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIV 154
Query: 285 LRDDSGNL--KVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSF 340
           L+     L  K+ D G +K L    D+   C +   + +Y+APE+ + ++Y   VD +SF
Sbjct: 155 LQPGPQRLIHKIIDLGYAKEL----DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSF 210
Query: 341 ALILQEMIEGCPPF 354
             +  E I G  PF
Sbjct: 211 GTLAFECITGFRPF 224

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 95/193 (49%), Gaps = 9/193 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + A+K + +  ++      A  DE+A+L+++ HPN+++            +V E    
Sbjct: 46  GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRG 105
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--- 291
           G+L   +  +       A      +  G  YLH++    I+HRDL+P N+L +       
Sbjct: 106 GELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDAL 162
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +K+ DFG+S    V     +  +  +  Y+APEV + ++YD K DV+S  +IL  ++ G 
Sbjct: 163 IKIVDFGLSAHFEV--GGKMKERLGTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGY 219
Query: 352 PPFTMKHDNEVPK 364
           PPF  + D E+ K
Sbjct: 220 PPFGGQTDQEILK 232

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 65/194 (33%), Positives = 100/194 (51%), Gaps = 23/194 (11%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF------LGAVTQSSPMMIV 228
           G QVA+K+  +E +S  +R R +  E+ +++K+ HPNVV        L  +  +   ++ 
Sbjct: 39  GEQVAIKQCRQE-LSPKNRER-WCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96
Query: 229 TEYLPKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI- 284
            EY   GDLR +L +      LK         DI+  + YLHEN+   IIHRDL+P NI 
Sbjct: 97  MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIV 153
Query: 285 LRDDSGNL--KVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSF 340
           L+     L  K+ D G +K L    D+   C +   + +Y+APE+ + ++Y   VD +SF
Sbjct: 154 LQPGPQRLIHKIIDLGYAKEL----DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSF 209
Query: 341 ALILQEMIEGCPPF 354
             +  E I G  PF
Sbjct: 210 GTLAFECITGFRPF 223

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 64/192 (33%), Positives = 94/192 (48%), Gaps = 15/192 (7%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VAVK +      D++  R    E+   + +RHPN+V+F   +   + + I+ EY   G+L
Sbjct: 48  VAVKYIERGAAIDENVQR----EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGEL 103
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVA 295
              +   G      A  F   +  G++Y H  +   I HRDL+  N L D S    LK+ 
Sbjct: 104 YERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKIC 160
Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV-DVFSFALILQEMIEGCPPF 354
           DFG SK  +V   +P +   T   Y+APEV   +EYD K+ DV+S  + L  M+ G  PF
Sbjct: 161 DFGYSK-SSVLHSQPKSTVGTPA-YIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF 218
Query: 355 TMKHDNEVPKAY 366
               D E P+ Y
Sbjct: 219 ---EDPEEPRDY 227

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 14/272 (5%)
Query: 142 AREVPEYEIDPHELDFTNSVE-ITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVR 195
           A+E+PE  +DP           + KG F   F           A K + + ++    +  
Sbjct: 3   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 62
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
               E+++ + + H +VV F G    +  + +V E   +  L    KR+ AL    A  +
Sbjct: 63  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 122
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
              I  G  YLH N+   +IHRDL+  N+  ++   +K+ DFG++  +    +R  T   
Sbjct: 123 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCG 179
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
           T   Y+APEV   + +  +VDV+S   I+  ++ G PPF      E    Y   ++  + 
Sbjct: 180 TP-NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRIKKNEYS 235
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            P  +       LI++     P  RPT  +++
Sbjct: 236 IPKHINPVA-ASLIQKMLQTDPTARPTINELL 266

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 14/272 (5%)
Query: 142 AREVPEYEIDPHELDFTNSVE-ITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVR 195
           A+E+PE  +DP           + KG F   F           A K + + ++    +  
Sbjct: 3   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 62
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
               E+++ + + H +VV F G    +  + +V E   +  L    KR+ AL    A  +
Sbjct: 63  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 122
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
              I  G  YLH N+   +IHRDL+  N+  ++   +K+ DFG++  +    +R  T   
Sbjct: 123 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCG 179
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
           T   Y+APEV   + +  +VDV+S   I+  ++ G PPF      E    Y   ++  + 
Sbjct: 180 TP-NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRIKKNEYS 235
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            P  +       LI++     P  RPT  +++
Sbjct: 236 IPKHINPVA-ASLIQKMLQTDPTARPTINELL 266

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 68/272 (25%), Positives = 118/272 (43%), Gaps = 14/272 (5%)
Query: 142 AREVPEYEIDPHELDFTNSVE-ITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVR 195
           A+E+PE  +DP           + KG F   F           A K + + ++    +  
Sbjct: 7   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 66
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
               E+++ + + H +VV F G    +  + +V E   +  L    KR+ AL    A  +
Sbjct: 67  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 126
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
              I  G  YLH N+   +IHRDL+  N+  ++   +K+ DFG++  +    +R  T   
Sbjct: 127 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCG 183
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
           T   Y+APEV   + +  +VDV+S   I+  ++ G PPF      E    Y   ++  + 
Sbjct: 184 TP-NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRIKKNEYS 239
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            P  +       LI++     P  RPT  +++
Sbjct: 240 IPKHINPVA-ASLIQKMLQTDPTARPTINELL 270

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 121/264 (45%), Gaps = 19/264 (7%)
Query: 151 DPHEL--DFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           DP E   +F    E + G   +A  +  G QVAVKK+    +    R     +E+ +++ 
Sbjct: 42  DPREYLANFIKIGEGSTGIVCIATEKHTGKQVAVKKMD---LRKQQRRELLFNEVVIMRD 98
Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
             H NVV    +      + +V E+L  G L   +      +   A    L + R ++YL
Sbjct: 99  YHHDNVVDMYSSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAT-VCLSVLRALSYL 157
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF 326
           H      +IHRD++  +IL    G +K++DFG    ++ KE         +  ++APEV 
Sbjct: 158 HNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVS-KEVPKRKXLVGTPYWMAPEVI 213
Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR---PPFKAPAKLYAR 383
               Y T+VD++S  +++ EMI+G PP+     NE P     R R   PP        + 
Sbjct: 214 SRLPYGTEVDIWSLGIMVIEMIDGEPPYF----NEPPLQAMRRIRDSLPPRVKDLHKVSS 269
Query: 384 GLKELIEECWNEKPAKRPTFRQII 407
            L+  ++     +P++R T ++++
Sbjct: 270 VLRGFLDLMLVREPSQRATAQELL 293

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 97/194 (50%), Gaps = 19/194 (9%)
Query: 178 VAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VAVK +  GE++ ++  R      E+   + +RHPN+V+F   +   + + IV EY   G
Sbjct: 47  VAVKYIERGEKIAANVKR------EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 100
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLK 293
           +L   +   G      A  F   +  G++Y H  +   + HRDL+  N L D S    LK
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLK 157
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV-DVFSFALILQEMIEGCP 352
           + DFG SK  +V   +P +   T   Y+APEV   +EYD KV DV+S  + L  M+ G  
Sbjct: 158 ICDFGYSK-SSVLHSQPKSTVGTPA-YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAY 215
Query: 353 PFTMKHDNEVPKAY 366
           PF    D E PK +
Sbjct: 216 PF---EDPEEPKNF 226

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 54/193 (27%), Positives = 95/193 (49%), Gaps = 9/193 (4%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + A+K + +  ++      A  DE+A+L+++ HPN+++            +V E    
Sbjct: 29  GAERAIKIIKKSSVTTTSNSGALLDEVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRG 88
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--- 291
           G+L   +  +       A      +  G  YLH++    I+HRDL+P N+L +       
Sbjct: 89  GELFDEIILRQKFSEVDAAVIMKQVLSGTTYLHKHN---IVHRDLKPENLLLESKSRDAL 145
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +K+ DFG+S    V     +  +  +  Y+APEV + ++YD K DV+S  +IL  ++ G 
Sbjct: 146 IKIVDFGLSAHFEV--GGKMKERLGTAYYIAPEVLR-KKYDEKCDVWSCGVILYILLCGY 202
Query: 352 PPFTMKHDNEVPK 364
           PPF  + D E+ K
Sbjct: 203 PPFGGQTDQEILK 215

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 138/292 (47%), Gaps = 52/292 (17%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGAVT 220
           E+ +G+     W+G  VAVK     + S  D    FR+ EL     +RH N++ F+ +  
Sbjct: 23  EVWRGS-----WQGENVAVK-----IFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 221 ----QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------ENK 270
                S+ + ++T Y   G L  +L+    L   + +R  L IA G+ +LH      + K
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD---TSCRYVAPEVF- 326
           P  I HRDL+  NIL   +G   +AD G++ + +   ++     +    + RY+APEV  
Sbjct: 132 PA-IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 327 ---KNEEYDT--KVDVFSFALILQE----MIEGC------PPF--TMKHD---NEVPKAY 366
              + + +D+  +VD+++F L+L E    M+         PPF   + +D    ++ K  
Sbjct: 191 ETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV 250
Query: 367 AARQRPPFKAPAKLYA----RGLKELIEECWNEKPAKRPTFRQIITRLESIN 414
              Q+ P   P + ++      L +L++ECW + P+ R T  +I   L  I+
Sbjct: 251 CVDQQRP-NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/281 (27%), Positives = 133/281 (47%), Gaps = 47/281 (16%)
Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGAVT----QSSPMMI 227
           W+G  VAVK     + S  D    FR+ EL     +RH N++ F+ +       S+ + +
Sbjct: 58  WQGENVAVK-----IFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWL 112
Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------ENKPVPIIHRDLEP 281
           +T Y   G L  +L+    L   + +R  L IA G+ +LH      + KP  I HRDL+ 
Sbjct: 113 ITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA-IAHRDLKS 170
Query: 282 SNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD---TSCRYVAPEVF----KNEEYDT- 333
            NIL   +G   +AD G++ + +   ++     +    + RY+APEV     + + +D+ 
Sbjct: 171 KNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSY 230
Query: 334 -KVDVFSFALILQE----MIEGC------PPF--TMKHD---NEVPKAYAARQRPPFKAP 377
            +VD+++F L+L E    M+         PPF   + +D    ++ K     Q+ P   P
Sbjct: 231 KRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRP-NIP 289
Query: 378 AKLYA----RGLKELIEECWNEKPAKRPTFRQIITRLESIN 414
            + ++      L +L++ECW + P+ R T  +I   L  I+
Sbjct: 290 NRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 330

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 56/204 (27%), Positives = 108/204 (52%), Gaps = 14/204 (6%)
Query: 153 HELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           H  +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++
Sbjct: 2   HMENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKEL 60
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNY 265
            HPN+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ +
Sbjct: 61  NHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAF 119
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
            H ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+
Sbjct: 120 CHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEI 175
Query: 326 FKN-EEYDTKVDVFSFALILQEMI 348
               + Y T VD++S   I  EM+
Sbjct: 176 LLGCKYYSTAVDIWSLGCIFAEMV 199

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 138/292 (47%), Gaps = 52/292 (17%)
Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGAVT 220
           E+ +G+     W+G  VAVK     + S  D    FR+ EL     +RH N++ F+ +  
Sbjct: 23  EVWRGS-----WQGENVAVK-----IFSSRDEKSWFRETELYNTVMLRHENILGFIASDM 72
Query: 221 ----QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------ENK 270
                S+ + ++T Y   G L  +L+    L   + +R  L IA G+ +LH      + K
Sbjct: 73  TSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQGK 131
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD---TSCRYVAPEVF- 326
           P  I HRDL+  NIL   +G   +AD G++ + +   ++     +    + RY+APEV  
Sbjct: 132 PA-IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190
Query: 327 ---KNEEYDT--KVDVFSFALILQE----MIEGC------PPF--TMKHD---NEVPKAY 366
              + + +D+  +VD+++F L+L E    M+         PPF   + +D    ++ K  
Sbjct: 191 ETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV 250
Query: 367 AARQRPPFKAPAKLYA----RGLKELIEECWNEKPAKRPTFRQIITRLESIN 414
              Q+ P   P + ++      L +L++ECW + P+ R T  +I   L  I+
Sbjct: 251 CVDQQRP-NIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 120/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 45  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 101
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 158
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 219 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 275
Query: 413 I 413
           +
Sbjct: 276 M 276

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 84/171 (49%), Gaps = 9/171 (5%)
Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
           LL+  +HPN++           + +VTE    G+L   + R+       A      I + 
Sbjct: 69  LLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAVLFTITKT 128
Query: 263 MNYLHENKPVPIIHRDLEPSNILR-DDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSC 318
           + YLH      ++HRDL+PSNIL  D+SGN   +++ DFG +K L   E+  L     + 
Sbjct: 129 VEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA-ENGLLXTPCYTA 184
Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
            +VAPEV + + YD   D++S  ++L   + G  PF    D + P+   AR
Sbjct: 185 NFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPD-DTPEEILAR 234

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 108/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E++ + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R  T +  +  Y APE+   
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLG 176
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMV 197

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 9/204 (4%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF     + KGTF   IL   +  G   A+K L +EVI   D V     E  +LQ  RHP
Sbjct: 9   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 68
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
            +     A      +  V EY   G+L   L R+       A  +  +I   + YLH   
Sbjct: 69  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 128
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
              +++RD++  N++ D  G++K+ DFG+ K   + +   +     +  Y+APEV ++ +
Sbjct: 129 ---VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND 184
Query: 331 YDTKVDVFSFALILQEMIEGCPPF 354
           Y   VD +   +++ EM+ G  PF
Sbjct: 185 YGRAVDWWGLGVVMYEMMCGRLPF 208

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 9/204 (4%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF     + KGTF   IL   +  G   A+K L +EVI   D V     E  +LQ  RHP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
            +     A      +  V EY   G+L   L R+       A  +  +I   + YLH   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
              +++RD++  N++ D  G++K+ DFG+ K   + +   +     +  Y+APEV ++ +
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 331 YDTKVDVFSFALILQEMIEGCPPF 354
           Y   VD +   +++ EM+ G  PF
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 204 LQKIRHPNVVQFLGAVTQS-----SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFA 256
           L+   HPNVV+     T S     + + +V E++ + DL  +L +  +  +   T     
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
             + RG+++LH ++   ++HRDL+P NIL   SG +K+ADFG++++ + +    LT    
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVV 181
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359
           +  Y APEV     Y T VD++S   I  EM    P F    D
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 120/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 45  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 101
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 102 XLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 158
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 219 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275
Query: 413 I 413
           +
Sbjct: 276 M 276

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 204 LQKIRHPNVVQFLGAVTQS-----SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFA 256
           L+   HPNVV+     T S     + + +V E++ + DL  +L +  +  +   T     
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
             + RG+++LH ++   ++HRDL+P NIL   SG +K+ADFG++++ + +    LT    
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVV 181
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359
           +  Y APEV     Y T VD++S   I  EM    P F    D
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 120/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 48  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 104
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 105 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 161
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 162 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 221
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 222 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 278
Query: 413 I 413
           +
Sbjct: 279 M 279

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 120/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 55  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 111
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 112 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 168
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 169 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 228
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 229 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 285
Query: 413 I 413
           +
Sbjct: 286 M 286

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 9/204 (4%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF     + KGTF   IL   +  G   A+K L +EVI   D V     E  +LQ  RHP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
            +     A      +  V EY   G+L   L R+       A  +  +I   + YLH   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
              +++RD++  N++ D  G++K+ DFG+ K   + +   +     +  Y+APEV ++ +
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKTFCGTPEYLAPEVLEDND 181
Query: 331 YDTKVDVFSFALILQEMIEGCPPF 354
           Y   VD +   +++ EM+ G  PF
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 51/163 (31%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 204 LQKIRHPNVVQFLGAVTQS-----SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFA 256
           L+   HPNVV+     T S     + + +V E++ + DL  +L +  +  +   T     
Sbjct: 68  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
             + RG+++LH ++   ++HRDL+P NIL   SG +K+ADFG++++ + +    LT    
Sbjct: 127 FQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ--MALTSVVV 181
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359
           +  Y APEV     Y T VD++S   I  EM    P F    D
Sbjct: 182 TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 180
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMV 201

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 67/194 (34%), Positives = 98/194 (50%), Gaps = 19/194 (9%)
Query: 178 VAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VAVK +  GE++   D+ V+    E+   + +RHPN+V+F   +   + + IV EY   G
Sbjct: 46  VAVKYIERGEKI---DENVKR---EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 99
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLK 293
           +L   +   G      A  F   +  G++Y H  +   + HRDL+  N L D S    LK
Sbjct: 100 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLK 156
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV-DVFSFALILQEMIEGCP 352
           + DFG SK  +V   +P +   T   Y+APEV   +EYD KV DV+S  + L  M+ G  
Sbjct: 157 ICDFGYSK-SSVLHSQPKSTVGTPA-YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAY 214
Query: 353 PFTMKHDNEVPKAY 366
           PF    D E PK +
Sbjct: 215 PF---EDPEEPKNF 225

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 90/173 (52%), Gaps = 14/173 (8%)
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK---PSTA 252
           +  +E+A+L+KI+H N+V         + + +V + +  G+L   +  KG       ST 
Sbjct: 66  SIENEIAVLRKIKHENIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTL 125
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDR 309
           +R  LD    + YLH    + I+HRDL+P N+L   +D+   + ++DFG+SK+    +  
Sbjct: 126 IRQVLD---AVYYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSKMEGKGDVM 179
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
              C      YVAPEV   + Y   VD +S  +I   ++ G PPF  ++D+++
Sbjct: 180 STACGTPG--YVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDSKL 230

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 120/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 39  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 95
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 96  CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 152
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 153 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 212
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 213 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 269
Query: 413 I 413
           +
Sbjct: 270 M 270

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 9/204 (4%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF     + KGTF   IL   +  G   A+K L +EVI   D V     E  +LQ  RHP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
            +     A      +  V EY   G+L   L R+       A  +  +I   + YLH   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
              +++RD++  N++ D  G++K+ DFG+ K   + +   +     +  Y+APEV ++ +
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 331 YDTKVDVFSFALILQEMIEGCPPF 354
           Y   VD +   +++ EM+ G  PF
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 9/204 (4%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF     + KGTF   IL   +  G   A+K L +EVI   D V     E  +LQ  RHP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
            +     A      +  V EY   G+L   L R+       A  +  +I   + YLH   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
              +++RD++  N++ D  G++K+ DFG+ K   + +   +     +  Y+APEV ++ +
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 331 YDTKVDVFSFALILQEMIEGCPPF 354
           Y   VD +   +++ EM+ G  PF
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 9/204 (4%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF     + KGTF   IL   +  G   A+K L +EVI   D V     E  +LQ  RHP
Sbjct: 11  DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 70
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
            +     A      +  V EY   G+L   L R+       A  +  +I   + YLH   
Sbjct: 71  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 130
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
              +++RD++  N++ D  G++K+ DFG+ K   + +   +     +  Y+APEV ++ +
Sbjct: 131 ---VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLEDND 186
Query: 331 YDTKVDVFSFALILQEMIEGCPPF 354
           Y   VD +   +++ EM+ G  PF
Sbjct: 187 YGRAVDWWGLGVVMYEMMCGRLPF 210

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 71/279 (25%), Positives = 123/279 (44%), Gaps = 24/279 (8%)
Query: 146 PEYEIDPHELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
           PE   D    D  +  EI +G +     ++    G  +AVK++    + + ++ +   D 
Sbjct: 13  PEQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI-RSTVDEKEQKQLLMDL 71
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPSTAVRF 255
             +++    P +VQF GA+ +     I  E L       F K         +      + 
Sbjct: 72  DVVMRSSDCPYIVQFYGALFREGDCWICME-LMSTSFDKFYKYVYSVLDDVIPEEILGKI 130
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
            L   + +N+L EN  + IIHRD++PSNIL D SGN+K+ DFG+S  L    D     +D
Sbjct: 131 TLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRD 185
Query: 316 TSCR-YVAPEVF----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370
             CR Y+APE        + YD + DV+S  + L E+  G  P+   +          + 
Sbjct: 186 AGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG 245
Query: 371 RPP--FKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            PP    +  + ++      +  C  +  +KRP +++++
Sbjct: 246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELL 284

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+ K+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R  T +  +  Y APE+   
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLG 177
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMV 198

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+ K+  +  ++     A R E++LL+++ HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R  T +  +  Y APE+   
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYTHEVVTLWYRAPEILLG 176
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMV 197

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 95/204 (46%), Gaps = 9/204 (4%)
Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF     + KGTF   IL   +  G   A+K L +EVI   D V     E  +LQ  RHP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
            +     A      +  V EY   G+L   L R+       A  +  +I   + YLH   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125
Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
              +++RD++  N++ D  G++K+ DFG+ K   + +   +     +  Y+APEV ++ +
Sbjct: 126 ---VVYRDIKLENLMLDKDGHIKITDFGLCK-EGISDGATMKXFCGTPEYLAPEVLEDND 181
Query: 331 YDTKVDVFSFALILQEMIEGCPPF 354
           Y   VD +   +++ EM+ G  PF
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPF 205

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 120/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 51  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 107
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 108 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 164
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 165 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 224
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 225 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 281
Query: 413 I 413
           +
Sbjct: 282 M 282

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 177
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMV 198

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 120/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 47  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 103
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 104 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 160
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 161 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 220
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 221 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 277
Query: 413 I 413
           +
Sbjct: 278 M 278

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 177
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMV 198

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 120/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 45  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 101
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 158
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 219 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275
Query: 413 I 413
           +
Sbjct: 276 M 276

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 120/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 45  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 101
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 158
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 219 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275
Query: 413 I 413
           +
Sbjct: 276 M 276

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 177
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMV 198

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 120/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 48  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 104
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 105 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 161
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 162 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 221
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 222 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 278
Query: 413 I 413
           +
Sbjct: 279 M 279

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 64
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 179
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMV 200

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 176
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMV 197

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 120/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 48  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 104
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 105 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 161
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 162 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 221
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 222 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 278
Query: 413 I 413
           +
Sbjct: 279 M 279

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 180
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMV 201

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 64
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 179
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMV 200

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 63
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 123 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 178
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMV 199

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 180
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMV 201

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 120/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 52  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 108
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 109 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 165
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 166 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 225
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 226 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 282
Query: 413 I 413
           +
Sbjct: 283 M 283

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 122 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 177
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMV 198

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 8/209 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+A+ + + +P+VV F G       + +V E   +  L    KR+ A+    A  F    
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            +G+ YLH N+   +IHRDL+  N+  +D  ++K+ DFG++  +    +R      T   
Sbjct: 152 IQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTP-N 207
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379
           Y+APEV   + +  +VD++S   IL  ++ G PPF      E    Y   ++  +  P  
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE---TYIRIKKNEYSVPRH 264
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQIIT 408
           +       LI    +  P  RP+  +++T
Sbjct: 265 INPVA-SALIRRMLHADPTLRPSVAELLT 292

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 121 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 176
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 177 CKYYSTAVDIWSLGCIFAEMV 197

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 120/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 70  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 126
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 127 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 183
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 184 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 243
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 244 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 300
Query: 413 I 413
           +
Sbjct: 301 M 301

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 49/160 (30%), Positives = 85/160 (53%), Gaps = 13/160 (8%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR-FALD 258
           E++LL+ ++H N+V     +     + +V EYL K DL+ +L   G +     V+ F   
Sbjct: 50  EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--- 315
           + RG+ Y H  K   ++HRDL+P N+L ++ G LK+ADFG+++  ++    P    D   
Sbjct: 109 LLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSI----PTKTYDNEV 161
Query: 316 TSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            +  Y  P++   + +Y T++D++    I  EM  G P F
Sbjct: 162 VTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLF 201

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 8   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 66
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 67  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 125
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 126 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 181
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 182 CKYYSTAVDIWSLGCIFAEMV 202

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 98/209 (46%), Gaps = 8/209 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+A+ + + +P+VV F G       + +V E   +  L    KR+ A+    A  F    
Sbjct: 92  EIAIHKSLDNPHVVGFHGFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQT 151
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            +G+ YLH N+   +IHRDL+  N+  +D  ++K+ DFG++  +    +R      T   
Sbjct: 152 IQGVQYLHNNR---VIHRDLKLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTP-N 207
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379
           Y+APEV   + +  +VD++S   IL  ++ G PPF      E    Y   ++  +  P  
Sbjct: 208 YIAPEVLCKKGHSFEVDIWSLGCILYTLLVGKPPFETSCLKE---TYIRIKKNEYSVPRH 264
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQIIT 408
           +       LI    +  P  RP+  +++T
Sbjct: 265 INPVA-SALIRRMLHADPTLRPSVAELLT 292

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 64
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 124 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 179
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMV 200

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 120/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 52  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 108
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 109 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 165
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 166 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 225
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 226 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 282
Query: 413 I 413
           +
Sbjct: 283 M 283

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score = 79.3 bits (194), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 63
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 123 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 178
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMV 199

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/272 (24%), Positives = 117/272 (43%), Gaps = 14/272 (5%)
Query: 142 AREVPEYEIDPHELDFTNSVE-ITKGTFILAFWRGIQ-----VAVKKLGEEVISDDDRVR 195
           A+E+PE  +DP           + KG F   F           A K + + ++    +  
Sbjct: 1   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
               E+++ + + H +VV F G    +  + +V E   +  L    KR+ AL    A  +
Sbjct: 61  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 120
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
              I  G  YLH N+   +IHRDL+  N+  ++   +K+ DFG++  +    +R      
Sbjct: 121 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCG 177
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
           T   Y+APEV   + +  +VDV+S   I+  ++ G PPF      E    Y   ++  + 
Sbjct: 178 TP-NYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRIKKNEYS 233
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            P  +       LI++     P  RPT  +++
Sbjct: 234 IPKHINPVA-ASLIQKMLQTDPTARPTINELL 264

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 68/266 (25%), Positives = 119/266 (44%), Gaps = 23/266 (8%)
Query: 156 DFTNSVEITKGTFILAFWR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH 209
           D  N  E+  GT     W+      G  +AVK++      ++++ R   D   +L+    
Sbjct: 26  DLENLGEMGSGT-CGQVWKMRFRKTGHVIAVKQMRRSGNKEENK-RILMDLDVVLKSHDC 83
Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
           P +VQ  G    ++ + I  E +     +   + +G +      +  + I + + YL E 
Sbjct: 84  PYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEK 143
Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT--VKEDRPLTCQDTSCRYVAPEVF- 326
             V  IHRD++PSNIL D+ G +K+ DFG+S  L     +DR   C      Y+APE   
Sbjct: 144 HGV--IHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGC----AAYMAPERID 197
Query: 327 ----KNEEYDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPKAYAARQRPPFKAPAKLY 381
                  +YD + DV+S  + L E+  G  P+   K D EV      ++ PP       +
Sbjct: 198 PPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEV-LTKVLQEEPPLLPGHMGF 256
Query: 382 ARGLKELIEECWNEKPAKRPTFRQII 407
           +   +  +++C  +   KRP + +++
Sbjct: 257 SGDFQSFVKDCLTKDHRKRPKYNKLL 282

>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 115/234 (49%), Gaps = 12/234 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K L E      +    F DE  ++  + HP++V+ LG V  S  + +VT+ +P G
Sbjct: 45  IPVAIKILNETTGPKANV--EFMDEALIMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHG 101
Query: 236 DLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  ++ + K  +     + + + IA+GM YL E +   ++HRDL   N+L     ++K+
Sbjct: 102 CLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKI 158
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG+++LL   E +          +++A E     ++  + DV+S+ + + E++  G  
Sbjct: 159 TDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGK 218
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           P+      E+P      +R P + P  +    +  ++ +CW      RP F+++
Sbjct: 219 PYDGIPTREIPDLLEKGERLP-QPP--ICTIDVYMVMVKCWMIDADSRPKFKEL 269

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 31/196 (15%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAV--------TQSSPM 225
           G + A+K+L   + +++++ RA   E+  ++K+  HPN+VQF  A         T  +  
Sbjct: 53  GREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109
Query: 226 MIVTEYLPKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           +++TE L KG L  FLK+   +G L   T ++      R + ++H  KP PIIHRDL+  
Sbjct: 110 LLLTE-LCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVE 167
Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ-----------DTSCRYVAPEV---FKN 328
           N+L  + G +K+ DFG +  ++   D   + Q           +T+  Y  PE+   + N
Sbjct: 168 NLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSN 227
Query: 329 EEYDTKVDVFSFALIL 344
                K D+++   IL
Sbjct: 228 FPIGEKQDIWALGCIL 243

>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 60/234 (25%), Positives = 115/234 (49%), Gaps = 12/234 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K L E      +    F DE  ++  + HP++V+ LG V  S  + +VT+ +P G
Sbjct: 68  IPVAIKILNETTGPKANV--EFMDEALIMASMDHPHLVRLLG-VCLSPTIQLVTQLMPHG 124
Query: 236 DLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  ++ + K  +     + + + IA+GM YL E +   ++HRDL   N+L     ++K+
Sbjct: 125 CLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKI 181
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG+++LL   E +          +++A E     ++  + DV+S+ + + E++  G  
Sbjct: 182 TDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGK 241
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           P+      E+P      +R P + P  +    +  ++ +CW      RP F+++
Sbjct: 242 PYDGIPTREIPDLLEKGERLP-QPP--ICTIDVYMVMVKCWMIDADSRPKFKEL 292

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 106/201 (52%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L   DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-SMDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 125 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 180
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMV 201

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 49/155 (31%), Positives = 74/155 (47%), Gaps = 5/155 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           EL +L +   P +V F GA      + I  E++  G L   LK    +      + ++ +
Sbjct: 64  ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 123
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            RG+ YL E     I+HRD++PSNIL +  G +K+ DFGVS  L    D        +  
Sbjct: 124 LRGLAYLREKHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQLI---DSMANSFVGTRS 178
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           Y+APE  +   Y  + D++S  L L E+  G  P 
Sbjct: 179 YMAPERLQGTHYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 60/221 (27%), Positives = 99/221 (44%), Gaps = 13/221 (5%)
Query: 142 AREVPEYEIDPHELD-----FTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRA 196
           A  VP+Y ID    D     F    E+ +G   + +    +   K    +V+      + 
Sbjct: 35  ASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKI 94
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
            R E+ +L ++ HPN+++        + + +V E +  G+L   +  KG      A    
Sbjct: 95  VRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAV 154
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTVKEDRPLTC 313
             I   + YLHEN    I+HRDL+P N+L         LK+ADFG+SK++  +      C
Sbjct: 155 KQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVC 211
Query: 314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
                 Y APE+ +   Y  +VD++S  +I   ++ G  PF
Sbjct: 212 GTPG--YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 4   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 62
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 63  NIVKLLDVIHTENKLYLVFEFLHQ-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 121
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 122 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 177
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 178 CKYYSTAVDIWSLGCIFAEMV 198

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 91/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 56  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 115
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 116 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 172
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R  +   T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 173 FGTAKVLSPESKQARANSFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 106/201 (52%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 5   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 63
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L   DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 64  NIVKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 122
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 123 HR---VLHRDLKPENLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 178
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 179 CKYYSTAVDIWSLGCIFAEMV 199

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 91/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 60  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 119
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 120 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 176
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R  +   T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 177 FGTAKVLSPESKQARANSFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 109/226 (48%), Gaps = 10/226 (4%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 175
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 176 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSAXKSSDLWALGCIIYQLVAGLPPF 234
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
              ++  +   +A   +  +  P K + +  ++L+E+       KR
Sbjct: 235 RAGNEGLI---FAKIIKLEYDFPEKFFPKA-RDLVEKLLVLDATKR 276

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 119/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 47  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 103
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 104 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 160
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG +KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 161 TDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 220
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 221 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 277
Query: 413 I 413
           +
Sbjct: 278 M 278

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 8/208 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+++ + + H +VV F G    +  + +V E   +  L    KR+ AL    A  +   I
Sbjct: 89  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 148
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
             G  YLH N+   +IHRDL+  N+  ++   +K+ DFG++  +    +R      T   
Sbjct: 149 VLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP-N 204
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379
           Y+APEV   + +  +VDV+S   I+  ++ G PPF      E    Y   ++  +  P  
Sbjct: 205 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRIKKNEYSIPKH 261
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQII 407
           +       LI++     P  RPT  +++
Sbjct: 262 INPVA-ASLIQKMLQTDPTARPTINELL 288

>pdb|4HQD|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or265. Length = 169

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/107 (43%), Positives = 61/107 (57%), Gaps = 5/107 (4%)
Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           K A++N  D DG        L + A E   E +K L+  G DVN +D D RT LH AA +
Sbjct: 59  KGADVNAKDSDGR-----TPLHYAAKEGHKEIVKLLISKGADVNAKDSDGRTPLHYAAKE 113
Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           G  E+V LL+ +GADV+  D  G TPL  A  + N E++KLLEK G 
Sbjct: 114 GHKEIVKLLISKGADVNTSDSDGRTPLDLAREHGNEEIVKLLEKQGG 160

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 106/201 (52%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L   DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEFL-SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 180
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMV 201

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 119/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 42  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 98
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 99  CLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 155
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 156 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 215
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 216 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 272
Query: 413 I 413
           +
Sbjct: 273 M 273

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/201 (27%), Positives = 106/201 (52%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 6   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 64
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E+L   DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 65  NIVKLLDVIHTENKLYLVFEFLSM-DLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 124 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 179
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 180 CKYYSTAVDIWSLGCIFAEMV 200

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 102/213 (47%), Gaps = 16/213 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G+++AVKKL     S     R +R EL LL+ ++H NV+  L   T ++ +     + + 
Sbjct: 76  GLKIAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPATSLEEFNDVYLV 134
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 135 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 190
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 191 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELL 246
Query: 349 EGCPPF-TMKHDNEVPKAYAARQRPPFKAPAKL 380
            G   F    H N++ +       PP    +++
Sbjct: 247 TGRTLFPGTDHINQLQQIMRLTGTPPASVISRM 279

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 104/232 (44%), Gaps = 41/232 (17%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFR-DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           G Q AVKK+         R+  FR +EL     +  P +V   GAV +   + I  E L 
Sbjct: 118 GFQCAVKKV---------RLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLE 168
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNL 292
            G L   +K +G L    A+ +      G+ YLH  +   I+H D++  N+ L  D  + 
Sbjct: 169 GGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHA 225
Query: 293 KVADF---------GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 343
            + DF         G+ K L   +  P T  +T   ++APEV      D KVDV+S   +
Sbjct: 226 ALCDFGHAVCLQPDGLGKSLLTGDYIPGT--ET---HMAPEVVLGRSCDAKVDVWSSCCM 280
Query: 344 LQEMIEGCPPFT--------MKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387
           +  M+ GC P+T        +K  +E P     R+ PP  AP  L A+ ++E
Sbjct: 281 MLHMLNGCHPWTQFFRGPLCLKIASEPPP---VREIPPSCAP--LTAQAIQE 327

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 116
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 173
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 174 FGTAKVLSPESKQARANAFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/208 (26%), Positives = 96/208 (46%), Gaps = 8/208 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+++ + + H +VV F G    +  + +V E   +  L    KR+ AL    A  +   I
Sbjct: 91  EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 150
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
             G  YLH N+   +IHRDL+  N+  ++   +K+ DFG++  +    +R      T   
Sbjct: 151 VLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTP-N 206
Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379
           Y+APEV   + +  +VDV+S   I+  ++ G PPF      E    Y   ++  +  P  
Sbjct: 207 YIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKE---TYLRIKKNEYSIPKH 263
Query: 380 LYARGLKELIEECWNEKPAKRPTFRQII 407
           +       LI++     P  RPT  +++
Sbjct: 264 INPVA-ASLIQKMLQTDPTARPTINELL 290

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 35  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 94
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 95  LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 151
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 152 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 210

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 34  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 93
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 94  LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 150
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 151 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 209

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G 
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGC 118
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 175
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R  +   T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 176 FGTAKVLSPESKQARANSFVGTA-QYVSPELLTEKSASKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 8/209 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS----TAVRF 255
           E  +L K+    +V    A    + + +V   +  GD+R  +       P      A+ +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
              I  G+ +LH+     II+RDL+P N+L DD GN++++D G++  L   + +      
Sbjct: 295 TAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
           T   ++APE+   EEYD  VD F+  + L EMI    PF  + +    K    R      
Sbjct: 352 TP-GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFR 404
                ++   K+  E    + P KR  FR
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKRLGFR 439

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 41  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 100
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 101 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 157
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 158 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 216

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 37  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 96
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 97  LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 153
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 154 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 212

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 36  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 95
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 96  LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 152
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 153 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 211

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 175
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 176 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/226 (23%), Positives = 109/226 (48%), Gaps = 10/226 (4%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 175
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 176 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
              ++  +   +A   +  +  P K + +  ++L+E+       KR
Sbjct: 235 RAGNEGLI---FAKIIKLEYDFPEKFFPKA-RDLVEKLLVLDATKR 276

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 92/184 (50%), Gaps = 15/184 (8%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVTEY 231
           +VAVKKL     S     R +R EL LL+ ++H NV+  L   T ++ +     + +   
Sbjct: 55  KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 113
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   DL   +K + AL           + RG+ Y+H      IIHRDL+PSN+  ++   
Sbjct: 114 LMGADLNNIVKSQ-ALSDEHVQFLVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDSE 169
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG 350
           L++ DFG+++    + D  +T    +  Y APE+  N   Y+  VD++S   I+ E+++G
Sbjct: 170 LRILDFGLAR----QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225
Query: 351 CPPF 354
              F
Sbjct: 226 KALF 229

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 8/209 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS----TAVRF 255
           E  +L K+    +V    A    + + +V   +  GD+R  +       P      A+ +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
              I  G+ +LH+     II+RDL+P N+L DD GN++++D G++  L   + +      
Sbjct: 295 TAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
           T   ++APE+   EEYD  VD F+  + L EMI    PF  + +    K    R      
Sbjct: 352 TP-GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFR 404
                ++   K+  E    + P KR  FR
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKRLGFR 439

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 56  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 115
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 116 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 172
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 173 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 231

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 119/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 46  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 102
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 103 XLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 159
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 160 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 219
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 220 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 276
Query: 413 I 413
           +
Sbjct: 277 M 277

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 116
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 173
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 174 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 64  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFCFQDDEKLYFGLSYAKNGE 123
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 124 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 180
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 181 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 239

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 116
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 173
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 174 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 175
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 176 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 60  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 119
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 120 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 176
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 177 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 235

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 8/209 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS----TAVRF 255
           E  +L K+    +V    A    + + +V   +  GD+R  +       P      A+ +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
              I  G+ +LH+     II+RDL+P N+L DD GN++++D G++  L   + +      
Sbjct: 295 TAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
           T   ++APE+   EEYD  VD F+  + L EMI    PF  + +    K    R      
Sbjct: 352 TP-GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFR 404
                ++   K+  E    + P KR  FR
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKRLGFR 439

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 57  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 116
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 117 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 173
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 174 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 74/289 (25%), Positives = 123/289 (42%), Gaps = 45/289 (15%)
Query: 166 GTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGA----VT 220
           G   +  WRG +VAVK     V    +    FR+ E+     +RH N++ F+ A      
Sbjct: 51  GEVWMGKWRGEKVAVK-----VFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTG 105
Query: 221 QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------ENKPVPI 274
             + + ++T+Y   G L  +LK    L   + ++ A     G+ +LH      + KP  I
Sbjct: 106 SWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA-I 163
Query: 275 IHRDLEPSNILRDDSGNLKVADFGVS-KLL--TVKEDRPLTCQDTSCRYVAPEVFKNE-- 329
            HRDL+  NIL   +G   +AD G++ K +  T + D P   +  + RY+ PEV      
Sbjct: 164 AHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLN 223
Query: 330 ----EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK----------------AYAAR 369
               +     D++SF LIL E+   C    +  + ++P                     +
Sbjct: 224 RNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK 283
Query: 370 QRPPF--KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
            RP F  +  +    R + +L+ ECW   PA R T  ++   L  ++ S
Sbjct: 284 LRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSES 332

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 61/232 (26%), Positives = 105/232 (45%), Gaps = 16/232 (6%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K L +  I  +      R E+ +   + HPN+++          + ++ EY P+G+L
Sbjct: 51  VALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYNYFYDRRRIYLILEYAPRGEL 110
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              L++              ++A  + Y H  K   +IHRD++P N+L    G LK+ADF
Sbjct: 111 YKELQKSCTFDEQRTATIMEELADALMYCHGKK---VIHRDIKPENLLLGLKGELKIADF 167
Query: 298 GVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G S         P   + T C    Y+ PE+ +   ++ KVD++   ++  E++ G PPF
Sbjct: 168 GWSV------HAPSLRRKTMCGTLDYLPPEMIEGRMHNEKVDLWCIGVLCYELLVGNPPF 221
Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
                NE    Y    +   K PA +   G ++LI +     P++R    Q+
Sbjct: 222 ESASHNE---TYRRIVKVDLKFPASV-PTGAQDLISKLLRHNPSERLPLAQV 269

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 69/269 (25%), Positives = 121/269 (44%), Gaps = 31/269 (11%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+++L+++ HPN++         + ++++ E +  G+L  FL +K +L    A  F   I
Sbjct: 65  EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLLTVKEDRPLTCQD 315
             G+NYLH  K   I H DL+P NI+  D      ++K+ DFG++    +++        
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKNIF 179
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF-------TMKHDNEVPKAYAA 368
            +  +VAPE+   E    + D++S  +I   ++ G  PF       T+ +   V   +  
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE 239
Query: 369 RQRPPFKAPAKLYARGL--KELIEECWNEKPAKRPTF-----RQIITRLESINNSINHK- 420
                    AK + R L  KE  +    ++  + P       +Q + R ES+ N  N K 
Sbjct: 240 EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKK 299
Query: 421 ----RRWKIR---TMKCFHNLEAMLKKDH 442
               RRWK+       C H   +++KK H
Sbjct: 300 QYVRRRWKLSFSIVSLCNHLTRSLMKKVH 328

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 59  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 118
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 119 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 175
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 176 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 234

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 56/209 (26%), Positives = 92/209 (44%), Gaps = 8/209 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS----TAVRF 255
           E  +L K+    +V    A    + + +V   +  GD+R  +       P      A+ +
Sbjct: 235 EKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFY 294
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
              I  G+ +LH+     II+RDL+P N+L DD GN++++D G++  L   + +      
Sbjct: 295 TAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAG 351
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
           T   ++APE+   EEYD  VD F+  + L EMI    PF  + +    K    R      
Sbjct: 352 TP-GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAV 410
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFR 404
                ++   K+  E    + P KR  FR
Sbjct: 411 TYPDKFSPASKDFCEALLQKDPEKRLGFR 439

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 119/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 52  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 108
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 109 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 165
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG +KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 166 TDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 225
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 226 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 282
Query: 413 I 413
           +
Sbjct: 283 M 283

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 45/180 (25%), Positives = 90/180 (50%), Gaps = 6/180 (3%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+
Sbjct: 62  EYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGE 121
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  ++++ G+   +    +  +I   + YLH      IIHRDL+P NIL ++  ++++ D
Sbjct: 122 LLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITD 178
Query: 297 FGVSKLLT--VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG +K+L+   K+ R      T+ +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 179 FGTAKVLSPESKQARANXFVGTA-QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 237

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 59/241 (24%), Positives = 119/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++T+ +P G
Sbjct: 45  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFG 101
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 158
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG +KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 159 TDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 219 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275
Query: 413 I 413
           +
Sbjct: 276 M 276

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/201 (26%), Positives = 107/201 (53%), Gaps = 14/201 (6%)
Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+ + +       G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 7   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 65
Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHE 268
           N+V+ L  +   + + +V E++ + DL+ F+        P   ++ +   + +G+ + H 
Sbjct: 66  NIVKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
           ++   ++HRDL+P N+L +  G +K+ADFG+++   V   R    +  +  Y APE+   
Sbjct: 125 HR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV-RTYXHEVVTLWYRAPEILLG 180
Query: 329 -EEYDTKVDVFSFALILQEMI 348
            + Y T VD++S   I  EM+
Sbjct: 181 CKYYSTAVDIWSLGCIFAEMV 201

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 89/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKSQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+ +      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 SELKILDFGLCR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 119/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 45  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 101
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 102 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 158
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 159 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 219 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 275
Query: 413 I 413
           +
Sbjct: 276 M 276

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 69/232 (29%), Positives = 104/232 (44%), Gaps = 41/232 (17%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFR-DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           G Q AVKK+         R+  FR +EL     +  P +V   GAV +   + I  E L 
Sbjct: 99  GFQCAVKKV---------RLEVFRAEELMACAGLTSPRIVPLYGAVREGPWVNIFMELLE 149
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNL 292
            G L   +K +G L    A+ +      G+ YLH  +   I+H D++  N+ L  D  + 
Sbjct: 150 GGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRR---ILHGDVKADNVLLSSDGSHA 206
Query: 293 KVADF---------GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 343
            + DF         G+ K L   +  P T  +T   ++APEV      D KVDV+S   +
Sbjct: 207 ALCDFGHAVCLQPDGLGKDLLTGDYIPGT--ET---HMAPEVVLGRSCDAKVDVWSSCCM 261
Query: 344 LQEMIEGCPPFT--------MKHDNEVPKAYAARQRPPFKAPAKLYARGLKE 387
           +  M+ GC P+T        +K  +E P     R+ PP  AP  L A+ ++E
Sbjct: 262 MLHMLNGCHPWTQFFRGPLCLKIASEPPP---VREIPPSCAP--LTAQAIQE 308

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/186 (31%), Positives = 91/186 (48%), Gaps = 15/186 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKXQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 XELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EGCPPF 354
            G   F
Sbjct: 218 TGRTLF 223

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 119/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 48  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 104
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 105 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 161
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 162 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 221
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 222 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 278
Query: 413 I 413
           +
Sbjct: 279 M 279

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 119/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 46  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 102
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 103 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 159
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 160 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 219
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 220 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 276
Query: 413 I 413
           +
Sbjct: 277 M 277

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 119/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 47  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 103
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 104 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 160
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 161 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 220
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 221 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 277
Query: 413 I 413
           +
Sbjct: 278 M 278

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 119/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 52  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 108
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 109 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 165
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 166 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 225
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 226 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 282
Query: 413 I 413
           +
Sbjct: 283 M 283

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 111
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 112 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 167
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 168 SELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
Query: 349 EG 350
            G
Sbjct: 224 TG 225

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 65/195 (33%), Positives = 96/195 (49%), Gaps = 25/195 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQF------LGAVTQSSPM 225
           G+ VA+KK     +  D R R    EL ++Q +    HPN+VQ       LG   +    
Sbjct: 48  GMSVAIKK-----VIQDPRFR--NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY 100
Query: 226 M-IVTEYLPKG---DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           + +V EY+P       R + +R+ A  P     F   + R +  LH    V + HRD++P
Sbjct: 101 LNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKP 159
Query: 282 SNILRDDS-GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE-VFKNEEYDTKVDVFS 339
            N+L +++ G LK+ DFG +K L+  E  P      S  Y APE +F N+ Y T VD++S
Sbjct: 160 HNVLVNEADGTLKLCDFGSAKKLSPSE--PNVAYICSRYYRAPELIFGNQHYTTAVDIWS 217
Query: 340 FALILQEMIEGCPPF 354
              I  EM+ G P F
Sbjct: 218 VGCIFAEMMLGEPIF 232

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 119/241 (49%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 49  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 105
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 106 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 162
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG++KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 163 TDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 222
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 223 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 279
Query: 413 I 413
           +
Sbjct: 280 M 280

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKXQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/236 (25%), Positives = 116/236 (49%), Gaps = 12/236 (5%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K L E      ++     DE  ++  +  P V + LG +  +S + +VT+ +P G
Sbjct: 47  IPVAIKVLRENTSPKANK--EILDEAYVMAGVGSPYVSRLLG-ICLTSTVQLVTQLMPYG 103
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L   ++  +G L     + + + IA+GM+YL +   V ++HRDL   N+L     ++K+
Sbjct: 104 CLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLED---VRLVHRDLAARNVLVKSPNHVKI 160
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG+++LL + E +          +++A E      +  + DV+S+ + + E++  G  
Sbjct: 161 TDFGLARLLDIDETEYHADGGKVPIKWMALESILRRRFTHQSDVWSYGVTVWELMTFGAK 220
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
           P+      E+P      +R P + P  +    +  ++ +CW      RP FR++++
Sbjct: 221 PYDGIPAREIPDLLEKGERLP-QPP--ICTIDVYMIMVKCWMIDSECRPRFRELVS 273

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 107
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 108 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 163
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 164 SELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219
Query: 349 EG 350
            G
Sbjct: 220 TG 221

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/212 (25%), Positives = 109/212 (51%), Gaps = 10/212 (4%)
Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFAL 257
           DE  ++  + +P+V + LG +  +S + ++T+ +P G L  +++  K  +     + + +
Sbjct: 100 DEAYVMASVDNPHVCRLLG-ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 158
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-DRPLTCQDT 316
            IA+GMNYL + +   ++HRDL   N+L     ++K+ DFG++KLL  +E +        
Sbjct: 159 QIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKV 215
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFK 375
             +++A E   +  Y  + DV+S+ + + E++  G  P+     +E+       +R P +
Sbjct: 216 PIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP-Q 274
Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            P  +    +  ++ +CW      RP FR++I
Sbjct: 275 PP--ICTIDVYMIMVKCWMIDADSRPKFRELI 304

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/165 (33%), Positives = 84/165 (50%), Gaps = 16/165 (9%)
Query: 200 ELALLQKIR---HPNVVQFLGAVTQSSP-----MMIVTEYLPKGDLRAFLKRKG--ALKP 249
           E+ALL+++    HPNVV+ +     S       + +V E++ + DLR +L +     L  
Sbjct: 61  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 119
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
            T         RG+++LH N    I+HRDL+P NIL    G +K+ADFG++++ + +   
Sbjct: 120 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA- 175
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            LT    +  Y APEV     Y T VD++S   I  EM    P F
Sbjct: 176 -LTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 219

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 111
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 112 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 167
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 168 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
Query: 349 EG 350
            G
Sbjct: 224 TG 225

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 92/184 (50%), Gaps = 15/184 (8%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVTEY 231
           +VAVKKL     S     R +R EL LL+ ++H NV+  L   T ++ +     + +   
Sbjct: 55  KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 113
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   DL   +K + AL           + RG+ Y+H      IIHRDL+PSN+  ++   
Sbjct: 114 LMGADLNNIVKCQ-ALSDEHVQFLVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDSE 169
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG 350
           L++ DFG+++    + D  +T    +  Y APE+  N   Y+  VD++S   I+ E+++G
Sbjct: 170 LRILDFGLAR----QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 225
Query: 351 CPPF 354
              F
Sbjct: 226 KALF 229

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 91/182 (50%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL +   S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 59  GLRVAVKKLSKPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 117
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 118 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 173
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 174 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 229
Query: 349 EG 350
            G
Sbjct: 230 TG 231

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 97/194 (50%), Gaps = 19/194 (9%)
Query: 178 VAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VAVK +  GE++   D+ V+    E+   + +RHPN+V+F   +   + + IV EY   G
Sbjct: 47  VAVKYIERGEKI---DENVKR---EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 100
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLK 293
           +L   +   G      A  F   +  G++Y H  +   + HRDL+  N L D S    LK
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLK 157
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV-DVFSFALILQEMIEGCP 352
           +  FG SK  +V   +P +   T   Y+APEV   +EYD KV DV+S  + L  M+ G  
Sbjct: 158 ICAFGYSK-SSVLHSQPKSTVGTPA-YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAY 215
Query: 353 PFTMKHDNEVPKAY 366
           PF    D E PK +
Sbjct: 216 PF---EDPEEPKNF 226

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 83/162 (51%), Gaps = 12/162 (7%)
Query: 200 ELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
           E+ +L+K+  HPN++Q       ++   +V + + KG+L  +L  K  L      +    
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           +   +  LH+   + I+HRDL+P NIL DD  N+K+ DFG S  L   E     C   S 
Sbjct: 133 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPS- 188
Query: 319 RYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPF 354
            Y+APE+ +      +  Y  +VD++S  +I+  ++ G PPF
Sbjct: 189 -YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 107
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 108 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 163
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 164 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219
Query: 349 EG 350
            G
Sbjct: 220 TG 221

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDFGLAR----HTDDEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 44  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 102
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 103 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 158
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 159 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 214
Query: 349 EG 350
            G
Sbjct: 215 TG 216

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 43  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 102 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 157
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 158 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213
Query: 349 EG 350
            G
Sbjct: 214 TG 215

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 58  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 116
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 117 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 172
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 173 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 228
Query: 349 EG 350
            G
Sbjct: 229 TG 230

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 45  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 103
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 104 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 159
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 160 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 215
Query: 349 EG 350
            G
Sbjct: 216 TG 217

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 58  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 116
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 117 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 172
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 173 XELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 228
Query: 349 EG 350
            G
Sbjct: 229 TG 230

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 53  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 111
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 112 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 167
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 168 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
Query: 349 EG 350
            G
Sbjct: 224 TG 225

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 107
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 108 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 163
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 164 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219
Query: 349 EG 350
            G
Sbjct: 220 TG 221

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 110
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 111 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 166
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 167 XELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222
Query: 349 EG 350
            G
Sbjct: 223 TG 224

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 44  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 102
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 103 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 158
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 159 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 214
Query: 349 EG 350
            G
Sbjct: 215 TG 216

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 110
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 111 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 166
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 167 XELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222
Query: 349 EG 350
            G
Sbjct: 223 TG 224

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 110
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 111 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 166
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 167 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222
Query: 349 EG 350
            G
Sbjct: 223 TG 224

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 118/241 (48%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 47  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 103
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 104 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 160
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG +KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 161 TDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 220
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 221 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMRKCWMIDADSRPKFRELIIEFSK 277
Query: 413 I 413
           +
Sbjct: 278 M 278

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 113 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 168
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 169 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 349 EG 350
            G
Sbjct: 225 TG 226

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 128
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 129 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 184
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 185 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 240
Query: 349 EG 350
            G
Sbjct: 241 TG 242

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 59  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 117
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 118 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 173
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 174 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 229
Query: 349 EG 350
            G
Sbjct: 230 TG 231

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 59  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 117
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 118 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 173
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 174 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 229
Query: 349 EG 350
            G
Sbjct: 230 TG 231

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 49  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 107
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 108 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 163
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 164 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 219
Query: 349 EG 350
            G
Sbjct: 220 TG 221

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 52  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 110
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 111 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 166
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 167 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 222
Query: 349 EG 350
            G
Sbjct: 223 TG 224

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 46  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 104
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 105 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 160
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 161 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 216
Query: 349 EG 350
            G
Sbjct: 217 TG 218

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 83/162 (51%), Gaps = 12/162 (7%)
Query: 200 ELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
           E+ +L+K+  HPN++Q       ++   +V + + KG+L  +L  K  L      +    
Sbjct: 73  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           +   +  LH+   + I+HRDL+P NIL DD  N+K+ DFG S  L   E     C   S 
Sbjct: 133 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPS- 188
Query: 319 RYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPF 354
            Y+APE+ +      +  Y  +VD++S  +I+  ++ G PPF
Sbjct: 189 -YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 229

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 67  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 125
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 126 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 181
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 182 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 237
Query: 349 EG 350
            G
Sbjct: 238 TG 239

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 66  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 124
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 125 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 180
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 181 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 236
Query: 349 EG 350
            G
Sbjct: 237 TG 238

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/162 (30%), Positives = 83/162 (51%), Gaps = 12/162 (7%)
Query: 200 ELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
           E+ +L+K+  HPN++Q       ++   +V + + KG+L  +L  K  L      +    
Sbjct: 60  EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 119
Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           +   +  LH+   + I+HRDL+P NIL DD  N+K+ DFG S  L   E     C   S 
Sbjct: 120 LLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPS- 175
Query: 319 RYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPF 354
            Y+APE+ +      +  Y  +VD++S  +I+  ++ G PPF
Sbjct: 176 -YLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPF 216

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 87/192 (45%), Gaps = 28/192 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFR-DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           G Q AVKK+         R+  FR +EL     +  P +V   GAV +   + I  E L 
Sbjct: 99  GFQCAVKKV---------RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 149
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNL 292
            G L   +K+ G L    A+ +      G+ YLH  +   I+H D++  N+ L  D    
Sbjct: 150 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRA 206
Query: 293 KVADF---------GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 343
            + DF         G+ K L   +  P T  +T   ++APEV   +  D KVD++S   +
Sbjct: 207 ALCDFGHALCLQPDGLGKSLLTGDYIPGT--ET---HMAPEVVMGKPCDAKVDIWSSCCM 261
Query: 344 LQEMIEGCPPFT 355
           +  M+ GC P+T
Sbjct: 262 MLHMLNGCHPWT 273

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 87/192 (45%), Gaps = 28/192 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFR-DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           G Q AVKK+         R+  FR +EL     +  P +V   GAV +   + I  E L 
Sbjct: 83  GFQCAVKKV---------RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 133
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNL 292
            G L   +K+ G L    A+ +      G+ YLH  +   I+H D++  N+ L  D    
Sbjct: 134 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRA 190
Query: 293 KVADF---------GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 343
            + DF         G+ K L   +  P T  +T   ++APEV   +  D KVD++S   +
Sbjct: 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGT--ET---HMAPEVVMGKPCDAKVDIWSSCCM 245
Query: 344 LQEMIEGCPPFT 355
           +  M+ GC P+T
Sbjct: 246 MLHMLNGCHPWT 257

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 89/190 (46%), Gaps = 23/190 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           GI VAVKKL     +     RA+R EL LL+ + H N++  L   T   P   + E+   
Sbjct: 49  GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFT---PQKTLEEF--- 101
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNI 284
            D+   ++   A      +   LD  R          G+ +LH      IIHRDL+PSNI
Sbjct: 102 QDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNI 157
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           +      LK+ DFG+++  T   +  +T    +  Y APEV     Y   VD++S   I+
Sbjct: 158 VVKSDCTLKILDFGLAR--TACTNFMMTPYVVTRYYRAPEVILGMGYAANVDIWSVGCIM 215
Query: 345 QEMIEGCPPF 354
            E+++GC  F
Sbjct: 216 GELVKGCVIF 225

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 57/192 (29%), Positives = 87/192 (45%), Gaps = 28/192 (14%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFR-DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
           G Q AVKK+         R+  FR +EL     +  P +V   GAV +   + I  E L 
Sbjct: 97  GFQCAVKKV---------RLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLE 147
Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNL 292
            G L   +K+ G L    A+ +      G+ YLH  +   I+H D++  N+ L  D    
Sbjct: 148 GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRA 204
Query: 293 KVADF---------GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALI 343
            + DF         G+ K L   +  P T  +T   ++APEV   +  D KVD++S   +
Sbjct: 205 ALCDFGHALCLQPDGLGKSLLTGDYIPGT--ET---HMAPEVVMGKPCDAKVDIWSSCCM 259
Query: 344 LQEMIEGCPPFT 355
           +  M+ GC P+T
Sbjct: 260 MLHMLNGCHPWT 271

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 56/298 (18%)
Query: 163 ITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGA 218
           I KG F   +   WRG +VAVK     + S  +    FR+ E+     +RH N++ F+ A
Sbjct: 12  IGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 66
Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------E 268
             +     + + +V++Y   G L  +L R   +     ++ AL  A G+ +LH      +
Sbjct: 67  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-------SCRYV 321
            KP  I HRDL+  NIL   +G   +AD G    L V+ D      D        + RY+
Sbjct: 126 GKP-AIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 180
Query: 322 APEVF------KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
           APEV       K+ E   + D+++  L+  E+   C    +  D ++P        P  +
Sbjct: 181 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 240
Query: 376 APAKLYA------------------RGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
              K+                    R + +++ ECW    A R T  +I   L  ++ 
Sbjct: 241 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 298

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 56/298 (18%)
Query: 163 ITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGA 218
           I KG F   +   WRG +VAVK     + S  +    FR+ E+     +RH N++ F+ A
Sbjct: 14  IGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 68
Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------E 268
             +     + + +V++Y   G L  +L R   +     ++ AL  A G+ +LH      +
Sbjct: 69  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-------SCRYV 321
            KP  I HRDL+  NIL   +G   +AD G    L V+ D      D        + RY+
Sbjct: 128 GKP-AIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 182
Query: 322 APEVF------KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
           APEV       K+ E   + D+++  L+  E+   C    +  D ++P        P  +
Sbjct: 183 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 242
Query: 376 APAKLYA------------------RGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
              K+                    R + +++ ECW    A R T  +I   L  ++ 
Sbjct: 243 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 300

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 56/184 (30%), Positives = 92/184 (50%), Gaps = 15/184 (8%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVTEY 231
           +VAVKKL     S     R +R EL LL+ ++H NV+  L   T ++ +     + +   
Sbjct: 47  KVAVKKLSRPFQSLIHARRTYR-ELRLLKHLKHENVIGLLDVFTPATSIEDFSEVYLVTT 105
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   DL   +K + AL           + RG+ Y+H      IIHRDL+PSN+  ++   
Sbjct: 106 LMGADLNNIVKCQ-ALSDEHVQFLVYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCE 161
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG 350
           L++ DFG+++    + D  +T    +  Y APE+  N   Y+  VD++S   I+ E+++G
Sbjct: 162 LRILDFGLAR----QADEEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQG 217
Query: 351 CPPF 354
              F
Sbjct: 218 KALF 221

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 56/298 (18%)
Query: 163 ITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGA 218
           I KG F   +   WRG +VAVK     + S  +    FR+ E+     +RH N++ F+ A
Sbjct: 11  IGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 65
Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------E 268
             +     + + +V++Y   G L  +L R   +     ++ AL  A G+ +LH      +
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-------SCRYV 321
            KP  I HRDL+  NIL   +G   +AD G    L V+ D      D        + RY+
Sbjct: 125 GKP-AIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 179
Query: 322 APEVF------KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
           APEV       K+ E   + D+++  L+  E+   C    +  D ++P        P  +
Sbjct: 180 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 239
Query: 376 APAKLYA------------------RGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
              K+                    R + +++ ECW    A R T  +I   L  ++ 
Sbjct: 240 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 56/298 (18%)
Query: 163 ITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGA 218
           I KG F   +   WRG +VAVK     + S  +    FR+ E+     +RH N++ F+ A
Sbjct: 17  IGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 71
Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------E 268
             +     + + +V++Y   G L  +L R   +     ++ AL  A G+ +LH      +
Sbjct: 72  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-------SCRYV 321
            KP  I HRDL+  NIL   +G   +AD G    L V+ D      D        + RY+
Sbjct: 131 GKP-AIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 185
Query: 322 APEVF------KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
           APEV       K+ E   + D+++  L+  E+   C    +  D ++P        P  +
Sbjct: 186 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 245
Query: 376 APAKLYA------------------RGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
              K+                    R + +++ ECW    A R T  +I   L  ++ 
Sbjct: 246 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 303

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 56/298 (18%)
Query: 163 ITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGA 218
           I KG F   +   WRG +VAVK     + S  +    FR+ E+     +RH N++ F+ A
Sbjct: 37  IGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 91
Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------E 268
             +     + + +V++Y   G L  +L R   +     ++ AL  A G+ +LH      +
Sbjct: 92  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-------SCRYV 321
            KP  I HRDL+  NIL   +G   +AD G    L V+ D      D        + RY+
Sbjct: 151 GKP-AIAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 205
Query: 322 APEVF------KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
           APEV       K+ E   + D+++  L+  E+   C    +  D ++P        P  +
Sbjct: 206 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 265
Query: 376 APAKLYA------------------RGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
              K+                    R + +++ ECW    A R T  +I   L  ++ 
Sbjct: 266 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 323

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 118/241 (48%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 47  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 103
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 104 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 160
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG +KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 161 TDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 220
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 221 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 277
Query: 413 I 413
           +
Sbjct: 278 M 278

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 58/241 (24%), Positives = 118/241 (48%), Gaps = 12/241 (4%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I VA+K+L E      ++     DE  ++  + +P+V + LG +  +S + ++ + +P G
Sbjct: 49  IPVAIKELREATSPKANK--EILDEAYVMASVDNPHVCRLLG-ICLTSTVQLIMQLMPFG 105
Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
            L  +++  K  +     + + + IA+GMNYL + +   ++HRDL   N+L     ++K+
Sbjct: 106 CLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKI 162
Query: 295 ADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
            DFG +KLL  +E +          +++A E   +  Y  + DV+S+ + + E++  G  
Sbjct: 163 TDFGRAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 222
Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
           P+     +E+       +R P + P  +    +  ++ +CW      RP FR++I     
Sbjct: 223 PYDGIPASEISSILEKGERLP-QPP--ICTIDVYMIMVKCWMIDADSRPKFRELIIEFSK 279
Query: 413 I 413
           +
Sbjct: 280 M 280

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/194 (34%), Positives = 96/194 (49%), Gaps = 19/194 (9%)
Query: 178 VAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VAVK +  GE++   D+ V+    E+   + +RHPN+V+F   +   + + IV EY   G
Sbjct: 47  VAVKYIERGEKI---DENVKR---EIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGG 100
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLK 293
           +L   +   G      A  F   +  G++Y H  +   + HRDL+  N L D S    LK
Sbjct: 101 ELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQ---VCHRDLKLENTLLDGSPAPRLK 157
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV-DVFSFALILQEMIEGCP 352
           +  FG SK  +V   +P     T   Y+APEV   +EYD KV DV+S  + L  M+ G  
Sbjct: 158 ICAFGYSK-SSVLHSQPKDTVGTPA-YIAPEVLLKKEYDGKVADVWSCGVTLYVMLVGAY 215
Query: 353 PFTMKHDNEVPKAY 366
           PF    D E PK +
Sbjct: 216 PF---EDPEEPKNF 226

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 123/298 (41%), Gaps = 56/298 (18%)
Query: 163 ITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQKIRHPNVVQFLGA 218
           I KG F   +   WRG +VAVK     + S  +    FR+ E+     +RH N++ F+ A
Sbjct: 50  IGKGRFGEVWRGKWRGEEVAVK-----IFSSREERSWFREAEIYQTVMLRHENILGFIAA 104
Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH------E 268
             +     + + +V++Y   G L  +L R   +     ++ AL  A G+ +LH      +
Sbjct: 105 DNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-------SCRYV 321
            KP  I HRDL+  NIL   +G   +AD G    L V+ D      D        + RY+
Sbjct: 164 GKPA-IAHRDLKSKNILVKKNGTCCIADLG----LAVRHDSATDTIDIAPNHRVGTKRYM 218
Query: 322 APEVF------KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
           APEV       K+ E   + D+++  L+  E+   C    +  D ++P        P  +
Sbjct: 219 APEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVE 278
Query: 376 APAKLYA------------------RGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
              K+                    R + +++ ECW    A R T  +I   L  ++ 
Sbjct: 279 EMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 336

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 90/182 (49%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ D+G+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDYGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 200 ELALLQKIR---HPNVVQFLGAVTQSSP-----MMIVTEYLPKGDLRAFLKRKG--ALKP 249
           E+ALL+++    HPNVV+ +     S       + +V E++ + DLR +L +     L  
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
            T         RG+++LH N    I+HRDL+P NIL    G +K+ADFG++++ + +   
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--M 166
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            L     +  Y APEV     Y T VD++S   I  EM    P F
Sbjct: 167 ALAPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 89/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 53  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 111
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 112 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 167
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 168 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 223
Query: 349 EG 350
            G
Sbjct: 224 TG 225

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 65/255 (25%), Positives = 118/255 (46%), Gaps = 40/255 (15%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
           E+  L  ++H N++QF+GA  + +     + ++T +  KG L  FLK    +  +     
Sbjct: 68  EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHI 126
Query: 256 ALDIARGMNYLHENKPV-------PIIHRDLEPSNILRDDSGNLKVADFGVS-KLLTVKE 307
           A  +ARG+ YLHE+ P         I HRD++  N+L  ++    +ADFG++ K    K 
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS 186
Query: 308 DRPLTCQDTSCRYVAPEVFK---NEEYDT--KVDVFSFALILQEMIEGCPP-------FT 355
                 Q  + RY+APEV +   N + D   ++D+++  L+L E+   C         + 
Sbjct: 187 AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYM 246
Query: 356 MKHDNEVPK----------AYAARQRPPFKAPAKLYA--RGLKELIEECWNEKPAKRPTF 403
           +  + E+ +              ++RP  +   + +A    L E IEECW+     R + 
Sbjct: 247 LPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSA 306
Query: 404 RQI---ITRLESINN 415
             +   IT+++ + N
Sbjct: 307 GCVGERITQMQRLTN 321

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 59/183 (32%), Positives = 92/183 (50%), Gaps = 17/183 (9%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            +L   DL   +K   A      V+F +  I RG+ Y+H      IIHRDL+PSN+  ++
Sbjct: 102 THLMGADLNNIVK--CAKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNE 156
Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEM 347
              LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E+
Sbjct: 157 DCELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 212
Query: 348 IEG 350
           + G
Sbjct: 213 LTG 215

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 200 ELALLQKIR---HPNVVQFLGAVTQSSP-----MMIVTEYLPKGDLRAFLKRKG--ALKP 249
           E+ALL+++    HPNVV+ +     S       + +V E++ + DLR +L +     L  
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
            T         RG+++LH N    I+HRDL+P NIL    G +K+ADFG++++ + +   
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--M 166
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            L     +  Y APEV     Y T VD++S   I  EM    P F
Sbjct: 167 ALDPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 89/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 125
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 126 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 181
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 182 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 237
Query: 349 EG 350
            G
Sbjct: 238 TG 239

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 89/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 102 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 157
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 158 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213
Query: 349 EG 350
            G
Sbjct: 214 TG 215

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 69/228 (30%), Positives = 106/228 (46%), Gaps = 23/228 (10%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY--- 231
           G +VA+KKL     S+    RA+R EL LL+ +RH NV+  L   T    +   T++   
Sbjct: 50  GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108
Query: 232 LP--KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +P    DL   +K +  L           + +G+ Y+H      IIHRDL+P N+  ++ 
Sbjct: 109 MPFMGTDLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIH---AAGIIHRDLKPGNLAVNED 164
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++    + D  +     +  Y APEV  N   Y   VD++S   I+ EMI
Sbjct: 165 CELKILDFGLAR----QADSEMXGXVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMI 220
Query: 349 EGCPPFTMK-HDNEVPKAYAARQRPPFKA-------PAKLYARGLKEL 388
            G   F    H +++ +       PP +         AK Y +GL EL
Sbjct: 221 TGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPEL 268

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 89/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 66  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 124
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 125 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 180
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 181 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 236
Query: 349 EG 350
            G
Sbjct: 237 TG 238

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 89/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|4GPM|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or264. Length = 169

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/107 (44%), Positives = 58/107 (54%), Gaps = 5/107 (4%)
Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           K A++N  D DG        L   A     E +K L+  G DVN +D D RT LH AA  
Sbjct: 59  KGADVNAKDSDGR-----TPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAEN 113
Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           G  EVV LL+ +GADV+  D  G TPL  A  + N EV+KLLEK G 
Sbjct: 114 GHKEVVKLLISKGADVNTSDSDGRTPLDLAREHGNEEVVKLLEKQGG 160

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 57/182 (31%), Positives = 89/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 57  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 115
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 116 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 171
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 172 CELKILDFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 227
Query: 349 EG 350
            G
Sbjct: 228 TG 229

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 75/292 (25%), Positives = 135/292 (46%), Gaps = 42/292 (14%)
Query: 162 EITKGTFILAFWRGIQ------VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF 215
           ++ KG + +  W+ I       VAVKK+ +   +  D  R FR+ + L +   H N+V  
Sbjct: 16  KLGKGAYGIV-WKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNL 74
Query: 216 LGAVTQSSP--MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVP 273
           L  +   +   + +V +Y+ + DL A + R   L+P         + + + YLH      
Sbjct: 75  LNVLRADNDRDVYLVFDYM-ETDLHAVI-RANILEPVHKQYVVYQLIKVIKYLHSGG--- 129
Query: 274 IIHRDLEPSNILRDDSGNLKVADFGVSKL------------LTVKE-------DRPLTCQ 314
           ++HRD++PSNIL +   ++KVADFG+S+             L++ E       D+P+   
Sbjct: 130 LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTD 189
Query: 315 DTSCR-YVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF----TMKHDNEVPKAYAA 368
             + R Y APE+   + +Y   +D++S   IL E++ G P F    TM   N++ +    
Sbjct: 190 YVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTM---NQLERIIGV 246
Query: 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420
              P  +    + +   K +IE    +   ++   R I T+ +++   IN K
Sbjct: 247 IDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPK 298

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 92/191 (48%), Gaps = 15/191 (7%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF-----LGAVTQSSPMMIVTE 230
           ++VA+KK+           +    E+ +L + RH N++          + Q   + +VT 
Sbjct: 69  VRVAIKKISP--FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVT- 125
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           +L   DL   LK +  L       F   I RG+ Y+H      ++HRDL+PSN+L + + 
Sbjct: 126 HLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTX 181
Query: 291 NLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEM 347
           +LK+ DFG++++     D    LT    +  Y APE+  N + Y   +D++S   IL EM
Sbjct: 182 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 241
Query: 348 IEGCPPFTMKH 358
           +   P F  KH
Sbjct: 242 LSNRPIFPGKH 252

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/165 (32%), Positives = 83/165 (50%), Gaps = 16/165 (9%)
Query: 200 ELALLQKIR---HPNVVQFLGAVTQSSP-----MMIVTEYLPKGDLRAFLKRKG--ALKP 249
           E+ALL+++    HPNVV+ +     S       + +V E++ + DLR +L +     L  
Sbjct: 53  EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPA 111
Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
            T         RG+++LH N    I+HRDL+P NIL    G +K+ADFG++++ + +   
Sbjct: 112 ETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLADFGLARIYSYQ--M 166
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            L     +  Y APEV     Y T VD++S   I  EM    P F
Sbjct: 167 ALFPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLF 211

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/192 (29%), Positives = 93/192 (48%), Gaps = 13/192 (6%)
Query: 174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI----VT 229
           R  +VA+KK+           +    E+ +L + RH NV+     +  S+   +    + 
Sbjct: 67  RKTRVAIKKISP--FEHQTYCQRTLREIQILLRFRHENVIGIRDILRASTLEAMRDVYIV 124
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           + L + DL   LK +  L       F   I RG+ Y+H      ++HRDL+PSN+L + +
Sbjct: 125 QDLMETDLYKLLKSQ-QLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLINTT 180
Query: 290 GNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQE 346
            +LK+ DFG++++   + D    LT    +  Y APE+  N + Y   +D++S   IL E
Sbjct: 181 CDLKICDFGLARIADPEHDHTGFLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAE 240
Query: 347 MIEGCPPFTMKH 358
           M+   P F  KH
Sbjct: 241 MLSNRPIFPGKH 252

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 48/165 (29%), Positives = 84/165 (50%), Gaps = 11/165 (6%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGA---LKPSTA 252
            + E ++   ++HP++V+ L   +    + +V E++   DL    +KR  A      + A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDR 309
             +   I   + Y H+N    IIHRD++P N+L   +++S  +K+ DFGV+  L  +   
Sbjct: 133 SHYMRQILEALRYCHDNN---IIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG-ESGL 188
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
               +  +  ++APEV K E Y   VDV+   +IL  ++ GC PF
Sbjct: 189 VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 91/182 (50%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 113 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 168
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++  T  E   +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 169 CELKILDFGLAR-HTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 349 EG 350
            G
Sbjct: 225 TG 226

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 89/186 (47%), Gaps = 15/186 (8%)
Query: 182 KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL 241
           K   + IS   +   F++EL ++  I++   +   G +T    + I+ EY+    +  F 
Sbjct: 75  KSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFD 134
Query: 242 -------KRKGALKPSTAVRFAL-DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
                  K      P   ++  +  +    +Y+H  K   I HRD++PSNIL D +G +K
Sbjct: 135 EYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVK 192
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYD-TKVDVFSFALILQEMIEGC 351
           ++DFG S+ +    D+ +     +  ++ PE F NE  Y+  KVD++S  + L  M    
Sbjct: 193 LSDFGESEYMV---DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNV 249
Query: 352 PPFTMK 357
            PF++K
Sbjct: 250 VPFSLK 255

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 73.9 bits (180), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 70  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 128
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 129 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 184
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +     +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 185 CELKILDFGLAR----HTDDEMXGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 240
Query: 349 EG 350
            G
Sbjct: 241 TG 242

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 91/182 (50%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 113 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 168
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++  T  E   +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 169 CELKILDFGLAR-HTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 349 EG 350
            G
Sbjct: 225 TG 226

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 45/154 (29%), Positives = 77/154 (50%), Gaps = 8/154 (5%)
Query: 209 HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
           HPN+V+            +V E L  G+L   +K+K     + A      +   ++++H+
Sbjct: 65  HPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHD 124
Query: 269 NKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
              V ++HRDL+P N+L    +D+  +K+ DFG ++L    +++PL     +  Y APE+
Sbjct: 125 ---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL-KPPDNQPLKTPCFTLHYAAPEL 180
Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359
                YD   D++S  +IL  M+ G  PF   HD
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSGQVPF-QSHD 213

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 58/182 (31%), Positives = 91/182 (50%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 54  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 112
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 113 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 168
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++  T  E   +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 169 CELKILDFGLAR-HTADE---MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224
Query: 349 EG 350
            G
Sbjct: 225 TG 226

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+  FG+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILGFGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 80
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 138
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y APE
Sbjct: 139 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 230

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 80
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 81  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 138
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y APE
Sbjct: 139 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 195
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 196 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 230

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 24/217 (11%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLG--EEVISDDDRVRAFRDELALLQKIRH 209
           +TN   I +G + +          ++VA+KK+   E        +R    E+ +L + RH
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLR----EIKILLRFRH 84
Query: 210 PNVVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN 264
            N++          + Q   + IV + L + DL   LK +  L       F   I RG+ 
Sbjct: 85  ENIIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLK 142
Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVA 322
           Y+H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y A
Sbjct: 143 YIHSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRA 199
Query: 323 PEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           PE+  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 200 PEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 81/152 (53%), Gaps = 12/152 (7%)
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF------AL 257
           L   RHP++V  +G   + + M+++ +Y+  G+L+  L   G+  P+ ++ +       +
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY--GSDLPTMSMSWEQRLEICI 146
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT-VKEDRPLTCQDT 316
             ARG++YLH      IIHRD++  NIL D++   K+ DFG+SK  T + +         
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELGQTHLXXVVKG 203
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
           +  Y+ PE F       K DV+SF ++L E++
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 82/292 (28%), Positives = 133/292 (45%), Gaps = 40/292 (13%)
Query: 134 MAPMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEE 186
           MAP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++
Sbjct: 21  MAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKD 79
Query: 187 VISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDL 237
            ISD        RV     E+ LL+K+      V++ L    +    +++ E   P  DL
Sbjct: 80  RISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDL 136
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVAD 296
             F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ D
Sbjct: 137 FDFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID 193
Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFT 355
           FG   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF 
Sbjct: 194 FGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF- 249
Query: 356 MKHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
            +HD E+ +     RQR          +   + LI  C   +P+ RPTF +I
Sbjct: 250 -EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 291

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 87
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 145
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y APE
Sbjct: 146 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 202
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 237

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 88
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 89  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 146
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y APE
Sbjct: 147 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 203
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 204 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 238

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 79
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 80  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 137
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y APE
Sbjct: 138 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 194
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 195 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 229

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 86
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 144
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y APE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 24/170 (14%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPST 251
           F +E  ++     P VVQ   A      + +V EY+P GDL   +       K A   + 
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 180
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
            V  ALD    M +         IHRD++P N+L D SG+LK+ADFG    + + ++  +
Sbjct: 181 EVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMV 229
Query: 312 TCQDTSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 354
            C DT+     Y++PEV K++     Y  + D +S  + L EM+ G  PF
Sbjct: 230 RC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 82/170 (48%), Gaps = 24/170 (14%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPST 251
           F +E  ++     P VVQ   A      + +V EY+P GDL   +       K A   + 
Sbjct: 121 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDVPEKWARFYTA 180
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
            V  ALD    M +         IHRD++P N+L D SG+LK+ADFG    + + ++  +
Sbjct: 181 EVVLALDAIHSMGF---------IHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMV 229
Query: 312 TCQDTSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 354
            C DT+     Y++PEV K++     Y  + D +S  + L EM+ G  PF
Sbjct: 230 RC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 278

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 86
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 144
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y APE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 46/152 (30%), Positives = 81/152 (53%), Gaps = 12/152 (7%)
Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF------AL 257
           L   RHP++V  +G   + + M+++ +Y+  G+L+  L   G+  P+ ++ +       +
Sbjct: 89  LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLY--GSDLPTMSMSWEQRLEICI 146
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT-VKEDRPLTCQDT 316
             ARG++YLH      IIHRD++  NIL D++   K+ DFG+SK  T + +         
Sbjct: 147 GAARGLHYLHTR---AIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKG 203
Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
           +  Y+ PE F       K DV+SF ++L E++
Sbjct: 204 TLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVL 235

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 51/166 (30%), Positives = 83/166 (50%), Gaps = 16/166 (9%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF- 255
           F +E  ++     P VVQ   A      + +V EY+P GDL   +       P    RF 
Sbjct: 116 FWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYDV--PEKWARFY 173
Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             ++   ++ +H    +  IHRD++P N+L D SG+LK+ADFG    + + ++  + C D
Sbjct: 174 TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTC--MKMNKEGMVRC-D 227
Query: 316 TSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGCPPF 354
           T+     Y++PEV K++     Y  + D +S  + L EM+ G  PF
Sbjct: 228 TAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 273

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 102/202 (50%), Gaps = 14/202 (6%)
Query: 166 GTFILAFWRGIQV--AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
           G   +A  +G ++  A KK+ +  + D DR   F+ E+ +++ + HPN+++       ++
Sbjct: 23  GEVKIAVQKGTRIRRAAKKIPKYFVEDVDR---FKQEIEIMKSLDHPNIIRLYETFEDNT 79
Query: 224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
            + +V E    G+L   +  K   + S A R   D+   + Y H+   + + HRDL+P N
Sbjct: 80  DIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPEN 136
Query: 284 IL-RDDSGN--LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSF 340
            L   DS +  LK+ DFG++     K  + +  +  +  YV+P+V +   Y  + D +S 
Sbjct: 137 FLFLTDSPDSPLKLIDFGLAARF--KPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSA 193
Query: 341 ALILQEMIEGCPPFTMKHDNEV 362
            +++  ++ G PPF+   D EV
Sbjct: 194 GVMMYVLLCGYPPFSAPTDXEV 215

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 84
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 142
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y APE
Sbjct: 143 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 234

>pdb|4GMR|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or266. Length = 169

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 42/90 (46%), Positives = 55/90 (61%)
Query: 43  RLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
           RL+  A   + + +K+LL++G DVN  D D +T LH+AA  G  EVV LLL +GAD + K
Sbjct: 7   RLIEAAENGNKDRVKDLLENGADVNASDSDGKTPLHLAAENGHKEVVKLLLSQGADPNAK 66
Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           D  G TPL  A    + EV+KLL   GA P
Sbjct: 67  DSDGKTPLHLAAENGHKEVVKLLLSQGADP 96

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 82
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 140
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y APE
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/190 (27%), Positives = 97/190 (51%), Gaps = 12/190 (6%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           I+ A KK+ +  + D DR   F+ E+ +++ + HPN+++       ++ + +V E    G
Sbjct: 52  IRRAAKKIPKYFVEDVDR---FKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGG 108
Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-RDDSGN--L 292
           +L   +  K   + S A R   D+   + Y H+   + + HRDL+P N L   DS +  L
Sbjct: 109 ELFERVVHKRVFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPL 165
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
           K+ DFG++     K  + +  +  +  YV+P+V +   Y  + D +S  +++  ++ G P
Sbjct: 166 KLIDFGLAARF--KPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYP 222
Query: 353 PFTMKHDNEV 362
           PF+   D EV
Sbjct: 223 PFSAPTDXEV 232

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/209 (25%), Positives = 101/209 (48%), Gaps = 12/209 (5%)
Query: 198 RDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA 256
           R E  +L+ IR  P +V    A    + + ++ +Y+  G+L   L ++          + 
Sbjct: 106 RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 165
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            +I   + +LH+   + II+RD++  NIL D +G++ + DFG+SK     E         
Sbjct: 166 GEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG 222
Query: 317 SCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---QR 371
           +  Y+AP++ +  +  +D  VD +S  +++ E++ G  PFT+  +       + R     
Sbjct: 223 TIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSE 282
Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKR 400
           PP+  P ++ A   K+LI+    + P KR
Sbjct: 283 PPY--PQEMSALA-KDLIQRLLMKDPKKR 308

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 14/196 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
           G  VA+KK  E   SDDD++  +    E+ LL+++RH N+V  L    +     +V E++
Sbjct: 50  GRIVAIKKFLE---SDDDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFV 106
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
               L         L      ++   I  G+ + H +    IIHRD++P NIL   SG +
Sbjct: 107 DHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVV 163
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVFKNE-EYDTKVDVFSFALILQEMIEG 350
           K+ DFG ++ L    +  +   + + R Y APE+   + +Y   VDV++   ++ EM  G
Sbjct: 164 KLCDFGFARTLAAPGE--VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221
Query: 351 CPPFTMKHDNEVPKAY 366
            P F    D+++ + Y
Sbjct: 222 EPLFP--GDSDIDQLY 235

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 80/161 (49%), Gaps = 5/161 (3%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ LL++++H N+V+    +     + +V E+  +   + F    G L P     F   +
Sbjct: 51  EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQL 110
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            +G+ + H      ++HRDL+P N+L + +G LK+ADFG+++   +   R  + +  +  
Sbjct: 111 LKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPV-RCYSAEVVTLW 166
Query: 320 YVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359
           Y  P+V F  + Y T +D++S   I  E+     P    +D
Sbjct: 167 YRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGND 207

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 102
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 103 IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 160
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y APE
Sbjct: 161 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 217
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 218 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 252

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/191 (29%), Positives = 92/191 (48%), Gaps = 15/191 (7%)
Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF-----LGAVTQSSPMMIVTE 230
           ++VA+KK+           +    E+ +L + RH N++          + Q   + IV +
Sbjct: 49  VRVAIKKISP--FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD 106
Query: 231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            L + DL   LK +  L       F   I RG+ Y+H      ++HRDL+PSN+L + + 
Sbjct: 107 -LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTX 161
Query: 291 NLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEM 347
           +LK+ DFG++++     D    LT    +  Y APE+  N + Y   +D++S   IL EM
Sbjct: 162 DLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEM 221
Query: 348 IEGCPPFTMKH 358
           +   P F  KH
Sbjct: 222 LSNRPIFPGKH 232

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 90
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 91  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 148
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y APE
Sbjct: 149 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 205
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 206 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 240

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 82
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 140
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y APE
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 82
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 83  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 140
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y APE
Sbjct: 141 HSAN---VLHRDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 197
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 198 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 86
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKCQ-HLSNDHICYFLYQILRGLKYI 144
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y APE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 201
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L++IRHPN++         + ++++ E +  G+L  FL  K +L    A +F   I
Sbjct: 65  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 124
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLLTVKEDRPLTCQD 315
             G++YLH  +   I H DL+P NI+  D       +K+ DFG++    ++         
Sbjct: 125 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNEFKNIF 179
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            +  +VAPE+   E    + D++S  +I   ++ G  PF
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L++IRHPN++         + ++++ E +  G+L  FL  K +L    A +F   I
Sbjct: 58  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLLTVKEDRPLTCQD 315
             G++YLH  +   I H DL+P NI+  D       +K+ DFG++    ++         
Sbjct: 118 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNEFKNIF 172
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            +  +VAPE+   E    + D++S  +I   ++ G  PF
Sbjct: 173 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 211

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 83/167 (49%), Gaps = 13/167 (7%)
Query: 200 ELALLQKIRHPNVVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR 254
           E+ +L + RH N++          + Q   + IV + L + DL   LK +  L       
Sbjct: 75  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICY 132
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LT 312
           F   I RG+ Y+H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT
Sbjct: 133 FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 313 CQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
               +  Y APE+  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 190 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|1N0R|A Chain A, 4ank: A Designed Ankyrin Repeat Protein With Four Identical Consensus Repeats Length = 126

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 45/101 (44%), Positives = 60/101 (59%)
Query: 30  GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVV 89
           G D + ++      L   A    +E +K LL++G DVN +D + RT LH+AA  G  EVV
Sbjct: 25  GADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVV 84
Query: 90  SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            LLLE GADV+ KD+ G TPL  A    + EV+KLL + GA
Sbjct: 85  KLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 125

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 79/159 (49%), Gaps = 9/159 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L++IRHPN++         + ++++ E +  G+L  FL  K +L    A +F   I
Sbjct: 79  EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 138
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLLTVKEDRPLTCQD 315
             G++YLH  +   I H DL+P NI+  D       +K+ DFG++    ++         
Sbjct: 139 LDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAH--KIEAGNEFKNIF 193
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            +  +VAPE+   E    + D++S  +I   ++ G  PF
Sbjct: 194 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 232

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 52/167 (31%), Positives = 83/167 (49%), Gaps = 13/167 (7%)
Query: 200 ELALLQKIRHPNVVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVR 254
           E+ +L + RH N++          + Q   + IV + L + DL   LK +  L       
Sbjct: 71  EIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICY 128
Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LT 312
           F   I RG+ Y+H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT
Sbjct: 129 FLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTXDLKIXDFGLARVADPDHDHTGFLT 185
Query: 313 CQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
               +  Y APE+  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 186 EYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 232

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ D G+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDAGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L   RH N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRTLREIKILLAFRHEN 84
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 142
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y APE
Sbjct: 143 HSAN---VLHRDLKPSNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 234

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 72/248 (29%), Positives = 108/248 (43%), Gaps = 38/248 (15%)
Query: 176 IQVAVKK------LGEEVISDDDRVRAFRDELALLQKIR----HPNVVQFLGAV-TQSSP 224
           +QVA+K       LG   +SD         E+ALL K+     HP V++ L    TQ   
Sbjct: 57  LQVAIKVIPRNRVLGWSPLSDSVTCPL---EVALLWKVGAGGGHPGVIRLLDWFETQEGF 113
Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           M+++   LP  DL  ++  KG L    +  F   +   + + H      ++HRD++  NI
Sbjct: 114 MLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENI 170
Query: 285 LRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT-KVDVFSFAL 342
           L D   G  K+ DFG   LL    D P T  D +  Y  PE     +Y      V+S  +
Sbjct: 171 LIDLRRGCAKLIDFGSGALL---HDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGI 227
Query: 343 ILQEMIEGCPPFTMKHDNEVPKA---YAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
           +L +M+ G  PF  + D E+ +A   + A   P   A           LI  C   KP+ 
Sbjct: 228 LLYDMVCGDIPF--ERDQEILEAELHFPAHVSPDCCA-----------LIRRCLAPKPSS 274
Query: 400 RPTFRQII 407
           RP+  +I+
Sbjct: 275 RPSLEEIL 282

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ D G+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDGGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 112/239 (46%), Gaps = 15/239 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G++ A K +  + +S  D  +  R E  + +K++HPN+V+   ++ + S   +V + +  
Sbjct: 31  GLEFAAKIINTKKLSARDFQKLER-EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +     + A      I   + Y H N    I+HR+L+P N+L   +     
Sbjct: 90  GELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 146
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +K+ADFG++  + V +         +  Y++PEV K + Y   VD+++  +IL  ++ G 
Sbjct: 147 VKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 204
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLY---ARGLKELIEECWNEKPAKRPTFRQII 407
           PPF    D +  + YA  +   +  P+  +       K LI+      P KR T  Q +
Sbjct: 205 PPFW---DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 260

>pdb|1N0Q|A Chain A, 3ank: A Designed Ankyrin Repeat Protein With Three Identical Consensus Repeats Length = 93

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 43/87 (49%), Positives = 55/87 (63%)
Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A    +E +K LL++G DVN +D + RT LH+AA  G  EVV LLLE GADV+ KD
Sbjct: 6   LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKD 65
Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           + G TPL  A    + EV+KLL + GA
Sbjct: 66  KNGRTPLHLAARNGHLEVVKLLLEAGA 92

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 112/239 (46%), Gaps = 15/239 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G++ A K +  + +S  D  +  R E  + +K++HPN+V+   ++ + S   +V + +  
Sbjct: 30  GLEFAAKIINTKKLSARDFQKLER-EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 88
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +     + A      I   + Y H N    I+HR+L+P N+L   +     
Sbjct: 89  GELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 145
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +K+ADFG++  + V +         +  Y++PEV K + Y   VD+++  +IL  ++ G 
Sbjct: 146 VKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 203
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLY---ARGLKELIEECWNEKPAKRPTFRQII 407
           PPF    D +  + YA  +   +  P+  +       K LI+      P KR T  Q +
Sbjct: 204 PPFW---DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 259

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 57/187 (30%), Positives = 94/187 (50%), Gaps = 12/187 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE-YLP 233
           G +VA+KKL     S+    RA+R EL LL+ ++H NV+  L   T +S +    + YL 
Sbjct: 49  GEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107
Query: 234 KGDLRAFLKRKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
              ++  L++   LK S          + +G+ Y+H      ++HRDL+P N+  ++   
Sbjct: 108 MPFMQTDLQKIMGLKFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCE 164
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG 350
           LK+ DFG+++      D  +T    +  Y APEV  +   Y+  VD++S   I+ EM+ G
Sbjct: 165 LKILDFGLAR----HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 220
Query: 351 CPPFTMK 357
              F  K
Sbjct: 221 KTLFKGK 227

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 60/239 (25%), Positives = 112/239 (46%), Gaps = 15/239 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G++ A K +  + +S  D  +  R E  + +K++HPN+V+   ++ + S   +V + +  
Sbjct: 31  GLEFAAKIINTKKLSARDFQKLER-EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +     + A      I   + Y H N    I+HR+L+P N+L   +     
Sbjct: 90  GELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 146
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +K+ADFG++  + V +         +  Y++PEV K + Y   VD+++  +IL  ++ G 
Sbjct: 147 VKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 204
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLY---ARGLKELIEECWNEKPAKRPTFRQII 407
           PPF    D +  + YA  +   +  P+  +       K LI+      P KR T  Q +
Sbjct: 205 PPFW---DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 260

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 89/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G++VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ D G+++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDRGLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 88/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 67  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 125
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 126 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 181
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +     +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 182 CELKILDFGLAR----HTDDEMXGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 237
Query: 349 EG 350
            G
Sbjct: 238 TG 239

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/239 (24%), Positives = 111/239 (46%), Gaps = 15/239 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G++ A K +  + +S  D  +    E  + +K++HPN+V+   ++ + S   +V + +  
Sbjct: 54  GLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 112
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +     + A      I   + Y H N    I+HR+L+P N+L   +     
Sbjct: 113 GELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 169
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +K+ADFG++  + V +         +  Y++PEV K + Y   VD+++  +IL  ++ G 
Sbjct: 170 VKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 227
Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLY---ARGLKELIEECWNEKPAKRPTFRQII 407
           PPF    D +  + YA  +   +  P+  +       K LI+      P KR T  Q +
Sbjct: 228 PPFW---DEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQAL 283

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 123/278 (44%), Gaps = 34/278 (12%)
Query: 95  RGADVDPKDRWGSTPLGDAIYYKNHE--VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDP 152
           RG DVD +   G    G      N++  V  + +++  +P+     +KH   +  Y+I  
Sbjct: 5   RGYDVDEQ---GKIVRGKGTVSSNYDNYVFDIWKQYYPQPV----EIKHDHVLDHYDI-- 55
Query: 153 HELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           HE       E+  G F     +     G   A K +     SD + VR    E+  +  +
Sbjct: 56  HE-------ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVL 105
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGALKPSTAVRFALDIARGMNYL 266
           RHP +V    A    + M+++ E++  G+L          +    AV +   + +G+ ++
Sbjct: 106 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 165
Query: 267 HENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
           HEN     +H DL+P NI+     S  LK+ DFG++  L  K+   +T    +  + APE
Sbjct: 166 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPE 220
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
           V + +      D++S  ++   ++ G  PF  ++D+E 
Sbjct: 221 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 258

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 86
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 87  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 144
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCR-YVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D      +  + R Y APE
Sbjct: 145 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 201
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 202 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 236

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/215 (27%), Positives = 100/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L + RH N
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--FEHQTYCQRTLREIKILLRFRHEN 87
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 88  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 145
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCR-YVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D      +  + R Y APE
Sbjct: 146 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPE 202
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 203 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 237

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 85/315 (26%), Positives = 142/315 (45%), Gaps = 42/315 (13%)
Query: 111 GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFI 169
           G+ +Y++   + K+     A    AP +  HA ++ P  E +P E  +     +  G F 
Sbjct: 8   GENLYFQGSLLSKI--NSLAHLRAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG 65
Query: 170 LAFWRGIQV------AVKKLGEEVISD------DDRVRAFRDELALLQKIRH--PNVVQF 215
            + + GI+V      A+K + ++ ISD        RV     E+ LL+K+      V++ 
Sbjct: 66  -SVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRL 121
Query: 216 LGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPI 274
           L    +    +++ E   P  DL  F+  +GAL+   A  F   +   + + H      +
Sbjct: 122 LDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN---CGV 178
Query: 275 IHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
           +HRD++  NIL D + G LK+ DFG   LL   +D   T  D +  Y  PE  +   Y  
Sbjct: 179 LHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHG 235
Query: 334 K-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEE 391
           +   V+S  ++L +M+ G  PF  +HD E+ +     RQR          +   + LI  
Sbjct: 236 RSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQR---------VSSECQHLIRW 284
Query: 392 CWNEKPAKRPTFRQI 406
           C   +P+ RPTF +I
Sbjct: 285 CLALRPSDRPTFEEI 299

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 100/213 (46%), Gaps = 23/213 (10%)
Query: 200 ELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFA 256
           E+ LL+K+      V++ L    +    +++ E + P  DL  F+  +GAL+   A  F 
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFF 120
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             +   + + H      ++HRD++  NIL D + G LK+ DFG   LL   +D   T  D
Sbjct: 121 WQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD 174
Query: 316 TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRPP 373
            +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  +HD E+ +     RQR  
Sbjct: 175 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQR-- 230
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
                   +   + LI  C   +P+ RPTF +I
Sbjct: 231 -------VSSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 68/278 (24%), Positives = 123/278 (44%), Gaps = 34/278 (12%)
Query: 95  RGADVDPKDRWGSTPLGDAIYYKNHE--VIKLLEKHGAKPLMAPMHVKHAREVPEYEIDP 152
           RG DVD +   G    G      N++  V  + +++  +P+     +KH   +  Y+I  
Sbjct: 111 RGYDVDEQ---GKIVRGKGTVSSNYDNYVFDIWKQYYPQPV----EIKHDHVLDHYDI-- 161
Query: 153 HELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
           HE       E+  G F     +     G   A K +     SD + VR    E+  +  +
Sbjct: 162 HE-------ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRK---EIQTMSVL 211
Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGALKPSTAVRFALDIARGMNYL 266
           RHP +V    A    + M+++ E++  G+L          +    AV +   + +G+ ++
Sbjct: 212 RHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHM 271
Query: 267 HENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
           HEN     +H DL+P NI+     S  LK+ DFG++  L  K+   +T    +  + APE
Sbjct: 272 HENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTT--GTAEFAAPE 326
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
           V + +      D++S  ++   ++ G  PF  ++D+E 
Sbjct: 327 VAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDET 364

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 88/190 (46%), Gaps = 23/190 (12%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           GI VAVKKL     +     RA+R EL LL+ + H N++  L   T   P   + E+   
Sbjct: 47  GINVAVKKLSRPFQNQTHAKRAYR-ELVLLKCVNHKNIISLLNVFT---PQKTLEEF--- 99
Query: 235 GDLRAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNI 284
            D+   ++   A      +   LD  R          G+ +LH      IIHRDL+PSNI
Sbjct: 100 QDVYLVMELMDA-NLCQVIHMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNI 155
Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           +      LK+ DFG+++  T   +  +T    +  Y APEV     Y   VD++S   I+
Sbjct: 156 VVKSDCTLKILDFGLAR--TASTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 213
Query: 345 QEMIEGCPPF 354
            E+++G   F
Sbjct: 214 GELVKGSVIF 223

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/215 (27%), Positives = 99/215 (46%), Gaps = 20/215 (9%)
Query: 157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN 211
           +TN   I +G + +          ++VA+KK+           +    E+ +L   RH N
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISP--FEHQTYCQRTLREIKILLAFRHEN 84
Query: 212 VVQF-----LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           ++          + Q   + IV + L + DL   LK +  L       F   I RG+ Y+
Sbjct: 85  IIGINDIIRAPTIEQMKDVYIVQD-LMETDLYKLLKTQ-HLSNDHICYFLYQILRGLKYI 142
Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYVAPE 324
           H      ++HRDL+PSN+L + + +LK+ DFG++++     D    LT    +  Y APE
Sbjct: 143 HSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 199
Query: 325 VFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKH 358
           +  N + Y   +D++S   IL EM+   P F  KH
Sbjct: 200 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 234

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 46/163 (28%), Positives = 89/163 (54%), Gaps = 13/163 (7%)
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
           + ++  +ARGM +L   K    IHRDL   NIL  ++  +K+ DFG+++ +    D  + 
Sbjct: 202 ISYSFQVARGMEFLSSRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKNPDY-VR 257
Query: 313 CQDTS--CRYVAPEVFKNEEYDTKVDVFSFALILQEM--IEGCPPFTMKHDNEVPKAYAA 368
             DT    +++APE   ++ Y TK DV+S+ ++L E+  + G P   ++ D +    + +
Sbjct: 258 KGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFSLGGSPYPGVQMDED----FCS 313
Query: 369 RQRPPFKAPAKLYAR-GLKELIEECWNEKPAKRPTFRQIITRL 410
           R R   +  A  Y+   + +++ +CW+  P +RP F +++ +L
Sbjct: 314 RLREGMRMRAPEYSTPEIYQIMLDCWHRDPKERPRFAELVEKL 356

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 73/291 (25%), Positives = 127/291 (43%), Gaps = 24/291 (8%)
Query: 129 GAKPLMAPMHVKHA--REVPEYEIDPHE----LD-FTNSVEITKGTFILAFWR--GIQVA 179
           G+ P   P  V H   R   +  +DP +    LD F    E + G   +A  R  G  VA
Sbjct: 1   GSSPQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVA 60
Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
           VKK+    +    R     +E+ +++  +H NVV+   +      + +V E+L  G L  
Sbjct: 61  VKKMD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD 117
Query: 240 FLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV 299
            +      +   A    L + + ++ LH      +IHRD++  +IL    G +K++DFG 
Sbjct: 118 IVTHTRMNEEQIAA-VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGF 173
Query: 300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359
              ++ +  R      T   ++APE+     Y  +VD++S  +++ EM++G PP+     
Sbjct: 174 CAQVSKEVPRRKXLVGTPY-WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF---- 228
Query: 360 NEVPKAYAARQR---PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           NE P       R   PP        +  LK  ++      PA+R T  +++
Sbjct: 229 NEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 279

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 40/291 (13%)
Query: 135 APMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEEV 187
           AP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++ 
Sbjct: 15  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKDR 73
Query: 188 ISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLR 238
           ISD        RV     E+ LL+K+      V++ L    +    +++ E   P  DL 
Sbjct: 74  ISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 130
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF 297
            F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ DF
Sbjct: 131 DFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTM 356
           G   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  
Sbjct: 188 GSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-- 242
Query: 357 KHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +HD E+ +     RQR          +   + LI  C   +P+ RPTF +I
Sbjct: 243 EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 88/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 43  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 101
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 102 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 157
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +     +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 158 CELKILDFGLAR----HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 213
Query: 349 EG 350
            G
Sbjct: 214 TG 215

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 88/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +     +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDFGLAR----HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 88/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DFG+++      D  +     +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDFGLAR----HTDDEMAGFVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 40/291 (13%)
Query: 135 APMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEEV 187
           AP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++ 
Sbjct: 35  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKDR 93
Query: 188 ISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLR 238
           ISD        RV     E+ LL+K+      V++ L    +    +++ E   P  DL 
Sbjct: 94  ISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 150
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF 297
            F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ DF
Sbjct: 151 DFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 207
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTM 356
           G   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  
Sbjct: 208 GSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-- 262
Query: 357 KHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +HD E+ +     RQR   +          + LI  C   +P+ RPTF +I
Sbjct: 263 EHDEEIIRGQVFFRQRVSXEC---------QHLIRWCLALRPSDRPTFEEI 304

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 40/291 (13%)
Query: 135 APMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEEV 187
           AP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++ 
Sbjct: 3   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKDR 61
Query: 188 ISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLR 238
           ISD        RV     E+ LL+K+      V++ L    +    +++ E   P  DL 
Sbjct: 62  ISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 118
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF 297
            F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ DF
Sbjct: 119 DFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTM 356
           G   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  
Sbjct: 176 GSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-- 230
Query: 357 KHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +HD E+ +     RQR          +   + LI  C   +P+ RPTF +I
Sbjct: 231 EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 272

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 40/291 (13%)
Query: 135 APMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEEV 187
           AP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++ 
Sbjct: 2   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKDR 60
Query: 188 ISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLR 238
           ISD        RV     E+ LL+K+      V++ L    +    +++ E   P  DL 
Sbjct: 61  ISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 117
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF 297
            F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ DF
Sbjct: 118 DFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTM 356
           G   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  
Sbjct: 175 GSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-- 229
Query: 357 KHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +HD E+ +     RQR          +   + LI  C   +P+ RPTF +I
Sbjct: 230 EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 271

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 30/220 (13%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQ 205
           P E+ +T++  I  G+F + +       G  VA+KK+ +         +AF++ EL +++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMR 68
Query: 206 KIRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFA 256
           K+ H N+V+       S        + +V +Y+P+   R    + + K  L       + 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P     
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYI 183
Query: 316 TSCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 71.6 bits (174), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 106/220 (48%), Gaps = 30/220 (13%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQ 205
           P E+ +T++  I  G+F + +       G  VA+KK+ +         +AF++ EL +++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMR 68
Query: 206 KIRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFA 256
           K+ H N+V+       S        + +V +Y+P+   R    + + K  L       + 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P     
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYI 183
Query: 316 TSCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 40/291 (13%)
Query: 135 APMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEEV 187
           AP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++ 
Sbjct: 30  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKDR 88
Query: 188 ISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLR 238
           ISD        RV     E+ LL+K+      V++ L    +    +++ E   P  DL 
Sbjct: 89  ISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 145
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF 297
            F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ DF
Sbjct: 146 DFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 202
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTM 356
           G   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  
Sbjct: 203 GSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-- 257
Query: 357 KHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +HD E+ +     RQR          +   + LI  C   +P+ RPTF +I
Sbjct: 258 EHDEEIIRGQVFFRQR---------VSXECQHLIRWCLALRPSDRPTFEEI 299

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 40/291 (13%)
Query: 135 APMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEEV 187
           AP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++ 
Sbjct: 3   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKDR 61
Query: 188 ISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLR 238
           ISD        RV     E+ LL+K+      V++ L    +    +++ E   P  DL 
Sbjct: 62  ISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 118
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF 297
            F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ DF
Sbjct: 119 DFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTM 356
           G   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  
Sbjct: 176 GSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-- 230
Query: 357 KHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +HD E+ +     RQR          +   + LI  C   +P+ RPTF +I
Sbjct: 231 EHDEEIIRGQVFFRQR---------VSXECQHLIRWCLALRPSDRPTFEEI 272

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 54/170 (31%), Positives = 80/170 (47%), Gaps = 24/170 (14%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPST 251
           F +E  ++     P VVQ   A      + +V EY+P GDL   +       K A   + 
Sbjct: 122 FWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTA 181
Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
            V  ALD    M          +IHRD++P N+L D  G+LK+ADFG    + + E   +
Sbjct: 182 EVVLALDAIHSMG---------LIHRDVKPDNMLLDKHGHLKLADFGTC--MKMDETGMV 230
Query: 312 TCQDTSCR---YVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPF 354
            C DT+     Y++PEV K++     Y  + D +S  + L EM+ G  PF
Sbjct: 231 HC-DTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 279

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 85/169 (50%), Gaps = 13/169 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L+K+ HP +++ +     +    IV E +  G+L   +     LK +T   +   +
Sbjct: 204 EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 262
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
              + YLHEN    IIHRDL+P N+L   +++   +K+ DFG SK+L         C   
Sbjct: 263 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 319
Query: 317 SCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
           +  Y+APEV        Y+  VD +S  +IL   + G PPF+ +H  +V
Sbjct: 320 T--YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS-EHRTQV 365

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 132/291 (45%), Gaps = 40/291 (13%)
Query: 135 APMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEEV 187
           AP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++ 
Sbjct: 2   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKDR 60
Query: 188 ISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLR 238
           ISD        RV     E+ LL+K+      V++ L    +    +++ E   P  DL 
Sbjct: 61  ISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 117
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF 297
            F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ DF
Sbjct: 118 DFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 174
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTM 356
           G   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  
Sbjct: 175 GSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-- 229
Query: 357 KHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +HD E+ +     RQR          +   + LI  C   +P+ RPTF +I
Sbjct: 230 EHDEEIIRGQVFFRQR---------VSXECQHLIRWCLALRPSDRPTFEEI 271

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 85/169 (50%), Gaps = 13/169 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L+K+ HP +++ +     +    IV E +  G+L   +     LK +T   +   +
Sbjct: 190 EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
              + YLHEN    IIHRDL+P N+L   +++   +K+ DFG SK+L         C   
Sbjct: 249 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 305
Query: 317 SCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
           +  Y+APEV        Y+  VD +S  +IL   + G PPF+ +H  +V
Sbjct: 306 T--YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS-EHRTQV 351

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 85/169 (50%), Gaps = 13/169 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L+K+ HP +++ +     +    IV E +  G+L   +     LK +T   +   +
Sbjct: 65  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
              + YLHEN    IIHRDL+P N+L   +++   +K+ DFG SK+L         C   
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 317 SCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
           +  Y+APEV        Y+  VD +S  +IL   + G PPF+ +H  +V
Sbjct: 181 T--YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS-EHRTQV 226

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 85/169 (50%), Gaps = 13/169 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L+K+ HP +++ +     +    IV E +  G+L   +     LK +T   +   +
Sbjct: 65  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
              + YLHEN    IIHRDL+P N+L   +++   +K+ DFG SK+L         C   
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 317 SCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
           +  Y+APEV        Y+  VD +S  +IL   + G PPF+ +H  +V
Sbjct: 181 T--YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS-EHRTQV 226

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 85/169 (50%), Gaps = 13/169 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L+K+ HP +++ +     +    IV E +  G+L   +     LK +T   +   +
Sbjct: 64  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 122
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
              + YLHEN    IIHRDL+P N+L   +++   +K+ DFG SK+L         C   
Sbjct: 123 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 179
Query: 317 SCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
           +  Y+APEV        Y+  VD +S  +IL   + G PPF+ +H  +V
Sbjct: 180 T--YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS-EHRTQV 225

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 56/182 (30%), Positives = 88/182 (48%), Gaps = 15/182 (8%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G +VAVKKL     S     R +R EL LL+ ++H NV+  L   T +  +     + + 
Sbjct: 47  GHRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLV 105
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
            +L   DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++ 
Sbjct: 106 THLMGADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNED 161
Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI 348
             LK+ DF +++      D  +T    +  Y APE+  N   Y+  VD++S   I+ E++
Sbjct: 162 CELKILDFYLAR----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 217
Query: 349 EG 350
            G
Sbjct: 218 TG 219

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 85/169 (50%), Gaps = 13/169 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L+K+ HP +++ +     +    IV E +  G+L   +     LK +T   +   +
Sbjct: 71  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 129
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
              + YLHEN    IIHRDL+P N+L   +++   +K+ DFG SK+L         C   
Sbjct: 130 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 186
Query: 317 SCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
           +  Y+APEV        Y+  VD +S  +IL   + G PPF+ +H  +V
Sbjct: 187 T--YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS-EHRTQV 232

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/169 (30%), Positives = 85/169 (50%), Gaps = 13/169 (7%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+ +L+K+ HP +++ +     +    IV E +  G+L   +     LK +T   +   +
Sbjct: 65  EIEILKKLNHPCIIK-IKNFFDAEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
              + YLHEN    IIHRDL+P N+L   +++   +K+ DFG SK+L         C   
Sbjct: 124 LLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTP 180
Query: 317 SCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
           +  Y+APEV        Y+  VD +S  +IL   + G PPF+ +H  +V
Sbjct: 181 T--YLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFS-EHRTQV 226

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               +K+ DFG++  +    +        +  +VAPE+   E    + D++S  +I   +
Sbjct: 153 PKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210
Query: 348 IEGCPPF 354
           + G  PF
Sbjct: 211 LSGASPF 217

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 62/220 (28%), Positives = 105/220 (47%), Gaps = 30/220 (13%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRD-ELALLQ 205
           P E+ +T++  I  G+F + +       G  VA+KK+ +         +AF++ EL +++
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQG--------KAFKNRELQIMR 68
Query: 206 KIRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFA 256
           K+ H N+V+       S        + +V +Y+P    R    + + K  L       + 
Sbjct: 69  KLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYM 128
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P     
Sbjct: 129 YQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXI 183
Query: 316 TSCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 184 CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 88/187 (47%), Gaps = 23/187 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFT---PQKSLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A   S  ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YIVMELMDA-NLSQVIQMELDHERMSYLLYQMLVGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S  +I+ EM
Sbjct: 161 SDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEM 218
Query: 348 IEGCPPF 354
           I+G   F
Sbjct: 219 IKGGVLF 225

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               +K+ DFG++  +    +        +  +VAPE+   E    + D++S  +I   +
Sbjct: 153 PKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210
Query: 348 IEGCPPF 354
           + G  PF
Sbjct: 211 LSGASPF 217

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 88/187 (47%), Gaps = 23/187 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFT---PQKSLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A   S  ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YIVMELMDA-NLSQVIQMELDHERMSYLLYQMLVGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S  +I+ EM
Sbjct: 161 SDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGVIMGEM 218
Query: 348 IEGCPPF 354
           I+G   F
Sbjct: 219 IKGGVLF 225

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 112/249 (44%), Gaps = 28/249 (11%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+++L+++ H NV+         + ++++ E +  G+L  FL +K +L    A  F   I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLLTVKEDRPLTCQD 315
             G+NYLH  K   I H DL+P NI+  D      ++K+ DFG++    +++        
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKNIF 179
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF-------TMKHDNEVPKAYAA 368
            +  +VAPE+   E    + D++S  +I   ++ G  PF       T+ +   V   +  
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDE 239
Query: 369 RQRPPFKAPAKLYARGL--KELIEECWNEKPAKRPTF-----RQIITRLESINNSINH-- 419
                    AK + R L  KE  +    ++  + P       +Q + R ES+ N  N   
Sbjct: 240 EFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRK 299
Query: 420 ---KRRWKI 425
              +RRWK+
Sbjct: 300 QYVRRRWKL 308

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 131/291 (45%), Gaps = 40/291 (13%)
Query: 135 APMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEEV 187
           AP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++ 
Sbjct: 15  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKDR 73
Query: 188 ISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLR 238
           ISD        RV     E+ LL+K+      V++ L    +    +++ E   P  DL 
Sbjct: 74  ISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 130
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF 297
            F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ DF
Sbjct: 131 DFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTM 356
           G   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  
Sbjct: 188 GSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-- 242
Query: 357 KHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +HD E+       RQR          +   + LI  C   +P+ RPTF +I
Sbjct: 243 EHDEEIIGGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 86/176 (48%), Gaps = 9/176 (5%)
Query: 188 ISDDDR---VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK 244
           + DDD      A R E+ LL++++H N+V+    +     + +V E+  +   + F    
Sbjct: 37  LDDDDEGVPSSALR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN 95
Query: 245 GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
           G L P     F   + +G+ + H      ++HRDL+P N+L + +G LK+A+FG+++   
Sbjct: 96  GDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFG 152
Query: 305 VKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359
           +   R  + +  +  Y  P+V F  + Y T +D++S   I  E+     P    +D
Sbjct: 153 IPV-RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGND 207

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 68/264 (25%), Positives = 121/264 (45%), Gaps = 19/264 (7%)
Query: 151 DPHELDFTNSVEITKG-TFILAFWR----GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP  L   + V+I +G T I+   R    G QVAVK +    +    R     +E+ +++
Sbjct: 42  DPRLL-LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 97
Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
             +H NVV+   +      + ++ E+L  G L   + +   L           + + + Y
Sbjct: 98  DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAY 156
Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY-VAPE 324
           LH      +IHRD++  +IL    G +K++DFG      + +D P         Y +APE
Sbjct: 157 LHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCA--QISKDVPKRKXLVGTPYWMAPE 211
Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP-AKLYAR 383
           V     Y T+VD++S  +++ EM++G PP+    D+ V      R  PP K   +   + 
Sbjct: 212 VISRSLYATEVDIWSLGIMVIEMVDGEPPYF--SDSPVQAMKRLRDSPPPKLKNSHKVSP 269
Query: 384 GLKELIEECWNEKPAKRPTFRQII 407
            L++ +E      P +R T ++++
Sbjct: 270 VLRDFLERMLVRDPQERATAQELL 293

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 63/249 (25%), Positives = 112/249 (44%), Gaps = 28/249 (11%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+++L+++ H NV+         + ++++ E +  G+L  FL +K +L    A  F   I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLLTVKEDRPLTCQD 315
             G+NYLH  K   I H DL+P NI+  D      ++K+ DFG++    +++        
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKNIF 179
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF-------TMKHDNEVPKAYAA 368
            +  +VAPE+   E    + D++S  +I   ++ G  PF       T+ +   V   +  
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDE 239
Query: 369 RQRPPFKAPAKLYARGL--KELIEECWNEKPAKRPTF-----RQIITRLESINNSINH-- 419
                    AK + R L  KE  +    ++  + P       +Q + R ES+ N  N   
Sbjct: 240 EFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRK 299
Query: 420 ---KRRWKI 425
              +RRWK+
Sbjct: 300 QYVRRRWKL 308

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILIGEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               +K+ DFG++  +    +        +  +VAPE+   E    + D++S  +I   +
Sbjct: 153 PKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210
Query: 348 IEGCPPF 354
           + G  PF
Sbjct: 211 LSGASPF 217

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 131/291 (45%), Gaps = 40/291 (13%)
Query: 135 APMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEEV 187
           AP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++ 
Sbjct: 16  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKDR 74
Query: 188 ISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLR 238
           ISD        RV     E+ LL+K+      V++ L    +    +++ E   P  DL 
Sbjct: 75  ISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 131
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF 297
            F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ DF
Sbjct: 132 DFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTM 356
           G   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  
Sbjct: 189 GSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-- 243
Query: 357 KHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +HD E+       RQR          +   + LI  C   +P+ RPTF +I
Sbjct: 244 EHDEEIIGGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 80/159 (50%), Gaps = 9/159 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+++L+++ H NV+         + ++++ E +  G+L  FL +K +L    A  F   I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLLTVKEDRPLTCQD 315
             G+NYLH  K   I H DL+P NI+  D      ++K+ DFG++    +++        
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKNIF 179
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            +  +VAPE+   E    + D++S  +I   ++ G  PF
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 35  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 95  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 151
Query: 291 ---NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               +K+ DFG++  +    +        +  +VAPE+   E    + D++S  +I   +
Sbjct: 152 PKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 209
Query: 348 IEGCPPF 354
           + G  PF
Sbjct: 210 LSGASPF 216

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               +K+ DFG++  +    +        +  +VAPE+   E    + D++S  +I   +
Sbjct: 153 PKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210
Query: 348 IEGCPPF 354
           + G  PF
Sbjct: 211 LSGASPF 217

>pdb|4DUI|A Chain A, Darpin D1 Binding To Tubulin Beta Chain (not In Complex) Length = 169

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 63/120 (52%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D +  +      L   A    +E ++ LL  G DVN  D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNATDASGLTPLHLAATYGHLEIVEVLLKHGADVNAID 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           I   T LH+AA  G  E+V +LL+ GADV+  D WG TPL  A    + E++++L KHGA
Sbjct: 78  IXGSTPLHLAALIGHLEIVEVLLKHGADVNAVDTWGDTPLHLAAIMGHLEIVEVLLKHGA 137

>pdb|4HB5|A Chain A, Crystal Structure Of Engineered Protein. Northeast Structural Genomics Consortium Target Or267. Length = 169

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 46/107 (42%), Positives = 56/107 (52%), Gaps = 5/107 (4%)
Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           K A+ N  D DG        L + A     E +K LL  G D N +D D RT LH AA  
Sbjct: 59  KGADPNAKDSDGR-----TPLHYAAENGHKEIVKLLLSKGADPNAKDSDGRTPLHYAAEN 113
Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           G  E+V LLL +GAD +  D  G TPL  A  + N E++KLLEK G 
Sbjct: 114 GHKEIVKLLLSKGADPNTSDSDGRTPLDLAREHGNEEIVKLLEKQGG 160

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               +K+ DFG++  +    +        +  +VAPE+   E    + D++S  +I   +
Sbjct: 153 PKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210
Query: 348 IEGCPPF 354
           + G  PF
Sbjct: 211 LSGASPF 217

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 35  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 94
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 95  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 151
Query: 291 ---NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               +K+ DFG++  +    +        +  +VAPE+   E    + D++S  +I   +
Sbjct: 152 PKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 209
Query: 348 IEGCPPF 354
           + G  PF
Sbjct: 210 LSGASPF 216

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 200 ELALLQKIR--HPNVVQFLGAVTQSSPMMIVTEY-LPKGDLRAFLKRKGALKPSTAVRFA 256
           E+ LL+K+      V++ L    +    +++ E   P  DL  F+  +GAL+   A  F 
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             +   + + H      ++HRD++  NIL D + G LK+ DFG   LL   +D   T  D
Sbjct: 117 WQVLEAVRHCHNXG---VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD 170
Query: 316 TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRPP 373
            +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  +HD E+ +     RQR  
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQRVS 228
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
            +          + LI  C   +P+ RPTF +I
Sbjct: 229 XEC---------QHLIRWCLALRPSDRPTFEEI 252

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 29  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 81
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 82  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 142 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXIC 196
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 131/291 (45%), Gaps = 40/291 (13%)
Query: 135 APMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEEV 187
           AP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++ 
Sbjct: 16  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKDR 74
Query: 188 ISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLR 238
           ISD        RV     E+ LL+K+      V++ L    +    +++ E   P  DL 
Sbjct: 75  ISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 131
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF 297
            F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ DF
Sbjct: 132 DFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTM 356
           G   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  
Sbjct: 189 GSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-- 243
Query: 357 KHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +HD E+       RQR   +          + LI  C   +P+ RPTF +I
Sbjct: 244 EHDEEIIGGQVFFRQRVSXEC---------QHLIRWCLALRPSDRPTFEEI 285

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               +K+ DFG++  +    +        +  +VAPE+   E    + D++S  +I   +
Sbjct: 153 PKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210
Query: 348 IEGCPPF 354
           + G  PF
Sbjct: 211 LSGASPF 217

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 131/291 (45%), Gaps = 40/291 (13%)
Query: 135 APMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEEV 187
           AP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++ 
Sbjct: 16  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKDR 74
Query: 188 ISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLR 238
           ISD        RV     E+ LL+K+      V++ L    +    +++ E   P  DL 
Sbjct: 75  ISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 131
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF 297
            F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ DF
Sbjct: 132 DFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTM 356
           G   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  
Sbjct: 189 GSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-- 243
Query: 357 KHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +HD E+       RQR          +   + LI  C   +P+ RPTF +I
Sbjct: 244 EHDEEIIGGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 285

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 70.9 bits (172), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 131/291 (45%), Gaps = 40/291 (13%)
Query: 135 APMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEEV 187
           AP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++ 
Sbjct: 15  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKDR 73
Query: 188 ISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLR 238
           ISD        RV     E+ LL+K+      V++ L    +    +++ E   P  DL 
Sbjct: 74  ISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 130
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF 297
            F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ DF
Sbjct: 131 DFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTM 356
           G   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  
Sbjct: 188 GSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-- 242
Query: 357 KHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +HD E+       RQR          +   + LI  C   +P+ RPTF +I
Sbjct: 243 EHDEEIIGGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTFEEI 284

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               +K+ DFG++  +    +        +  +VAPE+   E    + D++S  +I   +
Sbjct: 153 PKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210
Query: 348 IEGCPPF 354
           + G  PF
Sbjct: 211 LSGASPF 217

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           ++IV E L  G+L + ++ +G  A     A      I   + YLH    + I HRD++P 
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 146
Query: 283 NIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           N+L   +  +  LK+ DFG +K  T      LT    +  YVAPEV   E+YD   D++S
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 204
Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
             +I+  ++ G PPF   H   +      R R
Sbjct: 205 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 236

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 131/291 (45%), Gaps = 40/291 (13%)
Query: 135 APMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEEV 187
           AP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++ 
Sbjct: 15  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKDR 73
Query: 188 ISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLR 238
           ISD        RV     E+ LL+K+      V++ L    +    +++ E   P  DL 
Sbjct: 74  ISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 130
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF 297
            F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ DF
Sbjct: 131 DFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 187
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTM 356
           G   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  
Sbjct: 188 GSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-- 242
Query: 357 KHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +HD E+       RQR   +          + LI  C   +P+ RPTF +I
Sbjct: 243 EHDEEIIGGQVFFRQRVSXEC---------QHLIRWCLALRPSDRPTFEEI 284

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           ++IV E L  G+L + ++ +G  A     A      I   + YLH    + I HRD++P 
Sbjct: 134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 190
Query: 283 NIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           N+L   +  +  LK+ DFG +K  T      LT    +  YVAPEV   E+YD   D++S
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 248
Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
             +I+  ++ G PPF   H   +      R R
Sbjct: 249 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 280

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 131/291 (45%), Gaps = 40/291 (13%)
Query: 135 APMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEEV 187
           AP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++ 
Sbjct: 3   APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKDR 61
Query: 188 ISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLR 238
           ISD        RV     E+ LL+K+      V++ L    +    +++ E   P  DL 
Sbjct: 62  ISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 118
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF 297
            F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ DF
Sbjct: 119 DFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 175
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTM 356
           G   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  
Sbjct: 176 GSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-- 230
Query: 357 KHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +HD E+ +     RQR          +   + LI  C   +P  RPTF +I
Sbjct: 231 EHDEEIIRGQVFFRQR---------VSXECQHLIRWCLALRPXDRPTFEEI 272

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 36  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 88
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 89  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 148
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 149 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXIC 203
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 204 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 242

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 81/291 (27%), Positives = 131/291 (45%), Gaps = 40/291 (13%)
Query: 135 APMHVKHAREV-PEYEIDPHELDFTNSVEITKGTFILAFWRGIQV------AVKKLGEEV 187
           AP +  HA ++ P  E +P E  +     +  G F  + + GI+V      A+K + ++ 
Sbjct: 16  APCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFG-SVYSGIRVSDNLPVAIKHVEKDR 74
Query: 188 ISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLR 238
           ISD        RV     E+ LL+K+      V++ L    +    +++ E   P  DL 
Sbjct: 75  ISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLF 131
Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF 297
            F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D + G LK+ DF
Sbjct: 132 DFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDF 188
Query: 298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTM 356
           G   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  
Sbjct: 189 GSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF-- 243
Query: 357 KHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +HD E+       RQR   +          + LI  C   +P+ RPTF +I
Sbjct: 244 EHDEEIIGGQVFFRQRVSXEC---------QHLIRWCLALRPSDRPTFEEI 285

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 69
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 130 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXIC 184
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           ++IV E L  G+L + ++ +G  A     A      I   + YLH    + I HRD++P 
Sbjct: 94  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 150
Query: 283 NIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           N+L   +  +  LK+ DFG +K  T      LT    +  YVAPEV   E+YD   D++S
Sbjct: 151 NLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 208
Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
             +I+  ++ G PPF   H   +      R R
Sbjct: 209 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 240

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 21  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 73
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 74  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 133
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 134 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXIC 188
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 189 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 227

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           ++IV E L  G+L + ++ +G  A     A      I   + YLH    + I HRD++P 
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 144
Query: 283 NIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           N+L   +  +  LK+ DFG +K  T      LT    +  YVAPEV   E+YD   D++S
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 202
Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
             +I+  ++ G PPF   H   +      R R
Sbjct: 203 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 234

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           ++IV E L  G+L + ++ +G  A     A      I   + YLH    + I HRD++P 
Sbjct: 140 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 196
Query: 283 NIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           N+L   +  +  LK+ DFG +K  T      LT    +  YVAPEV   E+YD   D++S
Sbjct: 197 NLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 254
Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
             +I+  ++ G PPF   H   +      R R
Sbjct: 255 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 286

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           ++IV E L  G+L + ++ +G  A     A      I   + YLH    + I HRD++P 
Sbjct: 104 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 160
Query: 283 NIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           N+L   +  +  LK+ DFG +K  T      LT    +  YVAPEV   E+YD   D++S
Sbjct: 161 NLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 218
Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
             +I+  ++ G PPF   H   +      R R
Sbjct: 219 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 250

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 29  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 81
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 82  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 141
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 142 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXIC 196
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 197 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 235

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           ++IV E L  G+L + ++ +G  A     A      I   + YLH    + I HRD++P 
Sbjct: 95  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 151
Query: 283 NIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           N+L   +  +  LK+ DFG +K  T      LT    +  YVAPEV   E+YD   D++S
Sbjct: 152 NLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 209
Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
             +I+  ++ G PPF   H   +      R R
Sbjct: 210 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 241

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               +K+ DFG++  +    +        +  +VAPE+   E    + D++S  +I   +
Sbjct: 153 PKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210
Query: 348 IEGCPPF 354
           + G  PF
Sbjct: 211 LSGASPF 217

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           ++IV E L  G+L + ++ +G  A     A      I   + YLH    + I HRD++P 
Sbjct: 96  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 152
Query: 283 NIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           N+L   +  +  LK+ DFG +K  T      LT    +  YVAPEV   E+YD   D++S
Sbjct: 153 NLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 210
Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
             +I+  ++ G PPF   H   +      R R
Sbjct: 211 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 242

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 25  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 77
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 78  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 137
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 138 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXIC 192
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 193 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 231

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               +K+ DFG++  +    +        +  +VAPE+   E    + D++S  +I   +
Sbjct: 153 PKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210
Query: 348 IEGCPPF 354
           + G  PF
Sbjct: 211 LSGASPF 217

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 22  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 74
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 75  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 134
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 135 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYIC 189
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 190 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 228

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 80/159 (50%), Gaps = 9/159 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+++L+++ H NV+         + ++++ E +  G+L  FL +K +L    A  F   I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLLTVKEDRPLTCQD 315
             G+NYLH  K   I H DL+P NI+  D      ++K+ DFG++    +++        
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKNIF 179
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            +  +VAPE+   E    + D++S  +I   ++ G  PF
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 69
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 130 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXIC 184
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           ++IV E L  G+L + ++ +G  A     A      I   + YLH    + I HRD++P 
Sbjct: 90  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 146
Query: 283 NIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           N+L   +  +  LK+ DFG +K  T      LT    +  YVAPEV   E+YD   D++S
Sbjct: 147 NLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 204
Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
             +I+  ++ G PPF   H   +      R R
Sbjct: 205 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 236

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               +K+ DFG++  +    +        +  +VAPE+   E    + D++S  +I   +
Sbjct: 153 PKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210
Query: 348 IEGCPPF 354
           + G  PF
Sbjct: 211 LSGASPF 217

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               +K+ DFG++  +    +        +  +VAPE+   E    + D++S  +I   +
Sbjct: 153 PKPRIKIIDFGLAHKIDFGNE--FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYIL 210
Query: 348 IEGCPPF 354
           + G  PF
Sbjct: 211 LSGASPF 217

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 18  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 70
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 71  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 130
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 131 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXIC 185
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 186 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 224

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 73/152 (48%), Gaps = 10/152 (6%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           ++IV E L  G+L + ++ +G  A     A      I   + YLH    + I HRD++P 
Sbjct: 89  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 145
Query: 283 NIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           N+L   +  +  LK+ DFG +K  T      LT    +  YVAPEV   E+YD   D++S
Sbjct: 146 NLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWS 203
Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
             +I+  ++ G PPF   H   +      R R
Sbjct: 204 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 235

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 30  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 82
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 83  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 142
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 143 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYIC 197
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 198 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 236

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 69
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 130 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYIC 184
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 69
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 130 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXIC 184
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 185 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 223

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 200 ELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEY-LPKGDLRAFLKRKGALKPSTAVRFA 256
           E+ LL+K+      V++ L    +    +++ E   P  DL  F+  +GAL+   A  F 
Sbjct: 60  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 119
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             +   + + H      ++HRD++  NIL D + G LK+ DFG   LL   +D   T  D
Sbjct: 120 WQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD 173
Query: 316 TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRPP 373
            +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  +HD E+ +     RQR  
Sbjct: 174 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQR-- 229
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
                   +   + LI  C   +P+ RPTF +I
Sbjct: 230 -------VSSECQHLIRWCLALRPSDRPTFEEI 255

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 103
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 164 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSXIC 218
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 44/159 (27%), Positives = 80/159 (50%), Gaps = 9/159 (5%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E+++L+++ H NV+         + ++++ E +  G+L  FL +K +L    A  F   I
Sbjct: 65  EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLLTVKEDRPLTCQD 315
             G+NYLH  K   I H DL+P NI+  D      ++K+ DFG++    +++        
Sbjct: 125 LDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH--EIEDGVEFKNIF 179
Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
            +  +VAPE+   E    + D++S  +I   ++ G  PF
Sbjct: 180 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 45  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 97
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 98  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 157
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 158 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYIC 212
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 213 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 251

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 94/187 (50%), Gaps = 12/187 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE-YLP 233
           G +VA+KKL     S+    RA+R EL LL+ ++H NV+  L   T +S +    + YL 
Sbjct: 67  GEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 125
Query: 234 KGDLRAFLKRKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
              ++  L++   ++ S          + +G+ Y+H      ++HRDL+P N+  ++   
Sbjct: 126 MPFMQTDLQKIMGMEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCE 182
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEG 350
           LK+ DFG+++      D  +T    +  Y APEV  +   Y+  VD++S   I+ EM+ G
Sbjct: 183 LKILDFGLAR----HADAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTG 238
Query: 351 CPPFTMK 357
              F  K
Sbjct: 239 KTLFKGK 245

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 85/173 (49%), Gaps = 27/173 (15%)
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--- 309
           + ++  +A+GM +L   K    IHRDL   NIL  +   +K+ DFG+++ +    D    
Sbjct: 194 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 250
Query: 310 -----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF-TMKHDNEV 362
                PL       +++APE   +  Y  + DV+SF ++L E+   G  P+  +K D E 
Sbjct: 251 GDARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 303
Query: 363 PKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
            +      R R P     ++Y   L     +CW+ +P++RPTF +++  L ++
Sbjct: 304 CRRLKEGTRMRAPDYTTPEMYQTML-----DCWHGEPSQRPTFSELVEHLGNL 351

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 85/173 (49%), Gaps = 27/173 (15%)
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--- 309
           + ++  +A+GM +L   K    IHRDL   NIL  +   +K+ DFG+++ +    D    
Sbjct: 196 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 252
Query: 310 -----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF-TMKHDNEV 362
                PL       +++APE   +  Y  + DV+SF ++L E+   G  P+  +K D E 
Sbjct: 253 GDARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305
Query: 363 PKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
            +      R R P     ++Y   L     +CW+ +P++RPTF +++  L ++
Sbjct: 306 CRRLKEGTRMRAPDYTTPEMYQTML-----DCWHGEPSQRPTFSELVEHLGNL 353

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 51  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 103
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 104 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 163
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 164 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYIC 218
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 219 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 257

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 55  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 107
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 108 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 167
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 168 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYIC 222
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 223 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 261

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 53  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 105
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 106 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 165
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 166 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYIC 220
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 221 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 259

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 200 ELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEY-LPKGDLRAFLKRKGALKPSTAVRFA 256
           E+ LL+K+      V++ L    +    +++ E   P  DL  F+  +GAL+   A  F 
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             +   + + H      ++HRD++  NIL D + G LK+ DFG   LL   +D   T  D
Sbjct: 117 WQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD 170
Query: 316 TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRPP 373
            +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  +HD E+ +     RQR  
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQR-- 226
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
                   +   + LI  C   +P+ RPTF +I
Sbjct: 227 -------VSSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|4DRX|E Chain E, Gtp-Tubulin In Complex With A Darpin Length = 169

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 63/120 (52%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D +  +      L   A    +E ++ LL  G DVN  D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNATDASGLTPLHLAATYGHLEIVEVLLKHGADVNAID 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           I   T LH+AA  G  E+V +LL+ GADV+  D WG TPL  A    + E++++L KHGA
Sbjct: 78  IMGSTPLHLAALIGHLEIVEVLLKHGADVNAVDTWGDTPLHLAAIMGHLEIVEVLLKHGA 137

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 85/173 (49%), Gaps = 27/173 (15%)
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--- 309
           + ++  +A+GM +L   K    IHRDL   NIL  +   +K+ DFG+++ +    D    
Sbjct: 201 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 257
Query: 310 -----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF-TMKHDNEV 362
                PL       +++APE   +  Y  + DV+SF ++L E+   G  P+  +K D E 
Sbjct: 258 GDARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 310
Query: 363 PKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
            +      R R P     ++Y   L     +CW+ +P++RPTF +++  L ++
Sbjct: 311 CRRLKEGTRMRAPDYTTPEMYQTML-----DCWHGEPSQRPTFSELVEHLGNL 358

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 48/173 (27%), Positives = 85/173 (49%), Gaps = 27/173 (15%)
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--- 309
           + ++  +A+GM +L   K    IHRDL   NIL  +   +K+ DFG+++ +    D    
Sbjct: 203 ICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRK 259
Query: 310 -----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF-TMKHDNEV 362
                PL       +++APE   +  Y  + DV+SF ++L E+   G  P+  +K D E 
Sbjct: 260 GDARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 312
Query: 363 PKAY--AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
            +      R R P     ++Y   L     +CW+ +P++RPTF +++  L ++
Sbjct: 313 CRRLKEGTRMRAPDYTTPEMYQTML-----DCWHGEPSQRPTFSELVEHLGNL 360

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 88/187 (47%), Gaps = 12/187 (6%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRD---ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           G+Q A K + +       R  +  D   E+++L++I+HPNV+         + ++++ E 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILEL 95
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG- 290
           +  G+L  FL  K +L    A  F   I  G+ YLH    + I H DL+P NI+  D   
Sbjct: 96  VAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLH---SLQIAHFDLKPENIMLLDRNV 152
Query: 291 ---NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               +K+ DFG++  +    +        +  +VAPE+   E    + D++S  +I   +
Sbjct: 153 PKPRIKIIDFGLAHKIDFGNE--FKNIFGTPAFVAPEIVNYEPLGLEADMWSIGVITYIL 210
Query: 348 IEGCPPF 354
           + G  PF
Sbjct: 211 LSGASPF 217

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 62/219 (28%), Positives = 103/219 (47%), Gaps = 28/219 (12%)
Query: 152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F + +       G  VA+KK     +  D R +    EL +++K
Sbjct: 96  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKK-----VLQDKRFK--NRELQIMRK 148
Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRA---FLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+   R    + + K  L       +  
Sbjct: 149 LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 208
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+L D D+  LK+ DFG +K L   E  P      
Sbjct: 209 QLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE--PNVSYIC 263
Query: 317 SCRYVAPE-VFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           S  Y APE +F   +Y + +DV+S   +L E++ G P F
Sbjct: 264 SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIF 302

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 87/187 (46%), Gaps = 23/187 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFT---PQKSLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A   S  ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YIVMELMDA-NLSQVIQMELDHERMSYLLYQMLVGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 161 SDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 348 IEGCPPF 354
           I+G   F
Sbjct: 219 IKGGVLF 225

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 200 ELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFA 256
           E+ LL+K+      V++ L    +    +++ E   P  DL  F+  +GAL+   A  F 
Sbjct: 61  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 120
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             +   + + H      ++HRD++  NIL D + G LK+ DFG   LL   +D   T  D
Sbjct: 121 WQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD 174
Query: 316 TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRPP 373
            +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  +HD E+ +     RQR  
Sbjct: 175 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQR-- 230
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
                   +   + LI  C   +P+ RPTF +I
Sbjct: 231 -------VSSECQHLIRWCLALRPSDRPTFEEI 256

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 200 ELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEY-LPKGDLRAFLKRKGALKPSTAVRFA 256
           E+ LL+K+      V++ L    +    +++ E   P  DL  F+  +GAL+   A  F 
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 121
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             +   + + H      ++HRD++  NIL D + G LK+ DFG   LL   +D   T  D
Sbjct: 122 WQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD 175
Query: 316 TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRPP 373
            +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  +HD E+ +     RQR  
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQR-- 231
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
                   +   + LI  C   +P+ RPTF +I
Sbjct: 232 -------VSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 200 ELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFA 256
           E+ LL+K+      V++ L    +    +++ E   P  DL  F+  +GAL+   A  F 
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 121
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             +   + + H      ++HRD++  NIL D + G LK+ DFG   LL   +D   T  D
Sbjct: 122 WQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD 175
Query: 316 TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRPP 373
            +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  +HD E+ +     RQR  
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQR-- 231
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
                   +   + LI  C   +P+ RPTF +I
Sbjct: 232 -------VSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 58/187 (31%), Positives = 87/187 (46%), Gaps = 23/187 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKVVNHKNIIGLLNVFT---PQKSLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A   S  ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YIVMELMDA-NLSQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 161 SDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 348 IEGCPPF 354
           I+G   F
Sbjct: 219 IKGGVLF 225

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 69/243 (28%), Positives = 112/243 (46%), Gaps = 32/243 (13%)
Query: 176 IQVAVKKLGEEVISD------DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMI 227
           + VA+K + ++ ISD        RV     E+ LL+K+      V++ L    +    ++
Sbjct: 77  LPVAIKHVEKDRISDWGELPNGTRVPM---EVVLLKKVSSGFSGVIRLLDWFERPDSFVL 133
Query: 228 VTEYL-PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
           + E   P  DL  F+  +GAL+   A  F   +   + + H      ++HRD++  NIL 
Sbjct: 134 ILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILI 190
Query: 287 D-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALIL 344
           D + G LK+ DFG   LL   +D   T  D +  Y  PE  +   Y  +   V+S  ++L
Sbjct: 191 DLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILL 247
Query: 345 QEMIEGCPPFTMKHDNEVPKAYAA-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 403
            +M+ G  PF  +HD E+ +     RQR          +   + LI  C   +P+ RPTF
Sbjct: 248 YDMVCGDIPF--EHDEEIIRGQVFFRQR---------VSSECQHLIRWCLALRPSDRPTF 296
Query: 404 RQI 406
            +I
Sbjct: 297 EEI 299

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 200 ELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFA 256
           E+ LL+K+      V++ L    +    +++ E   P  DL  F+  +GAL+   A  F 
Sbjct: 84  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 143
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             +   + + H      ++HRD++  NIL D + G LK+ DFG   LL   +D   T  D
Sbjct: 144 WQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD 197
Query: 316 TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRPP 373
            +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  +HD E+ +     RQR  
Sbjct: 198 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQRVS 255
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
            +          + LI  C   +P+ RPTF +I
Sbjct: 256 XEC---------QHLIRWCLALRPSDRPTFEEI 279

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 13/183 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G QVA+KK+        +  R  R EL +L+  +H N++     +  + P      + V 
Sbjct: 79  GQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV 137
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
             L + DL   +     L       F   + RG+ Y+H  +   +IHRDL+PSN+L +++
Sbjct: 138 LDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNEN 194
Query: 290 GNLKVADFGVSKLLTVK--EDRPLTCQDTSCR-YVAPEVFKN-EEYDTKVDVFSFALILQ 345
             LK+ DFG+++ L     E +    +  + R Y APE+  +  EY   +D++S   I  
Sbjct: 195 CELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFG 254
Query: 346 EMI 348
           EM+
Sbjct: 255 EML 257

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 69.7 bits (169), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 99/213 (46%), Gaps = 23/213 (10%)
Query: 200 ELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFA 256
           E+ LL+K+      V++ L    +    +++ E   P  DL  F+  +GAL+   A  F 
Sbjct: 62  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 121
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             +   + + H      ++HRD++  NIL D + G LK+ DFG   LL   +D   T  D
Sbjct: 122 WQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD 175
Query: 316 TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRPP 373
            +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  +HD E+ +     RQR  
Sbjct: 176 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIRGQVFFRQR-- 231
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
                   +   + LI  C   +P+ RPTF +I
Sbjct: 232 -------VSSECQHLIRWCLALRPSDRPTFEEI 257

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 52/183 (28%), Positives = 88/183 (48%), Gaps = 13/183 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVT 229
           G QVA+KK+        +  R  R EL +L+  +H N++     +  + P      + V 
Sbjct: 80  GQQVAIKKIPNAFDVVTNAKRTLR-ELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVV 138
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
             L + DL   +     L       F   + RG+ Y+H  +   +IHRDL+PSN+L +++
Sbjct: 139 LDLMESDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNEN 195
Query: 290 GNLKVADFGVSKLLTVK--EDRPLTCQDTSCR-YVAPEVFKN-EEYDTKVDVFSFALILQ 345
             LK+ DFG+++ L     E +    +  + R Y APE+  +  EY   +D++S   I  
Sbjct: 196 CELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFG 255
Query: 346 EMI 348
           EM+
Sbjct: 256 EML 258

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/152 (30%), Positives = 72/152 (47%), Gaps = 10/152 (6%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           ++IV E L  G+L + ++ +G  A     A      I   + YLH    + I HRD++P 
Sbjct: 88  LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPE 144
Query: 283 NIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           N+L   +  +  LK+ DFG +K  T        C   +  YVAPEV   E+YD   D++S
Sbjct: 145 NLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCY--TPYYVAPEVLGPEKYDKSCDMWS 202
Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
             +I+  ++ G PPF   H   +      R R
Sbjct: 203 LGVIMYILLCGYPPFYSNHGLAISPGMKTRIR 234

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 86/183 (46%), Gaps = 23/183 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFT---PQKSLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A   S  ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YIVMELMDA-NLSQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 161 SDATLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 348 IEG 350
           I+G
Sbjct: 219 IKG 221

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 47/191 (24%), Positives = 95/191 (49%), Gaps = 11/191 (5%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G+++A K +    + D + V+   +E++++ ++ H N++Q   A    + +++V EY+  
Sbjct: 114 GLKLAAKIIKTRGMKDKEEVK---NEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDG 170
Query: 235 GDL-RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGN 291
           G+L    +     L     + F   I  G+ ++H+   + I+H DL+P NIL    D+  
Sbjct: 171 GELFDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQ 227
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +K+ DFG+++    +E   L     +  ++APEV   +      D++S  +I   ++ G 
Sbjct: 228 IKIIDFGLARRYKPRE--KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGL 285
Query: 352 PPFTMKHDNEV 362
            PF   +D E 
Sbjct: 286 SPFLGDNDAET 296

>pdb|4ATZ|D Chain D, Ad5 Knob In Complex With A Designed Ankyrin Repeat Protein Length = 154

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 66/120 (55%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D +  +      L   A    +E ++ LL +G DVN  D
Sbjct: 6   LLEAARAGQDDEVRILMANGADANAYDHYGRTPLHMAAAVGHLEIVEVLLRNGADVNAVD 65
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            +  T LH+AA  G  E+V +LL+ GADV+ KD  G TPL  A Y+ + E++++L KHGA
Sbjct: 66  TNGTTPLHLAASLGHLEIVEVLLKYGADVNAKDATGITPLYLAAYWGHLEIVEVLLKHGA 125

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 55/200 (27%), Positives = 96/200 (48%), Gaps = 14/200 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
           G  VA+KK  E   S+DD V  +    E+ +L++++HPN+V  L    +   + +V EY 
Sbjct: 28  GQIVAIKKFLE---SEDDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYC 84
Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
               L    + +  +             + +N+ H++     IHRD++P NIL      +
Sbjct: 85  DHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVI 141
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVFKNE-EYDTKVDVFSFALILQEMIEG 350
           K+ DFG ++LLT   D      + + R Y +PE+   + +Y   VDV++   +  E++ G
Sbjct: 142 KLCDFGFARLLTGPSD--YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSG 199
Query: 351 CPPFTMKHDNEVPKAYAARQ 370
            P +  K D  V + Y  R+
Sbjct: 200 VPLWPGKSD--VDQLYLIRK 217

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 114/257 (44%), Gaps = 17/257 (6%)
Query: 156 DFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213
           +F    E + G   +A  R  G  VAVKK+    +    R     +E+ +++  +H NVV
Sbjct: 28  NFIKIGEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVV 84
Query: 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVP 273
           +   +      + +V E+L  G L   +      +   A    L + + ++ LH      
Sbjct: 85  EMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-VCLAVLQALSVLHAQG--- 140
Query: 274 IIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
           +IHRD++  +IL    G +K++DFG    ++ +  R      T   ++APE+     Y  
Sbjct: 141 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISRLPYGP 199
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR---PPFKAPAKLYARGLKELIE 390
           +VD++S  +++ EM++G PP+     NE P       R   PP        +  LK  ++
Sbjct: 200 EVDIWSLGIMVIEMVDGEPPYF----NEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 255
Query: 391 ECWNEKPAKRPTFRQII 407
                 PA+R T  +++
Sbjct: 256 RLLVRDPAQRATAAELL 272

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 68/249 (27%), Positives = 109/249 (43%), Gaps = 39/249 (15%)
Query: 191 DDRVRAFRDELALLQKIRHPNVVQF-------------LGAVTQSSPMMIVTEYLPKGDL 237
           ++++     E+ LL  + H  VV++             + AV + S + I  EY   G L
Sbjct: 43  EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL 102
Query: 238 RAFLKRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
              +  +   +      R    I   ++Y+H      IIHRDL+P NI  D+S N+K+ D
Sbjct: 103 YDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159
Query: 297 FGVSK-----LLTVKEDRP--------LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFAL 342
           FG++K     L  +K D          LT    +  YVA EV      Y+ K+D++S  +
Sbjct: 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219
Query: 343 ILQEMIEGCPPFT--MKHDNEVPKAYAAR-QRPPFKAPAKLYARGLKELIEECWNEKPAK 399
           I  EMI    PF+  M+  N + K  +   + PP     K+     K++I    +  P K
Sbjct: 220 IFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVE--KKIIRLLIDHDPNK 274
Query: 400 RPTFRQIIT 408
           RP  R ++ 
Sbjct: 275 RPGARTLLN 283

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 61/213 (28%), Positives = 98/213 (46%), Gaps = 23/213 (10%)
Query: 200 ELALLQKIRH--PNVVQFLGAVTQSSPMMIVTEY-LPKGDLRAFLKRKGALKPSTAVRFA 256
           E+ LL+K+      V++ L    +    +++ E   P  DL  F+  +GAL+   A  F 
Sbjct: 57  EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             +   + + H      ++HRD++  NIL D + G LK+ DFG   LL   +D   T  D
Sbjct: 117 WQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFD 170
Query: 316 TSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA-RQRPP 373
            +  Y  PE  +   Y  +   V+S  ++L +M+ G  PF  +HD E+       RQR  
Sbjct: 171 GTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEIIGGQVFFRQR-- 226
Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
                   +   + LI  C   +P+ RPTF +I
Sbjct: 227 -------VSSECQHLIRWCLALRPSDRPTFEEI 252

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 72/288 (25%), Positives = 125/288 (43%), Gaps = 24/288 (8%)
Query: 132 PLMAPMHVKHA--REVPEYEIDPHE----LD-FTNSVEITKGTFILAFWR--GIQVAVKK 182
           P   P  V H   R   +  +DP +    LD F    E + G   +A  R  G  VAVKK
Sbjct: 2   PQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKK 61
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
           +    +    R     +E+ +++  +H NVV+   +      + +V E+L  G L   + 
Sbjct: 62  MD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT 118
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
                +   A    L + + ++ LH      +IHRD++  +IL    G +K++DFG    
Sbjct: 119 HTRMNEEQIAA-VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ 174
Query: 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
           ++ +  R      T   ++APE+     Y  +VD++S  +++ EM++G PP+     NE 
Sbjct: 175 VSKEVPRRKXLVGTPY-WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYF----NEP 229
Query: 363 PKAYAARQR---PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           P       R   PP        +  LK  ++      PA+R T  +++
Sbjct: 230 PLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRATAAELL 277

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 92/183 (50%), Gaps = 12/183 (6%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+K++  E   +     A R E++LL++++H N+++    +  +  + ++ EY  + DL
Sbjct: 62  VAIKRIRLEHEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEY-AENDL 119
Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-----RDDSGNL 292
           + ++ +   +       F   +  G+N+ H  +    +HRDL+P N+L       ++  L
Sbjct: 120 KKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVL 176
Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGC 351
           K+ DFG+++   +   R  T +  +  Y  PE+   +  Y T VD++S A I  EM+   
Sbjct: 177 KIGDFGLARAFGIP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKT 235
Query: 352 PPF 354
           P F
Sbjct: 236 PLF 238

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 54/200 (27%), Positives = 94/200 (47%), Gaps = 19/200 (9%)
Query: 170 LAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
           ++   G + AVK +  E  +   R R FR+   L Q   + N+++ +      +   +V 
Sbjct: 33  VSLQNGKEYAVKII--EKQAGHSRSRVFREVETLYQCQGNKNILELIEFFEDDTRFYLVF 90
Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           E L  G + A ++++       A R   D+A  +++LH      I HRDL+P NIL +  
Sbjct: 91  EKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKG---IAHRDLKPENILCESP 147
Query: 290 ---GNLKVADFGVSKLLTVKED-RPLTCQD-----TSCRYVAP---EVFKNEE--YDTKV 335
                +K+ DF +   + +     P+T  +      S  Y+AP   EVF ++   YD + 
Sbjct: 148 EKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTDQATFYDKRC 207
Query: 336 DVFSFALILQEMIEGCPPFT 355
           D++S  ++L  M+ G PPF 
Sbjct: 208 DLWSLGVVLYIMLSGYPPFV 227

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 110/242 (45%), Gaps = 17/242 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  +AVK++   V S + + R   D    ++ +  P  V F GA+ +   + I  E +  
Sbjct: 76  GQIMAVKRIRATVNSQEQK-RLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELM-D 133
Query: 235 GDLRAFLKR---KGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
             L  F K+   KG   P   + + A+ I + + +LH    + +IHRD++PSN+L +  G
Sbjct: 134 TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALG 191
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVFKNE----EYDTKVDVFSFALILQ 345
            +K+ DFG+S  L    D      D  C+ Y+APE    E     Y  K D++S  + + 
Sbjct: 192 QVKMCDFGISGYLV---DSVAKTIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI 248
Query: 346 EMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
           E+     P+         +     + P  + PA  ++    +   +C  +   +RPT+ +
Sbjct: 249 ELAILRFPYD-SWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 307
Query: 406 II 407
           ++
Sbjct: 308 LM 309

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 114/257 (44%), Gaps = 17/257 (6%)
Query: 156 DFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213
           +F    E + G   +A  R  G  VAVKK+    +    R     +E+ +++  +H NVV
Sbjct: 24  NFIKIGEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVV 80
Query: 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVP 273
           +   +      + +V E+L  G L   +      +   A    L + + ++ LH      
Sbjct: 81  EMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-VCLAVLQALSVLHAQG--- 136
Query: 274 IIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
           +IHRD++  +IL    G +K++DFG    ++ +  R      T   ++APE+     Y  
Sbjct: 137 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISRLPYGP 195
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR---PPFKAPAKLYARGLKELIE 390
           +VD++S  +++ EM++G PP+     NE P       R   PP        +  LK  ++
Sbjct: 196 EVDIWSLGIMVIEMVDGEPPYF----NEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 251
Query: 391 ECWNEKPAKRPTFRQII 407
                 PA+R T  +++
Sbjct: 252 RLLVRDPAQRATAAELL 268

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 48/152 (31%), Positives = 71/152 (46%), Gaps = 10/152 (6%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           ++IV E L  G+L + ++ +G  A     A      I   + YLH    + I HRD++P 
Sbjct: 134 LLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEAIQYLHS---INIAHRDVKPE 190
Query: 283 NIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           N+L   +  +  LK+ DFG +K  T      LT    +  YVAPEV   E+YD   D +S
Sbjct: 191 NLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDXWS 248
Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
             +I   ++ G PPF   H   +      R R
Sbjct: 249 LGVIXYILLCGYPPFYSNHGLAISPGXKTRIR 280

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 11/165 (6%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGA---LKPSTA 252
            + E ++   ++HP++V+ L   +    + +V E++   DL    +KR  A      + A
Sbjct: 73  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 132
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDR 309
             +   I   + Y H+N    IIHRD++P  +L   +++S  +K+  FGV+  L  +   
Sbjct: 133 SHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGL 188
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
               +  +  ++APEV K E Y   VDV+   +IL  ++ GC PF
Sbjct: 189 VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 233

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/165 (27%), Positives = 82/165 (49%), Gaps = 11/165 (6%)
Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGA---LKPSTA 252
            + E ++   ++HP++V+ L   +    + +V E++   DL    +KR  A      + A
Sbjct: 75  LKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVA 134
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDR 309
             +   I   + Y H+N    IIHRD++P  +L   +++S  +K+  FGV+  L  +   
Sbjct: 135 SHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG-ESGL 190
Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
               +  +  ++APEV K E Y   VDV+   +IL  ++ GC PF
Sbjct: 191 VAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPF 235

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 86/183 (46%), Gaps = 23/183 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFT---PQKSLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A   S  ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YIVMELMDA-NLSQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 161 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 348 IEG 350
           I+G
Sbjct: 219 IKG 221

>pdb|2Y0B|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4_s76r Length = 136

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Composition-based stats.
 Identities = 41/102 (40%), Positives = 61/102 (59%), Gaps = 5/102 (4%)
Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N +DD G  + P   L   A    +E ++ LL  G DVN RDI  RT LH+AA  G 
Sbjct: 38  ADVNAMDDAG--VTP---LHLAAKRGHLEIVEVLLKHGADVNARDIWGRTPLHLAATVGH 92
Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
            E+V +LLE GADV+ +D++G T    +I   N ++ ++L+K
Sbjct: 93  LEIVEVLLEYGADVNAQDKFGKTAFDISIDNGNEDLAEILQK 134

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 68.6 bits (166), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 63/257 (24%), Positives = 114/257 (44%), Gaps = 17/257 (6%)
Query: 156 DFTNSVEITKGTFILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213
           +F    E + G   +A  R  G  VAVKK+    +    R     +E+ +++  +H NVV
Sbjct: 78  NFIKIGEGSTGIVCIATVRSSGKLVAVKKMD---LRKQQRRELLFNEVVIMRDYQHENVV 134
Query: 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVP 273
           +   +      + +V E+L  G L   +      +   A    L + + ++ LH      
Sbjct: 135 EMYNSYLVGDELWVVMEFLEGGALTDIVTHTRMNEEQIAA-VCLAVLQALSVLHAQG--- 190
Query: 274 IIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
           +IHRD++  +IL    G +K++DFG    ++ +  R      T   ++APE+     Y  
Sbjct: 191 VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPY-WMAPELISRLPYGP 249
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR---PPFKAPAKLYARGLKELIE 390
           +VD++S  +++ EM++G PP+     NE P       R   PP        +  LK  ++
Sbjct: 250 EVDIWSLGIMVIEMVDGEPPYF----NEPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLD 305
Query: 391 ECWNEKPAKRPTFRQII 407
                 PA+R T  +++
Sbjct: 306 RLLVRDPAQRATAAELL 322

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 84/179 (46%), Gaps = 15/179 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 109
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 110 LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 164
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
           LK+ DFG+++  T      +T +  +  Y APEV     Y   VD++S   I+ EMI+G
Sbjct: 165 LKILDFGLAR--TAGTSFMMTPEVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|2L6B|A Chain A, Nrc Consensus Ankyrin Repeat Protein Solution Structure Length = 115

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Composition-based stats.
 Identities = 36/77 (46%), Positives = 49/77 (63%)
Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
           E +K+LL  G DVN R  D  T LH+AA  G  E+V LLL +GADV+ + + G+TP   A
Sbjct: 23  EEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLA 82
Query: 114 IYYKNHEVIKLLEKHGA 130
               +HE++KLL+  GA
Sbjct: 83  KKNGHHEIVKLLDAKGA 99

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/266 (22%), Positives = 119/266 (44%), Gaps = 14/266 (5%)
Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           + A K +  + +S  D  +  R E  + + ++HPN+V+   ++++     +V + +  G+
Sbjct: 58  EYAAKIINTKKLSARDHQKLER-EARICRLLKHPNIVRLHDSISEEGFHYLVFDLVTGGE 116
Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLK 293
           L   +  +     + A      I   +N++H++    I+HRDL+P N+L   +     +K
Sbjct: 117 LFEDIVAREYYSEADASHCIHQILESVNHIHQHD---IVHRDLKPENLLLASKCKGAAVK 173
Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
           +ADFG++  +  ++        T   Y++PEV + + Y   VD+++  +IL  ++ G PP
Sbjct: 174 LADFGLAIEVQGEQQAWFGFAGTP-GYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPP 232
Query: 354 FTMKHDNEVPKAYAARQRPPFKAPAKLY---ARGLKELIEECWNEKPAKRPTFRQIITRL 410
           F    D +  K Y   +   +  P+  +       K LI +     PAKR T  Q +   
Sbjct: 233 FW---DEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHP 289
Query: 411 ESINNSINHKRRWKIRTMKCFHNLEA 436
                S       +  T++C     A
Sbjct: 290 WVCQRSTVASMMHRQETVECLRKFNA 315

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 61/242 (25%), Positives = 111/242 (45%), Gaps = 17/242 (7%)
Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  +AVK++   V S + + R   D    ++ +  P  V F GA+ +   + I  E L  
Sbjct: 32  GQIMAVKRIRATVNSQEQK-RLLMDLDISMRTVDCPFTVTFYGALFREGDVWICME-LMD 89
Query: 235 GDLRAFLKR---KGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
             L  F K+   KG   P   + + A+ I + + +LH    + +IHRD++PSN+L +  G
Sbjct: 90  TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALG 147
Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVFKNE----EYDTKVDVFSFALILQ 345
            +K+ DFG+S  L     + +   D  C+ Y+APE    E     Y  K D++S  + + 
Sbjct: 148 QVKMCDFGISGYLVDDVAKDI---DAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMI 204
Query: 346 EMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
           E+     P+         +     + P  + PA  ++    +   +C  +   +RPT+ +
Sbjct: 205 ELAILRFPYD-SWGTPFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263
Query: 406 II 407
           ++
Sbjct: 264 LM 265

>pdb|1MJ0|A Chain A, Sank E3_5: An Artificial Ankyrin Repeat Protein Length = 166

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/105 (40%), Positives = 62/105 (59%), Gaps = 5/105 (4%)
Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N  D+DG    P   L   A+   +E ++ LL +G DVN  D+   T LH+AA  G 
Sbjct: 38  ADVNATDNDG--YTP---LHLAASNGHLEIVEVLLKNGADVNASDLTGITPLHLAAATGH 92
Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            E+V +LL+ GADV+  D  G TPL  A  Y + E++++L KHGA
Sbjct: 93  LEIVEVLLKHGADVNAYDNDGHTPLHLAAKYGHLEIVEVLLKHGA 137

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 106/232 (45%), Gaps = 17/232 (7%)
Query: 132 PLMAPMHVKHA--REVPEYEIDPHE----LD-FTNSVEITKGTFILAFWR--GIQVAVKK 182
           P   P  V H   R   +  +DP +    LD F    E + G   +A  R  G  VAVKK
Sbjct: 124 PQREPQRVSHEQFRAALQLVVDPGDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKK 183
Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
           +    +    R     +E+ +++  +H NVV+   +      + +V E+L  G L   + 
Sbjct: 184 MD---LRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT 240
Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
                +   A    L + + ++ LH      +IHRD++  +IL    G +K++DFG    
Sbjct: 241 HTRMNEEQIAA-VCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ 296
Query: 303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           ++ +  R      T   ++APE+     Y  +VD++S  +++ EM++G PP+
Sbjct: 297 VSKEVPRRKXLVGTPY-WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 347

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 83/179 (46%), Gaps = 15/179 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV E 
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 110
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 111 LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 165
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
           LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EMI+G
Sbjct: 166 LKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 222

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 83/179 (46%), Gaps = 15/179 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 109
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 110 LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 164
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
           LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EMI+G
Sbjct: 165 LKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 55/179 (30%), Positives = 83/179 (46%), Gaps = 15/179 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV E 
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 109
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 110 LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 164
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
           LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EMI+G
Sbjct: 165 LKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 221

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
           L+L+     P +V    A      +  + + +  GDL   L + G    +    +A +I 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
            G+ ++H      +++RDL+P+NIL D+ G+++++D G++   + K  +P     T   Y
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHG-Y 356
Query: 321 VAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
           +APEV  K   YD+  D FS   +L +++ G  PF
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 69/135 (51%), Gaps = 11/135 (8%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           ++I+ E +  G+L + ++ +G  A     A     DI   + +LH +    I HRD++P 
Sbjct: 82  LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPE 138
Query: 283 NIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           N+L   ++    LK+ DFG +K  T      L     +  YVAPEV   E+YD   D++S
Sbjct: 139 NLLYTSKEKDAVLKLTDFGFAKETT---QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWS 195
Query: 340 FALILQEMIEGCPPF 354
             +I+  ++ G PPF
Sbjct: 196 LGVIMYILLCGFPPF 210

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 42/135 (31%), Positives = 69/135 (51%), Gaps = 11/135 (8%)
Query: 225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           ++I+ E +  G+L + ++ +G  A     A     DI   + +LH +    I HRD++P 
Sbjct: 101 LLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPE 157
Query: 283 NIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
           N+L   ++    LK+ DFG +K  T      L     +  YVAPEV   E+YD   D++S
Sbjct: 158 NLLYTSKEKDAVLKLTDFGFAKETT---QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWS 214
Query: 340 FALILQEMIEGCPPF 354
             +I+  ++ G PPF
Sbjct: 215 LGVIMYILLCGFPPF 229

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
           L+L+     P +V    A      +  + + +  GDL   L + G    +    +A +I 
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 301
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
            G+ ++H      +++RDL+P+NIL D+ G+++++D G++   + K  +P     T   Y
Sbjct: 302 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTHG-Y 355
Query: 321 VAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
           +APEV  K   YD+  D FS   +L +++ G  PF
Sbjct: 356 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 390

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 59/213 (27%), Positives = 102/213 (47%), Gaps = 14/213 (6%)
Query: 200 ELALLQKIRHPNVVQFLGAVTQSSP--MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
           E+A+L+K+ HPNVV+ +  +   +   + +V E + +G +      K  L    A  +  
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPTLK-PLSEDQARFYFQ 144
Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
           D+ +G+ YLH  K   IIHRD++PSN+L  + G++K+ADFGVS       D  L+    +
Sbjct: 145 DLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GSDALLSNTVGT 200
Query: 318 CRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374
             ++APE             +DV++  + L   + G  PF    D  +   ++  +    
Sbjct: 201 PAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFM---DERIMCLHSKIKSQAL 257
Query: 375 KAPAKL-YARGLKELIEECWNEKPAKRPTFRQI 406
           + P +   A  LK+LI    ++ P  R    +I
Sbjct: 258 EFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
           L+L+     P +V    A      +  + + +  GDL   L + G    +    +A +I 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
            G+ ++H      +++RDL+P+NIL D+ G+++++D G++   + K  +P     T   Y
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTH-GY 356
Query: 321 VAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
           +APEV  K   YD+  D FS   +L +++ G  PF
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/155 (27%), Positives = 78/155 (50%), Gaps = 7/155 (4%)
Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
           L+L+     P +V    A      +  + + +  GDL   L + G    +    +A +I 
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEII 302
Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
            G+ ++H      +++RDL+P+NIL D+ G+++++D G++   + K  +P     T   Y
Sbjct: 303 LGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK--KPHASVGTH-GY 356
Query: 321 VAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPPF 354
           +APEV  K   YD+  D FS   +L +++ G  PF
Sbjct: 357 MAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPF 391

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 63/250 (25%), Positives = 111/250 (44%), Gaps = 40/250 (16%)
Query: 207 IRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
           ++H N++QF+ A  + S     + ++T +  KG L  +LK    +  +     A  ++RG
Sbjct: 66  MKHENLLQFIAAEKRGSNLEVELWLITAFHDKGSLTDYLK-GNIITWNELCHVAETMSRG 124
Query: 263 MNYLHENKPV--------PIIHRDLEPSNILRDDSGNLKVADFGVS-KLLTVKEDRPLTC 313
           ++YLHE+ P          I HRD +  N+L        +ADFG++ +    K       
Sbjct: 125 LSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHG 184
Query: 314 QDTSCRYVAPEVFK---NEEYDT--KVDVFSFALILQEMIEGCPP-------FTMKHDNE 361
           Q  + RY+APEV +   N + D   ++D+++  L+L E++  C         + +  + E
Sbjct: 185 QVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELVSRCKAADGPVDEYMLPFEEE 244
Query: 362 VPK----------AYAARQRPPFKAPAKLYARGLKEL---IEECWNEKPAKRPTFRQIIT 408
           + +              + RP  K    L   GL +L   IEECW+     R +   +  
Sbjct: 245 IGQHPSLEELQEVVVHKKMRPTIK-DHWLKHPGLAQLCVTIEECWDHDAEARLSAGCVEE 303
Query: 409 RLESINNSIN 418
           R+  I  S+N
Sbjct: 304 RVSLIRRSVN 313

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 115/252 (45%), Gaps = 19/252 (7%)
Query: 162 EITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           E+ KG F      +    G + A K +  + +S  D  +  R E  + + ++HPN+V+  
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER-EARICRLLKHPNIVRLH 69
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            ++++     +V + +  G+L   +  +     + A      I   +N+ H N    I+H
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG---IVH 126
Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
           RDL+P N+L   +     +K+ADFG++  +   +        T   Y++PEV + + Y  
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTP-GYLSPEVLRKDPYGK 185
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY---ARGLKELIE 390
            VD+++  +IL  ++ G PPF    D +  + Y   +   +  P+  +       K+LI 
Sbjct: 186 PVDMWACGVILYILLVGYPPFW---DEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 391 ECWNEKPAKRPT 402
           +     PAKR T
Sbjct: 243 KMLTINPAKRIT 254

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 115/252 (45%), Gaps = 19/252 (7%)
Query: 162 EITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           E+ KG F      +    G + A K +  + +S  D  +  R E  + + ++HPN+V+  
Sbjct: 11  ELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLER-EARICRLLKHPNIVRLH 69
Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            ++++     +V + +  G+L   +  +     + A      I   +N+ H N    I+H
Sbjct: 70  DSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCHLNG---IVH 126
Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
           RDL+P N+L   +     +K+ADFG++  +   +        T   Y++PEV + + Y  
Sbjct: 127 RDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTP-GYLSPEVLRKDPYGK 185
Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY---ARGLKELIE 390
            VD+++  +IL  ++ G PPF    D +  + Y   +   +  P+  +       K+LI 
Sbjct: 186 PVDMWACGVILYILLVGYPPFW---DEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLIN 242
Query: 391 ECWNEKPAKRPT 402
           +     PAKR T
Sbjct: 243 KMLTINPAKRIT 254

>pdb|2XZD|G Chain G, Caspase-3 In Complex With An Inhibitory Darpin-3.4 Length = 136

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Composition-based stats.
 Identities = 40/102 (39%), Positives = 60/102 (58%), Gaps = 5/102 (4%)
Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N +DD G  + P   L   A    +E ++ LL  G DVN  DI  RT LH+AA  G 
Sbjct: 38  ADVNAMDDAG--VTP---LHLAAKRGHLEIVEVLLKHGADVNASDIWGRTPLHLAATVGH 92
Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
            E+V +LLE GADV+ +D++G T    +I   N ++ ++L+K
Sbjct: 93  LEIVEVLLEYGADVNAQDKFGKTAFDISIDNGNEDLAEILQK 134

>pdb|2XEH|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 68/120 (56%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D + ++      L   A E  +E ++ LL +G DVN +D
Sbjct: 6   LLEAARAGQDDEVRILMANGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAKD 65
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            D  T LH+AA +G  E+V +LL+ GADV+ KD+ G TPL  A    + E++++L K GA
Sbjct: 66  KDGYTPLHLAAREGHLEIVEVLLKAGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGA 125

>pdb|2XEE|A Chain A, Structural Determinants For Improved Thermal Stability Of Designed Ankyrin Repeat Proteins With A Redesigned C- Capping Module. Length = 157

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 68/120 (56%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D + ++      L   A E  +E ++ LL +G DVN +D
Sbjct: 6   LLEAARAGQDDEVRILMANGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAKD 65
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            D  T LH+AA +G  E+V +LL+ GADV+ KD+ G TPL  A    + E++++L K GA
Sbjct: 66  KDGYTPLHLAAREGHLEIVEVLLKAGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGA 125

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 9/174 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYLPKGD 236
           VA+KKL     +     RA+R EL L++ + H N++  L   T Q +       YL    
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 237 LRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           + A L +  +  L           +  G+ +LH      IIHRDL+PSNI+      LK+
Sbjct: 111 MDANLXQVIQMELDHERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKI 167
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
            DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM+
Sbjct: 168 LDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/249 (26%), Positives = 108/249 (43%), Gaps = 39/249 (15%)
Query: 191 DDRVRAFRDELALLQKIRHPNVVQF-------------LGAVTQSSPMMIVTEYLPKGDL 237
           ++++     E+ LL  + H  VV++             + AV + S + I  EY     L
Sbjct: 43  EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTL 102
Query: 238 RAFLKRKGALKPSTAV-RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
              +  +   +      R    I   ++Y+H      IIHRDL+P NI  D+S N+K+ D
Sbjct: 103 YDLIHSENLNQQRDEYWRLFRQILEALSYIHSQ---GIIHRDLKPMNIFIDESRNVKIGD 159
Query: 297 FGVSK-----LLTVKEDRP--------LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFAL 342
           FG++K     L  +K D          LT    +  YVA EV      Y+ K+D++S  +
Sbjct: 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219
Query: 343 ILQEMIEGCPPFT--MKHDNEVPKAYAAR-QRPPFKAPAKLYARGLKELIEECWNEKPAK 399
           I  EMI    PF+  M+  N + K  +   + PP     K+     K++I    +  P K
Sbjct: 220 IFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVE--KKIIRLLIDHDPNK 274
Query: 400 RPTFRQIIT 408
           RP  R ++ 
Sbjct: 275 RPGARTLLN 283

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFT---PQKTLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 161 SDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 348 I 348
           +
Sbjct: 219 V 219

>pdb|2QYJ|A Chain A, Crystal Structure Of A Designed Full Consensus Ankyrin Length = 166

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 68/120 (56%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D + ++      L   A E  +E ++ LL +G DVN +D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGADVNAKD 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            D  T LH+AA +G  E+V +LL+ GADV+ KD+ G TPL  A    + E++++L K GA
Sbjct: 78  KDGYTPLHLAAREGHLEIVEVLLKAGADVNAKDKDGYTPLHLAAREGHLEIVEVLLKAGA 137

>pdb|3ZU7|B Chain B, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 169

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/120 (37%), Positives = 65/120 (54%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D +  + +    L   A     E ++ LL  G DVN RD
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNAHDDQGSTPLHLAAWIGHPEIVEVLLKHGADVNARD 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            D  T LH+AA  G  E+V +LL+ GADV+ +D +G TPL  A    + E++++L KHGA
Sbjct: 78  TDGWTPLHLAADNGHLEIVEVLLKYGADVNAQDAYGLTPLHLAADRGHLEIVEVLLKHGA 137

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 50/179 (27%), Positives = 86/179 (48%), Gaps = 17/179 (9%)
Query: 193 RVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA 252
           R R FR+   L Q   H NV++ +    +     +V E +  G + + + ++       A
Sbjct: 54  RSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEA 113
Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTVKED- 308
                D+A  +++LH      I HRDL+P NIL +       +K+ DFG+   + +  D 
Sbjct: 114 SVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDC 170
Query: 309 RPLTCQD-----TSCRYVAPEVFK--NEE---YDTKVDVFSFALILQEMIEGCPPFTMK 357
            P++  +      S  Y+APEV +  +EE   YD + D++S  +IL  ++ G PPF  +
Sbjct: 171 SPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGR 229

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKXVNHKNIISLLNVFT---PQKTLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YLVMELMDA-NLXQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 161 SDXTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 348 I 348
           +
Sbjct: 219 V 219

>pdb|3Q9U|C Chain C, In Silico And In Vitro Co-Evolution Of A High Affinity Complementary Protein-Protein Interface Length = 158

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 47/125 (37%), Positives = 68/125 (54%), Gaps = 10/125 (8%)
Query: 11  LLKQSSLAPDRERK-----EAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID 65
           LL+ ++   D E +      A++N  DD+G  + P   L   A    +E ++ LL +G D
Sbjct: 10  LLEAAAAGQDDEVRILMANGADVNATDDNG--LTP---LHLAAANGQLEIVEVLLKNGAD 64
Query: 66  VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
           VN  D    T LH+AA  G  E+V +LL+ GADV+  DR G TPL  A      E++++L
Sbjct: 65  VNASDSAGITPLHLAAYDGHLEIVEVLLKHGADVNAYDRAGWTPLHLAALSGQLEIVEVL 124
Query: 126 EKHGA 130
            KHGA
Sbjct: 125 LKHGA 129

>pdb|1SVX|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Maltose Binding Protein Length = 169

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 36/90 (40%), Positives = 54/90 (60%), Gaps = 6/90 (6%)
Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ L+ +G DVN  D    T LH+AA  G  E+V +LL+ GADVD  D +G TPL  A Y
Sbjct: 30  VRILMANGADVNAADNTGTTPLHLAAYSGHLEIVEVLLKHGADVDASDVFGYTPLHLAAY 89
Query: 116 YKNHEVIKLLEKHGA------KPLMAPMHV 139
           + + E++++L K+GA         M P+H+
Sbjct: 90  WGHLEIVEVLLKNGADVNAMDSDGMTPLHL 119

>pdb|2BKG|A Chain A, Crystal Structure Of E3_19 An Designed Ankyrin Repeat Protein Length = 166

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/120 (36%), Positives = 66/120 (55%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D + E+   +  L   A    +E ++ LL +G DVN  D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNAEDTYGDTPLHLAARVGHLEIVEVLLKNGADVNALD 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               T LH+AA +G  E+V +LL+ GADV+  D  GSTPL  A    + E++++L K+GA
Sbjct: 78  FSGSTPLHLAAKRGHLEIVEVLLKYGADVNADDTIGSTPLHLAADTGHLEIVEVLLKYGA 137

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 9/174 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYLPKGD 236
           VA+KKL     +     RA+R EL L++ + H N++  L   T Q +       YL    
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 103
Query: 237 LRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           + A L +  +  L           +  G+ +LH      IIHRDL+PSNI+      LK+
Sbjct: 104 MDANLXQVIQMELDHERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKI 160
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
            DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM+
Sbjct: 161 LDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 212

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 161 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 348 I 348
           +
Sbjct: 219 V 219

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 53/174 (30%), Positives = 80/174 (45%), Gaps = 9/174 (5%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT-QSSPMMIVTEYLPKGD 236
           VA+KKL     +     RA+R EL L++ + H N++  L   T Q +       YL    
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL 110
Query: 237 LRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           + A L +  +  L           +  G+ +LH      IIHRDL+PSNI+      LK+
Sbjct: 111 MDANLXQVIQMELDHERMSYLLYQMLXGIKHLHS---AGIIHRDLKPSNIVVKSDXTLKI 167
Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
            DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM+
Sbjct: 168 LDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMV 219

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 52  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 104
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 105 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 160
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 161 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218
Query: 348 I 348
           +
Sbjct: 219 V 219

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/179 (30%), Positives = 82/179 (45%), Gaps = 15/179 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV E 
Sbjct: 54  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 111
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 112 LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 166
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
           LK+ DFG+++  T      +     +  Y APEV     Y   VD++S   I+ EMI+G
Sbjct: 167 LKILDFGLAR--TAGTSFMMVPFVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKG 223

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 98
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 99  YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 154
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 155 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 212
Query: 348 I 348
           +
Sbjct: 213 V 213

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 105
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 106 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 161
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 162 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 348 I 348
           +
Sbjct: 220 V 220

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 53  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 105
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 106 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 161
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 162 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 219
Query: 348 I 348
           +
Sbjct: 220 V 220

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 51  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 103
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 104 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 159
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 160 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 217
Query: 348 I 348
           +
Sbjct: 218 V 218

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 45  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 97
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 98  YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 153
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 154 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 211
Query: 348 I 348
           +
Sbjct: 212 V 212

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 142
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 143 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 198
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 199 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
Query: 348 I 348
           +
Sbjct: 257 V 257

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 98
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 99  YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 154
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 155 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 212
Query: 348 I 348
           +
Sbjct: 213 V 213

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 54/181 (29%), Positives = 83/181 (45%), Gaps = 23/181 (12%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KKL     +     RA+R EL L++ + H N++  L   T   P   + E+    D+
Sbjct: 90  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFT---PQKTLEEF---QDV 142
Query: 238 RAFLKRKGALKPSTAVRFALDIAR----------GMNYLHENKPVPIIHRDLEPSNILRD 287
              ++   A      ++  LD  R          G+ +LH      IIHRDL+PSNI+  
Sbjct: 143 YLVMELMDA-NLCQVIQMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVK 198
Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
               LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM
Sbjct: 199 SDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 256
Query: 348 I 348
           +
Sbjct: 257 V 257

>pdb|4F6R|D Chain D, Tubulin:stathmin-Like Domain Complex Length = 169

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 32/75 (42%), Positives = 50/75 (66%)
Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ L+ +G DVN  D   +T LH+AA +G  E+V +LL+ GADV+  D+ G TPL  A  
Sbjct: 30  VRILMANGADVNAEDDSGKTPLHLAAIKGHLEIVEVLLKHGADVNAADKMGDTPLHLAAL 89
Query: 116 YKNHEVIKLLEKHGA 130
           Y + E++++L K+GA
Sbjct: 90  YGHLEIVEVLLKNGA 104

>pdb|2XZT|G Chain G, Caspase-3 In Complex With Darpin-3.4_i78s Length = 136

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 39/102 (38%), Positives = 59/102 (57%), Gaps = 5/102 (4%)
Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N +DD G  + P   L   A    +E ++ LL  G DVN  D   RT LH+AA  G 
Sbjct: 38  ADVNAMDDAG--VTP---LHLAAKRGHLEIVEVLLKHGADVNASDSWGRTPLHLAATVGH 92
Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
            E+V +LLE GADV+ +D++G T    +I   N ++ ++L+K
Sbjct: 93  LEIVEVLLEYGADVNAQDKFGKTAFDISIDNGNEDLAEILQK 134

>pdb|2V4H|C Chain C, Nemo Cc2-Lz Domain - 1d5 Darpin Complex Length = 136

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Composition-based stats.
 Identities = 40/117 (34%), Positives = 63/117 (53%)
Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+ +    D E +    NG D +  + K    L   A+   +E ++ LL  G DVN  D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNANDRKGNTPLHLAADYDHLEIVEVLLKHGADVNAHD 77
Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
            D  T LH+AA  G  E+V +LL+ GADV+ +D++G T    +I   N ++ ++L+K
Sbjct: 78  NDGSTPLHLAALFGHLEIVEVLLKHGADVNAQDKFGKTAFDISIDNGNEDLAEILQK 134

>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 76/287 (26%), Positives = 131/287 (45%), Gaps = 37/287 (12%)
Query: 148 YEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGE----EVI------SDDDRVRAF 197
           ++I   +L F  S  + +GTF   F +G++  V   G+    EV+      +  +   +F
Sbjct: 3   HKIRNEDLIFNES--LGQGTFTKIF-KGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF 59
Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFA 256
            +  +++ K+ H ++V   G        ++V E++  G L  +LK+ K  +     +  A
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119
Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNIL--RDD---SGN---LKVADFGVSKLLTVKED 308
             +A  M++L EN    +IH ++   NIL  R++   +GN   +K++D G+S  +TV   
Sbjct: 120 KQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGIS--ITV--- 171
Query: 309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGC-PPFTMKHDNEVPKAY 366
            P         +V PE  +N +  +   D +SF   L E+  G   P +        + Y
Sbjct: 172 LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFY 231
Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
             R + P  AP    A  L  LI  C + +P  RP+FR II  L S+
Sbjct: 232 EDRHQLP--APK---AAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 15/177 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV E 
Sbjct: 46  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 103
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 104 LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 158
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
           LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM+
Sbjct: 159 LKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV 213

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/177 (29%), Positives = 81/177 (45%), Gaps = 15/177 (8%)
Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEY 231
           VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV E 
Sbjct: 57  VAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVME- 114
Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           L   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+      
Sbjct: 115 LMDANLCQVIQME--LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCT 169
Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
           LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EM+
Sbjct: 170 LKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDLWSVGCIMGEMV 224
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	458
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	9e-94
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	2e-93
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	1e-89
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	4e-86
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-84
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	4e-84
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	8e-81
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	4e-80
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	5e-79
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	1e-77
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-73
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-73
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	3e-72
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-68
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	5e-66
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	6e-61
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	7e-60
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-59
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	1e-59
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-59
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	5e-59
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	1e-58
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	2e-58
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	1e-57
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	3e-57
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	5e-57
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	7e-57
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	1e-56
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	1e-56
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-56
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-56
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	3e-56
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	9e-56
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-55
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-55
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	5e-55
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	6e-55
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	7e-55
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	1e-54
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	4e-54
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	6e-54
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	7e-54
3pls_A	298	Macrophage-stimulating protein receptor; protein k	9e-54
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	1e-53
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	2e-53
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	2e-53
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	3e-53
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	3e-53
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	7e-53
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	2e-52
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	4e-52
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	5e-52
4aoj_A	329	High affinity nerve growth factor receptor; transf	6e-52
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	7e-52
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	9e-52
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	1e-51
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	1e-51
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	2e-51
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	3e-51
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	5e-51
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	5e-51
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-51
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	6e-51
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	1e-50
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	2e-50
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	4e-50
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	8e-50
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-49
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	3e-49
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-48
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	7e-48
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-48
2a19_B	284	Interferon-induced, double-stranded RNA-activated	4e-46
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-45
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	9e-45
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	2e-44
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	2e-44
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-44
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	5e-44
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	7e-44
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-43
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	2e-43
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	2e-43
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-43
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	1e-42
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	6e-42
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-41
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-41
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-39
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-39
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	6e-39
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	9e-39
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-38
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-38
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	6e-38
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	2e-37
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-37
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	1e-36
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-36
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-36
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-36
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-36
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	6e-36
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	6e-36
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	6e-36
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-36
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-36
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	2e-35
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	2e-34
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	2e-34
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-34
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-34
3fme_A	290	Dual specificity mitogen-activated protein kinase;	5e-34
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	5e-34
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	6e-34
2dyl_A	318	Dual specificity mitogen-activated protein kinase	8e-34
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-34
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-33
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-33
3an0_A	340	Dual specificity mitogen-activated protein kinase;	1e-33
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-33
3ork_A	311	Serine/threonine protein kinase; structural genomi	3e-33
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	7e-33
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	9e-33
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	2e-32
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-31
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	1e-31
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-31
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	2e-31
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	2e-31
3aln_A	327	Dual specificity mitogen-activated protein kinase;	3e-31
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	3e-31
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	3e-31
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	4e-31
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	4e-31
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	6e-31
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	7e-31
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	7e-31
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-30
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	1e-30
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	2e-30
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-30
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	3e-30
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	3e-30
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-30
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	4e-30
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	5e-30
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-30
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-30
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	7e-30
3bhy_A	283	Death-associated protein kinase 3; death associate	8e-30
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	9e-30
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-29
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	1e-29
3o0g_A	292	Cell division protein kinase 5; kinase activator c	2e-29
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	2e-29
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	2e-29
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	3e-29
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	3e-29
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	7e-29
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	7e-29
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-28
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	1e-28
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-28
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	2e-28
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-28
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	3e-28
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-28
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	4e-28
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-28
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	1e-27
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	1e-27
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-27
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	2e-27
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	3e-27
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-27
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	4e-27
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	5e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	5e-27
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	6e-27
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	7e-27
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-26
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-26
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-26
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	3e-26
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-26
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	6e-26
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	8e-26
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	9e-26
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	1e-25
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	2e-25
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	2e-25
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-25
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	2e-25
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	4e-25
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	4e-25
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	8e-25
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-24
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	3e-24
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	5e-23
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	1e-22
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	1e-16
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	2e-13
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-24
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	4e-24
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	7e-24
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	2e-20
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	1e-07
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	6e-04
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	5e-24
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	9e-18
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	1e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-24
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	5e-24
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	5e-24
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	6e-24
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	7e-24
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	8e-21
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	9e-20
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	4e-19
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	5e-19
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	7e-19
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	6e-17
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	7e-24
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	9e-24
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	2e-20
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	5e-20
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	4e-19
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	7e-18
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	1e-17
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	3e-09
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	3e-08
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	1e-23
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-23
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-23
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	2e-23
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	3e-23
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	7e-22
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	3e-21
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	2e-18
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	9e-16
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	1e-15
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	5e-13
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	3e-23
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	1e-22
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	1e-21
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	8e-21
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	1e-20
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	7e-19
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	1e-17
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	9e-14
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	1e-10
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	2e-05
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	4e-23
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	3e-18
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	1e-16
3v30_A	172	DNA-binding protein rfxank; structural genomics co	4e-23
3v30_A	172	DNA-binding protein rfxank; structural genomics co	4e-22
3v30_A	172	DNA-binding protein rfxank; structural genomics co	1e-21
3v30_A	172	DNA-binding protein rfxank; structural genomics co	8e-17
3v30_A	172	DNA-binding protein rfxank; structural genomics co	4e-14
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	6e-23
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	2e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	2e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	2e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	3e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	5e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	5e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	9e-22
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	1e-21
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	6e-21
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	2e-19
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	3e-05
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	7e-23
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	2e-21
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	1e-19
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	2e-19
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	9e-19
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	2e-07
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	7e-23
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	8e-21
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	4e-20
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	2e-16
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	4e-13
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	6e-12
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	2e-07
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	8e-23
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	1e-22
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	3e-17
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	1e-09
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	1e-22
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	7e-18
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	2e-08
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	3e-06
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	6e-05
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	1e-22
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	2e-21
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	1e-19
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	2e-19
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	3e-18
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	1e-14
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	4e-09
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	2e-22
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	2e-22
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	6e-16
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	8e-12
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	5e-08
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	2e-22
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	1e-20
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	2e-20
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	7e-15
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	2e-22
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	2e-21
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	8e-14
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	2e-22
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	4e-22
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	2e-20
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	2e-18
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	2e-15
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	2e-22
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	8e-22
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	2e-20
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	2e-11
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	3e-22
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	1e-20
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	1e-20
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	2e-20
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	2e-20
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	1e-08
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	3e-22
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	1e-20
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	1e-20
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	7e-15
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	3e-22
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	3e-21
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	2e-15
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	4e-10
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	2e-07
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	2e-05
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	3e-22
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	1e-21
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	4e-20
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	2e-12
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	4e-22
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	4e-22
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	6e-20
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	1e-19
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	4e-14
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	1e-06
3hra_A	201	Ankyrin repeat family protein; structural protein;	4e-22
3hra_A	201	Ankyrin repeat family protein; structural protein;	2e-18
3hra_A	201	Ankyrin repeat family protein; structural protein;	4e-17
3hra_A	201	Ankyrin repeat family protein; structural protein;	1e-16
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	5e-22
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	9e-22
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	3e-21
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	5e-16
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	5e-22
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	2e-21
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	7e-12
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	6e-11
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-22
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	8e-22
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	3e-20
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	2e-15
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	8e-22
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	7e-21
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	1e-19
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	1e-19
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	4e-19
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	4e-17
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	7e-10
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	9e-22
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	1e-21
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	7e-17
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	2e-09
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	1e-21
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	6e-21
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	5e-20
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	5e-19
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	5e-19
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	1e-21
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	1e-20
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	6e-20
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	7e-18
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	2e-16
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	8e-11
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-21
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	2e-21
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	4e-20
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	6e-17
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	8e-14
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	2e-21
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	5e-19
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	2e-18
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	3e-13
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	3e-12
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	3e-21
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-21
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	3e-21
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	7e-18
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	1e-14
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	5e-14
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	9e-08
2rfa_A	232	Transient receptor potential cation channel subfa	4e-21
2rfa_A	232	Transient receptor potential cation channel subfa	4e-17
2rfa_A	232	Transient receptor potential cation channel subfa	2e-16
2rfa_A	232	Transient receptor potential cation channel subfa	6e-16
2rfa_A	232	Transient receptor potential cation channel subfa	5e-13
2rfa_A	232	Transient receptor potential cation channel subfa	8e-09
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	4e-21
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	4e-21
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	7e-21
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	3e-20
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	6e-08
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	5e-21
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-20
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	1e-20
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	1e-20
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	4e-20
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	2e-18
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	1e-12
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	4e-12
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	2e-20
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	2e-20
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	4e-20
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	1e-19
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	1e-18
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	2e-17
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	2e-16
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	4e-14
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	7e-09
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	5e-04
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	3e-20
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	2e-19
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	2e-19
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	2e-18
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	5e-15
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	3e-14
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	3e-20
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	5e-19
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	8e-10
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	5e-20
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	3e-15
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	2e-14
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	3e-14
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	3e-07
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	1e-19
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	2e-18
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	1e-17
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	7e-16
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	2e-15
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	7e-15
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	2e-12
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	1e-10
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	7e-06
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	1e-18
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-17
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	3e-16
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	8e-16
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	6e-13
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	4e-08
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	5e-08
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-15
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	4e-15
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	3e-13
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	2e-09
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	1e-07
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	4e-06
2pnn_A	273	Transient receptor potential cation channel subfa	8e-15
2pnn_A	273	Transient receptor potential cation channel subfa	1e-09
2pnn_A	273	Transient receptor potential cation channel subfa	5e-09
2pnn_A	273	Transient receptor potential cation channel subfa	3e-07
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	2e-14
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	1e-10
2etb_A	256	Transient receptor potential cation channel subfam	2e-14
2etb_A	256	Transient receptor potential cation channel subfam	3e-13
2etb_A	256	Transient receptor potential cation channel subfam	1e-12
2etb_A	256	Transient receptor potential cation channel subfam	3e-10
2etb_A	256	Transient receptor potential cation channel subfam	4e-08
2etb_A	256	Transient receptor potential cation channel subfam	6e-05
3jxi_A	260	Vanilloid receptor-related osmotically activated p	6e-14
3jxi_A	260	Vanilloid receptor-related osmotically activated p	1e-11
3jxi_A	260	Vanilloid receptor-related osmotically activated p	3e-11
3jxi_A	260	Vanilloid receptor-related osmotically activated p	1e-09
3jxi_A	260	Vanilloid receptor-related osmotically activated p	4e-06
3jxi_A	260	Vanilloid receptor-related osmotically activated p	2e-05
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	6e-13
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	3e-10
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	7e-13
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	9e-12
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-11
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-11
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	4e-11
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	6e-10
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	7e-10
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	2e-09
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	5e-07
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	7e-05
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	6e-05
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	8e-05
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	9e-05
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	1e-04
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-04
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	3e-04
3agd_A	456	Salt-tolerant glutaminase; glutaminase super famil	6e-04
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	7e-04
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-04

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  284 bits (730), Expect = 9e-94
 Identities = 81/280 (28%), Positives = 132/280 (47%), Gaps = 25/280 (8%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
            + ID  E++      + +G F     A WR   VA+K++       +   +AF  EL  
Sbjct: 2   LHMIDYKEIEVEE--VVGRGAFGVVCKAKWRAKDVAIKQI-----ESESERKAFIVELRQ 54

Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL---KRKGALKPSTAVRFALDIA 260
           L ++ HPN+V+  GA     P+ +V EY   G L   L   +       + A+ + L  +
Sbjct: 55  LSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCS 112

Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           +G+ YLH  +P  +IHRDL+P N+L    G  LK+ DFG +  +       +T    S  
Sbjct: 113 QGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH----MTNNKGSAA 168

Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKAP 377
           ++APEVF+   Y  K DVFS+ +IL E+I    PF           +A     RPP    
Sbjct: 169 WMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPL--- 225

Query: 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
            K   + ++ L+  CW++ P++RP+  +I+  +  +    
Sbjct: 226 IKNLPKPIESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYF 265

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  284 bits (728), Expect = 2e-93
 Identities = 99/296 (33%), Positives = 153/296 (51%), Gaps = 19/296 (6%)

Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEE 186
             P    ++ + A +  + +I   +L+     +I  G+F     A W G  VAVK L E+
Sbjct: 14  DIPTTENLYFQGAMDGDDMDIPWCDLNIKE--KIGAGSFGTVHRAEWHGSDVAVKILMEQ 71

Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA 246
               + RV  F  E+A+++++RHPN+V F+GAVTQ   + IVTEYL +G L   L + GA
Sbjct: 72  DFHAE-RVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGA 130

Query: 247 ---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
              L     +  A D+A+GMNYLH   P PI+HR+L+  N+L D    +KV DFG+S+L 
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLK 189

Query: 304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
                        +  ++APEV ++E  + K DV+SF +IL E+     P+   +  +V 
Sbjct: 190 A-STFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV 248

Query: 364 KAYAAR-QRP--PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
            A   + +R   P     +     +  +IE CW  +P KRP+F  I+  L  +  S
Sbjct: 249 AAVGFKCKRLEIPRNLNPQ-----VAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  272 bits (699), Expect = 1e-89
 Identities = 87/280 (31%), Positives = 126/280 (45%), Gaps = 26/280 (9%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISD-DDRVRAFRDELALL 204
           EID  EL       I  G F     AFW G +VAVK    +   D    +   R E  L 
Sbjct: 3   EIDFAELTLEE--IIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLF 60

Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMN 264
             ++HPN++   G   +   + +V E+   G L   L  K  + P   V +A+ IARGMN
Sbjct: 61  AMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK-RIPPDILVNWAVQIARGMN 119

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSG--------NLKVADFGVSKLLTVKEDRPLTCQDT 316
           YLH+   VPIIHRDL+ SNIL              LK+ DFG+++               
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR---EWHRTTKMSAAG 176

Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP--P 373
           +  ++APEV +   +    DV+S+ ++L E++ G  PF       V    A  +     P
Sbjct: 177 AYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIP 236

Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
              P         +L+E+CWN  P  RP+F  I+ +L +I
Sbjct: 237 STCPEPFA-----KLMEDCWNPDPHSRPSFTNILDQLTTI 271

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  264 bits (677), Expect = 4e-86
 Identities = 81/287 (28%), Positives = 130/287 (45%), Gaps = 32/287 (11%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFW--RGIQVAVKKLGEEVISDD----DRVRAF 197
              +  +E+++    +I KG F              VA+K L       +    ++ + F
Sbjct: 13  LPTLADNEIEYEK--QIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEF 70

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFA 256
           + E+ ++  + HPN+V+  G +    P  +V E++P GDL   L  +   +K S  +R  
Sbjct: 71  QREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLM 128

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-----NLKVADFGVSKLLTVKEDRPL 311
           LDIA G+ Y+    P PI+HRDL   NI             KVADFG+S+         +
Sbjct: 129 LDIALGIEYMQNQNP-PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ----SVHSV 183

Query: 312 TCQDTSCRYVAPEVF--KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
           +    + +++APE    + E Y  K D +SFA+IL  ++ G  PF      ++      R
Sbjct: 184 SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIR 243

Query: 370 Q---RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           +   RP    P     R L+ +IE CW+  P KRP F  I+  L  +
Sbjct: 244 EEGLRPTI--PEDCPPR-LRNVIELCWSGDPKKRPHFSYIVKELSEL 287

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  260 bits (667), Expect = 3e-84
 Identities = 68/284 (23%), Positives = 127/284 (44%), Gaps = 27/284 (9%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
           E++I   +L+      I KG F       W G +VA++ +  E   ++D+++AF+ E+  
Sbjct: 27  EWDIPFEQLEIGE--LIGKGRFGQVYHGRWHG-EVAIRLIDIERD-NEDQLKAFKREVMA 82

Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
            ++ RH NVV F+GA      + I+T       L + +   K  L  +   + A +I +G
Sbjct: 83  YRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKG 142

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV----KEDRPLTCQDTSC 318
           M YLH      I+H+DL+  N+  D+ G + + DFG+  +  V    + +  L  Q+   
Sbjct: 143 MGYLHAK---GILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRREDKLRIQNGWL 198

Query: 319 RYVAPEVFKNEE---------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
            ++APE+ +            +    DVF+   I  E+     PF  +    +       
Sbjct: 199 CHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTG 258

Query: 370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
            +P          + + +++  CW  +  +RPTF +++  LE +
Sbjct: 259 MKPNL--SQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKL 300

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  258 bits (662), Expect = 4e-84
 Identities = 76/280 (27%), Positives = 125/280 (44%), Gaps = 24/280 (8%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
              ID  +L+F    ++ +          W+G  + VK L     S   + R F +E   
Sbjct: 4   HSGIDFKQLNFLT--KLNENHSGELWKGRWQGNDIVVKVLKVRDWSTR-KSRDFNEECPR 60

Query: 204 LQKIRHPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFL--KRKGALKPSTAVRFALDI 259
           L+   HPNV+  LGA     +    ++T ++P G L   L       +  S AV+FALD+
Sbjct: 61  LRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDM 120

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           ARGM +LH  +P  I    L   +++ D+    +++   V                 +  
Sbjct: 121 ARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQSPGRM------YAPA 173

Query: 320 YVAPEVFKNEEYDT---KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFK 375
           +VAPE  + +  DT     D++SFA++L E++    PF    + E+    A    RP   
Sbjct: 174 WVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPTI- 232

Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
            P  + +  + +L++ C NE PAKRP F  I+  LE + +
Sbjct: 233 -PPGI-SPHVSKLMKICMNEDPAKRPKFDMIVPILEKMQD 270

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  251 bits (644), Expect = 8e-81
 Identities = 85/299 (28%), Positives = 135/299 (45%), Gaps = 40/299 (13%)

Query: 145 VPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRD 199
           +P     P +L       + KG F   I    R  G  + +K+L      D++  R F  
Sbjct: 2   MPHRIFRPSDLIHGE--VLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLK 56

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALD 258
           E+ +++ + HPNV++F+G + +   +  +TEY+  G LR  +K        S  V FA D
Sbjct: 57  EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-- 316
           IA GM YLH      IIHRDL   N L  ++ N+ VADFG+++L+  ++ +P   +    
Sbjct: 117 IASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173

Query: 317 -----------SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI------EGCPPFTMKHD 359
                      +  ++APE+     YD KVDVFSF ++L E+I          P TM   
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233

Query: 360 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418
             V       +  P   P   +      +   C +  P KRP+F ++   LE++   + 
Sbjct: 234 LNVRGFL--DRYCPPNCPPSFF-----PITVRCCDLDPEKRPSFVKLEHWLETLRMHLA 285

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  249 bits (637), Expect = 4e-80
 Identities = 73/277 (26%), Positives = 137/277 (49%), Gaps = 18/277 (6%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
           ++EI   ++       I  G+F       W G  VAVK L         +++AF++E+ +
Sbjct: 18  DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHG-DVAVKMLNVTAP-TPQQLQAFKNEVGV 73

Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
           L+K RH N++ F+G  T    + IVT++     L   L   +   +    +  A   ARG
Sbjct: 74  LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARG 132

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYV 321
           M+YLH      IIHRDL+ +NI   +   +K+ DFG++   +         Q + S  ++
Sbjct: 133 MDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWM 189

Query: 322 APEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFT-MKHDNEVPKAYAARQRPPFKAP 377
           APEV + ++   Y  + DV++F ++L E++ G  P++ + + +++ +        P  + 
Sbjct: 190 APEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSK 249

Query: 378 AKLYA-RGLKELIEECWNEKPAKRPTFRQIITRLESI 413
            +    + +K L+ EC  +K  +RP+F +I+  +E +
Sbjct: 250 VRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEEL 286

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  244 bits (625), Expect = 1e-77
 Identities = 70/313 (22%), Positives = 125/313 (39%), Gaps = 46/313 (14%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
                  ++      +I KG +    +  WRG +VAVK       + ++       E+  
Sbjct: 31  VQRTIAKQIQMVK--QIGKGRYGEVWMGKWRGEKVAVKVF----FTTEEASWFRETEIYQ 84

Query: 204 LQKIRHPNVVQFLGAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
              +RH N++ F+ A  + +     + ++T+Y   G L  +LK    L   + ++ A   
Sbjct: 85  TVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKLAYSS 143

Query: 260 ARGMNYLHENKPV-----PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
             G+ +LH           I HRDL+  NIL   +G   +AD G++       +      
Sbjct: 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPP 203

Query: 315 DTSC---RYVAPEV------FKNEEYDTKVDVFSFALILQEMIEGC------PPFTMKHD 359
           +T     RY+ PEV        + +     D++SF LIL E+   C        + + + 
Sbjct: 204 NTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYH 263

Query: 360 NEVPKAYAA----------RQRP--PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           + VP   +           + RP  P +  +    R + +L+ ECW   PA R T  ++ 
Sbjct: 264 DLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVK 323

Query: 408 TRLESINNSINHK 420
             L  ++ S + K
Sbjct: 324 KTLAKMSESQDIK 336

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  232 bits (593), Expect = 2e-73
 Identities = 70/291 (24%), Positives = 116/291 (39%), Gaps = 44/291 (15%)

Query: 163 ITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV 219
           + KG +       W+G  VAVK           R      EL     +RH N++ F+ + 
Sbjct: 16  VGKGRYGEVWRGSWQGENVAVKIFSSRDEKSWFRET----ELYNTVMLRHENILGFIASD 71

Query: 220 TQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV--- 272
             S      + ++T Y   G L  +L+    L   + +R  L IA G+ +LH        
Sbjct: 72  MTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRIVLSIASGLAHLHIEIFGTQG 130

Query: 273 --PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK 327
              I HRDL+  NIL   +G   +AD G++ + +   ++     +      RY+APEV  
Sbjct: 131 KPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLD 190

Query: 328 NE------EYDTKVDVFSFALILQEMIEGCPPFTMKHD------NEVPKAYAA------- 368
                   +   +VD+++F L+L E+        +  D      + VP   +        
Sbjct: 191 ETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVV 250

Query: 369 ---RQRPPFKAPAKLYA--RGLKELIEECWNEKPAKRPTFRQIITRLESIN 414
              +QRP              L +L++ECW + P+ R T  +I   L  I+
Sbjct: 251 CVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKID 301

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  230 bits (589), Expect = 3e-72
 Identities = 68/313 (21%), Positives = 115/313 (36%), Gaps = 46/313 (14%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
                   +       I KG F       WRG +VAVK           R      E+  
Sbjct: 36  VQRTIARTIVLQE--SIGKGRFGEVWRGKWRGEEVAVKIFSSREERSWFREA----EIYQ 89

Query: 204 LQKIRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
              +RH N++ F+ A  + +     + +V++Y   G L  +L R   +     ++ AL  
Sbjct: 90  TVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALST 148

Query: 260 ARGMNYLHENKPV-----PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQ 314
           A G+ +LH           I HRDL+  NIL   +G   +AD G++       D      
Sbjct: 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAP 208

Query: 315 DTSC---RYVAPEVFKNE------EYDTKVDVFSFALILQEMIEGC------PPFTMKHD 359
           +      RY+APEV  +       E   + D+++  L+  E+   C        + + + 
Sbjct: 209 NHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYY 268

Query: 360 NEVPKAYAA----------RQRPPFKAPAKL--YARGLKELIEECWNEKPAKRPTFRQII 407
           + VP   +           + RP      +     R + +++ ECW    A R T  +I 
Sbjct: 269 DLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIK 328

Query: 408 TRLESINNSINHK 420
             L  ++     K
Sbjct: 329 KTLSQLSQQEGIK 341

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  219 bits (561), Expect = 2e-68
 Identities = 68/312 (21%), Positives = 116/312 (37%), Gaps = 46/312 (14%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
                    L         +G F     A      VAVK    +    D +      E+ 
Sbjct: 17  ENLYFQSMPLQLLE--VKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVY 70

Query: 203 LLQKIRHPNVVQFLGAVTQSS----PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
            L  ++H N++QF+GA  + +     + ++T +  KG L  FLK    +  +     A  
Sbjct: 71  SLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAET 129

Query: 259 IARGMNYLHENKPV-------PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL 311
           +ARG+ YLHE+ P         I HRD++  N+L  ++    +ADFG++      +    
Sbjct: 130 MARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGD 189

Query: 312 TCQDT-SCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365
           T     + RY+APEV         +   ++D+++  L+L E+   C       D  +   
Sbjct: 190 THGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPF 249

Query: 366 YAA-----------------RQRPPFKA--PAKLYARGLKELIEECWNEKPAKRPTFRQI 406
                               ++RP  +           L E IEECW+     R +   +
Sbjct: 250 EEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCV 309

Query: 407 ITRLESINNSIN 418
             R+  +    N
Sbjct: 310 GERITQMQRLTN 321

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  214 bits (546), Expect = 5e-66
 Identities = 79/328 (24%), Positives = 119/328 (36%), Gaps = 61/328 (18%)

Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDE 200
              E  +D   L       I +G +            VAVK       S  +R + F +E
Sbjct: 4   AASEPSLDLDNLKLLEL--IGRGRYGAVYKGSLDERPVAVKVF-----SFANR-QNFINE 55

Query: 201 LA--LLQKIRHPNVVQFLGA-----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAV 253
                +  + H N+ +F+              ++V EY P G L  +L         ++ 
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114

Query: 254 RFALDIARGMNYLHENKPV------PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE 307
           R A  + RG+ YLH   P        I HRDL   N+L  + G   ++DFG+S  LT   
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNR 174

Query: 308 DRPLTCQDTSC-------RYVAPEVFKN-------EEYDTKVDVFSFALILQEMIEGC-- 351
                 +D +        RY+APEV +        E    +VD+++  LI  E+   C  
Sbjct: 175 LVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTD 234

Query: 352 -------PPFTMKHDNEVPKAYAA----------RQRPPFK---APAKLYARGLKELIEE 391
                  P + M    EV                +QRP F        L  R LKE IE+
Sbjct: 235 LFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIED 294

Query: 392 CWNEKPAKRPTFRQIITRLESINNSINH 419
           CW++    R T +    R+  +      
Sbjct: 295 CWDQDAEARLTAQXAEERMAELMMIWER 322

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  205 bits (523), Expect = 6e-61
 Identities = 77/309 (24%), Positives = 143/309 (46%), Gaps = 24/309 (7%)

Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
           +    + +     + A     P     +    ++E++  ++   +  ++  G +      
Sbjct: 182 HSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWEMERTDITMKH--KLGGGQYGEVYEG 239

Query: 172 FWRG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
            W+   + VAVK L E+ +  ++    F  E A++++I+HPN+VQ LG  T+  P  I+T
Sbjct: 240 VWKKYSLTVAVKTLKEDTMEVEE----FLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 295

Query: 230 EYLPKGDLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
           E++  G+L  +L+   +  +     +  A  I+  M YL +      IHR+L   N L  
Sbjct: 296 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVG 352

Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEM 347
           ++  +KVADFG+S+L+T              ++ APE     ++  K DV++F ++L E+
Sbjct: 353 ENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 412

Query: 348 I-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
              G  P+     ++V +      R   P   P K+Y     EL+  CW   P+ RP+F 
Sbjct: 413 ATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVY-----ELMRACWQWNPSDRPSFA 467

Query: 405 QIITRLESI 413
           +I    E++
Sbjct: 468 EIHQAFETM 476

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  199 bits (508), Expect = 7e-60
 Identities = 84/302 (27%), Positives = 129/302 (42%), Gaps = 30/302 (9%)

Query: 127 KHGAKPLMAPMHVKHAREVP--EYEIDPHELDFTNSVEITKGTF---ILAFWRG--IQVA 179
               +PL     V   R VP  ++ ++  +L      +I +G F        R     VA
Sbjct: 86  LSTQQPLTKKSGVVLHRAVPKDKWVLNHEDLVLGE--QIGRGNFGEVFSGRLRADNTLVA 143

Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
           VK   E +  D      F  E  +L++  HPN+V+ +G  TQ  P+ IV E +  GD   
Sbjct: 144 VKSCRETLPPDL--KAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLT 201

Query: 240 FLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           FL+     L+  T ++   D A GM YL        IHRDL   N L  +   LK++DFG
Sbjct: 202 FLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFG 258

Query: 299 VSKLLTVKEDRPLTCQDTSC----RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPP 353
           +S+      D              ++ APE      Y ++ DV+SF ++L E    G  P
Sbjct: 259 MSREE---ADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASP 315

Query: 354 FTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
           +    + +  +      R   P   P  ++      L+E+CW  +P +RP+F  I   L+
Sbjct: 316 YPNLSNQQTREFVEKGGRLPCPELCPDAVF-----RLMEQCWAYEPGQRPSFSTIYQELQ 370

Query: 412 SI 413
           SI
Sbjct: 371 SI 372

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score =  195 bits (498), Expect = 1e-59
 Identities = 85/278 (30%), Positives = 145/278 (52%), Gaps = 28/278 (10%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
           ++ IDP EL F    EI  G F    L +W    +VA+K + E  +S++D    F +E  
Sbjct: 2   KWVIDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAE 55

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 261
           ++ K+ HP +VQ  G   + +P+ +VTE++  G L  +L+ ++G     T +   LD+  
Sbjct: 56  VMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCE 115

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---C 318
           GM YL E     +IHRDL   N L  ++  +KV+DFG+++ +    D   T    +    
Sbjct: 116 GMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFV---LDDQYTSSTGTKFPV 169

Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFK 375
           ++ +PEVF    Y +K DV+SF +++ E+  EG  P+  + ++EV +  +   R   P  
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKPRL 229

Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           A   +Y     +++  CW E+P  RP F +++ +L  I
Sbjct: 230 ASTHVY-----QIMNHCWRERPEDRPAFSRLLRQLAEI 262

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score =  195 bits (499), Expect = 1e-59
 Identities = 76/278 (27%), Positives = 136/278 (48%), Gaps = 24/278 (8%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG--IQVAVKKLGEEVISDDDRVRAFRDE 200
            ++E++  ++   +  ++  G +       W+   + VAVK L E+ +  ++    F  E
Sbjct: 6   DKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE----FLKE 59

Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALD 258
            A++++I+HPN+VQ LG  T+  P  I+TE++  G+L  +L+   +  +     +  A  
Sbjct: 60  AAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQ 119

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
           I+  M YL +      IHRDL   N L  ++  +KVADFG+S+L+T              
Sbjct: 120 ISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPI 176

Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFK 375
           ++ APE     ++  K DV++F ++L E+   G  P+     ++V +      R   P  
Sbjct: 177 KWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEG 236

Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
            P K+Y     EL+  CW   P+ RP+F +I    E++
Sbjct: 237 CPEKVY-----ELMRACWQWNPSDRPSFAEIHQAFETM 269

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score =  195 bits (497), Expect = 2e-59
 Identities = 82/286 (28%), Positives = 138/286 (48%), Gaps = 34/286 (11%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
             + ++  EL       I KG F   +L  +RG +VAVK +  +  +       F  E +
Sbjct: 14  SGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQA-----FLAEAS 66

Query: 203 LLQKIRHPNVVQFLGAVTQSSP-MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDI 259
           ++ ++RH N+VQ LG + +    + IVTEY+ KG L  +L+   +  L     ++F+LD+
Sbjct: 67  VMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDV 126

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR---PLTCQDT 316
              M YL  N     +HRDL   N+L  +    KV+DFG++K  +  +D    P+     
Sbjct: 127 CEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV----- 178

Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PP 373
             ++ APE  + +++ TK DV+SF ++L E+   G  P+      +V        +   P
Sbjct: 179 --KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAP 236

Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419
              P  +Y     E+++ CW+   A RP+F Q+  +LE I     H
Sbjct: 237 DGCPPAVY-----EVMKNCWHLDAAMRPSFLQLREQLEHIKTHELH 277

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score =  195 bits (498), Expect = 5e-59
 Identities = 83/321 (25%), Positives = 141/321 (43%), Gaps = 31/321 (9%)

Query: 114 IYYKNH--EVIKLLEKHGAKPLMAPMHVKHAREVPEY-------EIDPHELDFTNSV--- 161
           +++ +H     + L   G  P        H  E P         EI+   +     +   
Sbjct: 1   MHHHHHHSSGRENLYFQGKLPEPQFYAEPHTYEEPGRAGRSFTREIEASRIHIEKIIGSG 60

Query: 162 ---EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
              E+  G   +   R + VA+K L       + + R F  E +++ +  HPN+++  G 
Sbjct: 61  DSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMGQFDHPNIIRLEGV 118

Query: 219 VTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
           VT+    MIVTEY+  G L  FL+   G       V     +  GM YL +      +HR
Sbjct: 119 VTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHR 175

Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--RYVAPEVFKNEEYDTKV 335
           DL   N+L D +   KV+DFG+S++L    D   T        R+ APE      + +  
Sbjct: 176 DLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSAS 235

Query: 336 DVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEEC 392
           DV+SF +++ E++  G  P+    + +V  +     R   P   P  L+     +L+ +C
Sbjct: 236 DVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPAPMGCPHALH-----QLMLDC 290

Query: 393 WNEKPAKRPTFRQIITRLESI 413
           W++  A+RP F QI++ L+++
Sbjct: 291 WHKDRAQRPRFSQIVSVLDAL 311

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score =  193 bits (492), Expect = 1e-58
 Identities = 83/276 (30%), Positives = 140/276 (50%), Gaps = 28/276 (10%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALL 204
           E+   E+      E+  G F    L  W+G   VAVK + E  +S+D+    F  E   +
Sbjct: 4   ELKREEITLLK--ELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE----FFQEAQTM 57

Query: 205 QKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGM 263
            K+ HP +V+F G  ++  P+ IVTEY+  G L  +L+     L+PS  +    D+  GM
Sbjct: 58  MKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGM 117

Query: 264 NYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---CRY 320
            +L  ++    IHRDL   N L D    +KV+DFG+++ +    D        +    ++
Sbjct: 118 AFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYV---LDDQYVSSVGTKFPVKW 171

Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAP 377
            APEVF   +Y +K DV++F +++ E+   G  P+ +  ++EV    +   R   P  A 
Sbjct: 172 SAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRPHLAS 231

Query: 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
             +Y     +++  CW+E P KRPTF+Q+++ +E +
Sbjct: 232 DTIY-----QIMYSCWHELPEKRPTFQQLLSSIEPL 262

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score =  192 bits (491), Expect = 2e-58
 Identities = 79/278 (28%), Positives = 136/278 (48%), Gaps = 28/278 (10%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
            +EIDP +L F    E+  G F       WRG   VA+K + E  +S+D+    F +E  
Sbjct: 18  SWEIDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAK 71

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIAR 261
           ++  + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+  
Sbjct: 72  VMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCE 131

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS---C 318
            M YL   +    +HRDL   N L +D G +KV+DFG+S+ +    D   T    S    
Sbjct: 132 AMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYV---LDDEYTSSVGSKFPV 185

Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFK 375
           R+  PEV    ++ +K D+++F +++ E+   G  P+    ++E  +  A   R   P  
Sbjct: 186 RWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRPHL 245

Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           A  K+Y      ++  CW+EK  +RPTF+ +++ +  +
Sbjct: 246 ASEKVY-----TIMYSCWHEKADERPTFKILLSNILDV 278

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score =  195 bits (498), Expect = 1e-57
 Identities = 87/302 (28%), Positives = 145/302 (48%), Gaps = 34/302 (11%)

Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEE 186
            K +   +  +       + ++  EL       I KG F   +L  +RG +VAVK     
Sbjct: 170 PKVMEGTVAAQDEFYRSGWALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVK----- 222

Query: 187 VISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-MMIVTEYLPKGDLRAFLKRKG 245
            I +D   +AF  E +++ ++RH N+VQ LG + +    + IVTEY+ KG L  +L+ +G
Sbjct: 223 CIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRG 282

Query: 246 --ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
              L     ++F+LD+   M YL  N     +HRDL   N+L  +    KV+DFG++K  
Sbjct: 283 RSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEA 339

Query: 304 TVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHD 359
           +  +D    P+       ++ APE  + +++ TK DV+SF ++L E+   G  P+     
Sbjct: 340 SSTQDTGKLPV-------KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392

Query: 360 NEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
            +V        +   P   P  +Y     ++++ CW+   A RPTF Q+  +LE I    
Sbjct: 393 KDVVPRVEKGYKMDAPDGCPPAVY-----DVMKNCWHLDAATRPTFLQLREQLEHIRTHE 447

Query: 418 NH 419
            H
Sbjct: 448 LH 449

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score =  194 bits (495), Expect = 3e-57
 Identities = 87/308 (28%), Positives = 135/308 (43%), Gaps = 26/308 (8%)

Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
           YY  H     L                      +EI    L      ++ +G F    + 
Sbjct: 148 YYSKHA--DGLCHRLTTVCPTSKPQTQGLAKDAWEIPRESLRLEV--KLGQGCFGEVWMG 203

Query: 172 FWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
            W G  +VA+K L    +S +     F  E  +++K+RH  +VQ    V++  P+ IVTE
Sbjct: 204 TWNGTTRVAIKTLKPGTMSPEA----FLQEAQVMKKLRHEKLVQLYAVVSEE-PIYIVTE 258

Query: 231 YLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           Y+ KG L  FLK +    L+    V  A  IA GM Y+        +HRDL  +NIL  +
Sbjct: 259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGE 315

Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
           +   KVADFG+++L+   E           ++ APE      +  K DV+SF ++L E+ 
Sbjct: 316 NLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375

Query: 349 -EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
            +G  P+    + EV        R   P + P  L+     +L+ +CW ++P +RPTF  
Sbjct: 376 TKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLH-----DLMCQCWRKEPEERPTFEY 430

Query: 406 IITRLESI 413
           +   LE  
Sbjct: 431 LQAFLEDY 438

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score =  189 bits (482), Expect = 5e-57
 Identities = 70/295 (23%), Positives = 122/295 (41%), Gaps = 37/295 (12%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFRD 199
           E  +D   L   +  E+  G F      +++       VAVK L  E  +D         
Sbjct: 10  EVYLDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLA 67

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           E  ++Q++ +P +V+ +G        M+V E    G L  +L++   +K    +     +
Sbjct: 68  EANVMQQLDNPYIVRMIGICEAE-SWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR---------P 310
           + GM YL E+     +HRDL   N+L       K++DFG+SK L   E+          P
Sbjct: 127 SMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWP 183

Query: 311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAAR 369
           +       ++ APE     ++ +K DV+SF +++ E    G  P+     +EV       
Sbjct: 184 V-------KWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKG 236

Query: 370 QR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 422
           +R   P   P ++Y     +L+  CW      RP F  +  RL +    + ++  
Sbjct: 237 ERMGCPAGCPREMY-----DLMNLCWTYDVENRPGFAAVELRLRNYYYDVVNEGH 286

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score =  190 bits (484), Expect = 7e-57
 Identities = 78/282 (27%), Positives = 130/282 (46%), Gaps = 27/282 (9%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
             EI P  +       I  G F        +       + VA+K L     ++  R   F
Sbjct: 38  TTEIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY-TEKQR-VDF 93

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFA 256
             E  ++ +  H N+++  G +++  PMMI+TEY+  G L  FL+ + G       V   
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGML 153

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
             IA GM YL        +HRDL   NIL + +   KV+DFG+S++L    +   T    
Sbjct: 154 RGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGG 210

Query: 317 SC--RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR-- 371
               R+ APE     ++ +  DV+SF +++ E++  G  P+    ++EV KA     R  
Sbjct: 211 KIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 270

Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
            P   P+ +Y     +L+ +CW ++ A+RP F  I++ L+ +
Sbjct: 271 TPMDCPSAIY-----QLMMQCWQQERARRPKFADIVSILDKL 307

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score =  188 bits (479), Expect = 1e-56
 Identities = 72/304 (23%), Positives = 135/304 (44%), Gaps = 45/304 (14%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
             + +   L F    ++ KG F    +  +          VAVKKL     S ++ +R F
Sbjct: 4   PTQFEERHLKFLQ--QLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQH---STEEHLRDF 58

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVR 254
             E+ +L+ ++H N+V++ G    +    + ++ EYLP G LR +L++ K  +     ++
Sbjct: 59  EREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQ 118

Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLT 312
           +   I +GM YL   +    IHRDL   NIL ++   +K+ DFG++K+L   ++  +   
Sbjct: 119 YTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKE 175

Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI----------------EGCPPFTM 356
             ++   + APE     ++    DV+SF ++L E+                  G      
Sbjct: 176 PGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQ 235

Query: 357 KHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN 414
                + +      R   P   P ++Y      ++ ECWN    +RP+FR +  R++ I 
Sbjct: 236 MIVFHLIELLKNNGRLPRPDGCPDEIY-----MIMTECWNNNVNQRPSFRDLALRVDQIR 290

Query: 415 NSIN 418
           +++ 
Sbjct: 291 DNMA 294

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score =  190 bits (485), Expect = 1e-56
 Identities = 83/277 (29%), Positives = 133/277 (48%), Gaps = 22/277 (7%)

Query: 149 EIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
           E+D   +     V      E+  G   L   + I VA+K L       + + R F  E +
Sbjct: 41  ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEAS 98

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIAR 261
           ++ +  HPN+++  G VT+S P+MIVTEY+  G L +FL K          V     IA 
Sbjct: 99  IMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIAS 158

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC--R 319
           GM YL +      +HRDL   NIL + +   KV+DFG+ ++L    +   T +      R
Sbjct: 159 GMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215

Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKA 376
           + +PE     ++ +  DV+S+ ++L E++  G  P+    + +V KA     R  PP   
Sbjct: 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPPPMDC 275

Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           PA LY     +L+ +CW +    RP F QI++ L+ +
Sbjct: 276 PAALY-----QLMLDCWQKDRNNRPKFEQIVSILDKL 307

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score =  188 bits (480), Expect = 2e-56
 Identities = 75/336 (22%), Positives = 142/336 (42%), Gaps = 47/336 (13%)

Query: 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---IL 170
            ++ +H    +          A       R+    + +   L F    ++ KG F    +
Sbjct: 4   YHHHHHHDYDIPTTENLYFQGAMGSAFEDRD--PTQFEERHLKFLQ--QLGKGNFGSVEM 59

Query: 171 AFWRG------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS- 223
             +          VAVKKL     S ++ +R F  E+ +L+ ++H N+V++ G    +  
Sbjct: 60  CRYDPLQDNTGEVVAVKKLQH---STEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGR 116

Query: 224 -PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
             + ++ EYLP G LR +L++ K  +     +++   I +GM YL   +    IHRDL  
Sbjct: 117 RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLAT 173

Query: 282 SNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS 339
            NIL ++   +K+ DFG++K+L   ++  +     ++   + APE     ++    DV+S
Sbjct: 174 RNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWS 233

Query: 340 FALILQEMI----------------EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLY 381
           F ++L E+                  G           + +      R   P   P ++Y
Sbjct: 234 FGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIY 293

Query: 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
                 ++ ECWN    +RP+FR +  R++ I + +
Sbjct: 294 -----MIMTECWNNNVNQRPSFRDLALRVDQIRDQM 324

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score =  194 bits (494), Expect = 2e-56
 Identities = 83/276 (30%), Positives = 131/276 (47%), Gaps = 24/276 (8%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELA 202
            +EI    L      ++ +G F    +  W G  +VA+K L    +S +     F  E  
Sbjct: 261 AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 314

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIA 260
           +++K+RH  +VQ    V++  P+ IVTEY+ KG L  FLK +    L+    V  A  IA
Sbjct: 315 VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 373

Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
            GM Y+        +HRDL  +NIL  ++   KVADFG+++L+   E           ++
Sbjct: 374 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 430

Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAP 377
            APE      +  K DV+SF ++L E+  +G  P+    + EV        R   P + P
Sbjct: 431 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECP 490

Query: 378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
             L+     +L+ +CW ++P +RPTF  +   LE  
Sbjct: 491 ESLH-----DLMCQCWRKEPEERPTFEYLQAFLEDY 521

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score =  187 bits (477), Expect = 3e-56
 Identities = 73/285 (25%), Positives = 119/285 (41%), Gaps = 26/285 (9%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVRAFR 198
              I   +L      ++  G+F       W       + VAVK L  +V+S  + +  F 
Sbjct: 12  TCLIGEKDLRLLE--KLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFI 69

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFAL 257
            E+  +  + H N+++  G V    PM +VTE  P G L   L+  +G     T  R+A+
Sbjct: 70  REVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAV 128

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT- 316
            +A GM YL   +    IHRDL   N+L      +K+ DFG+ + L   +D  +  +   
Sbjct: 129 QVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRK 185

Query: 317 -SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKA-YAARQR-- 371
               + APE  K   +    D + F + L EM   G  P+   + +++        +R  
Sbjct: 186 VPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP 245

Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
            P   P  +Y      ++ +CW  KP  RPTF  +   L     +
Sbjct: 246 RPEDCPQDIY-----NVMVQCWAHKPEDRPTFVALRDFLLEAQPT 285

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score =  185 bits (473), Expect = 9e-56
 Identities = 86/280 (30%), Positives = 137/280 (48%), Gaps = 30/280 (10%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDEL 201
            E+E+    L       +  G F    + ++ G  +VAVK L +  +S D     F  E 
Sbjct: 6   DEWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----FLAEA 59

Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFALDI 259
            L+++++H  +V+    VTQ  P+ I+TEY+  G L  FLK      L  +  +  A  I
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-- 317
           A GM ++ E      IHRDL  +NIL  D+ + K+ADFG+++L+   ED   T ++ +  
Sbjct: 119 AEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLI---EDNEYTAREGAKF 172

Query: 318 -CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PP 373
             ++ APE      +  K DV+SF ++L E++  G  P+    + EV +      R   P
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP 232

Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
              P +LY     +L+  CW E+P  RPTF  + + LE  
Sbjct: 233 DNCPEELY-----QLMRLCWKERPEDRPTFDYLRSVLEDF 267

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score =  184 bits (470), Expect = 3e-55
 Identities = 67/293 (22%), Positives = 121/293 (41%), Gaps = 39/293 (13%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFR 198
            +  +    L   + +E+  G F       +R     I VA+K L +   ++        
Sbjct: 2   KKLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMM 58

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
            E  ++ ++ +P +V+ +G    +  +M+V E    G L  FL  ++  +  S       
Sbjct: 59  REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 117

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-------- 309
            ++ GM YL E      +HRDL   N+L  +    K++DFG+SK L   +          
Sbjct: 118 QVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 174

Query: 310 -PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYA 367
            PL       ++ APE     ++ ++ DV+S+ + + E +  G  P+      EV     
Sbjct: 175 WPL-------KWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIE 227

Query: 368 ARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN 418
             +R   P + P +LY      L+ +CW  K   RP F  +  R+ +   S+ 
Sbjct: 228 QGKRMECPPECPPELY-----ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA 275

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score =  184 bits (469), Expect = 3e-55
 Identities = 67/283 (23%), Positives = 133/283 (46%), Gaps = 27/283 (9%)

Query: 144 EVPEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAF 197
              +YEI    ++    +      ++ +G ++      + VA+K       + D     F
Sbjct: 6   STRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKF 63

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFA 256
             E   +++  HP++V+ +G +T++ P+ I+ E    G+LR+FL+ RK +L  ++ + +A
Sbjct: 64  LQEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYA 122

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
             ++  + YL   +    +HRD+   N+L   +  +K+ DFG+S+ +   ED        
Sbjct: 123 YQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM---EDSTYYKASK 176

Query: 317 S---CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR- 371
                +++APE      + +  DV+ F + + E++  G  PF    +N+V       +R 
Sbjct: 177 GKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL 236

Query: 372 -PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
             P   P  LY      L+ +CW   P++RP F ++  +L +I
Sbjct: 237 PMPPNCPPTLY-----SLMTKCWAYDPSRRPRFTELKAQLSTI 274

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score =  185 bits (471), Expect = 5e-55
 Identities = 63/262 (24%), Positives = 122/262 (46%), Gaps = 31/262 (11%)

Query: 165 KGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
           KG +I    +  I VA+K+L E   +     +   DE  ++  + +P+V + LG     S
Sbjct: 33  KGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89

Query: 224 PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
            + ++T+ +P G L  ++ + K  +     + + + IA+GMNYL + +   ++HRDL   
Sbjct: 90  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146

Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDR--------PLTCQDTSCRYVAPEVFKNEEYDTK 334
           N+L     ++K+ DFG++KLL  +E          P+       +++A E   +  Y  +
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI-------KWMALESILHRIYTHQ 199

Query: 335 VDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEE 391
            DV+S+ + + E++  G  P+     +E+       +R   P      +Y      ++ +
Sbjct: 200 SDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY-----MIMRK 254

Query: 392 CWNEKPAKRPTFRQIITRLESI 413
           CW      RP FR++I     +
Sbjct: 255 CWMIDADSRPKFRELIIEFSKM 276

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score =  183 bits (467), Expect = 6e-55
 Identities = 73/281 (25%), Positives = 127/281 (45%), Gaps = 27/281 (9%)

Query: 146 PEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
           P+Y I   ++     +      E+ +G +       I VAVK   ++     D    F  
Sbjct: 5   PQYGIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKD--CTLDNKEKFMS 62

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALD 258
           E  +++ + HP++V+ +G + +  P  I+ E  P G+L  +L+R K +LK  T V ++L 
Sbjct: 63  EAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS- 317
           I + M YL        +HRD+   NIL      +K+ DFG+S+ +   ED        + 
Sbjct: 122 ICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRYI---EDEDYYKASVTR 175

Query: 318 --CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--P 372
              ++++PE      + T  DV+ FA+ + E++  G  PF    + +V        R   
Sbjct: 176 LPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK 235

Query: 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           P   P  LY      L+  CW+  P+ RP F +++  L  +
Sbjct: 236 PDLCPPVLY-----TLMTRCWDYDPSDRPRFTELVCSLSDV 271

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score =  184 bits (468), Expect = 7e-55
 Identities = 70/302 (23%), Positives = 135/302 (44%), Gaps = 45/302 (14%)

Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWR------GIQVAVKKLGEEVISDDDRV 194
           EV     +   L      ++ +G F    L  +       G QVAVK L  E  S  + +
Sbjct: 12  EVDPTHFEKRFLKRIR--DLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPE--SGGNHI 67

Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYLPKGDLRAFLKR-KGALKPST 251
              + E+ +L+ + H N+V++ G  T+   + + ++ E+LP G L+ +L + K  +    
Sbjct: 68  ADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQ 127

Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--R 309
            +++A+ I +GM+YL   +    +HRDL   N+L +    +K+ DFG++K +   ++   
Sbjct: 128 QLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYT 184

Query: 310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI----------------EGCPP 353
               +D+   + APE     ++    DV+SF + L E++                 G   
Sbjct: 185 VKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTH 244

Query: 354 FTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
             M     +       +R   P   P ++Y     +L+ +CW  +P+ R +F+ +I   E
Sbjct: 245 GQMTV-TRLVNTLKEGKRLPCPPNCPDEVY-----QLMRKCWEFQPSNRTSFQNLIEGFE 298

Query: 412 SI 413
           ++
Sbjct: 299 AL 300

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score =  183 bits (466), Expect = 1e-54
 Identities = 78/298 (26%), Positives = 139/298 (46%), Gaps = 30/298 (10%)

Query: 134 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGE 185
           ++ ++ +  + V    I P  L    +  I +G F               I  AVK L  
Sbjct: 4   LSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNR 63

Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFL-KR 243
             I+D   V  F  E  +++   HPNV+  LG   +S    ++V  Y+  GDLR F+   
Sbjct: 64  --ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNE 121

Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
                    + F L +A+GM YL   K    +HRDL   N + D+   +KVADFG+++  
Sbjct: 122 THNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARD- 177

Query: 304 TVKEDRPLTCQDTSC-----RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMK 357
            + +    +  + +      +++A E  + +++ TK DV+SF ++L E++  G PP+   
Sbjct: 178 -MYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 236

Query: 358 HDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           +  ++       +R   P   P  LY     E++ +CW+ K   RP+F ++++R+ +I
Sbjct: 237 NTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKCWHPKAEMRPSFSELVSRISAI 289

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score =  182 bits (465), Expect = 4e-54
 Identities = 76/299 (25%), Positives = 132/299 (44%), Gaps = 46/299 (15%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAF 197
               +   L + +  ++ KG F    L  +          VAVK+L     S  D+ R F
Sbjct: 17  PTIFEERHLKYIS--QLGKGNFGSVELCRYDPLGDNTGALVAVKQLQH---SGPDQQRDF 71

Query: 198 RDELALLQKIRHPNVVQFLGAVTQSS--PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVR 254
           + E+ +L+ +    +V++ G         + +V EYLP G LR FL + +  L  S  + 
Sbjct: 72  QREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLL 131

Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLT 312
           ++  I +GM YL   +    +HRDL   NIL +   ++K+ADFG++KLL + +D      
Sbjct: 132 YSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVRE 188

Query: 313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI----------------EGCPPFTM 356
              +   + APE   +  +  + DV+SF ++L E+                  GC     
Sbjct: 189 PGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVP 248

Query: 357 KHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
              + + +     QR   P   PA+++     EL++ CW   P  RP+F  +  +L+ +
Sbjct: 249 AL-SRLLELLEEGQRLPAPPACPAEVH-----ELMKLCWAPSPQDRPSFSALGPQLDML 301

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score =  183 bits (467), Expect = 6e-54
 Identities = 78/316 (24%), Positives = 142/316 (44%), Gaps = 30/316 (9%)

Query: 116 YKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAF 172
               E +     +     ++ ++ +  + V    I P  L    +  I +G F       
Sbjct: 50  KAGSENLYFQGANTVHIDLSALNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGT 109

Query: 173 WRG-----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMM 226
                   I  AVK L    I+D   V  F  E  +++   HPNV+  LG   +S    +
Sbjct: 110 LLDNDGKKIHCAVKSLNR--ITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPL 167

Query: 227 IVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           +V  Y+  GDLR F+            + F L +A+GM +L   K    +HRDL   N +
Sbjct: 168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCM 224

Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC-----RYVAPEVFKNEEYDTKVDVFSF 340
            D+   +KVADFG+++   + +    +  + +      +++A E  + +++ TK DV+SF
Sbjct: 225 LDEKFTVKVADFGLARD--MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSF 282

Query: 341 ALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKP 397
            ++L E++  G PP+   +  ++       +R   P   P  LY     E++ +CW+ K 
Sbjct: 283 GVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQPEYCPDPLY-----EVMLKCWHPKA 337

Query: 398 AKRPTFRQIITRLESI 413
             RP+F ++++R+ +I
Sbjct: 338 EMRPSFSELVSRISAI 353

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score =  185 bits (472), Expect = 7e-54
 Identities = 80/303 (26%), Positives = 132/303 (43%), Gaps = 31/303 (10%)

Query: 127 KHGAKPLM-------APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG- 175
           K G   L             +   E   +EI    L      ++  G F    +A +   
Sbjct: 155 KKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPRESLKLEK--KLGAGQFGEVWMATYNKH 212

Query: 176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
            +VAVK +    +S +     F  E  +++ ++H  +V+    VT+  P+ I+TE++ KG
Sbjct: 213 TKVAVKTMKPGSMSVEA----FLAEANVMKTLQHDKLVKLHAVVTKE-PIYIITEFMAKG 267

Query: 236 DLRAFLK--RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            L  FLK            + F+  IA GM ++ +      IHRDL  +NIL   S   K
Sbjct: 268 SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCK 324

Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCP 352
           +ADFG+++++   E           ++ APE      +  K DV+SF ++L E++  G  
Sbjct: 325 IADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRI 384

Query: 353 PFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
           P+    + EV +A     R   P   P +LY      ++  CW  +P +RPTF  I + L
Sbjct: 385 PYPGMSNPEVIRALERGYRMPRPENCPEELY-----NIMMRCWKNRPEERPTFEYIQSVL 439

Query: 411 ESI 413
           +  
Sbjct: 440 DDF 442

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score =  180 bits (460), Expect = 9e-54
 Identities = 82/288 (28%), Positives = 136/288 (47%), Gaps = 30/288 (10%)

Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVR 195
           EV +  I    +   +   I KG F       +       IQ A+K L    I++  +V 
Sbjct: 10  EVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSR--ITEMQQVE 67

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPM-MIVTEYLPKGDLRAFLK-RKGALKPSTAV 253
           AF  E  L++ + HPNV+  +G +     +  ++  Y+  GDL  F++  +        +
Sbjct: 68  AFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLI 127

Query: 254 RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC 313
            F L +ARGM YL E K    +HRDL   N + D+S  +KVADFG+++   + +    + 
Sbjct: 128 SFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVKVADFGLARD--ILDREYYSV 182

Query: 314 QDTSC-----RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYA 367
           Q         ++ A E  +   + TK DV+SF ++L E++  G PP+      ++    A
Sbjct: 183 QQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLA 242

Query: 368 ARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
             +R   P   P  LY     +++++CW   PA RPTFR ++  +E I
Sbjct: 243 QGRRLPQPEYCPDSLY-----QVMQQCWEADPAVRPTFRVLVGEVEQI 285

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score =  181 bits (461), Expect = 1e-53
 Identities = 69/279 (24%), Positives = 122/279 (43%), Gaps = 27/279 (9%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
                EL       +  G F       W        I V +K + ++  S     +A  D
Sbjct: 9   IFKETELRKLK--VLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDK--SGRQSFQAVTD 64

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALD 258
            +  +  + H ++V+ LG     S + +VT+YLP G L   ++  +GAL P   + + + 
Sbjct: 65  HMLAIGSLDHAHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTS 317
           IA+GM YL E+    ++HR+L   N+L      ++VADFGV+ LL   +     +   T 
Sbjct: 124 IAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180

Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPF 374
            +++A E     +Y  + DV+S+ + + E++  G  P+      EVP      +R   P 
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQPQ 240

Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
                +Y      ++ +CW      RPTF+++      +
Sbjct: 241 ICTIDVY-----MVMVKCWMIDENIRPTFKELANEFTRM 274

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score =  180 bits (460), Expect = 2e-53
 Identities = 75/313 (23%), Positives = 130/313 (41%), Gaps = 40/313 (12%)

Query: 127 KHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQV 178
            H +  L+     +   ++ +  ID + L       + +G F   +    +      ++V
Sbjct: 8   HHHSSGLVPRGSEELQNKLEDVVIDRNLLILGK--ILGEGEFGSVMEGNLKQEDGTSLKV 65

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM-----MIVTEYLP 233
           AVK +  +  S  +    F  E A ++   HPNV++ LG   + S       M++  ++ 
Sbjct: 66  AVKTMKLDNSSQREI-EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMK 124

Query: 234 KGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
            GDL  +L           +   T ++F +DIA GM YL        +HRDL   N +  
Sbjct: 125 YGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLR 181

Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC----RYVAPEVFKNEEYDTKVDVFSFALI 343
           D   + VADFG+SK +          Q        +++A E   +  Y +K DV++F + 
Sbjct: 182 DDMTVCVADFGLSKKI---YSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVT 238

Query: 344 LQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKR 400
           + E+   G  P+    ++E+        R   P     +LY     E++  CW   P  R
Sbjct: 239 MWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQPEDCLDELY-----EIMYSCWRTDPLDR 293

Query: 401 PTFRQIITRLESI 413
           PTF  +  +LE +
Sbjct: 294 PTFSVLRLQLEKL 306

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score =  179 bits (457), Expect = 2e-53
 Identities = 68/310 (21%), Positives = 122/310 (39%), Gaps = 48/310 (15%)

Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRG---------IQVAVKKLGEEVISDDDRVR 195
           ++I   +L F     + +GTF        R           +V +K L +   +  +   
Sbjct: 3   HKIRNEDLIFNE--SLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDK---AHRNYSE 57

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVR 254
           +F +  +++ K+ H ++V   G        ++V E++  G L  +LK+ K  +     + 
Sbjct: 58  SFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLE 117

Query: 255 FALDIARGMNYLHENKPVPIIHRDLEPSNIL--------RDDSGNLKVADFGVSKLLTVK 306
            A  +A  M++L EN    +IH ++   NIL          +   +K++D G+S  +  K
Sbjct: 118 VAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK 174

Query: 307 E--DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEV 362
           +     +        +V PE  +N +  +   D +SF   L E+   G  P +       
Sbjct: 175 DILQERI-------PWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRK 227

Query: 363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 422
            + Y  R + P    A+L       LI  C + +P  RP+FR II  L S+       R 
Sbjct: 228 LQFYEDRHQLPAPKAAELA-----NLINNCMDYEPDHRPSFRAIIRDLNSLFTPDLVPRG 282

Query: 423 WKIRTMKCFH 432
                    H
Sbjct: 283 ---SHHHHHH 289

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score =  180 bits (459), Expect = 3e-53
 Identities = 71/296 (23%), Positives = 128/296 (43%), Gaps = 45/296 (15%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
                 L      ++ +G F    L  +          VAVK L  +  +       ++ 
Sbjct: 27  VFHKRYLKKIR--DLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQ 82

Query: 200 ELALLQKIRHPNVVQFLGAVTQS--SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL 257
           E+ +L+ + H +++++ G    +  + + +V EY+P G LR +L  + ++  +  + FA 
Sbjct: 83  EIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYL-PRHSIGLAQLLLFAQ 141

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQD 315
            I  GM YLH       IHRDL   N+L D+   +K+ DFG++K +    +  R     D
Sbjct: 142 QICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 198

Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI----------------EGCPPFTMKHD 359
           +   + APE  K  ++    DV+SF + L E++                 G     M   
Sbjct: 199 SPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV- 257

Query: 360 NEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
             + +     +R   P K PA++Y      L++ CW  + + RPTF  +I  L+++
Sbjct: 258 LRLTELLERGERLPRPDKCPAEVY-----HLMKNCWETEASFRPTFENLIPILKTV 308

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score =  180 bits (458), Expect = 3e-53
 Identities = 87/309 (28%), Positives = 133/309 (43%), Gaps = 60/309 (19%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
            ++E   + L F     +  G F   + A   G+        VAVK L     +      
Sbjct: 16  HKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTERE 71

Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
           A   EL +L  +  H N+V  LGA T   P +++TEY   GDL  FL+RK          
Sbjct: 72  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131

Query: 245 --------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
                    AL     + F+  +A+GM +L        IHRDL   NIL       K+ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188

Query: 297 FGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
           FG+++ +       VK +   P+       +++APE   N  Y  + DV+S+ + L E+ 
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPV-------KWMAPESIFNCVYTFESDVWSYGIFLWELF 241

Query: 349 E--GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
                P   M  D++  K      R   P  APA++Y     ++++ CW+  P KRPTF+
Sbjct: 242 SLGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMY-----DIMKTCWDADPLKRPTFK 296

Query: 405 QIITRLESI 413
           QI+  +E  
Sbjct: 297 QIVQLIEKQ 305

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score =  179 bits (456), Expect = 7e-53
 Identities = 76/302 (25%), Positives = 128/302 (42%), Gaps = 51/302 (16%)

Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRG-----IQVAVKKLGEEVISDDDRVR 195
           ++ +  I   +        + KG F     A  +      ++VAVK L  ++I+  D   
Sbjct: 14  KLEDVLIPEQQFTLGR--MLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDI-E 70

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRAFLKR------ 243
            F  E A +++  HP+V + +G   +S         M++  ++  GDL AFL        
Sbjct: 71  EFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130

Query: 244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL 303
              L   T VRF +DIA GM YL        IHRDL   N +  +   + VADFG+S   
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMTVCVADFGLS--- 184

Query: 304 TVKEDRPLTCQDTSC---------RYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPP 353
                R +   D            +++A E   +  Y    DV++F + + E++  G  P
Sbjct: 185 -----RKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTP 239

Query: 354 FTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE 411
           +    + E+        R   P +   ++Y     +L+ +CW+  P +RP+F  +   LE
Sbjct: 240 YAGIENAEIYNYLIGGNRLKQPPECMEEVY-----DLMYQCWSADPKQRPSFTCLRMELE 294

Query: 412 SI 413
           +I
Sbjct: 295 NI 296

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score =  178 bits (453), Expect = 2e-52
 Identities = 73/303 (24%), Positives = 135/303 (44%), Gaps = 58/303 (19%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
            E+E+   ++  +   E+ +G+F        +G+       +VA+K + E   S  +R  
Sbjct: 18  DEWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA-SMRER-I 73

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------G 245
            F +E +++++    +VV+ LG V+Q  P +++ E + +GDL+++L+             
Sbjct: 74  EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLA 133

Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
               S  ++ A +IA GM YL+ NK    +HRDL   N +  +   +K+ DFG++     
Sbjct: 134 PPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIGDFGMT----- 185

Query: 306 KEDRPLTCQDTSCRYV------------APEVFKNEEYDTKVDVFSFALILQEMIE-GCP 352
              R +   D    Y             +PE  K+  + T  DV+SF ++L E+      
Sbjct: 186 ---RDIYETDY---YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQ 239

Query: 353 PFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
           P+    + +V +          P   P  L+     EL+  CW   P  RP+F +II+ +
Sbjct: 240 PYQGLSNEQVLRFVMEGGLLDKPDNCPDMLF-----ELMRMCWQYNPKMRPSFLEIISSI 294

Query: 411 ESI 413
           +  
Sbjct: 295 KEE 297

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score =  178 bits (453), Expect = 4e-52
 Identities = 87/339 (25%), Positives = 136/339 (40%), Gaps = 72/339 (21%)

Query: 124 LLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---- 176
           LL++    P+   M +    ++   E   + +++    +I +G F     A   G+    
Sbjct: 18  LLDRLHPNPMYQRMPLLLNPKLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYE 75

Query: 177 ---QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
               VAVK L EE  S D +   F+ E AL+ +  +PN+V+ LG      PM ++ EY+ 
Sbjct: 76  PFTMVAVKMLKEEA-SADMQ-ADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMA 133

Query: 234 KGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHEN 269
            GDL  FL+                            L  +  +  A  +A GM YL E 
Sbjct: 134 YGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER 193

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV-------- 321
           K    +HRDL   N L  ++  +K+ADFG+S        R +   D    Y         
Sbjct: 194 K---FVHRDLATRNCLVGENMVVKIADFGLS--------RNIYSADY---YKADGNDAIP 239

Query: 322 ----APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPF 374
                PE      Y T+ DV+++ ++L E+   G  P+      EV            P 
Sbjct: 240 IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPE 299

Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
             P +LY      L+  CW++ PA RP+F  I   L+ +
Sbjct: 300 NCPLELY-----NLMRLCWSKLPADRPSFCSIHRILQRM 333

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score =  176 bits (448), Expect = 5e-52
 Identities = 84/302 (27%), Positives = 132/302 (43%), Gaps = 52/302 (17%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRAFR 198
           EI    + F    E+ +  F         G         VA+K L ++      R   FR
Sbjct: 5   EISLSAVRFME--ELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA-EGPLR-EEFR 60

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR--------------- 243
            E  L  +++HPNVV  LG VT+  P+ ++  Y   GDL  FL                 
Sbjct: 61  HEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRT 120

Query: 244 -KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
            K AL+P   V     IA GM YL  +    ++H+DL   N+L  D  N+K++D G+ + 
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLATRNVLVYDKLNVKISDLGLFRE 177

Query: 303 L------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT 355
           +       +  +  L       R++APE     ++    D++S+ ++L E+   G  P+ 
Sbjct: 178 VYAADYYKLLGNSLL-----PIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYC 232

Query: 356 MKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
              + +V +    RQ    P   PA +Y      L+ ECWNE P++RP F+ I +RL + 
Sbjct: 233 GYSNQDVVEMIRNRQVLPCPDDCPAWVY-----ALMIECWNEFPSRRPRFKDIHSRLRAW 287

Query: 414 NN 415
            N
Sbjct: 288 GN 289

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score =  177 bits (450), Expect = 6e-52
 Identities = 79/314 (25%), Positives = 131/314 (41%), Gaps = 59/314 (18%)

Query: 141 HAREVPEY-------EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKL 183
           H  E P+Y        I   ++      E+ +G F    LA    +        VAVK L
Sbjct: 22  HIIENPQYFSDACVHHIKRRDIVLKW--ELGEGAFGKVFLAECHNLLPEQDKMLVAVKAL 79

Query: 184 GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR 243
            E   S+  R + F+ E  LL  ++H ++V+F G  T+  P+++V EY+  GDL  FL+ 
Sbjct: 80  KEA--SESAR-QDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRS 136

Query: 244 ---------------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
                           G L     +  A  +A GM YL        +HRDL   N L   
Sbjct: 137 HGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQ 193

Query: 289 SGNLKVADFGVSKLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
              +K+ DFG+S+ +       V     L       R++ PE     ++ T+ DV+SF +
Sbjct: 194 GLVVKIGDFGMSRDIYSTDYYRVGGRTML-----PIRWMPPESILYRKFTTESDVWSFGV 248

Query: 343 ILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAK 399
           +L E+   G  P+    + E        +    P   P ++Y      ++  CW  +P +
Sbjct: 249 VLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPRACPPEVY-----AIMRGCWQREPQQ 303

Query: 400 RPTFRQIITRLESI 413
           R + + +  RL+++
Sbjct: 304 RHSIKDVHARLQAL 317

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score =  177 bits (450), Expect = 7e-52
 Identities = 62/259 (23%), Positives = 120/259 (46%), Gaps = 25/259 (9%)

Query: 165 KGTFILAFWRG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS 223
           KG +I    +  I VA+K+L E   +     +   DE  ++  + +P+V + LG     S
Sbjct: 33  KGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLT-S 89

Query: 224 PMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
            + ++T+ +P G L  ++ + K  +     + + + IA+GMNYL + +   ++HRDL   
Sbjct: 90  TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAAR 146

Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----CRYVAPEVFKNEEYDTKVDV 337
           N+L     ++K+ DFG++KLL  +E                +++A E   +  Y  + DV
Sbjct: 147 NVLVKTPQHVKITDFGLAKLLGAEEK----EYHAEGGKVPIKWMALESILHRIYTHQSDV 202

Query: 338 FSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWN 394
           +S+ + + E++  G  P+     +E+       +R   P      +Y      ++ +CW 
Sbjct: 203 WSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVY-----MIMVKCWM 257

Query: 395 EKPAKRPTFRQIITRLESI 413
                RP FR++I     +
Sbjct: 258 IDADSRPKFRELIIEFSKM 276

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score =  176 bits (449), Expect = 9e-52
 Identities = 88/312 (28%), Positives = 143/312 (45%), Gaps = 55/312 (17%)

Query: 138 HVKHAREVPEY----EIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEE 186
           H  H +  P+      +D +++ F +   I +G F   + A  +     +  A+K++ E 
Sbjct: 6   HHHHGKNNPDPTIYPVLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY 63

Query: 187 VISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK- 244
             S DD  R F  EL +L K+  HPN++  LGA      + +  EY P G+L  FL++  
Sbjct: 64  A-SKDDH-RDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSR 121

Query: 245 ---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
                            L     + FA D+ARGM+YL + +    IHRDL   NIL  ++
Sbjct: 122 VLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGEN 178

Query: 290 GNLKVADFGVSKLLTVKEDR-----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
              K+ADFG+S+   V   +     P+       R++A E      Y T  DV+S+ ++L
Sbjct: 179 YVAKIADFGLSRGQEVYVKKTMGRLPV-------RWMAIESLNYSVYTTNSDVWSYGVLL 231

Query: 345 QEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRP 401
            E++  G  P+      E+ +      R   P     ++Y     +L+ +CW EKP +RP
Sbjct: 232 WEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPLNCDDEVY-----DLMRQCWREKPYERP 286

Query: 402 TFRQIITRLESI 413
           +F QI+  L  +
Sbjct: 287 SFAQILVSLNRM 298

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score =  176 bits (448), Expect = 1e-51
 Identities = 77/303 (25%), Positives = 132/303 (43%), Gaps = 52/303 (17%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
            ++E   + L F     +  G F   + A   G+       +VAVK L     +  D   
Sbjct: 39  EKWEFPRNNLQFGK--TLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKST--AHADEKE 94

Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--------- 245
           A   EL ++  + +H N+V  LGA T   P++++TEY   GDL  FL+RK          
Sbjct: 95  ALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAF 154

Query: 246 -----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
                       + F+  +A+GM +L        IHRD+   N+L  +    K+ DFG++
Sbjct: 155 AIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLLTNGHVAKIGDFGLA 211

Query: 301 KLL------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE--GCP 352
           + +       VK +  L       +++APE   +  Y  + DV+S+ ++L E+      P
Sbjct: 212 RDIMNDSNYIVKGNARLP-----VKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNP 266

Query: 353 PFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
              +  +++  K      +   P  AP  +Y      +++ CW  +P  RPTF+QI + L
Sbjct: 267 YPGILVNSKFYKLVKDGYQMAQPAFAPKNIY-----SIMQACWALEPTHRPTFQQICSFL 321

Query: 411 ESI 413
           +  
Sbjct: 322 QEQ 324

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score =  175 bits (446), Expect = 1e-51
 Identities = 77/306 (25%), Positives = 124/306 (40%), Gaps = 65/306 (21%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRAFR 198
            I   ++      E+ +G F    LA    +        VAVK L +   +   R + F+
Sbjct: 11  HIKRRDIVLKR--ELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDP--TLAAR-KDFQ 65

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK---------------- 242
            E  LL  ++H ++V+F G      P+++V EY+  GDL  FL+                
Sbjct: 66  REAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQ 125

Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
            KG L  S  +  A  IA GM YL        +HRDL   N L   +  +K+ DFG+S  
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLLVKIGDFGMS-- 180

Query: 303 LTVKEDRPLTCQDTSCRYV------------APEVFKNEEYDTKVDVFSFALILQEMI-E 349
                 R +   D    Y              PE     ++ T+ DV+SF +IL E+   
Sbjct: 181 ------RDVYSTDY---YRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTY 231

Query: 350 GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           G  P+    + EV +     +    P   P ++Y     +++  CW  +P +R   ++I 
Sbjct: 232 GKQPWFQLSNTEVIECITQGRVLERPRVCPKEVY-----DVMLGCWQREPQQRLNIKEIY 286

Query: 408 TRLESI 413
             L ++
Sbjct: 287 KILHAL 292

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score =  175 bits (445), Expect = 2e-51
 Identities = 81/314 (25%), Positives = 133/314 (42%), Gaps = 66/314 (21%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
           P++E     L       + +G F   + A    +        VAVK L E   +    +R
Sbjct: 16  PKWEFPRKNLVLGK--TLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELR 71

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------- 244
               E  +L+++ HP+V++  GA +Q  P++++ EY   G LR FL+             
Sbjct: 72  DLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSG 131

Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
                         AL     + FA  I++GM YL E K   ++HRDL   NIL  +   
Sbjct: 132 GSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK---LVHRDLAARNILVAEGRK 188

Query: 292 LKVADFGVSKLLTVKEDRPLTCQD----TSC-----RYVAPEVFKNEEYDTKVDVFSFAL 342
           +K++DFG+S        R +  +D     S      +++A E   +  Y T+ DV+SF +
Sbjct: 189 MKISDFGLS--------RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGV 240

Query: 343 ILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAK 399
           +L E++  G  P+       +        R   P     ++Y      L+ +CW ++P K
Sbjct: 241 LLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERPDNCSEEMY-----RLMLQCWKQEPDK 295

Query: 400 RPTFRQIITRLESI 413
           RP F  I   LE +
Sbjct: 296 RPVFADISKDLEKM 309

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score =  176 bits (449), Expect = 3e-51
 Identities = 86/339 (25%), Positives = 150/339 (44%), Gaps = 59/339 (17%)

Query: 115 YYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILA 171
           ++ +   I   E    + ++A +      E P +E+    L       + +G F   +LA
Sbjct: 31  HHHHDYDIPTTENLYFQGMLAGVSEYELPEDPRWELPRDRLVLGK--PLGEGAFGQVVLA 88

Query: 172 FWRGI---------QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ 221
              G+         +VAVK L  +  ++ D       E+ +++ I +H N++  LGA TQ
Sbjct: 89  EAIGLDKDKPNRVTKVAVKMLKSDA-TEKDL-SDLISEMEMMKMIGKHKNIINLLGACTQ 146

Query: 222 SSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNY 265
             P+ ++ EY  KG+LR +L+ +                  L     V  A  +ARGM Y
Sbjct: 147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEY 206

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL------TVKEDR--PLTCQDTS 317
           L   K    IHRDL   N+L  +   +K+ADFG+++ +          +   P+      
Sbjct: 207 LASKK---CIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV------ 257

Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPF 374
            +++APE   +  Y  + DV+SF ++L E+   G  P+      E+ K      R   P 
Sbjct: 258 -KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS 316

Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
               +LY      ++ +CW+  P++RPTF+Q++  L+ I
Sbjct: 317 NCTNELY-----MMMRDCWHAVPSQRPTFKQLVEDLDRI 350

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score =  175 bits (445), Expect = 5e-51
 Identities = 78/315 (24%), Positives = 126/315 (40%), Gaps = 67/315 (21%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
            ++E     L+F     +  G F   + A   GI       QVAVK L E+  +D     
Sbjct: 38  LKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSERE 93

Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
           A   EL ++ ++  H N+V  LGA T S P+ ++ EY   GDL  +L+ K          
Sbjct: 94  ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 153

Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
                          L     + FA  +A+GM +L        +HRDL   N+L      
Sbjct: 154 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAARNVLVTHGKV 210

Query: 292 LKVADFGVSKLLTVKEDRPLTCQD-----TSC----RYVAPEVFKNEEYDTKVDVFSFAL 342
           +K+ DFG++        R +          +     +++APE      Y  K DV+S+ +
Sbjct: 211 VKICDFGLA--------RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGI 262

Query: 343 ILQEMIE-GCPPF-TMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPA 398
           +L E+   G  P+  +  D    K      +   PF A  ++Y      +++ CW     
Sbjct: 263 LLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIY-----IIMQSCWAFDSR 317

Query: 399 KRPTFRQIITRLESI 413
           KRP+F  + + L   
Sbjct: 318 KRPSFPNLTSFLGCQ 332

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score =  175 bits (445), Expect = 5e-51
 Identities = 82/323 (25%), Positives = 146/323 (45%), Gaps = 59/323 (18%)

Query: 131 KPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---------QV 178
            P++A +      E P++E    +L       + +G F   ++A   GI          V
Sbjct: 13  DPMLAGVSEYELPEDPKWEFPRDKLTLGK--PLGEGAFGQVVMAEAVGIDKDKPKEAVTV 70

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           AVK L ++  ++ D       E+ +++ I +H N++  LGA TQ  P+ ++ EY  KG+L
Sbjct: 71  AVKMLKDDA-TEKDL-SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128

Query: 238 RAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEP 281
           R +L+ +                  +     V     +ARGM YL   K    IHRDL  
Sbjct: 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAA 185

Query: 282 SNILRDDSGNLKVADFGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDT 333
            N+L  ++  +K+ADFG+++ +          +   P+       +++APE   +  Y  
Sbjct: 186 RNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV-------KWMAPEALFDRVYTH 238

Query: 334 KVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIE 390
           + DV+SF +++ E+   G  P+      E+ K      R   P     +LY      ++ 
Sbjct: 239 QSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY-----MMMR 293

Query: 391 ECWNEKPAKRPTFRQIITRLESI 413
           +CW+  P++RPTF+Q++  L+ I
Sbjct: 294 DCWHAVPSQRPTFKQLVEDLDRI 316

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  173 bits (441), Expect = 5e-51
 Identities = 67/267 (25%), Positives = 128/267 (47%), Gaps = 17/267 (6%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELAL 203
            +          +EI +G+F            ++VA  +L +  ++  +R + F++E  +
Sbjct: 20  GMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSER-QRFKEEAEM 78

Query: 204 LQKIRHPNVVQFLGA----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDI 259
           L+ ++HPN+V+F  +    V     +++VTE +  G L+ +LKR   +K      +   I
Sbjct: 79  LKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQI 138

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC 318
            +G+ +LH   P PIIHRDL+  NI     +G++K+ D G++ L      +      T  
Sbjct: 139 LKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK--AVIGTPE 195

Query: 319 RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA 378
            ++APE+++ E+YD  VDV++F + + EM     P++   +             P  +  
Sbjct: 196 -FMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-ASFD 252

Query: 379 KLYARGLKELIEECWNEKPAKRPTFRQ 405
           K+    +KE+IE C  +   +R + + 
Sbjct: 253 KVAIPEVKEIIEGCIRQNKDERYSIKD 279

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score =  174 bits (443), Expect = 6e-51
 Identities = 81/298 (27%), Positives = 125/298 (41%), Gaps = 50/298 (16%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
             E+    +       +  G F         G+       QVAVK L E   S+ D    
Sbjct: 24  LKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDE-LD 79

Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-------KGALKP 249
           F  E  ++ K  H N+V+ +G   QS P  I+ E +  GDL++FL+          +L  
Sbjct: 80  FLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAM 139

Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLL--- 303
              +  A DIA G  YL EN     IHRD+   N L    G     K+ DFG+++ +   
Sbjct: 140 LDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRA 196

Query: 304 --TVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMK 357
               K      P+       +++ PE F    + +K D +SF ++L E+   G  P+  K
Sbjct: 197 SYYRKGGCAMLPV-------KWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSK 249

Query: 358 HDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
            + EV +   +  R  PP   P  +Y      ++ +CW  +P  RP F  I+ R+E  
Sbjct: 250 SNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRPNFAIILERIEYC 302

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score =  174 bits (444), Expect = 1e-50
 Identities = 81/324 (25%), Positives = 146/324 (45%), Gaps = 59/324 (18%)

Query: 130 AKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI---------Q 177
             P++A +      E P++E    +L       + +G F   ++A   GI          
Sbjct: 58  DTPMLAGVSEYELPEDPKWEFPRDKLTLGK--PLGEGCFGQVVMAEAVGIDKDKPKEAVT 115

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           VAVK L ++  + +  +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  KG+
Sbjct: 116 VAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 173

Query: 237 LRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE 280
           LR +L+ +                  +     V     +ARGM YL   K    IHRDL 
Sbjct: 174 LREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLA 230

Query: 281 PSNILRDDSGNLKVADFGVSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYD 332
             N+L  ++  +K+ADFG+++ +          +   P+       +++APE   +  Y 
Sbjct: 231 ARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPV-------KWMAPEALFDRVYT 283

Query: 333 TKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELI 389
            + DV+SF +++ E+   G  P+      E+ K      R   P     +LY      ++
Sbjct: 284 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELY-----MMM 338

Query: 390 EECWNEKPAKRPTFRQIITRLESI 413
            +CW+  P++RPTF+Q++  L+ I
Sbjct: 339 RDCWHAVPSQRPTFKQLVEDLDRI 362

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score =  180 bits (458), Expect = 2e-50
 Identities = 67/285 (23%), Positives = 133/285 (46%), Gaps = 35/285 (12%)

Query: 146 PEYEIDPHELDFTNSV------EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRD 199
            +YEI    ++    +      ++ +G ++      + VA+K       + D     F  
Sbjct: 383 RDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQ 440

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
           E   +++  HP++V+ +G +T++ P+ I+ E    G+LR+FL  RK +L  ++ + +A  
Sbjct: 441 EALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL-------TVKEDRPL 311
           ++  + YL   +    +HRD+   N+L   +  +K+ DFG+S+ +         K   P+
Sbjct: 500 LSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556

Query: 312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQ 370
                  +++APE      + +  DV+ F + + E++  G  PF    +N+V       +
Sbjct: 557 -------KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE 609

Query: 371 R--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           R   P   P  LY      L+ +CW   P++RP F ++  +L +I
Sbjct: 610 RLPMPPNCPPTLY-----SLMTKCWAYDPSRRPRFTELKAQLSTI 649

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score =  173 bits (441), Expect = 4e-50
 Identities = 80/300 (26%), Positives = 122/300 (40%), Gaps = 52/300 (17%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVR 195
              E+    +       +  G F         G+       QVAVK L E   S+ D   
Sbjct: 64  DLKEVPRKNITLIR--GLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVC-SEQDE-L 119

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-------KGALK 248
            F  E  ++ K  H N+V+ +G   QS P  I+ E +  GDL++FL+          +L 
Sbjct: 120 DFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLA 179

Query: 249 PSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTV 305
               +  A DIA G  YL EN     IHRD+   N L    G     K+ DFG++     
Sbjct: 180 MLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMA----- 231

Query: 306 KEDRPLTCQDTSC---------RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFT 355
              R +                +++ PE F    + +K D +SF ++L E+   G  P+ 
Sbjct: 232 ---RDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYP 288

Query: 356 MKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
            K + EV +   +  R  PP   P  +Y      ++ +CW  +P  RP F  I+ R+E  
Sbjct: 289 SKSNQEVLEFVTSGGRMDPPKNCPGPVY-----RIMTQCWQHQPEDRPNFAIILERIEYC 343

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score =  171 bits (435), Expect = 8e-50
 Identities = 83/307 (27%), Positives = 136/307 (44%), Gaps = 59/307 (19%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
           ++E     L       + +G F   I A   GI        VAVK L E   +     RA
Sbjct: 21  KWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRA 76

Query: 197 FRDELALLQKI-RHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKR----------- 243
              EL +L  I  H NVV  LGA T+   P+M++ E+   G+L  +L+            
Sbjct: 77  LMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVA 136

Query: 244 -----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
                K  L     + ++  +A+GM +L   K    IHRDL   NIL  +   +K+ DFG
Sbjct: 137 PEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFG 193

Query: 299 VSKLL------TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE- 349
           +++ +        K D   PL       +++APE   +  Y  + DV+SF ++L E+   
Sbjct: 194 LARDIYKDPDYVRKGDARLPL-------KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSL 246

Query: 350 GCPPF-TMKHDNEVPKAYAARQR--PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           G  P+  +K D E  +      R   P     ++Y     + + +CW+ +P++RPTF ++
Sbjct: 247 GASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMY-----QTMLDCWHGEPSQRPTFSEL 301

Query: 407 ITRLESI 413
           +  L ++
Sbjct: 302 VEHLGNL 308

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  170 bits (433), Expect = 3e-49
 Identities = 60/288 (20%), Positives = 128/288 (44%), Gaps = 13/288 (4%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G Q  +K++    +S  +R  + R E+A+L  ++HPN+VQ+  +  ++  + IV +Y   
Sbjct: 49  GRQYVIKEINISRMSSKEREESRR-EVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEG 107

Query: 235 GDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
           GDL   +        +    + + + I   + ++H+ K   I+HRD++  NI     G +
Sbjct: 108 GDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTV 164

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP 352
           ++ DFG++++L    +    C  T   Y++PE+ +N+ Y+ K D+++   +L E+     
Sbjct: 165 QLGDFGIARVLNSTVELARACIGTPY-YLSPEICENKPYNNKSDIWALGCVLYELCTLKH 223

Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--- 409
            F       +     +   PP       Y+  L+ L+ + +   P  RP+   I+ +   
Sbjct: 224 AFEAGSMKNLVLKIISGSFPPV--SLH-YSYDLRSLVSQLFKRNPRDRPSVNSILEKGFI 280

Query: 410 LESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSSPSSRSKSSCSTSS 457
            + I   ++ +   +   +K F    +         S ++  S   + 
Sbjct: 281 AKRIEKFLSPQLIAEEFCLKTFSKFGSQPIPAKRPASGQNSISVMPAQ 328

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score =  176 bits (447), Expect = 3e-49
 Identities = 65/288 (22%), Positives = 120/288 (41%), Gaps = 25/288 (8%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFR 198
            +  +    L   + +E+  G F       +R     I VA+K L +   ++        
Sbjct: 328 KKLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMM 384

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
            E  ++ ++ +P +V+ +G    +  +M+V E    G L  FL  ++  +  S       
Sbjct: 385 REAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLH 443

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
            ++ GM YL E      +HR+L   N+L  +    K++DFG+SK L   +          
Sbjct: 444 QVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGK 500

Query: 318 --CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQR--P 372
              ++ APE     ++ ++ DV+S+ + + E +  G  P+      EV       +R   
Sbjct: 501 WPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC 560

Query: 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420
           P + P +LY      L+ +CW  K   RP F  +  R+ +   S+  K
Sbjct: 561 PPECPPELY-----ALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 603

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  166 bits (422), Expect = 4e-48
 Identities = 61/254 (24%), Positives = 113/254 (44%), Gaps = 13/254 (5%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           +I +G F     A     G+ VA+KK+    + D         E+ LL+++ HPNV+++ 
Sbjct: 39  KIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYY 98

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGA----LKPSTAVRFALDIARGMNYLHENKPV 272
            +  + + + IV E    GDL   +K        +   T  ++ + +   + ++H  +  
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR-- 156

Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD 332
            ++HRD++P+N+    +G +K+ D G+ +  + K     +   T   Y++PE      Y+
Sbjct: 157 -VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPY-YMSPERIHENGYN 214

Query: 333 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEEC 392
            K D++S   +L EM     PF     N         Q      P+  Y+  L++L+  C
Sbjct: 215 FKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMC 274

Query: 393 WNEKPAKRPTFRQI 406
            N  P KRP    +
Sbjct: 275 INPDPEKRPDVTYV 288

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  165 bits (421), Expect = 7e-48
 Identities = 53/257 (20%), Positives = 90/257 (35%), Gaps = 18/257 (7%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
            F     +  G++        +  G   AVK+         DR R   +  +  +  +HP
Sbjct: 58  SFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHP 117

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHEN 269
             V+   A  +   + + TE      L+   +  GA L  +    +  D    + +LH  
Sbjct: 118 CCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
               ++H D++P+NI     G  K+ DFG+   L          +    RY+APE+    
Sbjct: 177 G---LVHLDVKPANIFLGPRGRCKLGDFGLLVELG-TAGAGEVQEGD-PRYMAPELL-QG 230

Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389
            Y T  DVFS  L + E+                +       P F A     +  L+ ++
Sbjct: 231 SYGTAADVFSLGLTILEVACNMELP--HGGEGWQQLRQGYLPPEFTAG---LSSELRSVL 285

Query: 390 EECWNEKPAKRPTFRQI 406
                  P  R T   +
Sbjct: 286 VMMLEPDPKLRATAEAL 302

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  164 bits (418), Expect = 8e-48
 Identities = 59/241 (24%), Positives = 111/241 (46%), Gaps = 13/241 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV--TQSSPMMIVTEYL 232
           G  +  K+L    +++ ++      E+ LL++++HPN+V++   +    ++ + IV EY 
Sbjct: 31  GKILVWKELDYGSMTEAEKQMLVS-EVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYC 89

Query: 233 PKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVP--IIHRDLEPSNILR 286
             GDL + + +    +  L     +R    +   +   H        ++HRDL+P+N+  
Sbjct: 90  EGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL 149

Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
           D   N+K+ DFG++++L        T   T   Y++PE      Y+ K D++S   +L E
Sbjct: 150 DGKQNVKLGDFGLARILNHDTSFAKTFVGTPY-YMSPEQMNRMSYNEKSDIWSLGCLLYE 208

Query: 347 MIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +    PPFT     E+       +      P + Y+  L E+I    N K   RP+  +I
Sbjct: 209 LCALMPPFTAFSQKELAGKIREGKFRRI--PYR-YSDELNEIITRMLNLKDYHRPSVEEI 265

Query: 407 I 407
           +
Sbjct: 266 L 266

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  160 bits (407), Expect = 4e-46
 Identities = 71/303 (23%), Positives = 127/303 (41%), Gaps = 50/303 (16%)

Query: 147 EYEIDPHEL-DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 200
            + +D     DF     I  G F     A  R  G    +K++        +  +A R E
Sbjct: 2   AHTVDKRFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRV------KYNNEKAER-E 54

Query: 201 LALLQKIRHPNVVQFLGA----------------VTQSSPMMIVTEYLPKGDLRAFLKRK 244
           +  L K+ H N+V + G                  +++  + I  E+  KG L  +++++
Sbjct: 55  VKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKR 114

Query: 245 GA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
               L    A+     I +G++Y+H  K   +I+RDL+PSNI   D+  +K+ DFG+   
Sbjct: 115 RGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQVKIGDFGLVTS 171

Query: 303 LTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHD 359
           L     R       S    RY++PE   +++Y  +VD+++  LIL E++  C        
Sbjct: 172 LKNDGKR-----TRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTA----- 221

Query: 360 NEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH 419
            E  K +   +         ++ +  K L+++  ++KP  RP   +I+  L     S   
Sbjct: 222 FETSKFFTDLRDGIIS---DIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSPEK 278

Query: 420 KRR 422
             R
Sbjct: 279 NER 281

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  158 bits (402), Expect = 3e-45
 Identities = 67/288 (23%), Positives = 110/288 (38%), Gaps = 48/288 (16%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF     + +G F   + A         A+KK+     +++        E+ LL  + H 
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIR---HTEEKLSTILS-EVMLLASLNHQ 62

Query: 211 NVVQFLGA-------------VTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFA 256
            VV++  A             V + S + I  EY   G L   +  +   +      R  
Sbjct: 63  YVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD- 315
             I   ++Y+H      IIHRDL+P NI  D+S N+K+ DFG++K +    D        
Sbjct: 123 RQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQN 179

Query: 316 ---------TSC---RYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
                    ++     YVA EV      Y+ K+D++S  +I  EMI   P  T      +
Sbjct: 180 LPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNI 237

Query: 363 PKAYAARQRPPFKAPAKL---YARGLKELIEECWNEKPAKRPTFRQII 407
                  +    + P        +  K++I    +  P KRP  R ++
Sbjct: 238 ---LKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLL 282

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  157 bits (399), Expect = 9e-45
 Identities = 56/259 (21%), Positives = 99/259 (38%), Gaps = 36/259 (13%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA------------VTQS 222
               A+K++      +  R +  R E+  L K+ HP +V++  A             +  
Sbjct: 30  DCNYAIKRIRLPN-RELAREKVMR-EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPK 87

Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDL 279
             + I  +   K +L+ ++  +  ++    S  +   L IA  + +LH      ++HRDL
Sbjct: 88  VYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDL 144

Query: 280 EPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS-----------CRYVAPEVFKN 328
           +PSNI       +KV DFG+   +   E+                      Y++PE    
Sbjct: 145 KPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG 204

Query: 329 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388
             Y  KVD+FS  LIL E++   P  T     E  +     +   F             +
Sbjct: 205 NSYSHKVDIFSLGLILFELL--YPFST---QMERVRTLTDVRNLKFPPLFTQKYPCEYVM 259

Query: 389 IEECWNEKPAKRPTFRQII 407
           +++  +  P +RP    II
Sbjct: 260 VQDMLSPSPMERPEAINII 278

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  156 bits (397), Expect = 2e-44
 Identities = 66/275 (24%), Positives = 121/275 (44%), Gaps = 20/275 (7%)

Query: 142 AREVPEYEIDPHEL-DFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVR 195
           A+E+PE  +DP     +     + KG F     I         A K + + ++    +  
Sbjct: 1   AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60

Query: 196 AFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRF 255
               E+++ + + H +VV F G    +  + +V E   +  L    KR+ AL    A  +
Sbjct: 61  KMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYY 120

Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
              I  G  YLH N+   +IHRDL+  N+  ++   +K+ DFG++  +    +R    + 
Sbjct: 121 LRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER----KK 173

Query: 316 TSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP 372
             C    Y+APEV   + +  +VDV+S   I+  ++ G PPF     + + + Y   ++ 
Sbjct: 174 VLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPF---ETSCLKETYLRIKKN 230

Query: 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            +  P  +       LI++     P  RPT  +++
Sbjct: 231 EYSIPKHI-NPVAASLIQKMLQTDPTARPTINELL 264

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  155 bits (395), Expect = 2e-44
 Identities = 60/236 (25%), Positives = 110/236 (46%), Gaps = 16/236 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
              +A+K L +  +         R E+ +   +RHPN+++  G    ++ + ++ EY P 
Sbjct: 34  KFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPL 93

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G +   L++           +  ++A  ++Y H  +   +IHRD++P N+L   +G LK+
Sbjct: 94  GTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKI 150

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           ADFG S         P + +   C    Y+ PE+ +   +D KVD++S  ++  E + G 
Sbjct: 151 ADFGWSVHA------PSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGK 204

Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           PPF     N   + Y    R  F  P  +   G ++LI       P++RP  R+++
Sbjct: 205 PPF---EANTYQETYKRISRVEFTFPDFV-TEGARDLISRLLKHNPSQRPMLREVL 256

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  155 bits (395), Expect = 2e-44
 Identities = 57/280 (20%), Positives = 105/280 (37%), Gaps = 43/280 (15%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I  G F        R  G   A+K+  + +    D   A R+  A     +H 
Sbjct: 12  EFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHS 71

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYL 266
           +VV++  A  +   M+I  EY   G L   +          K +      L + RG+ Y+
Sbjct: 72  HVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYI 131

Query: 267 HENKPVPIIHRDLEPSNILRDDSGNL-------------------KVADFGVSKLLTVKE 307
           H      ++H D++PSNI    +                      K+ D G    ++   
Sbjct: 132 HSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS--- 185

Query: 308 DRPLTCQDTSCRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366
             P   +    R++A EV + N  +  K D+F+ AL +       P    ++ ++    +
Sbjct: 186 -SPQVEEGD-SRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP--RNGDQW---H 238

Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
             RQ    + P    ++   EL++   +  P +RP+   +
Sbjct: 239 EIRQGRLPRIPQV-LSQEFTELLKVMIHPDPERRPSAMAL 277

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  155 bits (395), Expect = 5e-44
 Identities = 52/261 (19%), Positives = 102/261 (39%), Gaps = 26/261 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM----IVTE 230
           G   A+K++   +  +       + E  + +   HPN+++ +    +         ++  
Sbjct: 54  GHFYALKRI---LCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLP 110

Query: 231 YLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR 286
           +  +G L   ++R       L     +   L I RG+  +H        HRDL+P+NIL 
Sbjct: 111 FFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAK---GYAHRDLKPTNILL 167

Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTC--------QDTSCRYVAPEVFKNEEY---DTKV 335
            D G   + D G      +  +             Q  +  Y APE+F  + +   D + 
Sbjct: 168 GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERT 227

Query: 336 DVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNE 395
           DV+S   +L  M+ G  P+ M        A A + +       + ++  L +L+      
Sbjct: 228 DVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPR-HSSALWQLLNSMMTV 286

Query: 396 KPAKRPTFRQIITRLESINNS 416
            P +RP    ++++LE++   
Sbjct: 287 DPHQRPHIPLLLSQLEALQPP 307

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  156 bits (395), Expect = 7e-44
 Identities = 66/269 (24%), Positives = 107/269 (39%), Gaps = 26/269 (9%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE 200
            +YE        T+   + +G+F        +  G Q AVKK+  EV   +        E
Sbjct: 49  VDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFRVE--------E 100

Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIA 260
           L     +  P +V   GAV +   + I  E L  G L   +K+ G L    A+ +     
Sbjct: 101 LVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQAL 160

Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNL-KVADFGVSKLLTVKEDRPLTCQDTSCR 319
            G+ YLH  +   I+H D++  N+L    G+   + DFG +  L                
Sbjct: 161 EGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIP 217

Query: 320 ----YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--AARQRPP 373
               ++APEV   +  D KVD++S   ++  M+ GC P+T       P     A+   P 
Sbjct: 218 GTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWT--QYFRGPLCLKIASEPPPI 275

Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPT 402
            + P    A    + I+E   ++P  R +
Sbjct: 276 REIPPSC-APLTAQAIQEGLRKEPVHRAS 303

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  155 bits (394), Expect = 1e-43
 Identities = 56/236 (23%), Positives = 106/236 (44%), Gaps = 14/236 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
               A K + + ++    +      E+++ + + H +VV F G    +  + +V E   +
Sbjct: 66  KEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRR 125

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
             L    KR+ AL    A  +   I  G  YLH N+   +IHRDL+  N+  ++   +K+
Sbjct: 126 RSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKI 182

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
            DFG++  +    +R    +   C    Y+APEV   + +  +VDV+S   I+  ++ G 
Sbjct: 183 GDFGLATKVEYDGER----KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           PPF     + + + Y   ++  +  P  +       LI++     P  RPT  +++
Sbjct: 239 PPF---ETSCLKETYLRIKKNEYSIPKHI-NPVAASLIQKMLQTDPTARPTINELL 290

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  155 bits (393), Expect = 2e-43
 Identities = 55/249 (22%), Positives = 113/249 (45%), Gaps = 27/249 (10%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
               A+K +  E   +   + ++R+E+A L K++  +  +++          + +V E  
Sbjct: 33  KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 90

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
              DL ++LK+K ++ P     +  ++   ++ +H++    I+H DL+P+N L  D G L
Sbjct: 91  GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 146

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN-----------EEYDTKVDVF 338
           K+ DFG++  +  + D     +D+      Y+ PE  K+            +   K DV+
Sbjct: 147 KLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 204

Query: 339 SFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQRPPFKAPAKLYARGLKELIEECWNEKP 397
           S   IL  M  G  PF  +  N++ K +A        + P     + L+++++ C    P
Sbjct: 205 SLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIP-EKDLQDVLKCCLKRDP 262

Query: 398 AKRPTFRQI 406
            +R +  ++
Sbjct: 263 KQRISIPEL 271

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  153 bits (389), Expect = 2e-43
 Identities = 60/235 (25%), Positives = 108/235 (45%), Gaps = 16/235 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
              +A+K L +  +  +      R E+ +   +RHPN+++          + ++ E+ P+
Sbjct: 39  KFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPR 98

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L   L++ G      +  F  ++A  ++Y HE K   +IHRD++P N+L    G LK+
Sbjct: 99  GELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKI 155

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           ADFG S         P   + T C    Y+ PE+ + + +D KVD++   ++  E + G 
Sbjct: 156 ADFGWSVH------APSLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGM 209

Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           PPF         + +        K P  L + G K+LI +     P +R   + +
Sbjct: 210 PPF---DSPSHTETHRRIVNVDLKFPPFL-SDGSKDLISKLLRYHPPQRLPLKGV 260

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  154 bits (390), Expect = 2e-43
 Identities = 55/249 (22%), Positives = 113/249 (45%), Gaps = 27/249 (10%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
               A+K +  E   +   + ++R+E+A L K++  +  +++          + +V E  
Sbjct: 52  KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 109

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
              DL ++LK+K ++ P     +  ++   ++ +H++    I+H DL+P+N L  D G L
Sbjct: 110 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 165

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN-----------EEYDTKVDVF 338
           K+ DFG++  +  + D     +D+      Y+ PE  K+            +   K DV+
Sbjct: 166 KLIDFGIANQM--QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 223

Query: 339 SFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQRPPFKAPAKLYARGLKELIEECWNEKP 397
           S   IL  M  G  PF  +  N++ K +A        + P     + L+++++ C    P
Sbjct: 224 SLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIP-EKDLQDVLKCCLKRDP 281

Query: 398 AKRPTFRQI 406
            +R +  ++
Sbjct: 282 KQRISIPEL 290

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  154 bits (390), Expect = 1e-42
 Identities = 55/249 (22%), Positives = 113/249 (45%), Gaps = 27/249 (10%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYL 232
               A+K +  E   +   + ++R+E+A L K++  +  +++          + +V E  
Sbjct: 80  KQIYAIKYVNLEEADNQT-LDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC- 137

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
              DL ++LK+K ++ P     +  ++   ++ +H++    I+H DL+P+N L  D G L
Sbjct: 138 GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GML 193

Query: 293 KVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKN-----------EEYDTKVDVF 338
           K+ DFG++  +  + D     +D+      Y+ PE  K+            +   K DV+
Sbjct: 194 KLIDFGIANQM--QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVW 251

Query: 339 SFALILQEMIEGCPPFTMKHDNEVPKAYA-ARQRPPFKAPAKLYARGLKELIEECWNEKP 397
           S   IL  M  G  PF  +  N++ K +A        + P     + L+++++ C    P
Sbjct: 252 SLGCILYYMTYGKTPFQ-QIINQISKLHAIIDPNHEIEFPDIP-EKDLQDVLKCCLKRDP 309

Query: 398 AKRPTFRQI 406
            +R +  ++
Sbjct: 310 KQRISIPEL 318

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  149 bits (379), Expect = 6e-42
 Identities = 74/255 (29%), Positives = 118/255 (46%), Gaps = 27/255 (10%)

Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           + KGT+            +++A+K    E+   D    +   +E+AL + ++H N+VQ+L
Sbjct: 30  LGKGTYGIVYAGRDLSNQVRIAIK----EIPERDSRYSQPLHEEIALHKHLKHKNIVQYL 85

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAV--RFALDIARGMNYLHENKPVP 273
           G+ +++  + I  E +P G L A L+ K G LK +      +   I  G+ YLH+N+   
Sbjct: 86  GSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ--- 142

Query: 274 IIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE-- 330
           I+HRD++  N+L +  SG LK++DFG SK L        T   T   Y+APE+       
Sbjct: 143 IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQ-YMAPEIIDKGPRG 201

Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP---KAYAARQRPPFKAPAKLYARGLKE 387
           Y    D++S    + EM  G PPF  +         K    +  P    P  + A   K 
Sbjct: 202 YGKAADIWSLGCTIIEMATGKPPFY-ELGEPQAAMFKVGMFKVHPEI--PESMSAEA-KA 257

Query: 388 LIEECWNEKPAKRPT 402
            I +C+   P KR  
Sbjct: 258 FILKCFEPDPDKRAC 272

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  149 bits (379), Expect = 1e-41
 Identities = 64/237 (27%), Positives = 113/237 (47%), Gaps = 17/237 (7%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VA+K + +  ++     + FR E+ +++ + HPN+V+    +     + ++ EY   
Sbjct: 40  GREVAIKIIDKTQLNPTSLQKLFR-EVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASG 98

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G++  +L   G +K   A      I   + Y H+ +   I+HRDL+  N+L D   N+K+
Sbjct: 99  GEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKI 155

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEG 350
           ADFG S          L   D  C    Y APE+F+ ++YD  +VDV+S  +IL  ++ G
Sbjct: 156 ADFGFSNE--FTVGGKL---DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210

Query: 351 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             PF       + +      R  ++ P  + +   + L++      P KR T  QI+
Sbjct: 211 SLPF---DGQNLKELRERVLRGKYRIPFYM-STDCENLLKRFLVLNPIKRGTLEQIM 263

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  147 bits (373), Expect = 3e-41
 Identities = 59/237 (24%), Positives = 115/237 (48%), Gaps = 15/237 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G++VA+K + ++ +     V+  ++E+ +  +++HP++++       S+ + +V E    
Sbjct: 36  GLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHN 95

Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
           G++  +LK R      + A  F   I  GM YLH +    I+HRDL  SN+L   + N+K
Sbjct: 96  GEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIK 152

Query: 294 VADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
           +ADFG++  L +  ++      T C    Y++PE+     +  + DV+S   +   ++ G
Sbjct: 153 IADFGLATQLKMPHEK----HYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIG 208

Query: 351 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            PPF     + V           ++ P+ L +   K+LI +     PA R +   ++
Sbjct: 209 RPPF---DTDTVKNTLNKVVLADYEMPSFL-SIEAKDLIHQLLRRNPADRLSLSSVL 261

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  144 bits (366), Expect = 1e-39
 Identities = 65/298 (21%), Positives = 119/298 (39%), Gaps = 40/298 (13%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSP--------M 225
           G + A+K+L   + +++++ RA   E+  ++K+  HPN+VQF  A +             
Sbjct: 53  GREYALKRL---LSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEF 109

Query: 226 MIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           +++TE      +    K   +G L   T ++      R + ++H  KP PIIHRDL+  N
Sbjct: 110 LLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVEN 168

Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----------TSCRYVAPEVF---KNE 329
           +L  + G +K+ DFG +  ++   D   + Q            T+  Y  PE+     N 
Sbjct: 169 LLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF 228

Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389
               K D+++   IL  +     PF    D    +    +   P              LI
Sbjct: 229 PIGEKQDIWALGCILYLLCFRQHPF---EDGAKLRIVNGKYSIPPHDT---QYTVFHSLI 282

Query: 390 EECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSSPSS 447
                  P +R +  +++ +L+ I  + N   +  I  +     LE       ++ S 
Sbjct: 283 RAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITEL-----LEQNGGYGSATLSR 335

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  142 bits (360), Expect = 5e-39
 Identities = 54/303 (17%), Positives = 94/303 (31%), Gaps = 67/303 (22%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYL 232
           G   A+K            V     E  +L+K+ H N+V+      +++      + E+ 
Sbjct: 34  GDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91

Query: 233 PKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--- 286
           P G L   L+       L  S  +    D+  GMN+L EN    I+HR+++P NI+R   
Sbjct: 92  PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148

Query: 287 -DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK--------NEEYDTK 334
            D     K+ DFG ++ L   +D       +      Y+ P++++         ++Y   
Sbjct: 149 EDGQSVYKLTDFGAARELE--DDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203

Query: 335 VDVFSFALILQEMIEGCPPF----------------TMKHDNEVPKAYAARQRPPFKAPA 378
           VD++S  +       G  PF                     +         +  P     
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG 263

Query: 379 KLYARG---------LKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMK 429
            +             L  ++         K   F Q                   I    
Sbjct: 264 DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQF----------FAET--SDILHRG 311

Query: 430 CFH 432
             H
Sbjct: 312 NSH 314

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  141 bits (357), Expect = 6e-39
 Identities = 71/237 (29%), Positives = 114/237 (48%), Gaps = 16/237 (6%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G +VAVK L  + I   D V   + E+  L+  RHP++++    ++  +   +V EY+  
Sbjct: 36  GHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSG 95

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L  ++ + G ++   A R    I   ++Y H +    ++HRDL+P N+L D   N K+
Sbjct: 96  GELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKI 152

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEG 350
           ADFG+S ++   +   L    TSC    Y APEV     Y   +VD++S  +IL  ++ G
Sbjct: 153 ADFGLSNMM--SDGEFL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCG 207

Query: 351 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             PF    D  VP  +   +   F  P  L  R +  L+       P KR T + I 
Sbjct: 208 TLPF---DDEHVPTLFKKIRGGVFYIPEYL-NRSVATLLMHMLQVDPLKRATIKDIR 260

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  147 bits (373), Expect = 9e-39
 Identities = 71/286 (24%), Positives = 115/286 (40%), Gaps = 32/286 (11%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL------GAVTQSSPMMIV 228
           G QVA+K+   + +S  +R R    E+ +++K+ HPNVV           +  +   ++ 
Sbjct: 39  GEQVAIKQC-RQELSPKNRERWCL-EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLA 96

Query: 229 TEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
            EY   GDLR +L +      LK         DI+  + YLHEN+   IIHRDL+P NI+
Sbjct: 97  MEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIV 153

Query: 286 RDDSGN---LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFS 339
                     K+ D G +K L   +    T         +Y+APE+ + ++Y   VD +S
Sbjct: 154 LQPGPQRLIHKIIDLGYAKEL--DQGELCT---EFVGTLQYLAPELLEQKKYTVTVDYWS 208

Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK 399
           F  +  E I G  PF     N  P  +  + R        +Y      +        P  
Sbjct: 209 FGTLAFECITGFRPF---LPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNH 265

Query: 400 RPTFRQI-ITRLESINNSINHKRRWK---IRTMKCFHNLEAMLKKD 441
                   + R        + ++R        + CF  L+++L   
Sbjct: 266 LSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQALDSILSLK 311

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  143 bits (361), Expect = 2e-38
 Identities = 53/286 (18%), Positives = 93/286 (32%), Gaps = 55/286 (19%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYL 232
           G   A+K            V     E  +L+K+ H N+V+      +++      + E+ 
Sbjct: 34  GDLFAIKVFNNISFLRPVDV--QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFC 91

Query: 233 PKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--- 286
           P G L   L+       L  S  +    D+  GMN+L EN    I+HR+++P NI+R   
Sbjct: 92  PCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIG 148

Query: 287 -DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK--------NEEYDTK 334
            D     K+ DFG ++ L   +D       +      Y+ P++++         ++Y   
Sbjct: 149 EDGQSVYKLTDFGAARELE--DDEQFV---SLYGTEEYLHPDMYERAVLRKDHQKKYGAT 203

Query: 335 VDVFSFALILQEMIEGCPPFTMKHDNE----------------VPKAYAARQRPPFKAPA 378
           VD++S  +       G  PF                               +  P     
Sbjct: 204 VDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSG 263

Query: 379 KL---------YARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
            +             L  ++         K   F Q       I +
Sbjct: 264 DMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILH 309

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  139 bits (352), Expect = 4e-38
 Identities = 88/313 (28%), Positives = 142/313 (45%), Gaps = 36/313 (11%)

Query: 134 MAPMHVKHA-REVPEYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEV 187
           MA   V+     +   + DP EL FT   +I KG+F   F          VA+K +  E 
Sbjct: 1   MAHSPVQSGLPGMQNLKADPEEL-FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLE- 58

Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL 247
              +D +   + E+ +L +   P V ++ G+  + + + I+ EYL  G     L+     
Sbjct: 59  -EAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLD 117

Query: 248 KPSTAV--RFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV 305
           +   A   R  L   +G++YLH  K    IHRD++ +N+L  + G +K+ADFGV+  LT 
Sbjct: 118 ETQIATILREIL---KGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTD 171

Query: 306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365
            + +  T   T   ++APEV K   YD+K D++S  +   E+  G PP +  H       
Sbjct: 172 TQIKRNTFVGTPF-WMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELH------P 224

Query: 366 YAARQRPPFKAPAKL---YARGLKELIEECWNEKPAKRPT---------FRQIITRLESI 413
                  P   P  L   Y++ LKE +E C N++P+ RPT           +   +   +
Sbjct: 225 MKVLFLIPKNNPPTLEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAKKTSYL 284

Query: 414 NNSINHKRRWKIR 426
              I+  +RWK  
Sbjct: 285 TELIDRYKRWKAE 297

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  140 bits (353), Expect = 6e-38
 Identities = 49/242 (20%), Positives = 90/242 (37%), Gaps = 22/242 (9%)

Query: 180 VKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRA 239
             +  +  +S    + A   ++  +      N V  L   +    + I  +   K +L+ 
Sbjct: 91  KDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKD 150

Query: 240 FLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           ++ R+ +L+       +   + IA  + +LH      ++HRDL+PSNI       +KV D
Sbjct: 151 WMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGD 207

Query: 297 FGVSKLLTVKEDRPLTCQDTSCR-----------YVAPEVFKNEEYDTKVDVFSFALILQ 345
           FG+   +   E+                      Y++PE      Y  KVD+FS  LIL 
Sbjct: 208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILF 267

Query: 346 EMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
           E++      T     E  +     +   F             ++++  +  P +RP    
Sbjct: 268 ELL--YSFST---QMERVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERPEATD 322

Query: 406 II 407
           II
Sbjct: 323 II 324

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  136 bits (345), Expect = 5e-37
 Identities = 66/287 (22%), Positives = 127/287 (44%), Gaps = 23/287 (8%)

Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP +  +T   +I +G     +       G +VA++++    +    +     +E+ +++
Sbjct: 17  DPKKK-YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR 72

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           + ++PN+V +L +      + +V EYL  G L   +      +   A     +  + + +
Sbjct: 73  ENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEF 131

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
           LH N+   +IHRD++  NIL    G++K+ DFG    +T ++ +  T   T   ++APEV
Sbjct: 132 LHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY-WMAPEV 187

Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385
              + Y  KVD++S  ++  EMIEG PP+  ++        A    P  + P K  +   
Sbjct: 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEK-LSAIF 246

Query: 386 KELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRWK 424
           ++ +  C      KR +        F +I   L S+   I   +   
Sbjct: 247 RDFLNRCLEMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAAKEAT 293

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  135 bits (341), Expect = 1e-36
 Identities = 62/240 (25%), Positives = 108/240 (45%), Gaps = 18/240 (7%)

Query: 175 GIQVAVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
              VAVK +  +  +   + ++  + E+ + + + H NVV+F G   + +   +  EY  
Sbjct: 32  EEAVAVKIVDMKRAVDCPENIK--K-EICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88

Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            G+L   ++    +    A RF   +  G+ YLH      I HRD++P N+L D+  NLK
Sbjct: 89  GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK 145

Query: 294 VADFGVSKLLT-VKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMI 348
           ++DFG++ +      +R L   +  C    YVAPE+ K  E+    VDV+S  ++L  M+
Sbjct: 146 ISDFGLATVFRYNNRERLL---NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

Query: 349 EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY-ARGLKELIEECWNEKPAKRPTFRQII 407
            G  P+    D+   + Y+  +                  L+ +   E P+ R T   I 
Sbjct: 203 AGELPWDQPSDS--CQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVENPSARITIPDIK 260

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  136 bits (344), Expect = 1e-36
 Identities = 69/237 (29%), Positives = 118/237 (49%), Gaps = 17/237 (7%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
             +VA+K +  +++   D       E++ L+ +RHP++++    +T  + +++V EY   
Sbjct: 34  QQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-G 92

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G+L  ++  K  +      RF   I   + Y H +K   I+HRDL+P N+L DD+ N+K+
Sbjct: 93  GELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKI 149

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEG 350
           ADFG+S ++   +   L    TSC    Y APEV   + Y   +VDV+S  ++L  M+ G
Sbjct: 150 ADFGLSNIM--TDGNFL---KTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVG 204

Query: 351 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             PF    D  +P  +       +  P  L + G + LI       P +R T ++I 
Sbjct: 205 RLPF---DDEFIPNLFKKVNSCVYVMPDFL-SPGAQSLIRRMIVADPMQRITIQEIR 257

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  136 bits (344), Expect = 2e-36
 Identities = 59/290 (20%), Positives = 107/290 (36%), Gaps = 58/290 (20%)

Query: 165 KGTF---ILAFWRGIQVAVKKL--------------GEEVISDDDRVRAFRDELALLQKI 207
           +G F   IL        A+KK                 + IS   +   F++EL ++  I
Sbjct: 41  QGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDI 100

Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR------ 261
           ++   +   G +T    + I+ EY+    +  F +    L  +      + + +      
Sbjct: 101 KNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV 160

Query: 262 --GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 318
               +Y+H  K   I HRD++PSNIL D +G +K++DFG S+ +    D+ +     S  
Sbjct: 161 LNSFSYIHNEKN--ICHRDVKPSNILMDKNGRVKLSDFGESEYM---VDKKIK---GSRG 212

Query: 319 --RYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF 374
              ++ PE F NE      KVD++S  + L  M     PF       + + +   +    
Sbjct: 213 TYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPF--SLKISLVELFNNIRTKNI 270

Query: 375 KAPAKLYAR------------------GLKELIEECWNEKPAKRPTFRQI 406
           + P                           + ++    + PA+R T    
Sbjct: 271 EYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  135 bits (341), Expect = 3e-36
 Identities = 55/243 (22%), Positives = 99/243 (40%), Gaps = 28/243 (11%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
             +V VK     K+ E+   +D ++     E+A+L ++ H N+++ L          +V 
Sbjct: 49  NKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVM 108

Query: 230 E-YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           E +    DL AF+ R   L    A      +   + YL       IIHRD++  NI+  +
Sbjct: 109 EKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAE 165

Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALIL 344
              +K+ DFG +    ++  +      T C    Y APEV     Y   +++++S  + L
Sbjct: 166 DFTIKLIDFGSAAY--LERGKLF---YTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220

Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
             ++    PF      E+ +   A   PP+          L  L+       P +R T  
Sbjct: 221 YTLVFEENPF-----CELEETVEAAIHPPYLVSK-----ELMSLVSGLLQPVPERRTTLE 270

Query: 405 QII 407
           +++
Sbjct: 271 KLV 273

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  134 bits (339), Expect = 5e-36
 Identities = 65/287 (22%), Positives = 119/287 (41%), Gaps = 23/287 (8%)

Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP  L   + V+I +G+  +         G QVAVK +    +    R     +E+ +++
Sbjct: 42  DPRLL-LDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR 97

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
             +H NVV+   +      + ++ E+L  G L   +  +  L           + + + Y
Sbjct: 98  DYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAVLQALAY 156

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV 325
           LH      +IHRD++  +IL    G +K++DFG    ++    +  +   T   ++APEV
Sbjct: 157 LHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPY-WMAPEV 212

Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL 385
                Y T+VD++S  +++ EM++G PP+      +  K       P  K   K  +  L
Sbjct: 213 ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHK-VSPVL 271

Query: 386 KELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRWK 424
           ++ +E      P +R T        F       E +   I   R+  
Sbjct: 272 RDFLERMLVRDPQERATAQELLDHPFLLQTGLPECLVPLIQLYRKQT 318

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  137 bits (347), Expect = 6e-36
 Identities = 82/282 (29%), Positives = 128/282 (45%), Gaps = 26/282 (9%)

Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVIS 189
            PM  K   +     I  + L  T    +  GTF    +      G +VAVK L  + I 
Sbjct: 1   GPMAEKQKHDGRVK-IGHYILGDT----LGVGTFGKVKVGKHELTGHKVAVKILNRQKIR 55

Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
             D V   R E+  L+  RHP++++    ++  S + +V EY+  G+L  ++ + G L  
Sbjct: 56  SLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDE 115

Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR 309
             + R    I  G++Y H +    ++HRDL+P N+L D   N K+ADFG+S ++   +  
Sbjct: 116 KESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMM--SDGE 170

Query: 310 PLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA 365
            L    TSC    Y APEV     Y   +VD++S  +IL  ++ G  PF    D+ VP  
Sbjct: 171 FL---RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPF---DDDHVPTL 224

Query: 366 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           +       F  P  L    +  L++      P KR T + I 
Sbjct: 225 FKKICDGIFYTPQYL-NPSVISLLKHMLQVDPMKRATIKDIR 265

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score =  133 bits (338), Expect = 6e-36
 Identities = 64/271 (23%), Positives = 111/271 (40%), Gaps = 46/271 (16%)

Query: 175 GIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
              VAVKKL   V    +   + F  E+ ++ K +H N+V+ LG  +    + +V  Y+P
Sbjct: 54  NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMP 113

Query: 234 KGDLRAFLKRKGALKP---STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
            G L   L       P       + A   A G+N+LHEN     IHRD++ +NIL D++ 
Sbjct: 114 NGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHEN---HHIHRDIKSANILLDEAF 170

Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCR------YVAPEVFKNEEYDT-----KVDVFS 339
             K++DFG+++               + R      Y+AP      E        K D++S
Sbjct: 171 TAKISDFGLARASEKFAQ-----TVMTSRIVGTTAYMAP------EALRGEITPKSDIYS 219

Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL-----------YARGLKEL 388
           F ++L E+I G P      + ++                 +            +  ++ +
Sbjct: 220 FGVVLLEIITGLPAVDEHREPQLLLDIK---EEIEDEEKTIEDYIDKKMNDADSTSVEAM 276

Query: 389 IE---ECWNEKPAKRPTFRQIITRLESINNS 416
                +C +EK  KRP  +++   L+ +  S
Sbjct: 277 YSVASQCLHEKKNKRPDIKKVQQLLQEMTAS 307

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  134 bits (338), Expect = 6e-36
 Identities = 61/245 (24%), Positives = 103/245 (42%), Gaps = 32/245 (13%)

Query: 175 GIQVAVKKLGEEVISD----DDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSSPMMIV 228
            + VA+K + ++ ISD     +  R    E+ LL+K+      V++ L    +    +++
Sbjct: 68  NLPVAIKHVEKDRISDWGELPNGTRVPM-EVVLLKKVSSGFSGVIRLLDWFERPDSFVLI 126

Query: 229 TEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
            E   P  DL  F+  +GAL+   A  F   +   + + H      ++HRD++  NIL D
Sbjct: 127 LERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILID 183

Query: 288 -DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFAL 342
            + G LK+ DFG   LL    D              Y  PE  +   Y      V+S  +
Sbjct: 184 LNRGELKLIDFGSGALLK---DTVY---TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGI 237

Query: 343 ILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402
           +L +M+ G  PF     +E  +    +     +  +       + LI  C   +P+ RPT
Sbjct: 238 LLYDMVCGDIPF---EHDE--EIIRGQVFFRQRVSS-----ECQHLIRWCLALRPSDRPT 287

Query: 403 FRQII 407
           F +I 
Sbjct: 288 FEEIQ 292

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  133 bits (337), Expect = 7e-36
 Identities = 59/218 (27%), Positives = 102/218 (46%), Gaps = 24/218 (11%)

Query: 200 ELALLQKIRHPNVVQF---LGAVTQSSPMMIVTEYLPKGDLRAF-LKRKGALKPSTAVRF 255
           E+A+L+K+ HPNVV+    L    +   + +V E + +G +    +     L    A  +
Sbjct: 86  EIAILKKLDHPNVVKLVEVLDDPNEDH-LYMVFELVNQGPV--MEVPTLKPLSEDQARFY 142

Query: 256 ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD 315
             D+ +G+ YLH  K   IIHRD++PSN+L  + G++K+ADFGVS       D  L+   
Sbjct: 143 FQDLIKGIEYLHYQK---IIHRDIKPSNLLVGEDGHIKIADFGVSNEFK-GSDALLS--- 195

Query: 316 TSC---RYVAPEVFKNE--EYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR 369
            +     ++APE        +    +DV++  + L   + G  PF    D  +   ++  
Sbjct: 196 NTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPF---MDERIMCLHSKI 252

Query: 370 QRPPFKAPAKLY-ARGLKELIEECWNEKPAKRPTFRQI 406
           +    + P +   A  LK+LI    ++ P  R    +I
Sbjct: 253 KSQALEFPDQPDIAEDLKDLITRMLDKNPESRIVVPEI 290

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  133 bits (336), Expect = 9e-36
 Identities = 60/231 (25%), Positives = 105/231 (45%), Gaps = 14/231 (6%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           +VA+K +       ++ ++ F  E+    ++ H N+V  +    +     +V EY+    
Sbjct: 38  KVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPT 97

Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L  +++  G L   TA+ F   I  G+ + H+ +   I+HRD++P NIL D +  LK+ D
Sbjct: 98  LSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFD 154

Query: 297 FGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
           FG++K L+   +  LT  +    + +Y +PE  K E  D   D++S  ++L EM+ G PP
Sbjct: 155 FGIAKALS---ETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPP 211

Query: 354 FTMKHDNEVPKAYAARQRPPFKAPAKLYAR---GLKELIEECWNEKPAKRP 401
           F    +  V  A    Q         +       L  +I     +  A R 
Sbjct: 212 FN--GETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRY 260

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  132 bits (335), Expect = 2e-35
 Identities = 63/242 (26%), Positives = 107/242 (44%), Gaps = 22/242 (9%)

Query: 175 GIQVAVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP 233
              VAVK +  +  +   + ++  + E+ + + + H NVV+F G   + +   +  EY  
Sbjct: 32  EEAVAVKIVDMKRAVDCPENIK--K-EICINKMLNHENVVKFYGHRREGNIQYLFLEYCS 88

Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            G+L   ++    +    A RF   +  G+ YLH      I HRD++P N+L D+  NLK
Sbjct: 89  GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLK 145

Query: 294 VADFGVSKLLT-VKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMI 348
           ++DFG++ +      +R L   +  C    YVAPE+ K  E+    VDV+S  ++L  M+
Sbjct: 146 ISDFGLATVFRYNNRERLL---NKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAML 202

Query: 349 EGCPPFTMKHDNEVP---KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
            G  P+    D+               P+K            L+ +   E P+ R T   
Sbjct: 203 AGELPWDQPSDSCQEYSDWKEKKTYLNPWKK----IDSAPLALLHKILVENPSARITIPD 258

Query: 406 II 407
           I 
Sbjct: 259 IK 260

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  130 bits (328), Expect = 2e-34
 Identities = 67/247 (27%), Positives = 101/247 (40%), Gaps = 34/247 (13%)

Query: 175 GIQVAVKKLG----EEVISDDDRVRAFRDELALLQKIR----HPNVVQFLGAVTQSSPMM 226
            +QVA+K +            D V     E+ALL K+     HP V++ L         M
Sbjct: 56  RLQVAIKVIPRNRVLGWSPLSDSVTCPL-EVALLWKVGAGGGHPGVIRLLDWFETQEGFM 114

Query: 227 IVTEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           +V E  LP  DL  ++  KG L    +  F   +   + + H      ++HRD++  NIL
Sbjct: 115 LVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENIL 171

Query: 286 RD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSF 340
            D   G  K+ DFG   LL    D P            Y  PE     +Y      V+S 
Sbjct: 172 IDLRRGCAKLIDFGSGALL---HDEPY---TDFDGTRVYSPPEWISRHQYHALPATVWSL 225

Query: 341 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
            ++L +M+ G  PF  + D E+ +A           PA + +     LI  C   KP+ R
Sbjct: 226 GILLYDMVCGDIPF--ERDQEILEA-------ELHFPAHV-SPDCCALIRRCLAPKPSSR 275

Query: 401 PTFRQII 407
           P+  +I+
Sbjct: 276 PSLEEIL 282

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  129 bits (327), Expect = 2e-34
 Identities = 49/197 (24%), Positives = 79/197 (40%), Gaps = 16/197 (8%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD 236
            VA+K + E + SD       + E     +++ P+VV           + +    +   D
Sbjct: 61  IVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVD 120

Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L A L+R+G L P  AV     I   ++  H        HRD++P NIL        + D
Sbjct: 121 LAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVD 177

Query: 297 FGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
           FG++   T   D  LT       +  Y+APE F       + D+++   +L E + G PP
Sbjct: 178 FGIASATT---DEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPP 234

Query: 354 FT-------MKHDNEVP 363
           +          H N+  
Sbjct: 235 YQGDQLSVMGAHINQAI 251

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  129 bits (326), Expect = 3e-34
 Identities = 66/272 (24%), Positives = 110/272 (40%), Gaps = 31/272 (11%)

Query: 156 DFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           D+     I  G   +        +  +VA+K++  E       +     E+  + +  HP
Sbjct: 16  DYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLE--KCQTSMDELLKEIQAMSQCHHP 73

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFA-LDIA-------RG 262
           N+V +  +      + +V + L  G +   +K   A     +       IA        G
Sbjct: 74  NIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD-----TS 317
           + YLH+N     IHRD++  NIL  + G++++ADFGVS  L    D            T 
Sbjct: 134 LEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTP 190

Query: 318 CRYVAPEVFK-NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376
           C ++APEV +    YD K D++SF +   E+  G  P+      +V         P  + 
Sbjct: 191 C-WMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLET 249

Query: 377 PA------KLYARGLKELIEECWNEKPAKRPT 402
                   K Y +  +++I  C  + P KRPT
Sbjct: 250 GVQDKEMLKKYGKSFRKMISLCLQKDPEKRPT 281

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  129 bits (327), Expect = 5e-34
 Identities = 66/279 (23%), Positives = 111/279 (39%), Gaps = 63/279 (22%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G+ +A K +  E I    R +  R EL +L +   P +V F GA      + I  E++  
Sbjct: 58  GLVMARKLIHLE-IKPAIRNQIIR-ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDG 115

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           G L   LK+ G +      + ++ + +G+ YL E     I+HRD++PSNIL +  G +K+
Sbjct: 116 GSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK--IMHRDVKPSNILVNSRGEIKL 173

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCR-------YVAPEVFKNEEYDTKVDVFSFALILQEM 347
            DFGVS  L           D+          Y++PE  +   Y  + D++S  L L EM
Sbjct: 174 CDFGVSGQLI----------DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223

Query: 348 IEGCPPFTMKHDNEVPKAYAA--------------------------------------- 368
             G  P       E+   +                                         
Sbjct: 224 AVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDY 283

Query: 369 --RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
              + PP K P+ +++   ++ + +C  + PA+R   +Q
Sbjct: 284 IVNEPPP-KLPSGVFSLEFQDFVNKCLIKNPAERADLKQ 321

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  128 bits (323), Expect = 5e-34
 Identities = 57/272 (20%), Positives = 115/272 (42%), Gaps = 24/272 (8%)

Query: 148 YEIDPHELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELA 202
            E+   +L+     E+ +G +     +     G  +AVK++   V +  ++ R   D   
Sbjct: 2   MEVKADDLEPIM--ELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDI 58

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG---DLRAFLKRKGALKPSTAVRFALDI 259
            ++ +  P  V F GA+ +   + I  E +        +  + +   +      + A+ I
Sbjct: 59  SMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSI 118

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
            + + +LH      +IHRD++PSN+L +  G +K+ DFG+S  L     +     D  C+
Sbjct: 119 VKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAK---DIDAGCK 173

Query: 320 -YVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPF-TMKHDNEVPKAYAARQRPP 373
            Y+APE    E     Y  K D++S  + + E+     P+ +     +        + P 
Sbjct: 174 PYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ--LKQVVEEPS 231

Query: 374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
            + PA  ++    +   +C  +   +RPT+ +
Sbjct: 232 PQLPADKFSAEFVDFTSQCLKKNSKERPTYPE 263

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  129 bits (325), Expect = 5e-34
 Identities = 68/290 (23%), Positives = 129/290 (44%), Gaps = 25/290 (8%)

Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
            P E+ F    ++ +G++   +       G  VA+K      +  +  ++    E++++Q
Sbjct: 26  QPEEV-FDVLEKLGEGSYGSVYKAIHKETGQIVAIK-----QVPVESDLQEIIKEISIMQ 79

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
           +   P+VV++ G+  +++ + IV EY   G +   ++ R   L             +G+ 
Sbjct: 80  QCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE 139

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
           YLH  +    IHRD++  NIL +  G+ K+ADFGV+  LT    +  T   T   ++APE
Sbjct: 140 YLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPF-WMAPE 195

Query: 325 VFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384
           V +   Y+   D++S  +   EM EG PP+   H             P F+ P   ++  
Sbjct: 196 VIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL-WSDN 254

Query: 385 LKELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRWKIR 426
             + +++C  + P +R T        F +    +  + + IN     K++
Sbjct: 255 FTDFVKQCLVKSPEQRATATQLLQHPFVRSAKGVSILRDLINEAMDVKLK 304

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  129 bits (327), Expect = 6e-34
 Identities = 74/288 (25%), Positives = 114/288 (39%), Gaps = 40/288 (13%)

Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVIS 189
            P+ +    +   Y+            +I  G F    L   +     VAVK +      
Sbjct: 9   GPLDMPIMHDSDRYDFVK---------DIGSGNFGVARLMRDKLTKELVAVKYIERGAA- 58

Query: 190 DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP 249
            D+ V+  R E+   + +RHPN+V+F   +   + + I+ EY   G+L   +   G    
Sbjct: 59  IDENVQ--R-EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSE 115

Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE 307
             A  F   +  G++Y H  +   I HRDL+  N L D S    LK+ DFG SK      
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSS--VL 170

Query: 308 DRPLTCQDTSC---RYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
                   ++     Y+APEV   +EYD    DV+S  + L  M+ G  PF    D E P
Sbjct: 171 HSQP---KSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPF---EDPEEP 224

Query: 364 KAYAAR----QRPPFKAPAKLY-ARGLKELIEECWNEKPAKRPTFRQI 406
           + Y           +  P  +  +     LI   +   PA R +  +I
Sbjct: 225 RDYRKTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRISIPEI 272

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  128 bits (323), Expect = 8e-34
 Identities = 60/270 (22%), Positives = 117/270 (43%), Gaps = 19/270 (7%)

Query: 147 EYEIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDEL 201
            Y+ + ++L+     E+  GT    +       G  +AVK++     + ++  R   D  
Sbjct: 19  RYQAEINDLENLG--EMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG-NKEENKRILMDLD 75

Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 261
            +L+    P +VQ  G    ++ + I  E +     +   + +G +      +  + I +
Sbjct: 76  VVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVK 135

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-Y 320
            + YL E     +IHRD++PSNIL D+ G +K+ DFG+S  L   + +    +   C  Y
Sbjct: 136 ALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAK---DRSAGCAAY 190

Query: 321 VAPEVFKNEE-----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK 375
           +APE     +     YD + DV+S  + L E+  G  P+     +        ++ PP  
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL 250

Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQ 405
                ++   +  +++C  +   KRP + +
Sbjct: 251 PGHMGFSGDFQSFVKDCLTKDHRKRPKYNK 280

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  130 bits (329), Expect = 9e-34
 Identities = 60/249 (24%), Positives = 105/249 (42%), Gaps = 28/249 (11%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
             +VA++     K       + D       E+ +L+K+ HP +++       +    IV 
Sbjct: 160 CKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 218

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---R 286
           E +  G+L   +     LK +T   +   +   + YLHEN    IIHRDL+P N+L   +
Sbjct: 219 ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQ 275

Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---YDTKVDVFSF 340
           ++   +K+ DFG SK+  + E   +    T C    Y+APEV  +     Y+  VD +S 
Sbjct: 276 EEDCLIKITDFGHSKI--LGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 330

Query: 341 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR---GLKELIEECWNEKP 397
            +IL   + G PPF+                  +    +++A       +L+++     P
Sbjct: 331 GVILFICLSGYPPFS--EHRTQVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDP 388

Query: 398 AKRPTFRQI 406
             R T  + 
Sbjct: 389 KARFTTEEA 397

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  127 bits (322), Expect = 1e-33
 Identities = 57/244 (23%), Positives = 101/244 (41%), Gaps = 22/244 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTE 230
             + AVK L ++ +           + E+ LL+++RH NV+Q +  +       +  V E
Sbjct: 30  LCRRAVKILKKKKLRRIPNGEANVKK-EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVME 88

Query: 231 YLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           Y   G         +       A  +   +  G+ YLH      I+H+D++P N+L    
Sbjct: 89  YCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTG 145

Query: 290 GNLKVADFGVSKLL-TVKEDRPLTCQDTSC---RYVAPEVFKNEE-YD-TKVDVFSFALI 343
           G LK++  GV++ L     D       TS     +  PE+    + +   KVD++S  + 
Sbjct: 146 GTLKISALGVAEALHPFAADDTC---RTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVT 202

Query: 344 LQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTF 403
           L  +  G  PF     + + K +    +  +  P       L +L++     +PAKR + 
Sbjct: 203 LYNITTGLYPF---EGDNIYKLFENIGKGSYAIPGDC-GPPLSDLLKGMLEYEPAKRFSI 258

Query: 404 RQII 407
           RQI 
Sbjct: 259 RQIR 262

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score =  128 bits (323), Expect = 1e-33
 Identities = 61/266 (22%), Positives = 107/266 (40%), Gaps = 42/266 (15%)

Query: 175 GIQVAVKKLGEEVISDDDR--VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL 232
           G +VA+K+      + +    +  F  E+  L   RHP++V  +G   + + M+++ +Y+
Sbjct: 63  GAKVALKRR-----TPESSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYM 117

Query: 233 PKGDLRAFLKRKGALKP----STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
             G+L+  L               +   +  ARG++YLH      IIHRD++  NIL D+
Sbjct: 118 ENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTR---AIIHRDVKSINILLDE 174

Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDT--SCR------YVAPEVFKNEEYDTKVDVFSF 340
           +   K+ DFG+SK  T  +        T  S        Y+ PE F       K DV+SF
Sbjct: 175 NFVPKITDFGISKKGTELD-------QTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSF 227

Query: 341 ALILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFKA------PAKLYARGLK---E 387
            ++L E++            E       A  +      +         K+    L+   +
Sbjct: 228 GVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGD 287

Query: 388 LIEECWNEKPAKRPTFRQIITRLESI 413
              +C       RP+   ++ +LE  
Sbjct: 288 TAVKCLALSSEDRPSMGDVLWKLEYA 313

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  129 bits (326), Expect = 2e-33
 Identities = 63/258 (24%), Positives = 101/258 (39%), Gaps = 31/258 (12%)

Query: 166 GTFILA-FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223
           GT +    +    VAVK++  E  S  DR      E+ LL++   HPNV+++        
Sbjct: 38  GTIVYRGMFDNRDVAVKRILPECFSFADR------EVQLLRESDEHPNVIRYFCTEKDRQ 91

Query: 224 PMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
              I  E      L+ ++++K  A      +        G+ +LH      I+HRDL+P 
Sbjct: 92  FQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPH 147

Query: 283 NILRDDSGN-----LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFK---NEEY 331
           NIL             ++DFG+ K L        + +        ++APE+      E  
Sbjct: 148 NILISMPNAHGKIKAMISDFGLCKKLA-VGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206

Query: 332 DTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKA--PAKLYARGLKEL 388
              VD+FS   +   +I EG  PF     +   +A             P K      +EL
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHPF---GKSLQRQANILLGACSLDCLHPEKHEDVIAREL 263

Query: 389 IEECWNEKPAKRPTFRQI 406
           IE+     P KRP+ + +
Sbjct: 264 IEKMIAMDPQKRPSAKHV 281

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  126 bits (320), Expect = 3e-33
 Identities = 62/240 (25%), Positives = 106/240 (44%), Gaps = 27/240 (11%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL--GAVTQSSPMM--IVTEYL 232
            VAVK L  ++  D      FR E      + HP +V     G     +  +  IV EY+
Sbjct: 39  DVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYV 98

Query: 233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL 292
               LR  +  +G + P  A+    D  + +N+ H+N    IIHRD++P+NI+   +  +
Sbjct: 99  DGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAV 155

Query: 293 KVADFGVSKLLTVKEDRPLTCQDT---SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
           KV DFG+++ +       +T       + +Y++PE  + +  D + DV+S   +L E++ 
Sbjct: 156 KVMDFGIARAIA-DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLT 214

Query: 350 GCPPFT--------MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           G PPFT         +H  E P         P  A  +  +  L  ++ +   + P  R 
Sbjct: 215 GEPPFTGDSPVSVAYQHVREDP--------IPPSARHEGLSADLDAVVLKALAKNPENRY 266

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  129 bits (325), Expect = 7e-33
 Identities = 62/236 (26%), Positives = 112/236 (47%), Gaps = 11/236 (4%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G + AVK + +  +       +   E+ LL+++ HPN+++            +V E    
Sbjct: 51  GQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTG 110

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +       A R    +  G+ Y+H+NK   I+HRDL+P N+L   +    N
Sbjct: 111 GELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDAN 167

Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +++ DFG+S     +  + +  +  +  Y+APEV     YD K DV+S  +IL  ++ GC
Sbjct: 168 IRIIDFGLSTH--FEASKKMKDKIGTAYYIAPEVLH-GTYDEKCDVWSTGVILYILLSGC 224

Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQI 406
           PPF   ++ ++ K    + +  F+ P  K  +   K+LI +     P+ R + R  
Sbjct: 225 PPFNGANEYDILKK-VEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRISARDA 279

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  125 bits (316), Expect = 9e-33
 Identities = 56/194 (28%), Positives = 90/194 (46%), Gaps = 23/194 (11%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
             +VA+K     K       + D       E+ +L+K+ HP +++       +    IV 
Sbjct: 35  CKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFF-DAEDYYIVL 93

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---R 286
           E +  G+L   +     LK +T   +   +   + YLHEN    IIHRDL+P N+L   +
Sbjct: 94  ELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQ 150

Query: 287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---YDTKVDVFSF 340
           ++   +K+ DFG SK+  + E   +    T C    Y+APEV  +     Y+  VD +S 
Sbjct: 151 EEDCLIKITDFGHSKI--LGETSLMR---TLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL 205

Query: 341 ALILQEMIEGCPPF 354
            +IL   + G PPF
Sbjct: 206 GVILFICLSGYPPF 219

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  123 bits (312), Expect = 2e-32
 Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 29/245 (11%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G++ A K +  + +S  D  +    E  + +K++HPN+V+   ++ + S   +V + +  
Sbjct: 31  GLEFAAKIINTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTG 89

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +     + A      I   + Y H N    I+HR+L+P N+L   +     
Sbjct: 90  GELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAA 146

Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
           +K+ADFG++    V +               Y++PEV K + Y   VD+++  +IL  ++
Sbjct: 147 VKLADFGLAIE--VNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILL 201

Query: 349 EGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNEKPAKRP 401
            G PPF  +  + +     A       P +      A       K LI+      P KR 
Sbjct: 202 VGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA-------KSLIDSMLTVNPKKRI 254

Query: 402 TFRQI 406
           T  Q 
Sbjct: 255 TADQA 259

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  122 bits (308), Expect = 1e-31
 Identities = 63/263 (23%), Positives = 115/263 (43%), Gaps = 37/263 (14%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
            +  G F    L   R  G   A+K + +     D  +    +E+A+L+KI+H N+V   
Sbjct: 16  VLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIAVLKKIKHENIVTLE 72

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
                ++   +V + +  G+L   +  +G      A      +   + YLHEN    I+H
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVH 129

Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE 330
           RDL+P N+L    +++  + + DFG+SK+    ++  ++   T+C    YVAPEV   + 
Sbjct: 130 RDLKPENLLYLTPEENSKIMITDFGLSKME---QNGIMS---TACGTPGYVAPEVLAQKP 183

Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYAR 383
           Y   VD +S  +I   ++ G PPF  + ++++ +           P +      A     
Sbjct: 184 YSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESA----- 238

Query: 384 GLKELIEECWNEKPAKRPTFRQI 406
             K+ I     + P +R T  + 
Sbjct: 239 --KDFICHLLEKDPNERYTCEKA 259

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  122 bits (307), Expect = 1e-31
 Identities = 66/302 (21%), Positives = 125/302 (41%), Gaps = 40/302 (13%)

Query: 149 EIDPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
           ++DP+E+ +    E+  G F   +       G   A K +       ++ +  +  E+ +
Sbjct: 14  DLDPNEV-WEIVGELGDGAFGKVYKAKNKETGALAAAKVIE---TKSEEELEDYIVEIEI 69

Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFAL-DIARG 262
           L    HP +V+ LGA      + I+ E+ P G + A +           ++     +   
Sbjct: 70  LATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEA 129

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV- 321
           +N+LH  +   IIHRDL+  N+L    G++++ADFGVS        +  +       ++ 
Sbjct: 130 LNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS-------FIG 179

Query: 322 -----APEV-----FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
                APEV      K+  YD K D++S  + L EM +  PP    +   V    A    
Sbjct: 180 TPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDP 239

Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRW 423
           P    P+K ++   ++ ++   ++ P  RP+        F   IT  +++   +   +  
Sbjct: 240 PTLLTPSK-WSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAE 298

Query: 424 KI 425
            +
Sbjct: 299 VM 300

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  125 bits (316), Expect = 1e-31
 Identities = 59/236 (25%), Positives = 117/236 (49%), Gaps = 12/236 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            ++ A+K + +  +S     +   +E+A+L+ + HPN+++            +V E    
Sbjct: 62  HVERAIKIIRKTSVSTSSNSK-LLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  +       A      +  G+ YLH++    I+HRDL+P N+L   ++    
Sbjct: 121 GELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDAL 177

Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +K+ DFG+S +   +  + +  +  +  Y+APEV + ++YD K DV+S  +IL  ++ G 
Sbjct: 178 IKIVDFGLSAV--FENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGY 234

Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQI 406
           PPF  + D E+ +    + +  F +P  K  + G K+LI++       +R + +Q 
Sbjct: 235 PPFGGQTDQEILRK-VEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQA 289

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  120 bits (304), Expect = 2e-31
 Identities = 57/239 (23%), Positives = 103/239 (43%), Gaps = 20/239 (8%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            I+ A KK+ +  + D DR +    E+ +++ + HPN+++       ++ + +V E    
Sbjct: 34  RIRRAAKKIPKYFVEDVDRFK---QEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTG 90

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   +  K   + S A R   D+   + Y H+     + HRDL+P N L         
Sbjct: 91  GELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSP 147

Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
           LK+ DFG++     K  + +    T      YV+P+V +   Y  + D +S  +++  ++
Sbjct: 148 LKLIDFGLAAR--FKPGKMMR---TKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLL 201

Query: 349 EGCPPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQI 406
            G PPF+   D+EV           F        +   + LI     + P +R T  Q 
Sbjct: 202 CGYPPFSAPTDSEVMLK-IREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  120 bits (304), Expect = 2e-31
 Identities = 57/242 (23%), Positives = 106/242 (43%), Gaps = 22/242 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G++  +K + ++       +     E+ +L+ + HPN+++          M IV E    
Sbjct: 47  GLERVIKTINKDRSQVP--MEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEG 104

Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RD 287
           G+L     +   R  AL           +   + Y H      ++H+DL+P NIL     
Sbjct: 105 GELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTS 161

Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALIL 344
               +K+ DFG+++L   K D   T    +     Y+APEVFK  +   K D++S  +++
Sbjct: 162 PHSPIKIIDFGLAEL--FKSDEHST---NAAGTALYMAPEVFK-RDVTFKCDIWSAGVVM 215

Query: 345 QEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
             ++ GC PFT     EV +  A  + P +    +       +L+++   + P +RP+  
Sbjct: 216 YFLLTGCLPFTGTSLEEVQQK-ATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRPSAA 274

Query: 405 QI 406
           Q+
Sbjct: 275 QV 276

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  121 bits (306), Expect = 3e-31
 Identities = 68/276 (24%), Positives = 119/276 (43%), Gaps = 26/276 (9%)

Query: 147 EYEIDPHELDFTNSVEITKGTF-----ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDEL 201
            ++    +L      EI +G +     ++    G  +AVK++   V  + ++ +   D  
Sbjct: 16  HWDFTAEDLKDLG--EIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV-DEKEQKQLLMDLD 72

Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST-----AVRFA 256
            +++    P +VQF GA+ +     I  E +       F K   ++           +  
Sbjct: 73  VVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKIT 131

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
           L   + +N+L EN    IIHRD++PSNIL D SGN+K+ DFG+S  L    D     +D 
Sbjct: 132 LATVKALNHLKENLK--IIHRDIKPSNILLDRSGNIKLCDFGISGQLV---DSIAKTRDA 186

Query: 317 SCR-YVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR 371
            CR Y+APE          YD + DV+S  + L E+  G  P+   +          +  
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246

Query: 372 PP--FKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
           PP    +  + ++      +  C  +  +KRP +++
Sbjct: 247 PPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKE 282

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  122 bits (308), Expect = 3e-31
 Identities = 54/335 (16%), Positives = 104/335 (31%), Gaps = 68/335 (20%)

Query: 134 MAPMHVKHAREVPEYEI----DPHELDFTNSVEITKGTFILAF-WRGIQ------VAVKK 182
           MA  H  H   +    +          +     I KG   L              V V++
Sbjct: 1   MAHHHHHHMENLYFQGMSSFLPEGG-CYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRR 59

Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
           +  E  S++  V   + EL + +   HPN+V +       + + +VT ++  G  +  + 
Sbjct: 60  INLEACSNEM-VTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLIC 118

Query: 243 --RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS 300
                 +           + + ++Y+H       +HR ++ S+IL    G + ++    +
Sbjct: 119 THFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSN 175

Query: 301 KLLTVKEDRPLTCQDTSCRYV------APEVFK--NEEYDTKVDVFSFALILQEMIEGCP 352
             +     R     D     V      +PEV +   + YD K D++S  +   E+  G  
Sbjct: 176 LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHV 235

Query: 353 PF---------TMKHDNEVPK---------------------------------AYAARQ 370
           PF           K +  VP                                     +  
Sbjct: 236 PFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNG 295

Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQ 405
             P     + ++      +E+C    P  RP+   
Sbjct: 296 DSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSAST 330

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score =  121 bits (306), Expect = 3e-31
 Identities = 69/286 (24%), Positives = 115/286 (40%), Gaps = 56/286 (19%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G  VAVK+L EE     +    F+ E+ ++    H N+++  G     +  ++V  Y+  
Sbjct: 54  GTLVAVKRLKEERTQGGEL--QFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMAN 111

Query: 235 GDLRAFLKRKGALKP----STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG 290
           G + + L+ +   +P        R AL  ARG+ YLH++    IIHRD++ +NIL D+  
Sbjct: 112 GSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEF 171

Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDT--SCR------YVAPEVFKNEEYDTKVDVFSFAL 342
              V DFG++KL+  K        DT  +        ++APE     +   K DVF + +
Sbjct: 172 EAVVGDFGLAKLMDYK--------DTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGV 223

Query: 343 ILQEMIEGCPPFTMKHDNEVPKAYA---ARQRPPFKAPAKLYARG-LKELI--------- 389
           +L E+I G   F +               +          L     L+ L+         
Sbjct: 224 MLLELITGQRAFDLARLANDDDVMLLDWVK---------GLLKEKKLEALVDVDLQGNYK 274

Query: 390 -EE----------CWNEKPAKRPTFRQIITRLESINNSINHKRRWK 424
            EE          C    P +RP   +++  LE  +        W+
Sbjct: 275 DEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEG-DGLAERWEEWQ 319

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  122 bits (308), Expect = 4e-31
 Identities = 54/228 (23%), Positives = 107/228 (46%), Gaps = 15/228 (6%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K + ++   + + VR    EL ++Q + HP +V    +      M +V + L  GDLR
Sbjct: 44  AMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLR 103

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L++    K  T   F  ++   ++YL   +   IIHRD++P NIL D+ G++ + DF 
Sbjct: 104 YHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFN 160

Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCP 352
           ++ +  +  +  +T   T      Y+APE+F + +   Y   VD +S  +   E++ G  
Sbjct: 161 IAAM--LPRETQIT---TMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRR 215

Query: 353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
           P+ ++      +     +      P+   ++ +  L+++     P +R
Sbjct: 216 PYHIRSSTSSKEIVHTFETTVVTYPSAW-SQEMVSLLKKLLEPNPDQR 262

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  124 bits (312), Expect = 4e-31
 Identities = 65/236 (27%), Positives = 115/236 (48%), Gaps = 12/236 (5%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
             + AVK + +    + D       E+ LL+K+ HPN+++    +  SS   IV E    
Sbjct: 47  QQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   + ++       A R    +  G+ Y+H++    I+HRDL+P NIL   ++   +
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCD 162

Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +K+ DFG+S     +++  +  +  +  Y+APEV +   YD K DV+S  +IL  ++ G 
Sbjct: 163 IKIIDFGLSTC--FQQNTKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGT 219

Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQI 406
           PPF  K++ ++ K      +  F  P  +  +   K+LI +     P+ R T  Q 
Sbjct: 220 PPFYGKNEYDILKR-VETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQC 274

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  120 bits (303), Expect = 6e-31
 Identities = 48/185 (25%), Positives = 83/185 (44%), Gaps = 20/185 (10%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KK  E       +  A R E+ +L++++HPN+V  L    +   + +V EY     +
Sbjct: 31  VAIKKFLESEDDPVIKKIALR-EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TV 88

Query: 238 RAFLKRKGALKPSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
              L R     P   V+       + +N+ H++     IHRD++P NIL      +K+ D
Sbjct: 89  LHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCD 145

Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFALILQEMIE 349
           FG ++LLT                V      +PE+   + +Y   VDV++   +  E++ 
Sbjct: 146 FGFARLLTG-PSDYYDD------EVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198

Query: 350 GCPPF 354
           G P +
Sbjct: 199 GVPLW 203

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  122 bits (308), Expect = 7e-31
 Identities = 64/278 (23%), Positives = 109/278 (39%), Gaps = 50/278 (17%)

Query: 166 GTFILA-FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSS 223
           GT +    ++G  VAVK++        D       E+ LL +   HPNV+++  + T   
Sbjct: 29  GTVVFQGSFQGRPVAVKRM------LIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDR 82

Query: 224 PMMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            + I  E     +L+  ++ K          K    +     IA G+ +LH  K   IIH
Sbjct: 83  FLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIH 138

Query: 277 RDLEPSNIL-------------RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RY 320
           RDL+P NIL               ++  + ++DFG+ K L   +    T  +       +
Sbjct: 139 RDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGW 198

Query: 321 VAPEVFKNEE-------YDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRP 372
            APE+ +              +D+FS   +   ++ +G  PF    D    ++   R   
Sbjct: 199 RAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF---GDKYSRESNIIRGIF 255

Query: 373 PFKAPAKLYARGL----KELIEECWNEKPAKRPTFRQI 406
                  L+ R L     +LI +  +  P KRPT  ++
Sbjct: 256 SLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKV 293

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  121 bits (305), Expect = 7e-31
 Identities = 82/372 (22%), Positives = 145/372 (38%), Gaps = 62/372 (16%)

Query: 132 PLMAPMHVKHAREVPEYEIDPHELDFTNSVEITK----GTF---ILAFWR--GIQVAVKK 182
           P MA M            +      F+++ ++ +    G F        +  G++ A K 
Sbjct: 2   PHMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKI 61

Query: 183 LGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK 242
           +  + +S  D  +    E  + +K++HPN+V+   ++ + S   +V + +  G+L   + 
Sbjct: 62  INTKKLSARD-FQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIV 120

Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGV 299
            +     + A      I   + Y H N    I+HR+L+P N+L   +     +K+ADFG+
Sbjct: 121 AREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGL 177

Query: 300 SKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM 356
           +    V +               Y++PEV K + Y   VD+++  +IL  ++ G PPF  
Sbjct: 178 AIE--VNDSEAWH---GFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWD 232

Query: 357 KHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNEKPAKRPTFRQI--- 406
           +  + +     A       P +      A       K LI+      P KR T  Q    
Sbjct: 233 EDQHRLYAQIKAGAYDYPSPEWDTVTPEA-------KSLIDSMLTVNPKKRITADQALKV 285

Query: 407 --ITRLESINNSI------------NHKRRWK---IRTMKCFHNLE----AMLKKDHSSP 445
             I   E + ++I            N +R+ K   + TM    NL      +L K    P
Sbjct: 286 PWICNRERVASAIHRQDTVDCLKKFNARRKLKGAILTTMIATRNLSNLGRNLLNKKEQGP 345

Query: 446 SSRSKSSCSTSS 457
            S  K S  +S 
Sbjct: 346 PSTIKESSESSQ 357

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  118 bits (299), Expect = 1e-30
 Identities = 66/246 (26%), Positives = 112/246 (45%), Gaps = 32/246 (13%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
             + AVK + +    + D       E+ LL+K+ HPN+++    +  SS   IV E    
Sbjct: 47  QQEYAVKVINKASAKNKD-TSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTG 105

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGN 291
           G+L   + ++       A R    +  G+ Y+H++    I+HRDL+P NIL   ++   +
Sbjct: 106 GELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCD 162

Query: 292 LKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
           +K+ DFG+S     +++  +           Y+APEV +   YD K DV+S  +IL  ++
Sbjct: 163 IKIIDFGLSTC--FQQNTKMK---DRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILL 216

Query: 349 EGCPPFTMKHDNEVPKAYAARQRPPFKAP--------AKLYARGLKELIEECWNEKPAKR 400
            G PPF  K++ ++ K      +  F  P        A       K+LI +     P+ R
Sbjct: 217 SGTPPFYGKNEYDILKR-VETGKYAFDLPQWRTISDDA-------KDLIRKMLTFHPSLR 268

Query: 401 PTFRQI 406
            T  Q 
Sbjct: 269 ITATQC 274

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  119 bits (300), Expect = 1e-30
 Identities = 52/226 (23%), Positives = 106/226 (46%), Gaps = 14/226 (6%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  I  +++V     E  ++ ++ HP  V+          +     Y   G+L 
Sbjct: 59  AIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELL 118

Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
            ++++ G+   +   RF   +I   + YLH      IIHRDL+P NIL ++  ++++ DF
Sbjct: 119 KYIRKIGSFDETCT-RFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDF 174

Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G +K+L+ +  +      +     +YV+PE+   +      D+++   I+ +++ G PPF
Sbjct: 175 GTAKVLSPESKQARAN--SFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPF 232

Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
             +  NE    +    +  +  P K + +  ++L+E+       KR
Sbjct: 233 --RAGNEY-LIFQKIIKLEYDFPEKFFPKA-RDLVEKLLVLDATKR 274

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  120 bits (302), Expect = 2e-30
 Identities = 46/334 (13%), Positives = 103/334 (30%), Gaps = 47/334 (14%)

Query: 138 HVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR-------GIQVAVKKLGEEV 187
            +   +   E+++    +   +   + +G F     A            +  +K      
Sbjct: 50  KLPAIKPKTEFQLGSKLVYVHH--LLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN 107

Query: 188 ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA- 246
             +          +  L+       ++F  A    +  ++V E    G L   +      
Sbjct: 108 PWEFYIGT---QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNT 164

Query: 247 ----LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-----------RDDSGN 291
               +     + FA+ +   +  +H+ +   IIH D++P N +            D S  
Sbjct: 165 PEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILGNGFLEQDDEDDLSAG 221

Query: 292 LKVADFGVSKLLTV-KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG 350
           L + D G S  + +  +    T +  +  +   E+  N+ ++ ++D F  A  +  M+ G
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281

Query: 351 CPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL 410
                     E       +    F+    L      E      N           ++ + 
Sbjct: 282 TYMKVKNEGGEC------KPEGLFRRLPHLDM--WNEFFHVMLNIPDCHHLPSLDLLRQK 333

Query: 411 ESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSS 444
             +          KIR ++  + L  +L +   S
Sbjct: 334 --LKKVFQQHYTNKIRALR--NRLIVLLLECKRS 363

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  118 bits (299), Expect = 2e-30
 Identities = 58/181 (32%), Positives = 104/181 (57%), Gaps = 12/181 (6%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+K++  +  ++D+ +   A R E++LL+++ HPN+V  +  +     + +V E++ K 
Sbjct: 48  VALKRIRLD--AEDEGIPSTAIR-EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK- 103

Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           DL+  L   K  L+ S    +   + RG+ + H+++   I+HRDL+P N+L +  G LK+
Sbjct: 104 DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKL 160

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPP 353
           ADFG+++   +   R  T +  +  Y AP+V   +++Y T VD++S   I  EMI G P 
Sbjct: 161 ADFGLARAFGI-PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPL 219

Query: 354 F 354
           F
Sbjct: 220 F 220

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  119 bits (300), Expect = 3e-30
 Identities = 28/271 (10%), Positives = 53/271 (19%), Gaps = 46/271 (16%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT----- 229
               A+K       +    +    +      ++   +  +         P   V      
Sbjct: 87  LEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQP 146

Query: 230 --------------------EYLPKGDLRAFLKR-------KGALKPSTAVRFALDIARG 262
                                     DL             +G             + R 
Sbjct: 147 PFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRL 206

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
              L       ++H    P N+     G L + D         K             Y  
Sbjct: 207 AANLQSKG---LVHGHFTPDNLFIMPDGRLMLGDVSAL----WKVGTRGPASSVPVTYAP 259

Query: 323 PEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380
            E        +   ++ +   L +  +     PF +              R P       
Sbjct: 260 REFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAF 319

Query: 381 YAR-----GLKELIEECWNEKPAKRPTFRQI 406
            +       +K LI    N    +R    + 
Sbjct: 320 GSCTPLPDFVKTLIGRFLNFDRRRRLLPLEA 350

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  117 bits (296), Expect = 3e-30
 Identities = 56/181 (30%), Positives = 103/181 (56%), Gaps = 12/181 (6%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
            A+KK+  E   +D+ +     R E+++L++++H N+V+    +     +++V E+L + 
Sbjct: 29  FALKKIRLE--KEDEGIPSTTIR-EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ- 84

Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           DL+  L   +G L+  TA  F L +  G+ Y H+ +   ++HRDL+P N+L +  G LK+
Sbjct: 85  DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKI 141

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPP 353
           ADFG+++   +   R  T +  +  Y AP+V   +++Y T +D++S   I  EM+ G P 
Sbjct: 142 ADFGLARAFGI-PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPL 200

Query: 354 F 354
           F
Sbjct: 201 F 201

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  118 bits (298), Expect = 4e-30
 Identities = 61/242 (25%), Positives = 104/242 (42%), Gaps = 23/242 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
            ++ AVK      I D  +     +   LL+  +HPN++           + +VTE +  
Sbjct: 47  NMEFAVK------IIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKG 100

Query: 235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL----RDDSG 290
           G+L   + R+       A      I + + YLH      ++HRDL+PSNIL      +  
Sbjct: 101 GELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPE 157

Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEM 347
           ++++ DFG +K L   E+  L    T C    +VAPEV + + YD   D++S  ++L  M
Sbjct: 158 SIRICDFGFAKQLR-AENGLLM---TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTM 213

Query: 348 IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR---GLKELIEECWNEKPAKRPTFR 404
           + G  PF    D+   +  A      F      +       K+L+ +  +  P +R T  
Sbjct: 214 LTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAA 273

Query: 405 QI 406
            +
Sbjct: 274 LV 275

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  117 bits (296), Expect = 5e-30
 Identities = 56/279 (20%), Positives = 110/279 (39%), Gaps = 35/279 (12%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
           G++ A K     +                 E+++L+++ H NV+         + ++++ 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVS--REEIEREVSILRQVLHHNVITLHDVYENRTDVVLIL 94

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
           E +  G+L  FL +K +L    A  F   I  G+NYLH  K   I H DL+P NI+    
Sbjct: 95  ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151

Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
                ++K+ DFG++  +  ++         +  +VAPE+   E    + D++S  +I  
Sbjct: 152 NIPIPHIKLIDFGLAHEI--EDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209

Query: 346 EMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNEKPA 398
            ++ G  PF      E      +         F      A       K+ I +   ++  
Sbjct: 210 ILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTSELA-------KDFIRKLLVKETR 262

Query: 399 KRPTFRQI-----ITRLESINNSINHKRRWKIRTMKCFH 432
           KR T ++      IT +++    +  +    +   +  +
Sbjct: 263 KRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQY 301

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  116 bits (294), Expect = 7e-30
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 24/196 (12%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVR-AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI 227
             + AVK       G     +   +R A   E+ +L+K+  HPN++Q       ++   +
Sbjct: 42  CKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFL 101

Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
           V + + KG+L  +L  K  L      +    +   +  LH+     I+HRDL+P NIL D
Sbjct: 102 VFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLD 158

Query: 288 DSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE------YDTKVDVF 338
           D  N+K+ DFG S    +     L      C    Y+APE+ +         Y  +VD++
Sbjct: 159 DDMNIKLTDFGFSCQ--LDPGEKLR---EVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW 213

Query: 339 SFALILQEMIEGCPPF 354
           S  +I+  ++ G PPF
Sbjct: 214 STGVIMYTLLAGSPPF 229

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  118 bits (297), Expect = 7e-30
 Identities = 61/182 (33%), Positives = 96/182 (52%), Gaps = 11/182 (6%)

Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           VA+KK+         D     A R E+ LLQ++ HPN++  L A    S + +V +++  
Sbjct: 38  VAIKKIKLGHRSEAKDGINRTALR-EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET 96

Query: 235 GDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            DL   +K     L PS    + L   +G+ YLH++    I+HRDL+P+N+L D++G LK
Sbjct: 97  -DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLK 152

Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 352
           +ADFG++K      +R  T Q  +  Y APE+ F    Y   VD+++   IL E++   P
Sbjct: 153 LADFGLAKSFGS-PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211

Query: 353 PF 354
             
Sbjct: 212 FL 213

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  120 bits (303), Expect = 7e-30
 Identities = 62/246 (25%), Positives = 114/246 (46%), Gaps = 21/246 (8%)

Query: 175 GIQVAVK----------KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
             + A+K          +  ++  + +       +E++LL+ + HPN+++          
Sbjct: 61  HSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKY 120

Query: 225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
             +VTE+   G+L   +  +       A      I  G+ YLH++    I+HRD++P NI
Sbjct: 121 FYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENI 177

Query: 285 L---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFA 341
           L   ++   N+K+ DFG+S      +D  L  +  +  Y+APEV K ++Y+ K DV+S  
Sbjct: 178 LLENKNSLLNIKIVDFGLSSF--FSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCG 234

Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKR 400
           +I+  ++ G PPF  ++D ++ K    + +  F     K  +   KELI+        KR
Sbjct: 235 VIMYILLCGYPPFGGQNDQDIIKK-VEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKR 293

Query: 401 PTFRQI 406
            T  + 
Sbjct: 294 CTAEEA 299

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  116 bits (293), Expect = 8e-30
 Identities = 57/250 (22%), Positives = 99/250 (39%), Gaps = 36/250 (14%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
           G + A K     +L                E+ +L++IRHPN++         + ++++ 
Sbjct: 30  GKEYAAKFIKKRRLSSSRRGVS--REEIEREVNILREIRHPNIITLHDIFENKTDVVLIL 87

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
           E +  G+L  FL  K +L    A +F   I  G++YLH  +   I H DL+P NI+    
Sbjct: 88  ELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDK 144

Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFAL 342
              +  +K+ DFG++  +  +                +VAPE+   E    + D++S  +
Sbjct: 145 NVPNPRIKLIDFGIAHKI--EAGNEFK---NIFGTPEFVAPEIVNYEPLGLEADMWSIGV 199

Query: 343 ILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNE 395
           I   ++ G  PF  +   E     +A         F      A       K+ I     +
Sbjct: 200 ITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSELA-------KDFIRRLLVK 252

Query: 396 KPAKRPTFRQ 405
            P +R T  Q
Sbjct: 253 DPKRRMTIAQ 262

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  117 bits (295), Expect = 9e-30
 Identities = 51/179 (28%), Positives = 84/179 (46%), Gaps = 8/179 (4%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           VA+KK  E       +  A R E+ LL+++RH N+V  L    +     +V E++    +
Sbjct: 53  VAIKKFLESDDDKMVKKIAMR-EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TI 110

Query: 238 RAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
              L+     L      ++   I  G+ + H +    IIHRD++P NIL   SG +K+ D
Sbjct: 111 LDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCD 167

Query: 297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           FG ++ L          +  +  Y APE+   + +Y   VDV++   ++ EM  G P F
Sbjct: 168 FGFARTLAAP-GEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLF 225

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  117 bits (296), Expect = 1e-29
 Identities = 55/195 (28%), Positives = 94/195 (48%), Gaps = 23/195 (11%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIV 228
           G + AVK              ++   A R E  +L+++  HP+++  + +   SS M +V
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            + + KG+L  +L  K AL           +   +++LH N    I+HRDL+P NIL DD
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDD 235

Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE------YDTKVDVFS 339
           +  ++++DFG S    ++    L      C    Y+APE+ K         Y  +VD+++
Sbjct: 236 NMQIRLSDFGFSCH--LEPGEKLR---ELCGTPGYLAPEILKCSMDETHPGYGKEVDLWA 290

Query: 340 FALILQEMIEGCPPF 354
             +IL  ++ G PPF
Sbjct: 291 CGVILFTLLAGSPPF 305

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  117 bits (294), Expect = 1e-29
 Identities = 71/297 (23%), Positives = 116/297 (39%), Gaps = 37/297 (12%)

Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP +L F++  EI  G+F   +          VA+KK+       +++ +    E+  LQ
Sbjct: 51  DPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ 109

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNY 265
           K+RHPN +Q+ G   +     +V EY            K  L+            +G+ Y
Sbjct: 110 KLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAY 169

Query: 266 LHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED---RPLTCQDTSCRYVA 322
           LH +    +IHRD++  NIL  + G +K+ DFG + ++         P         ++A
Sbjct: 170 LHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANSFVGTPY--------WMA 218

Query: 323 PEV---FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-KA-YAARQRPPFKAP 377
           PEV       +YD KVDV+S  +   E+ E  PP      N     A Y   Q       
Sbjct: 219 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPP----LFNMNAMSALYHIAQNESPALQ 274

Query: 378 AKLYARGLKELIEECWNEKPAKRPT--------FRQIITRLESINNSINHKRRWKIR 426
           +  ++   +  ++ C  + P  RPT        F         I + I   +     
Sbjct: 275 SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRE 331

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  115 bits (291), Expect = 2e-29
 Identities = 49/181 (27%), Positives = 93/181 (51%), Gaps = 12/181 (6%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+K++  +   DD+ V   A R E+ LL++++H N+V+    +     + +V E+  + 
Sbjct: 30  VALKRVRLD--DDDEGVPSSALR-EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ- 85

Query: 236 DLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
           DL+ +     G L P     F   + +G+ + H      ++HRDL+P N+L + +G LK+
Sbjct: 86  DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKL 142

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPP 353
           A+FG+++   +   R  + +  +  Y  P+V F  + Y T +D++S   I  E+     P
Sbjct: 143 ANFGLARAFGI-PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRP 201

Query: 354 F 354
            
Sbjct: 202 L 202

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  116 bits (293), Expect = 2e-29
 Identities = 57/257 (22%), Positives = 101/257 (39%), Gaps = 49/257 (19%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
               AVK     +IS        + E+  L+    HPN+V+            +V E L 
Sbjct: 36  NQAFAVK-----IISKRMEANTQK-EITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLN 89

Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 290
            G+L   +K+K     + A      +   ++++H+     ++HRDL+P N+L    +D+ 
Sbjct: 90  GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNL 146

Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEM 347
            +K+ DFG ++L    +++PL    T C    Y APE+     YD   D++S  +IL  M
Sbjct: 147 EIKIIDFGFARLKPP-DNQPLK---TPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTM 202

Query: 348 IEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL------------------KELI 389
           + G  PF            +  +     +  ++  +                    K+LI
Sbjct: 203 LSGQVPF-----------QSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLI 251

Query: 390 EECWNEKPAKRPTFRQI 406
           +      P KR     +
Sbjct: 252 QGLLTVDPNKRLKMSGL 268

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  116 bits (293), Expect = 2e-29
 Identities = 64/288 (22%), Positives = 111/288 (38%), Gaps = 32/288 (11%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
           G+Q A K     +                 E+++L++I+HPNV+         + ++++ 
Sbjct: 36  GLQYAAKFIKKRRTKSSRRGVS--REDIEREVSILKEIQHPNVITLHEVYENKTDVILIL 93

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
           E +  G+L  FL  K +L    A  F   I  G+ YLH  +   I H DL+P NI+    
Sbjct: 94  ELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDR 150

Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
                 +K+ DFG++  +             +  +VAPE+   E    + D++S  +I  
Sbjct: 151 NVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 208

Query: 346 EMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNEKPA 398
            ++ G  PF      E     +A         F    A A       K+ I     + P 
Sbjct: 209 ILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALA-------KDFIRRLLVKDPK 261

Query: 399 KRPTFRQIITR--LESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSS 444
           KR T +  +    ++  +      R+     M+ F    A  K ++ S
Sbjct: 262 KRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARKKSNNGS 309

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  116 bits (292), Expect = 3e-29
 Identities = 56/285 (19%), Positives = 97/285 (34%), Gaps = 60/285 (21%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
               A+K     K+ +    D +R++    E+ L++K+ HPN+ +          + +V 
Sbjct: 51  RAIRAIKIMNKNKIRQINPKDVERIK---TEVRLMKKLHHPNIARLYEVYEDEQYICLVM 107

Query: 230 EYLPKGDLRAFLKRKGALKPST-------------------------------------- 251
           E    G L   L                                                
Sbjct: 108 ELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQRE 167

Query: 252 --AVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKE 307
                    I   ++YLH      I HRD++P N L   + S  +K+ DFG+SK      
Sbjct: 168 KLISNIMRQIFSALHYLHNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN 224

Query: 308 DRPLTCQDTSC---RYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
           +       T      +VAPEV    NE Y  K D +S  ++L  ++ G  PF   +D + 
Sbjct: 225 NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADT 284

Query: 363 PKAYAARQRPPFKAPA-KLYARGLKELIEECWNEKPAKRPTFRQI 406
                  ++  F+ P   + +   ++L+    N    +R    + 
Sbjct: 285 ISQ-VLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRA 328

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  115 bits (291), Expect = 3e-29
 Identities = 53/182 (29%), Positives = 93/182 (51%), Gaps = 15/182 (8%)

Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           VA+K++    EE         A R E++LL+ ++H N+V     +     + +V EYL K
Sbjct: 30  VALKEIRLEHEEGAP----CTAIR-EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK 84

Query: 235 GDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK 293
            DL+ +L   G  +       F   + RG+ Y H  K   ++HRDL+P N+L ++ G LK
Sbjct: 85  -DLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELK 140

Query: 294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCP 352
           +ADFG+++  ++   +    +  +  Y  P++   + +Y T++D++    I  EM  G P
Sbjct: 141 LADFGLARAKSI-PTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRP 199

Query: 353 PF 354
            F
Sbjct: 200 LF 201

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  115 bits (290), Expect = 7e-29
 Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 29/229 (12%)

Query: 142 AREVPEYEIDPHELDFTNSV-----EITKGTF---ILAFWR--GIQVAVKKLGEEVISDD 191
           A  VP+Y ID    D  +       E+ +G          +      A+K     V+   
Sbjct: 35  ASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGTQKPYALK-----VLKKT 89

Query: 192 DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST 251
              +  R E+ +L ++ HPN+++        + + +V E +  G+L   +  KG      
Sbjct: 90  VDKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERD 149

Query: 252 AVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVADFGVSKLLTVKED 308
           A      I   + YLHEN    I+HRDL+P N+L         LK+ADFG+SK+  V+  
Sbjct: 150 AADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKI--VEHQ 204

Query: 309 RPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
             +    T C    Y APE+ +   Y  +VD++S  +I   ++ G  PF
Sbjct: 205 VLMK---TVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  115 bits (290), Expect = 7e-29
 Identities = 66/321 (20%), Positives = 124/321 (38%), Gaps = 51/321 (15%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
           G++ A K     +                 E+++L+++ HPN++         + ++++ 
Sbjct: 37  GLEYAAKFIKKRQSRASRRGVC--REEIEREVSILRQVLHPNIITLHDVYENRTDVVLIL 94

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---- 285
           E +  G+L  FL +K +L    A  F   I  G+NYLH  K   I H DL+P NI+    
Sbjct: 95  ELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDK 151

Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
                ++K+ DFG++    +++         +  +VAPE+   E    + D++S  +I  
Sbjct: 152 NIPIPHIKLIDFGLAHE--IEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITY 209

Query: 346 EMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNEKPA 398
            ++ G  PF      E      A         F      A       K+ I +   ++  
Sbjct: 210 ILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTSELA-------KDFIRKLLVKETR 262

Query: 399 KRPTFRQI-----ITRLESINNSINH--------------KRRWK--IRTMKCFHNLEAM 437
           KR T ++      IT +++    +                +RRWK     +   ++L   
Sbjct: 263 KRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRRRWKLSFSIVSLCNHLTRS 322

Query: 438 LKKDHSSPSSRSKSSCSTSSI 458
           L K     +S    +C + + 
Sbjct: 323 LMKKVHLRTSEDLRNCESDTE 343

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  114 bits (288), Expect = 1e-28
 Identities = 48/185 (25%), Positives = 94/185 (50%), Gaps = 16/185 (8%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           VA+K++  E   +++ V   A R E++LL++++H N+++    +  +  + ++ EY    
Sbjct: 62  VAIKRIRLE--HEEEGVPGTAIR-EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN- 117

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-----RDDSG 290
           DL+ ++ +   +       F   +  G+N+ H  +    +HRDL+P N+L       ++ 
Sbjct: 118 DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETP 174

Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIE 349
            LK+ DFG+++   +   R  T +  +  Y  PE+   +  Y T VD++S A I  EM+ 
Sbjct: 175 VLKIGDFGLARAFGI-PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLM 233

Query: 350 GCPPF 354
             P F
Sbjct: 234 KTPLF 238

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  114 bits (287), Expect = 1e-28
 Identities = 73/274 (26%), Positives = 124/274 (45%), Gaps = 36/274 (13%)

Query: 151 DPHELDFTNSVEITKGTFILAF-----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           DP  + F     +  GT+   +       G   A+K +  +V  D++     + E+ +L+
Sbjct: 21  DPAGI-FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVTGDEEE--EIKQEINMLK 75

Query: 206 KI-RHPNVVQFLGAVTQSSP------MMIVTEYLPKGDLRAFLK--RKGALKPSTAVRFA 256
           K   H N+  + GA  + +P      + +V E+   G +   +K  +   LK        
Sbjct: 76  KYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYIC 135

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            +I RG+++LH++K   +IHRD++  N+L  ++  +K+ DFGVS  L     R  T   T
Sbjct: 136 REILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGT 192

Query: 317 SCRYVAPEVFKNEE-----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-KAYA--A 368
              ++APEV   +E     YD K D++S  +   EM EG PP    H    P +A     
Sbjct: 193 PY-WMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH----PMRALFLIP 247

Query: 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402
           R   P     K +++  +  IE C  +  ++RP 
Sbjct: 248 RNPAPRLKSKK-WSKKFQSFIESCLVKNHSQRPA 280

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  116 bits (292), Expect = 1e-28
 Identities = 53/264 (20%), Positives = 111/264 (42%), Gaps = 35/264 (13%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           E+ KG F           G + A   +  + +S  D  +    E  + + ++HPN+V+  
Sbjct: 18  ELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARD-HQKLEREARICRLLKHPNIVRLH 76

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            ++++     ++ + +  G+L   +  +     + A      I   + + H+     ++H
Sbjct: 77  DSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVH 133

Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE 330
           R+L+P N+L   +     +K+ADFG++  +   E +             Y++PEV + + 
Sbjct: 134 RNLKPENLLLASKLKGAAVKLADFGLAIEVE-GEQQAWF---GFAGTPGYLSPEVLRKDP 189

Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP--------AKLYA 382
           Y   VD+++  +IL  ++ G PPF  +  + + +         F +P        A    
Sbjct: 190 YGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQ-IKAGAYDFPSPEWDTVTPEA---- 244

Query: 383 RGLKELIEECWNEKPAKRPTFRQI 406
              K+LI +     P+KR T  + 
Sbjct: 245 ---KDLINKMLTINPSKRITAAEA 265

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  117 bits (294), Expect = 2e-28
 Identities = 56/230 (24%), Positives = 95/230 (41%), Gaps = 16/230 (6%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL- 237
           A KKL ++ +      +    E  +L K+    +V    A    + + +V   +  GD+ 
Sbjct: 214 ACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIR 273

Query: 238 ---RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV 294
                  +     +   A+ +   I  G+ +LH+     II+RDL+P N+L DD GN+++
Sbjct: 274 YHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRI 330

Query: 295 ADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC 351
           +D G++  L   + +             ++APE+   EEYD  VD F+  + L EMI   
Sbjct: 331 SDLGLAVELKAGQTKT----KGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAAR 386

Query: 352 PPFTM-KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
            PF       E  +            P K  +   K+  E    + P KR
Sbjct: 387 GPFRARGEKVENKELKQRVLEQAVTYPDKF-SPASKDFCEALLQKDPEKR 435

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  114 bits (287), Expect = 2e-28
 Identities = 49/195 (25%), Positives = 86/195 (44%), Gaps = 25/195 (12%)

Query: 175 GIQVAVK-----KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT 229
           G Q AVK     K         + ++    E ++   ++HP++V+ L   +    + +V 
Sbjct: 49  GQQFAVKIVDVAKFTSSPGLSTEDLK---REASICHMLKHPHIVELLETYSSDGMLYMVF 105

Query: 230 EYLPKGDLRAFLKRKGALKPS----TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           E++   DL   + ++           A  +   I   + Y H+N    IIHRD++P  +L
Sbjct: 106 EFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVL 162

Query: 286 ---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YVAPEVFKNEEYDTKVDVFS 339
              +++S  +K+  FGV+  L  +                ++APEV K E Y   VDV+ 
Sbjct: 163 LASKENSAPVKLGGFGVAIQLG-ESGLVAG---GRVGTPHFMAPEVVKREPYGKPVDVWG 218

Query: 340 FALILQEMIEGCPPF 354
             +IL  ++ GC PF
Sbjct: 219 CGVILFILLSGCLPF 233

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  112 bits (283), Expect = 3e-28
 Identities = 53/187 (28%), Positives = 97/187 (51%), Gaps = 20/187 (10%)

Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           VA+K++    EE         A R E++L+++++H N+V+    +   + + +V E++  
Sbjct: 33  VALKEVKLDSEEGTP----STAIR-EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN 87

Query: 235 GDLRAFLK------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            DL+ ++           L+ +    F   + +G+ + HENK   I+HRDL+P N+L + 
Sbjct: 88  -DLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINK 143

Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEM 347
            G LK+ DFG+++   +      + +  +  Y AP+V   +  Y T +D++S   IL EM
Sbjct: 144 RGQLKLGDFGLARAFGI-PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEM 202

Query: 348 IEGCPPF 354
           I G P F
Sbjct: 203 ITGKPLF 209

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  113 bits (284), Expect = 3e-28
 Identities = 73/304 (24%), Positives = 117/304 (38%), Gaps = 56/304 (18%)

Query: 136 PMHVKHAREVPEYEIDPHELDFTNSVEITK-----GTF---ILAFWR--GIQVAVKKLGE 185
             H     EV     +P +   T+  +++K     G     +  F R  G + A+K L  
Sbjct: 5   HHHHSSGLEVLFQGPEPKKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLL-- 62

Query: 186 EVISDDDRVRAFRDELALLQKIRHPNVVQFLGA----VTQSSPMMIVTEYLPKGDLRAFL 241
                 D  +A ++     Q    P++V  L            ++I+ E +  G+L + +
Sbjct: 63  -----YDSPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI 117

Query: 242 KRKGALKPS--TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNLKVAD 296
           + +G    +   A     DI   + +LH +    I HRD++P N+L   ++    LK+ D
Sbjct: 118 QERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTD 174

Query: 297 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
           FG +K         L    T C    YVAPEV   E+YD   D++S  +I+  ++ G PP
Sbjct: 175 FGFAKET---TQNALQ---TPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPP 228

Query: 354 FTMKHDNEVPKAYAARQR---PPFKAP--------AKLYARGLKELIEECWNEKPAKRPT 402
           F       +      R R     F  P        A       K+LI       P +R T
Sbjct: 229 FYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDA-------KQLIRLLLKTDPTERLT 281

Query: 403 FRQI 406
             Q 
Sbjct: 282 ITQF 285

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  112 bits (283), Expect = 4e-28
 Identities = 51/280 (18%), Positives = 104/280 (37%), Gaps = 35/280 (12%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
                 K +  +           + E+++L   RH N++    +      ++++ E++  
Sbjct: 30  KKTYMAKFVKVKGTDQVL----VKKEISILNIARHRNILHLHESFESMEELVMIFEFISG 85

Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
            D+  F         L     V +   +   + +LH +    I H D+ P NI+     S
Sbjct: 86  LDI--FERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRS 140

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
             +K+ +FG ++ L  K         T+  Y APEV +++   T  D++S   ++  ++ 
Sbjct: 141 STIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLS 198

Query: 350 GCPPFTMKHDNE----VPKAYAARQRPPFK---APAKLYARGLKELIEECWNEKPAKRPT 402
           G  PF  + + +    +  A        FK     A        + ++    ++   R T
Sbjct: 199 GINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEA-------MDFVDRLLVKERKSRMT 251

Query: 403 FRQIITRLES--INNSINHKRRWKIRTMKCFHNLEAMLKK 440
             +    L+   +   I       IRT+K       ++KK
Sbjct: 252 ASEA---LQHPWLKQKIERVSTKVIRTLKHRRYYHTLIKK 288

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  112 bits (282), Expect = 6e-28
 Identities = 55/247 (22%), Positives = 98/247 (39%), Gaps = 32/247 (12%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLP 233
           G + A K L +     D R      E+A+L+  +  P V+        +S ++++ EY  
Sbjct: 54  GQEYAAKFLKKRRRGQDCR-AEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAA 112

Query: 234 KGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDD 288
            G++      +    +  +  +R    I  G+ YLH+N    I+H DL+P NIL      
Sbjct: 113 GGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYP 169

Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQ 345
            G++K+ DFG+S+ +       L           Y+APE+   +   T  D+++  +I  
Sbjct: 170 LGDIKIVDFGMSRKI--GHACELR---EIMGTPEYLAPEILNYDPITTATDMWNIGIIAY 224

Query: 346 EMIEGCPPFTMKHDNEVPKAYAARQ----RPPFK---APAKLYARGLKELIEECWNEKPA 398
            ++    PF  + + E     +          F      A        + I+    + P 
Sbjct: 225 MLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLA-------TDFIQSLLVKNPE 277

Query: 399 KRPTFRQ 405
           KRPT   
Sbjct: 278 KRPTAEI 284

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  115 bits (289), Expect = 1e-27
 Identities = 44/235 (18%), Positives = 82/235 (34%), Gaps = 39/235 (16%)

Query: 177 QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVTEY 231
            V +K L      D +       E   L ++ HP++VQ    V  +         IV EY
Sbjct: 108 PVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEY 165

Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
           +    L+        L  + A+ + L+I   ++YLH      +++ DL+P NI+  +   
Sbjct: 166 VGGQSLKRSKG--QKLPVAEAIAYLLEILPALSYLHSI---GLVYNDLKPENIMLTEEQ- 219

Query: 292 LKVADFGVSKLLTVKEDRPLTCQDT-----SCRYVAPEVFKNEEYDTKVDVFSFALILQE 346
           LK+ D G    +                  +  + APE+ +        D+++    L  
Sbjct: 220 LKLIDLGAVSRIN----------SFGYLYGTPGFQAPEIVRTGP-TVATDIYTVGRTLAA 268

Query: 347 MIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRP 401
           +    P    ++ + +P        P  K            L+    +  P +R 
Sbjct: 269 LTLDLPTRNGRYVDGLP-----EDDPVLKTYDSYGR-----LLRRAIDPDPRQRF 313

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  115 bits (289), Expect = 1e-27
 Identities = 52/229 (22%), Positives = 98/229 (42%), Gaps = 17/229 (7%)

Query: 179 AVKKLGEEVISDDDRVRAFRDE---LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKG 235
           A+K L ++ I          +E   L+L+     P +V    A      +  + + +  G
Sbjct: 218 AMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGG 277

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
           DL   L + G    +    +A +I  G+ ++H      +++RDL+P+NIL D+ G+++++
Sbjct: 278 DLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRIS 334

Query: 296 DFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGC 351
           D G++      + +P      S     Y+APEV  K   YD+  D FS   +L +++ G 
Sbjct: 335 DLGLACD--FSKKKP----HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGH 388

Query: 352 PPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
            PF      +  +          + P    +  L+ L+E        +R
Sbjct: 389 SPFRQHKTKDKHEIDRMTLTMAVELPDSF-SPELRSLLEGLLQRDVNRR 436

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  111 bits (279), Expect = 2e-27
 Identities = 58/225 (25%), Positives = 105/225 (46%), Gaps = 17/225 (7%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L ++ +    ++    +E  +LQ +  P +V+   +   +S + +V EY+  G++ 
Sbjct: 70  AMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMF 129

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           + L+R G      A  +A  I     YLH      +I+RDL+P N+L D  G ++V DFG
Sbjct: 130 SHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFG 186

Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
            +     K  +  T   T C     +APE+  ++ Y+  VD ++  +++ EM  G PPF 
Sbjct: 187 FA-----KRVKGRT--WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPF- 238

Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
               ++  + Y        + P+   +  LK+L+         KR
Sbjct: 239 --FADQPIQIYEKIVSGKVRFPSHF-SSDLKDLLRNLLQVDLTKR 280

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  110 bits (278), Expect = 2e-27
 Identities = 52/187 (27%), Positives = 84/187 (44%), Gaps = 10/187 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +EVI   D V     E  +LQ  RHP +     A      +  V EY   G+L 
Sbjct: 34  AMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELF 93

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L R+       A  +  +I   + YLH      +++RD++  N++ D  G++K+ DFG
Sbjct: 94  FHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFG 150

Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
           + K              T C    Y+APEV ++ +Y   VD +   +++ EM+ G  PF 
Sbjct: 151 LCKEGISDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 206

Query: 356 MKHDNEV 362
            +    +
Sbjct: 207 NQDHERL 213

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  111 bits (280), Expect = 3e-27
 Identities = 39/193 (20%), Positives = 85/193 (44%), Gaps = 15/193 (7%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G     K +      D   V+   +E++++ ++ HP ++    A      M+++ E+L  
Sbjct: 76  GRVFVAKFINTPYPLDKYTVK---NEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSG 132

Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
           G+L  F         +  +  + +      G+ ++HE+    I+H D++P NI+     +
Sbjct: 133 GEL--FDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKA 187

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
            ++K+ DFG++  L    D  +     +  + APE+   E      D+++  ++   ++ 
Sbjct: 188 SSVKIIDFGLATKL--NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLS 245

Query: 350 GCPPFTMKHDNEV 362
           G  PF  + D E 
Sbjct: 246 GLSPFAGEDDLET 258

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  113 bits (285), Expect = 3e-27
 Identities = 61/228 (26%), Positives = 103/228 (45%), Gaps = 15/228 (6%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A KKL ++ I          +E  +L+K+    VV    A      + +V   +  GDL+
Sbjct: 213 ACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLK 272

Query: 239 AFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
             +   G      + AV +A +I  G+  LH  +   I++RDL+P NIL DD G+++++D
Sbjct: 273 FHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISD 329

Query: 297 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP 353
            G++    V E + +           Y+APEV KNE Y    D ++   +L EMI G  P
Sbjct: 330 LGLAV--HVPEGQTIK---GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 384

Query: 354 FT-MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
           F   K   +  +     +  P +   +  +   + L  +   + PA+R
Sbjct: 385 FQQRKKKIKREEVERLVKEVPEEYSERF-SPQARSLCSQLLCKDPAER 431

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  111 bits (279), Expect = 4e-27
 Identities = 67/246 (27%), Positives = 106/246 (43%), Gaps = 41/246 (16%)

Query: 131 KPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGI----------QVAV 180
            PL  P  V           +  E+ +TN   I  G+F      G+          +VA+
Sbjct: 16  NPLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSF------GVVFQAKLVESDEVAI 69

Query: 181 KKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IVTEYLPK 234
           KK     +  D R    R EL +++ ++HPNVV        +          +V EY+P+
Sbjct: 70  KK-----VLQDKR-FKNR-ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE 122

Query: 235 GDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DS 289
             +    R + K K  +       +   + R + Y+H      I HRD++P N+L D  S
Sbjct: 123 -TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPS 178

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMI 348
           G LK+ DFG +K+L      P      S  Y APE+ F    Y T +D++S   ++ E++
Sbjct: 179 GVLKLIDFGSAKILI--AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELM 236

Query: 349 EGCPPF 354
           +G P F
Sbjct: 237 QGQPLF 242

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  111 bits (280), Expect = 5e-27
 Identities = 59/225 (26%), Positives = 98/225 (43%), Gaps = 13/225 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +EVI   D V     E  +LQ  RHP +     +      +  V EY   G+L 
Sbjct: 177 AMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELF 236

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L R+       A  +  +I   ++YLH  K   +++RDL+  N++ D  G++K+ DFG
Sbjct: 237 FHLSRERVFSEDRARFYGAEIVSALDYLHSEKN--VVYRDLKLENLMLDKDGHIKITDFG 294

Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
           + K              T C    Y+APEV ++ +Y   VD +   +++ EM+ G  PF 
Sbjct: 295 LCKEGIKDGAT----MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY 350

Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
            +   ++   +        + P  L     K L+     + P +R
Sbjct: 351 NQDHEKL---FELILMEEIRFPRTL-GPEAKSLLSGLLKKDPKQR 391

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  108 bits (272), Expect = 5e-27
 Identities = 34/240 (14%), Positives = 70/240 (29%), Gaps = 44/240 (18%)

Query: 172 FWRGI------QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM 225
           FW+ +      QVA+  +  + +  DD ++        L +I  P V + L  V   +  
Sbjct: 47  FWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGG 106

Query: 226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           ++V E++  G L+       +  P  A+R    +A   +  H      +      PS + 
Sbjct: 107 LVVAEWIRGGSLQEVA--DTSPSPVGAIRAMQSLAAAADAAHRA---GVALSIDHPSRVR 161

Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
               G++ +A                         +          + + D+      L 
Sbjct: 162 VSIDGDVVLAYPA---------------------TMPDA-------NPQDDIRGIGASLY 193

Query: 346 EMIEGCPPFTMK-HDNEVPKAYAARQRPPFKAPAKLYA---RGLKELIEECWNEKPAKRP 401
            ++    P       + +  A       P   PA +       +  +           R 
Sbjct: 194 ALLVNRWPLPEAGVRSGLAPAERDTAGQP-IEPADIDRDIPFQISAVAARSVQGDGGIRS 252

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score =  110 bits (275), Expect = 6e-27
 Identities = 49/181 (27%), Positives = 88/181 (48%), Gaps = 23/181 (12%)

Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL 302
            K  L     + ++  +A+GM +L   K    IHRDL   NIL  +   +K+ DFG+++ 
Sbjct: 186 YKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARD 242

Query: 303 L------TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF- 354
           +        K D  L       +++APE   +  Y  + DV+SF ++L E+   G  P+ 
Sbjct: 243 IYKDPDYVRKGDARL-----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYP 297

Query: 355 TMKHDNEVPKAYAA--RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES 412
            +K D E  +      R R P     ++Y     + + +CW+ +P++RPTF +++  L +
Sbjct: 298 GVKIDEEFCRRLKEGTRMRAPDYTTPEMY-----QTMLDCWHGEPSQRPTFSELVEHLGN 352

Query: 413 I 413
           +
Sbjct: 353 L 353

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  112 bits (282), Expect = 7e-27
 Identities = 58/312 (18%), Positives = 107/312 (34%), Gaps = 45/312 (14%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK 234
           G   A K +     SD + VR    E+  +  +RHP +V    A    + M+++ E++  
Sbjct: 182 GNNFAAKFVMTPHESDKETVR---KEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSG 238

Query: 235 GDLRAF---LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
           G+L  F         +    AV +   + +G+ ++HEN     +H DL+P NI+     S
Sbjct: 239 GEL--FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRS 293

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE 349
             LK+ DFG++  L     + +     +  + APEV + +      D++S  ++   ++ 
Sbjct: 294 NELKLIDFGLTAHL--DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLS 351

Query: 350 GCPPFTMKHDNE----VPKAYAARQRPPFK---APAKLYARGLKELIEECWNEKPAKRPT 402
           G  PF  ++D+E    V           F              K+ I +     P  R T
Sbjct: 352 GLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDG-------KDFIRKLLLADPNTRMT 404

Query: 403 FRQ----------------IITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSSPS 446
             Q                            +  +       +    L  +         
Sbjct: 405 IHQALEHPWLTPGNAPGRDSQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKH 464

Query: 447 SRSKSSCSTSSI 458
              + S   +  
Sbjct: 465 RPQEYSIRDAFW 476

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  108 bits (272), Expect = 1e-26
 Identities = 55/265 (20%), Positives = 99/265 (37%), Gaps = 42/265 (15%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
             + AVK + ++      RV     E+ +L + + H NV++ +    +     +V E + 
Sbjct: 38  SQEYAVKIIEKQPGHIRSRVF---REVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMR 94

Query: 234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSG 290
            G + + + ++       A     D+A  +++LH      I HRDL+P NIL    +   
Sbjct: 95  GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVS 151

Query: 291 NLKVADFGVSKLLTVKEDRPLTCQD---TSC---RYVAPEVFK-----NEEYDTKVDVFS 339
            +K+ DF +   + +  D          T C    Y+APEV +        YD + D++S
Sbjct: 152 PVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS 211

Query: 340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL-------------- 385
             +IL  ++ G PPF              R          L+                  
Sbjct: 212 LGVILYILLSGYPPF---VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHI 268

Query: 386 ----KELIEECWNEKPAKRPTFRQI 406
               K+LI +       +R +  Q+
Sbjct: 269 SCAAKDLISKLLVRDAKQRLSAAQV 293

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  109 bits (274), Expect = 1e-26
 Identities = 60/279 (21%), Positives = 117/279 (41%), Gaps = 26/279 (9%)

Query: 95  RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVP---EYEID 151
           R    + K+ W +  L + +  K+     L     A P      +  A++      Y + 
Sbjct: 33  RSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVS 92

Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
             E        +  G F           G+++A K +    + D + V+   +E++++ +
Sbjct: 93  KTE-------ILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVMNQ 142

Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL-RAFLKRKGALKPSTAVRFALDIARGMNY 265
           + H N++Q   A    + +++V EY+  G+L    +     L     + F   I  G+ +
Sbjct: 143 LDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRH 202

Query: 266 LHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP 323
           +H+     I+H DL+P NIL    D+  +K+ DFG+++    K    L     +  ++AP
Sbjct: 203 MHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRY--KPREKLKVNFGTPEFLAP 257

Query: 324 EVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV 362
           EV   +      D++S  +I   ++ G  PF   +D E 
Sbjct: 258 EVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET 296

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  109 bits (275), Expect = 2e-26
 Identities = 56/192 (29%), Positives = 89/192 (46%), Gaps = 25/192 (13%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
           G  VA+KK     +  D R    R EL +++K+ H N+V+       S          +V
Sbjct: 79  GELVAIKK-----VLQDKR-FKNR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLV 131

Query: 229 TEYLPKGDL----RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
            +Y+P+  +    R + + K  L       +   + R + Y+H      I HRD++P N+
Sbjct: 132 LDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNL 187

Query: 285 LRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFAL 342
           L D D+  LK+ DFG +K L      P      S  Y APE+ F   +Y + +DV+S   
Sbjct: 188 LLDPDTAVLKLCDFGSAKQLV--RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC 245

Query: 343 ILQEMIEGCPPF 354
           +L E++ G P F
Sbjct: 246 VLAELLLGQPIF 257

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  107 bits (269), Expect = 3e-26
 Identities = 60/225 (26%), Positives = 109/225 (48%), Gaps = 17/225 (7%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +E++    +V    DE  +L  + HP +++  G    +  + ++ +Y+  G+L 
Sbjct: 35  AMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELF 94

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
           + L++        A  +A ++   + YLH      II+RDL+P NIL D +G++K+ DFG
Sbjct: 95  SLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFG 151

Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
            +     K    +T   T C    Y+APEV   + Y+  +D +SF +++ EM+ G  PF 
Sbjct: 152 FA-----KYVPDVT--YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF- 203

Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
             +D+   K Y        + P       +K+L+        ++R
Sbjct: 204 --YDSNTMKTYEKILNAELRFPPFF-NEDVKDLLSRLITRDLSQR 245

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  110 bits (275), Expect = 6e-26
 Identities = 58/188 (30%), Positives = 92/188 (48%), Gaps = 11/188 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDE-LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           AVK L ++V+  DD V     E   L    + P + Q          +  V EY+  GDL
Sbjct: 370 AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 429

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              +++ G  K   AV +A +IA G+ +L       II+RDL+  N++ D  G++K+ADF
Sbjct: 430 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 486

Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G+ K              T C    Y+APE+   + Y   VD ++F ++L EM+ G  PF
Sbjct: 487 GMCKENIWDGVTT----KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 542

Query: 355 TMKHDNEV 362
             + ++E+
Sbjct: 543 EGEDEDEL 550

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  106 bits (268), Expect = 6e-26
 Identities = 58/188 (30%), Positives = 93/188 (49%), Gaps = 11/188 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           AVK L ++V+  DD V     E  +L    + P + Q          +  V EY+  GDL
Sbjct: 49  AVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL 108

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              +++ G  K   AV +A +IA G+ +L       II+RDL+  N++ D  G++K+ADF
Sbjct: 109 MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADF 165

Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G+ K              T C    Y+APE+   + Y   VD ++F ++L EM+ G  PF
Sbjct: 166 GMCKENIWDGVTT----KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPF 221

Query: 355 TMKHDNEV 362
             + ++E+
Sbjct: 222 EGEDEDEL 229

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  106 bits (267), Expect = 8e-26
 Identities = 58/188 (30%), Positives = 94/188 (50%), Gaps = 11/188 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K L ++V+  DD V     E  +L     HP +            +  V EYL  GDL
Sbjct: 46  AIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL 105

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++       S A  +A +I  G+ +LH      I++RDL+  NIL D  G++K+ADF
Sbjct: 106 MYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADF 162

Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G+ K   + + +     +T C    Y+APE+   ++Y+  VD +SF ++L EM+ G  PF
Sbjct: 163 GMCKENMLGDAKT----NTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPF 218

Query: 355 TMKHDNEV 362
             + + E+
Sbjct: 219 HGQDEEEL 226

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  106 bits (267), Expect = 9e-26
 Identities = 56/191 (29%), Positives = 100/191 (52%), Gaps = 11/191 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K + +E+++DD+ +   + E  + ++   HP +V         S +  V EY+  GDL
Sbjct: 38  AMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 97

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  ++ +I+  +NYLHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 98  MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 154

Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G+ K      D   T   T C    Y+APE+ + E+Y   VD ++  +++ EM+ G  PF
Sbjct: 155 GMCKEGLRPGDT--T--STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 210

Query: 355 TMKHDNEVPKA 365
            +   ++ P  
Sbjct: 211 DIVGSSDNPDQ 221

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  107 bits (269), Expect = 1e-25
 Identities = 46/188 (24%), Positives = 78/188 (41%), Gaps = 17/188 (9%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K + +  +     V  FR+E  +L       + Q   A    + + +V EY   GDL 
Sbjct: 90  AMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLL 149

Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
             L + G   P+   RF   +I   ++ +H       +HRD++P NIL D  G++++ADF
Sbjct: 150 TLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADF 206

Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE-------YDTKVDVFSFALILQEM 347
           G    L             +     Y++PE+ +          Y  + D ++  +   EM
Sbjct: 207 GSCLKLRADGT---VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM 263

Query: 348 IEGCPPFT 355
             G  PF 
Sbjct: 264 FYGQTPFY 271

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  107 bits (267), Expect = 2e-25
 Identities = 32/271 (11%), Positives = 72/271 (26%), Gaps = 49/271 (18%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR----------------------HPNV 212
           G    V           + ++  ++E+  L+ +R                       P  
Sbjct: 103 GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 162

Query: 213 VQFLGAVTQSSPMMIVTEYLPK-----------GDLRAFLKRKGALKPSTAVRFALDIAR 261
            + +        M +++ +                L +      +L     ++  L + R
Sbjct: 163 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 222

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
            +  LH      ++H  L P +I+ D  G + +  F            P+          
Sbjct: 223 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSPIGRGFAPPETT 279

Query: 322 APEVFKNEEYDTK-----VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA 376
           A  +    ++         D ++  L +  +     P     D+          R     
Sbjct: 280 AERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN---TDDAALGGSEWIFRSCKNI 336

Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           P     + ++ L+E         R    Q +
Sbjct: 337 P-----QPVRALLEGFLRYPKEDRLLPLQAM 362

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  106 bits (265), Expect = 2e-25
 Identities = 32/277 (11%), Positives = 73/277 (26%), Gaps = 60/277 (21%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-------------------------H 209
           G    V           + ++  ++E+  L+ +R                          
Sbjct: 98  GESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQK 157

Query: 210 PNVVQFLGAVTQSSPMMIVTEY-LPKGD-------LRAFLKRKGALKPSTAVRFALDIAR 261
             +++          +     Y   + +       L +      +L     ++  L + R
Sbjct: 158 KKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIR 217

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
            +  LH      ++H  L P +I+ D  G + +  F       V++   +     S  + 
Sbjct: 218 LLASLHHYG---LVHTYLRPVDIVLDQRGGVFLTGFEHL----VRDGARVVS-SVSRGFE 269

Query: 322 APEVFKNEE-----------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ 370
            PE+                     D ++  L++  +     P      +          
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPI---TKDAALGGSEWIF 326

Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           R     P       ++ L+E         R    Q +
Sbjct: 327 RSCKNIPQ-----PVRALLEGFLRYPKEDRLLPLQAM 358

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  106 bits (266), Expect = 2e-25
 Identities = 55/191 (28%), Positives = 100/191 (52%), Gaps = 11/191 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A++ + +E+++DD+ +   + E  + ++   HP +V         S +  V EY+  GDL
Sbjct: 81  AMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL 140

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              ++R+  L    A  ++ +I+  +NYLHE     II+RDL+  N+L D  G++K+ D+
Sbjct: 141 MFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDY 197

Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G+ K      D   T   T C    Y+APE+ + E+Y   VD ++  +++ EM+ G  PF
Sbjct: 198 GMCKEGLRPGDT--T--STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 253

Query: 355 TMKHDNEVPKA 365
            +   ++ P  
Sbjct: 254 DIVGSSDNPDQ 264

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  104 bits (262), Expect = 2e-25
 Identities = 59/190 (31%), Positives = 90/190 (47%), Gaps = 20/190 (10%)

Query: 178 VAVKKL---GEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSP-----MM 226
           VA+K +             +   R E+ALL+++    HPNVV+ +     S       + 
Sbjct: 37  VALKSVRVPNGGGGGGGLPISTVR-EVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVT 95

Query: 227 IVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           +V E++ + DLR +L +     L   T         RG+++LH N    I+HRDL+P NI
Sbjct: 96  LVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENI 151

Query: 285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
           L    G +K+ADFG++++ +      LT    +  Y APEV     Y T VD++S   I 
Sbjct: 152 LVTSGGTVKLADFGLARIYSY--QMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIF 209

Query: 345 QEMIEGCPPF 354
            EM    P F
Sbjct: 210 AEMFRRKPLF 219

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  105 bits (264), Expect = 4e-25
 Identities = 65/256 (25%), Positives = 100/256 (39%), Gaps = 47/256 (18%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGA----VTQSSPMMIVT 229
             + A+K     ++ D  + R    E+ L  +  + P++V+ +            ++IV 
Sbjct: 87  QEKFALK-----MLQDCPKAR---REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 138

Query: 230 EYLPKGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 285
           E L  G+L  R   +   A     A      I   + YLH      I HRD++P N+L  
Sbjct: 139 ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYT 195

Query: 286 -RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFA 341
            +  +  LK+ DFG +K         LT   T C    YVAPEV   E+YD   D++S  
Sbjct: 196 SKRPNAILKLTDFGFAKE--TTSHNSLT---TPCYTPYYVAPEVLGPEKYDKSCDMWSLG 250

Query: 342 LILQEMIEGCPPFTMKHDNEVPKAYAARQR---PPFKAP--------AKLYARGLKELIE 390
           +I+  ++ G PPF   H   +      R R     F  P                K LI 
Sbjct: 251 VIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV-------KMLIR 303

Query: 391 ECWNEKPAKRPTFRQI 406
                +P +R T  + 
Sbjct: 304 NLLKTEPTQRMTITEF 319

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  104 bits (262), Expect = 4e-25
 Identities = 55/188 (29%), Positives = 91/188 (48%), Gaps = 11/188 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           AVK L ++VI  DD V     E  +L     HP + Q          +  V E++  GDL
Sbjct: 52  AVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL 111

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              +++      + A  +A +I   + +LH+     II+RDL+  N+L D  G+ K+ADF
Sbjct: 112 MFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADF 168

Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G+ K          T   T C    Y+APE+ +   Y   VD ++  ++L EM+ G  PF
Sbjct: 169 GMCKEGICNGVT--T--ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPF 224

Query: 355 TMKHDNEV 362
             ++++++
Sbjct: 225 EAENEDDL 232

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  103 bits (259), Expect = 8e-25
 Identities = 55/187 (29%), Positives = 93/187 (49%), Gaps = 11/187 (5%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  +   DRVR  + E  +L ++ HP +V+   A      + ++ ++L  GDL 
Sbjct: 56  AMKVLKKATLKVRDRVRT-KMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLF 114

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L ++          +  ++A  +++LH      II+RDL+P NIL D+ G++K+ DFG
Sbjct: 115 TRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFG 171

Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
           +SK     E +      + C    Y+APEV     +    D +SF +++ EM+ G  PF 
Sbjct: 172 LSKESIDHEKK----AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQ 227

Query: 356 MKHDNEV 362
            K   E 
Sbjct: 228 GKDRKET 234

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  103 bits (258), Expect = 1e-24
 Identities = 56/189 (29%), Positives = 96/189 (50%), Gaps = 21/189 (11%)

Query: 178 VAVKKLGEEVISDDDRV--RAFRDELALLQKIR---HPNVVQFLGAVTQSSP-----MMI 227
           VA+K++  +  + ++ +     R E+A+L+ +    HPNVV+     T S       + +
Sbjct: 40  VALKRVRVQ--TGEEGMPLSTIR-EVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTL 96

Query: 228 VTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL 285
           V E++ + DL  +L +     +   T       + RG+++LH ++   ++HRDL+P NIL
Sbjct: 97  VFEHVDQ-DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNIL 152

Query: 286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQ 345
              SG +K+ADFG++++ +      LT    +  Y APEV     Y T VD++S   I  
Sbjct: 153 VTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 210

Query: 346 EMIEGCPPF 354
           EM    P F
Sbjct: 211 EMFRRKPLF 219

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 97.5 bits (244), Expect = 3e-24
 Identities = 21/87 (24%), Positives = 37/87 (42%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           +  LA + ++  +   ++    +N  D +  T L  AA  G   VV  LL+ GAD     
Sbjct: 7   VHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLG 66

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           +   + L  A      +++K+L   G 
Sbjct: 67  KGRESALSLACSKGYTDIVKMLLDCGV 93

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 94.4 bits (236), Expect = 5e-23
 Identities = 29/106 (27%), Positives = 44/106 (41%), Gaps = 5/106 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A+   L    E       L    ++   + +K LLD G+DVN  D +  T L  A     
Sbjct: 60  ADPQLLGKGRE--SA---LSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNH 114

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
            + V +LLE GAD   +   G   +  A+      V +++E H  K
Sbjct: 115 VKCVKMLLESGADPTIETDSGYNSMDLAVALGYRSVQQVIESHLLK 160

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 93.2 bits (233), Expect = 1e-22
 Identities = 33/107 (30%), Positives = 58/107 (54%), Gaps = 5/107 (4%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           +E  +N  D++G    P   LM+ A    +  ++ LL +G D         +AL +A  +
Sbjct: 25  QENVINHTDEEGF--TP---LMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSK 79

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           G+T++V +LL+ G DV+  D  G TPL  A++  + + +K+L + GA
Sbjct: 80  GYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGA 126

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 76.3 bits (189), Expect = 1e-16
 Identities = 17/61 (27%), Positives = 30/61 (49%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
            N  ++H  A QG    ++  +E+   ++  D  G TPL  A  +    V++ L ++GA 
Sbjct: 2   ANSLSVHQLAAQGEMLYLATRIEQENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGAD 61

Query: 132 P 132
           P
Sbjct: 62  P 62

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A Length = 167

 Score = 67.4 bits (166), Expect = 2e-13
 Identities = 15/79 (18%), Positives = 32/79 (40%), Gaps = 5/79 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
            ++N  D +G    P   L++  +   V+ +K LL+SG D          ++ +A   G+
Sbjct: 93  VDVNEYDWNGG--TP---LLYAVHGNHVKCVKMLLESGADPTIETDSGYNSMDLAVALGY 147

Query: 86  TEVVSLLLERGADVDPKDR 104
             V  ++      +    +
Sbjct: 148 RSVQQVIESHLLKLLQNIK 166

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  102 bits (256), Expect = 3e-24
 Identities = 55/186 (29%), Positives = 84/186 (45%), Gaps = 15/186 (8%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
              VA+KKL     +     RA+R EL L++ + H N++  L   T    +       IV
Sbjct: 50  ERNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIV 108

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            E +   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+   
Sbjct: 109 MELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 162

Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
              LK+ DFG+++  T      +T    +  Y APEV     Y   VD++S   I+ EMI
Sbjct: 163 DCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMI 220

Query: 349 EGCPPF 354
           +G   F
Sbjct: 221 KGGVLF 226

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 96.3 bits (241), Expect = 4e-24
 Identities = 29/89 (32%), Positives = 45/89 (50%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   + + D+  ++ LL +G D N +D    T LH A   G  +VV LLL+  A V+   
Sbjct: 14  LHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTG 73

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
               +PL DA    + +++KLL  +GA  
Sbjct: 74  YQNDSPLHDAAKNGHVDIVKLLLSYGASR 102

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 96.0 bits (240), Expect = 7e-24
 Identities = 27/105 (25%), Positives = 44/105 (41%), Gaps = 5/105 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           ++ N  D  G    P   L    N   ++ ++ LL     VN     N + LH AA  G 
Sbjct: 34  SDPNVKDHAGW--TP---LHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGH 88

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            ++V LLL  GA  +  + +G  P+          ++ L EK+ +
Sbjct: 89  VDIVKLLLSYGASRNAVNIFGLRPVDYTDDESMKSLLLLPEKNES 133

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 85.9 bits (214), Expect = 2e-20
 Identities = 25/68 (36%), Positives = 39/68 (57%), Gaps = 1/68 (1%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
           GID    +    T LH+A+ +G    V  LL+ G+D + KD  G TPL +A  + + +V+
Sbjct: 1   GIDPF-TNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVV 59

Query: 123 KLLEKHGA 130
           +LL +H A
Sbjct: 60  ELLLQHKA 67

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 49.7 bits (120), Expect = 1e-07
 Identities = 13/73 (17%), Positives = 24/73 (32%), Gaps = 5/73 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A +N      +   P   L   A    V+ +K LL  G   N  +I     +     +  
Sbjct: 67  ALVNTTGYQND--SP---LHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRPVDYTDDESM 121

Query: 86  TEVVSLLLERGAD 98
             ++ L  +  + 
Sbjct: 122 KSLLLLPEKNESS 134

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1 Length = 137

 Score = 38.9 bits (92), Expect = 6e-04
 Identities = 9/37 (24%), Positives = 16/37 (43%), Gaps = 1/37 (2%)

Query: 96  GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           G D    +  G T L  A    +   ++ L ++G+ P
Sbjct: 1   GIDPF-TNHRGETLLHIASIKGDIPSVEYLLQNGSDP 36

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score = 95.5 bits (239), Expect = 5e-24
 Identities = 30/89 (33%), Positives = 45/89 (50%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
            M+     D++ +K+ +  G DVN      R  LH AA  G  E++  LL +GAD++  D
Sbjct: 11  FMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPD 70

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           +   TPL  A+Y  +   +KLL   GA  
Sbjct: 71  KHHITPLLSAVYEGHVSCVKLLLSKGADK 99

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score = 78.2 bits (194), Expect = 9e-18
 Identities = 28/100 (28%), Positives = 43/100 (43%), Gaps = 5/100 (5%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           K  ++N   + G   KP   L + A+   +E ++ LL  G D+N  D  + T L  A  +
Sbjct: 29  KGEDVNRTLEGGR--KP---LHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYE 83

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
           G    V LLL +GAD   K   G T            +++
Sbjct: 84  GHVSCVKLLLSKGADKTVKGPDGLTAFEATDNQAIKALLQ 123

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A Length = 123

 Score = 72.0 bits (178), Expect = 1e-15
 Identities = 14/59 (23%), Positives = 21/59 (35%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
                   A   G  + V   + +G DV+     G  PL  A      E+++ L   GA
Sbjct: 6   MCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGA 64

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  101 bits (255), Expect = 5e-24
 Identities = 64/226 (28%), Positives = 102/226 (45%), Gaps = 15/226 (6%)

Query: 179 AVKKLGEEVISDDDRVRAFRDE-LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           AVK L ++ I      +    E   LL+ ++HP +V    +   +  +  V +Y+  G+L
Sbjct: 67  AVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGEL 126

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              L+R+       A  +A +IA  + YLH      I++RDL+P NIL D  G++ + DF
Sbjct: 127 FYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDF 183

Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G+ K          T   T C    Y+APEV   + YD  VD +    +L EM+ G PPF
Sbjct: 184 GLCKENIEHNST--T--STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPF 239

Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
             ++  E+   Y      P +    +     + L+E    +   KR
Sbjct: 240 YSRNTAEM---YDNILNKPLQLKPNI-TNSARHLLEGLLQKDRTKR 281

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  102 bits (257), Expect = 5e-24
 Identities = 44/186 (23%), Positives = 79/186 (42%), Gaps = 15/186 (8%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  +        FR+E  +L       +     A    + + +V +Y   GDL 
Sbjct: 103 AMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLL 162

Query: 239 AFLKRKGALKPSTAVRF-ALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
             L +     P    RF   ++   ++ +H+      +HRD++P NIL D +G++++ADF
Sbjct: 163 TLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADF 219

Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE-----YDTKVDVFSFALILQEMIE 349
           G    L             +     Y++PE+ +  E     Y  + D +S  + + EM+ 
Sbjct: 220 GSCLKLMEDGT---VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLY 276

Query: 350 GCPPFT 355
           G  PF 
Sbjct: 277 GETPFY 282

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  101 bits (253), Expect = 5e-24
 Identities = 51/188 (27%), Positives = 95/188 (50%), Gaps = 11/188 (5%)

Query: 179 AVKKLG-EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDL 237
           A+K L    ++ +       + E  +L++++HP +V  + A      + ++ EYL  G+L
Sbjct: 49  AMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL 108

Query: 238 RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF 297
              L+R+G     TA  +  +I+  + +LH+     II+RDL+P NI+ +  G++K+ DF
Sbjct: 109 FMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDF 165

Query: 298 GVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF 354
           G+ K              T C    Y+APE+     ++  VD +S   ++ +M+ G PPF
Sbjct: 166 GLCKESIHDGTV----THTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPF 221

Query: 355 TMKHDNEV 362
           T ++  + 
Sbjct: 222 TGENRKKT 229

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  101 bits (254), Expect = 6e-24
 Identities = 68/231 (29%), Positives = 99/231 (42%), Gaps = 31/231 (13%)

Query: 145 VPEYEIDPHELD-FTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
               E    E+D F       +GTF    L   +  G+ VA+KK+        D     R
Sbjct: 12  AAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKV------IQDPRFRNR 65

Query: 199 D--ELALLQKIRHPNVVQFLGAVTQSSP-------MMIVTEYLPKGDL----RAFLKRKG 245
           +   +  L  + HPN+VQ                 + +V EY+P   L    R + +R+ 
Sbjct: 66  ELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQV 124

Query: 246 ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLT 304
           A  P     F   + R +  LH    V + HRD++P N+L +   G LK+ DFG +K L+
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183

Query: 305 VKEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
                P      S  Y APE+ F N+ Y T VD++S   I  EM+ G P F
Sbjct: 184 --PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIF 232

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  101 bits (253), Expect = 7e-24
 Identities = 48/190 (25%), Positives = 85/190 (44%), Gaps = 18/190 (9%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP--------MMIVT 229
           VA+KK+  E   +   + A R E+ +LQ ++H NVV  +      +         + +V 
Sbjct: 45  VALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVF 103

Query: 230 EYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
           ++    DL   L         S   R    +  G+ Y+H NK   I+HRD++ +N+L   
Sbjct: 104 DFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITR 159

Query: 289 SGNLKVADFGVSKLLTV---KEDRPLTCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALIL 344
            G LK+ADFG+++  ++    +    T +  +  Y  PE+     +Y   +D++    I+
Sbjct: 160 DGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIM 219

Query: 345 QEMIEGCPPF 354
            EM    P  
Sbjct: 220 AEMWTRSPIM 229

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 99.5 bits (249), Expect = 9e-24
 Identities = 25/89 (28%), Positives = 39/89 (43%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           +   A       ++ L+  G  VN    D+ + LH A   G    V +LL+ GA V+   
Sbjct: 63  MHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVT 122

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
               TPL +A    + + + LL +HGA  
Sbjct: 123 ADWHTPLFNACVSGSWDCVNLLLQHGASV 151

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 89.9 bits (224), Expect = 2e-20
 Identities = 25/105 (23%), Positives = 41/105 (39%), Gaps = 7/105 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
             ++          P   L      +    +K+LL+SG DVN +     + LH       
Sbjct: 181 GNIDHKISHLG--TP---LYLACENQQRACVKKLLESGADVN-QGKGQDSPLHAVVRTAS 234

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            E+  LL++ GAD   K+  G  P+      ++      LE+ GA
Sbjct: 235 EELACLLMDFGADTQAKNAEGKRPVELVP-PESPLAQLFLEREGA 278

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 89.1 bits (222), Expect = 5e-20
 Identities = 20/77 (25%), Positives = 35/77 (45%), Gaps = 1/77 (1%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           +  L+  G +++ +     T L++A        V  LLE GADV+ + +   +PL   + 
Sbjct: 173 VNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADVN-QGKGQDSPLHAVVR 231

Query: 116 YKNHEVIKLLEKHGAKP 132
             + E+  LL   GA  
Sbjct: 232 TASEELACLLMDFGADT 248

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 86.4 bits (215), Expect = 4e-19
 Identities = 28/107 (26%), Positives = 43/107 (40%), Gaps = 6/107 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
             +N +  D     P   L        +  +K LL  G  VN    D  T L  A   G 
Sbjct: 83  WAVNIITADHV--SP---LHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGS 137

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            + V+LLL+ GA V P+    ++P+ +A    + E +  L  +G   
Sbjct: 138 WDCVNLLLQHGASVQPESD-LASPIHEAARRGHVECVNSLIAYGGNI 183

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 82.5 bits (205), Expect = 7e-18
 Identities = 29/107 (27%), Positives = 45/107 (42%), Gaps = 6/107 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++NG+  D     P   L         + +  LL  G  V   + D  + +H AA +G 
Sbjct: 116 AQVNGVTADWH--TP---LFNACVSGSWDCVNLLLQHGASVQ-PESDLASPIHEAARRGH 169

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            E V+ L+  G ++D K     TPL  A   +    +K L + GA  
Sbjct: 170 VECVNSLIAYGGNIDHKISHLGTPLYLACENQQRACVKKLLESGADV 216

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 81.8 bits (203), Expect = 1e-17
 Identities = 22/84 (26%), Positives = 40/84 (47%), Gaps = 3/84 (3%)

Query: 49  NERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST 108
             RD  GI+ LL + +  +   + + + +H AA  G    +  L+ +G  V+       +
Sbjct: 38  GPRDFPGIR-LLSNPLMGD--AVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVS 94

Query: 109 PLGDAIYYKNHEVIKLLEKHGAKP 132
           PL +A    +   +K+L KHGA+ 
Sbjct: 95  PLHEACLGGHLSCVKILLKHGAQV 118

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 57.1 bits (139), Expect = 3e-09
 Identities = 12/80 (15%), Positives = 22/80 (27%), Gaps = 12/80 (15%)

Query: 56  IKELLDSGIDVNFRD-----IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
              L+  G  +   D     +D           G       LL      D       +P+
Sbjct: 11  SSGLVPRGSHMASMDGKQGGMDGSKPAGPRDFPGI-----RLLSNPLMGDAVS--DWSPM 63

Query: 111 GDAIYYKNHEVIKLLEKHGA 130
            +A  + +   ++ L   G 
Sbjct: 64  HEAAIHGHQLSLRNLISQGW 83

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens} Length = 285

 Score = 53.6 bits (130), Expect = 3e-08
 Identities = 7/45 (15%), Positives = 17/45 (37%), Gaps = 1/45 (2%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
              L+D G D   ++ + +  + +   +     +  L   GA + 
Sbjct: 238 ACLLMDFGADTQAKNAEGKRPVELVPPESPLAQL-FLEREGASLP 281

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  100 bits (252), Expect = 1e-23
 Identities = 55/193 (28%), Positives = 90/193 (46%), Gaps = 30/193 (15%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
           G +VA+KKL     S+    RA+R EL LL+ ++H NV+  L   T +S +       +V
Sbjct: 49  GEKVAIKKLSRPFQSEIFAKRAYR-ELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLV 107

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
             ++   DL+  +  K              + +G+ Y+H      ++HRDL+P N+  ++
Sbjct: 108 MPFMQT-DLQKIMGLK--FSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNE 161

Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFA 341
              LK+ DFG+++      D  +T       YV      APEV      Y+  VD++S  
Sbjct: 162 DCELKILDFGLAR----HADAEMT------GYVVTRWYRAPEVILSWMHYNQTVDIWSVG 211

Query: 342 LILQEMIEGCPPF 354
            I+ EM+ G   F
Sbjct: 212 CIMAEMLTGKTLF 224

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  101 bits (254), Expect = 1e-23
 Identities = 52/183 (28%), Positives = 84/183 (45%), Gaps = 14/183 (7%)

Query: 179 AVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLR 238
           A+K L +  +        F +E  ++     P VVQ   A      + +V EY+P GDL 
Sbjct: 98  AMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDL- 156

Query: 239 AFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG 298
             L     +    A  +  ++   ++ +H       IHRD++P N+L D SG+LK+ADFG
Sbjct: 157 VNLMSNYDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFG 213

Query: 299 VSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNE----EYDTKVDVFSFALILQEMIEGC 351
               +  +        DT+     Y++PEV K++     Y  + D +S  + L EM+ G 
Sbjct: 214 TCMKMNKEGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGD 270

Query: 352 PPF 354
            PF
Sbjct: 271 TPF 273

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  101 bits (253), Expect = 1e-23
 Identities = 52/198 (26%), Positives = 86/198 (43%), Gaps = 33/198 (16%)

Query: 178 VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI--VTEYLPKG 235
            A+K++    IS      A R E+ALL++++HPNV+         +   +  + +Y    
Sbjct: 51  YALKQIEGTGISMS----ACR-EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH- 104

Query: 236 DLRAFLK---------RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL- 285
           DL   +K         +   L           I  G++YLH N    ++HRDL+P+NIL 
Sbjct: 105 DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILV 161

Query: 286 ---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-----YVAPEV-FKNEEYDTKVD 336
                + G +K+AD G ++L      +PL   D         Y APE+      Y   +D
Sbjct: 162 MGEGPERGRVKIADMGFARLFNS-PLKPLA--DLDPVVVTFWYRAPELLLGARHYTKAID 218

Query: 337 VFSFALILQEMIEGCPPF 354
           +++   I  E++   P F
Sbjct: 219 IWAIGCIFAELLTSEPIF 236

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  100 bits (250), Expect = 2e-23
 Identities = 50/203 (24%), Positives = 81/203 (39%), Gaps = 35/203 (17%)

Query: 174 RGIQVAVKKLGEEVISDDDRV---------RAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
            GI VA+K++   V                R  R E+ LL    HPN++           
Sbjct: 45  EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR-EIRLLNHFHHPNILGLRDIFVHFEE 103

Query: 225 MM-----IVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
                  +VTE +   DL   +  ++  + P     F   I  G++ LHE     ++HRD
Sbjct: 104 PAMHKLYLVTELMRT-DLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRD 159

Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEY 331
           L P NIL  D+ ++ + DF +++      D   T       YV      APE+  + + +
Sbjct: 160 LHPGNILLADNNDITICDFNLAR--EDTADANKT------HYVTHRWYRAPELVMQFKGF 211

Query: 332 DTKVDVFSFALILQEMIEGCPPF 354
              VD++S   ++ EM      F
Sbjct: 212 TKLVDMWSAGCVMAEMFNRKALF 234

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 98.3 bits (246), Expect = 3e-23
 Identities = 30/105 (28%), Positives = 48/105 (45%), Gaps = 4/105 (3%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A +N  +++G    P   L         + ++ LL  G D   R  +  T   +AA  G 
Sbjct: 29  ANVNFQEEEGGWT-P---LHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGS 84

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            +++ L L +GADV+  D +G T   +A  Y   + +K L K GA
Sbjct: 85  VKLLKLFLSKGADVNECDFYGFTAFMEAAVYGKVKALKFLYKRGA 129

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 94.1 bits (235), Expect = 7e-22
 Identities = 28/88 (31%), Positives = 47/88 (53%), Gaps = 1/88 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNR-TALHVAACQGFTEVVSLLLERGADVDPK 102
           L+      DV+ +++LL+ G +VNF++ +   T LH A      ++V LLL  GAD   +
Sbjct: 9   LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLR 68

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            + G+TP   A    + +++KL    GA
Sbjct: 69  KKNGATPFLLAAIAGSVKLLKLFLSKGA 96

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 92.1 bits (230), Expect = 3e-21
 Identities = 32/112 (28%), Positives = 50/112 (44%), Gaps = 10/112 (8%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKE----LLDSGIDVNFRDIDNRTALHVAA 81
           A++N  D+ G        L+      D   ++     LLD G DVN R    +T L +A 
Sbjct: 173 ADVNACDNMGR--NA---LIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAV 227

Query: 82  CQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            +    +V  LLE+   +++  D  G T L  A+  K  ++ +LL K GA  
Sbjct: 228 EKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAST 279

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 84.4 bits (210), Expect = 2e-18
 Identities = 34/116 (29%), Positives = 51/116 (43%), Gaps = 16/116 (13%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A+      +G    P    +  A    V+ +K  L  G DVN  D    TA   AA  G 
Sbjct: 63  ADPVLRKKNGA--TP---FLLAAIAGSVKLLKLFLSKGADVNECDFYGFTAFMEAAVYGK 117

Query: 86  TEVVSLLLERGADVDPKD----------RWGSTPLGDAIYYKNHEVIK-LLEKHGA 130
            + +  L +RGA+V+ +           + G+T L DA    + EV+K LL++ GA
Sbjct: 118 VKALKFLYKRGANVNLRRKTKEDQERLRKGGATALMDAAEKGHVEVLKILLDEMGA 173

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 76.4 bits (189), Expect = 9e-16
 Identities = 37/120 (30%), Positives = 49/120 (40%), Gaps = 20/120 (16%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN----------RT 75
           A++N  D  G         M  A    V+ +K L   G +VN R               T
Sbjct: 96  ADVNECDFYGF--TA---FMEAAVYGKVKALKFLYKRGANVNLRRKTKEDQERLRKGGAT 150

Query: 76  ALHVAACQGFTEVVSLLL-ERGADVDPKDRWGSTPLGDAIYYKNH----EVIKLLEKHGA 130
           AL  AA +G  EV+ +LL E GADV+  D  G   L  A+   +      +  LL  HGA
Sbjct: 151 ALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGA 210

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 76.0 bits (188), Expect = 1e-15
 Identities = 19/62 (30%), Positives = 35/62 (56%), Gaps = 1/62 (1%)

Query: 70  DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKH 128
            +++   L  A      ++V  LLE GA+V+ ++   G TPL +A+     ++++LL +H
Sbjct: 2   AVEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRH 61

Query: 129 GA 130
           GA
Sbjct: 62  GA 63

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1 Length = 285

 Score = 68.3 bits (168), Expect = 5e-13
 Identities = 22/79 (27%), Positives = 40/79 (50%), Gaps = 6/79 (7%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
           A++N   + G+   P   L+    ++ +  ++ LL+   I++N  D D +TAL +A    
Sbjct: 210 ADVNVRGERGK--TP---LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELK 264

Query: 85  FTEVVSLLLERGADVDPKD 103
             ++  LL +RGA  D  D
Sbjct: 265 LKKIAELLCKRGASTDCGD 283

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 99.1 bits (248), Expect = 3e-23
 Identities = 35/106 (33%), Positives = 53/106 (50%), Gaps = 6/106 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
           A+     +  ++      L+  A   + E +  LL    ++ +  D    T LH+AA   
Sbjct: 15  AKAVLTGEYKKDE-----LLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAAGYN 69

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
              +V LLL+ GADV  KD+ G  PL +A  Y ++EV +LL KHGA
Sbjct: 70  RVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGA 115

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 97.6 bits (244), Expect = 1e-22
 Identities = 35/89 (39%), Positives = 42/89 (47%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A    V  ++ LL  G DV+ +D      LH A   G  EV  LLL+ GA V+  D
Sbjct: 62  LHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMD 121

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            W  TPL +A      EV  LL  HGA P
Sbjct: 122 LWQFTPLHEAASKNRVEVCSLLLSHGADP 150

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 94.5 bits (236), Expect = 1e-21
 Identities = 25/77 (32%), Positives = 41/77 (53%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
            + LL  G +VN ++ D  T LHVAA +   +V+ +L + GA ++  D  G T L  A  
Sbjct: 230 AELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQTALHRAAL 289

Query: 116 YKNHEVIKLLEKHGAKP 132
             + +  +LL  +G+ P
Sbjct: 290 AGHLQTCRLLLSYGSDP 306

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 92.2 bits (230), Expect = 8e-21
 Identities = 32/110 (29%), Positives = 45/110 (40%), Gaps = 6/110 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A+++  D  G    P   L    +    E  + LL  G  VN  D+   T LH AA +  
Sbjct: 82  ADVHAKDKGGL--VP---LHNACSYGHYEVTELLLKHGACVNAMDLWQFTPLHEAASKNR 136

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135
            EV SLLL  GAD    +  G + +  A   +  E +    K  +  L A
Sbjct: 137 VEVCSLLLSHGADPTLVNCHGKSAVDMAPTPELRERLTYEFKGHS-LLQA 185

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 91.8 bits (229), Expect = 1e-20
 Identities = 31/92 (33%), Positives = 49/92 (53%), Gaps = 3/92 (3%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---TEVVSLLLERGADVD 100
           L+  A E D+  +K+ L   I    +   + TALH A         +V  LLL +GA+V+
Sbjct: 182 LLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVN 241

Query: 101 PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            K++   TPL  A    +++V+++L KHGAK 
Sbjct: 242 EKNKDFMTPLHVAAERAHNDVMEVLHKHGAKM 273

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 86.8 bits (216), Expect = 7e-19
 Identities = 20/76 (26%), Positives = 31/76 (40%), Gaps = 1/76 (1%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
             +L D            +  L  AA  G   ++++LL     +    D   STPL  A 
Sbjct: 7   ALDLADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNVNCHASDGRKSTPLHLAA 66

Query: 115 YYKNHEVIKLLEKHGA 130
            Y    +++LL +HGA
Sbjct: 67  GYNRVRIVQLLLQHGA 82

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 82.9 bits (206), Expect = 1e-17
 Identities = 19/77 (24%), Positives = 29/77 (37%), Gaps = 5/77 (6%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ L   G  +N  D   +TALH AA  G  +   LLL  G+D       G T       
Sbjct: 263 MEVLHKHGAKMNALDSLGQTALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMG-- 320

Query: 116 YKNHEVIKLLEKHGAKP 132
              +E ++ +       
Sbjct: 321 ---NEAVQQILSESTPM 334

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 71.4 bits (176), Expect = 9e-14
 Identities = 26/131 (19%), Positives = 43/131 (32%), Gaps = 29/131 (22%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVA----- 80
           A +N +D       P   L   A++  VE    LL  G D    +   ++A+ +A     
Sbjct: 115 ACVNAMDLWQF--TP---LHEAASKNRVEVCSLLLSHGADPTLVNCHGKSAVDMAPTPEL 169

Query: 81  ----------------ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA---IYYKNHEV 121
                           A +     V   L        + +   T L  A   ++ K  +V
Sbjct: 170 RERLTYEFKGHSLLQAAREADLAKVKKTLALEIINFKQPQSHETALHCAVASLHPKRKQV 229

Query: 122 IKLLEKHGAKP 132
            +LL + GA  
Sbjct: 230 AELLLRKGANV 240

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 62.1 bits (152), Expect = 1e-10
 Identities = 17/83 (20%), Positives = 28/83 (33%), Gaps = 10/83 (12%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N LD  G+       L   A    ++  + LL  G D +   +   TA  +      
Sbjct: 271 AKMNALDSLGQTA-----LHRAALAGHLQTCRLLLSYGSDPSIISLQGFTAAQMGN---- 321

Query: 86  TEVVSLLLERGADVDPKDRWGST 108
            E V  +L     +   D     
Sbjct: 322 -EAVQQILSESTPMRTSDVDYRL 343

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus} Length = 351

 Score = 45.2 bits (108), Expect = 2e-05
 Identities = 9/60 (15%), Positives = 17/60 (28%), Gaps = 14/60 (23%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH-EVIKLLEKHGA 130
             ++AL              L +  A       +    L +A    N  +++ LL     
Sbjct: 3   FGKSALD-------------LADPSAKAVLTGEYKKDELLEAARSGNEEKLMALLTPLNV 49

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115

 Score = 93.2 bits (233), Expect = 4e-23
 Identities = 38/87 (43%), Positives = 51/87 (58%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A     E +K+LL  G DVN R  D  T LH+AA  G  E+V LLL +GADV+ + 
Sbjct: 13  LHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARS 72

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           + G+TP   A    +HE++KLL+  GA
Sbjct: 73  KDGNTPEHLAKKNGHHEIVKLLDAKGA 99

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115

 Score = 79.0 bits (196), Expect = 3e-18
 Identities = 27/68 (39%), Positives = 35/68 (51%), Gaps = 2/68 (2%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
           G        D  T LH AA  G  E V  LL +GADV+ + + G+TPL  A    + E++
Sbjct: 1   GHMWG--SKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIV 58

Query: 123 KLLEKHGA 130
           KLL   GA
Sbjct: 59  KLLLAKGA 66

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli} Length = 115

 Score = 74.3 bits (184), Expect = 1e-16
 Identities = 30/85 (35%), Positives = 38/85 (44%), Gaps = 5/85 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N    DG    P   L   A     E +K LL  G DVN R  D  T  H+A   G 
Sbjct: 33  ADVNARSKDGN--TP---LHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGH 87

Query: 86  TEVVSLLLERGADVDPKDRWGSTPL 110
            E+V LL  +GADV+ +    S   
Sbjct: 88  HEIVKLLDAKGADVNARSWGSSHHH 112

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 94.8 bits (237), Expect = 4e-23
 Identities = 27/107 (25%), Positives = 46/107 (42%), Gaps = 5/107 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A+ + L  + E       L   +     + +  LL+  +D+N  D +  T L  A     
Sbjct: 60  ADPHILAKERE--SA---LSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNH 114

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            + V  LL RGAD+  +   G TP+  A+     +V +++E H  K 
Sbjct: 115 VKCVEALLARGADLTTEADSGYTPMDLAVALGYRKVQQVIENHILKL 161

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 92.1 bits (230), Expect = 4e-22
 Identities = 27/87 (31%), Positives = 50/87 (57%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L++ +   ++E ++ LL+ G D +    +  +AL +A+  G+T++V LLLER  D++  D
Sbjct: 40  LIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYD 99

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             G TPL  A+   + + ++ L   GA
Sbjct: 100 WNGGTPLLYAVRGNHVKCVEALLARGA 126

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 90.6 bits (226), Expect = 1e-21
 Identities = 25/90 (27%), Positives = 39/90 (43%), Gaps = 1/90 (1%)

Query: 44  LMFLANERDVEGIKELLDSGID-VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
           +  LA + +++ +KE L  G + VN  D    T L  A+  G  E V  LLE GAD    
Sbjct: 6   IHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHIL 65

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            +   + L  A      +++ LL +     
Sbjct: 66  AKERESALSLASTGGYTDIVGLLLERDVDI 95

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 77.1 bits (191), Expect = 8e-17
 Identities = 15/84 (17%), Positives = 33/84 (39%), Gaps = 5/84 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
            ++N  D +G    P   L++      V+ ++ LL  G D+        T + +A   G+
Sbjct: 93  VDINIYDWNGG--TP---LLYAVRGNHVKCVEALLARGADLTTEADSGYTPMDLAVALGY 147

Query: 86  TEVVSLLLERGADVDPKDRWGSTP 109
            +V  ++      +   +   + P
Sbjct: 148 RKVQQVIENHILKLFQSNLVPADP 171

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A Length = 172

 Score = 69.0 bits (170), Expect = 4e-14
 Identities = 18/61 (29%), Positives = 30/61 (49%), Gaps = 1/61 (1%)

Query: 73  NRTALHVAACQGFTEVVSLLLERGAD-VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
           +  ++H  A QG  + +   L +G + V+  D  G TPL  A  +   E ++ L + GA 
Sbjct: 2   DSLSIHQLAAQGELDQLKEHLRKGDNLVNKPDERGFTPLIWASAFGEIETVRFLLEWGAD 61

Query: 132 P 132
           P
Sbjct: 62  P 62

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 99.9 bits (250), Expect = 6e-23
 Identities = 32/107 (29%), Positives = 47/107 (43%), Gaps = 5/107 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
               G  + G    P   L   +    +  +K LL  G   N  ++   T LH+AA  G 
Sbjct: 5   ISGGGGGESGL--TP---LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGH 59

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           TEV   LL+  A V+ K +   TPL  A    +  ++KLL ++ A P
Sbjct: 60  TEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNMVKLLLENNANP 106

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 97.9 bits (245), Expect = 2e-22
 Identities = 32/107 (29%), Positives = 45/107 (42%), Gaps = 5/107 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
              N     G    P   L   A E   E +  LL    + N  +    T LH+ A +G 
Sbjct: 236 GSANAESVQGV--TP---LHLAAQEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGH 290

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
             V  +L++ G  VD   R G TPL  A +Y N +++K L +H A  
Sbjct: 291 VPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADV 337

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 97.9 bits (245), Expect = 2e-22
 Identities = 35/109 (32%), Positives = 53/109 (48%), Gaps = 5/109 (4%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           K+A  N  +  G    P   L  +A E  V     L+  G+ V+       T LHVA+  
Sbjct: 267 KQANGNLGNKSGL--TP---LHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHY 321

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           G  ++V  LL+  ADV+ K + G +PL  A    + +++ LL K+GA P
Sbjct: 322 GNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASP 370

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 97.9 bits (245), Expect = 2e-22
 Identities = 36/107 (33%), Positives = 46/107 (42%), Gaps = 5/107 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A  N     G    P   L   A E  VE +  LL+             T LHVAA  G 
Sbjct: 104 ANPNLATTAGH--TP---LHIAAREGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGK 158

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
             V  LLLER A  +   + G TPL  A+++ N +++KLL   G  P
Sbjct: 159 VRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSP 205

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 97.9 bits (245), Expect = 3e-22
 Identities = 29/109 (26%), Positives = 46/109 (42%), Gaps = 5/109 (4%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           ++A  N    +G    P   L    +  +++ +K LL  G   +    +  T LH+AA Q
Sbjct: 168 RDAHPNAAGKNGL--TP---LHVAVHHNNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQ 222

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
              EV   LL+ G   + +   G TPL  A    + E++ LL    A  
Sbjct: 223 NQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQANG 271

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 96.8 bits (242), Expect = 5e-22
 Identities = 33/110 (30%), Positives = 48/110 (43%), Gaps = 5/110 (4%)

Query: 23  RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
           + +A++N    D +   P   L   A       +K LL++  + N       T LH+AA 
Sbjct: 68  QNKAKVNAKAKDDQT--P---LHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAR 122

Query: 83  QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           +G  E V  LLE+ A      + G TPL  A  Y    V +LL +  A P
Sbjct: 123 EGHVETVLALLEKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHP 172

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 96.8 bits (242), Expect = 5e-22
 Identities = 31/109 (28%), Positives = 40/109 (36%), Gaps = 5/109 (4%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           KEA    +   G    P   L   A    V   + LL+     N    +  T LHVA   
Sbjct: 135 KEASQACMTKKGF--TP---LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHH 189

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
              ++V LLL RG         G TPL  A      EV + L ++G   
Sbjct: 190 NNLDIVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSA 238

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 96.4 bits (241), Expect = 9e-22
 Identities = 34/109 (31%), Positives = 46/109 (42%), Gaps = 5/109 (4%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           + A  N  +   E   P   L   A     E  K LL +   VN +  D++T LH AA  
Sbjct: 36  RGASPNVSNVKVE--TP---LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARI 90

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           G T +V LLLE  A+ +     G TPL  A    + E +  L +  A  
Sbjct: 91  GHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQ 139

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 96.0 bits (240), Expect = 1e-21
 Identities = 29/106 (27%), Positives = 48/106 (45%), Gaps = 5/106 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
             ++     G    P   L   ++  +++ +K LL    DVN +     + LH AA QG 
Sbjct: 302 VMVDATTRMGY--TP---LHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGH 356

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
           T++V+LLL+ GA  +     G+TPL  A       V  +L+    +
Sbjct: 357 TDIVTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDE 402

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 93.7 bits (234), Expect = 6e-21
 Identities = 31/107 (28%), Positives = 47/107 (43%), Gaps = 5/107 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
              +    +G    P   L   A +  VE  + LL  G   N   +   T LH+AA +G 
Sbjct: 203 GSPHSPAWNGY--TP---LHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGH 257

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            E+V+LLL + A+ +  ++ G TPL       +  V  +L KHG   
Sbjct: 258 AEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMV 304

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 89.1 bits (222), Expect = 2e-19
 Identities = 24/70 (34%), Positives = 32/70 (45%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
           GI          T LHVA+  G   +V  LL+RGA  +  +    TPL  A    + EV 
Sbjct: 4   GISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVA 63

Query: 123 KLLEKHGAKP 132
           K L ++ AK 
Sbjct: 64  KYLLQNKAKV 73

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1 Length = 437

 Score = 45.2 bits (108), Expect = 3e-05
 Identities = 11/38 (28%), Positives = 16/38 (42%)

Query: 95  RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            G         G TPL  A +  +  ++K L + GA P
Sbjct: 3   PGISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASP 40

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 95.6 bits (239), Expect = 7e-23
 Identities = 28/113 (24%), Positives = 54/113 (47%), Gaps = 6/113 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N +DD G+       L + A   +V+    LL +G + + ++    T L +AA +G 
Sbjct: 116 ADVNAVDDLGK--SA---LHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGS 170

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
            E   +LL+  A+ D  D     P   A    +H++++LL+++        +H
Sbjct: 171 YETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDEYNLVRS-PQLH 222

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 91.3 bits (228), Expect = 2e-21
 Identities = 27/87 (31%), Positives = 44/87 (50%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L+  A       +++L++S  DVN  D   ++ALH AA     +   +LL+ GA+ D ++
Sbjct: 96  LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 155

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               TPL  A    ++E  K+L  H A
Sbjct: 156 NREETPLFLAAREGSYETAKVLLDHFA 182

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 86.7 bits (216), Expect = 1e-19
 Identities = 25/90 (27%), Positives = 37/90 (41%), Gaps = 1/90 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPK 102
           L   A     +  K LL++  D N +D   RT LH A       V  +L+   A D+D +
Sbjct: 29  LHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDAR 88

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
              G+TPL  A       +++ L    A  
Sbjct: 89  MHDGTTPLILAARLAVEGMLEDLINSHADV 118

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 85.9 bits (214), Expect = 2e-19
 Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 1/77 (1%)

Query: 56  IKELLDSGIDV-NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
           I + +  G  + N  D    TALH+AA    ++    LLE  AD + +D  G TPL  A+
Sbjct: 7   ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 66

Query: 115 YYKNHEVIKLLEKHGAK 131
                 V ++L ++ A 
Sbjct: 67  SADAQGVFQILIRNRAT 83

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 83.6 bits (208), Expect = 9e-19
 Identities = 27/106 (25%), Positives = 44/106 (41%), Gaps = 6/106 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
           A+ N  D+ G    P   L    +       + L+ +   D++ R  D  T L +AA   
Sbjct: 49  ADANIQDNMGR--TP---LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLA 103

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
              ++  L+   ADV+  D  G + L  A    N +   +L K+GA
Sbjct: 104 VEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGA 149

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A Length = 223

 Score = 50.9 bits (123), Expect = 2e-07
 Identities = 14/48 (29%), Positives = 21/48 (43%), Gaps = 1/48 (2%)

Query: 84  GFTEVVSLLLERGADV-DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               V+S  + +GA + +  DR G T L  A  Y   +  K L +  A
Sbjct: 2   DAPAVISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASA 49

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 97.2 bits (243), Expect = 7e-23
 Identities = 34/141 (24%), Positives = 57/141 (40%), Gaps = 17/141 (12%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
            +     DDG         +   +  D E +  LL+ G D+N+ ++D  TALH A     
Sbjct: 32  KKTKVKFDDGAV------FLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDN 85

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PLMA 135
            ++V  L+E GA+++  D  G  PL  A      ++ + L   GA           PL  
Sbjct: 86  VDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDI 145

Query: 136 PMHVKHAREVPEYEIDPHELD 156
                   E+ + E++   +D
Sbjct: 146 AEEEAM-EELLQNEVNRQGVD 165

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 91.4 bits (228), Expect = 8e-21
 Identities = 27/78 (34%), Positives = 43/78 (55%), Gaps = 1/78 (1%)

Query: 56  IKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
            ++ L+S  I+         TALHVAA +G+TEV+ LL++   DV+ KD  G TPL  A 
Sbjct: 181 ARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAA 240

Query: 115 YYKNHEVIKLLEKHGAKP 132
           ++   E  ++L ++    
Sbjct: 241 HWGKEEACRILVENLCDM 258

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 89.5 bits (223), Expect = 4e-20
 Identities = 22/76 (28%), Positives = 35/76 (46%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           +K L+ +  DVN +D D  T LH AA  G  E   +L+E   D++  ++ G T    A  
Sbjct: 215 LKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADE 274

Query: 116 YKNHEVIKLLEKHGAK 131
                + +L +K    
Sbjct: 275 DILGYLEELQKKQNLL 290

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 78.3 bits (194), Expect = 2e-16
 Identities = 22/77 (28%), Positives = 35/77 (45%), Gaps = 1/77 (1%)

Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
             ++  +        +  D+      A   G TE V  LLERGAD++  +  G T L  A
Sbjct: 22  TDLEPPVVKRKKTKVKF-DDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQA 80

Query: 114 IYYKNHEVIKLLEKHGA 130
               N +++K L ++GA
Sbjct: 81  CIDDNVDMVKFLVENGA 97

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 68.7 bits (169), Expect = 4e-13
 Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 11/105 (10%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A +  ++ +G+   P   L     E   E ++  ++         +D   A         
Sbjct: 130 AHVGAVNSEGD--TP---LDIAEEEAMEELLQNEVNRQ------GVDIEAARKEEERIML 178

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            +    L     +     + G T L  A      EV+KLL +   
Sbjct: 179 RDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARY 223

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 65.2 bits (160), Expect = 6e-12
 Identities = 10/67 (14%), Positives = 20/67 (29%), Gaps = 1/67 (1%)

Query: 66  VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
           +   D   +    +    G    +   + +      K   G+  L  A    + E +  L
Sbjct: 1   MKMADAKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFL-AACSSGDTEEVLRL 59

Query: 126 EKHGAKP 132
            + GA  
Sbjct: 60  LERGADI 66

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1 Length = 299

 Score = 51.7 bits (125), Expect = 2e-07
 Identities = 16/78 (20%), Positives = 29/78 (37%), Gaps = 5/78 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
            ++N  D DG    P   L   A+    E  + L+++  D+   +   +TA  VA     
Sbjct: 223 YDVNIKDYDGWT--P---LHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDVADEDIL 277

Query: 86  TEVVSLLLERGADVDPKD 103
             +  L  ++      K 
Sbjct: 278 GYLEELQKKQNLLHSEKR 295

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score = 99.5 bits (248), Expect = 8e-23
 Identities = 53/192 (27%), Positives = 82/192 (42%), Gaps = 27/192 (14%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
              VA+KKL     +     RA+R EL L++ + H N++  L   T    +       +V
Sbjct: 87  DRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLV 145

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            E +   +L   ++ +  L           +  G+ +LH      IIHRDL+PSNI+   
Sbjct: 146 MELMDA-NLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKS 199

Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEVFKNEEYDTKVDVFSFAL 342
              LK+ DFG+++  T      +T       YV      APEV     Y   VD++S   
Sbjct: 200 DCTLKILDFGLAR--TAGTSFMMT------PYVVTRYYRAPEVILGMGYKENVDIWSVGC 251

Query: 343 ILQEMIEGCPPF 354
           I+ EM+     F
Sbjct: 252 IMGEMVRHKILF 263

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93

 Score = 90.9 bits (227), Expect = 1e-22
 Identities = 40/74 (54%), Positives = 50/74 (67%)

Query: 57  KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
           K LL++G DVN +D + RT LH+AA  G  EVV LLLE GADV+ KD+ G TPL  A   
Sbjct: 19  KLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 78

Query: 117 KNHEVIKLLEKHGA 130
            + EV+KLL + GA
Sbjct: 79  GHLEVVKLLLEAGA 92

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93

 Score = 75.5 bits (187), Expect = 3e-17
 Identities = 32/59 (54%), Positives = 39/59 (66%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           + RT LH+AA  G  EVV LLLE GADV+ KD+ G TPL  A    + EV+KLL + GA
Sbjct: 1   NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1 Length = 93

 Score = 53.9 bits (131), Expect = 1e-09
 Identities = 32/74 (43%), Positives = 42/74 (56%), Gaps = 5/74 (6%)

Query: 24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
            A++N  D +G    P   L   A    +E +K LL++G DVN +D + RT LH+AA  
Sbjct: 24 AGADVNAKDKNGR--TP---LHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 78

Query: 84 GFTEVVSLLLERGA 97
          G  EVV LLLE GA
Sbjct: 79 GHLEVVKLLLEAGA 92

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 95.0 bits (237), Expect = 1e-22
 Identities = 28/108 (25%), Positives = 45/108 (41%), Gaps = 2/108 (1%)

Query: 23  RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
           RK               P   L+  A   ++E +++ +    D +  + +  TALH A C
Sbjct: 6   RKAGSPRKARRARLN--PLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAIC 63

Query: 83  QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
                +V  L+  GA+V+  D  G TPL  A    +  +   L +HGA
Sbjct: 64  GANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGA 111

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 81.5 bits (202), Expect = 7e-18
 Identities = 20/109 (18%), Positives = 37/109 (33%), Gaps = 8/109 (7%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
            + +  +++G        L       +   +  L+ +G +VN  D    T LH AA    
Sbjct: 45  NDPSQPNEEGI--TA---LHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCND 99

Query: 86  TEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKN--HEVIKLLEKHGAK 131
           T +   L++ GA +       G+T       Y+    +    L      
Sbjct: 100 TVICMALVQHGAAIFATTLSDGATAFEKCDPYREGYADCATYLADVEQS 148

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 53.8 bits (130), Expect = 2e-08
 Identities = 10/67 (14%), Positives = 18/67 (26%), Gaps = 1/67 (1%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
              L D    +   +     AL   +   F + +S        V  +D    T    A  
Sbjct: 139 ATYLADVEQSMGLMNSGAVYALWDYS-AEFGDELSFREGESVTVLRRDGPEETDWWWAAL 197

Query: 116 YKNHEVI 122
           +     +
Sbjct: 198 HGQEGYV 204

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 47.3 bits (113), Expect = 3e-06
 Identities = 11/88 (12%), Positives = 21/88 (23%), Gaps = 7/88 (7%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
            E  +  ++            ++  +    + +       + V  RD    T    AA  
Sbjct: 145 VEQSMGLMNSGAVY------ALWDYSAEFGDELSFREGESVTVLRRDGPEETDWWWAALH 198

Query: 84  GFTEVV-SLLLERGADVDPKDRWGSTPL 110
           G    V          V P+        
Sbjct: 199 GQEGYVPRNYFGLFPRVKPQRSKVKHHH 226

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens} Length = 229

 Score = 43.4 bits (103), Expect = 6e-05
 Identities = 9/47 (19%), Positives = 14/47 (29%), Gaps = 3/47 (6%)

Query: 89  VSLLLERGADVDPKDRW---GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           +  +L +        R        L DA      EV++   K    P
Sbjct: 1   MRSVLRKAGSPRKARRARLNPLVLLLDAALTGELEVVQQAVKEMNDP 47

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 95.6 bits (239), Expect = 1e-22
 Identities = 27/105 (25%), Positives = 50/105 (47%), Gaps = 5/105 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N +DD G+       L + A   +V+    LL +G + + ++    T L +AA +G 
Sbjct: 148 ADVNAVDDLGK--SA---LHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLFLAAREGS 202

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            E   +LL+  A+ D  D     P   A    +H++++LL+    
Sbjct: 203 YETAKVLLDHFANRDITDHMDRLPRDIAQERMHHDIVRLLDLEHH 247

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 91.8 bits (229), Expect = 2e-21
 Identities = 27/87 (31%), Positives = 44/87 (50%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L+  A       +++L++S  DVN  D   ++ALH AA     +   +LL+ GA+ D ++
Sbjct: 128 LILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQN 187

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               TPL  A    ++E  K+L  H A
Sbjct: 188 NREETPLFLAAREGSYETAKVLLDHFA 214

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 87.5 bits (218), Expect = 1e-19
 Identities = 27/106 (25%), Positives = 44/106 (41%), Gaps = 6/106 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
           A+ N  D+ G    P   L    +       + L+ +   D++ R  D  T L +AA   
Sbjct: 81  ADANIQDNMGR--TP---LHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLA 135

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
              ++  L+   ADV+  D  G + L  A    N +   +L K+GA
Sbjct: 136 VEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGA 181

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 86.8 bits (216), Expect = 2e-19
 Identities = 25/88 (28%), Positives = 37/88 (42%), Gaps = 1/88 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPK 102
           L   A     +  K LL++  D N +D   RT LH A       V  +L+   A D+D +
Sbjct: 61  LHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDAR 120

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
              G+TPL  A       +++ L    A
Sbjct: 121 MHDGTTPLILAARLAVEGMLEDLINSHA 148

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 83.3 bits (207), Expect = 3e-18
 Identities = 24/77 (31%), Positives = 37/77 (48%), Gaps = 1/77 (1%)

Query: 56  IKELLDSGIDV-NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
           I + +  G  + N  D    TALH+AA    ++    LLE  AD + +D  G TPL  A+
Sbjct: 39  ISDFIYQGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAV 98

Query: 115 YYKNHEVIKLLEKHGAK 131
                 V ++L ++ A 
Sbjct: 99  SADAQGVFQILIRNRAT 115

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 72.9 bits (180), Expect = 1e-14
 Identities = 24/83 (28%), Positives = 34/83 (40%), Gaps = 14/83 (16%)

Query: 64  IDVNFRDIDNRTALHVAACQGFT-------------EVVSLLLERGADV-DPKDRWGSTP 109
           +DVN R  D  T L +A+C G                V+S  + +GA + +  DR G T 
Sbjct: 1   MDVNVRGPDGFTPLMIASCSGGGLETGNSEEEEDAPAVISDFIYQGASLHNQTDRTGETA 60

Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
           L  A  Y   +  K L +  A  
Sbjct: 61  LHLAARYSRSDAAKRLLEASADA 83

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A Length = 253

 Score = 56.3 bits (137), Expect = 4e-09
 Identities = 17/77 (22%), Positives = 27/77 (35%), Gaps = 5/77 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A  +  ++  E   P   L   A E   E  K LLD   + +  D  +R    +A  +  
Sbjct: 181 ANKDMQNNREE--TP---LFLAAREGSYETAKVLLDHFANRDITDHMDRLPRDIAQERMH 235

Query: 86  TEVVSLLLERGADVDPK 102
            ++V LL          
Sbjct: 236 HDIVRLLDLEHHHHHHH 252

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 59/193 (30%), Positives = 89/193 (46%), Gaps = 29/193 (15%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IV 228
           G +VA+KKL     S+    RA+R EL LL+ +RH NV+  L   T    +       +V
Sbjct: 50  GAKVAIKKLYRPFQSELFAKRAYR-ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLV 108

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
             ++   DL   +K +  L           + +G+ Y+H      IIHRDL+P N+  ++
Sbjct: 109 MPFMGT-DLGKLMKHE-KLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNE 163

Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFA 341
              LK+ DFG+++    + D  +T       YV      APEV      Y   VD++S  
Sbjct: 164 DCELKILDFGLAR----QADSEMT------GYVVTRWYRAPEVILNWMRYTQTVDIWSVG 213

Query: 342 LILQEMIEGCPPF 354
            I+ EMI G   F
Sbjct: 214 CIMAEMITGKTLF 226

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 93.6 bits (233), Expect = 2e-22
 Identities = 19/120 (15%), Positives = 36/120 (30%), Gaps = 18/120 (15%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANE------RDVEGIKELLDSGIDVNFRDIDNRTALHV 79
           A++     +G           L            E  K  L+ G D+       +  +  
Sbjct: 66  ADIKSRTKEGT--TL---FFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFK 120

Query: 80  AACQGFTEVVS-------LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
                F +          +  + G  +  KD+WG T L      +    +K++E +  K 
Sbjct: 121 NIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKKY 180

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 74.7 bits (184), Expect = 6e-16
 Identities = 16/96 (16%), Positives = 34/96 (35%), Gaps = 9/96 (9%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDN---RTALHVAACQGFTEVVSLLLERGADVD 100
           +   A     E   EL + G +     + +      L     +   ++   L+ +GAD+ 
Sbjct: 10  VSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFLINKGADIK 69

Query: 101 PKDRWGSTPLGDAIYYKNH------EVIKLLEKHGA 130
            + + G+T          +      E+ K+  + GA
Sbjct: 70  SRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGA 105

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 62.8 bits (153), Expect = 8e-12
 Identities = 10/85 (11%), Positives = 25/85 (29%), Gaps = 12/85 (14%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKE-------LLDSGIDVNFRDIDNRTALH 78
           A++  L    +       +        V+  +           SG+ +  +D    TAL 
Sbjct: 105 ADITALYKPYK--IV---VFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTALE 159

Query: 79  VAACQGFTEVVSLLLERGADVDPKD 103
                     + ++ +     + K+
Sbjct: 160 FVKRCQKPIALKMMEDYIKKYNLKE 184

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis} Length = 186

 Score = 52.0 bits (125), Expect = 5e-08
 Identities = 12/63 (19%), Positives = 20/63 (31%), Gaps = 3/63 (4%)

Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADV---DPKDRWGSTPLGDAIYYKNHEVIKLLEK 127
           +     +  AA  G  E    L E+G +      K       L +      +++   L  
Sbjct: 4   MSEYRTVSAAAMLGTYEDFLELFEKGYEDKESVLKSNILYDVLRNNNDEARYKISMFLIN 63

Query: 128 HGA 130
            GA
Sbjct: 64  KGA 66

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 92.1 bits (230), Expect = 2e-22
 Identities = 32/87 (36%), Positives = 48/87 (55%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A        + LL +G+  + R   +RT LH+AA +G   +V +LL+ GADV+ KD
Sbjct: 38  LHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKD 97

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               T L  A  + + EV++LL K+GA
Sbjct: 98  MLKMTALHWATEHNHQEVVELLIKYGA 124

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 87.4 bits (218), Expect = 1e-20
 Identities = 28/83 (33%), Positives = 44/83 (53%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A+E     ++ LL  G DVN +D+   TALH A      EVV LL++ GADV  + 
Sbjct: 71  LHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQS 130

Query: 104 RWGSTPLGDAIYYKNHEVIKLLE 126
           ++  T    +I   N ++ ++L+
Sbjct: 131 KFCKTAFDISIDNGNEDLAEILQ 153

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 86.7 bits (216), Expect = 2e-20
 Identities = 23/87 (26%), Positives = 39/87 (44%), Gaps = 1/87 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L+  A     + ++ L+ +G      D    + LH+AA  G      +LL  G   D + 
Sbjct: 6   LLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDART 64

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           +   TPL  A    +  ++++L KHGA
Sbjct: 65  KVDRTPLHMAASEGHANIVEVLLKHGA 91

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1 Length = 153

 Score = 70.9 bits (175), Expect = 7e-15
 Identities = 17/59 (28%), Positives = 26/59 (44%), Gaps = 1/59 (1%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           D    L  AA  G  + V +L+  GA     D  G++PL  A  Y +    ++L + G 
Sbjct: 1   DLGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGV 58

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 92.9 bits (232), Expect = 2e-22
 Identities = 20/85 (23%), Positives = 33/85 (38%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           +++LL    D+N  +      LH A   G  +V   L+  GA V   +++G  P+  A  
Sbjct: 88  VQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMPVDKAKA 147

Query: 116 YKNHEVIKLLEKHGAKPLMAPMHVK 140
                + +  EK G      P    
Sbjct: 148 PLRELLRERAEKMGQNLNRIPYKDT 172

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 90.2 bits (225), Expect = 2e-21
 Identities = 31/111 (27%), Positives = 53/111 (47%), Gaps = 5/111 (4%)

Query: 22  ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
           +  E +LN  DD G    P   L +   E     ++ L+  G  +N  +  + T LH+AA
Sbjct: 26  DNTENDLNQGDDHGF--SP---LHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAA 80

Query: 82  CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
             G  ++V  LL+  AD++  +  G+ PL  A ++   +V + L  +GA  
Sbjct: 81  SHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALV 131

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A Length = 179

 Score = 68.6 bits (169), Expect = 8e-14
 Identities = 14/62 (22%), Positives = 24/62 (38%), Gaps = 1/62 (1%)

Query: 70  DIDNRTALHVAACQGFTEVVSLLLERGA-DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
             +    +     +G    V L L+    D++  D  G +PL  A       V+++L   
Sbjct: 2   SPEFMDDIFTQCREGNAVAVRLWLDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMR 61

Query: 129 GA 130
           GA
Sbjct: 62  GA 63

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 95.7 bits (239), Expect = 2e-22
 Identities = 24/108 (22%), Positives = 39/108 (36%), Gaps = 8/108 (7%)

Query: 28  LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQG 84
              + +DG+       L      +    +  LL        ++ ++   +TALH+AA  G
Sbjct: 2   FGYVTEDGD--TA---LHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILG 56

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
               V  L   GA V   +R G T L  A   + H    +L +     
Sbjct: 57  EASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSH 104

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 94.9 bits (237), Expect = 4e-22
 Identities = 36/108 (33%), Positives = 51/108 (47%), Gaps = 6/108 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQG 84
            +L   + DG    P   L      +D E ++ L D+G D+N  +    RT LH+A    
Sbjct: 149 LQLEAENYDGH--TP---LHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQ 203

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
              V+ LLL+ GAD   +   G TPLG A+   N  + +LL  HGA  
Sbjct: 204 AASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPE 251

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 89.9 bits (224), Expect = 2e-20
 Identities = 30/115 (26%), Positives = 47/115 (40%), Gaps = 1/115 (0%)

Query: 19  PDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALH 78
             R+  +  L    D   +       +      + E      D  + +   + D  T LH
Sbjct: 104 HPRDASDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRLQLEAENYDGHTPLH 163

Query: 79  VAACQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           VA      E+V LL + GAD++  +   G TPL  A+  +   V++LL K GA P
Sbjct: 164 VAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADP 218

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 84.1 bits (209), Expect = 2e-18
 Identities = 14/74 (18%), Positives = 26/74 (35%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           ++ LL +G D   R    RT L  A  +    +  LL   GA          +P   +  
Sbjct: 208 LELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSSSGS 267

Query: 116 YKNHEVIKLLEKHG 129
             + +     +++ 
Sbjct: 268 DSDSDNRDEGDEYD 281

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D Length = 282

 Score = 75.7 bits (187), Expect = 2e-15
 Identities = 14/101 (13%), Positives = 24/101 (23%), Gaps = 14/101 (13%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A   +   +++L  +G  V   +    TALH+A          +LL+         
Sbjct: 49  LHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSHPRDA 108

Query: 104 RWGSTPLGDAIYYKN--------------HEVIKLLEKHGA 130
                                        +E     E    
Sbjct: 109 SDTYLTQSQDCTPDTSHAPAAVDSQPNPENEEEPRDEDWRL 149

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 91.3 bits (228), Expect = 2e-22
 Identities = 21/76 (27%), Positives = 34/76 (44%), Gaps = 1/76 (1%)

Query: 56  IKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
            + LL  G + N  D    T  +H AA +GF + + +L   GA +D  D WG  P+  A 
Sbjct: 60  AELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAE 119

Query: 115 YYKNHEVIKLLEKHGA 130
              + ++ + L     
Sbjct: 120 EQGHRDIARYLHAATG 135

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 89.8 bits (224), Expect = 8e-22
 Identities = 27/106 (25%), Positives = 45/106 (42%), Gaps = 7/106 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
             ++ L    +       L   A    VE +++LL++G D N  +   R  + V    G 
Sbjct: 3   PGIHMLGGSSD--AG---LATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMM-MGS 56

Query: 86  TEVVSLLLERGADVDPKDRWGST-PLGDAIYYKNHEVIKLLEKHGA 130
            +V  LLL  GA+ +  D    T P+ DA      + + +L + GA
Sbjct: 57  AQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGA 102

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 86.0 bits (214), Expect = 2e-20
 Identities = 22/71 (30%), Positives = 34/71 (47%), Gaps = 3/71 (4%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH-EV 121
              ++     +   L  AA +G  E V  LLE GAD +  +R+G  P+   +      +V
Sbjct: 2   SPGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM--GSAQV 59

Query: 122 IKLLEKHGAKP 132
            +LL  HGA+P
Sbjct: 60  AELLLLHGAEP 70

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1 Length = 136

 Score = 60.5 bits (148), Expect = 2e-11
 Identities = 16/73 (21%), Positives = 28/73 (38%), Gaps = 4/73 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           AE N  D      +P   +   A E  ++ +  L  +G  ++  D   R  + +A  QG 
Sbjct: 68  AEPNCADPATLT-RP---VHDAAREGFLDTLVVLHRAGARLDVCDAWGRLPVDLAEEQGH 123

Query: 86  TEVVSLLLERGAD 98
            ++   L     D
Sbjct: 124 RDIARYLHAATGD 136

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 94.4 bits (236), Expect = 3e-22
 Identities = 30/88 (34%), Positives = 43/88 (48%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A    V+    L+ +G +++    D RT L  AA     E V  L++ GA VDPKD
Sbjct: 15  LHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKD 74

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
             GST L  A    ++EV++ L  +G  
Sbjct: 75  AEGSTCLHLAAKKGHYEVVQYLLSNGQM 102

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 89.8 bits (224), Expect = 1e-20
 Identities = 26/105 (24%), Positives = 46/105 (43%), Gaps = 5/105 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           +++N  D++         L + A    V+  + LL +  D++  +I   + LH+AA +  
Sbjct: 135 SDINIRDNEEN--IC---LHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAARENR 189

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            + V L L R +DV  K++ G TPL  A           + K   
Sbjct: 190 YDCVVLFLSRDSDVTLKNKEGETPLQCASLNSQVWSALQMSKALQ 234

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 89.4 bits (223), Expect = 1e-20
 Identities = 21/75 (28%), Positives = 34/75 (45%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           +K LL  G D+N RD +    LH AA  G  ++  +LL    D+   +  G +PL  A  
Sbjct: 127 VKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPLHIAAR 186

Query: 116 YKNHEVIKLLEKHGA 130
              ++ + L     +
Sbjct: 187 ENRYDCVVLFLSRDS 201

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 88.6 bits (221), Expect = 2e-20
 Identities = 20/67 (29%), Positives = 34/67 (50%)

Query: 64  IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
           ++      + R+ LH AA  G  ++  +L++ GA++D       TPL +A    + E +K
Sbjct: 2   MNFKMEHQNKRSPLHAAAEAGHVDICHMLVQAGANIDTCSEDQRTPLMEAAENNHLEAVK 61

Query: 124 LLEKHGA 130
            L K GA
Sbjct: 62  YLIKAGA 68

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 88.6 bits (221), Expect = 2e-20
 Identities = 25/108 (23%), Positives = 48/108 (44%), Gaps = 6/108 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQG 84
           A ++  D +G        L   A +   E ++ LL +G +DVN +D    T +  A    
Sbjct: 68  ALVDPKDAEGS--TC---LHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGWTPMIWATEYK 122

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
             ++V LLL +G+D++ +D   +  L  A +    ++ ++L       
Sbjct: 123 HVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDL 170

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A* Length = 237

 Score = 54.3 bits (132), Expect = 1e-08
 Identities = 13/75 (17%), Positives = 27/75 (36%), Gaps = 5/75 (6%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
            + +L+ ++  G+   P   L   A E   + +   L    DV  ++ +  T L  A+  
Sbjct: 166 AKCDLHAVNIHGD--SP---LHIAARENRYDCVVLFLSRDSDVTLKNKEGETPLQCASLN 220

Query: 84  GFTEVVSLLLERGAD 98
                   + +   D
Sbjct: 221 SQVWSALQMSKALQD 235

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 92.1 bits (230), Expect = 3e-22
 Identities = 26/77 (33%), Positives = 39/77 (50%)

Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
           E  + LL  G + + +D      +H AA  GF + +  LLE  ADV+ +D  G+ PL  A
Sbjct: 51  EIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLA 110

Query: 114 IYYKNHEVIKLLEKHGA 130
               +  V++ L KH A
Sbjct: 111 AKEGHLRVVEFLVKHTA 127

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 87.8 bits (219), Expect = 1e-20
 Identities = 29/87 (33%), Positives = 43/87 (49%), Gaps = 1/87 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A   D+E +  LL + ++VN ++   RTAL V    G  E+   LL RGA+ D KD
Sbjct: 9   LASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKD 67

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           R G   + DA      + ++ L +  A
Sbjct: 68  RTGFAVIHDAARAGFLDTLQTLLEFQA 94

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 87.4 bits (218), Expect = 1e-20
 Identities = 29/106 (27%), Positives = 49/106 (46%), Gaps = 6/106 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A  +  D  G        +   A    ++ ++ LL+   DVN  D +    LH+AA +G 
Sbjct: 61  ANPDLKDRTGF--AV---IHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGH 115

Query: 86  TEVVSLLLERGA-DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             VV  L++  A +V  ++  G T    A  Y  +EV+ L++ +GA
Sbjct: 116 LRVVEFLVKHTASNVGHRNHKGDTACDLARLYGRNEVVSLMQANGA 161

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A Length = 162

 Score = 70.9 bits (175), Expect = 7e-15
 Identities = 17/61 (27%), Positives = 28/61 (45%), Gaps = 1/61 (1%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
                L  AA +G  E ++ LL+   +V+ ++ +G T L       N E+ + L   GA 
Sbjct: 4   PWGNELASAAARGDLEQLTSLLQNNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGAN 62

Query: 132 P 132
           P
Sbjct: 63  P 63

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 94.6 bits (236), Expect = 3e-22
 Identities = 30/107 (28%), Positives = 53/107 (49%), Gaps = 6/107 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQG 84
            +++ +D++G        L+F+A     + ++ L ++G D++ RD+    TALH+AA   
Sbjct: 68  RDVDAVDENGR--TA---LLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYV 122

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
             EVV  L+E GAD++ +D  G T L  A             + G +
Sbjct: 123 RPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRR 169

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 91.5 bits (228), Expect = 3e-21
 Identities = 33/90 (36%), Positives = 45/90 (50%), Gaps = 2/90 (2%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
               A + D + + +LL    DV+  D + RTAL   A  G  + V LL E GAD+D +D
Sbjct: 49  WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD 107

Query: 104 -RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            R G T L  A  Y   EV++ L + GA  
Sbjct: 108 MRGGLTALHMAAGYVRPEVVEALVELGADI 137

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 74.6 bits (184), Expect = 2e-15
 Identities = 18/87 (20%), Positives = 35/87 (40%), Gaps = 3/87 (3%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A     E ++ L++ G D+   D    TAL +A     T      ++ G  +  + 
Sbjct: 115 LHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEK 174

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
                 + +   ++  EV +++EK G 
Sbjct: 175 ---VINVLEGQVFEYAEVDEIVEKRGK 198

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 58.8 bits (143), Expect = 4e-10
 Identities = 9/69 (13%), Positives = 17/69 (24%), Gaps = 4/69 (5%)

Query: 64  IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK 123
           I  +    +      +    G +          ADV  +     TP   A    + + + 
Sbjct: 6   IIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPWWTAARKADEQALS 62

Query: 124 LLEKHGAKP 132
            L       
Sbjct: 63  QL-LEDRDV 70

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 50.7 bits (122), Expect = 2e-07
 Identities = 12/106 (11%), Positives = 27/106 (25%), Gaps = 16/106 (15%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++   D+ G        L               +  G  +    +     +       +
Sbjct: 135 ADIEVEDERGL--TA---LELAREILKTTPKGNPMQFGRRIGLEKV---INVLEGQVFEY 186

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
            EV  ++ +RG         G        +    +   +   H A+
Sbjct: 187 AEVDEIVEKRGK--------GKDVEYLVRWKDGGDCEWVKGVHVAE 224

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A Length = 244

 Score = 44.9 bits (107), Expect = 2e-05
 Identities = 4/48 (8%), Positives = 14/48 (29%), Gaps = 2/48 (4%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
             ++  +    +   ++   +   +   +     A+   KD      L
Sbjct: 189 VDEIVEKRGKGKDVEYLVRWKDGGDCEWVKGVHVAEDVAKD--YEDGL 234

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 91.7 bits (229), Expect = 3e-22
 Identities = 26/88 (29%), Positives = 45/88 (51%), Gaps = 2/88 (2%)

Query: 44  LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
           L   A   DV+ ++ LL    +  +  +   +TAL V    G T +   LL++GA  + +
Sbjct: 6   LSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQ 64

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           D  G++P+ DA      + +K+L +HGA
Sbjct: 65  DTSGTSPVHDAARTGFLDTLKVLVEHGA 92

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 90.2 bits (225), Expect = 1e-21
 Identities = 23/73 (31%), Positives = 36/73 (49%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
             ELL  G   N +D    + +H AA  GF + + +L+E GADV+  D  G+ P+  A+ 
Sbjct: 51  ALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQ 110

Query: 116 YKNHEVIKLLEKH 128
             +  V+  L   
Sbjct: 111 EGHTAVVSFLAAE 123

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 85.9 bits (214), Expect = 4e-20
 Identities = 30/103 (29%), Positives = 48/103 (46%), Gaps = 6/103 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A  N  D  G    P   +   A    ++ +K L++ G DVN  D      +H+A  +G 
Sbjct: 59  ASPNVQDTSGT--SP---VHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGH 113

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
           T VVS L    +D+  +D  G TPL  A+     +++ +L+ H
Sbjct: 114 TAVVSFLAA-ESDLHRRDARGLTPLELALQRGAQDLVDILQGH 155

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B Length = 156

 Score = 64.0 bits (157), Expect = 2e-12
 Identities = 17/60 (28%), Positives = 24/60 (40%), Gaps = 4/60 (6%)

Query: 75  TALHVAACQGFTEVV-SLLLERGADVDPKDRWGSTPLGDAIYYKNH-EVIKLLEKHGAKP 132
             L  AA +G  + V  LL       D  +R+G T L   ++      +   L K GA P
Sbjct: 4   DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMF--GSTAIALELLKQGASP 61

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 96.6 bits (241), Expect = 4e-22
 Identities = 69/246 (28%), Positives = 107/246 (43%), Gaps = 41/246 (16%)

Query: 134 MAPMHVKHAREVPEY---EIDPHELDFTNSVEITK-------GTFILAFWR--GIQVAVK 181
           MA  H  H++E P +   E++    +     +          G+   AF    G++VAVK
Sbjct: 1   MAHHHHHHSQERPTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVK 60

Query: 182 KLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM------IVTEYLPKG 235
           KL     S     R +R EL LL+ ++H NV+  L   T +  +       +VT  +   
Sbjct: 61  KLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA- 118

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA 295
           DL   +K +  L           I RG+ Y+H      IIHRDL+PSN+  ++   LK+ 
Sbjct: 119 DLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKIL 174

Query: 296 DFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNEEYDTKVDVFSFALILQEMI 348
           DFG++        R    + T   YV      APE+      Y+  VD++S   I+ E++
Sbjct: 175 DFGLA--------RHTADEMTG--YVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELL 224

Query: 349 EGCPPF 354
            G   F
Sbjct: 225 TGRTLF 230

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 91.7 bits (229), Expect = 4e-22
 Identities = 35/89 (39%), Positives = 46/89 (51%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L F A    V  ++ LL  G DV+ +D      LH A   G  EV  LL++ GA V+  D
Sbjct: 46  LHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVAD 105

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            W  TPL +A     +E+ KLL +HGA P
Sbjct: 106 LWKFTPLHEAAAKGKYEICKLLLQHGADP 134

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 85.5 bits (213), Expect = 6e-20
 Identities = 28/72 (38%), Positives = 39/72 (54%), Gaps = 1/72 (1%)

Query: 59  LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
           L+  G  VN  D+   T LH AA +G  E+  LLL+ GAD   K+R G+TPL D +   +
Sbjct: 94  LVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPL-DLVKDGD 152

Query: 119 HEVIKLLEKHGA 130
            ++  LL    A
Sbjct: 153 TDIQDLLRGDAA 164

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 84.7 bits (211), Expect = 1e-19
 Identities = 35/88 (39%), Positives = 47/88 (53%), Gaps = 1/88 (1%)

Query: 44  LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
           L+  A   DVE +K+L     ++    +    T LH AA      VV  LL+ GADV  K
Sbjct: 12  LLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAK 71

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           D+ G  PL +A  Y ++EV +LL KHGA
Sbjct: 72  DKGGLVPLHNACSYGHYEVAELLVKHGA 99

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 69.0 bits (170), Expect = 4e-14
 Identities = 20/69 (28%), Positives = 26/69 (37%), Gaps = 4/69 (5%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEV 121
           G   N    +    L  AA  G  E V  L      +    +   STPL  A  Y    V
Sbjct: 1   GAMGN---SEADRQLLEAAKAGDVETVKKLCTVQSVNCRDIEGRQSTPLHFAAGYNRVSV 57

Query: 122 IKLLEKHGA 130
           ++ L +HGA
Sbjct: 58  VEYLLQHGA 66

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S* Length = 165

 Score = 47.0 bits (113), Expect = 1e-06
 Identities = 20/72 (27%), Positives = 27/72 (37%), Gaps = 6/72 (8%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A +N  D       P   L   A +   E  K LL  G D   ++ D  T L +    G 
Sbjct: 99  AVVNVADLWKF--TP---LHEAAAKGKYEICKLLLQHGADPTKKNRDGNTPLDLVK-DGD 152

Query: 86  TEVVSLLLERGA 97
           T++  LL    A
Sbjct: 153 TDIQDLLRGDAA 164

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 92.9 bits (232), Expect = 4e-22
 Identities = 24/88 (27%), Positives = 44/88 (50%), Gaps = 1/88 (1%)

Query: 44  LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
           L+  AN+RD + +KE+L      V+  D +  T L++A      E+   L++RGAD++ +
Sbjct: 9   LLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQ 68

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           +    +P   A      E++  + KH  
Sbjct: 69  NSISDSPYLYAGAQGRTEILAYMLKHAT 96

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 82.1 bits (204), Expect = 2e-18
 Identities = 28/91 (30%), Positives = 47/91 (51%), Gaps = 6/91 (6%)

Query: 44  LMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAAC-----QGFTEVVSLLLERGA 97
           L+  A +  ++ +K LL+ G  D++F++    TAL  A       Q + ++V LL+E GA
Sbjct: 110 LIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEAVGLREGNQLYQDIVKLLMENGA 169

Query: 98  DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
           D   KD  G T +  A      E+ K+L ++
Sbjct: 170 DQSIKDNSGRTAMDYANQKGYTEISKILAQY 200

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 78.6 bits (195), Expect = 4e-17
 Identities = 25/82 (30%), Positives = 44/82 (53%), Gaps = 7/82 (8%)

Query: 56  IKELLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGSTPLGDA 113
           +  +L     D+N  +     AL  AA +G  + V LLLE G  D+D ++ +G T L +A
Sbjct: 88  LAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDFGYTALIEA 147

Query: 114 IYY----KNH-EVIKLLEKHGA 130
           +      + + +++KLL ++GA
Sbjct: 148 VGLREGNQLYQDIVKLLMENGA 169

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis} Length = 201

 Score = 77.1 bits (191), Expect = 1e-16
 Identities = 17/62 (27%), Positives = 28/62 (45%)

Query: 69  RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
           +  +    L  A  +   +V  +L +    VD  D  G+TPL  A++  + E+ K L   
Sbjct: 2   KTYEVGALLEAANQRDTKKVKEILQDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDR 61

Query: 129 GA 130
           GA
Sbjct: 62  GA 63

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 91.7 bits (229), Expect = 5e-22
 Identities = 33/87 (37%), Positives = 51/87 (58%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L+  A     + ++ L+ +G DVN  D    T LH+AA  G  E+V +LL+ GADV+  D
Sbjct: 18  LLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVD 77

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             G TPL  A  + + E++++L K+GA
Sbjct: 78  HAGMTPLRLAALFGHLEIVEVLLKNGA 104

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 90.9 bits (227), Expect = 9e-22
 Identities = 39/105 (37%), Positives = 57/105 (54%), Gaps = 5/105 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N  D  G    P   L   A    +E ++ LL +G DVN  D    T L +AA  G 
Sbjct: 38  ADVNAEDASGW--TP---LHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGH 92

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            E+V +LL+ GADV+  D  G TPL  A  + + E++++L K+GA
Sbjct: 93  LEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGA 137

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 89.7 bits (224), Expect = 3e-21
 Identities = 36/103 (34%), Positives = 59/103 (57%), Gaps = 5/103 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N +D  G    P   L   A    +E ++ LL +G DVN  D++  T LH+AA  G 
Sbjct: 71  ADVNAVDHAGM--TP---LRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGH 125

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
            E+V +LL+ GADV+ +D++G T    +I   N ++ ++L+K 
Sbjct: 126 LEIVEVLLKNGADVNAQDKFGKTAFDISIDNGNEDLAEILQKL 168

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C* Length = 169

 Score = 74.7 bits (185), Expect = 5e-16
 Identities = 22/61 (36%), Positives = 34/61 (55%)

Query: 70  DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
             D    L  AA  G  + V +L+  GADV+ +D  G TPL  A +  + E++++L K+G
Sbjct: 11  GSDLGKKLLEAARAGRDDEVRILMANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNG 70

Query: 130 A 130
           A
Sbjct: 71  A 71

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 92.2 bits (230), Expect = 5e-22
 Identities = 33/90 (36%), Positives = 45/90 (50%), Gaps = 2/90 (2%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
               A + D + + +LL    DV+  D + RTAL   A  G  + V LL E GAD+D +D
Sbjct: 48  WWTAARKADEQALSQLL-EDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRD 106

Query: 104 -RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            R G T L  A  Y   EV++ L + GA  
Sbjct: 107 MRGGLTALHMAAGYVRPEVVEALVELGADI 136

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 90.6 bits (226), Expect = 2e-21
 Identities = 31/109 (28%), Positives = 54/109 (49%), Gaps = 10/109 (9%)

Query: 26  AELNGLDDDGEEIKPEFR--LMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAAC 82
            +++ +D++G       R  L+F+A     + ++ L ++G D++ RD+    TALH+AA 
Sbjct: 67  RDVDAVDENG-------RTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAG 119

Query: 83  QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
               EVV  L+E GAD++ +D  G T L  A             + G +
Sbjct: 120 YVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRR 168

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 62.9 bits (154), Expect = 7e-12
 Identities = 17/85 (20%), Positives = 28/85 (32%), Gaps = 17/85 (20%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A     E ++ L++ G D+   D    TAL +A     T      ++ G  +  + 
Sbjct: 114 LHMAAGYVRPEVVEALVELGADIEVEDERGLTALELAREILKTTPKGNPMQFGRRIGLEK 173

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKH 128
                            VI +LE  
Sbjct: 174 -----------------VINVLEGQ 181

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A Length = 183

 Score = 60.2 bits (147), Expect = 6e-11
 Identities = 9/69 (13%), Positives = 18/69 (26%), Gaps = 4/69 (5%)

Query: 62  SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
           + I  +    +      +    G +          ADV  +     TP   A    + + 
Sbjct: 3   NKIIGSRTAGEGAMEYLIEWKDGHSPSWVPSSYIAADVVSEYE---TPWWTAARKADEQA 59

Query: 122 IKLLEKHGA 130
           +  L     
Sbjct: 60  LSQL-LEDR 67

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 96.7 bits (241), Expect = 6e-22
 Identities = 47/216 (21%), Positives = 84/216 (38%), Gaps = 32/216 (14%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVT 229
              VA+KK+        D  R  R E+ +L +++   +++    +     +      IV 
Sbjct: 51  EKNVAIKKVNRMFEDLIDCKRILR-EITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVL 109

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           E     DL+   K    L          ++  G N++HE+    IIHRDL+P+N L +  
Sbjct: 110 EIADS-DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQD 165

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR---------------YV------APEV-FK 327
            ++KV DFG+++ +  ++D  +                       +V      APE+   
Sbjct: 166 CSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL 225

Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
            E Y   +D++S   I  E++           N  P
Sbjct: 226 QENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFP 261

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 90.1 bits (225), Expect = 8e-22
 Identities = 32/87 (36%), Positives = 50/87 (57%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L+  A     + ++ L+ +G DVN +D    T L++A   G  E+V +LL+ GADV+  D
Sbjct: 18  LLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVD 77

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             G TPL  A +  + E+ ++L KHGA
Sbjct: 78  AIGFTPLHLAAFIGHLEIAEVLLKHGA 104

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 85.5 bits (213), Expect = 3e-20
 Identities = 34/103 (33%), Positives = 55/103 (53%), Gaps = 5/103 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N  D+ G    P   L        +E ++ LL +G DVN  D    T LH+AA  G 
Sbjct: 38  ADVNAKDEYGL--TP---LYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGH 92

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
            E+  +LL+ GADV+ +D++G T    +I   N ++ ++L+K 
Sbjct: 93  LEIAEVLLKHGADVNAQDKFGKTAFDISIGNGNEDLAEILQKL 135

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C Length = 136

 Score = 72.0 bits (178), Expect = 2e-15
 Identities = 23/59 (38%), Positives = 35/59 (59%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           D    L  AA  G  + V +L+  GADV+ KD +G TPL  A  + + E++++L K+GA
Sbjct: 13  DLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGA 71

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 92.9 bits (232), Expect = 8e-22
 Identities = 28/90 (31%), Positives = 43/90 (47%), Gaps = 1/90 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           ++        E  +EL+++G DV   D +N T LH AA     ++V   + +GA VD   
Sbjct: 13  IVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLG 72

Query: 104 R-WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
               STPL  A    +  ++  L K+GA P
Sbjct: 73  GDLNSTPLHWATRQGHLSMVVQLMKYGADP 102

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 90.2 bits (225), Expect = 7e-21
 Identities = 30/84 (35%), Positives = 41/84 (48%), Gaps = 3/84 (3%)

Query: 49  NERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
           +  D    + LL   + VN  D     TALH A   G T V+SLLLE GA+VD ++  G 
Sbjct: 154 HSVDP--TRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGANVDAQNIKGE 211

Query: 108 TPLGDAIYYKNHEVIKLLEKHGAK 131
           + L  A   KN  +I  L++    
Sbjct: 212 SALDLAKQRKNVWMINHLQEARQA 235

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 86.7 bits (216), Expect = 1e-19
 Identities = 28/134 (20%), Positives = 49/134 (36%), Gaps = 16/134 (11%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-NRTALHVAACQG 84
            ++   D +         L + A    ++ +K  +  G  V+    D N T LH A  QG
Sbjct: 33  YDVRQPDKENV--TL---LHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQG 87

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PLM 134
              +V  L++ GAD    D  G + +  A  + +  ++  L   G            PLM
Sbjct: 88  HLSMVVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLM 147

Query: 135 APMHVKHAREVPEY 148
              +  H+ +    
Sbjct: 148 WAAYRTHSVDPTRL 161

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 86.7 bits (216), Expect = 1e-19
 Identities = 24/76 (31%), Positives = 40/76 (52%), Gaps = 1/76 (1%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           + +L+  G D +  D +  + +H+AA  G T +V+ L+ +G DVD  D+ G TPL  A Y
Sbjct: 92  VVQLMKYGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAY 151

Query: 116 YKNH-EVIKLLEKHGA 130
             +  +  +LL     
Sbjct: 152 RTHSVDPTRLLLTFNV 167

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 85.2 bits (212), Expect = 4e-19
 Identities = 28/107 (26%), Positives = 46/107 (42%), Gaps = 7/107 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A+ + +D +G        +   A       +  L+  G DV+  D +  T L  AA +  
Sbjct: 100 ADPSLIDGEGC--SC---IHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTH 154

Query: 86  T-EVVSLLLERGADVDPKDRW-GSTPLGDAIYYKNHEVIKLLEKHGA 130
           + +   LLL     V+  D++  +T L  A+   N  VI LL + GA
Sbjct: 155 SVDPTRLLLTFNVSVNLGDKYHKNTALHWAVLAGNTTVISLLLEAGA 201

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 79.4 bits (197), Expect = 4e-17
 Identities = 16/65 (24%), Positives = 24/65 (36%)

Query: 66  VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
           +   D  +   +  A   G  E    L+E G DV   D+   T L  A      +++K  
Sbjct: 2   MTHIDDYSTWDIVKATQYGIYERCRELVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYY 61

Query: 126 EKHGA 130
              GA
Sbjct: 62  ISKGA 66

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens} Length = 240

 Score = 58.2 bits (142), Expect = 7e-10
 Identities = 12/60 (20%), Positives = 27/60 (45%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L +     +   I  LL++G +V+ ++I   +AL +A  +    +++ L E        +
Sbjct: 181 LHWAVLAGNTTVISLLLEAGANVDAQNIKGESALDLAKQRKNVWMINHLQEARQAKGYDN 240

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 89.3 bits (223), Expect = 9e-22
 Identities = 40/75 (53%), Positives = 51/75 (68%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           +K LL++G DVN +D + RT LH+AA  G  EVV LLLE GADV+ KD+ G TPL  A  
Sbjct: 18  VKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAAR 77

Query: 116 YKNHEVIKLLEKHGA 130
             + EV+KLL + GA
Sbjct: 78  NGHLEVVKLLLEAGA 92

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 89.3 bits (223), Expect = 1e-21
 Identities = 40/74 (54%), Positives = 50/74 (67%)

Query: 57  KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
           K LL++G DVN +D + RT LH+AA  G  EVV LLLE GADV+ KD+ G TPL  A   
Sbjct: 52  KLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARN 111

Query: 117 KNHEVIKLLEKHGA 130
            + EV+KLL + GA
Sbjct: 112 GHLEVVKLLLEAGA 125

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 75.8 bits (188), Expect = 7e-17
 Identities = 32/59 (54%), Positives = 39/59 (66%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           + RT LH+AA  G  EVV LLLE GADV+ KD+ G TPL  A    + EV+KLL + GA
Sbjct: 1   NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 59

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1 Length = 126

 Score = 54.7 bits (133), Expect = 2e-09
 Identities = 24/42 (57%), Positives = 30/42 (71%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA 97
           +K LL++G DVN +D + RT LH+AA  G  EVV LLLE GA
Sbjct: 84  VKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGA 125

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 92.5 bits (231), Expect = 1e-21
 Identities = 21/105 (20%), Positives = 36/105 (34%), Gaps = 19/105 (18%)

Query: 47  LANERDVEG-------------------IKELLDSGIDVNFRDIDNRTALHVAACQGFTE 87
           +A   D +G                   +      G +++  +   +T LH+A       
Sbjct: 1   MATRADEDGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPS 60

Query: 88  VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           VV LL+  GA     DR G T    A  +++   ++ L    A  
Sbjct: 61  VVRLLVTAGASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAPG 105

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 90.6 bits (226), Expect = 6e-21
 Identities = 22/87 (25%), Positives = 39/87 (44%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L+       +  ++ LL  G +VN +     +ALH A+ +G   +V  L+  GAD   K+
Sbjct: 154 LIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKN 213

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               TPL  A   +  ++++      A
Sbjct: 214 CHNDTPLMVARSRRVIDILRGKATRPA 240

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 87.9 bits (219), Expect = 5e-20
 Identities = 23/78 (29%), Positives = 40/78 (51%), Gaps = 1/78 (1%)

Query: 56  IKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
           ++ LL+ G D++  DI + R+ L  A       +V LLL+ GA+V+ +   GS+ L  A 
Sbjct: 132 VQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSAS 191

Query: 115 YYKNHEVIKLLEKHGAKP 132
                 +++ L + GA  
Sbjct: 192 GRGLLPLVRTLVRSGADS 209

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 85.2 bits (212), Expect = 5e-19
 Identities = 24/109 (22%), Positives = 45/109 (41%), Gaps = 9/109 (8%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
            EL+  ++  +   P   L           ++ L+ +G      D   +TA H+A     
Sbjct: 37  RELDIYNNLRQ--TP---LHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLACEHRS 91

Query: 86  TEVVSLLLERGA----DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
              +  LL+  A    D++ ++  G T L  A+  +  E ++LL + GA
Sbjct: 92  PTCLRALLDSAAPGTLDLEARNYDGLTALHVAVNTECQETVQLLLERGA 140

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A Length = 241

 Score = 84.8 bits (211), Expect = 5e-19
 Identities = 39/110 (35%), Positives = 53/110 (48%), Gaps = 10/110 (9%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG----IDVNFRDIDNRTALHVAA 81
           A    LD  G+              R    ++ LLDS     +D+  R+ D  TALHVA 
Sbjct: 70  ASPMALDRHGQ--TA---AHLACEHRSPTCLRALLDSAAPGTLDLEARNYDGLTALHVAV 124

Query: 82  CQGFTEVVSLLLERGADVDPKDR-WGSTPLGDAIYYKNHEVIKLLEKHGA 130
                E V LLLERGAD+D  D   G +PL  A+   +  +++LL +HGA
Sbjct: 125 NTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGA 174

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 93.7 bits (234), Expect = 1e-21
 Identities = 25/87 (28%), Positives = 39/87 (44%), Gaps = 2/87 (2%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
             +   + +V  +  LL++G   N  +  N   LH AA    T++V +LL  G D    D
Sbjct: 35  SYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFD 92

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             G+T L  A+   N + +KL  K   
Sbjct: 93  DKGNTALYYAVDSGNMQTVKLFVKKNW 119

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 19/85 (22%), Positives = 33/85 (38%), Gaps = 3/85 (3%)

Query: 48  ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
            N    + +K  L S  D    D+   +A + A       +V  LL  GA  +  +    
Sbjct: 7   INTWKSKQLKSFL-SSKDTFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NE 63

Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKP 132
            PL  A   ++ +++K+L   G   
Sbjct: 64  FPLHQAATLEDTKIVKILLFSGLDD 88

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 88.7 bits (221), Expect = 6e-20
 Identities = 20/88 (22%), Positives = 35/88 (39%), Gaps = 1/88 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A   D + +K LL SG+D +  D    TAL+ A   G  + V L +++   +    
Sbjct: 66  LHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYG 125

Query: 104 RWG-STPLGDAIYYKNHEVIKLLEKHGA 130
           + G  T    A+   +  ++        
Sbjct: 126 KTGWKTSFYHAVMLNDVSIVSYFLSEIP 153

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 82.6 bits (205), Expect = 7e-18
 Identities = 18/106 (16%), Positives = 35/106 (33%), Gaps = 6/106 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
             L      G +              DV  +   L       F      + +H+    G 
Sbjct: 119 WRLMFYGKTGWKT-S---FYHAVMLNDVSIVSYFLSEI-PSTFDLAILLSCIHITIKNGH 173

Query: 86  TEVVSLLLERGADVDPKDRWGSTP-LGDAIYYKNHEVIKLLEKHGA 130
            +++ LLL+     +  +     P +  AI  K+ E+++ L K+  
Sbjct: 174 VDMMILLLDYMTSTNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDI 219

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 78.3 bits (194), Expect = 2e-16
 Identities = 10/81 (12%), Positives = 29/81 (35%), Gaps = 8/81 (9%)

Query: 53  VEGIKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG 111
           V+ +  LLD     N  +       + +A      E++  L +   ++        +   
Sbjct: 174 VDMMILLLDYMTSTNTNNSLLFIPDIKLAIDNKDIEMLQALFKYDINIY-------SANL 226

Query: 112 DAIYYKNHEVIKLLEKHGAKP 132
           + +   + E+ K++ +   + 
Sbjct: 227 ENVLLDDAEIAKMIIEKHVEY 247

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus} Length = 285

 Score = 61.8 bits (151), Expect = 8e-11
 Identities = 11/97 (11%), Positives = 29/97 (29%), Gaps = 13/97 (13%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
              N  +           +    + +D+E ++ L    I++        +A         
Sbjct: 185 TSTNTNNSLLFIPD----IKLAIDNKDIEMLQALFKYDINIY-------SANLENVLLDD 233

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
            E+  +++E+  +           +      K  E+I
Sbjct: 234 AEIAKMIIEKHVEYKSDSYTKDLDI--VKNNKLDEII 268

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 51/196 (26%), Positives = 83/196 (42%), Gaps = 24/196 (12%)

Query: 175 GIQVAVKKLGEEVISDD-DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IV 228
           G  VA+KK+  E        +R  R E+ +L+  +H N++         S        I+
Sbjct: 36  GEIVAIKKI--EPFDKPLFALRTLR-EIKILKHFKHENIITIFNIQRPDSFENFNEVYII 92

Query: 229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            E +   DL   +  +  L       F     R +  LH +    +IHRDL+PSN+L + 
Sbjct: 93  QELMQT-DLHRVISTQ-MLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINS 147

Query: 289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCR---YV------APEV-FKNEEYDTKVDVF 338
           + +LKV DFG+++++                   +V      APEV   + +Y   +DV+
Sbjct: 148 NCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVW 207

Query: 339 SFALILQEMIEGCPPF 354
           S   IL E+    P F
Sbjct: 208 SCGCILAELFLRRPIF 223

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score = 89.5 bits (223), Expect = 2e-21
 Identities = 22/76 (28%), Positives = 35/76 (46%), Gaps = 1/76 (1%)

Query: 56  IKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
            + LL  G + N  D    T  +H AA +GF + + +L   GA +D +D WG  P+  A 
Sbjct: 60  AELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAE 119

Query: 115 YYKNHEVIKLLEKHGA 130
              + +V + L     
Sbjct: 120 ELGHRDVARYLRAAAG 135

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score = 86.0 bits (214), Expect = 4e-20
 Identities = 25/90 (27%), Positives = 40/90 (44%), Gaps = 2/90 (2%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A    VE ++ LL++G + N  +   R  + V    G   V  LLL  GA+ +  D
Sbjct: 16  LATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCAD 74

Query: 104 RWGST-PLGDAIYYKNHEVIKLLEKHGAKP 132
               T P+ DA      + + +L + GA+ 
Sbjct: 75  PATLTRPVHDAAREGFLDTLVVLHRAGARL 104

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score = 76.7 bits (190), Expect = 6e-17
 Identities = 20/74 (27%), Positives = 33/74 (44%), Gaps = 5/74 (6%)

Query: 60  LDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
           ++     +     +   L  AA +G  E V  LLE GA+ +  + +G  P+   +     
Sbjct: 1   MEPAAGSS--MEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMMM--GS 56

Query: 120 -EVIKLLEKHGAKP 132
             V +LL  HGA+P
Sbjct: 57  ARVAELLLLHGAEP 70

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A Length = 156

 Score = 67.9 bits (167), Expect = 8e-14
 Identities = 18/96 (18%), Positives = 31/96 (32%), Gaps = 9/96 (9%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           AE N  D      +P   +   A E  ++ +  L  +G  ++ RD   R  + +A   G 
Sbjct: 68  AEPNCADPATLT-RP---VHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGH 123

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
            +V   L             GS            ++
Sbjct: 124 RDVARYLRAAAGGTR-----GSNHARIDAAEGPSDI 154

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 91.5 bits (228), Expect = 2e-21
 Identities = 28/87 (32%), Positives = 46/87 (52%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L+  + E + + ++ ++    D +  + +  TALH A C G TE+V  L++ G +V+  D
Sbjct: 41  LLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAAD 100

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             G TPL  A    N +V K L + GA
Sbjct: 101 SDGWTPLHCAASCNNVQVCKFLVESGA 127

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 85.0 bits (211), Expect = 5e-19
 Identities = 26/110 (23%), Positives = 41/110 (37%), Gaps = 8/110 (7%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
            + +  +D+G  I     L         E +K L+  G++VN  D D  T LH AA    
Sbjct: 61  DDPSLPNDEG--ITA---LHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNN 115

Query: 86  TEVVSLLLERGADV---DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            +V   L+E GA V      D   +    + +     +  + L     K 
Sbjct: 116 VQVCKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKM 165

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 83.4 bits (207), Expect = 2e-18
 Identities = 16/77 (20%), Positives = 33/77 (42%), Gaps = 1/77 (1%)

Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
           +   E +  G+ V F        L  ++ +G  ++V  ++    D    +  G T L +A
Sbjct: 19  KTGSERIAHGMRVKFNP-LPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNA 77

Query: 114 IYYKNHEVIKLLEKHGA 130
           +   + E++K L + G 
Sbjct: 78  VCAGHTEIVKFLVQFGV 94

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 68.0 bits (167), Expect = 3e-13
 Identities = 8/63 (12%), Positives = 19/63 (30%), Gaps = 1/63 (1%)

Query: 70  DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
           +I  + +L         +  S  +  G  V          L D+      ++++ +    
Sbjct: 2   EITGQVSLPPGKRTNLRKTGSERIAHGMRVKFNPL-PLALLLDSSLEGEFDLVQRIIYEV 60

Query: 130 AKP 132
             P
Sbjct: 61  DDP 63

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B Length = 239

 Score = 65.3 bits (160), Expect = 3e-12
 Identities = 25/124 (20%), Positives = 44/124 (35%), Gaps = 13/124 (10%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVN---FRDIDNRTALHVAAC 82
             +N  D DG    P   L   A+  +V+  K L++SG  V    + D+           
Sbjct: 94  VNVNAADSDGW--TP---LHCAASCNNVQVCKFLVESGAAVFAMTYSDMQTAADKCEEME 148

Query: 83  QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA 142
           +G+T+    L      +   ++     L     Y+     +L  K G    M  +H +  
Sbjct: 149 EGYTQCSQFLYGVQEKMGIMNKGVIYAL---WDYEPQNDDELPMKEGDC--MTIIHREDE 203

Query: 143 REVP 146
            E+ 
Sbjct: 204 DEIE 207

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score = 93.5 bits (233), Expect = 3e-21
 Identities = 42/191 (21%), Positives = 83/191 (43%), Gaps = 19/191 (9%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI--VTEY 231
             +V VK      +    + +  R E+ +L+ +R  PN++     V          V E+
Sbjct: 61  NEKVVVKI-----LKPVKKKKIKR-EIKILENLRGGPNIITLADIVKDPVSRTPALVFEH 114

Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSG 290
           +   D +   +    L       +  +I + ++Y H      I+HRD++P N++ D +  
Sbjct: 115 VNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHR 168

Query: 291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIE 349
            L++ D+G+++       +    +  S  +  PE+  + + YD  +D++S   +L  MI 
Sbjct: 169 KLRLIDWGLAE--FYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 226

Query: 350 GCPPFTMKHDN 360
              PF   HDN
Sbjct: 227 RKEPFFHGHDN 237

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 94.9 bits (236), Expect = 3e-21
 Identities = 49/221 (22%), Positives = 83/221 (37%), Gaps = 37/221 (16%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----IVT 229
              VA+KK+        D  R  R E+A+L ++ H +VV+ L  V            +V 
Sbjct: 78  KRVVAIKKILRVFEDLIDCKRILR-EIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVL 136

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           E     D +   +    L          ++  G+ Y+H      I+HRDL+P+N L +  
Sbjct: 137 EIADS-DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQD 192

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR--------------------YV------AP 323
            ++KV DFG+++ +   E+       +                       +V      AP
Sbjct: 193 CSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP 252

Query: 324 EV-FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP 363
           E+    E Y   +DV+S   I  E++         H +  P
Sbjct: 253 ELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGP 293

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 90.8 bits (226), Expect = 3e-21
 Identities = 26/108 (24%), Positives = 46/108 (42%), Gaps = 6/108 (5%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD-SGIDVNFRDIDNRTALHVAACQG 84
             +NGLD  G        L +  +    + ++ L     I++N ++    TALH AA +G
Sbjct: 97  VGVNGLDKAGS--TA---LYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKG 151

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           + ++V LLL +GA  D ++         A       ++K  +   A  
Sbjct: 152 YADIVQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVR 199

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 81.1 bits (201), Expect = 7e-18
 Identities = 18/108 (16%), Positives = 39/108 (36%), Gaps = 11/108 (10%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           +E ++  + D  +            ++      +  L     V  +       LH AA +
Sbjct: 34  EEGDIIYITDMSDT-----NWWKGTSK-----GRTGLIPSNYVAEQAESIDNPLHEAAKR 83

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIK-LLEKHGA 130
           G    +   L+    V+  D+ GST L  A +  + ++++ L  +   
Sbjct: 84  GNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNI 131

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 71.9 bits (177), Expect = 1e-14
 Identities = 11/89 (12%), Positives = 24/89 (26%), Gaps = 5/89 (5%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           +       +     EL     D+ +    + T       +G T ++         V  + 
Sbjct: 16  VFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLI-----PSNYVAEQA 70

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
                PL +A    N   ++    +    
Sbjct: 71  ESIDNPLHEAAKRGNLSWLRECLDNRVGV 99

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 70.0 bits (172), Expect = 5e-14
 Identities = 9/58 (15%), Positives = 20/58 (34%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
           ++ LL  G   + R+I+ + A  +A       ++       A     +        D+
Sbjct: 156 VQLLLAKGARTDLRNIEKKLAFDMATNAACASLLKKKQGTDAVRTLSNAEDYLDDEDS 213

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A Length = 222

 Score = 51.9 bits (125), Expect = 9e-08
 Identities = 7/66 (10%), Positives = 12/66 (18%), Gaps = 5/66 (7%)

Query: 74  RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL-----EKH 128
           +  +  A           L     D+        T            +I         + 
Sbjct: 13  QVKVFRALYTFEPRTPDELYIEEGDIIYITDMSDTNWWKGTSKGRTGLIPSNYVAEQAES 72

Query: 129 GAKPLM 134
              PL 
Sbjct: 73  IDNPLH 78

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 90.7 bits (226), Expect = 4e-21
 Identities = 27/93 (29%), Positives = 44/93 (47%), Gaps = 6/93 (6%)

Query: 44  LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP- 101
           L+  A E DV+ + +LL   G +V+ R     TALH+AA     E   +L+E   ++   
Sbjct: 7   LLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFE 66

Query: 102 ----KDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               +   G T L  A+  +N  +++ L   GA
Sbjct: 67  PMTSELYEGQTALHIAVINQNVNLVRALLARGA 99

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 79.6 bits (197), Expect = 4e-17
 Identities = 28/105 (26%), Positives = 40/105 (38%), Gaps = 17/105 (16%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDN-------------RTALHVAACQGFTEVVS 90
           L      ++V  ++ LL  G  V+ R   +                L  AAC G  E+V 
Sbjct: 79  LHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVR 138

Query: 91  LLLERGADVDPKDRWGSTPLGDAIYYKNHEV----IKLLEKHGAK 131
           LL+E GAD+  +D  G+T L   I   N         LL  +   
Sbjct: 139 LLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGG 183

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 77.6 bits (192), Expect = 2e-16
 Identities = 29/123 (23%), Positives = 49/123 (39%), Gaps = 23/123 (18%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV-----NFRDIDNRTALHVA 80
            E++     GE       L   A   ++E    L+++  ++          + +TALH+A
Sbjct: 28  CEVHQRGAMGETA-----LHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIA 82

Query: 81  ACQGFTEVVSLLLERGADVDPKDR-------------WGSTPLGDAIYYKNHEVIKLLEK 127
                  +V  LL RGA V  +               +G  PL  A    + E+++LL +
Sbjct: 83  VINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIE 142

Query: 128 HGA 130
           HGA
Sbjct: 143 HGA 145

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 75.7 bits (187), Expect = 6e-16
 Identities = 22/97 (22%), Positives = 33/97 (34%), Gaps = 10/97 (10%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS----LLLERGADV 99
           L F A     E ++ L++ G D+  +D    T LH+   Q           LLL      
Sbjct: 125 LSFAACVGSEEIVRLLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGD 184

Query: 100 DPK------DRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             K      +  G TP   A    N  + + L +   
Sbjct: 185 HLKSLELVPNNQGLTPFKLAGVEGNIVMFQHLMQKRK 221

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus} Length = 232

 Score = 67.6 bits (166), Expect = 5e-13
 Identities = 18/67 (26%), Positives = 30/67 (44%), Gaps = 1/67 (1%)

Query: 75  TALHVAACQGFTEVVS-LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
           + L +AA +   + +S LL   G +V  +   G T L  A  Y N E   +L +   + +
Sbjct: 5   SPLLLAAKENDVQALSKLLKFEGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELV 64

Query: 134 MAPMHVK 140
             PM  +
Sbjct: 65  FEPMTSE 71

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score = 93.6 bits (233), Expect = 4e-21
 Identities = 47/224 (20%), Positives = 86/224 (38%), Gaps = 57/224 (25%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-------- 226
           G + A+KK     +  D R    R EL +++ + H N+++ +     +            
Sbjct: 32  GKRFALKK-----VLQDPR-YKNR-ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPD 84

Query: 227 ------------------------------IVTEYLPKGDL----RAFLKRKGALKPSTA 252
                                         ++ EY+P   L    ++F++   ++  +  
Sbjct: 85  DHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLI 143

Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPL 311
             +   + R + ++H      I HRD++P N+L +     LK+ DFG +K L      P 
Sbjct: 144 SIYIYQLFRAVGFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI--PSEPS 198

Query: 312 TCQDTSCRYVAPEV-FKNEEYDTKVDVFSFALILQEMIEGCPPF 354
                S  Y APE+     EY   +D++S   +  E+I G P F
Sbjct: 199 VAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 89.8 bits (224), Expect = 4e-21
 Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 15/100 (15%)

Query: 46  FLANERDVEG---------------IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVS 90
           FL N RD                  I +L+++   +  +DI+  TAL  A       +  
Sbjct: 26  FLRNYRDSYNRTPLMVACMLGMENAIDKLVENFDKLEDKDIEGSTALIWAVKNNRLGIAE 85

Query: 91  LLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            LL +G++V+ KD  G TPL  +I +   E+   L +HGA
Sbjct: 86  KLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGA 125

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 89.0 bits (222), Expect = 7e-21
 Identities = 28/87 (32%), Positives = 47/87 (54%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L++      +   ++LL  G +VN +D   +T L  +   G++E+   LLE GA+V+ ++
Sbjct: 72  LIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRN 131

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             G TPL  A  Y   E++K L + GA
Sbjct: 132 LEGETPLIVASKYGRSEIVKKLLELGA 158

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 87.1 bits (217), Expect = 3e-20
 Identities = 30/87 (34%), Positives = 44/87 (50%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           LM+       E    LL+ G +VN R+++  T L VA+  G +E+V  LLE GAD+  +D
Sbjct: 105 LMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARD 164

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             G T    A  +   EVIK+  +   
Sbjct: 165 LTGLTAEASARIFGRQEVIKIFTEVRR 191

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium} Length = 192

 Score = 51.6 bits (125), Expect = 6e-08
 Identities = 9/64 (14%), Positives = 19/64 (29%), Gaps = 6/64 (9%)

Query: 67  NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
           +  D +      +   +   + +  L         +D +  TPL  A        I  L 
Sbjct: 2   SHMDKNGEIVEKIKDEKSINQNLDFLRNY------RDSYNRTPLMVACMLGMENAIDKLV 55

Query: 127 KHGA 130
           ++  
Sbjct: 56  ENFD 59

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 93.1 bits (232), Expect = 5e-21
 Identities = 54/196 (27%), Positives = 89/196 (45%), Gaps = 31/196 (15%)

Query: 175 GIQVAVKKLG--EEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM-----I 227
            ++VA+KK+   E         R  R E+ +L + RH N++     +   +        I
Sbjct: 52  KVRVAIKKISPFEHQT---YCQRTLR-EIKILLRFRHENIIGINDIIRAPTIEQMKDVYI 107

Query: 228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD 287
           V + +   DL   L +   L       F   I RG+ Y+H      ++HRDL+PSN+L +
Sbjct: 108 VQDLMET-DLYKLL-KTQHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLN 162

Query: 288 DSGNLKVADFGVSKLLTVKEDRP--LTCQDTSCRYV------APEV-FKNEEYDTKVDVF 338
            + +LK+ DFG++++     D    LT       YV      APE+   ++ Y   +D++
Sbjct: 163 TTCDLKICDFGLARVADPDHDHTGFLT------EYVATRWYRAPEIMLNSKGYTKSIDIW 216

Query: 339 SFALILQEMIEGCPPF 354
           S   IL EM+   P F
Sbjct: 217 SVGCILAEMLSNRPIF 232

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 92.0 bits (229), Expect = 1e-20
 Identities = 54/230 (23%), Positives = 105/230 (45%), Gaps = 15/230 (6%)

Query: 179 AVKKLG-EEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLPKGD 236
           A+K L    ++         R E  +L+ IR  P +V    A    + + ++ +Y+  G+
Sbjct: 86  AMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGE 145

Query: 237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
           L   L ++          +  +I   + +LH+     II+RD++  NIL D +G++ + D
Sbjct: 146 LFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTD 202

Query: 297 FGVSKLLTVKEDRPLTCQDTSC---RYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGC 351
           FG+SK   V ++         C    Y+AP++ +  +  +D  VD +S  +++ E++ G 
Sbjct: 203 FGLSK-EFVADETERA--YDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 259

Query: 352 PPFTMK-HDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
            PFT+    N   +      +     P ++ +   K+LI+    + P KR
Sbjct: 260 SPFTVDGEKNSQAEISRRILKSEPPYPQEM-SALAKDLIQRLLMKDPKKR 308

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 91.2 bits (227), Expect = 1e-20
 Identities = 47/205 (22%), Positives = 84/205 (40%), Gaps = 40/205 (19%)

Query: 175 GIQVAVKKLGEEVISDDDRV---RAFRDELALLQKIRHPNVVQFLGAVTQSSPMM----- 226
             +VA+KK     I   D      A R E+ +++++ H N+V+    +  S   +     
Sbjct: 36  DKRVAIKK-----IVLTDPQSVKHALR-EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVG 89

Query: 227 ---------IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
                    IV EY+   DL   L  +G L    A  F   + RG+ Y+H      ++HR
Sbjct: 90  SLTELNSVYIVQEYMET-DLANVL-EQGPLLEEHARLFMYQLLRGLKYIHSAN---VLHR 144

Query: 278 DLEPSNILRDDSG-NLKVADFGVSKLLTVKEDRPLTCQDTSCRYV------APEV-FKNE 329
           DL+P+N+  +     LK+ DFG+++   +          +    +      +P +     
Sbjct: 145 DLKPANLFINTEDLVLKIGDFGLAR--IMDPHYSHKGHLSE--GLVTKWYRSPRLLLSPN 200

Query: 330 EYDTKVDVFSFALILQEMIEGCPPF 354
            Y   +D+++   I  EM+ G   F
Sbjct: 201 NYTKAIDMWAAGCIFAEMLTGKTLF 225

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 89.5 bits (223), Expect = 1e-20
 Identities = 26/91 (28%), Positives = 44/91 (48%), Gaps = 1/91 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPK 102
           L   +    +  ++ L+  G DVN ++  N RTALH+A      ++VSLLL+ GADV+  
Sbjct: 121 LHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRV 180

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
              G +P        +  + + L +   + L
Sbjct: 181 TYQGYSPYQLTWGRPSTRIQQQLGQLTLENL 211

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 88.0 bits (219), Expect = 4e-20
 Identities = 21/87 (24%), Positives = 38/87 (43%)

Query: 50  ERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP 109
              +E I+++      +NF++   +T LH+A      E+   LL  G D + +D  G+TP
Sbjct: 22  ALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTP 81

Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAP 136
           L  A        + +L +    P +  
Sbjct: 82  LHLACEQGCLASVGVLTQSCTTPHLHS 108

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 83.4 bits (207), Expect = 2e-18
 Identities = 28/114 (24%), Positives = 48/114 (42%), Gaps = 12/114 (10%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID------VNFRDIDNRTALHV 79
            +    D  G    P   L     +  +  +  L  S         +   + +  T LH+
Sbjct: 69  CDPELRDFRGN--TP---LHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHL 123

Query: 80  AACQGFTEVVSLLLERGADVDPKDRW-GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           A+  G+  +V LL+  GADV+ ++   G T L  A+  +N +++ LL K GA  
Sbjct: 124 ASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADV 177

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 66.4 bits (163), Expect = 1e-12
 Identities = 15/67 (22%), Positives = 26/67 (38%), Gaps = 4/67 (5%)

Query: 70  DIDNRTALHVAACQGFT----EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
             D  + LH+A          EV+  +    A ++ ++    TPL  A+     E+ + L
Sbjct: 5   TEDGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQPEIAEAL 64

Query: 126 EKHGAKP 132
              G  P
Sbjct: 65  LGAGCDP 71

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E Length = 236

 Score = 64.9 bits (159), Expect = 4e-12
 Identities = 9/66 (13%), Positives = 17/66 (25%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
           +  LL  G DVN       +   +   +  T +   L +   +                 
Sbjct: 167 VSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLENLQMLPESEDEESYDTE 226

Query: 116 YKNHEV 121
            +  E 
Sbjct: 227 SEFTEF 232

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score = 90.4 bits (225), Expect = 2e-20
 Identities = 62/298 (20%), Positives = 102/298 (34%), Gaps = 84/298 (28%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGA----VTQSSPMMIVT 229
             + A+K     ++ D  + R    E+ L  +  + P++V+ +            ++IV 
Sbjct: 43  QEKFALK-----MLQDCPKAR---REVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVM 94

Query: 230 EYLPKGDL--RAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 285
           E L  G+L  R   +   A     A      I   + YLH      I HRD++P N+L  
Sbjct: 95  ECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYT 151

Query: 286 -RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALIL 344
            +  +  LK+ DFG                       A E    E+YD   D++S  +I+
Sbjct: 152 SKRPNAILKLTDFG----------------------FAKETTG-EKYDKSCDMWSLGVIM 188

Query: 345 QEMIEGCPPFTMKHDNEVPKAYAAR---QRPPFKAP--------AKLYARGLKELIEECW 393
             ++ G PPF   H   +      R    +  F  P                K LI    
Sbjct: 189 YILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEV-------KMLIRNLL 241

Query: 394 NEKPAKRPTFRQII-------------TRLESINNSINHKRRWK---------IRTMK 429
             +P +R T  + +             T L +       K RW+         + TM+
Sbjct: 242 KTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEEMTSALATMR 299

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 91.1 bits (227), Expect = 2e-20
 Identities = 22/78 (28%), Positives = 35/78 (44%), Gaps = 1/78 (1%)

Query: 55  GIKELLD-SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
           G   + D   ++    D +N   +HVAA +G T+ V  L+E G     ++R+G T L  A
Sbjct: 1   GPGSMTDFPKLNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLA 60

Query: 114 IYYKNHEVIKLLEKHGAK 131
             +   +  K L   G  
Sbjct: 61  CKFGCVDTAKYLASVGEV 78

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 90.7 bits (226), Expect = 4e-20
 Identities = 20/111 (18%), Positives = 41/111 (36%), Gaps = 5/111 (4%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           +   A +   + ++ L+++G+    ++    TALH+A   G  +    L   G       
Sbjct: 24  IHVAARKGQTDEVRRLIETGVSPTIQNRFGCTALHLACKFGCVDTAKYLASVGEVHSLWH 83

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV---KHAREVPEYEID 151
             G  P+  A+     +++  L +   +    P  +      REV E    
Sbjct: 84  --GQKPIHLAVMANKTDLVVALVEGAKERGQMPESLLNECDEREVNEIGSH 132

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 24/125 (19%), Positives = 47/125 (37%), Gaps = 10/125 (8%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-----GIDVNFRDIDNRTALHVA 80
           A     D   E   P   LM     R+ E +  ++D+      + +++ +    + LH A
Sbjct: 164 ASPTAKDKADE--TP---LMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWA 218

Query: 81  ACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
               + +V    +E G DV+ +D   + PL  ++      + K L +     L+      
Sbjct: 219 ILINWEDVAMRFVEMGIDVNMEDNEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQACPYH 278

Query: 141 HAREV 145
           +   V
Sbjct: 279 NGTTV 283

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 86.1 bits (214), Expect = 1e-18
 Identities = 14/86 (16%), Positives = 23/86 (26%)

Query: 47  LANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
           L              +G  V    +     +  AA     EV+ LL E+  +V      G
Sbjct: 264 LQKTDVFLIQACPYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSLNTG 323

Query: 107 STPLGDAIYYKNHEVIKLLEKHGAKP 132
           +             V ++     A  
Sbjct: 324 AGGAVKRKKKAAPAVKRMKLAPSAPV 349

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 82.6 bits (205), Expect = 2e-17
 Identities = 17/82 (20%), Positives = 31/82 (37%), Gaps = 5/82 (6%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-----GADVDPKDRWGSTPL 110
           IK L+  G     +D  + T L  A      E + L+++         +D  ++ G++ L
Sbjct: 156 IKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHL 215

Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
             AI     +V     + G   
Sbjct: 216 HWAILINWEDVAMRFVEMGIDV 237

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 79.5 bits (197), Expect = 2e-16
 Identities = 20/75 (26%), Positives = 35/75 (46%), Gaps = 7/75 (9%)

Query: 63  GIDVNFRDIDNRTALHVAACQG--FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
            I  + +    +TALH     G  + E++ +L++ GA    KD+   TPL  A+ ++N E
Sbjct: 128 EIGSHVKHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNRE 187

Query: 121 VIKLL-----EKHGA 130
            + L+      K   
Sbjct: 188 ALDLMMDTVPSKSSL 202

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 72.2 bits (178), Expect = 4e-14
 Identities = 13/100 (13%), Positives = 29/100 (29%), Gaps = 2/100 (2%)

Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL+++       +     NG     + +     +   A+    E ++ L +   +V    
Sbjct: 263 LLQKT--DVFLIQACPYHNGTTVLPDRVVWLDFVPAAADPSKQEVLQLLQEKLDEVVRSL 320

Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
                       +    V  + L   A V  + R  +   
Sbjct: 321 NTGAGGAVKRKKKAAPAVKRMKLAPSAPVRTRSRSRARSS 360

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 56.4 bits (137), Expect = 7e-09
 Identities = 14/91 (15%), Positives = 27/91 (29%), Gaps = 14/91 (15%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           +         + +  L++   +        +    +       EV             K 
Sbjct: 88  IHLAVMANKTDLVVALVEGAKE------RGQMPESLLNECDEREVN------EIGSHVKH 135

Query: 104 RWGSTPLGDAIYY-KNH-EVIKLLEKHGAKP 132
             G T L   +     + E+IK+L + GA P
Sbjct: 136 CKGQTALHWCVGLGPEYLEMIKILVQLGASP 166

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major} Length = 364

 Score = 41.0 bits (97), Expect = 5e-04
 Identities = 6/43 (13%), Positives = 13/43 (30%)

Query: 90  SLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           S+      +    D      +  A      + ++ L + G  P
Sbjct: 4   SMTDFPKLNRIKSDDENMEKIHVAARKGQTDEVRRLIETGVSP 46

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 88.3 bits (220), Expect = 3e-20
 Identities = 29/93 (31%), Positives = 39/93 (41%), Gaps = 4/93 (4%)

Query: 44  LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV--- 99
           L     E +   ++ELL S    +  +D D R  LH +      E+ S LL +  +V   
Sbjct: 6   LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD 65

Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           D  D  G TP   A    N EV+K L     KP
Sbjct: 66  DYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKP 98

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 86.0 bits (214), Expect = 2e-19
 Identities = 23/76 (30%), Positives = 35/76 (46%), Gaps = 3/76 (3%)

Query: 58  ELL---DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI 114
           + L       D+N       T LH+A  + + EV   L+E GA V  KD++   PL  A 
Sbjct: 89  KSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAA 148

Query: 115 YYKNHEVIKLLEKHGA 130
              + ++I+LL   G 
Sbjct: 149 SVGSLKLIELLCGLGK 164

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 86.0 bits (214), Expect = 2e-19
 Identities = 31/109 (28%), Positives = 54/109 (49%), Gaps = 7/109 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
            +LN + + G        L     ++  E  + L+++G  V  +D  N+  LH AA  G 
Sbjct: 98  PDLNKITNQGV--TC---LHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGS 152

Query: 86  TEVVSLLLERG-ADVDPKDRWGSTPLGDAIYYKNHEVIKLL-EKHGAKP 132
            +++ LL   G + V+ +D+ G TPL  A+   + +   LL EK+GA+ 
Sbjct: 153 LKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEY 201

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 82.9 bits (206), Expect = 2e-18
 Identities = 32/110 (29%), Positives = 45/110 (40%), Gaps = 10/110 (9%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI---DNRTALHVAAC 82
           + L   D DG    P   L +  + +  E    LL    +VN  D       T  H+A  
Sbjct: 27  SLLLQKDQDGR--IP---LHWSVSFQAHEITSFLLSKMENVNLDDYPDDSGWTPFHIACS 81

Query: 83  QGFTEVVSLLLER--GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            G  EVV  L +R    D++     G T L  A+  K  EV + L ++GA
Sbjct: 82  VGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGA 131

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 73.3 bits (181), Expect = 5e-15
 Identities = 26/105 (24%), Positives = 42/105 (40%), Gaps = 10/105 (9%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAACQG 84
           A +   D   +   P   L   A+   ++ I+ L   G   VN++D    T L  A  +G
Sbjct: 131 ASVRIKDKFNQ--IP---LHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEG 185

Query: 85  FTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKH 128
             +   LL+E+ GA+ D  D  G+          N +V K    +
Sbjct: 186 HGDAAVLLVEKYGAEYDLVDNKGAKAE---DVALNEQVKKFFLNN 227

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A Length = 228

 Score = 70.9 bits (175), Expect = 3e-14
 Identities = 15/59 (25%), Positives = 27/59 (45%), Gaps = 1/59 (1%)

Query: 73  NRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           +   LH A  +  F +V  LL  + + +  KD+ G  PL  ++ ++ HE+   L     
Sbjct: 2   SNYPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKME 60

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110

 Score = 84.5 bits (210), Expect = 3e-20
 Identities = 28/75 (37%), Positives = 37/75 (49%), Gaps = 3/75 (4%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY 115
              L+  G  +     D    L  AA  G  + V +L+  GADV  KD+ GSTPL  A  
Sbjct: 10  SSGLVPRGSHMG---SDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAAR 66

Query: 116 YKNHEVIKLLEKHGA 130
             + EV+KLL + GA
Sbjct: 67  NGHLEVVKLLLEAGA 81

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110

 Score = 81.1 bits (201), Expect = 5e-19
 Identities = 30/83 (36%), Positives = 48/83 (57%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L+  A     + ++ L+ +G DV  +D +  T LH+AA  G  EVV LLLE GADV  +D
Sbjct: 28  LLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQD 87

Query: 104 RWGSTPLGDAIYYKNHEVIKLLE 126
           ++G T    +I   N ++ ++L+
Sbjct: 88  KFGKTAFDISIDNGNEDLAEILQ 110

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A Length = 110

 Score = 55.3 bits (134), Expect = 8e-10
 Identities = 9/51 (17%), Positives = 19/51 (37%), Gaps = 3/51 (5%)

Query: 80  AACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
            +        S L+ RG+ +          L +A      + +++L  +GA
Sbjct: 1   GSSHHHHHHSSGLVPRGSHMGSD---LGKKLLEAARAGQDDEVRILMANGA 48

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 87.6 bits (217), Expect = 5e-20
 Identities = 44/183 (24%), Positives = 67/183 (36%), Gaps = 11/183 (6%)

Query: 44  LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
           +  LA    ++ +KE + +        D D+RTALH A   G TE+V  LL+ G  V+ K
Sbjct: 10  ICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 69

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL------MAPMHV---KHAREVPEYEIDPH 153
           D  G +PL  A      E++K L   GA           P+H    K+  E+    ++  
Sbjct: 70  DDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLE-G 128

Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213
             +              A  +G    V  L     S + +       L L          
Sbjct: 129 GANPDAKDHYDATAMHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEA 188

Query: 214 QFL 216
           +FL
Sbjct: 189 KFL 191

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 74.1 bits (182), Expect = 3e-15
 Identities = 11/60 (18%), Positives = 23/60 (38%)

Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           + N    ++A      E+   +L   +     D+   T L  A    + E+++ L + G 
Sbjct: 5   VSNIMICNLAYSGKLDELKERILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGV 64

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 71.4 bits (175), Expect = 2e-14
 Identities = 31/106 (29%), Positives = 52/106 (49%), Gaps = 5/106 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A +N ++ +G        L + A++   E    LL+ G + + +D  + TA+H AA +G 
Sbjct: 97  AHVNAVNQNGCTP-----LHYAASKNRHEIAVMLLEGGANPDAKDHYDATAMHRAAAKGN 151

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
            ++V +LL   A  + +D  G+TPL  A   +  E  K L   GA 
Sbjct: 152 LKMVHILLFYKASTNIQDTEGNTPLHLACDEERVEEAKFLVTQGAS 197

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 71.1 bits (174), Expect = 3e-14
 Identities = 21/107 (19%), Positives = 40/107 (37%), Gaps = 7/107 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A  +  D           +   A + +++ +  LL      N +D +  T LH+A  +  
Sbjct: 130 ANPDAKDHYDATA-----MHRAAAKGNLKMVHILLFYKASTNIQDTEGNTPLHLACDEER 184

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            E    L+ +GA +  +++   TPL  A       +I      G + 
Sbjct: 185 VEEAKFLVTQGASIYIENKEEKTPLQVA--KGGLGLILKRLAEGEEA 229

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A Length = 231

 Score = 50.3 bits (120), Expect = 3e-07
 Identities = 18/75 (24%), Positives = 28/75 (37%), Gaps = 7/75 (9%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A  N  D +G        L    +E  VE  K L+  G  +   + + +T L VA   G 
Sbjct: 163 ASTNIQDTEGNTP-----LHLACDEERVEEAKFLVTQGASIYIENKEEKTPLQVAK--GG 215

Query: 86  TEVVSLLLERGADVD 100
             ++   L  G +  
Sbjct: 216 LGLILKRLAEGEEAS 230

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 89.2 bits (222), Expect = 1e-19
 Identities = 23/110 (20%), Positives = 53/110 (48%), Gaps = 4/110 (3%)

Query: 26  AELNGLDDDGEEIKPEFR---LMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAA 81
           A+++      ++ +       L + A   ++  +K L+ + G + + +D D +T + +AA
Sbjct: 262 AKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAA 321

Query: 82  CQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
            +G  EVV  L+++GA V+  D    T    A    +H ++ + ++   +
Sbjct: 322 QEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDRCRPE 371

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 85.4 bits (212), Expect = 2e-18
 Identities = 18/72 (25%), Positives = 33/72 (45%)

Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
              KE + +G DVN  D D  T L +A       +V+ L++ GAD    ++   + L  A
Sbjct: 147 HEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQA 206

Query: 114 IYYKNHEVIKLL 125
              ++  ++  +
Sbjct: 207 AANRDFGMMVYM 218

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 83.1 bits (206), Expect = 1e-17
 Identities = 31/124 (25%), Positives = 50/124 (40%), Gaps = 11/124 (8%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N +D D     P   LM     R    +  L+ +G D    +   R+ALH AA    
Sbjct: 157 ADVNAMDCDEN--TP---LMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRD 211

Query: 86  TEVVSLLLE---RGADVDPKDRWGSTPLGDAIYYKNHEVI---KLLEKHGAKPLMAPMHV 139
             ++  +L       D++  DR G T L    + +  + +   KLL + GAK        
Sbjct: 212 FGMMVYMLNSTKLKGDIEELDRNGMTALMIVAHNEGRDQVASAKLLVEKGAKVDYDGAAR 271

Query: 140 KHAR 143
           K + 
Sbjct: 272 KDSE 275

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 77.7 bits (192), Expect = 7e-16
 Identities = 27/87 (31%), Positives = 40/87 (45%), Gaps = 9/87 (10%)

Query: 53  VEGIKELLDSGIDVNFR--------DIDNRTALHVAACQGFTEVVSLLL-ERGADVDPKD 103
           V   K L++ G  V++             RTALH AA      +V  L+ E+G++ D +D
Sbjct: 251 VASAKLLVEKGAKVDYDGAARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQD 310

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGA 130
             G TP+  A      EV+  L + GA
Sbjct: 311 EDGKTPIMLAAQEGRIEVVMYLIQQGA 337

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 76.9 bits (190), Expect = 2e-15
 Identities = 21/83 (25%), Positives = 33/83 (39%), Gaps = 9/83 (10%)

Query: 56  IKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL--------ERGADVDPKDRWGS 107
            + +    +++      NRT LH  A     E    L+          GADV+  D   +
Sbjct: 109 TEPITRESVNII-DPRHNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDEN 167

Query: 108 TPLGDAIYYKNHEVIKLLEKHGA 130
           TPL  A+  +   ++  L K GA
Sbjct: 168 TPLMLAVLARRRRLVAYLMKAGA 190

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 74.6 bits (184), Expect = 7e-15
 Identities = 14/111 (12%), Positives = 29/111 (26%), Gaps = 7/111 (6%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
            + + N L          +         +         +       + ++   LH  A  
Sbjct: 50  IKRQRNELQHYSL-----YPNPQGYGNGNDFLGDFNHTNLQIPTEPEPESPIKLHTEA-A 103

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134
           G   +   +     ++    R   T L       + E  + L  H AK  +
Sbjct: 104 GSYAITEPITRESVNII-DPRHNRTVLHWIASNSSAEKSEDLIVHEAKECI 153

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 9/116 (7%), Positives = 26/116 (22%), Gaps = 5/116 (4%)

Query: 19  PDRERKEAELNGL----DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNR 74
            +R RK   +N        + EE   +      +++  +             N     + 
Sbjct: 3   GNRTRKRRMINASVWMPPMENEEKNRKNHQSITSSQHSLLEASYDGYIKRQRNELQHYSL 62

Query: 75  TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
                    G   +              +      L       ++ + + + +   
Sbjct: 63  YPNPQGYGNGNDFLGDFNHTNLQIPTEPEPESPIKLHTEAAG-SYAITEPITRESV 117

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 61.9 bits (151), Expect = 1e-10
 Identities = 16/75 (21%), Positives = 30/75 (40%), Gaps = 5/75 (6%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           +  +  D+DG+   P   +M  A E  +E +  L+  G  V   D  + TA  +A     
Sbjct: 304 SNKDKQDEDGK--TP---IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNH 358

Query: 86  TEVVSLLLERGADVD 100
             +V +      + +
Sbjct: 359 HNIVDIFDRCRPERE 373

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1 Length = 373

 Score = 46.9 bits (112), Expect = 7e-06
 Identities = 6/72 (8%), Positives = 18/72 (25%), Gaps = 9/72 (12%)

Query: 61  DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
           +     +     ++ +L  A+  G+ +            +    +   P        N  
Sbjct: 25  EKNRKNHQSITSSQHSLLEASYDGYIKRQ---------RNELQHYSLYPNPQGYGNGNDF 75

Query: 121 VIKLLEKHGAKP 132
           +      +   P
Sbjct: 76  LGDFNHTNLQIP 87

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score = 86.7 bits (215), Expect = 1e-18
 Identities = 56/206 (27%), Positives = 92/206 (44%), Gaps = 34/206 (16%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMM----IVT 229
           G  VAVKK+ +   +  D  R FR E+ +L ++  H N+V  L  +   +       +V 
Sbjct: 34  GEVVAVKKIFDAFQNSTDAQRTFR-EIMILTELSGHENIVNLLNVLR--ADNDRDVYLVF 90

Query: 230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
           +Y+   DL A + R   L+P         + + + YLH      ++HRD++PSNIL +  
Sbjct: 91  DYMET-DLHAVI-RANILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAE 145

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCR--------------YV------APEV-FKN 328
            ++KVADFG+S+              +                 YV      APE+   +
Sbjct: 146 CHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGS 205

Query: 329 EEYDTKVDVFSFALILQEMIEGCPPF 354
            +Y   +D++S   IL E++ G P F
Sbjct: 206 TKYTKGIDMWSLGCILGEILCGKPIF 231

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 68/319 (21%), Positives = 115/319 (36%), Gaps = 57/319 (17%)

Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIR---------- 208
            G F    LA        VA+K     ++  D     A  DE+ LLQ++           
Sbjct: 29  WGHFSTVWLAKDMVNNTHVAMK-----IVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 209 -HPNVVQFLGAVTQSSPMM----IVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIAR 261
              ++++ L       P      +V E L   +L A +K+      P   V+  +  +  
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDS------GNLKVADFGVSKLLTVKEDRPLTCQD 315
           G++Y+H      IIH D++P N+L +          +K+AD G +       D   T   
Sbjct: 143 GLDYMHRR--CGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNA----CWYDEHYTNSI 196

Query: 316 TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK-----AYAARQ 370
            +  Y +PEV     +    D++S A ++ E+I G   F     +   K     A     
Sbjct: 197 QTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL 256

Query: 371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKC 430
                 P+ L   G  +     +N +   R   +     LE +   +  K ++     K 
Sbjct: 257 LGEL--PSYLLRNG--KYTRTFFNSRGLLRNISKLKFWPLEDV---LTEKYKFSKDEAKE 309

Query: 431 FHN-LEAMLKKDHSSPSSR 448
             + L  ML+ D   P  R
Sbjct: 310 ISDFLSPMLQLD---PRKR 325

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 79.8 bits (197), Expect = 3e-16
 Identities = 59/214 (27%), Positives = 97/214 (45%), Gaps = 31/214 (14%)

Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRH------PNV 212
           KG+F   + A+       VA+K     ++ ++ R  R   +E+ +L+ +R        NV
Sbjct: 107 KGSFGQVVKAYDHKVHQHVALK-----MVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP--STAVR-FALDIARGMNYLHEN 269
           +  L   T  + + +  E L   +L   +K K   +      VR FA  I + ++ LH+N
Sbjct: 162 IHMLENFTFRNHICMTFELLSM-NLYELIK-KNKFQGFSLPLVRKFAHSILQCLDALHKN 219

Query: 270 KPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
           +   IIH DL+P NIL  +     +KV DFG S      E + +     S  Y APEV  
Sbjct: 220 R---IIHCDLKPENILLKQQGRSGIKVIDFGSS----CYEHQRVYTYIQSRFYRAPEVIL 272

Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361
              Y   +D++S   IL E++ G P    + + +
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 77.7 bits (191), Expect = 8e-16
 Identities = 21/127 (16%), Positives = 35/127 (27%), Gaps = 2/127 (1%)

Query: 11  LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD 70
           LL       +R  K+   +      +     F          ++ +  LL S   V    
Sbjct: 66  LLCLYYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQ 125

Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGSTPLGDAIYYKNHEVIKLLEKH 128
            +N  A  +AA  G   V++ L E                    A    +  V+  L + 
Sbjct: 126 AENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCEL 185

Query: 129 GAKPLMA 135
                 A
Sbjct: 186 APTEATA 192

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 69.2 bits (169), Expect = 6e-13
 Identities = 17/87 (19%), Positives = 24/87 (27%), Gaps = 5/87 (5%)

Query: 57  KELLDSGIDVNFRDI--DNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGSTPLGD 112
             L +         I  +N  A  +AA  G   V++ L E                    
Sbjct: 145 NRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENYYAFRW 204

Query: 113 AIYYKNH-EVIKLLEKHGAKPLMAPMH 138
           A   + H  VI  L         A +H
Sbjct: 205 AAVGRGHHNVINFLLDCPVMLAYAEIH 231

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 54.2 bits (130), Expect = 4e-08
 Identities = 15/118 (12%), Positives = 33/118 (27%), Gaps = 14/118 (11%)

Query: 24  KEAELNGLDD--DGEEIKPEFRLMFLANERDVEGIKELL---------DSGIDVNFRDID 72
           K +  +G+ D     E    F ++     R+ E + + +          +         D
Sbjct: 259 KLSNPDGVFDLVTKSECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGD 318

Query: 73  NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
               L +A   G     +LLL   + +                    ++  +  +H  
Sbjct: 319 ANELLRLALRLGNQGACALLLSIPSVLALTKA---NNYYINETGGRLDLRAVALEHHH 373

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1 Length = 376

 Score = 53.8 bits (129), Expect = 5e-08
 Identities = 14/91 (15%), Positives = 27/91 (29%), Gaps = 12/91 (13%)

Query: 56  IKELLDSGIDVNFRDI--DNRTALHVAACQ-GFTEVVSLLLERGADVDPKDRWGSTPLGD 112
           +  L +         I  +N  A   AA   G   V++ LL+    +   +         
Sbjct: 179 LNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEIHEFE---- 234

Query: 113 AIYYKNHEVIKLLEKHGA--KPLMAPMHVKH 141
              Y    V   + +H    K +     + +
Sbjct: 235 ---YGEKYVNPFIARHVNRLKEMHDAFKLSN 262

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 77.1 bits (190), Expect = 1e-15
 Identities = 47/199 (23%), Positives = 79/199 (39%), Gaps = 22/199 (11%)

Query: 174 RGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMM 226
               VA+K     +I +        + E+ LL+ +          +V         + + 
Sbjct: 78  EQEWVAIK-----IIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLC 132

Query: 227 IVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           +V E L   +L   L+            R FA  +   + +L   + + IIH DL+P NI
Sbjct: 133 LVFEMLSY-NLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPE-LSIIHCDLKPENI 190

Query: 285 L--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFAL 342
           L        +K+ DFG S     +  + +     S  Y +PEV     YD  +D++S   
Sbjct: 191 LLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGC 246

Query: 343 ILQEMIEGCPPFTMKHDNE 361
           IL EM  G P F+  ++ +
Sbjct: 247 ILVEMHTGEPLFSGANEVD 265

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 75.1 bits (184), Expect = 4e-15
 Identities = 21/125 (16%), Positives = 48/125 (38%), Gaps = 8/125 (6%)

Query: 14  QSSLAPDRERKEAEL--NGLDDDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNF-R 69
           Q  L P+ +     L  +  + + E      +   ++ +  ++ + +   ++ +++N   
Sbjct: 68  QRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPV 127

Query: 70  DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH----EVIKLL 125
           D    T LH        E+V  L++ G++    D  G + L  A+   N+        LL
Sbjct: 128 DEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALL 187

Query: 126 EKHGA 130
           +    
Sbjct: 188 DYLYP 192

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 69.7 bits (170), Expect = 3e-13
 Identities = 18/87 (20%), Positives = 33/87 (37%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           K+          E+            +  +E +         +N +D +  T L++AA  
Sbjct: 234 KKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAARL 293

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPL 110
           G   +V  LL+ GAD    ++ G  P+
Sbjct: 294 GNISIVDALLDYGADPFIANKSGLRPV 320

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 19/145 (13%), Positives = 46/145 (31%), Gaps = 22/145 (15%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG-------FTEVVSLLLERG 96
           L +L +  ++E +K L+  G +  + D    + L  A           F  ++  L    
Sbjct: 135 LHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYL---Y 191

Query: 97  ADVDPKDRWGSTPL------------GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHARE 144
             +  +D    T L              A  Y    ++  + K   +P+ +  + K ++ 
Sbjct: 192 PCLILEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKP 251

Query: 145 VPEYEIDPHELDFTNSVEITKGTFI 169
             +       +     ++      +
Sbjct: 252 NDKNGERKDSILENLDLKWIIANML 276

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 52.0 bits (124), Expect = 1e-07
 Identities = 12/83 (14%), Positives = 25/83 (30%), Gaps = 4/83 (4%)

Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAA----CQGFTEVVSLLLERGADVDPKDRWGSTP 109
             +  ++           + + +              E + L       ++ +D  G T 
Sbjct: 227 ILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTC 286

Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
           L  A    N  ++  L  +GA P
Sbjct: 287 LNIAARLGNISIVDALLDYGADP 309

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1 Length = 327

 Score = 47.7 bits (113), Expect = 4e-06
 Identities = 16/121 (13%), Positives = 30/121 (24%), Gaps = 21/121 (17%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLA---NERDVEGIKELLDSGI-DVNFRDIDNRTALHVAA 81
           +     D+ GE       L+      N  D    + LLD     +   D  NRT LH   
Sbjct: 155 SNRLYGDNMGE--SC---LVKAVKSVNNYDSGTFEALLDYLYPCLILEDSMNRTILHHII 209

Query: 82  CQGFTE------------VVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
                             ++  ++++                +    +  + I       
Sbjct: 210 ITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLK 269

Query: 130 A 130
            
Sbjct: 270 W 270

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 73.7 bits (181), Expect = 8e-15
 Identities = 27/121 (22%), Positives = 46/121 (38%), Gaps = 21/121 (17%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A LN  +   + I      + L   R  + +K+ +             +TALH+A  +  
Sbjct: 61  AMLNLHNGQNDTIA-----LLLDVARKTDSLKQFV--NASYTDSYYKGQTALHIAIERRN 113

Query: 86  TEVVSLLLERGADVDPKDR--------------WGSTPLGDAIYYKNHEVIKLLEKHGAK 131
             +V+LL+E GADV                   +G  PL  A       ++K L ++  +
Sbjct: 114 MTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQ 173

Query: 132 P 132
           P
Sbjct: 174 P 174

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 58.3 bits (141), Expect = 1e-09
 Identities = 25/112 (22%), Positives = 38/112 (33%), Gaps = 22/112 (19%)

Query: 44  LMFLANERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQG---------FTEVVSL 91
           L   A    +  +K LL +     D++ RD    T LH                T + + 
Sbjct: 152 LSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNE 211

Query: 92  LLERGADVDP-------KDRWGSTPLGDAIYYKNHEVIKLL---EKHGAKPL 133
           +L  GA + P        +R G TPL  A       V+  +   E H  +  
Sbjct: 212 ILILGAKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIHEPECR 263

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 55.9 bits (135), Expect = 5e-09
 Identities = 11/64 (17%), Positives = 22/64 (34%), Gaps = 8/64 (12%)

Query: 57  KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
            +L  +       +    T L +AA  G   V++ +L+R                 A ++
Sbjct: 217 AKLHPTLKLEEITNRKGLTPLALAASSGKIGVLAYILQREIH-------EPECRHAAAHH 269

Query: 117 KNHE 120
            +H 
Sbjct: 270 -HHH 272

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A* Length = 273

 Score = 50.9 bits (122), Expect = 3e-07
 Identities = 18/88 (20%), Positives = 29/88 (32%), Gaps = 11/88 (12%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-------RGADVDPKDR-WGSTPLGDA- 113
                   + +R ++  A  Q   + +  LL        R  D + KD   G T L  A 
Sbjct: 3   SAGEKPPRLYDRRSIFDAVAQSNCQELESLLPFLQRSKKRLTDSEFKDPETGKTCLLKAM 62

Query: 114 --IYYKNHEVIKLLEKHGAKPLMAPMHV 139
             ++   ++ I LL     K       V
Sbjct: 63  LNLHNGQNDTIALLLDVARKTDSLKQFV 90

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 27/93 (29%), Positives = 44/93 (47%)

Query: 48  ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
           AN+  +  +  ++ +G  ++ +  D  TALH AA     + + LLL+  A V   +  G 
Sbjct: 201 ANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALVGTVNEAGE 260

Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
           T L  A    + E  +LLE+  A     P+HV 
Sbjct: 261 TALDIARKKHHKECEELLEQAQAGTFAFPLHVD 293

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens} Length = 301

 Score = 61.2 bits (148), Expect = 1e-10
 Identities = 22/93 (23%), Positives = 34/93 (36%), Gaps = 9/93 (9%)

Query: 49  NERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQGF---TEVVSLLLERGADV 99
             RD+  + E   +G D                 LH+A          +V  +++ G  +
Sbjct: 160 CNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHL 219

Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           D K   G+T L  A  Y   + +KLL K  A  
Sbjct: 220 DAKAADGNTALHYAALYNQPDCLKLLLKGRALV 252

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 71.7 bits (176), Expect = 2e-14
 Identities = 27/142 (19%), Positives = 46/142 (32%), Gaps = 37/142 (26%)

Query: 21  RERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDN------- 73
           +    A+       G        L     +R ++ +K L+++G DV+ R           
Sbjct: 76  KPLVNAQCTDEFYQGH--SA---LHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQG 130

Query: 74  ------RTALHVAACQGFTEVVSLLLERG---ADVDPKDRWGSTPL------GD------ 112
                    L +AAC    +VV+ LLE     A ++  D  G+T L       D      
Sbjct: 131 TCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENS 190

Query: 113 ----AIYYKNHEVIKLLEKHGA 130
                +Y    ++   L     
Sbjct: 191 ALVIHMYDGLLQMGARLCPTVQ 212

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 68.7 bits (168), Expect = 3e-13
 Identities = 21/91 (23%), Positives = 34/91 (37%), Gaps = 15/91 (16%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-------------WGSTP 109
                       +ALH+A  +   + V LL+E GADV  +               +G  P
Sbjct: 80  NAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELP 139

Query: 110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
           L  A   K  +V+  L ++  +P  A +   
Sbjct: 140 LSLAACTKQWDVVTYLLENPHQP--ASLEAT 168

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 66.7 bits (163), Expect = 1e-12
 Identities = 13/76 (17%), Positives = 26/76 (34%), Gaps = 1/76 (1%)

Query: 66  VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLL 125
           +   +    +AL +    G  ++ + L       +  +  G TPL  A      E+ + +
Sbjct: 181 MIADNSPENSALVIHMYDGLLQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHI 240

Query: 126 EKHGAKPLMAPMHVKH 141
            +       A  H  H
Sbjct: 241 LQREFSG-AAAHHHHH 255

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 59.8 bits (145), Expect = 3e-10
 Identities = 21/110 (19%), Positives = 36/110 (32%), Gaps = 22/110 (20%)

Query: 43  RLMFLANERDVEGIKELLDS--------GIDVNFRDIDNRTALHVAAC---QGFTEVVSL 91
           RL  + +    E +  LL+                    +T L  A      G    +  
Sbjct: 5   RLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNACIMP 64

Query: 92  LLERG-----------ADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
           LL+             A    +   G + L  AI  ++ + +KLL ++GA
Sbjct: 65  LLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGA 114

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 53.3 bits (128), Expect = 4e-08
 Identities = 9/48 (18%), Positives = 18/48 (37%)

Query: 53  VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
           ++    L  +       +    T L +AA +G  E+   +L+R     
Sbjct: 201 LQMGARLCPTVQLEEISNHQGLTPLKLAAKEGKIEIFRHILQREFSGA 248

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A Length = 256

 Score = 43.2 bits (102), Expect = 6e-05
 Identities = 13/71 (18%), Positives = 20/71 (28%), Gaps = 11/71 (15%)

Query: 73  NRTALHVAACQGFTEVVSLLLE--------RGADVDPKDRWGSTPLGDAIY--YKNH-EV 121
           +R  L     +G  E ++ LLE               +   G T L  A+          
Sbjct: 2   DRDRLFSVVSRGVPEELTGLLEYLRWNSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNAC 61

Query: 122 IKLLEKHGAKP 132
           I  L +     
Sbjct: 62  IMPLLQIDKDS 72

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 70.6 bits (173), Expect = 6e-14
 Identities = 24/114 (21%), Positives = 40/114 (35%), Gaps = 26/114 (22%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDN--------------RTALHVAACQGFTEVV 89
           L      R    ++ L++ G DV+ +                     L +AAC     +V
Sbjct: 97  LHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIV 156

Query: 90  SLLLERG---ADVDPKDRWGSTPLGDAIYYKNH---------EVIKLLEKHGAK 131
             L E G   AD+  +D  G+T L   +   ++         ++  LL    AK
Sbjct: 157 HYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAK 210

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 64.0 bits (156), Expect = 1e-11
 Identities = 30/113 (26%), Positives = 45/113 (39%), Gaps = 25/113 (22%)

Query: 45  MFLANERDVEGIKELLDSG---------IDVNFRDIDNR--TALHVAACQGFTEVVSLLL 93
           +   +    + I  LLD           I+  FRD+  R  TALH+A  +     V LL+
Sbjct: 54  LLNLSAGRNDTIPILLDIAEKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLV 113

Query: 94  ERGADVDPKDR--------------WGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           E+GADV  + R              +G  PL  A       ++  L ++G K 
Sbjct: 114 EKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENGHKQ 166

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 62.5 bits (152), Expect = 3e-11
 Identities = 18/105 (17%), Positives = 33/105 (31%), Gaps = 22/105 (20%)

Query: 48  ANERDVEGIKE----LLDSGIDVNFRDIDN----RTALHVAA---CQGFTEVVSLLLERG 96
            +    +G++     LL     +   +       +T L  A      G  + + +LL+  
Sbjct: 13  VSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDTIPILLDIA 72

Query: 97  ADVDP-----------KDRWGSTPLGDAIYYKNHEVIKLLEKHGA 130
                               G T L  AI  +    ++LL + GA
Sbjct: 73  EKTGNMREFINSPFRDVYYRGQTALHIAIERRCKHYVELLVEKGA 117

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 57.9 bits (140), Expect = 1e-09
 Identities = 19/107 (17%), Positives = 34/107 (31%), Gaps = 19/107 (17%)

Query: 44  LMFLANERDVEGIKELLDSGI---DVNFRDIDNRTALHVAACQG---------FTEVVSL 91
           L   A       +  L ++G    D+  +D    T LH                T++  L
Sbjct: 144 LSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDL 203

Query: 92  LLERGADVDPK-------DRWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
           LL + A + P        +  G +PL  A       + + + +    
Sbjct: 204 LLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIA 250

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 47.1 bits (112), Expect = 4e-06
 Identities = 14/70 (20%), Positives = 23/70 (32%), Gaps = 11/70 (15%)

Query: 73  NRTALHVAA----CQGFTEVVSLLLERGADVDPKDRW----GSTPLGDA---IYYKNHEV 121
           NR  L          G   ++S LL     +  ++      G T L  A   +    ++ 
Sbjct: 5   NRPILFDIVSRGSPDGLEGLLSFLLTHKKRLTDEEFREPSTGKTCLPKALLNLSAGRNDT 64

Query: 122 IKLLEKHGAK 131
           I +L     K
Sbjct: 65  IPILLDIAEK 74

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A Length = 260

 Score = 44.8 bits (106), Expect = 2e-05
 Identities = 8/59 (13%), Positives = 17/59 (28%), Gaps = 7/59 (11%)

Query: 49  NERDVEGIKELLDSGIDVN-------FRDIDNRTALHVAACQGFTEVVSLLLERGADVD 100
            +   +    LL     +          + D  + L +AA  G   +   ++ R     
Sbjct: 194 TKFVTKMYDLLLIKCAKLFPDTNLEALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADA 252

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278

 Score = 68.1 bits (166), Expect = 6e-13
 Identities = 20/93 (21%), Positives = 40/93 (43%)

Query: 48  ANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS 107
            +   +  +  L+ +  +++ +     TALH        E + LLL   A ++  +  G 
Sbjct: 180 VDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGE 239

Query: 108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK 140
           TPL  A   K+    +LL +  +    + +HV+
Sbjct: 240 TPLDIAKRLKHEHCEELLTQALSGRFNSHVHVE 272

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1 Length = 278

 Score = 59.6 bits (144), Expect = 3e-10
 Identities = 23/93 (24%), Positives = 38/93 (40%), Gaps = 9/93 (9%)

Query: 49  NERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQG---FTEVVSLLLERGADV 99
             RD+ G+ +    G+D+            + TALH+A          +V  L++   ++
Sbjct: 139 KTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNL 198

Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           D +   GST L       N E +KLL +  A  
Sbjct: 199 DKQTGKGSTALHYCCLTDNAECLKLLLRGKASI 231

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 68.5 bits (168), Expect = 7e-13
 Identities = 68/323 (21%), Positives = 122/323 (37%), Gaps = 59/323 (18%)

Query: 165 KGTF---ILAF--WRGIQVAVKKLGEEVISDDDRVR-AFRDELALLQKIRH-----PNVV 213
            GTF   +L          AVK     V+ +  +   + + E  +L+KI++      N+V
Sbjct: 45  DGTFGRVLLCQHIDNKKYYAVK-----VVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKP 271
           ++ G       M ++ E L    L   + R          ++ + ++I + +NYL +   
Sbjct: 100 KYHGKFMYYDHMCLIFEPLGP-SLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS- 157

Query: 272 VPIIHRDLEPSNIL-------------------------RDDSGNLKVADFGVSKLLTVK 306
             + H DL+P NIL                         R  S  +K+ DFG +      
Sbjct: 158 --LTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCA----TF 211

Query: 307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY 366
           +         + +Y APEV  N  +D   D++SF  +L E+  G   F   H++    A 
Sbjct: 212 KSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFR-THEHMEHLAM 270

Query: 367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIR 426
                 P   P  +     K    +  N K   +  + +  + + SI +       +KI 
Sbjct: 271 MESIIQPI--PKNMLYEATKTNGSKYVN-KDELKLAWPENASSINSIKHVKKCLPLYKII 327

Query: 427 TMKCFHN-LEAMLKKDHSSPSSR 448
             + F + L ++L+ D   P+ R
Sbjct: 328 KHELFCDFLYSILQID---PTLR 347

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 65.4 bits (160), Expect = 9e-12
 Identities = 55/213 (25%), Positives = 80/213 (37%), Gaps = 41/213 (19%)

Query: 177 QVAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMMIVT 229
           QVA+K     +I +  + R A R E+ +L+KI+          V           M I  
Sbjct: 47  QVALK-----IIRNVGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAF 101

Query: 230 EYLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNIL-- 285
           E L K +   FLK       P   VR  A  +   + +LHEN+   + H DL+P NIL  
Sbjct: 102 ELLGK-NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFV 157

Query: 286 -----------------RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
                               + +++VADFG +      +    T    +  Y  PEV   
Sbjct: 158 NSEFETLYNEHKSCEEKSVKNTSIRVADFGSA----TFDHEHHTTIVATRHYRPPEVILE 213

Query: 329 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE 361
             +    DV+S   IL E   G   F    + E
Sbjct: 214 LGWAQPCDVWSIGCILFEYYRGFTLFQTHENRE 246

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 64.2 bits (157), Expect = 2e-11
 Identities = 52/207 (25%), Positives = 77/207 (37%), Gaps = 34/207 (16%)

Query: 178 VAVKKLGEEVISDDDRVR-AFRDELALLQKIRHP------NVVQFLGAVTQSSPMMIVTE 230
           VAVK     ++ + DR   A R E+ +L+ +           VQ L        + IV E
Sbjct: 43  VAVK-----IVKNVDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFE 97

Query: 231 YLPKGDLRAFLKRKGALK-PSTAVR-FALDIARGMNYLHENKPVPIIHRDLEPSNILRDD 288
            L       F+K  G L      +R  A  I + +N+LH NK   + H DL+P NIL   
Sbjct: 98  LLGL-STYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQ 153

Query: 289 SGNLKVADFGVSKLLTVKEDRPL-------TC--QDTSCRYV------APEVFKNEEYDT 333
           S   +  +  + +      +  +            +     V      APEV     +  
Sbjct: 154 SDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYRAPEVILALGWSQ 213

Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDN 360
             DV+S   IL E   G   F   HD+
Sbjct: 214 PCDVWSIGCILIEYYLGFTVFP-THDS 239

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 64.2 bits (156), Expect = 3e-11
 Identities = 52/256 (20%), Positives = 83/256 (32%), Gaps = 76/256 (29%)

Query: 164 TKGTFILA--FWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----HPN---VV 213
              T  L+        VA+K     V S +       DE+ LL+ +R      PN   VV
Sbjct: 49  HFSTVWLSWDIQGKKFVAMKV----VKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104

Query: 214 QFLGAVTQSSP----MMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLH 267
           Q L     S      + +V E L    L  ++ +     L      +    + +G++YLH
Sbjct: 105 QLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLH 163

Query: 268 ENKPVPIIHRDLEPSNIL------------------------------------------ 285
                 IIH D++P NIL                                          
Sbjct: 164 TK--CRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFL 221

Query: 286 -------RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
                    +   +K+AD G +        +  T    + +Y + EV     Y+T  D++
Sbjct: 222 VNPLEPKNAEKLKVKIADLGNA----CWVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIW 277

Query: 339 SFALILQEMIEGCPPF 354
           S A +  E+  G   F
Sbjct: 278 STACMAFELATGDYLF 293

>3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E* Length = 497

 Score = 59.9 bits (145), Expect = 6e-10
 Identities = 26/99 (26%), Positives = 38/99 (38%), Gaps = 9/99 (9%)

Query: 43  RLMFLANERDVEGIKELLDSGIDVN------FRDIDNRTALHVA---ACQGFTEVVSLLL 93
           RL      RD+  + E   +G D                 LH+A   A Q    +V  ++
Sbjct: 135 RLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFII 194

Query: 94  ERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           + G  +D K   G+T L  A  Y   + +KLL K  A  
Sbjct: 195 QNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRALV 233

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368

 Score = 59.4 bits (143), Expect = 7e-10
 Identities = 30/101 (29%), Positives = 48/101 (47%), Gaps = 3/101 (2%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N ++   +   P   L+       +   + LL +G +VN  D   R  LH A   G 
Sbjct: 224 ADVNWVNGGQDNATP---LIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGH 280

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
           T +  L L+RGAD+  +D  G  PL  A+   N +++ LL 
Sbjct: 281 TGLACLFLKRGADLGARDSEGRDPLTIAMETANADIVTLLR 321

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} Length = 368

 Score = 58.3 bits (140), Expect = 2e-09
 Identities = 24/87 (27%), Positives = 34/87 (39%), Gaps = 2/87 (2%)

Query: 48  ANERDVEGIKELLDSGIDVNFR--DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW 105
            +   +  + + L  G DVN+     DN T L  A           LL+ GA+V+  D  
Sbjct: 208 GHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSA 267

Query: 106 GSTPLGDAIYYKNHEVIKLLEKHGAKP 132
           G  PL  A    +  +  L  K GA  
Sbjct: 268 GRGPLHHATILGHTGLACLFLKRGADL 294

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 51.4 bits (122), Expect = 5e-07
 Identities = 51/461 (11%), Positives = 130/461 (28%), Gaps = 153/461 (33%)

Query: 19  PDRER---KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRT 75
            D  +    + E++ +    + +    RL +    +  E +++ ++  + +N+       
Sbjct: 39  QDMPKSILSKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEEVLRINY------- 91

Query: 76  ALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA 135
                    F      L+      + +     T +    Y +  + +     +    + A
Sbjct: 92  --------KF------LMSPIKT-EQRQPSMMTRM----YIEQRDRL-----YNDNQVFA 127

Query: 136 PMHVKHAREVPE-----YEIDPHELDFTNSVEIT----KGTFILAFWRGIQVAVKKLGEE 186
             +V   +   +      E+ P +        +      G+       G       +  +
Sbjct: 128 KYNVSRLQPYLKLRQALLELRPAKN-------VLIDGVLGS-------GKTW----VALD 169

Query: 187 VISDDDRVRAF---------------RDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY 231
           V                            L +LQK+ +     +      SS + +    
Sbjct: 170 VCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIH- 228

Query: 232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DS 289
                ++A L+R                      L ++KP       L    +L +  ++
Sbjct: 229 ----SIQAELRR----------------------LLKSKPYE---NCLL---VLLNVQNA 256

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFS-------FAL 342
                 +     LLT +  + +T       +++     +   D      +          
Sbjct: 257 KAWNAFNLSCKILLTTR-FKQVT------DFLSAATTTHISLDHHSMTLTPDEVKSLLLK 309

Query: 343 ILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPT 402
            L      C P       ++P+        P +    + A  +++ +   W+        
Sbjct: 310 YL-----DCRPQ------DLPR--EVLTTNPRR--LSIIAESIRDGLAT-WD-------N 346

Query: 403 FRQI-ITRLES-INNSINHKRRWKIRTMKCFHNLEAMLKKD 441
           ++ +   +L + I +S+N     + R  K F  L ++    
Sbjct: 347 WKHVNCDKLTTIIESSLNVLEPAEYR--KMFDRL-SVFPPS 384

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 44.5 bits (104), Expect = 7e-05
 Identities = 32/249 (12%), Positives = 70/249 (28%), Gaps = 72/249 (28%)

Query: 29  NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
           + +  D   +  +     L  ++  E    +    +++    ++N  ALH          
Sbjct: 398 DVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELK-VKLENEYALH---------- 446

Query: 89  VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEY 148
              +++        D     P     Y+ +H        H         H+K+       
Sbjct: 447 -RSIVDHYNIPKTFDSDDLIPPYLDQYFYSHIG------H---------HLKNIEHPERM 490

Query: 149 EIDPHE-LDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI 207
            +     LDF              F          L +++  D     A    L  LQ++
Sbjct: 491 TLFRMVFLDF-------------RF----------LEQKIRHDSTAWNASGSILNTLQQL 527

Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGAL----KPSTAVRFALDIARGM 263
           +      +   +  + P       +    +  FL +        K +  +R AL      
Sbjct: 528 K-----FYKPYICDNDPKY--ERLV--NAILDFLPKIEENLICSKYTDLLRIAL------ 572

Query: 264 NYLHENKPV 272
             + E++ +
Sbjct: 573 --MAEDEAI 579

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 43.9 bits (104), Expect = 6e-05
 Identities = 21/77 (27%), Positives = 41/77 (53%), Gaps = 6/77 (7%)

Query: 227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL- 285
           +V E L   DL+    + G  K ST ++  + +   + Y+HEN+    +H D++ +N+L 
Sbjct: 129 MVMERLGI-DLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLL 184

Query: 286 -RDDSGNLKVADFGVSK 301
              +   + +AD+G+S 
Sbjct: 185 GYKNPDQVYLADYGLSY 201

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 43.5 bits (103), Expect = 8e-05
 Identities = 30/135 (22%), Positives = 50/135 (37%), Gaps = 18/135 (13%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIVTEYLP 233
              VA+K     +     R      E    +++     + Q            +V E L 
Sbjct: 34  NEYVAIK-----LEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELLG 88

Query: 234 K--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDS 289
               DL     R  +LK  T +  A+ +   M Y+H      +I+RD++P N L  R  +
Sbjct: 89  PSLEDLFDLCDRTFSLK--TVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGN 143

Query: 290 GNLKVA---DFGVSK 301
              +V    DF ++K
Sbjct: 144 KTQQVIHIIDFALAK 158

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 43.1 bits (102), Expect = 9e-05
 Identities = 22/69 (31%), Positives = 33/69 (47%), Gaps = 8/69 (11%)

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDDSGNL 292
           DL  F  RK +LK  T +  A  +   + Y+H       IHRD++P N L         +
Sbjct: 93  DLFNFCSRKFSLK--TVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLV 147

Query: 293 KVADFGVSK 301
            + DFG++K
Sbjct: 148 YIIDFGLAK 156

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 27/133 (20%), Positives = 54/133 (40%), Gaps = 16/133 (12%)

Query: 175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLP 233
             +VA+K    E  +   +      E  + + ++    +        +    ++V + L 
Sbjct: 32  NEEVAIKL---E--NVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLLG 86

Query: 234 K--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL---RDD 288
               DL  F  RK +LK  T +  A  +   + ++H       +HRD++P N L      
Sbjct: 87  PSLEDLFNFCSRKLSLK--TVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRR 141

Query: 289 SGNLKVADFGVSK 301
           +  + + DFG++K
Sbjct: 142 ANQVYIIDFGLAK 154

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 42.6 bits (99), Expect = 2e-04
 Identities = 29/202 (14%), Positives = 52/202 (25%), Gaps = 52/202 (25%)

Query: 152 PHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDD-----RVRAFRDELAL 203
                     +I +G F            VA+K +  E     +            E+ +
Sbjct: 17  LPTEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 204 LQKI---------RHPNVVQFLGA--VTQSSP---------------------------- 224
            +++         R    +       V  S P                            
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 225 MMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           + IV E+   G DL     +      +TA      +   +     +  +   HRDL   N
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKL--SSLATAKSILHQLTASLAVAEAS--LRFEHRDLHWGN 192

Query: 284 ILRDDSGNLKVADFGVSKLLTV 305
           +L   +   K+      K  T+
Sbjct: 193 VLLKKTSLKKLHYTLNGKSSTI 214

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 41.6 bits (98), Expect = 3e-04
 Identities = 21/82 (25%), Positives = 37/82 (45%), Gaps = 12/82 (14%)

Query: 227 IVTEYLPK--GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI 284
           +V + L     DL     RK ++K  T    A  +   +  +HE     +++RD++P N 
Sbjct: 83  LVIDLLGPSLEDLLDLCGRKFSVK--TVAMAAKQMLARVQSIHEKS---LVYRDIKPDNF 137

Query: 285 L-----RDDSGNLKVADFGVSK 301
           L       ++  + V DFG+ K
Sbjct: 138 LIGRPNSKNANMIYVVDFGMVK 159

>3agd_A Salt-tolerant glutaminase; glutaminase super family, hydrolase; 2.20A {Micrococcus luteus} PDB: 3age_A* 3if5_A 3ih8_A 3ih9_A 3iha_A* 3ihb_A 2dfw_A Length = 456

 Score = 40.9 bits (95), Expect = 6e-04
 Identities = 6/85 (7%), Positives = 17/85 (20%), Gaps = 2/85 (2%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           + F   E  ++ + +L                     A      + +             
Sbjct: 335 IRFGGAEAVLDALTDLRTGAEKPGTGWDAAVYPRWQEAAADRAALSAATGGGAVHEAAAA 394

Query: 104 RWGSTPLGD--AIYYKNHEVIKLLE 126
                  G    +      V ++ +
Sbjct: 395 AARDENDGPIRTVVLNLARVDRIDD 419

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 40.9 bits (96), Expect = 7e-04
 Identities = 12/68 (17%), Positives = 28/68 (41%), Gaps = 6/68 (8%)

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLK 293
                  +   L   + ++ A  +   + +LHEN+    +H ++   NI    +D   + 
Sbjct: 146 SALDVSPKH-VLSERSVLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVT 201

Query: 294 VADFGVSK 301
           +A +G + 
Sbjct: 202 LAGYGFAF 209

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 40.5 bits (95), Expect = 7e-04
 Identities = 14/68 (20%), Positives = 35/68 (51%), Gaps = 7/68 (10%)

Query: 236 DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLK 293
            +     ++ + K  T ++ +L I   + Y+HE++    +H D++ SN+L    +   + 
Sbjct: 140 KIYEANAKRFSRK--TVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVY 194

Query: 294 VADFGVSK 301
           + D+G++ 
Sbjct: 195 LVDYGLAY 202

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	458
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.97
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.93
4gpm_A	169	Engineered protein OR264; de novo protein, structu	99.9
4gpm_A	169	Engineered protein OR264; de novo protein, structu	99.89
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	99.89
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.85
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	99.84
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	99.84
1d9s_A	136	Cyclin-dependent kinase 4 inhibitor B; helix-turn-	99.84
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	99.84
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	99.83
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	99.83
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	99.83
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	99.83
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	99.83
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	99.83
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	99.83
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	99.82
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	99.82
2jab_A	136	H10-2-G3; HER2, darpin, ankyrin repeat protein, me	99.82
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	99.82
3v30_A	172	DNA-binding protein rfxank; structural genomics co	99.81
3v30_A	172	DNA-binding protein rfxank; structural genomics co	99.81
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	99.81
4b93_B	269	Ankyrin repeat domain-containing protein 27; endoc	99.81
1ihb_A	162	P18-INK4C(INK6), cyclin-dependent kinase 6 inhibit	99.81
3f6q_A	179	Integrin-linked protein kinase; ILK, integrin-link	99.81
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	99.8
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	99.8
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	99.8
4b93_B	269	Ankyrin repeat domain-containing protein 27; endoc	99.8
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	99.8
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	99.8
2y1l_E	169	Darpin-8.4; hydrolase-inhibitor complex, DEVD darp	99.79
1n0r_A	126	4ANK, 4 ankyrin repeats; structural protein; 1.50A	99.79
3twr_A	165	Tankyrase-2; ankyrin repeat, protein-protein inter	99.79
1awc_B	153	Protein (GA binding protein beta 1); complex (tran	99.79
1bd8_A	156	P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyr	99.79
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	99.79
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	99.78
3aaa_C	123	Myotrophin, protein V-1; actin capping protein, ba	99.78
2vge_A	229	RELA-associated inhibitor; iaspp, nucleus, apoptos	99.78
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	99.78
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	99.78
2rfm_A	192	Putative ankyrin repeat protein TV1425; ANK repeat	99.78
3v31_A	167	Ankyrin repeat family A protein 2; structural geno	99.78
1bi7_B	156	P16INK4A, MTS1, multiple tumor suppressor; cyclin	99.78
3c5r_A	137	BARD-1, BRCA1-associated ring domain protein 1; an	99.78
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	99.78
1ycs_B	239	53BP2, P53BP2; ankyrin repeats, SH3, tumor suppres	99.78
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	99.78
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	99.78
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	99.77
2rfa_A	232	Transient receptor potential cation channel subfa	99.77
3ehr_A	222	Osteoclast-stimulating factor 1; beta barrel, heli	99.77
2rfa_A	232	Transient receptor potential cation channel subfa	99.76
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	99.76
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	99.76
3t8k_A	186	Uncharacterized protein; structural genomics, PSI-	99.76
2f8y_A	223	Notch homolog 1, translocation-associated (drosoph	99.76
4hbd_A	276	KN motif and ankyrin repeat domain-containing Pro;	99.76
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	99.76
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	99.76
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	99.76
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	99.76
1ikn_D	236	Protein (I-kappa-B-alpha), protein (NF-kappa-B P50	99.76
3hra_A	201	Ankyrin repeat family protein; structural protein;	99.76
2etb_A	256	Transient receptor potential cation channel subfam	99.76
2pnn_A	273	Transient receptor potential cation channel subfa	99.76
3aji_A	231	26S proteasome non-ATPase regulatory subunit 10; g	99.76
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	99.75
3deo_A	183	Signal recognition particle 43 kDa protein; chloro	99.75
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	99.75
3jxi_A	260	Vanilloid receptor-related osmotically activated p	99.75
3jxi_A	260	Vanilloid receptor-related osmotically activated p	99.75
3ui2_A	244	Signal recognition particle 43 kDa protein, chlor;	99.75
1yyh_A	253	HN1;, notch 1, ankyrin domain; ankyrin repeats, ce	99.75
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	99.74
3hra_A	201	Ankyrin repeat family protein; structural protein;	99.74
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.74
4g8k_A	337	2-5A-dependent ribonuclease; ankyrin-repeat domain	99.74
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	99.74
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	99.74
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	99.74
2etb_A	256	Transient receptor potential cation channel subfam	99.74
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	99.74
1oy3_D	282	Transcription factor inhibitor I-kappa-B-beta; pro	99.74
2xai_A	261	ASB-9, ankyrin repeat and SOCS box protein 9; tran	99.73
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	99.73
1n11_A	437	Ankyrin; clathrin, BAND 3, anion exchanger, struct	99.73
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	99.73
2dzn_A	228	Probable 26S proteasome regulatory subunit P28; an	99.72
2pnn_A	273	Transient receptor potential cation channel subfa	99.72
3d9h_A	285	CDNA FLJ77766, highly similar to HOMO sapiens anky	99.72
3ljn_A	364	Hypothetical protein; ankyrin, structural genomics	99.72
1s70_B	299	130 kDa myosin-binding subunit of smooth muscle my	99.72
4hbd_A	276	KN motif and ankyrin repeat domain-containing Pro;	99.72
3b7b_A	237	Euchromatic histone-lysine N-methyltransferase 1;	99.72
1k1a_A	241	B-cell lymphoma 3-encoded protein; BCL-3, NF-kappa	99.71
1wdy_A	285	2-5A-dependent ribonuclease; hydrolase, RNA-bindin	99.7
3kea_A	285	K1L; tropism, ANK repeat, viral protein; 2.30A {Va	99.7
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	99.69
3utm_A	351	Tankyrase-1; tankyrase, TNKS, ankryin repeat clust	99.69
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	99.68
2fo1_E	373	LIN-12 protein; beta-barrel, protein-DNA complex,	99.68
3jue_A	368	Arfgap with coiled-coil, ANK repeat and PH domain	99.67
3eu9_A	240	Huntingtin-interacting protein 14; epigenetics, an	99.66
4g8k_A	337	2-5A-dependent ribonuclease; ankyrin-repeat domain	99.66
2b0o_E	301	UPLC1; arfgap, structural genomics, structural gen	99.62
3lvq_E	497	ARF-GAP with SH3 domain, ANK repeat and PH domain	99.61
1dcq_A	278	PYK2-associated protein beta; zinc-binding module,	99.61
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.59
1n0q_A	93	3ANK, 3 ankyrin repeats; structural protein; 1.26A	99.58
2l6b_A	115	NR1C; ankyrin, consensus, repeat protein, ising mo	99.57
1sw6_A	327	Regulatory protein SWI6; transcription regulation,	99.53
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	99.45
2aja_A	376	Ankyrin repeat family protein; NESG, Q5ZSV0, struc	99.39
2zgd_A	110	3 repeat synthetic ankyrin; ankyrin repeat, hydrox	99.31
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.18
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.95
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.91
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.88
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.68
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.49
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.32
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.15
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.91
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.86
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.81
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	97.61
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	97.57
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	97.38
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	97.29
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	96.79
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.49
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	96.45
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	96.31
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	95.99
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	95.96
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	95.83
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	95.81
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	95.72
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.27
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	86.91
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	84.13
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	83.9

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=4.3e-55  Score=420.90  Aligned_cols=252  Identities=25%  Similarity=0.378  Sum_probs=218.1

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      ..|+..++||+|+||.||.     +|+.||||+++....        ..+|+.+++.++|||||++++++.+++.+||||
T Consensus        58 ~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~--------~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivm  129 (336)
T 4g3f_A           58 HWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVF--------RVEELVACAGLSSPRIVPLYGAVREGPWVNIFM  129 (336)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC--------CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHh--------HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            3577888999999999984     689999999976432        236999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC-CEEEeecCCccccccCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVKED  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~-~vkl~Dfg~~~~~~~~~~  308 (458)
                      |||+||+|.+++++.+.+++..+..++.|++.||+|||+++   |+||||||+|||++.+| .+||+|||++..+.....
T Consensus       130 Ey~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~  206 (336)
T 4g3f_A          130 ELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRR---ILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGL  206 (336)
T ss_dssp             CCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCCGGGEEECTTSCCEEECCCTTCEEC-----
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCc
Confidence            99999999999999899999999999999999999999999   99999999999999987 699999999987643221


Q ss_pred             C----CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          309 R----PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       309 ~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      .    ......||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..++...+... .+++...++.+++.
T Consensus       207 ~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~  285 (336)
T 4g3f_A          207 GKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASE-PPPIREIPPSCAPL  285 (336)
T ss_dssp             -------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHS-CCGGGGSCTTSCHH
T ss_pred             ccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcC-CCCchhcCccCCHH
Confidence            1    123457999999999999999999999999999999999999999998888777776443 33333446678999


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      +.+||.+||++||.+|||+.|++++|........
T Consensus       286 ~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~  319 (336)
T 4g3f_A          286 TAQAIQEGLRKEPVHRASAMELRRKVGKALQEVG  319 (336)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhh
Confidence            9999999999999999999999999988776544

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=8.2e-54  Score=408.11  Aligned_cols=265  Identities=28%  Similarity=0.475  Sum_probs=218.2

Q ss_pred             CCcccCcCCccccCceeeccceEEEEEE--cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          146 PEYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       146 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      ..|||+..++  ++.++||+|+||.||.  ....||||+++... ......+.|.+|+.++++++|||||++++++.+ +
T Consensus        29 ~~Wei~~~~l--~l~~~iG~G~fG~Vy~~~~~~~vAvK~~~~~~-~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~  104 (307)
T 3omv_A           29 YYWEIEASEV--MLSTRIGSGSFGTVYKGKWHGDVAVKILKVVD-PTPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-D  104 (307)
T ss_dssp             CCCBCCTTSC--CEEEECCCCSSSEEEEEESSSEEEEEECCCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-S
T ss_pred             cCcEEcHHHe--EEeeEEeeCCCcEEEEEEECCcEEEEEEEecC-CCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-C
Confidence            4678877655  4568999999999984  34579999997543 345667889999999999999999999998865 5


Q ss_pred             ceEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      .++||||||+||+|.+++... +++++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+|..
T Consensus       105 ~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla~~  181 (307)
T 3omv_A          105 NLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKN---IIHRDMKSNNIFLHEGLTVKIGDFGLATV  181 (307)
T ss_dssp             SCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCCSSSEEEETTEEEEECCCSSCBC
T ss_pred             eEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCccCHHHEEECCCCcEEEeeccCcee
Confidence            689999999999999999764 56999999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCC-CCCcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC--CCCCCC
Q 012684          303 LTVKE-DRPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKA  376 (458)
Q Consensus       303 ~~~~~-~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--~~~~~~  376 (458)
                      ..... ........||+.|||||++.+   .+++.++|||||||++|||+||+.||.+.+...........+  .+..+.
T Consensus       182 ~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~  261 (307)
T 3omv_A          182 KSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSK  261 (307)
T ss_dssp             ------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTT
T ss_pred             cccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCccc
Confidence            64332 223345679999999999864   358899999999999999999999999877665544443433  344445


Q ss_pred             ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       377 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      .+..+++.+.+||.+||+.||.+|||+.++++.|+.+..++
T Consensus       262 ~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l  302 (307)
T 3omv_A          262 LYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL  302 (307)
T ss_dssp             SCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred             ccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence            56778999999999999999999999999999999886553

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=6e-55  Score=421.83  Aligned_cols=246  Identities=22%  Similarity=0.444  Sum_probs=210.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.||.     +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+++.+|||||
T Consensus        25 ~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmE  103 (350)
T 4b9d_A           25 KYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMD  103 (350)
T ss_dssp             CEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEe
Confidence            799999999999999884     689999999986654 44556789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      ||+||+|.+++...  ..+++.++..++.||+.||+|||++|   |+||||||+|||++.+|.+||+|||+++...... 
T Consensus       104 y~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-  179 (350)
T 4b9d_A          104 YCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV-  179 (350)
T ss_dssp             CCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CEETTCCGGGEEECTTCCEEECSTTEESCCCHHH-
T ss_pred             CCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCCEEEcccccceeecCCc-
Confidence            99999999999754  34789999999999999999999999   9999999999999999999999999998754321 


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      .......||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..++...+.....++   .+..+|+++++|
T Consensus       180 ~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~s~~~~~l  256 (350)
T 4b9d_A          180 ELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---VSLHYSYDLRSL  256 (350)
T ss_dssp             HHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHHH
T ss_pred             ccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---CCccCCHHHHHH
Confidence            11234569999999999999999999999999999999999999999887777766665544443   345688999999


Q ss_pred             HHHHcccCCCCCCCHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~  409 (458)
                      |.+||++||.+|||+.+++++
T Consensus       257 i~~~L~~dP~~R~s~~e~l~h  277 (350)
T 4b9d_A          257 VSQLFKRNPRDRPSVNSILEK  277 (350)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHccCChhHCcCHHHHhcC
Confidence            999999999999999999987

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=2.5e-55  Score=417.63  Aligned_cols=247  Identities=21%  Similarity=0.402  Sum_probs=217.1

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.|+.     +|+.||||++.+.........+.+.+|+.++++++||||++++++|.+++.+|+|||
T Consensus        33 dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmE  112 (311)
T 4aw0_A           33 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS  112 (311)
T ss_dssp             GEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            589999999999999984     689999999975433233345678999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC-CC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-DR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~-~~  309 (458)
                      ||+||+|.+++.+.+.+++..+..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++..+.... ..
T Consensus       113 y~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          113 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             cCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            9999999999999899999999999999999999999999   9999999999999999999999999998765332 22


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..++...+... ...+   +..+++++++||
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-~~~~---p~~~s~~~~dli  265 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKL-EYDF---PEKFFPKARDLV  265 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT-CCCC---CTTCCHHHHHHH
T ss_pred             cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCC---CcccCHHHHHHH
Confidence            345678999999999999999999999999999999999999999987776666666433 3333   346889999999


Q ss_pred             HHHcccCCCCCCCHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+||++||.+|||+++++.+
T Consensus       266 ~~lL~~dp~~R~t~~e~~~~  285 (311)
T 4aw0_A          266 EKLLVLDATKRLGCEEMEGY  285 (311)
T ss_dssp             HHHSCSSGGGSTTSGGGTCH
T ss_pred             HHHccCCHhHCcChHHHcCC
Confidence            99999999999999998655

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=3e-54  Score=404.64  Aligned_cols=244  Identities=27%  Similarity=0.452  Sum_probs=200.2

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.|+.     +|+.||||++...........+.+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus        14 ~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE   93 (275)
T 3hyh_A           14 NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIE   93 (275)
T ss_dssp             CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEe
Confidence            689999999999999984     689999999987655555556779999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+ +|+|.+++.+.+.+++.++..++.|++.||+|||++|   |+||||||+|||++.++.+||+|||+|......  ..
T Consensus        94 y~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~--~~  167 (275)
T 3hyh_A           94 YA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK---IVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG--NF  167 (275)
T ss_dssp             CC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTCCEEECCSSCC----------
T ss_pred             CC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCChHHeEECCCCCEEEeecCCCeecCCC--Cc
Confidence            99 7899999999999999999999999999999999999   999999999999999999999999999865432  23


Q ss_pred             cccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      .....||+.|+|||++.+..+ +.++|||||||++|+|++|+.||.+.+..+....+. .+...+   +..+|+++++||
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~-~~~~~~---p~~~s~~~~~li  243 (275)
T 3hyh_A          168 LKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNIS-NGVYTL---PKFLSPGAAGLI  243 (275)
T ss_dssp             -------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HTCCCC---CTTSCHHHHHHH
T ss_pred             cCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH-cCCCCC---CCCCCHHHHHHH
Confidence            345679999999999998876 579999999999999999999998876665555553 333333   356889999999


Q ss_pred             HHHcccCCCCCCCHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+||+.||.+|||+.++++|
T Consensus       244 ~~~L~~dP~~R~s~~eil~h  263 (275)
T 3hyh_A          244 KRMLIVNPLNRISIHEIMQD  263 (275)
T ss_dssp             HHHSCSSGGGSCCHHHHHHC
T ss_pred             HHHccCChhHCcCHHHHHcC
Confidence            99999999999999999987

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=3.6e-54  Score=415.73  Aligned_cols=245  Identities=22%  Similarity=0.386  Sum_probs=214.4

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .|+..++||+|+||.||.     +|+.||||++.......   .+.+.+|+.+++.++||||++++++|.+++.+|||||
T Consensus        75 ~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmE  151 (346)
T 4fih_A           75 YLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME  151 (346)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSS---GGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhH---HHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            588889999999999984     68999999997543322   3457889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      ||+||+|.+++.+ +.+++.++..++.||+.||+|||++|   |+||||||+|||++.+|.+||+|||++..+.... ..
T Consensus       152 y~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~-~~  226 (346)
T 4fih_A          152 FLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV-PR  226 (346)
T ss_dssp             CCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred             CCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEECCCCCEEEecCcCceecCCCC-Cc
Confidence            9999999999876 56999999999999999999999999   9999999999999999999999999998765432 23


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+... .++....+..+|+++++||.
T Consensus       227 ~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~-~~~~~~~~~~~s~~~~dli~  305 (346)
T 4fih_A          227 RKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDN-LPPRLKNLHKVSPSLKGFLD  305 (346)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS-SCCCCSCGGGSCHHHHHHHH
T ss_pred             ccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcC-CCCCCCccccCCHHHHHHHH
Confidence            34568999999999999999999999999999999999999999987766666655433 33333446678999999999


Q ss_pred             HHcccCCCCCCCHHHHHHH
Q 012684          391 ECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~  409 (458)
                      +||++||.+|||+.++++|
T Consensus       306 ~~L~~dP~~R~ta~e~l~H  324 (346)
T 4fih_A          306 RLLVRDPAQRATAAELLKH  324 (346)
T ss_dssp             HHSCSSTTTSCCHHHHTTC
T ss_pred             HHcCCChhHCcCHHHHhcC
Confidence            9999999999999999987

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=2.5e-54  Score=411.51  Aligned_cols=252  Identities=28%  Similarity=0.487  Sum_probs=217.3

Q ss_pred             cccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      +|.+.++||+|+||.||.          +|..||||+++..   .....+.|.+|+.++++++|||||+++++|.+++.+
T Consensus        14 ~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           14 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEE
Confidence            577889999999999874          3678999999743   456677899999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhc-------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCE
Q 012684          226 MIVTEYLPKGDLRAFLKRK-------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL  292 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~-------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~v  292 (458)
                      |||||||++|+|.+++...             ..+++.++..++.|++.||.|||+++   |+||||||+|||++.++.+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDlKp~NILl~~~~~~  167 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLV  167 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccCHhhEEECCCCcE
Confidence            9999999999999999764             35899999999999999999999999   9999999999999999999


Q ss_pred             EEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcC
Q 012684          293 KVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ  370 (458)
Q Consensus       293 kl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~  370 (458)
                      ||+|||+++......... .....||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+..++...+....
T Consensus       168 Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~  247 (299)
T 4asz_A          168 KIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR  247 (299)
T ss_dssp             EECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTC
T ss_pred             EECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999998654332221 123458999999999999999999999999999999998 899999988777777775555


Q ss_pred             CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      +++.   +..+|+++.+||.+||+.||.+|||+.++.+.|+++...
T Consensus       248 ~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~~i~~~L~~~~~~  290 (299)
T 4asz_A          248 VLQR---PRTCPQEVYELMLGCWQREPHMRKNIKGIHTLLQNLAKA  290 (299)
T ss_dssp             CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            5444   456789999999999999999999999999999887543

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=1.3e-53  Score=412.03  Aligned_cols=252  Identities=27%  Similarity=0.482  Sum_probs=212.5

Q ss_pred             cccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          156 DFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      ++.+.++||+|+||.||.          +++.||||+++..   .....+.|.+|+.++++++|||||+++++|.++..+
T Consensus        42 d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           42 DIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             GEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSE
T ss_pred             HeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEE
Confidence            567778999999999984          3688999999743   456677899999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC
Q 012684          226 MIVTEYLPKGDLRAFLKRK---------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG  290 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~  290 (458)
                      |||||||++|+|.+++...               +++++.+++.++.|++.||.|||+++   |+||||||+|||++.++
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLKp~NILl~~~~  195 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLH---FVHRDLATRNCLVGQGL  195 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHhhEEECCCC
Confidence            9999999999999999753               35899999999999999999999999   99999999999999999


Q ss_pred             CEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHh
Q 012684          291 NLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAA  368 (458)
Q Consensus       291 ~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~  368 (458)
                      .+||+|||+++........ ......||+.|||||++.+..++.++|||||||++|||+| |+.||...+..+....+..
T Consensus       196 ~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~  275 (329)
T 4aoj_A          196 VVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ  275 (329)
T ss_dssp             EEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHH
T ss_pred             cEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHc
Confidence            9999999999866433222 2234568999999999999999999999999999999999 8999998887777776655


Q ss_pred             cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ..+++.   +..+++++.+||.+||+.||++|||+.+++++|+.+.+.
T Consensus       276 g~~~~~---p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~L~~l~~~  320 (329)
T 4aoj_A          276 GRELER---PRACPPEVYAIMRGCWQREPQQRHSIKDVHARLQALAQA  320 (329)
T ss_dssp             TCCCCC---CTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             CCCCCC---cccccHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHhhC
Confidence            445444   456789999999999999999999999999999988643

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=1.4e-53  Score=407.91  Aligned_cols=257  Identities=30%  Similarity=0.511  Sum_probs=218.2

Q ss_pred             CcccCcCCccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeee
Q 012684          147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL  216 (458)
Q Consensus       147 ~~~~~~~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~  216 (458)
                      ..+++..++  +..++||+|+||.||.          +++.||||++....  .....+.|.+|+.++++++|||||+++
T Consensus        20 ~~ei~~~~~--~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~~l~HpNIV~l~   95 (308)
T 4gt4_A           20 LKEISLSAV--RFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRARLQHPNVVCLL   95 (308)
T ss_dssp             CCBCCGGGE--EEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred             cccCCHHHC--eEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHHhCCCCCCCCcc
Confidence            344554444  4457899999999973          45789999997543  333456799999999999999999999


Q ss_pred             eEEEeCCceEEEEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 012684          217 GAVTQSSPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE  280 (458)
Q Consensus       217 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dik  280 (458)
                      ++|.+++.++||||||++|+|.+++...                ..+++.++..++.|++.||+|||+++   |+|||||
T Consensus        96 g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHRDLK  172 (308)
T 4gt4_A           96 GVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHH---VVHKDLA  172 (308)
T ss_dssp             EEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCcc
Confidence            9999999999999999999999999643                35899999999999999999999999   9999999


Q ss_pred             CCCEEecCCCCEEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCC
Q 012684          281 PSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKH  358 (458)
Q Consensus       281 p~Nil~~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~  358 (458)
                      |+|||++.++.+||+|||+++....... .......||+.|||||++.+..++.++|||||||++|||+| |+.||.+.+
T Consensus       173 ~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~  252 (308)
T 4gt4_A          173 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS  252 (308)
T ss_dssp             GGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred             ccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence            9999999999999999999987644322 22345678999999999999999999999999999999998 899999988


Q ss_pred             CCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          359 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      ..++...+....+++.   +..+++.+.+||.+||+.||.+|||+.+|+++|+++
T Consensus       253 ~~~~~~~i~~~~~~~~---p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~L~a~  304 (308)
T 4gt4_A          253 NQDVVEMIRNRQVLPC---PDDCPAWVYALMIECWNEFPSRRPRFKDIHSRLRAW  304 (308)
T ss_dssp             HHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTS
T ss_pred             HHHHHHHHHcCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            8777777655555544   456789999999999999999999999999999875

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=7.1e-53  Score=398.76  Aligned_cols=246  Identities=26%  Similarity=0.498  Sum_probs=206.1

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe----CCceEE
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPMMI  227 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~----~~~~~l  227 (458)
                      |...++||+|+||.||.     ++..||+|.+..... .....+.+.+|+.++++++|||||+++++|..    +..+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEE
Confidence            35677899999999984     588999999976543 44556789999999999999999999999865    345899


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC-CCCEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~-~~~vkl~Dfg~~~~~~~~  306 (458)
                      |||||+||+|.+++.+.+.+++..+..++.|++.||+|||++++ +|+||||||+|||++. +|.+||+|||+|....  
T Consensus       107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~-~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~--  183 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR--  183 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSS-CCCCCCCCGGGEEESSTTSCEEECCTTGGGGCC--
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC-CEEecccChhheeEECCCCCEEEEeCcCCEeCC--
Confidence            99999999999999998899999999999999999999999873 4999999999999984 7999999999997543  


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                       ........||+.|||||++.+ .++.++|||||||++|+|+||+.||..................+ ...+..++++++
T Consensus       184 -~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~  260 (290)
T 3fpq_A          184 -ASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-ASFDKVAIPEVK  260 (290)
T ss_dssp             -TTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-GGGGGCCCHHHH
T ss_pred             -CCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCCC-CCCCccCCHHHH
Confidence             233445689999999999875 69999999999999999999999998765543333332333221 223455778999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +||.+||+.||.+|||+.++++|
T Consensus       261 ~li~~~L~~dP~~R~s~~e~l~H  283 (290)
T 3fpq_A          261 EIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHccCChhHCcCHHHHhcC
Confidence            99999999999999999999886

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=3.4e-53  Score=418.81  Aligned_cols=246  Identities=22%  Similarity=0.381  Sum_probs=214.7

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      ..|+..++||+|+||.||.     +|+.||||++.......   .+.+.+|+.+|+.++|||||+++++|.+++.+||||
T Consensus       151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~---~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVm  227 (423)
T 4fie_A          151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQR---RELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVM  227 (423)
T ss_dssp             GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSS---GGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhH---HHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEE
Confidence            3588899999999999984     68999999997543322   356789999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |||+||+|.+++.. +.+++.++..++.||+.||+|||++|   |+||||||+|||++.+|.+||+|||++..+... ..
T Consensus       228 Ey~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~---IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~-~~  302 (423)
T 4fie_A          228 EFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE-VP  302 (423)
T ss_dssp             ECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSTTTEEECTTCCEEECCCTTCEECCSS-CC
T ss_pred             eCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEecCccceECCCC-Cc
Confidence            99999999999875 56999999999999999999999999   999999999999999999999999999876543 22


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......||+.|||||++.+..|+.++|||||||++|+|++|+.||.+.+..+....+.... ++....+..+++++++||
T Consensus       303 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~-~~~~~~~~~~s~~~~dli  381 (423)
T 4fie_A          303 RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNL-PPRLKNLHKVSPSLKGFL  381 (423)
T ss_dssp             CBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCSCTTSSCHHHHHHH
T ss_pred             cccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCC-CCCCcccccCCHHHHHHH
Confidence            3345679999999999999999999999999999999999999999877666666554333 333334567899999999


Q ss_pred             HHHcccCCCCCCCHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+||.+||.+|||+.++++|
T Consensus       382 ~~~L~~dP~~R~ta~ell~H  401 (423)
T 4fie_A          382 DRLLVRDPAQRATAAELLKH  401 (423)
T ss_dssp             HHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHcCCChhHCcCHHHHhcC
Confidence            99999999999999999987

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=1e-53  Score=406.53  Aligned_cols=245  Identities=24%  Similarity=0.360  Sum_probs=205.0

Q ss_pred             cccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      +|++.+.||+|+||.||.        +++.||||++........ ....+.+|+.++++++||||+++++++.+++.+|+
T Consensus        25 ~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~i  103 (304)
T 3ubd_A           25 QFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYL  103 (304)
T ss_dssp             GEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCCCCCCTTEECEEEEEEETTEEEE
T ss_pred             ccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEE
Confidence            699999999999999983        467899999975433221 12357789999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |||||+||+|.+++.+.+.+++.++..++.|++.||+|||++|   |+||||||+|||++.+|.+||+|||+|+......
T Consensus       104 vmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~---IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~  180 (304)
T 3ubd_A          104 ILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE  180 (304)
T ss_dssp             EECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTSCEEEESSEEEEC-----
T ss_pred             EEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHeEEcCCCCEEecccccceeccCCC
Confidence            9999999999999999899999999999999999999999999   9999999999999999999999999998654332


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                       .......||+.|||||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.. ....+   +..+|+++++
T Consensus       181 -~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~-~~~~~---p~~~s~~~~~  255 (304)
T 3ubd_A          181 -KKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILK-AKLGM---PQFLSPEAQS  255 (304)
T ss_dssp             -CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCC---CTTSCHHHHH
T ss_pred             -ccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHc-CCCCC---CCcCCHHHHH
Confidence             233456799999999999999999999999999999999999999998877766666643 33333   4568899999


Q ss_pred             HHHHHcccCCCCCCCH-----HHHHHH
Q 012684          388 LIEECWNEKPAKRPTF-----RQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~-----~~ll~~  409 (458)
                      ||.+||++||.+|||+     +++++|
T Consensus       256 li~~~L~~dP~~R~ta~~~~~~eil~H  282 (304)
T 3ubd_A          256 LLRMLFKRNPANRLGAGPDGVEEIKRH  282 (304)
T ss_dssp             HHHHHTCSSGGGSTTCSTTTHHHHHTS
T ss_pred             HHHHHcccCHHHCCCCCcCCHHHHHcC
Confidence            9999999999999995     566654

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=2.6e-51  Score=399.06  Aligned_cols=260  Identities=27%  Similarity=0.475  Sum_probs=217.0

Q ss_pred             CcccCcCCccccCceeeccceEEEEEE---c-------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCC-Ccceee
Q 012684          147 EYEIDPHELDFTNSVEITKGTFILAFW---R-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQF  215 (458)
Q Consensus       147 ~~~~~~~~~~~~~~~~lg~G~~~~v~~---~-------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~i~~~  215 (458)
                      .|||+..  +|++.+.||+|+||.||.   .       ++.||||.+....  .....+.+.+|+.++.++.| ||||++
T Consensus        58 ~wEi~~~--~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l  133 (353)
T 4ase_A           58 KWEFPRD--RLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNL  133 (353)
T ss_dssp             HHBCCGG--GEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             ccEecHH--HeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEE
Confidence            4666643  677889999999999984   1       3579999997542  44556779999999999965 899999


Q ss_pred             eeEEEeC-CceEEEEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 012684          216 LGAVTQS-SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRD  278 (458)
Q Consensus       216 ~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~D  278 (458)
                      +++|... ..+++|||||++|+|.++++..                ..+++.++..++.|++.||+|||+++   |+|||
T Consensus       134 ~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~---iiHRD  210 (353)
T 4ase_A          134 LGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRD  210 (353)
T ss_dssp             EEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSC
T ss_pred             EEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCC---eecCc
Confidence            9999764 5689999999999999999752                34789999999999999999999999   99999


Q ss_pred             CCCCCEEecCCCCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 012684          279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTM  356 (458)
Q Consensus       279 ikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~  356 (458)
                      |||+|||++.++.+||+|||+|+.+...... ......||+.|||||++.+..++.++|||||||++|||+| |+.||.+
T Consensus       211 LK~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~  290 (353)
T 4ase_A          211 LAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG  290 (353)
T ss_dssp             CSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             cCccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCC
Confidence            9999999999999999999999876433222 2234568999999999999999999999999999999998 9999998


Q ss_pred             CCCCcHHHHHHhc-CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          357 KHDNEVPKAYAAR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       357 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ....+........ .+++.   +..+++++.++|..||+.||.+|||+.+++++|+++.+.
T Consensus       291 ~~~~~~~~~~i~~g~~~~~---p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~L~~llq~  348 (353)
T 4ase_A          291 VKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  348 (353)
T ss_dssp             CCCSHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcCCCCCC---CccCCHHHHHHHHHHcCcChhHCcCHHHHHHHHHHHHHH
Confidence            7765544443333 34443   355789999999999999999999999999999988654

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.3e-50  Score=384.70  Aligned_cols=244  Identities=25%  Similarity=0.412  Sum_probs=191.1

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-------
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-------  223 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-------  223 (458)
                      +|++.+.||+|+||.||.     +|+.||||++...  ......+.+.+|+.++++++||||++++++|...+       
T Consensus         6 dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~--~~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~   83 (299)
T 4g31_A            6 DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLP--NRELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQP   83 (299)
T ss_dssp             HEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEEC--SSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC-------
T ss_pred             hCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEecc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccc
Confidence            477889999999999984     5899999999754  24555677899999999999999999999987544       


Q ss_pred             -----ceEEEEEccCCCCHHHHHHhcCCC---CHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEe
Q 012684          224 -----PMMIVTEYLPKGDLRAFLKRKGAL---KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVA  295 (458)
Q Consensus       224 -----~~~lv~e~~~~~~L~~~l~~~~~~---~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~  295 (458)
                           .+|+|||||+||+|.+++...+.+   +...+..++.|+++||+|||+++   |+||||||+|||++.++.+||+
T Consensus        84 ~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~---IiHRDlKp~NILl~~~~~vKl~  160 (299)
T 4g31_A           84 SSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVG  160 (299)
T ss_dssp             ---CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEEC
T ss_pred             cCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCc---CccccCcHHHeEECCCCcEEEc
Confidence                 379999999999999999876654   44568889999999999999999   9999999999999999999999


Q ss_pred             ecCCccccccCCCC-----------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHH
Q 012684          296 DFGVSKLLTVKEDR-----------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK  364 (458)
Q Consensus       296 Dfg~~~~~~~~~~~-----------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~  364 (458)
                      |||+++........           ......||+.|||||++.+..++.++|||||||++|+|++   ||....  +...
T Consensus       161 DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~--~~~~  235 (299)
T 4g31_A          161 DFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM--ERVR  235 (299)
T ss_dssp             CCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH--HHHH
T ss_pred             cCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc--HHHH
Confidence            99999876543211           1133569999999999999999999999999999999996   776432  1122


Q ss_pred             HHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+.......++......++.+.+||.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~p~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  280 (299)
T 4g31_A          236 TLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIEN  280 (299)
T ss_dssp             HHHHHHTTCCCHHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhcCCCCCCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            221222333434455667788999999999999999999999875

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=1.7e-49  Score=380.28  Aligned_cols=253  Identities=27%  Similarity=0.450  Sum_probs=197.0

Q ss_pred             cccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC----ceEEE
Q 012684          156 DFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMMIV  228 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~----~~~lv  228 (458)
                      +|.+.+.||+|+||.||   ++|+.||||++...    .......+.|+..+.+++||||+++++++.+++    .+|||
T Consensus         4 ~i~L~~~iG~G~fG~Vy~~~~~g~~VAvK~l~~~----~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV   79 (303)
T 3hmm_A            4 TIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLV   79 (303)
T ss_dssp             GEEEEEEEEECSSSEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEE
T ss_pred             EEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc----chhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEE
Confidence            57778899999999887   68999999999643    222223445677777889999999999998654    57999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeeeCCCCCCCEEecCCCCEEEeecCCc
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN--------KPVPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~  300 (458)
                      ||||++|+|.++++.. .+++..+.+++.|++.||+|||++        +   |+||||||+|||++.++.+||+|||++
T Consensus        80 ~Ey~~~gsL~~~l~~~-~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~---IiHRDlKp~NILl~~~~~~Ki~DFGla  155 (303)
T 3hmm_A           80 SDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGLA  155 (303)
T ss_dssp             EECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             ecCCCCCcHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---EeeccCCcccEEECCCCCEEEEeCCCC
Confidence            9999999999999864 589999999999999999999987        6   999999999999999999999999999


Q ss_pred             cccccCCCC---CcccCCCCCcccCCcccCCC------CCCCchhHHHHHHHHHHHHcCCCCCCCCCC----------C-
Q 012684          301 KLLTVKEDR---PLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALILQEMIEGCPPFTMKHD----------N-  360 (458)
Q Consensus       301 ~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~~lltg~~pf~~~~~----------~-  360 (458)
                      +........   ......||+.|||||++.+.      .++.++|||||||++|||+||+.||.....          . 
T Consensus       156 ~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~  235 (303)
T 3hmm_A          156 VRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSD  235 (303)
T ss_dssp             EEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             ccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhccccc
Confidence            876443221   22345799999999998764      356799999999999999999876643221          1 


Q ss_pred             ----cHHHHHHhcC-CCCCCCCh--hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          361 ----EVPKAYAARQ-RPPFKAPA--KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       361 ----~~~~~~~~~~-~~~~~~~~--~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                          .....+.... ++.++...  ...++.+.+|+.+||+.||.+|||+.++++.|+++.+.
T Consensus       236 ~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~l~~~  298 (303)
T 3hmm_A          236 PSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             chHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHH
Confidence                1111121122 34443222  23456899999999999999999999999999988654

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=6.2e-49  Score=388.80  Aligned_cols=250  Identities=22%  Similarity=0.327  Sum_probs=207.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe------CC
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------SS  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~------~~  223 (458)
                      .+|++.+.||+|+||.|+.     +|+.||||++..... .....+.+.+|+.+|+.++||||+++++++..      .+
T Consensus        54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~  132 (398)
T 4b99_A           54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFD-VVTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFK  132 (398)
T ss_dssp             SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCC
T ss_pred             CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECcccc-chHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCC
Confidence            3699999999999999984     689999999976543 44556678899999999999999999998753      35


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      .+|||||||+ |+|.+++.+.+.+++..+..++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||++..+
T Consensus       133 ~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          133 SVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQ---VIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             CEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             EEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CcCCCcCccccccCCCCCEEEeecceeeec
Confidence            7899999995 689999998889999999999999999999999999   999999999999999999999999999866


Q ss_pred             ccCC---CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCC-----
Q 012684          304 TVKE---DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP-----  373 (458)
Q Consensus       304 ~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~-----  373 (458)
                      ....   ........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.+..+....+.... .++     
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            4321   2233567899999999998775 56899999999999999999999999876655544442221 111     


Q ss_pred             ----------------C-CC----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 ----------------F-KA----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ----------------~-~~----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                      . +.    ..+.+++++.+||.+||..||.+|||+.++++|
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  345 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRH  345 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                            0 00    113467899999999999999999999999987

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=5.1e-48  Score=398.61  Aligned_cols=246  Identities=22%  Similarity=0.359  Sum_probs=206.4

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCC---CCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI---SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      .+|++.+.||+|+||.|+.     +|+.||||++.+...   .........+.++.+++.++||||++++++|.+.+.+|
T Consensus       189 ddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~ly  268 (689)
T 3v5w_A          189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS  268 (689)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred             HHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEE
Confidence            3689999999999999984     789999999965322   12222233344567778889999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      +|||||+||+|.+++.+.+.+++..+..++.||+.||+|||++|   |+||||||+|||++.+|.+||+|||+|......
T Consensus       269 lVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~g---IiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          269 FILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            99999999999999999999999999999999999999999999   999999999999999999999999999876432


Q ss_pred             CCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH--HhcCCCCCCCChhhhHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY--AARQRPPFKAPAKLYAR  383 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~  383 (458)
                         ......||+.|||||++.+ ..|+.++|+|||||++|+|++|+.||.+.+........  .......+   +..+|+
T Consensus       346 ---~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~---p~~~S~  419 (689)
T 3v5w_A          346 ---KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL---PDSFSP  419 (689)
T ss_dssp             ---CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCC---CTTSCH
T ss_pred             ---CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCC---CccCCH
Confidence               2344679999999999964 57999999999999999999999999876554433222  12223332   456899


Q ss_pred             HHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPT-----FRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps-----~~~ll~~  409 (458)
                      ++++||.+||++||.+|++     +.++++|
T Consensus       420 ~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~H  450 (689)
T 3v5w_A          420 ELRSLLEGLLQRDVNRRLGCLGRGAQEVKES  450 (689)
T ss_dssp             HHHHHHHHHTCSCGGGCTTCSSSTHHHHTTS
T ss_pred             HHHHHHHHHccCCHhHCCCCCCCCHHHHhcC
Confidence            9999999999999999998     7888876

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=9.7e-48  Score=398.16  Aligned_cols=246  Identities=22%  Similarity=0.377  Sum_probs=216.3

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.|+.     +|+.||+|++...   .....+.+.+|+.+|+.++||||++++++|.++..+|||||
T Consensus       158 ~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~---~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E  234 (573)
T 3uto_A          158 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  234 (573)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             ccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEecc---chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            689999999999999984     6899999999654   34456778899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC--CCEEEeecCCccccccCC
Q 012684          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~--~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||+||+|.+++.. .+.+++.++..++.||+.||+|||+++   |+||||||+|||++.+  +.+||+|||++..+... 
T Consensus       235 ~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-  310 (573)
T 3uto_A          235 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  310 (573)
T ss_dssp             CCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-
T ss_pred             ecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhccccCCCCCCEEEeeccceeEccCC-
Confidence            9999999999864 467999999999999999999999999   9999999999999854  89999999999876432 


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...........+..+|+++++
T Consensus       311 -~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~d  389 (573)
T 3uto_A          311 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD  389 (573)
T ss_dssp             -SEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHH
T ss_pred             -CceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence             3334567999999999999999999999999999999999999999988777777666444433333445678999999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ||.+||+.||.+|||+.++++|
T Consensus       390 li~~~L~~dp~~R~t~~e~l~H  411 (573)
T 3uto_A          390 FIRKLLLADPNTRMTIHQALEH  411 (573)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHccCChhHCcCHHHHhcC
Confidence            9999999999999999999987

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=7.1e-47  Score=370.11  Aligned_cols=244  Identities=20%  Similarity=0.281  Sum_probs=194.7

Q ss_pred             ccccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCce
Q 012684          155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~  225 (458)
                      .+|++.+.||+|+||.||.        +++.||+|.+....  .   ...+.+|+.+++.+ +||||++++++|.+++.+
T Consensus        21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~--~---~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~   95 (361)
T 4f9c_A           21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS--H---PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV   95 (361)
T ss_dssp             GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS--C---HHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred             CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc--C---HHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence            4689999999999999984        36789999986432  1   24577899999988 699999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC-CCEEEeecCCccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVADFGVSKLLT  304 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~-~~vkl~Dfg~~~~~~  304 (458)
                      |+||||++||+|.+++.   .+++.++..++.|++.||+|||++|   |+||||||+|||++.+ +.+||+|||+|+...
T Consensus        96 ~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g---IiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~  169 (361)
T 4f9c_A           96 VIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG---IVHRDVKPSNFLYNRRLKKYALVDFGLAQGTH  169 (361)
T ss_dssp             EEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCEECT
T ss_pred             EEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC---eEeCcCCHHHeEEeCCCCeEEECcCCCCcccC
Confidence            99999999999999984   4999999999999999999999999   9999999999999876 799999999997543


Q ss_pred             cCCC---------------------------CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCC
Q 012684          305 VKED---------------------------RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTM  356 (458)
Q Consensus       305 ~~~~---------------------------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~  356 (458)
                      ....                           .......||+.|+|||++.+. .++.++||||+||++|+|++|+.||..
T Consensus       170 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~  249 (361)
T 4f9c_A          170 DTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYK  249 (361)
T ss_dssp             TCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred             CccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCC
Confidence            2211                           112345799999999998775 488999999999999999999999965


Q ss_pred             CCCCcH-HHHHHh-------------------------------------cC---CC----------CCCCChhhhHHHH
Q 012684          357 KHDNEV-PKAYAA-------------------------------------RQ---RP----------PFKAPAKLYARGL  385 (458)
Q Consensus       357 ~~~~~~-~~~~~~-------------------------------------~~---~~----------~~~~~~~~~~~~l  385 (458)
                      ...... ...+..                                     ..   .+          .....+..+|+++
T Consensus       250 ~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a  329 (361)
T 4f9c_A          250 ASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEA  329 (361)
T ss_dssp             CSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHH
T ss_pred             CCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHH
Confidence            443211 111100                                     00   00          0011234567899


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+||.+||+.||.+|||++|+++|
T Consensus       330 ~DLl~~lL~~dP~~R~ta~eaL~H  353 (361)
T 4f9c_A          330 YDLLDKLLDLNPASRITAEEALLH  353 (361)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHCcCChhHCcCHHHHhcC
Confidence            999999999999999999999987

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=4.7e-45  Score=348.90  Aligned_cols=259  Identities=24%  Similarity=0.390  Sum_probs=216.1

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     ++..||+|.+...........+.+.+|+.++++++||||+++++++..++..++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   90 (294)
T 4eqm_A           11 ERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVM   90 (294)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEE
Confidence            4799999999999999984     58899999997666566777788999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||++|++|.+++...+.+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++.........
T Consensus        91 e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  167 (294)
T 4eqm_A           91 EYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMR---IVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT  167 (294)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCSSSTTC------
T ss_pred             eCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEEeCCCcccccccccc
Confidence            99999999999998888999999999999999999999999   999999999999999999999999999876544333


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCC-CCChhhhHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF-KAPAKLYARGLKEL  388 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~l  388 (458)
                      ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||.................+.. ......+++.+.++
T Consensus       168 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  247 (294)
T 4eqm_A          168 QTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNV  247 (294)
T ss_dssp             -------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHH
T ss_pred             ccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHH
Confidence            33445689999999999998899999999999999999999999988765544433333332222 11234578899999


Q ss_pred             HHHHcccCCCCCC-CHHHHHHHHHHHHhh
Q 012684          389 IEECWNEKPAKRP-TFRQIITRLESINNS  416 (458)
Q Consensus       389 i~~~l~~dp~~Rp-s~~~ll~~L~~~~~~  416 (458)
                      |.+||+.||.+|| ++.++.+.|+++...
T Consensus       248 i~~~l~~dp~~R~~~~~~l~~~l~~~~~~  276 (294)
T 4eqm_A          248 ILRATEKDKANRYKTIQEMKDDLSSVLHE  276 (294)
T ss_dssp             HHHHSCSSGGGSCSSHHHHHHHHHTSSSS
T ss_pred             HHHHhcCCHhHccccHHHHHHHHHHHHhh
Confidence            9999999999998 888888888876433

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.1e-45  Score=352.40  Aligned_cols=247  Identities=27%  Similarity=0.459  Sum_probs=215.4

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      .-.+|++.+.||+|+||.|+.     +|+.||||++..... .....+.+.+|+.+++.++||||+++++++...+..|+
T Consensus        13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~l   91 (328)
T 3fe3_A           13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYL   91 (328)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEE
Confidence            344799999999999999883     789999999976543 44556778899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++...... 
T Consensus        92 v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-  167 (328)
T 3fe3_A           92 IMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR---IVHRDLKAENLLLDADMNIKIADFGFSNEFTVG-  167 (328)
T ss_dssp             EECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTCCGGGSSS-
T ss_pred             EEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCCHHHEEEcCCCCEEEeeccCceecCCC-
Confidence            9999999999999998889999999999999999999999999   999999999999999999999999999765432 


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                       .......||+.|+|||++.+..+. .++|||||||++|+|++|+.||.+.+..+....+.... ...   +..+++.+.
T Consensus       168 -~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~-~~~---p~~~s~~~~  242 (328)
T 3fe3_A          168 -GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGK-YRI---PFYMSTDCE  242 (328)
T ss_dssp             -CGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCC---CTTSCHHHH
T ss_pred             -CccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-CCC---CCCCCHHHH
Confidence             234556789999999999887765 78999999999999999999999877666665554332 222   345788999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +||.+||..||.+|||+.+++++
T Consensus       243 ~li~~~L~~dP~~R~t~~eil~h  265 (328)
T 3fe3_A          243 NLLKRFLVLNPIKRGTLEQIMKD  265 (328)
T ss_dssp             HHHHHHCCSSTTTSCCHHHHTTC
T ss_pred             HHHHHHCCCChhHCcCHHHHhcC
Confidence            99999999999999999999987

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=2.6e-44  Score=346.19  Aligned_cols=260  Identities=36%  Similarity=0.598  Sum_probs=211.7

Q ss_pred             CCccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          153 HELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      ...+|++.+.||+|+||.||   .+|..||||++..... .....+.+.+|+.++++++||||+++++++......++||
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEWHGSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVT  113 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEECCCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEE
Confidence            34578889999999999887   5799999999976543 4556678899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          230 EYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ||+++++|.+++...+.   +++..++.++.|++.||+|||+.++ +|+||||||+||+++.++.+||+|||++......
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~-~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~  192 (309)
T 3p86_A          114 EYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNP-PIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAST  192 (309)
T ss_dssp             ECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSS-CCCCTTCCGGGEEECTTCCEEECCCC--------
T ss_pred             ecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCC-CEECCCCChhhEEEeCCCcEEECCCCCCcccccc
Confidence            99999999999987553   9999999999999999999999872 4999999999999999999999999999754332


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                       ........||+.|+|||++.+..++.++||||||+++|+|++|+.||......+..........  ....+..+++.+.
T Consensus       193 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~  269 (309)
T 3p86_A          193 -FLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCK--RLEIPRNLNPQVA  269 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCC--CCCCCTTSCHHHH
T ss_pred             -ccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC--CCCCCccCCHHHH
Confidence             1223345689999999999999999999999999999999999999998776655554432221  1123456889999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          387 ELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      +||.+||+.||.+|||+.++++.|+.+....
T Consensus       270 ~li~~~l~~dP~~Rps~~~ll~~L~~~~~~~  300 (309)
T 3p86_A          270 AIIEGCWTNEPWKRPSFATIMDLLRPLIKSA  300 (309)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHC--
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHHHhC
Confidence            9999999999999999999999999987553

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=3.3e-44  Score=361.47  Aligned_cols=250  Identities=19%  Similarity=0.323  Sum_probs=216.8

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.|+.     +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++.+++..++||
T Consensus        11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~   89 (444)
T 3soa_A           11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIF   89 (444)
T ss_dssp             HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEE
Confidence            3688899999999999984     689999999976543 3445667899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec---CCCCEEEeecCCccccccC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~---~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ||++||+|.+++...+.+++..+..++.|++.||.|||+.|   |+||||||+|||++   .++.+||+|||++......
T Consensus        90 E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~g---ivHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           90 DLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMG---VVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             CCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            99999999999999889999999999999999999999999   99999999999999   4678999999999766433


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                       ........||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...........+..+++++.
T Consensus       167 -~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  245 (444)
T 3soa_A          167 -QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK  245 (444)
T ss_dssp             -CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHH
T ss_pred             -CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence             2233456789999999999998999999999999999999999999998777766666655444333344567889999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +||.+||+.||.+|||+.+++++
T Consensus       246 ~li~~~L~~dP~~Rpta~e~L~h  268 (444)
T 3soa_A          246 DLINKMLTINPSKRITAAEALKH  268 (444)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHcCCChhHCCCHHHHhcC
Confidence            99999999999999999999987

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-44  Score=349.96  Aligned_cols=247  Identities=16%  Similarity=0.291  Sum_probs=212.8

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     +|..||+|.+...    ......+.+|+.+++.++||||+++++++.+....++||
T Consensus         5 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEE
Confidence            4788999999999999984     5899999998743    234466889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC--CCCEEEeecCCccccccC
Q 012684          230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~--~~~vkl~Dfg~~~~~~~~  306 (458)
                      ||++|++|.+++...+ .+++..++.++.|++.||.|||+.|   |+||||||+||+++.  ++.+||+|||++......
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~g---ivH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~  157 (321)
T 1tki_A           81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG  157 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCC
Confidence            9999999999997654 6999999999999999999999999   999999999999997  789999999999876432


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                        .......+|+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...........+..+++++.
T Consensus       158 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  235 (321)
T 1tki_A          158 --DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAM  235 (321)
T ss_dssp             --CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHH
T ss_pred             --CccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHH
Confidence              223445689999999999988889999999999999999999999998776666665544433332223456789999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      +||.+||..||.+|||+.+++++-
T Consensus       236 ~li~~~L~~dp~~Rpt~~e~l~hp  259 (321)
T 1tki_A          236 DFVDRLLVKERKSRMTASEALQHP  259 (321)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSH
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCh
Confidence            999999999999999999999974

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.5e-44  Score=354.72  Aligned_cols=251  Identities=23%  Similarity=0.348  Sum_probs=214.8

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCH---HHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      ..+|++.+.||+|+||.|+.     +|+.||+|++........   ...+.+.+|+.+++.++||||+++++++.+....
T Consensus        11 ~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   90 (361)
T 2yab_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDV   90 (361)
T ss_dssp             GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEE
T ss_pred             hhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEE
Confidence            34688999999999999984     589999999976543211   1245788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC----CEEEeecCCcc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSK  301 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~----~vkl~Dfg~~~  301 (458)
                      ++||||++|++|.+++...+.+++..+..++.|++.||.|||+.|   |+||||||+||+++.++    .+||+|||++.
T Consensus        91 ~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~~~vkl~DFG~a~  167 (361)
T 2yab_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (361)
T ss_dssp             EEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCSSCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEeCCCCCccCEEEEecCCce
Confidence            999999999999999998888999999999999999999999999   99999999999998877    79999999998


Q ss_pred             ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhh
Q 012684          302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY  381 (458)
Q Consensus       302 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (458)
                      .....  .......||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+....+........+..+..+
T Consensus       168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (361)
T 2yab_A          168 EIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQT  245 (361)
T ss_dssp             ECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             EcCCC--CccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCC
Confidence            76432  2334557899999999999989999999999999999999999999987766666655433322222234567


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++.+++||..||..||.+|||+.++++|
T Consensus       246 s~~~~~li~~~L~~dP~~R~t~~e~l~h  273 (361)
T 2yab_A          246 SELAKDFIRKLLVKETRKRLTIQEALRH  273 (361)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            8999999999999999999999999976

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=4.7e-44  Score=342.46  Aligned_cols=248  Identities=22%  Similarity=0.431  Sum_probs=213.8

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      ...+|++.+.||+|+||.||.     +|+.||+|.+.......   .+.+.+|+.+++.++||||+++++++..++..++
T Consensus        18 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~l   94 (297)
T 3fxz_A           18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWV   94 (297)
T ss_dssp             GGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             hhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccH---HHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEE
Confidence            345799999999999999984     58899999987543323   3567889999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||||++|++|.+++... .+++..+..++.|++.||.|||+.|   |+||||||+||+++.++.+||+|||++.......
T Consensus        95 v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (297)
T 3fxz_A           95 VMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ  170 (297)
T ss_dssp             EEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTT
T ss_pred             EEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc
Confidence            99999999999999875 5899999999999999999999999   9999999999999999999999999987664332


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                       .......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....+... .+..+++.+.+
T Consensus       171 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  248 (297)
T 3fxz_A          171 -SKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQ-NPEKLSAIFRD  248 (297)
T ss_dssp             -CCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCCS-CGGGSCHHHHH
T ss_pred             -cccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCC-CccccCHHHHH
Confidence             2334557899999999999989999999999999999999999999887665555544444443332 35678899999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ||.+||+.||.+|||+.+++++
T Consensus       249 li~~~l~~dp~~Rps~~ell~h  270 (297)
T 3fxz_A          249 FLNRCLEMDVEKRGSAKELLQH  270 (297)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHccCChhHCcCHHHHhhC
Confidence            9999999999999999999986

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=4.5e-44  Score=353.15  Aligned_cols=257  Identities=28%  Similarity=0.526  Sum_probs=220.2

Q ss_pred             CccccCceeeccceEEEEEE------------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT  220 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~  220 (458)
                      ..+|++.+.||+|+||.||.            ++..||||++...  ......+.+.+|+.+++.+ +||||+++++++.
T Consensus        80 ~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  157 (370)
T 2psq_A           80 RDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLGACT  157 (370)
T ss_dssp             GGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEEC
T ss_pred             HHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEc
Confidence            45788899999999999883            2357999999754  3456677899999999999 8999999999999


Q ss_pred             eCCceEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCE
Q 012684          221 QSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI  284 (458)
Q Consensus       221 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Ni  284 (458)
                      ..+..|+||||+++|+|.+++....                .+++..++.++.|++.||.|||+++   |+||||||+||
T Consensus       158 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NI  234 (370)
T 2psq_A          158 QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---CIHRDLAARNV  234 (370)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGE
T ss_pred             cCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchhhE
Confidence            9999999999999999999998643                3788999999999999999999999   99999999999


Q ss_pred             EecCCCCEEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcH
Q 012684          285 LRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV  362 (458)
Q Consensus       285 l~~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~  362 (458)
                      |++.++.+||+|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......+.
T Consensus       235 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~  314 (370)
T 2psq_A          235 LVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEEL  314 (370)
T ss_dssp             EECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGH
T ss_pred             EECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHH
Confidence            999999999999999986543322 22234456889999999998899999999999999999999 9999998877777


Q ss_pred             HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      ...+.....+..   +..+++.+.++|..||+.||.+|||+.++++.|+++.....
T Consensus       315 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~L~~il~~~~  367 (370)
T 2psq_A          315 FKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  367 (370)
T ss_dssp             HHHHHTTCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             HHHHhcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHhc
Confidence            666644444333   45678899999999999999999999999999999876543

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=1.9e-44  Score=350.93  Aligned_cols=247  Identities=25%  Similarity=0.398  Sum_probs=212.2

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.|+.     +|+.||+|++.............+.+|+.+++.++||||+++++++......|+||
T Consensus         5 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~   84 (337)
T 1o6l_A            5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM   84 (337)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEE
Confidence            3688889999999999984     68999999997532212223456788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||++||+|.+++...+.+++..+..++.|++.||.|||++|   |+||||||+|||++.+|.+||+|||++...... ..
T Consensus        85 E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~~  160 (337)
T 1o6l_A           85 EYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GA  160 (337)
T ss_dssp             ECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TC
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCCHHHEEECCCCCEEEeeccchhhcccC-CC
Confidence            99999999999998888999999999999999999999999   999999999999999999999999999754322 22


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+... ...+   +..+++++.++|
T Consensus       161 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~s~~~~~li  236 (337)
T 1o6l_A          161 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILME-EIRF---PRTLSPEAKSLL  236 (337)
T ss_dssp             CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCC---CTTSCHHHHHHH
T ss_pred             cccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcC-CCCC---CCCCCHHHHHHH
Confidence            334556899999999999999999999999999999999999999887666555555332 2222   346789999999


Q ss_pred             HHHcccCCCCCC-----CHHHHHHH
Q 012684          390 EECWNEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rp-----s~~~ll~~  409 (458)
                      .+||+.||.+||     ++.++++|
T Consensus       237 ~~lL~~dP~~R~g~~~~~~~ei~~h  261 (337)
T 1o6l_A          237 AGLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHHcC
Confidence            999999999999     89999987

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=4.3e-44  Score=352.18  Aligned_cols=249  Identities=23%  Similarity=0.368  Sum_probs=216.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     +|..||+|++..... .....+.+.+|+.+++.++||||+++++++.++...|+||
T Consensus        29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  107 (362)
T 2bdw_A           29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVF  107 (362)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            3688999999999999984     589999999976543 4455677899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC---CEEEeecCCccccccC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTVK  306 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~---~vkl~Dfg~~~~~~~~  306 (458)
                      ||++|++|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++   .+||+|||++......
T Consensus       108 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~  184 (362)
T 2bdw_A          108 DLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  184 (362)
T ss_dssp             CCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTC
T ss_pred             ecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEeecCcceEecCC
Confidence            99999999999988888999999999999999999999999   99999999999998654   5999999999876432


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+...........+..+++++.
T Consensus       185 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  262 (362)
T 2bdw_A          185 --EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  262 (362)
T ss_dssp             --CSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred             --cccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence              233446789999999999998999999999999999999999999998776666666544443333344567889999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +||.+||+.||.+|||+.+++++
T Consensus       263 ~li~~~L~~dP~~R~t~~e~l~h  285 (362)
T 2bdw_A          263 SLIDSMLTVNPKKRITADQALKV  285 (362)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHHHHcCCChhhCcCHHHHhcC
Confidence            99999999999999999999987

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=7.2e-44  Score=345.61  Aligned_cols=258  Identities=29%  Similarity=0.490  Sum_probs=217.6

Q ss_pred             CCccccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          153 HELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      ...+|++.+.||+|+||.||.        .+..||||++....  .....+.+.+|+.+++.++||||+++++++..+..
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~  124 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRL  124 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGC
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCc
Confidence            345788999999999999873        24469999997542  45566789999999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      .++||||+++++|.+++... +.+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++...
T Consensus       125 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  201 (325)
T 3kul_A          125 AMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLG---YVHRDLAARNVLVDSNLVCKVSDFGLSRVL  201 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             cEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEECCCCCEEECCCCccccc
Confidence            99999999999999999754 57999999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCCCCc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhh
Q 012684          304 TVKEDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL  380 (458)
Q Consensus       304 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (458)
                      ........  ....+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+......+.   +..
T Consensus       202 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  278 (325)
T 3kul_A          202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLPA---PMG  278 (325)
T ss_dssp             C----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CTT
T ss_pred             ccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCCC---CCC
Confidence            54322221  23345778999999988889999999999999999999 9999998777766666644433333   456


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          381 YARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      +++.+.++|..||..||.+|||+.++++.|+.+....+
T Consensus       279 ~~~~l~~li~~~l~~dp~~Rps~~eil~~L~~l~~~~~  316 (325)
T 3kul_A          279 CPHALHQLMLDCWHKDRAQRPRFSQIVSVLDALIRSPE  316 (325)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSCC
T ss_pred             cCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhCcc
Confidence            78999999999999999999999999999999876533

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=5.4e-44  Score=336.90  Aligned_cols=251  Identities=29%  Similarity=0.562  Sum_probs=215.5

Q ss_pred             ccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .+|++.+.||+|+||.||.    ++..||+|++......    .+.+.+|+.++++++||||+++++++.++...++|||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (269)
T 4hcu_A           10 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE   85 (269)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEE
T ss_pred             hhceeeheecCCCccEEEEEEecCCCeEEEEEecccccC----HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEE
Confidence            4688889999999998874    6789999999765332    2468899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |+++++|.+++... +.+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.........
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~  162 (269)
T 4hcu_A           86 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  162 (269)
T ss_dssp             CCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             eCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCC---eecCCcchheEEEcCCCCEEeccccccccccccccc
Confidence            99999999999764 45899999999999999999999999   999999999999999999999999999865433222


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.......   .+..+++.+.++
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  239 (269)
T 4hcu_A          163 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHVYQI  239 (269)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCHHHHHH
T ss_pred             cccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCC---CCCcCCHHHHHH
Confidence            3334456788999999988889999999999999999999 999999877766666554433332   245568899999


Q ss_pred             HHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          389 IEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      |..||+.||.+|||+.+++++|+++.+
T Consensus       240 i~~~l~~~p~~Rps~~~ll~~l~~l~~  266 (269)
T 4hcu_A          240 MNHCWRERPEDRPAFSRLLRQLAEIAE  266 (269)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHccCCcccCcCHHHHHHHHHHHHH
Confidence            999999999999999999999999864

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=4.7e-44  Score=337.04  Aligned_cols=254  Identities=30%  Similarity=0.539  Sum_probs=215.6

Q ss_pred             cCCccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          152 PHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      ....+|++.+.||+|+||.||.    ++..||+|++......    .+.+.+|+.+++.++||||+++++++..+...++
T Consensus         5 l~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   80 (268)
T 3sxs_A            5 LKREEITLLKELGSGQFGVVKLGKWKGQYDVAVKMIKEGSMS----EDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYI   80 (268)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECBTTBC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             echhheeeeeeeccCCCceEEEEEecCceeEEEEEeccCCCc----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEE
Confidence            3456789999999999998873    4568999999754332    2468889999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ||||+++++|.+++...+ .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++......
T Consensus        81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~  157 (268)
T 3sxs_A           81 VTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQ---FIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDD  157 (268)
T ss_dssp             EEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCSGGGEEECTTCCEEECCTTCEEECCTT
T ss_pred             EEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCcceEEECCCCCEEEccCccceecchh
Confidence            999999999999998754 4999999999999999999999999   999999999999999999999999999866443


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL  385 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (458)
                      .........+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||....................   +..+++.+
T Consensus       158 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l  234 (268)
T 3sxs_A          158 QYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR---PHLASDTI  234 (268)
T ss_dssp             CEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTSCHHH
T ss_pred             hhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCC---CCcChHHH
Confidence            3223334456778999999988889999999999999999999 9999988776655555533333222   34567899


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          386 KELIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      .++|..||+.||.+|||+.+++++|+.+.+
T Consensus       235 ~~li~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (268)
T 3sxs_A          235 YQIMYSCWHELPEKRPTFQQLLSSIEPLRE  264 (268)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHHHGGGCC
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHHHhhh
Confidence            999999999999999999999999998754

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=7.9e-44  Score=338.19  Aligned_cols=254  Identities=26%  Similarity=0.499  Sum_probs=213.9

Q ss_pred             CCccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          153 HELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ...+|++.+.||+|+||.||.    ++..||+|++......    .+.+.+|+.+++.++||||+++++++......++|
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv   97 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFII   97 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEETTTEEEEEEEECTTSBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEE
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEcCCCeEEEEEecCCCCC----HHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEE
Confidence            344788899999999999874    5678999999765332    24688899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |||+++++|.+++.. ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        98 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~  174 (283)
T 3gen_A           98 TEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE  174 (283)
T ss_dssp             ECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCccceEEEcCCCCEEEccccccccccccc
Confidence            999999999999986 566999999999999999999999999   9999999999999999999999999998654332


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                      ........+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+........   +..+++.+.
T Consensus       175 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~  251 (283)
T 3gen_A          175 YTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVY  251 (283)
T ss_dssp             HHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHH
T ss_pred             cccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC---CCcCCHHHH
Confidence            223334456788999999988889999999999999999998 9999998776666665544333322   345678999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          387 ELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ++|..||+.||.+|||+.+++++|+++...
T Consensus       252 ~li~~~l~~~p~~Rps~~~ll~~L~~~~~~  281 (283)
T 3gen_A          252 TIMYSCWHEKADERPTFKILLSNILDVMDE  281 (283)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHccCChhHCcCHHHHHHHHHHHhhc
Confidence            999999999999999999999999998754

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=1.2e-43  Score=336.64  Aligned_cols=255  Identities=24%  Similarity=0.467  Sum_probs=206.6

Q ss_pred             CCccccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          153 HELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      ...+|++.+.||+|+||.||.        .+..||+|.+...  ......+.+.+|+.+++.++||||+++++++. ++.
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~   89 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENP   89 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSS
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCc
Confidence            345788999999999998873        2457999998753  34556678999999999999999999999984 467


Q ss_pred             eEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      .++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++...
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~  166 (281)
T 1mp8_A           90 VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYM  166 (281)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-------
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHEEECCCCCEEECcccccccc
Confidence            899999999999999998654 5999999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhH
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA  382 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (458)
                      ............+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+....+......+.   +..++
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~~---~~~~~  243 (281)
T 1mp8_A          167 EDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---PPNCP  243 (281)
T ss_dssp             ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTTCC
T ss_pred             CcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCCC---CCCCC
Confidence            5433333334456789999999988889999999999999999997 9999998877777666644443333   45678


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      +.+.++|..||+.||.+|||+.++++.|+++.+.
T Consensus       244 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~  277 (281)
T 1mp8_A          244 PTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  277 (281)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            9999999999999999999999999999998755

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.1e-44  Score=345.80  Aligned_cols=250  Identities=24%  Similarity=0.361  Sum_probs=212.9

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCH---HHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      .+|.+.+.||+|+||.||.     +|..||+|++........   ...+.+.+|+.+++.++||||+++++++......+
T Consensus        11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~   90 (326)
T 2y0a_A           11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   90 (326)
T ss_dssp             HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEE
Confidence            3688999999999999984     589999999975433211   12467889999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC----CEEEeecCCccc
Q 012684          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKL  302 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~----~vkl~Dfg~~~~  302 (458)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+||+++.++    .+||+|||++..
T Consensus        91 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~  167 (326)
T 2y0a_A           91 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  167 (326)
T ss_dssp             EEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCC---eEcCCCCHHHEEEecCCCCCCCEEEEECCCCeE
Confidence            99999999999999988888999999999999999999999999   99999999999999887    899999999987


Q ss_pred             cccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhH
Q 012684          303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA  382 (458)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (458)
                      ....  .......||+.|+|||++.+..++.++||||||+++|+|++|..||......+....+...........+..++
T Consensus       168 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (326)
T 2y0a_A          168 IDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  245 (326)
T ss_dssp             CCTT--SCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             CCCC--CccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence            6432  22334568999999999998899999999999999999999999998876655555543333222222335678


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.+.+||.+||+.||.+|||+.+++++
T Consensus       246 ~~~~~li~~~L~~dP~~Rpt~~e~l~h  272 (326)
T 2y0a_A          246 ALAKDFIRRLLVKDPKKRMTIQDSLQH  272 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            899999999999999999999999986

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=9.6e-44  Score=342.28  Aligned_cols=254  Identities=30%  Similarity=0.490  Sum_probs=213.5

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|++.+.||+|+||.||.     +|+.||+|.+..   ......+.+.+|+.+++.++||||+++++++.++...++|
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~---~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv   85 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFI   85 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESC---CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEecc---CCHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEE
Confidence            34788899999999999884     589999998854   2456677899999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |||+++++|.+++.. .+.+++.++..++.|++.||+|||+.+   ++||||||+||+++.++.+||+|||++.......
T Consensus        86 ~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  162 (310)
T 3s95_A           86 TEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMN---IIHRDLNSHNCLVRENKNVVVADFGLARLMVDEK  162 (310)
T ss_dssp             EECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEECTTSCEEECCCTTCEECC---
T ss_pred             EEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCcCeEEECCCCCEEEeecccceeccccc
Confidence            999999999999987 566999999999999999999999999   9999999999999999999999999998654332


Q ss_pred             CCC-------------cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH-----HHHHHhc
Q 012684          308 DRP-------------LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-----PKAYAAR  369 (458)
Q Consensus       308 ~~~-------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~-----~~~~~~~  369 (458)
                      ...             .....||+.|+|||++.+..++.++||||||+++|+|++|..||........     .......
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~  242 (310)
T 3s95_A          163 TQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDR  242 (310)
T ss_dssp             -----------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHH
T ss_pred             ccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccccc
Confidence            211             1145689999999999999999999999999999999999999876544321     1111111


Q ss_pred             CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012684          370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH  419 (458)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  419 (458)
                      .      .+..+++.+.++|.+||+.||.+|||+.++++.|+.+...+..
T Consensus       243 ~------~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~~L~~l~~~~~~  286 (310)
T 3s95_A          243 Y------CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEHWLETLRMHLAG  286 (310)
T ss_dssp             T------CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHH
T ss_pred             c------CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhccC
Confidence            1      1234667899999999999999999999999999999877654

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=1.7e-44  Score=353.48  Aligned_cols=247  Identities=25%  Similarity=0.390  Sum_probs=208.7

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      .+|++.+.||+|+||.|+.     +|+.||||++...........+.+..|..+++.+ +||||+++++++.....+|+|
T Consensus        23 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv  102 (353)
T 3txo_A           23 DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFV  102 (353)
T ss_dssp             CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEE
Confidence            3688899999999999984     5889999999754322333456678899999988 799999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |||++||+|.+++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++...... .
T Consensus       103 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~-~  178 (353)
T 3txo_A          103 MEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGICN-G  178 (353)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC---
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCCHHHEEECCCCCEEEccccceeecccC-C
Confidence            999999999999998888999999999999999999999999   999999999999999999999999999753322 2


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ...+   +..+++.+.++
T Consensus       179 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~~~~~~~l  254 (353)
T 3txo_A          179 VTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILND-EVVY---PTWLHEDATGI  254 (353)
T ss_dssp             -------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCC---CTTSCHHHHHH
T ss_pred             ccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcC-CCCC---CCCCCHHHHHH
Confidence            2334557899999999998888999999999999999999999999988777666666433 3332   34578899999


Q ss_pred             HHHHcccCCCCCCCH------HHHHHH
Q 012684          389 IEECWNEKPAKRPTF------RQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rps~------~~ll~~  409 (458)
                      |.+||+.||.+||++      .++++|
T Consensus       255 i~~lL~~dP~~R~~~~~~~~~~~il~h  281 (353)
T 3txo_A          255 LKSFMTKNPTMRLGSLTQGGEHAILRH  281 (353)
T ss_dssp             HHHHTCSSGGGSTTSGGGTCTHHHHTS
T ss_pred             HHHHhhhCHHHccCCcccCCHHHHhhC
Confidence            999999999999998      788876

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=1.4e-43  Score=351.21  Aligned_cols=248  Identities=23%  Similarity=0.404  Sum_probs=207.0

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      .+|++.+.||+|+||.|+.     +++.||+|++...........+.+..|..++.++ +||||+++++++.....+|+|
T Consensus        52 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV  131 (396)
T 4dc2_A           52 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV  131 (396)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEE
Confidence            3688999999999999984     5889999999876655555566788899999887 899999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |||++||+|.+++.+.+.+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||++...... .
T Consensus       132 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~  207 (396)
T 4dc2_A          132 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-G  207 (396)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred             EEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEECCCCCEEEeecceeeecccC-C
Confidence            999999999999998888999999999999999999999999   999999999999999999999999999753222 2


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC--------cHHHHHHhcCCCCCCCChhh
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN--------EVPKAYAARQRPPFKAPAKL  380 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~--------~~~~~~~~~~~~~~~~~~~~  380 (458)
                      .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||......        .............+   +..
T Consensus       208 ~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~---p~~  284 (396)
T 4dc2_A          208 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRI---PRS  284 (396)
T ss_dssp             CCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCC---CTT
T ss_pred             CccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCC---CCc
Confidence            3344567899999999999999999999999999999999999999754221        11112222333333   345


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCH------HHHHHH
Q 012684          381 YARGLKELIEECWNEKPAKRPTF------RQIITR  409 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~------~~ll~~  409 (458)
                      +++.+++||.+||+.||.+||++      .++++|
T Consensus       285 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~H  319 (396)
T 4dc2_A          285 LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  319 (396)
T ss_dssp             SCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHS
T ss_pred             CCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcC
Confidence            78999999999999999999996      566665

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-44  Score=343.59  Aligned_cols=244  Identities=24%  Similarity=0.452  Sum_probs=210.9

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.|+.     +|+.||+|++...........+.+.+|..+++.++||||+++++++.+....|+||
T Consensus         6 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~   85 (318)
T 1fot_A            6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM   85 (318)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEE
Confidence            3688899999999999884     68999999997532212223456788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||++||+|.+++...+.+++..+..++.|++.||.|||++|   |+||||||+|||++.+|.+||+|||++.....    
T Consensus        86 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~----  158 (318)
T 1fot_A           86 DYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPD----  158 (318)
T ss_dssp             CCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSS----
T ss_pred             eCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChheEEEcCCCCEEEeecCcceecCC----
Confidence            99999999999998888999999999999999999999999   99999999999999999999999999986542    


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......||+.|+|||++.+..++.++|+||||+++|+|++|+.||...+.......+... ...+   +..+++++.++|
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~-~~~~---p~~~~~~~~~li  234 (318)
T 1fot_A          159 VTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRF---PPFFNEDVKDLL  234 (318)
T ss_dssp             CBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-CCCC---CTTSCHHHHHHH
T ss_pred             ccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CCCC---CCCCCHHHHHHH
Confidence            223456899999999999999999999999999999999999999887665555555333 2222   346789999999


Q ss_pred             HHHcccCCCCCC-----CHHHHHHH
Q 012684          390 EECWNEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rp-----s~~~ll~~  409 (458)
                      .+||..||.+||     ++.++++|
T Consensus       235 ~~lL~~dp~~R~~~~~~~~~~i~~h  259 (318)
T 1fot_A          235 SRLITRDLSQRLGNLQNGTEDVKNH  259 (318)
T ss_dssp             HHHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHhccCHHHcCCCcCCCHHHHhcC
Confidence            999999999999     89999876

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.7e-44  Score=345.47  Aligned_cols=257  Identities=24%  Similarity=0.380  Sum_probs=208.7

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc----
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----  224 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~----  224 (458)
                      ..+|++.+.||+|+||.||.     +|+.||||++.............+.+|+.+++.++||||+++++++.....    
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~   90 (311)
T 3ork_A           11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL   90 (311)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcc
Confidence            34799999999999999883     689999999987766667777889999999999999999999999876543    


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      .|+||||++|++|.+++...+.+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++....
T Consensus        91 ~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~  167 (311)
T 3ork_A           91 PYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIA  167 (311)
T ss_dssp             EEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEETTSCEEECCCSCC----
T ss_pred             cEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcCCCCHHHEEEcCCCCEEEeeccCccccc
Confidence            4999999999999999998888999999999999999999999999   9999999999999999999999999998654


Q ss_pred             cCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhH
Q 012684          305 VKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA  382 (458)
Q Consensus       305 ~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (458)
                      .....  ......||+.|+|||++.+..++.++||||||+++|+|++|+.||..................+.......++
T Consensus       168 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (311)
T 3ork_A          168 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS  247 (311)
T ss_dssp             --------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTTCC
T ss_pred             ccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCCCC
Confidence            33221  2233468999999999999899999999999999999999999998876655544443333332222234578


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHH-HHHH
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITR-LESI  413 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~-L~~~  413 (458)
                      +.+.++|.+||+.||.+||++.+++.+ |.+.
T Consensus       248 ~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          248 ADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             HHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            899999999999999999987776654 4443

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=4.1e-43  Score=342.80  Aligned_cols=247  Identities=24%  Similarity=0.409  Sum_probs=210.6

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      .+|++.+.||+|+||.|+.     +|+.||+|++...........+.+.+|..+++++ +||||+++++++......|+|
T Consensus         9 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   88 (345)
T 3a8x_A            9 QDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFV   88 (345)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEE
Confidence            3688899999999999884     5899999999877666777778889999999988 899999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |||++||+|.+++.+.+.+++..+..++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++...... .
T Consensus        89 ~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~-~  164 (345)
T 3a8x_A           89 IEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRP-G  164 (345)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCGGGCBCSCCT-T
T ss_pred             EeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEEeccccccccCC-C
Confidence            999999999999998888999999999999999999999999   999999999999999999999999999754322 2


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC---------cHHHHHHhcCCCCCCCChh
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN---------EVPKAYAARQRPPFKAPAK  379 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~---------~~~~~~~~~~~~~~~~~~~  379 (458)
                      .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||......         .....+ ......+   +.
T Consensus       165 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i-~~~~~~~---p~  240 (345)
T 3a8x_A          165 DTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-LEKQIRI---PR  240 (345)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHH-HHCCCCC---CT
T ss_pred             CcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHH-HcCCCCC---CC
Confidence            2334567899999999999989999999999999999999999999753221         112222 2233332   34


Q ss_pred             hhHHHHHHHHHHHcccCCCCCCCH------HHHHHH
Q 012684          380 LYARGLKELIEECWNEKPAKRPTF------RQIITR  409 (458)
Q Consensus       380 ~~~~~l~~li~~~l~~dp~~Rps~------~~ll~~  409 (458)
                      .+++.++++|.+||+.||.+||++      .++++|
T Consensus       241 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~h  276 (345)
T 3a8x_A          241 SLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGH  276 (345)
T ss_dssp             TSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTS
T ss_pred             CCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcC
Confidence            678999999999999999999996      667665

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=3.3e-43  Score=338.85  Aligned_cols=261  Identities=28%  Similarity=0.516  Sum_probs=221.5

Q ss_pred             CCcccCcCCccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceee
Q 012684          146 PEYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF  215 (458)
Q Consensus       146 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~  215 (458)
                      +.+++  ...+|.+.+.||+|+||.||.          ++..||+|++...  ......+.+.+|+.+++.++||||+++
T Consensus        16 ~~~~~--~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~   91 (314)
T 2ivs_A           16 PKWEF--PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLKQVNHPHVIKL   91 (314)
T ss_dssp             TTTBC--CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHTTCCCTTBCCE
T ss_pred             ccccc--chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHhhCCCCceeeE
Confidence            44443  456788999999999998874          2378999999754  345666789999999999999999999


Q ss_pred             eeEEEeCCceEEEEEccCCCCHHHHHHhcCC------------------------CCHHHHHHHHHHHHHHHHHHHhCCC
Q 012684          216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA------------------------LKPSTAVRFALDIARGMNYLHENKP  271 (458)
Q Consensus       216 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~------------------------~~~~~~~~i~~qi~~~l~~LH~~~~  271 (458)
                      ++++...+..++||||+++++|.+++.....                        +++.+++.++.|++.||.|||+++ 
T Consensus        92 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~-  170 (314)
T 2ivs_A           92 YGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMK-  170 (314)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTT-
T ss_pred             EEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCC-
Confidence            9999999999999999999999999987543                        889999999999999999999999 


Q ss_pred             CCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-
Q 012684          272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-  349 (458)
Q Consensus       272 ~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-  349 (458)
                        ++||||||+||+++.++.++|+|||++......... ......+|+.|+|||.+.+..++.++||||||+++|+|++ 
T Consensus       171 --ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~  248 (314)
T 2ivs_A          171 --LVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTL  248 (314)
T ss_dssp             --EECCCCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred             --CcccccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhC
Confidence              999999999999999999999999999765433211 1233456788999999988889999999999999999999 


Q ss_pred             CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          350 GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       350 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      |+.||...........+.......   .+..+++.+.++|.+||+.||.+|||+.+++++|+++...
T Consensus       249 g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~  312 (314)
T 2ivs_A          249 GGNPYPGIPPERLFNLLKTGHRME---RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKDLEKMMVK  312 (314)
T ss_dssp             SCCSSTTCCGGGHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             CCCCCCCCCHHHHHHHhhcCCcCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhh
Confidence            999999888777766664443333   2456789999999999999999999999999999998654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5e-44  Score=346.34  Aligned_cols=249  Identities=26%  Similarity=0.391  Sum_probs=207.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     +|+.||||++.....  ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         7 ~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~   84 (323)
T 3tki_A            7 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   84 (323)
T ss_dssp             TCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEE
Confidence            4788999999999999984     689999999965432  223456889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC-C
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-D  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~-~  308 (458)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+.|   |+||||||+|||++.++.+||+|||++....... .
T Consensus        85 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~  161 (323)
T 3tki_A           85 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  161 (323)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             EcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccchHHEEEeCCCCEEEEEeeccceeccCCcc
Confidence            99999999999988878999999999999999999999999   9999999999999999999999999997654222 1


Q ss_pred             CCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||................ .........+++.+.+
T Consensus       162 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  240 (323)
T 3tki_A          162 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK-KTYLNPWKKIDSAPLA  240 (323)
T ss_dssp             CCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTT-CTTSTTGGGSCHHHHH
T ss_pred             cccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcc-cccCCccccCCHHHHH
Confidence            22345678999999999987665 678999999999999999999998766654333222222 2222335678899999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ||.+||+.||.+|||+.+++++
T Consensus       241 li~~~L~~dP~~R~t~~eil~h  262 (323)
T 3tki_A          241 LLHKILVENPSARITIPDIKKD  262 (323)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHccCChhhCcCHHHHhhC
Confidence            9999999999999999999987

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=8.1e-43  Score=345.79  Aligned_cols=258  Identities=28%  Similarity=0.519  Sum_probs=221.1

Q ss_pred             CccccCceeeccceEEEEEEc------------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEE
Q 012684          154 ELDFTNSVEITKGTFILAFWR------------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT  220 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~~------------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~  220 (458)
                      ..+|.+.+.||+|+||.||..            +..||||++...  ......+.+.+|+.+++++ +||||+++++++.
T Consensus        68 ~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~  145 (382)
T 3tt0_A           68 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGACT  145 (382)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             hhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhheeeec
Confidence            457889999999999999842            257999999754  3456667889999999999 8999999999999


Q ss_pred             eCCceEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCE
Q 012684          221 QSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI  284 (458)
Q Consensus       221 ~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Ni  284 (458)
                      .++..++||||+++++|.+++....                .+++..++.++.|++.||.|||+.+   |+||||||+||
T Consensus       146 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NI  222 (382)
T 3tt0_A          146 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNV  222 (382)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGE
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCcceE
Confidence            9999999999999999999998753                4899999999999999999999999   99999999999


Q ss_pred             EecCCCCEEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcH
Q 012684          285 LRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEV  362 (458)
Q Consensus       285 l~~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~  362 (458)
                      |++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||......+.
T Consensus       223 ll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~  302 (382)
T 3tt0_A          223 LVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEEL  302 (382)
T ss_dssp             EECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHH
T ss_pred             EEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999986643322 22234456889999999999899999999999999999999 9999998776666


Q ss_pred             HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012684          363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH  419 (458)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  419 (458)
                      ...+........   +..+++.+.+||..||+.||.+|||+.+++++|+++......
T Consensus       303 ~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~~~~  356 (382)
T 3tt0_A          303 FKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVALTSN  356 (382)
T ss_dssp             HHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHSCS
T ss_pred             HHHHHcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHhc
Confidence            665544444333   345788999999999999999999999999999999766543

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.8e-43  Score=348.41  Aligned_cols=261  Identities=30%  Similarity=0.514  Sum_probs=218.4

Q ss_pred             CCcccCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE
Q 012684          146 PEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT  220 (458)
Q Consensus       146 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~  220 (458)
                      ..|+++.  .+|++.+.||+|+||.||.     +|+.||||.+...  ......+.+.+|+.+++.++||||+++++++.
T Consensus       107 ~~~~~~~--~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~  182 (377)
T 3cbl_A          107 DKWVLNH--EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCT  182 (377)
T ss_dssp             CTTBCCG--GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEEC
T ss_pred             cccEEch--HHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEe
Confidence            3454443  4678889999999999873     5889999999754  24455567889999999999999999999999


Q ss_pred             eCCceEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCC
Q 012684          221 QSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (458)
Q Consensus       221 ~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~  299 (458)
                      .+...++||||+++|+|.+++...+ .+++..+..++.|++.||+|||+++   ++||||||+|||++.++.+||+|||+
T Consensus       183 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nil~~~~~~~kl~DfG~  259 (377)
T 3cbl_A          183 QKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKC---CIHRDLAARNCLVTEKNVLKISDFGM  259 (377)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGG
T ss_pred             cCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCcccCHHHEEEcCCCcEEECcCCC
Confidence            9999999999999999999998654 5999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCCc-ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCC
Q 012684          300 SKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP  377 (458)
Q Consensus       300 ~~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  377 (458)
                      +........... ....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+....+....+.+.   
T Consensus       260 s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---  336 (377)
T 3cbl_A          260 SREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC---  336 (377)
T ss_dssp             CEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC---
T ss_pred             ceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence            876432211111 11224678999999988889999999999999999998 9999998777666666544444443   


Q ss_pred             hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       378 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      +..+++.+.++|..||+.||.+|||+.++++.|+++...
T Consensus       337 ~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i~~~  375 (377)
T 3cbl_A          337 PELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR  375 (377)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHhh
Confidence            345778999999999999999999999999999998643

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=3.4e-44  Score=348.82  Aligned_cols=246  Identities=27%  Similarity=0.435  Sum_probs=207.4

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|.+.+.||+|+||.|+.     +|+.||+|++.............+.+|+.+++.++||||+++++++......++||
T Consensus         9 ~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~   88 (336)
T 3h4j_B            9 GPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVI   88 (336)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEE
Confidence            3688999999999999873     68899999986432211122346889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||+ +|+|.+++...+.+++..+..++.|++.||.|||+.|   |+||||||+||+++.++.+||+|||++......  .
T Consensus        89 E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~--~  162 (336)
T 3h4j_B           89 EYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHK---IVHRDLKPENLLLDDNLNVKIADFGLSNIMTDG--N  162 (336)
T ss_dssp             CCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---CCCCCCSTTTEEECTTCCEEECCSSCTBTTTTS--B
T ss_pred             ECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCchhhEEEcCCCCEEEEEeccceeccCC--c
Confidence            999 7899999988888999999999999999999999999   999999999999999999999999999865433  2


Q ss_pred             CcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      ......||+.|+|||++.+..+ ++++||||||+++|+|++|+.||...........+    .......+..+++.+.+|
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i----~~~~~~~p~~~s~~~~~l  238 (336)
T 3h4j_B          163 FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKV----NSCVYVMPDFLSPGAQSL  238 (336)
T ss_dssp             TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCC----CSSCCCCCTTSCHHHHHH
T ss_pred             ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHH----HcCCCCCcccCCHHHHHH
Confidence            2344568999999999988776 68999999999999999999999876554432222    111122345678999999


Q ss_pred             HHHHcccCCCCCCCHHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      |.+||+.||.+|||+.+++++-
T Consensus       239 i~~~L~~dP~~Rpt~~eil~hp  260 (336)
T 3h4j_B          239 IRRMIVADPMQRITIQEIRRDP  260 (336)
T ss_dssp             HHTTSCSSGGGSCCHHHHTTCH
T ss_pred             HHHHcCCChhHCcCHHHHHhCh
Confidence            9999999999999999999874

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=1.1e-43  Score=347.34  Aligned_cols=244  Identities=24%  Similarity=0.403  Sum_probs=211.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.|+.     +|+.||+|++...........+.+.+|+.+++.++||||+++++++.++...|+||
T Consensus        41 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  120 (350)
T 1rdq_E           41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM  120 (350)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEE
Confidence            4788899999999998884     58999999996532222223456888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||++|++|.+++.+.+.+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||++......   
T Consensus       121 e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~---  194 (350)
T 1rdq_E          121 EYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR---  194 (350)
T ss_dssp             ECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC---
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCccceEEECCCCCEEEcccccceeccCC---
Confidence            99999999999998888999999999999999999999999   999999999999999999999999999865422   


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                       .....||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+... ...+   +..+++.+.++|
T Consensus       195 -~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~~~~~~~li  269 (350)
T 1rdq_E          195 -TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-KVRF---PSHFSSDLKDLL  269 (350)
T ss_dssp             -BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCC---CTTCCHHHHHHH
T ss_pred             -cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcC-CCCC---CCCCCHHHHHHH
Confidence             23456899999999999989999999999999999999999999987766665555433 3332   346789999999


Q ss_pred             HHHcccCCCCCCC-----HHHHHHH
Q 012684          390 EECWNEKPAKRPT-----FRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps-----~~~ll~~  409 (458)
                      .+||+.||.+||+     +.++++|
T Consensus       270 ~~lL~~dp~~R~~~~~~~~~ei~~h  294 (350)
T 1rdq_E          270 RNLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHHhhcCHHhccCCccCCHHHHHhC
Confidence            9999999999998     8888876

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=4.6e-44  Score=349.13  Aligned_cols=251  Identities=28%  Similarity=0.441  Sum_probs=211.0

Q ss_pred             CcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCc
Q 012684          151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       151 ~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~  224 (458)
                      .....+|++.+.||+|+||.|+.     +|+.||+|++...........+.+..|..++..+ +||||+++++++.+...
T Consensus        13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~   92 (345)
T 1xjd_A           13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN   92 (345)
T ss_dssp             ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred             CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence            34445788999999999999884     5899999999753221122345577888888876 89999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      .|+||||++||+|.+++...+.+++..+..++.|++.||+|||++|   |+||||||+|||++.+|.+||+|||++....
T Consensus        93 ~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~  169 (345)
T 1xjd_A           93 LFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENM  169 (345)
T ss_dssp             EEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCC
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCChhhEEECCCCCEEEeEChhhhhcc
Confidence            9999999999999999998888999999999999999999999999   9999999999999999999999999997543


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      .. ........||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+.. ..+.+   +..++++
T Consensus       170 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~-~~~~~---p~~~s~~  244 (345)
T 1xjd_A          170 LG-DAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRM-DNPFY---PRWLEKE  244 (345)
T ss_dssp             CT-TCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCC---CTTSCHH
T ss_pred             cC-CCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHh-CCCCC---CcccCHH
Confidence            22 2233456789999999999998999999999999999999999999998776666555533 33333   3457899


Q ss_pred             HHHHHHHHcccCCCCCCCHH-HHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFR-QIITR  409 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~-~ll~~  409 (458)
                      +.++|.+||+.||.+||++. ++++|
T Consensus       245 ~~~li~~lL~~dp~~R~~~~~~i~~h  270 (345)
T 1xjd_A          245 AKDLLVKLFVREPEKRLGVRGDIRQH  270 (345)
T ss_dssp             HHHHHHHHSCSSGGGSBTTBSCGGGS
T ss_pred             HHHHHHHHhcCCHhHcCCChHHHHcC
Confidence            99999999999999999997 77654

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=9.3e-43  Score=330.90  Aligned_cols=250  Identities=23%  Similarity=0.368  Sum_probs=217.0

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|++.+.||+|+||.||.     +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++..+...++|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v   83 (284)
T 3kk8_A            5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV   83 (284)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEE
Confidence            34788999999999999984     588999999976543 445567788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC---EEEeecCCcccccc
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTV  305 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~---vkl~Dfg~~~~~~~  305 (458)
                      |||+++++|.+.+...+.+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.   ++|+|||++.....
T Consensus        84 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  160 (284)
T 3kk8_A           84 FDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNG---IVHRNLKPENLLLASKAKGAAVKLADFGLAIEVND  160 (284)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSTTCCEEECCCTTCEECCS
T ss_pred             EecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cCcCCCCHHHEEEecCCCCCcEEEeeceeeEEccc
Confidence            999999999999988888999999999999999999999999   999999999999986655   99999999976543


Q ss_pred             CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHH
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL  385 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (458)
                      .  .......+|+.|+|||++.+..++.++||||||+++|+|++|+.||...........+..............+++.+
T Consensus       161 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T 3kk8_A          161 S--EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEA  238 (284)
T ss_dssp             S--CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHH
T ss_pred             C--ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHH
Confidence            2  23344568999999999999899999999999999999999999998877666666664444333333445788999


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .++|..||+.||.+|||+.+++++
T Consensus       239 ~~li~~~l~~dp~~Rps~~~~l~h  262 (284)
T 3kk8_A          239 KSLIDSMLTVNPKKRITADQALKV  262 (284)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHHHHHHcccChhhCCCHHHHhcC
Confidence            999999999999999999999987

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=3.6e-43  Score=338.21  Aligned_cols=259  Identities=20%  Similarity=0.272  Sum_probs=208.9

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     +|+.||+|++...........+.+.+|+.+++.++||||+++++++..++..++||
T Consensus        34 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  113 (309)
T 2h34_A           34 GPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDM  113 (309)
T ss_dssp             CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             ccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEE
Confidence            4789999999999998874     58899999998665555666778999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.........
T Consensus       114 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~  190 (309)
T 2h34_A          114 RLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAG---ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT  190 (309)
T ss_dssp             ECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSCCC----------
T ss_pred             EecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCc---CCcCCCChHHEEEcCCCCEEEecCccCccccccccc
Confidence            99999999999998888999999999999999999999999   999999999999999999999999998776544333


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+ ....+.....+..+++.+.++|
T Consensus       191 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~l~~li  269 (309)
T 2h34_A          191 QLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHI-NQAIPRPSTVRPGIPVAFDAVI  269 (309)
T ss_dssp             ------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHH-HSCCCCGGGTSTTCCTHHHHHH
T ss_pred             cccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHh-ccCCCCccccCCCCCHHHHHHH
Confidence            334556899999999999988999999999999999999999999876544332222 2223322234456788999999


Q ss_pred             HHHcccCCCCCC-CHHHHHHHHHHHHhhh
Q 012684          390 EECWNEKPAKRP-TFRQIITRLESINNSI  417 (458)
Q Consensus       390 ~~~l~~dp~~Rp-s~~~ll~~L~~~~~~~  417 (458)
                      .+||+.||.+|| ++.++++.|++.....
T Consensus       270 ~~~l~~dP~~Rp~s~~~l~~~l~~~l~~~  298 (309)
T 2h34_A          270 ARGMAKNPEDRYVTCGDLSAAAHAALATA  298 (309)
T ss_dssp             HHHTCSSGGGSCSSHHHHHHHHHHTCC--
T ss_pred             HHhccCCHHHHHHhHHHHHHHHHHHHHhh
Confidence            999999999999 9999999998875443

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.7e-43  Score=349.50  Aligned_cols=247  Identities=23%  Similarity=0.424  Sum_probs=208.2

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.|+.     +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+....|+||
T Consensus        15 ~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~   94 (384)
T 4fr4_A           15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVV   94 (384)
T ss_dssp             GGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             HHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            4688999999999998874     57899999986543222233467888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||+.||+|.+++...+.+++..+..++.|++.||.|||+.|   |+||||||+|||++.+|.++|+|||++.....  ..
T Consensus        95 e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~--~~  169 (384)
T 4fr4_A           95 DLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQR---IIHRDMKPDNILLDEHGHVHITDFNIAAMLPR--ET  169 (384)
T ss_dssp             CCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT--TC
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEECCCCCEEEeccceeeeccC--CC
Confidence            99999999999998888999999999999999999999999   99999999999999999999999999987543  23


Q ss_pred             CcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh--cCCCCCCCChhhhHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA--RQRPPFKAPAKLYARG  384 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~  384 (458)
                      ......||+.|+|||++.+   ..++.++|||||||++|+|++|+.||..............  .....   .+..+++.
T Consensus       170 ~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~---~p~~~s~~  246 (384)
T 4fr4_A          170 QITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVT---YPSAWSQE  246 (384)
T ss_dssp             CBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCC---CCTTSCHH
T ss_pred             ceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccC---CCCcCCHH
Confidence            3455679999999999864   3588999999999999999999999987665544333322  22222   24567899


Q ss_pred             HHHHHHHHcccCCCCCCC-HHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPT-FRQIITR  409 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps-~~~ll~~  409 (458)
                      +.+||.+||+.||.+||+ +.+++++
T Consensus       247 ~~~li~~lL~~dP~~R~s~~~~l~~h  272 (384)
T 4fr4_A          247 MVSLLKKLLEPNPDQRFSQLSDVQNF  272 (384)
T ss_dssp             HHHHHHHHSCSSGGGSCCSHHHHHTS
T ss_pred             HHHHHHHHhcCCHhHhcccHHHHHcC
Confidence            999999999999999999 6766654

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.8e-43  Score=346.02  Aligned_cols=247  Identities=27%  Similarity=0.408  Sum_probs=210.7

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      .+|++.+.||+|+||.|+.     +|+.||+|++...........+.+..|..++..+ +||+|+++++++......|+|
T Consensus        20 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv   99 (353)
T 2i0e_A           20 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV   99 (353)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEE
T ss_pred             HHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEE
Confidence            4688899999999999884     4788999999754221222345678899999988 799999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |||++||+|.+++...+.+++..+..++.|++.||.|||+.|   |+||||||+|||++.+|.+||+|||++...... .
T Consensus       100 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-~  175 (353)
T 2i0e_A          100 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-G  175 (353)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-T
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeccCCHHHEEEcCCCcEEEEeCCcccccccC-C
Confidence            999999999999998888999999999999999999999999   999999999999999999999999999754322 2


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      .......||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+... ...+   +..+++++.+|
T Consensus       176 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~s~~~~~l  251 (353)
T 2i0e_A          176 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-NVAY---PKSMSKEAVAI  251 (353)
T ss_dssp             CCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCC---CTTSCHHHHHH
T ss_pred             cccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-CCCC---CCCCCHHHHHH
Confidence            2334567899999999999999999999999999999999999999987766666655433 2332   34678999999


Q ss_pred             HHHHcccCCCCCCC-----HHHHHHH
Q 012684          389 IEECWNEKPAKRPT-----FRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rps-----~~~ll~~  409 (458)
                      |.+||+.||.+||+     +.++++|
T Consensus       252 i~~lL~~dP~~R~~~~~~~~~~i~~h  277 (353)
T 2i0e_A          252 CKGLMTKHPGKRLGCGPEGERDIKEH  277 (353)
T ss_dssp             HHHHTCSCTTSCTTCSTTHHHHHHTS
T ss_pred             HHHHhhcCHHHcCCCCCCCHHHHhcC
Confidence            99999999999995     5777776

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=5e-43  Score=334.19  Aligned_cols=262  Identities=26%  Similarity=0.401  Sum_probs=216.7

Q ss_pred             ccCcCCccccCce-eeccceEEEEEE-------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE
Q 012684          149 EIDPHELDFTNSV-EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT  220 (458)
Q Consensus       149 ~~~~~~~~~~~~~-~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~  220 (458)
                      ++.....+|.+.+ .||+|+||.||.       .+..||||++..... .....+.+.+|+.+++.++||||+++++++ 
T Consensus        10 ~~~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~-   87 (291)
T 1xbb_A           10 EVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGIC-   87 (291)
T ss_dssp             -CBCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEE-
T ss_pred             eeeecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEE-
Confidence            3344455788877 999999999874       268899999976532 334567789999999999999999999999 


Q ss_pred             eCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCc
Q 012684          221 QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (458)
Q Consensus       221 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~  300 (458)
                      .....++||||+++++|.+++...+.+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++
T Consensus        88 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~  164 (291)
T 1xbb_A           88 EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLS  164 (291)
T ss_dssp             ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTC
T ss_pred             CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCC---eEcCCCCcceEEEeCCCcEEEccCCcc
Confidence            56778999999999999999998888999999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCC
Q 012684          301 KLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAP  377 (458)
Q Consensus       301 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~  377 (458)
                      .........  ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.....+..   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---  241 (291)
T 1xbb_A          165 KALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---  241 (291)
T ss_dssp             EECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---
T ss_pred             eeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC---
Confidence            866433221  1123346788999999988888999999999999999999 9999998776665555544333333   


Q ss_pred             hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       378 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      +..+++.+.++|..||+.||.+|||+.++++.|+++.....
T Consensus       242 ~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~  282 (291)
T 1xbb_A          242 PAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDVV  282 (291)
T ss_dssp             CTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHHHH
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHHh
Confidence            45678999999999999999999999999999999987654

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=4.6e-43  Score=339.47  Aligned_cols=265  Identities=24%  Similarity=0.385  Sum_probs=210.3

Q ss_pred             CCCCcccCcCCccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE
Q 012684          144 EVPEYEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT  220 (458)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~  220 (458)
                      ..+.-++.....+|++.+.||+|+||.||   +.++.||||++...    .........|+.++++++||||+++++++.
T Consensus        13 ~~~~~n~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~hpniv~~~~~~~   88 (322)
T 3soc_A           13 DLGTENLYFQSMPLQLLEVKARGRFGCVWKAQLLNEYVAVKIFPIQ----DKQSWQNEYEVYSLPGMKHENILQFIGAEK   88 (322)
T ss_dssp             -CCCCCEEETTEEEEEEEEEECSTTCEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEE
T ss_pred             ccCccccccchhhchhhheecccCceEEEEEEECCCEEEEEEeecC----chHHHHHHHHHHHHhcCCCCCchhhcceec
Confidence            33444555666789999999999999887   57999999999643    233345667999999999999999999998


Q ss_pred             eCCc----eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC----------CCCCeeeCCCCCCCEEe
Q 012684          221 QSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN----------KPVPIIHRDLEPSNILR  286 (458)
Q Consensus       221 ~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~----------~~~~i~H~Dikp~Nil~  286 (458)
                      ....    +++||||+++|+|.+++... .+++..++.++.|++.||.|||+.          +   |+||||||+|||+
T Consensus        89 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~---ivH~Dlkp~Nill  164 (322)
T 3soc_A           89 RGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA---ISHRDIKSKNVLL  164 (322)
T ss_dssp             EECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE---EECSCCSGGGEEE
T ss_pred             cCCCCCceEEEEEecCCCCCHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC---EEeCCCChHhEEE
Confidence            7543    69999999999999999764 599999999999999999999999          8   9999999999999


Q ss_pred             cCCCCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCC-----CCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 012684          287 DDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNE-----EYDTKVDVFSFALILQEMIEGCPPFTMKHDN  360 (458)
Q Consensus       287 ~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwslG~~l~~lltg~~pf~~~~~~  360 (458)
                      +.++.+||+|||++......... ......||+.|+|||++.+.     .++.++||||||+++|+|++|+.||......
T Consensus       165 ~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~  244 (322)
T 3soc_A          165 KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDE  244 (322)
T ss_dssp             CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCC
T ss_pred             CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcch
Confidence            99999999999999766543222 22345689999999998863     4556889999999999999999999865432


Q ss_pred             c----------------HHHHHHhcC-CCCCCCC--hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          361 E----------------VPKAYAARQ-RPPFKAP--AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       361 ~----------------~~~~~~~~~-~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      .                ......... .+..+..  ....++.+.+||.+||+.||.+|||+.++++.|+++.+.
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~l~~~  319 (322)
T 3soc_A          245 YMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGERITQMQRL  319 (322)
T ss_dssp             CCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             hccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHH
Confidence            1                111111111 2222211  123456799999999999999999999999999998654

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=4.4e-43  Score=342.30  Aligned_cols=259  Identities=29%  Similarity=0.452  Sum_probs=217.7

Q ss_pred             CcCCccccCceeeccceEEEEEE---c-------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE
Q 012684          151 DPHELDFTNSVEITKGTFILAFW---R-------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT  220 (458)
Q Consensus       151 ~~~~~~~~~~~~lg~G~~~~v~~---~-------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~  220 (458)
                      .....+|++.+.||+|+||.||.   .       +..||||++....  .....+.+.+|+.+++.++||||+++++++.
T Consensus        43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~  120 (343)
T 1luf_A           43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCA  120 (343)
T ss_dssp             BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC
T ss_pred             EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEc
Confidence            44456788999999999998873   2       2789999997542  4556678999999999999999999999999


Q ss_pred             eCCceEEEEEccCCCCHHHHHHhc------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 012684          221 QSSPMMIVTEYLPKGDLRAFLKRK------------------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH  276 (458)
Q Consensus       221 ~~~~~~lv~e~~~~~~L~~~l~~~------------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H  276 (458)
                      .+...++||||+++++|.+++...                        ..+++.+++.++.|++.||.|||+++   |+|
T Consensus       121 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~---ivH  197 (343)
T 1luf_A          121 VGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVH  197 (343)
T ss_dssp             SSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eec
Confidence            999999999999999999999863                        56899999999999999999999999   999


Q ss_pred             CCCCCCCEEecCCCCEEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCC
Q 012684          277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPF  354 (458)
Q Consensus       277 ~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf  354 (458)
                      |||||+||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||
T Consensus       198 ~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~  277 (343)
T 1luf_A          198 RDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPY  277 (343)
T ss_dssp             SCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTT
T ss_pred             CCCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcC
Confidence            99999999999999999999999976543221 12234457889999999988889999999999999999999 99999


Q ss_pred             CCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       355 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      ......+....+.....+.   .+..+++.+.++|..||+.||.+|||+.++++.|+++....
T Consensus       278 ~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~L~~~~~~~  337 (343)
T 1luf_A          278 YGMAHEEVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCERA  337 (343)
T ss_dssp             TTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC--
T ss_pred             CCCChHHHHHHHhCCCcCC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHHHHHhhh
Confidence            9877666655554433333   24567889999999999999999999999999999986543

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=1.9e-42  Score=350.37  Aligned_cols=247  Identities=30%  Similarity=0.550  Sum_probs=213.3

Q ss_pred             ccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-ceEEEEE
Q 012684          155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-PMMIVTE  230 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-~~~lv~e  230 (458)
                      .+|++.+.||+|+||.|+   +.|+.||||+++...     ..+.+.+|+.++++++||||+++++++.... ..++|||
T Consensus       193 ~~~~~~~~lG~G~fg~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          193 KELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTEEEEEEEESSCT-----TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEE
T ss_pred             HHeEEEeeecCcCCeeEEEEEecCCeEEEEEeCCch-----HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEE
Confidence            367788999999999887   589999999997542     2356889999999999999999999987665 7999999


Q ss_pred             ccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+++|+|.+++...+.  +++..++.++.|++.||+|||+++   ++||||||+|||++.++.+||+|||++......  
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--  342 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--  342 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTSCEEECCCTTCEECC----
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEECCCCCEEEeeCCCccccccc--
Confidence            9999999999987654  789999999999999999999999   999999999999999999999999999754322  


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                        .....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+....+.+.   +..+++.+.+
T Consensus       343 --~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~  417 (450)
T 1k9a_A          343 --QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---PDGCPPAVYD  417 (450)
T ss_dssp             ------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCCC---CTTCCHHHHH
T ss_pred             --ccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCHHHHH
Confidence              122356889999999999899999999999999999998 9999999888887777655444443   4567899999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          388 LIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      +|..||+.||.+|||+.++++.|+.+...
T Consensus       418 li~~cl~~dp~~Rpt~~~l~~~L~~i~~~  446 (450)
T 1k9a_A          418 VMKNCWHLDAATRPTFLQLREQLEHIRTH  446 (450)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHHHHHh
Confidence            99999999999999999999999998654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=4.2e-44  Score=359.51  Aligned_cols=255  Identities=21%  Similarity=0.310  Sum_probs=213.8

Q ss_pred             cCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      ....+|++.+.||+|+||.|+.     +|+.||+|++.............+.+|..++..++||||++++++|.++..+|
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  150 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLY  150 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEE
Confidence            3345788899999999999984     57899999996422111111233788999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          227 IVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      +||||++||+|.+++.+ .+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       151 lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILl~~~g~vkL~DFGla~~~~~  227 (437)
T 4aw2_A          151 LVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLME  227 (437)
T ss_dssp             EEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeeEcCCCCEEEcchhhhhhccc
Confidence            99999999999999987 567999999999999999999999999   99999999999999999999999999976644


Q ss_pred             CCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChh
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAK  379 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~  379 (458)
                      ..........||+.|+|||++.     ...++.++|||||||++|+|++|+.||...+..+....+.... ...++....
T Consensus       228 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~  307 (437)
T 4aw2_A          228 DGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVT  307 (437)
T ss_dssp             TSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCSSCC
T ss_pred             CCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCcccc
Confidence            3333334467999999999986     4578999999999999999999999999877766666554332 344444445


Q ss_pred             hhHHHHHHHHHHHcccCCCC--CCCHHHHHHH
Q 012684          380 LYARGLKELIEECWNEKPAK--RPTFRQIITR  409 (458)
Q Consensus       380 ~~~~~l~~li~~~l~~dp~~--Rps~~~ll~~  409 (458)
                      .+++.+++||.+||..+|++  ||+++++++|
T Consensus       308 ~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~H  339 (437)
T 4aw2_A          308 DVSENAKDLIRRLICSREHRLGQNGIEDFKKH  339 (437)
T ss_dssp             CSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTS
T ss_pred             cCCHHHHHHHHHHhcccccccCCCCHHHHhCC
Confidence            68899999999999998888  9999999987

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.3e-42  Score=337.96  Aligned_cols=265  Identities=28%  Similarity=0.533  Sum_probs=221.2

Q ss_pred             CCCCcccCcCCccccCceeeccceEEEEEE------------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCC
Q 012684          144 EVPEYEIDPHELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHP  210 (458)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  210 (458)
                      +.+.|++.  ..+|++.+.||+|+||.||.            ++..||+|++...  ......+.+.+|+.+++++ +||
T Consensus        26 ~~~~~~~~--~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp  101 (334)
T 2pvf_A           26 EDPKWEFP--RDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHK  101 (334)
T ss_dssp             CCTTTBCC--GGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT--CCHHHHHHHHHHHHHHHHHCCCT
T ss_pred             CCccccCC--HhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC--CcHHHHHHHHHHHHHHHHhhcCC
Confidence            33455443  45788999999999998873            3568999999754  2455667889999999999 899


Q ss_pred             cceeeeeEEEeCCceEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012684          211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPI  274 (458)
Q Consensus       211 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i  274 (458)
                      ||+++++++...+..++||||+++++|.+++....                .+++..++.++.|++.||.|||+.+   +
T Consensus       102 ~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i  178 (334)
T 2pvf_A          102 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQK---C  178 (334)
T ss_dssp             TBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTT---E
T ss_pred             CEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---e
Confidence            99999999999999999999999999999998643                3889999999999999999999999   9


Q ss_pred             eeCCCCCCCEEecCCCCEEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCC
Q 012684          275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP  352 (458)
Q Consensus       275 ~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~  352 (458)
                      +||||||+||+++.++.+||+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |..
T Consensus       179 vH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~  258 (334)
T 2pvf_A          179 IHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS  258 (334)
T ss_dssp             ECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCC
T ss_pred             eCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999986543321 11233456788999999988889999999999999999999 999


Q ss_pred             CCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       353 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      ||......+....+........   +..+++.+.++|..||+.||.+|||+.+++++|+++.....
T Consensus       259 p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~l~~~~~  321 (334)
T 2pvf_A          259 PYPGIPVEELFKLLKEGHRMDK---PANCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILTLTT  321 (334)
T ss_dssp             SSTTCCHHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHC
T ss_pred             CcCcCCHHHHHHHHhcCCCCCC---CccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccc
Confidence            9988776666555544433332   45678899999999999999999999999999999976544

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=9.7e-43  Score=336.99  Aligned_cols=268  Identities=25%  Similarity=0.401  Sum_probs=218.8

Q ss_pred             CCCCCcccCcCCccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeE
Q 012684          143 REVPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA  218 (458)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~  218 (458)
                      ...+..++.....+|+..+.||+|+||.||.    +|..||||.+....   ....+.+.+|+.+++.++||||++++++
T Consensus        27 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~  103 (321)
T 2qkw_B           27 YRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPES---SQGIEEFETEIETLSFCRHPHLVSLIGF  103 (321)
T ss_dssp             ---CCSCCCCCCCCCSCCCCSCBCSSSEEEEEECTTCCEEEEEECCSCC---SSHHHHHHHHHHGGGSCCCTTBCCEEEE
T ss_pred             eeecHHHHHHHHhccCccceeecCCCeeEEEEEECCCCEEEEEEecccC---hHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            3445666667778999999999999999885    58999999987542   2345678999999999999999999999


Q ss_pred             EEeCCceEEEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEE
Q 012684          219 VTQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV  294 (458)
Q Consensus       219 ~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl  294 (458)
                      +...+..++||||+++++|.+++....    .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||
T Consensus       104 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl  180 (321)
T 2qkw_B          104 CDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKI  180 (321)
T ss_dssp             CCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCSTTEEECTTCCEEE
T ss_pred             EcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCC---eecCCCCHHHEEECCCCCEEE
Confidence            999999999999999999999986543    4899999999999999999999999   999999999999999999999


Q ss_pred             eecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH------H
Q 012684          295 ADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY------A  367 (458)
Q Consensus       295 ~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~------~  367 (458)
                      +|||++......... ......||+.|+|||++.+..++.++||||||+++|+|++|+.||....+.+.....      .
T Consensus       181 ~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~  260 (321)
T 2qkw_B          181 TDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESH  260 (321)
T ss_dssp             CCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHH
T ss_pred             eecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhcc
Confidence            999999765432222 223345789999999998888999999999999999999999999876554321111      0


Q ss_pred             hcC------CC-CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          368 ARQ------RP-PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       368 ~~~------~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ...      .+ ........++..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~l~~  316 (321)
T 2qkw_B          261 NNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKLEYALRL  316 (321)
T ss_dssp             TTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             ccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHhhc
Confidence            011      01 11123456788999999999999999999999999999988643

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-43  Score=346.78  Aligned_cols=254  Identities=30%  Similarity=0.485  Sum_probs=215.1

Q ss_pred             ccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      .+|++.+.||+|+||.||.          ++..||||++...  ........+.+|+.+++.++||||+++++++.....
T Consensus        71 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~  148 (367)
T 3l9p_A           71 KNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLP  148 (367)
T ss_dssp             GGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             hHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCC
Confidence            4688899999999998873          3568999999743  345556678899999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC---CEEE
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKV  294 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~---~vkl  294 (458)
                      .++||||+++|+|.+++...+       .+++.+++.++.|++.||.|||+++   |+||||||+|||++.++   .+||
T Consensus       149 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kL  225 (367)
T 3l9p_A          149 RFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAKI  225 (367)
T ss_dssp             CEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEE
T ss_pred             CEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEEecCCCCceEEE
Confidence            999999999999999998643       4889999999999999999999999   99999999999999555   5999


Q ss_pred             eecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCC
Q 012684          295 ADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRP  372 (458)
Q Consensus       295 ~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~  372 (458)
                      +|||++........ .......+|+.|+|||++.+..++.++|||||||++|+|++ |..||......+....+......
T Consensus       226 ~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~  305 (367)
T 3l9p_A          226 GDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRM  305 (367)
T ss_dssp             CCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCC
T ss_pred             CCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC
Confidence            99999975533221 22234457889999999988889999999999999999998 99999987776666666444433


Q ss_pred             CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       373 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ..   +..+++.+.+||..||+.||.+|||+.+++++|+.+...
T Consensus       306 ~~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~~~  346 (367)
T 3l9p_A          306 DP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  346 (367)
T ss_dssp             CC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CC---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhhC
Confidence            33   456788999999999999999999999999999988654

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2.6e-43  Score=345.27  Aligned_cols=250  Identities=24%  Similarity=0.351  Sum_probs=205.2

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCC--CCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      .+|++.+.||+|+||.||.     +|+.||||++.....  ......+.+.+|+.+++.++||||+++++++..++..|+
T Consensus        24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l  103 (351)
T 3c0i_A           24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYM  103 (351)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred             cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEE
Confidence            3688999999999999984     589999999863211  111124568899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC---EEEeecCCc
Q 012684          228 VTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVS  300 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~---vkl~Dfg~~  300 (458)
                      ||||++|++|.+++...    ..+++..+..++.|++.||.|||+++   |+||||||+|||++.++.   +||+|||++
T Consensus       104 v~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a  180 (351)
T 3c0i_A          104 VFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNN---IIHRDVKPHCVLLASKENSAPVKLGGFGVA  180 (351)
T ss_dssp             EEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECSSSTTCCEEECCCTTC
T ss_pred             EEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChHHeEEecCCCCCcEEEecCcce
Confidence            99999999998887642    34899999999999999999999999   999999999999987654   999999999


Q ss_pred             cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhh
Q 012684          301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL  380 (458)
Q Consensus       301 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (458)
                      ...... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.... ......+........+..+..
T Consensus       181 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~~~~~~~~  258 (351)
T 3c0i_A          181 IQLGES-GLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH  258 (351)
T ss_dssp             EECCTT-SCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCCCHHHHTT
T ss_pred             eEecCC-CeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCCCcccccc
Confidence            876432 222344578999999999999899999999999999999999999998743 223333322222222222356


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          381 YARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +++.+.+||.+||+.||.+|||+.+++++
T Consensus       259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~h  287 (351)
T 3c0i_A          259 ISESAKDLVRRMLMLDPAERITVYEALNH  287 (351)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcC
Confidence            78999999999999999999999999986

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.9e-43  Score=343.66  Aligned_cols=257  Identities=27%  Similarity=0.469  Sum_probs=214.7

Q ss_pred             cCCccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEE
Q 012684          152 PHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT  220 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~  220 (458)
                      ....+|++.+.||+|+||.||.          +++.||||++...  ......+.+.+|+.+++++ +||||+++++++.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~   96 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGACT   96 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeeee
Confidence            3456789999999999999884          2378999999754  3455567789999999999 7999999999998


Q ss_pred             eCC-ceEEEEEccCCCCHHHHHHhcCC-----------------------------------------------------
Q 012684          221 QSS-PMMIVTEYLPKGDLRAFLKRKGA-----------------------------------------------------  246 (458)
Q Consensus       221 ~~~-~~~lv~e~~~~~~L~~~l~~~~~-----------------------------------------------------  246 (458)
                      ..+ ..++||||+++|+|.+++.....                                                     
T Consensus        97 ~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  176 (359)
T 3vhe_A           97 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDV  176 (359)
T ss_dssp             STTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-----------------------------------------------
T ss_pred             cCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchh
Confidence            754 48999999999999999986533                                                     


Q ss_pred             -------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC-Ccc
Q 012684          247 -------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLT  312 (458)
Q Consensus       247 -------------~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~-~~~  312 (458)
                                   +++..++.++.|++.||.|||+.+   |+||||||+|||++.++.++|+|||++......... ...
T Consensus       177 ~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~  253 (359)
T 3vhe_A          177 EEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG  253 (359)
T ss_dssp             -------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC-
T ss_pred             hhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcc
Confidence                         889999999999999999999999   999999999999999999999999999865433221 223


Q ss_pred             cCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHHHHHHHHH
Q 012684          313 CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       313 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~  390 (458)
                      ...+|+.|+|||++.+..++.++||||||+++|+|++ |..||................ ...   .+..+++++.++|.
T Consensus       254 ~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~  330 (359)
T 3vhe_A          254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR---APDYTTPEMYQTML  330 (359)
T ss_dssp             -CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCC---CCTTCCHHHHHHHH
T ss_pred             ccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCC---CCCCCCHHHHHHHH
Confidence            4457889999999988889999999999999999998 999999877665544443333 222   23557889999999


Q ss_pred             HHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          391 ECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      .||+.||.+|||+.+++++|+++.+.
T Consensus       331 ~~l~~dP~~Rps~~ell~~L~~~~~~  356 (359)
T 3vhe_A          331 DCWHGEPSQRPTFSELVEHLGNLLQA  356 (359)
T ss_dssp             HHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHccCChhhCCCHHHHHHHHHHHHHH
Confidence            99999999999999999999998754

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=1.6e-42  Score=334.07  Aligned_cols=250  Identities=26%  Similarity=0.443  Sum_probs=203.8

Q ss_pred             CccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      ..+|++.+.||+|+||.||.    +|+.||+|++..... .....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus        20 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   98 (311)
T 3niz_A           20 MEKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIRLDAE-DEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVF   98 (311)
T ss_dssp             SCEEEEEEEEEECSSCEEEEEEETTSCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEE
T ss_pred             HhhhHhhhhccCCCCeEEEEEEECCCCEEEEEEEecccc-cchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEE
Confidence            34799999999999999874    688999999975432 2333466888999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      ||++ ++|.+++... ..+++..+..++.|++.||.|||+.|   |+||||||+|||++.++.+||+|||++...... .
T Consensus        99 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~  173 (311)
T 3niz_A           99 EFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHR---ILHRDLKPQNLLINSDGALKLADFGLARAFGIP-V  173 (311)
T ss_dssp             ECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEETTSC-C
T ss_pred             cCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCchHhEEECCCCCEEEccCcCceecCCC-c
Confidence            9996 5888888764 45999999999999999999999999   999999999999999999999999999875432 2


Q ss_pred             CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCC-----------
Q 012684          309 RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA-----------  376 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-----------  376 (458)
                      .......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+......+.+.           
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence            23344567999999999876 468999999999999999999999999887776655543322111110           


Q ss_pred             ---------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          377 ---------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       377 ---------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                     ..+.+++++.+||.+||+.||.+|||+.+++++
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  301 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNH  301 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence                           112356789999999999999999999999986

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=2.5e-42  Score=330.18  Aligned_cols=258  Identities=16%  Similarity=0.243  Sum_probs=214.6

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~l  227 (458)
                      ..+|++.+.||+|+||.||.     +|+.||||++.....     .+.+.+|+.+++.+ +|++++++++++......++
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l   83 (298)
T 1csn_A            9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   83 (298)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCc-----cHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence            44789999999999998873     689999999864432     13477899999999 79999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC-----EEEeecCCcc
Q 012684          228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADFGVSK  301 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~-----vkl~Dfg~~~  301 (458)
                      ||||+ +++|.+++...+ .+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.     ++|+|||++.
T Consensus        84 v~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~  159 (298)
T 1csn_A           84 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  159 (298)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEeccCCCCCCCeEEEEECcccc
Confidence            99999 999999998754 5999999999999999999999999   999999999999987776     9999999998


Q ss_pred             ccccCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH---hc-CC
Q 012684          302 LLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA---AR-QR  371 (458)
Q Consensus       302 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~---~~-~~  371 (458)
                      ........      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||.............   .. ..
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~  239 (298)
T 1csn_A          160 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  239 (298)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccC
Confidence            76543221      2345568999999999999899999999999999999999999999866544332221   11 12


Q ss_pred             CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 012684          372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK  420 (458)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  420 (458)
                      .+.+.....+++.+.++|..||+.||.+|||+.++++.|+++...++..
T Consensus       240 ~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~l~~~~~~~~~~  288 (298)
T 1csn_A          240 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT  288 (298)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             ccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHHHHHHHHhcCCC
Confidence            2222223467889999999999999999999999999999998776543

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=7.6e-43  Score=329.22  Aligned_cols=254  Identities=31%  Similarity=0.531  Sum_probs=200.4

Q ss_pred             CccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCC-HHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISD-DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~-~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      -.+|++.+.||+|+||.||   ..|..||||++....... ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVM   85 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEETTEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEcCCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEE
Confidence            3478889999999999887   479999999997543222 233567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC--------CCCEEEeecCCcc
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--------SGNLKVADFGVSK  301 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~--------~~~vkl~Dfg~~~  301 (458)
                      ||+++++|.+++.. +.+++..++.++.|++.||.|||+.+..+++||||||+||+++.        ++.++|+|||++.
T Consensus        86 e~~~~~~L~~~~~~-~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~  164 (271)
T 3dtc_A           86 EFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR  164 (271)
T ss_dssp             ECCTTEEHHHHHTS-SCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--
T ss_pred             EcCCCCCHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccc
Confidence            99999999998864 57999999999999999999999998444889999999999986        6789999999997


Q ss_pred             ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhh
Q 012684          302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY  381 (458)
Q Consensus       302 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (458)
                      ......   .....+|+.|+|||.+.+..++.++||||||+++|+|++|+.||..................  ...+..+
T Consensus       165 ~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~  239 (271)
T 3dtc_A          165 EWHRTT---KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLA--LPIPSTC  239 (271)
T ss_dssp             --------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCC--CCCCTTC
T ss_pred             cccccc---ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCC--CCCCccc
Confidence            654322   22346899999999998888999999999999999999999999886655444444332211  1234567


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      ++.+.++|.+||+.||.+|||+.+++++|+++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~L~~l  271 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSFTNILDQLTTI  271 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHC-
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHHHHHhcC
Confidence            88999999999999999999999999999763

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=3.9e-44  Score=357.08  Aligned_cols=253  Identities=23%  Similarity=0.326  Sum_probs=210.7

Q ss_pred             cCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      ....+|++.+.||+|+||.|+.     +|+.||+|++...........+.+.+|..+++.++||||+++++++.++..+|
T Consensus        66 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           66 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEE
Confidence            3455788999999999999984     58899999986421111111234778999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      +||||++||+|.+++.. ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.+|.+||+|||++......
T Consensus       146 lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~  221 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKE  221 (410)
T ss_dssp             EEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeeECCCCCEEEeccceeEeeccC
Confidence            99999999999999876 46999999999999999999999999   999999999999999999999999999876443


Q ss_pred             CCCCcccCCCCCcccCCcccCCCC----CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhh
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEE----YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLY  381 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~  381 (458)
                      .........||+.|+|||++.+..    ++.++|||||||++|+|++|+.||...+..+....+.... ...++ ....+
T Consensus       222 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~  300 (410)
T 3v8s_A          222 GMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP-DDNDI  300 (410)
T ss_dssp             SEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-TTCCC
T ss_pred             CcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCC-Ccccc
Confidence            222234567999999999997655    7789999999999999999999999877766666654432 22222 23457


Q ss_pred             HHHHHHHHHHHcccCCCC--CCCHHHHHHH
Q 012684          382 ARGLKELIEECWNEKPAK--RPTFRQIITR  409 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~--Rps~~~ll~~  409 (458)
                      ++++++||.+||..+|.+  ||++.++++|
T Consensus       301 s~~~~~li~~lL~~~~~rlgR~~~~ei~~H  330 (410)
T 3v8s_A          301 SKEAKNLICAFLTDREVRLGRNGVEEIKRH  330 (410)
T ss_dssp             CHHHHHHHHHHSSCGGGCTTSSCHHHHHTS
T ss_pred             cHHHHHHHHHHccChhhhCCCCCHHHHhcC
Confidence            899999999999999998  9999999988

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.1e-42  Score=343.42  Aligned_cols=256  Identities=29%  Similarity=0.506  Sum_probs=206.9

Q ss_pred             CCccccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          153 HELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      ...+|++.+.||+|+||.||.        ++..||||.+....  .....+.+.+|+.++++++||||+++++++.....
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~  120 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKP  120 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSS
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCc
Confidence            344789999999999999984        35679999997542  45566789999999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      .++||||+++++|.+++...+ .+++.+++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...
T Consensus       121 ~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  197 (373)
T 2qol_A          121 VMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILINSNLVCKVSDFGLGRVL  197 (373)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC------
T ss_pred             eEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCcceEEEcCCCCEEECcCcccccc
Confidence            999999999999999998754 5999999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCCCCc--ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhh
Q 012684          304 TVKEDRPL--TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL  380 (458)
Q Consensus       304 ~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (458)
                      ........  ....+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+......+.   +..
T Consensus       198 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~  274 (373)
T 2qol_A          198 EDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLPP---PMD  274 (373)
T ss_dssp             ----------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECCC---CTT
T ss_pred             ccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence            43322111  22234678999999998889999999999999999998 9999988776666555543333332   345


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          381 YARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ++..+.++|..||+.||.+||++.++++.|+++...
T Consensus       275 ~~~~l~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~  310 (373)
T 2qol_A          275 CPAALYQLMLDCWQKDRNNRPKFEQIVSILDKLIRN  310 (373)
T ss_dssp             CBHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             ccHHHHHHHHHHhCcChhhCcCHHHHHHHHHHHHhC
Confidence            778999999999999999999999999999998654

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=9.1e-43  Score=338.12  Aligned_cols=248  Identities=23%  Similarity=0.391  Sum_probs=201.7

Q ss_pred             CccccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCC-CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      ..+|++.+.||+|+||.||.        +|+.||+|++...... .......+.+|+.+++.++||||+++++++..++.
T Consensus        16 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~   95 (327)
T 3a62_A           16 PECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGK   95 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSC
T ss_pred             HHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCE
Confidence            34788999999999999873        6889999999765322 22344567889999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      .|+||||++|++|.+++...+.+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||++....
T Consensus        96 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~  172 (327)
T 3a62_A           96 LYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKG---IIYRDLKPENIMLNHQGHVKLTDFGLCKESI  172 (327)
T ss_dssp             EEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCTTTEEECTTSCEEECCCSCC----
T ss_pred             EEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEcccCCHHHeEECCCCcEEEEeCCcccccc
Confidence            9999999999999999998888999999999999999999999999   9999999999999999999999999987543


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      .. ........||+.|+|||++.+..++.++||||||+++|+|++|+.||...+.......+... ...+   +..+++.
T Consensus       173 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~-~~~~---p~~~~~~  247 (327)
T 3a62_A          173 HD-GTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKC-KLNL---PPYLTQE  247 (327)
T ss_dssp             -------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHT-CCCC---CTTSCHH
T ss_pred             cC-CccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC-CCCC---CCCCCHH
Confidence            22 12233456899999999999988999999999999999999999999987665555554332 2222   3457889


Q ss_pred             HHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rp-----s~~~ll~~  409 (458)
                      +.++|.+||+.||.+||     ++.++++|
T Consensus       248 ~~~li~~~L~~dp~~R~~~~~~~~~e~l~h  277 (327)
T 3a62_A          248 ARDLLKKLLKRNAASRLGAGPGDAGEVQAH  277 (327)
T ss_dssp             HHHHHHHHSCSCGGGSTTSSTTTHHHHHHS
T ss_pred             HHHHHHHHHhcCHhhccCCCCCCHHHHHcC
Confidence            99999999999999999     78888886

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=6.2e-42  Score=329.57  Aligned_cols=257  Identities=25%  Similarity=0.471  Sum_probs=204.9

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     +|..||+|++...........+.+.+|+.+++.++||||+++++++..++..++||
T Consensus        32 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  111 (310)
T 2wqm_A           32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL  111 (310)
T ss_dssp             GGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEE
Confidence            3799999999999999884     68999999998655556677788999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       230 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      ||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus       112 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          112 ELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             ECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             ecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999874    456899999999999999999999999   99999999999999999999999999876543


Q ss_pred             CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc--HHHHHHhcCCCCCCCChhhhHH
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE--VPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      .. .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.......  ....+.....+..  ....+++
T Consensus       189 ~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~  265 (310)
T 2wqm_A          189 KT-TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPL--PSDHYSE  265 (310)
T ss_dssp             -----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSCCC--CTTTSCH
T ss_pred             CC-ccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCCCC--cccccCH
Confidence            22 22234467899999999998889999999999999999999999998654432  2222222222222  2356789


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      .+.++|..||+.||.+|||+.++++.|+++....
T Consensus       266 ~l~~li~~~l~~dp~~Rps~~~il~~l~~l~~~~  299 (310)
T 2wqm_A          266 ELRQLVNMCINPDPEKRPDVTYVYDVAKRMHACT  299 (310)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhh
Confidence            9999999999999999999999999999987653

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=5.8e-43  Score=334.33  Aligned_cols=256  Identities=26%  Similarity=0.517  Sum_probs=207.0

Q ss_pred             CCccccCceeeccceEEEEEE---------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--
Q 012684          153 HELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--  221 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--  221 (458)
                      ...+|++.+.||+|+||.|+.         +|+.||||++...   .....+.+.+|+.+++.++||||+++++++..  
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   84 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG   84 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHH
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence            345789999999999999873         5789999999743   45666789999999999999999999999854  


Q ss_pred             CCceEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCc
Q 012684          222 SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (458)
Q Consensus       222 ~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~  300 (458)
                      ....++||||+++++|.+++...+ .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++
T Consensus        85 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~~  161 (295)
T 3ugc_A           85 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT  161 (295)
T ss_dssp             HTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCSC
T ss_pred             CCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHhhEEEcCCCeEEEccCccc
Confidence            356899999999999999998754 4999999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC----------------cH
Q 012684          301 KLLTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN----------------EV  362 (458)
Q Consensus       301 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~----------------~~  362 (458)
                      ........  .......+++.|+|||.+.+..++.++||||||+++|+|++|..||......                ..
T Consensus       162 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (295)
T 3ugc_A          162 KVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  241 (295)
T ss_dssp             C-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             ccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHH
Confidence            87643322  1123345677899999999889999999999999999999999998643211                01


Q ss_pred             HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      ........+.+   .+..+++.+.++|..||+.||.+|||+.++++.|+++...+
T Consensus       242 ~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~~L~~l~~~l  293 (295)
T 3ugc_A          242 IELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDNM  293 (295)
T ss_dssp             HHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHC-
T ss_pred             HHHHhccCcCC---CCcCcCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHHhc
Confidence            11111122222   34567899999999999999999999999999999987654

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.9e-43  Score=343.62  Aligned_cols=271  Identities=28%  Similarity=0.488  Sum_probs=217.4

Q ss_pred             CCCCcccCcCCccccCceeeccceEEEEEE-----c---CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceee
Q 012684          144 EVPEYEIDPHELDFTNSVEITKGTFILAFW-----R---GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF  215 (458)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~-----~---g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~  215 (458)
                      ....+.+......|...+.||+|+||.||.     +   +..||+|.+...  ......+.+.+|+.++++++||||+++
T Consensus        78 ~~~~~~i~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~  155 (373)
T 3c1x_A           78 AVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSL  155 (373)
T ss_dssp             TTTTTBCCSTTEEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCC
T ss_pred             hccccccChhhceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence            345667777788899999999999999883     1   246899998743  344566789999999999999999999


Q ss_pred             eeEEE-eCCceEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEE
Q 012684          216 LGAVT-QSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK  293 (458)
Q Consensus       216 ~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vk  293 (458)
                      ++++. .++..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+   |+||||||+||+++.++.+|
T Consensus       156 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~k  232 (373)
T 3c1x_A          156 LGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVK  232 (373)
T ss_dssp             CEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEE
T ss_pred             EEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCccchheEEECCCCCEE
Confidence            99875 456789999999999999999864 34889999999999999999999999   99999999999999999999


Q ss_pred             EeecCCccccccCCCC---CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhc
Q 012684          294 VADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR  369 (458)
Q Consensus       294 l~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~  369 (458)
                      |+|||++.........   ......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......+....+...
T Consensus       233 L~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~  312 (373)
T 3c1x_A          233 VADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQG  312 (373)
T ss_dssp             ECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTT
T ss_pred             EeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcC
Confidence            9999999865432211   1233456788999999988899999999999999999999 78899888777776666444


Q ss_pred             CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccc
Q 012684          370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR  422 (458)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~  422 (458)
                      .....   +..+++.+.++|.+||+.||.+|||+.++++.|+++...+.....
T Consensus       313 ~~~~~---p~~~~~~l~~li~~cl~~dp~~RPs~~ell~~L~~i~~~~~~~~~  362 (373)
T 3c1x_A          313 RRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHY  362 (373)
T ss_dssp             CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSCCB
T ss_pred             CCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhccccce
Confidence            43332   345788999999999999999999999999999999887765543

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=4.1e-43  Score=334.05  Aligned_cols=256  Identities=29%  Similarity=0.492  Sum_probs=219.8

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      ...+|++.+.||+|+||.||.     ++..||+|.+...    ....+.+.+|+.++++++||||+++++++..+...++
T Consensus        11 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~   86 (288)
T 3kfa_A           11 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYI   86 (288)
T ss_dssp             CGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEE
T ss_pred             cccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEE
Confidence            455788999999999998874     4889999999743    2345678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          228 VTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      ||||+++++|.+++...  ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        87 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~  163 (288)
T 3kfa_A           87 ITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTG  163 (288)
T ss_dssp             EEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHT---CCCSCCSGGGEEECGGGCEEECCCCGGGTSCS
T ss_pred             EEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCC---ccCCCCCcceEEEcCCCCEEEccCccceeccC
Confidence            99999999999999874  34899999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      ..........+|+.|+|||.+.+..++.++||||||+++|+|++ |..||...........+........   +..+++.
T Consensus       164 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  240 (288)
T 3kfa_A          164 DTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---PEGCPEK  240 (288)
T ss_dssp             SSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC---CTTCCHH
T ss_pred             CccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCC---CCCCCHH
Confidence            33323333446778999999988889999999999999999999 9999998877777666644433332   4567899


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      +.++|..||+.||.+|||+.++++.|+.+.....
T Consensus       241 l~~li~~~l~~dp~~Rps~~~~~~~l~~~~~~~~  274 (288)
T 3kfa_A          241 VYELMRACWQWNPSDRPSFAEIHQAFETMFQESS  274 (288)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCChhhCcCHHHHHHHHHHHHHhcc
Confidence            9999999999999999999999999999876543

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=1.2e-42  Score=332.57  Aligned_cols=266  Identities=29%  Similarity=0.507  Sum_probs=221.1

Q ss_pred             CCCcccCcCCccccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeee
Q 012684          145 VPEYEIDPHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL  216 (458)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~  216 (458)
                      .+.+.+.+...+|++.+.||+|+||.||.        .+..+|+|.+...  ......+.+.+|+.++++++||||++++
T Consensus        15 ~~~~~i~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~   92 (298)
T 3f66_A           15 VQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLL   92 (298)
T ss_dssp             HGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCC
T ss_pred             hhheecCccceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeee
Confidence            44667788888999999999999999983        1235899998753  3556677899999999999999999999


Q ss_pred             eEEE-eCCceEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEE
Q 012684          217 GAVT-QSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKV  294 (458)
Q Consensus       217 ~~~~-~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl  294 (458)
                      +++. .++..++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|
T Consensus        93 ~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl  169 (298)
T 3f66_A           93 GICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKK---FVHRDLAARNCMLDEKFTVKV  169 (298)
T ss_dssp             EEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEE
T ss_pred             eEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEECCCCCEEE
Confidence            9864 55678999999999999999976 345899999999999999999999999   999999999999999999999


Q ss_pred             eecCCccccccCCC---CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcC
Q 012684          295 ADFGVSKLLTVKED---RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ  370 (458)
Q Consensus       295 ~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~  370 (458)
                      +|||++........   .......+|+.|+|||.+.+..++.++||||||+++|+|++ |.+||......+.........
T Consensus       170 ~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~  249 (298)
T 3f66_A          170 ADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGR  249 (298)
T ss_dssp             CSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTC
T ss_pred             CcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCC
Confidence            99999986543321   12234456788999999988889999999999999999999 677787777777666654444


Q ss_pred             CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      ....   +..+++.+.++|..||+.||.+|||+.++++.|+++...+.
T Consensus       250 ~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~~~  294 (298)
T 3f66_A          250 RLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFI  294 (298)
T ss_dssp             CCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTSC
T ss_pred             CCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhhc
Confidence            3332   34567899999999999999999999999999999987654

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=2.5e-42  Score=343.12  Aligned_cols=259  Identities=17%  Similarity=0.345  Sum_probs=211.1

Q ss_pred             CcccCcCCccccCceeeccc--eEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEE
Q 012684          147 EYEIDPHELDFTNSVEITKG--TFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV  219 (458)
Q Consensus       147 ~~~~~~~~~~~~~~~~lg~G--~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~  219 (458)
                      ...+.+...+|++.+.||+|  +||.|+.     +|+.||||++..... .....+.+.+|+.+++.++||||+++++++
T Consensus        17 ~s~~~~~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~   95 (389)
T 3gni_B           17 MSSFLPEGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATF   95 (389)
T ss_dssp             -CCCCCCGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred             hhcccCCCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEE
Confidence            34455667789999999999  9998874     589999999976543 445667889999999999999999999999


Q ss_pred             EeCCceEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeec
Q 012684          220 TQSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (458)
Q Consensus       220 ~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Df  297 (458)
                      ..++..++||||+++++|.+++...  +.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+||
T Consensus        96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~kl~df  172 (389)
T 3gni_B           96 IADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGL  172 (389)
T ss_dssp             EETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCG
T ss_pred             EECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEccc
Confidence            9999999999999999999999875  66999999999999999999999999   999999999999999999999999


Q ss_pred             CCccccccCC------CCCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc
Q 012684          298 GVSKLLTVKE------DRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR  369 (458)
Q Consensus       298 g~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~  369 (458)
                      |.+.......      ........||+.|+|||++.+  ..++.++|||||||++|+|++|+.||.+.............
T Consensus       173 g~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~  252 (389)
T 3gni_B          173 RSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNG  252 (389)
T ss_dssp             GGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC---
T ss_pred             ccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcC
Confidence            9876542211      111233468899999999987  57899999999999999999999999887665544332111


Q ss_pred             CCC------------------------------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHH
Q 012684          370 QRP------------------------------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII  407 (458)
Q Consensus       370 ~~~------------------------------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll  407 (458)
                      ..+                                          +....+..+++.+.+||.+||+.||.+|||+.+++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell  332 (389)
T 3gni_B          253 TVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLL  332 (389)
T ss_dssp             -----------------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHT
T ss_pred             CCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHh
Confidence            110                                          00112345678899999999999999999999999


Q ss_pred             HH
Q 012684          408 TR  409 (458)
Q Consensus       408 ~~  409 (458)
                      ++
T Consensus       333 ~h  334 (389)
T 3gni_B          333 NH  334 (389)
T ss_dssp             TS
T ss_pred             cC
Confidence            87

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=8.6e-43  Score=328.00  Aligned_cols=251  Identities=29%  Similarity=0.568  Sum_probs=214.4

Q ss_pred             ccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .+|++.+.||+|+||.||.    ++..||+|.+......    .+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         8 ~~y~~~~~lg~G~~g~V~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   83 (267)
T 3t9t_A            8 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTE   83 (267)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTTBC----HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEC
T ss_pred             hheeeeeEecCCCceeEEEEEecCCCeEEEEEccccCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEe
Confidence            4688889999999998874    6789999999765332    2568889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |+++++|.+++... +.+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.........
T Consensus        84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~  160 (267)
T 3t9t_A           84 FMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT  160 (267)
T ss_dssp             CCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHH
T ss_pred             CCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEECCCCCEEEccccccccccccccc
Confidence            99999999999875 45899999999999999999999999   999999999999999999999999999865432222


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      ......+++.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.......   .+..+++.+.++
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~l  237 (267)
T 3t9t_A          161 SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY---KPRLASTHVYQI  237 (267)
T ss_dssp             STTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC---CCTTSCHHHHHH
T ss_pred             ccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCC---CCccCcHHHHHH
Confidence            2234456788999999988889999999999999999999 899999876666555554333332   234578899999


Q ss_pred             HHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          389 IEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      |.+||+.||.+|||+.+++++|+++..
T Consensus       238 i~~~l~~~p~~Rps~~~ll~~L~~l~~  264 (267)
T 3t9t_A          238 MNHCWRERPEDRPAFSRLLRQLAEIAE  264 (267)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHccCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999864

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2e-42  Score=330.44  Aligned_cols=259  Identities=24%  Similarity=0.379  Sum_probs=220.9

Q ss_pred             CCCCcccCcC-CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeee
Q 012684          144 EVPEYEIDPH-ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG  217 (458)
Q Consensus       144 ~~~~~~~~~~-~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~  217 (458)
                      +++.+.+++. ..+|.+.+.||+|+||.||.     +++.||+|++...........+.+.+|+.+++.++||||+++++
T Consensus         3 ~~p~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~   82 (294)
T 2rku_A            3 EIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG   82 (294)
T ss_dssp             CCCSEEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cCcceeeCCCcccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeee
Confidence            4555555443 34799999999999999884     57899999998766556677788999999999999999999999


Q ss_pred             EEEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeec
Q 012684          218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (458)
Q Consensus       218 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Df  297 (458)
                      ++..++..++||||+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+||
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~df  159 (294)
T 2rku_A           83 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDF  159 (294)
T ss_dssp             EEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCC
T ss_pred             eeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEcCCCCEEEEec
Confidence            99999999999999999999999998888999999999999999999999999   999999999999999999999999


Q ss_pred             CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCC
Q 012684          298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP  377 (458)
Q Consensus       298 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  377 (458)
                      |++...... ........+|+.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+... ...   .
T Consensus       160 g~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~-~~~---~  234 (294)
T 2rku_A          160 GLATKVEYD-GERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-EYS---I  234 (294)
T ss_dssp             TTCEECCST-TCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT-CCC---C
T ss_pred             cCceecccC-ccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc-cCC---C
Confidence            999865432 22234456899999999999888999999999999999999999999876655444444222 222   2


Q ss_pred             hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       378 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      +..+++.+.++|.+||+.||.+|||+.+++++-
T Consensus       235 ~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~  267 (294)
T 2rku_A          235 PKHINPVAASLIQKMLQTDPTARPTINELLNDE  267 (294)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSH
T ss_pred             ccccCHHHHHHHHHHcccChhhCcCHHHHhhCh
Confidence            346778999999999999999999999999873

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=2.2e-42  Score=329.46  Aligned_cols=263  Identities=27%  Similarity=0.493  Sum_probs=206.1

Q ss_pred             CCCcccCcCCccccCceeeccceEEEEEE--cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC
Q 012684          145 VPEYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS  222 (458)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~  222 (458)
                      .+.+++.  ..+|++.+.||+|+||.||.  ....||+|++.... ......+.+.+|+.++++++||||+++++++ ..
T Consensus        16 ~~~~ei~--~~~y~~~~~lG~G~~g~Vy~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~   91 (289)
T 3og7_A           16 ADDWEIP--DGQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TA   91 (289)
T ss_dssp             --CCBCC--TTSCEEEEEEEECSSEEEEEEESSSEEEEEEESCSS-CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CS
T ss_pred             CCCCccC--ccceeeeeEecCCCCeEEEEEEEcCceEEEEEeccC-CCHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cC
Confidence            3445544  45788999999999999984  45679999997654 3556677899999999999999999999965 45


Q ss_pred             CceEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          223 SPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                      ...++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||++.
T Consensus        92 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~  168 (289)
T 3og7_A           92 PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKS---IIHRDLKSNNIFLHEDNTVKIGDFGLAT  168 (289)
T ss_dssp             SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTTEEEECCCC---
T ss_pred             CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccccCccceEEECCCCCEEEccceecc
Confidence            678999999999999999965 355999999999999999999999999   9999999999999999999999999997


Q ss_pred             ccccCC-CCCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC--CCCCC
Q 012684          302 LLTVKE-DRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFK  375 (458)
Q Consensus       302 ~~~~~~-~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--~~~~~  375 (458)
                      ...... ........||+.|+|||++.   +..++.++||||||+++|+|++|+.||................  .+...
T Consensus       169 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  248 (289)
T 3og7_A          169 EKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLS  248 (289)
T ss_dssp             ---------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTT
T ss_pred             ccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchh
Confidence            654321 22224456899999999986   5567889999999999999999999998876655444433333  33333


Q ss_pred             CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       376 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      .....+++.+.+||..||+.||.+|||+.++++.|+++.
T Consensus       249 ~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~~L~~l~  287 (289)
T 3og7_A          249 KVRSNCPKRMKRLMAECLKKKRDERPSFPRILAEIEELA  287 (289)
T ss_dssp             SSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             hccccCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHh
Confidence            445678899999999999999999999999999998874

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=9e-43  Score=345.18  Aligned_cols=247  Identities=18%  Similarity=0.347  Sum_probs=211.8

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     +|+.||+|++...   .......+.+|+.+++.++||||+++++++.+....++||
T Consensus        51 ~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~---~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~  127 (387)
T 1kob_A           51 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL  127 (387)
T ss_dssp             GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred             cceEEEEEEecCCCEEEEEEEECCCCCEEEEEEeccc---chhhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEE
Confidence            3689999999999999984     6889999999754   2344567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC--CCCEEEeecCCccccccC
Q 012684          230 EYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~--~~~vkl~Dfg~~~~~~~~  306 (458)
                      ||++|++|.+++...+ .+++..+..++.|++.||.|||+.+   |+||||||+|||++.  .+.+||+|||++......
T Consensus       128 E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~  204 (387)
T 1kob_A          128 EFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD  204 (387)
T ss_dssp             ECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred             EcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccchHHeEEecCCCCceEEEecccceecCCC
Confidence            9999999999987654 6999999999999999999999999   999999999999984  577999999999876432


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+..............+++++.
T Consensus       205 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  282 (387)
T 1kob_A          205 --EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAK  282 (387)
T ss_dssp             --SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHH
T ss_pred             --cceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHH
Confidence              223344689999999999998999999999999999999999999998766555555544333333334557889999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +||..||+.||.+|||+.+++++
T Consensus       283 ~li~~~L~~dP~~Rpt~~ell~h  305 (387)
T 1kob_A          283 DFIKNLLQKEPRKRLTVHDALEH  305 (387)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHcCCChhHCcCHHHHhhC
Confidence            99999999999999999999987

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=1.7e-42  Score=335.49  Aligned_cols=260  Identities=28%  Similarity=0.467  Sum_probs=203.8

Q ss_pred             cCCccccCceeeccceEEEEEE-----cC---eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      ....+|++.+.||+|+||.||.     ++   ..||||++...... ....+.+.+|+.+++.++||||+++++++....
T Consensus        20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~   98 (323)
T 3qup_A           20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIA-SSDIEEFLREAACMKEFDHPHVAKLVGVSLRSR   98 (323)
T ss_dssp             CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-
T ss_pred             cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccC-HHHHHHHHHHHHHHHHCCCCceehhhceeeccc
Confidence            3455799999999999999983     22   27999999765433 344677899999999999999999999998765


Q ss_pred             ce------EEEEEccCCCCHHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC
Q 012684          224 PM------MIVTEYLPKGDLRAFLKRKG------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (458)
Q Consensus       224 ~~------~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~  291 (458)
                      ..      ++||||+++++|.+++....      .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.
T Consensus        99 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---ivH~Dikp~NIli~~~~~  175 (323)
T 3qup_A           99 AKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRN---FIHRDLAARNCMLAEDMT  175 (323)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSC
T ss_pred             cccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCC---cccCCCCcceEEEcCCCC
Confidence            54      99999999999999996532      5899999999999999999999999   999999999999999999


Q ss_pred             EEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhc
Q 012684          292 LKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR  369 (458)
Q Consensus       292 vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~  369 (458)
                      +||+|||++......... ......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+...
T Consensus       176 ~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~  255 (323)
T 3qup_A          176 VCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGG  255 (323)
T ss_dssp             EEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTT
T ss_pred             EEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcC
Confidence            999999999865433221 1223456788999999998889999999999999999999 99999988887777766544


Q ss_pred             CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      .....   +..+++.+.++|.+||+.||.+|||+.++++.|+++.....
T Consensus       256 ~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~  301 (323)
T 3qup_A          256 NRLKQ---PPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLS  301 (323)
T ss_dssp             CCCCC---CTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--
T ss_pred             CCCCC---CCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhh
Confidence            43333   45678899999999999999999999999999999876533

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=1.8e-42  Score=328.54  Aligned_cols=256  Identities=26%  Similarity=0.488  Sum_probs=213.4

Q ss_pred             cCCccccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          152 PHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      ....+|.+.+.||+|+||.||.        .+..||+|.+....  .....+.+.+|+.+++.++||||+++++++.. +
T Consensus         9 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~   85 (281)
T 3cc6_A            9 IAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEE-E   85 (281)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECS-S
T ss_pred             ecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcC-C
Confidence            3455788999999999998874        12359999997542  45566789999999999999999999999865 4


Q ss_pred             ceEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      ..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        86 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~  162 (281)
T 3cc6_A           86 PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESIN---CVHRDIAVRNILVASPECVKLGDFGLSRY  162 (281)
T ss_dssp             SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEEETTEEEECCCCGGGC
T ss_pred             CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEECCCCcEEeCccCCCcc
Confidence            568999999999999999765 45999999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhh
Q 012684          303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY  381 (458)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (458)
                      .............+++.|+|||.+.+..++.++||||||+++|+|++ |+.||...........+......+.   +..+
T Consensus       163 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~  239 (281)
T 3cc6_A          163 IEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLPK---PDLC  239 (281)
T ss_dssp             C---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC---CTTC
T ss_pred             cccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCCC---CCCC
Confidence            65443333344557889999999988889999999999999999998 9999988777776666544444333   3457


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ++.+.++|.+||+.||.+|||+.+++++|+++...
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~ell~~L~~~~~~  274 (281)
T 3cc6_A          240 PPVLYTLMTRCWDYDPSDRPRFTELVCSLSDVYQM  274 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHHHHHHHHHHh
Confidence            88999999999999999999999999999998654

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=7.3e-43  Score=344.15  Aligned_cols=244  Identities=26%  Similarity=0.410  Sum_probs=200.5

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHH-HhcCCCCcceeeeeEEEeCCceEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELAL-LQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      ..+|++.+.||+|+||.|+.     ++..||+|++.............+..|..+ ++.++||||+++++++......|+
T Consensus        37 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~l  116 (373)
T 2r5t_A           37 PSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYF  116 (373)
T ss_dssp             GGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEE
Confidence            34789999999999999884     578999999987655444555666777776 567899999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||||++||+|.+++.+.+.+++..+..++.|++.||+|||++|   |+||||||+|||++.+|.+||+|||++...... 
T Consensus       117 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~-  192 (373)
T 2r5t_A          117 VLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEH-  192 (373)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCBCGGGBCC-
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEECCCCCEEEeeCccccccccC-
Confidence            9999999999999998888999999999999999999999999   999999999999999999999999999764322 


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      ........||+.|+|||++.+..++.++|+|||||++|+|++|+.||...+..+....+.... ..+   +..+++.+++
T Consensus       193 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~-~~~---~~~~~~~~~~  268 (373)
T 2r5t_A          193 NSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKP-LQL---KPNITNSARH  268 (373)
T ss_dssp             CCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSC-CCC---CSSSCHHHHH
T ss_pred             CCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcc-cCC---CCCCCHHHHH
Confidence            223345678999999999999999999999999999999999999999877666666554332 222   3457889999


Q ss_pred             HHHHHcccCCCCCCCHHH
Q 012684          388 LIEECWNEKPAKRPTFRQ  405 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~  405 (458)
                      ||.+||+.||.+||++.+
T Consensus       269 li~~lL~~dp~~R~~~~~  286 (373)
T 2r5t_A          269 LLEGLLQKDRTKRLGAKD  286 (373)
T ss_dssp             HHHHHTCSSGGGSTTTTT
T ss_pred             HHHHHcccCHHhCCCCCC
Confidence            999999999999999853

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.9e-43  Score=356.08  Aligned_cols=247  Identities=25%  Similarity=0.398  Sum_probs=203.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     +|+.||||++.............+.+|+.+++.++||||+++++++...+.+++||
T Consensus       148 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~  227 (446)
T 4ejn_A          148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVM  227 (446)
T ss_dssp             GGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEE
T ss_pred             HHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEE
Confidence            4688999999999999984     68899999997544334445566788999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      ||+++++|.+++...+.+++..+..++.|++.||+|||+ .|   |+||||||+|||++.++.+||+|||++...... .
T Consensus       228 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-~  303 (446)
T 4ejn_A          228 EYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKD-G  303 (446)
T ss_dssp             CCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC---CCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             eeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC---EEECCCCHHHEEECCCCCEEEccCCCceeccCC-C
Confidence            999999999999988889999999999999999999998 88   999999999999999999999999999754322 2


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+.......+.... ..+   +..+++.+.+|
T Consensus       304 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~-~~~---p~~~~~~~~~l  379 (446)
T 4ejn_A          304 ATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEE-IRF---PRTLGPEAKSL  379 (446)
T ss_dssp             ---CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC-CCC---CTTSCHHHHHH
T ss_pred             cccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCC-CCC---CccCCHHHHHH
Confidence            23345678999999999999899999999999999999999999998877666655553332 222   34578899999


Q ss_pred             HHHHcccCCCCCC-----CHHHHHHH
Q 012684          389 IEECWNEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rp-----s~~~ll~~  409 (458)
                      |.+||+.||.+||     ++.++++|
T Consensus       380 i~~~L~~dP~~R~~~~~~t~~ell~h  405 (446)
T 4ejn_A          380 LSGLLKKDPKQRLGGGSEDAKEIMQH  405 (446)
T ss_dssp             HHHHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             HHHHcccCHHHhCCCCCCCHHHHHhC
Confidence            9999999999999     99999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.8e-42  Score=328.21  Aligned_cols=269  Identities=29%  Similarity=0.518  Sum_probs=221.7

Q ss_pred             CCCCcccCcCCccccCceeeccceEEEEEE-----cC---eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceee
Q 012684          144 EVPEYEIDPHELDFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF  215 (458)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~  215 (458)
                      +...+.++.....|...+.||+|+||.||.     ++   ..||+|.+...  ......+.+.+|+.+++.++||||+++
T Consensus        10 ~~~~~~i~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~   87 (298)
T 3pls_A           10 EVKDVLIPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMRGLNHPNVLAL   87 (298)
T ss_dssp             HTGGGBCCGGGEEEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCC
T ss_pred             hhhheEccccceEEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHHhCCCCCeeeE
Confidence            344566777777888889999999999983     22   37999999743  355667789999999999999999999


Q ss_pred             eeEEEeCCce-EEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEE
Q 012684          216 LGAVTQSSPM-MIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK  293 (458)
Q Consensus       216 ~~~~~~~~~~-~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vk  293 (458)
                      ++++...... ++||||+.+++|.+++.. ...+++..++.++.|++.||+|||+.|   ++||||||+||+++.++.++
T Consensus        88 ~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dikp~Nili~~~~~~k  164 (298)
T 3pls_A           88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQK---FVHRDLAARNCMLDESFTVK  164 (298)
T ss_dssp             CEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEE
T ss_pred             EEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcEE
Confidence            9999766554 999999999999999986 455899999999999999999999999   99999999999999999999


Q ss_pred             EeecCCccccccCC---CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCcHHHHHHhc
Q 012684          294 VADFGVSKLLTVKE---DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVPKAYAAR  369 (458)
Q Consensus       294 l~Dfg~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg-~~pf~~~~~~~~~~~~~~~  369 (458)
                      |+|||++.......   ........+|+.|+|||.+.+..++.++||||||+++|+|++| .+||...........+...
T Consensus       165 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~  244 (298)
T 3pls_A          165 VADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQG  244 (298)
T ss_dssp             ECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTT
T ss_pred             eCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcC
Confidence            99999997653321   1222345678899999999998999999999999999999995 5555555555555555433


Q ss_pred             CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 012684          370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK  420 (458)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  420 (458)
                      ...+.   +..+++.+.++|..||+.||.+|||+.++++.|+++...+...
T Consensus       245 ~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~l~~~  292 (298)
T 3pls_A          245 RRLPQ---PEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQIVSALLGD  292 (298)
T ss_dssp             CCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHCCSC
T ss_pred             CCCCC---CccchHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHHhcc
Confidence            33332   4557889999999999999999999999999999998776544

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.5e-44  Score=354.52  Aligned_cols=254  Identities=22%  Similarity=0.303  Sum_probs=209.6

Q ss_pred             cCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      ....+|++.+.||+|+||.|+.     +|+.||+|++.+.........+.+.+|..++..++||||+++++++.+...+|
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~  137 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLY  137 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            3345788899999999998874     68999999996432112222344788999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      +||||++||+|.+++.+.+ .+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++.....
T Consensus       138 lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~g---iiHrDLKp~NILld~~g~vkL~DFGla~~~~~  214 (412)
T 2vd5_A          138 LVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLG---YVHRDIKPDNILLDRCGHIRLADFGSCLKLRA  214 (412)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCT
T ss_pred             EEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccCHHHeeecCCCCEEEeechhheeccC
Confidence            9999999999999998754 6999999999999999999999999   99999999999999999999999999987644


Q ss_pred             CCCCCcccCCCCCcccCCcccC-------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCC
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFK-------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAP  377 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~  377 (458)
                      ..........||+.|+|||++.       +..++.++|+|||||++|+|++|+.||...+..+....+.... ...++..
T Consensus       215 ~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~  294 (412)
T 2vd5_A          215 DGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLV  294 (412)
T ss_dssp             TSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC--
T ss_pred             CCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCcc
Confidence            3222233457899999999986       3568899999999999999999999999877666655554322 2333333


Q ss_pred             hhhhHHHHHHHHHHHcccCCCCC---CCHHHHHHH
Q 012684          378 AKLYARGLKELIEECWNEKPAKR---PTFRQIITR  409 (458)
Q Consensus       378 ~~~~~~~l~~li~~~l~~dp~~R---ps~~~ll~~  409 (458)
                      ...+++++++||.+||. +|.+|   |+++++++|
T Consensus       295 ~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~H  328 (412)
T 2vd5_A          295 DEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTH  328 (412)
T ss_dssp             --CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTS
T ss_pred             ccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcC
Confidence            45688999999999999 99998   589999887

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-42  Score=327.21  Aligned_cols=257  Identities=25%  Similarity=0.420  Sum_probs=216.9

Q ss_pred             ccccCce-eeccceEEEEEE-------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          155 LDFTNSV-EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       155 ~~~~~~~-~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      .+|.+.. .||+|+||.||.       ++..||+|++...  ......+.+.+|+.+++.++||||+++++++ ..+..+
T Consensus         9 ~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            9 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEE
T ss_pred             HHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcE
Confidence            3555555 899999998873       5778999999754  3456677899999999999999999999999 456789


Q ss_pred             EEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          227 IVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      +||||+++++|.+++... ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.....
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~  162 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA  162 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred             EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCchheEEEcCCCCEEECcccceeeecc
Confidence            999999999999999754 45999999999999999999999999   99999999999999999999999999987643


Q ss_pred             CCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhH
Q 012684          306 KED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA  382 (458)
Q Consensus       306 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (458)
                      ...  .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.....+..   +..++
T Consensus       163 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~  239 (287)
T 1u59_A          163 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPECP  239 (287)
T ss_dssp             CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC---CTTCC
T ss_pred             CcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCCC---CCCcC
Confidence            322  11233456889999999988889999999999999999998 9999998877666665544433333   45678


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK  420 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  420 (458)
                      +.+.++|..||+.||.+||++.+++++|+.+..+...+
T Consensus       240 ~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~~  277 (287)
T 1u59_A          240 PELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK  277 (287)
T ss_dssp             HHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcCCc
Confidence            99999999999999999999999999999998775543

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=9.7e-43  Score=337.05  Aligned_cols=251  Identities=23%  Similarity=0.337  Sum_probs=212.8

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCH---HHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      ..+|++.+.||+|+||.|+.     +|+.||+|++........   ...+.+.+|+.+++.++||||+++++++......
T Consensus        11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~   90 (321)
T 2a2a_A           11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDV   90 (321)
T ss_dssp             HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred             hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEE
Confidence            34689999999999999874     588999999975433221   1246788999999999999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC----CEEEeecCCcc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSK  301 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~----~vkl~Dfg~~~  301 (458)
                      ++||||+++++|.+++...+.+++..++.++.|++.||.|||+.+   ++||||||+||+++.++    .++|+|||++.
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~  167 (321)
T 2a2a_A           91 VLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKK---IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH  167 (321)
T ss_dssp             EEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCTTSSSCCEEECCCTTCE
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChHHEEEecCCCCcCCEEEccCccce
Confidence            999999999999999998888999999999999999999999999   99999999999999888    79999999998


Q ss_pred             ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhh
Q 012684          302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY  381 (458)
Q Consensus       302 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (458)
                      .....  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+........+.....+
T Consensus       168 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  245 (321)
T 2a2a_A          168 EIEDG--VEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHT  245 (321)
T ss_dssp             ECCTT--CCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTC
T ss_pred             ecCcc--ccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhccc
Confidence            76432  2234456899999999999989999999999999999999999999887665555554333222221223467


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++.+.++|.+||+.||.+|||+.+++++
T Consensus       246 ~~~~~~li~~~l~~dp~~Rps~~e~l~h  273 (321)
T 2a2a_A          246 SELAKDFIRKLLVKETRKRLTIQEALRH  273 (321)
T ss_dssp             CHHHHHHHHTTSCSSTTTSCCHHHHHHS
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence            8899999999999999999999999986

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=2.4e-42  Score=334.24  Aligned_cols=245  Identities=22%  Similarity=0.391  Sum_probs=208.9

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .|...+.||+|+||.|+.     +|+.||||++.....   ...+.+.+|+.+++.++||||+++++++......++|||
T Consensus        46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e  122 (321)
T 2c30_A           46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLME  122 (321)
T ss_dssp             HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC---CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccch---hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence            356667899999999883     689999999975432   224568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+++++|.+++.. ..+++..+..++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++....... ..
T Consensus       123 ~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-~~  197 (321)
T 2c30_A          123 FLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV-PK  197 (321)
T ss_dssp             CCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSSS-CC
T ss_pred             cCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCcEEEeeeeeeeecccCc-cc
Confidence            9999999998875 46999999999999999999999999   9999999999999999999999999987664332 22


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.....+.. .....+++.+.++|.
T Consensus       198 ~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~  276 (321)
T 2c30_A          198 RKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVLRDFLE  276 (321)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHHHHHHH
T ss_pred             cccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHHHHHHH
Confidence            3445789999999999998999999999999999999999999987766555554433333322 234567899999999


Q ss_pred             HHcccCCCCCCCHHHHHHH
Q 012684          391 ECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~  409 (458)
                      +||+.||.+|||+.+++++
T Consensus       277 ~~l~~dp~~Rps~~ell~h  295 (321)
T 2c30_A          277 RMLVRDPQERATAQELLDH  295 (321)
T ss_dssp             HHSCSSTTTSCCHHHHHTS
T ss_pred             HHccCChhhCcCHHHHhcC
Confidence            9999999999999999987

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.5e-42  Score=335.72  Aligned_cols=257  Identities=26%  Similarity=0.437  Sum_probs=216.2

Q ss_pred             cCCccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe
Q 012684          152 PHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ  221 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~  221 (458)
                      ....+|++.+.||+|+||.||.          ++..||+|.+...  ........+.+|+.+++.++||||+++++++..
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~   99 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQ   99 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccc--cCHHHHHHHHHHHHHHHhcCCCCEeeeEEEEcc
Confidence            4456799999999999998873          3678999999754  244556678899999999999999999999999


Q ss_pred             CCceEEEEEccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC
Q 012684          222 SSPMMIVTEYLPKGDLRAFLKRK----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (458)
Q Consensus       222 ~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~  291 (458)
                      +...++||||+++++|.+++...          ..+++..++.++.|++.||.|||+++   |+||||||+||+++.++.
T Consensus       100 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~NIli~~~~~  176 (322)
T 1p4o_A          100 GQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFT  176 (322)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCC
T ss_pred             CCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---CccCCCccceEEEcCCCe
Confidence            99999999999999999999752          34689999999999999999999999   999999999999999999


Q ss_pred             EEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhc
Q 012684          292 LKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR  369 (458)
Q Consensus       292 vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~  369 (458)
                      +||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...........+...
T Consensus       177 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  256 (322)
T 1p4o_A          177 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEG  256 (322)
T ss_dssp             EEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTT
T ss_pred             EEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcC
Confidence            999999999765433211 1123345788999999988889999999999999999999 89999887666555555443


Q ss_pred             CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ....   .+..+++.+.++|..||+.||.+|||+.+++++|++....
T Consensus       257 ~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~L~~~~~~  300 (322)
T 1p4o_A          257 GLLD---KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP  300 (322)
T ss_dssp             CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred             CcCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHhhcc
Confidence            3332   3456788999999999999999999999999999887543

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=2.5e-42  Score=332.50  Aligned_cols=259  Identities=27%  Similarity=0.434  Sum_probs=217.7

Q ss_pred             cCCccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEE
Q 012684          152 PHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT  220 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~  220 (458)
                      ....+|++.+.||+|+||.||.          ++..||+|++...  ......+.+.+|+.+++++ +||||+++++++.
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~   97 (313)
T 1t46_A           20 FPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTEREALMSELKVLSYLGNHMNIVNLLGACT   97 (313)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcc--hhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEe
Confidence            3445788999999999999873          3579999999754  2345567899999999999 8999999999999


Q ss_pred             eCCceEEEEEccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCC
Q 012684          221 QSSPMMIVTEYLPKGDLRAFLKRKG------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS  282 (458)
Q Consensus       221 ~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~  282 (458)
                      .++..++||||+++++|.+++....                  .+++..++.++.|++.||.|||+.+   ++||||||+
T Consensus        98 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~  174 (313)
T 1t46_A           98 IGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAAR  174 (313)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGG
T ss_pred             cCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccc
Confidence            9999999999999999999998654                  3899999999999999999999999   999999999


Q ss_pred             CEEecCCCCEEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCC
Q 012684          283 NILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDN  360 (458)
Q Consensus       283 Nil~~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~  360 (458)
                      ||+++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......
T Consensus       175 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~  254 (313)
T 1t46_A          175 NILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVD  254 (313)
T ss_dssp             GEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSS
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccch
Confidence            9999999999999999998765432211 123346778999999988889999999999999999999 99999887766


Q ss_pred             cHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          361 EVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       361 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      ..............  .+..+++.+.++|.+||+.||.+|||+.+++++|+++....
T Consensus       255 ~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  309 (313)
T 1t46_A          255 SKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQISES  309 (313)
T ss_dssp             HHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHT
T ss_pred             hHHHHHhccCCCCC--CcccCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHh
Confidence            55444433332221  23567889999999999999999999999999999987653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=2.1e-42  Score=335.94  Aligned_cols=256  Identities=16%  Similarity=0.228  Sum_probs=212.1

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~l  227 (458)
                      ..+|++.+.||+|+||.||.     +|+.||||++......     +.+.+|+.+++.+ +||||+++++++..+...++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~l   82 (330)
T 2izr_A            8 GPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAM   82 (330)
T ss_dssp             TTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEE
T ss_pred             cCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEE
Confidence            34788999999999998873     6899999998754321     2477899999999 89999999999999999999


Q ss_pred             EEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC-----EEEeecCCcc
Q 012684          228 VTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADFGVSK  301 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~-----vkl~Dfg~~~  301 (458)
                      ||||+ +++|.+++.. .+.+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.     +||+|||++.
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~  158 (330)
T 2izr_A           83 VLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK  158 (330)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTCTTSEEECCCTTCE
T ss_pred             EEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeeccCCCCCCceEEEEEcccce
Confidence            99999 9999999987 467999999999999999999999999   999999999999998887     9999999998


Q ss_pred             ccccCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC---C-
Q 012684          302 LLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ---R-  371 (458)
Q Consensus       302 ~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~---~-  371 (458)
                      ........      ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...........+....   . 
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~  238 (330)
T 2izr_A          159 EYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRA  238 (330)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHH
T ss_pred             eeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhcc
Confidence            76433221      1245678999999999999999999999999999999999999999877665543332211   1 


Q ss_pred             CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012684          372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH  419 (458)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  419 (458)
                      .+.......++ ++.++|..||+.||.+||++.++++.|+++......
T Consensus       239 ~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~~l~~~~~~~~~  285 (330)
T 2izr_A          239 TPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRKLFTDLFDRKGY  285 (330)
T ss_dssp             SCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             CCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHHHHHHHHHHcCC
Confidence            11111122345 999999999999999999999999999988776543

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=6.6e-43  Score=354.16  Aligned_cols=259  Identities=28%  Similarity=0.501  Sum_probs=217.5

Q ss_pred             CcccCcCCccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC
Q 012684          147 EYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS  222 (458)
Q Consensus       147 ~~~~~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~  222 (458)
                      .|++.  ..+|.+.+.||+|+||.||.    ++..||||.+.....    ..+.+.+|+.+++.++||||+++++++. .
T Consensus       182 ~~~i~--~~~~~~~~~lG~G~fg~V~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~  254 (454)
T 1qcf_A          182 AWEIP--RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVT-K  254 (454)
T ss_dssp             CSBCC--GGGEEEEEEEECCSSEEEEEEEETTTEEEEEEEECTTSB----CHHHHHHHHHHHTTCCCTTBCCEEEEEC-S
T ss_pred             ceeec--hHHeEEEEEcccCCceEEEEEEECCccEEEEEEecCCCc----cHHHHHHHHHHHhhCCCCCEeeEEEEEe-C
Confidence            44443  34678889999999999874    478899999975432    2467889999999999999999999986 5


Q ss_pred             CceEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCc
Q 012684          223 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~  300 (458)
                      ...++||||+++|+|.+++...  ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       255 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a  331 (454)
T 1qcf_A          255 EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLA  331 (454)
T ss_dssp             SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCSGGGEEECTTCCEEECSTTGG
T ss_pred             CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCCHHHEEECCCCcEEEeeCCCc
Confidence            6789999999999999999753  35889999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChh
Q 012684          301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK  379 (458)
Q Consensus       301 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  379 (458)
                      ...............+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+....+....+....+.+.   +.
T Consensus       332 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~  408 (454)
T 1qcf_A          332 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR---PE  408 (454)
T ss_dssp             GGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC---CT
T ss_pred             eEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence            8754322122233446788999999988889999999999999999999 9999998877776666654444433   45


Q ss_pred             hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          380 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       380 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      .+++.+.+||.+||+.||.+|||+.++++.|+++....+
T Consensus       409 ~~~~~l~~li~~cl~~dp~~RPt~~~i~~~L~~~~~~~~  447 (454)
T 1qcf_A          409 NCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDFYTATE  447 (454)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSSSSC
T ss_pred             CCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHhccc
Confidence            678999999999999999999999999999998865543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=1.5e-42  Score=339.53  Aligned_cols=246  Identities=25%  Similarity=0.369  Sum_probs=195.9

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|++.+.||+|+||.||.     +++.||||++....     ..+.+.+|+.+++.++||||+++++++......++|
T Consensus        52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv  126 (349)
T 2w4o_A           52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLV  126 (349)
T ss_dssp             GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEE
Confidence            44689999999999999984     57899999997432     235678899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC---CCCEEEeecCCcccccc
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTV  305 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~---~~~vkl~Dfg~~~~~~~  305 (458)
                      |||+++++|.+++...+.+++.++..++.|++.||.|||+.+   |+||||||+||+++.   ++.+||+|||++.....
T Consensus       127 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~  203 (349)
T 2w4o_A          127 LELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENG---IVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH  203 (349)
T ss_dssp             ECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESSSSTTCCEEECCCC-------
T ss_pred             EEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCcccEEEecCCCCCCEEEccCccccccCc
Confidence            999999999999998888999999999999999999999999   999999999999975   88999999999986543


Q ss_pred             CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-HHHHHHhcCCCCCCCChhhhHHH
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      .  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||....... ....+..............++..
T Consensus       204 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  281 (349)
T 2w4o_A          204 Q--VLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLN  281 (349)
T ss_dssp             -----------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHH
T ss_pred             c--cccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHH
Confidence            2  22234568999999999999899999999999999999999999998766554 33333333333333334668899


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.+||.+||+.||.+|||+.+++++
T Consensus       282 ~~~li~~~L~~dP~~Rpt~~e~l~h  306 (349)
T 2w4o_A          282 AKDLVRKLIVLDPKKRLTTFQALQH  306 (349)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcC
Confidence            9999999999999999999999986

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=3e-42  Score=326.60  Aligned_cols=255  Identities=30%  Similarity=0.494  Sum_probs=213.9

Q ss_pred             CccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      ..+|++.+.||+|+||.||.    ++..||+|.+.....    ..+.+.+|+.+++.++||||+++++++.. +..++||
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~   86 (279)
T 1qpc_A           12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIIT   86 (279)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             HHhhhheeeecCCCCeEEEEEEEcCCcEEEEEEecCCcc----cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEE
Confidence            35788899999999998874    467899999975432    23568899999999999999999999864 5689999


Q ss_pred             EccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          230 EYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||+++++|.+++....  .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        87 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~  163 (279)
T 1qpc_A           87 EYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNE  163 (279)
T ss_dssp             ECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSC
T ss_pred             ecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHhhEEEcCCCCEEECCCcccccccCcc
Confidence            9999999999987543  6999999999999999999999999   9999999999999999999999999998765433


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                      ........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.......   .+..+++.+.
T Consensus       164 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~  240 (279)
T 1qpc_A          164 YTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDNCPEELY  240 (279)
T ss_dssp             EECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHH
T ss_pred             cccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC---CcccccHHHH
Confidence            223334456788999999988888999999999999999999 999998876665555554333322   2456789999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012684          387 ELIEECWNEKPAKRPTFRQIITRLESINNSINH  419 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  419 (458)
                      ++|..||+.||.+|||+.++++.|+.+......
T Consensus       241 ~li~~~l~~~p~~Rps~~~l~~~l~~~~~~~~~  273 (279)
T 1qpc_A          241 QLMRLCWKERPEDRPTFDYLRSVLEDFFTATEG  273 (279)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC--
T ss_pred             HHHHHHhccChhhCCCHHHHHHHHHHHHHhccC
Confidence            999999999999999999999999999876544

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=3e-42  Score=340.31  Aligned_cols=244  Identities=21%  Similarity=0.338  Sum_probs=203.7

Q ss_pred             cCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012684          158 TNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (458)
Q Consensus       158 ~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~  232 (458)
                      ...+.||+|+||.||.     +|+.||+|++...   .....+.+.+|+.++++++||||+++++++...+..++||||+
T Consensus        92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~  168 (373)
T 2x4f_A           92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTR---GMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYV  168 (373)
T ss_dssp             EEEEECC-----CEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECC
T ss_pred             ecceEEecCcCEEEEEEEEcCCCcEEEEEEEccc---ccccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCC
Confidence            3456899999999884     5889999999754   3345677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe--cCCCCEEEeecCCccccccCCCC
Q 012684          233 PKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR--DDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       233 ~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~--~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ++++|.+++... ..+++..+..++.|++.||.|||+.+   |+||||||+|||+  +.++.+||+|||++......  .
T Consensus       169 ~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~--~  243 (373)
T 2x4f_A          169 DGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPR--E  243 (373)
T ss_dssp             TTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEETTTTEEEECCCSSCEECCTT--C
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEecCCCCcEEEEeCCCceecCCc--c
Confidence            999999988654 46999999999999999999999999   9999999999999  56778999999999876432  2


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||......+....+..............+++++.+||
T Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  323 (373)
T 2x4f_A          244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI  323 (373)
T ss_dssp             BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred             ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence            23345689999999999988899999999999999999999999998776666555544433333334456889999999


Q ss_pred             HHHcccCCCCCCCHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+||+.||.+|||+.+++++
T Consensus       324 ~~~L~~dp~~Rps~~e~l~h  343 (373)
T 2x4f_A          324 SKLLIKEKSWRISASEALKH  343 (373)
T ss_dssp             HTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHcCCChhhCCCHHHHhcC
Confidence            99999999999999999986

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.1e-42  Score=326.17  Aligned_cols=246  Identities=23%  Similarity=0.370  Sum_probs=210.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.|+.     ++..||+|.+.......   .+.+.+|+.+++.++||||+++++++..+...++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~---~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (277)
T 3f3z_A            9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVED---VDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVM   85 (277)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccch---HHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEE
Confidence            3688999999999999884     46799999997654333   456889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe---cCCCCEEEeecCCccccccC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~---~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+++   ++|+||||+||++   +.++.++|+|||++......
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~  162 (277)
T 3f3z_A           86 ELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLN---VAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG  162 (277)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTT
T ss_pred             eccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEecCCCCCcEEEEecccceeccCc
Confidence            99999999999998888999999999999999999999999   9999999999999   78899999999999765432


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                        .......+|+.|+|||.+.+. ++.++||||||+++|+|++|+.||......+....+..............+++.+.
T Consensus       163 --~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (277)
T 3f3z_A          163 --KMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAE  239 (277)
T ss_dssp             --SCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHH
T ss_pred             --cchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHH
Confidence              233445689999999998764 89999999999999999999999998776665555544333322222336789999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++|..||+.||.+|||+.+++++
T Consensus       240 ~li~~~l~~dp~~R~s~~~~l~h  262 (277)
T 3f3z_A          240 SLIRRLLTKSPKQRITSLQALEH  262 (277)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHTTS
T ss_pred             HHHHHHccCChhhCcCHHHHhcC
Confidence            99999999999999999999986

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=5.9e-43  Score=354.74  Aligned_cols=246  Identities=28%  Similarity=0.443  Sum_probs=211.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|.+.+.||+|+||.|+.     +|+.||||++.............+.+|+.+++.++||||+++++++......++||
T Consensus        16 ~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~   95 (476)
T 2y94_A           16 GHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVM   95 (476)
T ss_dssp             TTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             cCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEE
Confidence            4788999999999998873     68999999996432212223457889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||++|++|.+++.+.+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++......  .
T Consensus        96 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~--~  170 (476)
T 2y94_A           96 EYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--E  170 (476)
T ss_dssp             ECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEECTTCCEEECCCSSCEECCTT--C
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CCcccccHHHEEEecCCCeEEEeccchhhcccc--c
Confidence            99999999999988888999999999999999999999999   999999999999999999999999999876432  2


Q ss_pred             CcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      ......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||...........+.... ..   .+..+++++.+|
T Consensus       171 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~-~~---~p~~~s~~~~~L  246 (476)
T 2y94_A          171 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI-FY---TPQYLNPSVISL  246 (476)
T ss_dssp             CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTC-CC---CCTTCCHHHHHH
T ss_pred             cccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCC-cC---CCccCCHHHHHH
Confidence            3344578999999999988765 679999999999999999999999877666655553322 22   234578899999


Q ss_pred             HHHHcccCCCCCCCHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~  409 (458)
                      |.+||+.||.+|||+.+++++
T Consensus       247 i~~~L~~dP~~Rpt~~eil~h  267 (476)
T 2y94_A          247 LKHMLQVDPMKRATIKDIREH  267 (476)
T ss_dssp             HHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHHcCCCchhCcCHHHHHhC
Confidence            999999999999999999986

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1.5e-42  Score=336.37  Aligned_cols=265  Identities=26%  Similarity=0.407  Sum_probs=214.6

Q ss_pred             CCCCcccCcCCccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEE
Q 012684          144 EVPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV  219 (458)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~  219 (458)
                      ....-++.....+|++.+.||+|+||.||.    +|+.||||++......  .....+.+|+.+++.++||||+++++++
T Consensus        19 ~~~~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~   96 (326)
T 3uim_A           19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQ--GGELQFQTEVEMISMAVHRNLLRLRGFC   96 (326)
T ss_dssp             ECCTHHHHTTTTSSCSTTEEECCSSSEEEEECCSSSCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEE
T ss_pred             eecHHHHHHHhhccccceeEecCCCcEEEEEEecCCCEEEEEEeccccCc--hHHHHHHHHHHHHHhccCCCccceEEEE
Confidence            344556666777899999999999999985    5889999999754321  1123578899999999999999999999


Q ss_pred             EeCCceEEEEEccCCCCHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhC---CCCCeeeCCCCCCCEEecCCCCE
Q 012684          220 TQSSPMMIVTEYLPKGDLRAFLKRKG----ALKPSTAVRFALDIARGMNYLHEN---KPVPIIHRDLEPSNILRDDSGNL  292 (458)
Q Consensus       220 ~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~i~~qi~~~l~~LH~~---~~~~i~H~Dikp~Nil~~~~~~v  292 (458)
                      ......++||||+++++|.+++....    .+++..+..++.|++.||.|||+.   +   |+||||||+||+++.++.+
T Consensus        97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~---ivH~Dlkp~Nil~~~~~~~  173 (326)
T 3uim_A           97 MTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPK---IIHRDVKAANILLDEEFEA  173 (326)
T ss_dssp             CCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSC---EECCCCSGGGEEECTTCCE
T ss_pred             ecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEeCCCchhhEEECCCCCE
Confidence            99999999999999999999998643    389999999999999999999999   8   9999999999999999999


Q ss_pred             EEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC-----CCCCcHHHHHH
Q 012684          293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM-----KHDNEVPKAYA  367 (458)
Q Consensus       293 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~-----~~~~~~~~~~~  367 (458)
                      +|+|||++...............||+.|+|||++.+..++.++||||||+++|+|++|+.||..     ...........
T Consensus       174 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~  253 (326)
T 3uim_A          174 VVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVK  253 (326)
T ss_dssp             EECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHT
T ss_pred             EeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHH
Confidence            9999999987654444444556689999999999888899999999999999999999999962     11122222221


Q ss_pred             hcCCC----------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          368 ARQRP----------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       368 ~~~~~----------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      .....          .........+..+.+++..||+.||.+|||+.+++++|+..
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L~~~  309 (326)
T 3uim_A          254 GLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRMLEGD  309 (326)
T ss_dssp             TTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHHHTS
T ss_pred             HHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHhcCc
Confidence            11000          01122345678899999999999999999999999999863

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=2.6e-42  Score=329.42  Aligned_cols=248  Identities=21%  Similarity=0.414  Sum_probs=200.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.|+.     +|+.||+|++..... .......+.+|+.++++++||||+++++++.++...++|||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   81 (292)
T 3o0g_A            3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEe
Confidence            688899999999998874     588999999976543 33445678889999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |+++ +|.+.+.. .+.+++..+..++.|++.||.|||+.|   |+||||||+||+++.++.+||+|||++...... ..
T Consensus        82 ~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~---ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  156 (292)
T 3o0g_A           82 FCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIP-VR  156 (292)
T ss_dssp             CCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECCSC-CS
T ss_pred             cCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecCCc-cc
Confidence            9965 66655554 677999999999999999999999999   999999999999999999999999999865432 22


Q ss_pred             CcccCCCCCcccCCcccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCC-CCCCcHHHHHHhcC-CCC-------------
Q 012684          310 PLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTM-KHDNEVPKAYAARQ-RPP-------------  373 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~lltg~~pf~~-~~~~~~~~~~~~~~-~~~-------------  373 (458)
                      ......+|+.|+|||++.+.. ++.++||||||+++|+|++|..||.. .........+.... .+.             
T Consensus       157 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (292)
T 3o0g_A          157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDY  236 (292)
T ss_dssp             CCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTC
T ss_pred             cccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccc
Confidence            334456799999999997765 79999999999999999998888543 33222222222111 110             


Q ss_pred             -----------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 -----------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 -----------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                 .....+.+++.+++||.+||+.||.+|||+.++++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  283 (292)
T 3o0g_A          237 KPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcC
Confidence                       011123467899999999999999999999999986

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=2.1e-42  Score=340.10  Aligned_cols=249  Identities=27%  Similarity=0.369  Sum_probs=197.5

Q ss_pred             cCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      ....+|++.+.||+|+||.|+.     +|+.||||++.......    +.+.+|+.+++.++||||+++++++......+
T Consensus        17 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~   92 (361)
T 3uc3_A           17 HDSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHRSLRHPNIVRFKEVILTPTHLA   92 (361)
T ss_dssp             CCTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEE
Confidence            4456899999999999998873     68999999997543322    45778999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC--EEEeecCCccccc
Q 012684          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--LKVADFGVSKLLT  304 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~--vkl~Dfg~~~~~~  304 (458)
                      +||||+++++|.+++...+.+++..+..++.|++.||.|||++|   |+||||||+||+++.++.  +||+|||++....
T Consensus        93 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~---ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~  169 (361)
T 3uc3_A           93 IIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQ---ICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV  169 (361)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCSCCCCGGGEEECSSSSCCEEECCCCCC----
T ss_pred             EEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCceEEEeecCcccccc
Confidence            99999999999999988888999999999999999999999999   999999999999987665  9999999987432


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCCCCCCc-hhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc---CCCCCCCChhh
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---QRPPFKAPAKL  380 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~---~~~~~~~~~~~  380 (458)
                      ..  .......||+.|+|||++.+..+..+ +|||||||++|+|++|+.||...............   ....++ ....
T Consensus       170 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~-~~~~  246 (361)
T 3uc3_A          170 LH--SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIP-DDIR  246 (361)
T ss_dssp             -------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCC-TTSC
T ss_pred             cc--CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCC-CcCC
Confidence            22  22234568999999999988777665 89999999999999999999876654433322111   111221 2235


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          381 YARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      +++.+.+||.+||+.||.+|||+.++++|-
T Consensus       247 ~s~~~~~li~~~L~~dP~~Rps~~ell~hp  276 (361)
T 3uc3_A          247 ISPECCHLISRIFVADPATRISIPEIKTHS  276 (361)
T ss_dssp             CCHHHHHHHHHHSCSCTTTSCCHHHHHTSH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHhCc
Confidence            788999999999999999999999999873

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.8e-43  Score=357.66  Aligned_cols=250  Identities=25%  Similarity=0.443  Sum_probs=216.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     +|+.||||++...........+.+.+|+.++++++||||+++++++......++||
T Consensus        26 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  105 (484)
T 3nyv_A           26 DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVG  105 (484)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             CceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEE
Confidence            3689999999999999983     68999999997654443444567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe---cCCCCEEEeecCCccccccC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~---~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ||+.+++|.+++...+.+++..+..++.|++.||.|||+++   |+||||||+|||+   +.++.+||+|||++......
T Consensus       106 e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  182 (484)
T 3nyv_A          106 EVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNK---IVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEAS  182 (484)
T ss_dssp             CCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCC
T ss_pred             ecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccc
Confidence            99999999999998888999999999999999999999999   9999999999999   56789999999999765432


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                        .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...+..+....+...........+..+++.++
T Consensus       183 --~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  259 (484)
T 3nyv_A          183 --KKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAK  259 (484)
T ss_dssp             --CSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHH
T ss_pred             --cccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHH
Confidence              23344568999999999876 689999999999999999999999998877666666644443333334567899999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      +||.+||+.||.+|||+.++++|-
T Consensus       260 ~li~~~L~~dp~~R~s~~e~l~h~  283 (484)
T 3nyv_A          260 DLIRKMLTYVPSMRISARDALDHE  283 (484)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHTSH
T ss_pred             HHHHHHCCCChhHCcCHHHHhhCh
Confidence            999999999999999999999873

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=1e-42  Score=329.98  Aligned_cols=247  Identities=25%  Similarity=0.466  Sum_probs=207.8

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      -.+|++.+.||+|+||.||.     ++..||+|++.............+.+|+.+++.++||||+++++++.+....++|
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   87 (279)
T 3fdn_A            8 LEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLI   87 (279)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEE
T ss_pred             cccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEE
Confidence            34788999999999999884     5678999998643222222245688899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++......  
T Consensus        88 ~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~--  162 (279)
T 3fdn_A           88 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS--  162 (279)
T ss_dssp             ECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---CEECCCCGGGEEECTTSCEEECSCCEESCC-----
T ss_pred             EecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHhEEEcCCCCEEEEeccccccCCcc--
Confidence            999999999999998888999999999999999999999999   999999999999999999999999998654322  


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                       ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+... ...+   +..+++.+.+|
T Consensus       163 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~~~~---~~~~~~~~~~l  237 (279)
T 3fdn_A          163 -RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV-EFTF---PDFVTEGARDL  237 (279)
T ss_dssp             ------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-CCCC---CTTSCHHHHHH
T ss_pred             -cccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhC-CCCC---CCcCCHHHHHH
Confidence             223456899999999999988999999999999999999999999877655555544332 2222   34577899999


Q ss_pred             HHHHcccCCCCCCCHHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      |.+||+.||.+|||+.+++++-
T Consensus       238 i~~~l~~~p~~Rps~~e~l~h~  259 (279)
T 3fdn_A          238 ISRLLKHNPSQRPMLREVLEHP  259 (279)
T ss_dssp             HHHHCCSSGGGSCCHHHHHHCH
T ss_pred             HHHHhccChhhCCCHHHHhhCc
Confidence            9999999999999999999983

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=5.4e-42  Score=330.46  Aligned_cols=260  Identities=26%  Similarity=0.434  Sum_probs=208.5

Q ss_pred             cCCccccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          152 PHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      ....+|.+.+.||+|+||.||.        ++..||+|.+..... .....+.+.+|+.++++++||||+++++++....
T Consensus        31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~  109 (313)
T 3brb_A           31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMS  109 (313)
T ss_dssp             CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC--
T ss_pred             cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeecc
Confidence            3455789999999999998873        345899999975532 4555677899999999999999999999997654


Q ss_pred             -----ceEEEEEccCCCCHHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCE
Q 012684          224 -----PMMIVTEYLPKGDLRAFLKR------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL  292 (458)
Q Consensus       224 -----~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~v  292 (458)
                           ..++||||+++++|.+++..      ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+
T Consensus       110 ~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~  186 (313)
T 3brb_A          110 SQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN---FLHRDLAARNCMLRDDMTV  186 (313)
T ss_dssp             -----CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCSGGGEEECTTSCE
T ss_pred             ccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCcE
Confidence                 45999999999999999843      345999999999999999999999999   9999999999999999999


Q ss_pred             EEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcC
Q 012684          293 KVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQ  370 (458)
Q Consensus       293 kl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~  370 (458)
                      ||+|||++........ .......+++.|+|||.+.+..++.++||||||+++|+|++ |..||...........+....
T Consensus       187 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  266 (313)
T 3brb_A          187 CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGH  266 (313)
T ss_dssp             EECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTC
T ss_pred             EEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCC
Confidence            9999999976543321 12233456889999999998889999999999999999999 899999888777766664444


Q ss_pred             CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      .+..   +..+++.+.++|..||+.||.+|||+.+++++|+++...+.
T Consensus       267 ~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~l~~~lp  311 (313)
T 3brb_A          267 RLKQ---PEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQLEKLLESLP  311 (313)
T ss_dssp             CCCC---BTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHC-
T ss_pred             CCCC---CccccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHhcC
Confidence            3333   45678899999999999999999999999999999977643

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=9.6e-42  Score=324.49  Aligned_cols=254  Identities=30%  Similarity=0.491  Sum_probs=206.7

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHH----HHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRV----RAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~----~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      ...+|++.+.||+|+||.||.     +++.||+|++...........    +.+.+|+.+++.++||||+++++++....
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~   96 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPP   96 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCC
Confidence            345788999999999998873     688999999976543332222    67889999999999999999999986654


Q ss_pred             ceEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC-----EEEeec
Q 012684          224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN-----LKVADF  297 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~-----vkl~Df  297 (458)
                        ++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+ .+++||||||+||+++.++.     ++|+||
T Consensus        97 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~-~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           97 --RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQN-PPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             --EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSS-SCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             --eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCC-CCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence              7999999999999888654 46999999999999999999999987 34999999999999998776     999999


Q ss_pred             CCccccccCCCCCcccCCCCCcccCCcccC--CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCC
Q 012684          298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFK--NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK  375 (458)
Q Consensus       298 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  375 (458)
                      |++.....    ......+|+.|+|||++.  ...++.++||||||+++|+|++|+.||....................+
T Consensus       174 g~~~~~~~----~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  249 (287)
T 4f0f_A          174 GLSQQSVH----SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRP  249 (287)
T ss_dssp             TTCBCCSS----CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCCC
T ss_pred             Cccccccc----cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCCC
Confidence            99875432    234456899999999984  445788999999999999999999999887766543222122222222


Q ss_pred             CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       376 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      ..+..+++.+.++|..||+.||.+|||+.++++.|+++
T Consensus       250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~l  287 (287)
T 4f0f_A          250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVKELSEL  287 (287)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTC
T ss_pred             CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhC
Confidence            33556889999999999999999999999999998753

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2e-42  Score=337.96  Aligned_cols=257  Identities=26%  Similarity=0.417  Sum_probs=211.2

Q ss_pred             CCccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEe
Q 012684          153 HELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQ  221 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~  221 (458)
                      ...+|.+.+.||+|+||.||.          ++..||+|++....  .....+.+.+|+.+++++ +||||+++++++..
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  120 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTL  120 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEee
Confidence            345788899999999999873          34579999997542  233456788999999999 89999999999999


Q ss_pred             CCceEEEEEccCCCCHHHHHHhcC-----------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCC
Q 012684          222 SSPMMIVTEYLPKGDLRAFLKRKG-----------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRD  278 (458)
Q Consensus       222 ~~~~~lv~e~~~~~~L~~~l~~~~-----------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~D  278 (458)
                      .+..++||||+++|+|.+++....                       .+++..++.++.|++.||.|||+.|   |+|||
T Consensus       121 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~D  197 (344)
T 1rjb_A          121 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRD  197 (344)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETT
T ss_pred             CCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---cccCC
Confidence            999999999999999999998643                       2789999999999999999999999   99999


Q ss_pred             CCCCCEEecCCCCEEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCC
Q 012684          279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTM  356 (458)
Q Consensus       279 ikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~  356 (458)
                      |||+||+++.++.++|+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..
T Consensus       198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~  277 (344)
T 1rjb_A          198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG  277 (344)
T ss_dssp             CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred             CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence            99999999999999999999998664332211 123346788999999988889999999999999999998 9999998


Q ss_pred             CCCCcHHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          357 KHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       357 ~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      .............. ...   .+..+++.+.+||..||+.||.+|||+.+++++|+.+....
T Consensus       278 ~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~  336 (344)
T 1rjb_A          278 IPVDANFYKLIQNGFKMD---QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGCQLADA  336 (344)
T ss_dssp             CCCSHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC---
T ss_pred             CCcHHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHHHHHHH
Confidence            77665544443333 222   23457889999999999999999999999999999886543

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=3.9e-42  Score=334.85  Aligned_cols=258  Identities=24%  Similarity=0.388  Sum_probs=219.8

Q ss_pred             CCCCcccCcC-CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeee
Q 012684          144 EVPEYEIDPH-ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG  217 (458)
Q Consensus       144 ~~~~~~~~~~-~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~  217 (458)
                      ..+....++. ..+|.+.+.||+|+||.||.     +++.||+|++...........+.+.+|+.+++.++||||+++++
T Consensus        29 ~~~~~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~  108 (335)
T 2owb_A           29 EIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG  108 (335)
T ss_dssp             CCCSEEEETTTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEE
T ss_pred             cCcceecCcccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEE
Confidence            3344444333 34799999999999999884     57899999998766556677788999999999999999999999


Q ss_pred             EEEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeec
Q 012684          218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (458)
Q Consensus       218 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Df  297 (458)
                      ++.+.+..++||||+++++|.+++...+.+++..++.++.|++.||.|||+++   |+|+||||+||+++.++.++|+||
T Consensus       109 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Df  185 (335)
T 2owb_A          109 FFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VIHRDLKLGNLFLNEDLEVKIGDF  185 (335)
T ss_dssp             EEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCC
T ss_pred             EEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CEecCCCchhEEEcCCCCEEEeec
Confidence            99999999999999999999999998888999999999999999999999999   999999999999999999999999


Q ss_pred             CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCC
Q 012684          298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP  377 (458)
Q Consensus       298 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  377 (458)
                      |++....... .......+|+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+... ...+   
T Consensus       186 g~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~---  260 (335)
T 2owb_A          186 GLATKVEYDG-ERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN-EYSI---  260 (335)
T ss_dssp             TTCEECCSTT-CCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHT-CCCC---
T ss_pred             cCceecccCc-ccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcC-CCCC---
Confidence            9998764322 2234456899999999998888999999999999999999999999876655544444322 2222   


Q ss_pred             hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          378 AKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       378 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       261 ~~~~~~~~~~li~~~l~~dp~~Rps~~ell~~  292 (335)
T 2owb_A          261 PKHINPVAASLIQKMLQTDPTARPTINELLND  292 (335)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             CccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            34577899999999999999999999999987

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.6e-42  Score=329.72  Aligned_cols=254  Identities=22%  Similarity=0.338  Sum_probs=206.9

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC--ce
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PM  225 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--~~  225 (458)
                      ...+|++.+.||+|+||.||.     +|+.||||++.....  ....+.+.+|+.+++.++||||+++++++....  ..
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~   84 (319)
T 4euu_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (319)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceE
Confidence            355799999999999999884     489999999975432  222456788999999999999999999998655  78


Q ss_pred             EEEEEccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe----cCCCCEEEeecC
Q 012684          226 MIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFG  298 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~----~~~~~vkl~Dfg  298 (458)
                      ++||||+++++|.+++.....   +++..++.++.|++.||.|||+.+   |+||||||+||++    +.++.+||+|||
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg  161 (319)
T 4euu_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (319)
T ss_dssp             EEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEECTTSCEEEEECCCT
T ss_pred             EEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEeccCCCCceEEEccCC
Confidence            999999999999999986433   899999999999999999999999   9999999999999    777889999999


Q ss_pred             CccccccCCCCCcccCCCCCcccCCcccC--------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc----HHHHH
Q 012684          299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFK--------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAY  366 (458)
Q Consensus       299 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--------~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~----~~~~~  366 (458)
                      ++......  .......||+.|+|||++.        +..++.++|||||||++|+|++|+.||.......    ....+
T Consensus       162 ~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~  239 (319)
T 4euu_A          162 AARELEDD--EQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (319)
T ss_dssp             TCEECCTT--CCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHH
T ss_pred             CceecCCC--CceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHH
Confidence            99876433  2333456899999999875        4678899999999999999999999997654432    22222


Q ss_pred             HhcCC---------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          367 AARQR---------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       367 ~~~~~---------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      .....                     +........++..+.++|..||+.||.+|||+.+++++..+-
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~~d~  307 (319)
T 4euu_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDI  307 (319)
T ss_dssp             HHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHH
T ss_pred             hcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhccHHH
Confidence            11111                     111123456788999999999999999999999999998764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=4.1e-42  Score=352.14  Aligned_cols=247  Identities=23%  Similarity=0.423  Sum_probs=208.7

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.||.     ++..||+|++....... .....+.+|+.+++.++||||+++++++......|+|||
T Consensus        38 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e  116 (494)
T 3lij_A           38 MYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVME  116 (494)
T ss_dssp             HEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEe
Confidence            699999999999999983     68899999997643322 224568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC---CCEEEeecCCccccccCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~---~~vkl~Dfg~~~~~~~~~  307 (458)
                      |+++|+|.+++.....+++..+..++.|++.||.|||+.|   |+||||||+|||++..   +.+||+|||++...... 
T Consensus       117 ~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~-  192 (494)
T 3lij_A          117 CYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN---IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ-  192 (494)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTT-
T ss_pred             cCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCC-
Confidence            9999999999988888999999999999999999999999   9999999999999864   45999999999876433 


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                       .......||+.|+|||++.+ .++.++|||||||++|+|++|..||......+....+...........+..+++.+.+
T Consensus       193 -~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  270 (494)
T 3lij_A          193 -KKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKD  270 (494)
T ss_dssp             -BCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHHH
T ss_pred             -ccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHHH
Confidence             23344578999999999875 6899999999999999999999999988777776666544444333445678899999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ||.+||+.||.+|||+.+++++
T Consensus       271 li~~~L~~dp~~R~s~~e~l~h  292 (494)
T 3lij_A          271 LIKQMLQFDSQRRISAQQALEH  292 (494)
T ss_dssp             HHHHHTCSSTTTSCCHHHHHTC
T ss_pred             HHHHHCCCChhhCccHHHHhcC
Confidence            9999999999999999999987

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=4.5e-42  Score=323.54  Aligned_cols=249  Identities=28%  Similarity=0.448  Sum_probs=210.6

Q ss_pred             ccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--CceEEEE
Q 012684          155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||   .+|..||+|++..... .....+.+.+|+.++++++||||+++++++...  ...++||
T Consensus        10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~   88 (271)
T 3kmu_A           10 KQLNFLTKLNENHSGELWKGRWQGNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLIT   88 (271)
T ss_dssp             GGCEEEEEEEEETTEEEEEEEETTEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEE
T ss_pred             HHhHHHHHhcCCCcceEEEEEECCeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeee
Confidence            368888999999999887   5799999999986533 445567799999999999999999999999876  7789999


Q ss_pred             EccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          230 EYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||+++++|.+++...+  .+++..++.++.|++.||.|||+.++ +++||||||+||+++.++.++|+|||+.....   
T Consensus        89 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~-~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~---  164 (271)
T 3kmu_A           89 HWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEP-LIPRHALNSRSVMIDEDMTARISMADVKFSFQ---  164 (271)
T ss_dssp             ECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSS-CCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---
T ss_pred             cccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCC-ceecCCCccceEEEcCCcceeEEeccceeeec---
Confidence            9999999999998765  48999999999999999999999763 49999999999999999999999998875422   


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCC---chhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDT---KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYAR  383 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~---~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  383 (458)
                         .....+|+.|+|||.+.+..++.   ++||||||+++|+|++|+.||................ .+.   .+..+++
T Consensus       165 ---~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  238 (271)
T 3kmu_A          165 ---SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT---IPPGISP  238 (271)
T ss_dssp             ---CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCCC---CCTTCCH
T ss_pred             ---ccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCCC---CCCCCCH
Confidence               12345789999999998765544   7999999999999999999998876665544443333 222   3456789


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      .+.++|..||+.||.+|||+.++++.|+++.
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~~L~~l~  269 (271)
T 3kmu_A          239 HVSKLMKICMNEDPAKRPKFDMIVPILEKMQ  269 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHHHHHhh
Confidence            9999999999999999999999999999874

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.1e-42  Score=353.01  Aligned_cols=251  Identities=24%  Similarity=0.398  Sum_probs=210.5

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCH----------HHHHHHHHHHHHHhcCCCCcceeeeeE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD----------DRVRAFRDELALLQKIRHPNVVQFLGA  218 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~----------~~~~~~~~E~~~l~~l~hp~i~~~~~~  218 (458)
                      ..+|++.+.||+|+||.||.     ++..||+|++........          ...+.+.+|+.+++.++||||++++++
T Consensus        35 ~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~  114 (504)
T 3q5i_A           35 GESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDV  114 (504)
T ss_dssp             GGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             ccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEE
Confidence            34699999999999999984     678999999976443211          224678899999999999999999999


Q ss_pred             EEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC---CEEEe
Q 012684          219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVA  295 (458)
Q Consensus       219 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~---~vkl~  295 (458)
                      +.+....++||||++||+|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++   .+||+
T Consensus       115 ~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~  191 (504)
T 3q5i_A          115 FEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHN---IVHRDIKPENILLENKNSLLNIKIV  191 (504)
T ss_dssp             EECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESSTTCCSSEEEC
T ss_pred             EEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCcHHHEEEecCCCCccEEEE
Confidence            9999999999999999999999988888999999999999999999999999   99999999999999776   69999


Q ss_pred             ecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCC
Q 012684          296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK  375 (458)
Q Consensus       296 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  375 (458)
                      |||++......  .......||+.|+|||++.+ .++.++|||||||++|+|++|..||...+..+....+.........
T Consensus       192 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~  268 (504)
T 3q5i_A          192 DFGLSSFFSKD--YKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF  268 (504)
T ss_dssp             CCTTCEECCTT--SCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCH
T ss_pred             ECCCCEEcCCC--CccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCc
Confidence            99999876432  23345568999999999875 6899999999999999999999999988777666666443332222


Q ss_pred             CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       376 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      ..+..+++.+.+||..||+.||.+|||+.+++++-
T Consensus       269 ~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~  303 (504)
T 3q5i_A          269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSR  303 (504)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             cccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCH
Confidence            23456789999999999999999999999999873

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=3.3e-42  Score=334.23  Aligned_cols=255  Identities=24%  Similarity=0.495  Sum_probs=208.5

Q ss_pred             CCccccCceeeccceEEEEEE-----cCe----EEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      ...+|+..+.||+|+||.||.     +|+    .||+|.+....  .....+.+.+|+.++++++||||+++++++..+ 
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-   89 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-   89 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESS-
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeeccccc--CHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecC-
Confidence            345789999999999999984     343    46888886432  233456788999999999999999999999875 


Q ss_pred             ceEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      ..++|+|++.+|+|.+++.. .+.+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~Dikp~NIll~~~~~~kl~Dfg~a~~  166 (327)
T 3poz_A           90 TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTHHHH
T ss_pred             CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCChheEEECCCCCEEEccCcceeE
Confidence            47899999999999999987 456999999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhh
Q 012684          303 LTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL  380 (458)
Q Consensus       303 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (458)
                      ....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+......+.   +..
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  243 (327)
T 3poz_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPI  243 (327)
T ss_dssp             HTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTT
T ss_pred             ccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC---Ccc
Confidence            6433222 2233456889999999999899999999999999999999 9999998877777666644443333   345


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          381 YARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ++..+.+++.+||+.||.+|||+.+++++|+.+...
T Consensus       244 ~~~~~~~li~~~l~~~p~~Rps~~ell~~l~~~~~~  279 (327)
T 3poz_A          244 CTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             BCHHHHHHHHHHTCSCGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHhh
Confidence            778999999999999999999999999999988654

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-41  Score=330.85  Aligned_cols=258  Identities=29%  Similarity=0.504  Sum_probs=211.1

Q ss_pred             CCccccCceeeccceEEEEEE---c------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          153 HELDFTNSVEITKGTFILAFW---R------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~---~------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      ...+|+..+.||+|+||.||.   .      +..||||.+....  .......+.+|+.+++.++||||+++++++....
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  119 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYK  119 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSS
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCC
Confidence            345688889999999998874   1      2359999997542  4455667899999999999999999999999999


Q ss_pred             ceEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      ..++||||+++++|.+++... +.+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.+||+|||++..
T Consensus       120 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~  196 (333)
T 1mqb_A          120 PMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRV  196 (333)
T ss_dssp             SEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC---
T ss_pred             CcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChheEEECCCCcEEECCCCcchh
Confidence            999999999999999999864 56999999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCCCC--cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChh
Q 012684          303 LTVKEDRP--LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK  379 (458)
Q Consensus       303 ~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  379 (458)
                      ........  .....+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+......+.   +.
T Consensus       197 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~---~~  273 (333)
T 1mqb_A          197 LEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT---PM  273 (333)
T ss_dssp             --------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CT
T ss_pred             hccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcCCC---cc
Confidence            64332211  123345778999999988889999999999999999999 9999988776666555544333332   34


Q ss_pred             hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          380 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       380 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      .+++.+.++|.+||+.||.+||++.++++.|+++.....
T Consensus       274 ~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~~  312 (333)
T 1mqb_A          274 DCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRAPD  312 (333)
T ss_dssp             TCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHSGG
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhcch
Confidence            678899999999999999999999999999999876543

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.4e-42  Score=338.71  Aligned_cols=245  Identities=23%  Similarity=0.405  Sum_probs=204.0

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      +|++.+.||+|+||.|+.     +|+.||||++......       ..+|+.++.++ +||||+++++++.++...|+||
T Consensus        23 ~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~   95 (342)
T 2qr7_A           23 GYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVT   95 (342)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEE
T ss_pred             cEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEE
Confidence            688899999999999884     5899999999765322       34577777777 7999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC----CCEEEeecCCcccccc
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS----GNLKVADFGVSKLLTV  305 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~----~~vkl~Dfg~~~~~~~  305 (458)
                      ||++||+|.+++...+.+++..+..++.|++.||.|||++|   |+||||||+|||+...    +.+||+|||++.....
T Consensus        96 E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~g---ivHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~  172 (342)
T 2qr7_A           96 ELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQG---VVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA  172 (342)
T ss_dssp             CCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBC
T ss_pred             eCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcC
Confidence            99999999999998888999999999999999999999999   9999999999998543    3499999999987643


Q ss_pred             CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc---HHHHHHhcCCCCCCCChhhhH
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---VPKAYAARQRPPFKAPAKLYA  382 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~---~~~~~~~~~~~~~~~~~~~~~  382 (458)
                      .. .......+|+.|+|||++.+..++.++|||||||++|+|++|..||.......   +...+...........+..++
T Consensus       173 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  251 (342)
T 2qr7_A          173 EN-GLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVS  251 (342)
T ss_dssp             TT-CCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSC
T ss_pred             CC-CceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCC
Confidence            32 22334568999999999988788899999999999999999999998643332   333333323332223456788


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      +.+.+||.+||+.||.+|||+.++++|-.
T Consensus       252 ~~~~~li~~~L~~dP~~R~t~~~il~hp~  280 (342)
T 2qr7_A          252 DTAKDLVSKMLHVDPHQRLTAALVLRHPW  280 (342)
T ss_dssp             HHHHHHHHHHTCSSTTTSCCHHHHTTSHH
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCCe
Confidence            99999999999999999999999998743

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=6e-42  Score=328.84  Aligned_cols=247  Identities=24%  Similarity=0.376  Sum_probs=209.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|.+.+.||+|+||.||.     +|+.||+|.+....   ....+.+.+|+.+++.++||||+++++++......++||
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   85 (304)
T 2jam_A            9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSP---AFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVM   85 (304)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEeccc---ccchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEE
Confidence            3688899999999999883     68999999997542   223356889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe---cCCCCEEEeecCCccccccC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~---~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||||+||++   +.++.++|+|||++......
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~  162 (304)
T 2jam_A           86 QLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENG---IVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG  162 (304)
T ss_dssp             CCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB
T ss_pred             EcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC
Confidence            99999999999988888999999999999999999999999   9999999999999   78889999999998754321


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                         ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||...........+...........+..+++.+.
T Consensus       163 ---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  239 (304)
T 2jam_A          163 ---IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAK  239 (304)
T ss_dssp             ---TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHH
T ss_pred             ---ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHH
Confidence               22234578999999999998999999999999999999999999988766655555544333322333456889999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      ++|.+||+.||.+|||+.+++++-
T Consensus       240 ~li~~~l~~dp~~Rps~~~~l~h~  263 (304)
T 2jam_A          240 DFICHLLEKDPNERYTCEKALSHP  263 (304)
T ss_dssp             HHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             HHHHHHcCCChhHCcCHHHHhcCc
Confidence            999999999999999999999873

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=4.5e-42  Score=331.96  Aligned_cols=255  Identities=25%  Similarity=0.479  Sum_probs=211.0

Q ss_pred             cccCceeeccceEEEEEE---------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--Cc
Q 012684          156 DFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--SP  224 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~~  224 (458)
                      .|++.+.||+|+||.|+.         +|+.||||++...  ......+.+.+|+.+++.++||||+++++++...  ..
T Consensus        32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~  109 (318)
T 3lxp_A           32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAAS  109 (318)
T ss_dssp             GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTE
T ss_pred             HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCce
Confidence            358899999999999952         6889999999754  3455667899999999999999999999999874  56


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      .++||||+++++|.+++... .+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....
T Consensus       110 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~  185 (318)
T 3lxp_A          110 LQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHAQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP  185 (318)
T ss_dssp             EEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCGGGCEECC
T ss_pred             EEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCchheEEEcCCCCEEECCcccccccc
Confidence            89999999999999999765 4999999999999999999999999   9999999999999999999999999998764


Q ss_pred             cCCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC---------------cHHHHHH
Q 012684          305 VKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN---------------EVPKAYA  367 (458)
Q Consensus       305 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~---------------~~~~~~~  367 (458)
                      ....  .......+|+.|+|||++.+..++.++||||||+++|+|++|+.||......               .......
T Consensus       186 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  265 (318)
T 3lxp_A          186 EGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLE  265 (318)
T ss_dssp             TTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHH
T ss_pred             ccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHHh
Confidence            3321  1123445788899999998888899999999999999999999998753211               0111111


Q ss_pred             hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012684          368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH  419 (458)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  419 (458)
                      .   ......+..+++.+.+||..||+.||.+|||+.++++.|+.+.+.+..
T Consensus       266 ~---~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~~~  314 (318)
T 3lxp_A          266 R---GERLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIPILKTVHEKYQG  314 (318)
T ss_dssp             T---TCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHHHC
T ss_pred             c---ccCCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHHhhcc
Confidence            1   112223456789999999999999999999999999999999877654

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=329.32  Aligned_cols=248  Identities=26%  Similarity=0.403  Sum_probs=199.6

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCC-----------------------HHHHHHHHHHHHHHhc
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD-----------------------DDRVRAFRDELALLQK  206 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~  206 (458)
                      .+|++.+.||+|+||.||.     +|+.||||++.......                       ....+.+.+|+.+++.
T Consensus        13 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~   92 (298)
T 2zv2_A           13 NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKK   92 (298)
T ss_dssp             TTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHT
T ss_pred             cceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHh
Confidence            3688999999999999984     58999999997543211                       1224568899999999


Q ss_pred             CCCCcceeeeeEEEe--CCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCE
Q 012684          207 IRHPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNI  284 (458)
Q Consensus       207 l~hp~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Ni  284 (458)
                      ++||||+++++++..  ....++||||+++++|.+++. .+.+++..+..++.|++.||.|||+.+   |+||||||+||
T Consensus        93 l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Ni  168 (298)
T 2zv2_A           93 LDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQK---IIHRDIKPSNL  168 (298)
T ss_dssp             CCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGE
T ss_pred             CCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHE
Confidence            999999999999986  567899999999999988654 356999999999999999999999999   99999999999


Q ss_pred             EecCCCCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCC---CCCchhHHHHHHHHHHHHcCCCCCCCCCCCc
Q 012684          285 LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNE  361 (458)
Q Consensus       285 l~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~~lltg~~pf~~~~~~~  361 (458)
                      +++.++.+||+|||++....... .......||+.|+|||++.+..   ++.++||||||+++|+|++|+.||.......
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~  247 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSD-ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMC  247 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSS-CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred             EECCCCCEEEecCCCcccccccc-ccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHH
Confidence            99999999999999998654332 2223456899999999998764   3678999999999999999999998765544


Q ss_pred             HHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          362 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ....+.. ....++ ....+++.+.++|.+||+.||.+|||+.+++++
T Consensus       248 ~~~~~~~-~~~~~~-~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~h  293 (298)
T 2zv2_A          248 LHSKIKS-QALEFP-DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLH  293 (298)
T ss_dssp             HHHHHHH-CCCCCC-SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTC
T ss_pred             HHHHHhc-ccCCCC-CccccCHHHHHHHHHHhhcChhhCCCHHHHhcC
Confidence            4444322 222222 234578899999999999999999999999876

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.3e-42  Score=336.77  Aligned_cols=239  Identities=24%  Similarity=0.390  Sum_probs=181.3

Q ss_pred             eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEccCC
Q 012684          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      +.||+|+||.|+.     +|+.||||++...      ....+.+|+.+++.+. ||||+++++++.++...|+||||+++
T Consensus        17 ~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~   90 (325)
T 3kn6_A           17 KPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNG   90 (325)
T ss_dssp             CCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCS
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCC
Confidence            6799999999884     5899999999643      2346778999999996 99999999999999999999999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC---CEEEeecCCccccccCCCCCc
Q 012684          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSKLLTVKEDRPL  311 (458)
Q Consensus       235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~---~vkl~Dfg~~~~~~~~~~~~~  311 (458)
                      ++|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+||+++.++   .+||+|||++...... ....
T Consensus        91 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~-~~~~  166 (325)
T 3kn6_A           91 GELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVG---VVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPD-NQPL  166 (325)
T ss_dssp             CBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEC----CEEEECCCTTCEECCC------
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---CeecCCCHHHEEEecCCCcccEEEeccccceecCCC-CCcc
Confidence            999999999888999999999999999999999999   99999999999998766   7999999999865432 2223


Q ss_pred             ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-------cHHHHHHhcCCCCCCCChhhhHHH
Q 012684          312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-------EVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      ....+|+.|+|||++.+..++.++||||||+++|+|++|+.||......       +....+...........+..++++
T Consensus       167 ~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  246 (325)
T 3kn6_A          167 KTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQE  246 (325)
T ss_dssp             -----------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCHH
T ss_pred             cccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCHH
Confidence            4456799999999999989999999999999999999999999875432       122222222222222233567899


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.+||..||+.||.+|||+.+++++
T Consensus       247 ~~~li~~~L~~dP~~Rpt~~ell~h  271 (325)
T 3kn6_A          247 AKDLIQGLLTVDPNKRLKMSGLRYN  271 (325)
T ss_dssp             HHHHHHHHHCCCTTTCCCTTTSTTC
T ss_pred             HHHHHHHHCCCChhHCCCHHHHhcC
Confidence            9999999999999999999999876

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.4e-42  Score=352.39  Aligned_cols=251  Identities=29%  Similarity=0.505  Sum_probs=215.5

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|++.+.||+|+||.||.     ++..||||.+.....    ..+.+.+|+.++++++||||+++++++......++|
T Consensus       219 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~----~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv  294 (495)
T 1opk_A          219 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII  294 (495)
T ss_dssp             GGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred             HHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCccc----chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEE
Confidence            34678889999999998873     378999999975432    246788999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          229 TEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      |||+++|+|.+++...  ..+++..++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++......
T Consensus       295 ~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~  371 (495)
T 1opk_A          295 TEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRNLAARNCLVGENHLVKVADFGLSRLMTGD  371 (495)
T ss_dssp             EECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCEEECCTTCEECCTTC
T ss_pred             EEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChhhEEECCCCcEEEeecccceeccCC
Confidence            9999999999999864  34899999999999999999999999   999999999999999999999999999876433


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL  385 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (458)
                      .........+++.|+|||++.+..++.++||||||+++|+|++ |..||......+....+....+...   +..+++.+
T Consensus       372 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l  448 (495)
T 1opk_A          372 TYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER---PEGCPEKV  448 (495)
T ss_dssp             CEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC---CTTCCHHH
T ss_pred             ceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHH
Confidence            2222333456788999999988889999999999999999999 9999998887777666644434333   45678999


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      .+||..||+.||.+|||+.++++.|+.+.
T Consensus       449 ~~li~~cl~~dP~~RPs~~el~~~L~~~~  477 (495)
T 1opk_A          449 YELMRACWQWNPSDRPSFAEIHQAFETMF  477 (495)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHHHHTSC
T ss_pred             HHHHHHHcCcChhHCcCHHHHHHHHHHHH
Confidence            99999999999999999999999998874

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4.1e-42  Score=326.27  Aligned_cols=249  Identities=24%  Similarity=0.386  Sum_probs=208.1

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCH---HHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      +|++.+.||+|+||.||.     +|+.||+|.+........   ...+.+.+|+.+++.++||||+++++++......++
T Consensus         6 ~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~l   85 (283)
T 3bhy_A            6 HYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVL   85 (283)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEE
T ss_pred             hhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEE
Confidence            688899999999999884     589999999876433221   124678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC----CEEEeecCCcccc
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKLL  303 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~----~vkl~Dfg~~~~~  303 (458)
                      ||||+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++    .++|+|||++...
T Consensus        86 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~  162 (283)
T 3bhy_A           86 ILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKR---IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKI  162 (283)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSSSSCCEEECCCTTCEEC
T ss_pred             EEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChHHEEEecCCCCCCceEEEecccceec
Confidence            9999999999999988888999999999999999999999999   99999999999999877    8999999999865


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      ...  .......+++.|+|||++.+..++.++||||||+++|+|++|+.||......+....+..............+++
T Consensus       163 ~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T 3bhy_A          163 EAG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSE  240 (283)
T ss_dssp             C----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCH
T ss_pred             cCC--CcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCH
Confidence            432  222345689999999999988999999999999999999999999988765555444433222222222345778


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+.++|.+||..||.+|||+.+++++
T Consensus       241 ~~~~li~~~l~~dp~~Rps~~~~l~h  266 (283)
T 3bhy_A          241 LAKDFIRRLLVKDPKRRMTIAQSLEH  266 (283)
T ss_dssp             HHHHHHHTTSCSSGGGSCCHHHHHHC
T ss_pred             HHHHHHHHHccCCHhHCcCHHHHHhC
Confidence            99999999999999999999999986

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=8.2e-42  Score=327.30  Aligned_cols=255  Identities=24%  Similarity=0.477  Sum_probs=204.7

Q ss_pred             ccccCceeeccceEEEEEE---------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC--C
Q 012684          155 LDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS--S  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~--~  223 (458)
                      .+|++.+.||+|+||.||.         +|+.||+|++....  .....+.+.+|+.+++.++||||+++++++...  .
T Consensus        21 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           21 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---C
T ss_pred             hhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCc
Confidence            4588899999999999872         68999999997543  223346788999999999999999999999876  6


Q ss_pred             ceEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      ..++||||+++++|.+++.. ...+++..++.++.|++.||+|||+.+   ++|+||||+||+++.++.++|+|||++..
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nil~~~~~~~kl~Dfg~~~~  175 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA  175 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEE
T ss_pred             eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCC---cccCCCchheEEEcCCCCEEECccccccc
Confidence            78999999999999999954 456999999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC-----------CCcHHHHH-Hh
Q 012684          303 LTVKED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH-----------DNEVPKAY-AA  368 (458)
Q Consensus       303 ~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~-----------~~~~~~~~-~~  368 (458)
                      ......  .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.|+....           ........ ..
T Consensus       176 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (302)
T 4e5w_A          176 IETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNT  255 (302)
T ss_dssp             CCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHH
T ss_pred             ccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHH
Confidence            654322  12234567888999999988888999999999999999999999864321           11111111 11


Q ss_pred             cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       369 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      .........+..+++.+.++|.+||+.||.+|||+.++++.|+++.
T Consensus       256 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~ll  301 (302)
T 4e5w_A          256 LKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIEGFEALL  301 (302)
T ss_dssp             HHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred             HhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHh
Confidence            1111112234568899999999999999999999999999999874

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=6.1e-42  Score=330.86  Aligned_cols=248  Identities=25%  Similarity=0.477  Sum_probs=190.6

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     +|+.||+|.+.....  ....+.+.+|+.+++.++||||+++++++..++..++||
T Consensus         5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSE--EGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             --------------CEEEEEECSSSCCEEEEEEEECCST--TCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEE
T ss_pred             cceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccc--cccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEE
Confidence            4688889999999999984     589999999975432  222356778999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          230 EYLPKGDLRAFLKRK------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       230 e~~~~~~L~~~l~~~------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ||++ ++|.+++...      ..+++..+..++.|++.||.|||+.|   |+||||||+||+++.++.+||+|||++...
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~  158 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENK---ILHRDLKPQNLLINKRGQLKLGDFGLARAF  158 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCSSCEET
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCChHHeEEcCCCCEEECcCccceec
Confidence            9996 6999998753      34899999999999999999999999   999999999999999999999999999865


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCC--------
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP--------  373 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~--------  373 (458)
                      .... .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+.... .+.        
T Consensus       159 ~~~~-~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  237 (317)
T 2pmi_A          159 GIPV-NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVT  237 (317)
T ss_dssp             TSCC-CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGG
T ss_pred             CCCc-ccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhh
Confidence            4322 223345689999999998764 68999999999999999999999998876655444432211 110        


Q ss_pred             --------CC-------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 --------FK-------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 --------~~-------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                              ..             .....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~h  294 (317)
T 2pmi_A          238 KLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHH  294 (317)
T ss_dssp             GCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             hhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCC
Confidence                    00             0012467889999999999999999999999886

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=3.3e-42  Score=328.10  Aligned_cols=248  Identities=27%  Similarity=0.472  Sum_probs=199.5

Q ss_pred             cccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      +|++.+.||+|+||.||.    +|+.||+|.+..... .....+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus         3 ~y~~~~~lg~G~~g~V~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~   81 (288)
T 1ob3_A            3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (288)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             cchhhhhcccCCCEEEEEEEcCCCCEEEEEEEecccc-ccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEe
Confidence            688889999999999884    588999999975432 222235677899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      +++ +|.+++... +.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++...... ...
T Consensus        82 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~  156 (288)
T 1ob3_A           82 LDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIP-VRK  156 (288)
T ss_dssp             CSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----
T ss_pred             cCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEeECccccccCcc-ccc
Confidence            965 999998764 56999999999999999999999999   999999999999999999999999998765422 122


Q ss_pred             cccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-CCCC---------------
Q 012684          311 LTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPP---------------  373 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~~~~---------------  373 (458)
                      .....+|+.|+|||++.+. .++.++||||||+++|+|++|+.||......+....+... +.+.               
T Consensus       157 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  236 (288)
T 1ob3_A          157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDP  236 (288)
T ss_dssp             -----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT
T ss_pred             cccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccc
Confidence            2344679999999998764 5889999999999999999999999876654443333221 1110               


Q ss_pred             -C--------CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 -F--------KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 -~--------~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                       +        ......+++.+.+||.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  281 (288)
T 1ob3_A          237 NFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (288)
T ss_dssp             TCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence             0        01123467899999999999999999999999876

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.9e-42  Score=332.99  Aligned_cols=255  Identities=24%  Similarity=0.502  Sum_probs=207.5

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeE----EEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      ...+|++.+.||+|+||.||.     +|+.    ||+|.+....  .....+.+.+|+.+++.++||||+++++++..+.
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~   90 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTST   90 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCS--SCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeecccc--CHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC
Confidence            355799999999999999984     3443    5777775432  2233467889999999999999999999998754


Q ss_pred             ceEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                       .++|++++.+++|.+++.. .+.+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        91 -~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kL~DfG~a~~  166 (327)
T 3lzb_A           91 -VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKL  166 (327)
T ss_dssp             -EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCTTC---
T ss_pred             -ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCC---CcCCCCCHHHEEEcCCCCEEEccCcceeE
Confidence             7899999999999999986 456999999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhh
Q 012684          303 LTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL  380 (458)
Q Consensus       303 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (458)
                      ....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+......+.   +..
T Consensus       167 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  243 (327)
T 3lzb_A          167 LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPI  243 (327)
T ss_dssp             -------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTT
T ss_pred             ccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence            6433221 2233456788999999999899999999999999999999 9999998887777666644443333   455


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          381 YARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ++..+.++|..||+.||.+|||+.++++.|+.+...
T Consensus       244 ~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  279 (327)
T 3lzb_A          244 CTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD  279 (327)
T ss_dssp             BCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHTS
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhC
Confidence            788999999999999999999999999999998654

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=3.4e-42  Score=352.04  Aligned_cols=249  Identities=26%  Similarity=0.430  Sum_probs=211.6

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|++.+.||+|+||.||.     +|+.||||++....... .....+.+|+.++++++||||+++++++......++|
T Consensus        21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv   99 (486)
T 3mwu_A           21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKN-KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIV   99 (486)
T ss_dssp             HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBC-SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccc-hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEE
Confidence            34799999999999999884     68999999986432111 1245688999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec---CCCCEEEeecCCcccccc
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~---~~~~vkl~Dfg~~~~~~~  305 (458)
                      |||+.+++|.+++...+.+++..+..++.|++.||.|||+.|   |+||||||+|||++   .++.+||+|||++.....
T Consensus       100 ~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~  176 (486)
T 3mwu_A          100 GELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (486)
T ss_dssp             ECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCC
T ss_pred             EEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCchHHEEEecCCCCCCEEEEECCcCeECCC
Confidence            999999999999988888999999999999999999999999   99999999999995   456799999999986543


Q ss_pred             CCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHH
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL  385 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (458)
                      .  .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||.+....+....+...........+..+++.+
T Consensus       177 ~--~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  253 (486)
T 3mwu_A          177 N--TKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDA  253 (486)
T ss_dssp             C------CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHH
T ss_pred             C--CccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHH
Confidence            2  23344578999999999976 58999999999999999999999999877766666664444333334456789999


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+||.+||+.||.+|||+.+++++
T Consensus       254 ~~li~~~L~~dp~~R~t~~~~l~h  277 (486)
T 3mwu_A          254 KDLIRKMLTFHPSLRITATQCLEH  277 (486)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHHC
T ss_pred             HHHHHHHcCCChhhCcCHHHHhcC
Confidence            999999999999999999999987

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3e-42  Score=349.04  Aligned_cols=254  Identities=31%  Similarity=0.502  Sum_probs=209.4

Q ss_pred             CccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      ..+|++.+.||+|+||.||.    .+..||||.+..... .   .+.+.+|+.++++++||||+++++++.. ...++||
T Consensus       183 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~-~---~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~  257 (452)
T 1fmk_A          183 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVT  257 (452)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-C---HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEE
T ss_pred             hhHceeeeeecCCCCeEEEEEEECCCceEEEEEeccCCC-C---HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEe
Confidence            34678889999999998873    346899999976432 2   3568899999999999999999999876 6789999


Q ss_pred             EccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          230 EYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       230 e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||+++|+|.+++..  ...+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.......
T Consensus       258 e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~  334 (452)
T 1fmk_A          258 EYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNE  334 (452)
T ss_dssp             CCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred             hhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChhhEEECCCCCEEECCCccceecCCCc
Confidence            99999999999974  356999999999999999999999999   9999999999999999999999999998765332


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                      ........+++.|+|||.+.+..++.++||||||+++|+|++ |+.||.+....+....+....+.+.   +..+++.+.
T Consensus       335 ~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~  411 (452)
T 1fmk_A          335 YTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PPECPESLH  411 (452)
T ss_dssp             --------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTSCHHHH
T ss_pred             eecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHH
Confidence            223334456789999999988889999999999999999999 9999998877666666644444443   346788999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          387 ELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      ++|..||+.||.+|||+.++++.|+.+....+
T Consensus       412 ~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~~~  443 (452)
T 1fmk_A          412 DLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  443 (452)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHhccCC
Confidence            99999999999999999999999998875543

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.4e-42  Score=339.20  Aligned_cols=253  Identities=21%  Similarity=0.323  Sum_probs=206.4

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCC--CCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVI--SDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      ..+|++.+.||+|+||.||.     ++..||+|++.....  ......+.+.+|+.+++.++||||+++++++.+....+
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~  104 (345)
T 3hko_A           25 QKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYIC  104 (345)
T ss_dssp             HHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             hhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEE
Confidence            45799999999999998874     578999999864321  12334567899999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHh----------------------------------------cCCCCHHHHHHHHHHHHHHHHHH
Q 012684          227 IVTEYLPKGDLRAFLKR----------------------------------------KGALKPSTAVRFALDIARGMNYL  266 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~----------------------------------------~~~~~~~~~~~i~~qi~~~l~~L  266 (458)
                      +||||++|++|.+++..                                        ...+++..++.++.|++.||.||
T Consensus       105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L  184 (345)
T 3hko_A          105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL  184 (345)
T ss_dssp             EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence            99999999999998852                                        01135677888999999999999


Q ss_pred             HhCCCCCeeeCCCCCCCEEecCCC--CEEEeecCCccccccCCCC---CcccCCCCCcccCCcccCC--CCCCCchhHHH
Q 012684          267 HENKPVPIIHRDLEPSNILRDDSG--NLKVADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKN--EEYDTKVDVFS  339 (458)
Q Consensus       267 H~~~~~~i~H~Dikp~Nil~~~~~--~vkl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~--~~~~~~~Diws  339 (458)
                      |+.+   |+||||||+||+++.++  .+||+|||++..+......   ......||+.|+|||++.+  ..++.++||||
T Consensus       185 H~~~---ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  261 (345)
T 3hko_A          185 HNQG---ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWS  261 (345)
T ss_dssp             HHTT---EECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHH
T ss_pred             HHCC---ccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHH
Confidence            9999   99999999999998776  8999999999865432211   2345568999999999865  57889999999


Q ss_pred             HHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          340 FALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       340 lG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ||+++|+|++|+.||......+....+..............+++.+.+||..||+.||.+|||+.+++++
T Consensus       262 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~h  331 (345)
T 3hko_A          262 AGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQH  331 (345)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHS
T ss_pred             HHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcC
Confidence            9999999999999999877766666654444333333445688999999999999999999999999986

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=7.3e-42  Score=334.42  Aligned_cols=246  Identities=26%  Similarity=0.455  Sum_probs=209.2

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      ..|+..+.||+|+||.||.     +|+.||||++...........+.+.+|+.+++.++||||+++++++..+...++||
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~  133 (348)
T 1u5q_A           54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM  133 (348)
T ss_dssp             HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEE
Confidence            3588889999999999883     68999999997655455566678899999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      ||+. |+|.+++.. ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.....   
T Consensus       134 e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~---  206 (348)
T 1u5q_A          134 EYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---  206 (348)
T ss_dssp             ECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---
T ss_pred             ecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEeeccCceecCC---
Confidence            9996 688888754 567999999999999999999999999   99999999999999999999999999976532   


Q ss_pred             CCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGL  385 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  385 (458)
                        .....||+.|+|||++.   +..++.++||||||+++|+|++|+.||...........+.....+..  ....+++.+
T Consensus       207 --~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l  282 (348)
T 1u5q_A          207 --ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYF  282 (348)
T ss_dssp             --BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCTTSCHHH
T ss_pred             --CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCCCHHH
Confidence              23456899999999984   56788999999999999999999999987665544444433333332  245678899


Q ss_pred             HHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          386 KELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       386 ~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      .+||..||+.||.+|||+.+++++..
T Consensus       283 ~~li~~~l~~dP~~Rps~~~ll~h~~  308 (348)
T 1u5q_A          283 RNFVDSCLQKIPQDRPTSEVLLKHRF  308 (348)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHTTCHH
T ss_pred             HHHHHHHcccChhhCcCHHHHhhChh
Confidence            99999999999999999999998743

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.9e-41  Score=323.46  Aligned_cols=254  Identities=26%  Similarity=0.448  Sum_probs=209.3

Q ss_pred             ccCceeeccceEEEEEE---cCeEEEEEEcCCCC-CCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012684          157 FTNSVEITKGTFILAFW---RGIQVAVKKLGEEV-ISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~---~g~~vavK~~~~~~-~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~  232 (458)
                      |...+.||+|+||.||.   +++.||+|.+.... .......+.+.+|+.+++.++||||+++++++...+..++||||+
T Consensus        33 ~~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~  112 (307)
T 2nru_A           33 SVGGNKMGEGGFGVVYKGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYM  112 (307)
T ss_dssp             TTTCCEEEECSSEEEEEEESSSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred             cccCCccccCCCeEEEEEEECCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEec
Confidence            33458999999998874   78999999997543 223445677899999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          233 PKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       233 ~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ++++|.+++..   ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.........
T Consensus       113 ~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  189 (307)
T 2nru_A          113 PNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT  189 (307)
T ss_dssp             TTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSC
T ss_pred             CCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEcCCCcEEEeeccccccccccccc
Confidence            99999999974   345899999999999999999999999   999999999999999999999999998765432221


Q ss_pred             -CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh---c--------CCCCCCCC
Q 012684          310 -PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA---R--------QRPPFKAP  377 (458)
Q Consensus       310 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~---~--------~~~~~~~~  377 (458)
                       ......||+.|+|||.+.+ .++.++||||||+++|+|++|..||...........+..   .        ........
T Consensus       190 ~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (307)
T 2nru_A          190 VMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA  268 (307)
T ss_dssp             EECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred             ccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence             1233568999999999876 578999999999999999999999987655442222111   0        01222334


Q ss_pred             hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       378 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      +..++..+.+++..||+.||.+|||+.+++++|+++.
T Consensus       269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~L~~l~  305 (307)
T 2nru_A          269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEMT  305 (307)
T ss_dssp             CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHC
T ss_pred             chHHHHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHh
Confidence            5667889999999999999999999999999999874

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=6.7e-42  Score=324.13  Aligned_cols=248  Identities=30%  Similarity=0.548  Sum_probs=205.7

Q ss_pred             CccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-CceEEEE
Q 012684          154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVT  229 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-~~~~lv~  229 (458)
                      ..+|++.+.||+|+||.||   .+|+.||||.+....     ..+.+.+|+.+++.++||||+++++++... +..++||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~   94 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT   94 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred             hhhceEEeEEecCCCceEEEEEEcCCEEEEEEecchh-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEE
Confidence            4578899999999999877   489999999997432     345788999999999999999999997544 5789999


Q ss_pred             EccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          230 EYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||+++++|.+++...+.  +++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++...... 
T Consensus        95 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-  170 (278)
T 1byg_A           95 EYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-  170 (278)
T ss_dssp             CCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred             ecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCCcceEEEeCCCcEEEeecccccccccc-
Confidence            99999999999986543  899999999999999999999999   999999999999999999999999998765322 


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                         .....+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+.......   .+..+++.+.
T Consensus       171 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~  244 (278)
T 1byg_A          171 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD---APDGCPPAVY  244 (278)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC---CCTTCCHHHH
T ss_pred             ---ccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC---CcccCCHHHH
Confidence               123356889999999988889999999999999999998 999999877766666554333332   3456789999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          387 ELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ++|..||+.||.+|||+.++++.|+++...
T Consensus       245 ~li~~~l~~~p~~Rps~~~l~~~L~~i~~~  274 (278)
T 1byg_A          245 EVMKNCWHLDAAMRPSFLQLREQLEHIKTH  274 (278)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHhcCChhhCCCHHHHHHHHHHHHhh
Confidence            999999999999999999999999998654

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=3.6e-42  Score=338.93  Aligned_cols=267  Identities=14%  Similarity=0.211  Sum_probs=207.6

Q ss_pred             cCCccccCceeeccceEEEEEEc----------CeEEEEEEcCCCCCCCHHHH--------HHHHHHHHHHhcCCCCcce
Q 012684          152 PHELDFTNSVEITKGTFILAFWR----------GIQVAVKKLGEEVISDDDRV--------RAFRDELALLQKIRHPNVV  213 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~~----------g~~vavK~~~~~~~~~~~~~--------~~~~~E~~~l~~l~hp~i~  213 (458)
                      ....+|++.+.||+|+||.||..          ++.||||++...........        ..+..|+..++.++||||+
T Consensus        32 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv  111 (364)
T 3op5_A           32 MAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVP  111 (364)
T ss_dssp             TTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSC
T ss_pred             cCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCC
Confidence            34558999999999999999842          57899999865421101111        1123455667788899999


Q ss_pred             eeeeEEEeC----CceEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec-
Q 012684          214 QFLGAVTQS----SPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-  287 (458)
Q Consensus       214 ~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~-  287 (458)
                      ++++++...    ...++||||+ |++|.+++... +.+++..++.++.|++.||.|||+.+   |+||||||+|||++ 
T Consensus       112 ~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~---iiHrDlkp~Nill~~  187 (364)
T 3op5_A          112 KYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNY  187 (364)
T ss_dssp             CEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEES
T ss_pred             eEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eEEecCCHHHEEEec
Confidence            999998764    4589999999 99999999875 57999999999999999999999999   99999999999999 


Q ss_pred             -CCCCEEEeecCCccccccCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 012684          288 -DSGNLKVADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN  360 (458)
Q Consensus       288 -~~~~vkl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~  360 (458)
                       .++.+||+|||++..+.....      .......||+.|+|||++.+..++.++|||||||++|+|++|+.||......
T Consensus       188 ~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~  267 (364)
T 3op5_A          188 KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKD  267 (364)
T ss_dssp             SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTC
T ss_pred             CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccC
Confidence             889999999999976543321      1123445899999999999989999999999999999999999999865444


Q ss_pred             cHHHHHHhcC-CCCCCC------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcccc
Q 012684          361 EVPKAYAARQ-RPPFKA------PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR  422 (458)
Q Consensus       361 ~~~~~~~~~~-~~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~~  422 (458)
                      .......... ......      ....+++++.++|..||+.||.+||++.++++.|+.+......+..
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~~l~~~~~~~~~~~~  336 (364)
T 3op5_A          268 PKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRDILLQGLKAIGSKDD  336 (364)
T ss_dssp             HHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCC
T ss_pred             HHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHHHHHHHHHHcCCCcC
Confidence            3222211111 111110      0134578999999999999999999999999999999887665543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=6.2e-42  Score=334.51  Aligned_cols=255  Identities=21%  Similarity=0.345  Sum_probs=202.8

Q ss_pred             cCcCCccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCC--CcceeeeeEEEeCC
Q 012684          150 IDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--PNVVQFLGAVTQSS  223 (458)
Q Consensus       150 ~~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p~i~~~~~~~~~~~  223 (458)
                      +.....+|++.+.||+|+||.||.    +++.||||++.... ......+.+.+|+.+++.++|  |||+++++++..+.
T Consensus         4 i~~~~~~y~i~~~lG~G~~g~Vy~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~   82 (343)
T 3dbq_A            4 ISVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQ   82 (343)
T ss_dssp             EESSSCEEEEEEEESCCSSEEEEEEECTTSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             eeeecCEEEEEEEEecCCCeEEEEEEeCCCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCC
Confidence            344566899999999999999984    57899999997653 345566789999999999976  99999999999999


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ..++|||+ .+++|.+++...+.+++.++..++.|++.||.|||+.+   |+||||||+|||++ ++.+||+|||++...
T Consensus        83 ~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~---iiHrDikp~NIll~-~~~~kl~DFG~a~~~  157 (343)
T 3dbq_A           83 YIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQM  157 (343)
T ss_dssp             EEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEE-TTEEEECCCSSSCCC
T ss_pred             EEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEE-CCcEEEeeccccccc
Confidence            99999995 48899999999888999999999999999999999999   99999999999997 578999999999876


Q ss_pred             ccCCCC-CcccCCCCCcccCCcccCC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCC
Q 012684          304 TVKEDR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR  371 (458)
Q Consensus       304 ~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~  371 (458)
                      ...... ......||+.|+|||++.+           ..++.++||||||+++|+|++|+.||................ 
T Consensus       158 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~-  236 (343)
T 3dbq_A          158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP-  236 (343)
T ss_dssp             ------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT-
T ss_pred             CcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcC-
Confidence            433221 2234568999999999854           568889999999999999999999998654322111111111 


Q ss_pred             CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      ......+...++.+.+||..||+.||.+|||+.+++++..
T Consensus       237 ~~~~~~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~  276 (343)
T 3dbq_A          237 NHEIEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPY  276 (343)
T ss_dssp             TSCCCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHH
T ss_pred             CcccCCcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcc
Confidence            1111223345678999999999999999999999998743

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=4.1e-42  Score=326.67  Aligned_cols=245  Identities=25%  Similarity=0.463  Sum_probs=209.1

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     ++..||+|++.............+.+|+.+++.++||||+++++++...+..++||
T Consensus        14 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   93 (284)
T 2vgo_A           14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLML   93 (284)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEE
Confidence            4688899999999999884     57899999986432111122356889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......   
T Consensus        94 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~---  167 (284)
T 2vgo_A           94 EFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERK---VIHRDIKPENLLMGYKGELKIADFGWSVHAPSL---  167 (284)
T ss_dssp             CCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEECTTCCEEECCCTTCEECSSS---
T ss_pred             EeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCHHHEEEcCCCCEEEecccccccCccc---
Confidence            99999999999998888999999999999999999999999   999999999999999999999999998765432   


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......+++.|+|||++.+..++.++||||||+++|+|++|+.||......+....+.. ....+   +..++..+.++|
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~li  243 (284)
T 2vgo_A          168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVN-VDLKF---PPFLSDGSKDLI  243 (284)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-TCCCC---CTTSCHHHHHHH
T ss_pred             ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhc-cccCC---CCcCCHHHHHHH
Confidence            22345689999999999998899999999999999999999999987665554444422 22222   345788999999


Q ss_pred             HHHcccCCCCCCCHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ..||+.||.+|||+.+++++
T Consensus       244 ~~~l~~~p~~Rps~~~ll~h  263 (284)
T 2vgo_A          244 SKLLRYHPPQRLPLKGVMEH  263 (284)
T ss_dssp             HHHSCSSGGGSCCHHHHHTC
T ss_pred             HHHhhcCHhhCCCHHHHhhC
Confidence            99999999999999999987

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=3.7e-42  Score=325.82  Aligned_cols=247  Identities=23%  Similarity=0.438  Sum_probs=185.4

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     +|+.||+|++...........+.+.+|+.+++.++||||+++++++...+..++||
T Consensus        11 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (278)
T 3cok_A           11 EDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVL   90 (278)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEE
Confidence            4688899999999998873     68899999986432111122467889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          230 EYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      ||+++++|.+++... ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++........
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           91 EMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHG---ILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             ECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             ecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            999999999999875 56999999999999999999999999   99999999999999999999999999986543222


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                       ......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||............... .  . ..+..++..+.++
T Consensus       168 -~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-~--~-~~~~~~~~~~~~l  242 (278)
T 3cok_A          168 -KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLA-D--Y-EMPSFLSIEAKDL  242 (278)
T ss_dssp             -------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSS-C--C-CCCTTSCHHHHHH
T ss_pred             -cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhc-c--c-CCccccCHHHHHH
Confidence             222346899999999999888999999999999999999999999876655443332111 1  1 1244578899999


Q ss_pred             HHHHcccCCCCCCCHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~  409 (458)
                      |.+||+.||.+|||+.+++++
T Consensus       243 i~~~l~~dp~~Rps~~~~l~h  263 (278)
T 3cok_A          243 IHQLLRRNPADRLSLSSVLDH  263 (278)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTS
T ss_pred             HHHHcccCHhhCCCHHHHhcC
Confidence            999999999999999999976

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=1.8e-42  Score=356.24  Aligned_cols=248  Identities=25%  Similarity=0.398  Sum_probs=208.6

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|++.+.||+|+||.|+.     +|+.||+|++.............+.+|+.+++.++||||+++++++.+...+|+|
T Consensus       183 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  262 (576)
T 2acx_A          183 KNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLV  262 (576)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             ccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEE
Confidence            44688999999999999984     6899999999653222222345678899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          229 TEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      |||++||+|.+++...+.  +++..+..++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||++......
T Consensus       263 mEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g---IvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          263 LTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             ECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            999999999999987544  999999999999999999999999   999999999999999999999999999876432


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHH---HHhcCCCCCCCChhhhHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKA---YAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~  383 (458)
                        .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........   ........+   +..+++
T Consensus       340 --~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~---p~~~s~  414 (576)
T 2acx_A          340 --QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEY---SERFSP  414 (576)
T ss_dssp             --CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCC---CTTSCH
T ss_pred             --ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccC---CccCCH
Confidence              233445799999999999998999999999999999999999999987654322221   112222222   356889


Q ss_pred             HHHHHHHHHcccCCCCCC-----CHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rp-----s~~~ll~~  409 (458)
                      .+.+||.+||+.||.+||     ++.++++|
T Consensus       415 ~~~dLI~~lL~~dP~~R~g~~~~sa~eil~H  445 (576)
T 2acx_A          415 QARSLCSQLLCKDPAERLGCRGGSAREVKEH  445 (576)
T ss_dssp             HHHHHHHHHTCSSGGGSTTCSSSHHHHHHTS
T ss_pred             HHHHHHHHhccCCHHHcCCCCCCCHHHHHhC
Confidence            999999999999999999     78999886

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=7.8e-42  Score=329.50  Aligned_cols=257  Identities=27%  Similarity=0.468  Sum_probs=214.2

Q ss_pred             cCCccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEE
Q 012684          152 PHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT  220 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~  220 (458)
                      ....+|++.+.||+|+||.||.          +++.||||++....  .....+.+.+|+.+++++ +||||+++++++.
T Consensus        24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  101 (316)
T 2xir_A           24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT  101 (316)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence            4456899999999999999874          34789999997542  445567789999999999 7999999999987


Q ss_pred             eCC-ceEEEEEccCCCCHHHHHHhcCC----------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCC
Q 012684          221 QSS-PMMIVTEYLPKGDLRAFLKRKGA----------------LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN  283 (458)
Q Consensus       221 ~~~-~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~N  283 (458)
                      ..+ ..++||||+++++|.+++.....                +++..++.++.|++.||.|||+.+   ++||||||+|
T Consensus       102 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~N  178 (316)
T 2xir_A          102 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARN  178 (316)
T ss_dssp             CTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGG
T ss_pred             cCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCC---cccccCccce
Confidence            654 58999999999999999987543                789999999999999999999999   9999999999


Q ss_pred             EEecCCCCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCc
Q 012684          284 ILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNE  361 (458)
Q Consensus       284 il~~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~  361 (458)
                      |+++.++.+||+|||++......... ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.......
T Consensus       179 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~  258 (316)
T 2xir_A          179 ILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE  258 (316)
T ss_dssp             EEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSH
T ss_pred             EEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhH
Confidence            99999999999999999865433221 1123446788999999988889999999999999999998 999998876655


Q ss_pred             HHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          362 VPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       362 ~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ......... ...   .+..+++.+.++|..||+.||.+|||+.+++++|+.+...
T Consensus       259 ~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~  311 (316)
T 2xir_A          259 EFCRRLKEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQA  311 (316)
T ss_dssp             HHHHHHHHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHhccCccCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            443333333 222   2345788999999999999999999999999999998755

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=1.3e-41  Score=329.96  Aligned_cols=244  Identities=23%  Similarity=0.378  Sum_probs=197.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC-------
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS-------  223 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~-------  223 (458)
                      +|++.+.||+|+||.||.     +|+.||||++....  .....+.+.+|+.++++++||||+++++++.+..       
T Consensus         7 ~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~   84 (332)
T 3qd2_B            7 DFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEE   84 (332)
T ss_dssp             HEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHH
T ss_pred             cCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhh
Confidence            588889999999999883     68999999997543  3334567899999999999999999999986543       


Q ss_pred             --------------------------------------------------ceEEEEEccCCCCHHHHHHhcCC---CCHH
Q 012684          224 --------------------------------------------------PMMIVTEYLPKGDLRAFLKRKGA---LKPS  250 (458)
Q Consensus       224 --------------------------------------------------~~~lv~e~~~~~~L~~~l~~~~~---~~~~  250 (458)
                                                                        ..++||||+++++|.+++.....   .++.
T Consensus        85 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~  164 (332)
T 3qd2_B           85 MDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHG  164 (332)
T ss_dssp             HHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHH
T ss_pred             hhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhH
Confidence                                                              27999999999999999987654   4555


Q ss_pred             HHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC-----------CCcccCCCCCc
Q 012684          251 TAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-----------RPLTCQDTSCR  319 (458)
Q Consensus       251 ~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~-----------~~~~~~~gt~~  319 (458)
                      .++.++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++........           .......||+.
T Consensus       165 ~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  241 (332)
T 3qd2_B          165 VCLHIFIQIAEAVEFLHSKG---LMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL  241 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGG
T ss_pred             HHHHHHHHHHHHHHHHHhCC---eeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcC
Confidence            68899999999999999999   99999999999999999999999999987654321           12234568999


Q ss_pred             ccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCC
Q 012684          320 YVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAK  399 (458)
Q Consensus       320 y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~  399 (458)
                      |+|||++.+..++.++||||||+++|+|++|..|+..     .............+......++.+.++|.+||+.||.+
T Consensus       242 y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  316 (332)
T 3qd2_B          242 YMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME-----RVRIITDVRNLKFPLLFTQKYPQEHMMVQDMLSPSPTE  316 (332)
T ss_dssp             GSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH-----HHHHHHHHHTTCCCHHHHHHCHHHHHHHHHHHCSSGGG
T ss_pred             ccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH-----HHHHHHHhhccCCCcccccCChhHHHHHHHHccCCCCc
Confidence            9999999998999999999999999999998766432     11111112233344445667788999999999999999


Q ss_pred             CCCHHHHHHH
Q 012684          400 RPTFRQIITR  409 (458)
Q Consensus       400 Rps~~~ll~~  409 (458)
                      |||+.+++++
T Consensus       317 Rps~~~~l~~  326 (332)
T 3qd2_B          317 RPEATDIIEN  326 (332)
T ss_dssp             SCCHHHHHHS
T ss_pred             CCCHHHHhhc
Confidence            9999999975

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=7.7e-42  Score=328.99  Aligned_cols=249  Identities=22%  Similarity=0.370  Sum_probs=202.4

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.||.     +|+.||+|++.... ......+.+.+|+.++++++||||+++++++...+..++|||
T Consensus         4 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   82 (311)
T 4agu_A            4 KYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFE   82 (311)
T ss_dssp             CEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             cceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEE
Confidence            688899999999999884     48999999987553 344556678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.|   ++||||||+||+++.++.++|+|||++....... ..
T Consensus        83 ~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~~  158 (311)
T 4agu_A           83 YCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHN---CIHRDVKPENILITKHSVIKLCDFGFARLLTGPS-DY  158 (311)
T ss_dssp             CCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             eCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc-cc
Confidence            9999999999888888999999999999999999999999   9999999999999999999999999998764322 22


Q ss_pred             cccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCC-----------------
Q 012684          311 LTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP-----------------  372 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~-----------------  372 (458)
                      .....+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+......                 
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (311)
T 4agu_A          159 YDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSG  238 (311)
T ss_dssp             -------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTT
T ss_pred             cCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhccccccccccccccccccc
Confidence            234568999999999876 56799999999999999999999999887655443332211000                 


Q ss_pred             -CCCC---------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 -PFKA---------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 -~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                       ..+.         ..+.+++.+.+||..||+.||.+|||+++++++
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  285 (311)
T 4agu_A          239 VKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHH  285 (311)
T ss_dssp             CCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTS
T ss_pred             CcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcC
Confidence             0000         013567889999999999999999999999987

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=2.8e-42  Score=334.42  Aligned_cols=255  Identities=25%  Similarity=0.491  Sum_probs=209.9

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeE----EEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQ----VAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~----vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      ...+|++.+.||+|+||.||.     +|..    ||+|.+.....  ......+.+|+.+++.++||||+++++++. +.
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~   87 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSG--RQSFQAVTDHMLAIGSLDHAHIVRLLGLCP-GS   87 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTS--CSCBCSCCHHHHHHHTCCCTTBCCEEEEEC-BS
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEecccccc--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEc-CC
Confidence            345788999999999999884     3443    88888754321  122345677999999999999999999986 45


Q ss_pred             ceEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      ..++||||+.+++|.+++... +.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++..
T Consensus        88 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~  164 (325)
T 3kex_A           88 SLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG---MVHRNLAARNVLLKSPSQVQVADFGVADL  164 (325)
T ss_dssp             SEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTT---CCCSCCSSTTEEESSSSCEEECSCSGGGG
T ss_pred             ccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCC---CCCCccchheEEECCCCeEEECCCCcccc
Confidence            689999999999999999864 56999999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhh
Q 012684          303 LTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL  380 (458)
Q Consensus       303 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (458)
                      ....... ......+|+.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+........   +..
T Consensus       165 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~  241 (325)
T 3kex_A          165 LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQ---PQI  241 (325)
T ss_dssp             SCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCC---CTT
T ss_pred             cCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCC---CCc
Confidence            6543222 2344567889999999998889999999999999999999 9999999887777666654443333   334


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          381 YARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ++..+.++|.+||+.||.+|||+.+++++|+++...
T Consensus       242 ~~~~~~~li~~~l~~dp~~Rps~~el~~~l~~~~~~  277 (325)
T 3kex_A          242 CTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD  277 (325)
T ss_dssp             BCTTTTHHHHHHTCSCTTTSCCHHHHHHHHHHHTTS
T ss_pred             CcHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhc
Confidence            677899999999999999999999999999988543

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=7.2e-42  Score=325.27  Aligned_cols=246  Identities=23%  Similarity=0.434  Sum_probs=202.0

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|.+.+.||+|+||.||.     +|..||+|.+......  ...+.+.+|+.+++.++||||+++++++......++||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~   99 (285)
T 3is5_A           22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQ--VPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVM   99 (285)
T ss_dssp             HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCC--SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccc--hhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEE
Confidence            3699999999999999883     5889999999765422  22467889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe---cCCCCEEEeecCCccc
Q 012684          230 EYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKL  302 (458)
Q Consensus       230 e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~---~~~~~vkl~Dfg~~~~  302 (458)
                      ||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   |+||||||+||++   +.++.++|+|||++..
T Consensus       100 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A          100 ETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQH---VVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             CCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            99999999998854    367999999999999999999999999   9999999999999   4567899999999976


Q ss_pred             cccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhH
Q 012684          303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA  382 (458)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (458)
                      ....  .......+|+.|+|||++.+ .++.++||||||+++|+|++|+.||......+..... ....+........++
T Consensus       177 ~~~~--~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~-~~~~~~~~~~~~~~~  252 (285)
T 3is5_A          177 FKSD--EHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKA-TYKEPNYAVECRPLT  252 (285)
T ss_dssp             ------------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH-HHCCCCCCC--CCCC
T ss_pred             cCCc--ccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhh-ccCCcccccccCcCC
Confidence            5432  22334568999999999864 6889999999999999999999999887655554444 223333333344578


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.+.++|.+||+.||.+|||+.+++++
T Consensus       253 ~~~~~li~~~L~~dP~~Rps~~e~l~h  279 (285)
T 3is5_A          253 PQAVDLLKQMLTKDPERRPSAAQVLHH  279 (285)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHHTS
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            899999999999999999999999875

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=326.37  Aligned_cols=249  Identities=30%  Similarity=0.563  Sum_probs=200.9

Q ss_pred             ccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      .+|++.+.||+|+||.||   +.++.||+|.+...     ...+.+.+|+.++++++||||+++++++.+  ..++||||
T Consensus         8 ~~~~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~   80 (307)
T 2eva_A            8 KEIEVEEVVGRGAFGVVCKAKWRAKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEY   80 (307)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEEC
T ss_pred             hHeeeeeEeecCCCceEEEEEECCeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEc
Confidence            368888999999998876   57899999998632     235678899999999999999999998873  47999999


Q ss_pred             cCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHh---CCCCCeeeCCCCCCCEEecCCCC-EEEeecCCccccc
Q 012684          232 LPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHE---NKPVPIIHRDLEPSNILRDDSGN-LKVADFGVSKLLT  304 (458)
Q Consensus       232 ~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~---~~~~~i~H~Dikp~Nil~~~~~~-vkl~Dfg~~~~~~  304 (458)
                      +++++|.+++.....   ++...++.++.|+++||.|||+   ++   |+||||||+||+++.++. +||+|||++....
T Consensus        81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~---ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~  157 (307)
T 2eva_A           81 AEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKA---LIHRDLKPPNLLLVAGGTVLKICDFGTACDIQ  157 (307)
T ss_dssp             CTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSC---CCCCCCSGGGEEEETTTTEEEECCCCC-----
T ss_pred             CCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCC---eecCCCChhHEEEeCCCCEEEEcccccccccc
Confidence            999999999987543   7889999999999999999999   66   999999999999998887 7999999987653


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      ..    .....||+.|+|||++.+..++.++||||||+++|+|++|+.||............... ....+.....+++.
T Consensus       158 ~~----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  232 (307)
T 2eva_A          158 TH----MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVH-NGTRPPLIKNLPKP  232 (307)
T ss_dssp             -----------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHH-TTCCCCCBTTCCHH
T ss_pred             cc----cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHh-cCCCCCcccccCHH
Confidence            22    22345899999999999989999999999999999999999999876544332221111 11122234567899


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      +.++|.+||+.||.+|||+.++++.|+.+...+.
T Consensus       233 l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~~  266 (307)
T 2eva_A          233 IESLMTRCWSKDPSQRPSMEEIVKIMTHLMRYFP  266 (307)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHHHHHGGGCC
T ss_pred             HHHHHHHHhcCChhhCcCHHHHHHHHHHHHHhcc
Confidence            9999999999999999999999999999865543

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=8e-42  Score=339.39  Aligned_cols=248  Identities=24%  Similarity=0.390  Sum_probs=193.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCC--ceEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSS--PMMI  227 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~--~~~l  227 (458)
                      +|++.+.||+|+||.|+.     +|+.||||++.... ......+.+.+|+.+++.+. ||||+++++++...+  .+|+
T Consensus        10 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~l   88 (388)
T 3oz6_A           10 KYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAF-QNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYL   88 (388)
T ss_dssp             TEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEE
T ss_pred             ceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccc-cChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEE
Confidence            688999999999998874     58999999997543 34556677888999999996 999999999997544  6899


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||||++ ++|.+++.. +.+++..+..++.|++.||+|||+.|   |+||||||+|||++.++.+||+|||++.......
T Consensus        89 v~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           89 VFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGG---LLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             EecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            999996 699998876 56999999999999999999999999   9999999999999999999999999997653211


Q ss_pred             --------------------CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH
Q 012684          308 --------------------DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY  366 (458)
Q Consensus       308 --------------------~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~  366 (458)
                                          ........||+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                                112244578999999999876 57899999999999999999999999887655444333


Q ss_pred             HhcC-CCC-----------------------------CCCC-------------hhhhHHHHHHHHHHHcccCCCCCCCH
Q 012684          367 AARQ-RPP-----------------------------FKAP-------------AKLYARGLKELIEECWNEKPAKRPTF  403 (458)
Q Consensus       367 ~~~~-~~~-----------------------------~~~~-------------~~~~~~~l~~li~~~l~~dp~~Rps~  403 (458)
                      .... .+.                             ....             ...+++.+.+||.+||+.||.+|||+
T Consensus       244 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~  323 (388)
T 3oz6_A          244 IGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISA  323 (388)
T ss_dssp             HHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCH
T ss_pred             HHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCH
Confidence            2111 110                             0000             11457889999999999999999999


Q ss_pred             HHHHHH
Q 012684          404 RQIITR  409 (458)
Q Consensus       404 ~~ll~~  409 (458)
                      .++++|
T Consensus       324 ~e~l~H  329 (388)
T 3oz6_A          324 NDALKH  329 (388)
T ss_dssp             HHHTTS
T ss_pred             HHHhCC
Confidence            999998

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.1e-41  Score=337.30  Aligned_cols=243  Identities=26%  Similarity=0.369  Sum_probs=194.5

Q ss_pred             cccCc-eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHh-cCCCCcceeeeeEEEe----CCc
Q 012684          156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQ-KIRHPNVVQFLGAVTQ----SSP  224 (458)
Q Consensus       156 ~~~~~-~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~i~~~~~~~~~----~~~  224 (458)
                      +|.+. +.||+|+||.|+.     +|+.||||++...        ..+.+|+.++. ..+||||+++++++..    ...
T Consensus        62 ~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~  133 (400)
T 1nxk_A           62 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC  133 (400)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             cceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcE
Confidence            45554 6899999999984     5889999998632        24667888764 4589999999999875    567


Q ss_pred             eEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC---CCCEEEeecCC
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV  299 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~---~~~vkl~Dfg~  299 (458)
                      +|+||||++||+|.+++...+  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.   ++.+||+|||+
T Consensus       134 ~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~~~kl~DFG~  210 (400)
T 1nxk_A          134 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  210 (400)
T ss_dssp             EEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCcceEEEecCCCCccEEEEeccc
Confidence            899999999999999998754  4999999999999999999999999   999999999999997   78899999999


Q ss_pred             ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc----HHHHHHhcCCCCCC
Q 012684          300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFK  375 (458)
Q Consensus       300 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~----~~~~~~~~~~~~~~  375 (458)
                      +......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......    ....+.........
T Consensus       211 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~  288 (400)
T 1nxk_A          211 AKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  288 (400)
T ss_dssp             CEECC-------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCT
T ss_pred             ccccCCC--CccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCC
Confidence            9865432  22344568999999999999899999999999999999999999998765433    33333333222222


Q ss_pred             CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       376 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      ..+..+++++.+||..||+.||.+|||+.+++++-.
T Consensus       289 ~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~  324 (400)
T 1nxk_A          289 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPW  324 (400)
T ss_dssp             TTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHH
T ss_pred             cccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence            234568899999999999999999999999999854

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.7e-41  Score=324.51  Aligned_cols=242  Identities=21%  Similarity=0.236  Sum_probs=193.2

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHH-hcCCCCcceeeeeEEEeCCceEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      .+|++.+.||+|+||.||.     +|+.||||++.......... .....|+..+ +..+||||+++++++.+++..++|
T Consensus        57 ~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv  135 (311)
T 3p1a_A           57 QSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDR-ARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQ  135 (311)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHH-HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHH-HHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEE
Confidence            4689999999999999984     68999999987654433333 3444455444 444899999999999999999999


Q ss_pred             EEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          229 TEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |||+ +++|.+++... ..+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++...... 
T Consensus       136 ~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~-  210 (311)
T 3p1a_A          136 TELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQG---LVHLDVKPANIFLGPRGRCKLGDFGLLVELGTA-  210 (311)
T ss_dssp             EECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECGGGCEEECCCTTCEECC---
T ss_pred             Eecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEccceeeeecccC-
Confidence            9999 77999988764 45999999999999999999999999   999999999999999999999999998765432 


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                       .......||+.|+|||++.+ .++.++||||||+++|+|++|..||....   ....+ .... ..+..+..+++.+.+
T Consensus       211 -~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~-~~~~-~~~~~~~~~~~~l~~  283 (311)
T 3p1a_A          211 -GAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQL-RQGY-LPPEFTAGLSSELRS  283 (311)
T ss_dssp             -----CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHH-TTTC-CCHHHHTTSCHHHHH
T ss_pred             -CCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHH-hccC-CCcccccCCCHHHHH
Confidence             22334568999999999886 78999999999999999999976654321   12222 1111 111234457889999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +|.+||+.||.+|||+.+++++
T Consensus       284 li~~~L~~dP~~Rpt~~ell~h  305 (311)
T 3p1a_A          284 VLVMMLEPDPKLRATAEALLAL  305 (311)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHHcCCChhhCcCHHHHHhC
Confidence            9999999999999999999975

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=1.3e-41  Score=330.72  Aligned_cols=259  Identities=26%  Similarity=0.446  Sum_probs=215.6

Q ss_pred             cCCccccCceeeccceEEEEEE-----cC-----eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEE
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----RG-----IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT  220 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~g-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~  220 (458)
                      ....+|++.+.||+|+||.||.     ++     ..||+|.+....  .....+.+.+|+.+++.+ +||||+++++++.
T Consensus        43 ~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~  120 (333)
T 2i1m_A           43 FPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGACT  120 (333)
T ss_dssp             CCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred             CCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEe
Confidence            3345788899999999999984     12     479999997542  445667789999999999 8999999999999


Q ss_pred             eCCceEEEEEccCCCCHHHHHHhc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe
Q 012684          221 QSSPMMIVTEYLPKGDLRAFLKRK--------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR  286 (458)
Q Consensus       221 ~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~  286 (458)
                      .++..++||||+++|+|.+++...              ..+++..++.++.|++.||.|||+.+   |+||||||+||++
T Consensus       121 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~  197 (333)
T 2i1m_A          121 HGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKN---CIHRDVAARNVLL  197 (333)
T ss_dssp             SSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGCEE
T ss_pred             cCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCC---cccCCcccceEEE
Confidence            999999999999999999999753              35799999999999999999999999   9999999999999


Q ss_pred             cCCCCEEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHH
Q 012684          287 DDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPK  364 (458)
Q Consensus       287 ~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~  364 (458)
                      +.++.++|+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|+|++ |..||..........
T Consensus       198 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~  277 (333)
T 2i1m_A          198 TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFY  277 (333)
T ss_dssp             EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHH
T ss_pred             CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHH
Confidence            999999999999998654332211 223345778999999988889999999999999999998 999999877665554


Q ss_pred             HHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      ..........  .+..+++.+.++|..||+.||.+|||+.++++.|+++....
T Consensus       278 ~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~L~~~~~~~  328 (333)
T 2i1m_A          278 KLVKDGYQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICSFLQEQAQED  328 (333)
T ss_dssp             HHHHHTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHhcCCCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHHHHHHHHhh
Confidence            4433332211  23456789999999999999999999999999999987653

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=9.6e-42  Score=330.89  Aligned_cols=253  Identities=32%  Similarity=0.536  Sum_probs=208.9

Q ss_pred             ccccCceeeccceEEEEEE-----cCeE--EEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQ--VAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~--vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~  226 (458)
                      .+|++.+.||+|+||.||.     +|..  +|+|.+...  ......+.+.+|+.+++++ +||||+++++++...+..+
T Consensus        25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~  102 (327)
T 1fvr_A           25 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY  102 (327)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred             HHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceE
Confidence            3688889999999998873     5654  499998643  2334456788999999999 8999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC
Q 012684          227 IVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG  290 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~  290 (458)
                      +||||+++++|.+++...+                .+++..++.++.|++.||.|||+.+   ++||||||+||+++.++
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~~~  179 (327)
T 1fvr_A          103 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENY  179 (327)
T ss_dssp             EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGG
T ss_pred             EEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCccceEEEcCCC
Confidence            9999999999999997654                6899999999999999999999999   99999999999999999


Q ss_pred             CEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhc
Q 012684          291 NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAAR  369 (458)
Q Consensus       291 ~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~  369 (458)
                      .+||+|||++......  .......+++.|+|||.+.+..++.++||||||+++|+|++ |+.||......+....+...
T Consensus       180 ~~kL~Dfg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~  257 (327)
T 1fvr_A          180 VAKIADFGLSRGQEVY--VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG  257 (327)
T ss_dssp             CEEECCTTCEESSCEE--CCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGT
T ss_pred             eEEEcccCcCcccccc--ccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcC
Confidence            9999999998754322  12233456788999999988888999999999999999998 99999887665555544333


Q ss_pred             CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          370 QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       370 ~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      ....   .+..+++.+.++|.+||+.||.+|||+.+++++|+++....
T Consensus       258 ~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~L~~~~~~~  302 (327)
T 1fvr_A          258 YRLE---KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEER  302 (327)
T ss_dssp             CCCC---CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHSS
T ss_pred             CCCC---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHhh
Confidence            2222   24567899999999999999999999999999999987654

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.1e-41  Score=328.68  Aligned_cols=247  Identities=21%  Similarity=0.353  Sum_probs=198.0

Q ss_pred             cccCc-eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012684          156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       156 ~~~~~-~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      .|++. +.||+|+||.|+.     +|+.||||++.....   ...+.+.+|+.+++++ +||||+++++++..++..++|
T Consensus        13 ~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv   89 (316)
T 2ac3_A           13 VYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPG---HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLV   89 (316)
T ss_dssp             SCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSS---CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             eEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcc---hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEE
Confidence            56663 6799999999985     689999999975432   2245678899999885 799999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC---EEEeecCCcccccc
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKLLTV  305 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~---vkl~Dfg~~~~~~~  305 (458)
                      |||+++++|.+++...+.+++..+..++.|++.||+|||+.+   |+||||||+||+++.++.   +||+|||++.....
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~  166 (316)
T 2ac3_A           90 FEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG---IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL  166 (316)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEESCSSSSCSEEECCTTCCC----
T ss_pred             EEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ceeCCCCHHHEEEccCCCcCceEEEEccCcccccc
Confidence            999999999999998888999999999999999999999999   999999999999998776   99999999876532


Q ss_pred             CCC------CCcccCCCCCcccCCcccCC-----CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-------------
Q 012684          306 KED------RPLTCQDTSCRYVAPEVFKN-----EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-------------  361 (458)
Q Consensus       306 ~~~------~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~-------------  361 (458)
                      ...      .......||+.|+|||++.+     ..++.++||||||+++|+|++|+.||.......             
T Consensus       167 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~  246 (316)
T 2ac3_A          167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQ  246 (316)
T ss_dssp             ---------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHH
T ss_pred             CCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHH
Confidence            211      11223458999999999865     457889999999999999999999998765432             


Q ss_pred             --HHHHHHhcCCCCCC-CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          362 --VPKAYAARQRPPFK-APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       362 --~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                        ....+ ......++ .....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       247 ~~~~~~i-~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  296 (316)
T 2ac3_A          247 NMLFESI-QEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQH  296 (316)
T ss_dssp             HHHHHHH-HHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             HHHHHHH-hccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence              22222 22222222 1224578899999999999999999999999986

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.2e-41  Score=335.13  Aligned_cols=249  Identities=26%  Similarity=0.398  Sum_probs=208.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCC-C----HHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCc
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-D----DDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~-~----~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~  224 (458)
                      +|++.+.||.|+||.||.     +|+.||||++...... .    ....+.+.+|+.+++.+ +||||+++++++.....
T Consensus        95 ~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~  174 (365)
T 2y7j_A           95 KYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSF  174 (365)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSE
T ss_pred             hcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCE
Confidence            588889999999999884     5899999998754321 1    12245678899999999 79999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      .++||||++|++|.+++.....+++..+..++.|++.||.|||+.|   ++|+||||.||+++.++.++|+|||++....
T Consensus       175 ~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g---i~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~  251 (365)
T 2y7j_A          175 MFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN---IVHRDLKPENILLDDNMQIRLSDFGFSCHLE  251 (365)
T ss_dssp             EEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEEecCcccccC
Confidence            9999999999999999998888999999999999999999999999   9999999999999999999999999988764


Q ss_pred             cCCCCCcccCCCCCcccCCcccCC------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCCh
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKN------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPA  378 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~  378 (458)
                      ..  .......||+.|+|||++.+      ..++.++||||||+++|+|++|+.||...........+...........+
T Consensus       252 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  329 (365)
T 2y7j_A          252 PG--EKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW  329 (365)
T ss_dssp             TT--CCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH
T ss_pred             CC--cccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc
Confidence            32  23345678999999998853      35788999999999999999999999876655544444333322222223


Q ss_pred             hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          379 KLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       379 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       330 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~h  360 (365)
T 2y7j_A          330 DDRSSTVKDLISRLLQVDPEARLTAEQALQH  360 (365)
T ss_dssp             SSSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHhcC
Confidence            4567899999999999999999999999975

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.7e-41  Score=320.42  Aligned_cols=258  Identities=16%  Similarity=0.224  Sum_probs=209.0

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEE-EeCCceEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV-TQSSPMMI  227 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-~~~~~~~l  227 (458)
                      ..+|++.+.||+|+||.||.     +|+.||||++......     +.+.+|+.+++.+.|++++..+..+ ......++
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l   82 (296)
T 3uzp_A            8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM   82 (296)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred             ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence            34789999999999998873     6899999998754332     2578899999999887766555554 66777899


Q ss_pred             EEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec---CCCCEEEeecCCcccc
Q 012684          228 VTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLL  303 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~---~~~~vkl~Dfg~~~~~  303 (458)
                      ||||+ +++|.+++.. ...+++..++.++.|++.||.|||+++   ++||||||+||+++   .++.+||+|||++...
T Consensus        83 v~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~  158 (296)
T 3uzp_A           83 VMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY  158 (296)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCTTCEEC
T ss_pred             EEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccc
Confidence            99999 9999999974 456999999999999999999999999   99999999999994   8889999999999876


Q ss_pred             ccCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC---cHHHHHHhcC-CCC
Q 012684          304 TVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN---EVPKAYAARQ-RPP  373 (458)
Q Consensus       304 ~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~---~~~~~~~~~~-~~~  373 (458)
                      ......      ......||+.|+|||.+.+..++.++||||||+++|+|++|+.||......   .....+.... ..+
T Consensus       159 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  238 (296)
T 3uzp_A          159 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTP  238 (296)
T ss_dssp             BCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCc
Confidence            543221      124456899999999999989999999999999999999999999875433   2333322211 122


Q ss_pred             CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 012684          374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK  420 (458)
Q Consensus       374 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  420 (458)
                      .+..+..+++.+.++|..||+.||.+|||+.++++.|+++......+
T Consensus       239 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~~~~~~~~  285 (296)
T 3uzp_A          239 IEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             HHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHTTCC
T ss_pred             hHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHHHHHHHHhcCCc
Confidence            11223457889999999999999999999999999999998776543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=8.2e-41  Score=318.64  Aligned_cols=256  Identities=24%  Similarity=0.442  Sum_probs=210.0

Q ss_pred             CcccCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe
Q 012684          147 EYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ  221 (458)
Q Consensus       147 ~~~~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~  221 (458)
                      ...+......|.+.+.||+|+||.||.     ++..||+|.+..... .....+.+.+|+.+++.++||||+++++++..
T Consensus        18 ~~~~~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~   96 (290)
T 1t4h_A           18 AVGMSNDGRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWES   96 (290)
T ss_dssp             CCEECTTSCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEE
T ss_pred             hhhcccCceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecc
Confidence            334445556688889999999999884     578999999976543 44556788999999999999999999999865


Q ss_pred             ----CCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec-CCCCEEEee
Q 012684          222 ----SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVAD  296 (458)
Q Consensus       222 ----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~-~~~~vkl~D  296 (458)
                          ....++||||+++++|.+++...+.+++..++.++.|++.||.|||+.+ .+++|+||||+||+++ .++.++|+|
T Consensus        97 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~-~~i~H~dikp~Nil~~~~~~~~kl~D  175 (290)
T 1t4h_A           97 TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGD  175 (290)
T ss_dssp             ESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECC
T ss_pred             ccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCC-CCEEECCCCHHHEEEECCCCCEEEee
Confidence                3558999999999999999998888999999999999999999999986 2499999999999998 789999999


Q ss_pred             cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCC
Q 012684          297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA  376 (458)
Q Consensus       297 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  376 (458)
                      ||++.....   .......+|+.|+|||++.+ .++.++||||||+++|+|++|+.||.................. ...
T Consensus       176 fg~~~~~~~---~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~-~~~  250 (290)
T 1t4h_A          176 LGLATLKRA---SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK-PAS  250 (290)
T ss_dssp             TTGGGGCCT---TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC-CGG
T ss_pred             CCCcccccc---cccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC-ccc
Confidence            999875432   23344568999999998875 5899999999999999999999999875554333332222222 222


Q ss_pred             ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       377 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+...++.+.++|..||+.||.+|||+.+++++
T Consensus       251 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h  283 (290)
T 1t4h_A          251 FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNH  283 (290)
T ss_dssp             GGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cCCCCCHHHHHHHHHHccCChhhCCCHHHHhhC
Confidence            344567899999999999999999999999976

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=6.9e-42  Score=332.25  Aligned_cols=249  Identities=21%  Similarity=0.379  Sum_probs=196.4

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.|+.     +|+.||||++..... .....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus        34 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  112 (329)
T 3gbz_A           34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIF  112 (329)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEE
Confidence            4799999999999998874     689999999976532 3334456778999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec-----CCCCEEEeecCCccccc
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-----DSGNLKVADFGVSKLLT  304 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~-----~~~~vkl~Dfg~~~~~~  304 (458)
                      ||++ ++|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+|||++     ..+.+||+|||++....
T Consensus       113 e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~  188 (329)
T 3gbz_A          113 EYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR---CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG  188 (329)
T ss_dssp             ECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC
T ss_pred             ecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EECCCCCHHHEEEecCCCCccceEEECcCCCccccC
Confidence            9996 599999999888999999999999999999999999   99999999999995     44559999999997654


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCC------
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKA------  376 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~------  376 (458)
                      .. ........+|+.|+|||++.+. .++.++|||||||++|+|++|+.||......+....+.... .+....      
T Consensus       189 ~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (329)
T 3gbz_A          189 IP-IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTA  267 (329)
T ss_dssp             ------------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGG
T ss_pred             Cc-ccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhh
Confidence            32 2223345679999999999774 47999999999999999999999998766554444332221 111100      


Q ss_pred             -------------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          377 -------------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       377 -------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                         ....+++++.+||.+||+.||.+|||+.+++++
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  319 (329)
T 3gbz_A          268 LPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEH  319 (329)
T ss_dssp             STTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCC
Confidence                               011256889999999999999999999999876

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=4.2e-41  Score=322.13  Aligned_cols=250  Identities=29%  Similarity=0.482  Sum_probs=197.6

Q ss_pred             CccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhc--CCCCcceeeeeEEEeC----Cc
Q 012684          154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK--IRHPNVVQFLGAVTQS----SP  224 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~i~~~~~~~~~~----~~  224 (458)
                      ..+|++.+.||+|+||.||   ++|+.||||++...      ....+..|.+++..  ++||||+++++++...    ..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~   80 (301)
T 3q4u_A            7 ARDITLLECVGKGRYGEVWRGSWQGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQ   80 (301)
T ss_dssp             GGGCEEEEEEEECSSEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEE
T ss_pred             cCcEEEEEeeccCCCcEEEEEEECCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCce
Confidence            3478899999999999887   58999999998643      12344556666655  7999999999987543    45


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCCEEecCCCCEEEee
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH--------ENKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~~i~H~Dikp~Nil~~~~~~vkl~D  296 (458)
                      .++||||+++|+|.++++. ..+++..++.++.|++.||.|||        +.+   |+||||||+|||++.++.+||+|
T Consensus        81 ~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~Nill~~~~~~kl~D  156 (301)
T 3q4u_A           81 LWLITHYHEMGSLYDYLQL-TTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPA---IAHRDLKSKNILVKKNGQCCIAD  156 (301)
T ss_dssp             EEEEECCCTTCBHHHHHTT-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECC
T ss_pred             eEEehhhccCCCHHHHHhh-cccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCC---eecCCCChHhEEEcCCCCEEEee
Confidence            8999999999999999964 56999999999999999999999        888   99999999999999999999999


Q ss_pred             cCCccccccCCCC---CcccCCCCCcccCCcccCCC------CCCCchhHHHHHHHHHHHHcC----------CCCCCCC
Q 012684          297 FGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNE------EYDTKVDVFSFALILQEMIEG----------CPPFTMK  357 (458)
Q Consensus       297 fg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwslG~~l~~lltg----------~~pf~~~  357 (458)
                      ||++.........   ......||+.|+|||++.+.      .++.++||||||+++|+|++|          +.||...
T Consensus       157 fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~  236 (301)
T 3q4u_A          157 LGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDV  236 (301)
T ss_dssp             CTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTT
T ss_pred             CCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCcccccccccccccc
Confidence            9999765433221   12334689999999999876      445789999999999999999          8888765


Q ss_pred             CCCcH----HHHHHhc-C-CCCCCC--ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          358 HDNEV----PKAYAAR-Q-RPPFKA--PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       358 ~~~~~----~~~~~~~-~-~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      .....    ....... . .+..+.  ....+++.+.+||..||+.||.+|||+.++++.|+++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~i  300 (301)
T 3q4u_A          237 VPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKKTLTKI  300 (301)
T ss_dssp             SCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHH
T ss_pred             CCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHHHHhcc
Confidence            43321    1111111 1 222221  1234678899999999999999999999999999875

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=1.8e-41  Score=320.52  Aligned_cols=248  Identities=26%  Similarity=0.401  Sum_probs=208.0

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.||.     +|+.||+|++.....  ....+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus         8 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e   85 (276)
T 2yex_A            8 DWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE   85 (276)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             ceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEE
Confidence            688889999999998874     589999999975432  2345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC-CC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-DR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~-~~  309 (458)
                      |+++++|.+++.....+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++....... ..
T Consensus        86 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~  162 (276)
T 2yex_A           86 YCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (276)
T ss_dssp             CCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             ecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCChHHEEEccCCCEEEeeCCCccccCCCcchh
Confidence            9999999999987778999999999999999999999999   9999999999999999999999999997654321 12


Q ss_pred             CcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||................. ........+++.+.++
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~l  241 (276)
T 2yex_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK-TYLNPWKKIDSAPLAL  241 (276)
T ss_dssp             CBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTC-TTSTTGGGSCHHHHHH
T ss_pred             cccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhcc-cccCchhhcCHHHHHH
Confidence            2344568999999999987665 6789999999999999999999988665543222212222 2222345688999999


Q ss_pred             HHHHcccCCCCCCCHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~  409 (458)
                      |..||+.||.+|||+.+++++
T Consensus       242 i~~~l~~~p~~Rps~~~il~~  262 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKKD  262 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHCCCCchhCCCHHHHhcC
Confidence            999999999999999999875

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=5.5e-42  Score=351.69  Aligned_cols=248  Identities=25%  Similarity=0.397  Sum_probs=206.6

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|...+.||+|+||.||.     +|+.||+|++...........+.+.+|+.+++.++||||+++++++.....+|+|
T Consensus       184 ~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lV  263 (543)
T 3c4z_A          184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLV  263 (543)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEE
T ss_pred             hhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEE
Confidence            34688889999999999884     6899999999654322222345678899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          229 TEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      |||++||+|.+++...    ..+++..+..++.||+.||.|||++|   |+||||||+|||++.+|.+||+|||++....
T Consensus       264 mE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~g---IvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          264 MTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRN---IIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             ECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcC---CcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999999763    35999999999999999999999999   9999999999999999999999999998764


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc----HHHHHHhcCCCCCCCChhh
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAYAARQRPPFKAPAKL  380 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~----~~~~~~~~~~~~~~~~~~~  380 (458)
                      ... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.......    +...+ ......+   +..
T Consensus       341 ~~~-~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i-~~~~~~~---p~~  415 (543)
T 3c4z_A          341 AGQ-TKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRV-LEQAVTY---PDK  415 (543)
T ss_dssp             TTC-CCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHH-HHCCCCC---CTT
T ss_pred             CCC-cccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHH-hhcccCC---Ccc
Confidence            332 22234578999999999999999999999999999999999999998765432    22222 2222222   356


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCH-----HHHHHH
Q 012684          381 YARGLKELIEECWNEKPAKRPTF-----RQIITR  409 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~-----~~ll~~  409 (458)
                      +++.+.+||.+||+.||.+||++     .++++|
T Consensus       416 ~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~H  449 (543)
T 3c4z_A          416 FSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH  449 (543)
T ss_dssp             SCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTS
T ss_pred             cCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcC
Confidence            78999999999999999999965     667665

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=1.1e-41  Score=322.14  Aligned_cols=246  Identities=28%  Similarity=0.437  Sum_probs=200.9

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     +|+.||||++...........+.+.+|+.+++.++||||+++++++......++||
T Consensus        11 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   90 (276)
T 2h6d_A           11 GHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVM   90 (276)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             ccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEE
Confidence            4788999999999998884     58999999986432212223457889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++......  .
T Consensus        91 e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~--~  165 (276)
T 2h6d_A           91 EYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHM---VVHRDLKPENVLLDAHMNAKIADFGLSNMMSDG--E  165 (276)
T ss_dssp             ECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHC---SSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred             eccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChhhEEECCCCCEEEeecccccccCCC--c
Confidence            99999999999998888999999999999999999999999   999999999999999999999999998765432  2


Q ss_pred             CcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      ......+++.|+|||.+.+..+ +.++||||||+++|+|++|+.||...........+.. .....   +..++..+.++
T Consensus       166 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~-~~~~~---~~~~~~~l~~l  241 (276)
T 2h6d_A          166 FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRG-GVFYI---PEYLNRSVATL  241 (276)
T ss_dssp             -----------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCC---CTTSCHHHHHH
T ss_pred             ceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhc-CcccC---chhcCHHHHHH
Confidence            2234467899999999988765 5799999999999999999999987655554444422 22222   34567899999


Q ss_pred             HHHHcccCCCCCCCHHHHHHH
Q 012684          389 IEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rps~~~ll~~  409 (458)
                      |.+||+.||.+|||+.+++++
T Consensus       242 i~~~l~~~p~~Rps~~~~l~h  262 (276)
T 2h6d_A          242 LMHMLQVDPLKRATIKDIREH  262 (276)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHccCChhhCCCHHHHHhC
Confidence            999999999999999999987

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2.2e-41  Score=355.46  Aligned_cols=249  Identities=26%  Similarity=0.431  Sum_probs=210.0

Q ss_pred             eeeccceEEEEEE-------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccC
Q 012684          161 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP  233 (458)
Q Consensus       161 ~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~  233 (458)
                      +.||+|+||.||.       .+..||||++..... .....+.+.+|+.++++++||||+++++++.. ...++||||++
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccC
Confidence            4799999999973       357899999976432 33445678999999999999999999999964 56899999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC--CCc
Q 012684          234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPL  311 (458)
Q Consensus       234 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~--~~~  311 (458)
                      +|+|.+++...+.+++..++.++.||+.||.|||+++   |+||||||+|||++.++.+||+|||++..+.....  ...
T Consensus       453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~---iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~  529 (635)
T 4fl3_A          453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  529 (635)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------
T ss_pred             CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccc
Confidence            9999999998888999999999999999999999999   99999999999999999999999999986643322  122


Q ss_pred             ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      ....+|+.|+|||++.+..++.++||||||+++|+|++ |+.||.+....+....+........   +..+++++.+||.
T Consensus       530 ~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~  606 (635)
T 4fl3_A          530 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCPREMYDLMN  606 (635)
T ss_dssp             -----CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHH
T ss_pred             cCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHHHHHHHH
Confidence            33446788999999998899999999999999999998 9999998877777666655544443   3467899999999


Q ss_pred             HHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          391 ECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      .||+.||.+|||+.++++.|+++...+
T Consensus       607 ~cl~~dP~~RPs~~~l~~~L~~~~~~l  633 (635)
T 4fl3_A          607 LCWTYDVENRPGFAAVELRLRNYYYDV  633 (635)
T ss_dssp             HHTCSSTTTSCCHHHHHHHHHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHHHHHHHHHh
Confidence            999999999999999999999987654

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=6.2e-41  Score=320.59  Aligned_cols=251  Identities=24%  Similarity=0.351  Sum_probs=211.9

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCC--C----HHHHHHHHHHHHHHhcCC-CCcceeeeeEEEe
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS--D----DDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ  221 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~--~----~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~  221 (458)
                      ..+|++.+.||+|+||.|+.     +|+.||||++......  .    ....+.+.+|+.+++++. ||||+++++++..
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (298)
T 1phk_A           16 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET   95 (298)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred             hhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeecc
Confidence            45788999999999999884     6899999999754311  1    233456788999999995 9999999999999


Q ss_pred             CCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          222 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       222 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                      +...++||||+++++|.+++.....+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.
T Consensus        96 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~  172 (298)
T 1phk_A           96 NTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSC  172 (298)
T ss_dssp             SSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred             CCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEcCCCcEEEecccchh
Confidence            9999999999999999999998888999999999999999999999999   9999999999999999999999999997


Q ss_pred             ccccCCCCCcccCCCCCcccCCcccC------CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCC
Q 012684          302 LLTVKEDRPLTCQDTSCRYVAPEVFK------NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK  375 (458)
Q Consensus       302 ~~~~~~~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  375 (458)
                      .....  .......+++.|+|||++.      ...++.++||||||+++|+|++|+.||...........+.........
T Consensus       173 ~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~  250 (298)
T 1phk_A          173 QLDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGS  250 (298)
T ss_dssp             ECCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCT
T ss_pred             hcCCC--cccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCc
Confidence            65432  2334456899999999874      456788999999999999999999999877665555555443333333


Q ss_pred             CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       376 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .....++..+.++|.+||+.||.+|||+.+++++
T Consensus       251 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (298)
T 1phk_A          251 PEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  284 (298)
T ss_dssp             TTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ccccccCHHHHHHHHHHccCCcccCCCHHHHHhC
Confidence            3446788999999999999999999999999875

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-42  Score=340.16  Aligned_cols=250  Identities=24%  Similarity=0.380  Sum_probs=205.1

Q ss_pred             ccccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCC-CHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCc
Q 012684          155 LDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~  224 (458)
                      .+|++.+.||+|+||.||.        +|+.||||++...... .....+.+.+|+.+++.+ +||||+++++++..+..
T Consensus        54 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~  133 (355)
T 1vzo_A           54 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  133 (355)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             cceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCce
Confidence            4799999999999999883        6899999998753211 111223466799999999 79999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      .++||||+++++|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       134 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~  210 (355)
T 1vzo_A          134 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFV  210 (355)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECC
T ss_pred             EEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCcEEEeeCCCCeecc
Confidence            9999999999999999998888999999999999999999999999   9999999999999999999999999997654


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH---hcCCCCCCCChh
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA---ARQRPPFKAPAK  379 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~---~~~~~~~~~~~~  379 (458)
                      ...........||+.|+|||++.+.  .++.++|||||||++|+|++|+.||...........+.   ....+.   .+.
T Consensus       211 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~  287 (355)
T 1vzo_A          211 ADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP---YPQ  287 (355)
T ss_dssp             GGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC---CCT
T ss_pred             cCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCC---CCc
Confidence            3322233345689999999999863  47889999999999999999999998655443322221   122232   245


Q ss_pred             hhHHHHHHHHHHHcccCCCCCC-----CHHHHHHHH
Q 012684          380 LYARGLKELIEECWNEKPAKRP-----TFRQIITRL  410 (458)
Q Consensus       380 ~~~~~l~~li~~~l~~dp~~Rp-----s~~~ll~~L  410 (458)
                      .++..+.+||.+||..||.+||     ++.+++++.
T Consensus       288 ~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~  323 (355)
T 1vzo_A          288 EMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHL  323 (355)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSG
T ss_pred             ccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCc
Confidence            6788999999999999999999     999998874

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=5e-41  Score=320.67  Aligned_cols=257  Identities=16%  Similarity=0.227  Sum_probs=206.1

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEE-EeCCceEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV-TQSSPMMIV  228 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~-~~~~~~~lv  228 (458)
                      .+|++.+.||+|+||.|+.     +|+.||||++.....     ...+.+|+.+++.++|++++..+..+ ......++|
T Consensus         9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-----~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv   83 (296)
T 4hgt_A            9 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV   83 (296)
T ss_dssp             --CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CceEEeeeecCCCCeEEEEEEEcCCCceEEEEeeccccc-----chHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEE
Confidence            4689999999999998873     689999998754322     23477899999999887766665555 667788999


Q ss_pred             EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe---cCCCCEEEeecCCccccc
Q 012684          229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~---~~~~~vkl~Dfg~~~~~~  304 (458)
                      |||+ +++|.+++.. .+.+++..+..++.|++.||.|||+.+   |+||||||+||++   +.++.+||+|||++....
T Consensus        84 ~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~  159 (296)
T 4hgt_A           84 MELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR  159 (296)
T ss_dssp             EECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeeeeccCCCCeEEEecCccceecc
Confidence            9999 9999999985 456999999999999999999999999   9999999999999   788999999999998765


Q ss_pred             cCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc---HHHHHHhcC-CCCC
Q 012684          305 VKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---VPKAYAARQ-RPPF  374 (458)
Q Consensus       305 ~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~---~~~~~~~~~-~~~~  374 (458)
                      ....      .......+|+.|+|||.+.+..++.++||||||+++|+|++|+.||.......   ......... ..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  239 (296)
T 4hgt_A          160 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPI  239 (296)
T ss_dssp             CTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCH
T ss_pred             CcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchh
Confidence            4322      12234578999999999999899999999999999999999999998755442   222221111 1221


Q ss_pred             CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 012684          375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK  420 (458)
Q Consensus       375 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  420 (458)
                      ......+++.+.++|..||+.||.+|||+.++++.|+++......+
T Consensus       240 ~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~~~~~~~~~  285 (296)
T 4hgt_A          240 EVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS  285 (296)
T ss_dssp             HHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHHHHHHHHHHTCC
T ss_pred             hhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHHHHHHHHHHhCCC
Confidence            1122456789999999999999999999999999999998776543

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=1.3e-41  Score=327.18  Aligned_cols=250  Identities=28%  Similarity=0.396  Sum_probs=199.9

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCC--HHHHHHHHHHHHHHhcC---CCCcceeeeeEEEeCC
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKI---RHPNVVQFLGAVTQSS  223 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l---~hp~i~~~~~~~~~~~  223 (458)
                      ..+|++.+.||+|+||.||.     +|+.||||++.......  ......+.+|+.+++.+   +||||+++++++....
T Consensus         8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~   87 (308)
T 3g33_A            8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSR   87 (308)
T ss_dssp             --CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECC
T ss_pred             ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccC
Confidence            44799999999999998883     68899999986432111  11112455666666666   5999999999998755


Q ss_pred             -----ceEEEEEccCCCCHHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEee
Q 012684          224 -----PMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (458)
Q Consensus       224 -----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~D  296 (458)
                           ..++||||+. ++|.+++.....  +++..+..++.|++.||+|||+.+   |+||||||+||+++.++.+||+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~D  163 (308)
T 3g33_A           88 TDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGTVKLAD  163 (308)
T ss_dssp             SSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCTTTEEECTTSCEEECS
T ss_pred             CCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEEee
Confidence                 4799999995 699999987654  999999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCC
Q 012684          297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFK  375 (458)
Q Consensus       297 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~  375 (458)
                      ||++......  .......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...........+.... .++..
T Consensus       164 fg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (308)
T 3g33_A          164 FGLARIYSYQ--MALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED  241 (308)
T ss_dssp             CSCTTTSTTC--CCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTT
T ss_pred             CccccccCCC--cccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChh
Confidence            9999865432  23344568999999999988899999999999999999999999998876655544443221 11100


Q ss_pred             C----------------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          376 A----------------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       376 ~----------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .                      ..+.+++.+.+||.+||+.||.+|||+.++++|
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  297 (308)
T 3g33_A          242 DWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQH  297 (308)
T ss_dssp             TSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcC
Confidence            0                      113467899999999999999999999999986

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.1e-41  Score=345.49  Aligned_cols=246  Identities=25%  Similarity=0.353  Sum_probs=196.1

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC------
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~------  223 (458)
                      .+|++.+.||+|+||.|+.     +|+.||||++.... ......+.+.+|+.+++.++||||+++++++....      
T Consensus        62 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  140 (464)
T 3ttj_A           62 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ  140 (464)
T ss_dssp             TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred             CCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCC
Confidence            4789999999999999874     58999999997653 34556677889999999999999999999996543      


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      .+|+||||+++ +|.+.+..  .+++..+..++.|++.||+|||+.|   |+||||||+|||++.++.+||+|||++...
T Consensus       141 ~~~lv~E~~~~-~l~~~~~~--~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          141 DVYLVMELMDA-NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             EEEEEEECCSE-EHHHHHTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             eEEEEEeCCCC-CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence            46999999965 67776653  4899999999999999999999999   999999999999999999999999999865


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-------------
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-------------  370 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-------------  370 (458)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+....             
T Consensus       215 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~  292 (464)
T 3ttj_A          215 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQP  292 (464)
T ss_dssp             --C--CCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCH
T ss_pred             CCC--cccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcch
Confidence            432  23345678999999999999999999999999999999999999998866443333322111             


Q ss_pred             --------CCCCCC-----------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          371 --------RPPFKA-----------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       371 --------~~~~~~-----------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                              .+....                 .....++.+.+||.+||..||.+|||+.++++|
T Consensus       293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  356 (464)
T 3ttj_A          293 TVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  356 (464)
T ss_dssp             HHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                    010000                 011126789999999999999999999999987

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=7.1e-42  Score=332.91  Aligned_cols=240  Identities=23%  Similarity=0.394  Sum_probs=203.0

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCH-----HHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      .+|++.+.||+|+||.||.     +|+.||||++........     ...+.+.+|+.+++.++||||+++++++...+.
T Consensus        24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~  103 (335)
T 3dls_A           24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGF  103 (335)
T ss_dssp             HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSE
T ss_pred             cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCE
Confidence            3689999999999998874     689999999976543221     123456779999999999999999999999999


Q ss_pred             eEEEEEccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          225 MMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       225 ~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      .++||||+.+| +|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus       104 ~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~  180 (335)
T 3dls_A          104 FQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKD---IIHRDIKDENIVIAEDFTIKLIDFGSAAYL  180 (335)
T ss_dssp             EEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEEC
T ss_pred             EEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEEeccCHHHEEEcCCCcEEEeecccceEC
Confidence            99999998666 99999998888999999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhH
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA  382 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (458)
                      ...  .......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||......          .......+..++
T Consensus       181 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~----------~~~~~~~~~~~~  248 (335)
T 3dls_A          181 ERG--KLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEET----------VEAAIHPPYLVS  248 (335)
T ss_dssp             CTT--CCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGGG----------TTTCCCCSSCCC
T ss_pred             CCC--CceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHHH----------HhhccCCCcccC
Confidence            432  22334568999999999988776 78999999999999999999999753211          011111234478


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +++.+||..||+.||.+|||+.+++++
T Consensus       249 ~~l~~li~~~L~~dP~~Rps~~ell~h  275 (335)
T 3dls_A          249 KELMSLVSGLLQPVPERRTTLEKLVTD  275 (335)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            899999999999999999999999987

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=8.1e-42  Score=331.46  Aligned_cols=248  Identities=22%  Similarity=0.364  Sum_probs=206.8

Q ss_pred             cccCc-eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012684          156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       156 ~~~~~-~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      +|.+. +.||+|+||.|+.     +|+.||+|++...... ......+.+|+.+++.+ +||||+++++++......++|
T Consensus        29 ~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv  107 (327)
T 3lm5_A           29 FYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRG-QDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILI  107 (327)
T ss_dssp             HEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETT-EECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             EEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcc-hHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEE
Confidence            45555 7899999999984     5899999999764432 22345688899999999 579999999999999999999


Q ss_pred             EEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC---CCCEEEeecCCcccc
Q 012684          229 TEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLL  303 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~---~~~vkl~Dfg~~~~~  303 (458)
                      |||+++++|.+++...  +.+++..++.++.|++.||.|||+.|   |+||||||+||+++.   ++.+||+|||++...
T Consensus       108 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~g---ivH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~  184 (327)
T 3lm5_A          108 LEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNN---IVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI  184 (327)
T ss_dssp             EECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEESCBTTBCCEEECCGGGCEEC
T ss_pred             EEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCcCChHHEEEecCCCCCcEEEeeCcccccc
Confidence            9999999999988643  56999999999999999999999999   999999999999998   789999999999876


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      ...  .......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+....+..............+++
T Consensus       185 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  262 (327)
T 3lm5_A          185 GHA--CELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ  262 (327)
T ss_dssp             -----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             CCc--cccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence            432  222345689999999999998999999999999999999999999988776665555544443333344567889


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+.++|..||+.||.+|||+.+++++
T Consensus       263 ~~~~li~~~L~~dP~~Rpt~~~ll~h  288 (327)
T 3lm5_A          263 LATDFIQSLLVKNPEKRPTAEICLSH  288 (327)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTTC
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhCC
Confidence            99999999999999999999999986

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=4e-41  Score=352.50  Aligned_cols=249  Identities=24%  Similarity=0.424  Sum_probs=208.3

Q ss_pred             eeccceEEEEEE-------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccCC
Q 012684          162 EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       162 ~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      .||+|+||.||.       ++..||||++....  .....+.+.+|+.+++.++||||+++++++.. ...++||||+++
T Consensus       343 ~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~  419 (613)
T 2ozo_A          343 ELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGG  419 (613)
T ss_dssp             EEEECSSSEEEEEEEECSSCEEEEEEEECCCCC--SSTTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred             EEecCCCcEEEEEEEecCCCcEEEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCC
Confidence            799999999873       35679999997642  22345678999999999999999999999976 568999999999


Q ss_pred             CCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC--Cc
Q 012684          235 GDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--PL  311 (458)
Q Consensus       235 ~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~--~~  311 (458)
                      |+|.+++... ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++.........  ..
T Consensus       420 g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~  496 (613)
T 2ozo_A          420 GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTAR  496 (613)
T ss_dssp             CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------
T ss_pred             CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeec
Confidence            9999999754 45999999999999999999999999   999999999999999999999999999876432211  11


Q ss_pred             ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      ....+|+.|+|||++.+..++.++|||||||++|+|++ |+.||......+....+....+...   +..+++.+.+||.
T Consensus       497 ~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~  573 (613)
T 2ozo_A          497 SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPECPPELYALMS  573 (613)
T ss_dssp             -----CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC---CTTCCHHHHHHHH
T ss_pred             cCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCHHHHHHHH
Confidence            23345688999999988899999999999999999998 9999999888777776655444443   3467899999999


Q ss_pred             HHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012684          391 ECWNEKPAKRPTFRQIITRLESINNSINH  419 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  419 (458)
                      .||+.||.+||++.++++.|+.+....+.
T Consensus       574 ~cl~~dP~~RPs~~~l~~~L~~~~~~~~~  602 (613)
T 2ozo_A          574 DCWIYKWEDRPDFLTVEQRMRACYYSLAS  602 (613)
T ss_dssp             HTTCSSTTTSCCHHHHHHHHHHHHHHHSC
T ss_pred             HHcCCChhHCcCHHHHHHHHHHHHHHhcc
Confidence            99999999999999999999998777554

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.9e-41  Score=328.81  Aligned_cols=255  Identities=29%  Similarity=0.476  Sum_probs=210.5

Q ss_pred             CccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          154 ELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      ..+|++.+.||+|+||.||.          ++..||||.+...  ........+.+|+.++++++||||+++++++....
T Consensus        29 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           29 RKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISKFNHQNIVRCIGVSLQSL  106 (327)
T ss_dssp             GGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             hhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCC
Confidence            44789999999999998873          3568999999743  34555667889999999999999999999999999


Q ss_pred             ceEEEEEccCCCCHHHHHHhcC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC---CCCEE
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKG-------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLK  293 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~---~~~vk  293 (458)
                      ..++||||+++++|.+++....       .+++..++.++.|++.||.|||+.+   ++||||||+||+++.   +..++
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~---i~H~dlkp~NIli~~~~~~~~~k  183 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH---FIHRDIAARNCLLTCPGPGRVAK  183 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEE
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eecCcCCHhHEEEecCCCcceEE
Confidence            9999999999999999998753       4889999999999999999999999   999999999999994   44699


Q ss_pred             EeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCC
Q 012684          294 VADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQR  371 (458)
Q Consensus       294 l~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~  371 (458)
                      |+|||++........ .......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+.....
T Consensus       184 l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~  263 (327)
T 2yfx_A          184 IGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGR  263 (327)
T ss_dssp             ECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCC
T ss_pred             ECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCC
Confidence            999999875433221 12233456889999999988889999999999999999998 9999988766655555544433


Q ss_pred             CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ...   +..+++.+.++|..||+.||.+|||+.+++++|+.+...
T Consensus       264 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~~~  305 (327)
T 2yfx_A          264 MDP---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQD  305 (327)
T ss_dssp             CCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHC
T ss_pred             CCC---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHhcC
Confidence            332   456788999999999999999999999999999987654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.4e-41  Score=330.22  Aligned_cols=245  Identities=25%  Similarity=0.362  Sum_probs=198.7

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC------
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~------  223 (458)
                      .+|+..+.||+|+||.|+.     +|+.||||++.... ......+.+.+|+.+++.++||||+++++++....      
T Consensus        25 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~  103 (367)
T 1cm8_A           25 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT  103 (367)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             ceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCc
Confidence            4799999999999998874     58999999997543 34556677899999999999999999999997653      


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      .+|+||||+ +++|.+++.. +.+++..+..++.|++.||.|||+.|   |+||||||+||+++.++.+||+|||++...
T Consensus       104 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~  178 (367)
T 1cm8_A          104 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA  178 (367)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCcCHHHEEEcCCCCEEEEeeeccccc
Confidence            469999999 8899999876 56999999999999999999999999   999999999999999999999999999865


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-CC----------
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QR----------  371 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~~----------  371 (458)
                      ..    ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+... +.          
T Consensus       179 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~  254 (367)
T 1cm8_A          179 DS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  254 (367)
T ss_dssp             CS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             cc----ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhh
Confidence            32    2344578999999999876 67899999999999999999999999876654333322111 11          


Q ss_pred             ----------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 ----------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 ----------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                      ..+......+++.+.+||.+||..||.+|||+.++++|
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~h  308 (367)
T 1cm8_A          255 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  308 (367)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcC
Confidence                            11112234567899999999999999999999999987

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=2.4e-41  Score=332.49  Aligned_cols=249  Identities=27%  Similarity=0.477  Sum_probs=207.8

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|++.+.||+|+||.||.     +|..||+|++...  ......+.+.+|+.+++.++||||+++++++..++..++|
T Consensus        32 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv  109 (360)
T 3eqc_A           32 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC  109 (360)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEE
T ss_pred             cccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc--cCHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEE
Confidence            34788999999999999884     5889999999754  2455667889999999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |||+++++|.+++...+.+++..+..++.|++.||.|||+. +   |+||||||+||+++.++.++|+|||++...... 
T Consensus       110 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-  185 (360)
T 3eqc_A          110 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-  185 (360)
T ss_dssp             ECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-
T ss_pred             EECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEcCCccHHHEEECCCCCEEEEECCCCcccccc-
Confidence            99999999999999888899999999999999999999996 8   999999999999999999999999998755322 


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH--------------------
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA--------------------  367 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~--------------------  367 (458)
                        ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......+......                    
T Consensus       186 --~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  263 (360)
T 3eqc_A          186 --MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRP  263 (360)
T ss_dssp             --C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC--------------------
T ss_pred             --cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCc
Confidence              2233568999999999999899999999999999999999999998654332211110                    


Q ss_pred             -------------------h-cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          368 -------------------A-RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       368 -------------------~-~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                                         . ............++.++.+||..||+.||.+|||+.++++|-
T Consensus       264 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  326 (360)
T 3eqc_A          264 LNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHA  326 (360)
T ss_dssp             ----------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSH
T ss_pred             ccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhCh
Confidence                               0 001111122345788999999999999999999999999873

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=3.2e-41  Score=327.22  Aligned_cols=259  Identities=27%  Similarity=0.485  Sum_probs=209.9

Q ss_pred             cCCccccCceeeccceEEEEEE---------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE--
Q 012684          152 PHELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT--  220 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~--  220 (458)
                      ....+|++.+.||+|+||.||.         ++..||||++...   .....+.+.+|+.++++++||||+++++++.  
T Consensus        20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~   96 (327)
T 3lxl_A           20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILKALHSDFIVKYRGVSYGP   96 (327)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred             hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecC
Confidence            3456789999999999998873         5789999999753   4556677999999999999999999999986  


Q ss_pred             eCCceEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCC
Q 012684          221 QSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (458)
Q Consensus       221 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~  299 (458)
                      .....++||||+++++|.+++.. ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||+
T Consensus        97 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~  173 (327)
T 3lxl_A           97 GRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRR---CVHRDLAARNILVESEAHVKIADFGL  173 (327)
T ss_dssp             SSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCGGG
T ss_pred             CCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCChhhEEECCCCCEEEccccc
Confidence            45668999999999999999986 456999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC------------cHHHH
Q 012684          300 SKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN------------EVPKA  365 (458)
Q Consensus       300 ~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~------------~~~~~  365 (458)
                      +.........  ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||......            .....
T Consensus       174 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~  253 (327)
T 3lxl_A          174 AKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRL  253 (327)
T ss_dssp             CEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHH
T ss_pred             ceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHH
Confidence            9876433221  223445788899999998888899999999999999999999998643321            01111


Q ss_pred             HHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          366 YAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       366 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ............+..+++.+.+||..||+.||.+|||+.+++++|+.+...
T Consensus       254 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~~~~~  304 (327)
T 3lxl_A          254 LELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQLDMLWSG  304 (327)
T ss_dssp             HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHC---
T ss_pred             HHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHhh
Confidence            111111111223456789999999999999999999999999999988654

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=4.8e-41  Score=333.78  Aligned_cols=250  Identities=22%  Similarity=0.374  Sum_probs=201.9

Q ss_pred             cCCccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC--CCcceeeeeEEEeCCce
Q 012684          152 PHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~i~~~~~~~~~~~~~  225 (458)
                      ....+|++.+.||+|+||.||.    +|+.||||++..... .....+.+.+|+.+++.+.  ||||+++++++..+..+
T Consensus        53 ~~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~  131 (390)
T 2zmd_A           53 VKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI  131 (390)
T ss_dssp             ETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred             ccCCceEEEEEEccCCCeEEEEEEcCCCCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEE
Confidence            3455699999999999999984    488999999976533 4556678999999999996  59999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      |+|||+ .+++|.+++...+.+++..+..++.||+.||.|||+.+   |+||||||+|||++ ++.+||+|||++.....
T Consensus       132 ~lv~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~  206 (390)
T 2zmd_A          132 YMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIV-DGMLKLIDFGIANQMQP  206 (390)
T ss_dssp             EEEEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTT---CCCCCCCGGGEEES-SSCEEECCCSSSCCC--
T ss_pred             EEEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEEE-CCeEEEEecCccccccC
Confidence            999994 58899999998888999999999999999999999999   99999999999996 58999999999987643


Q ss_pred             CCCC-CcccCCCCCcccCCcccCC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-HHHHHHhcC-C
Q 012684          306 KEDR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQ-R  371 (458)
Q Consensus       306 ~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~-~~~~~~~~~-~  371 (458)
                      .... ......||+.|+|||++.+           ..++.++|||||||++|+|++|+.||....... ....+.... .
T Consensus       207 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~  286 (390)
T 2zmd_A          207 DTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHE  286 (390)
T ss_dssp             -------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSC
T ss_pred             CCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCcccc
Confidence            3221 2244578999999999864           368889999999999999999999998654321 122221111 1


Q ss_pred             CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      ..+   +...+..+.+||..||+.||.+|||+.+++++-
T Consensus       287 ~~~---~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp  322 (390)
T 2zmd_A          287 IEF---PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  322 (390)
T ss_dssp             CCC---CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             CCC---CccchHHHHHHHHHHcccChhhCCCHHHHhhCc
Confidence            122   233467899999999999999999999999874

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=5.9e-41  Score=329.68  Aligned_cols=244  Identities=23%  Similarity=0.331  Sum_probs=201.7

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-----CCcceeeeeEEEeCC
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----HPNVVQFLGAVTQSS  223 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----hp~i~~~~~~~~~~~  223 (458)
                      ..+|++.+.||+|+||.||.     +|+.||||++..    .......+..|+.+++.+.     ||||+++++++...+
T Consensus        34 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~  109 (360)
T 3llt_A           34 NNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYD  109 (360)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECS----CHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETT
T ss_pred             cCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEecc----chhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECC
Confidence            44799999999999999984     688999999963    2444566788999999986     999999999999999


Q ss_pred             ceEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC-------------
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-------------  288 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~-------------  288 (458)
                      ..++||||+ +++|.+++....  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.             
T Consensus       110 ~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~~~~~~~~~~  185 (360)
T 3llt_A          110 HMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMS---LTHTDLKPENILLDDPYFEKSLITVRRV  185 (360)
T ss_dssp             EEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCTTCCEEEEEEECT
T ss_pred             eeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCcccEEEccccccccccchhcc
Confidence            999999999 999999998754  4999999999999999999999999   999999999999975             


Q ss_pred             ------------CCCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC
Q 012684          289 ------------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM  356 (458)
Q Consensus       289 ------------~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~  356 (458)
                                  ++.+||+|||++.....    ......||+.|+|||++.+..++.++|||||||++|+|++|+.||..
T Consensus       186 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~  261 (360)
T 3llt_A          186 TDGKKIQIYRTKSTGIKLIDFGCATFKSD----YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRT  261 (360)
T ss_dssp             TTCCEEEEEEESCCCEEECCCTTCEETTS----CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCC
T ss_pred             cccccccccccCCCCEEEEeccCceecCC----CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCC
Confidence                        78999999999986432    22345689999999999999999999999999999999999999987


Q ss_pred             CCCCcHHHHHHhcCCCCC-------------------------CC-----------------ChhhhHHHHHHHHHHHcc
Q 012684          357 KHDNEVPKAYAARQRPPF-------------------------KA-----------------PAKLYARGLKELIEECWN  394 (458)
Q Consensus       357 ~~~~~~~~~~~~~~~~~~-------------------------~~-----------------~~~~~~~~l~~li~~~l~  394 (458)
                      ....+....+.....+..                         +.                 .....++.+.+||.+||+
T Consensus       262 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~  341 (360)
T 3llt_A          262 HEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQ  341 (360)
T ss_dssp             SSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCC
T ss_pred             CcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhc
Confidence            665444333322111110                         00                 001123678899999999


Q ss_pred             cCCCCCCCHHHHHHH
Q 012684          395 EKPAKRPTFRQIITR  409 (458)
Q Consensus       395 ~dp~~Rps~~~ll~~  409 (458)
                      .||.+|||+.+++++
T Consensus       342 ~dP~~Rpta~elL~h  356 (360)
T 3llt_A          342 IDPTLRPSPAELLKH  356 (360)
T ss_dssp             SSGGGSCCHHHHTTS
T ss_pred             CChhhCCCHHHHhcC
Confidence            999999999999875

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.1e-41  Score=341.66  Aligned_cols=249  Identities=23%  Similarity=0.350  Sum_probs=197.7

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCC-----CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      .+|.+.+.||+|+||.||.     +++.||||++......     .......+.+|+.++++++||||+++++++.. ..
T Consensus       135 ~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~  213 (419)
T 3i6u_A          135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDA-ED  213 (419)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEES-SE
T ss_pred             ccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEec-Cc
Confidence            3688999999999999984     5789999998754321     12223357889999999999999999999864 45


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC---CEEEeecCCcc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG---NLKVADFGVSK  301 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~---~vkl~Dfg~~~  301 (458)
                      .++||||+++++|.+++...+.+++..+..++.|++.||.|||+.+   |+||||||+|||++.++   .+||+|||++.
T Consensus       214 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~  290 (419)
T 3i6u_A          214 YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSK  290 (419)
T ss_dssp             EEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSSSCCEEECCSSTTT
T ss_pred             eEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCCCcceEEEeecccce
Confidence            7999999999999999988888999999999999999999999999   99999999999997544   59999999998


Q ss_pred             ccccCCCCCcccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH-HHHHHhcCCCCCCCC
Q 012684          302 LLTVKEDRPLTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAP  377 (458)
Q Consensus       302 ~~~~~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~~~  377 (458)
                      .....  .......||+.|+|||++.+   ..++.++||||||+++|+|++|+.||........ ...+........+..
T Consensus       291 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~  368 (419)
T 3i6u_A          291 ILGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  368 (419)
T ss_dssp             SCC-------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred             ecCCC--ccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence            76432  22344568999999999864   4677899999999999999999999987655443 344333333333333


Q ss_pred             hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          378 AKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       378 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +..+++.+.+||.+||+.||.+|||+.++++|
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~h  400 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRH  400 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             hcccCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence            45678999999999999999999999999987

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=8e-42  Score=331.06  Aligned_cols=247  Identities=23%  Similarity=0.404  Sum_probs=195.8

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.||.     +|+.||+|++.....  ......+.+|+.+++.++||||+++++++..+...++|||
T Consensus         3 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            3 TYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             SEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred             ceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEec
Confidence            688899999999999984     688999999974321  1112234579999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |++ ++|.+++...+ .+++..+..++.|++.||.|||+.|   |+||||||+||+++.++.+||+|||++...... ..
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~-~~  155 (324)
T 3mtl_A           81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQK---VLHRDLKPQNLLINERGELKLADFGLARAKSIP-TK  155 (324)
T ss_dssp             CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EEESSCCGGGEEECTTCCEEECSSSEEECC------
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCcCHHHEEECCCCCEEEccCcccccccCC-cc
Confidence            996 59999888754 4899999999999999999999999   999999999999999999999999998765432 22


Q ss_pred             CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCC------------
Q 012684          310 PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA------------  376 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~------------  376 (458)
                      ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+..+....+......+...            
T Consensus       156 ~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~  235 (324)
T 3mtl_A          156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFK  235 (324)
T ss_dssp             -------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHH
T ss_pred             ccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhc
Confidence            2334567999999999876 568999999999999999999999999876655544443322111110            


Q ss_pred             --------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          377 --------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       377 --------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                    ....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  282 (324)
T 3mtl_A          236 TYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKH  282 (324)
T ss_dssp             HTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence                          012457889999999999999999999999987

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=2e-41  Score=343.93  Aligned_cols=250  Identities=23%  Similarity=0.329  Sum_probs=188.0

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----Cc
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~  224 (458)
                      .+|++.+.||+|+||.|+.     +|+.||||++.... ......+.+.+|+.+++.++||||+++++++...     ..
T Consensus        53 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~  131 (458)
T 3rp9_A           53 DRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVF-EDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDE  131 (458)
T ss_dssp             TTEEECCC-------CEEEEEECC--CEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCC
T ss_pred             CCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhh-cCHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCce
Confidence            4799999999999998873     68999999997543 3555667889999999999999999999998433     56


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      +|+||||+ +++|.+++.....+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       132 ~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          132 LYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAG---ILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             EEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             EEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            89999998 6799999998888999999999999999999999999   9999999999999999999999999998764


Q ss_pred             cCCC--------------------------CCcccCCCCCcccCCccc-CCCCCCCchhHHHHHHHHHHHHc--------
Q 012684          305 VKED--------------------------RPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIE--------  349 (458)
Q Consensus       305 ~~~~--------------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~~llt--------  349 (458)
                      ....                          .......||+.|+|||++ .+..++.++|||||||++|+|++        
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~  287 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY  287 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence            3211                          122445679999999976 55679999999999999999998        


Q ss_pred             ---CCCCCCCCCCCc--------------------HHHHH-HhcC--------------------------CCCCCCChh
Q 012684          350 ---GCPPFTMKHDNE--------------------VPKAY-AARQ--------------------------RPPFKAPAK  379 (458)
Q Consensus       350 ---g~~pf~~~~~~~--------------------~~~~~-~~~~--------------------------~~~~~~~~~  379 (458)
                         |+++|.+.....                    ....+ ...+                          ...+....+
T Consensus       288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (458)
T 3rp9_A          288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP  367 (458)
T ss_dssp             GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred             cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence               677776543210                    00000 0000                          001111223


Q ss_pred             hhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          380 LYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       380 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+++.+.+||.+||..||.+|||+.++++|
T Consensus       368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~H  397 (458)
T 3rp9_A          368 ASSADAIHLLKRMLVFNPNKRITINECLAH  397 (458)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             CCCHHHHHHHHHHhccCccccCCHHHHhcC
Confidence            457899999999999999999999999997

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.2e-41  Score=359.82  Aligned_cols=247  Identities=27%  Similarity=0.412  Sum_probs=211.9

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      .+|++.+.||+|+||.||.     +|+.||||++...........+.+..|..++..+ +||+|+++++++.....+|+|
T Consensus       341 ~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV  420 (674)
T 3pfq_A          341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFV  420 (674)
T ss_dssp             TTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEE
T ss_pred             cceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEE
Confidence            4688899999999998884     5788999999753222223345677899999988 799999999999999999999


Q ss_pred             EEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          229 TEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |||++||+|.+++...+.+++..+..++.||+.||+|||+.+   |+||||||+|||++.++.+||+|||++...... .
T Consensus       421 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g---IiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~-~  496 (674)
T 3pfq_A          421 MEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIWD-G  496 (674)
T ss_dssp             EECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTS---EECCCCCSTTEEECSSSCEEECCCTTCEECCCT-T
T ss_pred             EeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeccCChhhEEEcCCCcEEEeecceeeccccC-C
Confidence            999999999999998889999999999999999999999999   999999999999999999999999999854322 2


Q ss_pred             CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL  388 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  388 (458)
                      .......||+.|+|||++.+..++.++||||||+++|+|++|+.||.+.+..++...+... ...+   +..+++++.+|
T Consensus       497 ~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~s~~~~~l  572 (674)
T 3pfq_A          497 VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEH-NVAY---PKSMSKEAVAI  572 (674)
T ss_dssp             CCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSS-CCCC---CTTSCHHHHHH
T ss_pred             cccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhC-CCCC---CccCCHHHHHH
Confidence            2344567999999999999999999999999999999999999999987776666666433 3333   34688999999


Q ss_pred             HHHHcccCCCCCCCH-----HHHHHH
Q 012684          389 IEECWNEKPAKRPTF-----RQIITR  409 (458)
Q Consensus       389 i~~~l~~dp~~Rps~-----~~ll~~  409 (458)
                      |..||+.||.+||++     .++++|
T Consensus       573 i~~lL~~dP~~R~~~~~~~~~ei~~h  598 (674)
T 3pfq_A          573 CKGLMTKHPGKRLGCGPEGERDIKEH  598 (674)
T ss_dssp             HHHHSCSSSTTCTTCSTTHHHHHHSS
T ss_pred             HHHHccCCHHHCCCCCCCcHHHHhcC
Confidence            999999999999997     777765

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.1e-42  Score=324.90  Aligned_cols=249  Identities=25%  Similarity=0.386  Sum_probs=201.1

Q ss_pred             CccccCceeeccceEEEEEE-----cC-------eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RG-------IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ  221 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g-------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~  221 (458)
                      ..+|++.+.||+|+||.||.     ++       ..||+|.+....   ....+.+.+|+.+++.++||||+++++++..
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~   83 (289)
T 4fvq_A            7 NEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCVC   83 (289)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEECC
T ss_pred             hhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEe
Confidence            44788899999999998874     23       579999986532   3345678899999999999999999999999


Q ss_pred             CCceEEEEEccCCCCHHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC--------E
Q 012684          222 SSPMMIVTEYLPKGDLRAFLKRKGA-LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--------L  292 (458)
Q Consensus       222 ~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~--------v  292 (458)
                      ++..++||||+++++|.+++...+. +++..++.++.|++.||.|||+++   ++||||||+||+++.++.        +
T Consensus        84 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~~  160 (289)
T 4fvq_A           84 GDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENT---LIHGNVCAKNILLIREEDRKTGNPPFI  160 (289)
T ss_dssp             TTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEEECCBGGGTBCCEE
T ss_pred             CCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCC---eECCCcCcceEEEecCCccccccccee
Confidence            9999999999999999999987654 999999999999999999999999   999999999999998887        9


Q ss_pred             EEeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCC
Q 012684          293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR  371 (458)
Q Consensus       293 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~  371 (458)
                      +|+|||++......     ....+|+.|+|||++.+ ..++.++||||||+++|+|++|..|+.............. ..
T Consensus       161 kl~Dfg~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~-~~  234 (289)
T 4fvq_A          161 KLSDPGISITVLPK-----DILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYE-DR  234 (289)
T ss_dssp             EECCCCSCTTTSCH-----HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHH-TT
T ss_pred             eeccCcccccccCc-----cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhh-cc
Confidence            99999998654221     22346788999999987 6789999999999999999996554443333222222212 22


Q ss_pred             CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      ...   +...++.+.++|..||+.||.+|||+.+++++|+++.++-
T Consensus       235 ~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~l~~p~  277 (289)
T 4fvq_A          235 HQL---PAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSLFTPD  277 (289)
T ss_dssp             CCC---CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHHHHTCC---
T ss_pred             CCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCCC
Confidence            222   2234677999999999999999999999999999986653

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=1.6e-41  Score=332.74  Aligned_cols=256  Identities=14%  Similarity=0.198  Sum_probs=208.0

Q ss_pred             cCCccccCceeeccceEEEEEE-------------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCccee----
Q 012684          152 PHELDFTNSVEITKGTFILAFW-------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ----  214 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~----  214 (458)
                      ....+|++.+.||+|+||.||.             .++.||+|++...        +.+.+|+.+++.++||||++    
T Consensus        39 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~  110 (352)
T 2jii_A           39 KSGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKK  110 (352)
T ss_dssp             TTSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHH
T ss_pred             ccCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhh
Confidence            4456899999999999999883             2789999998743        25778999999999999887    


Q ss_pred             -----------eeeEEEe-CCceEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 012684          215 -----------FLGAVTQ-SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE  280 (458)
Q Consensus       215 -----------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dik  280 (458)
                                 +++++.. +...++||||+ +++|.+++...  +.+++..++.++.|++.||.|||+++   |+|||||
T Consensus       111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dik  186 (352)
T 2jii_A          111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENE---YVHGNVT  186 (352)
T ss_dssp             HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCC
T ss_pred             hccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCCCCC
Confidence                       6777765 67889999999 99999999875  67999999999999999999999999   9999999


Q ss_pred             CCCEEecCCC--CEEEeecCCccccccCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCC
Q 012684          281 PSNILRDDSG--NLKVADFGVSKLLTVKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP  352 (458)
Q Consensus       281 p~Nil~~~~~--~vkl~Dfg~~~~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~  352 (458)
                      |+||+++.++  .++|+|||++.........      ......||+.|+|||++.+..++.++||||||+++|+|++|+.
T Consensus       187 p~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~  266 (352)
T 2jii_A          187 AENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFL  266 (352)
T ss_dssp             GGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCC
T ss_pred             HHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence            9999999998  8999999999766433211      1234478999999999999899999999999999999999999


Q ss_pred             CCCCCCCCc-HHHHHHh---cCCCCCC---CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhc
Q 012684          353 PFTMKHDNE-VPKAYAA---RQRPPFK---APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINH  419 (458)
Q Consensus       353 pf~~~~~~~-~~~~~~~---~~~~~~~---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~  419 (458)
                      ||....... .......   .....+.   .....+++.+.+||..||+.||.+|||+.++++.|+++......
T Consensus       267 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~~~~~~  340 (352)
T 2jii_A          267 PWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNNLEALLQDLRV  340 (352)
T ss_dssp             TTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTC
T ss_pred             CcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHHHHHHHHhcCC
Confidence            998765322 2211111   1111111   11235689999999999999999999999999999999877553

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.2e-41  Score=351.38  Aligned_cols=259  Identities=32%  Similarity=0.509  Sum_probs=216.3

Q ss_pred             CcccCcCCccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC
Q 012684          147 EYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS  222 (458)
Q Consensus       147 ~~~~~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~  222 (458)
                      .|++.  ..+|++.+.||+|+||.||.    .+..||||++......    .+.+.+|+.++++++||||+++++++.+ 
T Consensus       261 ~~~i~--~~~~~~~~~lG~G~fg~Vy~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~hpniv~~~~~~~~-  333 (535)
T 2h8h_A          261 AWEIP--RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE-  333 (535)
T ss_dssp             CSBCC--GGGEEEEEEEEECSSEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-
T ss_pred             ceecc--hhhhhhheecccCCCeEEEEEEECCCceEEEEEeCCCCCC----HHHHHHHHHHHHhCCCCCEeeEEEEEee-
Confidence            44443  34678889999999999874    3468999999764322    3568899999999999999999999876 


Q ss_pred             CceEEEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCc
Q 012684          223 SPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~  300 (458)
                      ...++||||+++|+|.+++..  ...+++.+++.++.|++.||.|||+++   |+||||||+|||++.++.+||+|||++
T Consensus       334 ~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivHrDlkp~NIll~~~~~~kl~DFG~a  410 (535)
T 2h8h_A          334 EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLA  410 (535)
T ss_dssp             SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCTTST
T ss_pred             ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHhhEEEcCCCcEEEcccccc
Confidence            678999999999999999974  355999999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChh
Q 012684          301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAK  379 (458)
Q Consensus       301 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  379 (458)
                      ...............++..|+|||++.+..++.++||||||+++|+|++ |+.||......+....+....+.+.   +.
T Consensus       411 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~---~~  487 (535)
T 2h8h_A          411 RLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---PP  487 (535)
T ss_dssp             TTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC---CT
T ss_pred             eecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CC
Confidence            8654321112233456788999999988889999999999999999999 9999998877666666644444433   34


Q ss_pred             hhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          380 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       380 ~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      .++..+.+||..||+.||.+|||+.+|++.|+.+....+
T Consensus       488 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~~L~~~~~~~~  526 (535)
T 2h8h_A          488 ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  526 (535)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTSSCCCS
T ss_pred             CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHhhccC
Confidence            678899999999999999999999999999998865544

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=2.2e-42  Score=342.11  Aligned_cols=241  Identities=13%  Similarity=0.139  Sum_probs=193.6

Q ss_pred             cCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHH---HHhcCCCCcceeee-------
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA---LLQKIRHPNVVQFL-------  216 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~---~l~~l~hp~i~~~~-------  216 (458)
                      ....+|++.+.||+|+||.||.     +|+.||||++...........+.+.+|+.   .++.++||||++++       
T Consensus        70 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~  149 (377)
T 3byv_A           70 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  149 (377)
T ss_dssp             CCCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCS
T ss_pred             CCCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhh
Confidence            3456799999999999999883     58999999997654445556678999995   45555799999998       


Q ss_pred             eEEEeCC-----------------ceEEEEEccCCCCHHHHHHhcCCCCH-------HHHHHHHHHHHHHHHHHHhCCCC
Q 012684          217 GAVTQSS-----------------PMMIVTEYLPKGDLRAFLKRKGALKP-------STAVRFALDIARGMNYLHENKPV  272 (458)
Q Consensus       217 ~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~~~~~-------~~~~~i~~qi~~~l~~LH~~~~~  272 (458)
                      +++...+                 ..|+||||+ +|+|.+++...+.+++       ..++.++.|++.||+|||+++  
T Consensus       150 ~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--  226 (377)
T 3byv_A          150 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--  226 (377)
T ss_dssp             EEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             hhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCC--
Confidence            6665543                 289999999 6899999987655655       778889999999999999999  


Q ss_pred             CeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-----------CCCCchhHHHHH
Q 012684          273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-----------EYDTKVDVFSFA  341 (458)
Q Consensus       273 ~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----------~~~~~~DiwslG  341 (458)
                       |+||||||+|||++.++.+||+|||++....    .......| +.|+|||++.+.           .++.++||||||
T Consensus       227 -ivHrDikp~NIll~~~~~~kL~DFG~a~~~~----~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG  300 (377)
T 3byv_A          227 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG----ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALG  300 (377)
T ss_dssp             -EECSCCCGGGEEECTTCCEEECCGGGCEETT----CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHH
T ss_pred             -eecCCCCHHHEEEcCCCCEEEEechhheecC----CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHH
Confidence             9999999999999999999999999998532    22334456 899999999877           789999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          342 LILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       342 ~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      |++|+|++|+.||...........+.        ..+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       301 ~il~elltg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  360 (377)
T 3byv_A          301 LVIYWIWCADLPITKDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMET  360 (377)
T ss_dssp             HHHHHHHHSSCCC------CCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTS
T ss_pred             HHHHHHHHCCCCCcccccccchhhhh--------hhccCCCHHHHHHHHHHcCCCchhCCCHHHHhhC
Confidence            99999999999998765443322221        1124567899999999999999999999999975

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.5e-41  Score=323.68  Aligned_cols=257  Identities=26%  Similarity=0.468  Sum_probs=203.4

Q ss_pred             CCccccCceeeccceEEEEEE------cC--eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          153 HELDFTNSVEITKGTFILAFW------RG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~------~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      ...+|++.+.||+|+||.||.      ++  ..||+|++...........+.+.+|+.+++.++||||+++++++..+. 
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-
Confidence            355799999999999998763      12  269999998665445566788999999999999999999999998754 


Q ss_pred             eEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      .++||||+++++|.+++... +.+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++...
T Consensus        95 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~Nili~~~~~~kl~Dfg~~~~~  171 (291)
T 1u46_A           95 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL  171 (291)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred             ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC---cccCCCchheEEEcCCCCEEEccccccccc
Confidence            89999999999999999764 56999999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhh
Q 012684          304 TVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL  380 (458)
Q Consensus       304 ~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (458)
                      ......  ......+|+.|+|||++.+..++.++||||||+++|+|++ |+.||......+....+......  ...+..
T Consensus       172 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~  249 (291)
T 1u46_A          172 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGER--LPRPED  249 (291)
T ss_dssp             CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCC--CCCCTT
T ss_pred             cccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCC--CCCCcC
Confidence            433221  1233456788999999988888999999999999999999 99999987766655555333322  123456


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          381 YARGLKELIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      +++.+.++|..||+.||.+|||+.++++.|+++..
T Consensus       250 ~~~~l~~li~~~l~~~p~~Rps~~~l~~~l~~~~~  284 (291)
T 1u46_A          250 CPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQP  284 (291)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC-
T ss_pred             cCHHHHHHHHHHccCCcccCcCHHHHHHHHHHhCc
Confidence            78999999999999999999999999999988754

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.9e-40  Score=320.49  Aligned_cols=253  Identities=27%  Similarity=0.479  Sum_probs=199.6

Q ss_pred             ccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC--CCCcceeeeeEEEeC----Cce
Q 012684          155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFLGAVTQS----SPM  225 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~i~~~~~~~~~~----~~~  225 (458)
                      .+|++.+.||+|+||.||   .+|+.||||++...    .  ...+..|.+++...  +||||+++++++...    ...
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~----~--~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~  110 (337)
T 3mdy_A           37 KQIQMVKQIGKGRYGEVWMGKWRGEKVAVKVFFTT----E--EASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQL  110 (337)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEETTEEEEEEEEEGG----G--HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEE
T ss_pred             cceEEEeEeecCCCeEEEEEEECCceEEEEEEecc----c--cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCce
Confidence            479999999999999887   58999999998532    1  12344455555554  899999999999877    678


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCCCeeeCCCCCCCEEecCCCCEEEeec
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN--------KPVPIIHRDLEPSNILRDDSGNLKVADF  297 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~--------~~~~i~H~Dikp~Nil~~~~~~vkl~Df  297 (458)
                      ++||||+++++|.+++... .+++..++.++.|++.||.|||+.        +   |+||||||+||+++.++.+||+||
T Consensus       111 ~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kl~Df  186 (337)
T 3mdy_A          111 YLITDYHENGSLYDYLKST-TLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPA---IAHRDLKSKNILVKKNGTCCIADL  186 (337)
T ss_dssp             EEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCC---EECSCCCGGGEEECTTSCEEECCC
T ss_pred             EEEEeccCCCcHHHHhhcc-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---EEecccchHHEEECCCCCEEEEeC
Confidence            9999999999999999764 699999999999999999999998        8   999999999999999999999999


Q ss_pred             CCccccccCCCC---CcccCCCCCcccCCcccCCCCCCCc------hhHHHHHHHHHHHHcC----------CCCCCCCC
Q 012684          298 GVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTK------VDVFSFALILQEMIEG----------CPPFTMKH  358 (458)
Q Consensus       298 g~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~------~DiwslG~~l~~lltg----------~~pf~~~~  358 (458)
                      |++.........   ......||+.|+|||++.+......      +|||||||++|+|++|          ..||....
T Consensus       187 g~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~  266 (337)
T 3mdy_A          187 GLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLV  266 (337)
T ss_dssp             TTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhc
Confidence            999765433221   1134568999999999987766654      9999999999999999          67776543


Q ss_pred             CCcH----HHHHHhcC--CCCCCC--ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          359 DNEV----PKAYAARQ--RPPFKA--PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       359 ~~~~----~~~~~~~~--~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      ....    ........  .+.++.  ....+++.+.+||..||+.||.+|||+.+++++|+.+.+..
T Consensus       267 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L~~l~~~~  333 (337)
T 3mdy_A          267 PSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKTLAKMSESQ  333 (337)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             CCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHHHHHHHhhc
Confidence            3321    11111111  222221  12367888999999999999999999999999999997664

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=2.4e-40  Score=333.18  Aligned_cols=251  Identities=24%  Similarity=0.354  Sum_probs=197.6

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----C
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----S  223 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~  223 (458)
                      ..+|++.+.||+|+||.|+.     +|+.||||++.... ......+.+.+|+.+++.++||||+++++++...     .
T Consensus        25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~  103 (432)
T 3n9x_A           25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMF-EDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFD  103 (432)
T ss_dssp             CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTT-TSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCC
T ss_pred             cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchh-cChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCC
Confidence            34799999999999999884     58999999997543 3555667889999999999999999999999766     5


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ..|+||||++ ++|.+++.....+++..+..++.||+.||.|||+.|   |+||||||+|||++.++.+||+|||++...
T Consensus       104 ~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~g---ivHrDlkp~NILl~~~~~~kL~DFGla~~~  179 (432)
T 3n9x_A          104 ELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESG---IIHRDLKPANCLLNQDCSVKVCDFGLARTI  179 (432)
T ss_dssp             CEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHeEECCCCCEEEccCCCcccc
Confidence            6899999995 699999998888999999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCC---------------------CCcccCCCCCcccCCccc-CCCCCCCchhHHHHHHHHHHHHcCCCC--------
Q 012684          304 TVKED---------------------RPLTCQDTSCRYVAPEVF-KNEEYDTKVDVFSFALILQEMIEGCPP--------  353 (458)
Q Consensus       304 ~~~~~---------------------~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwslG~~l~~lltg~~p--------  353 (458)
                      .....                     .......||+.|+|||++ .+..++.++|||||||++|+|++|..|        
T Consensus       180 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~  259 (432)
T 3n9x_A          180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNR  259 (432)
T ss_dssp             -------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGC
T ss_pred             cccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhcccccccccccc
Confidence            43321                     123556789999999986 556789999999999999999985444        


Q ss_pred             ---CCCCCCC-----------------------------------------cHHHHHHhcCCCCC---CCChhhhHHHHH
Q 012684          354 ---FTMKHDN-----------------------------------------EVPKAYAARQRPPF---KAPAKLYARGLK  386 (458)
Q Consensus       354 ---f~~~~~~-----------------------------------------~~~~~~~~~~~~~~---~~~~~~~~~~l~  386 (458)
                         |.+.+..                                         .....+........   ....+.+++.+.
T Consensus       260 ~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  339 (432)
T 3n9x_A          260 FPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGI  339 (432)
T ss_dssp             CCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHH
T ss_pred             cccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHH
Confidence               4332210                                         00001100000000   001135788999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +||.+||+.||.+|||+.++++|
T Consensus       340 dLl~~mL~~dP~~R~ta~e~L~H  362 (432)
T 3n9x_A          340 NLLESMLKFNPNKRITIDQALDH  362 (432)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTC
T ss_pred             HHHHHHhcCCcccCCCHHHHhcC
Confidence            99999999999999999999987

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=5.3e-41  Score=323.99  Aligned_cols=255  Identities=21%  Similarity=0.375  Sum_probs=204.6

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe----CC
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SS  223 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~----~~  223 (458)
                      ...+|++.+.||+|+||.||.     +|+.||||++...   .....+.+.+|+.+++.++||||+++++++..    ..
T Consensus        27 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~  103 (317)
T 2buj_A           27 DNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKH  103 (317)
T ss_dssp             TTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEE
T ss_pred             CCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCc
Confidence            345799999999999998873     6899999998643   45566788999999999999999999999863    34


Q ss_pred             ceEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCC
Q 012684          224 PMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~  299 (458)
                      ..++||||+++++|.+++..    ...+++..++.++.|++.||.|||+.+   ++||||||+||+++.++.++|+|||+
T Consensus       104 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~dfg~  180 (317)
T 2buj_A          104 EAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKG---YAHRDLKPTNILLGDEGQPVLMDLGS  180 (317)
T ss_dssp             EEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCSS
T ss_pred             eeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCCEEEEecCc
Confidence            68999999999999999876    466999999999999999999999999   99999999999999999999999998


Q ss_pred             ccccccCCCCC--------cccCCCCCcccCCcccCCCC---CCCchhHHHHHHHHHHHHcCCCCCCCC--CCCcHHHHH
Q 012684          300 SKLLTVKEDRP--------LTCQDTSCRYVAPEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMK--HDNEVPKAY  366 (458)
Q Consensus       300 ~~~~~~~~~~~--------~~~~~gt~~y~aPE~~~~~~---~~~~~DiwslG~~l~~lltg~~pf~~~--~~~~~~~~~  366 (458)
                      +..........        .....||+.|+|||++.+..   ++.++||||||+++|+|++|+.||...  .........
T Consensus       181 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~  260 (317)
T 2buj_A          181 MNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAV  260 (317)
T ss_dssp             CEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHH
T ss_pred             chhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHh
Confidence            87543211110        01234688999999987654   688999999999999999999999642  122233322


Q ss_pred             HhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          367 AARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       367 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      .....  . .....+++.+.++|.+||+.||.+|||+.+++++|+.+...
T Consensus       261 ~~~~~--~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  307 (317)
T 2buj_A          261 QNQLS--I-PQSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEALQPP  307 (317)
T ss_dssp             HCC----C-CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTCCC
T ss_pred             hccCC--C-CccccCCHHHHHHHHHHhhcChhhCCCHHHHHHHhhhcCCC
Confidence            22111  1 12356788999999999999999999999999999987544

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=2.1e-40  Score=319.40  Aligned_cols=246  Identities=25%  Similarity=0.432  Sum_probs=203.9

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|++.+.||+|+||.||.     +|+.||+|.+....     ..+.+.+|+.+++.++||||+++++++......++|
T Consensus        28 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv  102 (314)
T 3com_A           28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIV  102 (314)
T ss_dssp             --CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEE
T ss_pred             hhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEE
Confidence            44688999999999998874     48999999997542     134678899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |||+++++|.+++.. ...+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus       103 ~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~  179 (314)
T 3com_A          103 MEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMR---KIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM  179 (314)
T ss_dssp             EECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECBTTB
T ss_pred             eecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCcCHHHEEECCCCCEEEeecccchhhhhhc
Confidence            999999999999974 567999999999999999999999999   9999999999999999999999999997654332


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                       .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||.................+ ....+..++..+.+
T Consensus       180 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~  257 (314)
T 3com_A          180 -AKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPP-TFRKPELWSDNFTD  257 (314)
T ss_dssp             -SCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSSGGGSCHHHHH
T ss_pred             -cccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCc-ccCCcccCCHHHHH
Confidence             2223456899999999999988999999999999999999999999876554433333222222 22345667899999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +|..||..||.+|||+.+++++
T Consensus       258 li~~~l~~dp~~Rpt~~~ll~~  279 (314)
T 3com_A          258 FVKQCLVKSPEQRATATQLLQH  279 (314)
T ss_dssp             HHHHHTCSCTTTSCCHHHHTTS
T ss_pred             HHHHHccCChhhCcCHHHHHhC
Confidence            9999999999999999999986

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.6e-41  Score=328.72  Aligned_cols=254  Identities=28%  Similarity=0.407  Sum_probs=199.5

Q ss_pred             cCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCC--HHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      ....+|++.+.||+|+||.||.     +|+.||||++.......  ....+.+.+|+.+++.++||||+++++++.....
T Consensus         7 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            7 SRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             ------CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTC
T ss_pred             HHhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCc
Confidence            3455799999999999999984     58899999997543221  1122467789999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      .++||||+++ +|.+++... ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF  162 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTT
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEEcCCCCEEEEecccceec
Confidence            9999999965 899888764 35899999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCC-----
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKA-----  376 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~-----  376 (458)
                      ... ........+|+.|+|||++.+. .++.++||||||+++|+|++|..||.+....+....+.... .+....     
T Consensus       163 ~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~  241 (346)
T 1ua2_A          163 GSP-NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMC  241 (346)
T ss_dssp             TSC-CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTT
T ss_pred             cCC-cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhc
Confidence            433 2233445689999999998764 57889999999999999999999998876555444443221 111000     


Q ss_pred             ------------------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          377 ------------------PAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       377 ------------------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                                        ....+++.+.+||.+||+.||.+|||+.+++++-
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~  293 (346)
T 1ua2_A          242 SLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMK  293 (346)
T ss_dssp             SSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSG
T ss_pred             cCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcCh
Confidence                              0134568999999999999999999999999873

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=6.2e-41  Score=321.54  Aligned_cols=249  Identities=30%  Similarity=0.499  Sum_probs=212.0

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      ..|+..+.||+|+||.||.     +|+.||+|++.....  ....+.+.+|+.+++.++||||+++++++..+...++||
T Consensus        22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~   99 (303)
T 3a7i_A           22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIM   99 (303)
T ss_dssp             GTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             HHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEE
Confidence            4588899999999998874     588999999975432  233567889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||+++++|.+++.. +.+++..+..++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|||++....... .
T Consensus       100 e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  174 (303)
T 3a7i_A          100 EYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-I  174 (303)
T ss_dssp             ECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECBTTB-C
T ss_pred             EeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCChheEEECCCCCEEEeecccceecCccc-c
Confidence            99999999999875 56999999999999999999999999   9999999999999999999999999997764332 2


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......+++.|+|||.+.+..++.++||||||+++|+|++|+.||...........+.....+.   .+..++..+.++|
T Consensus       175 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li  251 (303)
T 3a7i_A          175 KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSKPLKEFV  251 (303)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---CCSSCCHHHHHHH
T ss_pred             ccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC---CccccCHHHHHHH
Confidence            2344568999999999999899999999999999999999999998766555444443333322   3456788999999


Q ss_pred             HHHcccCCCCCCCHHHHHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      ..||+.||.+|||+.+++++..-.
T Consensus       252 ~~~l~~dp~~Rps~~~ll~~~~~~  275 (303)
T 3a7i_A          252 EACLNKEPSFRPTAKELLKHKFIL  275 (303)
T ss_dssp             HHHCCSSGGGSCCHHHHTTCHHHH
T ss_pred             HHHcCCChhhCcCHHHHhhChhhh
Confidence            999999999999999999985443

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=324.13  Aligned_cols=261  Identities=26%  Similarity=0.455  Sum_probs=192.7

Q ss_pred             CcccCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEE
Q 012684          147 EYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVT  220 (458)
Q Consensus       147 ~~~~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~  220 (458)
                      ...+.....+|++.+.||+|+||.||.     +|+.||||++...   .....+.+.+|+.+++++. ||||+++++++.
T Consensus        20 ~~~~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~   96 (337)
T 3ll6_A           20 GQTVELGELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAAS   96 (337)
T ss_dssp             TCEEEETTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEE
T ss_pred             cceeeccCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccc
Confidence            344555667899999999999998873     6889999998543   4555677889999999995 999999999984


Q ss_pred             --------eCCceEEEEEccCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC
Q 012684          221 --------QSSPMMIVTEYLPKGDLRAFLKR---KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS  289 (458)
Q Consensus       221 --------~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~  289 (458)
                              .....++||||+. |+|.+++..   .+.+++..++.++.|++.||.|||+.++ +|+||||||+|||++.+
T Consensus        97 ~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~-~ivH~Dikp~NIl~~~~  174 (337)
T 3ll6_A           97 IGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKP-PIIHRDLKVENLLLSNQ  174 (337)
T ss_dssp             ECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSS-CCBCCCCCGGGCEECTT
T ss_pred             ccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCC-CEEEccCCcccEEECCC
Confidence                    3344899999994 799998865   4569999999999999999999999862 49999999999999999


Q ss_pred             CCEEEeecCCccccccCCCCC-----------cccCCCCCcccCCccc---CCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 012684          290 GNLKVADFGVSKLLTVKEDRP-----------LTCQDTSCRYVAPEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFT  355 (458)
Q Consensus       290 ~~vkl~Dfg~~~~~~~~~~~~-----------~~~~~gt~~y~aPE~~---~~~~~~~~~DiwslG~~l~~lltg~~pf~  355 (458)
                      +.+||+|||++..........           .....+|+.|+|||++   .+..++.++||||||+++|+|++|+.||.
T Consensus       175 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~  254 (337)
T 3ll6_A          175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFE  254 (337)
T ss_dssp             SCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-
T ss_pred             CCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCc
Confidence            999999999998765432211           1134589999999998   56678889999999999999999999998


Q ss_pred             CCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      ...........   ...+   .....+..+.+||..||+.||.+|||+.+++++|+.+.....
T Consensus       255 ~~~~~~~~~~~---~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~~~~~~~  311 (337)
T 3ll6_A          255 DGAKLRIVNGK---YSIP---PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARN  311 (337)
T ss_dssp             --------------CCCC---TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHTT
T ss_pred             chhHHHhhcCc---ccCC---cccccchHHHHHHHHHccCChhhCcCHHHHHHHHHHHHhccC
Confidence            65543322211   1111   123345678999999999999999999999999999976644

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1.9e-41  Score=331.35  Aligned_cols=258  Identities=16%  Similarity=0.216  Sum_probs=200.5

Q ss_pred             CCccccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHH--------HHHHHHHHHHHhcCCCCcceeee
Q 012684          153 HELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDR--------VRAFRDELALLQKIRHPNVVQFL  216 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~hp~i~~~~  216 (458)
                      ...+|++.+.||+|+||.||.        ++..+|+|++..........        ...+.+|+..++.++||||++++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~  114 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFY  114 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceee
Confidence            345799999999999998873        56889999987542111111        12355788899999999999999


Q ss_pred             eEEEe----CCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC--
Q 012684          217 GAVTQ----SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG--  290 (458)
Q Consensus       217 ~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~--  290 (458)
                      +++..    ....++||||+ +++|.+++...+.+++..++.++.|++.||.|||+.+   |+||||||+|||++.++  
T Consensus       115 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~  190 (345)
T 2v62_A          115 GSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPD  190 (345)
T ss_dssp             EEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEESSSTT
T ss_pred             cccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCcCHHHEEEccCCCC
Confidence            99987    67899999999 9999999988778999999999999999999999999   99999999999999877  


Q ss_pred             CEEEeecCCccccccCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH-H
Q 012684          291 NLKVADFGVSKLLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-P  363 (458)
Q Consensus       291 ~vkl~Dfg~~~~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~-~  363 (458)
                      .+||+|||++..+.....      .......||+.|+|||++.+..++.++||||||+++|+|++|+.||........ .
T Consensus       191 ~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~  270 (345)
T 2v62_A          191 QVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAV  270 (345)
T ss_dssp             SEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHH
T ss_pred             cEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHH
Confidence            999999999976543211      112445789999999999998899999999999999999999999965433322 1


Q ss_pred             HHHHhcCCCCCCCC------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          364 KAYAARQRPPFKAP------AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       364 ~~~~~~~~~~~~~~------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      ...........+..      ...+++.+.++|..||+.||.+|||+.++++.|+++.
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~L~~~~  327 (345)
T 2v62_A          271 QTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKILNPHG  327 (345)
T ss_dssp             HHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHHHCTTC
T ss_pred             HHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHHHhccC
Confidence            21111111111110      1157789999999999999999999999999998764

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.9e-41  Score=329.43  Aligned_cols=250  Identities=25%  Similarity=0.401  Sum_probs=202.9

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     +|+.||+|++.... ......+.+.+|+.+++.++||||+++++++......++||
T Consensus        25 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~  103 (331)
T 4aaa_A           25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVF  103 (331)
T ss_dssp             GGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             hhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEE
Confidence            3799999999999998873     48899999986543 34455667889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+.|   ++||||||+||+++.++.++|+|||++....... .
T Consensus       104 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-~  179 (331)
T 4aaa_A          104 EFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-E  179 (331)
T ss_dssp             ECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCTTC---------
T ss_pred             ecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC---EEccCcChheEEEcCCCcEEEEeCCCceeecCCc-c
Confidence            99999999988887788999999999999999999999999   9999999999999999999999999997654322 2


Q ss_pred             CcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCC-----------------
Q 012684          310 PLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR-----------------  371 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~-----------------  371 (458)
                      ......+|+.|+|||++.+. .++.++||||||+++|+|++|+.||......+....+.....                 
T Consensus       180 ~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (331)
T 4aaa_A          180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFA  259 (331)
T ss_dssp             ----CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGT
T ss_pred             ccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccc
Confidence            23345689999999998775 688999999999999999999999987765443332221100                 


Q ss_pred             ----CCCC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 ----PPFK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 ----~~~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                          +...      ...+.+++.+.+||.+||+.||.+|||+.+++++
T Consensus       260 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~h  307 (331)
T 4aaa_A          260 GVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHH  307 (331)
T ss_dssp             TCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGS
T ss_pred             cccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcC
Confidence                0000      0112467899999999999999999999999987

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=4.5e-41  Score=329.39  Aligned_cols=251  Identities=23%  Similarity=0.323  Sum_probs=201.0

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe-------
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-------  221 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-------  221 (458)
                      ..+|++.+.||+|+||.|+.     +|+.||+|++....... .....+.+|+.+++.++||||+++++++..       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKE-GFPITALREIKILQLLKHENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSS-SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccc-cchHHHHHHHHHHHhccCCCcccHhheeecccccccc
Confidence            34799999999999998873     68899999996554322 223456789999999999999999999976       


Q ss_pred             -CCceEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCC
Q 012684          222 -SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (458)
Q Consensus       222 -~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~  299 (458)
                       .+..++||||+++ +|.+.+... ..+++..+..++.|++.||.|||+.|   |+||||||+|||++.++.+||+|||+
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~  170 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGL  170 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTT
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCCEEEccchh
Confidence             3468999999964 777777653 56999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCC---CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCC
Q 012684          300 SKLLTVKE---DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFK  375 (458)
Q Consensus       300 ~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~  375 (458)
                      +.......   ........||+.|+|||++.+ ..++.++||||||+++|+|++|+.||...........+........+
T Consensus       171 a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~  250 (351)
T 3mi9_A          171 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP  250 (351)
T ss_dssp             CEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred             cccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCh
Confidence            98664322   222344568999999999876 45799999999999999999999999987665554444332211111


Q ss_pred             CChhh----------------------------hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          376 APAKL----------------------------YARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       376 ~~~~~----------------------------~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ...+.                            .++.+.+||.+||+.||.+|||+.+++++
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  312 (351)
T 3mi9_A          251 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  312 (351)
T ss_dssp             TTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCC
Confidence            11111                            25779999999999999999999999987

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=1.1e-40  Score=317.50  Aligned_cols=250  Identities=23%  Similarity=0.405  Sum_probs=191.5

Q ss_pred             CcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       151 ~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      .....+|++.+.||+|+||.|+.     +|+.||+|++.... ......+.+.++...++.++||||+++++++..++..
T Consensus         3 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~   81 (290)
T 3fme_A            3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV-NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV   81 (290)
T ss_dssp             CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred             cccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc-CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence            34456789999999999999874     78999999997543 2333344455566668888999999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCEEecCCCCEEEeecCCc
Q 012684          226 MIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~  300 (458)
                      ++||||++ ++|.+++..    ...+++..+..++.|++.||.|||++ +   ++||||||+||+++.++.++|+|||++
T Consensus        82 ~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~  157 (290)
T 3fme_A           82 WICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLS---VIHRDVKPSNVLINALGQVKMCDFGIS  157 (290)
T ss_dssp             EEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSC---CCCCCCSGGGCEECTTCCEEBCCC---
T ss_pred             EEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeecCCc
Confidence            99999996 588777754    46799999999999999999999998 8   999999999999999999999999999


Q ss_pred             cccccCCCCCcccCCCCCcccCCccc----CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH-HHHHHhcCCCCCC
Q 012684          301 KLLTVKEDRPLTCQDTSCRYVAPEVF----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFK  375 (458)
Q Consensus       301 ~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~-~~~~~~~~~~~~~  375 (458)
                      ......  .......+|+.|+|||++    .+..++.++||||||+++|+|++|+.||........ .........+.  
T Consensus       158 ~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--  233 (290)
T 3fme_A          158 GYLVDD--VAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ--  233 (290)
T ss_dssp             --------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC--
T ss_pred             cccccc--ccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCC--
Confidence            765433  222334689999999996    455788899999999999999999999986443322 22222222222  


Q ss_pred             CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       376 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .....+++.+.++|.+||+.||.+|||+.+++++
T Consensus       234 ~~~~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~h  267 (290)
T 3fme_A          234 LPADKFSAEFVDFTSQCLKKNSKERPTYPELMQH  267 (290)
T ss_dssp             CCTTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             cccccCCHHHHHHHHHHhhcChhhCcCHHHHHhC
Confidence            2345678999999999999999999999999986

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=4.9e-41  Score=325.17  Aligned_cols=248  Identities=24%  Similarity=0.368  Sum_probs=200.4

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCC-----CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      +|++.+.||+|+||.||.     +|+.||||++......     .......+.+|+.+++.++||||+++++++..+. .
T Consensus        11 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~   89 (322)
T 2ycf_A           11 EYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAED-Y   89 (322)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSS-E
T ss_pred             ceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-e
Confidence            688999999999999884     5789999999754321     1223345788999999999999999999987654 8


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC---EEEeecCCccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADFGVSKL  302 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~---vkl~Dfg~~~~  302 (458)
                      ++||||+++++|.+++...+.+++..+..++.|++.||.|||+++   ++||||||+||+++.++.   +||+|||++..
T Consensus        90 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~  166 (322)
T 2ycf_A           90 YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENG---IIHRDLKPENVLLSSQEEDCLIKITDFGHSKI  166 (322)
T ss_dssp             EEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSSSCCEEECCCTTCEE
T ss_pred             EEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEecCCCCCeEEEccCcccee
Confidence            999999999999999988888999999999999999999999999   999999999999987664   99999999986


Q ss_pred             cccCCCCCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-HHHHHHhcCCCCCCCCh
Q 012684          303 LTVKEDRPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAARQRPPFKAPA  378 (458)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~-~~~~~~~~~~~~~~~~~  378 (458)
                      ....  .......||+.|+|||++.   +..++.++||||||+++|+|++|..||....... ....+........+..+
T Consensus       167 ~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (322)
T 2ycf_A          167 LGET--SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  244 (322)
T ss_dssp             CCCC--HHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred             cccc--cccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence            5322  1122345789999999963   4578899999999999999999999998766553 33333332233222334


Q ss_pred             hhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          379 KLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       379 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h  275 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARFTTEEALRH  275 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhcCHHHHHHHHHHcccCHhhCCCHHHHhhC
Confidence            5678999999999999999999999999976

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9.8e-42  Score=322.98  Aligned_cols=254  Identities=23%  Similarity=0.397  Sum_probs=208.0

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CCceE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMM  226 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~  226 (458)
                      ..+|++.+.||+|+||.||.     +|+.||+|.+..... .....+.+.+|+.++++++||||+++++++..  +...+
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEE
Confidence            44788999999999998874     689999999976543 44566789999999999999999999998854  56789


Q ss_pred             EEEEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCC--CCeeeCCCCCCCEEecCCCCEEEeecCCc
Q 012684          227 IVTEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKP--VPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~--~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~  300 (458)
                      +||||+++++|.+++...    ..+++..++.++.|++.||.|||+.++  .+++|+||||+||+++.++.++|+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            999999999999999753    349999999999999999999999761  23999999999999999999999999998


Q ss_pred             cccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhh
Q 012684          301 KLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL  380 (458)
Q Consensus       301 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (458)
                      ....... .......+++.|+|||.+.+..++.++||||||+++|+|++|+.||......+....+.....+..   +..
T Consensus       164 ~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~  239 (279)
T 2w5a_A          164 RILNHDT-SFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI---PYR  239 (279)
T ss_dssp             HHC---C-HHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC---CTT
T ss_pred             eeecccc-ccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccC---Ccc
Confidence            7653221 111233578899999999888899999999999999999999999998766555555544433333   456


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHH
Q 012684          381 YARGLKELIEECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      +++.+.++|.+||+.||.+|||+.++++++..
T Consensus       240 ~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~  271 (279)
T 2w5a_A          240 YSDELNEIITRMLNLKDYHRPSVEEILENPLI  271 (279)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             cCHHHHHHHHHHcCCCcccCCCHHHHHhChhh
Confidence            78999999999999999999999999987543

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.2e-40  Score=328.92  Aligned_cols=247  Identities=25%  Similarity=0.343  Sum_probs=194.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC------
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~------  223 (458)
                      .+|++.+.||+|+||.|+.     +|+.||||++.... ......+.+.+|+.+++.++||||+++++++....      
T Consensus        25 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~  103 (371)
T 2xrw_A           25 KRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ  103 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCC
T ss_pred             hheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHHhcCCCCccceEEeecccccccccc
Confidence            4799999999999999874     58999999997543 34556677889999999999999999999997654      


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ..++||||++ ++|.+++.  ..+++..+..++.|++.||.|||+.|   |+||||||+|||++.++.+||+|||++...
T Consensus       104 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          104 DVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             EEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             ceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCC---eecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence            6899999995 58888886  35899999999999999999999999   999999999999999999999999999765


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCC------------
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR------------  371 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~------------  371 (458)
                      ...  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....            
T Consensus       178 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  255 (371)
T 2xrw_A          178 GTS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQP  255 (371)
T ss_dssp             --------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCH
T ss_pred             ccc--cccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhh
Confidence            422  223345689999999999998999999999999999999999999987665443333322111            


Q ss_pred             ---------CCCC-----------------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          372 ---------PPFK-----------------APAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       372 ---------~~~~-----------------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                               +.+.                 ......++.+.+||.+||..||.+|||+.+++++-
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp  320 (371)
T 2xrw_A          256 TVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHP  320 (371)
T ss_dssp             HHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             HHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCc
Confidence                     1100                 00122367899999999999999999999999873

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=2.5e-40  Score=336.10  Aligned_cols=258  Identities=15%  Similarity=0.219  Sum_probs=211.8

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCC-CcceeeeeEEEeCCceEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~i~~~~~~~~~~~~~~lv  228 (458)
                      .+|++.+.||+|+||.||.     +|+.||||++......     ..+..|+.+++.+.| ++|+.+..++......++|
T Consensus         7 ~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lv   81 (483)
T 3sv0_A            7 NKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKH-----PQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLV   81 (483)
T ss_dssp             TTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSS-----CCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEE
T ss_pred             CcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEecccccc-----HHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEE
Confidence            4788999999999999884     4899999988654332     246789999999976 6666777777788889999


Q ss_pred             EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe---cCCCCEEEeecCCccccc
Q 012684          229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR---DDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~---~~~~~vkl~Dfg~~~~~~  304 (458)
                      |||+ +++|.+++.. .+.+++..++.++.||+.||.|||+++   |+||||||+|||+   +.++.+||+|||++..+.
T Consensus        82 me~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~  157 (483)
T 3sv0_A           82 MDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYR  157 (483)
T ss_dssp             EECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECCGGGTTCEEECCCTTCEECB
T ss_pred             EECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCcceEEEecCCCCCeEEEEeCCcceecc
Confidence            9999 9999999985 456999999999999999999999999   9999999999999   588999999999998765


Q ss_pred             cCCCC------CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC----CCCC
Q 012684          305 VKEDR------PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ----RPPF  374 (458)
Q Consensus       305 ~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~----~~~~  374 (458)
                      .....      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...........+....    ....
T Consensus       158 ~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~  237 (483)
T 3sv0_A          158 DTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSI  237 (483)
T ss_dssp             CTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCH
T ss_pred             CCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccH
Confidence            43221      1235678999999999999999999999999999999999999999877654433332111    1122


Q ss_pred             CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhccc
Q 012684          375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKR  421 (458)
Q Consensus       375 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~  421 (458)
                      ...+..+++++.+||..||+.||.+||++.+|++.|+.+......+.
T Consensus       238 ~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~  284 (483)
T 3sv0_A          238 EALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQF  284 (483)
T ss_dssp             HHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCC
T ss_pred             HHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCc
Confidence            22235678899999999999999999999999999999987665443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.6e-40  Score=314.11  Aligned_cols=240  Identities=21%  Similarity=0.353  Sum_probs=199.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      .+|++.+.||+|+||.||.     +|+.||+|.+....... .....+.+|+..+..+ +||||+++++++.+++..++|
T Consensus        11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv   89 (289)
T 1x8b_A           11 TEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGS-VDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQ   89 (289)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTS-HHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEE
T ss_pred             chhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccccc-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEE
Confidence            3688899999999999884     68999999997654433 3456677899999888 899999999999999999999


Q ss_pred             EEccCCCCHHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC---------------
Q 012684          229 TEYLPKGDLRAFLKRK----GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---------------  289 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~~----~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~---------------  289 (458)
                      |||+++++|.+++...    +.+++..++.++.|++.||.|||+++   |+||||||+||+++.+               
T Consensus        90 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~  166 (289)
T 1x8b_A           90 NEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMS---LVHMDIKPSNIFISRTSIPNAASEEGDEDDW  166 (289)
T ss_dssp             EECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEC-----------------
T ss_pred             EEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeecCCCHHHEEEcCCCCCcccccccccccc
Confidence            9999999999999764    66999999999999999999999999   9999999999999844               


Q ss_pred             ----CCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHH
Q 012684          290 ----GNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPK  364 (458)
Q Consensus       290 ----~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~  364 (458)
                          ..++|+|||++......     ....+|+.|+|||.+.+. .++.++||||||+++|+|++|..|+...   ....
T Consensus       167 ~~~~~~~kl~Dfg~~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~---~~~~  238 (289)
T 1x8b_A          167 ASNKVMFKIGDLGHVTRISSP-----QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG---DQWH  238 (289)
T ss_dssp             ---CCCEEECCCTTCEETTCS-----CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS---HHHH
T ss_pred             cCCceEEEEcccccccccCCc-----cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch---hHHH
Confidence                47999999999875432     223589999999999775 5567999999999999999998776432   2233


Q ss_pred             HHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       365 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+.....+.   .+..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       239 ~~~~~~~~~---~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  280 (289)
T 1x8b_A          239 EIRQGRLPR---IPQVLSQEFTELLKVMIHPDPERRPSAMALVKH  280 (289)
T ss_dssp             HHHTTCCCC---CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred             HHHcCCCCC---CCcccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence            332322322   345678999999999999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=323.22  Aligned_cols=256  Identities=26%  Similarity=0.516  Sum_probs=209.4

Q ss_pred             CCccccCceeeccceEEEEEE---------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC
Q 012684          153 HELDFTNSVEITKGTFILAFW---------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS  223 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~---------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~  223 (458)
                      ...+|++.+.||+|+||.|+.         +|+.||||++...   .....+.+.+|+.+++.++||||+++++++....
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~  115 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAG  115 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC--
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecC
Confidence            345788999999999998873         5889999999753   3455678999999999999999999999986543


Q ss_pred             --ceEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCc
Q 012684          224 --PMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVS  300 (458)
Q Consensus       224 --~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~  300 (458)
                        ..++||||+++++|.+++... ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++
T Consensus       116 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dikp~NIli~~~~~~kL~Dfg~~  192 (326)
T 2w1i_A          116 RRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKR---YIHRDLATRNILVENENRVKIGDFGLT  192 (326)
T ss_dssp             --CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTC
T ss_pred             CCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEEcCCCcEEEecCcch
Confidence              789999999999999999875 45999999999999999999999999   999999999999999999999999999


Q ss_pred             cccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCC----------CC-c-----H
Q 012684          301 KLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKH----------DN-E-----V  362 (458)
Q Consensus       301 ~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~----------~~-~-----~  362 (458)
                      .........  ......++..|+|||.+.+..++.++||||||+++|+|++|..||....          .. .     .
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (326)
T 2w1i_A          193 KVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHL  272 (326)
T ss_dssp             EECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHH
T ss_pred             hhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHH
Confidence            876433221  1223456778999999988888999999999999999999999986421          11 1     1


Q ss_pred             HHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          363 PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       363 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      ...+......+   .+..+++.+.++|..||+.||.+|||+.++++.|+++...+
T Consensus       273 ~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~~L~~l~~~l  324 (326)
T 2w1i_A          273 IELLKNNGRLP---RPDGCPDEIYMIMTECWNNNVNQRPSFRDLALRVDQIRDQM  324 (326)
T ss_dssp             HHHHHTTCCCC---CCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHHH
T ss_pred             HHHhhcCCCCC---CCCcccHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHHHh
Confidence            11111112222   24567899999999999999999999999999999987664

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.5e-41  Score=322.10  Aligned_cols=253  Identities=26%  Similarity=0.463  Sum_probs=191.3

Q ss_pred             cCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      ....+|.+.+.||+|+||.|+.     +|+.||||.+.....  ....+.+.+|+.+++.++||||+++++++...+..+
T Consensus        12 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~   89 (303)
T 2vwi_A           12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELW   89 (303)
T ss_dssp             -CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEE
T ss_pred             cchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcE
Confidence            3455788999999999998873     689999999875432  234567888999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecC
Q 012684          227 IVTEYLPKGDLRAFLKR--------KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg  298 (458)
                      +||||+++++|.+++..        .+.+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||
T Consensus        90 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~kl~dfg  166 (303)
T 2vwi_A           90 LVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG---QIHRDVKAGNILLGEDGSVQIADFG  166 (303)
T ss_dssp             EEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCEEECCCH
T ss_pred             EEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---CCCCCCChhhEEEcCCCCEEEEecc
Confidence            99999999999999874        355899999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCC----CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCC
Q 012684          299 VSKLLTVKED----RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP  373 (458)
Q Consensus       299 ~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~  373 (458)
                      ++........    .......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||.................+.
T Consensus       167 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  246 (303)
T 2vwi_A          167 VSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPS  246 (303)
T ss_dssp             HHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCC
T ss_pred             chheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCc
Confidence            9876543211    11234568999999999865 468899999999999999999999999877665554443333222


Q ss_pred             CC------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 FK------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ~~------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ..      .....+++.+.++|.+||+.||.+|||+.+++++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  288 (303)
T 2vwi_A          247 LETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRH  288 (303)
T ss_dssp             TTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhC
Confidence            21      1234577899999999999999999999999986

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=7.8e-41  Score=325.53  Aligned_cols=255  Identities=27%  Similarity=0.448  Sum_probs=195.5

Q ss_pred             CccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHH--HhcCCCCcceeeeeEEEe-----CC
Q 012684          154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELAL--LQKIRHPNVVQFLGAVTQ-----SS  223 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~--l~~l~hp~i~~~~~~~~~-----~~  223 (458)
                      -.+|++.+.||+|+||.||   .+|+.||||++....      ...+..|..+  +..++||||+++++.+..     ..
T Consensus        12 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   85 (336)
T 3g2f_A           12 LDNLKLLELIGRGRYGAVYKGSLDERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRM   85 (336)
T ss_dssp             TTSEEEEEEEEECSSEEEEEEEETTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCE
T ss_pred             hHHhheeeecccCCCeEEEEEEECCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccccCCCc
Confidence            3478889999999999887   579999999986431      1233334444  555799999999986542     23


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC---------CCCCeeeCCCCCCCEEecCCCCEEE
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN---------KPVPIIHRDLEPSNILRDDSGNLKV  294 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~---------~~~~i~H~Dikp~Nil~~~~~~vkl  294 (458)
                      ..++||||+++|+|.+++.... .++..++.++.|++.||.|||+.         +   |+||||||+|||++.++.+||
T Consensus        86 ~~~lv~e~~~~g~L~~~l~~~~-~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~---ivH~Dikp~Nill~~~~~~kL  161 (336)
T 3g2f_A           86 EYLLVMEYYPNGSLXKYLSLHT-SDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPA---ISHRDLNSRNVLVKNDGTCVI  161 (336)
T ss_dssp             EEEEEECCCTTCBHHHHHHHCC-BCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCC---EECSSCSGGGEEECTTSCEEE
T ss_pred             eEEEEEecCCCCcHHHHHhhcc-cchhHHHHHHHHHHHHHHHHHhhhccccccccc---eeecccccceEEEcCCCcEEE
Confidence            5789999999999999997654 58899999999999999999999         8   999999999999999999999


Q ss_pred             eecCCccccccCC-------CCCcccCCCCCcccCCcccCC-------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCC-
Q 012684          295 ADFGVSKLLTVKE-------DRPLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIEGCPPFTMKHD-  359 (458)
Q Consensus       295 ~Dfg~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~lltg~~pf~~~~~-  359 (458)
                      +|||++..+....       ........||+.|+|||++.+       ..++.++||||||+++|+|++|+.||..... 
T Consensus       162 ~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~  241 (336)
T 3g2f_A          162 SDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESV  241 (336)
T ss_dssp             CCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCC
T ss_pred             eeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccch
Confidence            9999998664321       111234568999999999987       3556789999999999999999777643222 


Q ss_pred             Cc-----------------HHHHHHh-cCCCCCCCC---hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          360 NE-----------------VPKAYAA-RQRPPFKAP---AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       360 ~~-----------------~~~~~~~-~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      ..                 ....... ..++.++..   ...+++.+.+||.+||+.||.+|||+.++++.|+++.....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~  321 (336)
T 3g2f_A          242 PEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWE  321 (336)
T ss_dssp             CCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCC
T ss_pred             hHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHH
Confidence            11                 0011111 112333221   23467789999999999999999999999999999986644

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=4e-40  Score=324.37  Aligned_cols=249  Identities=26%  Similarity=0.412  Sum_probs=205.2

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----C
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----S  223 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~  223 (458)
                      ..+|++.+.||+|+||.|+.     ++..||||++...  ......+.+.+|+.++++++||||+++++++...     .
T Consensus        26 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~  103 (364)
T 3qyz_A           26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMK  103 (364)
T ss_dssp             TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCC
T ss_pred             cccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccc
Confidence            45799999999999999874     6889999999743  3455567789999999999999999999999654     3


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ..++||||+. ++|.+++.. +.+++..+..++.|++.||.|||+.|   |+||||||+||+++.++.++|+|||++...
T Consensus       104 ~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~  178 (364)
T 3qyz_A          104 DVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA  178 (364)
T ss_dssp             CEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChHhEEECCCCCEEEEeCcceEec
Confidence            6899999995 599998876 46999999999999999999999999   999999999999999999999999999866


Q ss_pred             ccCCCC--CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCC-------
Q 012684          304 TVKEDR--PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP-------  373 (458)
Q Consensus       304 ~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~-------  373 (458)
                      ......  ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+......+       
T Consensus       179 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  258 (364)
T 3qyz_A          179 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC  258 (364)
T ss_dssp             CGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHT
T ss_pred             CCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHH
Confidence            433221  1244578999999998654 458899999999999999999999999877666554442211110       


Q ss_pred             --------------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 --------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 --------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                          .....+.+++.+.+||.+||+.||.+|||+.+++++
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  314 (364)
T 3qyz_A          259 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  314 (364)
T ss_dssp             CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence                                000113467889999999999999999999999987

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2.3e-40  Score=348.89  Aligned_cols=254  Identities=24%  Similarity=0.467  Sum_probs=212.4

Q ss_pred             CccccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          154 ELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      ..+|++.+.||+|+||.||.        .+..||+|.+...  ......+.+.+|+.+++.++||||+++++++. ++..
T Consensus       389 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          389 RERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             GGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSC
T ss_pred             cccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCce
Confidence            45688899999999998873        2467999998743  34556678999999999999999999999985 4568


Q ss_pred             EEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      ++||||+++|+|.+++...+ .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++....
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g---ivHrDikp~NILl~~~~~vkL~DFG~a~~~~  542 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME  542 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECCCCCCCSCC
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchHhEEEeCCCCEEEEecCCCeecC
Confidence            99999999999999998654 5899999999999999999999999   9999999999999999999999999998765


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      ...........+|+.|+|||++.+..++.++||||||+++|+|++ |..||.+....+....+......+.   +..+++
T Consensus       543 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~~~  619 (656)
T 2j0j_A          543 DSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM---PPNCPP  619 (656)
T ss_dssp             C----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC---CTTCCH
T ss_pred             CCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC---CccccH
Confidence            433333334456789999999988889999999999999999997 9999998777666666644444443   456789


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      .+.++|.+||+.||.+|||+.++++.|+++...
T Consensus       620 ~l~~li~~~l~~dP~~RPs~~el~~~L~~il~~  652 (656)
T 2j0j_A          620 TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  652 (656)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHHHHHHHHHH
Confidence            999999999999999999999999999998654

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=1.3e-40  Score=316.78  Aligned_cols=248  Identities=26%  Similarity=0.431  Sum_probs=208.1

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     +++.||+|++...... ....+.+.+|+.++++++||||+++++++......++||
T Consensus        22 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~  100 (287)
T 2wei_A           22 ERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVG  100 (287)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred             hcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccc-hHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEE
Confidence            3688999999999998884     6889999998654332 223457889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC---CCEEEeecCCccccccC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS---GNLKVADFGVSKLLTVK  306 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~---~~vkl~Dfg~~~~~~~~  306 (458)
                      ||+++++|.+++...+.+++..++.++.|++.||.|||+.+   ++|+||||+||+++.+   +.++|+|||++......
T Consensus       101 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~  177 (287)
T 2wei_A          101 ELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHN---IVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (287)
T ss_dssp             CCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCC
T ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChhhEEEecCCCcccEEEeccCcceeecCC
Confidence            99999999999988888999999999999999999999999   9999999999999764   46999999998765432


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                      .  ......+++.|+|||.+.+ .++.++||||||+++|+|++|+.||......+....+..............+++.+.
T Consensus       178 ~--~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  254 (287)
T 2wei_A          178 T--KMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAK  254 (287)
T ss_dssp             S--SCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHH
T ss_pred             C--ccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHH
Confidence            2  2223346889999999876 488999999999999999999999998766555555543332222223356789999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++|.+||+.||.+|||+.+++++
T Consensus       255 ~li~~~l~~dp~~Rps~~ell~h  277 (287)
T 2wei_A          255 DLIRKMLTFHPSLRITATQCLEH  277 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHcccChhhCcCHHHHhcC
Confidence            99999999999999999999986

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=3.1e-40  Score=319.95  Aligned_cols=253  Identities=25%  Similarity=0.404  Sum_probs=201.9

Q ss_pred             CcccCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEE
Q 012684          147 EYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVT  220 (458)
Q Consensus       147 ~~~~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~  220 (458)
                      .-++.....+|++.+.||+|+||.||.     +|+.||||++.....    ..+.+.+|+.+++++ +||||+++++++.
T Consensus        16 ~~~l~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~----~~~~~~~e~~~l~~l~~h~~i~~~~~~~~   91 (326)
T 2x7f_A           16 LSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGD----EEEEIKQEINMLKKYSHHRNIATYYGAFI   91 (326)
T ss_dssp             CCCCCCCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----TTHHHHHHHHHHHHHCCSTTBCCEEEEEE
T ss_pred             chhccCCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcc----cHHHHHHHHHHHHhccCCCCeeeeeeEEe
Confidence            334445566899999999999998874     688999999975432    224678899999998 7999999999997


Q ss_pred             e------CCceEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCE
Q 012684          221 Q------SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL  292 (458)
Q Consensus       221 ~------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~v  292 (458)
                      .      ....++||||+++++|.+++...  ..+++..+..++.|++.||.|||+.|   ++|+||||+||+++.++.+
T Consensus        92 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~NIl~~~~~~~  168 (326)
T 2x7f_A           92 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEV  168 (326)
T ss_dssp             ECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTCCE
T ss_pred             eccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCcHHHEEEcCCCCE
Confidence            6      46789999999999999999864  46999999999999999999999999   9999999999999999999


Q ss_pred             EEeecCCccccccCCCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHH
Q 012684          293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA  367 (458)
Q Consensus       293 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~  367 (458)
                      +|+|||++....... .......+|+.|+|||++.     +..++.++||||||+++|+|++|+.||...........+.
T Consensus       169 kl~Dfg~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~  247 (326)
T 2x7f_A          169 KLVDFGVSAQLDRTV-GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIP  247 (326)
T ss_dssp             EECCCTTTC--------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred             EEeeCcCceecCcCc-cccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence            999999987654321 1223446899999999986     4568899999999999999999999998766544433332


Q ss_pred             hcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       368 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ....+.  .....+++.+.++|.+||..||.+|||+.+++++
T Consensus       248 ~~~~~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h  287 (326)
T 2x7f_A          248 RNPAPR--LKSKKWSKKFQSFIESCLVKNHSQRPATEQLMKH  287 (326)
T ss_dssp             HSCCCC--CSCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             cCcccc--CCccccCHHHHHHHHHHhccChhhCCCHHHHhhC
Confidence            222222  2345678999999999999999999999999986

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=6.2e-41  Score=321.19  Aligned_cols=248  Identities=25%  Similarity=0.416  Sum_probs=203.1

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      ..+|++.+.||+|+||.||.     +|..||+|++....   ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus        18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv   94 (302)
T 2j7t_A           18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIM   94 (302)
T ss_dssp             GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEE
T ss_pred             ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEE
Confidence            34699999999999998874     48899999987542   22346788899999999999999999999999999999


Q ss_pred             EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      |||+++++|.+++.. ...+++..+..++.|++.||.|||+.+   ++|+||||+||+++.++.++|+|||++.......
T Consensus        95 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  171 (302)
T 2j7t_A           95 IEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKR---IIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL  171 (302)
T ss_dssp             EECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH
T ss_pred             EEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEECCCCCEEEEECCCCccccccc
Confidence            999999999999876 456999999999999999999999999   9999999999999999999999999875432111


Q ss_pred             CCCcccCCCCCcccCCccc-----CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhH
Q 012684          308 DRPLTCQDTSCRYVAPEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA  382 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~-----~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (458)
                       .......+|+.|+|||++     .+..++.++||||||+++|+|++|+.||...........+.... .+....+..++
T Consensus       172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~  249 (302)
T 2j7t_A          172 -QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSD-PPTLLTPSKWS  249 (302)
T ss_dssp             -HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC-CCCCSSGGGSC
T ss_pred             -cccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccC-CcccCCccccC
Confidence             112234689999999998     46678899999999999999999999998876655544443333 22233456788


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ..+.++|..||+.||.+|||+.+++++
T Consensus       250 ~~l~~li~~~l~~dp~~Rps~~~ll~h  276 (302)
T 2j7t_A          250 VEFRDFLKIALDKNPETRPSAAQLLEH  276 (302)
T ss_dssp             HHHHHHHHHHSCSCTTTSCCHHHHTTS
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHhcC
Confidence            999999999999999999999999886

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=7.4e-41  Score=333.27  Aligned_cols=257  Identities=22%  Similarity=0.335  Sum_probs=207.5

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC--ce
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS--PM  225 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~--~~  225 (458)
                      ...+|++.+.||+|+||.||.     +|+.||||++.....  ....+.+.+|+.+++.++||||+++++++....  ..
T Consensus         7 ~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~   84 (396)
T 4eut_A            7 SNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHK   84 (396)
T ss_dssp             SSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCE
T ss_pred             CCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCee
Confidence            345799999999999999984     489999999975432  222456778999999999999999999998655  68


Q ss_pred             EEEEEccCCCCHHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe----cCCCCEEEeecC
Q 012684          226 MIVTEYLPKGDLRAFLKRKGA---LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLKVADFG  298 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~----~~~~~vkl~Dfg  298 (458)
                      ++||||+++++|.+++.....   +++..++.++.|++.||.|||+.+   |+||||||+|||+    +.++.+||+|||
T Consensus        85 ~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~kL~DFG  161 (396)
T 4eut_A           85 VLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENG---IVHRNIKPGNIMRVIGEDGQSVYKLTDFG  161 (396)
T ss_dssp             EEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEEEECTTSCEEEEECCGG
T ss_pred             EEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCcCHHHEEEeecCCCceeEEEecCC
Confidence            999999999999999976432   999999999999999999999999   9999999999999    777789999999


Q ss_pred             CccccccCCCCCcccCCCCCcccCCcccCC--------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc----HHHHH
Q 012684          299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE----VPKAY  366 (458)
Q Consensus       299 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~----~~~~~  366 (458)
                      ++.......  ......||+.|+|||++.+        ..++.++|||||||++|+|++|+.||.......    ....+
T Consensus       162 ~a~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~  239 (396)
T 4eut_A          162 AARELEDDE--QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI  239 (396)
T ss_dssp             GCEECCCGG--GSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHH
T ss_pred             CceEccCCC--ccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHH
Confidence            998754332  2234568999999999864        456789999999999999999999997544322    22222


Q ss_pred             HhcCC---------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          367 AARQR---------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       367 ~~~~~---------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      .....                     +........+++.+.++|..||+.||.+||++.++++.++++...
T Consensus       240 ~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~l~~il~~  310 (396)
T 4eut_A          240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAETSDILHR  310 (396)
T ss_dssp             HHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHHHHHHTC
T ss_pred             hcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHHHHHHhhc
Confidence            11111                     111122356788999999999999999999999999999887654

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=3.3e-40  Score=331.76  Aligned_cols=244  Identities=25%  Similarity=0.345  Sum_probs=200.1

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC------CCCcceeeeeEEEeC
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI------RHPNVVQFLGAVTQS  222 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l------~hp~i~~~~~~~~~~  222 (458)
                      ..+|++.+.||+|+||.||.     +++.||||++...    ......+.+|+.+++.+      +|+||+++++++...
T Consensus        96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~  171 (429)
T 3kvw_A           96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNE----KRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR  171 (429)
T ss_dssp             TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred             cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCc----cchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence            44799999999999999984     5899999999642    34455677788877776      578999999999999


Q ss_pred             CceEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC--EEEeecC
Q 012684          223 SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN--LKVADFG  298 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~--vkl~Dfg  298 (458)
                      ...++||||+ +++|.+++....  .+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.  +||+|||
T Consensus       172 ~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NILl~~~~~~~vkL~DFG  247 (429)
T 3kvw_A          172 NHICMTFELL-SMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNR---IIHCDLKPENILLKQQGRSGIKVIDFG  247 (429)
T ss_dssp             TEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHT---EECSCCSGGGEEESSTTSCCEEECCCT
T ss_pred             CeEEEEEecc-CCCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEccCCCcceEEeecc
Confidence            9999999999 469999998754  4899999999999999999999999   999999999999999887  9999999


Q ss_pred             CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCC----
Q 012684          299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF----  374 (458)
Q Consensus       299 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~----  374 (458)
                      ++.....    ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......+.    
T Consensus       248 ~a~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~  323 (429)
T 3kvw_A          248 SSCYEHQ----RVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLL  323 (429)
T ss_dssp             TCEETTC----CCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHH
T ss_pred             cceecCC----cccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHH
Confidence            9976432    23345789999999999998999999999999999999999999988765444333321110000    


Q ss_pred             ----------------------------------------------CCC-----hhhhHHHHHHHHHHHcccCCCCCCCH
Q 012684          375 ----------------------------------------------KAP-----AKLYARGLKELIEECWNEKPAKRPTF  403 (458)
Q Consensus       375 ----------------------------------------------~~~-----~~~~~~~l~~li~~~l~~dp~~Rps~  403 (458)
                                                                    ...     ....++.+.+||.+||+.||.+|||+
T Consensus       324 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta  403 (429)
T 3kvw_A          324 DASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTP  403 (429)
T ss_dssp             HTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred             HhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCH
Confidence                                                          000     01236789999999999999999999


Q ss_pred             HHHHHH
Q 012684          404 RQIITR  409 (458)
Q Consensus       404 ~~ll~~  409 (458)
                      .++++|
T Consensus       404 ~e~L~H  409 (429)
T 3kvw_A          404 GQALRH  409 (429)
T ss_dssp             HHHHTS
T ss_pred             HHHhCC
Confidence            999987

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=6.3e-41  Score=330.95  Aligned_cols=248  Identities=12%  Similarity=0.114  Sum_probs=185.6

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC--CCCcceeee-------eEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI--RHPNVVQFL-------GAV  219 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hp~i~~~~-------~~~  219 (458)
                      ..+|...+.||+|+||.||.     +|+.||||++...........+.+.+|+.+++.+  +||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            44588999999999999874     6899999999876555566677788885544444  699988755       455


Q ss_pred             EeCC-----------------ceEEEEEccCCCCHHHHHHhcC-CCCHHHH------HHHHHHHHHHHHHHHhCCCCCee
Q 012684          220 TQSS-----------------PMMIVTEYLPKGDLRAFLKRKG-ALKPSTA------VRFALDIARGMNYLHENKPVPII  275 (458)
Q Consensus       220 ~~~~-----------------~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~------~~i~~qi~~~l~~LH~~~~~~i~  275 (458)
                      ...+                 ..|+||||++ ++|.+++...+ .++....      +.++.|++.||+|||+++   |+
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~---iv  216 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKG---LV  216 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTT---EE
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCC---Cc
Confidence            4332                 3799999997 89999998643 3455555      677899999999999999   99


Q ss_pred             eCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHcCCCC
Q 012684          276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPP  353 (458)
Q Consensus       276 H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~p  353 (458)
                      ||||||+|||++.++.+||+|||++......    .....+|+.|+|||++.+  ..++.++|||||||++|+|++|+.|
T Consensus       217 HrDikp~NIll~~~~~~kL~DFG~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~P  292 (371)
T 3q60_A          217 HGHFTPDNLFIMPDGRLMLGDVSALWKVGTR----GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLP  292 (371)
T ss_dssp             ETTCSGGGEEECTTSCEEECCGGGEEETTCE----EEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCS
T ss_pred             cCcCCHHHEEECCCCCEEEEecceeeecCCC----ccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCC
Confidence            9999999999999999999999999865322    113446699999999987  6789999999999999999999999


Q ss_pred             CCCCCCCcHHHHH----Hhc-CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          354 FTMKHDNEVPKAY----AAR-QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       354 f~~~~~~~~~~~~----~~~-~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      |............    ... ........+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       293 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  353 (371)
T 3q60_A          293 FGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMET  353 (371)
T ss_dssp             TTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTS
T ss_pred             CCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence            9877543211000    000 1111111234678999999999999999999999999976

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=5.7e-40  Score=320.14  Aligned_cols=253  Identities=26%  Similarity=0.439  Sum_probs=204.2

Q ss_pred             ccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhc--CCCCcceeeeeEEEeCC----ce
Q 012684          155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQK--IRHPNVVQFLGAVTQSS----PM  225 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hp~i~~~~~~~~~~~----~~  225 (458)
                      .+|++.+.||+|+||.||   .+|+.||||++...      ....+.+|..+++.  ++||||+++++++....    ..
T Consensus        42 ~~y~~~~~lg~G~~g~Vy~~~~~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~  115 (342)
T 1b6c_B           42 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQL  115 (342)
T ss_dssp             HHCEEEEEEEEETTEEEEEEEETTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCE
T ss_pred             ccEEEEeeecCCCCcEEEEEEEcCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCcccee
Confidence            478899999999999887   47999999998643      23456778888877  68999999999998775    78


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeeeCCCCCCCEEecCCCCEEEeec
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH--------ENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH--------~~~~~~i~H~Dikp~Nil~~~~~~vkl~Df  297 (458)
                      ++||||+++++|.+++.+ ..+++..++.++.|++.||.|||        +.+   ++||||||+||+++.++.+||+||
T Consensus       116 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~---ivH~Dlkp~NIll~~~~~~kL~Df  191 (342)
T 1b6c_B          116 WLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADL  191 (342)
T ss_dssp             EEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCSGGGEEECTTSCEEECCC
T ss_pred             EEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCC---eeeCCCCHHHEEECCCCCEEEEEC
Confidence            999999999999999976 46899999999999999999999        788   999999999999999999999999


Q ss_pred             CCccccccCCCC---CcccCCCCCcccCCcccCCCC------CCCchhHHHHHHHHHHHHcC----------CCCCCCCC
Q 012684          298 GVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEG----------CPPFTMKH  358 (458)
Q Consensus       298 g~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~~l~~lltg----------~~pf~~~~  358 (458)
                      |++.........   ......||+.|+|||++.+..      ++.++||||||+++|+|++|          ..||....
T Consensus       192 g~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~  271 (342)
T 1b6c_B          192 GLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV  271 (342)
T ss_dssp             TTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred             CCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence            999766443221   224456899999999987752      33689999999999999999          78987754


Q ss_pred             CCc-----HHHHHHhcC-CCCCCC--ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          359 DNE-----VPKAYAARQ-RPPFKA--PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       359 ~~~-----~~~~~~~~~-~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      ...     ....+.... ++.++.  .....+..+.++|..||+.||.+|||+.+++++|+++.+..
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~L~~i~~~~  338 (342)
T 1b6c_B          272 PSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQE  338 (342)
T ss_dssp             CSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHHHHHHHHTT
T ss_pred             cCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHHHHHHHHHh
Confidence            432     122221111 222221  12346678999999999999999999999999999987654

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.6e-40  Score=327.95  Aligned_cols=246  Identities=22%  Similarity=0.352  Sum_probs=195.9

Q ss_pred             CcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe----
Q 012684          151 DPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----  221 (458)
Q Consensus       151 ~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~----  221 (458)
                      .....+|++.+.||+|+||.|+.     +|+.||||++.....       ...+|+.+++.++||||+++++++..    
T Consensus         3 ~~~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~-------~~~~E~~il~~l~hpnIv~l~~~~~~~~~~   75 (383)
T 3eb0_A            3 ETSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPR-------YKNRELDIMKVLDHVNIIKLVDYFYTTGDE   75 (383)
T ss_dssp             ---CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHTTCCCTTBCCEEEEEEEC---
T ss_pred             ccccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHHcCCCCccchhheeeecCcc
Confidence            34456899999999999999984     689999999864421       22369999999999999999999843    


Q ss_pred             ----------------------------------CCceEEEEEccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHH
Q 012684          222 ----------------------------------SSPMMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGM  263 (458)
Q Consensus       222 ----------------------------------~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l  263 (458)
                                                        ....++||||++ ++|.+.+.    ....+++..+..++.|++.||
T Consensus        76 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL  154 (383)
T 3eb0_A           76 EPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV  154 (383)
T ss_dssp             ----------------------------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cccccccccccccccccccccccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence                                              334889999996 58777665    356799999999999999999


Q ss_pred             HHHHhCCCCCeeeCCCCCCCEEec-CCCCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHH
Q 012684          264 NYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFA  341 (458)
Q Consensus       264 ~~LH~~~~~~i~H~Dikp~Nil~~-~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG  341 (458)
                      .|||+.|   |+||||||+||+++ .++.+||+|||++......  .......+|+.|+|||++.+. .++.++||||+|
T Consensus       155 ~~LH~~g---i~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG  229 (383)
T 3eb0_A          155 GFIHSLG---ICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPS--EPSVAYICSRFYRAPELMLGATEYTPSIDLWSIG  229 (383)
T ss_dssp             HHHHTTT---EECSCCCGGGEEEETTTTEEEECCCTTCEECCTT--SCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHH
T ss_pred             HHHHHCc---CccCccCHHHEEEcCCCCcEEEEECCCCcccCCC--CCCcCcccCCCccCHHHhcCCCCCCcchhhhhHH
Confidence            9999999   99999999999998 6889999999999865432  233445679999999998765 489999999999


Q ss_pred             HHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CC---------------CCCC---------ChhhhHHHHHHHHHHHcccC
Q 012684          342 LILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP---------------PFKA---------PAKLYARGLKELIEECWNEK  396 (458)
Q Consensus       342 ~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~---------------~~~~---------~~~~~~~~l~~li~~~l~~d  396 (458)
                      |++|+|++|+.||.+....+....+.... .+               .++.         .+..+++.+.+||.+||+.|
T Consensus       230 ~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~d  309 (383)
T 3eb0_A          230 CVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYE  309 (383)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSS
T ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCC
Confidence            99999999999999876555444332211 11               0000         12346788999999999999


Q ss_pred             CCCCCCHHHHHHH
Q 012684          397 PAKRPTFRQIITR  409 (458)
Q Consensus       397 p~~Rps~~~ll~~  409 (458)
                      |.+|||+.++++|
T Consensus       310 P~~R~t~~e~l~h  322 (383)
T 3eb0_A          310 PDLRINPYEAMAH  322 (383)
T ss_dssp             GGGSCCHHHHHTS
T ss_pred             hhhCCCHHHHhcC
Confidence            9999999999976

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=1.1e-40  Score=328.40  Aligned_cols=245  Identities=27%  Similarity=0.376  Sum_probs=185.9

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC------C
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS------S  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~------~  223 (458)
                      .+|++.+.||+|+||.|+.     +|+.||||++.... ......+.+.+|+.+++.++||||+++++++...      .
T Consensus        29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~  107 (367)
T 2fst_X           29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN  107 (367)
T ss_dssp             TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCC
Confidence            4799999999999998874     58999999997543 3455667788999999999999999999998654      5


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ..++|||++ +++|.+++.. +.+++..+..++.|++.||.|||+.|   |+||||||+||+++.++.+||+|||++...
T Consensus       108 ~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~g---ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          108 DVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             CCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             eEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence            679999999 7899998876 56999999999999999999999999   999999999999999999999999999765


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CC---------
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP---------  372 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~---------  372 (458)
                      ..    ......+|+.|+|||++.+ ..++.++|||||||++|+|++|+.||.+.+.......+.... .+         
T Consensus       183 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~  258 (367)
T 2fst_X          183 AD----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKIS  258 (367)
T ss_dssp             ------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCC
T ss_pred             cc----cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhh
Confidence            32    2334568999999999877 678999999999999999999999998866544333322110 10         


Q ss_pred             ------------CCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 ------------PFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 ------------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                  ..+     ......++.+.+||.+||..||.+|||+.++++|
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~h  312 (367)
T 2fst_X          259 SESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  312 (367)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcC
Confidence                        000     0112456889999999999999999999999987

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=9.5e-40  Score=321.77  Aligned_cols=255  Identities=16%  Similarity=0.226  Sum_probs=208.1

Q ss_pred             CCcccCcCCccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC---CCcc
Q 012684          146 PEYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNV  212 (458)
Q Consensus       146 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~i  212 (458)
                      +..++.....+|.+.+.||+|+||.||.          +++.||||++...   .   ...+..|..+++.+.   |+||
T Consensus        56 ~~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~---~---~~~~~~e~~~~~~l~~~~~~~i  129 (365)
T 3e7e_A           56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPA---N---PWEFYIGTQLMERLKPSMQHMF  129 (365)
T ss_dssp             SSCEEECSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSC---C---HHHHHHHHHHHHHSCGGGGGGB
T ss_pred             cceeEEECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCC---C---hhHHHHHHHHHHHhhhhhhhhh
Confidence            3445556677899999999999998874          3789999999753   2   235667777777775   9999


Q ss_pred             eeeeeEEEeCCceEEEEEccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec
Q 012684          213 VQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD  287 (458)
Q Consensus       213 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~  287 (458)
                      +++++++..++..++||||+++|+|.+++..     ...+++..++.++.|++.||+|||+.+   |+||||||+|||++
T Consensus       130 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~---ivHrDiKp~NIll~  206 (365)
T 3e7e_A          130 MKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCE---IIHGDIKPDNFILG  206 (365)
T ss_dssp             CCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCSGGGEEEC
T ss_pred             hhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEec
Confidence            9999999999999999999999999999974     456999999999999999999999999   99999999999999


Q ss_pred             C-----------CCCEEEeecCCccccccCC-CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 012684          288 D-----------SGNLKVADFGVSKLLTVKE-DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT  355 (458)
Q Consensus       288 ~-----------~~~vkl~Dfg~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~  355 (458)
                      .           ++.+||+|||++....... ........||+.|+|||++.+..++.++|||||||++|+|++|+.||.
T Consensus       207 ~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~  286 (365)
T 3e7e_A          207 NGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKV  286 (365)
T ss_dssp             GGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCE
T ss_pred             ccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccc
Confidence            8           8999999999997654221 223345678999999999999999999999999999999999999997


Q ss_pred             CCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCC-CCHHHHHHHHHHHHhhh
Q 012684          356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR-PTFRQIITRLESINNSI  417 (458)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R-ps~~~ll~~L~~~~~~~  417 (458)
                      ........      ....+...  ..++.+.+++..||+.+|.+| |++.++.+.|+.+....
T Consensus       287 ~~~~~~~~------~~~~~~~~--~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~l~~~l~~~  341 (365)
T 3e7e_A          287 KNEGGECK------PEGLFRRL--PHLDMWNEFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQH  341 (365)
T ss_dssp             EEETTEEE------ECSCCTTC--SSHHHHHHHHHHHHCCCCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             cCCCCcee------echhcccc--CcHHHHHHHHHHHcCCCCCCcchHHHHHHHHHHHHHHHh
Confidence            54432210      11111111  235788999999999999998 67888888888887653

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=7.7e-41  Score=327.15  Aligned_cols=248  Identities=23%  Similarity=0.413  Sum_probs=205.9

Q ss_pred             ccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCH--------------HHHHHHHHHHHHHhcCCCCcceeeee
Q 012684          155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDD--------------DRVRAFRDELALLQKIRHPNVVQFLG  217 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~--------------~~~~~~~~E~~~l~~l~hp~i~~~~~  217 (458)
                      .+|++.+.||+|+||.||   .+|+.||||.+........              ...+.+.+|+.+++.++||||+++++
T Consensus        31 ~~y~~~~~lg~G~~g~V~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~  110 (348)
T 2pml_X           31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEG  110 (348)
T ss_dssp             TTEEEEEEEECCSSCCEEEEEETTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSE
T ss_pred             CceEEEEEEcCCCCeEEEEEEcCCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEE
Confidence            479999999999998776   4899999999864322111              11267889999999999999999999


Q ss_pred             EEEeCCceEEEEEccCCCCHHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEecC
Q 012684          218 AVTQSSPMMIVTEYLPKGDLRAF------LKR--KGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDD  288 (458)
Q Consensus       218 ~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dikp~Nil~~~  288 (458)
                      ++...+..++||||+++++|.++      +..  ...+++..++.++.|++.||.|||+ .|   ++|+||||+||+++.
T Consensus       111 ~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~---i~H~dl~p~Nil~~~  187 (348)
T 2pml_X          111 IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKN---ICHRDVKPSNILMDK  187 (348)
T ss_dssp             EEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSC---EECCCCCGGGEEECT
T ss_pred             EEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCC---EeecCCChHhEEEcC
Confidence            99999999999999999999998      655  5679999999999999999999999 98   999999999999999


Q ss_pred             CCCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCC-chhHHHHHHHHHHHHcCCCCCCCCCC-CcHHHH
Q 012684          289 SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDT-KVDVFSFALILQEMIEGCPPFTMKHD-NEVPKA  365 (458)
Q Consensus       289 ~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~-~~DiwslG~~l~~lltg~~pf~~~~~-~~~~~~  365 (458)
                      ++.++|+|||++......   ......+++.|+|||++.+. .++. ++||||||+++|+|++|+.||..... .+....
T Consensus       188 ~~~~kl~dfg~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~  264 (348)
T 2pml_X          188 NGRVKLSDFGESEYMVDK---KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNN  264 (348)
T ss_dssp             TSCEEECCCTTCEECBTT---EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHHHHH
T ss_pred             CCcEEEeccccccccccc---cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHH
Confidence            999999999999865432   33445689999999999887 5665 99999999999999999999998776 333333


Q ss_pred             HHhcCCCCCCCC----------------hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          366 YAARQRPPFKAP----------------AKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       366 ~~~~~~~~~~~~----------------~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      + ......++..                ...+++.+.+||.+||+.||.+|||+.+++++
T Consensus       265 i-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~h  323 (348)
T 2pml_X          265 I-RTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKH  323 (348)
T ss_dssp             H-TSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             H-hccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            3 3332222211                15578999999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=3e-40  Score=313.31  Aligned_cols=242  Identities=26%  Similarity=0.457  Sum_probs=201.1

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe---------
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ---------  221 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~---------  221 (458)
                      +|++.+.||+|+||.||.     +|+.||+|.+....       +.+.+|+.+++.++||||+++++++..         
T Consensus        12 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   84 (284)
T 2a19_B           12 DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSS   84 (284)
T ss_dssp             HEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC-----
T ss_pred             ccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCccccc
Confidence            688899999999998873     58999999997542       246789999999999999999998854         


Q ss_pred             -------CCceEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCE
Q 012684          222 -------SSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNL  292 (458)
Q Consensus       222 -------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~v  292 (458)
                             ....++||||+++++|.+++...  ..+++..++.++.|++.||.|||+.+   ++|+||||+||+++.++.+
T Consensus        85 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~  161 (284)
T 2a19_B           85 KNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKK---LINRDLKPSNIFLVDTKQV  161 (284)
T ss_dssp             ----CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEE
T ss_pred             ccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHEEEcCCCCE
Confidence                   34589999999999999999754  56999999999999999999999999   9999999999999999999


Q ss_pred             EEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCC
Q 012684          293 KVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP  372 (458)
Q Consensus       293 kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~  372 (458)
                      +|+|||++.......  ......+++.|+|||.+.+..++.++||||||+++|+|++|..||....  .......   ..
T Consensus       162 kl~Dfg~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~--~~~~~~~---~~  234 (284)
T 2a19_B          162 KIGDFGLVTSLKNDG--KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFETS--KFFTDLR---DG  234 (284)
T ss_dssp             EECCCTTCEESSCCS--CCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHHH--HHHHHHH---TT
T ss_pred             EECcchhheeccccc--cccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhHH--HHHHHhh---cc
Confidence            999999988764332  2234568999999999998889999999999999999999998875321  1111111   11


Q ss_pred             CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       373 ~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      .   .+..+++.+.++|.+||+.||.+|||+.+++++|+.+....
T Consensus       235 ~---~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~~  276 (284)
T 2a19_B          235 I---ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKSP  276 (284)
T ss_dssp             C---CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC--
T ss_pred             c---ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhCC
Confidence            1   12456788999999999999999999999999999886543

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4e-40  Score=314.38  Aligned_cols=246  Identities=27%  Similarity=0.464  Sum_probs=197.4

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      ++.....||+|+||.||.     ++..||+|.+....   ....+.+.+|+.+++.++||||+++++++...+..++|||
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e   99 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFME   99 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEE
Confidence            344556899999998874     57899999987542   3345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC-CCCEEEeecCCccccccC
Q 012684          231 YLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~-~~~vkl~Dfg~~~~~~~~  306 (458)
                      |+++++|.+++....   .+++..+..++.|++.||.|||+.+   ++|+||||+||+++. ++.++|+|||++......
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~  176 (295)
T 2clq_A          100 QVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI  176 (295)
T ss_dssp             CCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTCCEEECCTTTCEESCC-
T ss_pred             eCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCC---EEccCCChhhEEEECCCCCEEEeecccccccCCC
Confidence            999999999998652   3668888999999999999999999   999999999999997 899999999999865432


Q ss_pred             CCCCcccCCCCCcccCCcccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      . .......+++.|+|||++.+..  ++.++||||||+++|+|++|+.||............... ....+..+..+++.
T Consensus       177 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~  254 (295)
T 2clq_A          177 N-PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGM-FKVHPEIPESMSAE  254 (295)
T ss_dssp             -----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHH-HCCCCCCCTTSCHH
T ss_pred             C-CcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhcc-ccccccccccCCHH
Confidence            1 2223456899999999987643  788999999999999999999999765443222111111 11112234567899


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.++|.+||+.||.+|||+.+++.+
T Consensus       255 ~~~li~~~l~~dp~~Rps~~~ll~~  279 (295)
T 2clq_A          255 AKAFILKCFEPDPDKRACANDLLVD  279 (295)
T ss_dssp             HHHHHHHTTCSSTTTSCCHHHHHTS
T ss_pred             HHHHHHHHccCChhhCCCHHHHhcC
Confidence            9999999999999999999999875

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=6e-40  Score=314.79  Aligned_cols=247  Identities=23%  Similarity=0.347  Sum_probs=200.4

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCC-CHHHHHHHHHHHHHHhcCCCCcceeeeeEEE--eCCceE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRHPNVVQFLGAVT--QSSPMM  226 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~--~~~~~~  226 (458)
                      .+|.+.+.||+|+||.|+.     ++..||+|++...... .......+.+|+.+++.++||||+++++++.  .....+
T Consensus         5 ~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~   84 (305)
T 2wtk_C            5 GKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMY   84 (305)
T ss_dssp             CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEE
T ss_pred             cceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEE
Confidence            3688999999999999874     6789999999753211 1233567889999999999999999999984  456789


Q ss_pred             EEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          227 IVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      +||||++++ |.+++..  ...+++..+..++.|++.||.|||+++   ++|+||||+||+++.++.++|+|||++....
T Consensus        85 lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           85 MVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQG---IVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             EEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             EEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            999999765 8787765  356999999999999999999999999   9999999999999999999999999997654


Q ss_pred             cCC-CCCcccCCCCCcccCCcccCCCC--CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhh
Q 012684          305 VKE-DRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY  381 (458)
Q Consensus       305 ~~~-~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (458)
                      ... ........+|+.|+|||++.+..  .+.++||||||+++|+|++|+.||......+....+... ....   +..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~-~~~~---~~~~  236 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKG-SYAI---PGDC  236 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHC-CCCC---CSSS
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcC-CCCC---CCcc
Confidence            321 12223456899999999987643  367999999999999999999999876655554444332 2222   3457


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ++.+.++|.+||+.||.+|||+.+++++
T Consensus       237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~  264 (305)
T 2wtk_C          237 GPPLSDLLKGMLEYEPAKRFSIRQIRQH  264 (305)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            7899999999999999999999999987

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=7.4e-40  Score=323.25  Aligned_cols=244  Identities=24%  Similarity=0.385  Sum_probs=198.7

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce----
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM----  225 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~----  225 (458)
                      .+|.+.+.||+|+||.||.     +|+.||||++.... ......+.+.+|+.+++.++||||+++++++......    
T Consensus        42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~  120 (371)
T 4exu_A           42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  120 (371)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCC
T ss_pred             ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccce
Confidence            4788999999999999984     58999999997653 3455667788999999999999999999999876654    


Q ss_pred             --EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          226 --MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       226 --~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                        ++||||+. ++|.+++.  ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.+||+|||++...
T Consensus       121 ~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          121 DFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             CCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             eEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence              99999995 68988774  34999999999999999999999999   999999999999999999999999999765


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCC---------
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP---------  373 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~---------  373 (458)
                      ..    ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+......+         
T Consensus       195 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  270 (371)
T 4exu_A          195 DA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  270 (371)
T ss_dssp             ---------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCS
T ss_pred             cc----CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhh
Confidence            32    2334567999999999877 678999999999999999999999998766544433332211100         


Q ss_pred             ------------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 ------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                        +......+++.+.+||.+||+.||.+|||+.+++++
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  324 (371)
T 4exu_A          271 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  324 (371)
T ss_dssp             CHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcC
Confidence                              001123457899999999999999999999999987

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=2e-39  Score=317.71  Aligned_cols=249  Identities=23%  Similarity=0.325  Sum_probs=200.4

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----C
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----S  223 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~  223 (458)
                      ..+|++.+.||+|+||.|+.     +|+.||||.+...  ........+.+|+.+++.++||||+++++++...     .
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~   87 (353)
T 2b9h_A           10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFN   87 (353)
T ss_dssp             CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCC
T ss_pred             ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccc
Confidence            45799999999999999874     5899999999643  3455566788999999999999999999988654     6


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      ..++||||+. ++|.+++.. +.+++..+..++.|++.||.|||+.|   ++||||||+||+++.++.+||+|||++...
T Consensus        88 ~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~  162 (353)
T 2b9h_A           88 EVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII  162 (353)
T ss_dssp             CEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEEcCCCcEEEEeccccccc
Confidence            7899999995 699998876 56999999999999999999999999   999999999999999999999999999866


Q ss_pred             ccCCCC---------CcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-CCC
Q 012684          304 TVKEDR---------PLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP  372 (458)
Q Consensus       304 ~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~~~  372 (458)
                      ......         ......||+.|+|||++.+ ..++.++||||||+++|+|++|+.||.+.+.......+... +.+
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  242 (353)
T 2b9h_A          163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTP  242 (353)
T ss_dssp             C----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCC
T ss_pred             ccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCC
Confidence            432111         1223468999999998754 67889999999999999999999999876543322222111 010


Q ss_pred             ----------------------CCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 ----------------------PFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 ----------------------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                            ..+     .....+++.+.+||.+||+.||.+|||+.+++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (353)
T 2b9h_A          243 HSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEH  306 (353)
T ss_dssp             CSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             chhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence                                  000     0123577899999999999999999999999986

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=2.1e-39  Score=315.30  Aligned_cols=244  Identities=27%  Similarity=0.365  Sum_probs=201.3

Q ss_pred             CccccCceeeccceEEEEEE------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCC------cceeeeeEEEe
Q 012684          154 ELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP------NVVQFLGAVTQ  221 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp------~i~~~~~~~~~  221 (458)
                      ..+|++.+.||+|+||.||.      +|+.||||++..    .....+.+.+|+.+++.++|+      +++++++++..
T Consensus        13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~   88 (339)
T 1z57_A           13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN----VDRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH   88 (339)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred             cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEec----CCchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence            34799999999999998873      578999999963    234556788899999888665      49999999999


Q ss_pred             CCceEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC-----------
Q 012684          222 SSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-----------  288 (458)
Q Consensus       222 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~-----------  288 (458)
                      .+..++||||+ +++|.+++...+  .+++..+..++.|++.||.|||+++   |+||||||+||+++.           
T Consensus        89 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~~~~  164 (339)
T 1z57_A           89 HGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNK---LTHTDLKPENILFVQSDYTEAYNPKI  164 (339)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESCCCEEEEEC---
T ss_pred             CCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeccccccccCCcc
Confidence            99999999999 889999998765  5889999999999999999999999   999999999999987           


Q ss_pred             --------CCCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 012684          289 --------SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN  360 (458)
Q Consensus       289 --------~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~  360 (458)
                              ++.++|+|||++.....    ......||+.|+|||++.+..++.++||||||+++|+|++|+.||...+..
T Consensus       165 ~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  240 (339)
T 1z57_A          165 KRDERTLINPDIKVVDFGSATYDDE----HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK  240 (339)
T ss_dssp             -CEEEEESCCCEEECCCSSCEETTS----CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred             ccccccccCCCceEeeCcccccCcc----ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence                    67899999999976432    223456899999999999989999999999999999999999999876654


Q ss_pred             cHHHHHHhcCCCC----------------------------------------CCCChhhhHHHHHHHHHHHcccCCCCC
Q 012684          361 EVPKAYAARQRPP----------------------------------------FKAPAKLYARGLKELIEECWNEKPAKR  400 (458)
Q Consensus       361 ~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~R  400 (458)
                      +....+.....+.                                        ........++.+.+||.+||+.||.+|
T Consensus       241 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  320 (339)
T 1z57_A          241 EHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKR  320 (339)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccc
Confidence            4333221111100                                        001123456789999999999999999


Q ss_pred             CCHHHHHHH
Q 012684          401 PTFRQIITR  409 (458)
Q Consensus       401 ps~~~ll~~  409 (458)
                      ||+.+++++
T Consensus       321 pt~~ell~h  329 (339)
T 1z57_A          321 ITLREALKH  329 (339)
T ss_dssp             CCHHHHTTS
T ss_pred             cCHHHHhcC
Confidence            999999976

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=7.7e-41  Score=323.07  Aligned_cols=256  Identities=24%  Similarity=0.425  Sum_probs=205.2

Q ss_pred             CccccCceeeccceEEEEEE--cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          154 ELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      ..+|++.+.||+|+||.||.  .+..||+|++...... ....+.+.+|+.++++++||||+++++++......++||||
T Consensus        32 ~~~~~~~~~lg~G~~g~V~~~~~~~~~avk~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~  110 (319)
T 2y4i_B           32 FEQLEIGELIGKGRFGQVYHGRWHGEVAIRLIDIERDN-EDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSL  110 (319)
T ss_dssp             CSCEECCCBCCCSSSSEEEEEEESSSEEEEECCCCSCC-CCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBC
T ss_pred             HHHeEEeeEeccCCceEEEEEEEcCeEEEEEeecCCCC-HHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeec
Confidence            44688899999999998873  3456999999754322 22234567899999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC----
Q 012684          232 LPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK----  306 (458)
Q Consensus       232 ~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~----  306 (458)
                      +++++|.+++...+ .+++..++.++.|++.||.|||+.+   ++||||||+||+++ ++.++|+|||++......    
T Consensus       111 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~  186 (319)
T 2y4i_B          111 CKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG---ILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGR  186 (319)
T ss_dssp             CCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT---CCCCCCCSTTEEEC---CCEECCCSCCC---------
T ss_pred             ccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChhhEEEe-CCCEEEeecCCccccccccccc
Confidence            99999999998754 6999999999999999999999999   99999999999998 689999999998654321    


Q ss_pred             CCCCcccCCCCCcccCCcccCC---------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCC
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKN---------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP  377 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~---------~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  377 (458)
                      .........|++.|+|||++.+         ..++.++||||||+++|+|++|+.||...........+.....+...  
T Consensus       187 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--  264 (319)
T 2y4i_B          187 REDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLS--  264 (319)
T ss_dssp             -CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCC--
T ss_pred             cccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCC--
Confidence            1122234458899999999864         35788999999999999999999999887666555555443333332  


Q ss_pred             hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       378 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ...++..+.++|..||..||.+|||+.++++.|+++...
T Consensus       265 ~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~l~~l~~~  303 (319)
T 2y4i_B          265 QIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPKR  303 (319)
T ss_dssp             CSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHHHTTC---
T ss_pred             cCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHh
Confidence            235678899999999999999999999999999988654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=1e-39  Score=326.07  Aligned_cols=244  Identities=24%  Similarity=0.389  Sum_probs=179.3

Q ss_pred             ccC-ceeeccceEEEEEE-------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CCceE
Q 012684          157 FTN-SVEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMM  226 (458)
Q Consensus       157 ~~~-~~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~  226 (458)
                      |.+ .++||+|+||.||.       ++..||||++......     ..+.+|+.+++.++||||+++++++..  +...+
T Consensus        22 y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~-----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~   96 (405)
T 3rgf_A           22 FEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVW   96 (405)
T ss_dssp             EECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCC-----HHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEE
T ss_pred             hhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCC-----HHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEE
Confidence            444 45799999999873       3678999999754321     357789999999999999999999954  66799


Q ss_pred             EEEEccCCCCHHHHHHhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe----cCCCCEE
Q 012684          227 IVTEYLPKGDLRAFLKRK---------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR----DDSGNLK  293 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~----~~~~~vk  293 (458)
                      +||||+. ++|.+++...         ..+++..+..++.||+.||.|||+.+   |+||||||+|||+    +.++.+|
T Consensus        97 lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           97 LLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             EEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---EeCCCcCHHHeEEecCCCCCCcEE
Confidence            9999995 5888887632         24899999999999999999999999   9999999999999    6778999


Q ss_pred             EeecCCccccccCCC--CCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCC---------c
Q 012684          294 VADFGVSKLLTVKED--RPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDN---------E  361 (458)
Q Consensus       294 l~Dfg~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~---------~  361 (458)
                      |+|||++........  .......||+.|+|||++.+. .++.++|||||||++|+|++|+.||......         +
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            999999987643211  223445789999999998874 5889999999999999999999999765432         1


Q ss_pred             HHHHH-HhcCCCCCCCChh----------------------------------hhHHHHHHHHHHHcccCCCCCCCHHHH
Q 012684          362 VPKAY-AARQRPPFKAPAK----------------------------------LYARGLKELIEECWNEKPAKRPTFRQI  406 (458)
Q Consensus       362 ~~~~~-~~~~~~~~~~~~~----------------------------------~~~~~l~~li~~~l~~dp~~Rps~~~l  406 (458)
                      ....+ ...+.+... .+.                                  ..++.+.+||.+||+.||.+|||+.++
T Consensus       253 ~l~~i~~~~g~p~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~  331 (405)
T 3rgf_A          253 QLDRIFNVMGFPADK-DWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQA  331 (405)
T ss_dssp             HHHHHHHHHCCCCTT-TCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHH
T ss_pred             HHHHHHHhhCCCChh-hcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHH
Confidence            11111 111111111 000                                  015678899999999999999999999


Q ss_pred             HHHH
Q 012684          407 ITRL  410 (458)
Q Consensus       407 l~~L  410 (458)
                      ++|-
T Consensus       332 L~hp  335 (405)
T 3rgf_A          332 MQDP  335 (405)
T ss_dssp             HTSG
T ss_pred             hcCh
Confidence            9983

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=2.4e-39  Score=311.95  Aligned_cols=255  Identities=21%  Similarity=0.354  Sum_probs=201.6

Q ss_pred             ccCcCCccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC--CCcceeeeeEEEeC
Q 012684          149 EIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQS  222 (458)
Q Consensus       149 ~~~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~i~~~~~~~~~~  222 (458)
                      .+.....+|++.+.||+|+||.||.    +|+.||+|++..... .....+.+.+|+.+++.+.  ||||+++++++..+
T Consensus        22 ~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~  100 (313)
T 3cek_A           22 SMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITD  100 (313)
T ss_dssp             EEEETTEEEEEEEEEECCSSEEEEEEECTTCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECS
T ss_pred             eeeeccceEEEEEEecCCCCEEEEEEEcCCCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecC
Confidence            3445566799999999999999984    588999999975432 4556678999999999996  59999999999999


Q ss_pred             CceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      ...++|||+ .+++|.+++...+.+++..+..++.|++.||.|||+.+   ++||||||+||+++. +.+||+|||++..
T Consensus       101 ~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~  175 (313)
T 3cek_A          101 QYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHG---IVHSDLKPANFLIVD-GMLKLIDFGIANQ  175 (313)
T ss_dssp             SEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEEET-TEEEECCCSSSCC
T ss_pred             CEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEEEC-CeEEEeecccccc
Confidence            999999995 58899999998888999999999999999999999999   999999999999975 8899999999986


Q ss_pred             cccCCCC-CcccCCCCCcccCCcccCC-----------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC
Q 012684          303 LTVKEDR-PLTCQDTSCRYVAPEVFKN-----------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ  370 (458)
Q Consensus       303 ~~~~~~~-~~~~~~gt~~y~aPE~~~~-----------~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~  370 (458)
                      ....... ......||+.|+|||.+.+           ..++.++||||||+++|+|++|+.||................
T Consensus       176 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  255 (313)
T 3cek_A          176 MQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP  255 (313)
T ss_dssp             --------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCT
T ss_pred             ccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhc
Confidence            5433221 1234468999999999875           467889999999999999999999998654432211111111


Q ss_pred             CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      ... ...+...++.+.++|..||+.||.+|||+.+++++-
T Consensus       256 ~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~  294 (313)
T 3cek_A          256 NHE-IEFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHP  294 (313)
T ss_dssp             TSC-CCCCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             ccc-cCCcccchHHHHHHHHHHccCCcccCcCHHHHhcCc
Confidence            111 112334578899999999999999999999999874

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.8e-39  Score=310.62  Aligned_cols=244  Identities=27%  Similarity=0.425  Sum_probs=191.7

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe---------
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ---------  221 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~---------  221 (458)
                      +|++.+.||+|+||.|+.     +|+.||||.+..    .....+.+.+|+.+++.++||||+++++++.+         
T Consensus         7 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            7 DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRH----TEEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEE----EHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC---
T ss_pred             cchhhheeccCCcEEEEEEEEcCCCeEEEEEEEec----cHHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhc
Confidence            588889999999998874     689999999963    34556778999999999999999999998865         


Q ss_pred             ----CCceEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEee
Q 012684          222 ----SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (458)
Q Consensus       222 ----~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~D  296 (458)
                          ....++||||+++++|.+++...+ .+++..++.++.|++.||.|||+++   ++|+||||+||+++.++.++|+|
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~---i~H~dlkp~Nil~~~~~~~kl~d  159 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQG---IIHRDLKPMNIFIDESRNVKIGD  159 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCC---eecccCCHHhEEEcCCCCEEEee
Confidence                356899999999999999998644 4788999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccccCC-------------CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCC-Cc
Q 012684          297 FGVSKLLTVKE-------------DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHD-NE  361 (458)
Q Consensus       297 fg~~~~~~~~~-------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~-~~  361 (458)
                      ||++.......             ........+|+.|+|||++.+. .++.++||||||+++|+|++   ||..... ..
T Consensus       160 fg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~  236 (303)
T 1zy4_A          160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVN  236 (303)
T ss_dssp             CCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHH
T ss_pred             CcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHH
Confidence            99997654221             1122345688999999999764 68899999999999999998   5543211 12


Q ss_pred             HHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          362 VPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       362 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ....+........+......++.+.++|..||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  284 (303)
T 1zy4_A          237 ILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNS  284 (303)
T ss_dssp             HHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHS
T ss_pred             HHHhccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCC
Confidence            222222222222222345567889999999999999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.6e-39  Score=311.98  Aligned_cols=256  Identities=27%  Similarity=0.438  Sum_probs=183.8

Q ss_pred             CcccCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHH-HHhcCCCCcceeeeeEEE
Q 012684          147 EYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELA-LLQKIRHPNVVQFLGAVT  220 (458)
Q Consensus       147 ~~~~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hp~i~~~~~~~~  220 (458)
                      .........+|...+.||+|+||.||.     +|+.||||++....  .......+..|.. +++.++||||+++++++.
T Consensus        14 ~~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~   91 (327)
T 3aln_A           14 EQHWDFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALF   91 (327)
T ss_dssp             CEEECCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEE
T ss_pred             HHhcccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEE
Confidence            334445566888999999999999874     58999999997542  3334445555665 777789999999999999


Q ss_pred             eCCceEEEEEccCCCCHHHHHHh-----cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCEEecCCCCEEE
Q 012684          221 QSSPMMIVTEYLPKGDLRAFLKR-----KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKV  294 (458)
Q Consensus       221 ~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dikp~Nil~~~~~~vkl  294 (458)
                      .++..++||||++ ++|.+++..     ...+++..+..++.|++.||.|||+. +   ++||||||+||+++.++.+||
T Consensus        92 ~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~---ivH~dlkp~NIll~~~~~~kl  167 (327)
T 3aln_A           92 REGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLK---IIHRDIKPSNILLDRSGNIKL  167 (327)
T ss_dssp             CSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHS---CCCSCCCGGGEEEETTTEEEE
T ss_pred             eCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCC---EeECCCCHHHEEEcCCCCEEE
Confidence            9999999999996 488888764     56799999999999999999999998 8   999999999999999999999


Q ss_pred             eecCCccccccCCCCCcccCCCCCcccCCccc----CCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-HHHHHHhc
Q 012684          295 ADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAAR  369 (458)
Q Consensus       295 ~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~-~~~~~~~~  369 (458)
                      +|||++......  .......||+.|+|||++    .+..++.++||||||+++|+|++|+.||....... ........
T Consensus       168 ~Dfg~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~  245 (327)
T 3aln_A          168 CDFGISGQLVDS--IAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKG  245 (327)
T ss_dssp             CCCSSSCC--------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCS
T ss_pred             ccCCCceecccc--cccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcC
Confidence            999999765432  122334689999999998    45578899999999999999999999998654321 11111111


Q ss_pred             CCCCCC-CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          370 QRPPFK-APAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       370 ~~~~~~-~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      ..+.++ .....+++.+.+||..||+.||.+|||+.+++++-
T Consensus       246 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp  287 (327)
T 3aln_A          246 DPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHP  287 (327)
T ss_dssp             CCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSH
T ss_pred             CCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhCh
Confidence            112221 12345788999999999999999999999999873

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=2.2e-39  Score=317.62  Aligned_cols=244  Identities=24%  Similarity=0.383  Sum_probs=199.1

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc-----
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-----  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~-----  224 (458)
                      .+|...+.||+|+||.||.     +|+.||||.+.... ......+.+.+|+.+++.++||||+++++++.....     
T Consensus        24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~  102 (353)
T 3coi_A           24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY  102 (353)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCC
T ss_pred             ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccce
Confidence            4688999999999999874     58999999997643 345556778899999999999999999999987654     


Q ss_pred             -eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          225 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       225 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                       .++||||+. ++|.+++..  .+++..+..++.|++.||.|||++|   ++||||||+||+++.++.+||+|||++...
T Consensus       103 ~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          103 DFYLVMPFMQ-TDLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             CCEEEEECCS-EEGGGTTTS--CCCHHHHHHHHHHHHHHHHHHHHTT---CCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             eEEEEecccc-CCHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEeECCCCcEEEeecccccCC
Confidence             499999995 688887643  4999999999999999999999999   999999999999999999999999999764


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-------------
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-------------  369 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-------------  369 (458)
                      ..    ......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||...+..+....+...             
T Consensus       177 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  252 (353)
T 3coi_A          177 DA----EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLN  252 (353)
T ss_dssp             -----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCS
T ss_pred             CC----CccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHh
Confidence            32    2234567999999999877 57889999999999999999999999876543332222111             


Q ss_pred             --------------CCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          370 --------------QRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       370 --------------~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                    ....+......+++.+.+||.+||+.||.+|||+.+++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~h  306 (353)
T 3coi_A          253 DKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTH  306 (353)
T ss_dssp             CHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTS
T ss_pred             hHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                          0122223345678999999999999999999999999987

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=4e-39  Score=312.61  Aligned_cols=241  Identities=21%  Similarity=0.355  Sum_probs=196.7

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEe--CCceE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMM  226 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~--~~~~~  226 (458)
                      .+|++.+.||+|+||.||.     +|+.||||++....      .+.+.+|+.+++.+. ||||+++++++..  ....+
T Consensus        36 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~------~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~  109 (330)
T 3nsz_A           36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPA  109 (330)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEE
T ss_pred             CceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccc------hHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceE
Confidence            4699999999999999984     68999999986431      356889999999996 9999999999987  66789


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC-CEEEeecCCcccccc
Q 012684          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTV  305 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~-~vkl~Dfg~~~~~~~  305 (458)
                      +||||+++++|.+++..   +++..+..++.|++.||.|||+.|   |+||||||+|||++.++ .++|+|||++.....
T Consensus       110 lv~e~~~~~~l~~~~~~---~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~  183 (330)
T 3nsz_A          110 LVFEHVNNTDFKQLYQT---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP  183 (330)
T ss_dssp             EEEECCCCCCHHHHGGG---CCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EEEeccCchhHHHHHHh---CCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCC
Confidence            99999999999998753   899999999999999999999999   99999999999999777 899999999986543


Q ss_pred             CCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH-HHHH------------HhcCC
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAY------------AARQR  371 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~-~~~~------------~~~~~  371 (458)
                      .  .......+++.|+|||++.+ ..++.++||||||+++|+|++|+.||........ ...+            .....
T Consensus       184 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~  261 (330)
T 3nsz_A          184 G--QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYN  261 (330)
T ss_dssp             T--CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTT
T ss_pred             C--CccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhc
Confidence            3  23344568999999999877 5789999999999999999999999965433211 0000            00000


Q ss_pred             CC---------------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 PP---------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 ~~---------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ..                     .......+++.+.+||.+||+.||.+|||+.++++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~h  320 (330)
T 3nsz_A          262 IELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  320 (330)
T ss_dssp             CCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             cccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcC
Confidence            00                     011233478999999999999999999999999986

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=1.1e-39  Score=327.26  Aligned_cols=245  Identities=25%  Similarity=0.360  Sum_probs=194.2

Q ss_pred             cCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC----
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS----  222 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~----  222 (458)
                      +...+|+..+.||+|+||.||.     +|+.||||++.....       ...+|+.+++.++||||++++++|...    
T Consensus        51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~-------~~~~E~~il~~l~hpniv~l~~~~~~~~~~~  123 (420)
T 1j1b_A           51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKK  123 (420)
T ss_dssp             CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEEETTT
T ss_pred             cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccch-------hHHHHHHHHHHcCCCCccceeeEEeccCCCC
Confidence            3455799999999999999884     589999999864321       234699999999999999999998542    


Q ss_pred             --CceEEEEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC-CCEEEe
Q 012684          223 --SPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-GNLKVA  295 (458)
Q Consensus       223 --~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~-~~vkl~  295 (458)
                        .++++||||+++ +|.+++..    ...+++..+..++.|++.||.|||+.+   |+||||||+|||++.+ +.+||+
T Consensus       124 ~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~NILl~~~~~~~kl~  199 (420)
T 1j1b_A          124 DEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLC  199 (420)
T ss_dssp             TEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECSCCSGGGEEEETTTTEEEEC
T ss_pred             cceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCChhhEEEeCCCCeEEec
Confidence              236799999964 77766642    466999999999999999999999999   9999999999999965 568999


Q ss_pred             ecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-CCC-
Q 012684          296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP-  372 (458)
Q Consensus       296 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~~~-  372 (458)
                      |||++......  .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+... +.+ 
T Consensus       200 DFG~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~  277 (420)
T 1j1b_A          200 DFGSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPT  277 (420)
T ss_dssp             CCTTCEECCTT--CCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCC
T ss_pred             cchhhhhcccC--CCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCC
Confidence            99999865432  223345789999999998764 7899999999999999999999999886654333322211 000 


Q ss_pred             --------------CCCC---------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 --------------PFKA---------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 --------------~~~~---------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                    .++.         ....+++++.+||.+||..||.+|||+.++++|
T Consensus       278 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~h  337 (420)
T 1j1b_A          278 REQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  337 (420)
T ss_dssp             HHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCC
Confidence                          1110         123457899999999999999999999999987

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.2e-39  Score=314.60  Aligned_cols=248  Identities=23%  Similarity=0.397  Sum_probs=194.0

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEE--------
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVT--------  220 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~--------  220 (458)
                      ..+|++.+.||+|+||.||.     +|+.||+|.+...   .....+.+.+|+.+++.++||||+++++++.        
T Consensus        10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A           10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC
T ss_pred             CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHHhcCCCCeeEEEEecccccccccc
Confidence            34789999999999998874     4899999998643   4566778899999999999999999999873        


Q ss_pred             ------eCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec-CCCCEE
Q 012684          221 ------QSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLK  293 (458)
Q Consensus       221 ------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~-~~~~vk  293 (458)
                            .....++||||++ ++|.+++.. +.+++..+..++.|++.||.|||+.|   ++||||||+||+++ .++.+|
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~k  161 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVLEQ-GPLLEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFINTEDLVLK  161 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTTEEE
T ss_pred             ccccccccCceeEEeeccC-CCHHHHhhc-CCccHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCeEE
Confidence                  3467899999996 699998865 56999999999999999999999999   99999999999997 567899


Q ss_pred             EeecCCccccccCC--CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC
Q 012684          294 VADFGVSKLLTVKE--DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ  370 (458)
Q Consensus       294 l~Dfg~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~  370 (458)
                      |+|||++.......  ........+|+.|+|||.+.+ ..++.++||||||+++|+|++|+.||......+....+....
T Consensus       162 l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~  241 (320)
T 2i6l_A          162 IGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI  241 (320)
T ss_dssp             ECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHS
T ss_pred             EccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhc
Confidence            99999998654221  112233456889999998765 578899999999999999999999998776544333332111


Q ss_pred             C--------------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          371 R--------------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       371 ~--------------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .                          .+.....+.+++.+.++|.+||+.||.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  306 (320)
T 2i6l_A          242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSH  306 (320)
T ss_dssp             CCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTS
T ss_pred             CCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCC
Confidence            0                          00001123468899999999999999999999999986

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.8e-39  Score=314.74  Aligned_cols=244  Identities=25%  Similarity=0.354  Sum_probs=171.9

Q ss_pred             CccccCce-eeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe----CC
Q 012684          154 ELDFTNSV-EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SS  223 (458)
Q Consensus       154 ~~~~~~~~-~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~----~~  223 (458)
                      ..+|.+.+ .||+|+||.||.     +|+.||||++...    ....   ......++.++||||+++++++..    +.
T Consensus        27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~---~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~   99 (336)
T 3fhr_A           27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDS----PKAR---QEVDHHWQASGGPHIVCILDVYENMHHGKR   99 (336)
T ss_dssp             GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESS----HHHH---HHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred             cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCc----HHHH---HHHHHHHHhcCCCChHHHHHHHhhccCCCc
Confidence            44677744 699999999984     5899999998642    2222   222334566799999999999976    44


Q ss_pred             ceEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC---CCCEEEeecC
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFG  298 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~---~~~vkl~Dfg  298 (458)
                      ..++||||++|++|.+++...+  .+++.+++.++.|++.||.|||+.+   |+||||||+||+++.   ++.++|+|||
T Consensus       100 ~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~---ivH~dlkp~NIll~~~~~~~~~kl~Dfg  176 (336)
T 3fhr_A          100 CLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHN---IAHRDVKPENLLYTSKEKDAVLKLTDFG  176 (336)
T ss_dssp             EEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEESCSSTTCCEEECCCT
T ss_pred             eEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEEecCCCceEEEeccc
Confidence            5899999999999999998754  5999999999999999999999999   999999999999986   4459999999


Q ss_pred             CccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH----HhcCCCCC
Q 012684          299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY----AARQRPPF  374 (458)
Q Consensus       299 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~----~~~~~~~~  374 (458)
                      ++......   ......+|+.|+|||++.+..++.++||||||+++|+|++|+.||............    ........
T Consensus       177 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  253 (336)
T 3fhr_A          177 FAKETTQN---ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFP  253 (336)
T ss_dssp             TCEEC-------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCC
T ss_pred             cceecccc---ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccC
Confidence            99765422   223456799999999998888899999999999999999999999876654432211    11111111


Q ss_pred             CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       375 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                      ......+++.+.+||..||+.||.+|||+.+++++-
T Consensus       254 ~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp  289 (336)
T 3fhr_A          254 NPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHP  289 (336)
T ss_dssp             TTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSH
T ss_pred             chhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCc
Confidence            123356789999999999999999999999999974

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.2e-39  Score=322.30  Aligned_cols=243  Identities=23%  Similarity=0.311  Sum_probs=197.4

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC--------CCcceeeeeEEE-
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--------HPNVVQFLGAVT-  220 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hp~i~~~~~~~~-  220 (458)
                      .+|++.+.||+|+||.||.     +|+.||||++..    .....+.+.+|+.+++.+.        ||||+++++++. 
T Consensus        37 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~  112 (397)
T 1wak_A           37 GRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKS----AEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKI  112 (397)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEE
T ss_pred             CeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEec----CCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceee
Confidence            4799999999999999984     589999999963    2445667889999999885        788999999987 


Q ss_pred             ---eCCceEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCEEecCCC----
Q 012684          221 ---QSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSG----  290 (458)
Q Consensus       221 ---~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dikp~Nil~~~~~----  290 (458)
                         .....++||||+ +++|.+.+...  +.+++..+..++.||+.||.|||++ |   |+||||||+|||++.++    
T Consensus       113 ~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~g---ivHrDikp~NIll~~~~~~~~  188 (397)
T 1wak_A          113 SGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCR---IIHTDIKPENILLSVNEQYIR  188 (397)
T ss_dssp             EETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECCCCSGGGEEECCCHHHHH
T ss_pred             cCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHeeEeccchhhh
Confidence               456789999999 66777776654  4599999999999999999999998 8   99999999999999775    


Q ss_pred             ---------------------------------------------CEEEeecCCccccccCCCCCcccCCCCCcccCCcc
Q 012684          291 ---------------------------------------------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV  325 (458)
Q Consensus       291 ---------------------------------------------~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~  325 (458)
                                                                   .+||+|||++......    .....||+.|+|||+
T Consensus       189 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~----~~~~~gt~~y~aPE~  264 (397)
T 1wak_A          189 RLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH----FTEDIQTRQYRSLEV  264 (397)
T ss_dssp             HHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC----SCSCCSCGGGCCHHH
T ss_pred             hhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc----CccCCCCCcccCChh
Confidence                                                         8999999999865432    334568999999999


Q ss_pred             cCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHH------HHH-HhcCCCC-------------------------
Q 012684          326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP------KAY-AARQRPP-------------------------  373 (458)
Q Consensus       326 ~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~------~~~-~~~~~~~-------------------------  373 (458)
                      +.+..++.++|||||||++|+|++|+.||...+.....      ..+ ...+.++                         
T Consensus       265 ~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  344 (397)
T 1wak_A          265 LIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITK  344 (397)
T ss_dssp             HHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCC
T ss_pred             hcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccc
Confidence            99988999999999999999999999999876644311      111 0001000                         


Q ss_pred             ------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 ------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                  ....+...++.+.+||.+||+.||.+|||+.++++|
T Consensus       345 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  392 (397)
T 1wak_A          345 LKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRH  392 (397)
T ss_dssp             CCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTS
T ss_pred             cCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhC
Confidence                        001134567789999999999999999999999976

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=5.6e-39  Score=309.76  Aligned_cols=248  Identities=25%  Similarity=0.443  Sum_probs=185.7

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv  228 (458)
                      -.+|+..+.||+|+||.||.     +|+.||||++..... .....+.+..+..+++.++||||+++++++..+...++|
T Consensus        24 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv  102 (318)
T 2dyl_A           24 INDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGN-KEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIA  102 (318)
T ss_dssp             GGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSC-HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             hccccccceeeecCCeeEEEEEEecCCeEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEE
Confidence            34688889999999998874     589999999975432 233334455556678888999999999999999999999


Q ss_pred             EEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          229 TEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       229 ~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      |||+ ++.+..+... .+.+++..+..++.|++.||.|||+. +   ++|+||||+||+++.++.++|+|||++......
T Consensus       103 ~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  178 (318)
T 2dyl_A          103 MELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHG---VIHRDVKPSNILLDERGQIKLCDFGISGRLVDD  178 (318)
T ss_dssp             ECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHC---CCCCCCCGGGEEECTTSCEEECCCTTC------
T ss_pred             Eecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCC---EEeCCCCHHHEEECCCCCEEEEECCCchhccCC
Confidence            9999 6677766654 46799999999999999999999995 8   999999999999999999999999998765432


Q ss_pred             CCCCcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC-cHHHHHHhcCCCCCCCChhh
Q 012684          307 EDRPLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN-EVPKAYAARQRPPFKAPAKL  380 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~-~~~~~~~~~~~~~~~~~~~~  380 (458)
                        .......+|+.|+|||++.     +..++.++||||||+++|+|++|+.||...... +....+.....+.. .....
T Consensus       179 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~-~~~~~  255 (318)
T 2dyl_A          179 --KAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLL-PGHMG  255 (318)
T ss_dssp             ----------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCC-CSSSC
T ss_pred             --ccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCC-CccCC
Confidence              2223446899999999984     456788999999999999999999999874433 23333322222222 23345


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          381 YARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +++.+.++|..||+.||.+|||+.+++++
T Consensus       256 ~~~~l~~li~~~l~~dp~~Rps~~~ll~h  284 (318)
T 2dyl_A          256 FSGDFQSFVKDCLTKDHRKRPKYNKLLEH  284 (318)
T ss_dssp             CCHHHHHHHHHHTCSCTTTSCCHHHHTTS
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence            78999999999999999999999999986

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.7e-39  Score=314.56  Aligned_cols=250  Identities=28%  Similarity=0.449  Sum_probs=199.8

Q ss_pred             CCccccCceeeccceEEEEEE------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC---CCCcceeeeeEEE---
Q 012684          153 HELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVT---  220 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~i~~~~~~~~---  220 (458)
                      ...+|++.+.||+|+||.||.      +|+.||+|++....... .....+.+|+.+++.+   +||||+++++++.   
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~   87 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   87 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecc
Confidence            345799999999999998873      47899999986533211 1112345676666655   8999999999987   


Q ss_pred             --eCCceEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEee
Q 012684          221 --QSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (458)
Q Consensus       221 --~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~D  296 (458)
                        .....++||||+. ++|.+++....  .+++..+..++.|++.||.|||+.|   ++|+||||+||+++.++.++|+|
T Consensus        88 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~g---i~H~dlkp~Nili~~~~~~kl~D  163 (326)
T 1blx_A           88 TDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD  163 (326)
T ss_dssp             CSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred             cCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHHHeEEcCCCCEEEec
Confidence              4567899999996 69999998753  4899999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CC---
Q 012684          297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RP---  372 (458)
Q Consensus       297 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~---  372 (458)
                      ||++......  .......+|+.|+|||++.+..++.++||||||+++|+|++|+.||...........+.... .+   
T Consensus       164 fg~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~  241 (326)
T 1blx_A          164 FGLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEE  241 (326)
T ss_dssp             CCSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGG
T ss_pred             CcccccccCC--CCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcc
Confidence            9999765432  12334568999999999998899999999999999999999999998776554443332211 00   


Q ss_pred             -------------------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 -------------------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 -------------------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                         ........+++.+.+||.+||+.||.+|||+.+++++
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  297 (326)
T 1blx_A          242 DWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  297 (326)
T ss_dssp             GSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             cCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcC
Confidence                               0111224578899999999999999999999999875

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=3.2e-39  Score=321.09  Aligned_cols=244  Identities=26%  Similarity=0.397  Sum_probs=193.3

Q ss_pred             CCccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc----
Q 012684          153 HELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----  224 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~----  224 (458)
                      ...+|++.+.||+|+||.||.    .+..||+|++.....       ...+|+.+++.++||||+++++++.....    
T Consensus        38 ~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~~aikk~~~~~~-------~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~  110 (394)
T 4e7w_A           38 REIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQDKR-------FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDE  110 (394)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTEEEEEEEEECCTT-------SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSC
T ss_pred             ccceEEEeEEEeeCCCeEEEEEEECCCCeEEEEEEecCcc-------hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCc
Confidence            345799999999999999984    455699998864321       12369999999999999999999965433    


Q ss_pred             --eEEEEEccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec-CCCCEEEeec
Q 012684          225 --MMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADF  297 (458)
Q Consensus       225 --~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~-~~~~vkl~Df  297 (458)
                        .++||||+++ ++.+.+.    ....+++..+..++.|++.||.|||+.|   |+||||||+|||++ .++.+||+||
T Consensus       111 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~~kL~DF  186 (394)
T 4e7w_A          111 VFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIG---ICHRDIKPQNLLLDPPSGVLKLIDF  186 (394)
T ss_dssp             EEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCC
T ss_pred             eEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccCCCCCHHHEEEcCCCCcEEEeeC
Confidence              7899999966 4444433    2567999999999999999999999999   99999999999999 7999999999


Q ss_pred             CCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-C----
Q 012684          298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R----  371 (458)
Q Consensus       298 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~----  371 (458)
                      |++......  .......+|+.|+|||++.+. .++.++|||||||++|+|++|+.||.+.+..+....+.... .    
T Consensus       187 G~a~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~  264 (394)
T 4e7w_A          187 GSAKILIAG--EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSRE  264 (394)
T ss_dssp             TTCEECCTT--CCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             CCcccccCC--CCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999865432  233445789999999998765 58999999999999999999999999876544433332210 1    


Q ss_pred             --------------CCCCC------ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 --------------PPFKA------PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 --------------~~~~~------~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                    +....      .+..+++++.+||.+||+.||.+|||+.++++|
T Consensus       265 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (394)
T 4e7w_A          265 QIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCH  322 (394)
T ss_dssp             HHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             HHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcC
Confidence                          00000      122367899999999999999999999999987

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=3.7e-39  Score=316.74  Aligned_cols=245  Identities=26%  Similarity=0.360  Sum_probs=184.4

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc-----
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP-----  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~-----  224 (458)
                      .+|++.+.||+|+||.||.     +|..||||++.......    .....++..++.++||||+++++++.....     
T Consensus        23 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~   98 (360)
T 3e3p_A           23 DRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFR----NRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRD   98 (360)
T ss_dssp             TTEEEC----------CEEEEETTTCCEEEEEEEECCTTCC----CHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTC
T ss_pred             cceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCcccc----HHHHHHHHHHHhcCCCCcccHHHhhhccccccccc
Confidence            3688999999999998873     58899999886543222    245567778888899999999999975433     


Q ss_pred             --eEEEEEccCCCCHHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeeeCCCCCCCEEecC-CCCEEEe
Q 012684          225 --MMIVTEYLPKGDLRAFLK----RKGALKPSTAVRFALDIARGMNYLH--ENKPVPIIHRDLEPSNILRDD-SGNLKVA  295 (458)
Q Consensus       225 --~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~i~~qi~~~l~~LH--~~~~~~i~H~Dikp~Nil~~~-~~~vkl~  295 (458)
                        .++||||+++ +|.+.+.    ....+++..+..++.|++.||.|||  +.+   |+||||||+|||++. ++.+||+
T Consensus        99 ~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~---ivH~Dlkp~NIll~~~~~~~kl~  174 (360)
T 3e3p_A           99 IYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVN---VCHRDIKPHNVLVNEADGTLKLC  174 (360)
T ss_dssp             EEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTC---CBCSCCCGGGEEEETTTTEEEEC
T ss_pred             eeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCC---eecCcCCHHHEEEeCCCCcEEEe
Confidence              8899999965 5554443    4566899999999999999999999  888   999999999999996 8999999


Q ss_pred             ecCCccccccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCC-
Q 012684          296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPP-  373 (458)
Q Consensus       296 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~-  373 (458)
                      |||++......  .......||+.|+|||++.+. .++.++||||||+++|+|++|+.||...........+......+ 
T Consensus       175 Dfg~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~  252 (360)
T 3e3p_A          175 DFGSAKKLSPS--EPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPS  252 (360)
T ss_dssp             CCTTCBCCCTT--SCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCC
T ss_pred             eCCCceecCCC--CCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCC
Confidence            99999876533  223345689999999998665 48999999999999999999999999876655444432211110 


Q ss_pred             ---------------------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 ---------------------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ---------------------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                                 ++.....+++.+.+||.+||+.||.+|||+.++++|
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~h  315 (360)
T 3e3p_A          253 REVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCH  315 (360)
T ss_dssp             HHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTS
T ss_pred             HHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcC
Confidence                                       011112257889999999999999999999999987

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=1.5e-39  Score=319.90  Aligned_cols=252  Identities=24%  Similarity=0.328  Sum_probs=195.6

Q ss_pred             cCCccccCceeeccceEEEEEE----cCeEEEEEEcCCCCC--------CCHHHHHHHHHHHHHHhcCCCCcceeeeeEE
Q 012684          152 PHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVI--------SDDDRVRAFRDELALLQKIRHPNVVQFLGAV  219 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~--------~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~  219 (458)
                      ....+|++.+.||+|+||.||.    +|..||||++.....        ......+.+.+|+.++++++||||+++++++
T Consensus        19 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~   98 (362)
T 3pg1_A           19 AMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIF   98 (362)
T ss_dssp             HTTCSCEEEEEEEEETTEEEEEEECTTSCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEE
T ss_pred             HhccceEEeEEeccCCCEEEEEEECCCCCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeE
Confidence            3455789999999999999984    588999999865322        1334457789999999999999999999998


Q ss_pred             Ee-----CCceEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEE
Q 012684          220 TQ-----SSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLK  293 (458)
Q Consensus       220 ~~-----~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vk  293 (458)
                      ..     ....++||||++ ++|.+++... ..+++..+..++.|++.||.|||+.+   |+||||||+||+++.++.++
T Consensus        99 ~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~NIl~~~~~~~k  174 (362)
T 3pg1_A           99 VHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDIT  174 (362)
T ss_dssp             EECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEE
T ss_pred             EeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCc---CEecCCChHHEEEcCCCCEE
Confidence            54     235899999996 6888888754 46999999999999999999999999   99999999999999999999


Q ss_pred             EeecCCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-C
Q 012684          294 VADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R  371 (458)
Q Consensus       294 l~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~  371 (458)
                      |+|||++......  .......+|+.|+|||++.+ ..++.++||||||+++|+|++|+.||......+....+.... .
T Consensus       175 l~Dfg~~~~~~~~--~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~  252 (362)
T 3pg1_A          175 ICDFNLAREDTAD--ANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGT  252 (362)
T ss_dssp             ECCTTC-----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCC
T ss_pred             EEecCcccccccc--cccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCC
Confidence            9999999754322  22334568899999999877 678999999999999999999999998866544433332111 1


Q ss_pred             C----------------------CCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 P----------------------PFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 ~----------------------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +                      ..+     ...+.+++.+.+||.+||+.||.+|||+.+++++
T Consensus       253 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h  317 (362)
T 3pg1_A          253 PKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRH  317 (362)
T ss_dssp             CCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcC
Confidence            0                      000     0123456789999999999999999999999987

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=7.2e-39  Score=317.45  Aligned_cols=244  Identities=24%  Similarity=0.268  Sum_probs=197.0

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CC-----cceeeeeEEEeC
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HP-----NVVQFLGAVTQS  222 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp-----~i~~~~~~~~~~  222 (458)
                      ..+|++.+.||+|+||.||.     +|+.||||++..    .......+..|+.+++.+. |+     +|+++++++...
T Consensus        53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECS----SHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEec----cHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            34799999999999999984     588999999974    2344566778888888774 44     599999999999


Q ss_pred             CceEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh--CCCCCeeeCCCCCCCEEec--CCCCEEEee
Q 012684          223 SPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHE--NKPVPIIHRDLEPSNILRD--DSGNLKVAD  296 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~--~~~~~i~H~Dikp~Nil~~--~~~~vkl~D  296 (458)
                      ...|+||||+. ++|.+++...  +.+++..+..++.|++.||.|||+  .+   |+||||||+|||++  .++.+||+|
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~---ivHrDlkp~NIll~~~~~~~~kL~D  204 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELS---IIHCDLKPENILLCNPKRSAIKIVD  204 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTC---EECCCCSGGGEEESSTTSCCEEECC
T ss_pred             CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCC---EEcCCCCcccEEEecCCCCcEEEEe
Confidence            99999999995 5999999875  458999999999999999999994  56   99999999999995  477899999


Q ss_pred             cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCC--
Q 012684          297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF--  374 (458)
Q Consensus       297 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~--  374 (458)
                      ||++.....    ......+|+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+......+.  
T Consensus       205 FG~a~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~  280 (382)
T 2vx3_A          205 FGSSCQLGQ----RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAH  280 (382)
T ss_dssp             CTTCEETTC----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHH
T ss_pred             ccCceeccc----ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHH
Confidence            999987532    23345689999999999998999999999999999999999999998765544433322111000  


Q ss_pred             --------------------------------CC--------------------------ChhhhHHHHHHHHHHHcccC
Q 012684          375 --------------------------------KA--------------------------PAKLYARGLKELIEECWNEK  396 (458)
Q Consensus       375 --------------------------------~~--------------------------~~~~~~~~l~~li~~~l~~d  396 (458)
                                                      ..                          .....++.+.+||.+||+.|
T Consensus       281 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~d  360 (382)
T 2vx3_A          281 ILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYD  360 (382)
T ss_dssp             HHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSC
T ss_pred             HHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCC
Confidence                                            00                          00011247899999999999


Q ss_pred             CCCCCCHHHHHHH
Q 012684          397 PAKRPTFRQIITR  409 (458)
Q Consensus       397 p~~Rps~~~ll~~  409 (458)
                      |.+|||+.+++++
T Consensus       361 P~~Rpta~e~L~h  373 (382)
T 2vx3_A          361 PKTRIQPYYALQH  373 (382)
T ss_dssp             TTTSCCHHHHTTS
T ss_pred             hhhCCCHHHHhcC
Confidence            9999999999986

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=4.3e-39  Score=323.53  Aligned_cols=247  Identities=24%  Similarity=0.342  Sum_probs=191.9

Q ss_pred             cCCccccCceeeccceEEEEE----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceE
Q 012684          152 PHELDFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~  226 (458)
                      ....+|...+.||+|+||.|+    ++|+.||||++.....      ..+.+|+.+++.+ +||||+++++++.+....|
T Consensus        21 i~~~~y~~~~~LG~G~~G~V~~~~~~~~~~vAvK~~~~~~~------~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~   94 (432)
T 3p23_A           21 VGKISFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILPECF------SFADREVQLLRESDEHPNVIRYFCTEKDRQFQY   94 (432)
T ss_dssp             ETTEEEEEEEEEEECGGGCEEEEEESSSSEEEEEEECTTTE------EECHHHHHHHHHSCCCTTBCCEEEEEEETTEEE
T ss_pred             EccEEEecCCeeecCcCEEEEEEEEeCCeEEEEEEECHHHH------HHHHHHHHHHHhccCCCCcCeEEEEEecCCEEE
Confidence            345578899999999999754    3789999999965432      2346799999999 7999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC-----CCCEEEeecCCc
Q 012684          227 IVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-----SGNLKVADFGVS  300 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~-----~~~vkl~Dfg~~  300 (458)
                      +||||+. |+|.+++.... .+++..++.++.|++.||.|||+.+   |+||||||+|||++.     ...++|+|||++
T Consensus        95 lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a  170 (432)
T 3p23_A           95 IAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLN---IVHRDLKPHNILISMPNAHGKIKAMISDFGLC  170 (432)
T ss_dssp             EEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTT---CCCCCCSTTSEEECCCBTTTBCCEEECCTTEE
T ss_pred             EEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCc---CEeCCCCHHHEEEecCCCCCceeEEEecccce
Confidence            9999995 69999998654 3666678899999999999999999   999999999999953     336889999999


Q ss_pred             cccccCCC--CCcccCCCCCcccCCcccC---CCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCC
Q 012684          301 KLLTVKED--RPLTCQDTSCRYVAPEVFK---NEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPF  374 (458)
Q Consensus       301 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~  374 (458)
                      ........  .......||+.|+|||++.   +..++.++|||||||++|+|++ |..||......... ..........
T Consensus       171 ~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~-~~~~~~~~~~  249 (432)
T 3p23_A          171 KKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQAN-ILLGACSLDC  249 (432)
T ss_dssp             ECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHH-HHTTCCCCTT
T ss_pred             eeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHH-HHhccCCccc
Confidence            87643321  2224456899999999997   3567789999999999999999 99999765433322 2222222222


Q ss_pred             CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       375 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .......+..+.+||.+||+.||.+|||+.++++|
T Consensus       250 ~~~~~~~~~~~~~li~~~L~~dP~~Rps~~evl~h  284 (432)
T 3p23_A          250 LHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKH  284 (432)
T ss_dssp             SCTTCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             cCccccccHHHHHHHHHHHhCCHhhCCCHHHHHhC
Confidence            23344567789999999999999999999999965

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=1.3e-38  Score=311.90  Aligned_cols=244  Identities=25%  Similarity=0.308  Sum_probs=198.6

Q ss_pred             CccccCceeeccceEEEEEE-----cC-eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCc------ceeeeeEEEe
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RG-IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN------VVQFLGAVTQ  221 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~------i~~~~~~~~~  221 (458)
                      ..+|++.+.||+|+||.||.     ++ ..||+|++..    .....+.+.+|+.+++.+.|++      ++.+++++..
T Consensus        18 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~----~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~   93 (355)
T 2eu9_A           18 QERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN----VGKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNF   93 (355)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEE
T ss_pred             cccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcc----cccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeee
Confidence            45799999999999999884     33 7899999963    2345567888999999987655      8999999999


Q ss_pred             CCceEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe-------------
Q 012684          222 SSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR-------------  286 (458)
Q Consensus       222 ~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~-------------  286 (458)
                      .+..++||||+ +++|.+++....  .+++..+..++.|++.||.|||+.+   |+||||||+|||+             
T Consensus        94 ~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~~~~~~~~  169 (355)
T 2eu9_A           94 HGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQ---LTHTDLKPENILFVNSEFETLYNEHK  169 (355)
T ss_dssp             TTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEESCCCEEEEECCC-
T ss_pred             CCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecccccccccccc
Confidence            99999999999 678887777643  6999999999999999999999999   9999999999999             


Q ss_pred             ------cCCCCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCC
Q 012684          287 ------DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN  360 (458)
Q Consensus       287 ------~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~  360 (458)
                            +.++.+||+|||++.....    ......||+.|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus       170 ~~~~~~~~~~~~kl~Dfg~~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~  245 (355)
T 2eu9_A          170 SCEEKSVKNTSIRVADFGSATFDHE----HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENR  245 (355)
T ss_dssp             CCCEEEESCCCEEECCCTTCEETTS----CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred             cccccccCCCcEEEeecCccccccc----cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence                  5678999999999976432    223456899999999999989999999999999999999999999876654


Q ss_pred             cHHHHHHhcCCCCC----------------------------------------CCChhhhHHHHHHHHHHHcccCCCCC
Q 012684          361 EVPKAYAARQRPPF----------------------------------------KAPAKLYARGLKELIEECWNEKPAKR  400 (458)
Q Consensus       361 ~~~~~~~~~~~~~~----------------------------------------~~~~~~~~~~l~~li~~~l~~dp~~R  400 (458)
                      +....+.....+..                                        .......+..+.+||.+||+.||.+|
T Consensus       246 ~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~R  325 (355)
T 2eu9_A          246 EHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQR  325 (355)
T ss_dssp             HHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTS
T ss_pred             HHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhC
Confidence            43332221111100                                        01112345689999999999999999


Q ss_pred             CCHHHHHHH
Q 012684          401 PTFRQIITR  409 (458)
Q Consensus       401 ps~~~ll~~  409 (458)
                      ||+.+++++
T Consensus       326 pt~~e~l~h  334 (355)
T 2eu9_A          326 ITLAEALLH  334 (355)
T ss_dssp             CCHHHHTTS
T ss_pred             cCHHHHhcC
Confidence            999999876

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=4.9e-39  Score=323.75  Aligned_cols=242  Identities=25%  Similarity=0.358  Sum_probs=186.0

Q ss_pred             cccCceeeccceEEEEE----EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAF----WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~----~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .|...+.||+|+||.|+    .+|+.||||++....      .+.+.+|+.+++.+ +||||+++++++..+...++|||
T Consensus        16 ~~~~~~~LG~G~~g~V~~~~~~~g~~vAvK~~~~~~------~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E   89 (434)
T 2rio_A           16 LVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF------CDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALE   89 (434)
T ss_dssp             CEEEEEEEEECSTTCEEEEEESSSSEEEEEEEEGGG------HHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEEC
T ss_pred             eeeccCeEeeCCCeEEEEEEEECCeEEEEEEEcHHH------HHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEe
Confidence            35567889999999875    368999999986431      24567899999876 89999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC-------------C
Q 012684          231 YLPKGDLRAFLKRKGAL-------KPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS-------------G  290 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~-------~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~-------------~  290 (458)
                      |+. |+|.+++...+..       ++..++.++.|++.||+|||+.+   |+||||||+|||++.+             +
T Consensus        90 ~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~~~~~~~~~~~~  165 (434)
T 2rio_A           90 LCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLK---IIHRDLKPQNILVSTSSRFTADQQTGAENL  165 (434)
T ss_dssp             CCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEECCHHHHSCCTTCCCSC
T ss_pred             cCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCC---ccccCCChHhEEEecCcccccccccCCCce
Confidence            995 6999999875432       23356789999999999999999   9999999999999754             4


Q ss_pred             CEEEeecCCccccccCCCC---CcccCCCCCcccCCcccCC-------CCCCCchhHHHHHHHHHHHHc-CCCCCCCCCC
Q 012684          291 NLKVADFGVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKN-------EEYDTKVDVFSFALILQEMIE-GCPPFTMKHD  359 (458)
Q Consensus       291 ~vkl~Dfg~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~  359 (458)
                      .+||+|||++.........   ......||+.|+|||++.+       ..++.++|||||||++|+|++ |+.||.....
T Consensus       166 ~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~  245 (434)
T 2rio_A          166 RILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYS  245 (434)
T ss_dssp             EEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTT
T ss_pred             EEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchh
Confidence            7999999999876543211   1234568999999999865       568899999999999999999 9999986544


Q ss_pred             CcHHHHHHhcC--CCCC-CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          360 NEVPKAYAARQ--RPPF-KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       360 ~~~~~~~~~~~--~~~~-~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ..  ..+....  .+.. ......+++++.++|.+||+.||.+|||+.+++++
T Consensus       246 ~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h  296 (434)
T 2rio_A          246 RE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRH  296 (434)
T ss_dssp             HH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             hH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhC
Confidence            33  2221221  1111 11234678899999999999999999999999975

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=1.8e-39  Score=314.03  Aligned_cols=246  Identities=26%  Similarity=0.403  Sum_probs=201.2

Q ss_pred             cccCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCH---HHHHHHHHHHHHHhcCC--CCcceeeee
Q 012684          148 YEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIR--HPNVVQFLG  217 (458)
Q Consensus       148 ~~~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--hp~i~~~~~  217 (458)
                      .+......+|++.+.||+|+||.||.     +|+.||||++........   ...+.+.+|+.+++.+.  ||||+++++
T Consensus        36 ~~~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~  115 (320)
T 3a99_A           36 KEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLD  115 (320)
T ss_dssp             ----CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEE
T ss_pred             cccCCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEE
Confidence            34445566899999999999999884     689999999975433221   11234667999999995  699999999


Q ss_pred             EEEeCCceEEEEEccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec-CCCCEEEe
Q 012684          218 AVTQSSPMMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVA  295 (458)
Q Consensus       218 ~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~-~~~~vkl~  295 (458)
                      ++...+..++|||++.+ ++|.+++...+.+++..++.++.|++.||.|||+.+   |+||||||+||+++ .++.+||+
T Consensus       116 ~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---ivH~Dlkp~NIll~~~~~~~kL~  192 (320)
T 3a99_A          116 WFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLI  192 (320)
T ss_dssp             EEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEEC
T ss_pred             EEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---cEeCCCCHHHEEEeCCCCCEEEe
Confidence            99999999999999976 899999998888999999999999999999999999   99999999999999 78899999


Q ss_pred             ecCCccccccCCCCCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCC
Q 012684          296 DFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPF  374 (458)
Q Consensus       296 Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~  374 (458)
                      |||++......   ......||+.|+|||++.+..+ +.++||||||+++|+|++|+.||....      .... .... 
T Consensus       193 Dfg~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~-~~~~-  261 (320)
T 3a99_A          193 DFGSGALLKDT---VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIR-GQVF-  261 (320)
T ss_dssp             CCTTCEECCSS---CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHH-CCCC-
T ss_pred             eCccccccccc---cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhc-cccc-
Confidence            99999876432   2334568999999999877665 678999999999999999999997531      1111 1111 


Q ss_pred             CCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       375 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                        .+..+++.+.+||.+||+.||.+|||+.+++++
T Consensus       262 --~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h  294 (320)
T 3a99_A          262 --FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNH  294 (320)
T ss_dssp             --CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             --ccccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence              234577899999999999999999999999876

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=1.2e-38  Score=314.61  Aligned_cols=245  Identities=21%  Similarity=0.323  Sum_probs=194.7

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-----------CCcceeee
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----------HPNVVQFL  216 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~i~~~~  216 (458)
                      ...+|++.+.||+|+||.||.     +|+.||||++..    .....+.+.+|+.+++++.           ||||++++
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~----~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~   92 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRG----DKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLL   92 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECS----CHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCC
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecC----CccchhhhhHHHHHHHHhhcccccchhccccchHHHHH
Confidence            345799999999999999884     689999999964    2344567888999988885           89999999


Q ss_pred             eEEEeCC----ceEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCEEec--
Q 012684          217 GAVTQSS----PMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRD--  287 (458)
Q Consensus       217 ~~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dikp~Nil~~--  287 (458)
                      +++...+    ..++|||++ +++|.+++...  ..+++..+..++.|++.||.|||++ +   |+||||||+|||++  
T Consensus        93 ~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~---ivH~Dikp~NIll~~~  168 (373)
T 1q8y_A           93 DHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIV  168 (373)
T ss_dssp             EEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEE
T ss_pred             HHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCC---EEecCCChHHeEEecc
Confidence            9997654    689999999 89999999863  4599999999999999999999998 9   99999999999995  


Q ss_pred             ----CCCCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH-
Q 012684          288 ----DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-  362 (458)
Q Consensus       288 ----~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~-  362 (458)
                          ..+.+||+|||++......    .....+|+.|+|||++.+..++.++||||||+++|+|++|+.||........ 
T Consensus       169 ~~~~~~~~~kl~Dfg~a~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  244 (373)
T 1q8y_A          169 DSPENLIQIKIADLGNACWYDEH----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT  244 (373)
T ss_dssp             ETTTTEEEEEECCCTTCEETTBC----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------
T ss_pred             CCCcCcceEEEcccccccccCCC----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccC
Confidence                3447999999999865432    2334689999999999998899999999999999999999999986543211 


Q ss_pred             -----HHHHHh-cCCCC-------------------------------------CCCChhhhHHHHHHHHHHHcccCCCC
Q 012684          363 -----PKAYAA-RQRPP-------------------------------------FKAPAKLYARGLKELIEECWNEKPAK  399 (458)
Q Consensus       363 -----~~~~~~-~~~~~-------------------------------------~~~~~~~~~~~l~~li~~~l~~dp~~  399 (458)
                           ...+.. .+..+                                     ....+..+++.+.+||.+||+.||.+
T Consensus       245 ~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~  324 (373)
T 1q8y_A          245 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRK  324 (373)
T ss_dssp             CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTT
T ss_pred             ChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccc
Confidence                 111100 00000                                     00123467789999999999999999


Q ss_pred             CCCHHHHHHH
Q 012684          400 RPTFRQIITR  409 (458)
Q Consensus       400 Rps~~~ll~~  409 (458)
                      |||+.+++++
T Consensus       325 Rpt~~ell~h  334 (373)
T 1q8y_A          325 RADAGGLVNH  334 (373)
T ss_dssp             CBCHHHHHTC
T ss_pred             cCCHHHHhhC
Confidence            9999999986

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-38  Score=306.75  Aligned_cols=241  Identities=28%  Similarity=0.430  Sum_probs=193.3

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCH---HHHHHHHHHHHHHhcC----CCCcceeeeeEEE
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKI----RHPNVVQFLGAVT  220 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l----~hp~i~~~~~~~~  220 (458)
                      -..+|++.+.||+|+||.||.     +|+.||||++........   .....+.+|+.+++++    +||||+++++++.
T Consensus        29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~  108 (312)
T 2iwi_A           29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE  108 (312)
T ss_dssp             ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred             hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence            345799999999999999984     578999999976543221   1223456788888888    8999999999999


Q ss_pred             eCCceEEEEEc-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec-CCCCEEEeecC
Q 012684          221 QSSPMMIVTEY-LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFG  298 (458)
Q Consensus       221 ~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~-~~~~vkl~Dfg  298 (458)
                      ..+..++|||+ +.+++|.+++...+.+++..++.++.|++.||.|||+.+   ++||||||+||+++ .++.++|+|||
T Consensus       109 ~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~kl~dfg  185 (312)
T 2iwi_A          109 TQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRG---VVHRDIKDENILIDLRRGCAKLIDFG  185 (312)
T ss_dssp             ----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHT---EECCCCSGGGEEEETTTTEEEECCCS
T ss_pred             cCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChhhEEEeCCCCeEEEEEcc
Confidence            98999999999 789999999998888999999999999999999999999   99999999999999 88999999999


Q ss_pred             CccccccCCCCCcccCCCCCcccCCcccCCCCCC-CchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCC
Q 012684          299 VSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD-TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP  377 (458)
Q Consensus       299 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~  377 (458)
                      ++......   ......+++.|+|||++.+..+. .++||||||+++|+|++|+.||....      .. ......+   
T Consensus       186 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~-~~~~~~~---  252 (312)
T 2iwi_A          186 SGALLHDE---PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EI-LEAELHF---  252 (312)
T ss_dssp             SCEECCSS---CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH-HHTCCCC---
T ss_pred             hhhhcccC---cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HH-hhhccCC---
Confidence            99876432   23345689999999998776654 48999999999999999999997531      11 1122222   


Q ss_pred             hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          378 AKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       378 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +..+++.+.++|.+||+.||.+|||+.+++++
T Consensus       253 ~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  284 (312)
T 2iwi_A          253 PAHVSPDCCALIRRCLAPKPSSRPSLEEILLD  284 (312)
T ss_dssp             CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHS
T ss_pred             cccCCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence            34578899999999999999999999999986

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=2.5e-38  Score=300.93  Aligned_cols=228  Identities=13%  Similarity=0.099  Sum_probs=189.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.||.     +|+.||||++...........+.+.+|+..++.++||||+++++++..++..|+||
T Consensus        31 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~  110 (286)
T 3uqc_A           31 GRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVA  110 (286)
T ss_dssp             TTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             CcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEE
Confidence            5799999999999998884     48999999998776666677788999999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||++|++|.+++...  ....++..++.|++.||.|||++|   |+||||||+|||++.+|.++|+++|           
T Consensus       111 e~~~g~~L~~~l~~~--~~~~~~~~i~~ql~~aL~~lH~~g---ivH~Dikp~NIll~~~g~~kl~~~~-----------  174 (286)
T 3uqc_A          111 EWIRGGSLQEVADTS--PSPVGAIRAMQSLAAAADAAHRAG---VALSIDHPSRVRVSIDGDVVLAYPA-----------  174 (286)
T ss_dssp             ECCCEEEHHHHHTTC--CCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCSGGGEEEETTSCEEECSCC-----------
T ss_pred             EecCCCCHHHHHhcC--CChHHHHHHHHHHHHHHHHHHHCC---CccCCCCcccEEEcCCCCEEEEecc-----------
Confidence            999999999999653  466778999999999999999999   9999999999999999999997443           


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHH---HhcCCCCCCCChhhhHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY---AARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~l~  386 (458)
                                |++       +++.++||||||+++|+|++|+.||...+........   .....+........+++.+.
T Consensus       175 ----------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  237 (286)
T 3uqc_A          175 ----------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQIS  237 (286)
T ss_dssp             ----------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHH
T ss_pred             ----------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHH
Confidence                      333       3688999999999999999999999986654321100   00111111112245788999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          387 ELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ++|.+||+.||.+| |+.++++.|+++...
T Consensus       238 ~li~~~l~~dP~~R-s~~el~~~L~~~~~~  266 (286)
T 3uqc_A          238 AVAARSVQGDGGIR-SASTLLNLMQQATAV  266 (286)
T ss_dssp             HHHHHHHCTTSSCC-CHHHHHHHHHHHHC-
T ss_pred             HHHHHHcccCCccC-CHHHHHHHHHHHhcc
Confidence            99999999999999 999999999998644

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=1.2e-37  Score=323.57  Aligned_cols=247  Identities=27%  Similarity=0.360  Sum_probs=196.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe------CC
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------SS  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~------~~  223 (458)
                      .+|++.+.||+|+||.||.     +|+.||||++...  ......+.+.+|+.+++.++||||+++++++..      ++
T Consensus        14 grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~   91 (676)
T 3qa8_A           14 GPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPND   91 (676)
T ss_dssp             ---CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTS
T ss_pred             CCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCC
Confidence            4789999999999998873     6889999998754  245566789999999999999999999998755      66


Q ss_pred             ceEEEEEccCCCCHHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC---EEEeec
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKG---ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN---LKVADF  297 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~---vkl~Df  297 (458)
                      ..++||||++|++|.+++....   .+++..++.++.|++.||.|||+.|   |+||||||+||+++.++.   ++|+||
T Consensus        92 ~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~g---IVHrDLKP~NILl~~~g~~~~vKL~DF  168 (676)
T 3qa8_A           92 LPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENR---IIHRDLKPENIVLQPGPQRLIHKIIDL  168 (676)
T ss_dssp             SCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTT---BCCCCCCSTTEEEECCSSSCEEEECSC
T ss_pred             eEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHeEeecCCCceeEEEccc
Confidence            7899999999999999998744   5899999999999999999999999   999999999999997765   999999


Q ss_pred             CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCc---------HHHHHH-
Q 012684          298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNE---------VPKAYA-  367 (458)
Q Consensus       298 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~---------~~~~~~-  367 (458)
                      |++......  .......||+.|+|||.+.+..++.++||||||+++|+|++|..||.......         ...... 
T Consensus       169 G~a~~~~~~--~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~  246 (676)
T 3qa8_A          169 GYAKELDQG--ELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV  246 (676)
T ss_dssp             CCCCBTTSC--CCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCS
T ss_pred             ccccccccc--cccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhh
Confidence            999876433  22344578999999999999999999999999999999999999997531100         000000 


Q ss_pred             ---hcC-------CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHH
Q 012684          368 ---ARQ-------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT  408 (458)
Q Consensus       368 ---~~~-------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  408 (458)
                         ..+       .+........+++.+.++|..||..||.+|||+.++++
T Consensus       247 ~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~  297 (676)
T 3qa8_A          247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPN  297 (676)
T ss_dssp             CCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCC
T ss_pred             hhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhc
Confidence               000       11112234568899999999999999999999998653

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=6.5e-37  Score=293.11  Aligned_cols=221  Identities=25%  Similarity=0.415  Sum_probs=176.9

Q ss_pred             cccCc-eeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHH-hcCCCCcceeeeeEEEe----CCc
Q 012684          156 DFTNS-VEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQ----SSP  224 (458)
Q Consensus       156 ~~~~~-~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~i~~~~~~~~~----~~~  224 (458)
                      +|.+. +.||+|+||.|+.     +|+.||+|++...        ..+.+|+.++ +..+||||+++++++..    ...
T Consensus        18 ~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~   89 (299)
T 3m2w_A           18 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   89 (299)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             chhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCce
Confidence            56665 6799999999874     6889999998632        3466788887 55689999999999976    677


Q ss_pred             eEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC---CCCEEEeecCC
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV  299 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~---~~~vkl~Dfg~  299 (458)
                      .++||||+++++|.+++...+  .+++..++.++.|++.||.|||+.+   ++||||||+||+++.   ++.++|+|||+
T Consensus        90 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~  166 (299)
T 3m2w_A           90 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  166 (299)
T ss_dssp             EEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESSSSTTCCEEECCCTT
T ss_pred             EEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEecCCCCCcEEEecccc
Confidence            899999999999999998754  5999999999999999999999999   999999999999998   78899999999


Q ss_pred             ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCCCCCC-
Q 012684          300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPPFKAP-  377 (458)
Q Consensus       300 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~~~~~-  377 (458)
                      +....                       +..++.++||||||+++|+|++|+.||................ ....... 
T Consensus       167 a~~~~-----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  223 (299)
T 3m2w_A          167 AKETT-----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  223 (299)
T ss_dssp             CEECT-----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCH
T ss_pred             ccccc-----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCc
Confidence            86432                       2346789999999999999999999998765433221111111 1111111 


Q ss_pred             --hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHH
Q 012684          378 --AKLYARGLKELIEECWNEKPAKRPTFRQIITRL  410 (458)
Q Consensus       378 --~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L  410 (458)
                        ...+++++.++|.+||+.||.+|||+.+++++-
T Consensus       224 ~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp  258 (299)
T 3m2w_A          224 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHP  258 (299)
T ss_dssp             HHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSH
T ss_pred             hhcccCCHHHHHHHHHHcccChhhCCCHHHHhcCh
Confidence              145789999999999999999999999999873

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=7.2e-38  Score=313.25  Aligned_cols=248  Identities=13%  Similarity=0.122  Sum_probs=186.7

Q ss_pred             cCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCC-Ccce------------
Q 012684          152 PHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH-PNVV------------  213 (458)
Q Consensus       152 ~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-p~i~------------  213 (458)
                      ....+|...+.||+|+||.||.     +|+.||||++...........+.+.+|+.+++.+.| ++..            
T Consensus        75 ~~~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~  154 (413)
T 3dzo_A           75 ERPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPF  154 (413)
T ss_dssp             SCCEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCC
T ss_pred             CCceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccch
Confidence            3445688889999999999984     589999999985444444446778999999999976 2211            


Q ss_pred             ---------eeeeEEEe-----CCceEEEEEccCCCCHHHHHHh-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 012684          214 ---------QFLGAVTQ-----SSPMMIVTEYLPKGDLRAFLKR-------KGALKPSTAVRFALDIARGMNYLHENKPV  272 (458)
Q Consensus       214 ---------~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-------~~~~~~~~~~~i~~qi~~~l~~LH~~~~~  272 (458)
                               .++.++..     ....+++|+++ +++|.+++..       .+.+++..++.++.|++.||.|||+++  
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--  231 (413)
T 3dzo_A          155 DLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYG--  231 (413)
T ss_dssp             EEEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             hhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence                     11111111     22467888877 7899998852       223777888999999999999999999  


Q ss_pred             CeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCCCCCcccCCccc----------CCCCCCCchhHHHHHH
Q 012684          273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF----------KNEEYDTKVDVFSFAL  342 (458)
Q Consensus       273 ~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~----------~~~~~~~~~DiwslG~  342 (458)
                       |+||||||+|||++.++.+||+|||++......    .....| +.|+|||++          .+..++.++|||||||
T Consensus       232 -iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGv  305 (413)
T 3dzo_A          232 -LVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGL  305 (413)
T ss_dssp             -EECSCCCGGGEEECTTCCEEECCGGGCEETTEE----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHH
T ss_pred             -cccCCcccceEEEecCCeEEEEeccceeecCCc----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHH
Confidence             999999999999999999999999998765432    333456 899999998          5556888999999999


Q ss_pred             HHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH--HHHHHhh
Q 012684          343 ILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESINNS  416 (458)
Q Consensus       343 ~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~--L~~~~~~  416 (458)
                      ++|+|++|+.||......+....+..        ....+++.+.+||..||+.||.+||++.+++++  ++.+.+.
T Consensus       306 il~elltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~~~~  373 (413)
T 3dzo_A          306 AIYWIWCADLPNTDDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTE  373 (413)
T ss_dssp             HHHHHHHSSCCCCTTGGGSCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHH
T ss_pred             HHHHHHHCCCCCCCcchhhhHHHHHh--------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHHHHH
Confidence            99999999999987655433222211        122467899999999999999999999999876  4444433

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=1e-36  Score=323.69  Aligned_cols=237  Identities=20%  Similarity=0.306  Sum_probs=193.4

Q ss_pred             ccccCceeeccceEEEEEE------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc----
Q 012684          155 LDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP----  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~----  224 (458)
                      .+|++.+.||+|+||.||.      +|+.||||++...  ........+.+|+.+++.++||||+++++++...+.    
T Consensus        80 ~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~  157 (681)
T 2pzi_A           80 GQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDP  157 (681)
T ss_dssp             TTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCE
T ss_pred             CceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCc
Confidence            4799999999999999883      4789999998643  345566778899999999999999999999987665    


Q ss_pred             -eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          225 -MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       225 -~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                       .|+||||++|++|.+++..  .+++.+++.++.|++.||.|||++|   |+||||||+|||++.+ .+||+|||++...
T Consensus       158 ~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~g---iiHrDlkp~NIll~~~-~~kl~DFG~a~~~  231 (681)
T 2pzi_A          158 VGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIG---LVYNDLKPENIMLTEE-QLKLIDLGAVSRI  231 (681)
T ss_dssp             EEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSS-CEEECCCTTCEET
T ss_pred             eeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCC---CeecccChHHeEEeCC-cEEEEecccchhc
Confidence             7999999999999988765  6999999999999999999999999   9999999999999985 8999999999865


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      ...     ....||+.|+|||++.+. ++.++||||||+++|+|++|..||........          +........++
T Consensus       232 ~~~-----~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~----------~~~~~~~~~~~  295 (681)
T 2pzi_A          232 NSF-----GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL----------PEDDPVLKTYD  295 (681)
T ss_dssp             TCC-----SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC----------CTTCHHHHHCH
T ss_pred             ccC-----CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc----------cccccccccCH
Confidence            432     345689999999998765 48899999999999999999998875332211          11112234567


Q ss_pred             HHHHHHHHHcccCCCCCCC-HHHHHHHHHHHHh
Q 012684          384 GLKELIEECWNEKPAKRPT-FRQIITRLESINN  415 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps-~~~ll~~L~~~~~  415 (458)
                      .+.+||.+||+.||.+||+ ++++...|..+..
T Consensus       296 ~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~  328 (681)
T 2pzi_A          296 SYGRLLRRAIDPDPRQRFTTAEEMSAQLTGVLR  328 (681)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHH
T ss_pred             HHHHHHhhhccCChhhCCCHHHHHHHHHHHHHH
Confidence            8999999999999999996 5556566665543

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=6.5e-38  Score=305.11  Aligned_cols=240  Identities=13%  Similarity=0.148  Sum_probs=182.8

Q ss_pred             CccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCC-----CHHHHHHHHHHHHHHhcCC---------CCcceeee
Q 012684          154 ELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVIS-----DDDRVRAFRDELALLQKIR---------HPNVVQFL  216 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~---------hp~i~~~~  216 (458)
                      ..+|++.+.||+|+||.||   .+|+.||||++......     .....+.+.+|+.+++.++         ||||+++.
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~   98 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIADHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIGLN   98 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEETTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEE
T ss_pred             cccchheeeecccCceEEEEEEeCCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhhhc
Confidence            3478999999999999887   47999999999765321     2223356778888888775         55555555


Q ss_pred             eE-----------------EEe-------------CCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 012684          217 GA-----------------VTQ-------------SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL  266 (458)
Q Consensus       217 ~~-----------------~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~L  266 (458)
                      +.                 +..             ....|+||||+++|++.+.+.+ +.+++..+..++.|++.||.||
T Consensus        99 ~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~l  177 (336)
T 2vuw_A           99 SVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLAVA  177 (336)
T ss_dssp             EEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred             ceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHHHH
Confidence            54                 433             6789999999999976665543 5689999999999999999999


Q ss_pred             H-hCCCCCeeeCCCCCCCEEecCCC--------------------CEEEeecCCccccccCCCCCcccCCCCCcccCCcc
Q 012684          267 H-ENKPVPIIHRDLEPSNILRDDSG--------------------NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEV  325 (458)
Q Consensus       267 H-~~~~~~i~H~Dikp~Nil~~~~~--------------------~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~  325 (458)
                      | +.+   |+||||||+|||++.++                    .+||+|||++......      ...||+.|+|||+
T Consensus       178 H~~~~---ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~------~~~gt~~y~aPE~  248 (336)
T 2vuw_A          178 EASLR---FEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG------IVVFCDVSMDEDL  248 (336)
T ss_dssp             HHHHC---CBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT------EEECCCCTTCSGG
T ss_pred             HHhCC---EeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC------cEEEeecccChhh
Confidence            9 899   99999999999999887                    8999999999876422      2368999999999


Q ss_pred             cCCCCCCCchhHHHHHHH-HHHHHcCCCCCCCCCC-CcHHHHHHhc-C--CCCCCCChhhhHHHHHHHHHHHcccCCCCC
Q 012684          326 FKNEEYDTKVDVFSFALI-LQEMIEGCPPFTMKHD-NEVPKAYAAR-Q--RPPFKAPAKLYARGLKELIEECWNEKPAKR  400 (458)
Q Consensus       326 ~~~~~~~~~~DiwslG~~-l~~lltg~~pf~~~~~-~~~~~~~~~~-~--~~~~~~~~~~~~~~l~~li~~~l~~dp~~R  400 (458)
                      +.+.. +.++||||++++ .+++++|..||..... ......+... .  .......+..+++++.+||.+||+.|    
T Consensus       249 ~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d----  323 (336)
T 2vuw_A          249 FTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS----  323 (336)
T ss_dssp             GCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS----
T ss_pred             hcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC----
Confidence            98766 889999998777 6778889999853210 0111122111 1  12222235578999999999999976    


Q ss_pred             CCHHHHH-HH
Q 012684          401 PTFRQII-TR  409 (458)
Q Consensus       401 ps~~~ll-~~  409 (458)
                       |+.+++ +|
T Consensus       324 -sa~e~l~~H  332 (336)
T 2vuw_A          324 -SATDLLCQH  332 (336)
T ss_dssp             -SHHHHHHHC
T ss_pred             -CHHHHHhcC
Confidence             999998 65

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.97  E-value=3.8e-31  Score=273.87  Aligned_cols=172  Identities=15%  Similarity=0.116  Sum_probs=130.9

Q ss_pred             EEcCeEEEEEEcCCCCCC-------CHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEccCCCCHHHHHHh
Q 012684          172 FWRGIQVAVKKLGEEVIS-------DDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR  243 (458)
Q Consensus       172 ~~~g~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~  243 (458)
                      ++.|+.||+|++......       .+...+++.+|+++|+++ .|+||++++++++++...||||||++|++|.+++.+
T Consensus       256 ~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~  335 (569)
T 4azs_A          256 YFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAA  335 (569)
T ss_dssp             EEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHT
T ss_pred             ccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHh
Confidence            467899999999754322       134456799999999999 799999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcccCCCCCcccCC
Q 012684          244 KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAP  323 (458)
Q Consensus       244 ~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aP  323 (458)
                      .+++++.   +|+.||+.||+|+|++|   |+||||||+|||++.+|.+||+|||+++...... .......||+.|+||
T Consensus       336 ~~~l~~~---~I~~QIl~AL~ylH~~G---IIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~-~~~~t~vGTp~YmAP  408 (569)
T 4azs_A          336 GEEIDRE---KILGSLLRSLAALEKQG---FWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC-SWPTNLVQSFFVFVN  408 (569)
T ss_dssp             TCCCCHH---HHHHHHHHHHHHHHHTT---CEESCCCGGGEEECTTSCEEECCCTTEESCC----CCSHHHHHHHHHHHH
T ss_pred             CCCCCHH---HHHHHHHHHHHHHHHCC---ceeccCchHhEEECCCCCEEEeecccCeeCCCCC-ccccCceechhhccH
Confidence            8888765   47899999999999999   9999999999999999999999999998664332 223345689999999


Q ss_pred             cccCCCCCCCchhHHHHHHHHHHHHcCC
Q 012684          324 EVFKNEEYDTKVDVFSFALILQEMIEGC  351 (458)
Q Consensus       324 E~~~~~~~~~~~DiwslG~~l~~lltg~  351 (458)
                      |++.+ .+...+|+||+|++++++.++.
T Consensus       409 E~l~g-~~~~~~d~~s~g~~~~~l~~~~  435 (569)
T 4azs_A          409 ELFAE-NKSWNGFWRSAPVHPFNLPQPW  435 (569)
T ss_dssp             HHC------------------CCCCTTH
T ss_pred             HHhCC-CCCCcccccccccchhhhcccc
Confidence            99977 4677899999999887765543

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.93  E-value=2.6e-26  Score=236.30  Aligned_cols=184  Identities=20%  Similarity=0.244  Sum_probs=143.9

Q ss_pred             CceeeccceEEEEE---EcCeEEEEEEcCCCCCCCH-----HHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          159 NSVEITKGTFILAF---WRGIQVAVKKLGEEVISDD-----DRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       159 ~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~-----~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      ..+.||+|+||.||   +.+..+++|..........     ...+.+.+|+.++++++||||+++..++......|+|||
T Consensus       340 ~~~~LG~G~fg~Vy~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE  419 (540)
T 3en9_A          340 PEHLIGKGAEADIKRDSYLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMS  419 (540)
T ss_dssp             --------CCEEEEEEECSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEE
T ss_pred             CCCEEeeCCCEEEEEEEECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEE
Confidence            35689999999998   4788999998765433322     224557899999999999999966666667778899999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |++|++|.+++..        +..++.|+++||.|||+++   |+||||||+|||++.  .+||+|||+++.........
T Consensus       420 ~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~g---IiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~  486 (540)
T 3en9_A          420 YINGKLAKDVIED--------NLDIAYKIGEIVGKLHKND---VIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKA  486 (540)
T ss_dssp             CCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTT---EECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHH
T ss_pred             CCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCc---CccCCCCHHHEEECC--eEEEEECccCEECCCccccc
Confidence            9999999999875        5689999999999999999   999999999999999  99999999998764322111


Q ss_pred             ------cccCCCCCcccCCcccCC--CCCCCchhHHHHHHHHHHHHcCCCCCC
Q 012684          311 ------LTCQDTSCRYVAPEVFKN--EEYDTKVDVFSFALILQEMIEGCPPFT  355 (458)
Q Consensus       311 ------~~~~~gt~~y~aPE~~~~--~~~~~~~DiwslG~~l~~lltg~~pf~  355 (458)
                            .....||+.|+|||++..  ..|+...|+|+..+-..+-+.++.+|.
T Consensus       487 ~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          487 VDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             cchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                  124568999999999976  467778899999988888877776653

>4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A

Probab=99.90  E-value=1.5e-23  Score=182.55  Aligned_cols=107  Identities=41%  Similarity=0.514  Sum_probs=54.0

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      +|+|+|.+|.+|.||||+|+..++.++++.|++.|+++|.+|.+|+||||+|+..|+.+++++|+++|+++|.+|..|+|
T Consensus        26 ~Gadvn~~d~~g~t~l~~a~~~~~~~~~~~ll~~gad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G~T  105 (169)
T 4gpm_A           26 NGADVNASDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRT  105 (169)
T ss_dssp             TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred             CCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcccchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCC
Confidence            34444444444555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             hhHHHhhcchHHHHHHHHHhCCCCCCC
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGAKPLMA  135 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~~~~~~  135 (458)
                      |||+|+..|+.+++++|++.|+++...
T Consensus       106 pLh~A~~~g~~~~v~~Ll~~gad~~~~  132 (169)
T 4gpm_A          106 PLHHAAENGHKEVVKLLISKGADVNTS  132 (169)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred             HHHHHHHcCCHHHHHHHHHcCCCcccc
Confidence            555555555555555555555544433

>4gpm_A Engineered protein OR264; de novo protein, structural genomics, PSI-biology, northeast structural genomics consortium, NESG; 2.00A {Synthetic construct} PDB: 4gmr_A

Probab=99.89  E-value=1.2e-22  Score=176.82  Aligned_cols=108  Identities=41%  Similarity=0.475  Sum_probs=98.7

Q ss_pred             hhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Q 012684           27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG  106 (458)
Q Consensus        27 ~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g  106 (458)
                      .-.|+|++.++.+|.||||+||..|+.+++++|+++|+++|.+|.+|+||||+||..|+.+++++|+++|++++.+|..|
T Consensus        57 l~~gad~~~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~G  136 (169)
T 4gpm_A           57 ISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNAKDSDGRTPLHHAAENGHKEVVKLLISKGADVNTSDSDG  136 (169)
T ss_dssp             HHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred             HhcccchhhhccCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCC
Confidence            34677888889999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CChhHHHhhcchHHHHHHHHHhCCCCCC
Q 012684          107 STPLGDAIYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       107 ~tpl~~A~~~~~~~~~~~l~~~g~~~~~  134 (458)
                      +||||+|+..|+.+++++|+++||++..
T Consensus       137 ~TpL~~A~~~g~~~iv~~Ll~~GA~ie~  164 (169)
T 4gpm_A          137 RTPLDLAREHGNEEVVKLLEKQGGWLEH  164 (169)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHTC------
T ss_pred             CCHHHHHHHcCCHHHHHHHHHCCCCcCC
Confidence            9999999999999999999999999853

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1

Probab=99.89  E-value=1.4e-22  Score=158.07  Aligned_cols=93  Identities=46%  Similarity=0.578  Sum_probs=89.7

Q ss_pred             ccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcch
Q 012684           39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN  118 (458)
Q Consensus        39 ~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~  118 (458)
                      +|+||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+
T Consensus         1 ~g~t~L~~A~~~~~~~~v~~Ll~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~   80 (93)
T 1n0q_A            1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH   80 (93)
T ss_dssp             --CCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             CCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC
Confidence            48999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCC
Q 012684          119 HEVIKLLEKHGAK  131 (458)
Q Consensus       119 ~~~~~~l~~~g~~  131 (458)
                      .+++++|+++|++
T Consensus        81 ~~~~~~Ll~~ga~   93 (93)
T 1n0q_A           81 LEVVKLLLEAGAY   93 (93)
T ss_dssp             HHHHHHHHHTTCC
T ss_pred             HHHHHHHHHcCCC
Confidence            9999999999985

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1

Probab=99.86  E-value=2.6e-21  Score=162.20  Aligned_cols=112  Identities=29%  Similarity=0.336  Sum_probs=102.8

Q ss_pred             CCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 012684           30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP  109 (458)
Q Consensus        30 ~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp  109 (458)
                      |+|+ .++..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus         1 G~d~-~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~   79 (137)
T 3c5r_A            1 GIDP-FTNHRGETLLHIASIKGDIPSVEYLLQNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSP   79 (137)
T ss_dssp             ---C-CCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCH
T ss_pred             CCCC-CcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCH
Confidence            5677 678899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hHHHhhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684          110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus       110 l~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      ||+|+..|+.+++++|+++|+++......+.++
T Consensus        80 L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp  112 (137)
T 3c5r_A           80 LHDAAKNGHVDIVKLLLSYGASRNAVNIFGLRP  112 (137)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCG
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCH
Confidence            999999999999999999999987766555544

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.85  E-value=6.2e-22  Score=187.07  Aligned_cols=143  Identities=17%  Similarity=0.091  Sum_probs=112.3

Q ss_pred             cccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCH---------------HHHHHHHHHHHHHhcCCCCcceeee
Q 012684          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDD---------------DRVRAFRDELALLQKIRHPNVVQFL  216 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~---------------~~~~~~~~E~~~l~~l~hp~i~~~~  216 (458)
                      .|.+.+.||+|+||.||.    +|+.||+|.++.......               .....+.+|+.+++.++  | +++.
T Consensus        91 ~~~~~~~iG~G~~g~Vy~~~~~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~--~-~~v~  167 (282)
T 1zar_A           91 VDAIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ--G-LAVP  167 (282)
T ss_dssp             CSEEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT--T-SSSC
T ss_pred             EEEecCEeccCCCceEEEEEeCCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc--C-CCcC
Confidence            455679999999998874    589999999964321110               23566889999999998  4 5666


Q ss_pred             eEEEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEee
Q 012684          217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (458)
Q Consensus       217 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~D  296 (458)
                      +++.. +..|+||||++|++|.+ +.      ......++.|++.||.|||+.|   |+||||||+|||++ ++.++|+|
T Consensus       168 ~~~~~-~~~~lvmE~~~g~~L~~-l~------~~~~~~i~~qi~~~l~~lH~~g---iiHrDlkp~NILl~-~~~vkl~D  235 (282)
T 1zar_A          168 KVYAW-EGNAVLMELIDAKELYR-VR------VENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVS-EEGIWIID  235 (282)
T ss_dssp             CEEEE-ETTEEEEECCCCEEGGG-CC------CSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEE-TTEEEECC
T ss_pred             eEEec-cceEEEEEecCCCcHHH-cc------hhhHHHHHHHHHHHHHHHHHCC---CEeCCCCHHHEEEE-CCcEEEEE
Confidence            65543 55699999999999987 32      2345579999999999999999   99999999999999 99999999


Q ss_pred             cCCccccccCCCCCcccCCCCCcccCCcccC
Q 012684          297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK  327 (458)
Q Consensus       297 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  327 (458)
                      ||++..              +..+.|||++.
T Consensus       236 FG~a~~--------------~~~~~a~e~l~  252 (282)
T 1zar_A          236 FPQSVE--------------VGEEGWREILE  252 (282)
T ss_dssp             CTTCEE--------------TTSTTHHHHHH
T ss_pred             CCCCeE--------------CCCCCHHHHHH
Confidence            999864              23467888764

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C

Probab=99.84  E-value=1.3e-20  Score=157.84  Aligned_cols=101  Identities=32%  Similarity=0.436  Sum_probs=59.9

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      ++.|++..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus        36 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t  115 (136)
T 2jab_A           36 NGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAFIGHLEIAEVLLKHGADVNAQDKFGKT  115 (136)
T ss_dssp             TTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred             cCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcCcCCCCCC
Confidence            34555555555556666666666666666666666666666666666666666666666666666666666666666666


Q ss_pred             hhHHHhhcchHHHHHHHHHhC
Q 012684          109 PLGDAIYYKNHEVIKLLEKHG  129 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g  129 (458)
                      |||+|+..|+.+++++|+++|
T Consensus       116 pl~~A~~~~~~~~~~~Ll~~G  136 (136)
T 2jab_A          116 AFDISIGNGNEDLAEILQKLN  136 (136)
T ss_dssp             HHHHHHHTTCHHHHHHHHHC-
T ss_pred             HHHHHHHCCCHHHHHHHHHcC
Confidence            666666666666666665544

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1

Probab=99.84  E-value=3.3e-21  Score=161.50  Aligned_cols=104  Identities=24%  Similarity=0.233  Sum_probs=60.8

Q ss_pred             CCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCC-CCCh
Q 012684           31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW-GSTP  109 (458)
Q Consensus        31 ~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~-g~tp  109 (458)
                      .|.+..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+. |+.+++++|+++|++++.+|.. |.||
T Consensus         3 ~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~   81 (136)
T 1d9s_A            3 PGIHMLGGSSDAGLATAAARGQVETVRQLLEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTRP   81 (136)
T ss_dssp             CCCSCCCCCCSCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBCH
T ss_pred             CCccCCCCCCccHHHHHHHcCCHHHHHHHHHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCCH
Confidence            3445555555555666666666666666665555555555556666666655 6666666666556666555555 5566


Q ss_pred             hHHHhhcchHHHHHHHHHhCCCCCCC
Q 012684          110 LGDAIYYKNHEVIKLLEKHGAKPLMA  135 (458)
Q Consensus       110 l~~A~~~~~~~~~~~l~~~g~~~~~~  135 (458)
                      ||+|+..|+.+++++|+++|+++...
T Consensus        82 L~~A~~~~~~~~v~~Ll~~ga~~~~~  107 (136)
T 1d9s_A           82 VHDAAREGFLDTLVVLHRAGARLDVC  107 (136)
T ss_dssp             HHHHHHHTCHHHHHHHHHTCCCCCCC
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCCCcc
Confidence            66666555566666666655555443

>1d9s_A Cyclin-dependent kinase 4 inhibitor B; helix-turn-helix, ankyrin repeat, signaling protein; NMR {Mus musculus} SCOP: i.11.1.1

Probab=99.84  E-value=5.5e-21  Score=160.12  Aligned_cols=104  Identities=21%  Similarity=0.249  Sum_probs=99.9

Q ss_pred             hhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCC-CCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCC
Q 012684           27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-NRTALHVAACQGFTEVVSLLLERGADVDPKDRW  105 (458)
Q Consensus        27 ~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~-g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~  105 (458)
                      .-.++|++.++..|.||||+||. |+.+++++|+++|+++|.+|.. |.||||+|+..|+.+++++|+++|++++.+|..
T Consensus        32 l~~g~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~  110 (136)
T 1d9s_A           32 LEAGADPNALNRFGRRPIQVMMM-GSAQVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVCDAW  110 (136)
T ss_dssp             HHTTCCTTCCCTTCCTTTTTSTT-SCHHHHHHHHHHTCCSSCCBTTTTBCHHHHHHHHTCHHHHHHHHHTCCCCCCCSSS
T ss_pred             HHcCCCcCCcCCCCCCHHHHHHc-CCHHHHHHHHHCCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCC
Confidence            34578888889999999999999 9999999999999999999999 999999999999999999999999999999999


Q ss_pred             CCChhHHHhhcchHHHHHHHHHhCCC
Q 012684          106 GSTPLGDAIYYKNHEVIKLLEKHGAK  131 (458)
Q Consensus       106 g~tpl~~A~~~~~~~~~~~l~~~g~~  131 (458)
                      |.||||+|+..++.+++++|+++|+|
T Consensus       111 g~tpl~~A~~~~~~~~~~~Ll~~Gad  136 (136)
T 1d9s_A          111 GRLPVDLAEEQGHRDIARYLHAATGD  136 (136)
T ss_dssp             SSCHHHHHHHHTCHHHHHHHHHHHCC
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence            99999999999999999999999986

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli}

Probab=99.84  E-value=4.7e-21  Score=155.54  Aligned_cols=104  Identities=37%  Similarity=0.466  Sum_probs=98.0

Q ss_pred             CcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhh
Q 012684           36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY  115 (458)
Q Consensus        36 ~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~  115 (458)
                      +|.+|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus         5 ~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~   84 (115)
T 2l6b_A            5 GSKDGNTPLHNAAKNGHAEEVKKLLSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKK   84 (115)
T ss_dssp             CSCSSCCHHHHHHHHTCHHHHHHHTTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHT
T ss_pred             cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHH
Confidence            56789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cchHHHHHHHHHhCCCCCCCcccc
Q 012684          116 YKNHEVIKLLEKHGAKPLMAPMHV  139 (458)
Q Consensus       116 ~~~~~~~~~l~~~g~~~~~~~~~~  139 (458)
                      .++.+++++|+++|+++......+
T Consensus        85 ~~~~~~~~~Ll~~ga~~n~~~~~~  108 (115)
T 2l6b_A           85 NGHHEIVKLLDAKGADVNARSWGS  108 (115)
T ss_dssp             TTCHHHHHHHHTTSSSHHHHSCCC
T ss_pred             CCCHHHHHHHHHcCCCCCcCCccc
Confidence            999999999999999986544433

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A

Probab=99.83  E-value=4.3e-20  Score=162.22  Aligned_cols=117  Identities=21%  Similarity=0.261  Sum_probs=106.3

Q ss_pred             hhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCC
Q 012684           26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW  105 (458)
Q Consensus        26 ~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~  105 (458)
                      .+-.+.+++..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus        25 l~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~  104 (179)
T 3f6q_A           25 LDNTENDLNQGDDHGFSPLHWACREGRSAVVEMLIMRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEH  104 (179)
T ss_dssp             HHCTTSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             HhcCcccccccCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCC
Confidence            33446788888899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCChhHHHhhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684          106 GSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus       106 g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      |.||||+|+..|+.+++++|+++|+++......+.++
T Consensus       105 g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp  141 (179)
T 3f6q_A          105 GNVPLHYACFWGQDQVAEDLVANGALVSICNKYGEMP  141 (179)
T ss_dssp             SCCHHHHHHHTTCHHHHHHHHHTTCCSSBCCTTSCCG
T ss_pred             CCCHHHHHHHcCCHHHHHHHHHCCCCcchhccCCCCc
Confidence            9999999999999999999999999987655444444

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S*

Probab=99.83  E-value=4.8e-20  Score=159.55  Aligned_cols=116  Identities=31%  Similarity=0.378  Sum_probs=106.9

Q ss_pred             hhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Q 012684           27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG  106 (458)
Q Consensus        27 ~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g  106 (458)
                      +..+.+.+..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|
T Consensus        29 ~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g  108 (165)
T 3twr_A           29 TVQSVNCRDIEGRQSTPLHFAAGYNRVSVVEYLLQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWK  108 (165)
T ss_dssp             CTTTTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTC
T ss_pred             HcCCCCccccccCCCCHHHHHHHcChHHHHHHHHhcCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCC
Confidence            33566777778889999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CChhHHHhhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684          107 STPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus       107 ~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      .||||+|+..|+.+++++|+++|+++......+.++
T Consensus       109 ~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~  144 (165)
T 3twr_A          109 FTPLHEAAAKGKYEICKLLLQHGADPTKKNRDGNTP  144 (165)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCT
T ss_pred             CCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCh
Confidence            999999999999999999999999987766555544

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C*

Probab=99.83  E-value=3.4e-20  Score=161.31  Aligned_cols=110  Identities=35%  Similarity=0.408  Sum_probs=104.2

Q ss_pred             hhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Q 012684           27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG  106 (458)
Q Consensus        27 ~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g  106 (458)
                      .-+|.|++.++..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|
T Consensus        34 l~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g  113 (169)
T 2y1l_E           34 MANGADVNAEDASGWTPLHLAAFNGHLEIVEVLLKNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEG  113 (169)
T ss_dssp             HHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred             HHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCC
Confidence            34678888889999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CChhHHHhhcchHHHHHHHHHhCCCCCCCc
Q 012684          107 STPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       107 ~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      .||||+|+..|+.+++++|+++|+++....
T Consensus       114 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~  143 (169)
T 2y1l_E          114 HTPLHLAAMFGHLEIVEVLLKNGADVNAQD  143 (169)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             CCHHHHHHHcCCHHHHHHHHHcCCCCCCcC
Confidence            999999999999999999999999986544

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A

Probab=99.83  E-value=2.8e-20  Score=152.88  Aligned_cols=103  Identities=29%  Similarity=0.372  Sum_probs=95.5

Q ss_pred             CccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcc
Q 012684           38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK  117 (458)
Q Consensus        38 ~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~  117 (458)
                      ..|.||||+||..|+.++++.|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..|
T Consensus         5 ~~~~~~l~~A~~~~~~~~v~~ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~~   84 (123)
T 3aaa_C            5 SMCDKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEG   84 (123)
T ss_dssp             --CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHHT
T ss_pred             cccchHHHHHHHcCCHHHHHHHHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcC
Confidence            46789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHHHHhCCCCCCCccccc
Q 012684          118 NHEVIKLLEKHGAKPLMAPMHVK  140 (458)
Q Consensus       118 ~~~~~~~l~~~g~~~~~~~~~~~  140 (458)
                      +.+++++|+++|+++......+.
T Consensus        85 ~~~~v~~Ll~~ga~~~~~~~~g~  107 (123)
T 3aaa_C           85 HVSCVKLLLSKGADKTVKGPDGL  107 (123)
T ss_dssp             CHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             CHHHHHHHHHcCCCCCCcCCCCC
Confidence            99999999999999866554443

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A

Probab=99.83  E-value=7.3e-21  Score=163.34  Aligned_cols=115  Identities=21%  Similarity=0.236  Sum_probs=96.1

Q ss_pred             hhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCC-HHHHHHHcCCHHHHHHHHHCCCCCCCCCCC
Q 012684           27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRT-ALHVAACQGFTEVVSLLLERGADVDPKDRW  105 (458)
Q Consensus        27 ~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t-~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~  105 (458)
                      .-+|+|++..+..|.||||+|+ .|+.+++++|++.|+++|.+|..|.| |||+|+..|+.+++++|+++|++++.+|..
T Consensus        32 l~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~~  110 (156)
T 1bi7_B           32 LEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAW  110 (156)
T ss_dssp             HTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTT
T ss_pred             HHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHHCCCHHHHHHHHHcCCCCcccCCC
Confidence            3457888888889999999986 89999999999999999999999999 999999999999999999999999999999


Q ss_pred             CCChhHHHhhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684          106 GSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus       106 g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      |.||||+|+..|+.+++++|+++|+++......+..+
T Consensus       111 g~tpl~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~t~  147 (156)
T 1bi7_B          111 GRLPVDLAEELGHRDVARYLRAAAGGTRGSNHARIDA  147 (156)
T ss_dssp             CCCHHHHHHHHTCHHHHHHHSSCC-------------
T ss_pred             CCCHHHHHHHhCHHHHHHHHHHcCCCCCccCcCcCcc
Confidence            9999999999999999999999999987655444444

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1

Probab=99.83  E-value=6.3e-20  Score=150.77  Aligned_cols=103  Identities=44%  Similarity=0.559  Sum_probs=96.0

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      ++.|++..+..|.||||+|+..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus        24 ~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t  103 (126)
T 1n0r_A           24 AGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRT  103 (126)
T ss_dssp             HTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred             cCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCcccCCCCCC
Confidence            56777888888999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhHHHhhcchHHHHHHHHHhCCC
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGAK  131 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~~  131 (458)
                      ||++|+..|+.+++++|+++|++
T Consensus       104 ~l~~A~~~~~~~~~~~Ll~~Gad  126 (126)
T 1n0r_A          104 PLHLAARNGHLEVVKLLLEAGAY  126 (126)
T ss_dssp             HHHHHHHTTCHHHHHHHHHHTCC
T ss_pred             HHHHHHHcCcHHHHHHHHHcCCC
Confidence            99999999999999999999986

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1

Probab=99.83  E-value=5.1e-20  Score=157.38  Aligned_cols=109  Identities=31%  Similarity=0.349  Sum_probs=100.5

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      ++.+.+ .+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus        24 ~g~~~~-~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t  102 (153)
T 1awc_B           24 NGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMT  102 (153)
T ss_dssp             HTCCCC-CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCC
T ss_pred             cCCCCC-cCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCC
Confidence            344544 4778999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhHHHhhcchHHHHHHHHHhCCCCCCCccc
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMH  138 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~~~~~~~~~  138 (458)
                      |||+|+..|+.+++++|+++|+++......
T Consensus       103 ~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~  132 (153)
T 1awc_B          103 ALHWATEHNHQEVVELLIKYGADVHTQSKF  132 (153)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             HHHHHHHcCCHHHHHHHHHcCCCccccCCC
Confidence            999999999999999999999998665433

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A

Probab=99.82  E-value=6.1e-20  Score=158.21  Aligned_cols=103  Identities=27%  Similarity=0.299  Sum_probs=75.4

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      ++.|++..+..|.||||+|+. |+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus        27 ~~~~~~~~~~~g~t~L~~A~~-~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t  105 (162)
T 1ihb_A           27 NNVNVNAQNGFGRTALQVMKL-GNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNL  105 (162)
T ss_dssp             SCCCTTCCCTTSCCHHHHCCS-SCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred             CCCCccccCccCccHHHHHHc-CcHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCC
Confidence            456666666677777777777 7777777777777777777777777777777777777777777777777777777777


Q ss_pred             hhHHHhhcchHHHHHHHHHhCCCC
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGAKP  132 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~~~  132 (458)
                      |||+|+..|+.+++++|+++|++.
T Consensus       106 ~L~~A~~~~~~~~v~~Ll~~g~~~  129 (162)
T 1ihb_A          106 PLHLAAKEGHLRVVEFLVKHTASN  129 (162)
T ss_dssp             HHHHHHHTTCHHHHHHHHHHSCCC
T ss_pred             HHHHHHHcCCHHHHHHHHHccCCC
Confidence            777777777777777777777763

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A

Probab=99.82  E-value=7.7e-20  Score=158.57  Aligned_cols=109  Identities=27%  Similarity=0.363  Sum_probs=102.4

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      .+.+.+..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus        25 ~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t  104 (167)
T 3v31_A           25 QENVINHTDEEGFTPLMWAAAHGQIAVVEFLLQNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGT  104 (167)
T ss_dssp             HSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCC
T ss_pred             cCCCcCCCCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCCCC
Confidence            46778888889999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhHHHhhcchHHHHHHHHHhCCCCCCCcc
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPM  137 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~~~~~~~~  137 (458)
                      |||+|+..|+.+++++|+++|+++.....
T Consensus       105 ~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~  133 (167)
T 3v31_A          105 PLLYAVHGNHVKCVKMLLESGADPTIETD  133 (167)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHHHHHHcCCHHHHHHHHHcCCCCCCcCC
Confidence            99999999999999999999999865443

>2jab_A H10-2-G3; HER2, darpin, ankyrin repeat protein, membrane protein, human epidermal growth factor receptor 2, de novo protein; 1.70A {} PDB: 3hg0_D 2xzt_G 2xzd_G 2y0b_G 2v4h_C

Probab=99.82  E-value=7.4e-20  Score=153.19  Aligned_cols=102  Identities=31%  Similarity=0.392  Sum_probs=95.7

Q ss_pred             CcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhh
Q 012684           36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY  115 (458)
Q Consensus        36 ~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~  115 (458)
                      ....+.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus        10 ~~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~   89 (136)
T 2jab_A           10 HGSDLGKKLLEAARAGQDDEVRILMANGADVNAKDEYGLTPLYLATAHGHLEIVEVLLKNGADVNAVDAIGFTPLHLAAF   89 (136)
T ss_dssp             --CHHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHH
T ss_pred             ccccccHHHHHHHHhCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHH
Confidence            34578999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cchHHHHHHHHHhCCCCCCCcc
Q 012684          116 YKNHEVIKLLEKHGAKPLMAPM  137 (458)
Q Consensus       116 ~~~~~~~~~l~~~g~~~~~~~~  137 (458)
                      .|+.+++++|+++|+++.....
T Consensus        90 ~~~~~~v~~Ll~~g~~~~~~~~  111 (136)
T 2jab_A           90 IGHLEIAEVLLKHGADVNAQDK  111 (136)
T ss_dssp             HTCHHHHHHHHHTTCCTTCCCT
T ss_pred             cCCHHHHHHHHHcCCCCcCcCC
Confidence            9999999999999999865443

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium}

Probab=99.82  E-value=7.6e-20  Score=162.49  Aligned_cols=111  Identities=27%  Similarity=0.350  Sum_probs=100.9

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      ++.|++..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus        57 ~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t  136 (192)
T 2rfm_A           57 NFDKLEDKDIEGSTALIWAVKNNRLGIAEKLLSKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGET  136 (192)
T ss_dssp             HHCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTCCC
T ss_pred             hccccccccccCccHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Confidence            45677778888999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhHHHhhcchHHHHHHHHHhCCCCCCCcccc
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV  139 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~  139 (458)
                      |||+|+..|+.+++++|+++|+++......+
T Consensus       137 ~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g  167 (192)
T 2rfm_A          137 PLIVASKYGRSEIVKKLLELGADISARDLTG  167 (192)
T ss_dssp             HHHHHHHHTCHHHHHHHHHTTCCTTCBCTTS
T ss_pred             HHHHHHHcCCHHHHHHHHHCCCCCCCcCCCC
Confidence            9999999999999999999999986654333

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A

Probab=99.81  E-value=1.3e-19  Score=157.87  Aligned_cols=104  Identities=26%  Similarity=0.352  Sum_probs=93.3

Q ss_pred             CCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHH
Q 012684           33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD  112 (458)
Q Consensus        33 ~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~  112 (458)
                      .+..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+
T Consensus        29 ~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~  108 (172)
T 3v30_A           29 VNKPDERGFTPLIWASAFGEIETVRFLLEWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLY  108 (172)
T ss_dssp             GGCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHH
T ss_pred             ccCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHH
Confidence            66677788899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhhcchHHHHHHHHHhCCCCCCCc
Q 012684          113 AIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       113 A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      |+..|+.+++++|+++|+++....
T Consensus       109 A~~~~~~~~v~~Ll~~ga~~~~~~  132 (172)
T 3v30_A          109 AVRGNHVKCVEALLARGADLTTEA  132 (172)
T ss_dssp             HHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             HHHcCCHHHHHHHHHcCCCccccC
Confidence            999999999999999998876543

>3v30_A DNA-binding protein rfxank; structural genomics consortium, SGC, rfxank, ANK repeat, Pro binding; 1.57A {Homo sapiens} PDB: 3uxg_A

Probab=99.81  E-value=5.8e-20  Score=160.19  Aligned_cols=114  Identities=24%  Similarity=0.246  Sum_probs=103.2

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~  107 (458)
                      -.|+|++..+..|.||||+|+..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus        57 ~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~  136 (172)
T 3v30_A           57 EWGADPHILAKERESALSLASTGGYTDIVGLLLERDVDINIYDWNGGTPLLYAVRGNHVKCVEALLARGADLTTEADSGY  136 (172)
T ss_dssp             HHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             HcCCCchhhcccCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCC
Confidence            35788888888999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChhHHHhhcchHHHHHHHHHhCCCCCCCcccccc
Q 012684          108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH  141 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~  141 (458)
                      ||||+|+..|+.+++++|+++|+++.........
T Consensus       137 t~l~~A~~~~~~~~~~~L~~~~~~~~~~~~~~~~  170 (172)
T 3v30_A          137 TPMDLAVALGYRKVQQVIENHILKLFQSNLVPAD  170 (172)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHHHHHHSCC------
T ss_pred             CHHHHHHHhCcHHHHHHHHHHHHHHhcccCCCCC
Confidence            9999999999999999999999987665544433

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1

Probab=99.81  E-value=1.4e-19  Score=170.58  Aligned_cols=101  Identities=20%  Similarity=0.183  Sum_probs=96.6

Q ss_pred             CCCCcCccchHHHHHHHh---CCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 012684           33 DDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP  109 (458)
Q Consensus        33 ~~~~~~~g~t~l~~a~~~---~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp  109 (458)
                      .+..+..|.||||+||..   |+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++||+++.+|..|.||
T Consensus       162 l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~TpLh~A~~~g~~~~v~~Ll~~gad~~~~d~~g~tp  241 (278)
T 1dcq_A          162 LANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETP  241 (278)
T ss_dssp             CSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred             ccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCccCCCCCH
Confidence            555678899999999999   89999999999999999999999999999999999999999999999999999999999


Q ss_pred             hHHHhhcchHHHHHHHHHhCCCCC
Q 012684          110 LGDAIYYKNHEVIKLLEKHGAKPL  133 (458)
Q Consensus       110 l~~A~~~~~~~~~~~l~~~g~~~~  133 (458)
                      ||+|+..|+.+++++|+++|++..
T Consensus       242 L~~A~~~~~~~~v~~Ll~~ga~~~  265 (278)
T 1dcq_A          242 LDIAKRLKHEHCEELLTQALSGRF  265 (278)
T ss_dssp             HHHHHHTTCHHHHHHHHHHHTTCC
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCCC
Confidence            999999999999999999999753

>4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens}

Probab=99.81  E-value=1.2e-19  Score=170.40  Aligned_cols=115  Identities=30%  Similarity=0.335  Sum_probs=85.0

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHH---------------------------------HcCCCCCccCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELL---------------------------------DSGIDVNFRDIDNR   74 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll---------------------------------~~g~~in~~~~~g~   74 (458)
                      -.|+|+|..+.+|.||||+||..|+.+++++|+                                 +.|+++|.+|..|.
T Consensus        74 ~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~  153 (269)
T 4b93_B           74 ASGLGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQAVPLHLACQQGHFQVVKCLLDSNAKPNKKDLSGN  153 (269)
T ss_dssp             -CCCCTTCCCTTSCCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCC
T ss_pred             HCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCCCccccccccChHHHHHHHHHCCCCCCCCCCCCC
Confidence            355666666666677777777666666555555                                 45566667777788


Q ss_pred             CHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684           75 TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus        75 t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      ||||+||..|+.+++++|+++|+++|.++..|.||||+|+..|+.+++++|+++|+++......+.+|
T Consensus       154 TpL~~A~~~g~~~~v~~Ll~~gadvn~~~~~g~t~Lh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~Tp  221 (269)
T 4b93_B          154 TPLIYACSGGHHELVALLLQHGASINASNNKGNTALHEAVIEKHVFVVELLLLHGASVQVLNKRQRTA  221 (269)
T ss_dssp             CHHHHHHHTTCGGGHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCS
T ss_pred             CHHHHHHHCCCHHHHHHHHHCCCCCCccccCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCH
Confidence            88888888888888888888888888888888888888888888888888888888876655544444

>1ihb_A P18-INK4C(INK6), cyclin-dependent kinase 6 inhibitor; cell cycle inhibitor, ankyrin repeat, CDK 4/6 inhibitor; 1.95A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bu9_A 1g3n_B 1mx4_A 1mx2_A 1mx6_A

Probab=99.81  E-value=1.4e-19  Score=155.89  Aligned_cols=107  Identities=27%  Similarity=0.338  Sum_probs=99.9

Q ss_pred             hhhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCC-CCCCC
Q 012684           25 EAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD-VDPKD  103 (458)
Q Consensus        25 ~~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~-~~~~~  103 (458)
                      -..-.|+|++.++..|.||||+|+..|+.+++++|++.|+++|.+|.+|.||||+|+..|+.+++++|+++|++ ++.+|
T Consensus        55 ~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~  134 (162)
T 1ihb_A           55 RLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRN  134 (162)
T ss_dssp             HHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCC
T ss_pred             HHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHccCCCCCCcC
Confidence            33446889999999999999999999999999999999999999999999999999999999999999999998 69999


Q ss_pred             CCCCChhHHHhhcchHHHHHHHHHhCCC
Q 012684          104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK  131 (458)
Q Consensus       104 ~~g~tpl~~A~~~~~~~~~~~l~~~g~~  131 (458)
                      ..|.||||+|+..|+.+++++|+++|||
T Consensus       135 ~~g~t~l~~A~~~~~~~~~~~Ll~~GAd  162 (162)
T 1ihb_A          135 HKGDTACDLARLYGRNEVVSLMQANGAG  162 (162)
T ss_dssp             TTSCCHHHHHHHTTCHHHHHHHHHTC--
T ss_pred             CCCCcHHHHHHHcCCHHHHHHHHHhCCC
Confidence            9999999999999999999999999986

>3f6q_A Integrin-linked protein kinase; ILK, integrin-linked kinase, pinch, ankyrin repeat, ANK, IPP; 1.60A {Homo sapiens} PDB: 3ixe_A 2kbx_A

Probab=99.81  E-value=2e-19  Score=157.98  Aligned_cols=109  Identities=21%  Similarity=0.211  Sum_probs=104.1

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~  107 (458)
                      -.|+|++..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus        60 ~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~  139 (179)
T 3f6q_A           60 MRGARINVMNRGDDTPLHLAASHGHRDIVQKLLQYKADINAVNEHGNVPLHYACFWGQDQVAEDLVANGALVSICNKYGE  139 (179)
T ss_dssp             HTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSSBCCTTSC
T ss_pred             HcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCcchhccCCC
Confidence            35788888899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChhHHHhhcchHHHHHHHHHhCCCCCCCc
Q 012684          108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      ||+++|+..++.+++++|+++|+++...+
T Consensus       140 tpl~~A~~~~~~~~~~~L~~~g~~~~~~~  168 (179)
T 3f6q_A          140 MPVDKAKAPLRELLRERAEKMGQNLNRIP  168 (179)
T ss_dssp             CGGGGSCHHHHHHHHHHHHHTTCCCSCBC
T ss_pred             CcHHHHHHHHHHHHHHHHHHhhcCcccCC
Confidence            99999999999999999999999986544

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A

Probab=99.80  E-value=2.5e-19  Score=144.26  Aligned_cols=93  Identities=32%  Similarity=0.455  Sum_probs=86.3

Q ss_pred             CCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHH
Q 012684           33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD  112 (458)
Q Consensus        33 ~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~  112 (458)
                      +...+.+|.||||+||..|+.+++++|++.|+++|.+|..|.||||+||..|+.+++++|+++|++++.+|..|.||||+
T Consensus        17 ~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~tpl~~   96 (110)
T 2zgd_A           17 GSHMGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDKFGKTAFDI   96 (110)
T ss_dssp             -----CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred             ccccCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccCCCcHHHH
Confidence            45567789999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhhcchHHHHHHH
Q 012684          113 AIYYKNHEVIKLL  125 (458)
Q Consensus       113 A~~~~~~~~~~~l  125 (458)
                      |+..|+.+++++|
T Consensus        97 A~~~~~~~~~~~L  109 (110)
T 2zgd_A           97 SIDNGNEDLAEIL  109 (110)
T ss_dssp             HHHHTCHHHHHHH
T ss_pred             HHHcCCHHHHHHh
Confidence            9999999999987

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B

Probab=99.80  E-value=3.2e-19  Score=152.73  Aligned_cols=106  Identities=24%  Similarity=0.255  Sum_probs=97.3

Q ss_pred             CCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 012684           30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP  109 (458)
Q Consensus        30 ~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp  109 (458)
                      +.+++..+..|.||||+ |..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||
T Consensus        26 ~~~~~~~~~~g~t~L~~-~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~  104 (156)
T 1bd8_A           26 LVHPDALNRFGKTALQV-MMFGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALP  104 (156)
T ss_dssp             CCCTTCCCTTSCCHHHH-SCTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCH
T ss_pred             CcCccccCCCCCcHHHH-HHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcH
Confidence            45888888889999999 99999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hHHHhhcchHHHHHHHHHhCCCCCCCcc
Q 012684          110 LGDAIYYKNHEVIKLLEKHGAKPLMAPM  137 (458)
Q Consensus       110 l~~A~~~~~~~~~~~l~~~g~~~~~~~~  137 (458)
                      ||+|+..|+.+++++|++. +++.....
T Consensus       105 L~~A~~~~~~~~v~~Ll~~-~~~~~~~~  131 (156)
T 1bd8_A          105 IHLAVQEGHTAVVSFLAAE-SDLHRRDA  131 (156)
T ss_dssp             HHHHHHHTCHHHHHHHHTT-SCTTCCCT
T ss_pred             HHHHHHhChHHHHHHHHhc-cCCCCcCC
Confidence            9999999999999999988 77755443

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens}

Probab=99.80  E-value=1.4e-19  Score=165.67  Aligned_cols=110  Identities=17%  Similarity=0.074  Sum_probs=97.9

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC-CCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWG  106 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~-~~g  106 (458)
                      -+|+|++..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.++ ..|
T Consensus        42 ~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g  121 (229)
T 2vge_A           42 KEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAASCNDTVICMALVQHGAAIFATTLSDG  121 (229)
T ss_dssp             HHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCTTCCCSSTT
T ss_pred             hcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCCCC
Confidence            3577888888889999999999999999999999999999999999999999999999999999999999999986 599


Q ss_pred             CChhHHH--hhcchHHHHHHHHHhCCCCCCCcc
Q 012684          107 STPLGDA--IYYKNHEVIKLLEKHGAKPLMAPM  137 (458)
Q Consensus       107 ~tpl~~A--~~~~~~~~~~~l~~~g~~~~~~~~  137 (458)
                      +||||+|  +..|+.+++++|++.|+++.....
T Consensus       122 ~tpL~~A~a~~~~~~~~v~~Ll~~ga~~~~~~~  154 (229)
T 2vge_A          122 ATAFEKCDPYREGYADCATYLADVEQSMGLMNS  154 (229)
T ss_dssp             CCTGGGCCTTSTTHHHHHHHHHHHHHHTTTSGG
T ss_pred             CCHHHHHHHHhcChHHHHHHHHHcCCCcccccC
Confidence            9999999  889999999999999998866543

>4b93_B Ankyrin repeat domain-containing protein 27; endocytosis, exocytosis, snare; 2.00A {Homo sapiens}

Probab=99.80  E-value=2e-19  Score=168.75  Aligned_cols=108  Identities=24%  Similarity=0.288  Sum_probs=71.8

Q ss_pred             CCCCcCccchHHHHHHHhCCH-HHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhH
Q 012684           33 DDGEEIKPEFRLMFLANERDV-EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG  111 (458)
Q Consensus        33 ~~~~~~~g~t~l~~a~~~~~~-~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~  111 (458)
                      .+..+..|.||||+|+..++. .++++|++.|+++|.+|.+|.||||+||..|+.+++++|++.|++++.++..|.||++
T Consensus        45 ~~~~~~~~~t~L~~a~~~~~~~~~v~~Ll~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~~a~~~~~~~~g~t~l~  124 (269)
T 4b93_B           45 VSAADPEFCHPLCQCPKCAPAQKRLAKVPASGLGVNVTSQDGSSPLHVAALHGRADLIPLLLKHGANAGARNADQAVPLH  124 (269)
T ss_dssp             ------------------------------CCCCTTCCCTTSCCHHHHHHHTTCTTHHHHHHHTTCCTTCCCTTCCCHHH
T ss_pred             ccccCccCCCHHHHHHHhCCHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHhcCCCcCccCCCCCCccc
Confidence            455667788999999988875 5889999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhhcchHHHHHHHHHhCCCCCCCccccc
Q 012684          112 DAIYYKNHEVIKLLEKHGAKPLMAPMHVK  140 (458)
Q Consensus       112 ~A~~~~~~~~~~~l~~~g~~~~~~~~~~~  140 (458)
                      +|+..++.+++++|++.|+++......+.
T Consensus       125 ~a~~~~~~~~~~~Ll~~g~~~n~~d~~g~  153 (269)
T 4b93_B          125 LACQQGHFQVVKCLLDSNAKPNKKDLSGN  153 (269)
T ss_dssp             HHHHHTCHHHHHHHHHTTCCSCCCCTTCC
T ss_pred             cccccChHHHHHHHHHCCCCCCCCCCCCC
Confidence            99999999999999999998876554443

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D

Probab=99.80  E-value=2.8e-19  Score=168.26  Aligned_cols=116  Identities=29%  Similarity=0.327  Sum_probs=101.0

Q ss_pred             CCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCC-CCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        30 ~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~-g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      +.+.+..+..|.||||+||..|+.+++++|++.|+++|.++.. |.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus       148 ~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g~t  227 (282)
T 1oy3_D          148 RLQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRT  227 (282)
T ss_dssp             GGGTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred             hhcCCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCcccccCCCC
Confidence            3456677888999999999999999999999999999999855 999999999999999999999999999999999999


Q ss_pred             hhHHHhhcchHHHHHHHHHhCCCCCCCccccccCCCC
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREV  145 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~  145 (458)
                      |||+|+..|+.+++++|+++|+++......+.++...
T Consensus       228 pL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~~  264 (282)
T 1oy3_D          228 PLGSALLRPNPILARLLRAHGAPEPEDGGDKLSPCSS  264 (282)
T ss_dssp             HHHHHHTSSCHHHHHHHHHTTCCCCCCC---------
T ss_pred             HHHHHHHcCCcHHHHHHHHcCCCcCcCCCcccccccc
Confidence            9999999999999999999999998777666666443

>2y1l_E Darpin-8.4; hydrolase-inhibitor complex, DEVD darpin, ankyrin repeat Pro ribosome display, apoptosis; 1.80A {Synthetic source} PDB: 3noc_D* 4dx5_D* 2j8s_D* 4dx6_D* 4dx7_D* 3nog_D* 1mj0_A 1svx_A 2qyj_A 2bkg_A 2p2c_P 2bkk_B* 2v5q_C 2xee_A 2xeh_A 3q9n_C* 3q9u_C*

Probab=99.79  E-value=4.7e-19  Score=154.08  Aligned_cols=102  Identities=33%  Similarity=0.465  Sum_probs=97.7

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~  107 (458)
                      -+|+|++..+..|.||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus        68 ~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~  147 (169)
T 2y1l_E           68 KNGADVNAVDHAGMTPLRLAALFGHLEIVEVLLKNGADVNANDMEGHTPLHLAAMFGHLEIVEVLLKNGADVNAQDKFGK  147 (169)
T ss_dssp             HTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             HcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCC
Confidence            36788888899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChhHHHhhcchHHHHHHHHHhC
Q 012684          108 TPLGDAIYYKNHEVIKLLEKHG  129 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l~~~g  129 (458)
                      |||++|+..|+.+++++|++.|
T Consensus       148 t~l~~A~~~~~~~~~~~L~~~G  169 (169)
T 2y1l_E          148 TAFDISIDNGNEDLAEILQKLN  169 (169)
T ss_dssp             CHHHHHHHTTCHHHHHHHHTC-
T ss_pred             CHHHHHHHhCCHHHHHHHHHcC
Confidence            9999999999999999999876

>1n0r_A 4ANK, 4 ankyrin repeats; structural protein; 1.50A {} SCOP: k.37.1.1

Probab=99.79  E-value=5.3e-19  Score=145.16  Aligned_cols=99  Identities=43%  Similarity=0.525  Sum_probs=94.8

Q ss_pred             ccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcch
Q 012684           39 KPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN  118 (458)
Q Consensus        39 ~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~  118 (458)
                      +|.||||+||..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+
T Consensus         1 ~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~   80 (126)
T 1n0r_A            1 NGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGH   80 (126)
T ss_dssp             CCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTC
T ss_pred             CCccHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCcHHHHHHHcCh
Confidence            58999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHHHhCCCCCCCcc
Q 012684          119 HEVIKLLEKHGAKPLMAPM  137 (458)
Q Consensus       119 ~~~~~~l~~~g~~~~~~~~  137 (458)
                      .+++++|+++|+++.....
T Consensus        81 ~~~~~~Ll~~g~~~~~~~~   99 (126)
T 1n0r_A           81 LEVVKLLLEAGADVNAKDK   99 (126)
T ss_dssp             HHHHHHHHHTTCCTTCCCT
T ss_pred             HHHHHHHHHcCCCCcccCC
Confidence            9999999999999865443

>3twr_A Tankyrase-2; ankyrin repeat, protein-protein interaction, substrate recru poly(ADP-ribosyl)ation; HET: PE8; 1.55A {Homo sapiens} SCOP: d.211.1.0 PDB: 3tws_A* 3twt_A* 3twv_A* 3tww_A 3twx_A 3twq_A 3twu_A 2y0i_S*

Probab=99.79  E-value=3.4e-19  Score=154.16  Aligned_cols=103  Identities=30%  Similarity=0.307  Sum_probs=96.5

Q ss_pred             hhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Q 012684           27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG  106 (458)
Q Consensus        27 ~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g  106 (458)
                      .-.+.|++.++..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|
T Consensus        62 l~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g  141 (165)
T 3twr_A           62 LQHGADVHAKDKGGLVPLHNACSYGHYEVAELLVKHGAVVNVADLWKFTPLHEAAAKGKYEICKLLLQHGADPTKKNRDG  141 (165)
T ss_dssp             HHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred             HhcCCCCCccCCCCCCHHHHHHHcCcHHHHHHHHhCCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCC
Confidence            34578889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CChhHHHhhcchHHHHHHHHHhCC
Q 012684          107 STPLGDAIYYKNHEVIKLLEKHGA  130 (458)
Q Consensus       107 ~tpl~~A~~~~~~~~~~~l~~~g~  130 (458)
                      .||+|+|+. ++.+++++|++.|+
T Consensus       142 ~t~l~~a~~-~~~~i~~~L~~~gA  164 (165)
T 3twr_A          142 NTPLDLVKD-GDTDIQDLLRGDAA  164 (165)
T ss_dssp             CCTGGGSCT-TCHHHHHHHHTC--
T ss_pred             CChhHhHhc-CChHHHHHHhhccc
Confidence            999999877 88999999999886

>1awc_B Protein (GA binding protein beta 1); complex (transcription regulation/DNA), DNA-binding, nuclear protein, ETS domain, ankyrin repeats; HET: DNA BRU CBR; 2.15A {Mus musculus} SCOP: d.211.1.1

Probab=99.79  E-value=5.8e-19  Score=150.78  Aligned_cols=98  Identities=31%  Similarity=0.398  Sum_probs=94.6

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~  107 (458)
                      -++.|++..+..|.||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus        55 ~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~  134 (153)
T 1awc_B           55 RAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCK  134 (153)
T ss_dssp             TTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             HcCCCCCCCCCCCCCHHHHHHHcChHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCC
Confidence            35788888899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChhHHHhhcchHHHHHHH
Q 012684          108 TPLGDAIYYKNHEVIKLL  125 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l  125 (458)
                      |||++|+..|+.+++++|
T Consensus       135 t~l~~A~~~~~~~i~~~L  152 (153)
T 1awc_B          135 TAFDISIDNGNEDLAEIL  152 (153)
T ss_dssp             CHHHHHHHTTCHHHHHHH
T ss_pred             CHHHHHHHcCCHHHHHHh
Confidence            999999999999999987

>1bd8_A P19INK4D CDK4/6 inhibitor; tumor suppressor, ankyrin motif; 1.80A {Homo sapiens} SCOP: d.211.1.1 PDB: 1bi8_B 1ap7_A 1blx_B

Probab=99.79  E-value=6.4e-19  Score=150.86  Aligned_cols=104  Identities=26%  Similarity=0.344  Sum_probs=97.9

Q ss_pred             hhhhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Q 012684           24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD  103 (458)
Q Consensus        24 ~~~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~  103 (458)
                      +-..-.|+|++.++..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++ ++++.+|
T Consensus        52 ~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~-~~~~~~~  130 (156)
T 1bd8_A           52 LELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRD  130 (156)
T ss_dssp             HHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTT-SCTTCCC
T ss_pred             HHHHHCCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHhChHHHHHHHHhc-cCCCCcC
Confidence            334456888899999999999999999999999999999999999999999999999999999999999999 9999999


Q ss_pred             CCCCChhHHHhhcchHHHHHHHHHh
Q 012684          104 RWGSTPLGDAIYYKNHEVIKLLEKH  128 (458)
Q Consensus       104 ~~g~tpl~~A~~~~~~~~~~~l~~~  128 (458)
                      ..|.||||+|+..|+.+++++|+++
T Consensus       131 ~~g~t~l~~A~~~~~~~~v~~Ll~~  155 (156)
T 1bd8_A          131 ARGLTPLELALQRGAQDLVDILQGH  155 (156)
T ss_dssp             TTSCCHHHHHHHSCCHHHHHHHHTT
T ss_pred             CCCCCHHHHHHHcCcHHHHHHHHhh
Confidence            9999999999999999999999864

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens}

Probab=99.79  E-value=3.8e-19  Score=169.63  Aligned_cols=112  Identities=26%  Similarity=0.272  Sum_probs=103.8

Q ss_pred             hhcCCCCCC------CcCccchHHHHHHHh---CCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCC
Q 012684           27 ELNGLDDDG------EEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA   97 (458)
Q Consensus        27 ~~n~~d~~~------~~~~g~t~l~~a~~~---~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga   97 (458)
                      ..++.|++.      .+..|.||||+||..   |+.+++++|++.|+++|.+|.+|.||||+|+..|+.+++++|+++||
T Consensus       171 l~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~TpLh~A~~~g~~~~v~~Ll~~ga  250 (301)
T 2b0o_E          171 FANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTALHYAALYNQPDCLKLLLKGRA  250 (301)
T ss_dssp             HHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTC
T ss_pred             HhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCC
Confidence            356777777      688999999999997   89999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCCCCCChhHHHhhcchHHHHHHHHHhCCCCCCCccc
Q 012684           98 DVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH  138 (458)
Q Consensus        98 ~~~~~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~  138 (458)
                      +++.+|..|.||||+|+..|+.+++++|++.|++...++++
T Consensus       251 d~~~~d~~G~TpL~~A~~~~~~~iv~~Ll~~ga~~g~tpLh  291 (301)
T 2b0o_E          251 LVGTVNEAGETALDIARKKHHKECEELLEQAQAGTFAFPLH  291 (301)
T ss_dssp             CCSCCCTTSCCHHHHHHHHTCHHHHHHHHHHHHHTTSSCCC
T ss_pred             CCCCcCCCCCCHHHHHHHcCCHHHHHHHHHhcCCCCCChhH
Confidence            99999999999999999999999999999999986555544

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis}

Probab=99.78  E-value=1.9e-19  Score=159.21  Aligned_cols=110  Identities=18%  Similarity=0.147  Sum_probs=92.8

Q ss_pred             CCCCc-CccchHHHHHHHhCCH----HHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC------HHHHHHHHHCCCCCCC
Q 012684           33 DDGEE-IKPEFRLMFLANERDV----EGIKELLDSGIDVNFRDIDNRTALHVAACQGF------TEVVSLLLERGADVDP  101 (458)
Q Consensus        33 ~~~~~-~~g~t~l~~a~~~~~~----~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~------~~~~~~Ll~~ga~~~~  101 (458)
                      ++..+ ..|.||||+|+..|+.    +++++|++.|+|+|.+|.+|+||||+|+..++      .+++++|+++||++|.
T Consensus        30 ~~~~~~~~g~T~Lh~A~~~~~~~~~~~iv~~Ll~~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~  109 (186)
T 3t8k_A           30 YEDKESVLKSNILYDVLRNNNDEARYKISMFLINKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITA  109 (186)
T ss_dssp             SSCHHHHHTTTHHHHHTTCSCHHHHHHHHHHHHHTTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSS
T ss_pred             cccccccCCCCHHHHHHHcCCcchHHHHHHHHHHCCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCc
Confidence            44444 6799999999999875    58999999999999999999999999999886      6789999999999999


Q ss_pred             CCCCCC-ChhHHHhh-----cchHHHHHHHHH-hCCCCCCCccccccC
Q 012684          102 KDRWGS-TPLGDAIY-----YKNHEVIKLLEK-HGAKPLMAPMHVKHA  142 (458)
Q Consensus       102 ~~~~g~-tpl~~A~~-----~~~~~~~~~l~~-~g~~~~~~~~~~~~~  142 (458)
                      +|..|. ||||+|+.     .+..+++++|++ +|+++......+.++
T Consensus       110 ~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll~~~gad~~~~d~~G~Tp  157 (186)
T 3t8k_A          110 LYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQSGLQLLIKDKWGLTA  157 (186)
T ss_dssp             CBGGGTBCTTGGGGGCCSCHHHHHHHHHHHHTSTTCCTTCCCTTSCCH
T ss_pred             cCCCcCchHHHHHHHcCCChhhHHHHHHHHHHhcCCCCcccCCCCCCH
Confidence            999999 99999998     345679999999 999987765544443

>3aaa_C Myotrophin, protein V-1; actin capping protein, barbed END capping, inhibition, prote binding, actin capping, actin-binding, cytoskeleton, ANK RE; 2.20A {Homo sapiens} PDB: 1myo_A 2kxp_C 2myo_A

Probab=99.78  E-value=4.1e-19  Score=145.84  Aligned_cols=97  Identities=26%  Similarity=0.220  Sum_probs=89.1

Q ss_pred             hhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCC
Q 012684           26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW  105 (458)
Q Consensus        26 ~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~  105 (458)
                      ..-.+.|++.++..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..
T Consensus        26 ll~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~  105 (123)
T 3aaa_C           26 YVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPD  105 (123)
T ss_dssp             HHHTTCCTTSCCTTSSCHHHHHHHTTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             HHHcCCCcCccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCC
Confidence            33467888888999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCChhHHHhhcchHHHH
Q 012684          106 GSTPLGDAIYYKNHEVI  122 (458)
Q Consensus       106 g~tpl~~A~~~~~~~~~  122 (458)
                      |.||+|+|...+..+++
T Consensus       106 g~t~l~~A~~~~~~~ll  122 (123)
T 3aaa_C          106 GLTAFEATDNQAIKALL  122 (123)
T ss_dssp             SCCHHHHCCCHHHHHHH
T ss_pred             CCCHHHHhCCHHHHHHh
Confidence            99999999665555544

>2vge_A RELA-associated inhibitor; iaspp, nucleus, apoptosis, repressor, cytoplasm, phosphorylation, P53 binding protein, ANK repeat, SH3 domain; 2.10A {Homo sapiens}

Probab=99.78  E-value=8.9e-19  Score=160.34  Aligned_cols=101  Identities=26%  Similarity=0.323  Sum_probs=96.3

Q ss_pred             CCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHh
Q 012684           35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI  114 (458)
Q Consensus        35 ~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~  114 (458)
                      ..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+||..|+.+++++|+++|++++.+|..|.||||+|+
T Consensus        16 ~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~tpLh~A~   95 (229)
T 2vge_A           16 RARLNPLVLLLDAALTGELEVVQQAVKEMNDPSQPNEEGITALHNAICGANYSIVDFLITAGANVNSPDSHGWTPLHCAA   95 (229)
T ss_dssp             CTTSCHHHHHHHHHHHTCHHHHHHHHHHSSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHH
T ss_pred             ccccchhHHHHHHHHcCCHHHHHHHHhcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHH
Confidence            44557899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hcchHHHHHHHHHhCCCCCCC
Q 012684          115 YYKNHEVIKLLEKHGAKPLMA  135 (458)
Q Consensus       115 ~~~~~~~~~~l~~~g~~~~~~  135 (458)
                      ..|+.+++++|++.|+++...
T Consensus        96 ~~g~~~~v~~Ll~~ga~~~~~  116 (229)
T 2vge_A           96 SCNDTVICMALVQHGAAIFAT  116 (229)
T ss_dssp             HTTCHHHHHHHHTTTCCTTCC
T ss_pred             HcCCHHHHHHHHHcCCCcccc
Confidence            999999999999999998654

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B

Probab=99.78  E-value=8.3e-19  Score=161.61  Aligned_cols=97  Identities=30%  Similarity=0.356  Sum_probs=61.8

Q ss_pred             CccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcc
Q 012684           38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK  117 (458)
Q Consensus        38 ~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~  117 (458)
                      ..|.||||+||..|+.++++.|++.|+++|.+|..|.||||+||..|+.+++++|+++|++++.+|..|+||||+|+..|
T Consensus        35 ~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~  114 (239)
T 1ycs_B           35 PLPLALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCN  114 (239)
T ss_dssp             --CHHHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTT
T ss_pred             chhhHHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcC
Confidence            44566666666666666666666666666666666666666666666666666666666666666666666666666666


Q ss_pred             hHHHHHHHHHhCCCCCC
Q 012684          118 NHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       118 ~~~~~~~l~~~g~~~~~  134 (458)
                      +.+++++|+++|+++..
T Consensus       115 ~~~~v~~Ll~~ga~~~~  131 (239)
T 1ycs_B          115 NVQVCKFLVESGAAVFA  131 (239)
T ss_dssp             CHHHHHHHHHTTCCTTC
T ss_pred             CHHHHHHHHHcCCCcce
Confidence            66666666666666543

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A

Probab=99.78  E-value=6e-19  Score=155.57  Aligned_cols=103  Identities=33%  Similarity=0.316  Sum_probs=96.1

Q ss_pred             cCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC-CCCCChhHHHhh
Q 012684           37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIY  115 (458)
Q Consensus        37 ~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~-~~g~tpl~~A~~  115 (458)
                      +.+|.||||+||..|+.++++.|++ |+++|.+|..|.||||+|+..|+.+++++|+++|++++.++ ..|+||||+|+.
T Consensus        41 ~~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~  119 (183)
T 3deo_A           41 VSEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAG  119 (183)
T ss_dssp             HHHHHHHHHHHHHTTCHHHHHHHTT-TSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHH
T ss_pred             CCCCCCHHHHHHHcCCHHHHHHHHh-cCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHh
Confidence            4578999999999999999999999 99999999999999999999999999999999999999998 899999999999


Q ss_pred             cchHHHHHHHHHhCCCCCCCccccc
Q 012684          116 YKNHEVIKLLEKHGAKPLMAPMHVK  140 (458)
Q Consensus       116 ~~~~~~~~~l~~~g~~~~~~~~~~~  140 (458)
                      .|+.+++++|+++|+++......+.
T Consensus       120 ~~~~~~v~~Ll~~ga~~~~~d~~g~  144 (183)
T 3deo_A          120 YVRPEVVEALVELGADIEVEDERGL  144 (183)
T ss_dssp             TTCHHHHHHHHHHTCCTTCCCTTSC
T ss_pred             cCcHHHHHHHHHcCCCCcCCCCCCC
Confidence            9999999999999999866544433

>2rfm_A Putative ankyrin repeat protein TV1425; ANK repeat, protein binding; HET: BU2 GOL; 1.65A {Thermoplasma volcanium}

Probab=99.78  E-value=7.5e-19  Score=156.01  Aligned_cols=102  Identities=30%  Similarity=0.346  Sum_probs=98.1

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~  107 (458)
                      -.++|++..+..|.||||+|+..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus        89 ~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~  168 (192)
T 2rfm_A           89 SKGSNVNTKDFSGKTPLMWSIIFGYSEMSYFLLEHGANVNDRNLEGETPLIVASKYGRSEIVKKLLELGADISARDLTGL  168 (192)
T ss_dssp             HHTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSC
T ss_pred             HCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCC
Confidence            35788888889999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChhHHHhhcchHHHHHHHHHhC
Q 012684          108 TPLGDAIYYKNHEVIKLLEKHG  129 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l~~~g  129 (458)
                      ||+++|+..|+.+++++|+++|
T Consensus       169 t~l~~A~~~~~~~~v~~Ll~~~  190 (192)
T 2rfm_A          169 TAEASARIFGRQEVIKIFTEVR  190 (192)
T ss_dssp             BHHHHHHHTTCHHHHHHHHHHH
T ss_pred             CHHHHHHHhCcHHHHHHHHhcc
Confidence            9999999999999999999876

>3v31_A Ankyrin repeat family A protein 2; structural genomics consortium, SGC, ankra2, ANK repeat, Pro binding, HDAC4; 1.57A {Homo sapiens} PDB: 3v2x_A 3v2o_A 3so8_A

Probab=99.78  E-value=6.9e-19  Score=152.52  Aligned_cols=106  Identities=29%  Similarity=0.289  Sum_probs=101.2

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~  107 (458)
                      -++.|++..+..|.||||+|+..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus        57 ~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~  136 (167)
T 3v31_A           57 QNGADPQLLGKGRESALSLACSKGYTDIVKMLLDCGVDVNEYDWNGGTPLLYAVHGNHVKCVKMLLESGADPTIETDSGY  136 (167)
T ss_dssp             HTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             HcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHHCCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCC
Confidence            35788888889999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChhHHHhhcchHHHHHHHHHhCCCCC
Q 012684          108 TPLGDAIYYKNHEVIKLLEKHGAKPL  133 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l~~~g~~~~  133 (458)
                      ||+++|+..|+.+++++|+++++++.
T Consensus       137 t~l~~A~~~~~~~~~~~L~~~~~~~~  162 (167)
T 3v31_A          137 NSMDLAVALGYRSVQQVIESHLLKLL  162 (167)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHHHHHHC
T ss_pred             CHHHHHHHcCcHHHHHHHHHHHHHHH
Confidence            99999999999999999999987753

>1bi7_B P16INK4A, MTS1, multiple tumor suppressor; cyclin dependent kinase, cyclin dependent kinase inhibitory protein, CDK, cell cycle; 3.40A {Homo sapiens} SCOP: d.211.1.1 PDB: 1a5e_A 1dc2_A 2a5e_A

Probab=99.78  E-value=3.5e-19  Score=152.76  Aligned_cols=104  Identities=24%  Similarity=0.243  Sum_probs=94.7

Q ss_pred             CCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC-hhHH
Q 012684           34 DGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST-PLGD  112 (458)
Q Consensus        34 ~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t-pl~~  112 (458)
                      +..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+ .|+.+++++|+++|++++.+|..|.| |||+
T Consensus         6 ~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~-~~~~~~v~~Ll~~g~~~~~~d~~g~ttpL~~   84 (156)
T 1bi7_B            6 GSSMEPSADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHD   84 (156)
T ss_dssp             ----CCSTTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHH
T ss_pred             cCCCccchHHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHH-cCCHHHHHHHHHcCCCCCCcCCCCCcHHHHH
Confidence            345667899999999999999999999999999999999999999985 99999999999999999999999999 9999


Q ss_pred             HhhcchHHHHHHHHHhCCCCCCCccc
Q 012684          113 AIYYKNHEVIKLLEKHGAKPLMAPMH  138 (458)
Q Consensus       113 A~~~~~~~~~~~l~~~g~~~~~~~~~  138 (458)
                      |+..|+.+++++|+++|+++......
T Consensus        85 A~~~~~~~~v~~Ll~~ga~~~~~d~~  110 (156)
T 1bi7_B           85 AAREGFLDTLVVLHRAGARLDVRDAW  110 (156)
T ss_dssp             HHHHTCHHHHHHHHHHTCCSSCCCTT
T ss_pred             HHHCCCHHHHHHHHHcCCCCcccCCC
Confidence            99999999999999999998765433

>3c5r_A BARD-1, BRCA1-associated ring domain protein 1; ankyrin repeat, helix, extended loop, four repeat, PR ANK repeat, disease mutation, metal-binding; 2.00A {Homo sapiens} SCOP: k.37.1.1

Probab=99.78  E-value=2.9e-19  Score=149.67  Aligned_cols=104  Identities=25%  Similarity=0.256  Sum_probs=94.5

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~  107 (458)
                      -+++|++..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus        31 ~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~  110 (137)
T 3c5r_A           31 QNGSDPNVKDHAGWTPLHEACNHGHLKVVELLLQHKALVNTTGYQNDSPLHDAAKNGHVDIVKLLLSYGASRNAVNIFGL  110 (137)
T ss_dssp             HTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             HcCCCCCcCCCCCCCHHHHHHHcCCHHHHHHHHHcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCC
Confidence            35788888999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChhHHHhhcchHHHHHHHHHhCCC
Q 012684          108 TPLGDAIYYKNHEVIKLLEKHGAK  131 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l~~~g~~  131 (458)
                      ||+++|+..+..+++++|.+.+..
T Consensus       111 tpl~~A~~~~~~~~l~~l~~~~~s  134 (137)
T 3c5r_A          111 RPVDYTDDESMKSLLLLPEKNESS  134 (137)
T ss_dssp             CGGGGCCCHHHHHHHSCC------
T ss_pred             CHHHHHhhccHHHHHhhccccccC
Confidence            999999999999999988876544

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A

Probab=99.78  E-value=1.9e-18  Score=157.47  Aligned_cols=112  Identities=26%  Similarity=0.221  Sum_probs=101.7

Q ss_pred             CCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCC-CCCCCCCCCCCCh
Q 012684           31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGSTP  109 (458)
Q Consensus        31 ~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~g-a~~~~~~~~g~tp  109 (458)
                      .|.+..+..|.||||+|+..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++| ++++.+|..|.||
T Consensus        98 ~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~d~~g~t~  177 (228)
T 2dzn_A           98 PDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTP  177 (228)
T ss_dssp             CCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCSCCCCTTSCCH
T ss_pred             cccccCCcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhcCcccccCcCCCCCCH
Confidence            777888888999999999999999999999999999999999999999999999999999999999 9999999999999


Q ss_pred             hHHHhhcchHHHHHHHH-HhCCCCCCCccccccC
Q 012684          110 LGDAIYYKNHEVIKLLE-KHGAKPLMAPMHVKHA  142 (458)
Q Consensus       110 l~~A~~~~~~~~~~~l~-~~g~~~~~~~~~~~~~  142 (458)
                      ||+|+..|+.+++++|+ +.|+++......+.++
T Consensus       178 L~~A~~~~~~~~v~~Ll~~~ga~~~~~~~~g~t~  211 (228)
T 2dzn_A          178 LFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKA  211 (228)
T ss_dssp             HHHHHHTTCHHHHHHHHHHHCCCSCCBCTTSCBG
T ss_pred             HHHHHHcCCHHHHHHHHHhcCCCCCccCCCCCcH
Confidence            99999999999999999 8999987766555544

>1ycs_B 53BP2, P53BP2; ankyrin repeats, SH3, tumor suppressor, multigene family, nuclear protein, phosphorylation, disease mutation, polymorphism; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.211.1.1 PDB: 4a63_B

Probab=99.78  E-value=6.4e-19  Score=162.36  Aligned_cols=111  Identities=22%  Similarity=0.088  Sum_probs=103.6

Q ss_pred             hhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Q 012684           27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG  106 (458)
Q Consensus        27 ~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g  106 (458)
                      .-.+.|++.++..|.||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++.++..|
T Consensus        57 l~~g~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~  136 (239)
T 1ycs_B           57 IYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSD  136 (239)
T ss_dssp             TSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSSS
T ss_pred             HHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcceecCCC
Confidence            34677899999999999999999999999999999999999999999999999999999999999999999999999887


Q ss_pred             C-ChhHHH--hhcchHHHHHHHHHhCCCCCCCcc
Q 012684          107 S-TPLGDA--IYYKNHEVIKLLEKHGAKPLMAPM  137 (458)
Q Consensus       107 ~-tpl~~A--~~~~~~~~~~~l~~~g~~~~~~~~  137 (458)
                      . ||||+|  +..|+.+++++|+++|+++.....
T Consensus       137 ~~t~l~~a~~~~~g~~~~~~~Ll~~~a~~~~~~~  170 (239)
T 1ycs_B          137 MQTAADKCEEMEEGYTQCSQFLYGVQEKMGIMNK  170 (239)
T ss_dssp             CCCHHHHCCSSSTTCCCHHHHHHHHHHHTTTTGG
T ss_pred             CcchHHHHHHhhhccHHHHHHHHHhhhccccccc
Confidence            7 999999  788999999999999999876543

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A

Probab=99.78  E-value=1e-18  Score=162.36  Aligned_cols=105  Identities=28%  Similarity=0.219  Sum_probs=75.3

Q ss_pred             CCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhH
Q 012684           32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG  111 (458)
Q Consensus        32 d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~  111 (458)
                      +.+..+..|.||||+|+..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.||||
T Consensus       116 ~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpL~  195 (253)
T 1yyh_A          116 DLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPLF  195 (253)
T ss_dssp             CTTCCCTTCCCHHHHHHHHTCSSHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHH
T ss_pred             CccccCCCCCcHHHHHHHcChHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHH
Confidence            56666666777777777777777777777777777777777777777777777777777777777777777777777777


Q ss_pred             HHhhcchHHHHHHHHHhCCCCCCCc
Q 012684          112 DAIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       112 ~A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      +|+..|+.+++++|+++|+++....
T Consensus       196 ~A~~~~~~~~v~~Ll~~ga~~~~~d  220 (253)
T 1yyh_A          196 LAAREGSYETAKVLLDHFANRDITD  220 (253)
T ss_dssp             HHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred             HHHHCCCHHHHHHHHHcCCCccccc
Confidence            7777777777777777777765443

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A

Probab=99.78  E-value=1.9e-18  Score=157.80  Aligned_cols=105  Identities=28%  Similarity=0.289  Sum_probs=57.3

Q ss_pred             CCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 012684           30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP  109 (458)
Q Consensus        30 ~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp  109 (458)
                      +.|++..+..|.||||+|+..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.++..|.||
T Consensus        63 g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~  142 (231)
T 3aji_A           63 GVPVNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYDATA  142 (231)
T ss_dssp             TCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred             CCCCCCcCCCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCcH
Confidence            44444455555555555555555555555555555555555555555555555555555555555555555555555555


Q ss_pred             hHHHhhcchHHHHHHHHHhCCCCCC
Q 012684          110 LGDAIYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       110 l~~A~~~~~~~~~~~l~~~g~~~~~  134 (458)
                      ||+|+..|+.+++++|+++|+++..
T Consensus       143 L~~A~~~~~~~~v~~Ll~~g~~~~~  167 (231)
T 3aji_A          143 MHRAAAKGNLKMVHILLFYKASTNI  167 (231)
T ss_dssp             HHHHHHHTCHHHHHHHHHTTCCSCC
T ss_pred             HHHHHHcCCHHHHHHHHhcCCCccc
Confidence            5555555555555555555555443

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A

Probab=99.77  E-value=9.2e-19  Score=159.26  Aligned_cols=107  Identities=23%  Similarity=0.320  Sum_probs=98.1

Q ss_pred             CcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHC-CCCCCCCCCCCCChhHHHh
Q 012684           36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAI  114 (458)
Q Consensus        36 ~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~-ga~~~~~~~~g~tpl~~A~  114 (458)
                      .+..|.||||+||..|+.++++.|++.|+++|.+|..|.||||+||..|+.+++++|+++ |++++.+|..|.||||+|+
T Consensus        69 ~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~  148 (222)
T 3ehr_A           69 QAESIDNPLHEAAKRGNLSWLRECLDNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAA  148 (222)
T ss_dssp             HEEEESCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHH
T ss_pred             cccccccccccccccCcHHHHHHHHhCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHH
Confidence            355788999999999999999999999999999999999999999999999999999998 9999999999999999999


Q ss_pred             hcchHHHHHHHHHhCCCCCCCccccccC
Q 012684          115 YYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus       115 ~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      ..|+.+++++|+++|+++......+.++
T Consensus       149 ~~~~~~~v~~Ll~~ga~~~~~~~~g~t~  176 (222)
T 3ehr_A          149 WKGYADIVQLLLAKGARTDLRNIEKKLA  176 (222)
T ss_dssp             HHTCHHHHHHHHHHTCCSCCCCTTSCCH
T ss_pred             HcCCHHHHHHHHHcCCCCccccCCCCCH
Confidence            9999999999999999987655444333

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus}

Probab=99.77  E-value=1.8e-18  Score=158.11  Aligned_cols=108  Identities=26%  Similarity=0.345  Sum_probs=98.5

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCC-----CccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDV-----NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD  103 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~i-----n~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~  103 (458)
                      .+.|++.++..|.||||+||..|+.+++++|++.|+++     +.+|..|.||||+|+..|+.+++++|+++|++++..+
T Consensus        26 ~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~  105 (232)
T 2rfa_A           26 EGCEVHQRGAMGETALHIAALYDNLEAAMVLMEAAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARA  105 (232)
T ss_dssp             TCSCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             cCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHcCchhccccccccCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCccc
Confidence            48888889999999999999999999999999999886     7778899999999999999999999999999999887


Q ss_pred             C-------------CCCChhHHHhhcchHHHHHHHHHhCCCCCCCc
Q 012684          104 R-------------WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       104 ~-------------~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      .             .|.||||+|+..|+.+++++|+++|+++....
T Consensus       106 ~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d  151 (232)
T 2rfa_A          106 TGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVRLLIEHGADIRAQD  151 (232)
T ss_dssp             CSGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred             CCcceeecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Confidence            6             79999999999999999999999999975543

>3ehr_A Osteoclast-stimulating factor 1; beta barrel, helix-turn-helix, SH3, ankyrin repeat, signaling protein, ANK repeat, cytoplasm, phosphoprotein; 1.95A {Homo sapiens} PDB: 3ehq_A

Probab=99.77  E-value=6.5e-19  Score=160.25  Aligned_cols=109  Identities=21%  Similarity=0.256  Sum_probs=93.4

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHc-CCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG  106 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~-g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g  106 (458)
                      -.++|++.++..|.||||+||..|+.+++++|++. |+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|
T Consensus        94 ~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g  173 (222)
T 3ehr_A           94 DNRVGVNGLDKAGSTALYWACHGGHKDIVEMLFTQPNIELNQQNKLGDTALHAAAWKGYADIVQLLLAKGARTDLRNIEK  173 (222)
T ss_dssp             HTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHTTSTTCCCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCSCCCCTTS
T ss_pred             hCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHcCCCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccCCC
Confidence            37888999999999999999999999999999998 99999999999999999999999999999999999999999999


Q ss_pred             CChhHHHhhcchHHHHHHHHHhCCCCCCCc
Q 012684          107 STPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       107 ~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      .|||++|+..+..++++.|++.|++.....
T Consensus       174 ~t~l~~A~~~~~~~~l~~l~~~~~~~~~~~  203 (222)
T 3ehr_A          174 KLAFDMATNAACASLLKKKQGTDAVRTLSN  203 (222)
T ss_dssp             CCHHHHCCSHHHHHHHC-------------
T ss_pred             CCHHHHhcchhHHHHHHHHhccchhhhccc
Confidence            999999999999999999999999875443

>2rfa_A Transient receptor potential cation channel subfa member 6; TRPV6, ankyrin reapeat, ANK RE calcium channel, calcium transport, calmodulin-binding; 1.70A {Mus musculus}

Probab=99.76  E-value=3.9e-18  Score=155.93  Aligned_cols=110  Identities=28%  Similarity=0.309  Sum_probs=101.5

Q ss_pred             hhhhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCC-------------CCCCHHHHHHHcCCHHHHH
Q 012684           24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-------------DNRTALHVAACQGFTEVVS   90 (458)
Q Consensus        24 ~~~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~-------------~g~t~l~~A~~~~~~~~~~   90 (458)
                      .+++++..+.+..+..|.||||+||..|+.+++++|++.|++++.++.             .|.||||+|+..|+.++++
T Consensus        59 ~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~  138 (232)
T 2rfa_A           59 AAPELVFEPMTSELYEGQTALHIAVINQNVNLVRALLARGASVSARATGSVFHYRPHNLIYYGEHPLSFAACVGSEEIVR  138 (232)
T ss_dssp             HCGGGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCTTCSCCCCSSHHHHHHHHTCHHHHH
T ss_pred             cCchhccccccccCCCCcCHHHHHHHcCCHHHHHHHHhCCCCCCcccCCcceeecccccccCCCCHHHHHHHcCCHHHHH
Confidence            455665566678888999999999999999999999999999998865             7999999999999999999


Q ss_pred             HHHHCCCCCCCCCCCCCChhHHHhhcchHHHH----HHHHHhCCCCC
Q 012684           91 LLLERGADVDPKDRWGSTPLGDAIYYKNHEVI----KLLEKHGAKPL  133 (458)
Q Consensus        91 ~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~----~~l~~~g~~~~  133 (458)
                      +|+++|++++.+|..|.||||+|+..|+.+++    ++|+++|+++.
T Consensus       139 ~Ll~~ga~~~~~d~~g~t~L~~A~~~~~~~~~~~i~~~Ll~~g~~~~  185 (232)
T 2rfa_A          139 LLIEHGADIRAQDSLGNTVLHILILQPNKTFACQMYNLLLSYDGGDH  185 (232)
T ss_dssp             HHHHTTCCTTCCCTTSCCHHHHHHTCSCHHHHHHHHHHHHHTTCSCS
T ss_pred             HHHHCCCCCCCCCCCCCCHHHHHHHcCChHHHHHHHHHHHhcCCchh
Confidence            99999999999999999999999999999888    99999999874

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A

Probab=99.76  E-value=3.8e-18  Score=154.91  Aligned_cols=109  Identities=27%  Similarity=0.190  Sum_probs=91.0

Q ss_pred             CCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChh
Q 012684           31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL  110 (458)
Q Consensus        31 ~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl  110 (458)
                      .+.+..+..|.||||+|+..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus        83 ~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L  162 (223)
T 2f8y_A           83 TDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGKSALHWAAAVNNVDAAVVLLKNGANKDMQNNREETPL  162 (223)
T ss_dssp             SCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHH
T ss_pred             CCcccCCCCCCcHHHHHHHhCcHHHHHHHHHcCCCCcCcCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCcCHH
Confidence            36777777888888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             HHHhhcchHHHHHHHHHhCCCCCCCcccc
Q 012684          111 GDAIYYKNHEVIKLLEKHGAKPLMAPMHV  139 (458)
Q Consensus       111 ~~A~~~~~~~~~~~l~~~g~~~~~~~~~~  139 (458)
                      |+|+..|+.+++++|+++|+++......+
T Consensus       163 ~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g  191 (223)
T 2f8y_A          163 FLAAREGSYETAKVLLDHFANRDITDHMD  191 (223)
T ss_dssp             HHHHHHTCHHHHHHHHHTTCCTTCCCTTC
T ss_pred             HHHHHcCCHHHHHHHHHcCCCCccccccC
Confidence            88888888888888888888876554333

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A

Probab=99.76  E-value=4.9e-18  Score=155.94  Aligned_cols=111  Identities=24%  Similarity=0.264  Sum_probs=97.5

Q ss_pred             CCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccC-CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChh
Q 012684           32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL  110 (458)
Q Consensus        32 d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~-~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl  110 (458)
                      +.+..+..|.||||+|+..|+.+++++|++.|++++..+ ..|.||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus       108 ~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L  187 (241)
T 1k1a_A          108 DLEARNYDGLTALHVAVNTECQETVQLLLERGADIDAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSAL  187 (241)
T ss_dssp             CTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHH
T ss_pred             cccccCcCCCcHHHHHHHcCCHHHHHHHHHcCCCcccccccCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHH
Confidence            677778888999999999999999999999999999888 7899999999999999999999999999999999999999


Q ss_pred             HHHhhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684          111 GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus       111 ~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      |+|+..|+.+++++|+++|+++......+.++
T Consensus       188 ~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tp  219 (241)
T 1k1a_A          188 HSASGRGLLPLVRTLVRSGADSSLKNCHNDTP  219 (241)
T ss_dssp             HHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCT
T ss_pred             HHHHHcCCHHHHHHHHhcCCCCCCcCCCCCCH
Confidence            99999999999999999999887665554444

>3t8k_A Uncharacterized protein; structural genomics, PSI-biology, protein structure initiati midwest center F or structural genomics, MCSG; 1.77A {Leptotrichia buccalis}

Probab=99.76  E-value=5.6e-19  Score=156.17  Aligned_cols=104  Identities=18%  Similarity=0.158  Sum_probs=95.9

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCC------HHHHHHHHHcCCCCCccCCCCC-CHHHHHHHcC-----CHHHHHHHHH-
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERD------VEGIKELLDSGIDVNFRDIDNR-TALHVAACQG-----FTEVVSLLLE-   94 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~------~~~~~~ll~~g~~in~~~~~g~-t~l~~A~~~~-----~~~~~~~Ll~-   94 (458)
                      -.|+|+|.++..|+||||+|+..++      .+++++|+++|+|+|.+|..|. ||||+|+..+     +.+++++|++ 
T Consensus        63 ~~Gadvn~~d~~g~TpLh~a~~~~~~~~~~~~~iv~~Ll~~Gadin~~d~~g~ttpLh~A~~~~~~~~~~~~iv~~Ll~~  142 (186)
T 3t8k_A           63 NKGADIKSRTKEGTTLFFPLFQGGGNDITGTTELCKIFLEKGADITALYKPYKIVVFKNIFNYFVDENEMIPLYKLIFSQ  142 (186)
T ss_dssp             HTTCCSSCCCTTCCCTHHHHHHHCTTCHHHHHHHHHHHHHTTCCSSSCBGGGTBCTTGGGGGCCSCHHHHHHHHHHHHTS
T ss_pred             HCCCCCCCCCCCCCcHHHHHHHcCCcchhhHHHHHHHHHHCCCCCCccCCCcCchHHHHHHHcCCChhhHHHHHHHHHHh
Confidence            4689999999999999999999997      6899999999999999999999 9999999944     4679999999 


Q ss_pred             CCCCCCCCCCCCCChhHHHhhcchHHHHHHHHHhCCC
Q 012684           95 RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK  131 (458)
Q Consensus        95 ~ga~~~~~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~  131 (458)
                      +|++++.+|..|.||||+|+..|+.+++++|.+...+
T Consensus       143 ~gad~~~~d~~G~TpL~~A~~~~~~~~v~~L~~~~~~  179 (186)
T 3t8k_A          143 SGLQLLIKDKWGLTALEFVKRCQKPIALKMMEDYIKK  179 (186)
T ss_dssp             TTCCTTCCCTTSCCHHHHHHTTTCHHHHHHHHHHHHH
T ss_pred             cCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHHHHH
Confidence            9999999999999999999999999999999987543

>2f8y_A Notch homolog 1, translocation-associated (drosophila); ankyrin repeats, transcription; 1.55A {Homo sapiens} PDB: 2qc9_A 1ymp_A

Probab=99.76  E-value=4.8e-18  Score=154.27  Aligned_cols=111  Identities=22%  Similarity=0.165  Sum_probs=90.0

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCC-CCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGI-DVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~-~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~  107 (458)
                      .+.|++..+..|.||||+|+..|+.+++++|++.|+ +++.++..|.||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus        47 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~  126 (223)
T 2f8y_A           47 ASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDGTTPLILAARLAVEGMLEDLINSHADVNAVDDLGK  126 (223)
T ss_dssp             TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHBTTSCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTSC
T ss_pred             cCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCcHHHHHHHhCcHHHHHHHHHcCCCCcCcCCCCC
Confidence            467777777788888888888888888888888776 7888888888888888888888888888888888888888888


Q ss_pred             ChhHHHhhcchHHHHHHHHHhCCCCCCCcccc
Q 012684          108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV  139 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~  139 (458)
                      ||||+|+..|+.+++++|+++|+++......+
T Consensus       127 t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g  158 (223)
T 2f8y_A          127 SALHWAAAVNNVDAAVVLLKNGANKDMQNNRE  158 (223)
T ss_dssp             BHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTC
T ss_pred             cHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCC
Confidence            88888888888888888888888876554433

>4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens}

Probab=99.76  E-value=2.4e-18  Score=162.06  Aligned_cols=101  Identities=31%  Similarity=0.323  Sum_probs=76.6

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHH-CCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDRWGS  107 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~-~ga~~~~~~~~g~  107 (458)
                      .|.+++..+..|.||||+||..|+.+++++|++.|+++|.+|.+|.||||+|+..|+.+++++|++ .|++++.+|..|.
T Consensus       172 ~g~~~~~~~~~g~tpLh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g~  251 (276)
T 4hbd_A          172 LGNINAKASQAGQTALMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDGS  251 (276)
T ss_dssp             HSCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTTSC
T ss_pred             cCCCccccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCCCC
Confidence            345555666667777777777777777777777777777777777777777777777777777777 6777777777777


Q ss_pred             ChhHHHhhcchHHHHHHHHHhC
Q 012684          108 TPLGDAIYYKNHEVIKLLEKHG  129 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l~~~g  129 (458)
                      ||||+|+..|+.+++++|++++
T Consensus       252 TpL~~A~~~g~~~iv~~Ll~~~  273 (276)
T 4hbd_A          252 TALMVALDAGQSEIASMLYSRM  273 (276)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHHC
T ss_pred             CHHHHHHHcCCHHHHHHHHhcc
Confidence            7777777777777777777664

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E

Probab=99.76  E-value=3.5e-18  Score=156.81  Aligned_cols=108  Identities=25%  Similarity=0.363  Sum_probs=72.7

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCC------CCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID------VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK  102 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~------in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~  102 (458)
                      .|+|++.++..|.||||+||..|+.+++++|++.|++      ++..+..|.||||+|+..|+.+++++|+++|++++.+
T Consensus        67 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~  146 (236)
T 1ikn_D           67 AGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQ  146 (236)
T ss_dssp             CCCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCC
T ss_pred             cCCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHhcccchhHHHHhhccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCC
Confidence            4556666666666777777777777777777766654      4555666777777777777777777777777777776


Q ss_pred             CC-CCCChhHHHhhcchHHHHHHHHHhCCCCCCCc
Q 012684          103 DR-WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       103 ~~-~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      +. .|.||||+|+..|+.+++++|+++|+++....
T Consensus       147 ~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~  181 (236)
T 1ikn_D          147 EPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVT  181 (236)
T ss_dssp             CTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCC
T ss_pred             CCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccc
Confidence            65 67777777777777777777777776665443

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus}

Probab=99.76  E-value=4.5e-18  Score=165.05  Aligned_cols=108  Identities=32%  Similarity=0.408  Sum_probs=103.2

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      .+.+.+..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus        47 ~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~iv~~Ll~~g~~~~~~~~~g~t  126 (351)
T 3utm_A           47 LNVNCHASDGRKSTPLHLAAGYNRVRIVQLLLQHGADVHAKDKGGLVPLHNACSYGHYEVTELLLKHGACVNAMDLWQFT  126 (351)
T ss_dssp             TTTTCCCSSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCC
T ss_pred             cCCCcccCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCcHHHHHHHCCCHHHHHHHHHCCCCCCCCCCCCCC
Confidence            47788888899999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhHHHhhcchHHHHHHHHHhCCCCCCCc
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      |||+|+..|+.+++++|+++|+++....
T Consensus       127 ~L~~A~~~~~~~~v~~Ll~~g~~~~~~~  154 (351)
T 3utm_A          127 PLHEAASKNRVEVCSLLLSHGADPTLVN  154 (351)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             HHHHHHHcCCHHHHHHHHHcCCCCcccc
Confidence            9999999999999999999999986544

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A

Probab=99.76  E-value=1.5e-18  Score=160.38  Aligned_cols=102  Identities=33%  Similarity=0.325  Sum_probs=95.5

Q ss_pred             CccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC-CCCCChhHHHhhc
Q 012684           38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIYY  116 (458)
Q Consensus        38 ~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~-~~g~tpl~~A~~~  116 (458)
                      ..|.||||+||..|+.++++.|++ |+++|.+|..|.||||+||..|+.+++++|+++|++++.++ ..|.||||+|+..
T Consensus        43 ~~g~t~L~~A~~~g~~~~v~~Ll~-~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~  121 (244)
T 3ui2_A           43 SEYETPWWTAARKADEQALSQLLE-DRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGY  121 (244)
T ss_dssp             HHHHHHHHHHHTTTCHHHHHHTTT-TCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHT
T ss_pred             cCCCCHHHHHHHcCCHHHHHHHHc-CCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHc
Confidence            478999999999999999999999 99999999999999999999999999999999999999998 7899999999999


Q ss_pred             chHHHHHHHHHhCCCCCCCccccc
Q 012684          117 KNHEVIKLLEKHGAKPLMAPMHVK  140 (458)
Q Consensus       117 ~~~~~~~~l~~~g~~~~~~~~~~~  140 (458)
                      |+.+++++|+++|+++......+.
T Consensus       122 g~~~~v~~Ll~~ga~~~~~d~~g~  145 (244)
T 3ui2_A          122 VRPEVVEALVELGADIEVEDERGL  145 (244)
T ss_dssp             TCHHHHHHHHHTTCCTTCCCTTCC
T ss_pred             CCHHHHHHHHHCCCCCCCCCCCCC
Confidence            999999999999999876554433

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1

Probab=99.76  E-value=5.7e-18  Score=160.97  Aligned_cols=67  Identities=36%  Similarity=0.399  Sum_probs=34.9

Q ss_pred             CCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcchHHHHHHHHHhCCCCCCCcccc
Q 012684           73 NRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV  139 (458)
Q Consensus        73 g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~  139 (458)
                      |.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|+++......+
T Consensus       199 g~t~L~~A~~~g~~~~v~~Ll~~g~d~~~~d~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~~d~~g  265 (299)
T 1s70_B          199 GGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVG  265 (299)
T ss_dssp             CCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTS
T ss_pred             CCCHHHHHHHCCcHHHHHHHHHcCCCCCCcCCCCCcHHHHHHhcCCHHHHHHHHHcCCCCCCcCCCC
Confidence            3344445555555555555555555555555555555555555555555555555555554433333

>1ikn_D Protein (I-kappa-B-alpha), protein (NF-kappa-B P50D subunit); transcription factor, IKB/NFKB complex; 2.30A {Homo sapiens} SCOP: d.211.1.1 PDB: 1nfi_E

Probab=99.76  E-value=2.6e-18  Score=157.65  Aligned_cols=101  Identities=25%  Similarity=0.229  Sum_probs=96.6

Q ss_pred             CCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCC-CCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhH
Q 012684           33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI-DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG  111 (458)
Q Consensus        33 ~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~-~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~  111 (458)
                      .+..+..|.||||+||..|+.+++++|++.|+++|.++. .|.||||+|+..|+.+++++|+++|++++.+|..|.||||
T Consensus       110 ~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~~~~g~tpl~  189 (236)
T 1ikn_D          110 LKATNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQ  189 (236)
T ss_dssp             GGCCCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGG
T ss_pred             hhccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccCCCCCHHH
Confidence            456677899999999999999999999999999999997 9999999999999999999999999999999999999999


Q ss_pred             HHhhcchHHHHHHHHHhCCCCC
Q 012684          112 DAIYYKNHEVIKLLEKHGAKPL  133 (458)
Q Consensus       112 ~A~~~~~~~~~~~l~~~g~~~~  133 (458)
                      +|+..|+.+++++|+++|++..
T Consensus       190 ~A~~~~~~~~~~~Ll~~ga~~~  211 (236)
T 1ikn_D          190 LTWGRPSTRIQQQLGQLTLENL  211 (236)
T ss_dssp             GCTTSSCHHHHHHHHTTSCGGG
T ss_pred             HHHccCchHHHHHHHHcchhhh
Confidence            9999999999999999999874

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis}

Probab=99.76  E-value=8.4e-18  Score=150.05  Aligned_cols=109  Identities=23%  Similarity=0.314  Sum_probs=100.2

Q ss_pred             hhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHH-HCCCCCCCCCCC
Q 012684           27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL-ERGADVDPKDRW  105 (458)
Q Consensus        27 ~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll-~~ga~~~~~~~~  105 (458)
                      .-.+.|++..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+ ..+++++.+|..
T Consensus        26 ~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~  105 (201)
T 3hra_A           26 QDTTYQVDEVDTEGNTPLNIAVHNNDIEIAKALIDRGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRY  105 (201)
T ss_dssp             TCTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTT
T ss_pred             HcCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCC
Confidence            3344588888899999999999999999999999999999999999999999999999999999999 568899999999


Q ss_pred             CCChhHHHhhcchHHHHHHHHHhC-CCCCCC
Q 012684          106 GSTPLGDAIYYKNHEVIKLLEKHG-AKPLMA  135 (458)
Q Consensus       106 g~tpl~~A~~~~~~~~~~~l~~~g-~~~~~~  135 (458)
                      |.||||+|+..|+.+++++|++.| +++...
T Consensus       106 g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~  136 (201)
T 3hra_A          106 GGNALIPAAEKGHIDNVKLLLEDGREDIDFQ  136 (201)
T ss_dssp             SCCSHHHHHHTTCHHHHHHHHHHCCCCTTCC
T ss_pred             CCcHHHHHHHcCCHHHHHHHHHcCCCCcCCC
Confidence            999999999999999999999999 766443

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A

Probab=99.76  E-value=2.6e-18  Score=159.69  Aligned_cols=109  Identities=25%  Similarity=0.327  Sum_probs=97.8

Q ss_pred             hhhhhcCCC------CCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCC-------------CCCHHHHHHHcC
Q 012684           24 KEAELNGLD------DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID-------------NRTALHVAACQG   84 (458)
Q Consensus        24 ~~~~~n~~d------~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~-------------g~t~l~~A~~~~   84 (458)
                      .+++++..+      ...++..|.||||+||..|+.+++++|++.|+++|.++..             |.||||+|+..|
T Consensus        68 ~g~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~~  147 (256)
T 2etb_A           68 IDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVKLLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTK  147 (256)
T ss_dssp             HHHHTTCSSCGGGCCCCSTTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCCSGGGSCCSSSCCCSCSSHHHHHHHTT
T ss_pred             cCCcccchhhhcccccccccccCCCHHHHHHHcCCHHHHHHHHHcCCCCCcccccccccccccccccCCCCHHHHHHHcC
Confidence            455555433      2234467999999999999999999999999999999886             999999999999


Q ss_pred             CHHHHHHHHH---CCCCCCCCCCCCCChhHHHhh--cchHH-------HHHHHHHhCCCC
Q 012684           85 FTEVVSLLLE---RGADVDPKDRWGSTPLGDAIY--YKNHE-------VIKLLEKHGAKP  132 (458)
Q Consensus        85 ~~~~~~~Ll~---~ga~~~~~~~~g~tpl~~A~~--~~~~~-------~~~~l~~~g~~~  132 (458)
                      +.+++++|++   +|++++.+|..|+||||+|+.  .++.+       ++++|+++|+++
T Consensus       148 ~~~~v~~Ll~~~~~ga~~n~~d~~g~TpLh~A~~~~~~~~~~~~~~~~iv~~Ll~~ga~~  207 (256)
T 2etb_A          148 QWDVVTYLLENPHQPASLEATDSLGNTVLHALVMIADNSPENSALVIHMYDGLLQMGARL  207 (256)
T ss_dssp             CHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHhccccCCCcCccCCCCCCHHHHHHHcccCCchhhHHHHHHHHHHHHcCCCc
Confidence            9999999999   999999999999999999998  77888       999999999987

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A*

Probab=99.76  E-value=1.1e-18  Score=163.90  Aligned_cols=98  Identities=24%  Similarity=0.210  Sum_probs=89.5

Q ss_pred             ccchHHHHHHHhCCHHHHHHHHH---cCCCCCccCCCCCCHHHHHHHcCC---------HHHHHHHHHCCCCCC------
Q 012684           39 KPEFRLMFLANERDVEGIKELLD---SGIDVNFRDIDNRTALHVAACQGF---------TEVVSLLLERGADVD------  100 (458)
Q Consensus        39 ~g~t~l~~a~~~~~~~~~~~ll~---~g~~in~~~~~g~t~l~~A~~~~~---------~~~~~~Ll~~ga~~~------  100 (458)
                      .|.||||+||..|+.+++++|++   .|+++|.+|..|+||||+|+..|+         .+++++|+++|++++      
T Consensus       147 ~g~tpL~~A~~~g~~~~v~~Ll~~~~~gad~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n~~~~~~  226 (273)
T 2pnn_A          147 FGELPLSLAACTNQLAIVKFLLQNSWQPADISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLHPTLKLE  226 (273)
T ss_dssp             SCBSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHCTTCCGG
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHhcccCCCCceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhcccccccc
Confidence            79999999999999999999999   999999999999999999999998         899999999999997      


Q ss_pred             -CCCCCCCChhHHHhhcchHHHHHHHHHhCC-CCCCCc
Q 012684          101 -PKDRWGSTPLGDAIYYKNHEVIKLLEKHGA-KPLMAP  136 (458)
Q Consensus       101 -~~~~~g~tpl~~A~~~~~~~~~~~l~~~g~-~~~~~~  136 (458)
                       .+|..|.||||+|+..|+.+++++|+++|+ |+...+
T Consensus       227 ~~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~dp~~~~  264 (273)
T 2pnn_A          227 EITNRKGLTPLALAASSGKIGVLAYILQREIHEPECRH  264 (273)
T ss_dssp             GCCCTTSCCHHHHHHHTTCHHHHHHHHHHHTC------
T ss_pred             cccCCCCCCHHHHHHHhChHHHHHHHHHCCCCCchhhh
Confidence             489999999999999999999999999999 665444

>3aji_A 26S proteasome non-ATPase regulatory subunit 10; gankyrin, S6 ATPase, P-benzoyl-L-phenylalanine, PBPA, amber suppression; HET: PBF; 2.05A {Mus musculus} PDB: 2dvw_A 2dwz_A* 1tr4_A 1uoh_A 1qym_A

Probab=99.76  E-value=6.5e-18  Score=154.27  Aligned_cols=108  Identities=29%  Similarity=0.351  Sum_probs=94.0

Q ss_pred             CCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChh
Q 012684           31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL  110 (458)
Q Consensus        31 ~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl  110 (458)
                      .+.+..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus        31 ~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L  110 (231)
T 3aji_A           31 SLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGXDEIVKALLVKGAHVNAVNQNGCTPL  110 (231)
T ss_dssp             GGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHH
T ss_pred             hhhhcCCCCCCCHHHHHHHcCcHHHHHHHHHhCCCCCCcCCCCCCHHHHHHHcCHHHHHHHHHHcCCCCCCCCCCCCCHH
Confidence            34556677788999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhcchHHHHHHHHHhCCCCCCCccc
Q 012684          111 GDAIYYKNHEVIKLLEKHGAKPLMAPMH  138 (458)
Q Consensus       111 ~~A~~~~~~~~~~~l~~~g~~~~~~~~~  138 (458)
                      |+|+..++.+++++|++.|+++......
T Consensus       111 ~~A~~~~~~~~~~~Ll~~g~~~~~~~~~  138 (231)
T 3aji_A          111 HYAASKNRHEIAVMLLEGGANPDAKDHY  138 (231)
T ss_dssp             HHHHHTTCHHHHHHHHHTTCCTTCCCTT
T ss_pred             HHHHHcCCHHHHHHHHHcCCCCCCcCCC
Confidence            9999999999999999999887654433

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A*

Probab=99.75  E-value=6.2e-18  Score=155.02  Aligned_cols=106  Identities=22%  Similarity=0.326  Sum_probs=72.7

Q ss_pred             CCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChh
Q 012684           31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL  110 (458)
Q Consensus        31 ~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl  110 (458)
                      .+.+..+..|.||||+|+..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus       102 ~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L  181 (237)
T 3b7b_A          102 MDVNCQDDGGWTPMIWATEYKHVDLVKLLLSKGSDINIRDNEENICLHWAAFSGCVDIAEILLAAKCDLHAVNIHGDSPL  181 (237)
T ss_dssp             CCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCHHHHHHHHTTTCCTTCCCTTCCCHH
T ss_pred             CCcccCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCcCCCCCCHH
Confidence            55566666666777777777777777777777777766666677777777777777777777777777777766677777


Q ss_pred             HHHhhcchHHHHHHHHHhCCCCCCCc
Q 012684          111 GDAIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       111 ~~A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      |+|+..|+.+++++|+++|+++....
T Consensus       182 ~~A~~~~~~~~v~~Ll~~gad~~~~d  207 (237)
T 3b7b_A          182 HIAARENRYDCVVLFLSRDSDVTLKN  207 (237)
T ss_dssp             HHHHHTTCHHHHHHHHTTTCCTTCCC
T ss_pred             HHHHHhCCHhHHHHHHHcCCCCCccC
Confidence            77777777777777777776665443

>3deo_A Signal recognition particle 43 kDa protein; chloroplast SRP system, signal sequence, ankyrin repeat, chromodomain, type I turn; 1.50A {Arabidopsis thaliana} SCOP: b.34.13.2 k.37.1.1 PDB: 3dep_A 1x32_A

Probab=99.75  E-value=4.9e-18  Score=149.70  Aligned_cols=92  Identities=33%  Similarity=0.341  Sum_probs=86.6

Q ss_pred             hhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccC-CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCC
Q 012684           26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDR  104 (458)
Q Consensus        26 ~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~-~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~  104 (458)
                      ..+.+.|++..+..|.||||+||..|+.+++++|++.|+++|.++ ..|.||||+|+..|+.+++++|+++|++++.+|.
T Consensus        62 ~Ll~~~~~~~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~ga~~~~~d~  141 (183)
T 3deo_A           62 QLLEDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVEDE  141 (183)
T ss_dssp             HHTTTSCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCT
T ss_pred             HHHhcCCCCCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHhcCcHHHHHHHHHcCCCCcCCCC
Confidence            344488999999999999999999999999999999999999998 8899999999999999999999999999999999


Q ss_pred             CCCChhHHHhhcc
Q 012684          105 WGSTPLGDAIYYK  117 (458)
Q Consensus       105 ~g~tpl~~A~~~~  117 (458)
                      .|.||||+|+..+
T Consensus       142 ~g~tpl~~A~~~~  154 (183)
T 3deo_A          142 RGLTALELAREIL  154 (183)
T ss_dssp             TSCCHHHHHHHHH
T ss_pred             CCCCHHHHHHHhc
Confidence            9999999998763

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A*

Probab=99.75  E-value=9.4e-19  Score=163.05  Aligned_cols=97  Identities=19%  Similarity=0.131  Sum_probs=92.3

Q ss_pred             CccchHHHHHHHhCCHHHHHHHHH---cCCCCCccCCCCCCHHHHHHHcCC---------HHHHHHHHHCCCCC------
Q 012684           38 IKPEFRLMFLANERDVEGIKELLD---SGIDVNFRDIDNRTALHVAACQGF---------TEVVSLLLERGADV------   99 (458)
Q Consensus        38 ~~g~t~l~~a~~~~~~~~~~~ll~---~g~~in~~~~~g~t~l~~A~~~~~---------~~~~~~Ll~~ga~~------   99 (458)
                      ..|.||||+||..|+.+++++|++   .|+++|.+|..|+||||+|+..++         .+++++|+++|+++      
T Consensus       138 ~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga~~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~~  217 (260)
T 3jxi_A          138 YFGELPLSLAACTNQPHIVHYLTENGHKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLFPDTNL  217 (260)
T ss_dssp             CSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHHHHHCTTCCG
T ss_pred             cCCCCHHHHHHHcCCHHHHHHHHhccccCCCCcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhCcccccccch
Confidence            689999999999999999999999   999999999999999999999888         79999999999999      


Q ss_pred             -CCCCCCCCChhHHHhhcchHHHHHHHHHhCCCCCC
Q 012684          100 -DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       100 -~~~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~  134 (458)
                       +.+|..|.||||+|+..|+.+++++|+++|++...
T Consensus       218 ~~~~d~~g~tpL~~A~~~g~~~~v~~Ll~~g~~~~~  253 (260)
T 3jxi_A          218 EALLNNDGLSPLMMAAKTGKIGIFQHIIRREIADAA  253 (260)
T ss_dssp             GGCCCTTSCCHHHHHHHTTCHHHHHHHHHHHHHHHC
T ss_pred             hhcccCCCCCHHHHHHHcCCHHHHHHHHHhCCCccc
Confidence             67999999999999999999999999999987643

>3jxi_A Vanilloid receptor-related osmotically activated protein; ankyrin repeats, ANK repeat, ION transport, ionic channel, R transmembrane, transport; 2.30A {Gallus gallus} PDB: 3jxj_A 4dx1_A 4dx2_A*

Probab=99.75  E-value=3.4e-18  Score=159.25  Aligned_cols=103  Identities=22%  Similarity=0.236  Sum_probs=95.7

Q ss_pred             CCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccC--------------CCCCCHHHHHHHcCCHHHHHHHHH--
Q 012684           31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD--------------IDNRTALHVAACQGFTEVVSLLLE--   94 (458)
Q Consensus        31 ~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~--------------~~g~t~l~~A~~~~~~~~~~~Ll~--   94 (458)
                      .+.+..+..|.||||+||..|+.+++++|++.|+++|.++              ..|.||||+|+..|+.+++++|++  
T Consensus        84 ~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~  163 (260)
T 3jxi_A           84 SPFRDVYYRGQTALHIAIERRCKHYVELLVEKGADVHAQARGRFFQPKDEGGYFYFGELPLSLAACTNQPHIVHYLTENG  163 (260)
T ss_dssp             CCBCCSSEESBCHHHHHHHTTCHHHHHHHHHTTCCTTCCCEECCCSSSCCCCSCCSCSSHHHHHHHTTCHHHHHHHHHCS
T ss_pred             ccccccccCCCCHHHHHHHcCCHHHHHHHHhCCCCcCccccccccCcccccccccCCCCHHHHHHHcCCHHHHHHHHhcc
Confidence            4455566689999999999999999999999999999998              689999999999999999999999  


Q ss_pred             -CCCCCCCCCCCCCChhHHHhhcch---------HHHHHHHHHhCCCCC
Q 012684           95 -RGADVDPKDRWGSTPLGDAIYYKN---------HEVIKLLEKHGAKPL  133 (458)
Q Consensus        95 -~ga~~~~~~~~g~tpl~~A~~~~~---------~~~~~~l~~~g~~~~  133 (458)
                       +|++++.+|..|.||||+|+..++         .+++++|+++|+++.
T Consensus       164 ~~ga~~~~~d~~g~TpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~~  212 (260)
T 3jxi_A          164 HKQADLRRQDSRGNTVLHALVAIADNTRENTKFVTKMYDLLLIKCAKLF  212 (260)
T ss_dssp             SCCCCTTCCCTTSCCHHHHHHHHCCSSHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             ccCCCCcccCCCCCcHHHHHHHhccCchhHHHHHHHHHHHHHHhCcccc
Confidence             999999999999999999998776         799999999999873

>3ui2_A Signal recognition particle 43 kDa protein, chlor; ankyrin repeat, chromodomain, aromatic CAGE, signal recognit particle, protein targeting; 3.18A {Arabidopsis thaliana} PDB: 1x3q_A 2hug_A

Probab=99.75  E-value=5.2e-18  Score=156.79  Aligned_cols=109  Identities=31%  Similarity=0.315  Sum_probs=99.9

Q ss_pred             hhhhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccC-CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Q 012684           24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPK  102 (458)
Q Consensus        24 ~~~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~-~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~  102 (458)
                      ....+.+.|++.++..|.||||+||..|+.+++++|+++|+++|.++ ..|.||||+|+..|+.+++++|+++|++++.+
T Consensus        61 v~~Ll~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~  140 (244)
T 3ui2_A           61 LSQLLEDRDVDAVDENGRTALLFVAGLGSDKCVRLLAEAGADLDHRDMRGGLTALHMAAGYVRPEVVEALVELGADIEVE  140 (244)
T ss_dssp             HHHTTTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCSSSCCCHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred             HHHHHcCCCCCCcCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC
Confidence            33445588999999999999999999999999999999999999998 88999999999999999999999999999999


Q ss_pred             CCCCCChhHHHh----------------hcchHHHHHHHHHhCCCC
Q 012684          103 DRWGSTPLGDAI----------------YYKNHEVIKLLEKHGAKP  132 (458)
Q Consensus       103 ~~~g~tpl~~A~----------------~~~~~~~~~~l~~~g~~~  132 (458)
                      |..|.||||+|+                ..|+.+++++|.+.+.+.
T Consensus       141 d~~g~t~l~~A~~~~~~~~~~~~l~~a~~~g~~~iv~~L~~~~~~~  186 (244)
T 3ui2_A          141 DERGLTALELAREILKTTPKGNPMQFGRRIGLEKVINVLEGQVFEY  186 (244)
T ss_dssp             CTTCCCHHHHHHHHHTTCCCSSHHHHHHHHHHHHHHHHHHHHHEEE
T ss_pred             CCCCCcHHHHHHHHHhccCCCCHHHHHHHcChHHHHHHHHHhcccc
Confidence            999999999888                568899999999887653

>1yyh_A HN1;, notch 1, ankyrin domain; ankyrin repeats, cell cycle,transcription; 1.90A {Homo sapiens} PDB: 2he0_A 2f8x_K 3nbn_B 3v79_K* 1ot8_A

Probab=99.75  E-value=5.7e-18  Score=157.26  Aligned_cols=108  Identities=25%  Similarity=0.252  Sum_probs=74.2

Q ss_pred             cCCCCCC-CcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCC-CCCCCCCCC
Q 012684           29 NGLDDDG-EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPKDRWG  106 (458)
Q Consensus        29 n~~d~~~-~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga-~~~~~~~~g  106 (458)
                      .|.+.+. .+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|+ +++.++..|
T Consensus        45 ~g~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g  124 (253)
T 1yyh_A           45 QGASLHNQTDRTGETALHLAARYSRSDAAKRLLEASADANIQDNMGRTPLHAAVSADAQGVFQILIRNRATDLDARMHDG  124 (253)
T ss_dssp             -------CCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHSTTSCTTCCCTTC
T ss_pred             ccCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCccccCCCC
Confidence            3444433 35667777777777777777777777777777777777777777777777777777777765 777777777


Q ss_pred             CChhHHHhhcchHHHHHHHHHhCCCCCCCc
Q 012684          107 STPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       107 ~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      .||||+|+..|+.+++++|++.|+++....
T Consensus       125 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~d  154 (253)
T 1yyh_A          125 TTPLILAARLAVEGMLEDLINSHADVNAVD  154 (253)
T ss_dssp             CCHHHHHHHHTCSSHHHHHHHTTCCTTCBC
T ss_pred             CcHHHHHHHcChHHHHHHHHHcCCCCCCcC
Confidence            777777777777777777777777765444

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus}

Probab=99.74  E-value=2.9e-18  Score=162.29  Aligned_cols=103  Identities=25%  Similarity=0.251  Sum_probs=98.0

Q ss_pred             CCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChh
Q 012684           31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL  110 (458)
Q Consensus        31 ~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl  110 (458)
                      .+++.+|..|.||||+||..|+.+++++|++.|+++|.+|  |.||||+|+..|+.+++++|+++|++++.+|..|.|||
T Consensus        22 ~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~--g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L   99 (285)
T 3kea_A           22 KDTFKADVHGHSASYYAIADNNVRLVCTLLNAGALKNLLE--NEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTAL   99 (285)
T ss_dssp             TTTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTGGGSCCT--TCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHH
T ss_pred             CCCCccCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCC--CCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHH
Confidence            3788999999999999999999999999999999999884  99999999999999999999999999999999999999


Q ss_pred             HHHhhcchHHHHHHHHHhCCCCCCC
Q 012684          111 GDAIYYKNHEVIKLLEKHGAKPLMA  135 (458)
Q Consensus       111 ~~A~~~~~~~~~~~l~~~g~~~~~~  135 (458)
                      |+|+..|+.+++++|+++|+++...
T Consensus       100 ~~A~~~g~~~~v~~Ll~~ga~~~~~  124 (285)
T 3kea_A          100 YYAVDSGNMQTVKLFVKKNWRLMFY  124 (285)
T ss_dssp             HHHHHTTCHHHHHHHHHHCGGGGGC
T ss_pred             HHHHHcCCHHHHHHHHhcCCCCCcc
Confidence            9999999999999999999997543

>3hra_A Ankyrin repeat family protein; structural protein; 1.69A {Enterococcus faecalis}

Probab=99.74  E-value=1.1e-17  Score=149.38  Aligned_cols=111  Identities=25%  Similarity=0.331  Sum_probs=101.9

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHH-HcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCC-CCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRW  105 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll-~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~g-a~~~~~~~~  105 (458)
                      -.|+|++..+..|.||||+|+..|+.+++++|+ ..+++++.+|..|.||||+|+..|+.+++++|+++| ++++.+|..
T Consensus        60 ~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~~  139 (201)
T 3hra_A           60 DRGADINLQNSISDSPYLYAGAQGRTEILAYMLKHATPDLNKHNRYGGNALIPAAEKGHIDNVKLLLEDGREDIDFQNDF  139 (201)
T ss_dssp             HTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCTTSCCSHHHHHHTTCHHHHHHHHHHCCCCTTCCCTT
T ss_pred             HcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhccCcccccccCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcCCCCCC
Confidence            357888888999999999999999999999999 567899999999999999999999999999999998 999999999


Q ss_pred             CCChhHHHhhcch-----HHHHHHHHHhCCCCCCCccc
Q 012684          106 GSTPLGDAIYYKN-----HEVIKLLEKHGAKPLMAPMH  138 (458)
Q Consensus       106 g~tpl~~A~~~~~-----~~~~~~l~~~g~~~~~~~~~  138 (458)
                      |.||||+|+..++     .+++++|+++|+++......
T Consensus       140 g~t~L~~A~~~~~~~~~~~~~v~~Ll~~ga~~~~~~~~  177 (201)
T 3hra_A          140 GYTALIEAVGLREGNQLYQDIVKLLMENGADQSIKDNS  177 (201)
T ss_dssp             SCCHHHHHHHSSCCSHHHHHHHHHHHHTTCCTTCCCTT
T ss_pred             CCCHHHHHHHhccchhhHHHHHHHHHHCCCCCCccCCC
Confidence            9999999999887     89999999999998765433

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.74  E-value=4.3e-18  Score=158.69  Aligned_cols=135  Identities=21%  Similarity=0.215  Sum_probs=102.9

Q ss_pred             ccCceeeccceEEEEEE-----cCeE--EEEEEcCCCCCCC---------------------HHHHHHHHHHHHHHhcCC
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQ--VAVKKLGEEVISD---------------------DDRVRAFRDELALLQKIR  208 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~--vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~  208 (458)
                      |.+...||+|+||.||.     +|+.  ||||+++......                     ......+.+|+.+++.+.
T Consensus        49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~  128 (258)
T 1zth_A           49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAK  128 (258)
T ss_dssp             EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHHH
Confidence            55668999999998872     6888  9999975432110                     112235788999999998


Q ss_pred             CCcc--eeeeeEEEeCCceEEEEEccCC-C----CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeeeCCCC
Q 012684          209 HPNV--VQFLGAVTQSSPMMIVTEYLPK-G----DLRAFLKRKGALKPSTAVRFALDIARGMNYLH-ENKPVPIIHRDLE  280 (458)
Q Consensus       209 hp~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH-~~~~~~i~H~Dik  280 (458)
                      |+++  +.+++.    ...++||||+.+ |    +|.++...   .++..+..++.|++.+|.||| +.|   |+|||||
T Consensus       129 ~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~g---ivHrDlk  198 (258)
T 1zth_A          129 EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAE---LVHADLS  198 (258)
T ss_dssp             HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSC---EECSSCS
T ss_pred             hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCC---EEeCCCC
Confidence            7754  445543    356899999932 3    77776432   345678899999999999999 998   9999999


Q ss_pred             CCCEEecCCCCEEEeecCCcccc
Q 012684          281 PSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       281 p~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      |.|||++.  .++|+|||++...
T Consensus       199 p~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          199 EYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TTSEEESS--SEEECCCTTCEET
T ss_pred             HHHEEEcC--cEEEEECcccccC
Confidence            99999998  9999999998753

>4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A*

Probab=99.74  E-value=7.1e-18  Score=163.39  Aligned_cols=103  Identities=26%  Similarity=0.332  Sum_probs=84.5

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHc-CCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG  106 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~-g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g  106 (458)
                      -.|+|++.++..|.||||+||..|+.++++.|++. |+++|.+|.+|+||||+|+..|+.+++++|+++||++|.+    
T Consensus       227 ~~gad~n~~d~~g~t~L~~a~~~~~~~~v~~Ll~~~~~~vn~~d~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~~----  302 (337)
T 4g8k_A          227 DHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCG----  302 (337)
T ss_dssp             HTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHTSTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHTTSCSSTTC----
T ss_pred             HCCCCCCCcCCCCCCHHHHHHHhhhhHHHHHHHHhcCCcccCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCC----
Confidence            35777888888888888888888888888888874 7888888888888888888888888888888888888754    


Q ss_pred             CChhHHHhhcchHHHHHHHHHhCCCCCCC
Q 012684          107 STPLGDAIYYKNHEVIKLLEKHGAKPLMA  135 (458)
Q Consensus       107 ~tpl~~A~~~~~~~~~~~l~~~g~~~~~~  135 (458)
                       +|||+|+..|+.+++++|+++||++++.
T Consensus       303 -~~L~~A~~~~~~~iv~~Ll~~GA~~d~~  330 (337)
T 4g8k_A          303 -DLVMTARRNYDHSLVKVLLSHGAKEDFH  330 (337)
T ss_dssp             -CHHHHHHHTTCHHHHHHHHHTTCCC---
T ss_pred             -CHHHHHHHcCCHHHHHHHHHCcCCCCCC
Confidence             4888888888888888888888887653

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major}

Probab=99.74  E-value=5.5e-18  Score=166.01  Aligned_cols=107  Identities=20%  Similarity=0.205  Sum_probs=96.7

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCC-----CCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID-----VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD  103 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~-----in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~  103 (458)
                      .|+|++..+..|.||||+||..|+.+++++|++.|++     +|.+|..|.||||+|+..|+.+++++|+++|++++.+|
T Consensus       162 ~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~~~~d  241 (364)
T 3ljn_A          162 LGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANKQGNSHLHWAILINWEDVAMRFVEMGIDVNMED  241 (364)
T ss_dssp             HTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTTCCTTCCC
T ss_pred             cCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCC
Confidence            4788888888899999999999999999999999888     99999999999999999999999999999999999999


Q ss_pred             CCCCChhHHHhhcchHHHHHHHHHhCCCCCCC
Q 012684          104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA  135 (458)
Q Consensus       104 ~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~  135 (458)
                      ..|.||||+|+..|+.+++++|+++|+++...
T Consensus       242 ~~g~tpL~~A~~~g~~~~v~~Ll~~~~~~~~~  273 (364)
T 3ljn_A          242 NEHTVPLYLSVRAAMVLLTKELLQKTDVFLIQ  273 (364)
T ss_dssp             TTSCCHHHHHHHTCCHHHHHHHHHHSCHHHHH
T ss_pred             CCCCCHHHHHHHhChHHHHHHHHHcCCchhhh
Confidence            99999999999999999999999998876443

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A

Probab=99.74  E-value=8.6e-18  Score=164.14  Aligned_cols=106  Identities=28%  Similarity=0.352  Sum_probs=90.2

Q ss_pred             hhhcCCCCCCCc--CccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Q 012684           26 AELNGLDDDGEE--IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD  103 (458)
Q Consensus        26 ~~~n~~d~~~~~--~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~  103 (458)
                      ..-.|+|++..+  ..|.||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|
T Consensus       219 LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~A~~~g~~~~v~~LL~~Gad~~~~d  298 (368)
T 3jue_A          219 ALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHHATILGHTGLACLFLKRGADLGARD  298 (368)
T ss_dssp             HHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred             HHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCcHHHHHHHHHCcCCCCCcC
Confidence            344677777776  678888999998888999999998888888888888899999998888999999998899888888


Q ss_pred             CCCCChhHHHhhcchHHHHHHHHHhCCC
Q 012684          104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK  131 (458)
Q Consensus       104 ~~g~tpl~~A~~~~~~~~~~~l~~~g~~  131 (458)
                      ..|.||||+|+..++.+++++|+..+..
T Consensus       299 ~~G~TpL~~A~~~g~~~iv~lLl~~~~~  326 (368)
T 3jue_A          299 SEGRDPLTIAMETANADIVTLLRLAKMR  326 (368)
T ss_dssp             TTSCCHHHHHHHTTCHHHHHHHHHHHC-
T ss_pred             CCCCCHHHHHHHCCCHHHHHHHHHcCCC
Confidence            8888999999888888888888888743

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1

Probab=99.74  E-value=8.4e-18  Score=162.37  Aligned_cols=115  Identities=19%  Similarity=0.152  Sum_probs=96.0

Q ss_pred             hcCCCCCC-CcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC---------------------
Q 012684           28 LNGLDDDG-EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF---------------------   85 (458)
Q Consensus        28 ~n~~d~~~-~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~---------------------   85 (458)
                      -.|+|+|. ++..|.||||+||..|+.++|++|+++|+++|.+|.+|.||||+|+..|+                     
T Consensus       118 ~~g~dvn~~~d~~g~TpLh~Aa~~g~~~~v~~Ll~~Gad~n~~d~~g~TpLh~A~~~g~~~~~~~~~~ll~~~~~~~~~~  197 (327)
T 1sw6_A          118 NTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILE  197 (327)
T ss_dssp             TSCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEE
T ss_pred             hcCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCHHHHHHHhcccccHHHHHHHHHhhhccccCC
Confidence            35788999 89999999999999999999999999999999999999999999998655                     


Q ss_pred             --------------------HHHHHHHHHCCC---------------------------------------------CCC
Q 012684           86 --------------------TEVVSLLLERGA---------------------------------------------DVD  100 (458)
Q Consensus        86 --------------------~~~~~~Ll~~ga---------------------------------------------~~~  100 (458)
                                          .+++++|++.++                                             ++|
T Consensus       198 d~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~Ll~~~~n  277 (327)
T 1sw6_A          198 DSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLN  277 (327)
T ss_dssp             CTTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTT
T ss_pred             CCCCCCHHHHHHHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHHHHhCCC
Confidence                                344555554422                                             578


Q ss_pred             CCCCCCCChhHHHhhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684          101 PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus       101 ~~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      .+|..|+||||+|+..|+.+++++|+++|+++......+.++
T Consensus       278 ~~d~~G~TpLh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~Tp  319 (327)
T 1sw6_A          278 AQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRP  319 (327)
T ss_dssp             CCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCG
T ss_pred             CCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCH
Confidence            888899999999999999999999999999987665555444

>2etb_A Transient receptor potential cation channel subfamily V member 2; TRPV2, ankyrin repeat domain, transport protein; 1.65A {Rattus norvegicus} PDB: 2eta_A 2etc_A 2f37_A

Probab=99.74  E-value=3.4e-18  Score=158.90  Aligned_cols=108  Identities=26%  Similarity=0.177  Sum_probs=98.8

Q ss_pred             cCCCCCC----CcCccchHHHHHHHh---CCHHHHHHHHHcCCCCCc-----------cCCCCCCHHHHHHHcCCHHHHH
Q 012684           29 NGLDDDG----EEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNF-----------RDIDNRTALHVAACQGFTEVVS   90 (458)
Q Consensus        29 n~~d~~~----~~~~g~t~l~~a~~~---~~~~~~~~ll~~g~~in~-----------~~~~g~t~l~~A~~~~~~~~~~   90 (458)
                      +++|++.    .+..|.||||+||..   |+.+++++|++.|++++.           +|..|.||||+|+..|+.++++
T Consensus        28 ~g~~i~~~~~~~d~~g~t~L~~A~~~~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~  107 (256)
T 2etb_A           28 NSKYLTDSAYTEGSTGKTCLMKAVLNLQDGVNACIMPLLQIDKDSGNPKPLVNAQCTDEFYQGHSALHIAIEKRSLQCVK  107 (256)
T ss_dssp             HTCCTTSGGGSBTTTTBCHHHHHHHTCBTTBCTTHHHHHHHHHHTTCSSCGGGCCCCSTTTTTCCHHHHHHHTTCHHHHH
T ss_pred             cCCCcccccccCCCCCCCHHHHHHHccccchHHHHHHHHhcCCcccchhhhcccccccccccCCCHHHHHHHcCCHHHHH
Confidence            5778887    788999999999999   999999999999988764           3477999999999999999999


Q ss_pred             HHHHCCCCCCCCCCC-------------CCChhHHHhhcchHHHHHHHHH---hCCCCCCCc
Q 012684           91 LLLERGADVDPKDRW-------------GSTPLGDAIYYKNHEVIKLLEK---HGAKPLMAP  136 (458)
Q Consensus        91 ~Ll~~ga~~~~~~~~-------------g~tpl~~A~~~~~~~~~~~l~~---~g~~~~~~~  136 (458)
                      +|+++|++++.++..             |.||||+|+..|+.+++++|++   +|+++....
T Consensus       108 ~Ll~~ga~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~~~~ga~~n~~d  169 (256)
T 2etb_A          108 LLVENGADVHLRACGRFFQKHQGTCFYFGELPLSLAACTKQWDVVTYLLENPHQPASLEATD  169 (256)
T ss_dssp             HHHHTTCCTTCCCCSGGGSCCSSSCCCSCSSHHHHHHHTTCHHHHHHHHHCSSCCCCTTCCC
T ss_pred             HHHHcCCCCCcccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhccccCCCcCccC
Confidence            999999999999986             9999999999999999999999   899986543

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1

Probab=99.74  E-value=9.3e-18  Score=168.50  Aligned_cols=111  Identities=27%  Similarity=0.322  Sum_probs=91.5

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      +++|++..+..|.||||+|+..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|+++|.+|..|.|
T Consensus       267 ~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~gad~n~~~~~g~t  346 (437)
T 1n11_A          267 KQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYS  346 (437)
T ss_dssp             TTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCC
T ss_pred             cCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCccCCCCCCCCCCHHHHHHHcCcHHHHHHHHhcCCCCCCCCCCCCC
Confidence            56677777778888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             hhHHHhhcchHHHHHHHHHhCCCCCCCcccc
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHV  139 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~  139 (458)
                      |||+|+..|+.+++++|+++|+++......+
T Consensus       347 ~L~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g  377 (437)
T 1n11_A          347 PLHQAAQQGHTDIVTLLLKNGASPNEVSSDG  377 (437)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCSCCCCSSS
T ss_pred             HHHHHHHCChHHHHHHHHHCcCCCCCCCCCC
Confidence            8888888888888888888888876544333

>1oy3_D Transcription factor inhibitor I-kappa-B-beta; protein-protein complex, transcription factors, nuclear localization, DNA binding protein; 2.05A {Mus musculus} SCOP: d.211.1.1 PDB: 1k3z_D

Probab=99.74  E-value=9.3e-18  Score=157.79  Aligned_cols=69  Identities=36%  Similarity=0.481  Sum_probs=36.4

Q ss_pred             CCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCC-CCChhHHHhhcchHHHHHHHHHhCCCCCC
Q 012684           66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW-GSTPLGDAIYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus        66 in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~-g~tpl~~A~~~~~~~~~~~l~~~g~~~~~  134 (458)
                      +|.++..|.||||+|+..|+.+++++|+++|++++.++.. |.||||+|+..|+.+++++|+++|+++..
T Consensus       151 ~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~A~~~~~~~~v~~Ll~~gad~~~  220 (282)
T 1oy3_D          151 LEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTA  220 (282)
T ss_dssp             TTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTC
T ss_pred             CCCcCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCCCCCCCCCcCHHHHHHHcCCHHHHHHHHHcCCCCcc
Confidence            3444445555555555555555555555555555555432 55555555555555555555555555443

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1

Probab=99.73  E-value=2.3e-17  Score=154.97  Aligned_cols=106  Identities=28%  Similarity=0.263  Sum_probs=100.5

Q ss_pred             CCCCCCCcCccchHHHHHHHhCC----HHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHH-CCCCCCCCCC
Q 012684           30 GLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDR  104 (458)
Q Consensus        30 ~~d~~~~~~~g~t~l~~a~~~~~----~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~-~ga~~~~~~~  104 (458)
                      +.|++..+..|.||||+|+..++    .+++++|++.|+++|.+|..|.||||+|+..|+.+++++|++ .|++++.+|.
T Consensus       172 ~~~~~~~~~~g~t~l~~a~~~~~~~~~~~i~~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~g~~~~~~~~  251 (285)
T 1wdy_A          172 GADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDS  251 (285)
T ss_dssp             CCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCT
T ss_pred             CCCCCccCCCCCCHHHHHHHccccchHHHHHHHHHHcCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhccCCCccccCC
Confidence            88888889999999999999999    999999999999999999999999999999999999999999 7999999999


Q ss_pred             CCCChhHHHhhcchHHHHHHHHHhCCCCCCC
Q 012684          105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA  135 (458)
Q Consensus       105 ~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~  135 (458)
                      .|.||||+|+..|+.+++++|+++|+++...
T Consensus       252 ~g~t~l~~A~~~~~~~i~~~Ll~~Ga~~~~~  282 (285)
T 1wdy_A          252 DGKTALLLAVELKLKKIAELLCKRGASTDCG  282 (285)
T ss_dssp             TSCCHHHHHHHTTCHHHHHHHHHHSSCSCCS
T ss_pred             CCCcHHHHHHHcCcHHHHHHHHHcCCCCCcc
Confidence            9999999999999999999999999998654

>1n11_A Ankyrin; clathrin, BAND 3, anion exchanger, structural protein; 2.70A {Homo sapiens} SCOP: d.211.1.1

Probab=99.73  E-value=9.6e-18  Score=168.38  Aligned_cols=107  Identities=30%  Similarity=0.365  Sum_probs=82.3

Q ss_pred             CCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 012684           30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP  109 (458)
Q Consensus        30 ~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp  109 (458)
                      |++++..+..|.||||+||..|+.++|++|++.|+++|.++..|.||||+||..|+.+++++|+++|++++.++..|.||
T Consensus         4 g~~~~~~~~~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~~~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~   83 (437)
T 1n11_A            4 GISGGGGGESGLTPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTP   83 (437)
T ss_dssp             -----------CCHHHHHHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCH
T ss_pred             CCCccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCH
Confidence            45666667778888888888888888888888888888888888888888888888888888888888888888888888


Q ss_pred             hHHHhhcchHHHHHHHHHhCCCCCCCc
Q 012684          110 LGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       110 l~~A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      ||+|+..|+.+++++|+++|+++....
T Consensus        84 L~~A~~~g~~~~v~~Ll~~ga~~~~~~  110 (437)
T 1n11_A           84 LHCAARIGHTNMVKLLLENNANPNLAT  110 (437)
T ss_dssp             HHHHHHHTCHHHHHHHHHHTCCTTCCC
T ss_pred             HHHHHHCCCHHHHHHHHhCCCCCCCCC
Confidence            888888888888888888888875543

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens}

Probab=99.73  E-value=2.3e-17  Score=156.13  Aligned_cols=102  Identities=25%  Similarity=0.272  Sum_probs=97.9

Q ss_pred             CCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhH
Q 012684           32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLG  111 (458)
Q Consensus        32 d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~  111 (458)
                      ..+.++..|+||||+||..|+.+++++|++.|+++|.+|.+|.||||+|+..|+.+++++|+++|++++.+|..|.||||
T Consensus        51 ~~~~~~~~g~t~L~~Aa~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~  130 (285)
T 3d9h_A           51 PLMGDAVSDWSPMHEAAIHGHQLSLRNLISQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLF  130 (285)
T ss_dssp             TTCSSSCCSCCHHHHHHHTTCHHHHHHHHHTTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHH
T ss_pred             cccCCCccCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHH
Confidence            35677889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHhhcchHHHHHHHHHhCCCCC
Q 012684          112 DAIYYKNHEVIKLLEKHGAKPL  133 (458)
Q Consensus       112 ~A~~~~~~~~~~~l~~~g~~~~  133 (458)
                      +|+..|+.+++++|++.|+++.
T Consensus       131 ~A~~~~~~~~v~~Ll~~g~~~~  152 (285)
T 3d9h_A          131 NACVSGSWDCVNLLLQHGASVQ  152 (285)
T ss_dssp             HHHHHTCHHHHHHHHHTTCCSS
T ss_pred             HHHHcCHHHHHHHHHHCCCCCC
Confidence            9999999999999999999874

>2dzn_A Probable 26S proteasome regulatory subunit P28; ankyrin repeats, A-helical domain, structural genomics, NPPSFA; 2.20A {Saccharomyces cerevisiae} SCOP: d.211.1.1 PDB: 2dzo_A 1ixv_A 1wg0_A

Probab=99.72  E-value=2.7e-17  Score=149.72  Aligned_cols=97  Identities=27%  Similarity=0.301  Sum_probs=53.2

Q ss_pred             CcCccchHHHHHHHhCCHHHHHHHHHcC--CCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHH
Q 012684           36 EEIKPEFRLMFLANERDVEGIKELLDSG--IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA  113 (458)
Q Consensus        36 ~~~~g~t~l~~a~~~~~~~~~~~ll~~g--~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A  113 (458)
                      .+..|.||||+|+..|+.+++++|++.|  ++++.++..|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|
T Consensus        68 ~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A  147 (228)
T 2dzn_A           68 PDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRA  147 (228)
T ss_dssp             CCTTSCCHHHHHHHHCCHHHHHHHHSSSSCCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHH
T ss_pred             CCCCCCCHHHHHHHcCCHHHHHHHHhCCCCcccccCCcCCCCHHHHHHHcCCHhHHHHHHHcCCCccccCCCCCCHHHHH
Confidence            3444555555555555555555555555  55555555555555555555555555555555555555555555555555


Q ss_pred             hhcchHHHHHHHHHhC-CCC
Q 012684          114 IYYKNHEVIKLLEKHG-AKP  132 (458)
Q Consensus       114 ~~~~~~~~~~~l~~~g-~~~  132 (458)
                      +..|+.+++++|++.| +++
T Consensus       148 ~~~~~~~~v~~Ll~~g~~~~  167 (228)
T 2dzn_A          148 ASVGSLKLIELLCGLGKSAV  167 (228)
T ss_dssp             HHTTCHHHHHHHHTTTCCCS
T ss_pred             HHcCCHHHHHHHHhcCcccc
Confidence            5555555555555555 443

>2pnn_A Transient receptor potential cation channel subfa member 1; TRPV1, ankyrin repeat domain, transport protein; HET: ATP; 2.70A {Rattus norvegicus} PDB: 2nyj_A*

Probab=99.72  E-value=1.5e-17  Score=156.24  Aligned_cols=99  Identities=23%  Similarity=0.283  Sum_probs=93.8

Q ss_pred             CCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCC--------------CCCCHHHHHHHcCCHHHHHHHHH---CCC
Q 012684           35 GEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDI--------------DNRTALHVAACQGFTEVVSLLLE---RGA   97 (458)
Q Consensus        35 ~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~--------------~g~t~l~~A~~~~~~~~~~~Ll~---~ga   97 (458)
                      ..+..|.||||+||..|+.+++++|+++|+++|.++.              .|.||||+|+..|+.+++++|++   +|+
T Consensus        96 ~~d~~g~tpL~~A~~~g~~~~v~~Ll~~ga~~~~~~~~~~~~~~~~~~~~~~g~tpL~~A~~~g~~~~v~~Ll~~~~~ga  175 (273)
T 2pnn_A           96 DSYYKGQTALHIAIERRNMTLVTLLVENGADVQAAANGDFFKKTKGRPGFYFGELPLSLAACTNQLAIVKFLLQNSWQPA  175 (273)
T ss_dssp             STTTTTCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBCSGGGSSCSSSCCCCSCBSHHHHHHHTTCHHHHHHHHHCSSCCC
T ss_pred             cccCCCCCHHHHHHHcCCHHHHHHHHHCCCCcCccccccccccccccccccCCCCHHHHHHHcCCHHHHHHHHhcccCCC
Confidence            3566899999999999999999999999999999987              79999999999999999999999   999


Q ss_pred             CCCCCCCCCCChhHHHhhcch---------HHHHHHHHHhCCCCC
Q 012684           98 DVDPKDRWGSTPLGDAIYYKN---------HEVIKLLEKHGAKPL  133 (458)
Q Consensus        98 ~~~~~~~~g~tpl~~A~~~~~---------~~~~~~l~~~g~~~~  133 (458)
                      +++.+|..|.||||+|+..|+         .+++++|+++|+++.
T Consensus       176 d~~~~d~~g~tpLh~A~~~~~~~~~~~~~~~~~v~~Ll~~ga~~n  220 (273)
T 2pnn_A          176 DISARDSVGNTVLHALVEVADNTVDNTKFVTSMYNEILILGAKLH  220 (273)
T ss_dssp             CTTCCCTTSCCHHHHHHHHCCSCHHHHHHHHHHHHHHHHHHHHHC
T ss_pred             CceeeCCCCCcHHHHHHHccCcchhHHHHHHHHHHHHHHhhhhcc
Confidence            999999999999999999887         799999999999875

>3d9h_A CDNA FLJ77766, highly similar to HOMO sapiens ankyrin repeat and SOCS box-containing...; ASB9, ANK repeat, L-shaped, structural protein; 2.20A {Homo sapiens}

Probab=99.72  E-value=2.7e-17  Score=155.61  Aligned_cols=107  Identities=24%  Similarity=0.186  Sum_probs=100.2

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~  107 (458)
                      -.|.|++.++.+|.||||+||..|+.+++++|++.|+++|.+|.+|.||||+|+..|+.+++++|+++|++++..+ .|.
T Consensus        80 ~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~-~g~  158 (285)
T 3d9h_A           80 SQGWAVNIITADHVSPLHEACLGGHLSCVKILLKHGAQVNGVTADWHTPLFNACVSGSWDCVNLLLQHGASVQPES-DLA  158 (285)
T ss_dssp             HTTCCSCEECTTCCCHHHHHHHTTCHHHHHHHHHTTCCSSCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCSC-TTS
T ss_pred             HCCCCCCCcCCCCCCHHHHHHHCCcHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCHHHHHHHHHHCCCCCCCCC-CCC
Confidence            4678889999999999999999999999999999999999999999999999999999999999999999998755 499


Q ss_pred             ChhHHHhhcchHHHHHHHHHhCCCCCCC
Q 012684          108 TPLGDAIYYKNHEVIKLLEKHGAKPLMA  135 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l~~~g~~~~~~  135 (458)
                      ||||+|+..|+.+++++|++.|+++...
T Consensus       159 t~L~~A~~~g~~~~v~~Ll~~g~~~~~~  186 (285)
T 3d9h_A          159 SPIHEAARRGHVECVNSLIAYGGNIDHK  186 (285)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHTTCCTTCC
T ss_pred             CHHHHHHHcCCHHHHHHHHHCCCCCCCc
Confidence            9999999999999999999999987543

>3ljn_A Hypothetical protein; ankyrin, structural genomics, PSI, structural genomics of pathogenic protozoa consortium, SGPP, ANK repeat; 2.90A {Leishmania major}

Probab=99.72  E-value=7.7e-18  Score=164.94  Aligned_cols=105  Identities=20%  Similarity=0.161  Sum_probs=98.9

Q ss_pred             CCCCCcCccchHHHHHHHhC--CHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCC-----CCCCCC
Q 012684           32 DDDGEEIKPEFRLMFLANER--DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD-----VDPKDR  104 (458)
Q Consensus        32 d~~~~~~~g~t~l~~a~~~~--~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~-----~~~~~~  104 (458)
                      +.+..+..|.||||+||..|  +.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++     ++.+|.
T Consensus       130 ~~~~~~~~g~t~L~~A~~~g~~~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~~~~~  209 (364)
T 3ljn_A          130 GSHVKHCKGQTALHWCVGLGPEYLEMIKILVQLGASPTAKDKADETPLMRAMEFRNREALDLMMDTVPSKSSLRLDYANK  209 (364)
T ss_dssp             TTEEEEESCCCHHHHHHHSCGGGHHHHHHHHHHTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCSCSSSCCTTCCCT
T ss_pred             ccccCCCCCCCHHHHHHHcCCchHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHhcccccccccccccCC
Confidence            34448889999999999999  99999999999999999999999999999999999999999999999     999999


Q ss_pred             CCCChhHHHhhcchHHHHHHHHHhCCCCCCCc
Q 012684          105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       105 ~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      .|.||||+|+..|+.+++++|+++|+++....
T Consensus       210 ~g~t~L~~A~~~g~~~~v~~Ll~~gad~~~~d  241 (364)
T 3ljn_A          210 QGNSHLHWAILINWEDVAMRFVEMGIDVNMED  241 (364)
T ss_dssp             TCCCTTHHHHTTTCHHHHHHHHTTTCCTTCCC
T ss_pred             CCCcHHHHHHHcCCHHHHHHHHHcCCCCCCCC
Confidence            99999999999999999999999999986544

>1s70_B 130 kDa myosin-binding subunit of smooth muscle myosin phophatase (M130), serine/threonine protein phosphatase PP1-beta (OR delta) catalytic subunit; myosin phosphatase; HET: PGE; 2.70A {Gallus gallus} SCOP: d.211.1.1

Probab=99.72  E-value=2.2e-17  Score=156.92  Aligned_cols=101  Identities=26%  Similarity=0.376  Sum_probs=96.0

Q ss_pred             CcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhh
Q 012684           36 EEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY  115 (458)
Q Consensus        36 ~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~  115 (458)
                      .+.+|.||||+||..|+.++++.|++.|+++|.+|.+|.||||+||..|+.+++++|+++|++++.+|..|.||||+|+.
T Consensus        36 ~~~~~~t~l~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~tpL~~A~~  115 (299)
T 1s70_B           36 VKFDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAAS  115 (299)
T ss_dssp             CEECHHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHH
T ss_pred             cccCCccHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCcHHHHHHH
Confidence            45578999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cchHHHHHHHHHhCCCCCCCc
Q 012684          116 YKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       116 ~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      .|+.+++++|+++|+++....
T Consensus       116 ~g~~~~v~~Ll~~g~~~~~~~  136 (299)
T 1s70_B          116 CGYLDIAEYLISQGAHVGAVN  136 (299)
T ss_dssp             HTCHHHHHHHHHTTCCTTCCC
T ss_pred             cCCHHHHHHHHhCCCCCCCcC
Confidence            999999999999999876543

>4hbd_A KN motif and ankyrin repeat domain-containing Pro; structural genomics consortium, SGC, protein binding; 1.72A {Homo sapiens}

Probab=99.72  E-value=1.5e-17  Score=156.68  Aligned_cols=104  Identities=27%  Similarity=0.282  Sum_probs=81.7

Q ss_pred             CcCccchHHHHHHHhCCHHHHHHHHHcCC-CCCc--------------------------------------cCCCCCCH
Q 012684           36 EEIKPEFRLMFLANERDVEGIKELLDSGI-DVNF--------------------------------------RDIDNRTA   76 (458)
Q Consensus        36 ~~~~g~t~l~~a~~~~~~~~~~~ll~~g~-~in~--------------------------------------~~~~g~t~   76 (458)
                      .|..|.||||+||..|+.+++++|++.|+ ++|.                                      .+..|.||
T Consensus       107 ~d~~g~T~Lh~A~~~g~~~~v~~Ll~~g~~~~~~~~~~g~tpL~~a~~~~~~~~~~~~~v~~Ll~~g~~~~~~~~~g~tp  186 (276)
T 4hbd_A          107 ADSNGNTALHYSVSHANFPVVQQLLDSGVCKVDKQNRAGYSPIMLTALATLKTQDDIETVLQLFRLGNINAKASQAGQTA  186 (276)
T ss_dssp             CCTTSCCHHHHHHHTTCHHHHHHHHHTSCCCTTCCCTTSCCHHHHGGGCCCCSHHHHHHHHHHHHHSCTTCCCTTTCCCH
T ss_pred             CCCCCCCHHHHHHHCCCHHHHHHHHHCCCCcCCCCCCCCCCHHHHHHHHHhhhhhhHHHHHHHHHcCCCccccCCCCCCH
Confidence            34455666777776666666666666665 4444                                      44557888


Q ss_pred             HHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcchHHHHHHHHH-hCCCCCCCcccc
Q 012684           77 LHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEK-HGAKPLMAPMHV  139 (458)
Q Consensus        77 l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~~~l~~-~g~~~~~~~~~~  139 (458)
                      ||+|+..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|++ .|+++......+
T Consensus       187 Lh~A~~~g~~~~v~~Ll~~gad~n~~d~~G~TpLh~A~~~g~~~iv~~Ll~~~gad~~~~d~~g  250 (276)
T 4hbd_A          187 LMLAVSHGRVDVVKALLACEADVNVQDDDGSTALMCACEHGHKEIAGLLLAVPSCDISLTDRDG  250 (276)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHTSTTCCTTCCCTTS
T ss_pred             HHHHHHcCCHHHHHHHHhCCCCCCCCCCCCCCHHHHHHHCCCHHHHHHHHhcCCCCCcCcCCCC
Confidence            999999999999999999999999999999999999999999999999998 888886654433

>3b7b_A Euchromatic histone-lysine N-methyltransferase 1; ankyrin repeat, alternative splicing, ANK repeat, chromatin regulator, nucleus, phosphorylation; 2.99A {Homo sapiens} SCOP: k.37.1.1 PDB: 3b95_A*

Probab=99.72  E-value=4.6e-17  Score=149.17  Aligned_cols=105  Identities=34%  Similarity=0.415  Sum_probs=68.3

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCC-CCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGS  107 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~g-a~~~~~~~~g~  107 (458)
                      +|+|++..+..|.||||+|+..|+.+++++|++.|++++.++..|.||||+|+..|+.+++++|+++| ++++.++..|.
T Consensus        33 ~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~g~  112 (237)
T 3b7b_A           33 AGANIDTCSEDQRTPLMEAAENNHLEAVKYLIKAGALVDPKDAEGSTCLHLAAKKGHYEVVQYLLSNGQMDVNCQDDGGW  112 (237)
T ss_dssp             TTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHTTTCCCCCCCTTSCCHHHHHHHTTCHHHHHHHHTTTCCCTTCCCTTSC
T ss_pred             cCCCcCccCCCCCCHHHHHHHhCCHHHHHHHHhCCCCCCCCCCCCCcHHHHHHHcCCHHHHHHHHhCCCCCcccCCCCCC
Confidence            35555555566666666666666666666666666666666666666666666666666666666665 66666666666


Q ss_pred             ChhHHHhhcchHHHHHHHHHhCCCCC
Q 012684          108 TPLGDAIYYKNHEVIKLLEKHGAKPL  133 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l~~~g~~~~  133 (458)
                      ||||+|+..++.+++++|++.|+++.
T Consensus       113 t~L~~A~~~~~~~~~~~Ll~~g~~~~  138 (237)
T 3b7b_A          113 TPMIWATEYKHVDLVKLLLSKGSDIN  138 (237)
T ss_dssp             CHHHHHHHTTCHHHHHHHHHTTCCTT
T ss_pred             CHHHHHHHcCCHHHHHHHHHCCCCCC
Confidence            66666666666666666666666553

>1k1a_A B-cell lymphoma 3-encoded protein; BCL-3, NF-kappab transcription factors, ikappab proteins; 1.86A {Homo sapiens} SCOP: d.211.1.1 PDB: 1k1b_A

Probab=99.71  E-value=8.4e-17  Score=147.67  Aligned_cols=108  Identities=21%  Similarity=0.172  Sum_probs=88.7

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCC----CCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA----DVDPKDR  104 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga----~~~~~~~  104 (458)
                      .+.+++..+..|.||||+||..|+.+++++|++.|++++.+|..|.||||+|+..|+.+++++|+++|+    +++..+.
T Consensus        35 ~~~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~~~~  114 (241)
T 1k1a_A           35 GGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASPMALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNY  114 (241)
T ss_dssp             TTCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCTTSCCTTCCCT
T ss_pred             cCCCCCcccccCCCHHHHHHHcCCHHHHHHHHHcCCCccccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccccccccCc
Confidence            567777777788888888888888888888888888888888888888888888888888888888876    7788888


Q ss_pred             CCCChhHHHhhcchHHHHHHHHHhCCCCCCCc
Q 012684          105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       105 ~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      .|.||||+|+..|+.+++++|++.|+++....
T Consensus       115 ~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~~  146 (241)
T 1k1a_A          115 DGLTALHVAVNTECQETVQLLLERGADIDAVD  146 (241)
T ss_dssp             TSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCC
T ss_pred             CCCcHHHHHHHcCCHHHHHHHHHcCCCccccc
Confidence            88888888888888888888888888775543

>1wdy_A 2-5A-dependent ribonuclease; hydrolase, RNA-binding; HET: 25A; 1.80A {Homo sapiens} SCOP: d.211.1.1

Probab=99.70  E-value=7.5e-17  Score=151.48  Aligned_cols=107  Identities=26%  Similarity=0.304  Sum_probs=99.8

Q ss_pred             cCCCCCCC-cCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 012684           29 NGLDDDGE-EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (458)
Q Consensus        29 n~~d~~~~-~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~  107 (458)
                      ++.|++.. +..|.||||+||..|+.+++++|++.|++++.+|.+|.||||+|+..|+.+++++|+++|++++.+|..|.
T Consensus        27 ~g~~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~~g~  106 (285)
T 1wdy_A           27 GGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLRKKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFYGF  106 (285)
T ss_dssp             TTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCBCTTCC
T ss_pred             cCCCcccccCCCCCcHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCcccC
Confidence            45667666 66799999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChhHHHhhcchHHHHHHHHHhCCCCCCC
Q 012684          108 TPLGDAIYYKNHEVIKLLEKHGAKPLMA  135 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l~~~g~~~~~~  135 (458)
                      ||||+|+..|+.+++++|++.|+++...
T Consensus       107 t~L~~A~~~~~~~~~~~Ll~~g~~~~~~  134 (285)
T 1wdy_A          107 TAFMEAAVYGKVKALKFLYKRGANVNLR  134 (285)
T ss_dssp             BHHHHHHHTTCHHHHHHHHHTTCCTTCC
T ss_pred             CHHHHHHHhCCHHHHHHHHHhCCCcccc
Confidence            9999999999999999999999987543

>3kea_A K1L; tropism, ANK repeat, viral protein; 2.30A {Vaccinia virus}

Probab=99.70  E-value=1.7e-17  Score=157.02  Aligned_cols=101  Identities=23%  Similarity=0.185  Sum_probs=94.0

Q ss_pred             CCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC-CC
Q 012684           30 GLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG-ST  108 (458)
Q Consensus        30 ~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g-~t  108 (458)
                      |+|++..  +|.||||+||..|+.+++++|+++|+++|.+|..|.||||+|+..|+.+++++|+++|++++.++..| .|
T Consensus        54 g~~~~~~--~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~~~~~~~g~~t  131 (285)
T 3kea_A           54 GALKNLL--ENEFPLHQAATLEDTKIVKILLFSGLDDSQFDDKGNTALYYAVDSGNMQTVKLFVKKNWRLMFYGKTGWKT  131 (285)
T ss_dssp             TGGGSCC--TTCCHHHHHTTSSSCHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHCGGGGGCSSSGGGS
T ss_pred             CCCCCCC--CCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCcHHHHHHHcCCHHHHHHHHhcCCCCCccCCCCCCC
Confidence            4444444  38999999999999999999999999999999999999999999999999999999999999999999 79


Q ss_pred             hhHHHhhcchHHHHHHHHHhCCCC
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGAKP  132 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~~~  132 (458)
                      |||+|+..|+.+++++|+++|++.
T Consensus       132 ~L~~A~~~~~~~~v~~Ll~~g~~~  155 (285)
T 3kea_A          132 SFYHAVMLNDVSIVSYFLSEIPST  155 (285)
T ss_dssp             HHHHHHHTTCHHHHHHHHTTSCTT
T ss_pred             HHHHHHHcCCHHHHHHHHhCCCcc
Confidence            999999999999999999998764

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1

Probab=99.69  E-value=5.4e-17  Score=159.64  Aligned_cols=97  Identities=24%  Similarity=0.317  Sum_probs=91.7

Q ss_pred             CCcCccchHHHHHHHhCCHHHHHHHHHcC-CCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHH
Q 012684           35 GEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA  113 (458)
Q Consensus        35 ~~~~~g~t~l~~a~~~~~~~~~~~ll~~g-~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A  113 (458)
                      ..+..|.||||+||..|+.+++++|++.| +++|.+|.+|.||||+|+..|+.+++++|+++|++++.+|..|.|||++|
T Consensus       274 ~~d~~g~t~Lh~A~~~g~~~~v~~Ll~~~~~~~n~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gad~~~~d~~g~t~l~~A  353 (373)
T 2fo1_E          274 SEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLA  353 (373)
T ss_dssp             SSSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHHHHH
T ss_pred             cccccCCCHHHHHHHhCCHHHHHHHHHhcCCCccCcCCCCCCHHHHHHHcCCHHHHHHHHHcCCCccCCCCCCCCHHHHH
Confidence            36678999999999999999999999875 99999999999999999999999999999999999999999999999999


Q ss_pred             hhcchHHHHHHHHHhCCC
Q 012684          114 IYYKNHEVIKLLEKHGAK  131 (458)
Q Consensus       114 ~~~~~~~~~~~l~~~g~~  131 (458)
                      +..|+.+++++|+++|++
T Consensus       354 ~~~g~~~iv~~Ll~~~a~  371 (373)
T 2fo1_E          354 QANNHHNIVDIFDRCRPE  371 (373)
T ss_dssp             HHTTCHHHHHHHHTTC--
T ss_pred             HHcCCHHHHHHHHhcCcc
Confidence            999999999999999876

>3utm_A Tankyrase-1; tankyrase, TNKS, ankryin repeat clusters, WNT signaling, POL ribosylation, transferase-signaling protein complex; 2.00A {Mus musculus}

Probab=99.69  E-value=1.3e-16  Score=154.70  Aligned_cols=111  Identities=25%  Similarity=0.277  Sum_probs=101.0

Q ss_pred             CCCCCcCccchHHHHHHHh---CCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           32 DDDGEEIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        32 d~~~~~~~g~t~l~~a~~~---~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      .....+..|.||||+|+..   +..+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus       203 ~~~~~~~~~~t~L~~A~~~~~~~~~~~~~~Ll~~g~~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~ga~~n~~d~~g~t  282 (351)
T 3utm_A          203 INFKQPQSHETALHCAVASLHPKRKQVAELLLRKGANVNEKNKDFMTPLHVAAERAHNDVMEVLHKHGAKMNALDSLGQT  282 (351)
T ss_dssp             TTCCCTTTCCCHHHHHHHCCSTTHHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred             ccccCCCCCCCHHHHHHHHhCccHHHHHHHHHHcCCCcCCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCC
Confidence            3344567899999999999   5589999999999999999999999999999999999999999999999999999999


Q ss_pred             hhHHHhhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      |||+|+..|+.+++++|+++|+++......+.++
T Consensus       283 ~L~~A~~~~~~~~v~~Ll~~gad~~~~~~~g~ta  316 (351)
T 3utm_A          283 ALHRAALAGHLQTCRLLLSYGSDPSIISLQGFTA  316 (351)
T ss_dssp             HHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred             HHHHHHHcCcHHHHHHHHHcCCCCCCcCCCCCCh
Confidence            9999999999999999999999987766555444

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens}

Probab=99.68  E-value=2.7e-16  Score=143.82  Aligned_cols=111  Identities=23%  Similarity=0.187  Sum_probs=100.1

Q ss_pred             hhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccC-CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCC
Q 012684           26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDR  104 (458)
Q Consensus        26 ~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~-~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~  104 (458)
                      ..-.|.|.+..+..|.||||+||..|+.+++++|++.|++++..+ ..|.||||+|+..|+.+++++|+++|++++.++.
T Consensus        28 Ll~~g~~~~~~~~~g~t~L~~A~~~~~~~~v~~Ll~~~~~~~~~~~~~~~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~~~  107 (240)
T 3eu9_A           28 LVEAGYDVRQPDKENVTLLHWAAINNRIDLVKYYISKGAIVDQLGGDLNSTPLHWATRQGHLSMVVQLMKYGADPSLIDG  107 (240)
T ss_dssp             HHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCBTTTTBCHHHHHHHHTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHHcCCCcCCCCCCCCCHHHHHHHhCCHHHHHHHHHcCCcchhhcCCcCCChhHHHHHcCCHHHHHHHHHcCCCCcccCC
Confidence            334678888888899999999999999999999999999988665 4499999999999999999999999999999999


Q ss_pred             CCCChhHHHhhcchHHHHHHHHHhCCCCCCCc
Q 012684          105 WGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAP  136 (458)
Q Consensus       105 ~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~  136 (458)
                      .|.||||+|+..|+.+++++|++.|+++....
T Consensus       108 ~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~  139 (240)
T 3eu9_A          108 EGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMD  139 (240)
T ss_dssp             TSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCC
T ss_pred             CCCCHHHHHHHcCHHHHHHHHHhcCCCccccC
Confidence            99999999999999999999999999875543

>2fo1_E LIN-12 protein; beta-barrel, protein-DNA complex, double helix, ankyrin repeat, gene regulation/signalling protein/DNA complex; 3.12A {Caenorhabditis elegans} SCOP: d.211.1.1

Probab=99.68  E-value=1.3e-16  Score=156.89  Aligned_cols=107  Identities=25%  Similarity=0.257  Sum_probs=102.3

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCC---CCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG---ADVDPKDR  104 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~g---a~~~~~~~  104 (458)
                      -+|+|+|..|.+|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|   ++++..|.
T Consensus       154 ~~ga~vn~~d~~g~TpL~~A~~~g~~~iv~~Ll~~ga~~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~~~~~~~~~~~d~  233 (373)
T 2fo1_E          154 AAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQAAANRDFGMMVYMLNSTKLKGDIEELDR  233 (373)
T ss_dssp             HTCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHHHHHHHTTCHHHHHHHTTSHHHHHTTSCCCT
T ss_pred             hcCCCCcCCCCCCCCHHHHHHHcChHHHHHHHHHCCCCCcccCCCCCCHHHHHHHCCCHHHHHHHHhcCccccChhhcCC
Confidence            468888889999999999999999999999999999999999999999999999999999999999998   89999999


Q ss_pred             CCCChhHHHhhcc---hHHHHHHHHHhCCCCCC
Q 012684          105 WGSTPLGDAIYYK---NHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       105 ~g~tpl~~A~~~~---~~~~~~~l~~~g~~~~~  134 (458)
                      .|.||||+|+..+   +.+++++|++.|+++..
T Consensus       234 ~g~t~L~~A~~~~~~~~~~~v~~Ll~~g~~~~~  266 (373)
T 2fo1_E          234 NGMTALMIVAHNEGRDQVASAKLLVEKGAKVDY  266 (373)
T ss_dssp             TSCCHHHHHHHSCSTTHHHHHHHHHHHTCCSSC
T ss_pred             CCCCHHHHHHHhCCcchHHHHHHHHHCCCCccc
Confidence            9999999999988   89999999999999865

>3jue_A Arfgap with coiled-coil, ANK repeat and PH domain containing protein 1; arfgap domain, zinc-binding module, GTPase activ metal-binding, nitration; 2.30A {Homo sapiens} PDB: 3t9k_A 4f1p_A

Probab=99.67  E-value=2e-16  Score=154.49  Aligned_cols=105  Identities=25%  Similarity=0.295  Sum_probs=96.4

Q ss_pred             CcCccchHHHHHHHh-CCHHHHHHHHHcCCCCCccC--CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHH
Q 012684           36 EEIKPEFRLMFLANE-RDVEGIKELLDSGIDVNFRD--IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD  112 (458)
Q Consensus        36 ~~~~g~t~l~~a~~~-~~~~~~~~ll~~g~~in~~~--~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~  112 (458)
                      ....+.|+||+||.. |++++++.|++.|+++|..+  ..|.||||+||..|+.+++++|+++|+++|.+|..|.||||+
T Consensus       195 ~~~~~~t~L~~Aa~~~g~~~~v~~LL~~Gadvn~~~~~~~g~TpLh~Aa~~g~~~iv~~LL~~Gadvn~~d~~G~TpLh~  274 (368)
T 3jue_A          195 GSLHPGALLFRASGHPPSLPTMADALAHGADVNWVNGGQDNATPLIQATAANSLLACEFLLQNGANVNQADSAGRGPLHH  274 (368)
T ss_dssp             --CCHHHHHHHHTSSSCCHHHHHHHHHTTCCTTCCCTTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHH
T ss_pred             ccCCCCcHHHHHHHccCCHHHHHHHHHcCCCCCccccccCCCCHHHHHHHCCCHHHHHHHHHcCCCCCCCCCCCCCHHHH
Confidence            344678999999999 99999999999999999998  889999999999999999999999999999999999999999


Q ss_pred             HhhcchHHHHHHHHHhCCCCCCCccccc
Q 012684          113 AIYYKNHEVIKLLEKHGAKPLMAPMHVK  140 (458)
Q Consensus       113 A~~~~~~~~~~~l~~~g~~~~~~~~~~~  140 (458)
                      |+..|+.+++++|+++|+++......+.
T Consensus       275 A~~~g~~~~v~~LL~~Gad~~~~d~~G~  302 (368)
T 3jue_A          275 ATILGHTGLACLFLKRGADLGARDSEGR  302 (368)
T ss_dssp             HHHHTCHHHHHHHHHTTCCTTCCCTTSC
T ss_pred             HHHcCcHHHHHHHHHCcCCCCCcCCCCC
Confidence            9999999999999999999876554433

>3eu9_A Huntingtin-interacting protein 14; epigenetics, ankyrin repeats, methyllyine binding, huntingti interacting protein 14, acyltransferase, ANK repeat; HET: HIS; 1.99A {Homo sapiens}

Probab=99.66  E-value=3.6e-16  Score=143.05  Aligned_cols=107  Identities=25%  Similarity=0.194  Sum_probs=67.4

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCC-HHHHHHHHHCCCCCCCCCC-CC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF-TEVVSLLLERGADVDPKDR-WG  106 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~-~~~~~~Ll~~ga~~~~~~~-~g  106 (458)
                      .++|++..+..|.||||+|+..|+.+++++|++.|++++.++..|.||||+|+..++ .+++++|++.|++++..+. .|
T Consensus        98 ~g~~~~~~~~~g~t~l~~A~~~~~~~~~~~Ll~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~~L~~~~~~~~~~~~~~g  177 (240)
T 3eu9_A           98 YGADPSLIDGEGCSCIHLAAQFGHTSIVAYLIAKGQDVDMMDQNGMTPLMWAAYRTHSVDPTRLLLTFNVSVNLGDKYHK  177 (240)
T ss_dssp             TTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHCCSSTTHHHHHHTTCCTTCCCTTTC
T ss_pred             cCCCCcccCCCCCCHHHHHHHcCHHHHHHHHHhcCCCccccCCCCCcHHHHHHHhCChHHHHHHHHhcCCCcchhhccCC
Confidence            355555555566666666666666666666666666666666666666666664443 5666666666666666665 66


Q ss_pred             CChhHHHhhcchHHHHHHHHHhCCCCCCC
Q 012684          107 STPLGDAIYYKNHEVIKLLEKHGAKPLMA  135 (458)
Q Consensus       107 ~tpl~~A~~~~~~~~~~~l~~~g~~~~~~  135 (458)
                      .||||+|+..|+.+++++|+++|+++...
T Consensus       178 ~t~L~~A~~~~~~~~v~~Ll~~g~~~~~~  206 (240)
T 3eu9_A          178 NTALHWAVLAGNTTVISLLLEAGANVDAQ  206 (240)
T ss_dssp             CCHHHHHHHHTCHHHHHHHHHHTCCTTCB
T ss_pred             CcHHHHHHHcCCHHHHHHHHHcCCCCCCc
Confidence            66666666666666777776666665443

>4g8k_A 2-5A-dependent ribonuclease; ankyrin-repeat domain, single-stranded RNA, hydrolase; 2.40A {Homo sapiens} PDB: 4g8l_A*

Probab=99.66  E-value=2.9e-16  Score=152.02  Aligned_cols=106  Identities=28%  Similarity=0.258  Sum_probs=93.2

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCC----HHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHC-CCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERD----VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKD  103 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~----~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~-ga~~~~~~  103 (458)
                      .|+|++..+..|.|+||+++..+.    ..++++|+++|+++|.+|..|.||||+|+..|+.++++.|+.. |+++|.+|
T Consensus       191 ~gad~n~~d~~g~t~l~~~~~~~~~~~~~~i~~lLl~~gad~n~~d~~g~t~L~~a~~~~~~~~v~~Ll~~~~~~vn~~d  270 (337)
T 4g8k_A          191 MGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTD  270 (337)
T ss_dssp             SCCCTTCCCTTSCCHHHHHHHHSCTTTHHHHHHHHHHTTCCTTCCCGGGCCHHHHHHHTTCHHHHHHHHTSTTCCTTCBC
T ss_pred             cCCCcCccCCCCCcHHHHHHHHcCcccHHHHHHHHHHCCCCCCCcCCCCCCHHHHHHHhhhhHHHHHHHHhcCCcccCcC
Confidence            477778888888888887776554    3577888888899999999999999999999999999999985 89999999


Q ss_pred             CCCCChhHHHhhcchHHHHHHHHHhCCCCCC
Q 012684          104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       104 ~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~  134 (458)
                      ..|+||||+|+..|+.+++++|+++|+++..
T Consensus       271 ~~G~TpL~~A~~~g~~~iv~~Ll~~GAd~n~  301 (337)
T 4g8k_A          271 SDGKTALLLAVELKLKKIAELLCKRGASTDC  301 (337)
T ss_dssp             TTSCBHHHHHHHTTCHHHHHHHHTTSCSSTT
T ss_pred             CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCC
Confidence            9999999999999999999999999999864

>2b0o_E UPLC1; arfgap, structural genomics, structural genomics consortium, SGC, metal binding protein; 2.06A {Homo sapiens}

Probab=99.62  E-value=1.9e-15  Score=143.97  Aligned_cols=101  Identities=24%  Similarity=0.243  Sum_probs=93.3

Q ss_pred             ccchHHHHHHHhCCHHHHHHHHHcCCCCCc------cCCCCCCHHHHHHHc---CCHHHHHHHHHCCCCCCCCCCCCCCh
Q 012684           39 KPEFRLMFLANERDVEGIKELLDSGIDVNF------RDIDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWGSTP  109 (458)
Q Consensus        39 ~g~t~l~~a~~~~~~~~~~~ll~~g~~in~------~~~~g~t~l~~A~~~---~~~~~~~~Ll~~ga~~~~~~~~g~tp  109 (458)
                      .+.++||.|+..|+++.++.|++.|+++|.      .+..|.||||+|+..   |+.+++++|+++|+++|.+|..|.||
T Consensus       150 ~~~~~L~~A~~~g~~~~v~~ll~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadvn~~d~~G~Tp  229 (301)
T 2b0o_E          150 PEPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTA  229 (301)
T ss_dssp             -CHHHHHHHHHTTCHHHHHHHHHTTCCTTSCEECSSSCSCEECHHHHHHHTCCTTTHHHHHHHHHHSSCTTCCCTTCCCH
T ss_pred             chHHHHhhhhhccCHHHHHHHHhcCCcccccCCCcccCCCCccHHHHHHHhcccCcHHHHHHHHhcCCCCCCCCCCCCCH
Confidence            456789999999999999999999999998      689999999999997   89999999999999999999999999


Q ss_pred             hHHHhhcchHHHHHHHHHhCCCCCCCcccc
Q 012684          110 LGDAIYYKNHEVIKLLEKHGAKPLMAPMHV  139 (458)
Q Consensus       110 l~~A~~~~~~~~~~~l~~~g~~~~~~~~~~  139 (458)
                      ||+|+..|+.+++++|+++|+++......+
T Consensus       230 Lh~A~~~g~~~~v~~Ll~~gad~~~~d~~G  259 (301)
T 2b0o_E          230 LHYAALYNQPDCLKLLLKGRALVGTVNEAG  259 (301)
T ss_dssp             HHHHHHTTCHHHHHHHHHTTCCCSCCCTTS
T ss_pred             HHHHHHcCCHHHHHHHHHcCCCCCCcCCCC
Confidence            999999999999999999999987654433

>3lvq_E ARF-GAP with SH3 domain, ANK repeat and PH domain containing protein 3, ADP-ribosylation...; GDP, ASAP3, UPLC1, linkers, alternat splicing; HET: GDP; 3.38A {Homo sapiens} PDB: 3lvr_E*

Probab=99.61  E-value=1.8e-15  Score=154.36  Aligned_cols=103  Identities=25%  Similarity=0.264  Sum_probs=95.0

Q ss_pred             cchHHHHHHHhCCHHHHHHHHHcCCCCCcc------CCCCCCHHHHHHH---cCCHHHHHHHHHCCCCCCCCCCCCCChh
Q 012684           40 PEFRLMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAAC---QGFTEVVSLLLERGADVDPKDRWGSTPL  110 (458)
Q Consensus        40 g~t~l~~a~~~~~~~~~~~ll~~g~~in~~------~~~g~t~l~~A~~---~~~~~~~~~Ll~~ga~~~~~~~~g~tpl  110 (458)
                      ..+.||.|+..|+.+.++.|++.|+++|.+      |..|.||||+||.   .|+.+++++|+++||++|.+|..|+|||
T Consensus       132 ~~~~L~~A~~~g~~~~v~~ll~~g~~~n~~~~~~~~~~~g~t~Lh~A~~~a~~g~~~~v~~Ll~~ga~vn~~d~~g~TpL  211 (497)
T 3lvq_E          132 EPQRLWTAICNRDLLSVLEAFANGQDFGQPLPGPDAQAPEELVLHLAVKVANQASLPLVDFIIQNGGHLDAKAADGNTAL  211 (497)
T ss_dssp             CHHHHHHHHHHTCHHHHHHHHHTTCCSSSCBCCSSSCCSCBCHHHHHHHTCCTTTHHHHHHHHHHSCCTTCCCSSSCCHH
T ss_pred             cHHHHHHHHhccCHHHHHHHHhhcccccCCCCCcccccccchHHHHHHHhcccccHHHHHHHHHcCCCCCccCCCCCcHH
Confidence            347899999999999999999999999988      8899999999966   9999999999999999999999999999


Q ss_pred             HHHhhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684          111 GDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus       111 ~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      |+|+..|+.+++++|+++|+++......+.++
T Consensus       212 h~A~~~g~~~~v~~Ll~~ga~~~~~d~~g~tp  243 (497)
T 3lvq_E          212 HYAALYNQPDCLKLLLKGRALVGTVNEAGETA  243 (497)
T ss_dssp             HHHTTTTCHHHHHHHHHTCCCCSCCCTTCCCH
T ss_pred             HHHHHcCCHHHHHHHHHcCCCCCCcCCCCCCH
Confidence            99999999999999999999997765554444

>1dcq_A PYK2-associated protein beta; zinc-binding module, ankyrin repeats, metal binding protein; 2.10A {Mus musculus} SCOP: d.211.1.1 g.45.1.1

Probab=99.61  E-value=3.1e-15  Score=140.81  Aligned_cols=104  Identities=24%  Similarity=0.261  Sum_probs=94.0

Q ss_pred             CccchHHHHHHHhCCHHHHHHHHHcCCCC------CccCCCCCCHHHHHHHc---CCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           38 IKPEFRLMFLANERDVEGIKELLDSGIDV------NFRDIDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        38 ~~g~t~l~~a~~~~~~~~~~~ll~~g~~i------n~~~~~g~t~l~~A~~~---~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      ....++||.|+..|+.+.+..+++.|+++      +..|..|.||||+||..   |+.+++++|+++|+++|.+|..|.|
T Consensus       128 ~~~l~~l~~a~~~~d~~~~~~ll~~g~~~~~~~~l~~~~~~g~t~Lh~A~~~~~~~~~~~v~~Ll~~ga~in~~d~~g~T  207 (278)
T 1dcq_A          128 AAKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGST  207 (278)
T ss_dssp             HHHHHHHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCC
T ss_pred             chhhhhhhhHhhhcccHHHHHHHHhhcchhhhccccccccCCCCcchHHHHhcccchHHHHHHHHHCCCCccccCCCCCC
Confidence            34678999999999999999999999994      44588999999999999   8999999999999999999999999


Q ss_pred             hhHHHhhcchHHHHHHHHHhCCCCCCCcccccc
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH  141 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~  141 (458)
                      |||+|+..|+.+++++|+++|+++......+.+
T Consensus       208 pLh~A~~~g~~~~v~~Ll~~gad~~~~d~~g~t  240 (278)
T 1dcq_A          208 ALHYCCLTDNAECLKLLLRGKASIEIANESGET  240 (278)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred             HHHHHHHcCCHHHHHHHHHcCCCCCCccCCCCC
Confidence            999999999999999999999998765544433

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.59  E-value=3.4e-16  Score=152.09  Aligned_cols=133  Identities=17%  Similarity=0.143  Sum_probs=96.0

Q ss_pred             ccCceeeccceEEEEEE----cCeEEEEEEcCCCCCC---------------CHHHH----HHHHHHHHHHhcCCCCcce
Q 012684          157 FTNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---------------DDDRV----RAFRDELALLQKIRHPNVV  213 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~---------------~~~~~----~~~~~E~~~l~~l~hp~i~  213 (458)
                      |++...||.|+||.||.    +|+.||||+++.....               .....    -....|...+.++.+.++.
T Consensus        97 Y~I~~~IG~Gk~a~VY~a~d~~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~~~gv~  176 (397)
T 4gyi_A           97 YSVGSRIGVGKESDIMIVADEKGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALYEEGFP  176 (397)
T ss_dssp             SEEEEEEEECSSEEEEEEECTTCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHHHTTCS
T ss_pred             EEecCEeeeCCceEEEEEECCCCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHHhcCCC
Confidence            77889999999999985    6899999997642111               00111    1123567777777544442


Q ss_pred             --eeeeEEEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC
Q 012684          214 --QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (458)
Q Consensus       214 --~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~  291 (458)
                        ..++.    ...+|||||++|++|.++.      .......++.|++.+|.+||+.|   |+||||||.|||++.++.
T Consensus       177 vp~p~~~----~~~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~g---IVHrDLKp~NILl~~dgd  243 (397)
T 4gyi_A          177 VPEPIAQ----SRHTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHG---LIHGDFNEFNILIREEKD  243 (397)
T ss_dssp             CCCEEEE----ETTEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEEEEEC
T ss_pred             CCeeeec----cCceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHHHEEEeCCCC
Confidence              33332    2347999999998886542      22345678899999999999999   999999999999998763


Q ss_pred             ----------EEEeecCCccc
Q 012684          292 ----------LKVADFGVSKL  302 (458)
Q Consensus       292 ----------vkl~Dfg~~~~  302 (458)
                                +.|+||+-+..
T Consensus       244 ~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          244 AEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             SSCTTSEEEEEEECCCTTCEE
T ss_pred             cccccccccceEEEEeCCccc
Confidence                      88999986653

>1n0q_A 3ANK, 3 ankyrin repeats; structural protein; 1.26A {} SCOP: k.37.1.1

Probab=99.58  E-value=5.1e-15  Score=114.81  Aligned_cols=71  Identities=41%  Similarity=0.526  Sum_probs=67.9

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD   98 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~   98 (458)
                      -+|+|++.++..|+||||+||..|+.+++++|++.|+++|.+|.+|.||||+|+..|+.+++++|+++||+
T Consensus        23 ~~g~~~n~~d~~g~t~L~~A~~~~~~~~v~~Ll~~ga~~~~~d~~g~t~l~~A~~~~~~~~~~~Ll~~ga~   93 (93)
T 1n0q_A           23 EAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGADVNAKDKNGRTPLHLAARNGHLEVVKLLLEAGAY   93 (93)
T ss_dssp             HTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCC
T ss_pred             HcCCCCcccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCC
Confidence            46788888999999999999999999999999999999999999999999999999999999999999986

>2l6b_A NR1C; ankyrin, consensus, repeat protein, ising model, DE NOV; NMR {Escherichia coli}

Probab=99.57  E-value=1.4e-15  Score=122.90  Aligned_cols=84  Identities=32%  Similarity=0.357  Sum_probs=77.2

Q ss_pred             hhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCC
Q 012684           27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWG  106 (458)
Q Consensus        27 ~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g  106 (458)
                      .-++.|++..+..|.||||+||..|+.+++++|++.|+++|.+|..|.||||+|+..|+.+++++|+++|+++|.++..|
T Consensus        29 l~~g~~~~~~d~~g~t~L~~A~~~~~~~~~~~Ll~~g~~~~~~d~~g~tpl~~A~~~~~~~~~~~Ll~~ga~~n~~~~~~  108 (115)
T 2l6b_A           29 LSKGADVNARSKDGNTPLHLAAKNGHAEIVKLLLAKGADVNARSKDGNTPEHLAKKNGHHEIVKLLDAKGADVNARSWGS  108 (115)
T ss_dssp             TTTTCCSSCCCSSSCCTTHHHHTTTCHHHHHHHTTTTCCTTCCCTTCCCTTHHHHTTTCHHHHHHHHTTSSSHHHHSCCC
T ss_pred             HHcCCCCCCcCCCCCCHHHHHHHcCcHHHHHHHHHcCCCCcccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCCCcCCccc
Confidence            34577888888999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CChh
Q 012684          107 STPL  110 (458)
Q Consensus       107 ~tpl  110 (458)
                      .+|-
T Consensus       109 ~~~~  112 (115)
T 2l6b_A          109 SHHH  112 (115)
T ss_dssp             C---
T ss_pred             cccc
Confidence            9874

>1sw6_A Regulatory protein SWI6; transcription regulation, ankyrin repeats, cell-cycle; 2.10A {Saccharomyces cerevisiae} SCOP: d.211.1.1

Probab=99.53  E-value=6e-15  Score=142.27  Aligned_cols=87  Identities=23%  Similarity=0.122  Sum_probs=78.1

Q ss_pred             CCCCCCcCccchHHHHHHH----hCCHHHHHHHHHcCC------------------------------------------
Q 012684           31 LDDDGEEIKPEFRLMFLAN----ERDVEGIKELLDSGI------------------------------------------   64 (458)
Q Consensus        31 ~d~~~~~~~g~t~l~~a~~----~~~~~~~~~ll~~g~------------------------------------------   64 (458)
                      .+++.++..|+||||+||.    .|+.+++++|++.++                                          
T Consensus       192 ~~~~~~d~~g~tpLh~A~~~~~~~g~~~~v~~Ll~~~~~~~~~~~~~~i~~~~~~~g~~~~~~~~~g~t~L~~a~~~~~L  271 (327)
T 1sw6_A          192 PCLILEDSMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWI  271 (327)
T ss_dssp             GGGGEECTTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHH
T ss_pred             ccccCCCCCCCCHHHHHHHHccccccHHHHHHHHHHHHHHHhcccchHHHhhhhcccCCcccccccCCChhHHHHHHHHH
Confidence            4667778889999999999    899999999998743                                          


Q ss_pred             ---CCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcc
Q 012684           65 ---DVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK  117 (458)
Q Consensus        65 ---~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~  117 (458)
                         ++|.+|..|+||||+||..|+.+++++|+++||+++.+|..|+||||+|+..|
T Consensus       272 l~~~~n~~d~~G~TpLh~A~~~g~~~~v~~Ll~~Gad~~~~d~~G~TpL~~A~~~g  327 (327)
T 1sw6_A          272 IANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGAGLE  327 (327)
T ss_dssp             HHHTTTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTCC--
T ss_pred             HHhCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHcCCCCcccCCCCCCHHHHHHhcC
Confidence               68889999999999999999999999999999999999999999999998764

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1

Probab=99.45  E-value=3.5e-15  Score=146.20  Aligned_cols=91  Identities=15%  Similarity=0.008  Sum_probs=44.2

Q ss_pred             chHHHHHHHhCCHHHHHHHHHcCCCC---CccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCC---CCCCCCCCChhHHHh
Q 012684           41 EFRLMFLANERDVEGIKELLDSGIDV---NFRDIDNRTALHVAACQGFTEVVSLLLERGADV---DPKDRWGSTPLGDAI  114 (458)
Q Consensus        41 ~t~l~~a~~~~~~~~~~~ll~~g~~i---n~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~---~~~~~~g~tpl~~A~  114 (458)
                      +||||+||..|+.+++++|++.|+..   +..+..|.||||+||..|+.+++++|+++|+++   +..+.. .||||+|+
T Consensus        93 ~T~Lh~Aa~~G~~e~v~~Ll~~ga~~~~~~~~~~~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~-~TpLh~Aa  171 (376)
T 2aja_A           93 EVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN-YHAFRLAA  171 (376)
T ss_dssp             HHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH-HHHHHHHH
T ss_pred             CCHHHHHHHcCCHHHHHHHHHcCCcHHHHHHhccCCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC-CCHHHHHH
Confidence            45555555555555555555555411   122233445555555555555555555555431   111111 55555555


Q ss_pred             hcchHHHHHHHHHhCCCC
Q 012684          115 YYKNHEVIKLLEKHGAKP  132 (458)
Q Consensus       115 ~~~~~~~~~~l~~~g~~~  132 (458)
                      ..|+.+++++|+++|+++
T Consensus       172 ~~G~~eiv~~Ll~~ga~~  189 (376)
T 2aja_A          172 ENGHLHVLNRLCELAPTE  189 (376)
T ss_dssp             HTTCHHHHHHHHHSCGGG
T ss_pred             HCCCHHHHHHHHHcCCcc
Confidence            555555555555555553

>2aja_A Ankyrin repeat family protein; NESG, Q5ZSV0, structural genomics, PSI, protein structure initiative; 2.80A {Legionella pneumophila} SCOP: a.118.24.1

Probab=99.39  E-value=3.6e-14  Score=138.93  Aligned_cols=93  Identities=15%  Similarity=0.073  Sum_probs=83.2

Q ss_pred             CCcCccchHHHHHHHhCCHHHHHHHHHcCCC-----CCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCC--CCCCCC
Q 012684           35 GEEIKPEFRLMFLANERDVEGIKELLDSGID-----VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP--KDRWGS  107 (458)
Q Consensus        35 ~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~-----in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~--~~~~g~  107 (458)
                      ..+..|.||||+||..|+.++|++|+++|++     ++.++   .||||+||..|+.+++++|+++|++++.  .|..|.
T Consensus       123 ~~~~~~~tpL~~Aa~~G~~eiv~~Ll~~gad~~~~~i~~~~---~TpLh~Aa~~G~~eiv~~Ll~~ga~~~~~~~d~~g~  199 (376)
T 2aja_A          123 VIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAEN---YHAFRLAAENGHLHVLNRLCELAPTEATAMIQAENY  199 (376)
T ss_dssp             --CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHH---HHHHHHHHHTTCHHHHHHHHHSCGGGHHHHHHHHHH
T ss_pred             HhccCCCCHHHHHHHcCCHHHHHHHHhCCCCccccccCCCC---CCHHHHHHHCCCHHHHHHHHHcCCccchhccCCCCC
Confidence            3345789999999999999999999999975     33333   9999999999999999999999999988  888999


Q ss_pred             ChhHHHh-hcchHHHHHHHHHhCC
Q 012684          108 TPLGDAI-YYKNHEVIKLLEKHGA  130 (458)
Q Consensus       108 tpl~~A~-~~~~~~~~~~l~~~g~  130 (458)
                      ||||+|+ ..|+.+++++|++.|+
T Consensus       200 TpL~~Aa~~~G~~eiv~~Ll~~ga  223 (376)
T 2aja_A          200 YAFRWAAVGRGHHNVINFLLDCPV  223 (376)
T ss_dssp             HHHHHHHSTTCCHHHHHHHTTSHH
T ss_pred             CHHHHHHHHCCCHHHHHHHHhCCC
Confidence            9999999 9999999999998774

>2zgd_A 3 repeat synthetic ankyrin; ankyrin repeat, hydroxylated, de novo protein; 1.90A {Synthetic} PDB: 2zgg_A 2xen_A

Probab=99.31  E-value=2.6e-12  Score=102.79  Aligned_cols=72  Identities=36%  Similarity=0.355  Sum_probs=63.6

Q ss_pred             CCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcchHHHHHHHHHhCCCCCCCcc
Q 012684           66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM  137 (458)
Q Consensus        66 in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~  137 (458)
                      .+..|.+|.||||+|+..|+.+++++|+++|++++.+|..|.||||+|+..|+.+++++|+++|+++.....
T Consensus        17 ~~~~~~~g~t~L~~A~~~g~~~~v~~Ll~~g~~i~~~d~~g~tpLh~A~~~~~~~~v~~Ll~~ga~~~~~d~   88 (110)
T 2zgd_A           17 GSHMGSDLGKKLLEAARAGQDDEVRILMANGADVAAKDKNGSTPLHLAARNGHLEVVKLLLEAGADVXAQDK   88 (110)
T ss_dssp             -----CCHHHHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             ccccCCccchHHHHHHHcCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccc
Confidence            445678899999999999999999999999999999999999999999999999999999999999865443

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.18  E-value=6.7e-11  Score=109.92  Aligned_cols=137  Identities=12%  Similarity=0.026  Sum_probs=101.1

Q ss_pred             ccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEEEEEcc
Q 012684          157 FTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYL  232 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~lv~e~~  232 (458)
                      |+....++.|+...|+   ..|..+++|.........   ...+.+|+.+++.+ .+..++++++++...+..|+|||++
T Consensus        16 ~~~~~~~~g~s~~~v~~~~~~~~~~vlK~~~~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i   92 (263)
T 3tm0_A           16 YRCVKDTEGMSPAKVYKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEA   92 (263)
T ss_dssp             SEEEECCSCCSSSEEEEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECC
T ss_pred             ceeEeeccCCCCCeEEEEECCCCcEEEEeCCcccCCC---HHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEec
Confidence            4444555555544444   357899999987532111   13478899999988 4678899999999888999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC------------------------------------------
Q 012684          233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK------------------------------------------  270 (458)
Q Consensus       233 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~------------------------------------------  270 (458)
                      +|.+|.+.+.     +......++.++.++|..||+..                                          
T Consensus        93 ~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  167 (263)
T 3tm0_A           93 DGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDP  167 (263)
T ss_dssp             SSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSH
T ss_pred             CCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCH
Confidence            9999987521     22344578889999999999811                                          


Q ss_pred             --------------CCCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          271 --------------PVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       271 --------------~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                                    +..++|+|++|.||+++.++.+.|+||+.+.
T Consensus       168 ~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          168 RELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             HHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCE
T ss_pred             HHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhcc
Confidence                          1238999999999999876556799998764

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.95  E-value=1.6e-09  Score=105.52  Aligned_cols=138  Identities=14%  Similarity=0.208  Sum_probs=98.8

Q ss_pred             eeeccceEEEEE---EcCeEEEEEEcC--CCCCCCHHHHHHHHHHHHHHhcCC--CCcceeeeeEEEeC---CceEEEEE
Q 012684          161 VEITKGTFILAF---WRGIQVAVKKLG--EEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQS---SPMMIVTE  230 (458)
Q Consensus       161 ~~lg~G~~~~v~---~~g~~vavK~~~--~~~~~~~~~~~~~~~E~~~l~~l~--hp~i~~~~~~~~~~---~~~~lv~e  230 (458)
                      +.++.|.+..+|   ..+..+++|+..  ....  ......+.+|..+++.+.  +..+++++.++.+.   +..|+|||
T Consensus        44 ~~l~~G~sn~~y~v~~~~~~~vlr~~~~p~~~~--~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme  121 (359)
T 3dxp_A           44 EQFKGGQSNPTFKLVTPGQTYVMRAKPGPKSKL--LPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIME  121 (359)
T ss_dssp             EECCC-CCSCEEEEECSSCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEE
T ss_pred             EEcCCcccceEEEEEECCceEEEEeCCCCCCCC--CCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEE
Confidence            356666654443   456789999876  3211  112346788999999986  45688999988776   45899999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK----------------------------------------  270 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------  270 (458)
                      +++|..+.+.  ....++..+...++.+++..|..||+..                                        
T Consensus       122 ~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  199 (359)
T 3dxp_A          122 FVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDS  199 (359)
T ss_dssp             CCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHH
T ss_pred             ecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHH
Confidence            9998877531  1233678888889999999999999731                                        


Q ss_pred             ---------------CCCeeeCCCCCCCEEecCCCC--EEEeecCCccc
Q 012684          271 ---------------PVPIIHRDLEPSNILRDDSGN--LKVADFGVSKL  302 (458)
Q Consensus       271 ---------------~~~i~H~Dikp~Nil~~~~~~--vkl~Dfg~~~~  302 (458)
                                     +..++|+|++|.||+++.++.  +.|+||+.+..
T Consensus       200 ~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          200 LMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL  248 (359)
T ss_dssp             HHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence                           234999999999999997753  68999998764

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.91  E-value=1.8e-09  Score=99.73  Aligned_cols=114  Identities=20%  Similarity=0.160  Sum_probs=83.9

Q ss_pred             cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCc--ceeeeeEEEeCCceEEEEEccCCCCHHHHHHhcCCCCHHH
Q 012684          174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN--VVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPST  251 (458)
Q Consensus       174 ~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~  251 (458)
                      +|..+++|......      ...+..|+.+++.+.+.+  ++++++++..++..++||||++|.+|.  .   ...+   
T Consensus        43 ~g~~~vlK~~~~~~------~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~---~~~~---  108 (264)
T 1nd4_A           43 GRPVLFVKTDLSGA------LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--S---SHLA---  108 (264)
T ss_dssp             TSCCEEEEEECSCT------TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--T---SCCC---
T ss_pred             CCCeEEEEeCCccc------chhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--c---CcCC---
Confidence            35789999976431      134677899888884333  677899888878899999999998884  1   1111   


Q ss_pred             HHHHHHHHHHHHHHHHhCC-------------------------------------------------------CCCeee
Q 012684          252 AVRFALDIARGMNYLHENK-------------------------------------------------------PVPIIH  276 (458)
Q Consensus       252 ~~~i~~qi~~~l~~LH~~~-------------------------------------------------------~~~i~H  276 (458)
                      ...++.+++..|..||+..                                                       +..++|
T Consensus       109 ~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~H  188 (264)
T 1nd4_A          109 PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTH  188 (264)
T ss_dssp             HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEEC
T ss_pred             HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEEC
Confidence            2356677778888888643                                                       122999


Q ss_pred             CCCCCCCEEecCCCCEEEeecCCcc
Q 012684          277 RDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       277 ~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                      +|++|.||+++.++.+.|+|||.+.
T Consensus       189 gDl~~~Nil~~~~~~~~liD~~~a~  213 (264)
T 1nd4_A          189 GDACLPNIMVENGRFSGFIDCGRLG  213 (264)
T ss_dssp             SSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             CCCCCCcEEEECCcEEEEEcchhcc
Confidence            9999999999877666799999865

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.88  E-value=2.4e-09  Score=101.70  Aligned_cols=185  Identities=17%  Similarity=0.135  Sum_probs=122.2

Q ss_pred             eeeccceEEEEEEcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCc--ceeeeeEEEeCC---ceEEEEEccCC
Q 012684          161 VEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPN--VVQFLGAVTQSS---PMMIVTEYLPK  234 (458)
Q Consensus       161 ~~lg~G~~~~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~--i~~~~~~~~~~~---~~~lv~e~~~~  234 (458)
                      +.++.|....++.-+..+++|+...     ......+.+|..+++.+ .+..  +++++.......   ..|+||++++|
T Consensus        26 ~~~~~G~~n~v~~v~~~~vlR~~~~-----~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G  100 (304)
T 3sg8_A           26 EISGEGNDCIAYEINRDFIFKFPKH-----SRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKG  100 (304)
T ss_dssp             CEEEECSSEEEEESTTSEEEEEESS-----HHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCC
T ss_pred             EecCCCCcceEEEECCEEEEEecCC-----cchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCC
Confidence            3588888888887778899998752     24456788999999887 3332  456665544333   34899999999


Q ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--------------------------------------------
Q 012684          235 GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK--------------------------------------------  270 (458)
Q Consensus       235 ~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~--------------------------------------------  270 (458)
                      .+|.+...  ..++..+...++.+++..|..||+..                                            
T Consensus       101 ~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~  178 (304)
T 3sg8_A          101 VPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYR  178 (304)
T ss_dssp             EECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHH
T ss_pred             eECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHH
Confidence            88875433  23777888888889999888888621                                            


Q ss_pred             -----------CCCeeeCCCCCCCEEecC--CCCEEEeecCCccccccCCCCCcccCCCCCcccCCccc----CC-CCC-
Q 012684          271 -----------PVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF----KN-EEY-  331 (458)
Q Consensus       271 -----------~~~i~H~Dikp~Nil~~~--~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~-~~~-  331 (458)
                                 +..++|+|++|.||+++.  .+.+.++||+.+.......+  .........-..|+..    .. +.. 
T Consensus       179 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D--l~~~~~~~~~~~~~~~~~~l~~Y~~~~  256 (304)
T 3sg8_A          179 DILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND--FISLMEDDEEYGMEFVSKILNHYKHKD  256 (304)
T ss_dssp             HHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH--HHTTCCTTTSCCHHHHHHHHHHHTCSC
T ss_pred             HHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH--HHHHHhhccccCHHHHHHHHHHcCCCC
Confidence                       123799999999999998  45678999998865321100  0000000000122211    00 011 


Q ss_pred             --------CCchhHHHHHHHHHHHHcCCCCC
Q 012684          332 --------DTKVDVFSFALILQEMIEGCPPF  354 (458)
Q Consensus       332 --------~~~~DiwslG~~l~~lltg~~pf  354 (458)
                              ....+.|+++.+++.+.+|..+|
T Consensus       257 ~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          257 IPTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             cHHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                    11268999999999999997765

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.49  E-value=1.3e-06  Score=82.83  Aligned_cols=135  Identities=19%  Similarity=0.174  Sum_probs=94.1

Q ss_pred             eeeccceEEEEEEcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCC--C-cceeeeeEEE-eCCceEEEEEccCCCC
Q 012684          161 VEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRH--P-NVVQFLGAVT-QSSPMMIVTEYLPKGD  236 (458)
Q Consensus       161 ~~lg~G~~~~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--p-~i~~~~~~~~-~~~~~~lv~e~~~~~~  236 (458)
                      +.++.|....+|.-|..+++|+..     .......+..|..+++.+.+  + .+++++.++. ..+..++|||+++|.+
T Consensus        25 ~~l~~G~~n~v~~vg~~~VlR~~~-----~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~   99 (306)
T 3tdw_A           25 ESLGEGFRNYAILVNGDWVFRFPK-----SQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQI   99 (306)
T ss_dssp             EEEEECSSEEEEEETTTEEEEEES-----SHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEE
T ss_pred             eecCCCcceeEEEECCEEEEEecC-----CchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeE
Confidence            356777766666658889999853     23445678899999999853  2 4677777774 4556789999999988


Q ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------------
Q 012684          237 LRAFLKRKGALKPSTAVRFALDIARGMNYLHENK----------------------------------------------  270 (458)
Q Consensus       237 L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~----------------------------------------------  270 (458)
                      |.+..-  ..++..+...++.++...|..||+..                                              
T Consensus       100 l~~~~~--~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~  177 (306)
T 3tdw_A          100 LGEDGM--AVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQ  177 (306)
T ss_dssp             CHHHHH--TTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHH
T ss_pred             Cchhhh--hhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHH
Confidence            876321  22444555555555555555555432                                              


Q ss_pred             -----------CCCeeeCCCCCCCEEecC---CCCE-EEeecCCccc
Q 012684          271 -----------PVPIIHRDLEPSNILRDD---SGNL-KVADFGVSKL  302 (458)
Q Consensus       271 -----------~~~i~H~Dikp~Nil~~~---~~~v-kl~Dfg~~~~  302 (458)
                                 +..++|+|++|.||+++.   ++.+ .|+||+.+..
T Consensus       178 ~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          178 SYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             HHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEE
T ss_pred             HHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCC
Confidence                       223699999999999997   4565 7999998753

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.32  E-value=3.7e-06  Score=77.95  Aligned_cols=118  Identities=14%  Similarity=0.151  Sum_probs=88.9

Q ss_pred             cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHH
Q 012684          174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTA  252 (458)
Q Consensus       174 ~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~  252 (458)
                      .+..+++|+-..      .....+..|...|+.+. +-.+++++.++.+.+..++|||+++|.++.+.....    ....
T Consensus        49 ~~~~~~lk~~~~------~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~  118 (272)
T 4gkh_A           49 NAPELFLKHGKG------SVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSG  118 (272)
T ss_dssp             TCCCEEEEEEET------HHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGH
T ss_pred             CCeEEEEEECCC------CCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHH
Confidence            356899998642      23456888999998883 444789999999989999999999998888765432    2334


Q ss_pred             HHHHHHHHHHHHHHHhCCC-------------------------------------------------------CCeeeC
Q 012684          253 VRFALDIARGMNYLHENKP-------------------------------------------------------VPIIHR  277 (458)
Q Consensus       253 ~~i~~qi~~~l~~LH~~~~-------------------------------------------------------~~i~H~  277 (458)
                      ..+..++...|..||+..+                                                       ..++|+
T Consensus       119 ~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HG  198 (272)
T 4gkh_A          119 ENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHG  198 (272)
T ss_dssp             HHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECS
T ss_pred             HHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcC
Confidence            4566677777777775321                                                       127899


Q ss_pred             CCCCCCEEecCCCCEEEeecCCcc
Q 012684          278 DLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       278 Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                      |+.+.||+++.++.+-|+||+.+.
T Consensus       199 Dl~~~Nil~~~~~~~~viDwe~a~  222 (272)
T 4gkh_A          199 DFSLDNLIFDEGKLIGCIDVGRVG  222 (272)
T ss_dssp             CCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CCCCCeEEEECCeEEEEEECcccc
Confidence            999999999987767799999875

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.91  E-value=7.9e-06  Score=79.06  Aligned_cols=78  Identities=6%  Similarity=-0.029  Sum_probs=48.4

Q ss_pred             eee-ccceEEEEE---Ec--------CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-C--CcceeeeeEEEeC---
Q 012684          161 VEI-TKGTFILAF---WR--------GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-H--PNVVQFLGAVTQS---  222 (458)
Q Consensus       161 ~~l-g~G~~~~v~---~~--------g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--p~i~~~~~~~~~~---  222 (458)
                      +.| +.|....+|   ..        +..+++|+..............+..|+.+++.+. +  -.+++++.++.+.   
T Consensus        26 ~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~  105 (357)
T 3ats_A           26 SGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVL  105 (357)
T ss_dssp             EEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTT
T ss_pred             EECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCcc
Confidence            456 666555444   22        6789999876432000000124667888888873 3  3578888887655   


Q ss_pred             CceEEEEEccCCCCHH
Q 012684          223 SPMMIVTEYLPKGDLR  238 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~  238 (458)
                      +..++|||+++|.++.
T Consensus       106 g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          106 GTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             SSCEEEEECCCCBCCC
T ss_pred             CCceEEEEecCCCChh
Confidence            3568999999886643

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.86  E-value=0.00022  Score=62.62  Aligned_cols=138  Identities=13%  Similarity=0.124  Sum_probs=93.9

Q ss_pred             CHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCccc
Q 012684          236 DLRAFLKR-KGALKPSTAVRFALDIARGMNYL-HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTC  313 (458)
Q Consensus       236 ~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~L-H~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~~  313 (458)
                      +|.++|+. ..+++++++|.++.|.+.+|.-+ +...   -..+=+.|..|++..+|.|.+.+ +.+.            
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~---~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQ---PRHRVRSAAQIRVWRDGAVTLAP-AADD------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTC---CCCCCCSGGGEEEETTSCEEECC-C---------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhccc---CCceecCCcceEEecCCceeccc-cccc------------
Confidence            79999986 45799999999999999998776 2222   12344567899999999998764 1110            


Q ss_pred             CCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHc
Q 012684          314 QDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW  393 (458)
Q Consensus       314 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  393 (458)
                       .....+.|||... ...+.+.-|||||+++|.-+--..|                     +..+..+|+.+.+||..|.
T Consensus        98 -~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt  154 (229)
T 2yle_A           98 -AGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMA  154 (229)
T ss_dssp             ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHT
T ss_pred             -ccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHH
Confidence             1122477888864 3456789999999999998853332                     1124567889999999997


Q ss_pred             cc-------------------------CCCCCCCHHHHHHHHHH
Q 012684          394 NE-------------------------KPAKRPTFRQIITRLES  412 (458)
Q Consensus       394 ~~-------------------------dp~~Rps~~~ll~~L~~  412 (458)
                      ..                         .+..|++++++++.=..
T Consensus       155 ~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~~C~~  198 (229)
T 2yle_A          155 NTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMKLCAA  198 (229)
T ss_dssp             TCCC--------------------CCSCCCCCCSHHHHHHHHHT
T ss_pred             hcccccccccccccccccccccccccccccCcCCHHHHHHHHHh
Confidence            65                         24678999998875443

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=97.61  E-value=0.00091  Score=63.72  Aligned_cols=30  Identities=20%  Similarity=0.305  Sum_probs=26.7

Q ss_pred             CCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          272 VPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       272 ~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                      ..++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            349999999999999888899999999764

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=97.57  E-value=0.00012  Score=71.89  Aligned_cols=73  Identities=19%  Similarity=0.160  Sum_probs=43.0

Q ss_pred             eeeccceEEEEEE-----cCeEEEEEEcCCCCC-CCH---HHHHHHHHHHHHHhcCC-C-C-cceeeeeEEEeCCceEEE
Q 012684          161 VEITKGTFILAFW-----RGIQVAVKKLGEEVI-SDD---DRVRAFRDELALLQKIR-H-P-NVVQFLGAVTQSSPMMIV  228 (458)
Q Consensus       161 ~~lg~G~~~~v~~-----~g~~vavK~~~~~~~-~~~---~~~~~~~~E~~~l~~l~-h-p-~i~~~~~~~~~~~~~~lv  228 (458)
                      +.+|.|.++.+|.     .+..++||....... ...   .....+..|..+++.+. . | .+++++.+  +....++|
T Consensus        36 ~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~lv  113 (397)
T 2olc_A           36 QEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVTV  113 (397)
T ss_dssp             EECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEEE
T ss_pred             EECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEEE
Confidence            4678887776652     457899998653211 000   11234566888888773 2 3 45566654  34456899


Q ss_pred             EEccCCC
Q 012684          229 TEYLPKG  235 (458)
Q Consensus       229 ~e~~~~~  235 (458)
                      ||+++|.
T Consensus       114 mE~l~g~  120 (397)
T 2olc_A          114 MEDLSHL  120 (397)
T ss_dssp             ECCCTTS
T ss_pred             EEeCCCc
Confidence            9999763

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=97.38  E-value=0.00094  Score=65.93  Aligned_cols=29  Identities=24%  Similarity=0.348  Sum_probs=26.2

Q ss_pred             CeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          273 PIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       273 ~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      .++|+|++|.||+++.++ +.++||+.+..
T Consensus       233 ~liHGDl~~~Nil~~~~~-~~lID~e~a~~  261 (420)
T 2pyw_A          233 ALIHGDLHTGSVMVTQDS-TQVIDPEFSFY  261 (420)
T ss_dssp             EEECSCCSGGGEEECSSC-EEECCCTTCEE
T ss_pred             eEEecCCCCCcEEEeCCC-CEEEeCccccc
Confidence            499999999999999876 99999998865

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=97.29  E-value=0.00096  Score=62.99  Aligned_cols=71  Identities=20%  Similarity=0.106  Sum_probs=52.4

Q ss_pred             eeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC---CCcceeeeeEEEeCCceEEEEEccCC
Q 012684          161 VEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR---HPNVVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       161 ~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hp~i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      +.|+.|....+|   .++..+++|+....      ....+..|...|+.+.   ...+++++.++...+..++|||+++|
T Consensus        42 ~~l~gG~~n~~y~v~~~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G  115 (312)
T 3jr1_A           42 EKLYSGEMNEIWLINDEVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNK  115 (312)
T ss_dssp             EEECCSSSSEEEEEESSSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCC
T ss_pred             EEeCCccceeeeEEEECCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccC
Confidence            456766554333   35778999987532      2456788998888883   36788999998877889999999998


Q ss_pred             CCH
Q 012684          235 GDL  237 (458)
Q Consensus       235 ~~L  237 (458)
                      ..+
T Consensus       116 ~~~  118 (312)
T 3jr1_A          116 SKN  118 (312)
T ss_dssp             CCC
T ss_pred             CCC
Confidence            764

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=96.79  E-value=0.0032  Score=59.85  Aligned_cols=31  Identities=32%  Similarity=0.505  Sum_probs=26.9

Q ss_pred             CCeeeCCCCCCCEEecCC----CCEEEeecCCccc
Q 012684          272 VPIIHRDLEPSNILRDDS----GNLKVADFGVSKL  302 (458)
Q Consensus       272 ~~i~H~Dikp~Nil~~~~----~~vkl~Dfg~~~~  302 (458)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            459999999999999874    6799999998764

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.49  E-value=0.0056  Score=57.27  Aligned_cols=71  Identities=14%  Similarity=0.108  Sum_probs=40.6

Q ss_pred             ceeeccceEEEEEEcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEcc-CCCCH
Q 012684          160 SVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYL-PKGDL  237 (458)
Q Consensus       160 ~~~lg~G~~~~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~-~~~~L  237 (458)
                      .+.|+.|....++.- ..+++|+......    ..-....|..+++.+. +.-.++++..+.  ..-++++||+ +|.+|
T Consensus        23 i~~l~gG~tN~~~~~-~~~vlR~~~~~~~----~~~~r~~E~~~l~~l~~~g~~P~~~~~~~--~~~~~v~e~i~~g~~l   95 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA-GDLCLRIPGKGTE----EYINRANEAVAAREAAKAGVSPEVLHVDP--ATGVMVTRYIAGAQTM   95 (301)
T ss_dssp             CEEEESCSSEEEEEE-TTEEEEEECC--------CCCHHHHHHHHHHHHHTTSSCCEEEECT--TTCCEEEECCTTCEEC
T ss_pred             eeEcCCcccccccee-eeEEEECCCCCcc----ceeCHHHHHHHHHHHHHcCCCCceEEEEC--CCCEEEEeecCCCccC
Confidence            456777766555533 7789998864211    1111245777777763 222257766543  3346899999 66544

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=96.45  E-value=0.0081  Score=56.62  Aligned_cols=136  Identities=17%  Similarity=0.104  Sum_probs=71.4

Q ss_pred             eeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCC--cceeeeeE------EEeCCceEEEE
Q 012684          161 VEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP--NVVQFLGA------VTQSSPMMIVT  229 (458)
Q Consensus       161 ~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp--~i~~~~~~------~~~~~~~~lv~  229 (458)
                      +.|+.|....+|   ..+..+++|+.....     ....+..|..+++.+...  .+++++..      ....+..+++|
T Consensus        28 ~~i~~G~~n~~~~v~~~~g~~vlk~~~~~~-----~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~  102 (322)
T 2ppq_A           28 KGIAEGVENSNFLLHTTKDPLILTLYEKRV-----EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALI  102 (322)
T ss_dssp             EEECC---EEEEEEEESSCCEEEEEECC--------CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEE
T ss_pred             eccCCCcccceEEEEeCCccEEEEEeCCCC-----CHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEE
Confidence            345555443333   345579999986421     112455677777666311  23444432      12345678999


Q ss_pred             EccCCCCHH-----H------H---HHhc-CCC--------CHHHHHHH---------------HHHHHHHHHHHHhC--
Q 012684          230 EYLPKGDLR-----A------F---LKRK-GAL--------KPSTAVRF---------------ALDIARGMNYLHEN--  269 (458)
Q Consensus       230 e~~~~~~L~-----~------~---l~~~-~~~--------~~~~~~~i---------------~~qi~~~l~~LH~~--  269 (458)
                      ++++|..+.     .      .   ++.. ..+        ........               ...+...+..+...  
T Consensus       103 ~~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~  182 (322)
T 2ppq_A          103 SFLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWP  182 (322)
T ss_dssp             ECCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCC
T ss_pred             EeCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCc
Confidence            999886531     1      1   1110 011        10000000               01133445555432  


Q ss_pred             --CCCCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          270 --KPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       270 --~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                        .+..++|+|+.+.||+++.++.+.++||+.+.
T Consensus       183 ~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          183 KDLPAGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             CSSCEEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             ccCCcccCCCCCCccCEEEeCCceEEEecchhcc
Confidence              13349999999999999987656899998765

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=96.31  E-value=0.0035  Score=60.80  Aligned_cols=119  Identities=21%  Similarity=0.278  Sum_probs=70.4

Q ss_pred             CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEccCCCCHH--------------H
Q 012684          175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLR--------------A  239 (458)
Q Consensus       175 g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~--------------~  239 (458)
                      +..+++|+..... .   ......+|..+++.+. +.-.+++++.+.+    .+||||++|.+|.              +
T Consensus        82 ~~~~vlR~~g~~~-~---~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~  153 (379)
T 3feg_A           82 PREVLLRLYGAIL-Q---GVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIAT  153 (379)
T ss_dssp             CSEEEEEECC----C---CHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHH
T ss_pred             CCeEEEEECCCcc-c---hHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHH
Confidence            4689999874321 1   1234567999888883 3334677777653    2899999876542              1


Q ss_pred             HHH---hc----C-CCC--HHHHHHHHHHHHH-------------------HHHH----HHhC-CCCCeeeCCCCCCCEE
Q 012684          240 FLK---RK----G-ALK--PSTAVRFALDIAR-------------------GMNY----LHEN-KPVPIIHRDLEPSNIL  285 (458)
Q Consensus       240 ~l~---~~----~-~~~--~~~~~~i~~qi~~-------------------~l~~----LH~~-~~~~i~H~Dikp~Nil  285 (458)
                      .+.   ..    + ...  +.++.++..++..                   .+..    |... .+..++|+|+.+.||+
T Consensus       154 ~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil  233 (379)
T 3feg_A          154 KMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNIL  233 (379)
T ss_dssp             HHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEE
T ss_pred             HHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEE
Confidence            111   11    1 111  2334444433321                   1222    2221 2345899999999999


Q ss_pred             ecCC----CCEEEeecCCcc
Q 012684          286 RDDS----GNLKVADFGVSK  301 (458)
Q Consensus       286 ~~~~----~~vkl~Dfg~~~  301 (458)
                      ++.+    +.+.++||..+.
T Consensus       234 ~~~~~~~~~~~~~IDwE~a~  253 (379)
T 3feg_A          234 LLSEPENADSLMLVDFEYSS  253 (379)
T ss_dssp             EESCC---CCEEECCCTTCE
T ss_pred             EcCCCCccCcEEEEecccCC
Confidence            9876    789999998765

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=95.99  E-value=0.032  Score=53.09  Aligned_cols=31  Identities=19%  Similarity=0.401  Sum_probs=27.3

Q ss_pred             CCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       272 ~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3499999999999999888899999987654

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=95.96  E-value=0.031  Score=52.72  Aligned_cols=29  Identities=24%  Similarity=0.264  Sum_probs=24.8

Q ss_pred             CCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          272 VPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       272 ~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      ..++|+|+++.||+++ + .+.++||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            3489999999999999 4 899999987653

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=95.83  E-value=0.089  Score=48.57  Aligned_cols=73  Identities=18%  Similarity=0.109  Sum_probs=47.9

Q ss_pred             cCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-C--CcceeeeeEEEeCCceEEEEE
Q 012684          158 TNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-H--PNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       158 ~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h--p~i~~~~~~~~~~~~~~lv~e  230 (458)
                      ...+.+|.|..+.+|.    +|+.|++|+........   ...+..|...|+.+. .  -.++++++..    .-++|||
T Consensus        18 ~~v~~~g~G~~~~vyrv~l~DG~~~~vK~~~~~~~~~---~~~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~lv~e   90 (288)
T 3f7w_A           18 AAVAERGHSHRWHLYRVELADGTPLFVKALPDDAPAL---DGLFRAEALGLDWLGRSFGSPVPQVAGWD----DRTLAME   90 (288)
T ss_dssp             EEEEEEEEETTEEEEEEEETTSCEEEEEECCTTCCCC---TTHHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEEEEE
T ss_pred             EEEEecCCCCCeEEEEEEECCCCEEEEEEeCCCCcch---hhHHHHHHHHHHHHHhhCCCCcceEEecc----CceEEEE
Confidence            3446788887766652    68999999876432211   234778999888883 2  2456666653    2478999


Q ss_pred             ccCCCCH
Q 012684          231 YLPKGDL  237 (458)
Q Consensus       231 ~~~~~~L  237 (458)
                      +++++..
T Consensus        91 ~l~~~~~   97 (288)
T 3f7w_A           91 WVDERPP   97 (288)
T ss_dssp             CCCCCCC
T ss_pred             eecccCC
Confidence            9977643

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=95.81  E-value=0.011  Score=58.49  Aligned_cols=53  Identities=11%  Similarity=0.118  Sum_probs=33.8

Q ss_pred             CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEccCCCC
Q 012684          175 GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGD  236 (458)
Q Consensus       175 g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~  236 (458)
                      +..+++|+....  ..   ...+..|..+++.+. +.-.+++++.+.+    .+|+||++|.+
T Consensus       105 ~~~~vlRi~~~~--~~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~  158 (429)
T 1nw1_A          105 PNKVLLRVYFNP--ET---ESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRP  158 (429)
T ss_dssp             CSEEEEEEECSC--CC---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEE
T ss_pred             CceEEEEEeCCC--Cc---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCcc
Confidence            478999998432  11   123446888888884 3334677776542    38999997643

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=95.72  E-value=0.035  Score=55.20  Aligned_cols=69  Identities=12%  Similarity=-0.009  Sum_probs=39.2

Q ss_pred             eeeccceEEE---EEEcC--eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCc-ceeeeeEEEeCCceEEEEEccCC
Q 012684          161 VEITKGTFIL---AFWRG--IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSSPMMIVTEYLPK  234 (458)
Q Consensus       161 ~~lg~G~~~~---v~~~g--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-i~~~~~~~~~~~~~~lv~e~~~~  234 (458)
                      +.|+.|-...   +...+  ..+++|+.......-    -.-..|..+++.+...+ .+++++.+.  +  .+||||++|
T Consensus       114 ~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~----idR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G  185 (458)
T 2qg7_A          114 QIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEI----INREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDG  185 (458)
T ss_dssp             EEECC--CEEEEEEEETTTTEEEEEEEECC-CCSC----SCHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCS
T ss_pred             EEcCCCeEeEEEEEEECCCCceEEEEECCCChhhh----cCHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCC
Confidence            3565554333   33444  789999885321100    01146888888885433 467787763  2  359999987


Q ss_pred             CCH
Q 012684          235 GDL  237 (458)
Q Consensus       235 ~~L  237 (458)
                      .+|
T Consensus       186 ~~l  188 (458)
T 2qg7_A          186 YAL  188 (458)
T ss_dssp             EEC
T ss_pred             ccC
Confidence            543

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=86.91  E-value=1  Score=39.28  Aligned_cols=115  Identities=10%  Similarity=0.118  Sum_probs=75.8

Q ss_pred             CCCcceeeeeEEEeCCceEEEEEccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEe
Q 012684          208 RHPNVVQFLGAVTQSSPMMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILR  286 (458)
Q Consensus       208 ~hp~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~  286 (458)
                      .||++++. ..-..++.+.+.++.-+.+ ++.. +   ..++....++++.+|+....+++.     =+|--+.|+|+++
T Consensus        43 ~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~-i---k~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f  112 (215)
T 4ann_A           43 HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDN-I---KSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFF  112 (215)
T ss_dssp             CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGG-G---GGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEE
T ss_pred             cCCcccce-EEEEcccEEEEEEEcCcccCCHHH-H---HhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEE
Confidence            57888876 4555556655555543211 2222 2   337888999999999998755544     4788999999999


Q ss_pred             cCCCCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCC
Q 012684          287 DDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT  355 (458)
Q Consensus       287 ~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~  355 (458)
                      +.++.+++.=.|+...                  ++|.     ..+...=.-..=+++..+++++..|.
T Consensus       113 ~~~~~p~i~~RGik~~------------------l~P~-----~~~ee~fL~qyKAliiall~~K~~Fe  158 (215)
T 4ann_A          113 TRDGLPIAKTRGLQNV------------------VDPL-----PVSEAEFLTRYKALVICAFNEKQSFD  158 (215)
T ss_dssp             CTTSCEEESCCEETTT------------------BSCC-----CCCHHHHHHHHHHHHHHHHCTTCCHH
T ss_pred             cCCCCEEEEEccCccC------------------CCCC-----CCCHHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999987665321                  1221     11222233447788888999988764

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=84.13  E-value=1.9  Score=37.81  Aligned_cols=113  Identities=13%  Similarity=0.152  Sum_probs=74.7

Q ss_pred             CCCcceeeeeEEEeCCceEEEEEccCCC-CHHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeeeCCCCCCCEE
Q 012684          208 RHPNVVQFLGAVTQSSPMMIVTEYLPKG-DLRAFLKRKGALKPSTAVRFALDIARGMN-YLHENKPVPIIHRDLEPSNIL  285 (458)
Q Consensus       208 ~hp~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~i~~qi~~~l~-~LH~~~~~~i~H~Dikp~Nil  285 (458)
                      .||++..  ..-..++.+.+.++.-+++ +... +   ..++....++++.+|+.... +++.     -+|--+.|+|++
T Consensus        48 ~~~~f~~--~I~~~eD~~~i~y~~~~~~~~f~~-i---~~~~~~eKlrll~nl~~L~~~~~~~-----r~tf~l~P~NL~  116 (219)
T 4ano_A           48 VDPCIVR--DIDVSEDEVKVVIKPPSSFLTFAA-I---RKTTLLSRIRAAIHLVSKVKHHSAR-----RLIFIVCPENLM  116 (219)
T ss_dssp             SCSSSEE--EEEECSSEEEEEEECCTTCEEHHH-H---HTSCHHHHHHHHHHHHHHHSSCCSS-----SEECCCCGGGEE
T ss_pred             cCCCCCe--EEEEeCCEEEEEEEcCcccCcHHH-H---HhcCHHHHHHHHHHHHHHHHHhhhC-----ceeEEEeCceEE
Confidence            5788832  3335666666766655333 3333 3   23788999999999988766 4444     578899999999


Q ss_pred             ecCCCCEEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhH-HHHHHHHHHHHcCCCCCC
Q 012684          286 RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV-FSFALILQEMIEGCPPFT  355 (458)
Q Consensus       286 ~~~~~~vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di-wslG~~l~~lltg~~pf~  355 (458)
                      ++.++.+++.-.|+-.                  -++|.-     .+ ..|. -+.=+++..++.++..|.
T Consensus       117 f~~~~~p~i~hRGi~~------------------~lpP~e-----~~-ee~fl~qyKali~all~~K~~Fe  163 (219)
T 4ano_A          117 FNRALEPFFLHVGVKE------------------SLPPDE-----WD-DERLLREVKATVLALTEGEYRFD  163 (219)
T ss_dssp             ECTTCCEEESCCEETT------------------TBSSCS-----CC-HHHHHHHHHHHHHHHTTCSSCHH
T ss_pred             EeCCCcEEEEEcCCcc------------------cCCCCC-----CC-HHHHHHHHHHHHHHHHcCCCCHH
Confidence            9999999998777532                  122222     12 2333 347778888888877654

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=83.90  E-value=0.39  Score=45.92  Aligned_cols=29  Identities=31%  Similarity=0.554  Sum_probs=24.2

Q ss_pred             CCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          272 VPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       272 ~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                      ..++|+|+.+.||+++.++ +.|+||..+.
T Consensus       212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~  240 (369)
T 3c5i_A          212 IVFCHNDLQENNIINTNKC-LRLIDFEYSG  240 (369)
T ss_dssp             EEEECSCCCGGGEEECC-C-EEECCCTTCE
T ss_pred             eEEEeCCCCcccEEecCCc-EEEEEecCCC
Confidence            3489999999999998654 8999998765

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	458
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	4e-63
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	3e-62
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	5e-59
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	1e-58
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	2e-58
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	2e-58
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	2e-57
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-57
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	7e-57
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	4e-56
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-55
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-55
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	8e-55
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-54
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-54
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-53
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-53
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	3e-53
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	5e-53
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-52
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-52
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	5e-52
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	1e-51
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	1e-51
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	4e-51
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	7e-51
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	1e-50
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	2e-50
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	3e-50
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	7e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	8e-49
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	1e-48
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	1e-48
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	3e-48
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	5e-48
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	8e-48
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	2e-46
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	2e-45
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-44
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	2e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-43
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	5e-43
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	6e-43
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	2e-41
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	2e-40
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	2e-40
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	3e-39
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-38
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	5e-38
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	7e-38
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-37
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-36
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	7e-36
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-35
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	1e-35
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-34
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-31
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	2e-30
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	6e-28
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	7e-27
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	4e-22
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	4e-16
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	2e-14
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	1e-13
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	2e-12
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	4e-12
d1n11a_	408	d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [Ta	2e-11
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	8e-20
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	8e-14
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	2e-09
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	3e-08
d1wdya_	285	d.211.1.1 (A:) RNase L, 2-5a-dependent ribonucleas	3e-07
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-19
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	2e-16
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	6e-11
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	3e-09
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	7e-06
d2fo1e1	277	d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis ele	0.004
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	2e-14
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	3e-11
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	1e-09
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	3e-06
d2ajaa1	346	a.118.24.1 (A:3-348) Hypothetical protein LPG2416	3e-05
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	8e-14
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	3e-10
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	2e-09
d1s70b_	291	d.211.1.1 (B:) Myosin phosphatase targeting subuni	1e-06
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	4e-13
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	1e-11
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	5e-10
d1oy3d_	255	d.211.1.1 (D:) Transcription factor inhibitor I-ka	4e-08
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	8e-13
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	1e-10
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	5e-08
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	7e-08
d1sw6a_	301	d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker	2e-04
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	2e-12
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	7e-07
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	1e-06
d1ot8a_	209	d.211.1.1 (A:) Neurogenic locus notch receptor dom	3e-06
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	2e-12
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	4e-12
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	6e-11
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	1e-07
d1uoha_	223	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	0.001
d1dcqa1	154	d.211.1.1 (A:369-522) Pyk2-associated protein beta	8e-12
d1dcqa1	154	d.211.1.1 (A:369-522) Pyk2-associated protein beta	1e-05
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	1e-11
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	1e-08
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	4e-05
d1k1aa_	228	d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId:	0.004
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	3e-11
d1iknd_	221	d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien	4e-10
d1iknd_	221	d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien	2e-08
d1iknd_	221	d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapien	7e-08
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	3e-09
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	8e-09
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	1e-07
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	6e-06
d1ixva_	229	d.211.1.1 (A:) 26S proteasome non-ATPase regulator	6e-06
d1ihba_	156	d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens	1e-07
d1ihba_	156	d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens	3e-06
d1ihba_	156	d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens	2e-04
d1awcb_	153	d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {	3e-07
d1awcb_	153	d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {	5e-05
d1awcb_	153	d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {	2e-04
d1bd8a_	156	d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma	6e-07
d1bd8a_	156	d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Huma	3e-04
d1ycsb1	130	d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens)	1e-04
d1bi7b_	125	d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Huma	0.001

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  203 bits (518), Expect = 4e-63
 Identities = 75/281 (26%), Positives = 134/281 (47%), Gaps = 18/281 (6%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELAL 203
           ++EI   ++       I  G+F       W G  VAVK L     +     +AF++E+ +
Sbjct: 2   DWEIPDGQITVGQ--RIGSGSFGTVYKGKWHG-DVAVKMLNVTAPTPQQL-QAFKNEVGV 57

Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
           L+K RH N++ F+G  T    + IVT++     L   L   +   +    +  A   A+G
Sbjct: 58  LRKTRHVNILLFMGYSTAP-QLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQG 116

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYV 321
           M+YLH      IIHRDL+ +NI   +   +K+ DFG++ + +         Q + S  ++
Sbjct: 117 MDYLHAK---SIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWM 173

Query: 322 APEVFKNEE---YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKA 376
           APEV + ++   Y  + DV++F ++L E++ G  P++  ++ +       R    P    
Sbjct: 174 APEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSK 233

Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
                 + +K L+ EC  +K  +RP F QI+  +E +  S+
Sbjct: 234 VRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARSL 274

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  201 bits (511), Expect = 3e-62
 Identities = 80/275 (29%), Positives = 134/275 (48%), Gaps = 24/275 (8%)

Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALL 204
           + ++  EL       I KG F   +L  +RG +VAVK      I +D   +AF  E +++
Sbjct: 2   WALNMKELKLLQ--TIGKGEFGDVMLGDYRGNKVAVK-----CIKNDATAQAFLAEASVM 54

Query: 205 QKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIAR 261
            ++RH N+VQ LG + +    + IVTEY+ KG L  +L+ +G   L     ++F+LD+  
Sbjct: 55  TQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE 114

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
            M YL  N     +HRDL   N+L  +    KV+DFG++K  +  +           ++ 
Sbjct: 115 AMEYLEGN---NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ----DTGKLPVKWT 167

Query: 322 APEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL 380
           APE  + +++ TK DV+SF ++L E+   G  P+      +V        +         
Sbjct: 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---PDG 224

Query: 381 YARGLKELIEECWNEKPAKRPTFRQIITRLESINN 415
               + E+++ CW+   A RP+F Q+  +LE I  
Sbjct: 225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (489), Expect = 5e-59
 Identities = 66/266 (24%), Positives = 119/266 (44%), Gaps = 19/266 (7%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDEL 201
           ++ ++    DF     + KG F    LA  +     +A+K L +  +         R E+
Sbjct: 2   QWALE----DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 57

Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIAR 261
            +   +RHPN+++  G    ++ + ++ EY P G +   L++           +  ++A 
Sbjct: 58  EIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 117

Query: 262 GMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYV 321
            ++Y H  +   +IHRD++P N+L   +G LK+ADFG S           T    +  Y+
Sbjct: 118 ALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHA---PSSRRTTLCGTLDYL 171

Query: 322 APEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY 381
            PE+ +   +D KVD++S  ++  E + G PPF      E    Y    R  F  P    
Sbjct: 172 PPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQET---YKRISRVEFTFP-DFV 227

Query: 382 ARGLKELIEECWNEKPAKRPTFRQII 407
             G ++LI       P++RP  R+++
Sbjct: 228 TEGARDLISRLLKHNPSQRPMLREVL 253

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 1e-58
 Identities = 72/270 (26%), Positives = 128/270 (47%), Gaps = 18/270 (6%)

Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP +L F    E+  G F       WR    VA+K + E  +S+D+    F +E  ++ 
Sbjct: 1   IDPKDLTFLK--ELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMM 54

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMN 264
            + H  +VQ  G  T+  P+ I+TEY+  G L  +L+  +   +    +    D+   M 
Sbjct: 55  NLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME 114

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
           YL        +HRDL   N L +D G +KV+DFG+S+ +   E           R+  PE
Sbjct: 115 YLESK---QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPE 171

Query: 325 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
           V    ++ +K D+++F +++ E+   G  P+    ++E  +  A   R        L + 
Sbjct: 172 VLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYRP---HLASE 228

Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESI 413
            +  ++  CW+EK  +RPTF+ +++ +  +
Sbjct: 229 KVYTIMYSCWHEKADERPTFKILLSNILDV 258

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 2e-58
 Identities = 82/273 (30%), Positives = 141/273 (51%), Gaps = 18/273 (6%)

Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQ 205
           IDP EL F    EI  G F    L +W    +VA+K + E  +S++D    F +E  ++ 
Sbjct: 2   IDPSELTFVQ--EIGSGQFGLVHLGYWLNKDKVAIKTIREGAMSEED----FIEEAEVMM 55

Query: 206 KIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIARGMN 264
           K+ HP +VQ  G   + +P+ +V E++  G L  +L+ +  L    T +   LD+  GM 
Sbjct: 56  KLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA 115

Query: 265 YLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPE 324
           YL E     +IHRDL   N L  ++  +KV+DFG+++ +   +    T      ++ +PE
Sbjct: 116 YLEEA---CVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPE 172

Query: 325 VFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
           VF    Y +K DV+SF +++ E+  EG  P+  + ++EV +  +   R       +L + 
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYKP---RLAST 229

Query: 384 GLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
            + +++  CW E+P  RP F +++ +L  I  S
Sbjct: 230 HVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  191 bits (486), Expect = 2e-58
 Identities = 80/278 (28%), Positives = 129/278 (46%), Gaps = 20/278 (7%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDEL 201
            E+E+    L       +  G F    + ++    +VAVK L +  +S D     F  E 
Sbjct: 6   DEWEVPRETLKLVE--RLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMSPDA----FLAEA 59

Query: 202 ALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPS--TAVRFALDI 259
            L+++++H  +V+    VTQ  P+ I+TEY+  G L  FLK    +K +    +  A  I
Sbjct: 60  NLMKQLQHQRLVRLYAVVTQE-PIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQI 118

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR 319
           A GM ++ E      IHRDL  +NIL  D+ + K+ADFG+++L+   E           +
Sbjct: 119 AEGMAFIEER---NYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIK 175

Query: 320 YVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPA 378
           + APE      +  K DV+SF ++L E++  G  P+    + EV +      R       
Sbjct: 176 WTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVRP--- 232

Query: 379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS 416
                 L +L+  CW E+P  RPTF  + + LE    +
Sbjct: 233 DNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA 270

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  189 bits (482), Expect = 2e-57
 Identities = 70/290 (24%), Positives = 122/290 (42%), Gaps = 24/290 (8%)

Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELA 202
           ++ DP +L F++  EI  G+F     A        VA+KK+       +++ +    E+ 
Sbjct: 9   FKDDPEKL-FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
            LQK+RHPN +Q+ G   +     +V EY            K  L+            +G
Sbjct: 68  FLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQG 127

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
           + YLH +    +IHRD++  NIL  + G +K+ DFG + ++      P      +  ++A
Sbjct: 128 LAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMA-----PANSFVGTPYWMA 179

Query: 323 PEVF---KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379
           PEV       +YD KVDV+S  +   E+ E  PP    +        A  + P     + 
Sbjct: 180 PEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSG 237

Query: 380 LYARGLKELIEECWNEKPAKRPTFRQI-----ITRLESINNSINHKRRWK 424
            ++   +  ++ C  + P  RPT   +     + R       ++  +R K
Sbjct: 238 HWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTK 287

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  188 bits (479), Expect = 2e-57
 Identities = 60/265 (22%), Positives = 116/265 (43%), Gaps = 18/265 (6%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           D+     I  G++        +  G  +  K+L    +++ ++ +    E+ LL++++HP
Sbjct: 5   DYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEK-QMLVSEVNLLRELKHP 63

Query: 211 NVVQFLGAVT--QSSPMMIVTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMN 264
           N+V++   +    ++ + IV EY   GDL + + +    +  L     +R    +   + 
Sbjct: 64  NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123

Query: 265 YLHENKPV--PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
             H        ++HRDL+P+N+  D   N+K+ DFG++++L            T   Y++
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGT-PYYMS 182

Query: 323 PEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA 382
           PE      Y+ K D++S   +L E+    PPFT     E+       +          Y+
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPYR---YS 239

Query: 383 RGLKELIEECWNEKPAKRPTFRQII 407
             L E+I    N K   RP+  +I+
Sbjct: 240 DELNEIITRMLNLKDYHRPSVEEIL 264

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (477), Expect = 7e-57
 Identities = 71/270 (26%), Positives = 124/270 (45%), Gaps = 20/270 (7%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELAL 203
           +++P +  +    E+  G F     A  +   +  A K +  +    ++ +  +  E+ +
Sbjct: 7   DLNPED-FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDI 62

Query: 204 LQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALDIARG 262
           L    HPN+V+ L A    + + I+ E+   G + A + + +  L  S            
Sbjct: 63  LASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDA 122

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVA 322
           +NYLH+NK   IIHRDL+  NIL    G++K+ADFGVS   T +  +       +  ++A
Sbjct: 123 LNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNT-RTIQRRDSFIGTPYWMA 178

Query: 323 PEVF-----KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAP 377
           PEV      K+  YD K DV+S  + L EM E  PP    +   V    A  + P    P
Sbjct: 179 PEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQP 238

Query: 378 AKLYARGLKELIEECWNEKPAKRPTFRQII 407
           ++ ++   K+ +++C  +    R T  Q++
Sbjct: 239 SR-WSSNFKDFLKKCLEKNVDARWTTSQLL 267

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (470), Expect = 4e-56
 Identities = 67/256 (26%), Positives = 126/256 (49%), Gaps = 17/256 (6%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           EI +G+F            ++VA  +L +  ++  +R R F++E  +L+ ++HPN+V+F 
Sbjct: 16  EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQR-FKEEAEMLKGLQHPNIVRFY 74

Query: 217 GA----VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
            +    V     +++VTE +  G L+ +LKR   +K      +   I +G+ +LH   P 
Sbjct: 75  DSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP- 133

Query: 273 PIIHRDLEPSNIL-RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEY 331
           PIIHRDL+  NI     +G++K+ D G++ L   K          +  ++APE+++  +Y
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATL---KRASFAKAVIGTPEFMAPEMYEE-KY 189

Query: 332 DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEE 391
           D  VDV++F + + EM     P++   +             P     K+    +KE+IE 
Sbjct: 190 DESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFD-KVAIPEVKEIIEG 248

Query: 392 CWNEKPAKRPTFRQII 407
           C  +   +R + + ++
Sbjct: 249 CIRQNKDERYSIKDLL 264

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (468), Expect = 1e-55
 Identities = 67/278 (24%), Positives = 118/278 (42%), Gaps = 19/278 (6%)

Query: 150 IDPHELDFTNSVEITKGTF---ILAFWR----GIQVAVKKLGEEVISDDDRVRAFRDELA 202
           +D   L   +  E+  G F      +++       VAVK L  E  +D         E  
Sbjct: 3   LDRKLLTLEDK-ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNE-ANDPALKDELLAEAN 60

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARG 262
           ++Q++ +P +V+ +G + ++   M+V E    G L  +L++   +K    +     ++ G
Sbjct: 61  VMQQLDNPYIVRMIG-ICEAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMG 119

Query: 263 MNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRY 320
           M YL E+     +HRDL   N+L       K++DFG+SK L   E+            ++
Sbjct: 120 MKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKW 176

Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379
            APE     ++ +K DV+SF +++ E    G  P+     +EV       +R    A   
Sbjct: 177 YAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAG-- 234

Query: 380 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
              R + +L+  CW      RP F  +  RL +    +
Sbjct: 235 -CPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 3e-55
 Identities = 64/282 (22%), Positives = 117/282 (41%), Gaps = 21/282 (7%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR----GIQVAVKKLGEEVISDDDRVRAFRD 199
           +  +    L   + +E+  G F       +R     I VA+K L +   ++         
Sbjct: 2   KLFLKRDNLLIAD-IELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMR 58

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFALD 258
           E  ++ ++ +P +V+ +G V Q+  +M+V E    G L  FL  ++  +  S        
Sbjct: 59  EAQIMHQLDNPYIVRLIG-VCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 117

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED--RPLTCQDT 316
           ++ GM YL E      +HRDL   N+L  +    K++DFG+SK L   +      +    
Sbjct: 118 VSMGMKYLEEK---NFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKW 174

Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFK 375
             ++ APE     ++ ++ DV+S+ + + E +  G  P+      EV       +R    
Sbjct: 175 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC- 233

Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI 417
                    L  L+ +CW  K   RP F  +  R+ +   S+
Sbjct: 234 --PPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSL 273

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  183 bits (466), Expect = 8e-55
 Identities = 67/296 (22%), Positives = 114/296 (38%), Gaps = 52/296 (17%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF    E+  G          +  G+ +A K +  E             EL +L +   P
Sbjct: 7   DFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHECNSP 64

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
            +V F GA      + I  E++  G L   LK+ G +      + ++ + +G+ YL E  
Sbjct: 65  YIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 124

Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
              I+HRD++PSNIL +  G +K+ DFGVS  L    D        +  Y++PE  +   
Sbjct: 125 --KIMHRDVKPSNILVNSRGEIKLCDFGVSGQL---IDSMANSFVGTRSYMSPERLQGTH 179

Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQR------------------- 371
           Y  + D++S  L L EM  G  P       E+   +  +                     
Sbjct: 180 YSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSS 239

Query: 372 ---------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
                                PP K P+ +++   ++ + +C  + PA+R   +Q+
Sbjct: 240 YGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQL 295

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 1e-54
 Identities = 82/283 (28%), Positives = 130/283 (45%), Gaps = 20/283 (7%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELA 202
            +EI    L      ++ +G F    +  W    +VA+K L    +S +     F  E  
Sbjct: 11  AWEIPRESLRLEV--KLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMSPEA----FLQEAQ 64

Query: 203 LLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA--LKPSTAVRFALDIA 260
           +++K+RH  +VQ    V++  P+ IVTEY+ KG L  FLK +    L+    V  A  IA
Sbjct: 65  VMKKLRHEKLVQLYAVVSEE-PIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIA 123

Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRY 320
            GM Y+        +HRDL  +NIL  ++   KVADFG+++L+   E           ++
Sbjct: 124 SGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKW 180

Query: 321 VAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAK 379
            APE      +  K DV+SF ++L E+  +G  P+    + EV        R P      
Sbjct: 181 TAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPE-- 238

Query: 380 LYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRR 422
                L +L+ +CW ++P +RPTF  +   LE    S   + +
Sbjct: 239 -CPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTEPQYQ 280

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (460), Expect = 2e-54
 Identities = 57/251 (22%), Positives = 118/251 (47%), Gaps = 14/251 (5%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           +I +G       A     G +VA++++    +    +     +E+ ++++ ++PN+V +L
Sbjct: 27  KIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMRENKNPNIVNYL 83

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            +      + +V EYL  G L   +                +  + + +LH N+   +IH
Sbjct: 84  DSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQ---VIH 139

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           RD++  NIL    G++K+ DFG    +T ++ +  +    +  ++APEV   + Y  KVD
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK-RSTMVGTPYWMAPEVVTRKAYGPKVD 198

Query: 337 VFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 396
           ++S  ++  EMIEG PP+  ++        A    P  + P KL +   ++ +  C +  
Sbjct: 199 IWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL-SAIFRDFLNRCLDMD 257

Query: 397 PAKRPTFRQII 407
             KR + ++++
Sbjct: 258 VEKRGSAKELL 268

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 4e-54
 Identities = 70/298 (23%), Positives = 116/298 (38%), Gaps = 44/298 (14%)

Query: 162 EITKGTF---ILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA 218
            I KG F       WRG +VAVK       S ++R      E+     +RH N++ F+ A
Sbjct: 10  SIGKGRFGEVWRGKWRGEEVAVKIFS----SREERSWFREAEIYQTVMLRHENILGFIAA 65

Query: 219 VTQS----SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV-- 272
             +     + + +V++Y   G L  +L R   +     ++ AL  A G+ +LH       
Sbjct: 66  DNKDNGTWTQLWLVSDYHEHGSLFDYLNRYT-VTVEGMIKLALSTASGLAHLHMEIVGTQ 124

Query: 273 ---PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEVF 326
               I HRDL+  NIL   +G   +AD G++       D      +      RY+APEV 
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184

Query: 327 ------KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP----------------- 363
                 K+ E   + D+++  L+  E+   C    +  D ++P                 
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV 244

Query: 364 -KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420
                 R   P +  +    R + +++ ECW    A R T  +I   L  ++     K
Sbjct: 245 VCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQEGIK 302

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  179 bits (454), Expect = 2e-53
 Identities = 74/278 (26%), Positives = 130/278 (46%), Gaps = 20/278 (7%)

Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
              ++E++  ++   +  ++  G +       W+   + VAVK L E    D   V  F 
Sbjct: 8   NYDKWEMERTDITMKH--KLGGGQYGEVYEGVWKKYSLTVAVKTLKE----DTMEVEEFL 61

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL--KRKGALKPSTAVRFA 256
            E A++++I+HPN+VQ LG  T+  P  I+TE++  G+L  +L    +  +     +  A
Sbjct: 62  KEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMA 121

Query: 257 LDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
             I+  M YL +      IHRDL   N L  ++  +KVADFG+S+L+T            
Sbjct: 122 TQISSAMEYLEKK---NFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF 178

Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFK 375
             ++ APE     ++  K DV++F ++L E+   G  P+     ++V +      R    
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 238

Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
              +     + EL+  CW   P+ RP+F +I    E++
Sbjct: 239 ---EGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETM 273

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (452), Expect = 2e-53
 Identities = 69/262 (26%), Positives = 117/262 (44%), Gaps = 13/262 (4%)

Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P   D+     + +G +    LA  R     VAVK +  +     D     + E+ + + 
Sbjct: 2   PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKM 59

Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + H NVV+F G   + +   +  EY   G+L   ++    +    A RF   +  G+ YL
Sbjct: 60  LNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYL 119

Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV-KEDRPLTCQDTSCRYVAPEV 325
           H      I HRD++P N+L D+  NLK++DFG++ +      +R L     +  YVAPE+
Sbjct: 120 HGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPEL 176

Query: 326 FKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384
            K  E+    VDV+S  ++L  M+ G  P+    D+   +    +++  +  P K     
Sbjct: 177 LKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ-EYSDWKEKKTYLNPWKKIDSA 235

Query: 385 LKELIEECWNEKPAKRPTFRQI 406
              L+ +   E P+ R T   I
Sbjct: 236 PLALLHKILVENPSARITIPDI 257

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  177 bits (450), Expect = 3e-53
 Identities = 65/277 (23%), Positives = 128/277 (46%), Gaps = 21/277 (7%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWR-----GIQVAVKKLGEEVISDDDRVRAFR 198
           +YEI    ++      I +G F       +       + VA+K    +  + D     F 
Sbjct: 1   DYEIQRERIELGR--CIGEGQFGDVHQGIYMSPENPALAVAIKTC--KNCTSDSVREKFL 56

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKPSTAVRFAL 257
            E   +++  HP++V+ +G +T++ P+ I+ E    G+LR+FL  RK +L  ++ + +A 
Sbjct: 57  QEALTMRQFDHPHIVKLIGVITEN-PVWIIMELCTLGELRSFLQVRKYSLDLASLILYAY 115

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTS 317
            ++  + YL   +    +HRD+   N+L   +  +K+ DFG+S+ +        +     
Sbjct: 116 QLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLP 172

Query: 318 CRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKA 376
            +++APE      + +  DV+ F + + E++  G  PF    +N+V       +R P   
Sbjct: 173 IKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP- 231

Query: 377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
                   L  L+ +CW   P++RP F ++  +L +I
Sbjct: 232 --PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTI 266

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  178 bits (453), Expect = 5e-53
 Identities = 73/304 (24%), Positives = 122/304 (40%), Gaps = 47/304 (15%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWRG-------IQVAVKKLGEEVISDDDRVR 195
            ++E     L+F     +  G F   + A   G       IQVAVK L E+  +D     
Sbjct: 30  LKWEFPRENLEFGK--VLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEK--ADSSERE 85

Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------- 244
           A   EL ++ ++  H N+V  LGA T S P+ ++ EY   GDL  +L+ K          
Sbjct: 86  ALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIE 145

Query: 245 -------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN 291
                          L     + FA  +A+GM +L        +HRDL   N+L      
Sbjct: 146 YENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFK---SCVHRDLAARNVLVTHGKV 202

Query: 292 LKVADFGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-E 349
           +K+ DFG+++ +    +  +        +++APE      Y  K DV+S+ ++L E+   
Sbjct: 203 VKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSL 262

Query: 350 GCPPFT-MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIIT 408
           G  P+  +  D    K      +             +  +++ CW     KRP+F  + +
Sbjct: 263 GVNPYPGIPVDANFYKLIQNGFKMDQP---FYATEEIYIIMQSCWAFDSRKRPSFPNLTS 319

Query: 409 RLES 412
            L  
Sbjct: 320 FLGC 323

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  176 bits (447), Expect = 2e-52
 Identities = 79/279 (28%), Positives = 127/279 (45%), Gaps = 24/279 (8%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWR-----GIQVAVKKLGEEVISDDDRVRAFRDE 200
           EID   +       I  G F        +      I VA+K L       + + R F  E
Sbjct: 22  EIDISCVKIEQ--VIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY--TEKQRRDFLSE 77

Query: 201 LALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDI 259
            +++ +  HPNV+   G VT+S+P+MI+TE++  G L +FL++  G       V     I
Sbjct: 78  ASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGI 137

Query: 260 ARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC- 318
           A GM YL +      +HRDL   NIL + +   KV+DFG+S+ L      P         
Sbjct: 138 AAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGK 194

Query: 319 ---RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPF 374
              R+ APE  +  ++ +  DV+S+ +++ E++  G  P+    + +V  A     R P 
Sbjct: 195 IPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLP- 253

Query: 375 KAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
             P       L +L+ +CW +    RP F QI+  L+ +
Sbjct: 254 --PPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKM 290

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 3e-52
 Identities = 66/253 (26%), Positives = 111/253 (43%), Gaps = 10/253 (3%)

Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP 224
           +G +     + + VAVK L  +V+S  + +  F  E+  +  + H N+++  G V  + P
Sbjct: 26  RGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG-VVLTPP 84

Query: 225 MMIVTEYLPKGDLRAF-LKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSN 283
           M +VTE  P G L     K +G     T  R+A+ +A GM YL        IHRDL   N
Sbjct: 85  MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESK---RFIHRDLAARN 141

Query: 284 ILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--TSCRYVAPEVFKNEEYDTKVDVFSFA 341
           +L      +K+ DFG+ + L   +D  +  +       + APE  K   +    D + F 
Sbjct: 142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFG 201

Query: 342 LILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
           + L EM   G  P+   + +++      ++      P     + +  ++ +CW  KP  R
Sbjct: 202 VTLWEMFTYGQEPWIGLNGSQILHKI-DKEGERLPRPEDC-PQDIYNVMVQCWAHKPEDR 259

Query: 401 PTFRQIITRLESI 413
           PTF  +   L   
Sbjct: 260 PTFVALRDFLLEA 272

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  177 bits (449), Expect = 5e-52
 Identities = 63/280 (22%), Positives = 116/280 (41%), Gaps = 25/280 (8%)

Query: 136 PMHVKHAREVPEYEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISD 190
           P+ +KH   +  Y+I           E+  G F        R  G   A K +     SD
Sbjct: 16  PVEIKHDHVLDHYDIHE---------ELGTGAFGVVHRVTERATGNNFAAKFVMTPHESD 66

Query: 191 DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFL-KRKGALKP 249
            +     R E+  +  +RHP +V    A    + M+++ E++  G+L   +      +  
Sbjct: 67  KET---VRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSE 123

Query: 250 STAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKE 307
             AV +   + +G+ ++HEN     +H DL+P NI+     S  LK+ DFG++  L  K+
Sbjct: 124 DEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 180

Query: 308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA 367
              +T       + APEV + +      D++S  ++   ++ G  PF  ++D+E  +   
Sbjct: 181 SVKVTTGT--AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238

Query: 368 ARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           +       +     +   K+ I +     P  R T  Q +
Sbjct: 239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQAL 278

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (441), Expect = 1e-51
 Identities = 54/257 (21%), Positives = 116/257 (45%), Gaps = 13/257 (5%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF     + +G+F   +LA       + A+K L +  I  +++V     E  ++ ++ HP
Sbjct: 9   DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHP 68

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
             V+          +     Y   G+L  ++++ G+   +    +  +I   + YLH   
Sbjct: 69  FFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGK- 127

Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCR-YVAPEVFKNE 329
              IIHRDL+P NIL ++  ++++ DFG +K+L+ +  +           YV+PE+   +
Sbjct: 128 --GIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 185

Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389
                 D+++   I+ +++ G PPF   ++  +   +    +  +  P K + +  ++L+
Sbjct: 186 SACKSSDLWALGCIIYQLVAGLPPFRAGNEYLI---FQKIIKLEYDFPEKFFPK-ARDLV 241

Query: 390 EECWNEKPAKRPTFRQI 406
           E+       KR    ++
Sbjct: 242 EKLLVLDATKRLGCEEM 258

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  174 bits (443), Expect = 1e-51
 Identities = 54/304 (17%), Positives = 121/304 (39%), Gaps = 18/304 (5%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           ++ +G F                 K +    +   D+V   + E+++L   RH N++   
Sbjct: 12  DLGRGEFGIVHRCVETSSKKTYMAKFV---KVKGTDQVL-VKKEISILNIARHRNILHLH 67

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPII 275
            +      ++++ E++   D+   +      L     V +   +   + +LH +    I 
Sbjct: 68  ESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IG 124

Query: 276 HRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
           H D+ P NI+     S  +K+ +FG ++ L  K         T+  Y APEV +++   T
Sbjct: 125 HFDIRPENIIYQTRRSSTIKIIEFGQARQL--KPGDNFRLLFTAPEYYAPEVHQHDVVST 182

Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
             D++S   ++  ++ G  PF  + + ++ +     +    +   K  +    + ++   
Sbjct: 183 ATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLL 242

Query: 394 NEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSSPSSRSKSSC 453
            ++   R T  + + +   +   I       IRT+K       ++KKD +   S ++ SC
Sbjct: 243 VKERKSRMTASEAL-QHPWLKQKIERVSTKVIRTLKHRRYYHTLIKKDLNMVVSAARISC 301

Query: 454 STSS 457
             + 
Sbjct: 302 GGAI 305

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (439), Expect = 4e-51
 Identities = 77/304 (25%), Positives = 125/304 (41%), Gaps = 39/304 (12%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR-------GIQVAVKKLGEEVISDDDRVR 195
            ++E   + L F     +  G F   + A           + VAVK L     +      
Sbjct: 16  HKWEFPRNRLSFGK--TLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPS--AHLTERE 71

Query: 196 AFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG--------- 245
           A   EL +L  +  H N+V  LGA T   P +++TEY   GDL  FL+RK          
Sbjct: 72  ALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTS 131

Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
                    AL     + F+  +A+GM +L        IHRDL   NIL       K+ D
Sbjct: 132 PAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILLTHGRITKICD 188

Query: 297 FGVSKLLTVKEDRPL-TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
           FG+++ +    +  +        +++APE   N  Y  + DV+S+ + L E+        
Sbjct: 189 FGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPY 248

Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLES-IN 414
                +       ++     +P       + ++++ CW+  P KRPTF+QI+  +E  I+
Sbjct: 249 PGMPVDSKFYKMIKEGFRMLSPEHA-PAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS 307

Query: 415 NSIN 418
            S N
Sbjct: 308 ESTN 311

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  172 bits (437), Expect = 7e-51
 Identities = 64/254 (25%), Positives = 115/254 (45%), Gaps = 15/254 (5%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
            +  G F   ILA  +     VA+K + ++ +  + +  +  +E+A+L KI+HPN+V   
Sbjct: 16  VLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHKIKHPNIVALD 73

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
                   + ++ + +  G+L   +  KG      A R    +   + YLH+     I+H
Sbjct: 74  DIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDL---GIVH 130

Query: 277 RDLEPSNIL---RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
           RDL+P N+L    D+   + ++DFG+SK+        L+    +  YVAPEV   + Y  
Sbjct: 131 RDLKPENLLYYSLDEDSKIMISDFGLSKME--DPGSVLSTACGTPGYVAPEVLAQKPYSK 188

Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
            VD +S  +I   ++ G PPF  ++D ++ +     +           +   K+ I    
Sbjct: 189 AVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIRHLM 248

Query: 394 NEKPAKRPTFRQII 407
            + P KR T  Q +
Sbjct: 249 EKDPEKRFTCEQAL 262

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (436), Expect = 1e-50
 Identities = 77/307 (25%), Positives = 143/307 (46%), Gaps = 24/307 (7%)

Query: 143 REVPEYEIDPHELDFTNSVEITKGTF---ILAFW-----RGIQVAVKKLGEEVISDDDRV 194
           + V    I P  L    +  I +G F             + I  AVK L    I+D   V
Sbjct: 15  QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSL--NRITDIGEV 72

Query: 195 RAFRDELALLQKIRHPNVVQFLGAVTQS-SPMMIVTEYLPKGDLRAFLK-RKGALKPSTA 252
             F  E  +++   HPNV+  LG   +S    ++V  Y+  GDLR F++           
Sbjct: 73  SQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDL 132

Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
           + F L +A+GM +L   K    +HRDL   N + D+   +KVADFG+++ +  KE   + 
Sbjct: 133 IGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189

Query: 313 CQDTSC---RYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAA 368
            +  +    +++A E  + +++ TK DV+SF ++L E++  G PP+   +  ++      
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249

Query: 369 RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTM 428
            +R       +     L E++ +CW+ K   RP+F ++++R+ +I ++   +    +   
Sbjct: 250 GRRLLQ---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEH--YVHVN 304

Query: 429 KCFHNLE 435
             + N++
Sbjct: 305 ATYVNVK 311

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  172 bits (438), Expect = 2e-50
 Identities = 46/254 (18%), Positives = 104/254 (40%), Gaps = 16/254 (6%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           E+  G F        +  G     K +      D       ++E++++ ++ HP ++   
Sbjct: 36  ELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYT---VKNEISIMNQLHHPKLINLH 92

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPII 275
            A      M+++ E+L  G+L   +  +   +  +  + +      G+ ++HE+    I+
Sbjct: 93  DAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IV 149

Query: 276 HRDLEPSNIL--RDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDT 333
           H D++P NI+     + ++K+ DFG++  L    D  +     +  + APE+   E    
Sbjct: 150 HLDIKPENIMCETKKASSVKIIDFGLATKLN--PDEIVKVTTATAEFAAPEIVDREPVGF 207

Query: 334 KVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECW 393
             D+++  ++   ++ G  PF  + D E  +          +      +   K+ I+   
Sbjct: 208 YTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIKNLL 267

Query: 394 NEKPAKRPTFRQII 407
            ++P KR T    +
Sbjct: 268 QKEPRKRLTVHDAL 281

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  170 bits (432), Expect = 3e-50
 Identities = 77/306 (25%), Positives = 127/306 (41%), Gaps = 46/306 (15%)

Query: 144 EVPEYEIDPHELDFTNSVEITKGTF----------ILAFWRGIQVAVKKLGEEVISDDDR 193
           ++   E   + +++    +I +G F          +L +     VAVK L EE  +  D 
Sbjct: 4   KLLSLEYPRNNIEYVR--DIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADM 59

Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG-------- 245
              F+ E AL+ +  +PN+V+ LG      PM ++ EY+  GDL  FL+           
Sbjct: 60  QADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119

Query: 246 ----------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS 289
                            L  +  +  A  +A GM YL E K    +HRDL   N L  ++
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLATRNCLVGEN 176

Query: 290 GNLKVADFGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI 348
             +K+ADFG+S+ +   +       D    R++ PE      Y T+ DV+++ ++L E+ 
Sbjct: 177 MVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 236

Query: 349 E-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
             G  P+      EV                +     L  L+  CW++ PA RP+F  I 
Sbjct: 237 SYGLQPYYGMAHEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIH 293

Query: 408 TRLESI 413
             L+ +
Sbjct: 294 RILQRM 299

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (424), Expect = 7e-49
 Identities = 60/269 (22%), Positives = 114/269 (42%), Gaps = 19/269 (7%)

Query: 156 DFTNSVEITKGTF---ILAFWR------GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           +F     +  G F       W        I VA+K+L E   +     +   DE  ++  
Sbjct: 10  EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMAS 67

Query: 207 IRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYL 266
           + +P+V + LG    S+  +I         L    + K  +     + + + IA+GMNYL
Sbjct: 68  VDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL 127

Query: 267 HENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-SCRYVAPEV 325
            + +   ++HRDL   N+L     ++K+ DFG++KLL  +E            +++A E 
Sbjct: 128 EDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALES 184

Query: 326 FKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG 384
             +  Y  + DV+S+ + + E++  G  P+     +E+       +R P      +    
Sbjct: 185 ILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP---PICTID 241

Query: 385 LKELIEECWNEKPAKRPTFRQIITRLESI 413
           +  ++ +CW      RP FR++I     +
Sbjct: 242 VYMIMVKCWMIDADSRPKFRELIIEFSKM 270

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (421), Expect = 8e-49
 Identities = 72/278 (25%), Positives = 124/278 (44%), Gaps = 23/278 (8%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG------IQVAVKKLGEEVISDDDRVRAFRD 199
           EI P  +       I  G F        +       + VA+K L       + +   F  
Sbjct: 3   EIHPSCVTRQK--VIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLG 58

Query: 200 ELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGD-LRAFLKRKGALKPSTAVRFALD 258
           E  ++ +  H N+++  G +++  PMMI+TEY+  G   +   ++ G       V     
Sbjct: 59  EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 118

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT-- 316
           IA GM YL        +HRDL   NIL + +   KV+DFG+S++L    +   T      
Sbjct: 119 IAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 175

Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPFTMKHDNEVPKAYAARQRPPFK 375
             R+ APE     ++ +  DV+SF +++ E++  G  P+    ++EV KA     R P  
Sbjct: 176 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPTP 235

Query: 376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
                    + +L+ +CW ++ A+RP F  I++ L+ +
Sbjct: 236 MD---CPSAIYQLMMQCWQQERARRPKFADIVSILDKL 270

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  167 bits (423), Expect = 1e-48
 Identities = 74/258 (28%), Positives = 122/258 (47%), Gaps = 14/258 (5%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK-IRH 209
           DF     + KG+F    LA ++      A+K L ++V+  DD V     E  +L     H
Sbjct: 3   DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEH 62

Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
           P +            +  V EYL  GDL   ++       S A  +A +I  G+ +LH  
Sbjct: 63  PFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSK 122

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
               I++RDL+  NIL D  G++K+ADFG+ K   + + +  T   T   Y+APE+   +
Sbjct: 123 G---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGT-PDYIAPEILLGQ 178

Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389
           +Y+  VD +SF ++L EM+ G  PF  + + E+   + + +      P  L  +  K+L+
Sbjct: 179 KYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL---FHSIRMDNPFYPRWL-EKEAKDLL 234

Query: 390 EECWNEKPAKRPTFRQII 407
            + +  +P KR   R  I
Sbjct: 235 VKLFVREPEKRLGVRGDI 252

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  165 bits (419), Expect = 1e-48
 Identities = 65/266 (24%), Positives = 113/266 (42%), Gaps = 15/266 (5%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
            +  G      LA        VAVK L  ++  D      FR E      + HP +V   
Sbjct: 14  ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 73

Query: 217 GAVTQSSP----MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
                 +P      IV EY+    LR  +  +G + P  A+    D  + +N+ H+N   
Sbjct: 74  DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG-- 131

Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT--SCRYVAPEVFKNEE 330
            IIHRD++P+NI+   +  +KV DFG+++ +    +          + +Y++PE  + + 
Sbjct: 132 -IIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 190

Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
            D + DV+S   +L E++ G PPFT      V   +      P  A  +  +  L  ++ 
Sbjct: 191 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSADLDAVVL 250

Query: 391 ECWNEKPAKRP-TFRQIITRLESINN 415
           +   + P  R  T  ++   L  ++N
Sbjct: 251 KALAKNPENRYQTAAEMRADLVRVHN 276

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (418), Expect = 3e-48
 Identities = 78/299 (26%), Positives = 131/299 (43%), Gaps = 41/299 (13%)

Query: 146 PEYEIDPHELDFTNSVEITKGTF---ILAFWR---------GIQVAVKKLGEEVISDDDR 193
           P +E+    L       + +G F   +LA              +VAVK L  +    D  
Sbjct: 6   PRWELPRDRLVLGK--PLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD-- 61

Query: 194 VRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------- 245
           +     E+ +++ I +H N++  LGA TQ  P+ ++ EY  KG+LR +L+ +        
Sbjct: 62  LSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYS 121

Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
                     L     V  A  +ARGM YL        IHRDL   N+L  +   +K+AD
Sbjct: 122 YNPSHNPEEQLSSKDLVSCAYQVARGMEYLASK---KCIHRDLAARNVLVTEDNVMKIAD 178

Query: 297 FGVSKLLTVKEDRPLT-CQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMI-EGCPPF 354
           FG+++ +   +    T       +++APE   +  Y  + DV+SF ++L E+   G  P+
Sbjct: 179 FGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPY 238

Query: 355 TMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
                 E+ K      R             L  ++ +CW+  P++RPTF+Q++  L+ I
Sbjct: 239 PGVPVEELFKLLKEGHRMDKP---SNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  164 bits (415), Expect = 5e-48
 Identities = 60/264 (22%), Positives = 109/264 (41%), Gaps = 23/264 (8%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIR-H 209
            + +G          +    + AVK +              +   A   E+ +L+K+  H
Sbjct: 10  ILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGH 69

Query: 210 PNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN 269
           PN++Q       ++   +V + + KG+L  +L  K  L      +    +   +  LH+ 
Sbjct: 70  PNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 129

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
               I+HRDL+P NIL DD  N+K+ DFG S  L       L     +  Y+APE+ +  
Sbjct: 130 N---IVHRDLKPENILLDDDMNIKLTDFGFSCQL--DPGEKLREVCGTPSYLAPEIIECS 184

Query: 330 E------YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR 383
                  Y  +VD++S  +I+  ++ G PPF  +    + +   +            Y+ 
Sbjct: 185 MNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDYSD 244

Query: 384 GLKELIEECWNEKPAKRPTFRQII 407
            +K+L+      +P KR T  + +
Sbjct: 245 TVKDLVSRFLVVQPQKRYTAEEAL 268

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 8e-48
 Identities = 79/290 (27%), Positives = 131/290 (45%), Gaps = 37/290 (12%)

Query: 149 EIDPHELDFTNSVEITKGTF---ILAFWRG----IQVAVKKLGEEVISDDDRVRAFRDEL 201
            +D +++ F +   I +G F   + A  +     +  A+K++  +  +  D  R F  EL
Sbjct: 6   VLDWNDIKFQD--VIGEGNFGQVLKARIKKDGLRMDAAIKRM--KEYASKDDHRDFAGEL 61

Query: 202 ALLQKI-RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRK---------------- 244
            +L K+  HPN++  LGA      + +  EY P G+L  FL++                 
Sbjct: 62  EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTA 121

Query: 245 GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT 304
             L     + FA D+ARGM+YL +      IHRDL   NIL  ++   K+ADFG+S+   
Sbjct: 122 STLSSQQLLHFAADVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-- 176

Query: 305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVP 363
            +     T      R++A E      Y T  DV+S+ ++L E++  G  P+      E+ 
Sbjct: 177 QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236

Query: 364 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
           +      R             + +L+ +CW EKP +RP+F QI+  L  +
Sbjct: 237 EKLPQGYRLEKP---LNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRM 283

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  160 bits (406), Expect = 2e-46
 Identities = 67/289 (23%), Positives = 132/289 (45%), Gaps = 32/289 (11%)

Query: 147 EYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDRVRA 196
           E+E+   ++  +   E+ +G+F        +G+       +VA+K + E   +       
Sbjct: 14  EWEVAREKITMSR--ELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIE 69

Query: 197 FRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------A 246
           F +E +++++    +VV+ LG V+Q  P +++ E + +GDL+++L+              
Sbjct: 70  FLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAP 129

Query: 247 LKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK 306
              S  ++ A +IA GM YL+ N     +HRDL   N +  +   +K+ DFG+++ +   
Sbjct: 130 PSLSKMIQMAGEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYET 186

Query: 307 ED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC-PPFTMKHDNEVPK 364
           +  R         R+++PE  K+  + T  DV+SF ++L E+      P+    + +V +
Sbjct: 187 DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 246

Query: 365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
                               L EL+  CW   P  RP+F +II+ ++  
Sbjct: 247 FVMEGGLLDKPDN---CPDMLFELMRMCWQYNPKMRPSFLEIISSIKEE 292

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  157 bits (398), Expect = 2e-45
 Identities = 60/258 (23%), Positives = 103/258 (39%), Gaps = 17/258 (6%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDR---VRAFRDELALLQKIRHPNVV 213
           E+  G F        +  G+Q A K + +       R         E+++L++I+HPNV+
Sbjct: 17  ELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVI 76

Query: 214 QFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVP 273
                    + ++++ E +  G+L  FL  K +L    A  F   I  G+ YLH      
Sbjct: 77  TLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSL---Q 133

Query: 274 IIHRDLEPSNILRDDSG----NLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
           I H DL+P NI+  D       +K+ DFG++  +             +  +VAPE+   E
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKI--DFGNEFKNIFGTPEFVAPEIVNYE 191

Query: 330 EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI 389
               + D++S  +I   ++ G  PF      E     +A             +   K+ I
Sbjct: 192 PLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTSALAKDFI 251

Query: 390 EECWNEKPAKRPTFRQII 407
                + P KR T +  +
Sbjct: 252 RRLLVKDPKKRMTIQDSL 269

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  157 bits (397), Expect = 2e-44
 Identities = 56/259 (21%), Positives = 105/259 (40%), Gaps = 16/259 (6%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDE---LALLQKI 207
           DF+    I +G F           G   A+K L ++ I          +E   L+L+   
Sbjct: 5   DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTG 64

Query: 208 RHPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLH 267
             P +V    A      +  + + +  GDL   L + G    +    +A +I  G+ ++H
Sbjct: 65  DCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMH 124

Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVF- 326
                 +++RDL+P+NIL D+ G+++++D G++        +       +  Y+APEV  
Sbjct: 125 NRF---VVYRDLKPANILLDEHGHVRISDLGLACDF---SKKKPHASVGTHGYMAPEVLQ 178

Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK 386
           K   YD+  D FS   +L +++ G  PF      +  +          + P   ++  L+
Sbjct: 179 KGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELPDS-FSPELR 237

Query: 387 ELIEECWNEKPAKRPTFRQ 405
            L+E        +R     
Sbjct: 238 SLLEGLLQRDVNRRLGCLG 256

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  153 bits (387), Expect = 2e-43
 Identities = 61/249 (24%), Positives = 113/249 (45%), Gaps = 16/249 (6%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
            +  G+F    L   R  G   A+K L +E++    +V    DE  +L  + HP +++  
Sbjct: 11  TLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMW 70

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
           G    +  + ++ +Y+  G+L + L++        A  +A ++   + YLH      II+
Sbjct: 71  GTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSK---DIIY 127

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           RDL+P NIL D +G++K+ DFG +K +             +  Y+APEV   + Y+  +D
Sbjct: 128 RDLKPENILLDKNGHIKITDFGFAKYV----PDVTYTLCGTPDYIAPEVVSTKPYNKSID 183

Query: 337 VFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 396
            +SF +++ EM+ G  PF   +  +    Y        + P       +K+L+       
Sbjct: 184 WWSFGILIYEMLAGYTPFYDSNTMKT---YEKILNAELRFPPFF-NEDVKDLLSRLITRD 239

Query: 397 PAKRPTFRQ 405
            ++R    Q
Sbjct: 240 LSQRLGNLQ 248

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (384), Expect = 2e-43
 Identities = 70/298 (23%), Positives = 125/298 (41%), Gaps = 35/298 (11%)

Query: 144 EVPEYEIDPHELDFTNSVEITKGTF---ILAFWRGI-------QVAVKKLGEEVISDDDR 193
           +  ++E     L       + +G F   I A   GI        VAVK L E     + R
Sbjct: 4   DASKWEFPRDRLKLGK--PLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHR 61

Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQ-SSPMMIVTEYLPKGDLRAFLKRKG------- 245
                +   L+    H NVV  LGA T+   P+M++ E+   G+L  +L+ K        
Sbjct: 62  -ALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 120

Query: 246 ---------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD 296
                     L     + ++  +A+GM +L   K    IHRDL   NIL  +   +K+ D
Sbjct: 121 VAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSEKNVVKICD 177

Query: 297 FGVSKLLTVKEDRPLTCQD-TSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFT 355
           FG+++ +    D           +++APE   +  Y  + DV+SF ++L E+        
Sbjct: 178 FGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY 237

Query: 356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESI 413
                +       ++    +AP       + + + +CW+ +P++RPTF +++  L ++
Sbjct: 238 PGVKIDEEFCRRLKEGTRMRAPDY-TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNL 294

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (385), Expect = 5e-43
 Identities = 64/263 (24%), Positives = 110/263 (41%), Gaps = 30/263 (11%)

Query: 163 ITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
           +  G     +  F +    + A+K L        D  +A R+     +  + P++V+ + 
Sbjct: 20  LGLGINGKVLQIFNKRTQEKFALKML-------QDCPKARREVELHWRASQCPHIVRIVD 72

Query: 218 A----VTQSSPMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKP 271
                      ++IV E L  G+L + ++ +G  A     A      I   + YLH    
Sbjct: 73  VYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN- 131

Query: 272 VPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN 328
             I HRD++P N+L      +  LK+ DFG +K  T      LT    +  YVAPEV   
Sbjct: 132 --IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT--SHNSLTTPCYTPYYVAPEVLGP 187

Query: 329 EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-PKAYAARQRPPFKAPAKLYAR---G 384
           E+YD   D++S  +I+  ++ G PPF   H   + P      +   ++ P   ++     
Sbjct: 188 EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEE 247

Query: 385 LKELIEECWNEKPAKRPTFRQII 407
           +K LI      +P +R T  + +
Sbjct: 248 VKMLIRNLLKTEPTQRMTITEFM 270

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  151 bits (382), Expect = 6e-43
 Identities = 41/278 (14%), Positives = 85/278 (30%), Gaps = 27/278 (9%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           +I  G+F    L      G +VA+K     +     +      E  + + ++    +  +
Sbjct: 14  KIGSGSFGDIYLGTDIAAGEEVAIK-----LECVKTKHPQLHIESKIYKMMQGGVGIPTI 68

Query: 217 GAV-TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
                +    ++V E L       F          T +  A  +   + Y+H       I
Sbjct: 69  RWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FI 125

Query: 276 HRDLEPSNILRDDSG---NLKVADFGVSKLLTVKEDRPLTCQDT------SCRYVAPEVF 326
           HRD++P N L         + + DFG++K                     + RY +    
Sbjct: 126 HRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTH 185

Query: 327 KNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG-- 384
              E   + D+ S   +L     G  P+         + Y          P ++  +G  
Sbjct: 186 LGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYP 245

Query: 385 --LKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420
                 +  C + +   +P +  +     ++ +     
Sbjct: 246 SEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQGFS 283

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  146 bits (369), Expect = 2e-41
 Identities = 68/259 (26%), Positives = 114/259 (44%), Gaps = 29/259 (11%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRV---RAFRDELALLQKIR--HPN 211
            +  G F            + VA+K + ++ ISD   +        E+ LL+K+      
Sbjct: 11  LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70

Query: 212 VVQFLGAVTQSSPMMIVTEYL-PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
           V++ L    +    +++ E   P  DL  F+  +GAL+   A  F   +   + + H   
Sbjct: 71  VIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 130

Query: 271 PVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
              ++HRD++  NIL D + G LK+ DFG   LL   +D   T  D +  Y  PE  +  
Sbjct: 131 ---VLHRDIKDENILIDLNRGELKLIDFGSGALL---KDTVYTDFDGTRVYSPPEWIRYH 184

Query: 330 EYDTK-VDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKEL 388
            Y  +   V+S  ++L +M+ G  PF  +HD E+      R +  F+      +   + L
Sbjct: 185 RYHGRSAAVWSLGILLYDMVCGDIPF--EHDEEI-----IRGQVFFRQR---VSSECQHL 234

Query: 389 IEECWNEKPAKRPTFRQII 407
           I  C   +P+ RPTF +I 
Sbjct: 235 IRWCLALRPSDRPTFEEIQ 253

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  144 bits (364), Expect = 2e-40
 Identities = 64/276 (23%), Positives = 107/276 (38%), Gaps = 34/276 (12%)

Query: 163 ITKGTF---ILAFWR--GIQVAVKKL--GEEVISDDDRVRAFRDELALLQKIRHPNVVQF 215
           + +G F     A  +     VA+KK+  G    + D   R    E+ LLQ++ HPN++  
Sbjct: 6   LGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGL 65

Query: 216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPII 275
           L A    S + +V +++              L PS    + L   +G+ YLH++    I+
Sbjct: 66  LDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQH---WIL 122

Query: 276 HRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKV 335
           HRDL+P+N+L D++G LK+ADFG++K              T        +F    Y   V
Sbjct: 123 HRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGV 182

Query: 336 DVFSFALILQEMIEGCPPFTMKHDNEVPKA------------------------YAARQR 371
           D+++   IL E++   P      D +                            + +   
Sbjct: 183 DMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPG 242

Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
            P           L +LI+  +   P  R T  Q +
Sbjct: 243 IPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQAL 278

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (367), Expect = 2e-40
 Identities = 65/255 (25%), Positives = 108/255 (42%), Gaps = 13/255 (5%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           DF     + KGTF   IL   +  G   A+K L +EVI   D V     E  +LQ  RHP
Sbjct: 6   DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHP 65

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
            +     A      +  V EY   G+L   L R+       A  +  +I   + YLH   
Sbjct: 66  FLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSR- 124

Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
              +++RD++  N++ D  G++K+ DFG+ K     +   +     +  Y+APEV ++ +
Sbjct: 125 --DVVYRDIKLENLMLDKDGHIKITDFGLCKEGI-SDGATMKTFCGTPEYLAPEVLEDND 181

Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
           Y   VD +   +++ EM+ G  PF  +    +   +        + P  L +   K L+ 
Sbjct: 182 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERL---FELILMEEIRFPRTL-SPEAKSLLA 237

Query: 391 ECWNEKPAKRPTFRQ 405
               + P +R     
Sbjct: 238 GLLKKDPKQRLGGGP 252

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  141 bits (356), Expect = 3e-39
 Identities = 42/279 (15%), Positives = 84/279 (30%), Gaps = 27/279 (9%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
            I +G+F             QVA+K       SD  ++R       LL        V + 
Sbjct: 12  RIGEGSFGVIFEGTNLLNNQQVAIKFEPRR--SDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
           G   +    ++V + L                  T    A  +   +  +HE     +++
Sbjct: 70  G--QEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVY 124

Query: 277 RDLEPSNIL-----RDDSGNLKVADFGVSKLLTVKEDRPLTCQDT------SCRYVAPEV 325
           RD++P N L       ++  + V DFG+ K       +             + RY++   
Sbjct: 125 RDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINT 184

Query: 326 FKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYA----ARQRPPFKAPAKLY 381
               E   + D+ +   +    + G  P+         + Y      +Q  P +     +
Sbjct: 185 HLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGF 244

Query: 382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK 420
                + +    N      P +  +      +   +N  
Sbjct: 245 PEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTT 283

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  138 bits (349), Expect = 2e-38
 Identities = 59/275 (21%), Positives = 119/275 (43%), Gaps = 33/275 (12%)

Query: 162 EITKGTF---ILAFWR-GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLG 217
           +I +GT+     A    G   A+KK+  E   +       R E+++L++++H N+V+   
Sbjct: 9   KIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIR-EISILKELKHSNIVKLYD 67

Query: 218 AVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHR 277
            +     +++V E+L +   +     +G L+  TA  F L +  G+ Y H+ +   ++HR
Sbjct: 68  VIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHR 124

Query: 278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDV 337
           DL+P N+L +  G LK+ADFG+++   +   +      T        +  +++Y T +D+
Sbjct: 125 DLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDI 184

Query: 338 FSFALILQEMIEGCPPFTMKHDNEV-------------------------PKAYAARQRP 372
           +S   I  EM+ G P F    + +                             +   +  
Sbjct: 185 WSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPL 244

Query: 373 PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           P+++  K       +L+ +     P +R T +Q +
Sbjct: 245 PWESFLKGLDESGIDLLSKMLKLDPNQRITAKQAL 279

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  139 bits (351), Expect = 5e-38
 Identities = 59/249 (23%), Positives = 112/249 (44%), Gaps = 16/249 (6%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
            +  G+F   +L   +  G   A+K L ++ +    ++    +E  +LQ +  P +V+  
Sbjct: 48  TLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLE 107

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
            +   +S + +V EY+  G++ + L+R G      A  +A  I     YLH      +I+
Sbjct: 108 FSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIY 164

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           RDL+P N+L D  G ++V DFG +K    +          +   +APE+  ++ Y+  VD
Sbjct: 165 RDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCGTPEALAPEIILSKGYNKAVD 220

Query: 337 VFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEK 396
            ++  +++ EM  G PPF      ++   Y        + P+  ++  LK+L+       
Sbjct: 221 WWALGVLIYEMAAGYPPFFADQPIQI---YEKIVSGKVRFPSH-FSSDLKDLLRNLLQVD 276

Query: 397 PAKRPTFRQ 405
             KR    +
Sbjct: 277 LTKRFGNLK 285

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 7e-38
 Identities = 55/245 (22%), Positives = 104/245 (42%), Gaps = 7/245 (2%)

Query: 165 KGTFILAFWRGIQVAVKKLGEEVISDDDR-VRAFRDELALLQKIRH-PNVVQFLGAVTQS 222
               I     G   A+K L +  I    +     R E  +L+ IR  P +V    A    
Sbjct: 42  LVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTE 101

Query: 223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPS 282
           + + ++ +Y+  G+L   L ++          +  +I   + +LH+     II+RD++  
Sbjct: 102 TKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLE 158

Query: 283 NILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE--YDTKVDVFSF 340
           NIL D +G++ + DFG+SK     E         +  Y+AP++ +  +  +D  VD +S 
Sbjct: 159 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSL 218

Query: 341 ALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKR 400
            +++ E++ G  PFT+  +       + R         +  +   K+LI+    + P KR
Sbjct: 219 GVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKR 278

Query: 401 PTFRQ 405
                
Sbjct: 279 LGCGP 283

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  136 bits (344), Expect = 2e-37
 Identities = 58/290 (20%), Positives = 109/290 (37%), Gaps = 49/290 (16%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           +I +GTF     A  R  G +VA+KK+  E   +   + A R E+ +LQ ++H NVV  +
Sbjct: 17  KIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR-EIKILQLLKHENVVNLI 75

Query: 217 GAVTQSSP--------MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE 268
                 +         + +V ++                  S   R    +  G+ Y+H 
Sbjct: 76  EICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR 135

Query: 269 NKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSC---RYVAPEV 325
           NK   I+HRD++ +N+L    G LK+ADFG+++  ++ ++              Y  PE+
Sbjct: 136 NK---ILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPEL 192

Query: 326 FKNE-EYDTKVDVFSFALILQEMIEGCPPFT----------------------------M 356
              E +Y   +D++    I+ EM    P                                
Sbjct: 193 LLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNY 252

Query: 357 KHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQI 406
           +   ++      +++   +  A +      +LI++     PA+R      
Sbjct: 253 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDA 302

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 2e-36
 Identities = 61/300 (20%), Positives = 123/300 (41%), Gaps = 39/300 (13%)

Query: 156 DFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHP 210
           +F    +I +GT+     A  +  G  VA+KK+  +  ++     A R E++LL+++ HP
Sbjct: 3   NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIR-EISLLKELNHP 61

Query: 211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHEN 269
           N+V+ L  +   + + +V E+L +   +         +       +   + +G+ + H +
Sbjct: 62  NIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSH 121

Query: 270 KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNE 329
               ++HRDL+P N+L +  G +K+ADFG+++       R  T +  +  Y APE+    
Sbjct: 122 ---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILLGC 177

Query: 330 EY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEV-------------------------P 363
           +Y  T VD++S   I  EM+     F    + +                           
Sbjct: 178 KYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYK 237

Query: 364 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR--LESINNSINHKR 421
            ++    R  F           + L+ +  +  P KR + +  +     + +   + H R
Sbjct: 238 PSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLR 297

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (336), Expect = 7e-36
 Identities = 65/296 (21%), Positives = 112/296 (37%), Gaps = 51/296 (17%)

Query: 152 PHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQK 206
           P E+ +T++  I  G+F     A     G  VA+KK+           R    EL +++K
Sbjct: 17  PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKV-------LQDKRFKNRELQIMRK 69

Query: 207 IRHPNVVQFLGAVTQSSP------MMIVTEYLPKG---DLRAFLKRKGALKPSTAVRFAL 257
           + H N+V+       S        + +V +Y+P+      R + + K  L       +  
Sbjct: 70  LDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMY 129

Query: 258 DIARGMNYLHENKPVPIIHRDLEPSNI-LRDDSGNLKVADFGVSKLLTVKEDRPLTCQDT 316
            + R + Y+H      I HRD++P N+ L  D+  LK+ DFG +K L V+ +  ++   +
Sbjct: 130 QLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL-VRGEPNVSYICS 185

Query: 317 SCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPF-------------------TMK 357
                   +F   +Y + +DV+S   +L E++ G P F                   T +
Sbjct: 186 RYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE 245

Query: 358 HDNEVPKAYAARQRPPFKAPAKLYARG------LKELIEECWNEKPAKRPTFRQII 407
              E+   Y   + P  KA                 L        P  R T  +  
Sbjct: 246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEAC 301

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  133 bits (334), Expect = 1e-35
 Identities = 63/299 (21%), Positives = 118/299 (39%), Gaps = 48/299 (16%)

Query: 148 YEIDPHELDFTNSVEITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELA 202
           +++ P    +TN   I +G +     A+     ++VA+KK+           +    E+ 
Sbjct: 4   FDVGPR---YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKI--SPFEHQTYCQRTLREIK 58

Query: 203 LLQKIRHPNVVQFLGAV----TQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALD 258
           +L + RH N++     +     +    + +  +L   DL   LK +  L       F   
Sbjct: 59  ILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQH-LSNDHICYFLYQ 117

Query: 259 IARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQD--T 316
           I RG+ Y+H      ++HRDL+PSN+L + + +LK+ DFG++++     D      +   
Sbjct: 118 ILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVA 174

Query: 317 SCRYVAPEVFKNEEYDT-KVDVFSFALILQEMIEGCPPFTMKHDNEV------------- 362
           +  Y APE+  N +  T  +D++S   IL EM+   P F  KH  +              
Sbjct: 175 TRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQ 234

Query: 363 --------------PKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
                           +   + + P+            +L+++     P KR    Q +
Sbjct: 235 EDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQAL 293

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  131 bits (331), Expect = 1e-35
 Identities = 66/283 (23%), Positives = 113/283 (39%), Gaps = 42/283 (14%)

Query: 162 EITKGTF---ILAFWR---GIQVAVKKLGEEVISDDDRVRAFR--DELALLQKIRHPNVV 213
           EI +G +     A      G  VA+K++  +   +   +   R    L  L+   HPNVV
Sbjct: 14  EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 73

Query: 214 QFLGAVTQSSP-----MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLH 267
           +     T S       + +V E++ +       K     +   T       + RG+++LH
Sbjct: 74  RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLH 133

Query: 268 ENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFK 327
            ++   ++HRDL+P NIL   SG +K+ADFG++++ + +          +  Y APEV  
Sbjct: 134 SHR---VVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVV--TLWYRAPEVLL 188

Query: 328 NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV-----------------------PK 364
              Y T VD++S   I  EM    P F    D +                         +
Sbjct: 189 QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQ 248

Query: 365 AYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQII 407
           A+ ++   P +          K+L+ +C    PAKR +    +
Sbjct: 249 AFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  128 bits (322), Expect = 2e-34
 Identities = 55/276 (19%), Positives = 110/276 (39%), Gaps = 35/276 (12%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           +I +GT+     A  R     VA+K++  +   +     A R E+ LL++++H N+V+  
Sbjct: 9   KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALR-EICLLKELKHKNIVRLH 67

Query: 217 GAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIH 276
             +     + +V E+  +   + F    G L P     F   + +G+ + H      ++H
Sbjct: 68  DVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLH 124

Query: 277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVD 336
           RDL+P N+L + +G LK+A+FG+++   +          T        +F  + Y T +D
Sbjct: 125 RDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSID 184

Query: 337 VFSFALILQEMIEGCPPFTMKHDNE--------------------VPKAYAARQRPPFKA 376
           ++S   I  E+     P    +D +                    + K    +  P + A
Sbjct: 185 MWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPA 244

Query: 377 PAKLYARG------LKELIEECWNEKPAKRPTFRQI 406
              L           ++L++      P +R +  + 
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEA 280

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 2e-31
 Identities = 66/302 (21%), Positives = 109/302 (36%), Gaps = 53/302 (17%)

Query: 148 YEIDPHELDFTNSVEITK----GTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFR 198
            E+     +        +    G +     A     G +VA+KKL     S+    RA+R
Sbjct: 7   QEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYR 66

Query: 199 DELALLQKIRHPNVVQFLGAVTQSSPM------MIVTEYLPKGDLRAFLKRKGALKPSTA 252
            EL LL+ +RH NV+  L   T    +       +V  ++  G     L +   L     
Sbjct: 67  -ELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRI 123

Query: 253 VRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT 312
                 + +G+ Y+H       IHRDL+P N+  ++   LK+ DFG+++    + D  +T
Sbjct: 124 QFLVYQMLKGLRYIHAAGI---IHRDLKPGNLAVNEDCELKILDFGLAR----QADSEMT 176

Query: 313 CQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-------- 363
               +  Y APEV  N   Y   VD++S   I+ EMI G   F      +          
Sbjct: 177 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 236

Query: 364 -------------------KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFR 404
                              K     ++  F +     +     L+E+       +R T  
Sbjct: 237 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAG 296

Query: 405 QI 406
           + 
Sbjct: 297 EA 298

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  118 bits (295), Expect = 2e-30
 Identities = 53/319 (16%), Positives = 113/319 (35%), Gaps = 62/319 (19%)

Query: 137 MHVKHAREVPEYEIDPHELDFTNS------VEITKGTF---ILAFWR--GIQVAVKKLGE 185
             V   R    ++ + H +++ N        ++ +G +     A       +V VK L  
Sbjct: 11  TDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKIL-- 68

Query: 186 EVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMMIVTEYLPKGDLRAFLK 242
                  + +  + E+ +L+ +R  PN++     V    S    +V E++   D +   +
Sbjct: 69  ----KPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124

Query: 243 RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSK 301
               L       +  +I + ++Y H      I+HRD++P N++ D +   L++ D+G+++
Sbjct: 125 T---LTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAE 178

Query: 302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDN- 360
                ++  +    +        +   + YD  +D++S   +L  MI    PF   HDN 
Sbjct: 179 FYHPGQEYNVRVA-SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNY 237

Query: 361 ----------------EVPKAYAARQRPPFKAPAKLYARG-----------------LKE 387
                           +    Y     P F      ++R                    +
Sbjct: 238 DQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALD 297

Query: 388 LIEECWNEKPAKRPTFRQI 406
            +++        R T R+ 
Sbjct: 298 FLDKLLRYDHQSRLTAREA 316

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  111 bits (278), Expect = 6e-28
 Identities = 65/298 (21%), Positives = 105/298 (35%), Gaps = 30/298 (10%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
            I  G       A+       VA+KKL     +     RA+R EL L++ + H N++  L
Sbjct: 24  PIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYR-ELVLMKCVNHKNIISLL 82

Query: 217 GAVTQSSPMM------IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENK 270
              T    +       +V E +     +                    +  G+ +LH   
Sbjct: 83  NVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL---DHERMSYLLYQMLCGIKHLHSA- 138

Query: 271 PVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEE 330
              IIHRDL+PSNI+      LK+ DFG+++  T      +T    +  Y APEV     
Sbjct: 139 --GIIHRDLKPSNIVVKSDCTLKILDFGLAR--TAGTSFMMTPYVVTRYYRAPEVILGMG 194

Query: 331 YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE 390
           Y   VD++S   I+ EM+     F  +   +       +   P     K     ++  +E
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254

Query: 391 ECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCFHNLEAMLKKDHSSPSSR 448
                     P       +L   +         K++  +    L  ML  D   P+ R
Sbjct: 255 NRPKYAGLTFP-------KLFPDSLFPADSEHNKLKASQARDLLSKMLVID---PAKR 302

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  108 bits (270), Expect = 7e-27
 Identities = 62/281 (22%), Positives = 99/281 (35%), Gaps = 43/281 (15%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
            +  G +     AF    G++VAVKKL     S     R +R EL LL+ ++H NV+  L
Sbjct: 25  PVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYR-ELRLLKHMKHENVIGLL 83

Query: 217 GAVTQSSPMMIVTEYL----PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPV 272
              T +  +    +        G     + +   L           I RG+ Y+H     
Sbjct: 84  DVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHSAD-- 141

Query: 273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYD 332
            IIHRDL+PSN+  ++   LK+ DFG+++     +D       T        +     Y+
Sbjct: 142 -IIHRDLKPSNLAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYN 197

Query: 333 TKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG-------- 384
             VD++S   I+ E++ G   F      +  K        P     K  +          
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257

Query: 385 -------------------LKELIEECWNEKPAKRPTFRQI 406
                                +L+E+       KR T  Q 
Sbjct: 258 LTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQA 298

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.8 bits (237), Expect = 4e-22
 Identities = 36/145 (24%), Positives = 57/145 (39%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   +    +  +K LL  G   N  ++   T LH+AA  G TEV   LL+  A V+ K 
Sbjct: 4   LHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKA 63

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEI 163
           +   TPL  A    +  ++KLL ++ A P +A         +   E     +      E 
Sbjct: 64  KDDQTPLHCAARIGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEA 123

Query: 164 TKGTFILAFWRGIQVAVKKLGEEVI 188
           ++       +  + VA K     V 
Sbjct: 124 SQACMTKKGFTPLHVAAKYGKVRVA 148

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 77.7 bits (190), Expect = 4e-16
 Identities = 33/119 (27%), Positives = 53/119 (44%)

Query: 29  NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
           +G+  D         L   ++  +++ +K LL    DVN +     + LH AA QG T++
Sbjct: 286 HGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDI 345

Query: 89  VSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPE 147
           V+LLL+ GA  +     G+TPL  A       V  +L+    +     +  KH    PE
Sbjct: 346 VTLLLKNGASPNEVSSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSDKHRMSFPE 404

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 72.3 bits (176), Expect = 2e-14
 Identities = 35/152 (23%), Positives = 56/152 (36%), Gaps = 12/152 (7%)

Query: 75  TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK--- 131
           T LHVA+  G   +V  LL+RGA  +  +    TPL  A    + EV K L ++ AK   
Sbjct: 2   TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNA 61

Query: 132 -------PLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLG 184
                  PL     + H   + +  ++ +  +   +         +A   G    V  L 
Sbjct: 62  KAKDDQTPLHCAARIGH-TNMVKLLLE-NNANPNLATTAGHTPLHIAAREGHVETVLALL 119

Query: 185 EEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
           E+  S     +     L +  K     V + L
Sbjct: 120 EKEASQACMTKKGFTPLHVAAKYGKVRVAELL 151

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 70.0 bits (170), Expect = 1e-13
 Identities = 46/217 (21%), Positives = 85/217 (39%), Gaps = 17/217 (7%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQ 83
           +    +    +G        L   A +  VE  + LL  G   N   +   T LH+AA +
Sbjct: 187 RGGSPHSPAWNGY-----TPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQE 241

Query: 84  GFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAK----------PL 133
           G  E+V+LLL + A+ +  ++ G TPL       +  V  +L KHG            PL
Sbjct: 242 GHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPL 301

Query: 134 MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDR 193
               H  + + V        +++    +  +      A  +G    V  L +   S ++ 
Sbjct: 302 HVASHYGNIKLVKFLLQHQADVNAKTKLGYS--PLHQAAQQGHTDIVTLLLKNGASPNEV 359

Query: 194 VRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE 230
                  LA+ +++ + +V   L  VT  +  ++V++
Sbjct: 360 SSDGTTPLAIAKRLGYISVTDVLKVVTDETSFVLVSD 396

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 66.2 bits (160), Expect = 2e-12
 Identities = 41/182 (22%), Positives = 55/182 (30%), Gaps = 12/182 (6%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A    V   + LL+     N    +  T LHVA      ++V LLL RG       
Sbjct: 136 LHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLDIVKLLLPRGGSPHSPA 195

Query: 104 RWGSTPLGDAIYYKNHEVIKLL----------EKHGAKPLMAPMHVKHAREVPEYEIDPH 153
             G TPL  A      EV + L             G  PL       HA  V        
Sbjct: 196 WNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAAQEGHAEMVALLLSKQA 255

Query: 154 ELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVV 213
             +  N   +T     L    G       L +  +  D   R     L +     +  +V
Sbjct: 256 NGNLGNKSGLT--PLHLVAQEGHVPVADVLIKHGVMVDATTRMGYTPLHVASHYGNIKLV 313

Query: 214 QF 215
           +F
Sbjct: 314 KF 315

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.4 bits (158), Expect = 4e-12
 Identities = 36/143 (25%), Positives = 47/143 (32%), Gaps = 38/143 (26%)

Query: 23  RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
           ++ A  N  +   E       L   A     E  K LL +   VN +  D++T LH AA 
Sbjct: 21  QRGASPNVSNVKVETP-----LHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAAR 75

Query: 83  QGFTEVVSLLLER---------------------------------GADVDPKDRWGSTP 109
            G T +V LLLE                                   A      + G TP
Sbjct: 76  IGHTNMVKLLLENNANPNLATTAGHTPLHIAAREGHVETVLALLEKEASQACMTKKGFTP 135

Query: 110 LGDAIYYKNHEVIKLLEKHGAKP 132
           L  A  Y    V +LL +  A P
Sbjct: 136 LHVAAKYGKVRVAELLLERDAHP 158

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]} Length = 408

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.1 bits (152), Expect = 2e-11
 Identities = 40/164 (24%), Positives = 63/164 (38%), Gaps = 8/164 (4%)

Query: 61  DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE 120
           +             T LHVAA  G   V  LLLER A  +   + G TPL  A+++ N +
Sbjct: 120 EKEASQACMTKKGFTPLHVAAKYGKVRVAELLLERDAHPNAAGKNGLTPLHVAVHHNNLD 179

Query: 121 VIKLLEKHGAKPL------MAPMHVKHAREVPEYEIDPHELDFTNSVEITKGT--FILAF 172
           ++KLL   G  P         P+H+   +   E      +   + + E  +G     LA 
Sbjct: 180 IVKLLLPRGGSPHSPAWNGYTPLHIAAKQNQVEVARSLLQYGGSANAESVQGVTPLHLAA 239

Query: 173 WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
             G    V  L  +  + +   ++    L L+ +  H  V   L
Sbjct: 240 QEGHAEMVALLLSKQANGNLGNKSGLTPLHLVAQEGHVPVADVL 283

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 87.3 bits (215), Expect = 8e-20
 Identities = 30/112 (26%), Positives = 48/112 (42%), Gaps = 2/112 (1%)

Query: 22  ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
           +   A++N  D+ G         +   +         LLD G DVN R    +T L +A 
Sbjct: 169 DEMGADVNACDNMGRNALIHAL-LSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAV 227

Query: 82  CQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            +    +V  LLE+   +++  D  G T L  A+  K  ++ +LL K GA  
Sbjct: 228 EKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGAST 279

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 69.6 bits (169), Expect = 8e-14
 Identities = 21/79 (26%), Positives = 39/79 (49%), Gaps = 6/79 (7%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG 84
           A++N   + G+       L+    ++ +  ++ LL+   I++N  D D +TAL +A    
Sbjct: 210 ADVNVRGERGKTP-----LILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELK 264

Query: 85  FTEVVSLLLERGADVDPKD 103
             ++  LL +RGA  D  D
Sbjct: 265 LKKIAELLCKRGASTDCGD 283

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 56.1 bits (134), Expect = 2e-09
 Identities = 20/72 (27%), Positives = 39/72 (54%), Gaps = 1/72 (1%)

Query: 71  IDNRTALHVAACQGFTEVVSLLLERGADVDPKD-RWGSTPLGDAIYYKNHEVIKLLEKHG 129
           +++   L  A      ++V  LLE GA+V+ ++   G TPL +A+     ++++LL +HG
Sbjct: 3   VEDNHLLIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHG 62

Query: 130 AKPLMAPMHVKH 141
           A P++   +   
Sbjct: 63  ADPVLRKKNGAT 74

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.7 bits (125), Expect = 3e-08
 Identities = 28/96 (29%), Positives = 48/96 (50%), Gaps = 1/96 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDN-RTALHVAACQGFTEVVSLLLERGADVDPK 102
           L+      DV+ +++LL+ G +VNF++ +   T LH A      ++V LLL  GAD   +
Sbjct: 9   LIKAVQNEDVDLVQQLLEGGANVNFQEEEGGWTPLHNAVQMSREDIVELLLRHGADPVLR 68

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
            + G+TP   A    + +++KL    GA       +
Sbjct: 69  KKNGATPFLLAAIAGSVKLLKLFLSKGADVNECDFY 104

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 49.6 bits (117), Expect = 3e-07
 Identities = 24/72 (33%), Positives = 31/72 (43%), Gaps = 5/72 (6%)

Query: 66  VNFRDIDNRTALHVAACQGFTEVVSLLL-ERGADVDPKDRWGSTPLGDAIYYKNH----E 120
                    TAL  AA +G  EV+ +LL E GADV+  D  G   L  A+   +      
Sbjct: 141 QERLRKGGATALMDAAEKGHVEVLKILLDEMGADVNACDNMGRNALIHALLSSDDSDVEA 200

Query: 121 VIKLLEKHGAKP 132
           +  LL  HGA  
Sbjct: 201 ITHLLLDHGADV 212

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 85.9 bits (211), Expect = 6e-19
 Identities = 64/317 (20%), Positives = 111/317 (35%), Gaps = 47/317 (14%)

Query: 162 EITKGTF---ILAFWR--GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQ-- 214
           ++  G F    LA        VA+K +      D     A  DE+ LLQ++   +  +  
Sbjct: 20  KLGWGHFSTVWLAKDMVNNTHVAMKIV----RGDKVYTEAAEDEIKLLQRVNDADNTKED 75

Query: 215 -------------FLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGALKP-STAVRFALDIA 260
                        F         +++V E L +  L    K +    P     + +  + 
Sbjct: 76  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135

Query: 261 RGMNYLHENKPVPIIHRDLEPSNILRDDSG------NLKVADFGVSKLLTVKEDRPLTCQ 314
            G++Y+H      IIH D++P N+L +          +K+AD G +       D   T  
Sbjct: 136 LGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC----WYDEHYTNS 189

Query: 315 DTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAY---AARQR 371
             +  Y +PEV     +    D++S A ++ E+I G   F     +   K     A    
Sbjct: 190 IQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIE 249

Query: 372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKRRWKIRTMKCF 431
              + P+ L   G        +N +   R   +     LE +        + + + +  F
Sbjct: 250 LLGELPSYLLRNGKYT--RTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307

Query: 432 HNLEAMLKKDHSSPSSR 448
             L  ML+ D   P  R
Sbjct: 308 --LSPMLQLD---PRKR 319

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 77.1 bits (188), Expect = 2e-16
 Identities = 18/65 (27%), Positives = 35/65 (53%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
           G + + +D D +T + +AA +G  EVV  L+++GA V+  D    T    A    +H ++
Sbjct: 211 GSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIV 270

Query: 123 KLLEK 127
            + ++
Sbjct: 271 DIFDR 275

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 60.5 bits (145), Expect = 6e-11
 Identities = 28/110 (25%), Positives = 39/110 (35%), Gaps = 10/110 (9%)

Query: 41  EFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLL------ 93
           E  +           I E +     VN  D   NRT LH  A     E    L+      
Sbjct: 1   ESPIKLHTEAAGSYAITEPITR-ESVNIIDPRHNRTVLHWIASNSSAEKSEDLIVHEAKE 59

Query: 94  --ERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
               GADV+  D   +TPL  A+  +   ++  L K GA P +     + 
Sbjct: 60  CIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERS 109

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 55.5 bits (132), Expect = 3e-09
 Identities = 12/51 (23%), Positives = 20/51 (39%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
           +M  A E  +E +  L+  G  V   D  + TA  +A       +V +   
Sbjct: 225 IMLAAQEGRIEVVMYLIQQGASVEAVDATDHTARQLAQANNHHNIVDIFDR 275

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 45.1 bits (105), Expect = 7e-06
 Identities = 22/71 (30%), Positives = 31/71 (43%), Gaps = 1/71 (1%)

Query: 63  GIDVNFRDIDNRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV 121
               +      RTALH AA       V  L+ E+G++ D +D  G TP+  A      EV
Sbjct: 177 AARKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEV 236

Query: 122 IKLLEKHGAKP 132
           +  L + GA  
Sbjct: 237 VMYLIQQGASV 247

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]} Length = 277

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

 Score = 36.6 bits (83), Expect = 0.004
 Identities = 18/88 (20%), Positives = 35/88 (39%)

Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA 113
              KE + +G DVN  D D  T L +A       +V+ L++ GAD    ++   + L  A
Sbjct: 55  HEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSALHQA 114

Query: 114 IYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
              ++  ++  +              ++
Sbjct: 115 AANRDFGMMVYMLNSTKLKGDIEELDRN 142

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 72.2 bits (176), Expect = 2e-14
 Identities = 15/82 (18%), Positives = 25/82 (30%), Gaps = 2/82 (2%)

Query: 53  VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR--WGSTPL 110
           ++ +  LL S   V     +N  A  +AA  G   V++ L E                  
Sbjct: 106 LDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAF 165

Query: 111 GDAIYYKNHEVIKLLEKHGAKP 132
             A    +  V+  L +     
Sbjct: 166 RLAAENGHLHVLNRLCELAPTE 187

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 62.6 bits (151), Expect = 3e-11
 Identities = 13/83 (15%), Positives = 22/83 (26%), Gaps = 3/83 (3%)

Query: 51  RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQG---FTEVVSLLLERGADVDPKDRWGS 107
                 +       D + + I +     VAA  G     + + LLL     V        
Sbjct: 68  YYAHYNRNAKQLWSDAHKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENY 127

Query: 108 TPLGDAIYYKNHEVIKLLEKHGA 130
                A    +  V+  L +   
Sbjct: 128 QAFRLAAENGHLHVLNRLCELAP 150

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 57.2 bits (137), Expect = 1e-09
 Identities = 27/166 (16%), Positives = 48/166 (28%), Gaps = 13/166 (7%)

Query: 24  KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDID--NRTALHVAA 81
            +  +  +  +  +          A    +  +  L +         I   N  A  +AA
Sbjct: 115 SDEIVKVIQAENYQA-----FRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAA 169

Query: 82  CQGFTEVVSLLLERGADVD---PKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMH 138
             G   V++ L E          +          A+   +H VI  L         A + 
Sbjct: 170 ENGHLHVLNRLCELAPTEATAMIQAENYYAFRWAAVGRGHHNVINFLLDCPVMLAYAEI- 228

Query: 139 VKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLG 184
             H  E  E  ++P      N ++     F L+   G+   V K  
Sbjct: 229 --HEFEYGEKYVNPFIARHVNRLKEMHDAFKLSNPDGVFDLVTKSE 272

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 46.8 bits (110), Expect = 3e-06
 Identities = 10/77 (12%), Positives = 20/77 (25%), Gaps = 7/77 (9%)

Query: 54  EGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRW-----GST 108
           +G+ +L+        +       L     +   + +  LL                  + 
Sbjct: 262 DGVFDLVTK--SECLQGFYMLRNLIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANE 319

Query: 109 PLGDAIYYKNHEVIKLL 125
            L  A+   N     LL
Sbjct: 320 LLRLALRLGNQGACALL 336

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]} Length = 346

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

 Score = 43.7 bits (102), Expect = 3e-05
 Identities = 12/56 (21%), Positives = 19/56 (33%), Gaps = 5/56 (8%)

Query: 44  LMFLANERDVEGIKELLDSG-----IDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
           L+   +E  ++ I+ LL                D    L +A   G     +LLL 
Sbjct: 283 LIRRNDEVLLDDIRFLLSIPGIKALAPTATIPGDANELLRLALRLGNQGACALLLS 338

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 69.4 bits (168), Expect = 8e-14
 Identities = 25/88 (28%), Positives = 41/88 (46%), Gaps = 4/88 (4%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
           L   A +   E +K L+ +  DVN +D D  T LH AA  G  E   +L+E   D++  +
Sbjct: 203 LHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVN 262

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAK 131
           + G T         + +++  LE+   K
Sbjct: 263 KVGQTAF----DVADEDILGYLEELQKK 286

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 59.0 bits (141), Expect = 3e-10
 Identities = 27/115 (23%), Positives = 41/115 (35%), Gaps = 9/115 (7%)

Query: 48  ANERDVEGIKELLDSGIDVNFR---------DIDNRTALHVAACQGFTEVVSLLLERGAD 98
           A ++  E +K  + S  D+              D+      A   G TE V  LLERGAD
Sbjct: 6   AKQKRNEQLKRWIGSETDLEPPVVKRKKTKVKFDDGAVFLAACSSGDTEEVLRLLERGAD 65

Query: 99  VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPH 153
           ++  +  G T L  A    N +++K L ++GA                       
Sbjct: 66  INYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLD 120

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 56.3 bits (134), Expect = 2e-09
 Identities = 26/74 (35%), Positives = 39/74 (52%)

Query: 59  LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
           L    I+         TALHVAA +G+TEV+ LL++   DV+ KD  G TPL  A ++  
Sbjct: 185 LNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLLIQARYDVNIKDYDGWTPLHAAAHWGK 244

Query: 119 HEVIKLLEKHGAKP 132
            E  ++L ++    
Sbjct: 245 EEACRILVENLCDM 258

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]} Length = 291

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

 Score = 47.8 bits (112), Expect = 1e-06
 Identities = 34/175 (19%), Positives = 65/175 (37%), Gaps = 2/175 (1%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
            +   +  D E +  LL+ G D+N+ ++D  TALH A      ++V  L+E GA+++  D
Sbjct: 44  FLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPD 103

Query: 104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPM--HVKHAREVPEYEIDPHELDFTNSV 161
             G  PL  A      ++ + L   GA                  E   +  + +     
Sbjct: 104 NEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNSEGDTPLDIAEEEAMEELLQNEVNRQG 163

Query: 162 EITKGTFILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFL 216
              +          ++ A + L    I+D    ++    L +     +  V++ L
Sbjct: 164 VDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKLL 218

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 67.0 bits (162), Expect = 4e-13
 Identities = 24/65 (36%), Positives = 31/65 (47%)

Query: 67  NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
                  RT LH+A       V+ LLL+ GAD   +   G TPLG A+   N  + +LL 
Sbjct: 186 KPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLR 245

Query: 127 KHGAK 131
            HGA 
Sbjct: 246 AHGAP 250

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 62.8 bits (151), Expect = 1e-11
 Identities = 15/59 (25%), Positives = 23/59 (38%), Gaps = 1/59 (1%)

Query: 45  MFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD 103
                 +    ++ LL +G D   R    RT L  A  +    +  LL   GA  +P+D
Sbjct: 197 HLAVEAQAASVLELLLKAGADPTARMYGGRTPLGSALLRPNPILARLLRAHGAP-EPED 254

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 57.8 bits (138), Expect = 5e-10
 Identities = 19/78 (24%), Positives = 28/78 (35%), Gaps = 3/78 (3%)

Query: 67  NFRDIDNRTALHVAACQGFTEVVSLLLERGAD---VDPKDRWGSTPLGDAIYYKNHEVIK 123
            +   D  TALH+A        +  LL   A    +D ++  G T L  A        ++
Sbjct: 3   GYVTEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVE 62

Query: 124 LLEKHGAKPLMAPMHVKH 141
            L   GA  L+A      
Sbjct: 63  KLYAAGAGVLVAERGGHT 80

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]} Length = 255

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 51.6 bits (122), Expect = 4e-08
 Identities = 24/108 (22%), Positives = 39/108 (36%), Gaps = 8/108 (7%)

Query: 28  LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQG 84
              + +DG+       L      +    +  LL        ++ ++   +TALH+AA  G
Sbjct: 2   FGYVTEDGDTA-----LHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILG 56

Query: 85  FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
               V  L   GA V   +R G T L  A   + H    +L +     
Sbjct: 57  EASTVEKLYAAGAGVLVAERGGHTALHLACRVRAHTCACVLLQPRPSH 104

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 66.6 bits (161), Expect = 8e-13
 Identities = 16/58 (27%), Positives = 28/58 (48%)

Query: 53  VEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL 110
           +E +         +N +D +  T L++AA  G   +V  LL+ GAD    ++ G  P+
Sbjct: 239 LENLDLKWIIANMLNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPV 296

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 60.1 bits (144), Expect = 1e-10
 Identities = 19/129 (14%), Positives = 45/129 (34%), Gaps = 2/129 (1%)

Query: 2   ETKVPVRTTLLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLD 61
           E K+ +   L +               +  + + E      +   ++ +  ++ + +   
Sbjct: 34  EQKMKLEAFLQRLLFPEIQEMPTSLNNDSSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFP 93

Query: 62  -SGIDVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
            + +++N   D    T LH        E+V  L++ G++    D  G + L  A+   N+
Sbjct: 94  NTQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNN 153

Query: 120 EVIKLLEKH 128
                 E  
Sbjct: 154 YDSGTFEAL 162

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 52.0 bits (123), Expect = 5e-08
 Identities = 11/77 (14%), Positives = 26/77 (33%), Gaps = 3/77 (3%)

Query: 59  LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER---GADVDPKDRWGSTPLGDAIY 115
           +      +     +  +  +    +    ++  L  +      ++ +D  G T L  A  
Sbjct: 209 VKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNAQDSNGDTCLNIAAR 268

Query: 116 YKNHEVIKLLEKHGAKP 132
             N  ++  L  +GA P
Sbjct: 269 LGNISIVDALLDYGADP 285

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 51.6 bits (122), Expect = 7e-08
 Identities = 28/132 (21%), Positives = 48/132 (36%), Gaps = 5/132 (3%)

Query: 6   PVRTT---LLKQSSLAPDRERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS 62
           P+ T    L      +P +  K      ++D+ +++K E  L  L      E    L + 
Sbjct: 2   PIITFTHDLTSDFLSSPLKIMKALPSPVVNDNEQKMKLEAFLQRLLFPEIQEMPTSLNND 61

Query: 63  GIDVNFRDIDNRTALHVAACQGFT-EVVSLLLERGADVD-PKDRWGSTPLGDAIYYKNHE 120
             + N     +       +      EV         +++ P D  G+TPL       N E
Sbjct: 62  SSNRNSEGGSSNQQQQHVSFDSLLQEVNDAFPNTQLNLNIPVDEHGNTPLHWLTSIANLE 121

Query: 121 VIKLLEKHGAKP 132
           ++K L KHG+  
Sbjct: 122 LVKHLVKHGSNR 133

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 301

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 40.8 bits (94), Expect = 2e-04
 Identities = 12/57 (21%), Positives = 19/57 (33%), Gaps = 5/57 (8%)

Query: 25  EAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAA 81
              LN  D +G+       L   A   ++  +  LLD G D    +      +   A
Sbjct: 249 ANMLNAQDSNGDTC-----LNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA 300

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 64.0 bits (154), Expect = 2e-12
 Identities = 25/104 (24%), Positives = 48/104 (46%), Gaps = 5/104 (4%)

Query: 23  RKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAAC 82
             +A++N  D+ G+       L + A   + E +  LL    + + +D  + T L +AA 
Sbjct: 111 TADADINAADNSGKTA-----LHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAR 165

Query: 83  QGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
           +G  E    LL+  A+ +  D     P   A    +H++++LL+
Sbjct: 166 EGSYEASKALLDNFANREITDHMDRLPRDVASERLHHDIVRLLD 209

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 47.5 bits (111), Expect = 7e-07
 Identities = 15/56 (26%), Positives = 25/56 (44%), Gaps = 1/56 (1%)

Query: 87  EVVSLLLERGADVDPK-DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
           +V+S LL +GA+++   D+ G T L  A  +   +  K L   GA         + 
Sbjct: 3   QVISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRLLDAGADANSQDNTGRT 58

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 47.1 bits (110), Expect = 1e-06
 Identities = 26/76 (34%), Positives = 39/76 (51%)

Query: 57  KELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYY 116
           ++L+ +  D+N  D   +TALH AA    TE V++LL   A+ D +D    TPL  A   
Sbjct: 107 EDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAARE 166

Query: 117 KNHEVIKLLEKHGAKP 132
            ++E  K L  + A  
Sbjct: 167 GSYEASKALLDNFANR 182

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 209

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

 Score = 45.9 bits (107), Expect = 3e-06
 Identities = 12/40 (30%), Positives = 19/40 (47%), Gaps = 1/40 (2%)

Query: 54 EGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLL 92
          + I +LL  G ++N   D    T+LH+AA     +    L
Sbjct: 3  QVISDLLAQGAELNATMDKTGETSLHLAARFARADAAKRL 42

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.8 bits (154), Expect = 2e-12
 Identities = 32/123 (26%), Positives = 46/123 (37%), Gaps = 34/123 (27%)

Query: 44  LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQG------------------ 84
           +  LA    +E +KE + +        D D+RTALH A   G                  
Sbjct: 7   VCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDK 66

Query: 85  ---------------FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
                            E+V  LL +GA V+  ++ G TPL  A     HE+  +L + G
Sbjct: 67  DDAGWSPLHIAASAGRDEIVKALLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGG 126

Query: 130 AKP 132
           A P
Sbjct: 127 ANP 129

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 63.4 bits (153), Expect = 4e-12
 Identities = 31/107 (28%), Positives = 53/107 (49%), Gaps = 5/107 (4%)

Query: 26  AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGF 85
           A++N ++ +G        L + A++   E    LL+ G + + +D    TA+H AA +G 
Sbjct: 94  AQVNAVNQNGCTP-----LHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGN 148

Query: 86  TEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKP 132
            +++ +LL   A  + +D  G+TPL  A   +  E  KLL   GA  
Sbjct: 149 LKMIHILLYYKASTNIQDTEGNTPLHLACDEERVEEAKLLVSQGASI 195

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 60.0 bits (144), Expect = 6e-11
 Identities = 24/70 (34%), Positives = 37/70 (52%)

Query: 59  LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKN 118
           LL  G  VN  + +  T LH AA +   E+  +LLE GA+ D KD + +T +  A    N
Sbjct: 89  LLGKGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGN 148

Query: 119 HEVIKLLEKH 128
            ++I +L  +
Sbjct: 149 LKMIHILLYY 158

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.4 bits (119), Expect = 1e-07
 Identities = 13/52 (25%), Positives = 23/52 (44%), Gaps = 1/52 (1%)

Query: 43  RLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLE 94
            L    +E  VE  K L+  G  +   + + +T L VA   G   ++  ++E
Sbjct: 172 PLHLACDEERVEEAKLLVSQGASIYIENKEEKTPLQVAK-GGLGLILKRMVE 222

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]} Length = 223

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.0 bits (87), Expect = 0.001
 Identities = 8/48 (16%), Positives = 15/48 (31%), Gaps = 1/48 (2%)

Query: 73  NRTALHVAACQG-FTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
           +   +   A  G   E+   +L   +     D+   T L  A    + 
Sbjct: 3   SNLMVCNLAYSGKLEELKESILADKSLATRTDQDSRTALHWACSAGHT 50

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 61.1 bits (147), Expect = 8e-12
 Identities = 24/140 (17%), Positives = 47/140 (33%), Gaps = 42/140 (30%)

Query: 43  RLMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAA---CQGFTEVVSLLL 93
            L      RD+ G+ +    G+D+  +         + TALH+A     +    +V  L+
Sbjct: 9   SLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLV 68

Query: 94  ERGADVDPK---------------------------------DRWGSTPLGDAIYYKNHE 120
           +   ++D +                                 +  G TPL  A   K+  
Sbjct: 69  QNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIAKRLKHEH 128

Query: 121 VIKLLEKHGAKPLMAPMHVK 140
             +LL +  +    + +HV+
Sbjct: 129 CEELLTQALSGRFNSHVHVE 148

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]} Length = 154

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 43.0 bits (100), Expect = 1e-05
 Identities = 15/129 (11%), Positives = 30/129 (23%), Gaps = 12/129 (9%)

Query: 72  DNRTALHV---AACQGFTEVVSLLLERGADVDPK------DRWGSTPLGDAIYYKNH--- 119
           D    LH    A        +      G D+  K           T L  A+   +    
Sbjct: 2   DTAAKLHSLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSL 61

Query: 120 EVIKLLEKHGAKPLMAPMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVA 179
            ++  L ++             A        +   L      + +      +    + +A
Sbjct: 62  HIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIA 121

Query: 180 VKKLGEEVI 188
            +   E   
Sbjct: 122 KRLKHEHCE 130

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 62.2 bits (149), Expect = 1e-11
 Identities = 21/82 (25%), Positives = 38/82 (46%)

Query: 42  FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP 101
             L+       +  ++ LL  G +VN +     +ALH A+ +G   +V  L+  GAD   
Sbjct: 146 SPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSL 205

Query: 102 KDRWGSTPLGDAIYYKNHEVIK 123
           K+    TPL  A   +  ++++
Sbjct: 206 KNCHNDTPLMVARSRRVIDILR 227

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.9 bits (125), Expect = 1e-08
 Identities = 15/52 (28%), Positives = 22/52 (42%), Gaps = 4/52 (7%)

Query: 72  DNRTALHVAACQGFTEVVSLLL----ERGADVDPKDRWGSTPLGDAIYYKNH 119
           D  T LH+A  QG    V  L+    + G ++D  +    TPL  A+     
Sbjct: 2   DGDTPLHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLP 53

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.5 bits (98), Expect = 4e-05
 Identities = 20/102 (19%), Positives = 40/102 (39%), Gaps = 4/102 (3%)

Query: 44  LMFLANERDVEGIKELLD----SGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADV 99
           L     + ++  +  L++     G +++  +   +T LH+A       VV LL+  GA  
Sbjct: 7   LHIAVVQGNLPAVHRLVNLFQQGGRELDIYNNLRQTPLHLAVITTLPSVVRLLVTAGASP 66

Query: 100 DPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
              DR G T    A  +++   ++ L    A   +      +
Sbjct: 67  MALDRHGQTAAHLACEHRSPTCLRALLDSAAPGTLDLEARNY 108

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]} Length = 228

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.4 bits (82), Expect = 0.004
 Identities = 17/66 (25%), Positives = 28/66 (42%)

Query: 67  NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
                  R+ L  A       +V LLL+ GA+V+ +   GS+ L  A       +++ L 
Sbjct: 138 AVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLV 197

Query: 127 KHGAKP 132
           + GA  
Sbjct: 198 RSGADS 203

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 59.8 bits (144), Expect = 3e-11
 Identities = 29/191 (15%), Positives = 61/191 (31%), Gaps = 37/191 (19%)

Query: 174 RGIQVAVKKLGEEVISDDD---------------RVRAFRDELALLQKIRHPNVVQFLGA 218
           +  +  VK       S                   +R+ R+E   LQK++   V +    
Sbjct: 23  KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82

Query: 219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRD 278
                   ++ E +   +L          +          I   +   +      I+H D
Sbjct: 83  ----EGNAVLMELIDAKELYRV-------RVENPDEVLDMILEEVAKFYHR---GIVHGD 128

Query: 279 LEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVF 338
           L   N+L  + G + + DF  S  +  +  R +  +D          + +  Y T+ D+ 
Sbjct: 129 LSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDVRN----IITYFSRTYRTEKDIN 183

Query: 339 SFALILQEMIE 349
           S    +  +++
Sbjct: 184 S---AIDRILQ 191

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 57.2 bits (136), Expect = 4e-10
 Identities = 19/67 (28%), Positives = 31/67 (46%)

Query: 67  NFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLE 126
                + RTALH+A      ++VSLLL+ GADV+     G +P        +  + + L 
Sbjct: 139 AQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLG 198

Query: 127 KHGAKPL 133
           +   + L
Sbjct: 199 QLTLENL 205

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 52.2 bits (123), Expect = 2e-08
 Identities = 9/55 (16%), Positives = 20/55 (36%)

Query: 44  LMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98
           L    + ++ + +  LL  G DVN       +   +   +  T +   L +   +
Sbjct: 149 LHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWGRPSTRIQQQLGQLTLE 203

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 221

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 50.7 bits (119), Expect = 7e-08
 Identities = 11/52 (21%), Positives = 20/52 (38%), Gaps = 4/52 (7%)

Query: 72  DNRTALHVAACQGFT----EVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
           D  + LH+A          EV+  +    A ++ ++    TPL  A+     
Sbjct: 1   DGDSFLHLAIIHEEKALTMEVIRQVKGDLAFLNFQNNLQQTPLHLAVITNQP 52

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 54.8 bits (130), Expect = 3e-09
 Identities = 19/66 (28%), Positives = 30/66 (45%), Gaps = 4/66 (6%)

Query: 66  VNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNHEVIKL 124
           VN++D    T L  A  +G  +   LL+E+ GA+ D  D  G+     A+   N +V K 
Sbjct: 165 VNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVAL---NEQVKKF 221

Query: 125 LEKHGA 130
              +  
Sbjct: 222 FLNNVV 227

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 53.7 bits (127), Expect = 8e-09
 Identities = 14/68 (20%), Positives = 25/68 (36%), Gaps = 1/68 (1%)

Query: 75  TALHVAACQGFTEVVSLLLE-RGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL 133
             LH A  +     V  LL  + + +  KD+ G  PL  ++ ++ HE+   L        
Sbjct: 2   YPLHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVN 61

Query: 134 MAPMHVKH 141
           +       
Sbjct: 62  LDDYPDDS 69

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 49.8 bits (117), Expect = 1e-07
 Identities = 10/55 (18%), Positives = 17/55 (30%), Gaps = 4/55 (7%)

Query: 45  MFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD 98
                E   +    L++  G + +  D     A  VA  +   +V    L    D
Sbjct: 177 FHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKAEDVALNE---QVKKFFLNNVVD 228

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 45.2 bits (105), Expect = 6e-06
 Identities = 26/90 (28%), Positives = 46/90 (51%), Gaps = 2/90 (2%)

Query: 45  MFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGAD-VDPKD 103
                ++  E  + L+++G  V  +D  N+  LH AA  G  +++ LL   G   V+ +D
Sbjct: 110 HLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQD 169

Query: 104 RWGSTPLGDAIYYKNHEVIK-LLEKHGAKP 132
           + G TPL  A+   + +    L+EK+GA+ 
Sbjct: 170 KQGWTPLFHALAEGHGDAAVLLVEKYGAEY 199

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 229

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 45.2 bits (105), Expect = 6e-06
 Identities = 19/99 (19%), Positives = 39/99 (39%), Gaps = 1/99 (1%)

Query: 44  LMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPK 102
           L     E +   ++ELL S    +  +D D R  LH +      E+ S LL +  +V+  
Sbjct: 4   LHQACMENEFFKVQELLHSKPSLLLQKDQDGRIPLHWSVSFQAHEITSFLLSKMENVNLD 63

Query: 103 DRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH 141
           D    +         +   +++++    +PL   ++   
Sbjct: 64  DYPDDSGWTPFHIACSVGNLEVVKSLYDRPLKPDLNKIT 102

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 48.7 bits (114), Expect = 1e-07
 Identities = 9/32 (28%), Positives = 18/32 (56%)

Query: 75  TALHVAACQGFTEVVSLLLERGADVDPKDRWG 106
             L  AA +G  E ++ LL+   +V+ ++ +G
Sbjct: 3   NELASAAARGDLEQLTSLLQNNVNVNAQNGFG 34

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (104), Expect = 3e-06
 Identities = 12/31 (38%), Positives = 15/31 (48%)

Query: 66  VNFRDIDNRTALHVAACQGFTEVVSLLLERG 96
           V  R+    TA  +A   G  EVVSL+   G
Sbjct: 126 VGHRNHKGDTACDLARLYGRNEVVSLMQANG 156

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.5 bits (90), Expect = 2e-04
 Identities = 9/31 (29%), Positives = 16/31 (51%)

Query: 99  VDPKDRWGSTPLGDAIYYKNHEVIKLLEKHG 129
           V  ++  G T    A  Y  +EV+ L++ +G
Sbjct: 126 VGHRNHKGDTACDLARLYGRNEVVSLMQANG 156

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 47.5 bits (111), Expect = 3e-07
 Identities = 23/64 (35%), Positives = 36/64 (56%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
           G DVN +D+   TALH A      EVV LL++ GADV  + ++  T    +I   N ++ 
Sbjct: 90  GADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDLA 149

Query: 123 KLLE 126
           ++L+
Sbjct: 150 EILQ 153

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 41.4 bits (95), Expect = 5e-05
 Identities = 12/64 (18%), Positives = 29/64 (45%)

Query: 29  NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEV 88
           +G D + +++     L +       E ++ L+  G DV+ +    +TA  ++   G  ++
Sbjct: 89  HGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKTAFDISIDNGNEDL 148

Query: 89  VSLL 92
             +L
Sbjct: 149 AEIL 152

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]} Length = 153

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

 Score = 39.8 bits (91), Expect = 2e-04
 Identities = 15/48 (31%), Positives = 21/48 (43%), Gaps = 1/48 (2%)

Query: 72  DNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNH 119
           D    L  AA  G  + V +L+  GA     D  G++PL  A  Y + 
Sbjct: 1   DLGKKLLEAARAGQDDEVRILMANGAPFT-TDWLGTSPLHLAAQYGHF 47

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.1 bits (110), Expect = 6e-07
 Identities = 22/66 (33%), Positives = 34/66 (51%), Gaps = 1/66 (1%)

Query: 63  GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVI 122
           G DVN  D      +H+A  +G T VVS L    +D+  +D  G TPL  A+     +++
Sbjct: 91  GADVNVPDGTGALPIHLAVQEGHTAVVSFLAAE-SDLHRRDARGLTPLELALQRGAQDLV 149

Query: 123 KLLEKH 128
            +L+ H
Sbjct: 150 DILQGH 155

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]} Length = 156

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.4 bits (90), Expect = 3e-04
 Identities = 13/46 (28%), Positives = 19/46 (41%), Gaps = 1/46 (2%)

Query: 75  TALHVAACQGFTEVVSLLLER-GADVDPKDRWGSTPLGDAIYYKNH 119
             L  AA +G  + V  LL R     D  +R+G T L   ++    
Sbjct: 4   DRLSGAAARGDVQEVRRLLHRELVHPDALNRFGKTALQVMMFGSTA 49

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]} Length = 130

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.7 bits (91), Expect = 1e-04
 Identities = 11/47 (23%), Positives = 18/47 (38%), Gaps = 3/47 (6%)

Query: 56  IKELLDSGIDVNFRDI-DNRTA--LHVAACQGFTEVVSLLLERGADV 99
            K L++SG  V      D +TA        +G+T+    L      +
Sbjct: 83  CKFLVESGAAVFAMTYSDMQTAADKCEEMEEGYTQCSQFLYGVQEKM 129

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]} Length = 125

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.5 bits (82), Expect = 0.001
 Identities = 20/114 (17%), Positives = 33/114 (28%)

Query: 75  TALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM 134
             L  AA +G  E V  LLE GA+ +  + +G  P+   +         LL         
Sbjct: 5   DWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMMMGSARVAELLLLHGAEPNCA 64

Query: 135 APMHVKHAREVPEYEIDPHELDFTNSVEITKGTFILAFWRGIQVAVKKLGEEVI 188
            P  +         E     L   +                + +A +    +V 
Sbjct: 65  DPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGRLPVDLAEELGHRDVA 118

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	458
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1myoa_	118	Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]	99.86
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.85
d1dcqa1	154	Pyk2-associated protein beta {Mouse (Mus musculus)	99.85
d1ycsb1	130	53BP2 {Human (Homo sapiens) [TaxId: 9606]}	99.83
d1ycsb1	130	53BP2 {Human (Homo sapiens) [TaxId: 9606]}	99.8
d1bi7b_	125	Cell cycle inhibitor p16ink4A {Human (Homo sapiens	99.79
d1myoa_	118	Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]	99.79
d1uoha_	223	26S proteasome non-ATPase regulatory subunit 10, g	99.78
d1oy3d_	255	Transcription factor inhibitor I-kappa-B-beta, IKB	99.77
d1bi7b_	125	Cell cycle inhibitor p16ink4A {Human (Homo sapiens	99.77
d1ot8a_	209	Neurogenic locus notch receptor domain {Fruit fly	99.72
d1bd8a_	156	Cell cycle inhibitor p19ink4D {Human (Homo sapiens	99.72
d1sw6a_	301	Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch	99.71
d1oy3d_	255	Transcription factor inhibitor I-kappa-B-beta, IKB	99.71
d1bd8a_	156	Cell cycle inhibitor p19ink4D {Human (Homo sapiens	99.7
d1awcb_	153	GA bindinig protein (GABP) beta 1 {Mouse (Mus musc	99.69
d1uoha_	223	26S proteasome non-ATPase regulatory subunit 10, g	99.69
d1ixva_	229	26S proteasome non-ATPase regulatory subunit 10, g	99.69
d1n11a_	408	Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}	99.68
d1k1aa_	228	bcl-3 {Human (Homo sapiens) [TaxId: 9606]}	99.68
d1s70b_	291	Myosin phosphatase targeting subunit 1, MYPT1 {Chi	99.68
d1n11a_	408	Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}	99.67
d2fo1e1	277	Lin-12 {Caenorhabditis elegans [TaxId: 6239]}	99.66
d1iknd_	221	I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606	99.64
d1ot8a_	209	Neurogenic locus notch receptor domain {Fruit fly	99.63
d1dcqa1	154	Pyk2-associated protein beta {Mouse (Mus musculus)	99.63
d1awcb_	153	GA bindinig protein (GABP) beta 1 {Mouse (Mus musc	99.63
d1ihba_	156	p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]	99.62
d1wdya_	285	RNase L, 2-5a-dependent ribonuclease {Human (Homo	99.62
d2ajaa1	346	Hypothetical protein LPG2416 {Legionella pneumophi	99.62
d2ajaa1	346	Hypothetical protein LPG2416 {Legionella pneumophi	99.6
d1ihba_	156	p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]	99.59
d2fo1e1	277	Lin-12 {Caenorhabditis elegans [TaxId: 6239]}	99.59
d1iknd_	221	I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606	99.59
d1s70b_	291	Myosin phosphatase targeting subunit 1, MYPT1 {Chi	99.59
d1ixva_	229	26S proteasome non-ATPase regulatory subunit 10, g	99.53
d1k1aa_	228	bcl-3 {Human (Homo sapiens) [TaxId: 9606]}	99.53
d1wdya_	285	RNase L, 2-5a-dependent ribonuclease {Human (Homo	99.45
d1sw6a_	301	Swi6 ankyrin-repeat fragment {Baker's yeast (Sacch	99.42
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.17
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	97.7
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	97.27
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	95.89
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	95.74
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	90.64

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-53  Score=397.82  Aligned_cols=244  Identities=25%  Similarity=0.487  Sum_probs=213.2

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.||.     +|+.||+|++...........+.+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus         7 dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmE   86 (263)
T d2j4za1           7 DFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILE   86 (263)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             HeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEe
Confidence            688899999999999984     688999999864332222334668899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      ||++|+|.+++.+.+.+++..+..++.|++.||+|||++|   |+||||||+|||++.++.+||+|||++......   .
T Consensus        87 y~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~---~  160 (263)
T d2j4za1          87 YAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS---R  160 (263)
T ss_dssp             CCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC---C
T ss_pred             ecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeeeeccccceecCCCCEeecccceeeecCCC---c
Confidence            9999999999998889999999999999999999999999   999999999999999999999999999865432   2


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+.. ....+   +..+|+++++||.
T Consensus       161 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~-~~~~~---p~~~s~~~~~li~  236 (263)
T d2j4za1         161 RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISR-VEFTF---PDFVTEGARDLIS  236 (263)
T ss_dssp             CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHT-TCCCC---CTTSCHHHHHHHH
T ss_pred             ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHc-CCCCC---CccCCHHHHHHHH
Confidence            3456789999999999999999999999999999999999999988766665555432 23332   3467899999999


Q ss_pred             HHcccCCCCCCCHHHHHHH
Q 012684          391 ECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~  409 (458)
                      +||+.||.+|||+.++++|
T Consensus       237 ~~L~~dp~~R~t~~eil~h  255 (263)
T d2j4za1         237 RLLKHNPSQRPMLREVLEH  255 (263)
T ss_dssp             HHTCSSGGGSCCHHHHHTC
T ss_pred             HHccCCHhHCcCHHHHHcC
Confidence            9999999999999999986

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-52  Score=393.36  Aligned_cols=263  Identities=28%  Similarity=0.471  Sum_probs=215.3

Q ss_pred             CcccCcCCccccCceeeccceEEEEEE--cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          147 EYEIDPHELDFTNSVEITKGTFILAFW--RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       147 ~~~~~~~~~~~~~~~~lg~G~~~~v~~--~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      +|||+..  +|++.+.||+|+||.||.  .+..||||+++.... .....+.+.+|+.++++++||||+++++++.+ +.
T Consensus         2 dwei~~~--~~~~~~~lG~G~fg~Vy~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~   77 (276)
T d1uwha_           2 DWEIPDG--QITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQ   77 (276)
T ss_dssp             CCBCCTT--CCCCCSEEEECSSCEEEEEESSSEEEEEECCCSSC-CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SS
T ss_pred             Ccccccc--cEEEEEEEeeCCCcEEEEEEECCEEEEEEEEcccC-CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cE
Confidence            5677654  567788999999999984  445799999976543 33456789999999999999999999998754 56


Q ss_pred             eEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      +++||||+++|+|.+++... +.+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|||++...
T Consensus        78 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~  154 (276)
T d1uwha_          78 LAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVK  154 (276)
T ss_dssp             CEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-
T ss_pred             EEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCC---EeccccCHHHEEEcCCCCEEEccccceeec
Confidence            89999999999999999764 56999999999999999999999999   999999999999999999999999999876


Q ss_pred             ccCCC-CCcccCCCCCcccCCcccCCC---CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC--CCCCCCC
Q 012684          304 TVKED-RPLTCQDTSCRYVAPEVFKNE---EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ--RPPFKAP  377 (458)
Q Consensus       304 ~~~~~-~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~--~~~~~~~  377 (458)
                      ..... .......||+.|+|||++.+.   .++.++|||||||++|||+||+.||.+.+...........+  .+.....
T Consensus       155 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~  234 (276)
T d1uwha_         155 SRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKV  234 (276)
T ss_dssp             -----------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGS
T ss_pred             cccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhc
Confidence            54322 233456789999999998643   57889999999999999999999999877665544443433  2333345


Q ss_pred             hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          378 AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       378 ~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      +..+++++.+||.+||+.||.+|||+.+++++|+.+.++
T Consensus       235 ~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~  273 (276)
T d1uwha_         235 RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS  273 (276)
T ss_dssp             CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred             cccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHc
Confidence            567889999999999999999999999999999988754

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-53  Score=396.25  Aligned_cols=249  Identities=26%  Similarity=0.399  Sum_probs=210.1

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|++.+.||+|+||.|+.     +|+.||||++.....  .+..+.+.+|+.++++++||||+++++++.+++..|+||
T Consensus         5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm   82 (271)
T d1nvra_           5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL   82 (271)
T ss_dssp             TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEE
Confidence            3688899999999999984     589999999975432  233456889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC-C
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE-D  308 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~-~  308 (458)
                      ||++||+|.+++...+.+++.++..++.|++.||+|||++|   |+||||||+|||++.++.+||+|||++....... .
T Consensus        83 Ey~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~  159 (271)
T d1nvra_          83 EYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE  159 (271)
T ss_dssp             ECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETTEE
T ss_pred             eccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CccCcccHHHEEECCCCCEEEccchhheeeccCCcc
Confidence            99999999999988888999999999999999999999999   9999999999999999999999999998764332 2


Q ss_pred             CCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||............. ............+++++.+
T Consensus       160 ~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~  238 (271)
T d1nvra_         160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW-KEKKTYLNPWKKIDSAPLA  238 (271)
T ss_dssp             CCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH-HTTCTTSTTGGGSCHHHHH
T ss_pred             ccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH-hcCCCCCCccccCCHHHHH
Confidence            23345679999999999988776 568999999999999999999998766554433332 2233333445678999999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ||.+||+.||.+|||+.++++|
T Consensus       239 li~~~L~~dP~~R~t~~eil~h  260 (271)
T d1nvra_         239 LLHKILVENPSARITIPDIKKD  260 (271)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTC
T ss_pred             HHHHHcCCChhHCcCHHHHhcC
Confidence            9999999999999999999875

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-52  Score=392.51  Aligned_cols=246  Identities=22%  Similarity=0.431  Sum_probs=214.9

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      .+|+..+.||+|+||.||.     +|+.||||++.......   .+.+.+|+.+++.++||||+++++++.+++.+|+||
T Consensus        20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~---~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPK---KELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSC---HHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred             cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChH---HHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEE
Confidence            4789999999999999984     68999999997543322   356889999999999999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      |||+||+|.+++.+ +.+++.++..++.||+.||+|||++|   |+||||||+|||++.++.+||+|||++..+... ..
T Consensus        97 Ey~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~-~~  171 (293)
T d1yhwa1          97 EYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE-QS  171 (293)
T ss_dssp             ECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCST-TC
T ss_pred             EecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCC---CcccCCcHHHeEECCCCcEeeccchhheeeccc-cc
Confidence            99999999998776 46999999999999999999999999   999999999999999999999999999876433 22


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+.....+.+ ..+..+++.+++||
T Consensus       172 ~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li  250 (293)
T d1yhwa1         172 KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPEL-QNPEKLSAIFRDFL  250 (293)
T ss_dssp             CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSCCC-SSGGGSCHHHHHHH
T ss_pred             cccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC-CCcccCCHHHHHHH
Confidence            33456799999999999999999999999999999999999999988766555555544444444 34567899999999


Q ss_pred             HHHcccCCCCCCCHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+||+.||.+|||+.++++|
T Consensus       251 ~~~L~~dP~~R~s~~eil~H  270 (293)
T d1yhwa1         251 NRCLDMDVEKRGSAKELLQH  270 (293)
T ss_dssp             HHHTCSSTTTSCCHHHHTTC
T ss_pred             HHHccCChhHCcCHHHHhcC
Confidence            99999999999999999876

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.8e-52  Score=385.96  Aligned_cols=251  Identities=29%  Similarity=0.565  Sum_probs=203.8

Q ss_pred             cccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      +|+..+.||+|+||.||.    +++.||||++......    .+.+.+|+.++++++||||+++++++..++..++||||
T Consensus         6 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~   81 (263)
T d1sm2a_           6 ELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEF   81 (263)
T ss_dssp             CEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HcEEEEEEeeCCCeEEEEEEECCCCEEEEEEECCCcCc----HHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEe
Confidence            467788999999998874    5788999999754322    25688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          232 LPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       232 ~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      +++|+|.+++... ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.........
T Consensus        82 ~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~  158 (263)
T d1sm2a_          82 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTS  158 (263)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC------------
T ss_pred             cCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccc---eeecccchhheeecCCCCeEecccchheeccCCCcee
Confidence            9999999998764 45889999999999999999999999   9999999999999999999999999998765444344


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      .....||+.|+|||++.+..++.++|||||||++|||+| |.+||...+..++...+....++..   +..+++++.+||
T Consensus       159 ~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li  235 (263)
T d1sm2a_         159 STGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQIM  235 (263)
T ss_dssp             ------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCHHHHHHH
T ss_pred             ecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHHHHHH
Confidence            445678999999999999999999999999999999999 5666666555555565544444433   355678999999


Q ss_pred             HHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          390 EECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ..||+.||.+|||+++++++|+++.++
T Consensus       236 ~~cl~~~p~~Rps~~~il~~L~~i~es  262 (263)
T d1sm2a_         236 NHCWKERPEDRPAFSRLLRQLAEIAES  262 (263)
T ss_dssp             HHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             HHHccCCHhHCcCHHHHHHHHHHHHhC
Confidence            999999999999999999999998653

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.9e-52  Score=395.88  Aligned_cols=247  Identities=24%  Similarity=0.397  Sum_probs=200.1

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .|++.+.||+|+||.||.     +|+.||||++......  .....+.+|+.+++.++||||+++++++.+++.+|+|||
T Consensus        10 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE   87 (307)
T d1a06a_          10 IYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQ   87 (307)
T ss_dssp             TEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEC
T ss_pred             ceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEe
Confidence            488999999999998874     5899999999765432  233567899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec---CCCCEEEeecCCccccccCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD---DSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~---~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||+||+|.+++.+.+.+++..+..++.|++.||+|||+++   |+||||||+||++.   .++.+||+|||++...... 
T Consensus        88 ~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~-  163 (307)
T d1a06a_          88 LVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG-  163 (307)
T ss_dssp             CCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC----------
T ss_pred             ccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhce---eeeEEecccceeecccCCCceEEEeccceeEEccCC-
Confidence            9999999999999889999999999999999999999999   99999999999995   5789999999999865432 


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+....+....+...........+..+|+++++
T Consensus       164 -~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  242 (307)
T d1a06a_         164 -SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKD  242 (307)
T ss_dssp             ----------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHH
T ss_pred             -CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHH
Confidence             2234467999999999999999999999999999999999999999987766666666544443333445678999999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ||.+||+.||.+|||+.++++|
T Consensus       243 li~~~L~~dP~~R~s~~eil~h  264 (307)
T d1a06a_         243 FIRHLMEKDPEKRFTCEQALQH  264 (307)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHccCCHhHCcCHHHHhcC
Confidence            9999999999999999999987

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-52  Score=396.03  Aligned_cols=247  Identities=21%  Similarity=0.402  Sum_probs=211.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.||.     +|+.||||++...........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus         9 dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmE   88 (288)
T d1uu3a_           9 DFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLS   88 (288)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEEC
T ss_pred             CCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEE
Confidence            588999999999999984     589999999975432223345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC-C
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED-R  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~-~  309 (458)
                      |++||+|.+++...+.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+..... .
T Consensus        89 y~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          89 YAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             CCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             ccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc---EEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            9999999999999899999999999999999999999999   99999999999999999999999999987654322 2


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.. ....+   +..+++++++||
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~-~~~~~---p~~~s~~~~~li  241 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK-LEYDF---PEKFFPKARDLV  241 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHT-TCCCC---CTTCCHHHHHHH
T ss_pred             ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHc-CCCCC---CccCCHHHHHHH
Confidence            33456799999999999999999999999999999999999999998776666555533 33333   356789999999


Q ss_pred             HHHcccCCCCCCCHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .+||+.||.+|||++|++++
T Consensus       242 ~~~L~~dP~~R~t~~e~~~~  261 (288)
T d1uu3a_         242 EKLLVLDATKRLGCEEMEGY  261 (288)
T ss_dssp             HTTSCSSGGGSTTSGGGTCH
T ss_pred             HHHccCCHhHCcCHHHHcCC
Confidence            99999999999999998765

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.4e-52  Score=391.49  Aligned_cols=246  Identities=28%  Similarity=0.406  Sum_probs=212.1

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .|++.+.||+|+||.||.     +|+.||||++....   ....+.+.+|+.++++++||||+++++++.+++.+++|||
T Consensus        13 ~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~---~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmE   89 (288)
T d2jfla1          13 FWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKS---EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIE   89 (288)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSS---SGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCC---HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEe
Confidence            478889999999999984     68899999997542   2335678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          231 YLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       231 ~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||+||+|.+++.+ .+.+++.++..++.||+.||.|||++|   |+||||||+|||++.++.+||+|||++....... .
T Consensus        90 y~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-~  165 (288)
T d2jfla1          90 FCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-Q  165 (288)
T ss_dssp             CCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH-H
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEeecChhheeECCCCCEEEEechhhhccCCCc-c
Confidence            9999999999765 456999999999999999999999999   9999999999999999999999999997653321 1


Q ss_pred             CcccCCCCCcccCCcccC-----CCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHH
Q 012684          310 PLTCQDTSCRYVAPEVFK-----NEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARG  384 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  384 (458)
                      ......||+.|+|||++.     +..++.++|||||||++|+|++|+.||.+.+..+....+.....+. ...+..++++
T Consensus       166 ~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~s~~  244 (288)
T d2jfla1         166 RRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSSN  244 (288)
T ss_dssp             HHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCC-CSSGGGSCHH
T ss_pred             cccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC-CCccccCCHH
Confidence            223457899999999984     4467899999999999999999999999988877777665444333 3445678999


Q ss_pred             HHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          385 LKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       385 l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +++||.+||+.||.+|||+.++++|
T Consensus       245 ~~~li~~~L~~dp~~R~t~~ell~h  269 (288)
T d2jfla1         245 FKDFLKKCLEKNVDARWTTSQLLQH  269 (288)
T ss_dssp             HHHHHHHHSCSSTTTSCCHHHHTTS
T ss_pred             HHHHHHHHccCChhHCcCHHHHhcC
Confidence            9999999999999999999999886

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.7e-52  Score=386.62  Aligned_cols=250  Identities=24%  Similarity=0.414  Sum_probs=202.3

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--CCceEE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--SSPMMI  227 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--~~~~~l  227 (458)
                      .+|++.+.||+|+||.||.     +|+.||+|.+..... .+...+.+.+|+.++++++||||+++++++.+  ++.+|+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEE
Confidence            3688889999999999984     588999999987644 45556789999999999999999999999864  466899


Q ss_pred             EEEccCCCCHHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCCC--CCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          228 VTEYLPKGDLRAFLKR----KGALKPSTAVRFALDIARGMNYLHENKP--VPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~----~~~~~~~~~~~i~~qi~~~l~~LH~~~~--~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                      |||||+||+|.+++.+    .+.+++..++.++.|++.||+|||+.++  .+|+||||||+|||++.++.+||+|||++.
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999999999999864    4569999999999999999999998641  139999999999999999999999999998


Q ss_pred             ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhh
Q 012684          302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY  381 (458)
Q Consensus       302 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (458)
                      ...... .......||+.|+|||++.+..++.++|||||||++|+|++|+.||...+..+....+.....+.   .+..+
T Consensus       163 ~~~~~~-~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~  238 (269)
T d2java1         163 ILNHDT-SFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYRY  238 (269)
T ss_dssp             HC------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTS
T ss_pred             ecccCC-CccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC---CCccc
Confidence            765332 22345678999999999999999999999999999999999999999877666666654443333   34568


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      |+++.+||.+||+.||.+|||+.++++|
T Consensus       239 s~~l~~li~~~L~~dp~~Rps~~ell~h  266 (269)
T d2java1         239 SDELNEIITRMLNLKDYHRPSVEEILEN  266 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHhC
Confidence            8999999999999999999999999875

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.5e-51  Score=392.71  Aligned_cols=244  Identities=25%  Similarity=0.445  Sum_probs=214.3

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      .|+..+.||+|+||.||.     +|+.||||++...........+.+.+|+.++++++||||+++++++.+++..|+|||
T Consensus        16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E   95 (309)
T d1u5ra_          16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME   95 (309)
T ss_dssp             HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEE
Confidence            588889999999999984     689999999987666566677789999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      ||.+|+|..++...+.+++.++..++.|++.||.|||++|   |+||||||+|||++.++.+||+|||++.....     
T Consensus        96 ~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~-----  167 (309)
T d1u5ra_          96 YCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP-----  167 (309)
T ss_dssp             CCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-----
T ss_pred             ecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccCCCcceEEECCCCCEEEeecccccccCC-----
Confidence            9999999888888888999999999999999999999999   99999999999999999999999999986532     


Q ss_pred             cccCCCCCcccCCcccCC---CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKN---EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~---~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                      .....||+.|+|||++.+   ..++.++|||||||++|+|++|+.||.+....+....+.....+.+  .+..+|+.+++
T Consensus       168 ~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~~~~  245 (309)
T d1u5ra_         168 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYFRN  245 (309)
T ss_dssp             BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTTSCHHHHH
T ss_pred             CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCCCHHHHH
Confidence            234579999999999864   3588999999999999999999999988766555555544444333  24568899999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ||.+||+.||.+|||+.++++|
T Consensus       246 li~~~L~~dP~~Rpt~~ell~H  267 (309)
T d1u5ra_         246 FVDSCLQKIPQDRPTSEVLLKH  267 (309)
T ss_dssp             HHHHHTCSSGGGSCCHHHHTTC
T ss_pred             HHHHHCcCChhHCcCHHHHHhC
Confidence            9999999999999999999986

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-51  Score=379.74  Aligned_cols=246  Identities=25%  Similarity=0.485  Sum_probs=204.9

Q ss_pred             ccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe----CCceEE
Q 012684          157 FTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ----SSPMMI  227 (458)
Q Consensus       157 ~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~----~~~~~l  227 (458)
                      |...++||+|+||.||.     ++..||+|.+..... .....+.+.+|++++++++||||+++++++..    +..+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEE
Confidence            35667899999999984     578999999976543 44556789999999999999999999999865    345899


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec-CCCCEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD-DSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~-~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ||||+++|+|.+++.+.+.+++..+..++.|++.||+|||+++ .+|+||||||+|||++ .++.+||+|||++..... 
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~-  167 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA-  167 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT-
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCC-CCEEeCCcChhhceeeCCCCCEEEeecCcceeccC-
Confidence            9999999999999999888999999999999999999999986 2499999999999997 578999999999975432 


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                        .......||+.|+|||++.+ .++.++|||||||++|+|++|+.||...............+..+ ...+..++++++
T Consensus       168 --~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~  243 (270)
T d1t4ha_         168 --SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP-ASFDKVAIPEVK  243 (270)
T ss_dssp             --TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCCC-GGGGGCCCHHHH
T ss_pred             --CccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCCC-cccCccCCHHHH
Confidence              23345679999999999876 69999999999999999999999998765444333332332222 223455788999


Q ss_pred             HHHHHHcccCCCCCCCHHHHHHH
Q 012684          387 ELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +||.+||+.||++|||+.++++|
T Consensus       244 ~li~~~l~~dp~~R~s~~ell~H  266 (270)
T d1t4ha_         244 EIIEGCIRQNKDERYSIKDLLNH  266 (270)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHHccCCHhHCcCHHHHhCC
Confidence            99999999999999999999875

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-51  Score=384.32  Aligned_cols=261  Identities=30%  Similarity=0.477  Sum_probs=216.8

Q ss_pred             CCCCCcccCcCCccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeE
Q 012684          143 REVPEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA  218 (458)
Q Consensus       143 ~~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~  218 (458)
                      .....|||+..  +|++.+.||+|+||.||.    ++..||||++..... .   .+.+.+|+.++++++||||++++++
T Consensus         3 ~~~~~wei~~~--~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~-~---~~~~~~E~~~l~~l~HpnIv~~~g~   76 (272)
T d1qpca_           3 WWEDEWEVPRE--TLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSM-S---PDAFLAEANLMKQLQHQRLVRLYAV   76 (272)
T ss_dssp             TTTCTTBCCGG--GEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSS-C---HHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCCCCeecCHH--HeEEeEEEecCCCcEEEEEEECCCCEEEEEEEccCcC-C---HHHHHHHHHHHHhCCCCCEeEEEee
Confidence            34567888654  677889999999999883    467899999975432 2   3568999999999999999999998


Q ss_pred             EEeCCceEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEee
Q 012684          219 VTQSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (458)
Q Consensus       219 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~D  296 (458)
                      +.+ +..++||||+++|+|.+++...  ..+++..+..++.|+++||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        77 ~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~D  152 (272)
T d1qpca_          77 VTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIAD  152 (272)
T ss_dssp             ECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECC
T ss_pred             ecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCccchhheeeecccceeecc
Confidence            754 5679999999999999977543  35999999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCC-CCCCCCCCcHHHHHHhcCCCCCC
Q 012684          297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCP-PFTMKHDNEVPKAYAARQRPPFK  375 (458)
Q Consensus       297 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~-pf~~~~~~~~~~~~~~~~~~~~~  375 (458)
                      ||+++..............||+.|+|||++.+..++.++|||||||++|||+||.. ||......+....+....++.. 
T Consensus       153 FGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~-  231 (272)
T d1qpca_         153 FGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-  231 (272)
T ss_dssp             CTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-
T ss_pred             ccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-
Confidence            99998775443334455678999999999998889999999999999999999655 5555554455555543334433 


Q ss_pred             CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       376 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                        +..+++++.+||.+||+.||++|||+.++++.|+.++++
T Consensus       232 --p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~fts  270 (272)
T d1qpca_         232 --PDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTA  270 (272)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             --cccChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhc
Confidence              456789999999999999999999999999999988754

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=9.1e-51  Score=386.07  Aligned_cols=253  Identities=30%  Similarity=0.524  Sum_probs=206.8

Q ss_pred             cccCceeeccceEEEEEE-----cC---eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RG---IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      +|++.+.||+|+||.||.     +|   ..||||.+...  ......+.+.+|+.++++++||||+++++++..++..++
T Consensus        27 ~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~i  104 (299)
T d1jpaa_          27 CVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMI  104 (299)
T ss_dssp             GEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEE
T ss_pred             hcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEE
Confidence            577788999999999973     22   35899988654  245566789999999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      |||||++|+|.+++... +.+++.++..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++.....
T Consensus       105 v~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~  181 (299)
T d1jpaa_         105 ITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD  181 (299)
T ss_dssp             EEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC---------
T ss_pred             EEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCC---CccCccccceEEECCCCcEEECCcccceEccCC
Confidence            99999999999988764 56999999999999999999999999   999999999999999999999999999876433


Q ss_pred             CCCC----cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhh
Q 012684          307 EDRP----LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLY  381 (458)
Q Consensus       307 ~~~~----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (458)
                      ....    .....+|+.|+|||.+.+..++.++|||||||++|||+| |+.||.+....++...+....+++.   +..+
T Consensus       182 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---~~~~  258 (299)
T d1jpaa_         182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRLPP---PMDC  258 (299)
T ss_dssp             --------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTC
T ss_pred             CCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---Cccc
Confidence            2211    123457899999999998899999999999999999998 8999998877777666655444443   4567


Q ss_pred             HHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          382 ARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       382 ~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ++.+.+||.+||+.||.+|||+.++++.|+++.+.
T Consensus       259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~  293 (299)
T d1jpaa_         259 PSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN  293 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhcC
Confidence            89999999999999999999999999999987644

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=2.3e-51  Score=387.85  Aligned_cols=259  Identities=28%  Similarity=0.469  Sum_probs=215.9

Q ss_pred             CCCCcccCcCCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeE
Q 012684          144 EVPEYEIDPHELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA  218 (458)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~  218 (458)
                      ....|||+..  +|++.+.||+|+||.||.     +|+.||||+++....    ..+.+.+|+.++++++||||++++++
T Consensus         8 ~~~~wei~~~--~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~   81 (287)
T d1opja_           8 NYDKWEMERT--DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGV   81 (287)
T ss_dssp             TCCTTBCCGG--GEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred             CCcccEecHH--HeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccc----hHHHHHHHHHHHHhCCCCCEecCCcc
Confidence            3346887765  577788999999998874     588999999975432    23568899999999999999999999


Q ss_pred             EEeCCceEEEEEccCCCCHHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEee
Q 012684          219 VTQSSPMMIVTEYLPKGDLRAFLKRK--GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVAD  296 (458)
Q Consensus       219 ~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~D  296 (458)
                      |.+++..++||||+++|+|.+++...  ..+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|
T Consensus        82 ~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~D  158 (287)
T d1opja_          82 CTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVAD  158 (287)
T ss_dssp             ECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECC
T ss_pred             EeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCC---cccCccccCeEEECCCCcEEEcc
Confidence            99999999999999999999999764  45899999999999999999999999   99999999999999999999999


Q ss_pred             cCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCCCcHHHHHHhcCCCCCC
Q 012684          297 FGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM-KHDNEVPKAYAARQRPPFK  375 (458)
Q Consensus       297 fg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~-~~~~~~~~~~~~~~~~~~~  375 (458)
                      ||++...............|++.|+|||++.+..++.++|||||||++|+|++|..||.. .+...+...+....+++. 
T Consensus       159 FG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~~~~~-  237 (287)
T d1opja_         159 FGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-  237 (287)
T ss_dssp             CCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC-
T ss_pred             ccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCCCCCC-
Confidence            999987654433333444578899999999998999999999999999999997666544 333333344433333333 


Q ss_pred             CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       376 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                        +..+++++.+||..||+.||++|||+.++++.|+.+.
T Consensus       238 --~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~  274 (287)
T d1opja_         238 --PEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMF  274 (287)
T ss_dssp             --CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             --CccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHH
Confidence              4567899999999999999999999999999888764

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-51  Score=383.23  Aligned_cols=248  Identities=26%  Similarity=0.422  Sum_probs=208.8

Q ss_pred             eeeccceEEEEEE-------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEccC
Q 012684          161 VEITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYLP  233 (458)
Q Consensus       161 ~~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~  233 (458)
                      ++||+|+||.||.       .++.||||+++.... +....+.+.+|+.++++++||||+++++++.. +..++||||++
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhC-CHHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCC
Confidence            5799999999974       246899999975543 34456779999999999999999999999865 46789999999


Q ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC--Cc
Q 012684          234 KGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR--PL  311 (458)
Q Consensus       234 ~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~--~~  311 (458)
                      +|+|.+++.+...+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||+++........  ..
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~  167 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQ  167 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC-
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC---cccCCCcchhhcccccCcccccchhhhhhccccccccccc
Confidence            9999999999888999999999999999999999999   999999999999999999999999999865433221  12


Q ss_pred             ccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          312 TCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      ....||+.|+|||.+.+..++.++|||||||++|||++ |+.||.+.+..++...+....+++.   +..+|+++.+||.
T Consensus       168 ~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~~~~li~  244 (277)
T d1xbba_         168 THGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC---PAGCPREMYDLMN  244 (277)
T ss_dssp             ---CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHH
T ss_pred             cccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC---CcccCHHHHHHHH
Confidence            34568999999999998899999999999999999998 8999998877766666655445544   4567899999999


Q ss_pred             HHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          391 ECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       391 ~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      +||+.||.+|||+.++.+.|+.....
T Consensus       245 ~cl~~dp~~RPs~~~i~~~L~~~~~~  270 (277)
T d1xbba_         245 LCWTYDVENRPGFAAVELRLRNYYYD  270 (277)
T ss_dssp             HHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence            99999999999999999988876543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.7e-51  Score=393.21  Aligned_cols=249  Identities=27%  Similarity=0.489  Sum_probs=208.2

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      ...+|++.+.||+|+||.||.     +|+.||+|+++...  .....+.+.+|+.+++.++||||++++++|.++..+|+
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~i   81 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI   81 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEE
Confidence            345788999999999999884     68999999997653  23345678899999999999999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHEN-KPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~-~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ||||++||+|.+++.+.+.+++..+..++.|++.||.|||++ +   |+||||||+|||++.+|.+||+|||+|......
T Consensus        82 VmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~  158 (322)
T d1s9ja_          82 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS  158 (322)
T ss_dssp             EEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCC---EEccccCHHHeeECCCCCEEEeeCCCccccCCC
Confidence            999999999999999888999999999999999999999974 8   999999999999999999999999999876432


Q ss_pred             CCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh------------------
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA------------------  368 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~------------------  368 (458)
                         ......||+.|+|||++.+..++.++||||+||++|+|++|+.||...+..+.......                  
T Consensus       159 ---~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  235 (322)
T d1s9ja_         159 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGR  235 (322)
T ss_dssp             ---TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------
T ss_pred             ---ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccc
Confidence               22345799999999999999999999999999999999999999987654322111000                  


Q ss_pred             ----------------------cCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          369 ----------------------RQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       369 ----------------------~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                            ....+.......+|+++.+||.+||..||.+|||+.++++|
T Consensus       236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H  298 (322)
T d1s9ja_         236 PLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH  298 (322)
T ss_dssp             ----------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhC
Confidence                                  00111111223467899999999999999999999999997

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=1.1e-50  Score=381.98  Aligned_cols=257  Identities=24%  Similarity=0.374  Sum_probs=216.0

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC----ce
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PM  225 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~----~~  225 (458)
                      .+|++.+.||+|+||.||.     +|+.||||+++.....+....+.+.+|+.+++.++||||+++++++....    ..
T Consensus         7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~   86 (277)
T d1o6ya_           7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLP   86 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEE
T ss_pred             ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceE
Confidence            3588999999999999984     68999999998777667777788999999999999999999999997654    37


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      |+||||++|++|.+++...+.+++.++..++.|++.||+|||++|   |+||||||+|||++.++.++++|||.+.....
T Consensus        87 ~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~  163 (277)
T d1o6ya_          87 YIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIARAIAD  163 (277)
T ss_dssp             EEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCEECC-
T ss_pred             EEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---ccCccccCcccccCccccceeehhhhhhhhcc
Confidence            999999999999999999889999999999999999999999999   99999999999999999999999999875533


Q ss_pred             CCC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          306 KED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       306 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      ...  .......||+.|+|||++.+..+++++|||||||++|+|+||++||...+..+...........+.......+|+
T Consensus       164 ~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  243 (277)
T d1o6ya_         164 SGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLSA  243 (277)
T ss_dssp             ---------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCCH
T ss_pred             ccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCCH
Confidence            222  223455789999999999999999999999999999999999999998776666655544443333334566889


Q ss_pred             HHHHHHHHHcccCCCCCC-CHHHHHHHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRP-TFRQIITRLESIN  414 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rp-s~~~ll~~L~~~~  414 (458)
                      ++.++|.+||+.||.+|| |++++++.|.++.
T Consensus       244 ~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~  275 (277)
T d1o6ya_         244 DLDAVVLKALAKNPENRYQTAAEMRADLVRVH  275 (277)
T ss_dssp             HHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHH
T ss_pred             HHHHHHHHHccCCHhHCHhHHHHHHHHHHHHh
Confidence            999999999999999999 8999999888764

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=7.9e-51  Score=394.13  Aligned_cols=246  Identities=22%  Similarity=0.381  Sum_probs=215.4

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.||.     +|+.||||++...   .....+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus        27 ~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE  103 (350)
T d1koaa2          27 HYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYE  103 (350)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCC---SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEccc---chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            689999999999999984     5899999999754   34456778999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC--CCCEEEeecCCccccccCC
Q 012684          231 YLPKGDLRAFLK-RKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD--SGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       231 ~~~~~~L~~~l~-~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~--~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||+||+|.+++. ..+.+++..+..++.||+.||.|||++|   |+||||||+|||++.  ++.+||+|||++..+... 
T Consensus       104 ~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~-  179 (350)
T d1koaa2         104 FMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-  179 (350)
T ss_dssp             CCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT-
T ss_pred             cCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcC---CeeeeechhHeeeccCCCCeEEEeecchheecccc-
Confidence            999999999985 4567999999999999999999999999   999999999999964  678999999999876432 


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+..............+++++++
T Consensus       180 -~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  258 (350)
T d1koaa2         180 -QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD  258 (350)
T ss_dssp             -SCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHH
T ss_pred             -cccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence             2334567899999999999999999999999999999999999999988777666666444433333445678999999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ||.+||+.||.+|||++++++|
T Consensus       259 li~~~L~~dP~~R~t~~eil~h  280 (350)
T d1koaa2         259 FIRKLLLADPNTRMTIHQALEH  280 (350)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHHS
T ss_pred             HHHHHccCChhHCcCHHHHhcC
Confidence            9999999999999999999987

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-51  Score=386.60  Aligned_cols=250  Identities=24%  Similarity=0.360  Sum_probs=215.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCC---HHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD---DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      .+|++.+.||+|+||.||.     +|+.||||++.......   ....+.+.+|+.++++++||||+++++++.+++.+|
T Consensus        10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~   89 (293)
T d1jksa_          10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVI   89 (293)
T ss_dssp             GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEE
T ss_pred             cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEE
Confidence            3689999999999999984     58999999997543322   123567899999999999999999999999999999


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC----CEEEeecCCccc
Q 012684          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG----NLKVADFGVSKL  302 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~----~vkl~Dfg~~~~  302 (458)
                      +|||||+||+|.+++.+.+.+++..+..++.|++.||+|||+.+   |+||||||+||+++.++    .+||+|||++..
T Consensus        90 iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~  166 (293)
T d1jksa_          90 LILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHK  166 (293)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             EEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcc---eeecccccceEEEecCCCcccceEecchhhhhh
Confidence            99999999999999998889999999999999999999999999   99999999999999776    599999999987


Q ss_pred             cccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhH
Q 012684          303 LTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA  382 (458)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (458)
                      ....  .......+|+.|+|||++.+..++.++||||+||++|+|++|+.||.+.+..+....+...........+..+|
T Consensus       167 ~~~~--~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  244 (293)
T d1jksa_         167 IDFG--NEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  244 (293)
T ss_dssp             CTTS--CBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             cCCC--ccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCCC
Confidence            6433  23344578999999999999899999999999999999999999999877666666554433332223345688


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +.+++||.+||+.||.+|||++++++|
T Consensus       245 ~~~~~li~~~L~~dP~~R~s~~eil~h  271 (293)
T d1jksa_         245 ALAKDFIRRLLVKDPKKRMTIQDSLQH  271 (293)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHhcC
Confidence            999999999999999999999999876

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-50  Score=380.43  Aligned_cols=254  Identities=24%  Similarity=0.420  Sum_probs=216.3

Q ss_pred             cccCce-eeccceEEEEEE-------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          156 DFTNSV-EITKGTFILAFW-------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       156 ~~~~~~-~lg~G~~~~v~~-------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      ++.+.. +||+|+||.||.       ++..||||+++..  ......+.+.+|+.++++++||||+++++++.. +.+|+
T Consensus         9 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           9 NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEE
T ss_pred             CeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEE
Confidence            455555 599999999874       3457999999754  345567789999999999999999999999865 46899


Q ss_pred             EEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ||||+++|+|.+++.. ++.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++..+...
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~  162 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGAD  162 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTTC
T ss_pred             EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCcCchhheeeccCCceeeccchhhhccccc
Confidence            9999999999999865 456999999999999999999999999   999999999999999999999999999876543


Q ss_pred             CC--CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          307 ED--RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       307 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      ..  .......||+.|+|||++.+..++.++|||||||++|||+| |+.||...+..++...+....+++.   +..+|+
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~  239 (285)
T d1u59a_         163 DSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC---PPECPP  239 (285)
T ss_dssp             SCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC---CTTCCH
T ss_pred             ccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC---CCcCCH
Confidence            22  22234568899999999998899999999999999999998 8999998887777766655445544   456889


Q ss_pred             HHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhh
Q 012684          384 GLKELIEECWNEKPAKRPTFRQIITRLESINNSIN  418 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~  418 (458)
                      ++.+||..||+.||++|||+.++.+.|+....++.
T Consensus       240 ~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~  274 (285)
T d1u59a_         240 ELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLA  274 (285)
T ss_dssp             HHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhh
Confidence            99999999999999999999999999988766544

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-50  Score=376.82  Aligned_cols=247  Identities=27%  Similarity=0.512  Sum_probs=216.1

Q ss_pred             cccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      +|+..+.||+|+||.||.    ++..||||+++.....    .+.+.+|+.++++++||||+++++++.+++.+++||||
T Consensus         5 ~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey   80 (258)
T d1k2pa_           5 DLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEY   80 (258)
T ss_dssp             CCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEEC
T ss_pred             HCEEeEEEecCCCeEEEEEEECCCCEEEEEEECcCcCC----HHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEc
Confidence            567778999999999984    5779999999865332    25688999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          232 LPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       232 ~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      +++|+|.+++.. ...+++..+++++.|+++||.|||+++   |+||||||+||+++.++.+||+|||++..........
T Consensus        81 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~  157 (258)
T d1k2pa_          81 MANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTS  157 (258)
T ss_dssp             CTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCC
T ss_pred             cCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC---cccccccceeEEEcCCCcEEECcchhheeccCCCcee
Confidence            999999999765 456899999999999999999999999   9999999999999999999999999998765554444


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      .....+|+.|+|||.+.+..++.++||||||+++|||+| |+.||...+..++...+....+++.   +...++++.+||
T Consensus       158 ~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li  234 (258)
T d1k2pa_         158 SVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVYTIM  234 (258)
T ss_dssp             CCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHH
T ss_pred             ecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC---cccccHHHHHHH
Confidence            455678999999999998899999999999999999998 8999999888777776654444443   456788999999


Q ss_pred             HHHcccCCCCCCCHHHHHHHHHH
Q 012684          390 EECWNEKPAKRPTFRQIITRLES  412 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~~ll~~L~~  412 (458)
                      .+||+.||.+|||+++++++|.+
T Consensus       235 ~~cl~~dP~~RPt~~eil~~L~d  257 (258)
T d1k2pa_         235 YSCWHEKADERPTFKILLSNILD  257 (258)
T ss_dssp             HHTTCSSGGGSCCHHHHHHHHHC
T ss_pred             HHHccCCHhHCcCHHHHHHHhhC
Confidence            99999999999999999999864

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-50  Score=390.96  Aligned_cols=246  Identities=25%  Similarity=0.404  Sum_probs=215.0

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.|+.     +|+.||||++.+.........+.+.+|+.++++++||||+++++++.++..+|+|||
T Consensus         6 dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~e   85 (337)
T d1o6la_           6 DFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVME   85 (337)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             hcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeecccccccccee
Confidence            588899999999999984     689999999975432223345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |++||+|.+++.+.+.+++..+..++.|++.||+|||++|   |+||||||+|||++.+|.+||+|||++...... ...
T Consensus        86 y~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~-~~~  161 (337)
T d1o6la_          86 YANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD-GAT  161 (337)
T ss_dssp             CCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCCT-TCC
T ss_pred             ccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC---ccccccCHHHeEecCCCCEEEeecccccccccC-Ccc
Confidence            9999999999999999999999999999999999999999   999999999999999999999999999865432 223


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..++...+.. ....+   +..+|+++++||.
T Consensus       162 ~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~-~~~~~---p~~~s~~~~dli~  237 (337)
T d1o6la_         162 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM-EEIRF---PRTLSPEAKSLLA  237 (337)
T ss_dssp             BCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH-CCCCC---CTTSCHHHHHHHH
T ss_pred             cccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc-CCCCC---CccCCHHHHHHHH
Confidence            3456789999999999999999999999999999999999999998877666665533 33333   4568899999999


Q ss_pred             HHcccCCCCCCC-----HHHHHHH
Q 012684          391 ECWNEKPAKRPT-----FRQIITR  409 (458)
Q Consensus       391 ~~l~~dp~~Rps-----~~~ll~~  409 (458)
                      +||++||.+||+     +.++++|
T Consensus       238 ~~L~~dP~~R~~~~~~~~~eil~H  261 (337)
T d1o6la_         238 GLLKKDPKQRLGGGPSDAKEVMEH  261 (337)
T ss_dssp             HHTCSSTTTSTTCSTTTHHHHHTS
T ss_pred             hhccCCchhhcccccccHHHHHcC
Confidence            999999999995     8888886

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-50  Score=378.91  Aligned_cols=259  Identities=25%  Similarity=0.482  Sum_probs=210.9

Q ss_pred             CcccCcCCccccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeE
Q 012684          147 EYEIDPHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGA  218 (458)
Q Consensus       147 ~~~~~~~~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~  218 (458)
                      +|||+..  +|++.+.||+|+||.||.        .+..||||.+...  ......+.+.+|+.++++++||||++++++
T Consensus         1 ~~ei~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~   76 (273)
T d1mp8a_           1 DYEIQRE--RIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGV   76 (273)
T ss_dssp             CCBCCGG--GEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEE
T ss_pred             CCCcCHH--HeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEE
Confidence            4666643  688889999999999873        2356899988643  355666789999999999999999999999


Q ss_pred             EEeCCceEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeec
Q 012684          219 VTQSSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (458)
Q Consensus       219 ~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Df  297 (458)
                      +. ++.+++||||+++|+|.+++.. .+.+++..+..++.|+++||.|||+++   ++||||||+||+++.++.+||+||
T Consensus        77 ~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~Df  152 (273)
T d1mp8a_          77 IT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDF  152 (273)
T ss_dssp             EC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC-
T ss_pred             Ee-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccC---eeccccchhheeecCCCcEEEccc
Confidence            86 4678999999999999998765 456999999999999999999999999   999999999999999999999999


Q ss_pred             CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCC
Q 012684          298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKA  376 (458)
Q Consensus       298 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~  376 (458)
                      |++...............||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..++...+....+++.  
T Consensus       153 G~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~--  230 (273)
T d1mp8a_         153 GLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPM--  230 (273)
T ss_dssp             ------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC--
T ss_pred             hhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC--
Confidence            9998765444444455668999999999998899999999999999999998 8999999888888777755555543  


Q ss_pred             ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       377 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                       +..+|+.+.+||.+||+.||.+|||+.+++++|+++.+.
T Consensus       231 -~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  269 (273)
T d1mp8a_         231 -PPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE  269 (273)
T ss_dssp             -CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             -CCCCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHH
Confidence             456889999999999999999999999999999988655

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=2e-50  Score=391.59  Aligned_cols=246  Identities=18%  Similarity=0.349  Sum_probs=214.8

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.||.     +|+.||||++...   .....+.+.+|+.++++++||||++++++|.+++.+|+|||
T Consensus        30 ~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE  106 (352)
T d1koba_          30 YYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILE  106 (352)
T ss_dssp             TEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---SHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCc---chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEE
Confidence            589999999999999984     6899999999754   23445678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEec--CCCCEEEeecCCccccccCC
Q 012684          231 YLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRD--DSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       231 ~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~--~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||+||+|.+++... .++++.++..++.||+.||.|||++|   |+||||||+|||++  .++.+||+|||++..+... 
T Consensus       107 ~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~-  182 (352)
T d1koba_         107 FLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD-  182 (352)
T ss_dssp             CCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT-
T ss_pred             cCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccccccccccccCCCeEEEeecccceecCCC-
Confidence            99999999887654 46999999999999999999999999   99999999999998  6789999999999876532 


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                       .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+...........+..+++++.+
T Consensus       183 -~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  261 (352)
T d1koba_         183 -EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD  261 (352)
T ss_dssp             -SCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHH
T ss_pred             -CceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHH
Confidence             2334457899999999999999999999999999999999999999987776666666444433333445678999999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ||.+||+.||.+|||+.++++|
T Consensus       262 li~~~L~~dp~~R~s~~eil~H  283 (352)
T d1koba_         262 FIKNLLQKEPRKRLTVHDALEH  283 (352)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHTS
T ss_pred             HHHHHccCChhHCcCHHHHhcC
Confidence            9999999999999999999987

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.6e-50  Score=384.22  Aligned_cols=245  Identities=16%  Similarity=0.293  Sum_probs=211.8

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.||.     +|+.||||+++...    .....+.+|+.+|+.++||||+++++++.+++.+|+|||
T Consensus         6 rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE   81 (321)
T d1tkia_           6 KYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFE   81 (321)
T ss_dssp             TEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEEC
T ss_pred             ceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEe
Confidence            588999999999999984     68899999997542    233568899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCC--CCEEEeecCCccccccCC
Q 012684          231 YLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDS--GNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~--~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||+||+|.+++.+.+ .+++.++..++.||+.||+|||++|   |+||||||+|||++.+  +.+||+|||++...... 
T Consensus        82 ~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~-  157 (321)
T d1tkia_          82 FISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG-  157 (321)
T ss_dssp             CCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT-
T ss_pred             cCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC---CCcccccccceeecCCCceEEEEcccchhhccccC-
Confidence            999999999998765 6999999999999999999999999   9999999999999854  48999999999865432 


Q ss_pred             CCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKE  387 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  387 (458)
                       .......+|+.|+|||.+.+..++.++|||||||++|+|++|+.||...+..+....+...........++.+|+++++
T Consensus       158 -~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  236 (321)
T d1tkia_         158 -DNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMD  236 (321)
T ss_dssp             -CEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHH
T ss_pred             -CcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHH
Confidence             2233456789999999999999999999999999999999999999988777766666444333222334568899999


Q ss_pred             HHHHHcccCCCCCCCHHHHHHH
Q 012684          388 LIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       388 li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ||.+||..||.+|||+.++++|
T Consensus       237 li~~~L~~dp~~R~s~~eil~h  258 (321)
T d1tkia_         237 FVDRLLVKERKSRMTASEALQH  258 (321)
T ss_dssp             HHHTTSCSSGGGSCCHHHHHHS
T ss_pred             HHHHHccCChhHCcCHHHHhcC
Confidence            9999999999999999999987

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=1.7e-49  Score=372.79  Aligned_cols=250  Identities=24%  Similarity=0.352  Sum_probs=215.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCC------HHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeC
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISD------DDRVRAFRDELALLQKIR-HPNVVQFLGAVTQS  222 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~------~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~  222 (458)
                      .+|++.+.||+|+||.|+.     +|+.||||++.......      ....+.+.+|+.++++++ ||||+++++++.++
T Consensus         3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~   82 (277)
T d1phka_           3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN   82 (277)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred             ccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccC
Confidence            3688899999999999984     78999999997654322      223346788999999996 99999999999999


Q ss_pred             CceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          223 SPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       223 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      +.+|+||||++||+|.+++...+.+++.++..++.||++||+|||++|   |+||||||+||+++.++.+||+|||++..
T Consensus        83 ~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG~a~~  159 (277)
T d1phka_          83 TFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFGFSCQ  159 (277)
T ss_dssp             SEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             cceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcC---CcccccccceEEEcCCCCeEEccchheeE
Confidence            999999999999999999999899999999999999999999999999   99999999999999999999999999987


Q ss_pred             cccCCCCCcccCCCCCcccCCcccCC------CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCC
Q 012684          303 LTVKEDRPLTCQDTSCRYVAPEVFKN------EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA  376 (458)
Q Consensus       303 ~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~  376 (458)
                      ....  .......||+.|+|||.+.+      ..++.++||||+||++|+|++|+.||...+.......+..........
T Consensus       160 ~~~~--~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~  237 (277)
T d1phka_         160 LDPG--EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSP  237 (277)
T ss_dssp             CCTT--CCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTT
T ss_pred             ccCC--CceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCc
Confidence            6542  23345678999999998753      356889999999999999999999999887666666554444333334


Q ss_pred             ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          377 PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       377 ~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      ...++|+++++||.+||+.||++|||+.++++|
T Consensus       238 ~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h  270 (277)
T d1phka_         238 EWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH  270 (277)
T ss_dssp             TGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred             ccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            556899999999999999999999999999876

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=4.4e-50  Score=383.90  Aligned_cols=243  Identities=24%  Similarity=0.456  Sum_probs=213.0

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.||.     +|+.||||++...........+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus         5 dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE   84 (316)
T d1fota_           5 DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMD   84 (316)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEEC
T ss_pred             HeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEee
Confidence            588899999999999874     589999999975432223345678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |++||+|..++.....+++..+..++.|++.||+|||++|   |+||||||+|||++.+|.+||+|||++......    
T Consensus        85 ~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~----  157 (316)
T d1fota_          85 YIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV----  157 (316)
T ss_dssp             CCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC----
T ss_pred             ecCCccccccccccccccccHHHHHHHHHHHhhhhhccCc---EEccccCchheeEcCCCCEEEecCccceEeccc----
Confidence            9999999999999889999999999999999999999999   999999999999999999999999999876432    


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+... ...+   +..++++++++|.
T Consensus       158 ~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~s~~~~~li~  233 (316)
T d1fota_         158 TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNA-ELRF---PPFFNEDVKDLLS  233 (316)
T ss_dssp             BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHC-CCCC---CTTSCHHHHHHHH
T ss_pred             cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcC-CCCC---CCCCCHHHHHHHH
Confidence            23467999999999999999999999999999999999999999987766666655333 2222   3467899999999


Q ss_pred             HHcccCCCCCC-----CHHHHHHH
Q 012684          391 ECWNEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       391 ~~l~~dp~~Rp-----s~~~ll~~  409 (458)
                      +||..||.+|+     |++++++|
T Consensus       234 ~~L~~dp~~R~~~~r~t~~~il~H  257 (316)
T d1fota_         234 RLITRDLSQRLGNLQNGTEDVKNH  257 (316)
T ss_dssp             HHTCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHhhhCHHhccccchhhHHHHHcC
Confidence            99999999996     89999987

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-50  Score=384.63  Aligned_cols=255  Identities=26%  Similarity=0.443  Sum_probs=210.1

Q ss_pred             CcccCcCCccccCceeeccceEEEEEE---c--C-----eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceee
Q 012684          147 EYEIDPHELDFTNSVEITKGTFILAFW---R--G-----IQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQF  215 (458)
Q Consensus       147 ~~~~~~~~~~~~~~~~lg~G~~~~v~~---~--g-----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~  215 (458)
                      .||++..  +|++.+.||+|+||.||.   .  +     ..||+|.+....  .......+.+|+.++.++ +||||+++
T Consensus        31 kwei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l  106 (325)
T d1rjba_          31 KWEFPRE--NLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNL  106 (325)
T ss_dssp             GGBCCGG--GEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHH--HeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEE
Confidence            3555443  577889999999999974   1  1     369999987542  233446788999999988 89999999


Q ss_pred             eeEEEeCCceEEEEEccCCCCHHHHHHhc-----------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 012684          216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRK-----------------------GALKPSTAVRFALDIARGMNYLHENKPV  272 (458)
Q Consensus       216 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----------------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~  272 (458)
                      ++++.+.+.+++|||||++|+|.+++...                       +.+++..++.++.|++.||+|||+++  
T Consensus       107 ~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~--  184 (325)
T d1rjba_         107 LGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS--  184 (325)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT--
T ss_pred             EEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC--
Confidence            99999999999999999999999999754                       24788999999999999999999999  


Q ss_pred             CeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-C
Q 012684          273 PIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-G  350 (458)
Q Consensus       273 ~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g  350 (458)
                       |+||||||+|||++.++.+||+|||+++......... .....||+.|+|||++.+..++.++|||||||++|+|+| |
T Consensus       185 -IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g  263 (325)
T d1rjba_         185 -CVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLG  263 (325)
T ss_dssp             -EEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTS
T ss_pred             -eeeccCchhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCC
Confidence             9999999999999999999999999998765433222 233457999999999999899999999999999999998 8


Q ss_pred             CCCCCCCCCCcHHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHH
Q 012684          351 CPPFTMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLE  411 (458)
Q Consensus       351 ~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~  411 (458)
                      +.||.+.+.......+.... +++.   +..+++++.+||.+||+.||++|||+++|+++|.
T Consensus       264 ~~Pf~~~~~~~~~~~~~~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~  322 (325)
T d1rjba_         264 VNPYPGIPVDANFYKLIQNGFKMDQ---PFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  322 (325)
T ss_dssp             CCSSTTCCCSHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             CCCCCCCCHHHHHHHHHhcCCCCCC---CCcCCHHHHHHHHHHcCCChhHCcCHHHHHHHHh
Confidence            99999877766555544443 3332   4567899999999999999999999999999985

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.3e-49  Score=370.39  Aligned_cols=258  Identities=29%  Similarity=0.499  Sum_probs=207.2

Q ss_pred             ccCcCCccccCceeeccceEEEEEE---c--C----eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEE
Q 012684          149 EIDPHELDFTNSVEITKGTFILAFW---R--G----IQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV  219 (458)
Q Consensus       149 ~~~~~~~~~~~~~~lg~G~~~~v~~---~--g----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~  219 (458)
                      ||++.  .|+..+.||+|+||.||.   .  +    ..||||.+....  .......+.+|+.++++++||||+++++++
T Consensus         3 ei~~~--~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~   78 (283)
T d1mqba_           3 EIHPS--CVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVI   78 (283)
T ss_dssp             BCCTT--TEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred             cCCHH--HeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEE
Confidence            45554  367788999999999873   2  1    479999997543  445566789999999999999999999999


Q ss_pred             EeCCceEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecC
Q 012684          220 TQSSPMMIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (458)
Q Consensus       220 ~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg  298 (458)
                      .+....++||||+.++++.+++... +.+++.++..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||
T Consensus        79 ~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG  155 (283)
T d1mqba_          79 SKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFG  155 (283)
T ss_dssp             CSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCC
T ss_pred             ecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccc---cccCccccceEEECCCCeEEEcccc
Confidence            9999999999999999999988764 56999999999999999999999999   9999999999999999999999999


Q ss_pred             CccccccCCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCC-CCCCCCCcHHHHHHhcCCCCCC
Q 012684          299 VSKLLTVKEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFK  375 (458)
Q Consensus       299 ~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p-f~~~~~~~~~~~~~~~~~~~~~  375 (458)
                      +++........  ......||+.|+|||++.+..++.++|||||||++|||++|..| |...+..++...+....+++. 
T Consensus       156 la~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~-  234 (283)
T d1mqba_         156 LSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLPT-  234 (283)
T ss_dssp             C-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-
T ss_pred             hhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCCCC-
Confidence            99876433222  22344679999999999999999999999999999999996555 454444455555544444443 


Q ss_pred             CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       376 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                        +..+++.+.+||.+||+.||++|||+.++++.|+.+...
T Consensus       235 --~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~~  273 (283)
T d1mqba_         235 --PMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIRA  273 (283)
T ss_dssp             --CTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred             --chhhHHHHHHHHHHHCcCCHhHCcCHHHHHHHHHHHhhC
Confidence              455788999999999999999999999999999887654

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=370.21  Aligned_cols=252  Identities=30%  Similarity=0.552  Sum_probs=210.2

Q ss_pred             cccCcCCccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe-CC
Q 012684          148 YEIDPHELDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ-SS  223 (458)
Q Consensus       148 ~~~~~~~~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~-~~  223 (458)
                      |+|+..+  |++.+.||+|+||.||   ++|+.||||+++...     ..+.+.+|+.++++++||||+++++++.+ ++
T Consensus         2 w~i~~~~--~~~~~~lG~G~fg~Vy~~~~~~~~vAvK~i~~~~-----~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~   74 (262)
T d1byga_           2 WALNMKE--LKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDA-----TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKG   74 (262)
T ss_dssp             CBCCGGG--EEEEEEEEECSSCEEEEEEETTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--
T ss_pred             CccCHHH--eEEeEEEecCCCeEEEEEEECCeEEEEEEECcHH-----HHHHHHHHHHHHHhCCCCCEeeEEEEEEecCC
Confidence            6777664  5567899999999887   689999999997532     23578899999999999999999999854 46


Q ss_pred             ceEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                      .+++||||+++|+|.+++...+  .+++..++.++.|++.||.|||+.+   |+||||||+|||++.++.+||+|||++.
T Consensus        75 ~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~  151 (262)
T d1byga_          75 GLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTK  151 (262)
T ss_dssp             CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC--
T ss_pred             cEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCc---eeccccchHhheecCCCCEeecccccce
Confidence            6899999999999999997643  4899999999999999999999999   9999999999999999999999999998


Q ss_pred             ccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhh
Q 012684          302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKL  380 (458)
Q Consensus       302 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (458)
                      .....    .....+|+.|+|||.+.+..+++++||||||+++|||+| |++||...+..++...+....+++.   +..
T Consensus       152 ~~~~~----~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~~---~~~  224 (262)
T d1byga_         152 EASST----QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDA---PDG  224 (262)
T ss_dssp             --------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCCC---CTT
T ss_pred             ecCCC----CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---Ccc
Confidence            65432    233457889999999988899999999999999999998 7899998888887777755555554   345


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          381 YARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      +++++.+||.+||+.||.+|||+.+++++|+++.+.
T Consensus       225 ~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~~  260 (262)
T d1byga_         225 CPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH  260 (262)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHhC
Confidence            778999999999999999999999999999998653

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.4e-49  Score=385.64  Aligned_cols=243  Identities=24%  Similarity=0.410  Sum_probs=212.2

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.||.     +|+.||||++...........+.+.+|+.+++.++||||+++++++......++|||
T Consensus        42 ~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e  121 (350)
T d1rdqe_          42 QFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVME  121 (350)
T ss_dssp             GEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccc
Confidence            688999999999999984     689999999865332223335678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      |+.||+|.+++.+.+.+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||++..+...    
T Consensus       122 ~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~----  194 (350)
T d1rdqe_         122 YVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR----  194 (350)
T ss_dssp             CCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC----
T ss_pred             cccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCcCCHHHcccCCCCCEEeeeceeeeecccc----
Confidence            9999999999999889999999999999999999999999   999999999999999999999999999876432    


Q ss_pred             cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHH
Q 012684          311 LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIE  390 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~  390 (458)
                      .....||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+... .+.+   +..+++++.+||.
T Consensus       195 ~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~-~~~~---p~~~s~~~~~li~  270 (350)
T d1rdqe_         195 TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSG-KVRF---PSHFSSDLKDLLR  270 (350)
T ss_dssp             BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHC-CCCC---CTTCCHHHHHHHH
T ss_pred             cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcC-CCCC---CccCCHHHHHHHH
Confidence            23456899999999999999999999999999999999999999887665555555333 2222   3568899999999


Q ss_pred             HHcccCCCCCC-----CHHHHHHH
Q 012684          391 ECWNEKPAKRP-----TFRQIITR  409 (458)
Q Consensus       391 ~~l~~dp~~Rp-----s~~~ll~~  409 (458)
                      +||+.||.+|+     |++++++|
T Consensus       271 ~~L~~dP~kR~~~~r~t~~ell~H  294 (350)
T d1rdqe_         271 NLLQVDLTKRFGNLKNGVNDIKNH  294 (350)
T ss_dssp             HHSCSCTTTCTTSSTTTTHHHHTS
T ss_pred             HHhhhCHHhccccccccHHHHHcC
Confidence            99999999994     89999886

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.8e-49  Score=383.85  Aligned_cols=247  Identities=22%  Similarity=0.349  Sum_probs=206.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCC---CHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVIS---DDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~---~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~l  227 (458)
                      +|++.+.||+|+||.||.     +|+.||||++......   ..........|+.+++.++||||+++++++..++.+|+
T Consensus         5 dy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~i   84 (364)
T d1omwa3           5 DFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSF   84 (364)
T ss_dssp             TEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEE
T ss_pred             hCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEE
Confidence            588889999999999983     6899999998643221   11222223345778888899999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCC
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKE  307 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~  307 (458)
                      ||||++||+|.+++.+.+.+++..+..++.||+.||.|||+++   |+||||||+|||++.+|.+||+|||++...... 
T Consensus        85 vmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-  160 (364)
T d1omwa3          85 ILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  160 (364)
T ss_dssp             EECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred             EEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCC---ccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence            9999999999999999889999999999999999999999999   999999999999999999999999999876433 


Q ss_pred             CCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHH
Q 012684          308 DRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLK  386 (458)
Q Consensus       308 ~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~  386 (458)
                        ......||+.|+|||++.+ ..++.++|||||||++|+|++|+.||................. .....+..++++++
T Consensus       161 --~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~~~  237 (364)
T d1omwa3         161 --KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT-MAVELPDSFSPELR  237 (364)
T ss_dssp             --CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHHSSS-CCCCCCSSSCHHHH
T ss_pred             --cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccc-CCCCCCCCCCHHHH
Confidence              2334579999999999864 5689999999999999999999999998766655443322222 22233456899999


Q ss_pred             HHHHHHcccCCCCCCC-----HHHHHHH
Q 012684          387 ELIEECWNEKPAKRPT-----FRQIITR  409 (458)
Q Consensus       387 ~li~~~l~~dp~~Rps-----~~~ll~~  409 (458)
                      +||.+||+.||.+|||     ++++++|
T Consensus       238 ~li~~~L~~dP~~R~t~~~~~a~eil~H  265 (364)
T d1omwa3         238 SLLEGLLQRDVNRRLGCLGRGAQEVKES  265 (364)
T ss_dssp             HHHHHHTCSSTTTSTTTSSSTHHHHHTS
T ss_pred             HHHHHHcccCHHHhCCCcccCHHHHHcC
Confidence            9999999999999999     7999886

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-49  Score=371.84  Aligned_cols=258  Identities=31%  Similarity=0.489  Sum_probs=208.3

Q ss_pred             CCcccCcCCccccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe
Q 012684          146 PEYEIDPHELDFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ  221 (458)
Q Consensus       146 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~  221 (458)
                      ..|+|+..  +|++.+.||+|+||.||.    ++..||||++..... .   .+.+.+|+.++++++||||+++++++.+
T Consensus        10 ~~~~i~~~--~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~-~---~~~~~~E~~~l~~l~h~nIv~~~g~~~~   83 (285)
T d1fmka3          10 DAWEIPRE--SLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTM-S---PEAFLQEAQVMKKLRHEKLVQLYAVVSE   83 (285)
T ss_dssp             TCSBCCGG--GEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSS-C---HHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cceEcCHH--HEEEeeEEeeCCCeEEEEEEECCCCEEEEEEECcccC-C---HHHHHHHHHHHHhcccCCEeEEEEEEec
Confidence            46777654  688899999999999874    456899999975432 2   3568899999999999999999999854


Q ss_pred             CCceEEEEEccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCC
Q 012684          222 SSPMMIVTEYLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (458)
Q Consensus       222 ~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~  299 (458)
                       +..++||||+++|+|..++..  .+.+++.+++.++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||+
T Consensus        84 -~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGl  159 (285)
T d1fmka3          84 -EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGL  159 (285)
T ss_dssp             -SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCT
T ss_pred             -CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh---eecccccceEEEECCCCcEEEcccch
Confidence             568999999999999988864  456999999999999999999999999   99999999999999999999999999


Q ss_pred             ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCC-CCCCCCCcHHHHHHhcCCCCCCCCh
Q 012684          300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPP-FTMKHDNEVPKAYAARQRPPFKAPA  378 (458)
Q Consensus       300 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~p-f~~~~~~~~~~~~~~~~~~~~~~~~  378 (458)
                      ++..............+|+.|+|||++.+..++.++||||||+++|+|++|..| |......+....+....+++.   +
T Consensus       160 a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~---~  236 (285)
T d1fmka3         160 ARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC---P  236 (285)
T ss_dssp             TC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC---C
T ss_pred             hhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC---C
Confidence            987654444444456789999999999999999999999999999999996555 455544445555544444443   4


Q ss_pred             hhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          379 KLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       379 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      ..+++++.+||.+||+.||++|||++++++.|+.....
T Consensus       237 ~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~  274 (285)
T d1fmka3         237 PECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS  274 (285)
T ss_dssp             TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred             cccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcC
Confidence            56789999999999999999999999999988886644

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.4e-49  Score=379.48  Aligned_cols=246  Identities=29%  Similarity=0.456  Sum_probs=209.6

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHH-hcCCCCcceeeeeEEEeCCceEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALL-QKIRHPNVVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hp~i~~~~~~~~~~~~~~lv~  229 (458)
                      +|.+.+.||+|+||.||.     +|+.||||++...........+.+..|..++ +.++||||+++++++.+++.+|+||
T Consensus         3 dy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivm   82 (320)
T d1xjda_           3 DFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVM   82 (320)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             CeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEE
Confidence            588889999999999984     6899999999753221222234555666665 4689999999999999999999999


Q ss_pred             EccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCC
Q 012684          230 EYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR  309 (458)
Q Consensus       230 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~  309 (458)
                      ||++||+|.+++...+.+++.++..++.||+.||+|||+++   |+||||||+|||++.++.+||+|||++...... ..
T Consensus        83 Ey~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~-~~  158 (320)
T d1xjda_          83 EYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENMLG-DA  158 (320)
T ss_dssp             ECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT-TC
T ss_pred             eecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCcccceeecCCCceeccccchhhhcccc-cc
Confidence            99999999999999889999999999999999999999999   999999999999999999999999999865433 23


Q ss_pred             CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHH
Q 012684          310 PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELI  389 (458)
Q Consensus       310 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li  389 (458)
                      ......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+....+. ...+.+   +..+|+++.+||
T Consensus       159 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~-~~~~~~---p~~~s~~~~dli  234 (320)
T d1xjda_         159 KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-MDNPFY---PRWLEKEAKDLL  234 (320)
T ss_dssp             CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH-HCCCCC---CTTSCHHHHHHH
T ss_pred             cccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH-cCCCCC---CccCCHHHHHHH
Confidence            3345678999999999999999999999999999999999999999877766666653 333333   456789999999


Q ss_pred             HHHcccCCCCCCCHH-HHHHH
Q 012684          390 EECWNEKPAKRPTFR-QIITR  409 (458)
Q Consensus       390 ~~~l~~dp~~Rps~~-~ll~~  409 (458)
                      .+||+.||.+|||+. ++++|
T Consensus       235 ~~~L~~dP~~R~s~~~~l~~h  255 (320)
T d1xjda_         235 VKLFVREPEKRLGVRGDIRQH  255 (320)
T ss_dssp             HHHSCSSGGGSBTTBSCGGGS
T ss_pred             HHhcccCCCCCcCHHHHHHhC
Confidence            999999999999995 77764

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-48  Score=370.02  Aligned_cols=261  Identities=27%  Similarity=0.458  Sum_probs=205.5

Q ss_pred             CCCcccCcCCccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcce
Q 012684          145 VPEYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVV  213 (458)
Q Consensus       145 ~~~~~~~~~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~  213 (458)
                      ...|+|+.  .+|++.+.||+|+||.||.          +++.||||++....  .....+.+..|...+.++ +||||+
T Consensus         5 ~~~wei~~--~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv   80 (299)
T d1ywna1           5 ASKWEFPR--DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVV   80 (299)
T ss_dssp             HHHHBCCG--GGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBC
T ss_pred             CccccccH--HHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEE
Confidence            34566654  3688889999999999974          24689999997542  344556677788777776 689999


Q ss_pred             eeeeEEEeC-CceEEEEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeee
Q 012684          214 QFLGAVTQS-SPMMIVTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIH  276 (458)
Q Consensus       214 ~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H  276 (458)
                      ++++++... ..+++|||||++|+|.+++...                ..+++.++..++.|++.||+|||+++   |+|
T Consensus        81 ~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivH  157 (299)
T d1ywna1          81 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIH  157 (299)
T ss_dssp             CEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCC
T ss_pred             EeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCC---CcC
Confidence            999998654 5689999999999999999753                23789999999999999999999999   999


Q ss_pred             CCCCCCCEEecCCCCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcC-CCCC
Q 012684          277 RDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPF  354 (458)
Q Consensus       277 ~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg-~~pf  354 (458)
                      |||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|+|++| ..||
T Consensus       158 rDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~  237 (299)
T d1ywna1         158 RDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPY  237 (299)
T ss_dssp             SCCCGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSS
T ss_pred             CcCCccceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCC
Confidence            999999999999999999999999865443322 23455789999999999999999999999999999999986 5688


Q ss_pred             CCCCCCcHHHHHHhcC-CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          355 TMKHDNEVPKAYAARQ-RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       355 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      ......+........+ ++..   +..+++++.++|.+||+.||.+|||+.+++++|+++.+
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq  296 (299)
T d1ywna1         238 PGVKIDEEFCRRLKEGTRMRA---PDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ  296 (299)
T ss_dssp             TTCCCSHHHHHHHHHTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCHHHHHHHHHhcCCCCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHh
Confidence            8776655544443333 4433   45678899999999999999999999999999998854

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-48  Score=366.71  Aligned_cols=262  Identities=29%  Similarity=0.539  Sum_probs=216.6

Q ss_pred             CCCCcccCcCCccccCceeeccceEEEEEE------------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCC
Q 012684          144 EVPEYEIDPHELDFTNSVEITKGTFILAFW------------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHP  210 (458)
Q Consensus       144 ~~~~~~~~~~~~~~~~~~~lg~G~~~~v~~------------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp  210 (458)
                      ..+.|+|+..  +|++.+.||+|+||.||.            ++..||||++....  .......+.+|...+.++ +||
T Consensus         4 ~~~~~~i~~~--~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~e~~~l~~~~~Hp   79 (299)
T d1fgka_           4 EDPRWELPRD--RLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHK   79 (299)
T ss_dssp             CCTTTBCCGG--GEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTC--CHHHHHHHHHHHHHHHHHCCCT
T ss_pred             cCCcCcccHH--HeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECccc--ChHHHHHHHHHHHHHHHhcCCC
Confidence            3456777655  677789999999998874            12479999997653  445567788898888888 799


Q ss_pred             cceeeeeEEEeCCceEEEEEccCCCCHHHHHHhcC----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 012684          211 NVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKG----------------ALKPSTAVRFALDIARGMNYLHENKPVPI  274 (458)
Q Consensus       211 ~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i  274 (458)
                      ||++++++|.+++.+++||||+++|+|.+++....                .+++.+++.++.|++.||+|||+.+   |
T Consensus        80 nIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---i  156 (299)
T d1fgka_          80 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---C  156 (299)
T ss_dssp             TBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---C
T ss_pred             eEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCC---E
Confidence            99999999999999999999999999999997542                4899999999999999999999999   9


Q ss_pred             eeCCCCCCCEEecCCCCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCC
Q 012684          275 IHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCP  352 (458)
Q Consensus       275 ~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~  352 (458)
                      +||||||+|||++.++.+||+|||++......... ......+|+.|+|||.+.++.++.++||||||+++|+|++ |..
T Consensus       157 vHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~  236 (299)
T d1fgka_         157 IHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS  236 (299)
T ss_dssp             CCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCC
T ss_pred             EeeeecccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCC
Confidence            99999999999999999999999999876544322 2344568899999999999999999999999999999998 788


Q ss_pred             CCCCCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          353 PFTMKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       353 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      ||.+.+..++...+....+++.   +..+++++.+||.+||+.||.+|||+.++++.|+++..
T Consensus       237 p~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~a  296 (299)
T d1fgka_         237 PYPGVPVEELFKLLKEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIVA  296 (299)
T ss_dssp             SSTTCCHHHHHHHHHTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCCCCHHHHHHHHHcCCCCCC---CccchHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHhh
Confidence            9988777666666544434443   45678999999999999999999999999999988753

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-48  Score=366.70  Aligned_cols=253  Identities=26%  Similarity=0.473  Sum_probs=203.0

Q ss_pred             ccccCceeeccceEEEEEE---c-----CeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceE
Q 012684          155 LDFTNSVEITKGTFILAFW---R-----GIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMM  226 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~---~-----g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~  226 (458)
                      .+|++.+.||+|+||.||.   .     +..||||++...........+.+.+|+.++++++||||+++++++.+ ...+
T Consensus         8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~   86 (273)
T d1u46a_           8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK   86 (273)
T ss_dssp             GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred             HHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchh
Confidence            4588889999999998873   1     24799999987665566677889999999999999999999999965 4678


Q ss_pred             EEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          227 IVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      +||||+++++|.+++.. .+.+++..+..++.|++.||.|||+++   |+||||||+||+++.++.+||+|||++.....
T Consensus        87 lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~  163 (273)
T d1u46a_          87 MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  163 (273)
T ss_dssp             EEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             eeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC---EeeeeecHHHhccccccceeeccchhhhhccc
Confidence            99999999999988765 456999999999999999999999999   99999999999999999999999999987643


Q ss_pred             CCCC--CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhH
Q 012684          306 KEDR--PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA  382 (458)
Q Consensus       306 ~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (458)
                      ....  ......+|+.|+|||.+.+..++.++||||||+++|||+| |+.||.+.+..+....+......+  +.+..+|
T Consensus       164 ~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~--~~~~~~~  241 (273)
T d1u46a_         164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERL--PRPEDCP  241 (273)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--CCCTTCC
T ss_pred             CCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCC--CCccccc
Confidence            3221  1234457889999999999999999999999999999998 899999887777766664444221  2345688


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHHHHHH
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITRLESI  413 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~  413 (458)
                      +.+.+||.+||+.||++|||+.+|++.|++.
T Consensus       242 ~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~  272 (273)
T d1u46a_         242 QDIYNVMVQCWAHKPEDRPTFVALRDFLLEA  272 (273)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHHHHHhc
Confidence            9999999999999999999999999988764

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.2e-48  Score=368.55  Aligned_cols=252  Identities=29%  Similarity=0.458  Sum_probs=214.5

Q ss_pred             ccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCc
Q 012684          155 LDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSP  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~  224 (458)
                      .+|++.+.||+|+||.||.          +++.||||++...  ......+.+.+|+.++++++||||+++++++.....
T Consensus        13 ~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~   90 (301)
T d1lufa_          13 NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKP   90 (301)
T ss_dssp             GGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSS
T ss_pred             HHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh--cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCc
Confidence            3688889999999999983          2478999999754  345566789999999999999999999999999999


Q ss_pred             eEEEEEccCCCCHHHHHHhcC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCC
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG------------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLE  280 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~------------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dik  280 (458)
                      .+++|||+++|+|.+++....                        .+++..+..++.|++.||+|||+.+   ++|||||
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---ivHrDlK  167 (301)
T d1lufa_          91 MCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FVHRDLA  167 (301)
T ss_dssp             CEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCS
T ss_pred             eEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCC---eEeeEEc
Confidence            999999999999999996532                        3788899999999999999999999   9999999


Q ss_pred             CCCEEecCCCCEEEeecCCccccccCCC-CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCC-CCCCCCC
Q 012684          281 PSNILRDDSGNLKVADFGVSKLLTVKED-RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC-PPFTMKH  358 (458)
Q Consensus       281 p~Nil~~~~~~vkl~Dfg~~~~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~-~pf~~~~  358 (458)
                      |+|||++.++.+||+|||++........ .......+++.|+|||.+.+..++.++|||||||++|||++|. .||...+
T Consensus       168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~  247 (301)
T d1lufa_         168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA  247 (301)
T ss_dssp             GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred             ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence            9999999999999999999976543322 2223456789999999999999999999999999999999985 6788877


Q ss_pred             CCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHH
Q 012684          359 DNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESIN  414 (458)
Q Consensus       359 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~  414 (458)
                      ..++...+.....++.   +..+++++.+||..||+.||++|||+.+|++.|+++.
T Consensus       248 ~~e~~~~v~~~~~~~~---p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~  300 (301)
T d1lufa_         248 HEEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMC  300 (301)
T ss_dssp             HHHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTT
T ss_pred             HHHHHHHHHcCCCCCC---CccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhc
Confidence            7777766655444443   4567889999999999999999999999999999864

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-48  Score=368.88  Aligned_cols=252  Identities=24%  Similarity=0.489  Sum_probs=209.1

Q ss_pred             ccccCceeeccceEEEEEE-----cCe----EEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCce
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGI----QVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPM  225 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~  225 (458)
                      .+|++.+.||+|+||.||.     +|+    .||+|.+....  .....+.+.+|+.++++++||||++++++|.++ ..
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~   85 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV   85 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-Ce
Confidence            3588899999999999973     233    68999886432  233456789999999999999999999999864 56


Q ss_pred             EEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRK-GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      +++||++.+++|.+++... ..+++..++.++.|++.||+|||+++   |+||||||+|||++.++.+||+|||++....
T Consensus        86 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~  162 (317)
T d1xkka_          86 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG  162 (317)
T ss_dssp             EEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred             eEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcC---cccCcchhhcceeCCCCCeEeeccccceecc
Confidence            8889999999999888764 56999999999999999999999999   9999999999999999999999999998765


Q ss_pred             cCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhH
Q 012684          305 VKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYA  382 (458)
Q Consensus       305 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  382 (458)
                      ...... .....||+.|+|||++.+..++.++|||||||++|||+| |..||...+..++...+....+++.   +..++
T Consensus       163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~---p~~~~  239 (317)
T d1xkka_         163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPICT  239 (317)
T ss_dssp             TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC---CTTBC
T ss_pred             cccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CcccC
Confidence            433222 234468999999999999899999999999999999998 8999998888777776655555544   45678


Q ss_pred             HHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          383 RGLKELIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       383 ~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      +.+.+||.+||+.||.+|||+.+++++|+.+..
T Consensus       240 ~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~  272 (317)
T d1xkka_         240 IDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR  272 (317)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCChhhCcCHHHHHHHHHHHHh
Confidence            999999999999999999999999999988754

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-47  Score=363.96  Aligned_cols=265  Identities=27%  Similarity=0.466  Sum_probs=213.4

Q ss_pred             cccCcCCccccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEE
Q 012684          148 YEIDPHELDFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAV  219 (458)
Q Consensus       148 ~~~~~~~~~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~  219 (458)
                      ..+....+.+...+.||+|+||.||.        +...||||.+...  ......+.+.+|+.++++++||||+++++++
T Consensus        20 ~~~~~~~~~~~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~   97 (311)
T d1r0pa_          20 VVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGIC   97 (311)
T ss_dssp             GBCCGGGEEEEEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEE
T ss_pred             eEeChHHceeccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEE
Confidence            33444444444467899999999983        1236999999643  4566678899999999999999999999998


Q ss_pred             Ee-CCceEEEEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeec
Q 012684          220 TQ-SSPMMIVTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (458)
Q Consensus       220 ~~-~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Df  297 (458)
                      .. ++..++||||+++++|.+++.... .+++..++.++.|++.||.|||+.+   |+||||||+|||+++++.+||+||
T Consensus        98 ~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DF  174 (311)
T d1r0pa_          98 LRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADF  174 (311)
T ss_dssp             EETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSS
T ss_pred             EecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccC---cccCCccHHhEeECCCCCEEEecc
Confidence            75 467899999999999999988544 4778889999999999999999999   999999999999999999999999


Q ss_pred             CCccccccCCCC---CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCC-CCCCcHHHHHHhcCCCC
Q 012684          298 GVSKLLTVKEDR---PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTM-KHDNEVPKAYAARQRPP  373 (458)
Q Consensus       298 g~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~-~~~~~~~~~~~~~~~~~  373 (458)
                      |++.........   ......||+.|+|||.+.+..++.++||||||+++|||++|..||.. .+..+....+....++.
T Consensus       175 G~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~  254 (311)
T d1r0pa_         175 GLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL  254 (311)
T ss_dssp             GGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCC
T ss_pred             cchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            999876543222   22335689999999999988999999999999999999997777654 34444555554444444


Q ss_pred             CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhcc
Q 012684          374 FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHK  420 (458)
Q Consensus       374 ~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~  420 (458)
                      .   +..+++.+.+||.+||+.||++|||+.+++++|+++.++....
T Consensus       255 ~---p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~~~~~~  298 (311)
T d1r0pa_         255 Q---PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGE  298 (311)
T ss_dssp             C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHTCCSC
T ss_pred             C---cccCcHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHhhhhh
Confidence            3   4567889999999999999999999999999999998765443

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=369.13  Aligned_cols=241  Identities=27%  Similarity=0.414  Sum_probs=197.9

Q ss_pred             cccCce-eeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhc-CCCCcceeeeeEEEe----CCc
Q 012684          156 DFTNSV-EITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQK-IRHPNVVQFLGAVTQ----SSP  224 (458)
Q Consensus       156 ~~~~~~-~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~-l~hp~i~~~~~~~~~----~~~  224 (458)
                      +|.+.. .||+|+||.||.     +|+.||||++...        ..+.+|+.++.+ .+||||++++++|.+    +..
T Consensus        12 ~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~   83 (335)
T d2ozaa1          12 DYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRKC   83 (335)
T ss_dssp             TEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEE
T ss_pred             CEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCE
Confidence            677654 599999999984     6899999998632        356779988655 489999999999875    466


Q ss_pred             eEEEEEccCCCCHHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC---CCCEEEeecCC
Q 012684          225 MMIVTEYLPKGDLRAFLKRKG--ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGV  299 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~---~~~vkl~Dfg~  299 (458)
                      +|+|||||+||+|.+++.+.+  .+++.++..++.|++.||+|||+.|   |+||||||+|||++.   .+.+||+|||+
T Consensus        84 ~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~  160 (335)
T d2ozaa1          84 LLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF  160 (335)
T ss_dssp             EEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred             EEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcC---Cccccccccccccccccccccccccccce
Confidence            899999999999999998753  5999999999999999999999999   999999999999985   56799999999


Q ss_pred             ccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc---CCCCCC-
Q 012684          300 SKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---QRPPFK-  375 (458)
Q Consensus       300 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~---~~~~~~-  375 (458)
                      +......  .......||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+.......+...   ....++ 
T Consensus       161 a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~  238 (335)
T d2ozaa1         161 AKETTSH--NSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPN  238 (335)
T ss_dssp             CEECCCC--CCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCT
T ss_pred             eeeccCC--CccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence            9876543  2334567999999999999999999999999999999999999999887665544433222   122222 


Q ss_pred             CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       376 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      .....+|+++.+||.+||+.||.+|||+.++++|
T Consensus       239 ~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h  272 (335)
T d2ozaa1         239 PEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH  272 (335)
T ss_dssp             THHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             cccccCCHHHHHHHHHHccCChhHCcCHHHHHcC
Confidence            2345688999999999999999999999999987

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-48  Score=366.85  Aligned_cols=246  Identities=28%  Similarity=0.393  Sum_probs=198.0

Q ss_pred             ceeeccceEEEEEE-----cCeEEEEEEcCCCCCCC--HHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEcc
Q 012684          160 SVEITKGTFILAFW-----RGIQVAVKKLGEEVISD--DDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEYL  232 (458)
Q Consensus       160 ~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~--~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~  232 (458)
                      .+.||+|+||.||.     +|+.||||+++......  ....+.+.+|+.++++++||||+++++++..++.+|+||||+
T Consensus         3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~   82 (299)
T d1ua2a_           3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM   82 (299)
T ss_dssp             EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred             ceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhh
Confidence            36799999999984     68999999997543321  122346889999999999999999999999999999999999


Q ss_pred             CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCcc
Q 012684          233 PKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPLT  312 (458)
Q Consensus       233 ~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~~  312 (458)
                      .++++..+....+.+++..+..++.||+.||+|||++|   |+||||||+|||++.++.+||+|||++....... ....
T Consensus        83 ~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~-~~~~  158 (299)
T d1ua2a_          83 ETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN-RAYT  158 (299)
T ss_dssp             SEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC-CCCC
T ss_pred             cchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccc---eecccCCcceEEecCCCccccccCccccccCCCc-cccc
Confidence            88877777666777999999999999999999999999   9999999999999999999999999998765432 2333


Q ss_pred             cCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-CCC-----------------
Q 012684          313 CQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-RPP-----------------  373 (458)
Q Consensus       313 ~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~~~-----------------  373 (458)
                      ...||+.|+|||++.+. .++.++|||||||++|+|++|..||...+..+....+.... .+.                 
T Consensus       159 ~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ua2a_         159 HQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFK  238 (299)
T ss_dssp             CSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCC
T ss_pred             ceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhc
Confidence            45789999999998654 57899999999999999999999998876655444432211 110                 


Q ss_pred             -CCC-----ChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 -FKA-----PAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 -~~~-----~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                       .+.     ..+.+++++.+||.+||+.||++|||++++++|
T Consensus       239 ~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H  280 (299)
T d1ua2a_         239 SFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM  280 (299)
T ss_dssp             CCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred             cCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence             000     012457899999999999999999999999876

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-47  Score=364.78  Aligned_cols=251  Identities=31%  Similarity=0.529  Sum_probs=207.2

Q ss_pred             cccCceeeccceEEEEEE-----cCe--EEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceeeeeEEEeCCceEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGI--QVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~~~~~~~~~~~~l  227 (458)
                      +|++.+.||+|+||.||.     +|.  .||||.+....  ..+..+.+.+|+.+++++ +||||+++++++.+++..++
T Consensus        11 ~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~i   88 (309)
T d1fvra_          11 DIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL   88 (309)
T ss_dssp             GCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECccc--ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEE
Confidence            456678999999999873     343  57888875332  334456789999999999 79999999999999999999


Q ss_pred             EEEccCCCCHHHHHHhc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCC
Q 012684          228 VTEYLPKGDLRAFLKRK----------------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGN  291 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~----------------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~  291 (458)
                      ||||+++|+|.+++...                ..+++..+..++.|++.||.|||+.+   |+||||||+|||++.++.
T Consensus        89 V~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~  165 (309)
T d1fvra_          89 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYV  165 (309)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGC
T ss_pred             EEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCC---ccccccccceEEEcCCCc
Confidence            99999999999999753                46899999999999999999999999   999999999999999999


Q ss_pred             EEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCC-CCCCCCCCCcHHHHHHhcC
Q 012684          292 LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGC-PPFTMKHDNEVPKAYAARQ  370 (458)
Q Consensus       292 vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~-~pf~~~~~~~~~~~~~~~~  370 (458)
                      +||+|||++.......  ......||+.|+|||.+.+..++.++||||||+++|+|++|. +||...+..++...+....
T Consensus       166 ~kl~DfG~a~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~  243 (309)
T d1fvra_         166 AKIADFGLSRGQEVYV--KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY  243 (309)
T ss_dssp             EEECCTTCEESSCEEC--CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTC
T ss_pred             eEEccccccccccccc--cccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcC
Confidence            9999999997654332  223446889999999999999999999999999999999965 5787777666666554444


Q ss_pred             CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          371 RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       371 ~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                      +++.   +..+++++++||.+||+.||++|||+++++++|+++.+.
T Consensus       244 ~~~~---~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~~  286 (309)
T d1fvra_         244 RLEK---PLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLEE  286 (309)
T ss_dssp             CCCC---CTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHS
T ss_pred             CCCC---CccCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHHhc
Confidence            4443   456789999999999999999999999999999998653

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8e-47  Score=361.21  Aligned_cols=260  Identities=28%  Similarity=0.455  Sum_probs=217.5

Q ss_pred             CcccCcCCccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC-CCCcceee
Q 012684          147 EYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI-RHPNVVQF  215 (458)
Q Consensus       147 ~~~~~~~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hp~i~~~  215 (458)
                      .|+++..  +|++.+.||+|+||.||.          +++.||||++....  .......+.+|+.+++.+ +||||+++
T Consensus        17 ~~~~~~~--~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~   92 (311)
T d1t46a_          17 KWEFPRN--RLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNL   92 (311)
T ss_dssp             GGBCCGG--GEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCE
T ss_pred             cccCCHH--HeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEE
Confidence            5776654  677788999999999984          34689999997543  455566789999999999 69999999


Q ss_pred             eeEEEeCCceEEEEEccCCCCHHHHHHhcC------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeC
Q 012684          216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRKG------------------ALKPSTAVRFALDIARGMNYLHENKPVPIIHR  277 (458)
Q Consensus       216 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~  277 (458)
                      ++++.++...++|||||++|+|.+++.+..                  .+++..+..++.||+.||+|||+++   ++||
T Consensus        93 ~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHr  169 (311)
T d1t46a_          93 LGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHR  169 (311)
T ss_dssp             EEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCS
T ss_pred             EEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeec
Confidence            999999999999999999999999997543                  4889999999999999999999999   9999


Q ss_pred             CCCCCCEEecCCCCEEEeecCCccccccCCCC-CcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHc-CCCCCC
Q 012684          278 DLEPSNILRDDSGNLKVADFGVSKLLTVKEDR-PLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIE-GCPPFT  355 (458)
Q Consensus       278 Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~llt-g~~pf~  355 (458)
                      ||||+||+++.++.++++|||++......... ......||+.|+|||.+.+..++.++|||||||++|+|+| |.+||.
T Consensus       170 DLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~  249 (311)
T d1t46a_         170 DLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYP  249 (311)
T ss_dssp             CCSGGGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred             ccccccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCC
Confidence            99999999999999999999999876543222 2234567999999999998899999999999999999998 666676


Q ss_pred             CCCCCcHHHHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          356 MKHDNEVPKAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       356 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      .....+....+...+..+.  .+..+++.+.+||.+||+.||.+|||+.++++.|++...
T Consensus       250 ~~~~~~~~~~~i~~~~~~~--~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i~  307 (311)
T d1t46a_         250 GMPVDSKFYKMIKEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQIS  307 (311)
T ss_dssp             TCCSSHHHHHHHHHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHHHHHHHHHhcCCCCC--CcccccHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhhc
Confidence            7666665555544443222  235678999999999999999999999999999987643

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-47  Score=360.96  Aligned_cols=260  Identities=26%  Similarity=0.444  Sum_probs=220.0

Q ss_pred             CCcccCcCCccccCceeeccceEEEEEE----------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceee
Q 012684          146 PEYEIDPHELDFTNSVEITKGTFILAFW----------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQF  215 (458)
Q Consensus       146 ~~~~~~~~~~~~~~~~~lg~G~~~~v~~----------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~  215 (458)
                      ..|||++.  +|+..+.||+|+||.||.          +++.||||+++..  ........+.+|+.++++++||||+++
T Consensus        13 ~~~ei~~~--~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~~l~h~nIv~~   88 (308)
T d1p4oa_          13 DEWEVARE--KITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMKEFNCHHVVRL   88 (308)
T ss_dssp             CTTBCCGG--GEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGGGCCCTTBCCE
T ss_pred             cceeecHH--HeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHHHcCCCCEeee
Confidence            46888864  667889999999999873          2578999999754  345556678999999999999999999


Q ss_pred             eeEEEeCCceEEEEEccCCCCHHHHHHhc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEE
Q 012684          216 LGAVTQSSPMMIVTEYLPKGDLRAFLKRK----------GALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNIL  285 (458)
Q Consensus       216 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil  285 (458)
                      ++++..+...++||||+++|+|.+++...          ..+++..+..++.|++.||.|||+++   |+||||||+|||
T Consensus        89 ~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiL  165 (308)
T d1p4oa_          89 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCM  165 (308)
T ss_dssp             EEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEE
T ss_pred             eeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeeceEcCCcee
Confidence            99999999999999999999999998642          23688899999999999999999999   999999999999


Q ss_pred             ecCCCCEEEeecCCccccccCCCCC-cccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcC-CCCCCCCCCCcHH
Q 012684          286 RDDSGNLKVADFGVSKLLTVKEDRP-LTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEG-CPPFTMKHDNEVP  363 (458)
Q Consensus       286 ~~~~~~vkl~Dfg~~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg-~~pf~~~~~~~~~  363 (458)
                      ++.++.+||+|||++.......... .....+|+.|+|||.+.+..++.++||||||+++|+|+|| ..||...+..+..
T Consensus       166 ld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~  245 (308)
T d1p4oa_         166 VAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL  245 (308)
T ss_dssp             ECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHH
T ss_pred             ecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            9999999999999998664432222 2334578999999999999999999999999999999998 5788887777777


Q ss_pred             HHHHhcCCCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHh
Q 012684          364 KAYAARQRPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINN  415 (458)
Q Consensus       364 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~  415 (458)
                      ..+....+++.   +..+++.+.++|.+||+.||.+|||+.++++.|++..+
T Consensus       246 ~~i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~  294 (308)
T d1p4oa_         246 RFVMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME  294 (308)
T ss_dssp             HHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred             HHHHhCCCCCC---cccchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcC
Confidence            66655444443   45678899999999999999999999999999877643

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-47  Score=358.36  Aligned_cols=240  Identities=27%  Similarity=0.416  Sum_probs=200.2

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCH---HHHHHHHHHHHHHhcCC--CCcceeeeeEEEeCC
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDD---DRVRAFRDELALLQKIR--HPNVVQFLGAVTQSS  223 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~---~~~~~~~~E~~~l~~l~--hp~i~~~~~~~~~~~  223 (458)
                      +.+|++.+.||+|+||.||.     +|+.||||++........   .....+.+|+.++++++  ||||+++++++.+++
T Consensus         3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~   82 (273)
T d1xwsa_           3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD   82 (273)
T ss_dssp             TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred             CCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCC
Confidence            45799999999999999984     689999999975433221   11233567999999986  899999999999999


Q ss_pred             ceEEEEEccCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC-CCCEEEeecCCcc
Q 012684          224 PMMIVTEYLPK-GDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-SGNLKVADFGVSK  301 (458)
Q Consensus       224 ~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~-~~~vkl~Dfg~~~  301 (458)
                      ..++||||+.+ +++.+++.+.+.+++.++..++.|++.||+|||+++   |+||||||+|||++. .+.+||+|||++.
T Consensus        83 ~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG~a~  159 (273)
T d1xwsa_          83 SFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFGSGA  159 (273)
T ss_dssp             EEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             eEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC---CccccCcccceEEecCCCeEEECccccce
Confidence            99999999975 688899988889999999999999999999999999   999999999999985 4789999999997


Q ss_pred             ccccCCCCCcccCCCCCcccCCcccCCCCC-CCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhh
Q 012684          302 LLTVKEDRPLTCQDTSCRYVAPEVFKNEEY-DTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKL  380 (458)
Q Consensus       302 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (458)
                      ....   .......||+.|+|||++.+..+ +.++|||||||++|+|++|+.||....      .+ ......+   +..
T Consensus       160 ~~~~---~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i-~~~~~~~---~~~  226 (273)
T d1xwsa_         160 LLKD---TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EI-IRGQVFF---RQR  226 (273)
T ss_dssp             ECCS---SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HH-HHCCCCC---SSC
T ss_pred             eccc---ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HH-hhcccCC---CCC
Confidence            6532   23345679999999999987665 567899999999999999999997531      22 1222222   345


Q ss_pred             hHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          381 YARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       381 ~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                      +|+++++||.+||+.||.+|||++++++|
T Consensus       227 ~s~~~~~li~~~L~~dp~~R~s~~eil~h  255 (273)
T d1xwsa_         227 VSSECQHLIRWCLALRPSDRPTFEEIQNH  255 (273)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHTS
T ss_pred             CCHHHHHHHHHHccCCHhHCcCHHHHhcC
Confidence            78999999999999999999999999886

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-46  Score=358.26  Aligned_cols=248  Identities=24%  Similarity=0.447  Sum_probs=198.2

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.|+.     +|+.||||++..... .....+.+.+|+.++++++||||+++++++.+++.+|+|||
T Consensus         3 ~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e   81 (298)
T d1gz8a_           3 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE   81 (298)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred             CCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEe
Confidence            688889999999999984     589999999975432 22335678899999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCC
Q 012684          231 YLPKGDLRAFLKR--KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKED  308 (458)
Q Consensus       231 ~~~~~~L~~~l~~--~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~  308 (458)
                      |+.+ ++.+++..  .+.+++..+..++.|++.||+|||++|   |+||||||+|||++.++.+||+|||++...... .
T Consensus        82 ~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~-~  156 (298)
T d1gz8a_          82 FLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVP-V  156 (298)
T ss_dssp             CCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCC-S
T ss_pred             ecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCC---EEccccCchheeecccCcceeccCCcceeccCC-c
Confidence            9965 55555543  355999999999999999999999999   999999999999999999999999999876433 2


Q ss_pred             CCcccCCCCCcccCCcccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-CCCC-------------
Q 012684          309 RPLTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRPP-------------  373 (458)
Q Consensus       309 ~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~~~~-------------  373 (458)
                      .......||+.|+|||++.... ++.++||||+||++|+|++|+.||...+..+....+... +.+.             
T Consensus       157 ~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  236 (298)
T d1gz8a_         157 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDY  236 (298)
T ss_dssp             BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTC
T ss_pred             ccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccc
Confidence            2334457899999999876655 578999999999999999999999876544433332111 1100             


Q ss_pred             ---CC--------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          374 ---FK--------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       374 ---~~--------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                         .+        .....+++++.+||.+||..||++|||+.++++|
T Consensus       237 ~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H  283 (298)
T d1gz8a_         237 KPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH  283 (298)
T ss_dssp             CTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             ccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCC
Confidence               00        0112456889999999999999999999999987

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.1e-46  Score=354.39  Aligned_cols=249  Identities=26%  Similarity=0.449  Sum_probs=202.1

Q ss_pred             cccCceeeccceEEEEEE----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEEc
Q 012684          156 DFTNSVEITKGTFILAFW----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTEY  231 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~  231 (458)
                      +|++.+.||+|+||.||.    +|+.||||++..... .....+.+.+|+.++++++||||+++++++..++..+++||+
T Consensus         3 ~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~   81 (286)
T d1ob3a_           3 KYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH   81 (286)
T ss_dssp             SEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred             CceeccEEecCCCcEEEEEEeCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEe
Confidence            688899999999999984    578999999976532 233346788999999999999999999999999999999999


Q ss_pred             cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCCc
Q 012684          232 LPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRPL  311 (458)
Q Consensus       232 ~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~~  311 (458)
                      +.++.+..+....+.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||.+....... ...
T Consensus        82 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~-~~~  157 (286)
T d1ob3a_          82 LDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPV-RKY  157 (286)
T ss_dssp             CSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             ehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCc---EEecCCCCceeeEcCCCCEEecccccceecccCc-ccc
Confidence            988777777777788999999999999999999999999   9999999999999999999999999998764332 223


Q ss_pred             ccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-CCC-----------------
Q 012684          312 TCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-QRP-----------------  372 (458)
Q Consensus       312 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~~~-----------------  372 (458)
                      ....+++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+..+....+... +.+                 
T Consensus       158 ~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  237 (286)
T d1ob3a_         158 THEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN  237 (286)
T ss_dssp             ----CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT
T ss_pred             ceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc
Confidence            344688999999998764 5689999999999999999999999876654443332111 110                 


Q ss_pred             -------CCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 -------PFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 -------~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                             +.......+++.+.+||++||+.||++|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~H  281 (286)
T d1ob3a_         238 FTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEH  281 (286)
T ss_dssp             CCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             cccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                   0011123467899999999999999999999999875

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-46  Score=354.68  Aligned_cols=251  Identities=26%  Similarity=0.400  Sum_probs=197.9

Q ss_pred             CCccccCceeeccceEEEEEE------cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcC---CCCcceeeeeEEEe--
Q 012684          153 HELDFTNSVEITKGTFILAFW------RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKI---RHPNVVQFLGAVTQ--  221 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~------~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hp~i~~~~~~~~~--  221 (458)
                      .+.+|++.+.||+|+||.||.      +++.||||++....... .....+.+|+.+++.+   +||||++++++|..  
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~   83 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSR   83 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEE
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccc
Confidence            345899999999999999984      35789999986543221 1122345677666655   79999999999853  


Q ss_pred             ---CCceEEEEEccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeec
Q 012684          222 ---SSPMMIVTEYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADF  297 (458)
Q Consensus       222 ---~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Df  297 (458)
                         ....+++||+++++.+...... ...+++..+..++.|++.||+|||+++   |+||||||+|||++..+.+||+||
T Consensus        84 ~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~df  160 (305)
T d1blxa_          84 TDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADF  160 (305)
T ss_dssp             CSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECSC
T ss_pred             cccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecCCCccEEEEcCCCCeeecch
Confidence               3468999999987766544433 345899999999999999999999999   999999999999999999999999


Q ss_pred             CCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-C-----
Q 012684          298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R-----  371 (458)
Q Consensus       298 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~-----  371 (458)
                      |++......  .......||+.|+|||++.+.+++.++||||+||++|+|++|+.||.+.+..+....+.... .     
T Consensus       161 g~~~~~~~~--~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  238 (305)
T d1blxa_         161 GLARIYSFQ--MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEED  238 (305)
T ss_dssp             CSCCCCCGG--GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGG
T ss_pred             hhhhhhccc--ccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhc
Confidence            998765332  23345679999999999999999999999999999999999999998876555444432211 0     


Q ss_pred             -----------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 -----------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 -----------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                       .+.......+++.+.+||.+||+.||.+|||+.++++|
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H  293 (305)
T d1blxa_         239 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH  293 (305)
T ss_dssp             SCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             ccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                             01111234567899999999999999999999999987

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-46  Score=358.72  Aligned_cols=251  Identities=23%  Similarity=0.353  Sum_probs=210.3

Q ss_pred             cccCceeeccceEEEEEE--------cCeEEEEEEcCCCCCC-CHHHHHHHHHHHHHHhcCCC-CcceeeeeEEEeCCce
Q 012684          156 DFTNSVEITKGTFILAFW--------RGIQVAVKKLGEEVIS-DDDRVRAFRDELALLQKIRH-PNVVQFLGAVTQSSPM  225 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~--------~g~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~h-p~i~~~~~~~~~~~~~  225 (458)
                      +|++.+.||+|+||.||.        +|+.||||+++..... .....+.+.+|+.++++++| |||+++++++.+....
T Consensus        25 ~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~  104 (322)
T d1vzoa_          25 NFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKL  104 (322)
T ss_dssp             GEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEE
T ss_pred             ceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCce
Confidence            588999999999999984        4789999998754321 12223457789999999965 8999999999999999


Q ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccccc
Q 012684          226 MIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTV  305 (458)
Q Consensus       226 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~  305 (458)
                      +++|||+.+|+|.+++...+.+++..+..++.|++.||+|||+.+   |+||||||+|||++.++.+||+|||++..+..
T Consensus       105 ~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~  181 (322)
T d1vzoa_         105 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKEFVA  181 (322)
T ss_dssp             EEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEEEECCG
T ss_pred             eeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCC---EEeccCCccceeecCCCCEEEeeccchhhhcc
Confidence            999999999999999999889999999999999999999999999   99999999999999999999999999987654


Q ss_pred             CCCCCcccCCCCCcccCCcccCCC--CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCCChhhhHH
Q 012684          306 KEDRPLTCQDTSCRYVAPEVFKNE--EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKAPAKLYAR  383 (458)
Q Consensus       306 ~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  383 (458)
                      ..........|++.|+|||.+.+.  .++.++|||||||+||+|++|+.||...........+........+..+..+++
T Consensus       182 ~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  261 (322)
T d1vzoa_         182 DETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSA  261 (322)
T ss_dssp             GGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCH
T ss_pred             cccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCH
Confidence            444444456789999999998764  467899999999999999999999988877766555544332222223457899


Q ss_pred             HHHHHHHHHcccCCCCCCC-----HHHHHHH
Q 012684          384 GLKELIEECWNEKPAKRPT-----FRQIITR  409 (458)
Q Consensus       384 ~l~~li~~~l~~dp~~Rps-----~~~ll~~  409 (458)
                      ++.+||.+||+.||.+|||     ++|+++|
T Consensus       262 ~~~~li~~~l~~dP~~R~s~~~~t~~eil~H  292 (322)
T d1vzoa_         262 LAKDLIQRLLMKDPKKRLGCGPRDADEIKEH  292 (322)
T ss_dssp             HHHHHHHHHTCSSGGGSTTSSTTTHHHHHTS
T ss_pred             HHHHHHHHHcccCHHHcCCCCcccHHHHHcC
Confidence            9999999999999999994     7888765

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-45  Score=347.80  Aligned_cols=254  Identities=26%  Similarity=0.432  Sum_probs=196.6

Q ss_pred             ccccCceeeccceEEEEE---EcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC----ceEE
Q 012684          155 LDFTNSVEITKGTFILAF---WRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMMI  227 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~---~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~----~~~l  227 (458)
                      .+|...+.||+|+||.||   ++|+.||||++...    .......+.|+..+.+++||||+++++++..++    .+|+
T Consensus         3 ~~~~l~~~iG~G~fg~Vy~~~~~g~~vAvK~~~~~----~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           3 RTIVLQESIGKGRFGEVWRGKWRGEEVAVKIFSSR----EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGEEEEEEEECCSSSEEEEEEETTEEEEEEEECGG----GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred             cEEEEEEEEeeCCCeEEEEEEECCEEEEEEEECcc----chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEE
Confidence            356778899999999886   68999999998643    222222344666667789999999999997654    5799


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCCCCeeeCCCCCCCEEecCCCCEEEeecCC
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHE--------NKPVPIIHRDLEPSNILRDDSGNLKVADFGV  299 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~--------~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~  299 (458)
                      ||||+++|+|.+++++. .+++..++.++.|++.||.|||+        ++   |+||||||+|||++.++.+||+|||+
T Consensus        79 v~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~---IvHrDlKp~NILl~~~~~~Kl~DFGl  154 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNRY-TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPA---IAHRDLKSKNILVKKNGTCCIADLGL  154 (303)
T ss_dssp             EEECCTTCBHHHHHHHC-CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCE---EECSCCCGGGEEECTTSCEEECCCTT
T ss_pred             EEecccCCCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCC---eeccccCccceEEcCCCCeEEEecCc
Confidence            99999999999999874 58999999999999999999997        46   99999999999999999999999999


Q ss_pred             ccccccCCC---CCcccCCCCCcccCCcccCCCC------CCCchhHHHHHHHHHHHHcCCCCCCCCCCCc---------
Q 012684          300 SKLLTVKED---RPLTCQDTSCRYVAPEVFKNEE------YDTKVDVFSFALILQEMIEGCPPFTMKHDNE---------  361 (458)
Q Consensus       300 ~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~------~~~~~DiwslG~~l~~lltg~~pf~~~~~~~---------  361 (458)
                      +........   .......||+.|+|||++.+..      ++.++|||||||++|||+||+.||.......         
T Consensus       155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~  234 (303)
T d1vjya_         155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPS  234 (303)
T ss_dssp             CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCS
T ss_pred             cccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccc
Confidence            987654322   1234567899999999987642      5668999999999999999988875322211         


Q ss_pred             ------HHHHHHhcC-CCCCCCC--hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhh
Q 012684          362 ------VPKAYAARQ-RPPFKAP--AKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNS  416 (458)
Q Consensus       362 ------~~~~~~~~~-~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~  416 (458)
                            ......... +++++..  .......+.+|+.+||+.||.+|||+.++++.|+++...
T Consensus       235 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~~  298 (303)
T d1vjya_         235 DPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQQ  298 (303)
T ss_dssp             SCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHHHHHHHHh
Confidence                  111111111 3333322  223446799999999999999999999999999988754

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.8e-44  Score=341.89  Aligned_cols=259  Identities=17%  Similarity=0.243  Sum_probs=212.6

Q ss_pred             CccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEE
Q 012684          154 ELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMI  227 (458)
Q Consensus       154 ~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~l  227 (458)
                      ..+|++.+.||+|+||.||.     +|+.||||++......     ..+.+|++.++.+. |+|++.+++++..+...++
T Consensus         4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~   78 (293)
T d1csna_           4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL   78 (293)
T ss_dssp             TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred             CCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCc-----HHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEE
Confidence            35799999999999999984     6899999998654321     24677889999996 4899999999999999999


Q ss_pred             EEEccCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC-----CCCEEEeecCCcc
Q 012684          228 VTEYLPKGDLRAFLKRKG-ALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD-----SGNLKVADFGVSK  301 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~-----~~~vkl~Dfg~~~  301 (458)
                      ||||+ +++|.+++...+ .++..++..++.|++.||+|||+.|   |+||||||+|||++.     .+.++|+|||++.
T Consensus        79 vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~  154 (293)
T d1csna_          79 VIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK  154 (293)
T ss_dssp             EEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred             EEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCC---ceeccCCccceeecCcccccCCceEEcccceeE
Confidence            99999 789999987654 5999999999999999999999999   999999999999974     5789999999998


Q ss_pred             ccccCCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHh----cCC
Q 012684          302 LLTVKED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAA----RQR  371 (458)
Q Consensus       302 ~~~~~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~----~~~  371 (458)
                      .......      .......||+.|+|||++.+..+++++|||||||++|+|++|+.||..............    ...
T Consensus       155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~  234 (293)
T d1csna_         155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQS  234 (293)
T ss_dssp             ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHH
T ss_pred             EcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCC
Confidence            7643321      122445799999999999999999999999999999999999999987766544332211    112


Q ss_pred             CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhhhccc
Q 012684          372 PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSINHKR  421 (458)
Q Consensus       372 ~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~~~~~  421 (458)
                      .+....+..+|+++.+++..|+..+|++||+++.+.+.|+++.+..+.+.
T Consensus       235 ~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~~~~~  284 (293)
T d1csna_         235 TPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERLNTTE  284 (293)
T ss_dssp             SCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHTTCCS
T ss_pred             CChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHcCCCC
Confidence            22222335678899999999999999999999999999998876655443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-44  Score=350.26  Aligned_cols=245  Identities=25%  Similarity=0.364  Sum_probs=197.4

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC------
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS------  223 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~------  223 (458)
                      .+|++.+.||+|+||.|+.     +|+.||||++.... ......+.+.+|+.+|+.++||||++++++|...+      
T Consensus        18 ~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~   96 (346)
T d1cm8a_          18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFT   96 (346)
T ss_dssp             SSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCC
T ss_pred             CcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccc
Confidence            4799999999999999984     58999999998654 35566678899999999999999999999997654      


Q ss_pred             ceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcccc
Q 012684          224 PMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLL  303 (458)
Q Consensus       224 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~  303 (458)
                      .+|+||||+ +.+|..+.+. +.+++..+..++.|++.||.|||++|   |+||||||+|||++.++.+|++|||++...
T Consensus        97 ~~~lv~e~~-~~~l~~~~~~-~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          97 DFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             CCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eEEEEEecc-cccHHHHHHh-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCcchhhcccccccccccccceecc
Confidence            579999999 7788887654 57999999999999999999999999   999999999999999999999999999865


Q ss_pred             ccCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC------------
Q 012684          304 TVKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ------------  370 (458)
Q Consensus       304 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~------------  370 (458)
                      ..    ......+|+.|+|||++.+. .++.++||||+||++|+|++|+.||...+............            
T Consensus       172 ~~----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (346)
T d1cm8a_         172 DS----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQ  247 (346)
T ss_dssp             CS----SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCS
T ss_pred             CC----ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhc
Confidence            42    33456789999999998664 56889999999999999999999998765433222211100            


Q ss_pred             ---------------CCCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          371 ---------------RPPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       371 ---------------~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                     ...+.....++++.+.+||.+||..||.+|||+.++++|
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H  301 (346)
T d1cm8a_         248 SDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAH  301 (346)
T ss_dssp             CHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             chhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                           111112234567899999999999999999999999987

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-44  Score=347.32  Aligned_cols=251  Identities=22%  Similarity=0.311  Sum_probs=196.9

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe--------
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ--------  221 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~--------  221 (458)
                      .+|++.++||+|+||.||.     +|+.||||++..... .+.....+.+|+.+++.++||||+++++++..        
T Consensus        10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~   88 (318)
T d3blha1          10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC   88 (318)
T ss_dssp             GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred             CCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeeccccccccc
Confidence            5799999999999999984     689999999875533 22334567889999999999999999999854        


Q ss_pred             CCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          222 SSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       222 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                      ++.+|+||||+.++.+..+......+++..+..++.|++.||.|||+.|   |+||||||+|||++.++.+||+|||++.
T Consensus        89 ~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg~~~  165 (318)
T d3blha1          89 KGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFGLAR  165 (318)
T ss_dssp             --CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             CceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCC---EEecCcCchheeecCCCcEEeeecceee
Confidence            3568999999977766655556677999999999999999999999999   9999999999999999999999999997


Q ss_pred             ccccCC---CCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCCCCCC-
Q 012684          302 LLTVKE---DRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRPPFKA-  376 (458)
Q Consensus       302 ~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~~~~~-  376 (458)
                      ......   ........||+.|+|||++.+. .++.++||||+||++|+|++|+.||.+.........+........+. 
T Consensus       166 ~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~  245 (318)
T d3blha1         166 AFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV  245 (318)
T ss_dssp             ECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT
T ss_pred             ecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhh
Confidence            654322   1222345689999999998765 68899999999999999999999998766544433332211110000 


Q ss_pred             ----------------------C-----hhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          377 ----------------------P-----AKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       377 ----------------------~-----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                            .     ....++.+.+||.+||+.||++|||++++++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H  305 (318)
T d3blha1         246 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH  305 (318)
T ss_dssp             STTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred             ccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcC
Confidence                                  0     01125678899999999999999999999987

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.8e-44  Score=341.95  Aligned_cols=253  Identities=17%  Similarity=0.229  Sum_probs=200.1

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCc-ceeeeeEEEeCCceEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPN-VVQFLGAVTQSSPMMIVT  229 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~-i~~~~~~~~~~~~~~lv~  229 (458)
                      +|++.+.||+|+||.||.     +|+.||||++......     ..+..|+.+++.++|++ |+.+.+++..+...++||
T Consensus         8 rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivm   82 (299)
T d1ckia_           8 RYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVM   82 (299)
T ss_dssp             TEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEE
T ss_pred             EEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEE
Confidence            699999999999999984     5899999998754322     24678999999997665 555566667788899999


Q ss_pred             EccCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecC---CCCEEEeecCCcccccc
Q 012684          230 EYLPKGDLRAFLKR-KGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDD---SGNLKVADFGVSKLLTV  305 (458)
Q Consensus       230 e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~---~~~vkl~Dfg~~~~~~~  305 (458)
                      ||+ +++|.+.+.. .+.+++..+..++.|++.||+|||++|   |+||||||+|||++.   +..++|+|||++..+..
T Consensus        83 e~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~  158 (299)
T d1ckia_          83 ELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRD  158 (299)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBC
T ss_pred             EEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHhhccccccCCCceeeeeccCcceeccc
Confidence            999 6677766654 557999999999999999999999999   999999999999864   45799999999987654


Q ss_pred             CCC------CCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc----CCCCCC
Q 012684          306 KED------RPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR----QRPPFK  375 (458)
Q Consensus       306 ~~~------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~----~~~~~~  375 (458)
                      ...      .......||+.|+|||.+.+..++.++|||||||++|+|++|+.||...............    ...+.+
T Consensus       159 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (299)
T d1ckia_         159 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIE  238 (299)
T ss_dssp             TTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHH
T ss_pred             cccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChh
Confidence            322      1224557999999999999999999999999999999999999999876655433222111    122222


Q ss_pred             CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHHHHHHHhhh
Q 012684          376 APAKLYARGLKELIEECWNEKPAKRPTFRQIITRLESINNSI  417 (458)
Q Consensus       376 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~L~~~~~~~  417 (458)
                      .....+|+++.+||..||+.||.+||++.++.+.|+.+....
T Consensus       239 ~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~  280 (299)
T d1ckia_         239 VLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ  280 (299)
T ss_dssp             HHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred             HhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence            234567899999999999999999999999999888876543

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.5e-44  Score=349.00  Aligned_cols=248  Identities=25%  Similarity=0.400  Sum_probs=195.9

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCC----ceE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSS----PMM  226 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~----~~~  226 (458)
                      +|++.+.||+|+||.||.     +|+.||||++...  ......+.+.+|+.+|++++||||+++++++....    ..+
T Consensus         9 rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~   86 (345)
T d1pmea_           9 RYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPF--EHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV   86 (345)
T ss_dssp             TEEEEEECC---CCCEEEEEETTTCSEEEEEEECCT--TCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred             CeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehh--cChHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceE
Confidence            599999999999999884     6899999999753  24555677899999999999999999999997543    234


Q ss_pred             EEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccC
Q 012684          227 IVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVK  306 (458)
Q Consensus       227 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~  306 (458)
                      ++++++.+|+|.+++... .+++..+..++.|++.||+|||++|   |+||||||+|||++.++.+||+|||++......
T Consensus        87 ~l~~~~~~g~L~~~l~~~-~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          87 YLVTHLMGADLYKLLKTQ-HLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             EEEEECCCEEHHHHHHHC-CCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             EEEEeecCCchhhhhhcC-CCCHHHHHHHHHHHHHHHHHHHHCC---CcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            444556699999999764 6999999999999999999999999   999999999999999999999999999765433


Q ss_pred             CC--CCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcC-C-----------
Q 012684          307 ED--RPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQ-R-----------  371 (458)
Q Consensus       307 ~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~-~-----------  371 (458)
                      ..  .......||+.|+|||++.. ..++.++||||+||++|+|++|+.||................ .           
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T d1pmea_         163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  242 (345)
T ss_dssp             GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence            22  22345668999999999854 467889999999999999999999998765433222221110 0           


Q ss_pred             ---------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 ---------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 ---------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                     .++....+.+++++.+||.+||+.||.+|||+.++++|
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h  295 (345)
T d1pmea_         243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH  295 (345)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                           00011123467789999999999999999999999987

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.8e-44  Score=337.46  Aligned_cols=249  Identities=21%  Similarity=0.377  Sum_probs=206.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeCCceEEEEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQSSPMMIVTE  230 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e  230 (458)
                      +|++.+.||+|+||.|+.     +|+.||||+++.... .......+.+|+.+++.++||||+++++++......++|++
T Consensus         3 ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~   81 (292)
T d1unla_           3 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE   81 (292)
T ss_dssp             SEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhC-ChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEee
Confidence            688999999999999984     688999999976543 44556788999999999999999999999999999999999


Q ss_pred             ccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccccCCCCC
Q 012684          231 YLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLTVKEDRP  310 (458)
Q Consensus       231 ~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~~~~~~~  310 (458)
                      ++.+++|..++...+.+++..+..++.|++.||+|||+++   |+||||||+|||++.++.+||+|||.+....... ..
T Consensus        82 ~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~-~~  157 (292)
T d1unla_          82 FCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV-RC  157 (292)
T ss_dssp             CCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC-SC
T ss_pred             eccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC---EeeecccCcccccccCCceeeeecchhhcccCCC-cc
Confidence            9999999998888888999999999999999999999999   9999999999999999999999999998765432 23


Q ss_pred             cccCCCCCcccCCcccCCCC-CCCchhHHHHHHHHHHHHcCCCCCCCCCCCc-HHHHHHhc-CC----------------
Q 012684          311 LTCQDTSCRYVAPEVFKNEE-YDTKVDVFSFALILQEMIEGCPPFTMKHDNE-VPKAYAAR-QR----------------  371 (458)
Q Consensus       311 ~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l~~lltg~~pf~~~~~~~-~~~~~~~~-~~----------------  371 (458)
                      .....+++.|+|||.+.+.. ++.++||||+||++|+|++|+.||....... ....+... ..                
T Consensus       158 ~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (292)
T d1unla_         158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYK  237 (292)
T ss_dssp             CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCC
T ss_pred             ceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhccccc
Confidence            34455788899999987654 6889999999999999999999975443322 22221111 00                


Q ss_pred             --------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 --------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 --------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                              .........+++.+.+||.+||+.||.+|||++|+++|
T Consensus       238 ~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~H  283 (292)
T d1unla_         238 PYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQH  283 (292)
T ss_dssp             CCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTS
T ss_pred             ccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                    11112234567899999999999999999999999886

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-44  Score=349.91  Aligned_cols=245  Identities=25%  Similarity=0.329  Sum_probs=194.0

Q ss_pred             CCccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----
Q 012684          153 HELDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----  222 (458)
Q Consensus       153 ~~~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----  222 (458)
                      .+.+|+..+.||+|+||.||.     +|+.||||++.....       ...+|+.++++++||||++++++|...     
T Consensus        18 ~~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~   90 (350)
T d1q5ka_          18 QEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKD   90 (350)
T ss_dssp             EEEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCS
T ss_pred             ccCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccch-------HHHHHHHHHHhcCCCCCCcEEEEEEecCccCC
Confidence            345788889999999999984     689999999975432       234699999999999999999998542     


Q ss_pred             -CceEEEEEccCCCCHHHHH---HhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC-CEEEeec
Q 012684          223 -SPMMIVTEYLPKGDLRAFL---KRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADF  297 (458)
Q Consensus       223 -~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~-~vkl~Df  297 (458)
                       .++|+||||++++.+..+.   .....+++.++..++.|++.||+|||++|   |+||||||+|||++.++ .+||+||
T Consensus        91 ~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DF  167 (350)
T d1q5ka_          91 EVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDF  167 (350)
T ss_dssp             CCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCC
T ss_pred             ceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcC---CcccCCCcceEEEecCCCceeEecc
Confidence             3479999999765333332   23556999999999999999999999999   99999999999999775 8999999


Q ss_pred             CCccccccCCCCCcccCCCCCcccCCcccCC-CCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc-C-----
Q 012684          298 GVSKLLTVKEDRPLTCQDTSCRYVAPEVFKN-EEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR-Q-----  370 (458)
Q Consensus       298 g~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~-~-----  370 (458)
                      |++......  .......||+.|+|||.+.+ ..++.++||||+||++|+|++|+.||...+..+....+... +     
T Consensus       168 G~a~~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~  245 (350)
T d1q5ka_         168 GSAKQLVRG--EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTRE  245 (350)
T ss_dssp             TTCEECCTT--SCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHH
T ss_pred             cchhhccCC--cccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHH
Confidence            999876433  23344578999999998765 46899999999999999999999999876654433322110 0     


Q ss_pred             ----------CCCCC---------CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          371 ----------RPPFK---------APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       371 ----------~~~~~---------~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                ...++         ......++++.+||.+||..||++|||+.|+++|
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H  303 (350)
T d1q5ka_         246 QIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH  303 (350)
T ss_dssp             HHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                      00000         1123467899999999999999999999999987

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-43  Score=339.54  Aligned_cols=245  Identities=25%  Similarity=0.338  Sum_probs=190.8

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEe------CCc
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQ------SSP  224 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~------~~~  224 (458)
                      +|++.+.||+|+||.|+.     +|+.||||++..... +....+.+.+|+.++++++||||++++++|..      ...
T Consensus        18 ~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~   96 (355)
T d2b1pa1          18 RYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQD   96 (355)
T ss_dssp             TEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCE
T ss_pred             CeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCce
Confidence            699999999999999984     599999999986543 45566778999999999999999999999964      357


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      +|+||||+.+ ++.+.+.  ..+++..+..++.|++.||.|||+.|   |+||||||+|||++.++.++++|||++....
T Consensus        97 ~~iv~Ey~~~-~l~~~~~--~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          97 VYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             EEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             eEEEEeccch-HHHHhhh--cCCCHHHHHHHHHHHHHHHHHhhhcc---cccccCCccccccccccceeeechhhhhccc
Confidence            8999999965 5555443  45999999999999999999999999   9999999999999999999999999987654


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhc---------------
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAAR---------------  369 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~---------------  369 (458)
                      ..  .......+|+.|+|||++.+..+++++||||+||++++|++|+.||.+.+.......+...               
T Consensus       171 ~~--~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  248 (355)
T d2b1pa1         171 TS--FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT  248 (355)
T ss_dssp             ------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHH
T ss_pred             cc--cccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhh
Confidence            32  2334556899999999999999999999999999999999999999876543322222110               


Q ss_pred             ------CCCC-----------------CCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          370 ------QRPP-----------------FKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       370 ------~~~~-----------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                            ..+.                 ........++++.+||++||..||.+|||++++++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H  311 (355)
T d2b1pa1         249 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH  311 (355)
T ss_dssp             HHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred             HHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcC
Confidence                  0000                 001123457889999999999999999999999987

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=1.2e-42  Score=335.03  Aligned_cols=240  Identities=21%  Similarity=0.347  Sum_probs=194.5

Q ss_pred             cccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEe--CCceEE
Q 012684          156 DFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQ--SSPMMI  227 (458)
Q Consensus       156 ~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~--~~~~~l  227 (458)
                      +|++.+.||+|+||.||.     +|+.||||+++...      .+.+.+|+.+|+.++ ||||++++++|..  ...+++
T Consensus        36 ~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~  109 (328)
T d3bqca1          36 DYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPAL  109 (328)
T ss_dssp             GEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEE
T ss_pred             CeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeE
Confidence            699999999999999985     68999999986432      356788999999995 9999999999974  356899


Q ss_pred             EEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCC-CEEEeecCCccccccC
Q 012684          228 VTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSG-NLKVADFGVSKLLTVK  306 (458)
Q Consensus       228 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~-~vkl~Dfg~~~~~~~~  306 (458)
                      ||||+++++|.++.   +.+++..+..++.||+.||.|||++|   |+||||||+|||++.++ .++|+|||++......
T Consensus       110 v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~  183 (328)
T d3bqca1         110 VFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPG  183 (328)
T ss_dssp             EEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCTT
T ss_pred             EEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcc---cccccccccceEEcCCCCeeeecccccceeccCC
Confidence            99999999997753   45999999999999999999999999   99999999999999765 5999999999876433


Q ss_pred             CCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHH-HHH-------------HhcCC
Q 012684          307 EDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVP-KAY-------------AARQR  371 (458)
Q Consensus       307 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~-~~~-------------~~~~~  371 (458)
                        .......+|+.|+|||.+.+. .++.++||||+||++|+|++|+.||......... ..+             .....
T Consensus       184 --~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~  261 (328)
T d3bqca1         184 --QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI  261 (328)
T ss_dssp             --CCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTC
T ss_pred             --CcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhccc
Confidence              233456789999999998765 4789999999999999999999999865543211 000             00000


Q ss_pred             --------------------CCCCCChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          372 --------------------PPFKAPAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       372 --------------------~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                          .........+++++.+||++||..||.+|||++++++|
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~H  319 (328)
T d3bqca1         262 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEH  319 (328)
T ss_dssp             CCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             ccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcC
Confidence                                01111234567899999999999999999999999886

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-43  Score=341.21  Aligned_cols=246  Identities=26%  Similarity=0.334  Sum_probs=196.4

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcceeeeeEEEeC-----Cc
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNVVQFLGAVTQS-----SP  224 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~-----~~  224 (458)
                      .+|++.+.||+|+||.||.     +|+.||||++.... ......+.+.+|+.++++++||||+++++++...     ..
T Consensus        18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~   96 (348)
T d2gfsa1          18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN   96 (348)
T ss_dssp             TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred             CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCc
Confidence            3699999999999998884     68999999998654 3445566788999999999999999999998632     33


Q ss_pred             eEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecCCccccc
Q 012684          225 MMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFGVSKLLT  304 (458)
Q Consensus       225 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~~~  304 (458)
                      .+++|+++.||+|.+++.. +++++..+..++.||+.||+|||++|   |+||||||+|||++.++.+|++|||++....
T Consensus        97 ~~~i~~~~~gg~L~~~~~~-~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a~~~~  172 (348)
T d2gfsa1          97 DVYLVTHLMGADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTD  172 (348)
T ss_dssp             CCEEEEECCSEEHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC----CCT
T ss_pred             eEEEEEeecCCchhhhccc-ccccHHHHHHHHHHHHHHHHHHHhCC---CcccccCCccccccccccccccccchhcccC
Confidence            4566677779999998865 56999999999999999999999999   9999999999999999999999999987653


Q ss_pred             cCCCCCcccCCCCCcccCCcccCCC-CCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcHHHHHHhcCCC-----------
Q 012684          305 VKEDRPLTCQDTSCRYVAPEVFKNE-EYDTKVDVFSFALILQEMIEGCPPFTMKHDNEVPKAYAARQRP-----------  372 (458)
Q Consensus       305 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~~~~~~~~~~~-----------  372 (458)
                      .    ......|++.|+|||.+.+. .++.++|||||||++|+|++|+.||.+.+.......+......           
T Consensus       173 ~----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  248 (348)
T d2gfsa1         173 D----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISS  248 (348)
T ss_dssp             G----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCC
T ss_pred             c----ccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccc
Confidence            2    23445688999999987665 4678999999999999999999999876544433333211110           


Q ss_pred             -----------CCC-----CChhhhHHHHHHHHHHHcccCCCCCCCHHHHHHH
Q 012684          373 -----------PFK-----APAKLYARGLKELIEECWNEKPAKRPTFRQIITR  409 (458)
Q Consensus       373 -----------~~~-----~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  409 (458)
                                 ..+     .....+++.+.+||.+||+.||.+|||+.++++|
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~H  301 (348)
T d2gfsa1         249 ESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH  301 (348)
T ss_dssp             HHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred             hhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcC
Confidence                       000     0113467889999999999999999999999987

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=6.5e-37  Score=298.83  Aligned_cols=244  Identities=20%  Similarity=0.308  Sum_probs=183.5

Q ss_pred             ccccCceeeccceEEEEEE-----cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-----------CCcceeeeeE
Q 012684          155 LDFTNSVEITKGTFILAFW-----RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-----------HPNVVQFLGA  218 (458)
Q Consensus       155 ~~~~~~~~lg~G~~~~v~~-----~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-----------hp~i~~~~~~  218 (458)
                      .+|++.++||+|+||.||.     +|+.||||+++..    ....+.+.+|+.+++.++           |+||++++++
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~----~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~   88 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH   88 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecc----ccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence            4599999999999999984     6899999999743    333456778888888774           5789999998


Q ss_pred             EEe--CCceEEEEEccCCCC-HHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeeeCCCCCCCEEecCCCC-
Q 012684          219 VTQ--SSPMMIVTEYLPKGD-LRAFLK--RKGALKPSTAVRFALDIARGMNYLHE-NKPVPIIHRDLEPSNILRDDSGN-  291 (458)
Q Consensus       219 ~~~--~~~~~lv~e~~~~~~-L~~~l~--~~~~~~~~~~~~i~~qi~~~l~~LH~-~~~~~i~H~Dikp~Nil~~~~~~-  291 (458)
                      +..  ....+++|+++..+. ......  ....+++..+..++.|++.||.|||+ .|   |+||||||+|||++.++. 
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~  165 (362)
T d1q8ya_          89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSP  165 (362)
T ss_dssp             EEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETT
T ss_pred             eeeccccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcC---cccccCChhHeeeeccCcc
Confidence            864  345666776664443 333222  24568999999999999999999998 77   999999999999986654 


Q ss_pred             -----EEEeecCCccccccCCCCCcccCCCCCcccCCcccCCCCCCCchhHHHHHHHHHHHHcCCCCCCCCCCCcH----
Q 012684          292 -----LKVADFGVSKLLTVKEDRPLTCQDTSCRYVAPEVFKNEEYDTKVDVFSFALILQEMIEGCPPFTMKHDNEV----  362 (458)
Q Consensus       292 -----vkl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~~lltg~~pf~~~~~~~~----  362 (458)
                           ++++|||.+.....    ......||+.|+|||++.+..++.++||||+||++++|++|+.||........    
T Consensus       166 ~~~~~~kl~dfg~s~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~  241 (362)
T d1q8ya_         166 ENLIQIKIADLGNACWYDE----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDD  241 (362)
T ss_dssp             TTEEEEEECCCTTCEETTB----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHH
T ss_pred             cccceeeEeeccccccccc----ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchh
Confidence                 99999999876532    22345689999999999998999999999999999999999999975433210    


Q ss_pred             ---HHHHHhcCC-------------------------CC------------CCCChhhhHHHHHHHHHHHcccCCCCCCC
Q 012684          363 ---PKAYAARQR-------------------------PP------------FKAPAKLYARGLKELIEECWNEKPAKRPT  402 (458)
Q Consensus       363 ---~~~~~~~~~-------------------------~~------------~~~~~~~~~~~l~~li~~~l~~dp~~Rps  402 (458)
                         .......+.                         ..            ........++++.+||.+||..||.+|||
T Consensus       242 ~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpt  321 (362)
T d1q8ya_         242 DHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRAD  321 (362)
T ss_dssp             HHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBC
T ss_pred             HHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcC
Confidence               000000000                         00            01123456788999999999999999999


Q ss_pred             HHHHHHH
Q 012684          403 FRQIITR  409 (458)
Q Consensus       403 ~~~ll~~  409 (458)
                      ++|+++|
T Consensus       322 a~e~L~H  328 (362)
T d1q8ya_         322 AGGLVNH  328 (362)
T ss_dssp             HHHHHTC
T ss_pred             HHHHhcC
Confidence            9999886

>d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myotrophin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.86  E-value=4.2e-22  Score=160.74  Aligned_cols=104  Identities=31%  Similarity=0.400  Sum_probs=98.5

Q ss_pred             chHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcchHH
Q 012684           41 EFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHE  120 (458)
Q Consensus        41 ~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~  120 (458)
                      +|||++||..|+.++++.|++.|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|+||||+|+..|+.+
T Consensus         3 ~tpL~~A~~~g~~~~v~~Ll~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~   82 (118)
T d1myoa_           3 DKEFMWALKNGDLDEVKDYVAKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVS   82 (118)
T ss_dssp             HHHHHHHHHTTCHHHHHHHHTTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCH
T ss_pred             ChHHHHHHHCCCHHHHHHHHHhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchh
Confidence            68999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhCCCCCCCccccccCCC
Q 012684          121 VIKLLEKHGAKPLMAPMHVKHARE  144 (458)
Q Consensus       121 ~~~~l~~~g~~~~~~~~~~~~~~~  144 (458)
                      ++++|+++|+++....-.+.++..
T Consensus        83 ~v~~Ll~~Gad~~~~d~~G~t~l~  106 (118)
T d1myoa_          83 CVKLLLSKGADKTVKGPDGLTALE  106 (118)
T ss_dssp             HHHHHHTTCCCSSSSSSSTCCCCC
T ss_pred             hhhhhhcccccceeeCCCCCCHHH
Confidence            999999999999877666666543

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.85  E-value=2.6e-22  Score=176.44  Aligned_cols=162  Identities=18%  Similarity=0.120  Sum_probs=117.8

Q ss_pred             cCceeeccceEEEEEE----cCeEEEEEEcCCCCCC---------------CHHHHHHHHHHHHHHhcCCCCcceeeeeE
Q 012684          158 TNSVEITKGTFILAFW----RGIQVAVKKLGEEVIS---------------DDDRVRAFRDELALLQKIRHPNVVQFLGA  218 (458)
Q Consensus       158 ~~~~~lg~G~~~~v~~----~g~~vavK~~~~~~~~---------------~~~~~~~~~~E~~~l~~l~hp~i~~~~~~  218 (458)
                      .+.+.||+|+||.||.    +|+.||||+++.....               ..........|...+.++.|++++..+++
T Consensus         3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~   82 (191)
T d1zara2           3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW   82 (191)
T ss_dssp             EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred             hhCCEeeeCcceEEEEEECCCCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHccCCCcceEEEe
Confidence            4678999999999984    6899999987632211               01122334568889999999999998876


Q ss_pred             EEeCCceEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeeeCCCCCCCEEecCCCCEEEeecC
Q 012684          219 VTQSSPMMIVTEYLPKGDLRAFLKRKGALKPSTAVRFALDIARGMNYLHENKPVPIIHRDLEPSNILRDDSGNLKVADFG  298 (458)
Q Consensus       219 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~~i~H~Dikp~Nil~~~~~~vkl~Dfg  298 (458)
                      .    ..+++|||+++..+.+       ++......++.|++.+|.|||++|   |+||||||+|||+++++ ++|+|||
T Consensus        83 ~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~~-~~liDFG  147 (191)
T d1zara2          83 E----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEEG-IWIIDFP  147 (191)
T ss_dssp             E----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETTE-EEECCCT
T ss_pred             c----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCC---EEEccCChhheeeeCCC-EEEEECC
Confidence            3    2379999998765432       566777889999999999999999   99999999999999755 8999999


Q ss_pred             CccccccCCCCCcccCCCCCcccCC------cccCCCCCCCchhHHHHHHHH
Q 012684          299 VSKLLTVKEDRPLTCQDTSCRYVAP------EVFKNEEYDTKVDVFSFALIL  344 (458)
Q Consensus       299 ~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~DiwslG~~l  344 (458)
                      .+........         ..|...      +. ....++.++|+||+.--+
T Consensus       148 ~a~~~~~~~~---------~~~l~rd~~~~~~~-f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         148 QSVEVGEEGW---------REILERDVRNIITY-FSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TCEETTSTTH---------HHHHHHHHHHHHHH-HHHHHCCCCCHHHHHHHH
T ss_pred             CcccCCCCCc---------HHHHHHHHHHHHHH-HcCCCCCcccHHHHHHHH
Confidence            9875432111         012111      11 134678899999986544

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.85  E-value=4.3e-21  Score=161.94  Aligned_cols=98  Identities=20%  Similarity=0.197  Sum_probs=92.6

Q ss_pred             cCccchHHHHHHHh---CCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHH
Q 012684           37 EIKPEFRLMFLANE---RDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA  113 (458)
Q Consensus        37 ~~~g~t~l~~a~~~---~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A  113 (458)
                      +..|+||||+|+..   ++.+++++|+++|+++|.+|.+|.||||+||..|+.+++++|+++|++++.+|..|+||||+|
T Consensus        42 ~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A~~~~~~~~v~~Ll~~gad~~~~d~~g~tpL~~A  121 (154)
T d1dcqa1          42 HEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYCCLTDNAECLKLLLRGKASIEIANESGETPLDIA  121 (154)
T ss_dssp             SSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHH
T ss_pred             CCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccccccccccccccccccCccccccCCCCCCHHHHH
Confidence            56799999999975   678999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhcchHHHHHHHHHhCCCCCC
Q 012684          114 IYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       114 ~~~~~~~~~~~l~~~g~~~~~  134 (458)
                      +..|+.+++++|++.++....
T Consensus       122 ~~~~~~~i~~~L~~~~~~~~~  142 (154)
T d1dcqa1         122 KRLKHEHCEELLTQALSGRFN  142 (154)
T ss_dssp             HHTTCHHHHHHHHHHHTTCCC
T ss_pred             HHcCCHHHHHHHHHhCCCCCC
Confidence            999999999999999887543

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.83  E-value=7.7e-21  Score=155.96  Aligned_cols=95  Identities=29%  Similarity=0.361  Sum_probs=90.2

Q ss_pred             hHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcchHHH
Q 012684           42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV  121 (458)
Q Consensus        42 t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~  121 (458)
                      +.||.||..|++++++.|+++|+|+|.+|.+|+||||+|+..|+.+++++|+++|++++.+|.+|+||||+|+.+|+.++
T Consensus         3 ~lL~~A~~~G~~~~v~~Ll~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~   82 (130)
T d1ycsb1           3 ALLLDSSLEGEFDLVQRIIYEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQV   82 (130)
T ss_dssp             HHHHHHHHHTCHHHHHHHTSTTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHH
T ss_pred             HHHHHHHHcCCHHHHHHHHHcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHH
Confidence            67999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCc
Q 012684          122 IKLLEKHGAKPLMAP  136 (458)
Q Consensus       122 ~~~l~~~g~~~~~~~  136 (458)
                      +++|+++|+++....
T Consensus        83 v~~Ll~~ga~v~~~~   97 (130)
T d1ycsb1          83 CKFLVESGAAVFAMT   97 (130)
T ss_dssp             HHHHHHTTCCTTCCC
T ss_pred             HHHHHHcCCCccccc
Confidence            999999999986543

>d1ycsb1 d.211.1.1 (B:327-456) 53BP2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 53BP2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.80  E-value=6.1e-20  Score=150.52  Aligned_cols=103  Identities=22%  Similarity=0.104  Sum_probs=93.6

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCC-CC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR-WG  106 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~-~g  106 (458)
                      -+|+|+|.+|.+|+||||+||..|+.+++++|++.|+++|.+|.+|+||||+|+.+|+.+++++|+++||+++..+. .|
T Consensus        22 ~~g~d~n~~d~~g~t~Lh~A~~~~~~~~~~~ll~~g~~~~~~d~~g~tpLh~A~~~g~~~~v~~Ll~~ga~v~~~~~~~~  101 (130)
T d1ycsb1          22 YEVDDPSLPNDEGITALHNAVCAGHTEIVKFLVQFGVNVNAADSDGWTPLHCAASCNNVQVCKFLVESGAAVFAMTYSDM  101 (130)
T ss_dssp             STTSSCCCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCSSSC
T ss_pred             HcCCCccccccccccccccccccccccccccccccccccccccccCcccccccchhhHHHHHHHHHHcCCCcccccCCCC
Confidence            46788899999999999999999999999999999999999999999999999999999999999999999998875 58


Q ss_pred             CChhHHH--hhcchHHHHHHHHHhCC
Q 012684          107 STPLGDA--IYYKNHEVIKLLEKHGA  130 (458)
Q Consensus       107 ~tpl~~A--~~~~~~~~~~~l~~~g~  130 (458)
                      .||++++  +..|+.+++++|+..+.
T Consensus       102 ~~~~~~~~a~~~g~~eiv~~L~~~~~  127 (130)
T d1ycsb1         102 QTAADKCEEMEEGYTQCSQFLYGVQE  127 (130)
T ss_dssp             CCHHHHCCSSSTTCCCHHHHHHHHHH
T ss_pred             CCHHHHHHHHHcChHHHHHHHHhHHH
Confidence            8886655  56788999999987654

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.79  E-value=6.1e-20  Score=149.46  Aligned_cols=98  Identities=22%  Similarity=0.319  Sum_probs=75.5

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCC-CHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNR-TALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~-t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~  107 (458)
                      .|+|+|.++..|.||||+|+ .|+.+++++|+++|+++|.++..|. ||||+|+..|+.+++++|+++|++++.+|..|+
T Consensus        25 ~gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~~~~v~~Ll~~ga~~~~~d~~G~  103 (125)
T d1bi7b_          25 AGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGFLDTLVVLHRAGARLDVRDAWGR  103 (125)
T ss_dssp             TTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTCC
T ss_pred             cCCccccccccccccccccc-cccccccccccccccccccccccccccccccccccccccccccccccccccccccCCCC
Confidence            45677777777777787664 5778888888888888887777765 578888888888888888888888888888888


Q ss_pred             ChhHHHhhcchHHHHHHHHH
Q 012684          108 TPLGDAIYYKNHEVIKLLEK  127 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l~~  127 (458)
                      ||||+|+..|+.+++++|+.
T Consensus       104 T~l~~A~~~g~~~~v~~Lls  123 (125)
T d1bi7b_         104 LPVDLAEELGHRDVARYLRA  123 (125)
T ss_dssp             CHHHHHHHHTCHHHHHHHSS
T ss_pred             CHHHHHHHcCCHHHHHHHHh
Confidence            88888888888888877753

>d1myoa_ d.211.1.1 (A:) Myotrophin {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myotrophin
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=99.79  E-value=2.1e-20  Score=150.55  Aligned_cols=88  Identities=30%  Similarity=0.264  Sum_probs=84.0

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~  107 (458)
                      -+|+|++.++..|+||||+||..|+.+++++|++.|+++|.+|..|+||||+|+.+|+.+++++|+++|+|++.+|..|.
T Consensus        23 ~~g~d~n~~~~~g~t~lh~A~~~~~~~~~~~ll~~g~din~~d~~g~tpLh~A~~~~~~~~v~~Ll~~Gad~~~~d~~G~  102 (118)
T d1myoa_          23 AKGEDVNRTLEGGRKPLHYAADCGQLEILEFLLLKGADINAPDKHHITPLLSAVYEGHVSCVKLLLSKGADKTVKGPDGL  102 (118)
T ss_dssp             TTTCCCCCCSSSSCCTTHHHHHHSTTTHHHHHHHSSCTTTCCSSSCSCHHHHHHTTTCCHHHHHHHTTCCCSSSSSSSTC
T ss_pred             HhhhccccccccccccccccccccccccccccccccceeeecccccccchhhhhhcCchhhhhhhhcccccceeeCCCCC
Confidence            46788899999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             ChhHHHhh
Q 012684          108 TPLGDAIY  115 (458)
Q Consensus       108 tpl~~A~~  115 (458)
                      ||||+|..
T Consensus       103 t~l~~a~~  110 (118)
T d1myoa_         103 TALEATDN  110 (118)
T ss_dssp             CCCCTCSS
T ss_pred             CHHHHHhH
Confidence            99999843

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.78  E-value=1e-18  Score=157.06  Aligned_cols=113  Identities=27%  Similarity=0.260  Sum_probs=106.0

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      ++.|++..+.+|.||||+|+..|+.+++++|+++|+++|.+|..|.||||+|+..++.+++++|+..|++++.+|..|+|
T Consensus        92 ~~~d~~~~d~~g~tpL~~A~~~~~~e~~~~Ll~~g~d~~~~~~~~~t~L~~a~~~~~~~~~~~L~~~~~~i~~~d~~g~T  171 (223)
T d1uoha_          92 KGAQVNAVNQNGCTPLHYAASKNRHEIAVMLLEGGANPDAKDHYEATAMHRAAAKGNLKMIHILLYYKASTNIQDTEGNT  171 (223)
T ss_dssp             TTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTCCC
T ss_pred             cCceeEeeCCCCCchhhHHHHcCCHHHHHHHHHCCCCCCCcCCCCCccchhhhhcCCcchhhhhccccceeeeccCCCCc
Confidence            67788889999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhHHHhhcchHHHHHHHHHhCCCCCCCcccccc
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKH  141 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~  141 (458)
                      |||+|+..|+.+++++|+++|+++......+.+
T Consensus       172 pL~~Aa~~g~~~~v~~LL~~Gad~~~~d~~g~t  204 (223)
T d1uoha_         172 PLHLACDEERVEEAKLLVSQGASIYIENKEEKT  204 (223)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCC
T ss_pred             eeccccccCcHHHHHHHHHCCCCCCCCCCCCCC
Confidence            999999999999999999999998765544433

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.77  E-value=7.1e-19  Score=161.00  Aligned_cols=101  Identities=34%  Similarity=0.417  Sum_probs=94.2

Q ss_pred             CCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCcc-CCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCh
Q 012684           31 LDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFR-DIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTP  109 (458)
Q Consensus        31 ~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~-~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tp  109 (458)
                      .+.+.++..|.||||+||..++.+++++|++.|++.+.. +..|.||||+||..|+.+++++|+++|++++.+|..|.||
T Consensus       149 ~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~~~~~~~~~~~g~TpL~~A~~~~~~~~v~~Ll~~gadin~~d~~g~t~  228 (255)
T d1oy3d_         149 LQLEAENYDGHTPLHVAVIHKDAEMVRLLRDAGADLNKPEPTCGRTPLHLAVEAQAASVLELLLKAGADPTARMYGGRTP  228 (255)
T ss_dssp             GGTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred             cccccccccCcccccccccccccccccchhcccccccccccccccccccccccccHHHHHHHHHHCCCCCCCCCCCCCCH
Confidence            345566778899999999999999999999999998864 6789999999999999999999999999999999999999


Q ss_pred             hHHHhhcchHHHHHHHHHhCCC
Q 012684          110 LGDAIYYKNHEVIKLLEKHGAK  131 (458)
Q Consensus       110 l~~A~~~~~~~~~~~l~~~g~~  131 (458)
                      ||+|+..++.+++++|+++||+
T Consensus       229 L~~A~~~~~~~i~~~Ll~~Ga~  250 (255)
T d1oy3d_         229 LGSALLRPNPILARLLRAHGAP  250 (255)
T ss_dssp             HHHHHTSSCHHHHHHHHHTTCC
T ss_pred             HHHHHHCCCHHHHHHHHHcCCC
Confidence            9999999999999999999996

>d1bi7b_ d.211.1.1 (B:) Cell cycle inhibitor p16ink4A {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p16ink4A
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.77  E-value=4e-19  Score=144.55  Aligned_cols=100  Identities=24%  Similarity=0.257  Sum_probs=91.2

Q ss_pred             cchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC-ChhHHHhhcch
Q 012684           40 PEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS-TPLGDAIYYKN  118 (458)
Q Consensus        40 g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~-tpl~~A~~~~~  118 (458)
                      +.++||+||..|+++++++|+++|+|+|.+|.+|.||||+|+ .|+.+++++|+++|++++.++..|. ||||+|+..|+
T Consensus         3 ~~~~L~~Aa~~G~~~~v~~Ll~~gad~n~~~~~g~t~l~~a~-~g~~~~v~~Ll~~ga~~~~~~~~~~~~~L~~A~~~g~   81 (125)
T d1bi7b_           3 SADWLATAAARGRVEEVRALLEAGANPNAPNSYGRRPIQVMM-MGSARVAELLLLHGAEPNCADPATLTRPVHDAAREGF   81 (125)
T ss_dssp             STTHHHHHHHHTCHHHHHHHHTTTCCTTCCCSSSCCTTTSSC-TTCHHHHHHHHTTTCCCCCCCTTTCCCHHHHHHHHTC
T ss_pred             ChhHHHHHHHCCCHHHHHHHHHcCCccccccccccccccccc-ccccccccccccccccccccccccccccccccccccc
Confidence            567899999999999999999999999999999999999765 7999999999999999999998876 69999999999


Q ss_pred             HHHHHHHHHhCCCCCCCccccc
Q 012684          119 HEVIKLLEKHGAKPLMAPMHVK  140 (458)
Q Consensus       119 ~~~~~~l~~~g~~~~~~~~~~~  140 (458)
                      .+++++|+++|+++......+.
T Consensus        82 ~~~v~~Ll~~ga~~~~~d~~G~  103 (125)
T d1bi7b_          82 LDTLVVLHRAGARLDVRDAWGR  103 (125)
T ss_dssp             HHHHHHHHHHTCCSSCCCTTCC
T ss_pred             ccccccccccccccccccCCCC
Confidence            9999999999999876544433

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.72  E-value=1.4e-17  Score=147.49  Aligned_cols=101  Identities=22%  Similarity=0.230  Sum_probs=95.8

Q ss_pred             hhhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCC
Q 012684           25 EAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR  104 (458)
Q Consensus        25 ~~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~  104 (458)
                      -..-.+.|.+..+..|.||||+|+..+..++++.+++.++++|.+|.+|.||||+||..|+.+++++|+++|||++.+|.
T Consensus       108 ~L~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~v~~Ll~~gad~n~~d~  187 (209)
T d1ot8a_         108 DLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEASKALLDNFANREITDH  187 (209)
T ss_dssp             HHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCT
T ss_pred             hhhhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHHHHHHHHHCCCCCCCcCC
Confidence            34456778888889999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCChhHHHhhcchHHHHHHH
Q 012684          105 WGSTPLGDAIYYKNHEVIKLL  125 (458)
Q Consensus       105 ~g~tpl~~A~~~~~~~~~~~l  125 (458)
                      .|+||||+|++.|+.+++++|
T Consensus       188 ~g~Tpl~~A~~~~~~~iv~lL  208 (209)
T d1ot8a_         188 MDRLPRDVASERLHHDIVRLL  208 (209)
T ss_dssp             TSCCHHHHHHHTTCHHHHHHH
T ss_pred             CCCCHHHHHHHcCCHHHHhhc
Confidence            999999999999999999987

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.72  E-value=1.7e-17  Score=140.12  Aligned_cols=111  Identities=23%  Similarity=0.236  Sum_probs=78.2

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGS  107 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~  107 (458)
                      -++.|++..|..|+||||+|+ .|+.+++++|++.++++|.++..|.+|+++|+..++.+++++++++|++++.+|..|.
T Consensus        24 ~~~~~~n~~d~~g~t~L~~A~-~~~~~~v~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~  102 (156)
T d1bd8a_          24 RELVHPDALNRFGKTALQVMM-FGSTAIALELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGA  102 (156)
T ss_dssp             TTCCCTTCCCTTSCCHHHHSC-TTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSC
T ss_pred             hCCCCCCccCCCCCccccccc-ccccccccccccccccccccccccccccccccccccccccccccccccccccccCCCC
Confidence            356677777777777777765 3667777777777777777777777777777777777777777777777777777777


Q ss_pred             ChhHHHhhcchHHHHHHHHHhCCCCCCCccccc
Q 012684          108 TPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVK  140 (458)
Q Consensus       108 tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~  140 (458)
                      ||||+|+..|+.+++++|+ .|+++......+.
T Consensus       103 t~L~~A~~~~~~~i~~~L~-~~~~~~~~d~~G~  134 (156)
T d1bd8a_         103 LPIHLAVQEGHTAVVSFLA-AESDLHRRDARGL  134 (156)
T ss_dssp             CHHHHHHHHTCHHHHHHHH-TTSCTTCCCTTSC
T ss_pred             eeecccccccccccccccc-ccccccccCCCCC
Confidence            7777777777777777665 5666655444433

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.71  E-value=2e-17  Score=155.59  Aligned_cols=114  Identities=19%  Similarity=0.201  Sum_probs=94.6

Q ss_pred             cCCCCCCC-cCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCH-------HHHHHH--------
Q 012684           29 NGLDDDGE-EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFT-------EVVSLL--------   92 (458)
Q Consensus        29 n~~d~~~~-~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~-------~~~~~L--------   92 (458)
                      .+.|+|.. |.+|+||||+||..|+.++|++|+++|+|++.+|..|.||||+||..++.       +++++|        
T Consensus        95 ~~~dvn~~~D~~G~T~LH~Aa~~g~~~~v~~Ll~~gad~~~~d~~G~TpL~~A~~~~~~~~~~~~~~ll~~l~~~~~~~d  174 (301)
T d1sw6a_          95 TQLNLNIPVDEHGNTPLHWLTSIANLELVKHLVKHGSNRLYGDNMGESCLVKAVKSVNNYDSGTFEALLDYLYPCLILED  174 (301)
T ss_dssp             SCCCSCSCCSTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTBCCTTCCCHHHHHHHSSHHHHTTCHHHHHHHHGGGGGEEC
T ss_pred             cCCCcCcCcCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcCCcccccHHHHhhhcccchhhhhHHHHHHHHhhhhhhcc
Confidence            46677765 78899999999999999999999999999999999999999999986542       233322        


Q ss_pred             ----------------------------------HHCCC-------------------------------------CCCC
Q 012684           93 ----------------------------------LERGA-------------------------------------DVDP  101 (458)
Q Consensus        93 ----------------------------------l~~ga-------------------------------------~~~~  101 (458)
                                                        +..+.                                     .+|.
T Consensus       175 ~~g~t~lh~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~in~  254 (301)
T d1sw6a_         175 SMNRTILHHIIITSGMTGCSAAAKYYLDILMGWIVKKQNRPIQSGTNEKESKPNDKNGERKDSILENLDLKWIIANMLNA  254 (301)
T ss_dssp             TTCCCHHHHHHHHHTSTTCHHHHHHHHHHHHHHHHHGGGCCEEEC----------------CHHHHHCSHHHHHHHTTTC
T ss_pred             cccCCHHHHHHHHhCccccHHHHHHHHHHHHHHHHhcCCcchhcccccccchhHHHHhcchHHHHHHHhhHHHHhcCccC
Confidence                                              22221                                     1788


Q ss_pred             CCCCCCChhHHHhhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684          102 KDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus       102 ~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      +|..|+||||+|++.|+.+++++|+++|+++.+..-.+.+|
T Consensus       255 ~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tp  295 (301)
T d1sw6a_         255 QDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRP  295 (301)
T ss_dssp             CCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCG
T ss_pred             CCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCH
Confidence            99999999999999999999999999999998876665554

>d1oy3d_ d.211.1.1 (D:) Transcription factor inhibitor I-kappa-B-beta, IKBB {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Transcription factor inhibitor I-kappa-B-beta, IKBB
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.71  E-value=1e-17  Score=153.19  Aligned_cols=95  Identities=23%  Similarity=0.178  Sum_probs=89.4

Q ss_pred             cCccchHHHHHHHhCCHHHHHHHHHcCCC---CCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHH
Q 012684           37 EIKPEFRLMFLANERDVEGIKELLDSGID---VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDA  113 (458)
Q Consensus        37 ~~~g~t~l~~a~~~~~~~~~~~ll~~g~~---in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A  113 (458)
                      +.+|+||||+||..|+.+++++|++.|++   +|.+|..|.||||+||..|+.+++++|+++||+++.+|..|.||||+|
T Consensus         6 ~~~G~t~Lh~A~~~~~~~~v~~Ll~~~a~~~~i~~~~~~g~TpL~~A~~~g~~~iv~~Ll~~ga~i~~~d~~g~tpL~~A   85 (255)
T d1oy3d_           6 TEDGDTALHLAVIHQHEPFLDFLLGFSAGHEYLDLQNDLGQTALHLAAILGEASTVEKLYAAGAGVLVAERGGHTALHLA   85 (255)
T ss_dssp             CTTCCCHHHHHHHTTCHHHHHHHHHHHTTSGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCTTSCCHHHHH
T ss_pred             CcCCCCHHHHHHHcCCHHHHHHHHHcCCCcccccCcCCCCCCccchHHhhcccccccccccccccccccccccchhhhhh
Confidence            46799999999999999999999999988   677889999999999999999999999999999999999999999999


Q ss_pred             hhcchHHHHHHHHHhCCC
Q 012684          114 IYYKNHEVIKLLEKHGAK  131 (458)
Q Consensus       114 ~~~~~~~~~~~l~~~g~~  131 (458)
                      +..++.+++++|++.+..
T Consensus        86 ~~~~~~~~~~~Ll~~~~~  103 (255)
T d1oy3d_          86 CRVRAHTCACVLLQPRPS  103 (255)
T ss_dssp             TTTTCHHHHHHHSSSCCS
T ss_pred             hccCchHHHHHHHhhccc
Confidence            999999999999876554

>d1bd8a_ d.211.1.1 (A:) Cell cycle inhibitor p19ink4D {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Cell cycle inhibitor p19ink4D
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.70  E-value=6.5e-17  Score=136.52  Aligned_cols=104  Identities=26%  Similarity=0.339  Sum_probs=97.9

Q ss_pred             hhhhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC
Q 012684           24 KEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD  103 (458)
Q Consensus        24 ~~~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~  103 (458)
                      +...-++.|++..+..|.+||++++..++.++++.+++.|+++|.+|.+|.||||+||..|+.+++++|+ .|++++.+|
T Consensus        52 ~~Ll~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~n~~~~~~~t~L~~A~~~~~~~i~~~L~-~~~~~~~~d  130 (156)
T d1bd8a_          52 LELLKQGASPNVQDTSGTSPVHDAARTGFLDTLKVLVEHGADVNVPDGTGALPIHLAVQEGHTAVVSFLA-AESDLHRRD  130 (156)
T ss_dssp             HHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHH-TTSCTTCCC
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccCCCCeeecccccccccccccccc-ccccccccC
Confidence            4445578889999999999999999999999999999999999999999999999999999999999887 799999999


Q ss_pred             CCCCChhHHHhhcchHHHHHHHHHh
Q 012684          104 RWGSTPLGDAIYYKNHEVIKLLEKH  128 (458)
Q Consensus       104 ~~g~tpl~~A~~~~~~~~~~~l~~~  128 (458)
                      ..|+||||+|+..|+.+++++|++|
T Consensus       131 ~~G~TpL~~A~~~g~~~iv~~Ll~h  155 (156)
T d1bd8a_         131 ARGLTPLELALQRGAQDLVDILQGH  155 (156)
T ss_dssp             TTSCCHHHHHHHSCCHHHHHHHHTT
T ss_pred             CCCCCHHHHHHHcCCHHHHHHHHhh
Confidence            9999999999999999999999976

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.69  E-value=5.4e-17  Score=136.24  Aligned_cols=105  Identities=32%  Similarity=0.366  Sum_probs=57.3

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      +|+|.+ .+..|+||||+|+..++.++++.++......+..+..+.++++.++...+.+++++|+.+|++++.+|..|.|
T Consensus        24 ~ga~~~-~~~~g~t~L~~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~T  102 (153)
T d1awcb_          24 NGAPFT-TDWLGTSPLHLAAQYGHFSTTEVLLRAGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMT  102 (153)
T ss_dssp             HTCCCC-CCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCC
T ss_pred             cCCCcc-cccCCCccccccccccccccccccccccccccccccccccccccccccccceeeecccccCCccccccccCch
Confidence            344444 4666777777777777765555554443333333333333333333333444555555555555556666666


Q ss_pred             hhHHHhhcchHHHHHHHHHhCCCCCC
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~~~~~  134 (458)
                      |||+|+..|+.+++++|+++|+++..
T Consensus       103 ~L~~A~~~g~~~iv~~ll~~gad~~~  128 (153)
T d1awcb_         103 ALHWATEHNHQEVVELLIKYGADVHT  128 (153)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCTTC
T ss_pred             HHHhhhhcchhheeeeccccccCCcc
Confidence            66666666666666666666665544

>d1uoha_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.69  E-value=7.9e-17  Score=144.48  Aligned_cols=113  Identities=27%  Similarity=0.336  Sum_probs=104.2

Q ss_pred             hhhhhhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCC
Q 012684           22 ERKEAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDP  101 (458)
Q Consensus        22 ~~~~~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~  101 (458)
                      -++-..-++.+++.+|.+|+||||+||..|+.+++++|++.+.+....+..+.++++.|+..++.+++++|+++|++++.
T Consensus        19 v~~~l~~~~~~~~~~D~~G~TpLh~Aa~~g~~e~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~Ll~~~~d~~~   98 (223)
T d1uoha_          19 LKESILADKSLATRTDQDSRTALHWACSAGHTEIVEFLLQLGVPVNDKDDAGWSPLHIAASAGRDEIVKALLGKGAQVNA   98 (223)
T ss_dssp             HHHHHHHCGGGGGCCCTTSCCHHHHHHHHTCHHHHHHHHHHTCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTC
T ss_pred             HHHHHHhCCCcCcCcCCCCCCHHHHHHHhhhhcccccccccccccccccccccccccccccccccchhHHHhccCceeEe
Confidence            33444556777888888999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCCCCChhHHHhhcchHHHHHHHHHhCCCCCC
Q 012684          102 KDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       102 ~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~  134 (458)
                      +|..|.||||+|+..|+.+++++|+++|+++..
T Consensus        99 ~d~~g~tpL~~A~~~~~~e~~~~Ll~~g~d~~~  131 (223)
T d1uoha_          99 VNQNGCTPLHYAASKNRHEIAVMLLEGGANPDA  131 (223)
T ss_dssp             CCTTCCCHHHHHHHHTCHHHHHHHHHTTCCTTC
T ss_pred             eCCCCCchhhHHHHcCCHHHHHHHHHCCCCCCC
Confidence            999999999999999999999999999998754

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.69  E-value=4.6e-17  Score=146.19  Aligned_cols=100  Identities=25%  Similarity=0.250  Sum_probs=75.9

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcC-CCCCccCCCCCCHHHHHHHcCCHHHHHHHHH-CCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSG-IDVNFRDIDNRTALHVAACQGFTEVVSLLLE-RGADVDPKDRWG  106 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g-~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~-~ga~~~~~~~~g  106 (458)
                      .+.+.+..+..|+||||+|+..|+.++++.|++.| .++|.+|.+|+||||+|+..|+.+++++|++ .|++++.+|..|
T Consensus       127 ~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpLh~A~~~~~~~~v~~Ll~~~gad~~~~d~~g  206 (229)
T d1ixva_         127 NGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPLFHALAEGHGDAAVLLVEKYGAEYDLVDNKG  206 (229)
T ss_dssp             TTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHHHHHHHTTCHHHHHHHHHHHCCCSCCCCTTS
T ss_pred             hcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCchhhhcccccHHHHHHHHHhcCCCCCCcCCCC
Confidence            45566666777778888888888888888888775 5677777788888888888888888888775 478888888888


Q ss_pred             CChhHHHhhcchHHHHHHHHHhCCC
Q 012684          107 STPLGDAIYYKNHEVIKLLEKHGAK  131 (458)
Q Consensus       107 ~tpl~~A~~~~~~~~~~~l~~~g~~  131 (458)
                      +||||+|+.   .+++++|++.|+|
T Consensus       207 ~t~l~~A~~---~~~~~~Ll~~g~d  228 (229)
T d1ixva_         207 AKAEDVALN---EQVKKFFLNNVVD  228 (229)
T ss_dssp             CCTGGGCSC---HHHHHHHHHHCCC
T ss_pred             CCHHHHHhh---HHHHHHHHHcCCC
Confidence            888887763   4677888887776

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.68  E-value=4.3e-17  Score=159.17  Aligned_cols=93  Identities=31%  Similarity=0.381  Sum_probs=90.1

Q ss_pred             hHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcchHHH
Q 012684           42 FRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV  121 (458)
Q Consensus        42 t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~  121 (458)
                      ||||+||..|+.++|++|++.|+++|.+|..|.||||+||..|+.+++++|+++|++++.++..|+||||+|+..|+.++
T Consensus         2 TpL~~Aa~~g~~~~v~~Ll~~g~~in~~d~~g~TpL~~A~~~g~~~iv~~Ll~~gadi~~~~~~g~t~L~~A~~~g~~~~   81 (408)
T d1n11a_           2 TPLHVASFMGHLPIVKNLLQRGASPNVSNVKVETPLHMAARAGHTEVAKYLLQNKAKVNAKAKDDQTPLHCAARIGHTNM   81 (408)
T ss_dssp             CHHHHHHHHTCHHHHHHHHHTTCCSCCSSSCCCCHHHHHHHHTCHHHHHHHHHHTCCSSCCCTTSCCHHHHHHHHTCHHH
T ss_pred             ChHHHHHHCcCHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCCCCCCCCHHHHHHHcCCHHH
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCC
Q 012684          122 IKLLEKHGAKPLM  134 (458)
Q Consensus       122 ~~~l~~~g~~~~~  134 (458)
                      +++|+..++++..
T Consensus        82 ~~~Ll~~~~~~~~   94 (408)
T d1n11a_          82 VKLLLENNANPNL   94 (408)
T ss_dssp             HHHHHHHTCCTTC
T ss_pred             HHHHHHhhhcccc
Confidence            9999999887643

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.68  E-value=1.2e-16  Score=141.56  Aligned_cols=69  Identities=26%  Similarity=0.285  Sum_probs=51.1

Q ss_pred             CCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684           74 RTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus        74 ~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      .++|+.|+..+...+++.++.+|.+++.+|..|.||||+|+..|+.+++++|+++|+|+......+.+|
T Consensus       145 ~~~l~~a~~~~~~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~Tp  213 (228)
T d1k1aa_         145 RSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTP  213 (228)
T ss_dssp             CCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCT
T ss_pred             hhHHHHHHHhhhhhhhhhhhhhccccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCH
Confidence            455666666666666666666666666677778899999999999999999999999887665555554

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.68  E-value=1.9e-16  Score=147.55  Aligned_cols=121  Identities=28%  Similarity=0.301  Sum_probs=102.3

Q ss_pred             hhhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCc------------------------------------
Q 012684           25 EAELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNF------------------------------------   68 (458)
Q Consensus        25 ~~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~------------------------------------   68 (458)
                      -..-+|+|+|..|.+|.||||+|+..|+.+++++|+++|++.+.                                    
T Consensus        58 ~Ll~~Gadvn~~d~~G~T~L~~A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~~~~~~~~~l~~~~~~~~~~~~  137 (291)
T d1s70b_          58 RLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCGYLDIAEYLISQGAHVGAVNS  137 (291)
T ss_dssp             HHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCT
T ss_pred             HHHHCCCCCCccCCCCCcHHHHHHhcCCceeeeeecccccccccccccccccccccccccccchhhcccccCcccccccc
Confidence            33457889999999999999999999999999999988866332                                    


Q ss_pred             ---------------------------------------------------------cCCCCCCHHHHHHHcCCHHHHHH
Q 012684           69 ---------------------------------------------------------RDIDNRTALHVAACQGFTEVVSL   91 (458)
Q Consensus        69 ---------------------------------------------------------~~~~g~t~l~~A~~~~~~~~~~~   91 (458)
                                                                               .+..|.||||+|+..|+.++++.
T Consensus       138 ~~~~~~~~a~~~~~~~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~t~L~~a~~~~~~~~~~~  217 (291)
T d1s70b_         138 EGDTPLDIAEEEAMEELLQNEVNRQGVDIEAARKEEERIMLRDARQWLNSGHINDVRHAKSGGTALHVAAAKGYTEVLKL  217 (291)
T ss_dssp             TSCCHHHHCCSHHHHHHHHHHHHHHTCCHHHHHHHHHHHHHHHHHHHHHHTCCCCCCCTTTCCCHHHHHHHHTCHHHHHH
T ss_pred             cCccccccccccccchhccccccccccccccccccccccccccchhhhcccccccccccCCCCChhhHHHHcCChhhhcc
Confidence                                                                     22445788889999999999999


Q ss_pred             HHHCCCCCCCCCCCCCChhHHHhhcchHHHHHHHHHhCCCCCCCccccccCCCC
Q 012684           92 LLERGADVDPKDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHAREV  145 (458)
Q Consensus        92 Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~~~~  145 (458)
                      |+++|+++|.++..|.||||+|+..|+.+++++|+++|+++......+.++..+
T Consensus       218 Ll~~g~din~~~~~g~TpL~~A~~~g~~~iv~lLl~~Gadv~~~d~~G~TaL~~  271 (291)
T d1s70b_         218 LIQARYDVNIKDYDGWTPLHAAAHWGKEEACRILVENLCDMEAVNKVGQTAFDV  271 (291)
T ss_dssp             HHTTTCCTTCCCTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCTTTS
T ss_pred             cccceecccccccCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCcCCCCCCHHHH
Confidence            999999999999999999999999999999999999999997765555555433

>d1n11a_ d.211.1.1 (A:) Ankyrin-R {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Ankyrin-R
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.67  E-value=9.1e-17  Score=156.83  Aligned_cols=105  Identities=29%  Similarity=0.282  Sum_probs=93.1

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      +|+|++..+..+.||||.|+..++.++++.+++.|+++|.+|.+|.||||+||++|+.+++++|+++|||+|.+|..|+|
T Consensus       286 ~g~~~~~~~~~~~t~L~~~~~~~~~~~~~~ll~~g~~in~~d~~G~T~Lh~A~~~g~~~iv~~Ll~~GAd~n~~d~~G~t  365 (408)
T d1n11a_         286 HGVMVDATTRMGYTPLHVASHYGNIKLVKFLLQHQADVNAKTKLGYSPLHQAAQQGHTDIVTLLLKNGASPNEVSSDGTT  365 (408)
T ss_dssp             HTCCTTCCCSSCCCHHHHHHHSSCSHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCSSSCC
T ss_pred             CCCccccccccccccchhhcccCcceeeeeeccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Confidence            47788888888899999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhHHHhhcchHHHHHHHH---HhCCCCC
Q 012684          109 PLGDAIYYKNHEVIKLLE---KHGAKPL  133 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~---~~g~~~~  133 (458)
                      |||+|+..|+.+++++|.   +.+.+..
T Consensus       366 ~L~~A~~~~~~~iv~~L~~~~~~~~~~~  393 (408)
T d1n11a_         366 PLAIAKRLGYISVTDVLKVVTDETSFVL  393 (408)
T ss_dssp             HHHHHHHTTCHHHHHHHHHHCCCCSSCC
T ss_pred             HHHHHHHcCCHHHHHHHHHHHhcccccc
Confidence            999999999988887553   3444443

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

Probab=99.66  E-value=4.2e-17  Score=150.66  Aligned_cols=91  Identities=22%  Similarity=0.294  Sum_probs=84.9

Q ss_pred             ccchHHHHHHHhCCHHHHHHH--------HHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChh
Q 012684           39 KPEFRLMFLANERDVEGIKEL--------LDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL  110 (458)
Q Consensus        39 ~g~t~l~~a~~~~~~~~~~~l--------l~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl  110 (458)
                      +|.||||+||..|+.++++.|        ++.|+|||.+|.+|.||||+|+..|+.+++++|+++||+++.+|..|.||+
T Consensus        32 ~g~T~Lh~A~~~g~~~~v~~Ll~~~~~~~l~~Gadvn~~d~~G~TpLh~A~~~g~~~iv~~Ll~~Gad~n~~~~~g~t~l  111 (277)
T d2fo1e1          32 HNRTVLHWIASNSSAEKSEDLIVHEAKECIAAGADVNAMDCDENTPLMLAVLARRRRLVAYLMKAGADPTIYNKSERSAL  111 (277)
T ss_dssp             SCCCHHHHHHCTTCCSCCTTHHHHHHHHHHHTCCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCSCCCCTTCCCHH
T ss_pred             CCccHHHHHHHcCCHHHHHHHHhcchhHHHHcCCCccccCCCCCeeeccccccccccccccccccccccccccccccccc
Confidence            589999999999999888776        567999999999999999999999999999999999999999999999999


Q ss_pred             HHHhhcchHHHHHHHHHhC
Q 012684          111 GDAIYYKNHEVIKLLEKHG  129 (458)
Q Consensus       111 ~~A~~~~~~~~~~~l~~~g  129 (458)
                      ++|+..++.++++.+...+
T Consensus       112 ~~a~~~~~~~~~~~l~~~~  130 (277)
T d2fo1e1         112 HQAAANRDFGMMVYMLNST  130 (277)
T ss_dssp             HHHHHTTCHHHHHHHTTSH
T ss_pred             cchhhhcchhhhhhhhhcc
Confidence            9999999999999887543

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.64  E-value=2.5e-16  Score=140.80  Aligned_cols=115  Identities=26%  Similarity=0.237  Sum_probs=91.9

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHH--------------
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLL--------------   93 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll--------------   93 (458)
                      -++.++|.+|.+|+||||+||..|+.+++++|++.|+|++.+|..|.||||+|+..++.++++.|+              
T Consensus        27 ~~~~~in~~d~~g~TpLh~A~~~~~~~iv~~L~~~g~d~~~~d~~g~t~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~  106 (221)
T d1iknd_          27 GDLAFLNFQNNLQQTPLHLAVITNQPEIAEALLGAGCDPELRDFRGNTPLHLACEQGCLASVGVLTQSCTTPHLHSILKA  106 (221)
T ss_dssp             --CCCCCCCCTTCCCHHHHHHHTTCHHHHHCCCSCCCCSCCCCTTCCCHHHHHHHHTCHHHHHHHHHSTTTTSSSCGGGC
T ss_pred             hCCCCcccCCCCCCccccccccccccccccccccccccccccccccccccccccccccccccchhhhhcccccccccccc
Confidence            357788888889999999999999999999999999999999888888887777777666665554              


Q ss_pred             -------------------------HCCCCCCCCC-CCCCChhHHHhhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684           94 -------------------------ERGADVDPKD-RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus        94 -------------------------~~ga~~~~~~-~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                                               ..|++++.++ ..|.||||+|+..|+.+++++|+++|+|+......+.+|
T Consensus       107 ~~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tp  181 (221)
T d1iknd_         107 TNYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSP  181 (221)
T ss_dssp             CCTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCG
T ss_pred             cccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCH
Confidence                                     4455665554 569999999999999999999999999987655554444

>d1ot8a_ d.211.1.1 (A:) Neurogenic locus notch receptor domain {Fruit fly (Drosophila melanogaster) [TaxId: 7227]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Neurogenic locus notch receptor domain
species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]

Probab=99.63  E-value=1.6e-16  Score=140.44  Aligned_cols=107  Identities=32%  Similarity=0.276  Sum_probs=94.2

Q ss_pred             CCCCCC-CcCccchHHHHHHHhCCHHHHHHHHHcCCCCCc----------------------------------------
Q 012684           30 GLDDDG-EEIKPEFRLMFLANERDVEGIKELLDSGIDVNF----------------------------------------   68 (458)
Q Consensus        30 ~~d~~~-~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~----------------------------------------   68 (458)
                      |+|+|. .|.+|+||||+||..|+.+++++|++.|+++|.                                        
T Consensus        12 g~din~~~d~~G~t~L~~A~~~g~~e~v~~Ll~~g~~~n~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   91 (209)
T d1ot8a_          12 GAELNATMDKTGETSLHLAARFARADAAKRLLDAGADANSQDNTGRTPLHAAVAADAMGVFQILLRNRATNLNARMHDGT   91 (209)
T ss_dssp             HHHHHHHHHHHCCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHTCTTCCTTCCCTTCC
T ss_pred             CCCcCcCcCCCCCCHHHHHHHcCCHHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccccc
Confidence            344444 367789999999999999999999999988763                                        


Q ss_pred             ---------------------------cCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcchHHH
Q 012684           69 ---------------------------RDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYKNHEV  121 (458)
Q Consensus        69 ---------------------------~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~~~~~  121 (458)
                                                 ++..|+|||++|+..+...+++.|+.++++++..|..|.||||+|+..|+.++
T Consensus        92 ~~~~~~~~~~~~~~~~~L~~~~~~~~~~~~~~~t~l~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~TpL~~A~~~g~~~~  171 (209)
T d1ot8a_          92 TPLILAARLAIEGMVEDLITADADINAADNSGKTALHWAAAVNNTEAVNILLMHHANRDAQDDKDETPLFLAAREGSYEA  171 (209)
T ss_dssp             CHHHHHHHTTCTTHHHHHHHTTCCTTCBCTTSCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTCCCHHHHHHHTTCHHH
T ss_pred             ccccccccccchhhhhhhhhhcccccccCCCCCCcchhhcccCcceeeeeeccccccccccccccccccchhccccHHHH
Confidence                                       33445899999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCCCCCCc
Q 012684          122 IKLLEKHGAKPLMAP  136 (458)
Q Consensus       122 ~~~l~~~g~~~~~~~  136 (458)
                      +++|+++|+|+....
T Consensus       172 v~~Ll~~gad~n~~d  186 (209)
T d1ot8a_         172 SKALLDNFANREITD  186 (209)
T ss_dssp             HHHHHHTTCCTTCCC
T ss_pred             HHHHHHCCCCCCCcC
Confidence            999999999986544

>d1dcqa1 d.211.1.1 (A:369-522) Pyk2-associated protein beta {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Pyk2-associated protein beta
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.63  E-value=7.5e-16  Score=129.29  Aligned_cols=100  Identities=25%  Similarity=0.301  Sum_probs=88.8

Q ss_pred             HHHHHHHhCCHHHHHHHHHcCCCCCcc------CCCCCCHHHHHHHc---CCHHHHHHHHHCCCCCCCCCCCCCChhHHH
Q 012684           43 RLMFLANERDVEGIKELLDSGIDVNFR------DIDNRTALHVAACQ---GFTEVVSLLLERGADVDPKDRWGSTPLGDA  113 (458)
Q Consensus        43 ~l~~a~~~~~~~~~~~ll~~g~~in~~------~~~g~t~l~~A~~~---~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A  113 (458)
                      .|+.|+..+++..+..++..|+|++..      +..|.||||+|+..   ++.+++++|+++|+++|.+|..|+||||+|
T Consensus         9 ~L~~Av~~~dl~~l~~~~~~g~d~~~~~~~~~~~~~g~t~Lh~A~~~~~~~~~~iv~~Ll~~gadin~~d~~g~TpLh~A   88 (154)
T d1dcqa1           9 SLCEAVKTRDIFGLLQAYADGVDLTEKIPLANGHEPDETALHLAVRSVDRTSLHIVDFLVQNSGNLDKQTGKGSTALHYC   88 (154)
T ss_dssp             HHHHHHHTTCHHHHHHHHHTTCCTTSBCCCSSCSSTTCBHHHHHHHHCCTTTHHHHHHHHHHCSCTTCCCTTCCCHHHHH
T ss_pred             HHHHHHHhCCHHHHHHHHHcCCCcCCCCCcccCCCCCCchHHHHHHhcCCCCHHHHHHHHHcCCChhhhhhhhccccccc
Confidence            456788999999999999999988765      67799999999974   688999999999999999999999999999


Q ss_pred             hhcchHHHHHHHHHhCCCCCCCccccccC
Q 012684          114 IYYKNHEVIKLLEKHGAKPLMAPMHVKHA  142 (458)
Q Consensus       114 ~~~~~~~~~~~l~~~g~~~~~~~~~~~~~  142 (458)
                      +..|+.+++++|+++|+++......+.+|
T Consensus        89 ~~~~~~~~v~~Ll~~gad~~~~d~~g~tp  117 (154)
T d1dcqa1          89 CLTDNAECLKLLLRGKASIEIANESGETP  117 (154)
T ss_dssp             HHTTCHHHHHHHHHTTCCTTCCCTTSCCH
T ss_pred             cccccccccccccccCccccccCCCCCCH
Confidence            99999999999999999987765544443

>d1awcb_ d.211.1.1 (B:) GA bindinig protein (GABP) beta 1 {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: GA bindinig protein (GABP) beta 1
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=99.63  E-value=1.1e-15  Score=128.13  Aligned_cols=97  Identities=31%  Similarity=0.410  Sum_probs=90.2

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      ........+..+.++++.++...+.+.+++++..|++++.+|.+|+||||+|+..|+.+++++|+++|++++.+|..|.|
T Consensus        56 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~T~L~~A~~~g~~~iv~~ll~~gad~~~~d~~g~T  135 (153)
T d1awcb_          56 AGVSRDARTKVDRTPLHMAASEGHANIVEVLLKHGADVNAKDMLKMTALHWATEHNHQEVVELLIKYGADVHTQSKFCKT  135 (153)
T ss_dssp             TTCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHTTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred             ccccccccccccccccccccccccceeeecccccCCccccccccCchHHHhhhhcchhheeeeccccccCCcccCCCCCC
Confidence            34445555667889999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hhHHHhhcchHHHHHHH
Q 012684          109 PLGDAIYYKNHEVIKLL  125 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l  125 (458)
                      |||+|+..|+.+++++|
T Consensus       136 pl~~A~~~g~~eiv~lL  152 (153)
T d1awcb_         136 AFDISIDNGNEDLAEIL  152 (153)
T ss_dssp             HHHHHHHTTCHHHHHHH
T ss_pred             HHHHHHHcCCHHHHHhC
Confidence            99999999999999987

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.62  E-value=1.4e-15  Score=127.86  Aligned_cols=101  Identities=28%  Similarity=0.308  Sum_probs=81.6

Q ss_pred             cCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGST  108 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~t  108 (458)
                      +|+|++.+|.+|.||||+|+ .|+.+++++|++.|++++.++..|.++|+.++..++..+++.|+..+.+++..+..|.+
T Consensus        23 ~g~d~n~~d~~g~TpL~~A~-~~~~ei~~~Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~  101 (156)
T d1ihba_          23 NNVNVNAQNGFGRTALQVMK-LGNPEIARRLLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNL  101 (156)
T ss_dssp             SCCCTTCCCTTSCCHHHHCC-SSCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCC
T ss_pred             CCCCcCccCCcccccccccc-cccccccccccccccccccccccCccccccccccccccccccccccccccccccccccc
Confidence            67777777888888888775 67888888888888888888888888888888888888888888888888888888888


Q ss_pred             hhHHHhhcchHHHHHHHHHhCC
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGA  130 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~  130 (458)
                      |+++|+..++.+++++|+++|+
T Consensus       102 ~l~~a~~~~~~~~~~~Ll~~~~  123 (156)
T d1ihba_         102 PLHLAAKEGHLRVVEFLVKHTA  123 (156)
T ss_dssp             HHHHHHHTTCHHHHHHHHHHSC
T ss_pred             cccccccccccccccccccccc
Confidence            8888888888888888877776

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.62  E-value=1.3e-15  Score=140.97  Aligned_cols=107  Identities=27%  Similarity=0.233  Sum_probs=91.4

Q ss_pred             cCCCCCCCcCccchHHHHHHHhC----CHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHC-CCCCCCCC
Q 012684           29 NGLDDDGEEIKPEFRLMFLANER----DVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLER-GADVDPKD  103 (458)
Q Consensus        29 n~~d~~~~~~~g~t~l~~a~~~~----~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~-ga~~~~~~  103 (458)
                      .++|++..+..|.++++.+...+    ..+++++|++.|+++|.++..|.||||+|+..|+.+++++|++. |+++|.+|
T Consensus       171 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~i~~~Li~~ga~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d  250 (285)
T d1wdya_         171 MGADVNACDNMGRNALIHALLSSDDSDVEAITHLLLDHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTD  250 (285)
T ss_dssp             SCCCTTCCCTTSCCHHHHHHHCSCTTTHHHHHHHHHHTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCC
T ss_pred             cCCCcccccCCCCcccccccccccchHHHHHHHHHHHCCCCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCC
Confidence            35666666666666666544333    24678888888999999999999999999999999999999985 99999999


Q ss_pred             CCCCChhHHHhhcchHHHHHHHHHhCCCCCCC
Q 012684          104 RWGSTPLGDAIYYKNHEVIKLLEKHGAKPLMA  135 (458)
Q Consensus       104 ~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~~~  135 (458)
                      ..|.||||+|+..|+.+++++|+++||++...
T Consensus       251 ~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~  282 (285)
T d1wdya_         251 SDGKTALLLAVELKLKKIAELLCKRGASTDCG  282 (285)
T ss_dssp             TTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCS
T ss_pred             CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcc
Confidence            99999999999999999999999999998754

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

Probab=99.62  E-value=2e-17  Score=158.56  Aligned_cols=99  Identities=19%  Similarity=0.071  Sum_probs=86.8

Q ss_pred             CCCcCccchHHHHHHHhCCHHHHHH---HHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCC--CCCCC
Q 012684           34 DGEEIKPEFRLMFLANERDVEGIKE---LLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKD--RWGST  108 (458)
Q Consensus        34 ~~~~~~g~t~l~~a~~~~~~~~~~~---ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~--~~g~t  108 (458)
                      +.++..|.||||+||.+|+.+++++   |++.|+++|.+|.+|+||||+||.+|+.++|++|+++|++++..+  ..|+|
T Consensus        84 ~~~~~~~~t~L~~Aa~~g~~~~~~~~~~L~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t  163 (346)
T d2ajaa1          84 HKKGIKSEVICFVAAITGCSSALDTLCLLLTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYH  163 (346)
T ss_dssp             HHHTCCHHHHHHHHHHHCCHHHHHHHTTC--CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHH
T ss_pred             HhccCCCCcHHHHHHHhCCHHHHHHHHHHHhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCC
Confidence            3566789999999999999877765   789999999999999999999999999999999999999999876  46999


Q ss_pred             hhHHHhhcchHHHHHHHHHhCCCC
Q 012684          109 PLGDAIYYKNHEVIKLLEKHGAKP  132 (458)
Q Consensus       109 pl~~A~~~~~~~~~~~l~~~g~~~  132 (458)
                      |||+|+..|+.+++++|++.|++.
T Consensus       164 ~L~~Aa~~g~~~iv~~Ll~~~~~~  187 (346)
T d2ajaa1         164 AFRLAAENGHLHVLNRLCELAPTE  187 (346)
T ss_dssp             HHHHHHHTTCHHHHHHHHHSCGGG
T ss_pred             hhHHHHHHhhHHHHHHHHHcCCcc
Confidence            999999999999999999998764

>d2ajaa1 a.118.24.1 (A:3-348) Hypothetical protein LPG2416 {Legionella pneumophila [TaxId: 446]}

class: All alpha proteins
fold: alpha-alpha superhelix
superfamily: Pseudo ankyrin repeat-like
family: Pseudo ankyrin repeat
domain: Hypothetical protein LPG2416
species: Legionella pneumophila [TaxId: 446]

Probab=99.60  E-value=1.2e-17  Score=160.27  Aligned_cols=107  Identities=14%  Similarity=-0.014  Sum_probs=92.6

Q ss_pred             hhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccC--CCCCCHHHHHHHcCCHHHHHHHHHCCCCCC---C
Q 012684           27 ELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD--IDNRTALHVAACQGFTEVVSLLLERGADVD---P  101 (458)
Q Consensus        27 ~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~--~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~---~  101 (458)
                      .-.|+++|..+.+|+||||+||.+|+.++|++|++.|++++..+  .+|.||||+||.+|+.+++++|++.|++.+   .
T Consensus       113 ~~~~~~in~~~~~g~taL~~Aa~~G~~~~v~~Ll~~g~~~~~~~~~~~g~t~L~~Aa~~g~~~iv~~Ll~~~~~~~~~~~  192 (346)
T d2ajaa1         113 LTSDEIVKVIQAENYQAFRLAAENGHLHVLNRLCELAPTEIMAMIQAENYHAFRLAAENGHLHVLNRLCELAPTEATAMI  192 (346)
T ss_dssp             --CCSSCC--CHHHHHHHHHHHHTTCHHHHHHHHHSCTTTHHHHHSHHHHHHHHHHHHTTCHHHHHHHHHSCGGGHHHHH
T ss_pred             HhCCCcccccCCCCCCHHHHHHHCCCHHHHHHHHHcCCCccccccccCCCChhHHHHHHhhHHHHHHHHHcCCccccccc
Confidence            34688899999999999999999999999999999999999876  459999999999999999999999998754   3


Q ss_pred             CCCCCCChhHHHhhcchHHHHHHHHHhCCCCC
Q 012684          102 KDRWGSTPLGDAIYYKNHEVIKLLEKHGAKPL  133 (458)
Q Consensus       102 ~~~~g~tpl~~A~~~~~~~~~~~l~~~g~~~~  133 (458)
                      .+..|.||++.|+..|+.+++++|++.|+++.
T Consensus       193 ~~~~~~t~l~~A~~~g~~~iv~~Ll~~ga~~~  224 (346)
T d2ajaa1         193 QAENYYAFRWAAVGRGHHNVINFLLDCPVMLA  224 (346)
T ss_dssp             HHHHHHHHHHHHSTTCCHHHHHHHTTSHHHHH
T ss_pred             ccCCCcchhhHHhhcCHHHHHHHHHhCCCCcc
Confidence            44567788899999999999999999998753

>d1ihba_ d.211.1.1 (A:) p18ink4C(ink6) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: p18ink4C(ink6)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=3.8e-15  Score=125.10  Aligned_cols=104  Identities=27%  Similarity=0.348  Sum_probs=98.3

Q ss_pred             hhhcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCC-CCCCCCC
Q 012684           26 AELNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGA-DVDPKDR  104 (458)
Q Consensus        26 ~~~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga-~~~~~~~  104 (458)
                      .-..++|++..+..|.|+|+.++..++.+.++.|++.+.+++..+..|.+|||+|+..++.+++++|+++|+ +++.+|.
T Consensus        52 Ll~~~a~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~~a~~~~~~~~~~~Ll~~~~~~~~~~d~  131 (156)
T d1ihba_          52 LLLRGANPDLKDRTGFAVIHDAARAGFLDTLQTLLEFQADVNIEDNEGNLPLHLAAKEGHLRVVEFLVKHTASNVGHRNH  131 (156)
T ss_dssp             HHHTTCCTTCCCTTSCCHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSCCCTTCCCT
T ss_pred             ccccccccccccccCcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccCC
Confidence            345678889999999999999999999999999999999999999999999999999999999999999876 8999999


Q ss_pred             CCCChhHHHhhcchHHHHHHHHHhC
Q 012684          105 WGSTPLGDAIYYKNHEVIKLLEKHG  129 (458)
Q Consensus       105 ~g~tpl~~A~~~~~~~~~~~l~~~g  129 (458)
                      .|+||||+|+..++.+++++|+++|
T Consensus       132 ~g~TpL~~A~~~~~~~iv~~Ll~~G  156 (156)
T d1ihba_         132 KGDTACDLARLYGRNEVVSLMQANG  156 (156)
T ss_dssp             TSCCHHHHHHHTTCHHHHHHHHHTC
T ss_pred             CCCCHHHHHHHcCCHHHHHHHHhcC
Confidence            9999999999999999999999987

>d2fo1e1 d.211.1.1 (E:1021-1297) Lin-12 {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Lin-12
species: Caenorhabditis elegans [TaxId: 6239]

Probab=99.59  E-value=2.1e-15  Score=139.02  Aligned_cols=97  Identities=26%  Similarity=0.367  Sum_probs=89.9

Q ss_pred             CCCCCcCccchHHHHHHHhCCHHHHHHHH-HcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChh
Q 012684           32 DDDGEEIKPEFRLMFLANERDVEGIKELL-DSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPL  110 (458)
Q Consensus        32 d~~~~~~~g~t~l~~a~~~~~~~~~~~ll-~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl  110 (458)
                      +.+..+..|.||||+++..++.+++++++ ..|.+++.+|..|.||||+||..|+.+++++|+++|||++.+|..|.|||
T Consensus       179 ~~~~~~~~g~t~L~~~~~~~~~~~~~~~l~~~~~~~~~~d~~g~tpL~~A~~~g~~~iv~~Ll~~gadin~~d~~G~T~L  258 (277)
T d2fo1e1         179 RKDSEKYKGRTALHYAAQVSNMPIVKYLVGEKGSNKDKQDEDGKTPIMLAAQEGRIEVVMYLIQQGASVEAVDATDHTAR  258 (277)
T ss_dssp             GTSSSSCCCCCTHHHHHSSCCHHHHHHHHHHSCCCTTCCCTTCCCHHHHHHHHTCHHHHHHHHHTTCCSSCCCSSSCCHH
T ss_pred             cccccccCCCCccccccccccccccccccccccccccccCCCCCCHHHHHHHcCCHHHHHHHHHCcCCCCCcCCCCCCHH
Confidence            34566778999999999999999999866 57899999999999999999999999999999999999999999999999


Q ss_pred             HHHhhcchHHHHHHHHHh
Q 012684          111 GDAIYYKNHEVIKLLEKH  128 (458)
Q Consensus       111 ~~A~~~~~~~~~~~l~~~  128 (458)
                      |+|+..|+.+++++|++.
T Consensus       259 ~~A~~~~~~~iv~lL~~c  276 (277)
T d2fo1e1         259 QLAQANNHHNIVDIFDRC  276 (277)
T ss_dssp             HHHHHTTCHHHHHHHHTT
T ss_pred             HHHHHcCCHHHHHHHHHh
Confidence            999999999999999863

>d1iknd_ d.211.1.1 (D:) I-kappa-B-alpha {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: I-kappa-B-alpha
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.59  E-value=1.9e-15  Score=135.01  Aligned_cols=96  Identities=25%  Similarity=0.243  Sum_probs=87.2

Q ss_pred             cCccchHHHHHHHhCCHHHHHHHHHcCCCCCccC-CCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhh
Q 012684           37 EIKPEFRLMFLANERDVEGIKELLDSGIDVNFRD-IDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIY  115 (458)
Q Consensus        37 ~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~-~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~  115 (458)
                      ...|.||||+|+..++.+.+++|+..|++++.++ .+|.||||+|+..|+.+++++|+++|+|++.+|..|+||||+|+.
T Consensus       108 ~~~~~t~l~~a~~~~~~~~~~~l~~~~~~~~~~~~~~G~T~L~~A~~~g~~~~v~~Ll~~gad~~~~~~~G~tpl~~A~~  187 (221)
T d1iknd_         108 NYNGHTCLHLASIHGYLGIVELLVSLGADVNAQEPCNGRTALHLAVDLQNPDLVSLLLKCGADVNRVTYQGYSPYQLTWG  187 (221)
T ss_dssp             CTTCCCHHHHHHHTTCHHHHHHHHHHTCCTTCCCTTTCCCHHHHHHHTTCHHHHHHHHTTTCCSCCCCTTCCCGGGGCTT
T ss_pred             ccccchhhhHHhhcCChhheeeecccCcccccccccCCCCccccccccccHHHHHHHHhcCCcccccCCCCCCHHHHHHH
Confidence            3457788888888888888888888898888765 679999999999999999999999999999999999999999999


Q ss_pred             cchHHHHHHHHHhCCCC
Q 012684          116 YKNHEVIKLLEKHGAKP  132 (458)
Q Consensus       116 ~~~~~~~~~l~~~g~~~  132 (458)
                      .++.+++++|.+.+.+.
T Consensus       188 ~~~~~~~~~l~~~~~~~  204 (221)
T d1iknd_         188 RPSTRIQQQLGQLTLEN  204 (221)
T ss_dssp             SSCHHHHHHHHTTSCGG
T ss_pred             CCCHHHHHHHHHcCCcc
Confidence            99999999999998763

>d1s70b_ d.211.1.1 (B:) Myosin phosphatase targeting subunit 1, MYPT1 {Chicken (Gallus gallus) [TaxId: 9031]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Myosin phosphatase targeting subunit 1, MYPT1
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=99.59  E-value=2.9e-15  Score=139.33  Aligned_cols=97  Identities=27%  Similarity=0.396  Sum_probs=92.7

Q ss_pred             CccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHhhcc
Q 012684           38 IKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAIYYK  117 (458)
Q Consensus        38 ~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~~~~  117 (458)
                      .++.||||.||..|++++|++|++.|+|+|.+|.+|.||||+|+..|+.+++++|+++|++....+..+.+||++|+..+
T Consensus        38 ~~~~t~l~~A~~~G~~~~v~~Ll~~Gadvn~~d~~G~T~L~~A~~~g~~eiv~~Ll~~~~~~~~~~~~~~~~L~~a~~~~  117 (291)
T d1s70b_          38 FDDGAVFLAACSSGDTEEVLRLLERGADINYANVDGLTALHQACIDDNVDMVKFLVENGANINQPDNEGWIPLHAAASCG  117 (291)
T ss_dssp             ECHHHHHHHHHHHTCHHHHHHHHHHCCCTTCBCTTCCBHHHHHHHTTCHHHHHHHHHTTCCTTCCCTTSCCHHHHHHHHT
T ss_pred             CCCchHHHHHHHcCCHHHHHHHHHCCCCCCccCCCCCcHHHHHHhcCCceeeeeeccccccccccccccccccccccccc
Confidence            45789999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             hHHHHHHHHHhCCCCCC
Q 012684          118 NHEVIKLLEKHGAKPLM  134 (458)
Q Consensus       118 ~~~~~~~l~~~g~~~~~  134 (458)
                      +.++++.|+++|+....
T Consensus       118 ~~~~~~~l~~~~~~~~~  134 (291)
T d1s70b_         118 YLDIAEYLISQGAHVGA  134 (291)
T ss_dssp             CHHHHHHHHHTTCCTTC
T ss_pred             ccchhhcccccCccccc
Confidence            99999999999987644

>d1ixva_ d.211.1.1 (A:) 26S proteasome non-ATPase regulatory subunit 10, gankyrin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: 26S proteasome non-ATPase regulatory subunit 10, gankyrin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.53  E-value=3.6e-14  Score=126.84  Aligned_cols=111  Identities=25%  Similarity=0.223  Sum_probs=99.6

Q ss_pred             CCCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCC-CCCCCCCCCCCChh
Q 012684           32 DDDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERG-ADVDPKDRWGSTPL  110 (458)
Q Consensus        32 d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~g-a~~~~~~~~g~tpl  110 (458)
                      +....+..+.|+++.++..++.++++.|++.|.+++.+|.+|+||||+|+..|+.+++++|++.| .+++.+|..|+|||
T Consensus        97 ~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~~~g~t~l~~a~~~~~~~~~~~Ll~~~~~~in~~d~~g~TpL  176 (229)
T d1ixva_          97 DLNKITNQGVTCLHLAVGKKWFEVSQFLIENGASVRIKDKFNQIPLHRAASVGSLKLIELLCGLGKSAVNWQDKQGWTPL  176 (229)
T ss_dssp             CTTCCCTTSCCHHHHHHHTTCHHHHHHHHHTTCCSCCCCTTSCCHHHHHHHHTCHHHHHHHHTTTCCCSCCCCTTSCCHH
T ss_pred             cccccccccccccccccccchhhhhhhhhhhcccccccCCCCCCccchhhhcccccccccccccccccccccccccCCch
Confidence            45556667899999999999999999999999999999999999999999999999999999986 78999999999999


Q ss_pred             HHHhhcchHHHHHHHHH-hCCCCCCCccccccC
Q 012684          111 GDAIYYKNHEVIKLLEK-HGAKPLMAPMHVKHA  142 (458)
Q Consensus       111 ~~A~~~~~~~~~~~l~~-~g~~~~~~~~~~~~~  142 (458)
                      |+|+..|+.+++++|++ .|+++....-.+.++
T Consensus       177 h~A~~~~~~~~v~~Ll~~~gad~~~~d~~g~t~  209 (229)
T d1ixva_         177 FHALAEGHGDAAVLLVEKYGAEYDLVDNKGAKA  209 (229)
T ss_dssp             HHHHHTTCHHHHHHHHHHHCCCSCCCCTTSCCT
T ss_pred             hhhcccccHHHHHHHHHhcCCCCCCcCCCCCCH
Confidence            99999999999999996 599987655444444

>d1k1aa_ d.211.1.1 (A:) bcl-3 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: bcl-3
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.53  E-value=1.1e-14  Score=128.76  Aligned_cols=91  Identities=24%  Similarity=0.304  Sum_probs=85.7

Q ss_pred             CCCCcCccchHHHHHHHhCCHHHHHHHHHcCCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHH
Q 012684           33 DDGEEIKPEFRLMFLANERDVEGIKELLDSGIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGD  112 (458)
Q Consensus        33 ~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~  112 (458)
                      .......|.++||+|+..+...+++.+++.|.+++.+|..|.||||+|+..|+.+++++|+++|||++.+|..|.||||+
T Consensus       137 ~~~~~~~~~~~l~~a~~~~~~~~~~~~~~~~~~~~~~d~~g~t~L~~A~~~g~~~~v~~Ll~~Gad~n~~d~~G~TpL~~  216 (228)
T d1k1aa_         137 DAVDIKSGRSPLIHAVENNSLSMVQLLLQHGANVNAQMYSGSSALHSASGRGLLPLVRTLVRSGADSSLKNCHNDTPLMV  216 (228)
T ss_dssp             TCCCTTTCCCHHHHHHHTTCHHHHHHHHHTTCCTTCBCTTSCBHHHHHHHHTCHHHHHHHHHTTCCTTCCCTTSCCTTTT
T ss_pred             ccccccchhhHHHHHHHhhhhhhhhhhhhhccccccccccCcchHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHH
Confidence            33445578999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             HhhcchHHHHH
Q 012684          113 AIYYKNHEVIK  123 (458)
Q Consensus       113 A~~~~~~~~~~  123 (458)
                      |+..|+.+++|
T Consensus       217 A~~~~~~divk  227 (228)
T d1k1aa_         217 ARSRRVIDILR  227 (228)
T ss_dssp             CSSHHHHHHHT
T ss_pred             HHhCCCccccC
Confidence            99999999875

>d1wdya_ d.211.1.1 (A:) RNase L, 2-5a-dependent ribonuclease {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: RNase L, 2-5a-dependent ribonuclease
species: Human (Homo sapiens) [TaxId: 9606]

Probab=99.45  E-value=6.2e-14  Score=129.42  Aligned_cols=77  Identities=26%  Similarity=0.347  Sum_probs=72.4

Q ss_pred             hcCCCCCCCcCccchHHHHHHHhCCHHHHHHHHHc-CCCCCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCC
Q 012684           28 LNGLDDDGEEIKPEFRLMFLANERDVEGIKELLDS-GIDVNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDR  104 (458)
Q Consensus        28 ~n~~d~~~~~~~g~t~l~~a~~~~~~~~~~~ll~~-g~~in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~  104 (458)
                      -.|+|++.++..|.||||+||..|+.+++++|++. |+++|.+|.+|.||||+|+..|+.+++++|+++|||+|.+|.
T Consensus       207 ~~ga~~n~~~~~g~t~L~~a~~~~~~~~v~~lL~~~g~din~~d~~G~TpL~~A~~~~~~eiv~~Ll~~GAd~n~~d~  284 (285)
T d1wdya_         207 DHGADVNVRGERGKTPLILAVEKKHLGLVQRLLEQEHIEINDTDSDGKTALLLAVELKLKKIAELLCKRGASTDCGDL  284 (285)
T ss_dssp             HTTCCSSCCCTTSCCHHHHHHHTTCHHHHHHHHHSSSCCTTCCCTTSCCHHHHHHHTTCHHHHHHHHHHSSCSCCSSC
T ss_pred             HCCCCCCccCCCCCCccchhhhcCcHHHHHHHHHcCCCCCcCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCcccC
Confidence            36788888899999999999999999999999984 999999999999999999999999999999999999999873

>d1sw6a_ d.211.1.1 (A:) Swi6 ankyrin-repeat fragment {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: beta-hairpin-alpha-hairpin repeat
superfamily: Ankyrin repeat
family: Ankyrin repeat
domain: Swi6 ankyrin-repeat fragment
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=99.42  E-value=1.3e-13  Score=129.08  Aligned_cols=49  Identities=31%  Similarity=0.376  Sum_probs=47.8

Q ss_pred             CCccCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCChhHHHh
Q 012684           66 VNFRDIDNRTALHVAACQGFTEVVSLLLERGADVDPKDRWGSTPLGDAI  114 (458)
Q Consensus        66 in~~~~~g~t~l~~A~~~~~~~~~~~Ll~~ga~~~~~~~~g~tpl~~A~  114 (458)
                      +|.+|.+|+||||+||+.|+.+++++|+++|||++.+|..|.|||++|+
T Consensus       252 in~~D~~G~TpLh~A~~~g~~~iv~~Ll~~GAd~~~~n~~G~Tpl~~A~  300 (301)
T d1sw6a_         252 LNAQDSNGDTCLNIAARLGNISIVDALLDYGADPFIANKSGLRPVDFGA  300 (301)
T ss_dssp             TTCCCTTSCCHHHHHHHHCCHHHHHHHHHTTCCTTCCCTTSCCGGGGTC
T ss_pred             ccCCCCCCCCHHHHHHHcCCHHHHHHHHHCCCCCCCCCCCCCCHHHHcC
Confidence            7889999999999999999999999999999999999999999999996

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.17  E-value=2.5e-06  Score=76.49  Aligned_cols=126  Identities=13%  Similarity=0.020  Sum_probs=86.4

Q ss_pred             EEEEEEcCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEccCCCCHHHHHHhcCC
Q 012684          168 FILAFWRGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDLRAFLKRKGA  246 (458)
Q Consensus       168 ~~~v~~~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~  246 (458)
                      +..+..++..++||+........   ...+.+|...++.+. +--+++++.+...++..++||++++|.++.+....   
T Consensus        30 v~rv~~~~~~~vlk~~~~~~~~~---~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~~~~---  103 (263)
T d1j7la_          30 VYKLVGENENLYLKMTDSRYKGT---TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYED---  103 (263)
T ss_dssp             EEEEECSSCEEEEEEECGGGTTS---TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHTTT---
T ss_pred             EEEEEeCCCeEEEEEcCCCcccc---hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEecccccccccccc---
Confidence            34555678889999886442222   224567888877773 44578899988888889999999999888654321   


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCC-------------------------------------------------------
Q 012684          247 LKPSTAVRFALDIARGMNYLHENKP-------------------------------------------------------  271 (458)
Q Consensus       247 ~~~~~~~~i~~qi~~~l~~LH~~~~-------------------------------------------------------  271 (458)
                        ......++.++.+.+..||+...                                                       
T Consensus       104 --~~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~  181 (263)
T d1j7la_         104 --EQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEE  181 (263)
T ss_dssp             --CSCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCC
T ss_pred             --cccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcC
Confidence              12223345555555666664321                                                       


Q ss_pred             -CCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          272 -VPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       272 -~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                       ..++|+|+.|.||++++++.+-|+||+.+.
T Consensus       182 ~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~  212 (263)
T d1j7la_         182 ELVFSHGDLGDSNIFVKDGKVSGFIDLGRSG  212 (263)
T ss_dssp             CEEEECSCCCTTSEEEETTEEEEECCCTTCE
T ss_pred             CcEEEEeeccCcceeecCCceEEEeechhcc
Confidence             127899999999999987666799999765

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=97.70  E-value=4e-05  Score=67.91  Aligned_cols=59  Identities=20%  Similarity=0.148  Sum_probs=42.0

Q ss_pred             cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC--CCcceeeeeEEEeCCceEEEEEccCCCCHH
Q 012684          174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIR--HPNVVQFLGAVTQSSPMMIVTEYLPKGDLR  238 (458)
Q Consensus       174 ~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~  238 (458)
                      .+..+++|.......      ..+..|...++.+.  .-.+++++.+..+++..++||++++|.++.
T Consensus        34 ~~~~~vlK~~~~~~~------~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~   94 (255)
T d1nd4a_          34 GRPVLFVKTDLSGAL------NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL   94 (255)
T ss_dssp             TSCCEEEEEECSCTT------SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT
T ss_pred             CCCEEEEEeCCccCH------hHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeeccccc
Confidence            455688898764422      23566777777663  234778898888888899999999887653

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=97.27  E-value=0.00032  Score=66.27  Aligned_cols=29  Identities=28%  Similarity=0.375  Sum_probs=25.2

Q ss_pred             CeeeCCCCCCCEEecCCCCEEEeecCCccc
Q 012684          273 PIIHRDLEPSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       273 ~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      .++|+|+.|.|||+++++ ++++||..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            499999999999999764 89999988764

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=95.89  E-value=0.0029  Score=59.50  Aligned_cols=53  Identities=13%  Similarity=0.182  Sum_probs=34.1

Q ss_pred             eEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCC-CCcceeeeeEEEeCCceEEEEEccCCCCH
Q 012684          176 IQVAVKKLGEEVISDDDRVRAFRDELALLQKIR-HPNVVQFLGAVTQSSPMMIVTEYLPKGDL  237 (458)
Q Consensus       176 ~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~~~L  237 (458)
                      ..|.+++....  ...   -...+|..+++.+. +.-.+++++++.+    .+|+||++|.+|
T Consensus        75 ~~vllRi~g~~--~~~---idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l  128 (395)
T d1nw1a_          75 NKVLLRVYFNP--ETE---SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL  128 (395)
T ss_dssp             SEEEEEEECSC--CCH---HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred             CcEEEEecCCc--chh---hHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence            46777776522  121   23457888888884 4445688887753    589999987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=95.74  E-value=0.011  Score=53.76  Aligned_cols=123  Identities=13%  Similarity=0.108  Sum_probs=66.8

Q ss_pred             cCeEEEEEEcCCCCCCCHHHHHHHHHHHHHHhcCCCCcc--eeeee-----EEEeCCceEEEEEccCCCCH-----HHHH
Q 012684          174 RGIQVAVKKLGEEVISDDDRVRAFRDELALLQKIRHPNV--VQFLG-----AVTQSSPMMIVTEYLPKGDL-----RAFL  241 (458)
Q Consensus       174 ~g~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i--~~~~~-----~~~~~~~~~lv~e~~~~~~L-----~~~l  241 (458)
                      +|..|++|+.+.... +   .+.+..|...+..+...++  +..+.     .+..++..+.+++++.|..+     ..+.
T Consensus        45 dg~~~VlK~~rp~~~-s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~~~~~~~~  120 (325)
T d1zyla1          45 DRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEADNIDQME  120 (325)
T ss_dssp             TCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCSSCHHHHH
T ss_pred             CCCEEEEEEeCCCCC-C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecCCcCCCCCCHHHHH
Confidence            678899999875422 2   3456778887777732222  22211     22345667889999866432     1111


Q ss_pred             H---------h---c------CCC-------------------CHHH---HHHHHHHHHHHHHHH-HhCCCCCeeeCCCC
Q 012684          242 K---------R---K------GAL-------------------KPST---AVRFALDIARGMNYL-HENKPVPIIHRDLE  280 (458)
Q Consensus       242 ~---------~---~------~~~-------------------~~~~---~~~i~~qi~~~l~~L-H~~~~~~i~H~Dik  280 (458)
                      .         .   .      ...                   +...   ....+.++...+.-. .+..+..++|+|+.
T Consensus       121 ~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~liHgDlh  200 (325)
T d1zyla1         121 AVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVLRLHGDCH  200 (325)
T ss_dssp             HHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCEECCSSCS
T ss_pred             HHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhccccCCceeecCCCC
Confidence            0         0   0      011                   1111   112223333333222 12224458999999


Q ss_pred             CCCEEecCCCCEEEeecCCccc
Q 012684          281 PSNILRDDSGNLKVADFGVSKL  302 (458)
Q Consensus       281 p~Nil~~~~~~vkl~Dfg~~~~  302 (458)
                      +.|||++++  ..++||+-+..
T Consensus       201 ~~NvL~~~~--~~~IDFdd~~~  220 (325)
T d1zyla1         201 AGNILWRDG--PMFVDLDDARN  220 (325)
T ss_dssp             GGGEEESSS--EEECCCTTCCE
T ss_pred             cccEEEeCC--ceEEechhccc
Confidence            999999743  56899997753

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=90.64  E-value=0.03  Score=50.27  Aligned_cols=30  Identities=23%  Similarity=0.207  Sum_probs=26.6

Q ss_pred             CCeeeCCCCCCCEEecCCCCEEEeecCCcc
Q 012684          272 VPIIHRDLEPSNILRDDSGNLKVADFGVSK  301 (458)
Q Consensus       272 ~~i~H~Dikp~Nil~~~~~~vkl~Dfg~~~  301 (458)
                      .+++|+|+.+.||+++++...-++||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            459999999999999988777899999875